{"meta":{"query_hash":"adb06e8f08bc","filters":{"topic":"Antiplatelet Therapy and Cardiovascular Diseases"},"cohort_total":1498,"direct_labels_cover":9,"predictions_cover":1498,"exported":1498,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/adb06e8f08bc","api":"https://metacan.xera.ac/api/v1/cohort?topic=Antiplatelet+Therapy+and+Cardiovascular+Diseases"},"results":[{"id":"W103182114","doi":"10.1161/circ.116.suppl_16.ii_683-a","title":"Abstract 3049: Clinical Outcomes after Urgent Coronary Artery Bypass Surgery in Patients on Clopidogrel: Are the Risks Tangible or Anecdotal?","year":2007,"lang":"en","type":"article","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Clopidogrel; Stroke (engine); Cardiology; Clinical endpoint; Cardiopulmonary bypass; Internal medicine; Anesthesia; Surgery; Myocardial infarction; Randomized controlled trial","score_opus":0.06386221894693322,"score_gpt":0.3334102237752275,"score_spread":0.2695480048282943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W103182114","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981426,0.00043186592,0.000061257386,0.00017766471,0.00055532606,0.00042565216,0.000011050383,0.00005186037,0.000142728],"genre_scores_gemma":[0.99810266,0.00010604914,0.0000075884786,0.0013665657,0.00022747512,0.000021748656,0.000107391854,0.000029085822,0.000031453877],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99825925,0.00010276739,0.00059723516,0.0003000034,0.00045996066,0.00028078348],"domain_scores_gemma":[0.99869597,0.00049477105,0.00015915869,0.00042121776,0.00007257478,0.00015629233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009891124,0.00017709965,0.0004151526,0.00012637828,0.000067017056,0.000017050694,0.000056329118,0.00016455386,0.00021863273],"category_scores_gemma":[0.00025381366,0.000112802256,0.00055938633,0.00018674834,0.00006718959,0.000098793884,0.000015169051,0.0002338601,0.00009016321],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019206717,0.0005067036,0.95236766,0.000027190814,0.00024543997,0.00037039444,0.000035993275,0.000059961363,0.0000021814838,0.000003400493,0.00021332657,0.04424706],"study_design_scores_gemma":[0.0017920942,0.000047269346,0.9965066,0.00012307487,0.0001084511,0.00001594158,0.00007534285,0.00001726082,0.000009508812,0.000016828646,0.0011419336,0.00014571399],"about_ca_topic_score_codex":0.0000145724825,"about_ca_topic_score_gemma":0.000024289055,"teacher_disagreement_score":0.044138905,"about_ca_system_score_codex":0.00008512274,"about_ca_system_score_gemma":0.00007047343,"threshold_uncertainty_score":0.45999426},"labels":[],"label_agreement":null},{"id":"W104746134","doi":"10.1111/j.1538-79333.2004.0615f.x","title":"Aspirin","year":2004,"lang":"en","type":"article","venue":"Journal of Thrombosis and Haemostasis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Antithrombotic; Aspirin; Platelet; Medicine; Whole blood; Blood flow; Blood viscosity; Internal medicine; Cardiology; Pharmacology","score_opus":0.04384217936008118,"score_gpt":0.3168566644423162,"score_spread":0.273014485082235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W104746134","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898861,0.006313801,0.0005354298,0.0025372137,0.000091476155,0.000061299754,0.0000028786894,0.000007804545,0.0005639743],"genre_scores_gemma":[0.9900868,0.007424041,0.0015483537,0.00074596715,0.0001668295,5.095186e-7,0.0000011410614,0.000010437294,0.000015921209],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9993435,0.000016000138,0.00022441646,0.000073997886,0.00023670043,0.00010539008],"domain_scores_gemma":[0.99951774,0.000011500628,0.00010515774,0.000108240056,0.000103583894,0.00015380027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019618649,0.00008224067,0.00034981268,0.00007529395,0.000055510547,0.00002008838,0.000042833995,0.00004547605,0.00008563929],"category_scores_gemma":[0.000019663072,0.000058474325,0.00033586434,0.000085664586,0.00005990967,0.00010157357,0.000013994463,0.000112319,0.0000067593264],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028621706,0.0025681143,0.10266153,0.00070182286,0.014725773,0.0015348145,0.0023441436,0.0002840478,0.020600902,0.0047804345,0.010518777,0.8364175],"study_design_scores_gemma":[0.030655963,0.0038216466,0.7448963,0.0017636628,0.0048251892,0.006557321,0.0019631789,0.0000067668543,0.06499873,0.005517649,0.13438983,0.0006037586],"about_ca_topic_score_codex":0.0000065945374,"about_ca_topic_score_gemma":7.1009475e-7,"teacher_disagreement_score":0.8358137,"about_ca_system_score_codex":0.000029121276,"about_ca_system_score_gemma":0.00007583048,"threshold_uncertainty_score":0.23845138},"labels":[],"label_agreement":null},{"id":"W109798193","doi":"10.1155/2013/596015","title":"Low-Dose Acetylsalicylic Acid Use and the Risk of Upper Gastrointestinal Bleeding: A Meta-Analysis of Randomized Clinical Trials and Observational Studies","year":2013,"lang":"en","type":"review","venue":"Canadian Journal of Gastroenterology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"AstraZeneca","keywords":"Medicine; Observational study; Internal medicine; Randomized controlled trial; Meta-analysis; Upper gastrointestinal bleeding; Placebo; Cohort study; Relative risk; Hazard ratio; Confidence interval; Pathology; Endoscopy","score_opus":0.3319103590896341,"score_gpt":0.4216448075122349,"score_spread":0.08973444842260075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W109798193","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05754136,0.94026303,0.00029136974,0.0004910303,0.00011144268,0.0010396779,0.0002580788,0.0000018812618,0.0000021226451],"genre_scores_gemma":[0.014401012,0.9841065,0.0008628906,0.0003138506,0.0001860474,0.00004569755,0.000029886542,0.000026367597,0.00002778611],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9847299,0.010303804,0.0040218616,0.00028951673,0.00032425445,0.00033068287],"domain_scores_gemma":[0.9854972,0.007474508,0.005010521,0.00038416465,0.0010197241,0.00061393215],"candidate_categories":["metaresearch","metaepi_broad"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.019782605,0.00042394202,0.020879354,0.0008872871,0.00007359982,0.000033086602,0.00022665173,0.00016814147,0.00014769468],"category_scores_gemma":[0.017588133,0.00020864657,0.013757865,0.00026603407,0.002379612,0.00010987887,0.000044865308,0.0006655178,5.159773e-7],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026255947,0.00006331711,0.026059967,0.001457095,0.9351224,0.00010739407,0.00011508665,0.000009995488,8.037901e-7,0.00012513324,0.0003975876,0.010285293],"study_design_scores_gemma":[0.052905276,0.0007706858,0.0032888548,0.0011629491,0.9342871,0.0021779102,0.00011503348,0.00002881219,3.4027494e-7,0.000051372554,0.005116653,0.000095024436],"about_ca_topic_score_codex":0.00032036036,"about_ca_topic_score_gemma":0.0004711306,"teacher_disagreement_score":0.043843426,"about_ca_system_score_codex":0.00003958708,"about_ca_system_score_gemma":0.0007687664,"threshold_uncertainty_score":0.9961191},"labels":[],"label_agreement":null},{"id":"W1127748106","doi":"10.1016/j.jtcvs.2015.08.066","title":"Dual antiplatelet therapy use by Canadian cardiac surgeons","year":2015,"lang":"en","type":"article","venue":"Journal of Thoracic and Cardiovascular Surgery","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; University of British Columbia; University of Manitoba; University of Calgary; McGill University; Libin Cardiovascular Institute of Alberta; University of Ottawa; Dalhousie University; University of Toronto; University of Alberta; St. Michael's Hospital","funders":"AstraZeneca Canada","keywords":"Medicine; Dual (grammatical number); Intensive care medicine; Cardiology; Internal medicine","score_opus":0.043477877366954576,"score_gpt":0.2689342339846625,"score_spread":0.2254563566177079,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1127748106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8184988,0.17972557,0.00023984474,0.00022735744,0.00077065366,0.00018587631,0.000044069508,0.000025165813,0.0002826523],"genre_scores_gemma":[0.9522655,0.046417803,0.000103323,0.00038662413,0.0005024284,0.000004629493,0.000042933138,0.000059367096,0.00021739265],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99688965,0.00055830245,0.0006105325,0.00030378156,0.0011160513,0.0005216594],"domain_scores_gemma":[0.99695736,0.00019091097,0.00017579911,0.00057529507,0.00061022426,0.0014903912],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004037309,0.00032631287,0.001704469,0.00038446608,0.00022589444,0.00022877709,0.00008973881,0.00022878831,0.000030833045],"category_scores_gemma":[0.0003176838,0.00026206512,0.0036425774,0.00038958152,0.0001512384,0.00047633713,0.00002589613,0.00038167599,0.00001373268],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021014293,0.00019576063,0.29464468,0.000100466554,0.026433641,0.007491022,0.00025710583,0.000084590574,0.0002655625,0.0000096809745,0.16408162,0.50433445],"study_design_scores_gemma":[0.0015193608,0.00019040957,0.03481292,0.00021271898,0.0019160552,0.0067567253,0.0005152092,0.000008760843,0.0017890956,0.000031231888,0.95174646,0.00050107547],"about_ca_topic_score_codex":0.005076139,"about_ca_topic_score_gemma":0.00006596985,"teacher_disagreement_score":0.78766483,"about_ca_system_score_codex":0.00009752689,"about_ca_system_score_gemma":0.0011480084,"threshold_uncertainty_score":0.99998313},"labels":[],"label_agreement":null},{"id":"W1171483306","doi":"10.1096/fasebj.29.1_supplement.625.2","title":"cAMP‐signaling via EPAC1 mediates vascular endothelial cell adaptation to fluid‐shear stress","year":2015,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Cell biology; Endothelial stem cell; Thrombomodulin; Chemistry; Tetrahydrobiopterin; Signal transduction; Leukocyte extravasation; Nitric oxide; Thrombin; Nitric oxide synthase; Cell adhesion molecule; Biology; Platelet; Immunology; Biochemistry; In vitro","score_opus":0.021744399536213724,"score_gpt":0.24140922913626855,"score_spread":0.21966482960005485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1171483306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9663411,0.0060482644,0.0259283,0.00046090307,0.00048239322,0.00031143788,0.000022166016,0.00004604881,0.00035939357],"genre_scores_gemma":[0.9965589,0.00043001262,0.00070651603,0.0006619933,0.0014125236,0.000008561653,0.000020535199,0.00003727148,0.00016369465],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99811167,0.0002595329,0.00028844073,0.0001741289,0.0008300174,0.00033620282],"domain_scores_gemma":[0.9986946,0.00007894792,0.00009191878,0.00031430356,0.00023978381,0.00058044394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010494844,0.0001857158,0.0003161937,0.000106163265,0.00022029747,0.00007256674,0.00019309894,0.00007032998,0.00020631326],"category_scores_gemma":[0.00012418754,0.00011989527,0.00043348246,0.00016937075,0.000059221467,0.00012324571,0.000031482712,0.00031269362,0.00021822826],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038795564,0.0007864701,0.01045094,0.00013153693,0.0033560335,0.0018266571,0.023902414,0.074009664,0.83033836,0.0000677514,0.005271938,0.04597866],"study_design_scores_gemma":[0.012038148,0.0013115176,0.002296894,0.000400131,0.0019828246,0.0022381847,0.012755995,0.003766102,0.9475753,0.00071454025,0.014234494,0.00068588],"about_ca_topic_score_codex":0.000046579957,"about_ca_topic_score_gemma":0.0000032241958,"teacher_disagreement_score":0.11723691,"about_ca_system_score_codex":0.000081932354,"about_ca_system_score_gemma":0.00024375085,"threshold_uncertainty_score":0.48891872},"labels":[],"label_agreement":null},{"id":"W1178092997","doi":"","title":"Post–hoc Analyses of the XLT Study Results. A Comparison of Latanoprost, Bimatoprost, and Travoprost in Patients with Elevated IOP: A 12–week Randomized, Masked–evaluator, Multicenter Study","year":2004,"lang":"en","type":"article","venue":"Investigative Ophthalmology & Visual Science","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Bimatoprost; Travoprost; Latanoprost; Medicine; Ophthalmology; Post-hoc analysis; Post hoc; Internal medicine; Glaucoma","score_opus":0.04481857717873616,"score_gpt":0.36463166991049617,"score_spread":0.31981309273176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1178092997","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949418,0.00024897026,0.0000011273315,0.00006169843,0.00005102572,0.004595231,0.000042297237,0.000013666855,0.00004419581],"genre_scores_gemma":[0.9996332,0.000003181714,0.00018249672,0.00005281519,0.000007869825,0.00008136748,0.0000106564175,0.000017136543,0.000011290377],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960092,0.00080607925,0.00091721816,0.0007315294,0.0011589963,0.00037699606],"domain_scores_gemma":[0.99791235,0.00020073031,0.00053356343,0.0005143078,0.00064890186,0.00019013423],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0019787273,0.00031319816,0.0013260065,0.00029618602,0.00019333251,0.000023839362,0.000332297,0.00007647072,0.0000092062255],"category_scores_gemma":[0.0010512111,0.00018152119,0.00016322365,0.0013679952,0.0058193896,0.00022972397,0.00018410513,0.00027570894,0.0000012556185],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.047973357,0.007143969,0.8960929,0.000037309015,0.00050092523,0.000074453375,0.009728981,0.000100472054,0.03826365,0.000006284751,3.1945527e-7,0.000077370394],"study_design_scores_gemma":[0.13698995,0.008072427,0.7907784,0.00019612725,0.00048285702,0.000020007747,0.0057342793,0.00009215243,0.057407465,0.000073312,1.3596673e-7,0.00015289517],"about_ca_topic_score_codex":0.00064872275,"about_ca_topic_score_gemma":0.000039625287,"teacher_disagreement_score":0.10531452,"about_ca_system_score_codex":0.00008163397,"about_ca_system_score_gemma":0.00041709482,"threshold_uncertainty_score":0.9968862},"labels":[],"label_agreement":null},{"id":"W1191182165","doi":"","title":"A Pilot Prospective Study Comparing the Effect of Corticosteroids versus NSAIDS on the Hypertensive Phase Following Ahmed Glaucoma Valve Surgery","year":2010,"lang":"en","type":"article","venue":"Investigative Ophthalmology & Visual Science","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Medicine; Glaucoma; Glaucoma valve; Surgery; Anesthesia; Ophthalmology","score_opus":0.053999324985594725,"score_gpt":0.35125588057505536,"score_spread":0.2972565555894606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1191182165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99632996,0.00014325403,0.0000013373981,0.00016648744,0.0010303484,0.0018493155,0.0000030024614,0.000038205384,0.0004380801],"genre_scores_gemma":[0.99950415,0.0000013649928,0.000014292975,0.00016526702,0.000101155536,0.00017712153,0.0000026948517,0.000020934263,0.000013047023],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968824,0.000772781,0.00036661027,0.00061414606,0.0008787458,0.00048536147],"domain_scores_gemma":[0.99532616,0.0033344508,0.00021782362,0.00063072174,0.00025062455,0.00024021509],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0027885681,0.00031392975,0.0008304337,0.00015163455,0.00068497413,0.000046255136,0.00044724162,0.000054463133,0.000032604985],"category_scores_gemma":[0.004198488,0.00016336147,0.0005219997,0.0010569403,0.004791653,0.00016478769,0.00016135123,0.00062445825,0.000018336588],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026199513,0.0006547539,0.6771907,0.000010459313,0.0008826179,0.00043896073,0.0008546087,0.0000015774597,0.31691146,0.000042718973,0.000013486609,0.00037866467],"study_design_scores_gemma":[0.005146944,0.015352095,0.7068634,0.00008279991,0.0006212331,0.00027847438,0.0010654998,0.00015210736,0.27015412,0.00010801648,0.0000028704594,0.00017246371],"about_ca_topic_score_codex":0.000104618346,"about_ca_topic_score_gemma":0.0000048847587,"teacher_disagreement_score":0.04675735,"about_ca_system_score_codex":0.00006505143,"about_ca_system_score_gemma":0.00032777287,"threshold_uncertainty_score":0.99791676},"labels":[],"label_agreement":null},{"id":"W1191896","doi":"10.1016/j.jacc.2007.12.013","title":"Clopidogrel 600-Mg Double Loading Dose Achieves Stronger Platelet Inhibition Than Conventional Regimens","year":2008,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Medicine; Clopidogrel; Morning; Adenosine diphosphate; Percutaneous coronary intervention; Loading dose; Platelet; Bolus (digestion); Anesthesia; Internal medicine; Platelet aggregation; Pharmacology; Cardiology; Aspirin; Myocardial infarction","score_opus":0.01944528617669128,"score_gpt":0.26018740565448273,"score_spread":0.24074211947779145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1191896","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99529594,0.0014595207,0.0004262469,0.001087144,0.00038653534,0.0002148336,0.000050467504,0.000011283197,0.001068017],"genre_scores_gemma":[0.99705863,0.0011065052,0.00036378083,0.00023000354,0.0007530178,0.0000039254182,0.0000057800735,0.000021312331,0.00045705013],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998291,0.00028827632,0.0005402042,0.00015900572,0.00047532812,0.000246175],"domain_scores_gemma":[0.9984049,0.0000946394,0.0007684329,0.00031663792,0.0002837657,0.00013157909],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043923786,0.00017259027,0.0010637132,0.00016560848,0.00014459225,0.0000031110585,0.00016838057,0.000074375996,0.000031578857],"category_scores_gemma":[0.000050261428,0.00011699306,0.0014044065,0.00031438787,0.0008790218,0.000096279386,0.000056811878,0.00033073587,0.0000066016214],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.067364484,0.0010506343,0.61314076,0.00031416307,0.029264372,0.012485886,0.00048610382,0.0059976643,0.14374,0.0047448752,0.116491124,0.004919919],"study_design_scores_gemma":[0.029796388,0.005042295,0.7110026,0.000597628,0.0022829424,0.10358861,0.0021338945,0.000048641778,0.036100626,0.00065085304,0.10810153,0.00065401586],"about_ca_topic_score_codex":0.0000067419537,"about_ca_topic_score_gemma":7.3954845e-7,"teacher_disagreement_score":0.10763937,"about_ca_system_score_codex":0.00008036433,"about_ca_system_score_gemma":0.00032922087,"threshold_uncertainty_score":0.47708386},"labels":[],"label_agreement":null},{"id":"W138586564","doi":"","title":"Association of aspirin dosage to clinical outcomes after percutaneous coronary intervention: observations from the Ottawa Heart Institute PCI Registry.","year":2009,"lang":"en","type":"article","venue":"PubMed","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Aspirin; Conventional PCI; Percutaneous coronary intervention; Clopidogrel; Internal medicine; Myocardial infarction; Odds ratio; Confidence interval; Cardiology; Surgery","score_opus":0.03698222066870302,"score_gpt":0.2899341828425663,"score_spread":0.2529519621738633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W138586564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98174834,0.0007783439,0.0001868816,0.01567931,0.00041407146,0.0007888833,0.00006733309,0.00005183539,0.00028498008],"genre_scores_gemma":[0.99078536,0.000078996134,0.00026384206,0.0062005385,0.0003143451,0.00016263008,0.00008274068,0.000009703073,0.002101871],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99857974,0.00015332541,0.00047703713,0.00022642079,0.00036093022,0.00020251775],"domain_scores_gemma":[0.99900013,0.00016938843,0.000124733,0.0004651625,0.00010171249,0.0001388562],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006640094,0.00011829699,0.00037673887,0.000026961328,0.000056834455,0.000022198114,0.00012743671,0.000110879286,0.00007600309],"category_scores_gemma":[0.0005924835,0.000085479136,0.0007090288,0.00013884934,0.00005014988,0.00010206252,0.000027708742,0.0001665625,0.000021086104],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033878261,0.00026148348,0.9172034,0.0000084321655,0.0006095082,0.00008451869,0.00005364492,0.000007444297,0.000009180887,0.000026801066,0.0053229104,0.076073855],"study_design_scores_gemma":[0.0010385652,0.00007408885,0.9326813,0.00003983466,0.00033973486,0.0000424234,0.000038503145,0.0000024188168,0.000011481259,0.00009608606,0.065552786,0.00008275578],"about_ca_topic_score_codex":0.00008181202,"about_ca_topic_score_gemma":0.0000884009,"teacher_disagreement_score":0.075991094,"about_ca_system_score_codex":0.00007805216,"about_ca_system_score_gemma":0.000034567056,"threshold_uncertainty_score":0.3485738},"labels":[],"label_agreement":null},{"id":"W14452866","doi":"10.1016/j.jcin.2014.01.160","title":"Prasugrel Versus Clopidogrel in Patients With ST-Segment Elevation Myocardial Infarction According to Timing of Percutaneous Coronary Intervention","year":2014,"lang":"en","type":"article","venue":"JACC: Cardiovascular Interventions","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Prasugrel; Medicine; Clopidogrel; Conventional PCI; Percutaneous coronary intervention; Myocardial infarction; Internal medicine; Cardiology; TIMI; Clinical endpoint; Hazard ratio; Confidence interval; Randomized controlled trial","score_opus":0.019101784259764793,"score_gpt":0.26596545548038253,"score_spread":0.24686367122061773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W14452866","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9466723,0.0010706361,0.04982708,0.000054390704,0.0006011477,0.0013088258,0.000031134045,0.0000807164,0.00035377438],"genre_scores_gemma":[0.99781734,0.00008509867,0.0013346236,0.000049595325,0.00016855166,0.00011389959,0.00033339128,0.000057272,0.000040208255],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9971241,0.00036653524,0.00072290644,0.0005335801,0.00090500887,0.00034790105],"domain_scores_gemma":[0.9984487,0.00006384797,0.00017809629,0.0007577274,0.0003861991,0.00016542262],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009562065,0.00029697575,0.00082346675,0.0005070389,0.00010844469,0.000036250716,0.0001512052,0.00014288661,0.00010141881],"category_scores_gemma":[0.00023527708,0.0002834515,0.002961466,0.0005318225,0.00006526979,0.00025396468,0.00010116665,0.000252959,0.00003271359],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008444595,0.002113335,0.41137648,0.001130841,0.016883124,0.000076616656,0.0004107192,0.011433354,0.00027821178,0.00021325216,0.0002276829,0.5474118],"study_design_scores_gemma":[0.016702855,0.0035482862,0.96784747,0.0023508929,0.0033262495,0.00012544692,0.0008294078,0.0003758756,0.00018355918,0.00002914959,0.0041791634,0.0005016237],"about_ca_topic_score_codex":0.00011365754,"about_ca_topic_score_gemma":0.00002699048,"teacher_disagreement_score":0.55647105,"about_ca_system_score_codex":0.0003136707,"about_ca_system_score_gemma":0.000046294714,"threshold_uncertainty_score":0.9999618},"labels":[],"label_agreement":null},{"id":"W145097280","doi":"10.1016/j.jcin.2013.06.014","title":"Concomitant Administration of Clopidogrel With Statins or Calcium-Channel Blockers","year":2013,"lang":"en","type":"article","venue":"JACC: Cardiovascular Interventions","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Clopidogrel; Internal medicine; Prasugrel; Percutaneous coronary intervention; Myocardial infarction; Cardiology; Atorvastatin; Hazard ratio; Statin; Stroke (engine); Confidence interval","score_opus":0.04288816357897569,"score_gpt":0.29993484817816163,"score_spread":0.25704668459918595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W145097280","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9201793,0.012312145,0.062030222,0.0005277186,0.0002676208,0.002391058,0.00012446918,0.00020090237,0.0019665451],"genre_scores_gemma":[0.996129,0.00037281535,0.0019068571,0.00008820948,0.00013435961,0.00026403955,0.00012952654,0.000051829677,0.00092338334],"study_design_codex":"meta_analysis","study_design_gemma":"observational","domain_scores_codex":[0.99781626,0.00018292815,0.00060566276,0.00039900487,0.0006781272,0.0003179899],"domain_scores_gemma":[0.9981961,0.000052350784,0.00015704476,0.00088141946,0.00047444974,0.00023860023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003813575,0.00027376242,0.0008792769,0.00017029734,0.00011259275,0.000044000513,0.00014218724,0.00012628728,0.0008831891],"category_scores_gemma":[0.000087081324,0.00019720523,0.0038678953,0.000357302,0.00020868276,0.00020809249,0.00004144062,0.00019903411,0.00009669853],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019633617,0.015599541,0.039101947,0.020125855,0.41551185,0.007863664,0.00449092,0.0039022062,0.0073567983,0.004707006,0.0595498,0.4021568],"study_design_scores_gemma":[0.091620825,0.029215828,0.48087767,0.018109519,0.06772399,0.018096063,0.028025206,0.0029315692,0.103925444,0.0012794131,0.15239461,0.0057998556],"about_ca_topic_score_codex":0.00019530949,"about_ca_topic_score_gemma":0.00003865776,"teacher_disagreement_score":0.44177574,"about_ca_system_score_codex":0.00006422353,"about_ca_system_score_gemma":0.00022531845,"threshold_uncertainty_score":0.9670301},"labels":[],"label_agreement":null},{"id":"W1451772007","doi":"10.1016/b978-012406061-6/50016-3","title":"Antiplatelet Agents","year":2006,"lang":"en","type":"book-chapter","venue":"Elsevier eBooks","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Cardiology; Myocardial infarction; Internal medicine; Thrombosis; Coronary arteries; Coronary artery disease; Coronary artery occlusion; Artery; Platelet; Platelet aggregation","score_opus":0.015157508470720987,"score_gpt":0.24212107259572777,"score_spread":0.2269635641250068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1451772007","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009574216,0.00892099,0.0000070750343,0.00004026145,0.0002999594,0.00073345745,0.000065725566,0.00017775298,0.98879737],"genre_scores_gemma":[0.005380454,0.00080840767,0.00008188513,0.0009245227,0.00093838264,0.000017392513,0.00032924901,0.00018431706,0.9913354],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99799675,0.000021196045,0.0004420586,0.00055394287,0.0006244286,0.00036162772],"domain_scores_gemma":[0.99864787,0.000019079162,0.00016493686,0.0008377561,0.000105841624,0.00022451945],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00014887634,0.00054528145,0.0010203193,0.00017123557,0.00010426526,0.000031625943,0.00015687809,0.0005022857,0.0011342359],"category_scores_gemma":[0.0000060271523,0.0004881028,0.0013393068,0.000013053249,0.00017048042,0.000026760406,0.00006508233,0.00048489403,0.000865537],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013087883,0.000025787316,0.000053315325,0.0002045837,0.0013422087,0.0017592583,0.000017033684,9.80333e-7,0.00002206049,0.0006639115,0.0072168903,0.9885631],"study_design_scores_gemma":[0.0014674874,0.00010110806,0.00030065494,0.0007151295,0.0011450707,0.00038087045,0.0000018724926,0.000002764304,0.000097598866,0.001311738,0.9940009,0.00047481703],"about_ca_topic_score_codex":5.138326e-7,"about_ca_topic_score_gemma":0.0000013689544,"teacher_disagreement_score":0.98808825,"about_ca_system_score_codex":0.000073544565,"about_ca_system_score_gemma":0.0001486761,"threshold_uncertainty_score":0.9999124},"labels":[],"label_agreement":null},{"id":"W148421620","doi":"10.3760/cma.j.issn.1003-9406.2012.04.009","title":"[Prevalence of CYP2C19 polymorphisms involved in clopidogrel metabolism in Fujian Han population].","year":2012,"lang":"en","type":"article","venue":"PubMed","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"CYP2C19; Kazakh; Genotyping; Traditional medicine; China; Allele frequency; Demography; Medicine; Internal medicine; Biology; Genotype; Genetics; Geography; Gene","score_opus":0.021055502194954886,"score_gpt":0.2337786394994573,"score_spread":0.2127231373045024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W148421620","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9753839,0.023086475,0.000020286367,0.00017263196,0.00019844525,0.00064573233,0.000008419219,0.000025950018,0.00045821033],"genre_scores_gemma":[0.9982721,0.0007041176,0.00008433443,0.0002087625,0.00018851626,0.00030323787,0.000018215505,0.00001894119,0.00020174943],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986599,0.00010577182,0.00034091974,0.00017696153,0.0002866553,0.0004298057],"domain_scores_gemma":[0.9993866,0.000026810341,0.00007761623,0.00030468608,0.000020320573,0.0001839437],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061301445,0.00012976903,0.00039160452,0.00024936846,0.000016203128,0.0000047095064,0.000091773276,0.000094094474,0.00004640083],"category_scores_gemma":[0.00010040207,0.000115954594,0.00019735751,0.0003730222,0.00005397459,0.00020376996,0.000026125039,0.00012632675,0.00000653751],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016618565,0.00021973197,0.93891436,0.00011102148,0.000070541464,0.000010475791,0.00019897266,0.0000045122747,0.0000813926,0.00029143994,0.000023328641,0.059908044],"study_design_scores_gemma":[0.0019440898,0.0000075218445,0.9960222,0.000048970465,0.0001095689,0.000009870479,0.000062818035,0.000008382879,0.00092771585,0.000096163705,0.00064685877,0.00011583778],"about_ca_topic_score_codex":0.00027576584,"about_ca_topic_score_gemma":0.00002806197,"teacher_disagreement_score":0.059792206,"about_ca_system_score_codex":0.00005066186,"about_ca_system_score_gemma":0.000021962243,"threshold_uncertainty_score":0.4728491},"labels":[],"label_agreement":null},{"id":"W1487210466","doi":"10.1111/j.1538-7836.2012.04764.x","title":"Aspirin twice a day keeps new COX‐1 at bay","year":2012,"lang":"en","type":"letter","venue":"Journal of Thrombosis and Haemostasis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; British Heart Foundation; Eli Lilly and Company","keywords":"Aspirin; Bay; Medicine; Internal medicine; Cardiology; Geology; Oceanography","score_opus":0.05963486145146572,"score_gpt":0.3054216001803763,"score_spread":0.24578673872891055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1487210466","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17929077,0.12702765,0.00040827176,0.6874614,0.002193953,0.0007387565,0.00017381759,0.000061346786,0.0026440504],"genre_scores_gemma":[0.043663993,0.070740834,0.001760772,0.84885395,0.028384356,0.000009084733,0.00028977313,0.00032613406,0.005971098],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972617,0.00019895134,0.0007482619,0.00030369082,0.0009800793,0.0005073363],"domain_scores_gemma":[0.99791884,0.00015025775,0.00070099364,0.0004965489,0.00022900719,0.000504327],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00063878286,0.0004704461,0.0016965643,0.00026197385,0.00015706464,0.0000701963,0.00022336544,0.00070353196,0.0016349952],"category_scores_gemma":[0.000057159148,0.00035071463,0.0015185265,0.00016318355,0.00014863377,0.00021449453,0.00011439466,0.0013951311,0.000071027316],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027195393,0.00009449239,0.0042005903,0.0002897264,0.0051901243,0.0006081413,0.00025218024,5.0168137e-7,0.00016220326,0.00000521379,0.9611629,0.027761955],"study_design_scores_gemma":[0.0028133437,0.00045907946,0.0150722135,0.00082957523,0.005795846,0.0019186074,0.00005306505,8.4037754e-7,0.00056164217,0.000041880525,0.9720903,0.00036363045],"about_ca_topic_score_codex":0.000027681823,"about_ca_topic_score_gemma":0.0000027443878,"teacher_disagreement_score":0.16139257,"about_ca_system_score_codex":0.00017210898,"about_ca_system_score_gemma":0.00026304543,"threshold_uncertainty_score":0.9998945},"labels":[],"label_agreement":null},{"id":"W1494218154","doi":"10.3310/hta19370","title":"The prognostic utility of tests of platelet function for the detection of ‘aspirin resistance’ in patients with established cardiovascular or cerebrovascular disease: a systematic review and economic evaluation","year":2015,"lang":"en","type":"review","venue":"Health Technology Assessment","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"Health Technology Assessment Programme; National Institute for Health and Care Research","keywords":"Medicine; Aspirin; Disease; Systematic review; Internal medicine; Intensive care medicine; Platelet; MEDLINE; Cardiology","score_opus":0.03475667582503944,"score_gpt":0.34833940921167794,"score_spread":0.3135827333866385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1494218154","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009831486,0.9751918,0.00073072384,0.00008727138,0.00006930287,0.022822585,0.0000890379,0.000023233104,0.000002931835],"genre_scores_gemma":[0.046993874,0.9487318,0.000086523294,0.000012853437,0.000010096044,0.0040097814,0.000118566306,0.000032908436,0.0000035923026],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99627346,0.0008884056,0.0015001552,0.00044267176,0.0006428782,0.00025241755],"domain_scores_gemma":[0.9961013,0.00043417662,0.0013834374,0.0014213278,0.0005829067,0.00007683346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006198667,0.0003153994,0.003504872,0.00023675799,0.00011181309,0.0000066595526,0.00019418723,0.00021580388,0.00000354914],"category_scores_gemma":[0.00063288695,0.00015725933,0.0006724761,0.0005301242,0.00028172025,0.00005476517,0.000047809313,0.00027976852,2.421292e-7],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033322693,0.0001494903,0.0013517129,0.736962,0.003902227,6.41138e-7,0.0000060098996,0.000003842717,1.1258592e-8,0.000044951787,0.000012709696,0.25723317],"study_design_scores_gemma":[0.009874384,0.0032766091,0.06724537,0.73727536,0.10067727,0.00003695483,0.00027291404,0.00020286109,0.0000016252516,0.0002703906,0.08032537,0.0005409096],"about_ca_topic_score_codex":0.000020662334,"about_ca_topic_score_gemma":0.00012131281,"teacher_disagreement_score":0.25669226,"about_ca_system_score_codex":0.00038962642,"about_ca_system_score_gemma":0.0024378954,"threshold_uncertainty_score":0.64128494},"labels":[],"label_agreement":null},{"id":"W1496998087","doi":"10.1159/000338056","title":"Antiplatelet Therapy in Acute Coronary Syndrome and Atrial Fibrillation: Aspirin","year":2012,"lang":"en","type":"review","venue":"Advances in cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Aspirin; Antithrombotic; Acute coronary syndrome; Atrial fibrillation; Cardiology; Internal medicine; Myocardial infarction; Stroke (engine); Clinical trial; Clopidogrel; Intensive care medicine","score_opus":0.03368447423201708,"score_gpt":0.3404150683527574,"score_spread":0.30673059412074033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1496998087","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011404034,0.98623914,0.0000185428,0.000016070415,0.00071386946,0.0011859974,0.00004965985,0.000040459647,0.00033225972],"genre_scores_gemma":[0.011705691,0.9867359,0.000089435576,0.00003805049,0.0009587093,0.000043498334,0.00033252462,0.000060921022,0.000035305442],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99750906,0.00053608936,0.0006598358,0.00060055614,0.00019345194,0.0005009971],"domain_scores_gemma":[0.9989151,0.00027822246,0.00017809814,0.00048255184,0.000025253335,0.000120798206],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004875603,0.00048339827,0.0036852786,0.00032926118,0.000038265902,0.000008172276,0.0001318696,0.0005975881,0.000037033224],"category_scores_gemma":[0.00002034724,0.00038668283,0.0011734705,0.00035350863,0.00023243,0.0002237569,0.000079549965,0.00048471914,0.000030993946],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003059842,0.0000066682933,0.021549892,0.0016726858,0.0013635973,0.0029817438,0.000014021011,0.000034626242,1.4789437e-7,0.000036034256,0.0000042541724,0.97203034],"study_design_scores_gemma":[0.0025450508,0.00035303977,0.007841024,0.0022264095,0.0010540466,0.018978354,0.000009001348,0.0000010656403,1.5389013e-7,0.00008048942,0.966542,0.00036935107],"about_ca_topic_score_codex":0.0000039308484,"about_ca_topic_score_gemma":0.000002749777,"teacher_disagreement_score":0.971661,"about_ca_system_score_codex":0.00009910435,"about_ca_system_score_gemma":0.00014903053,"threshold_uncertainty_score":0.9998585},"labels":[],"label_agreement":null},{"id":"W1500293590","doi":"10.1017/cbo9780511545283.024","title":"Aggregation","year":2002,"lang":"en","type":"book-chapter","venue":"Cambridge University Press eBooks","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; McMaster University; University of Toronto","funders":"","keywords":"Platelet; Medicine; Fibrin; Platelet aggregation; Hemostasis; Cardiology; Myocardial infarction; Platelet activation; Internal medicine; Immunology","score_opus":0.02117317619846665,"score_gpt":0.19432720573224374,"score_spread":0.1731540295337771,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1500293590","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00032948365,0.0017394946,0.00021825072,0.000013480299,0.000112505164,0.00040245452,0.00009095077,0.00016520814,0.99692816],"genre_scores_gemma":[0.002462496,0.0014911985,0.000037360216,0.000115744326,0.00023012175,3.9746018e-7,0.00011038909,0.00004981253,0.9955025],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990152,0.000019761259,0.00012115712,0.00035827907,0.00030843538,0.00017713121],"domain_scores_gemma":[0.9990533,0.000016926877,0.00010274371,0.0005147543,0.00012299868,0.00018926055],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00004357178,0.0002734902,0.00044010446,0.00013012353,0.00010689085,0.000014974383,0.00013054418,0.00033476256,0.000046313773],"category_scores_gemma":[0.000004567708,0.00030679326,0.0006461884,0.0000054846028,0.00015366,0.00004376985,0.000070057955,0.0003061504,0.00007002847],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005399294,0.00003627817,0.000012082799,0.00030310728,0.002124248,0.0038867085,0.000029634712,0.0000017095172,0.000038587765,0.8699408,0.086225964,0.036860906],"study_design_scores_gemma":[0.0013798699,0.000072444214,0.000039089424,0.00032239736,0.0012111061,0.00013899154,0.000008174709,0.000022665487,0.00026611568,0.000003453311,0.99624634,0.0002893694],"about_ca_topic_score_codex":0.000012443032,"about_ca_topic_score_gemma":9.573728e-8,"teacher_disagreement_score":0.91002035,"about_ca_system_score_codex":0.00012461841,"about_ca_system_score_gemma":0.000056681725,"threshold_uncertainty_score":0.9999384},"labels":[],"label_agreement":null},{"id":"W1511237418","doi":"10.1161/circ.130.suppl_2.13846","title":"Abstract 13846: The Relationship of Platelet Function Measurements with Bleeding Outcomes During Long-term Treatment with Dual Antiplatelet Therapy in Medically Managed NSTE-ACS Patients","year":2014,"lang":"en","type":"article","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; TIMI; Internal medicine; Clopidogrel; Cardiology; Hazard ratio; Prasugrel; Aspirin; Conventional PCI; Confidence interval; Myocardial infarction","score_opus":0.03502406940898585,"score_gpt":0.2502549056166524,"score_spread":0.2152308362076666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1511237418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99788266,0.00018059874,0.00059642404,0.00007857797,0.00006854227,0.0008996882,0.0000027233366,0.000048951126,0.00024180415],"genre_scores_gemma":[0.99955666,0.000074516516,0.000026215697,0.00005260896,0.00006323029,0.00004038163,0.00013882088,0.000034770193,0.0000127999665],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982329,0.00011375749,0.00037933924,0.0002982125,0.0007481931,0.00022760253],"domain_scores_gemma":[0.99910885,0.00010882971,0.00022638823,0.00034674216,0.00013069739,0.00007850885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040612387,0.0002346168,0.00039566297,0.00015950452,0.00016534446,0.000025146288,0.000059748723,0.00010478743,0.00003150943],"category_scores_gemma":[0.00004410132,0.00013674863,0.00013434933,0.00026476866,0.0000900248,0.00020504097,0.0000081147855,0.00014642038,0.0000051883044],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018176449,0.00031969862,0.9740464,0.00008287313,0.00074116496,0.000020522066,0.00027063713,0.0008109949,0.00090277364,0.000019822417,8.8263334e-7,0.020966547],"study_design_scores_gemma":[0.012184604,0.00050665834,0.98567426,0.0003044613,0.00020768339,0.00002210911,0.000056687448,0.00004682949,0.00081411074,0.000017842605,0.000009632391,0.00015512877],"about_ca_topic_score_codex":0.00002560186,"about_ca_topic_score_gemma":0.000033885994,"teacher_disagreement_score":0.020811418,"about_ca_system_score_codex":0.00012825032,"about_ca_system_score_gemma":0.00004892908,"threshold_uncertainty_score":0.5576447},"labels":[],"label_agreement":null},{"id":"W1519844508","doi":"10.71781/4955","title":"Étude de l’effet des médicaments antiplaquettaires sur la fonction plaquettaire : de la variabilité de réponse à l’effet rebond","year":2009,"lang":"fr","type":"dissertation","venue":"Open MIND","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Heart and Stroke Foundation of Canada","keywords":"Chemistry","score_opus":0.012630225742377963,"score_gpt":0.3097096321953151,"score_spread":0.2970794064529371,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1519844508","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97088957,0.0110243065,0.0013247913,0.0002448562,0.00041122708,0.0018706793,0.00017484867,0.000030781634,0.014028925],"genre_scores_gemma":[0.9773669,0.0043718438,0.007772942,0.00042572714,0.00069424126,0.00020945208,0.0014910524,0.00019305467,0.00747474],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9922169,0.0034765105,0.0009151148,0.0012163422,0.00076910143,0.0014060509],"domain_scores_gemma":[0.99602044,0.0014338668,0.0004508581,0.0009987077,0.00023606619,0.0008600652],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0050716684,0.000981173,0.0014498538,0.00027967725,0.00065602385,0.00059712346,0.0009090644,0.0016233831,0.0016071266],"category_scores_gemma":[0.0015079821,0.0010226958,0.0009588673,0.00048239602,0.000690975,0.000616915,0.00012960727,0.0011867575,0.00021832487],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010568137,0.0032385665,0.07910238,0.0012149625,0.0045047146,0.0048305113,0.010939365,0.0010874139,0.041456982,0.00019313222,0.0033131263,0.83955073],"study_design_scores_gemma":[0.014146289,0.0014784323,0.80111784,0.009147934,0.0069810296,0.0030734679,0.0062982696,0.0019315333,0.057519447,0.0017409036,0.09450277,0.0020621151],"about_ca_topic_score_codex":0.002644754,"about_ca_topic_score_gemma":0.0005965345,"teacher_disagreement_score":0.8374886,"about_ca_system_score_codex":0.0010513626,"about_ca_system_score_gemma":0.0032985476,"threshold_uncertainty_score":0.9996727},"labels":[],"label_agreement":null},{"id":"W1547549149","doi":"10.7326/m15-0083","title":"Longer- Versus Shorter-Duration Dual-Antiplatelet Therapy After Drug-Eluting Stent Placement","year":2015,"lang":"en","type":"review","venue":"Annals of Internal Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Myocardial infarction; Internal medicine; Confidence interval; Drug-eluting stent; Relative risk; Randomized controlled trial; Stent; Coronary artery disease; Percutaneous coronary intervention; Cardiology","score_opus":0.12729469020305123,"score_gpt":0.3963938974549362,"score_spread":0.26909920725188496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1547549149","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0056880903,0.98934364,0.00006774326,0.00033368135,0.0013727028,0.0012773069,0.000054845153,0.00006207112,0.0017998965],"genre_scores_gemma":[0.007143101,0.98890615,0.00002990622,0.0006823463,0.001960626,0.00012251362,0.000266773,0.00010924547,0.0007793466],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953522,0.00033326625,0.0017379582,0.00064281095,0.0014123727,0.0005214028],"domain_scores_gemma":[0.9970453,0.00020802168,0.00084944523,0.0008202558,0.0006353772,0.0004416252],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001598321,0.000770666,0.0035369082,0.00044556218,0.000045968256,0.000020778138,0.0002733367,0.00029473013,0.0007992731],"category_scores_gemma":[0.00019388307,0.0005030838,0.0015824621,0.00031392052,0.00026721414,0.00012174496,0.000103232094,0.0005766223,0.00008095331],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005088202,0.00024133813,0.000042314092,0.0046129483,0.006345624,0.0009983467,0.00038773924,9.882692e-7,0.0000047784083,0.000011314439,0.011964647,0.97030175],"study_design_scores_gemma":[0.0052174293,0.0021345022,0.0000417601,0.03955595,0.0023556212,0.0004513647,0.00028210075,0.000006776316,0.00009228464,0.000009117627,0.949432,0.00042108132],"about_ca_topic_score_codex":0.000054944507,"about_ca_topic_score_gemma":0.0000039804445,"teacher_disagreement_score":0.9698807,"about_ca_system_score_codex":0.00008542385,"about_ca_system_score_gemma":0.00031479675,"threshold_uncertainty_score":0.9997421},"labels":[],"label_agreement":null},{"id":"W1550085672","doi":"10.4212/cjhp.v54i1.620","title":"Guidelines for Antithrombotic Therapy","year":2001,"lang":"en","type":"article","venue":"The Canadian Journal of Hospital Pharmacy","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Antithrombotic; Medicine; Intensive care medicine; Internal medicine","score_opus":0.09453250004932258,"score_gpt":0.36355100909191407,"score_spread":0.2690185090425915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1550085672","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9436452,0.029338775,0.0003784614,0.02487992,0.0008397476,0.00039563552,0.000009842909,0.00000866772,0.0005037846],"genre_scores_gemma":[0.9907199,0.003458981,0.0002414734,0.0040027904,0.0012629069,0.000003716091,0.000003372295,0.000024189716,0.00028265858],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99915135,0.000029890703,0.00029048946,0.00007947791,0.0001961733,0.00025263714],"domain_scores_gemma":[0.9985388,0.000031465177,0.000116663556,0.00016300201,0.0007269723,0.0004231184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004201725,0.00011533559,0.00026278515,0.000092424394,0.00021147086,0.00004575952,0.00019418329,0.00002313946,0.00025880232],"category_scores_gemma":[0.0001317261,0.00006941156,0.00050697377,0.00013143805,0.000118788084,0.000118220145,0.0000033013316,0.00014016496,0.000011636741],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027497483,0.00044966114,0.16463517,0.00009247074,0.007616193,0.004139958,0.0017792705,0.000492436,0.002115237,0.001148303,0.35061893,0.46416262],"study_design_scores_gemma":[0.0079197865,0.0010607236,0.017558835,0.00011204248,0.00047045577,0.0017691572,0.0002636461,0.00012277468,0.0018092423,0.0010578864,0.96764123,0.0002142142],"about_ca_topic_score_codex":0.0009778765,"about_ca_topic_score_gemma":0.00043620137,"teacher_disagreement_score":0.6170223,"about_ca_system_score_codex":0.000053285734,"about_ca_system_score_gemma":0.00092907273,"threshold_uncertainty_score":0.2833704},"labels":[],"label_agreement":null},{"id":"W1552261360","doi":"10.1053/euhj.2000.2474","title":"The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme. Rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease","year":2000,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":303,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences","funders":"","keywords":"Medicine; Clopidogrel; Meta-analysis; Angina; Internal medicine; Cardiology; Unstable angina; Baseline (sea); Stable angina; Clinical trial; Coronary artery disease; Aspirin; Intensive care medicine; Myocardial infarction","score_opus":0.062005109110352875,"score_gpt":0.3048468594127678,"score_spread":0.24284175030241492,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1552261360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98270637,0.0142793935,0.0004974661,0.00078450586,0.00010469926,0.0015991575,0.000009967783,0.0000051452193,0.000013322435],"genre_scores_gemma":[0.99551284,0.0037484283,0.0003115388,0.00015392955,0.0001310489,0.000030604744,0.000008013759,0.00001934478,0.00008425838],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9963179,0.0022236262,0.0005600953,0.00018011782,0.0004994171,0.00021884977],"domain_scores_gemma":[0.9989607,0.0003213988,0.00015400858,0.00029322683,0.000098668315,0.00017200905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038771012,0.00014870602,0.0006715522,0.00020305332,0.00013009348,0.000027040558,0.00013069338,0.000019275638,0.000058213773],"category_scores_gemma":[0.0006076585,0.00008193876,0.0009886204,0.0007687655,0.00005235517,0.00006330817,0.00004376162,0.00020710184,0.0000014295409],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13470292,0.014540907,0.20040852,0.0019523505,0.25791606,0.0012213992,0.0062835524,0.03414087,0.0030693966,0.0002209599,0.0033703523,0.3421727],"study_design_scores_gemma":[0.020517774,0.0013509729,0.88039047,0.0006814514,0.0718923,0.000046984846,0.000076606295,0.0022860684,0.0004023504,0.000073125666,0.021942778,0.0003391073],"about_ca_topic_score_codex":0.0000037652494,"about_ca_topic_score_gemma":0.0000029600017,"teacher_disagreement_score":0.67998195,"about_ca_system_score_codex":0.000031543943,"about_ca_system_score_gemma":0.00011245401,"threshold_uncertainty_score":0.33413655},"labels":[],"label_agreement":null},{"id":"W1553109446","doi":"10.1161/circ.130.suppl_2.13993","title":"Abstract 13993: Impact of Prasugrel Pretreatment and Timing of Coronary Artery Bypass Grafting on Clinical Outcomes of Patients With Non-ST-Segment Elevation Myocardial Infarction: From the Accoast Study","year":2014,"lang":"en","type":"article","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"","keywords":"Medicine; Prasugrel; Cardiology; Myocardial infarction; TIMI; Internal medicine; Revascularization; Stroke (engine); Coronary artery disease; Conventional PCI; Clinical endpoint; Randomization; ST segment; Percutaneous coronary intervention; Artery; Randomized controlled trial","score_opus":0.024418841578591984,"score_gpt":0.2998948761342928,"score_spread":0.2754760345557008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1553109446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983751,0.000043376607,0.0006161511,0.000014202461,0.000057913818,0.00082176906,0.000036783436,0.000007758268,0.000026946853],"genre_scores_gemma":[0.99970055,0.000014733136,0.000043548323,0.000021440475,0.000062114836,0.00001092597,0.00013444234,0.000011763948,4.6610177e-7],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988061,0.00010897959,0.0004299718,0.00017808567,0.0003977671,0.00007907597],"domain_scores_gemma":[0.99892575,0.00026079582,0.00035903318,0.00027262056,0.00014134032,0.000040479335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003625732,0.00012104777,0.0003828889,0.000042656473,0.000044973553,0.0000056092294,0.000033205582,0.000053215364,0.000016235192],"category_scores_gemma":[0.00007552618,0.00007385636,0.00022695248,0.00006874834,0.000057750298,0.000081069025,0.0000133388385,0.00007465996,5.7746695e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000875602,0.00073146296,0.9586719,0.000015784033,0.0024991657,8.3239973e-7,0.00036396697,0.0008274154,0.00015047898,0.0000015259735,0.0000037941654,0.035858028],"study_design_scores_gemma":[0.005005666,0.0012921859,0.9923034,0.00009036711,0.0006707116,9.1221597e-7,0.00020852116,0.00032052843,0.00003322137,0.000010546569,0.0000013787233,0.000062597726],"about_ca_topic_score_codex":0.000079433594,"about_ca_topic_score_gemma":0.0000032898993,"teacher_disagreement_score":0.035795428,"about_ca_system_score_codex":0.0000386997,"about_ca_system_score_gemma":0.000041237974,"threshold_uncertainty_score":0.3011775},"labels":[],"label_agreement":null},{"id":"W1553345686","doi":"10.1056/nejmoa010746","title":"Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation","year":2001,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":6486,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Population Health Research Institute; Hamilton General Hospital","funders":"","keywords":"Medicine; Clopidogrel; Aspirin; Placebo; Internal medicine; Myocardial infarction; Relative risk; Stroke (engine); Acute coronary syndrome; Confidence interval; Cardiology; Anesthesia; Surgery","score_opus":0.006613261563669518,"score_gpt":0.24023750753979403,"score_spread":0.23362424597612452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1553345686","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967215,0.001006285,0.0010522034,0.00061670906,0.00012903128,0.00042401426,0.000002837746,0.0000048640836,0.000042546824],"genre_scores_gemma":[0.99818516,0.00077095523,0.0003078289,0.0003271384,0.00031528907,0.0000039574743,0.00003049081,0.000013567602,0.00004560471],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99859774,0.00009296556,0.00044067836,0.00011274726,0.0006064195,0.00014944655],"domain_scores_gemma":[0.9992956,0.00007907529,0.00019329264,0.00010908501,0.00013946646,0.00018346633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039021362,0.0001292518,0.00056647015,0.00036073744,0.000011626208,0.0000021183212,0.000059494043,0.000047900423,0.000072681105],"category_scores_gemma":[0.00008563422,0.0000822347,0.000066820554,0.00030920908,0.000038361166,0.00009782642,0.000008409404,0.00018288,0.0000012465587],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010982795,0.0003804167,0.7613707,0.000101342215,0.00039672182,0.0012969122,0.00040231182,0.00010643146,0.00051922794,0.0000064508217,0.00033057446,0.22410612],"study_design_scores_gemma":[0.08904196,0.0063239355,0.89882696,0.0025797975,0.00033210468,0.00052727776,0.00005684027,0.000007078094,0.00020882441,0.00003957293,0.0019794607,0.00007617113],"about_ca_topic_score_codex":0.000031884545,"about_ca_topic_score_gemma":0.00001893483,"teacher_disagreement_score":0.22402994,"about_ca_system_score_codex":0.00007788309,"about_ca_system_score_gemma":0.000101141006,"threshold_uncertainty_score":0.33534336},"labels":[],"label_agreement":null},{"id":"W1554857574","doi":"10.1111/j.1365-2036.2008.03713.x","title":"Underutilization of gastroprotective strategies in aspirin users at increased risk of upper gastrointestinal complications","year":2008,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Aspirin; Medicine; Risk factor; Internal medicine; Concomitant; Risk assessment; Disease; Computer security","score_opus":0.03188984781053404,"score_gpt":0.3018310319450234,"score_spread":0.26994118413448936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1554857574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963435,0.000966542,0.0016753756,0.00015684923,0.000037021848,0.0005669544,0.00006135136,0.000025295292,0.0001670897],"genre_scores_gemma":[0.9966328,0.0011518316,0.0012004133,0.0008220381,0.00002514149,0.00003153625,0.000105954816,0.000019302763,0.000010951133],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99879366,0.00026684714,0.00034251172,0.0002056704,0.00019075944,0.00020055931],"domain_scores_gemma":[0.9993405,0.000094949355,0.00018983326,0.00019510684,0.00011330987,0.000066348024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013682898,0.0001562494,0.00033874367,0.0001380829,0.00008671957,0.000001499031,0.00009328351,0.00004723753,0.00020292126],"category_scores_gemma":[4.93208e-7,0.0001505581,0.00018736544,0.00021271012,0.00044798572,0.00007843199,0.000033699675,0.00016388386,0.000004721466],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019263517,0.0007780044,0.72501963,0.000045490837,0.004199464,0.00003484608,0.00033231115,0.0009831291,0.2663255,0.000040830917,0.000016887629,0.00029753966],"study_design_scores_gemma":[0.005697283,0.0008459713,0.841388,0.000076246804,0.004294398,0.00042197725,0.0009319898,0.0010010594,0.14496382,0.00012617552,0.0001211221,0.00013198052],"about_ca_topic_score_codex":0.00022158511,"about_ca_topic_score_gemma":0.000017102222,"teacher_disagreement_score":0.121361695,"about_ca_system_score_codex":0.00010700457,"about_ca_system_score_gemma":0.0001631301,"threshold_uncertainty_score":0.6139581},"labels":[],"label_agreement":null},{"id":"W1557499563","doi":"","title":"Peri-operative Anti-thrombotic Therapy and Clinical Outcomes in Patients With Prior Coronary Stenting Undergoing Non-Cardiac Surgery","year":2009,"lang":"en","type":"article","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Acute coronary syndrome; Discontinuation; Clinical endpoint; Aspirin; Surgery; Stent; Stroke (engine); Clopidogrel; Internal medicine; Perioperative; Coronary stent; Cardiology; Myocardial infarction; Revascularization; Canadian Cardiovascular Society; Angina; Randomized controlled trial; Restenosis","score_opus":0.024655818237277936,"score_gpt":0.28563265545271777,"score_spread":0.26097683721543985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1557499563","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982873,0.0006259558,0.00020255463,0.00007404679,0.000094151204,0.00062798616,0.0000021530793,0.00003157416,0.000054239885],"genre_scores_gemma":[0.99901974,0.00047729872,0.000095216325,0.00025812542,0.000053944248,0.000004388587,0.00006894046,0.000016755872,0.0000056177546],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99885267,0.00013419727,0.00030981374,0.00028098535,0.00024902468,0.00017332562],"domain_scores_gemma":[0.9994121,0.00017428552,0.00008276735,0.00018253038,0.00007351975,0.00007475536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033309165,0.00014657485,0.0005631329,0.00008449134,0.00009192533,0.000027187727,0.000023049628,0.00008052817,0.000012770262],"category_scores_gemma":[0.00005541662,0.000113080925,0.00024001385,0.00012760912,0.00005700788,0.00020411244,0.0000070406118,0.00011495738,0.0000035425444],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020586526,0.0002756919,0.9392214,0.000014324633,0.00033545427,0.000014745703,0.00012187731,0.000051985593,0.00003588154,0.0000064873434,0.0000036606689,0.05971264],"study_design_scores_gemma":[0.0028778487,0.00016670399,0.9962527,0.00013791458,0.00010848901,0.0000035038995,0.000105116684,0.00017284349,0.00001181579,0.000013037591,0.000007606689,0.00014239515],"about_ca_topic_score_codex":0.000003813724,"about_ca_topic_score_gemma":0.0000010698693,"teacher_disagreement_score":0.059570245,"about_ca_system_score_codex":0.000038778046,"about_ca_system_score_gemma":0.00008786821,"threshold_uncertainty_score":0.46113062},"labels":[],"label_agreement":null},{"id":"W1568121710","doi":"10.1046/j.1365-3148.2001.00328.x","title":"Interleukins 1β, 6, 8 and tumour necrosis factor α do not induce platelet activation","year":2001,"lang":"en","type":"letter","venue":"Transfusion Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; St. Michael's Hospital","funders":"","keywords":"Transfusion medicine; Medicine; Freedman; Blood transfusion; Family medicine; Surgery; Law; Political science","score_opus":0.027603177016158827,"score_gpt":0.2660213123282331,"score_spread":0.2384181353120743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1568121710","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5577759,0.002033781,0.0012063549,0.43560162,0.000553451,0.0011720966,0.00007152215,0.00021725554,0.0013680216],"genre_scores_gemma":[0.30916524,0.035154406,0.00008664337,0.6399695,0.01023746,0.00008375013,0.0012115969,0.00025601572,0.0038353405],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99655896,0.00017392752,0.00068009715,0.0008613229,0.0011974318,0.0005282527],"domain_scores_gemma":[0.9985399,0.00021534566,0.00018257735,0.0006136721,0.00016672663,0.00028174339],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00029165123,0.00069012673,0.0014809731,0.00047506383,0.0001731228,0.000034846973,0.00019060718,0.001088304,0.0027677605],"category_scores_gemma":[0.00010364725,0.0005145041,0.0004404626,0.0003696999,0.00032446723,0.00018106724,0.000030480021,0.0022020587,0.000039312177],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023062767,0.00018798302,0.0008288487,0.0017066553,0.0017635677,0.0039529456,0.0024967508,0.0000012339798,0.0698773,0.0000142080335,0.7059711,0.21089312],"study_design_scores_gemma":[0.009413205,0.001097849,0.009437476,0.0035258734,0.0011533074,0.0011224982,0.0002677428,0.000012865084,0.008434134,0.00006980797,0.96476936,0.00069587753],"about_ca_topic_score_codex":0.00035710417,"about_ca_topic_score_gemma":0.00000827137,"teacher_disagreement_score":0.25879824,"about_ca_system_score_codex":0.000116390765,"about_ca_system_score_gemma":0.00012220413,"threshold_uncertainty_score":0.99973065},"labels":[],"label_agreement":null},{"id":"W1569841568","doi":"10.1111/j.1749-6632.2010.05801.x","title":"Effect of dipyridamole during acute stroke: exploring antithrombosis and neuroprotective benefits","year":2010,"lang":"en","type":"review","venue":"Annals of the New York Academy of Sciences","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Lawson Health Research Institute; Western University","funders":"","keywords":"Dipyridamole; Medicine; Antithrombotic; Stroke (engine); Neuroprotection; Thrombosis; Inflammation; Regimen; Endothelium; Cardiology; Anesthesia; Pharmacology; Internal medicine","score_opus":0.115078703463304,"score_gpt":0.36626510262175593,"score_spread":0.2511863991584519,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1569841568","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.33182493,0.6673419,5.948869e-7,0.00012211349,0.000067916306,0.000549682,0.000033003344,0.000009381042,0.0000504987],"genre_scores_gemma":[0.05737634,0.9423427,0.00003492016,0.000026942438,0.00013078641,0.000018915704,5.863404e-7,0.000020978881,0.000047857917],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99783796,0.00022941957,0.000524098,0.00041659726,0.00071809586,0.00027384332],"domain_scores_gemma":[0.9987036,0.00022590047,0.00067996874,0.00022058882,0.000038376496,0.00013158334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010315492,0.0003180316,0.0019324204,0.00021911012,0.00015914423,0.000013633347,0.0006061488,0.00023756146,0.000008345602],"category_scores_gemma":[0.00015469392,0.00017943195,0.001224111,0.00063417654,0.00096542144,0.00016701517,0.00021258977,0.00054290076,0.0000011122763],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009975707,0.00003089114,0.0002617359,0.00826087,0.0010924493,0.0000012029091,0.000078376346,0.0000073067426,0.0015544276,0.000061064864,0.000040279192,0.9885116],"study_design_scores_gemma":[0.0022736925,0.0031821951,0.016140392,0.085904226,0.012952932,0.00036356156,0.00010145322,0.000007698596,0.74547786,0.00017822703,0.13245945,0.0009583223],"about_ca_topic_score_codex":0.000024245963,"about_ca_topic_score_gemma":2.090299e-7,"teacher_disagreement_score":0.9875533,"about_ca_system_score_codex":0.000004319416,"about_ca_system_score_gemma":0.000111138834,"threshold_uncertainty_score":0.73170227},"labels":[],"label_agreement":null},{"id":"W1576385546","doi":"10.1111/j.1476-5381.2011.01683.x","title":"Effects of P2Y<sub>1</sub>receptor antagonism on the reactivity of platelets from patients with stable coronary artery disease using aspirin and clopidogrel","year":2011,"lang":"en","type":"article","venue":"British Journal of Pharmacology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"Agence Nationale de la Recherche","keywords":"Antagonism; Clopidogrel; Aspirin; Platelet; Medicine; Coronary artery disease; Cardiology; Internal medicine; Pharmacology; Receptor","score_opus":0.012327052904711266,"score_gpt":0.22422205045463,"score_spread":0.21189499754991875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1576385546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954102,0.003684422,0.00009398396,0.000023587383,0.00029802794,0.00037354577,0.0000980316,0.0000056779018,0.000012531432],"genre_scores_gemma":[0.99752325,0.0019550333,0.000087870685,0.0002551293,0.00014032482,0.0000037473742,0.000011227842,0.00002220097,0.0000011953945],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987605,0.00028020548,0.00032382004,0.00015398592,0.00029834465,0.00018313917],"domain_scores_gemma":[0.9989602,0.00021134577,0.00039161506,0.00007985051,0.00018239842,0.0001746205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021302084,0.00013893607,0.0005123217,0.00006947958,0.00006442079,0.0000060096113,0.000088796565,0.00006272349,0.000067989975],"category_scores_gemma":[0.000031935477,0.000110047746,0.00019021351,0.00007267994,0.00025493823,0.00014357864,0.00003104911,0.00026666885,9.4429566e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018263366,0.0030636522,0.087854356,0.0003558747,0.0035072104,0.0042127753,0.0002199986,0.00001527574,0.80798644,0.0000046233486,0.0005183916,0.073998064],"study_design_scores_gemma":[0.006127689,0.0008315665,0.5288892,0.0005001759,0.0010091327,0.0003589958,0.000021262013,0.000013398509,0.46208987,0.000028634098,0.00004245282,0.000087658314],"about_ca_topic_score_codex":0.000043541007,"about_ca_topic_score_gemma":0.000001146698,"teacher_disagreement_score":0.44103482,"about_ca_system_score_codex":0.000029431634,"about_ca_system_score_gemma":0.00013721907,"threshold_uncertainty_score":0.44876167},"labels":[],"label_agreement":null},{"id":"W1597029249","doi":"10.1016/j.jcin.2012.10.008","title":"Same-Day Discharge Compared With Overnight Hospitalization After Uncomplicated Percutaneous Coronary Intervention","year":2013,"lang":"en","type":"review","venue":"JACC: Cardiovascular Interventions","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"McGill University","keywords":"Medicine; Conventional PCI; Observational study; Mace; Percutaneous coronary intervention; Randomized controlled trial; Odds ratio; Confidence interval; Cochrane Library; Internal medicine; Meta-analysis; Myocardial infarction","score_opus":0.033474682529420534,"score_gpt":0.3005284721665361,"score_spread":0.26705378963711557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1597029249","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00086015544,0.97620916,0.01628659,0.000025926485,0.0005235169,0.0047994126,0.00043003605,0.00041306816,0.00045216052],"genre_scores_gemma":[0.0085219685,0.97959673,0.0003799763,0.000050583636,0.00042198595,0.002135207,0.005688025,0.00035273738,0.0028527882],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99389076,0.0011634823,0.0015829431,0.0014041,0.0012559969,0.0007026889],"domain_scores_gemma":[0.9960189,0.000078461264,0.00053382193,0.002425867,0.0005007724,0.0004421674],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0006954494,0.0012088661,0.004671471,0.0005383388,0.00025096838,0.00024212565,0.0004756435,0.00059813855,0.0027219632],"category_scores_gemma":[0.000071179886,0.00091610145,0.024190903,0.00078738085,0.00026421252,0.0003748995,0.00023651264,0.0007986127,0.0011987186],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021024878,0.0014242835,0.00022988586,0.03931228,0.06890951,0.0019285562,0.00009685304,0.00005456182,9.802997e-7,0.00006798177,0.0022670282,0.8854978],"study_design_scores_gemma":[0.002202123,0.0004866536,0.0012179962,0.05036058,0.04047707,0.008448306,0.0001130283,0.000036514295,0.0000018980655,0.000020821686,0.89550173,0.0011332838],"about_ca_topic_score_codex":0.00010848666,"about_ca_topic_score_gemma":0.00002649431,"teacher_disagreement_score":0.89323467,"about_ca_system_score_codex":0.0005283192,"about_ca_system_score_gemma":0.00019615082,"threshold_uncertainty_score":0.99957895},"labels":[],"label_agreement":null},{"id":"W159981109","doi":"","title":"Abstract 17076: A Novel Polymer-Free Ciglitazone-Eluting Stent Inhibits Neointimal Proliferation Stronger than Sirolimus-Eluting Stents: An Experimental Study Using Optical Coherence Tomography in Rabbit Iliacal Arteries","year":2010,"lang":"en","type":"article","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Sirolimus; Restenosis; Stent; Optical coherence tomography; Coronary arteries; Neointima; Ciglitazone; Urology; Internal medicine; Cardiology; Artery; Radiology; Agonist; Receptor","score_opus":0.028594497676032657,"score_gpt":0.28453754579995,"score_spread":0.2559430481239173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W159981109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99654126,0.00032374897,0.0012557126,0.00002830295,0.00024810559,0.0013817326,0.000011626862,0.00011025939,0.00009922754],"genre_scores_gemma":[0.99854404,0.0000013778707,0.0008138755,0.000042519507,0.0004050028,0.000058876925,0.00008359039,0.000048420403,0.000002270464],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99751097,0.00009351311,0.0006240319,0.0006123774,0.00070074975,0.0004583612],"domain_scores_gemma":[0.998888,0.000033987028,0.00017122332,0.00055649324,0.00012978974,0.00022051045],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005370757,0.0003204696,0.00045262877,0.0002552781,0.00024166431,0.00013056851,0.00013672146,0.00019117081,0.0000587864],"category_scores_gemma":[0.000076103985,0.00031820498,0.00027295342,0.00026527507,0.0001372323,0.0007297399,0.00006828122,0.00044514376,0.0000037668974],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041296502,0.0017810143,0.496274,0.000035535777,0.000117528325,0.00003507756,0.0013596045,0.0003008043,0.49718386,0.000057746816,3.298275e-7,0.0024415404],"study_design_scores_gemma":[0.0052214153,0.00039328428,0.93495226,0.00015094351,0.00017155815,0.0001224005,0.0056881984,0.0076356437,0.045298785,0.000015767917,0.000002171913,0.0003475926],"about_ca_topic_score_codex":0.00011967307,"about_ca_topic_score_gemma":0.00007748708,"teacher_disagreement_score":0.45188507,"about_ca_system_score_codex":0.00008772741,"about_ca_system_score_gemma":0.000108319735,"threshold_uncertainty_score":0.999927},"labels":[],"label_agreement":null},{"id":"W16565241","doi":"10.1155/2009/509258","title":"Acetylsalicylic Acid Use in Patients with Acute Myocardial Infarction and Peptic Ulcer Bleeding","year":2009,"lang":"en","type":"article","venue":"Canadian Journal of Gastroenterology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of Alberta Hospital","funders":"","keywords":"Medicine; Myocardial infarction; Internal medicine; Gastrointestinal bleeding; Multivariate analysis; Risk factor; Peptic ulcer; Aspirin; Surgery","score_opus":0.006167864121729999,"score_gpt":0.2006499150636043,"score_spread":0.1944820509418743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W16565241","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987616,0.00014506308,0.000110769506,0.00073395314,0.00010291354,0.00011056583,0.000006453662,0.0000030975084,0.00002561591],"genre_scores_gemma":[0.9977137,0.00006609731,0.00014584037,0.0019397141,0.00010843747,7.4863425e-7,0.0000072606254,0.000009767767,0.000008433719],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99920636,0.000060335282,0.00020652798,0.000108543696,0.000121510464,0.00029671297],"domain_scores_gemma":[0.9992575,0.0000058873657,0.00008905624,0.00009423678,0.00010964142,0.00044370283],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001210288,0.00010833934,0.0003349005,0.00033825473,0.000040896273,0.000022790538,0.000047429454,0.000059406488,0.00002181708],"category_scores_gemma":[0.000022487218,0.00008839834,0.00010842591,0.00008089203,0.00008351831,0.00019671973,0.000003411422,0.00021378523,0.000001085719],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026382345,0.000027391816,0.9944235,0.000003420112,0.00048815826,0.00043865442,0.00009638172,0.000016606145,0.0001041221,0.0000071501995,0.00017439766,0.001581962],"study_design_scores_gemma":[0.00568617,0.003701869,0.98839295,0.00006140351,0.00028820726,0.0012632612,0.000032178483,0.000004131056,0.00001175707,0.000011334064,0.00050038035,0.000046349753],"about_ca_topic_score_codex":0.00013429072,"about_ca_topic_score_gemma":0.0008783027,"teacher_disagreement_score":0.006030563,"about_ca_system_score_codex":0.00009103118,"about_ca_system_score_gemma":0.00015927815,"threshold_uncertainty_score":0.36047798},"labels":[],"label_agreement":null},{"id":"W1671633210","doi":"","title":"[Is long-term use of clopidogrel cost-effective in high-risk atherothrombotic patients?].","year":2009,"lang":"en","type":"article","venue":"PubMed","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Clopidogrel; Medicine; Aspirin; Life expectancy; Myocardial infarction; Internal medicine; Stroke (engine); Cardiology; Population","score_opus":0.02069251018256007,"score_gpt":0.24169643890414938,"score_spread":0.2210039287215893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1671633210","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99484414,0.0007764084,0.00014780682,0.00007592018,0.00010032338,0.0039055154,0.000029903744,0.00003655235,0.00008340922],"genre_scores_gemma":[0.9980175,0.0006061251,0.000037946465,0.0004580884,0.00006469348,0.00068255264,0.000034117576,0.000018280305,0.00008068986],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99876624,0.00012334037,0.00024855242,0.00025755327,0.0002867977,0.0003174908],"domain_scores_gemma":[0.99924606,0.00007276357,0.00010294686,0.00035345668,0.00008326701,0.0001414821],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018564779,0.00015744782,0.00045769056,0.000121188146,0.00002653134,0.000012000803,0.00006871393,0.00009595382,0.000032296775],"category_scores_gemma":[0.00012933568,0.00013363878,0.00029454814,0.0002387047,0.00006947175,0.00012966304,0.0000149440275,0.00014797229,0.000009983726],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031144507,0.0004101558,0.5755764,0.000024725627,0.00019186464,0.000020719724,0.00007171011,0.000008761092,0.0000042863085,0.000012908824,0.00005708613,0.4233099],"study_design_scores_gemma":[0.004830312,0.00021384636,0.9932107,0.00005905495,0.000277661,0.0000043912187,0.0000057256216,0.000005831215,0.0008945824,0.000060923052,0.00030894327,0.0001280836],"about_ca_topic_score_codex":0.000053338077,"about_ca_topic_score_gemma":0.000007801074,"teacher_disagreement_score":0.4231818,"about_ca_system_score_codex":0.00007768462,"about_ca_system_score_gemma":0.000017341235,"threshold_uncertainty_score":0.5449631},"labels":[],"label_agreement":null},{"id":"W1761831146","doi":"10.1016/j.ahj.2015.05.017","title":"Concomitant proton-pump inhibitor use, platelet activity, and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel and managed without revascularization: Insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes trial","year":2015,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; St. Michael's Hospital","funders":"","keywords":"Prasugrel; Medicine; Clopidogrel; Platelet inhibition; Concomitant; Platelet; Internal medicine; Cardiology; Platelet aggregation inhibitor; Revascularization; Proton-pump inhibitor; Pharmacology; Myocardial infarction","score_opus":0.031473324631165873,"score_gpt":0.3017784326389759,"score_spread":0.27030510800781005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1761831146","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99259156,0.00021130926,0.0002790594,0.0019293884,0.00017252399,0.0046470626,0.00010016987,0.00006062144,0.000008280469],"genre_scores_gemma":[0.9962297,0.00049257674,0.0012452049,0.0014670073,0.00017407279,0.00014827205,0.00013955553,0.0000759166,0.000027676359],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99579746,0.001042437,0.00073587813,0.00068864104,0.0012391153,0.0004964738],"domain_scores_gemma":[0.9975139,0.00052180287,0.0003396429,0.00052801793,0.00025988935,0.0008367701],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006966795,0.0005251855,0.0013897532,0.00019235432,0.00035511822,0.00022937608,0.00019211324,0.00023910611,0.000015183934],"category_scores_gemma":[0.00017287555,0.00027865602,0.00023485346,0.00060393225,0.00077624735,0.0005182831,0.00016096832,0.001318153,0.0000066651273],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18837179,0.0006630883,0.78870016,0.000014506491,0.008045387,0.0038981761,0.00051955844,0.00009793542,0.000027141068,0.000005872624,0.00037248316,0.009283895],"study_design_scores_gemma":[0.07112654,0.020757928,0.9030415,0.00032761326,0.0013496754,0.0016858922,0.0006044424,0.000087441345,0.000042987358,0.00000925724,0.0005480775,0.00041866457],"about_ca_topic_score_codex":0.00027509657,"about_ca_topic_score_gemma":0.00010459212,"teacher_disagreement_score":0.11724525,"about_ca_system_score_codex":0.00014358485,"about_ca_system_score_gemma":0.00039724167,"threshold_uncertainty_score":0.99996656},"labels":[],"label_agreement":null},{"id":"W1774426215","doi":"10.1212/wnl.0000000000001844","title":"Effect of clopidogrel with aspirin on functional outcome in TIA or minor stroke","year":2015,"lang":"en","type":"article","venue":"Neurology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences","funders":"","keywords":"Aspirin; Clopidogrel; Medicine; Stroke (engine); Modified Rankin Scale; Minor stroke; Internal medicine; Quality of life (healthcare); Anesthesia; Ischemic stroke","score_opus":0.030253705936865348,"score_gpt":0.28555951950881275,"score_spread":0.2553058135719474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1774426215","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997823,0.00016424197,0.000033344666,0.00028588573,0.00015425212,0.00021260735,0.000004703553,0.000020657722,0.0013012921],"genre_scores_gemma":[0.99852026,0.0000074504173,0.0000115696885,0.001047631,0.00008033817,0.000015445647,0.000010514881,0.000013027614,0.00029375564],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99918747,0.000166299,0.00013728836,0.0001750365,0.00019509718,0.0001387986],"domain_scores_gemma":[0.9995393,0.000121736426,0.00003582567,0.00019350827,0.000028458662,0.000081161656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000203561,0.0001015934,0.00034111278,0.00009163636,0.000008559694,0.0000014340167,0.000038942962,0.00008004958,0.00007577198],"category_scores_gemma":[0.000059106467,0.00006136649,0.000102148544,0.000083511775,0.00007311688,0.000017239896,0.0000115879275,0.00016136163,0.000037221824],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.059710734,0.00015585676,0.93070596,0.000067023684,0.00015734351,0.00076998345,0.00001892722,0.00016892141,0.00020450792,0.000048659622,0.00020979824,0.0077822525],"study_design_scores_gemma":[0.01658204,0.041805945,0.92741793,0.000022678554,0.00022644993,0.0005843195,0.000006844111,0.000054209195,0.0018297109,0.00000765411,0.011348803,0.00011343859],"about_ca_topic_score_codex":0.000021814465,"about_ca_topic_score_gemma":0.000020639613,"teacher_disagreement_score":0.04312869,"about_ca_system_score_codex":0.000008327201,"about_ca_system_score_gemma":0.000058361635,"threshold_uncertainty_score":0.25024527},"labels":[],"label_agreement":null},{"id":"W1788709049","doi":"10.1016/j.ahj.2015.06.011","title":"Long-term outcomes for women versus men with unstable angina/non–ST-segment elevation myocardial infarction managed medically without revascularization: Insights from the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes trial","year":2015,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Canadian VIGOUR Centre","funders":"Duke Clinical Research Institute; Daiichi-Sankyo; Daiichi Sankyo Europe; Eli Lilly and Company","keywords":"Medicine; Cardiology; Revascularization; Myocardial infarction; Internal medicine; Term (time); ST segment; Unstable angina; Elevation (ballistics); Angina; Myocardial revascularization","score_opus":0.02511108504855938,"score_gpt":0.2911695305461282,"score_spread":0.26605844549756885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1788709049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.943087,0.00021105059,0.04553025,0.0077942917,0.00041434183,0.0027678914,0.00004937646,0.0000656337,0.00008017309],"genre_scores_gemma":[0.9906927,0.00024063418,0.0023483732,0.004641949,0.0010588295,0.0004064295,0.00040133653,0.000063650594,0.00014609618],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99644893,0.0004568794,0.00056795386,0.0004408324,0.0015460001,0.000539415],"domain_scores_gemma":[0.9979396,0.00021058555,0.0002463447,0.00049514405,0.0003517247,0.0007566417],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012043453,0.0003508881,0.00081146654,0.00016702911,0.0005029286,0.00018027691,0.00023749296,0.00015460124,0.00008201743],"category_scores_gemma":[0.00018790386,0.00020201385,0.00036910363,0.00059342344,0.00025946464,0.0003037404,0.00007452739,0.00065753475,0.000017839435],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5697935,0.0016622547,0.12499351,0.00012956095,0.053352017,0.002772783,0.01267135,0.013402257,0.0023185674,0.00024993363,0.056583915,0.16207033],"study_design_scores_gemma":[0.12452049,0.02667646,0.8044454,0.00040467017,0.0034820181,0.0014413102,0.008454071,0.0008894906,0.00019012037,0.00018458981,0.028284641,0.001026737],"about_ca_topic_score_codex":0.00009624737,"about_ca_topic_score_gemma":0.000021318412,"teacher_disagreement_score":0.6794519,"about_ca_system_score_codex":0.0003944399,"about_ca_system_score_gemma":0.00064704835,"threshold_uncertainty_score":0.8237886},"labels":[],"label_agreement":null},{"id":"W1800020109","doi":"10.3109/09537104.2015.1064881","title":"The role of platelets in the recruitment of leukocytes during vascular disease","year":2015,"lang":"en","type":"review","venue":"Platelets","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":189,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"British Heart Foundation","keywords":"Platelet; Immunology; Medicine; Biology","score_opus":0.06576114881895714,"score_gpt":0.33559552715983293,"score_spread":0.26983437834087576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1800020109","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019388473,0.97708035,9.913426e-7,0.00002308008,0.000105146646,0.0027256007,0.00006213418,0.000025030928,0.0005891825],"genre_scores_gemma":[0.01637484,0.9828202,0.000011536605,0.000017519298,0.00015153922,0.00036456092,0.00013250357,0.00006716683,0.000060136896],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99649847,0.0005671343,0.001017676,0.0004266193,0.0010422252,0.00044790574],"domain_scores_gemma":[0.9974842,0.0003565942,0.00048193778,0.0013353468,0.0001331005,0.00020883301],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013477154,0.0005008037,0.002250354,0.0001871285,0.000109898974,0.000024883031,0.00060194865,0.00023792038,0.000022862892],"category_scores_gemma":[0.00017424936,0.00025961388,0.0018581898,0.00046408846,0.00022931512,0.00006240551,0.00010938932,0.00048738916,0.000026494941],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036292724,0.00030525363,0.00011363908,0.009988418,0.0022766625,0.0006671172,0.00023984074,0.00001191319,0.0000065466975,0.00032955542,0.000063123,0.985635],"study_design_scores_gemma":[0.0012617677,0.00009350736,0.00042047817,0.0077803344,0.0025899578,0.00020954318,0.00020051311,0.0000065638387,0.000087677276,0.00017946129,0.98690754,0.00026266018],"about_ca_topic_score_codex":0.000026096408,"about_ca_topic_score_gemma":0.0000034777001,"teacher_disagreement_score":0.9868444,"about_ca_system_score_codex":0.00012606452,"about_ca_system_score_gemma":0.0007470789,"threshold_uncertainty_score":0.99998564},"labels":[],"label_agreement":null},{"id":"W1808601199","doi":"10.1016/j.jacc.2015.06.1323","title":"Incidence, Predictors, and Impact of Post-Discharge Bleeding After Percutaneous Coronary Intervention","year":2015,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":448,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Sacré-Cœur de Montréal","funders":"","keywords":"Medicine; Percutaneous coronary intervention; Conventional PCI; Hazard ratio; Internal medicine; Proportional hazards model; Myocardial infarction; Incidence (geometry); Interquartile range; Population; Cardiology; Surgery; Confidence interval","score_opus":0.009565316787636596,"score_gpt":0.26834446774435433,"score_spread":0.2587791509567177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1808601199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99506104,0.0041396464,0.00010417535,0.00015361908,0.00018817643,0.00014010194,0.00009199089,0.0000036560555,0.00011760658],"genre_scores_gemma":[0.9989105,0.00064123044,0.00012176914,0.00005671229,0.00021125127,0.0000012817313,0.0000013772183,0.000012105558,0.00004376883],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987668,0.00027189121,0.00043020977,0.0000921001,0.0003045581,0.00013444139],"domain_scores_gemma":[0.99857104,0.00006958133,0.00056591723,0.00019608576,0.000453165,0.0001442109],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005371078,0.00011527786,0.0008870411,0.00013416963,0.000020145424,0.0000021223975,0.00013166362,0.00004562259,0.000013870959],"category_scores_gemma":[0.00017056624,0.00006844227,0.001088295,0.0001749177,0.00049209315,0.000077220146,0.000059155172,0.00016606091,3.9941872e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011450861,0.0000772979,0.9685076,0.00006476248,0.0040865275,0.0011654856,0.00020260757,0.00025116137,0.010137578,0.000011715797,0.0014813532,0.0025630367],"study_design_scores_gemma":[0.0021314907,0.008041583,0.92663765,0.00028395018,0.0011994252,0.058930945,0.0017725939,0.000034979865,0.0003095942,0.00009486032,0.00046334552,0.00009955535],"about_ca_topic_score_codex":0.000021876389,"about_ca_topic_score_gemma":0.0000011146252,"teacher_disagreement_score":0.05776546,"about_ca_system_score_codex":0.00007745019,"about_ca_system_score_gemma":0.00023108866,"threshold_uncertainty_score":0.2790995},"labels":[],"label_agreement":null},{"id":"W1825734667","doi":"10.1160/th13-07-0624","title":"Effects of vorapaxar on platelet reactivity and biomarker expression in non-ST-elevation acute coronary syndromes","year":2014,"lang":"en","type":"article","venue":"Thrombosis and Haemostasis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Tellabs (Canada); Université Laval","funders":"","keywords":"Medicine; Platelet activation; Internal medicine; Platelet; Pharmacology; Placebo; Pathology","score_opus":0.023825925995898726,"score_gpt":0.2867611377073741,"score_spread":0.2629352117114754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1825734667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982194,0.00082776195,0.00016826003,0.00016905428,0.000040753435,0.0004034395,0.000018358334,0.000021359605,0.00013164317],"genre_scores_gemma":[0.9949378,0.004633858,0.00016426451,0.00016477601,0.00001693184,0.000019318422,0.00003386158,0.00001870481,0.000010534684],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9990616,0.0001057048,0.00017944827,0.00028271053,0.0002119333,0.00015860787],"domain_scores_gemma":[0.99941087,0.0001777419,0.000081178645,0.0002106578,0.000028487066,0.00009105208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002572016,0.00016786277,0.0005238581,0.00012528362,0.00006390151,0.00001089918,0.000035406498,0.00011303845,0.00001912762],"category_scores_gemma":[0.000034101024,0.00013378791,0.00010366497,0.00013307451,0.00011262085,0.00011402712,0.000034423494,0.0000953242,0.0000020169155],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021315783,0.0008083035,0.11890569,0.0010429908,0.0011531434,0.00008840758,0.0005859999,0.0000023310226,0.27115986,0.00009523819,0.00066202995,0.6033644],"study_design_scores_gemma":[0.0033839368,0.00043987037,0.88269997,0.00057428115,0.00026082693,0.000032294058,0.000047554953,0.00010719012,0.11184998,0.00008576372,0.00038456675,0.00013374367],"about_ca_topic_score_codex":0.0000315572,"about_ca_topic_score_gemma":0.0000022637769,"teacher_disagreement_score":0.7637943,"about_ca_system_score_codex":0.000016508864,"about_ca_system_score_gemma":0.000012592795,"threshold_uncertainty_score":0.54557127},"labels":[],"label_agreement":null},{"id":"W1833202515","doi":"10.1111/jth.12924","title":"Use of genetic data to guide therapy in arterial disease","year":2015,"lang":"en","type":"review","venue":"Journal of Thrombosis and Haemostasis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"Canada Research Chairs","keywords":"Pharmacogenetics; Medicine; Clopidogrel; Pharmacogenomics; Warfarin; Intensive care medicine; Aspirin; Dabigatran; Drug response; Disease; VKORC1; Drug; Pharmacology; Bioinformatics; Internal medicine; CYP2C9; Atrial fibrillation; Biology; Genetics","score_opus":0.3889125946845949,"score_gpt":0.4359078335342217,"score_spread":0.04699523884962681,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1833202515","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013527882,0.9850734,0.000034747693,0.00015675998,0.00021438586,0.0005713804,0.0004082844,0.000003888737,0.000009281407],"genre_scores_gemma":[0.00027410014,0.99775106,0.0012766324,0.0001744702,0.00038228312,0.000005372268,0.00007504524,0.000045061166,0.00001599519],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975749,0.00023271333,0.0011654397,0.00029282356,0.0005416205,0.0001924849],"domain_scores_gemma":[0.9977475,0.00008132162,0.0005716559,0.0008708959,0.00022765937,0.0005009619],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066081877,0.00030754294,0.0027738912,0.00034154867,0.00002462077,0.000049618353,0.00034039727,0.00013685453,0.0000751895],"category_scores_gemma":[0.00017194216,0.00020752194,0.0007434408,0.00026942373,0.00007412815,0.00017994954,0.000146418,0.00021172767,0.0000036033423],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004874642,0.0002635697,0.00040664015,0.0019759012,0.001979741,0.00017294181,0.00005405685,0.0000023779985,0.0000035690045,0.0000015744907,0.012993443,0.9816587],"study_design_scores_gemma":[0.0015568904,0.00037280272,0.004411026,0.009323251,0.0038782933,0.00015592315,0.000026957978,0.0000023267282,0.0000020840437,0.000009064856,0.98006743,0.00019395072],"about_ca_topic_score_codex":0.000026278996,"about_ca_topic_score_gemma":0.000003057974,"teacher_disagreement_score":0.98146474,"about_ca_system_score_codex":0.000068749745,"about_ca_system_score_gemma":0.0007931638,"threshold_uncertainty_score":0.84624994},"labels":[],"label_agreement":null},{"id":"W18617680","doi":"10.1016/j.jacc.2014.11.034","title":"Economic Analysis of Ticagrelor Therapy From a U.S. Perspective","year":2015,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Merck; AstraZeneca; Bayer; St. Jude Medical; Pfizer; Duke Clinical Research Institute; U.S. Food and Drug Administration; Eli Lilly and Company; Gilead Sciences; Boehringer Ingelheim","keywords":"Ticagrelor; Medicine; Clopidogrel; Aspirin; Acute coronary syndrome; Population; Regimen; Quality-adjusted life year; Pharmacy; Life expectancy; Managed care; Cost effectiveness; Internal medicine; Intensive care medicine; Health care; Myocardial infarction","score_opus":0.01822530144121418,"score_gpt":0.28177854701305904,"score_spread":0.26355324557184484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W18617680","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924034,0.004930288,0.00031274214,0.000880337,0.00019487091,0.000106723804,0.00016117908,0.0000030473468,0.0010074265],"genre_scores_gemma":[0.9979518,0.0012611911,0.00026287828,0.00018219223,0.00029705034,0.0000011327119,0.0000015242822,0.000010436521,0.000031781783],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99874216,0.00034120213,0.00043511146,0.00011680609,0.00024812768,0.00011655978],"domain_scores_gemma":[0.9981442,0.00015377252,0.0007808306,0.0003849614,0.00042209012,0.00011415119],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042494424,0.00010942781,0.001646135,0.0002448864,0.000018021121,0.0000014965667,0.00023340512,0.000040721534,0.000024918532],"category_scores_gemma":[0.00012551967,0.000066846405,0.0019853297,0.00046245835,0.00055406854,0.000033810877,0.00003404425,0.00013391797,0.0000015148162],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026538584,0.00032625784,0.68779546,0.000014395383,0.22938304,0.0006285345,0.0011136465,0.024132375,0.008478053,0.0014499329,0.010985713,0.0091540245],"study_design_scores_gemma":[0.008763169,0.0039820326,0.925503,0.00006332688,0.019819323,0.0010574507,0.015111591,0.00036458203,0.004810278,0.0019206057,0.018330216,0.0002743939],"about_ca_topic_score_codex":0.000118404154,"about_ca_topic_score_gemma":0.0000053360354,"teacher_disagreement_score":0.23770759,"about_ca_system_score_codex":0.00013591655,"about_ca_system_score_gemma":0.00048797522,"threshold_uncertainty_score":0.2725917},"labels":[],"label_agreement":null},{"id":"W1872035376","doi":"10.1055/s-0037-1613448","title":"Differential regulation of P-selectin expression by protein kinase A and protein kinase G in thrombin-stimulated human platelets","year":2003,"lang":"en","type":"article","venue":"Thrombosis and Haemostasis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"Canadian Institutes of Health Research; Heart And Stroke Foundation Of Quebec","keywords":"Forskolin; Protein kinase A; Platelet activation; Adenylyl cyclase; Platelet; cGMP-dependent protein kinase; Gs alpha subunit; Chemistry; Thrombin; Intracellular; P-selectin; cAMP-dependent pathway; Phosphodiesterase 3; Kinase; Endocrinology; Internal medicine; Signal transduction; Biology; Mitogen-activated protein kinase kinase; Biochemistry; Receptor; Medicine","score_opus":0.026227241442548913,"score_gpt":0.2829478280812679,"score_spread":0.256720586638719,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1872035376","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99656516,0.0016195133,0.00013908709,0.00008423489,0.000016335762,0.0013315313,0.000025309404,0.000042983163,0.00017586551],"genre_scores_gemma":[0.9991719,0.00024758797,0.00026160994,0.000027793376,0.000017319857,0.000065940025,0.00007847795,0.00003582971,0.00009353055],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99837404,0.00020776712,0.0003965914,0.00043146499,0.0003069403,0.0002832195],"domain_scores_gemma":[0.99933285,0.000021274429,0.0001359099,0.00028963055,0.00006778404,0.00015252703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021235707,0.00026423176,0.0006575257,0.00013933283,0.00016230096,0.00002977867,0.000047190744,0.00018435744,0.00030258688],"category_scores_gemma":[0.00004484671,0.00022931484,0.00012995853,0.0002499326,0.00016688938,0.00012641413,0.00003208897,0.00017336423,0.0000013818621],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040646098,0.00069716934,0.005094227,0.00027294172,0.00018265612,0.000015102544,0.0002987035,0.000002691766,0.9861352,0.00036893724,0.00018402544,0.006341914],"study_design_scores_gemma":[0.006537931,0.0004978422,0.06829447,0.0007803055,0.00018093083,0.000018328705,0.00013486251,0.00007631691,0.9223568,0.0005269411,0.00032299678,0.0002722711],"about_ca_topic_score_codex":0.0001167451,"about_ca_topic_score_gemma":0.000009942234,"teacher_disagreement_score":0.06377837,"about_ca_system_score_codex":0.000033484423,"about_ca_system_score_gemma":0.000035304216,"threshold_uncertainty_score":0.93511873},"labels":[],"label_agreement":null},{"id":"W1877581810","doi":"10.1111/j.1538-7836.2012.04641.x","title":"Reversal of the anti‐platelet effects of aspirin and clopidogrel","year":2012,"lang":"en","type":"article","venue":"Journal of Thrombosis and Haemostasis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":151,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton General Hospital; Juravinski Hospital; Population Health Research Institute; McMaster University","funders":"","keywords":"Clopidogrel; Aspirin; Platelet; Medicine; Cohort; Arachidonic acid; Blood sampling; Internal medicine; Anesthesia; Pharmacology; Gastroenterology; Chemistry; Biochemistry","score_opus":0.021159140046642978,"score_gpt":0.2805099493730894,"score_spread":0.2593508093264464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1877581810","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97860616,0.02053528,0.00003729233,0.0004024741,0.0001971935,0.00013120608,0.0000065297613,0.0000022637446,0.00008161331],"genre_scores_gemma":[0.9882721,0.011129471,0.00029336283,0.00016131054,0.00012325557,5.0294153e-7,5.366969e-7,0.0000103017055,0.000009209055],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99910223,0.0000817157,0.00032455262,0.000066315326,0.00028920948,0.00013598385],"domain_scores_gemma":[0.99920154,0.00009013156,0.0003148551,0.00016292719,0.000105986066,0.00012457116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003873771,0.00010384384,0.00058053574,0.000064018015,0.00004802109,0.000006154266,0.00006510912,0.00006885249,0.000020585108],"category_scores_gemma":[0.00006955326,0.000060834478,0.0003555812,0.00011491628,0.00017590287,0.00012310164,0.000044411223,0.00012981668,3.470091e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057909155,0.0007326505,0.8170532,0.0020246538,0.0049108565,0.000024393134,0.0015105001,0.000003367682,0.04160975,0.0003116299,0.0033340056,0.12790589],"study_design_scores_gemma":[0.0028502617,0.00040006227,0.86376256,0.000778072,0.0013807586,0.00031896835,0.0002338538,0.0000020456691,0.12599932,0.000038795468,0.0041518346,0.00008346119],"about_ca_topic_score_codex":0.000010029818,"about_ca_topic_score_gemma":3.409758e-7,"teacher_disagreement_score":0.12782243,"about_ca_system_score_codex":0.000009732361,"about_ca_system_score_gemma":0.000035054625,"threshold_uncertainty_score":0.2480758},"labels":[],"label_agreement":null},{"id":"W1879451449","doi":"10.1111/j.1365-2036.2011.04935.x","title":"PPI co‐therapy did not adversely affect outcomes in clopidogrel users","year":2011,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"GlaxoSmithKline","keywords":"Clopidogrel; Medicine; Discontinuation; Proton-pump inhibitor; Percutaneous coronary intervention; Confounding; Hazard ratio; Internal medicine; Confidence interval; Population; Intensive care medicine; Adverse effect; Aspirin; Myocardial infarction","score_opus":0.06489476994855954,"score_gpt":0.3417638286430503,"score_spread":0.2768690586944908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1879451449","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6536531,0.020855619,0.00001944942,0.31380948,0.00512275,0.0045085987,0.00047631495,0.0004710995,0.0010836052],"genre_scores_gemma":[0.0468996,0.02371759,0.00010445394,0.92406166,0.0020421832,0.0002466718,0.0012197086,0.00025878838,0.0014493618],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954456,0.00085499045,0.00077689445,0.0010392413,0.0007213066,0.0011619637],"domain_scores_gemma":[0.99826354,0.00032781303,0.00031207353,0.00081443624,0.00008175475,0.00020037453],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00042237405,0.0010751383,0.0018913312,0.00051705894,0.00015321752,0.000023573903,0.00057589717,0.0012570948,0.0030109785],"category_scores_gemma":[3.379591e-7,0.0009480922,0.0014482872,0.00027431382,0.0005190469,0.00016126124,0.000080829195,0.0026255185,0.00033612503],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0085145775,0.0026369197,0.20278004,0.000416814,0.19772264,0.014316688,0.0011462517,0.000011549408,0.01202949,0.0000055060364,0.5501958,0.010223741],"study_design_scores_gemma":[0.015612492,0.0011853093,0.017923186,0.00009611131,0.018313466,0.00023747323,0.00007625157,0.000011105161,0.018895607,0.000025473963,0.9265656,0.001057935],"about_ca_topic_score_codex":0.00014904604,"about_ca_topic_score_gemma":0.0000070396336,"teacher_disagreement_score":0.61025214,"about_ca_system_score_codex":0.00030730892,"about_ca_system_score_gemma":0.00028429902,"threshold_uncertainty_score":0.99967545},"labels":[],"label_agreement":null},{"id":"W1886686547","doi":"10.1093/eurheartj/ehv443","title":"Long-term dual antiplatelet therapy for secondary prevention of cardiovascular events in the subgroup of patients with previous myocardial infarction: a collaborative meta-analysis of randomized trials","year":2015,"lang":"en","type":"review","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":371,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto; University Health Network","funders":"University of Toronto; Women's College Hospital; Cleveland Clinic; Heart and Stroke Foundation of Canada","keywords":"Medicine; Myocardial infarction; Aspirin; Randomized controlled trial; Subgroup analysis; Internal medicine; Meta-analysis; Cardiology; Platelet aggregation inhibitor; Intensive care medicine","score_opus":0.13455712037223283,"score_gpt":0.3756723557126026,"score_spread":0.24111523534036977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1886686547","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.021280658,0.9707743,0.00039365335,0.000010391898,0.00013174406,0.006914436,0.00043927328,0.000006218007,0.000049307084],"genre_scores_gemma":[0.017168514,0.9815459,0.00015603092,0.000025370371,0.0002635811,0.0001413633,0.00060396333,0.00007523792,0.000019992445],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9746531,0.02041082,0.0028504827,0.0003771288,0.0014630156,0.00024540286],"domain_scores_gemma":[0.9940673,0.0010042711,0.0027879975,0.00075709925,0.001260114,0.0001232019],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.027788652,0.0005198896,0.01717604,0.00078587886,0.00007213844,0.000022946344,0.00025390595,0.00014458886,0.0001123288],"category_scores_gemma":[0.0005699416,0.00026183832,0.026517069,0.0013040791,0.00020431947,0.00014377742,0.000034586054,0.00047583063,0.0000010991465],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03290511,0.0006728765,0.0008368138,0.0022408953,0.8556662,0.00004723167,0.00041843255,0.00009412646,3.220494e-7,0.000003057879,0.00012491866,0.10698998],"study_design_scores_gemma":[0.10853984,0.0014528595,0.008302702,0.0015503911,0.8056713,0.00017863089,0.000049477465,8.9051196e-7,0.0000035184332,0.000008424133,0.07396452,0.00027746288],"about_ca_topic_score_codex":0.0000033553247,"about_ca_topic_score_gemma":8.767957e-7,"teacher_disagreement_score":0.10671252,"about_ca_system_score_codex":0.000048907426,"about_ca_system_score_gemma":0.00076226046,"threshold_uncertainty_score":0.9999834},"labels":[],"label_agreement":null},{"id":"W1892727822","doi":"","title":"L’utilisation de l’aspirine à faible dose chez les femmes pour la prévention primaire des maladies cardiovasculaires; une autre preuve à la différence entre les sexes","year":2006,"lang":"fr","type":"article","venue":"","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Gynecology; Medicine","score_opus":0.018679913119137047,"score_gpt":0.25158537123716157,"score_spread":0.23290545811802452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1892727822","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7823236,0.187808,0.007470821,0.0019960008,0.00027866036,0.0007072321,0.000053485546,0.000364038,0.018998189],"genre_scores_gemma":[0.9128088,0.018838286,0.0012620882,0.0000488932,0.0010283293,0.00008839119,0.00020546059,0.00009463184,0.065625116],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99579865,0.0010902226,0.00062162307,0.0007679248,0.0007384573,0.0009831166],"domain_scores_gemma":[0.99836683,0.0003060792,0.00019298788,0.00063481665,0.00020757676,0.00029168965],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001175375,0.0006740457,0.0009307059,0.00020410873,0.0005238273,0.00017340167,0.00024650816,0.00058386597,0.001273631],"category_scores_gemma":[0.00012798533,0.0006153786,0.0015905824,0.00049955683,0.0011884673,0.0004700214,0.00011333379,0.00043024,0.00006884882],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051799155,0.0016271531,0.4993276,0.004983533,0.004040991,0.0009190261,0.0017676459,0.0027918871,0.0035554636,0.008181844,0.0052548735,0.467032],"study_design_scores_gemma":[0.0056863986,0.00021158496,0.87553793,0.0037786537,0.0035740086,0.0009786227,0.0059897914,0.0012917161,0.017567964,0.003446813,0.08104038,0.0008961094],"about_ca_topic_score_codex":0.004045353,"about_ca_topic_score_gemma":0.0018701829,"teacher_disagreement_score":0.46613586,"about_ca_system_score_codex":0.00040415503,"about_ca_system_score_gemma":0.0004054441,"threshold_uncertainty_score":0.99963933},"labels":[],"label_agreement":null},{"id":"W1912956730","doi":"10.1136/heartjnl-2014-307346","title":"Characterising and predicting bleeding in high-risk patients with an acute coronary syndrome","year":2015,"lang":"en","type":"article","venue":"Heart","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Heart Research Centre; St. Michael's Hospital; Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Medicine; TIMI; Acute coronary syndrome; Myocardial infarction; Internal medicine; Apixaban; Gastrointestinal bleeding; Placebo; Thrombolysis; Surgery; Warfarin; Atrial fibrillation; Rivaroxaban","score_opus":0.011168408466921674,"score_gpt":0.2315438711267125,"score_spread":0.22037546265979083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1912956730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992475,0.00031525808,0.000018938112,0.000045201963,0.000062208106,0.00022486321,0.000012016249,0.000050237417,0.000023808248],"genre_scores_gemma":[0.9992934,0.00006225155,0.0003552251,0.00014960604,0.00004444352,0.000006412016,0.00005240112,0.000020017782,0.000016249312],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99925363,0.000049086248,0.00011511663,0.00019103217,0.0002200734,0.00017103588],"domain_scores_gemma":[0.99957466,0.000011430727,0.000031784206,0.00014345717,0.00004445589,0.00019422312],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001953024,0.00009664329,0.00024206463,0.00005948675,0.000051555333,0.000018160628,0.000021657801,0.000045900753,0.000009480009],"category_scores_gemma":[0.00001406525,0.00007737635,0.000031752006,0.000086191714,0.000036526875,0.00023127579,0.000018551451,0.00012350536,0.00000507024],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047299985,0.00008668965,0.9960159,0.000017185124,0.00012918339,0.00021997621,0.00024686274,0.0000031036516,0.00004897412,0.0000015558793,0.000008819113,0.0027487401],"study_design_scores_gemma":[0.0036957737,0.00097318814,0.9940011,0.00017237297,0.00016033939,0.00048980484,0.00017637218,0.00009984655,0.000030870848,0.000011646103,0.00009705376,0.00009166101],"about_ca_topic_score_codex":0.000057767822,"about_ca_topic_score_gemma":0.0000030473393,"teacher_disagreement_score":0.0032227738,"about_ca_system_score_codex":0.000027293267,"about_ca_system_score_gemma":0.000036064586,"threshold_uncertainty_score":0.3155316},"labels":[],"label_agreement":null},{"id":"W192284609","doi":"10.1161/circ.120.suppl_18.s1032-c","title":"Abstract 5008: Effect of Clopidogrel Discontinuation on Platelet Function","year":2009,"lang":"en","type":"article","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Sacré-Cœur de Montréal","funders":"","keywords":"Medicine; Clopidogrel; Discontinuation; Platelet; Cardiology; Internal medicine; Aspirin","score_opus":0.009364859556167726,"score_gpt":0.25215026819369346,"score_spread":0.24278540863752573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W192284609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952375,0.00043825718,0.0013222852,0.000092475435,0.0001262431,0.00038782615,0.0000022819481,0.000061024726,0.0023320573],"genre_scores_gemma":[0.9994568,0.000037325357,0.000011611114,0.0001152237,0.0001870573,0.0000053433396,0.0001597482,0.0000097863785,0.000017103048],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.999212,0.000043290947,0.00019412354,0.00016902934,0.00027780424,0.00010372821],"domain_scores_gemma":[0.99955654,0.000041536572,0.00009354577,0.0002121286,0.000047411097,0.00004884709],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022606668,0.000110788584,0.00023995375,0.00009118002,0.000043798573,0.000008708705,0.000024166908,0.000088280365,0.00007138124],"category_scores_gemma":[0.00004605853,0.00009056666,0.00025578804,0.00012581247,0.000019603269,0.00010672903,0.0000019064443,0.00008031193,0.000038884704],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028720468,0.0002608961,0.067098446,0.000105426756,0.00027014286,0.00001785631,0.00008379433,0.0016397766,0.045686822,0.00071986194,0.00018113595,0.8810638],"study_design_scores_gemma":[0.0021442513,0.0006999859,0.98110956,0.00012460654,0.00016390653,0.000010251787,0.0000078949615,0.00028009823,0.014770957,0.00019427645,0.00040897026,0.00008526954],"about_ca_topic_score_codex":0.0000027649364,"about_ca_topic_score_gemma":2.121327e-7,"teacher_disagreement_score":0.91401106,"about_ca_system_score_codex":0.000033859393,"about_ca_system_score_gemma":0.000015660464,"threshold_uncertainty_score":0.36932012},"labels":[],"label_agreement":null},{"id":"W192358167","doi":"10.1161/circ.124.suppl_21.a16740","title":"Abstract 16740: Intracoronary versus Intravenous Administration of GP IIb/IIIa Inhibitors During Percutaneous Coronary Intervention for Acute Coronary Syndromes: A Meta-Analysis of Randomized Controlled Trials","year":2011,"lang":"en","type":"article","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Percutaneous coronary intervention; Randomized controlled trial; Cardiology; Internal medicine; Acute coronary syndrome; Myocardial infarction","score_opus":0.08045820289505413,"score_gpt":0.32820919274046345,"score_spread":0.24775098984540933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W192358167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98521733,0.006254317,0.0037789955,0.000024956264,0.0002592448,0.0041390355,0.00015701169,0.000055443405,0.00011366577],"genre_scores_gemma":[0.9978838,0.00040560064,0.000422335,0.000011239678,0.00006702927,0.00032760637,0.00081933296,0.00003671831,0.000026363834],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9955455,0.0007076347,0.0025617757,0.000410008,0.00055243773,0.00022263857],"domain_scores_gemma":[0.9961087,0.0011731293,0.0017396243,0.0004296211,0.0004334001,0.000115518975],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0032793328,0.0003387868,0.0068779406,0.0005472301,0.00008781374,0.000014041261,0.000103670536,0.00023660153,0.0010938357],"category_scores_gemma":[0.00087079057,0.00026132035,0.011984687,0.00032459083,0.00017992152,0.00021112706,0.000018374936,0.00012253571,0.000002616899],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4902492,0.0007477587,0.00051339454,0.0002883794,0.48993963,0.00021056349,0.00056331564,0.0004193272,0.013863279,0.00008898935,0.0000029229852,0.0031132563],"study_design_scores_gemma":[0.19199963,0.00068967626,0.12300093,0.000073938245,0.6779449,0.00051574054,0.00038536548,0.0011798363,0.0037778479,0.0001874964,0.0000010571682,0.0002435827],"about_ca_topic_score_codex":0.000054419525,"about_ca_topic_score_gemma":0.0000113738,"teacher_disagreement_score":0.29824954,"about_ca_system_score_codex":0.000090566566,"about_ca_system_score_gemma":0.00013148675,"threshold_uncertainty_score":0.9999839},"labels":[],"label_agreement":null},{"id":"W1929088536","doi":"10.1002/pds.3884","title":"Ticagrelor and bradycardia: a nested case–control study","year":2015,"lang":"en","type":"article","venue":"Pharmacoepidemiology and Drug Safety","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital; Health Sciences Centre; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; Vancouver General Hospital","funders":"Ontario Ministry of Health and Long-Term Care; Institute for Clinical Evaluative Sciences","keywords":"Medicine; Bradycardia; Nested case-control study; Ticagrelor; Internal medicine; Cardiology; Heart rate; Case-control study; Blood pressure; Acute coronary syndrome","score_opus":0.032166361953675074,"score_gpt":0.3299903061566307,"score_spread":0.29782394420295566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1929088536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97044474,0.023217916,0.0011804188,0.0031230813,0.00021917738,0.0008795612,0.000035541332,0.00010670039,0.0007928444],"genre_scores_gemma":[0.9948023,0.0010973986,0.00012818763,0.0034933605,0.00028590442,0.0000322712,0.000008697088,0.000017981749,0.00013392595],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973193,0.0015142531,0.0003490555,0.00040306148,0.00011313633,0.000301215],"domain_scores_gemma":[0.99820054,0.0009120219,0.00006596816,0.00022225655,0.00007628112,0.0005229468],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033390734,0.00021372459,0.0007920543,0.00006399699,0.00015205039,0.0000067938054,0.000041588042,0.00008869451,0.000049840928],"category_scores_gemma":[0.00057136005,0.00016335085,0.00015556569,0.00009713712,0.00021116738,0.000087766006,0.000049367154,0.00026075068,0.00001774908],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056845136,0.00047839008,0.8718382,0.000084950196,0.003755157,0.009881054,0.0015910938,0.000044087225,0.00007551526,0.00035331005,0.005521144,0.10069258],"study_design_scores_gemma":[0.064390644,0.0011789857,0.8028573,0.000066671026,0.008580548,0.04844543,0.006163253,0.0044136066,0.00006948747,0.0008652801,0.062078875,0.0008899263],"about_ca_topic_score_codex":0.00007734757,"about_ca_topic_score_gemma":0.000007208404,"teacher_disagreement_score":0.09980265,"about_ca_system_score_codex":0.000019575104,"about_ca_system_score_gemma":0.00006320198,"threshold_uncertainty_score":0.6661254},"labels":[],"label_agreement":null},{"id":"W1947176863","doi":"10.1136/heartjnl-2015-307686","title":"Predictors of bleeding in patients with acute coronary syndromes treated with prasugrel","year":2015,"lang":"en","type":"article","venue":"Heart","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Prasugrel; TIMI; Internal medicine; Cardiology; Percutaneous coronary intervention; Myocardial infarction; Acute coronary syndrome; Conventional PCI; Aspirin; Population; Thrombolysis; Clopidogrel","score_opus":0.012906743944433507,"score_gpt":0.2289975082989354,"score_spread":0.2160907643545019,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1947176863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99878895,0.00036807975,0.000010110428,0.000036762718,0.000023026952,0.0003439203,0.0000103674865,0.000035990466,0.00038278502],"genre_scores_gemma":[0.9995328,0.000028167071,0.00015236906,0.000058136007,0.00001623094,0.000010294201,0.000044909226,0.000019561328,0.00013753747],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99920607,0.000028172792,0.00012152554,0.00014690438,0.00034837957,0.00014897468],"domain_scores_gemma":[0.99954987,0.000010126205,0.000032828033,0.00017226623,0.000101907855,0.00013299142],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000082800376,0.00010477852,0.00030856076,0.00007584292,0.000014175943,0.0000034736356,0.000028729088,0.000043975713,0.000019892983],"category_scores_gemma":[0.000007643371,0.00006767538,0.00005379546,0.00018976943,0.0000718241,0.00008297936,0.0000096097165,0.00007080472,0.000006297473],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026414248,0.00023471142,0.9955153,0.00002739684,0.00064940756,0.00015916376,0.00012049821,0.000016385342,0.000029758654,0.0000027258511,0.0003228186,0.0002804055],"study_design_scores_gemma":[0.0069642947,0.002231063,0.9890047,0.00027769135,0.00032195903,0.0001487332,0.00012082201,0.000010533615,0.00034514334,0.0000016917868,0.0004885428,0.000084855186],"about_ca_topic_score_codex":0.000026732305,"about_ca_topic_score_gemma":0.00000230539,"teacher_disagreement_score":0.0065106335,"about_ca_system_score_codex":0.000031763197,"about_ca_system_score_gemma":0.00010621546,"threshold_uncertainty_score":0.2759722},"labels":[],"label_agreement":null},{"id":"W1964030178","doi":"10.1007/s10067-014-2769-x","title":"Sulfasalazine and its metabolites inhibit platelet function in patients with inflammatory arthritis","year":2014,"lang":"en","type":"article","venue":"Clinical Rheumatology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"University of Calgary","keywords":"Sulfasalazine; Medicine; Aspirin; Pharmacology; Sulfapyridine; Internal medicine; Platelet; Rheumatology; Gastroenterology; Disease; Chemistry; Ulcerative colitis","score_opus":0.008579243016059756,"score_gpt":0.2463901539975665,"score_spread":0.23781091098150675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964030178","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948609,0.0042203995,0.000104530445,0.00015198045,0.0001754641,0.00029681975,0.0000037068412,0.000057945654,0.00012827807],"genre_scores_gemma":[0.9969306,0.002436565,0.000049199298,0.00042941564,0.00003834945,0.00001710352,0.000051992578,0.000022863445,0.000023887771],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983943,0.00024896878,0.0005773145,0.0003602427,0.00016935825,0.00024983185],"domain_scores_gemma":[0.99906236,0.00030334445,0.0001115286,0.00023317931,0.000101681835,0.00018790948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005616548,0.0001617757,0.0007983664,0.00009654972,0.000040681276,0.000008727004,0.000044550718,0.00022024936,0.00007758843],"category_scores_gemma":[0.0005943429,0.0001260206,0.00013416118,0.000115380986,0.00018758477,0.00009375415,0.000035651527,0.00027335892,0.00006417291],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001825223,0.0002220581,0.93326163,0.00006434017,0.00021958264,0.000027101227,0.000016731883,0.0000017066836,0.0000060564307,0.0015866631,0.000086667926,0.062682256],"study_design_scores_gemma":[0.01436105,0.0008474935,0.9746526,0.00020092826,0.000078150595,0.00007785494,0.000013390051,0.00006422974,0.00005890106,0.00026716455,0.009223999,0.00015426353],"about_ca_topic_score_codex":0.0000028052402,"about_ca_topic_score_gemma":0.000011281859,"teacher_disagreement_score":0.06252799,"about_ca_system_score_codex":0.000007105022,"about_ca_system_score_gemma":0.00004621521,"threshold_uncertainty_score":0.5138971},"labels":[],"label_agreement":null},{"id":"W1964677041","doi":"10.2146/ajhp040599","title":"ASHP Therapeutic Position Statement on the Daily Use of Aspirin for Preventing Cardiovascular Events","year":2005,"lang":"en","type":"article","venue":"American Journal of Health-System Pharmacy","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Aspirin; Myocardial infarction; Framingham Risk Score; Internal medicine; Unstable angina; Canadian Cardiovascular Society; Antithrombotic; Cardiology; Coronary artery disease; Acute coronary syndrome; Intensive care medicine; Medicaid; Physical therapy; Disease; Angina; Health care","score_opus":0.05816818752525328,"score_gpt":0.3440754716969749,"score_spread":0.2859072841717216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964677041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9522695,0.015813671,0.017988179,0.012035808,0.00025193067,0.0015433315,0.00003601742,0.000025181676,0.00003636294],"genre_scores_gemma":[0.99520993,0.0014676321,0.0007675109,0.0020827693,0.0003693779,0.000032395033,0.0000075493494,0.000037342794,0.000025485238],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966981,0.000895871,0.0011139292,0.00017876811,0.00078817515,0.0003251714],"domain_scores_gemma":[0.9977605,0.00021730394,0.0011792951,0.0003546405,0.00030530494,0.00018299099],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028331575,0.00019040334,0.00093150407,0.00013663668,0.00016382277,0.000016350825,0.00015265228,0.00001633281,0.0000179192],"category_scores_gemma":[0.000029472278,0.00012535062,0.0013472061,0.00020121381,0.00007101104,0.00016962564,0.000014580664,0.00019906461,0.0000046913483],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002441184,0.00047474512,0.0032936565,0.0007401241,0.0076062754,0.000028397511,0.0005260312,0.0019745557,0.0010043302,0.00012266627,0.0007360903,0.9810519],"study_design_scores_gemma":[0.023927687,0.0088367285,0.02158905,0.006202864,0.005441342,0.0024703883,0.0052974243,0.002396496,0.01792605,0.000040601564,0.9051845,0.00068686577],"about_ca_topic_score_codex":0.00006915409,"about_ca_topic_score_gemma":5.930529e-7,"teacher_disagreement_score":0.9803651,"about_ca_system_score_codex":0.0003107783,"about_ca_system_score_gemma":0.0003789225,"threshold_uncertainty_score":0.511165},"labels":[],"label_agreement":null},{"id":"W1965137173","doi":"10.1136/bmj.b1180","title":"Clopidogrel in acute coronary syndromes","year":2009,"lang":"en","type":"review","venue":"BMJ","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; Providence Health Care","funders":"","keywords":"Clopidogrel; Medicine; Acute coronary syndrome; Cardiology; Internal medicine; Computer science; Myocardial infarction","score_opus":0.04836652188542478,"score_gpt":0.3674017245724916,"score_spread":0.3190352026870668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965137173","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007209502,0.99565405,0.000005475471,0.00010002184,0.00015841545,0.0012964716,0.000023465616,0.00006611864,0.0026238859],"genre_scores_gemma":[0.00003237097,0.9968,0.00011611664,0.00026279944,0.00029245034,0.00009517451,0.00028623457,0.00004634001,0.0020685054],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984968,0.0001350579,0.00048509633,0.00033886195,0.00028348592,0.00026074282],"domain_scores_gemma":[0.99914825,0.000039205534,0.00011939628,0.000553522,0.000019931964,0.000119696684],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023811316,0.000326145,0.002130823,0.00018677016,0.000023849936,0.000010654132,0.00013657402,0.0003165542,0.00017528755],"category_scores_gemma":[0.000021432541,0.000246614,0.0014865445,0.0002708541,0.000041690906,0.000036313722,0.00002997448,0.00033204633,0.0003300564],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034893535,0.00008433058,0.00005751048,0.0038827453,0.001389363,0.005935978,0.0000059533972,9.9010805e-8,2.058524e-8,0.000027075608,0.0059068394,0.9826752],"study_design_scores_gemma":[0.00066463515,0.00012243212,0.0012872852,0.016260853,0.0031591016,0.0062743737,0.000004551609,4.020869e-7,7.082492e-8,0.000020938254,0.9719499,0.00025549726],"about_ca_topic_score_codex":0.0000028921836,"about_ca_topic_score_gemma":6.323025e-7,"teacher_disagreement_score":0.98241967,"about_ca_system_score_codex":0.00007900109,"about_ca_system_score_gemma":0.00035692847,"threshold_uncertainty_score":0.9999986},"labels":[],"label_agreement":null},{"id":"W1965185896","doi":"10.1160/th12-01-0039","title":"Translational platelet research in patients with coronary artery disease: What are the major knowledge gaps?","year":2012,"lang":"en","type":"review","venue":"Thrombosis and Haemostasis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Coronary artery disease; Translational research; Thrombosis; Cardiology; Platelet; Internal medicine; Disease; Pathology","score_opus":0.14403257351677276,"score_gpt":0.3762078757098853,"score_spread":0.23217530219311253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965185896","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.023256097,0.97394687,0.0000020730533,0.00027874636,0.00010723756,0.0020146142,0.00026825233,0.000026882875,0.000099252866],"genre_scores_gemma":[0.02549735,0.97289723,0.000016166598,0.00008317179,0.00022988289,0.00023294249,0.00090671895,0.000087152126,0.00004937364],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970839,0.0005914967,0.00044278553,0.0005455029,0.0007729466,0.0005633614],"domain_scores_gemma":[0.99841267,0.00030323127,0.00012746522,0.0006480467,0.00015953263,0.00034907678],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00073272904,0.0004694246,0.0015901071,0.000273961,0.00031473333,0.00012706133,0.00019419634,0.00023509542,0.00023793048],"category_scores_gemma":[0.000008917356,0.0002682092,0.0005433924,0.0005609697,0.0004313744,0.00034056924,0.000073567346,0.00065861805,0.00006764258],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041136149,0.00065268215,0.016369084,0.007114928,0.0018299848,0.000044384873,0.00019487276,1.1042256e-7,1.0818355e-8,0.00004232908,0.00028022076,0.97306],"study_design_scores_gemma":[0.0029021313,0.00014767618,0.2773777,0.022752995,0.0040821666,0.000038350074,0.00029822372,7.5905456e-7,3.136516e-7,0.000036032612,0.69193697,0.00042669158],"about_ca_topic_score_codex":0.0000045897705,"about_ca_topic_score_gemma":0.000012705501,"teacher_disagreement_score":0.97263336,"about_ca_system_score_codex":0.00008446778,"about_ca_system_score_gemma":0.0002989495,"threshold_uncertainty_score":0.999977},"labels":[],"label_agreement":null},{"id":"W1965570919","doi":"10.1007/s11606-011-1757-y","title":"Effect of Aspirin Dose on Mortality and Cardiovascular Events in People with Diabetes: A Meta-Analysis","year":2011,"lang":"en","type":"review","venue":"Journal of General Internal Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Library; University of Alberta","funders":"Canadian Institutes of Health Research; Alberta Heritage Foundation for Medical Research; Fondation pour la Recherche Médicale; American Diabetes Association","keywords":"Medicine; Aspirin; Diabetes mellitus; Internal medicine; Myocardial infarction; Relative risk; Stroke (engine); Meta-analysis; Cohort study; Randomized controlled trial; Confidence interval; Endocrinology","score_opus":0.07756576960529629,"score_gpt":0.35943771451867684,"score_spread":0.2818719449133805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965570919","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12063361,0.87839186,0.000065134656,0.000013301322,0.0001271431,0.00057006045,0.000013224468,0.0000043511923,0.00018133884],"genre_scores_gemma":[0.03439624,0.96470815,0.000037692193,0.00007708058,0.00048416868,0.000032912532,0.000016839342,0.000051176405,0.0001957309],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99548,0.0011820054,0.0015385749,0.00039432297,0.0011322757,0.0002728342],"domain_scores_gemma":[0.9974449,0.0002532295,0.0010894453,0.000686558,0.00020689152,0.0003189404],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0034771836,0.0006124002,0.012069181,0.0011251861,0.000018101086,0.0000047725503,0.0002748618,0.0002079798,0.00021564485],"category_scores_gemma":[0.000156147,0.0002884129,0.009108795,0.0007415364,0.00015609725,0.00007234332,0.000048027403,0.00073852774,0.0000018435593],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009747123,0.00018964175,0.010014795,0.010339136,0.8023867,0.00075774215,0.00008552448,0.000037237103,0.0000024246042,0.000004002014,0.000052499636,0.17515557],"study_design_scores_gemma":[0.004124911,0.008253143,0.0052201827,0.010797398,0.93839794,0.0006264097,0.000011124036,0.000007961705,0.000037705904,0.0000073733254,0.032250583,0.00026528485],"about_ca_topic_score_codex":0.00039758906,"about_ca_topic_score_gemma":0.000033252392,"teacher_disagreement_score":0.17489028,"about_ca_system_score_codex":0.000085763735,"about_ca_system_score_gemma":0.00013530013,"threshold_uncertainty_score":0.9999568},"labels":[],"label_agreement":null},{"id":"W1965794747","doi":"10.1038/ki.2009.162","title":"Clopidogrel in ESRD patients with acute coronary syndrome","year":2009,"lang":"en","type":"letter","venue":"Kidney International","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Clopidogrel; Medicine; Acute coronary syndrome; Myocardial infarction; Internal medicine; Cardiology; Unstable angina; Aspirin; Angina; Canadian Cardiovascular Society; Hemodialysis","score_opus":0.005677567723497335,"score_gpt":0.22499043877597086,"score_spread":0.21931287105247352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965794747","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21730776,0.00045676914,0.00015095812,0.7681483,0.0017236485,0.001259375,0.0013215535,0.0001757333,0.009455913],"genre_scores_gemma":[0.055285666,0.00021604149,0.00066127704,0.9172623,0.0012324335,0.00005328184,0.01751031,0.0000823574,0.0076963305],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979356,0.00004590547,0.00029478804,0.00043958146,0.000996377,0.00028773842],"domain_scores_gemma":[0.99920547,0.000022012407,0.00011429805,0.00034223445,0.00016049965,0.00015546341],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00006153302,0.00031957706,0.00049586216,0.0002990386,0.000028099348,0.000030492776,0.00026797262,0.00040494135,0.0011969322],"category_scores_gemma":[0.00003233945,0.00026165848,0.00033389943,0.00009542182,0.000072757575,0.00011744176,0.00003671819,0.0009450028,0.00014919836],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004981122,0.00022612959,0.08518861,0.00004536819,0.0027443615,0.01562134,0.00002717843,0.0000012141542,0.0000010447526,0.000012547782,0.89294535,0.002688747],"study_design_scores_gemma":[0.004418228,0.0003057706,0.2806014,0.0005264267,0.0003650227,0.0010687746,0.00000194599,0.0000074002032,0.0000032614632,0.00011145145,0.7123225,0.00026782718],"about_ca_topic_score_codex":0.000013609612,"about_ca_topic_score_gemma":7.2166193e-7,"teacher_disagreement_score":0.1954128,"about_ca_system_score_codex":0.00019653472,"about_ca_system_score_gemma":0.00030458972,"threshold_uncertainty_score":0.99998355},"labels":[],"label_agreement":null},{"id":"W1966085166","doi":"10.12968/bjca.2010.5.11.79631","title":"The role of prasugrel in prevention of CV events","year":2010,"lang":"en","type":"article","venue":"British Journal of Cardiac Nursing","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Stroke Network","funders":"","keywords":"Prasugrel; Medicine; Clopidogrel; Conventional PCI; Myocardial infarction; Percutaneous coronary intervention; Aspirin; TIMI; Acute coronary syndrome; Internal medicine; Thienopyridine; Cardiology","score_opus":0.004254200675843352,"score_gpt":0.2568942095081053,"score_spread":0.25264000883226195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966085166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9552964,0.04295407,0.000046354955,0.0000394695,0.00047328687,0.00013017499,0.000004006215,0.000002286954,0.0010539404],"genre_scores_gemma":[0.9960774,0.0034483362,0.000217247,0.000004543727,0.00020393946,9.465783e-7,0.0000015580708,0.000010817166,0.000035207788],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99888396,0.00012390938,0.00041614,0.00006136474,0.00039422765,0.00012041046],"domain_scores_gemma":[0.99927336,0.000046128698,0.00028208067,0.00012053472,0.00021562589,0.000062242754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000871784,0.000057231395,0.00036859597,0.000062431165,0.000040005678,0.0000093023655,0.000077090896,0.000060935723,0.000009107395],"category_scores_gemma":[0.00013343517,0.000051965693,0.0006284366,0.00011380806,0.00010057099,0.00009770352,0.00000615928,0.0002725811,3.598601e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031519897,0.00020155226,0.021420555,0.000025861016,0.0003122707,0.000028277775,0.00012107396,0.0000064962865,0.03823324,0.000049062117,0.00008952751,0.9391969],"study_design_scores_gemma":[0.002375891,0.00031860583,0.9340934,0.0041988133,0.0006030861,0.0027242512,0.0012678753,0.000011266182,0.045050014,0.003653036,0.005599139,0.000104630824],"about_ca_topic_score_codex":0.000013553927,"about_ca_topic_score_gemma":0.0000029664457,"teacher_disagreement_score":0.9390923,"about_ca_system_score_codex":0.000021148202,"about_ca_system_score_gemma":0.00012553704,"threshold_uncertainty_score":0.21190993},"labels":[],"label_agreement":null},{"id":"W1966280081","doi":"10.3109/09537104.2014.951318","title":"Evidence of platelet sensitization to ADP following discontinuation of clopidogrel therapy in patients with stable coronary artery disease","year":2014,"lang":"en","type":"article","venue":"Platelets","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital du Sacré-Cœur de Montréal","funders":"","keywords":"Clopidogrel; Medicine; Discontinuation; P2Y12; Coronary artery disease; Platelet; Internal medicine; Cardiology; Aspirin; Anesthesia; Ticlopidine","score_opus":0.012630493062985795,"score_gpt":0.23240253711591335,"score_spread":0.21977204405292755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966280081","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99718946,0.0007932673,0.0009897945,0.00011385551,0.00006877901,0.0007649165,0.000011681486,0.000020211155,0.000048009922],"genre_scores_gemma":[0.99924254,0.00016361539,0.00023570906,0.00015466895,0.00003404142,0.000016593236,0.00010105779,0.000026333717,0.000025407597],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99859524,0.00010792784,0.00034809916,0.00026736662,0.00047538037,0.00020601788],"domain_scores_gemma":[0.99913555,0.00012369339,0.00012623481,0.0003354328,0.00013495366,0.00014415676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027667262,0.00016481588,0.00046259857,0.000155681,0.000030390489,0.000008247186,0.000067447094,0.0000544746,0.000028931483],"category_scores_gemma":[0.00012579323,0.00013315077,0.00015826919,0.00028551096,0.000038674854,0.00024141502,0.000018861583,0.00007338423,0.0000057213283],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00786072,0.0005197482,0.9276223,0.00014473077,0.00032109936,0.00006941695,0.0003663013,0.0009777561,0.0021341054,0.0000339018,0.00002930149,0.05992061],"study_design_scores_gemma":[0.00473337,0.0010192877,0.98800814,0.0014222425,0.000090257876,0.000004064235,0.000027545042,0.00031840618,0.004094748,0.00003909193,0.00007825652,0.00016457458],"about_ca_topic_score_codex":0.00001835712,"about_ca_topic_score_gemma":0.000007046176,"teacher_disagreement_score":0.060385846,"about_ca_system_score_codex":0.000030155654,"about_ca_system_score_gemma":0.000066323104,"threshold_uncertainty_score":0.54297304},"labels":[],"label_agreement":null},{"id":"W1967170278","doi":"10.1160/th11-08-0527","title":"Platelet activation in the pathogenesis of obesity and vascular disease","year":2011,"lang":"en","type":"letter","venue":"Thrombosis and Haemostasis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Pathogenesis; Platelet activation; Medicine; Platelet; Insulin resistance; Internal medicine; Diabetes mellitus; Vascular disease; Thrombosis; Disease; Obesity; Metabolic syndrome; Endocrinology; Immunology","score_opus":0.052502374125774,"score_gpt":0.2722570300550411,"score_spread":0.2197546559292671,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967170278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9587564,0.0053453483,0.00004422935,0.034797866,0.000035536486,0.0007291533,0.00011259499,0.000021094389,0.00015780547],"genre_scores_gemma":[0.84162855,0.029034048,0.00013946074,0.12801445,0.0004941116,0.0000792965,0.0005062069,0.000069799076,0.000034074983],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99844486,0.00022582167,0.0002832382,0.00039593963,0.00041648344,0.00023365469],"domain_scores_gemma":[0.99908596,0.00009377889,0.0001264292,0.0005509626,0.00006033486,0.00008252998],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003441833,0.00029263768,0.0007505779,0.00014033231,0.00009559567,0.000023941775,0.000114243805,0.00032079243,0.000090902446],"category_scores_gemma":[0.000030919957,0.00020150554,0.00035331456,0.00017066393,0.00021780336,0.00008121906,0.0000486501,0.00041530185,0.0000022942768],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001918373,0.002382696,0.26662287,0.013461855,0.0124912495,0.0012883932,0.008841441,0.0000032189464,0.0016193128,0.0005730394,0.39321095,0.2975866],"study_design_scores_gemma":[0.0018565912,0.0001246437,0.90995735,0.0005533236,0.0019892345,0.000015652979,0.00023205434,0.00000521561,0.00045287682,0.00032467511,0.08415014,0.0003382357],"about_ca_topic_score_codex":0.00015985116,"about_ca_topic_score_gemma":0.0000033516144,"teacher_disagreement_score":0.6433345,"about_ca_system_score_codex":0.000018091177,"about_ca_system_score_gemma":0.00006258648,"threshold_uncertainty_score":0.8217157},"labels":[],"label_agreement":null},{"id":"W1967735509","doi":"10.1159/000335254","title":"Safety of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration for Patients Taking Clopidogrel: A Report of 12 Consecutive Cases","year":2012,"lang":"en","type":"article","venue":"Respiration","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"Health Research Board; University of Calgary","keywords":"Medicine; Clopidogrel; Bronchoscopy; Aspirin; Prospective cohort study; Endobronchial ultrasound; Surgery; Radiology; Internal medicine","score_opus":0.03556757325063859,"score_gpt":0.3009818588237779,"score_spread":0.26541428557313934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967735509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98557496,0.0005576873,0.011422923,0.000018493842,0.00026809965,0.0012159413,0.000090190224,0.00002984002,0.0008218669],"genre_scores_gemma":[0.99818426,0.000036369238,0.00072726584,0.0000719719,0.00041878538,0.000044963137,0.00046795106,0.000021808963,0.000026621447],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984748,0.00010625066,0.00066600874,0.00017792897,0.00036666376,0.00020839101],"domain_scores_gemma":[0.9986839,0.00019057577,0.0004944638,0.00023727762,0.00030520099,0.00008852765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047944067,0.00014314444,0.0004032778,0.00009474468,0.000082673214,0.0000058020014,0.0000397098,0.000115129216,0.000043121923],"category_scores_gemma":[0.00078177603,0.00013169051,0.0003905198,0.00011488963,0.00009069558,0.00022116756,0.0000063649227,0.000061965984,0.0000011301416],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011886077,0.002359394,0.8241181,0.0009447001,0.0015692676,0.000025661906,0.0039086384,0.0002334062,0.09452897,0.0029625527,0.0008314821,0.056631744],"study_design_scores_gemma":[0.01720485,0.0043345103,0.7506651,0.0003760506,0.0017405901,0.0007485178,0.00052401394,0.000106534644,0.20993231,0.00012380438,0.013759757,0.00048392336],"about_ca_topic_score_codex":0.000074250485,"about_ca_topic_score_gemma":0.000011608881,"teacher_disagreement_score":0.11540334,"about_ca_system_score_codex":0.000058786194,"about_ca_system_score_gemma":0.00014575037,"threshold_uncertainty_score":0.5370183},"labels":[],"label_agreement":null},{"id":"W1968026572","doi":"10.1016/s0735-1097(13)60225-9","title":"IMMUNOLOGICAL MECHANISM AND HISTOLOGIC CHARACTERISTICS AF CLOPIDOGREL HYPERSENSITIVITY","year":2013,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Clopidogrel; Rash; Mechanism (biology); Hypersensitivity reaction; Delayed hypersensitivity; Dermatology; Immunology; Aspirin; Internal medicine; Antigen","score_opus":0.010082644684919104,"score_gpt":0.225272103474029,"score_spread":0.21518945878910992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968026572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99531335,0.0017959264,0.0004553436,0.0015824918,0.0002823418,0.0001817983,0.000021906942,0.0000072684397,0.00035959706],"genre_scores_gemma":[0.996455,0.0022102173,0.0005144109,0.0005194472,0.00022394647,0.0000026998805,6.4218875e-7,0.000009621449,0.000064029125],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987797,0.0003956689,0.000361098,0.000116691626,0.00017231244,0.00017452834],"domain_scores_gemma":[0.99871063,0.00014530777,0.0005342049,0.00025942107,0.00026177184,0.00008866345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033225527,0.00012971129,0.0011473077,0.00007479822,0.00006038019,0.0000031719744,0.00013183143,0.000073997486,0.000013106189],"category_scores_gemma":[0.00023687365,0.000074756405,0.0006357143,0.000143987,0.0008314055,0.00004163111,0.00007734934,0.00026547833,0.0000033039664],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010338153,0.0006880551,0.33119857,0.00028619947,0.01809698,0.006226344,0.00022585591,0.000055078144,0.373235,0.010741942,0.01007032,0.23883751],"study_design_scores_gemma":[0.0018718784,0.0022169088,0.9538847,0.00006576126,0.0008789546,0.026057383,0.00083200284,0.000030478448,0.0010877644,0.0018677113,0.011032453,0.00017400295],"about_ca_topic_score_codex":0.0000059027443,"about_ca_topic_score_gemma":1.2270283e-7,"teacher_disagreement_score":0.62268615,"about_ca_system_score_codex":0.00004139919,"about_ca_system_score_gemma":0.00009692312,"threshold_uncertainty_score":0.30633482},"labels":[],"label_agreement":null},{"id":"W1968545056","doi":"10.1016/j.jacc.2005.02.092","title":"Matching the Evaluation of the Clinical Efficacy of Clopidogrel to Platelet Function Tests Relevant to the Biological Properties of the Drug","year":2005,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":126,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Clopidogrel; Hirudin; Medicine; P2Y12; Aspirin; Platelet; Pharmacology; Platelet membrane glycoprotein; Drug; Thrombin; Internal medicine","score_opus":0.05125131941126933,"score_gpt":0.3287440939579782,"score_spread":0.2774927745467089,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968545056","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9827662,0.0020850964,0.00012533503,0.013284249,0.0005904512,0.0010063992,0.000026185438,0.0000038054056,0.00011223858],"genre_scores_gemma":[0.9976759,0.00041023124,0.00009388444,0.0010911021,0.0006612871,0.0000096016765,3.2721647e-7,0.000014001953,0.000043685133],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99467546,0.0029477554,0.0011052551,0.00016599457,0.0009117767,0.00019374654],"domain_scores_gemma":[0.9963113,0.0006931023,0.0013534423,0.00086040504,0.00071677513,0.00006499168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005143993,0.00016575091,0.0010889133,0.00006409373,0.00014379197,0.000003336091,0.0007911632,0.00007416757,0.0000079275505],"category_scores_gemma":[0.0017641635,0.000054169857,0.0016269891,0.0005682189,0.0010774289,0.000032743854,0.00022961778,0.00043675126,0.0000015138648],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04267565,0.0013701189,0.2580757,0.00022652638,0.017902432,0.000025342903,0.004274411,0.22917542,0.15112552,0.0009581183,0.029652266,0.2645385],"study_design_scores_gemma":[0.002793899,0.0017597466,0.9593432,0.00048123611,0.0021311222,0.0006436175,0.0033136716,0.000104474784,0.011189239,0.00026243803,0.017848311,0.00012904593],"about_ca_topic_score_codex":0.000022206403,"about_ca_topic_score_gemma":0.00001250469,"teacher_disagreement_score":0.7012675,"about_ca_system_score_codex":0.00006394544,"about_ca_system_score_gemma":0.0004520056,"threshold_uncertainty_score":0.39698318},"labels":[],"label_agreement":null},{"id":"W1968820256","doi":"10.1001/archinte.164.19.2106","title":"Comparative Benefits of Clopidogrel and Aspirin in High-Risk Patient Populations","year":2004,"lang":"en","type":"review","venue":"Archives of Internal Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":135,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Juravinski Hospital","funders":"","keywords":"Clopidogrel; Aspirin; Medicine; Internal medicine; Cardiology; Intensive care medicine","score_opus":0.045311191519162686,"score_gpt":0.33496341332722335,"score_spread":0.28965222180806066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968820256","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05368022,0.9447663,0.00013581394,0.000022776205,0.00012323904,0.00059569057,0.00009538581,0.000008108503,0.00057251303],"genre_scores_gemma":[0.072191946,0.9270168,0.00050497334,0.00002196676,0.00010114025,0.00001918212,0.00009973181,0.00002077574,0.000023520719],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9981829,0.00015927384,0.00094133115,0.00027237093,0.00029240083,0.00015171735],"domain_scores_gemma":[0.9987218,0.0002580356,0.0005654286,0.00029150577,0.00003921194,0.00012403834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010680503,0.00028779605,0.002546071,0.0004656409,0.000018031275,0.0000015576237,0.000120706965,0.000081574035,0.000029672468],"category_scores_gemma":[0.000088083565,0.00019276307,0.00044517347,0.00017206324,0.00044254732,0.000026071508,0.00006796415,0.00034598322,0.0000016665091],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022137092,0.00017278822,0.0026977842,0.010052124,0.000992399,0.000036617705,0.0010821577,0.000028567361,0.0000017542508,0.0009936482,0.000010558997,0.9837102],"study_design_scores_gemma":[0.011634607,0.006971331,0.09236677,0.76058835,0.008705744,0.0006833723,0.0007209118,0.000032238186,0.000071631395,0.0029283615,0.1145953,0.0007013767],"about_ca_topic_score_codex":0.0008013668,"about_ca_topic_score_gemma":0.00004820533,"teacher_disagreement_score":0.98300886,"about_ca_system_score_codex":0.000023861325,"about_ca_system_score_gemma":0.00009854345,"threshold_uncertainty_score":0.7860649},"labels":[],"label_agreement":null},{"id":"W1969908720","doi":"10.4212/cjhp.v65i2.1122","title":"Should All High-Risk Patients Receive Acetylsalicylic Acid 81 mg Daily for Primary Prevention of Cardiovascular Disease?","year":2012,"lang":"en","type":"article","venue":"The Canadian Journal of Hospital Pharmacy","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Primary prevention; Medicine; Disease; Primary (astronomy); Internal medicine","score_opus":0.026066363618101888,"score_gpt":0.27435975635205273,"score_spread":0.24829339273395085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969908720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9511103,0.04581075,0.00032800293,0.00066919223,0.0009112322,0.00085918914,0.00020026887,0.000008586626,0.000102468206],"genre_scores_gemma":[0.99621475,0.0021257626,0.0001468493,0.00041723475,0.0008814514,0.000020162117,0.00008716977,0.000047803456,0.00005879723],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981079,0.00020985406,0.0004664516,0.00015036698,0.00059636455,0.0004690634],"domain_scores_gemma":[0.99763864,0.000044300592,0.00035846172,0.00041818392,0.0004441392,0.0010962774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000977938,0.00021565001,0.0005685097,0.00014915744,0.00018520192,0.000025319761,0.00027643182,0.00005421832,0.00007523898],"category_scores_gemma":[0.00017951264,0.00015547409,0.0016711178,0.00015295208,0.0001588769,0.00038685554,0.000018875842,0.00029856188,0.0000073309557],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052094385,0.0018313787,0.5926901,0.0007707864,0.053832892,0.00022533214,0.0037409705,0.0010247049,0.00049710885,0.0003084071,0.023729544,0.3161393],"study_design_scores_gemma":[0.020766716,0.001915209,0.6912189,0.00042641987,0.021351783,0.00009050257,0.00028869204,0.00002582565,0.0045871884,0.0008999071,0.25777936,0.0006494971],"about_ca_topic_score_codex":0.0014263763,"about_ca_topic_score_gemma":0.00006944247,"teacher_disagreement_score":0.31548983,"about_ca_system_score_codex":0.00022056856,"about_ca_system_score_gemma":0.0008371343,"threshold_uncertainty_score":0.63400495},"labels":[],"label_agreement":null},{"id":"W1969956137","doi":"10.1016/j.amjmed.2011.01.018","title":"Effect of Aspirin on Mortality in the Primary Prevention of Cardiovascular Disease","year":2011,"lang":"en","type":"review","venue":"The American Journal of Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":166,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Aspirin; Relative risk; Myocardial infarction; Stroke (engine); Internal medicine; Randomized controlled trial; Confidence interval","score_opus":0.04193691237873496,"score_gpt":0.34845120963897713,"score_spread":0.30651429726024215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969956137","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05738757,0.9411697,0.000063982385,0.000064502805,0.00011476575,0.00091360393,0.000008685174,0.000003683182,0.0002735043],"genre_scores_gemma":[0.042149883,0.95717025,0.0000068439736,0.00011702524,0.00047828,0.000018496685,0.000015441043,0.00003220597,0.00001158244],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9936638,0.0034715682,0.0012230895,0.00019034189,0.0012658606,0.00018534862],"domain_scores_gemma":[0.99609625,0.0006190004,0.0018242922,0.0011941639,0.00012405221,0.00014224995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0077441875,0.00034771606,0.004701587,0.00027847028,0.000025856176,0.000002039752,0.0005518247,0.00005520187,0.00003053302],"category_scores_gemma":[0.0003251595,0.00013766604,0.0037774167,0.00060989155,0.0010923288,0.00003296105,0.000032088996,0.00064136804,0.0000019897207],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016296617,0.00020142017,0.00017012873,0.009517274,0.008218572,0.00027792135,0.00013117306,0.000011583198,0.0000010104276,0.000017748505,0.00006405038,0.97975945],"study_design_scores_gemma":[0.009224844,0.031840187,0.021137752,0.14293048,0.15623544,0.0019577881,0.00036898404,0.000001629716,0.000020937418,0.00016088712,0.63566864,0.00045245836],"about_ca_topic_score_codex":0.00006569857,"about_ca_topic_score_gemma":2.5971258e-7,"teacher_disagreement_score":0.979307,"about_ca_system_score_codex":0.000061026964,"about_ca_system_score_gemma":0.00035170166,"threshold_uncertainty_score":0.5613858},"labels":[],"label_agreement":null},{"id":"W1970967952","doi":"10.1007/s13311-011-0060-2","title":"Antiplatelet Agents for Stroke Prevention","year":2011,"lang":"en","type":"review","venue":"Neurotherapeutics","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Aspirin; Medicine; Clopidogrel; Stroke (engine); Dipyridamole; Neurology; Cardiology; Ischemic stroke; Ticlopidine; Internal medicine; Etiology; Intensive care medicine; Ischemia","score_opus":0.20949609005289802,"score_gpt":0.40766244407330166,"score_spread":0.19816635402040364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970967952","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000022455542,0.99333334,0.0015126267,0.000007795117,0.00043566976,0.0032036502,0.00015552684,0.00013514498,0.001193806],"genre_scores_gemma":[0.000009311591,0.99207115,0.00036016645,0.00042536188,0.00043095366,0.00027677615,0.00028146396,0.00021452583,0.005930273],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981838,0.00014876656,0.0005278817,0.00051706465,0.0002429206,0.0003796039],"domain_scores_gemma":[0.9987578,0.00006812947,0.0002502321,0.0006904426,0.00008152702,0.0001518622],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017259273,0.000499698,0.0017811082,0.00017989444,0.00009063824,0.000029667415,0.00020368038,0.00042804467,0.00021923428],"category_scores_gemma":[0.000015825535,0.00040928606,0.00275518,0.00015962667,0.000063257125,0.00004997454,0.000020097885,0.0003184471,0.00010227731],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000117310876,0.00021835104,0.000007513059,0.009683956,0.0021718184,0.000037857586,0.000015907975,8.198737e-8,0.0000014647021,0.00019101275,0.00041840845,0.9871363],"study_design_scores_gemma":[0.0013826791,0.00051379105,0.00001017022,0.0032458089,0.007148709,0.00027582762,0.0000036720658,0.0000043803843,0.000013276737,0.0000539426,0.98702365,0.0003240975],"about_ca_topic_score_codex":7.853777e-7,"about_ca_topic_score_gemma":2.9476135e-7,"teacher_disagreement_score":0.98681223,"about_ca_system_score_codex":0.00004017923,"about_ca_system_score_gemma":0.000259709,"threshold_uncertainty_score":0.9998359},"labels":[],"label_agreement":null},{"id":"W1971500923","doi":"10.1159/000083885","title":"Enhanced Antiplatelet Effects of Clopidogrel plus Acetylsalicylic Acid Compared with Acetylsalicylic Acid Alone or Combined with Extended-Release Dipyridamole in Healthy Volunteers","year":2005,"lang":"en","type":"article","venue":"Cerebrovascular Diseases","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"ASTER","funders":"","keywords":"Medicine; Dipyridamole; Clopidogrel; Aspirin; Pharmacology; Ticlopidine; Platelet; P2Y12; Anesthesia; Internal medicine; Cardiology","score_opus":0.006746893025472468,"score_gpt":0.23895295204239167,"score_spread":0.2322060590169192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971500923","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97508454,0.018427107,0.0023553907,0.00049146084,0.000107955784,0.002966325,0.000092358896,0.00035731163,0.000117563046],"genre_scores_gemma":[0.9938072,0.0025559065,0.000920042,0.0012958647,0.00027799836,0.00032232763,0.00045968962,0.00022332424,0.0001376293],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99446374,0.00045537486,0.0009851514,0.0013277648,0.0015148383,0.0012531509],"domain_scores_gemma":[0.9961676,0.00017490677,0.0003745284,0.0018637712,0.0003431444,0.0010760457],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002966365,0.0010087754,0.002572141,0.0005320904,0.0002178779,0.00006353729,0.00049231766,0.0002734492,0.00023348688],"category_scores_gemma":[0.00020604738,0.0007303709,0.0010250383,0.001486186,0.0007127585,0.00045967716,0.00012386606,0.00049363583,0.00006785051],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.53062296,0.03373296,0.13183056,0.028640743,0.045065176,0.0072308704,0.005731834,0.016551744,0.067459084,0.0007519536,0.0036507729,0.12873136],"study_design_scores_gemma":[0.224568,0.019772056,0.41409016,0.0072332593,0.009412725,0.0012227877,0.002090527,0.0030050424,0.31039497,0.0000497029,0.004213803,0.003946956],"about_ca_topic_score_codex":0.00018035604,"about_ca_topic_score_gemma":0.00036447225,"teacher_disagreement_score":0.30605495,"about_ca_system_score_codex":0.0003679905,"about_ca_system_score_gemma":0.0011221793,"threshold_uncertainty_score":0.99951476},"labels":[],"label_agreement":null},{"id":"W1972482307","doi":"10.1111/j.1538-7836.2010.03737.x","title":"Antithrombotic drugs in coronary artery disease: risk benefit ratio and bleeding","year":2010,"lang":"en","type":"review","venue":"Journal of Thrombosis and Haemostasis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Antithrombotic; Medicine; Bivalirudin; Fondaparinux; Aspirin; Heparin; Warfarin; Discovery and development of direct thrombin inhibitors; Anticoagulant; Vitamin K antagonist; Coronary artery disease; Low molecular weight heparin; Fibrinolytic agent; Intensive care medicine; Internal medicine; Cardiology; Thrombosis; Percutaneous coronary intervention; Thrombin; Myocardial infarction; Atrial fibrillation; Platelet","score_opus":0.045479908723541886,"score_gpt":0.32879075259939505,"score_spread":0.28331084387585315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972482307","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09346429,0.90558773,0.000015505464,0.00014341311,0.00025187212,0.00041952642,0.000073912786,0.000009615074,0.000034108747],"genre_scores_gemma":[0.014028418,0.9851851,0.00024046109,0.0000735363,0.00035980498,0.00000754338,0.000025621108,0.000059003025,0.000020520292],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99782574,0.00013392312,0.0009572242,0.00034612583,0.00045734792,0.00027961232],"domain_scores_gemma":[0.99819195,0.00017986438,0.00074427074,0.00031511314,0.0001180707,0.00045074915],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007297385,0.00043834487,0.0028397914,0.00041454367,0.00014458377,0.00010033675,0.00012993852,0.0002946458,0.000099037],"category_scores_gemma":[0.000077413155,0.00031834125,0.0010605429,0.00023579175,0.00018868952,0.0002500012,0.00007322,0.00096150406,0.000004015323],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012006291,0.0001887296,0.008738664,0.0049906406,0.0024385166,0.00026122807,0.00013249587,8.3059194e-7,0.0000026531575,0.000041811938,0.00021752289,0.9828668],"study_design_scores_gemma":[0.006382724,0.00073168107,0.17764498,0.057271414,0.04318373,0.0040410915,0.0005120885,0.00003327861,0.0000071283766,0.00037813312,0.7086582,0.0011555082],"about_ca_topic_score_codex":0.000007938495,"about_ca_topic_score_gemma":0.000003931579,"teacher_disagreement_score":0.9817113,"about_ca_system_score_codex":0.000064142325,"about_ca_system_score_gemma":0.0002644309,"threshold_uncertainty_score":0.99992687},"labels":[],"label_agreement":null},{"id":"W1972572266","doi":"10.1111/j.1538-7836.2009.03623.x","title":"Perioperative management of antithrombotic therapy: lifting the fog","year":2009,"lang":"en","type":"letter","venue":"Journal of Thrombosis and Haemostasis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton","funders":"","keywords":"Medicine; Antithrombotic; Perioperative; Intensive care medicine; Observational study; Clopidogrel; Aspirin; Randomized controlled trial; Vitamin K antagonist; Dosing; Warfarin; Surgery; Atrial fibrillation; Internal medicine","score_opus":0.06188098656177358,"score_gpt":0.3159596358246516,"score_spread":0.254078649262878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972572266","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.34584102,0.09421493,0.00023331553,0.5554926,0.0005527549,0.0011578877,0.00005056758,0.000024262916,0.0024326944],"genre_scores_gemma":[0.32404724,0.33437318,0.0024207018,0.3350962,0.0033930535,0.000010102843,0.000042208754,0.0001336321,0.0004836696],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99787885,0.00018016981,0.00069251924,0.0002252314,0.0007634167,0.00025981318],"domain_scores_gemma":[0.9984655,0.00007961551,0.00067425065,0.00039600825,0.0003073324,0.000077306155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005407372,0.00033240506,0.0013051486,0.00015092203,0.00017558411,0.00007110332,0.00023758628,0.00026290776,0.00015695437],"category_scores_gemma":[0.000013444099,0.00018804804,0.0010518418,0.00019705921,0.00023310924,0.00010960667,0.000046718807,0.00091344945,0.0000025578015],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070964894,0.00052334595,0.0024051543,0.0015356378,0.035525497,0.001898145,0.0019609039,0.000017178383,0.0003599591,0.00011803045,0.6432453,0.3117012],"study_design_scores_gemma":[0.007513411,0.0024019338,0.06451116,0.004856915,0.009132849,0.0012324738,0.002441297,0.000014655255,0.0019393464,0.00019354699,0.9051457,0.0006166981],"about_ca_topic_score_codex":0.000007542767,"about_ca_topic_score_gemma":2.3282108e-7,"teacher_disagreement_score":0.3110845,"about_ca_system_score_codex":0.00004179007,"about_ca_system_score_gemma":0.00009227803,"threshold_uncertainty_score":0.76683766},"labels":[],"label_agreement":null},{"id":"W1974935076","doi":"10.1007/s12012-008-9019-x","title":"Antiplatelet Agents Sarpogrelate and Cilostazol Affect Experimentally-induced Ventricular Arrhythmias and Mortality","year":2008,"lang":"en","type":"article","venue":"Cardiovascular Toxicology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; St. Boniface Hospital","funders":"Canadian Institutes of Health Research","keywords":"Cilostazol; Cardiology; Medicine; Internal medicine; Affect (linguistics); Aspirin; Psychology","score_opus":0.04056570846568505,"score_gpt":0.28406356289153356,"score_spread":0.2434978544258485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974935076","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93207884,0.06553541,0.00024159235,0.00006596741,0.00029249306,0.0009940516,0.000011610614,0.00013565813,0.00064440514],"genre_scores_gemma":[0.9898435,0.009024898,0.00014244934,0.0004487307,0.00028777163,0.0000732576,0.000049539824,0.000061555045,0.00006828666],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972545,0.00037725974,0.00036637104,0.0008525597,0.000575668,0.0005736374],"domain_scores_gemma":[0.9984565,0.0000577465,0.000078513585,0.00087284914,0.00008184664,0.0004525561],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005641351,0.0004305815,0.0013085805,0.00017313471,0.0003319515,0.000024615394,0.00009608106,0.0003862786,0.000118305594],"category_scores_gemma":[0.000086720254,0.000399676,0.0013017904,0.00024859217,0.00042310223,0.00014129205,0.00014717794,0.00032897512,0.000034992278],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027117964,0.001878752,0.43956634,0.001327954,0.11334816,0.27017814,0.0026767098,0.0002991489,0.05801545,0.00064164924,0.0026192116,0.106736675],"study_design_scores_gemma":[0.014677462,0.0010759196,0.8605545,0.0001367829,0.00399339,0.06086633,0.0002833098,0.00018636967,0.03815695,0.00008002276,0.018969256,0.0010197043],"about_ca_topic_score_codex":0.000027626427,"about_ca_topic_score_gemma":9.599094e-7,"teacher_disagreement_score":0.42098814,"about_ca_system_score_codex":0.00008147887,"about_ca_system_score_gemma":0.000095025476,"threshold_uncertainty_score":0.9998455},"labels":[],"label_agreement":null},{"id":"W1975144063","doi":"10.1016/j.cjca.2012.06.012","title":"Risk of Bleeding on Triple Antithrombotic Therapy After Percutaneous Coronary Intervention/Stenting: A Systematic Review and Meta-analysis","year":2012,"lang":"en","type":"review","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Providence Health Care; Montreal Heart Institute; University of British Columbia; Université de Montréal","funders":"European Society of Cardiology","keywords":"Medicine; Clopidogrel; Percutaneous coronary intervention; Conventional PCI; Aspirin; Thienopyridine; Internal medicine; Odds ratio; Vitamin K antagonist; Antithrombotic; Randomized controlled trial; Meta-analysis; Confidence interval; Surgery; Myocardial infarction; Atrial fibrillation; Warfarin","score_opus":0.06497129997300466,"score_gpt":0.3084202514903746,"score_spread":0.24344895151736995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975144063","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001923663,0.99806356,0.000106683365,0.000027411214,0.00016889561,0.0011750414,0.00016178207,0.0000039864685,0.00010027788],"genre_scores_gemma":[0.041146703,0.9582926,0.000026559397,0.00013348974,0.00017991304,0.00003364745,0.00002581469,0.000043387445,0.00011788889],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9958252,0.0017119254,0.0015899029,0.00026045647,0.0002684139,0.00034410582],"domain_scores_gemma":[0.99686044,0.00021181858,0.0015236659,0.0005394628,0.00030509374,0.0005595426],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0020176806,0.00043694832,0.013465867,0.0008669343,0.000064019914,0.000017962733,0.0002133335,0.000276067,0.00027972148],"category_scores_gemma":[0.00022187007,0.0002682136,0.014434852,0.0004177507,0.00018041942,0.000058174803,0.000014296025,0.00052270707,0.000008169974],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003842411,0.000010865028,0.0002436644,0.29274318,0.6960984,0.0010779749,0.000030522588,0.0000067005335,6.148517e-8,0.000005590287,0.000080807265,0.009663803],"study_design_scores_gemma":[0.00029790393,0.00033862906,0.00015143021,0.025319733,0.91135764,0.015436096,0.00003391488,2.38748e-7,6.8689936e-8,0.000003886569,0.046870608,0.00018985021],"about_ca_topic_score_codex":0.00008212721,"about_ca_topic_score_gemma":0.000041664833,"teacher_disagreement_score":0.26742345,"about_ca_system_score_codex":0.00011641253,"about_ca_system_score_gemma":0.0004503913,"threshold_uncertainty_score":0.999977},"labels":[],"label_agreement":null},{"id":"W1975234284","doi":"10.1016/j.cjca.2012.07.845","title":"Cardiovascular Pharmacogenomics: The Future of Cardiovascular Therapeutics?","year":2012,"lang":"en","type":"review","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Pharmacogenomics; Clopidogrel; Intensive care medicine; Warfarin; Adverse effect; Drug; Pharmacogenetics; Drug response; Efficacy; Internal medicine; Pharmacology; Atrial fibrillation; Aspirin","score_opus":0.046923717515373754,"score_gpt":0.2865176069491907,"score_spread":0.23959388943381696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975234284","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000045069504,0.99419373,0.00071961083,0.00005972777,0.0028557375,0.0008274071,0.00013137399,0.00000879431,0.0011585271],"genre_scores_gemma":[0.0036002055,0.98296785,0.00004718173,0.00011729326,0.0130322045,0.000021821597,0.00004493752,0.00013393232,0.000034558787],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954714,0.0014873822,0.0012759285,0.00034928936,0.0006273851,0.0007885949],"domain_scores_gemma":[0.9961278,0.00013460362,0.000633387,0.0016224778,0.0005731792,0.00090859074],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0026852873,0.00066125987,0.00708257,0.0005891668,0.0001689132,0.00002487482,0.0008267033,0.00077410816,0.00005456813],"category_scores_gemma":[0.00003042446,0.00041056814,0.02340679,0.00044963704,0.0005829705,0.00008790682,0.000038267306,0.0013071573,0.000030906038],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003241586,0.000004356044,0.00004725147,0.0025217237,0.12236238,0.00057557854,0.000062686486,0.00025989852,3.8675248e-7,0.000044881617,0.00068233686,0.8734061],"study_design_scores_gemma":[0.0008736328,0.000111381865,0.000033771114,0.0010804415,0.09951716,0.0118018715,0.00011654336,2.5404586e-7,0.0000030654926,0.000014428655,0.8861358,0.0003116265],"about_ca_topic_score_codex":0.0001320315,"about_ca_topic_score_gemma":0.000014412361,"teacher_disagreement_score":0.88545346,"about_ca_system_score_codex":0.00032115643,"about_ca_system_score_gemma":0.0047379886,"threshold_uncertainty_score":0.9998346},"labels":[],"label_agreement":null},{"id":"W1975519565","doi":"10.1016/j.ahj.2008.07.026","title":"Design and rationale of CURRENT-OASIS 7: A randomized, 2 × 2 factorial trial evaluating optimal dosing strategies for clopidogrel and aspirin in patients with ST and non–ST-elevation acute coronary syndromes managed with an early invasive strategy","year":2008,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":153,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Clopidogrel; Regimen; Loading dose; Maintenance dose; Aspirin; Dosing; Acute coronary syndrome; Randomized controlled trial; Internal medicine; Myocardial infarction; Cardiology","score_opus":0.051447547868562045,"score_gpt":0.31892655678826654,"score_spread":0.2674790089197045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975519565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875987,0.00049216434,0.009967221,0.000017778979,0.000042519052,0.0018554878,0.00001777932,0.0000070366277,0.000001323875],"genre_scores_gemma":[0.9919388,0.0004723284,0.0073513445,0.000019940197,0.00010715826,0.000050963514,0.00003866338,0.000019234853,0.0000015291398],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99849296,0.0003677001,0.00034300014,0.00022558248,0.00038883157,0.0001819324],"domain_scores_gemma":[0.99897754,0.00033137566,0.00026945173,0.00008176673,0.00020803812,0.00013185518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056225184,0.00017533737,0.0007200115,0.00014414015,0.00019374306,0.000064157626,0.000030093332,0.000032116393,0.0000050509134],"category_scores_gemma":[0.00004852693,0.00012555625,0.00007787307,0.00013006107,0.0004673003,0.0004904285,0.000010619223,0.00017226109,4.7247976e-8],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7423014,0.00027080037,0.23201554,0.000077165736,0.0012902287,0.000052133782,0.0012166755,0.0006862304,0.00018487619,0.000010823348,0.000009168758,0.021884935],"study_design_scores_gemma":[0.47714978,0.022802552,0.4951509,0.0003470496,0.0009900004,0.0005728917,0.0014205745,0.0011586478,0.000048842398,0.000101800295,0.0000032932405,0.00025368753],"about_ca_topic_score_codex":0.000040149913,"about_ca_topic_score_gemma":0.0000056532585,"teacher_disagreement_score":0.26515165,"about_ca_system_score_codex":0.000024547204,"about_ca_system_score_gemma":0.00043703595,"threshold_uncertainty_score":0.51200354},"labels":[],"label_agreement":null},{"id":"W1975593124","doi":"10.1016/j.thromres.2009.04.003","title":"Insights into the interpretation of light transmission aggregometry for evaluation of platelet aggregation inhibition by clopidogrel","year":2009,"lang":"en","type":"article","venue":"Thrombosis Research","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"American Heart Association","keywords":"Clopidogrel; Platelet aggregation; Platelet; Ticlopidine; Medicine; Agonist; Platelet aggregation inhibitor; Whole blood; Antiplatelet drug; Pharmacology; Cardiology; Internal medicine; Chemistry; Aspirin; Receptor","score_opus":0.04898406264184034,"score_gpt":0.3860057884486832,"score_spread":0.33702172580684286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975593124","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97727287,0.012034529,0.007309205,0.0013371966,0.000034216064,0.0015098336,0.0000054849493,0.000018328486,0.00047833397],"genre_scores_gemma":[0.9970518,0.0023490028,0.00018973577,0.000058015037,0.00006275428,0.00007178622,0.00017479804,0.000014460953,0.00002766685],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970946,0.00052625703,0.00039324004,0.00023945008,0.0015658939,0.00018056585],"domain_scores_gemma":[0.9980167,0.00020922239,0.000130358,0.00032621194,0.0012453962,0.00007209309],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002286869,0.00011511814,0.0003270227,0.00031209525,0.00015515796,0.000014237342,0.00010616645,0.00013845811,0.000057463116],"category_scores_gemma":[0.00030110482,0.00007882851,0.00027020386,0.00071528595,0.00015277253,0.00016502611,0.000012447507,0.00018276286,0.0000036958058],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009422632,0.00035551706,0.00008012572,0.00020432397,0.00022887246,4.3620605e-7,0.0038793774,0.0000632196,0.36407426,0.00030325557,0.00131269,0.62855566],"study_design_scores_gemma":[0.0042636665,0.001504606,0.0073724105,0.0009007735,0.00032229273,0.0000028331476,0.0007441826,0.011870139,0.9622911,0.0086900955,0.0019229213,0.000114943585],"about_ca_topic_score_codex":0.000025065921,"about_ca_topic_score_gemma":0.0000023867874,"teacher_disagreement_score":0.62844074,"about_ca_system_score_codex":0.00010359735,"about_ca_system_score_gemma":0.00016253021,"threshold_uncertainty_score":0.32145336},"labels":[],"label_agreement":null},{"id":"W1976188299","doi":"10.1038/ncpcardio0293","title":"Does clopidogrel provide additional benefit to aspirin and fibrinolytic therapy in patients after STEMI?","year":2005,"lang":"en","type":"article","venue":"Nature Clinical Practice Cardiovascular Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences","funders":"","keywords":"Clopidogrel; Fibrinolytic therapy; Aspirin; Medicine; Cardiology; Internal medicine; Intensive care medicine; Myocardial infarction","score_opus":0.013422614101113861,"score_gpt":0.3220356815078002,"score_spread":0.30861306740668637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976188299","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88159055,0.09351968,0.00012921043,0.018424552,0.001153009,0.0028437502,0.00016014896,0.00014591143,0.0020331768],"genre_scores_gemma":[0.9570445,0.007864069,0.0024295598,0.027512694,0.0043368074,0.00019728953,0.00027383392,0.00007923598,0.00026205435],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952946,0.00046870738,0.0010436984,0.0010456771,0.0016461591,0.00050121546],"domain_scores_gemma":[0.9961186,0.0013999161,0.00016841314,0.0010855563,0.00059301796,0.00063450483],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0025897478,0.0004385855,0.0014645146,0.0002485007,0.00007955304,0.000028591821,0.00017922265,0.0006944868,0.00067595084],"category_scores_gemma":[0.0056625498,0.00026433024,0.0011725762,0.00045791033,0.00028161783,0.00043735837,0.00010613658,0.0016725741,0.00008327609],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007458207,0.0010020053,0.0844597,0.00015233149,0.005519452,0.00058068935,0.00017554914,0.000046835015,0.00000529782,0.00007366506,0.0064932713,0.894033],"study_design_scores_gemma":[0.008657552,0.0008988796,0.45756516,0.00044427926,0.0007640684,0.00006820956,0.000075742006,0.000008473135,0.000011033644,0.000030294152,0.5312431,0.00023323705],"about_ca_topic_score_codex":0.000021459142,"about_ca_topic_score_gemma":0.000010521936,"teacher_disagreement_score":0.8937998,"about_ca_system_score_codex":0.00012466541,"about_ca_system_score_gemma":0.0001457073,"threshold_uncertainty_score":0.99998087},"labels":[],"label_agreement":null},{"id":"W1976259172","doi":"10.1016/s0735-1097(15)60108-5","title":"OPTIMIZING CROSSOVER FROM TICAGRELOR TO CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROME: THE CAPITAL OPTI-CROSS RANDOMIZED TRIAL","year":2015,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Ticagrelor; Medicine; Clopidogrel; Acute coronary syndrome; P2Y12; Crossover study; Prasugrel; Internal medicine; Cardiology; Randomized controlled trial; Aspirin; Myocardial infarction; Alternative medicine","score_opus":0.009315513376654634,"score_gpt":0.2573442759018283,"score_spread":0.24802876252517367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976259172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99620366,0.00074049906,0.00039060393,0.0006814,0.0006371531,0.0011311582,0.000119723016,0.0000053622725,0.00009043266],"genre_scores_gemma":[0.9981726,0.000103920676,0.0009133865,0.00046012443,0.00024293618,0.000017055821,0.0000043718337,0.000024638166,0.00006098323],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9974634,0.0007807256,0.0006775473,0.00018079871,0.00063376344,0.0002637448],"domain_scores_gemma":[0.9979038,0.0003903298,0.0006624548,0.0004532738,0.0004001706,0.00018994101],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010314175,0.00019981389,0.002037012,0.00010811093,0.00006180082,0.00001155936,0.00038747038,0.000064575084,0.0000078073745],"category_scores_gemma":[0.00036574143,0.00009520012,0.0010176712,0.00035853175,0.001011341,0.00008535408,0.00011467543,0.00032716602,0.000002968243],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9433718,0.00011122803,0.045295853,0.000003768279,0.005193547,0.0013254446,0.00020180827,0.0035790072,0.000014907621,0.000015145546,0.00059375644,0.0002937476],"study_design_scores_gemma":[0.7473126,0.0042695994,0.24237826,0.000106309395,0.0018010493,0.0024022488,0.0007100087,0.000020255076,0.00003971847,0.00010407357,0.00068245037,0.00017340794],"about_ca_topic_score_codex":0.000027624637,"about_ca_topic_score_gemma":0.0000017178271,"teacher_disagreement_score":0.1970824,"about_ca_system_score_codex":0.000115794515,"about_ca_system_score_gemma":0.0004409187,"threshold_uncertainty_score":0.38821483},"labels":[],"label_agreement":null},{"id":"W1977457877","doi":"10.1136/neurintsurg-2014-011357","title":"Platelet function inhibitors and platelet function testing in neurointerventional procedures","year":2014,"lang":"en","type":"review","venue":"Journal of NeuroInterventional Surgery","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal University Hospital; University of Saskatchewan","funders":"","keywords":"Medicine; Prasugrel; Ticagrelor; P2Y12; Clopidogrel; Aspirin; Platelet; Stent; Gold standard (test); Internal medicine","score_opus":0.054613327290578766,"score_gpt":0.30173923220477833,"score_spread":0.24712590491419956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977457877","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.038061026,0.9593689,0.00029128997,0.0000761381,0.0016301897,0.00045143094,0.000025041161,0.000037521768,0.00005848657],"genre_scores_gemma":[0.020208528,0.9771044,0.000054361604,0.0001828509,0.0019069487,0.000021858845,0.00016484618,0.00013305,0.0002231266],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950268,0.00061297964,0.0026135764,0.00050268957,0.0008786658,0.0003652499],"domain_scores_gemma":[0.9962099,0.0010083617,0.0019511922,0.00022629983,0.00033563402,0.00026859442],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018213837,0.00056009716,0.0027678378,0.0013565343,0.000098771605,0.000094958414,0.00012488292,0.0002828495,0.0001783165],"category_scores_gemma":[0.0012216481,0.00046418927,0.0046419716,0.0005616752,0.00010822687,0.00034587784,0.000076351374,0.0010696849,0.000021095035],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012270234,0.0007476377,0.0032426924,0.030648941,0.0017521203,0.0019919584,0.0000050320905,0.000022272514,0.000017487608,0.000049895767,0.005659129,0.9546358],"study_design_scores_gemma":[0.0021197523,0.001568209,0.03296305,0.090827845,0.0023772074,0.0347543,0.000014433098,0.000025643272,0.0000043823975,0.00032399193,0.83445394,0.0005672494],"about_ca_topic_score_codex":0.000004794914,"about_ca_topic_score_gemma":0.000003369037,"teacher_disagreement_score":0.95406854,"about_ca_system_score_codex":0.00011543204,"about_ca_system_score_gemma":0.00055259885,"threshold_uncertainty_score":0.99978095},"labels":[],"label_agreement":null},{"id":"W1977566571","doi":"10.1016/j.thromres.2011.02.019","title":"Genetic determinants of response to aspirin: Appraisal of 4 candidate genes","year":2011,"lang":"en","type":"article","venue":"Thrombosis Research","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Montréal; Hôpital du Sacré-Cœur de Montréal; Université de Montréal","funders":"Canadian Institutes of Health Research; Chinese Academy of Agricultural Sciences","keywords":"Aspirin; Arachidonic acid; Platelet; Platelet activation; Pharmacology; Adenosine diphosphate; Cyclooxygenase; Genotype; Platelet-poor plasma; Medicine; Internal medicine; Chemistry; Gene; Biochemistry; Platelet aggregation; Thrombin; Enzyme","score_opus":0.13378459610480303,"score_gpt":0.419411046074028,"score_spread":0.285626449969225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977566571","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973039,0.0012989286,0.00006155227,0.00003595089,0.000048399,0.00040956176,0.000022038126,0.000015808004,0.0008038423],"genre_scores_gemma":[0.9982845,0.0005915331,0.0008780238,0.000022471473,0.000046785142,0.000031816217,0.0000020403002,0.000027150492,0.000115635434],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977822,0.00046274936,0.00031884128,0.0002587716,0.00080323516,0.00037424575],"domain_scores_gemma":[0.9984762,0.0001889709,0.000047644848,0.0006810543,0.00037030873,0.00023578687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014331146,0.00011353347,0.00048699672,0.00033485403,0.00005795047,0.0000046230366,0.00023658645,0.00007998498,0.00045821117],"category_scores_gemma":[0.00027682047,0.000095051146,0.00022267763,0.0004986724,0.00032381402,0.000037335594,0.0001329724,0.00012687201,0.00007182044],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012126931,0.0007605136,0.5151479,0.0005555444,0.00071662705,0.00015522917,0.0025408177,0.0000045007628,0.38780144,0.000032982127,0.0004420418,0.07971542],"study_design_scores_gemma":[0.0008017511,0.0011027628,0.73479676,0.00014209205,0.000062956584,0.00001815648,0.00024746632,0.000012669453,0.2617649,0.000022873915,0.0009525271,0.00007504779],"about_ca_topic_score_codex":0.00054697617,"about_ca_topic_score_gemma":0.000028000453,"teacher_disagreement_score":0.21964884,"about_ca_system_score_codex":0.00002326369,"about_ca_system_score_gemma":0.00024614536,"threshold_uncertainty_score":0.5017091},"labels":[],"label_agreement":null},{"id":"W1977589478","doi":"10.1016/j.cjca.2011.08.112","title":"The Cost of Clopidogrel Use in Atrial Fibrillation in the ACTIVE-A Trial","year":2011,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Clopidogrel; Aspirin; Atrial fibrillation; Emergency medicine; Stroke (engine); Confidence interval; Randomized controlled trial; Anesthesia; Internal medicine; Cardiology","score_opus":0.05417693591260589,"score_gpt":0.2649889604945708,"score_spread":0.21081202458196494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977589478","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951954,0.0024620052,0.00010035547,0.00022322443,0.0005731182,0.0003689998,0.000008674044,8.5709866e-7,0.001067405],"genre_scores_gemma":[0.99814826,0.0006493356,0.000011901998,0.000056063906,0.0011163299,0.0000014426945,0.0000024692808,0.000005939666,0.000008244488],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99877304,0.00050787796,0.00034839284,0.00006570566,0.000120095036,0.00018487342],"domain_scores_gemma":[0.9992218,0.00025040936,0.00013962793,0.00017740934,0.0000975296,0.000113236216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000965901,0.00006886129,0.00038351506,0.00016400234,0.000043547632,0.000007372858,0.00012600522,0.00009589032,0.000009300326],"category_scores_gemma":[0.0004371489,0.000039648286,0.00050116173,0.00015297892,0.0001791908,0.00006562136,0.0000037007933,0.00021492735,0.0000011424127],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09556841,0.000009207216,0.71167094,0.000019628793,0.0019275858,0.0016251653,0.0030219767,0.0025392103,0.00004539256,0.0016313866,0.002102194,0.17983893],"study_design_scores_gemma":[0.028463976,0.0008029405,0.8574231,0.000052534448,0.00023787798,0.00076400134,0.0009157132,0.00000836217,0.000037767277,0.00036889975,0.11084611,0.0000786959],"about_ca_topic_score_codex":0.0013158107,"about_ca_topic_score_gemma":0.004118551,"teacher_disagreement_score":0.17976023,"about_ca_system_score_codex":0.00006594959,"about_ca_system_score_gemma":0.00078063447,"threshold_uncertainty_score":0.22982481},"labels":[],"label_agreement":null},{"id":"W1977673988","doi":"10.1016/j.thromres.2008.10.014","title":"Clopidogrel induces an acute hemostatic deficit and increases intra abdominal bleeding in rabbits","year":2009,"lang":"en","type":"article","venue":"Thrombosis Research","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Clopidogrel; Medicine; Platelet; Antiplatelet drug; Anesthesia; Abdominal surgery; Loading dose; Pharmacology; Internal medicine; Aspirin","score_opus":0.07786874046045564,"score_gpt":0.398746352171481,"score_spread":0.32087761171102536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977673988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99428934,0.0033092194,0.000014059131,0.00082827744,0.000020894706,0.00046572075,0.0000096476315,0.000047541653,0.0010153266],"genre_scores_gemma":[0.9944146,0.0046874173,0.00029661454,0.000377893,0.00009669782,0.00003236843,0.000036482357,0.000022333015,0.000035594614],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9974483,0.0004244854,0.00025418925,0.00041704343,0.0008837826,0.00057219766],"domain_scores_gemma":[0.9990257,0.00019052972,0.000030908126,0.0003344796,0.00011570675,0.0003026853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015319294,0.00017117544,0.00047063292,0.00044310745,0.00027676733,0.00007501193,0.00017010173,0.000093741386,0.0003585204],"category_scores_gemma":[0.00014597674,0.00015226648,0.00012753974,0.00070585083,0.00021911536,0.00026321813,0.00007833303,0.0005726657,0.000016000236],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005356543,0.004614284,0.20368771,0.00039252406,0.002064279,0.0015745318,0.0044471654,0.000029072899,0.23494695,0.0029253524,0.0016110584,0.5383505],"study_design_scores_gemma":[0.0050096493,0.003274953,0.977753,0.00031852617,0.00028149143,0.0002584342,0.004455119,0.0003400759,0.005722435,0.001632806,0.00058188045,0.00037165947],"about_ca_topic_score_codex":0.00026180552,"about_ca_topic_score_gemma":0.00001170651,"teacher_disagreement_score":0.77406526,"about_ca_system_score_codex":0.0001030662,"about_ca_system_score_gemma":0.00015984822,"threshold_uncertainty_score":0.62092465},"labels":[],"label_agreement":null},{"id":"W1978084866","doi":"10.1016/s0735-1097(13)60106-0","title":"TICAGRELOR VERSUS TICAGRELOR AND CLOPIDOGREL IN PATIENTS UNDERGOING PRIMARY PCI: A PLATELET REACTIVITY PHARMACODYNAMICS STUDY","year":2013,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Ticagrelor; Medicine; Clopidogrel; Conventional PCI; Pharmacodynamics; P2Y12; Internal medicine; Cardiology; Aspirin; Pharmacology; Myocardial infarction; Pharmacokinetics","score_opus":0.010129151722142344,"score_gpt":0.25357832115954326,"score_spread":0.24344916943740091,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978084866","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977919,0.00039749307,0.00004434973,0.0004037328,0.00034792945,0.00060493755,0.000017158394,0.000005924153,0.00038661613],"genre_scores_gemma":[0.99882567,0.0006239814,0.00017804121,0.00017455239,0.00014949263,0.00000640313,0.0000013121729,0.000019547033,0.000020974287],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982409,0.00047388673,0.00050317356,0.00017239849,0.00037694536,0.00023271106],"domain_scores_gemma":[0.99842936,0.00042007054,0.0005244923,0.0002838235,0.00022017807,0.000122069185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004345133,0.00017041102,0.0011382677,0.00016503553,0.00005094633,0.000005275524,0.0001795767,0.000051009443,0.00000656062],"category_scores_gemma":[0.00023284326,0.000114135764,0.00042062896,0.00032931918,0.0003837421,0.000113867354,0.000109165834,0.00035155538,0.0000020124785],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0114401365,0.0006530497,0.94800776,0.00007583341,0.0039637587,0.000410307,0.00012595253,0.00021721667,0.00095941784,0.000022100097,0.0009340177,0.03319043],"study_design_scores_gemma":[0.014408277,0.0036247713,0.9786792,0.00007037619,0.0006499055,0.00048329314,0.0010696738,0.000057359055,0.0000678278,0.00005119533,0.0007052611,0.00013289684],"about_ca_topic_score_codex":0.00001684978,"about_ca_topic_score_gemma":0.0000038555054,"teacher_disagreement_score":0.033057533,"about_ca_system_score_codex":0.0001364895,"about_ca_system_score_gemma":0.00023093008,"threshold_uncertainty_score":0.46543214},"labels":[],"label_agreement":null},{"id":"W1978591428","doi":"10.1007/s11239-012-0737-3","title":"Pharmacodynamic effects of cangrelor and clopidogrel: the platelet function substudy from the cangrelor versus standard therapy to achieve optimal management of platelet inhibition (CHAMPION) trials","year":2012,"lang":"en","type":"article","venue":"Journal of Thrombosis and Thrombolysis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":157,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Shared Health","funders":"","keywords":"Cangrelor; Clopidogrel; Medicine; P2Y12; Conventional PCI; Pharmacodynamics; Percutaneous coronary intervention; Internal medicine; Pharmacology; Cardiology; Anesthesia; Aspirin; Myocardial infarction; Pharmacokinetics","score_opus":0.03963388185997314,"score_gpt":0.322111469902556,"score_spread":0.2824775880425829,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978591428","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97729737,0.019547064,0.00067526696,0.0007863441,0.00071125006,0.00088114396,0.000069831425,0.0000100312445,0.000021677783],"genre_scores_gemma":[0.9651253,0.033996027,0.00025540692,0.00019258718,0.00036233597,0.00001983062,0.000014976621,0.000029344805,0.000004179413],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9975242,0.000481223,0.0008218194,0.00019721319,0.000710769,0.0002647812],"domain_scores_gemma":[0.9979009,0.0007059273,0.00071815605,0.00029670415,0.00018919678,0.00018910371],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019569574,0.000273238,0.0012925646,0.0001303707,0.00018287564,0.000032320877,0.00012435009,0.000097876225,0.000080864054],"category_scores_gemma":[0.000063590225,0.00014567873,0.0006310227,0.0003298002,0.0001784879,0.00021873332,0.00006804951,0.00023790584,0.0000013210723],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09889851,0.0029095528,0.036307905,0.0011259834,0.12513489,0.0001100841,0.015069816,0.0006192233,0.14127363,0.0008398985,0.003702613,0.5740079],"study_design_scores_gemma":[0.034863338,0.0069685997,0.86050636,0.0011433772,0.01154734,0.00007204551,0.006096667,0.000055505476,0.07486611,0.00014777083,0.0032850155,0.00044790303],"about_ca_topic_score_codex":0.000113343965,"about_ca_topic_score_gemma":0.000009363032,"teacher_disagreement_score":0.8241984,"about_ca_system_score_codex":0.000060313814,"about_ca_system_score_gemma":0.000045264827,"threshold_uncertainty_score":0.5940606},"labels":[],"label_agreement":null},{"id":"W1978913815","doi":"10.1161/circulationaha.109.900704","title":"Cost-Effectiveness of Prasugrel Versus Clopidogrel in Patients With Acute Coronary Syndromes and Planned Percutaneous Coronary Intervention","year":2009,"lang":"en","type":"article","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":142,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Daiichi-Sankyo; Sanofi; Daiichi Sankyo Europe; Eli Lilly and Company","keywords":"Medicine; Prasugrel; Clopidogrel; Percutaneous coronary intervention; Cardiology; Internal medicine; Acute coronary syndrome; Myocardial infarction","score_opus":0.019288475363857208,"score_gpt":0.27446749614102667,"score_spread":0.2551790207771695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978913815","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99788,0.0006831861,0.00035886499,0.000013225074,0.000066767614,0.0008999562,0.00001325298,0.00002668922,0.00005805519],"genre_scores_gemma":[0.9994671,0.000071764734,0.000056661534,0.000013678536,0.00000959629,0.000010043835,0.0003567987,0.000011367818,0.000003001699],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991971,0.000106151594,0.00016818749,0.0001997732,0.00021416288,0.00011458259],"domain_scores_gemma":[0.99960697,0.000052267336,0.000069678754,0.00014595952,0.00007364089,0.00005150183],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012695987,0.00011626038,0.00027277195,0.00009588432,0.000030127288,0.0000059728245,0.000028263963,0.000076309254,0.000012806333],"category_scores_gemma":[0.000015783713,0.0001032427,0.00009140484,0.000118211006,0.00004947639,0.0001265677,0.00000779394,0.00007436399,0.000001834767],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025039578,0.00042678887,0.91876656,0.00012927687,0.0004377717,0.00026512635,0.00009603793,0.00024825463,0.00029397846,0.0000452707,0.0000016384001,0.054249696],"study_design_scores_gemma":[0.010051563,0.0018402211,0.986549,0.00040459746,0.00030193376,0.00036113992,0.00005300879,0.00019275004,0.00007210134,0.000058799546,0.000006391616,0.00010846192],"about_ca_topic_score_codex":0.0000060828165,"about_ca_topic_score_gemma":0.0000016531175,"teacher_disagreement_score":0.06778245,"about_ca_system_score_codex":0.000076624085,"about_ca_system_score_gemma":0.000025951425,"threshold_uncertainty_score":0.42101154},"labels":[],"label_agreement":null},{"id":"W1980158169","doi":"10.1097/aco.0000000000000200","title":"Aspirin in the perioperative period","year":2015,"lang":"en","type":"review","venue":"Current Opinion in Anaesthesiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Perioperative; Aspirin; Discontinuation; Stroke (engine); Ischemia; Coronary artery disease; Surgery; Intensive care medicine; Anesthesia; Internal medicine","score_opus":0.18971728976822577,"score_gpt":0.4435583961084848,"score_spread":0.253841106340259,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980158169","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00035269695,0.9967498,0.0000038988983,0.00012894307,0.001171865,0.0013103732,0.000014398786,0.000020851156,0.00024714335],"genre_scores_gemma":[0.000069632675,0.9983944,0.000010610779,0.000088242996,0.00049663935,0.00040205676,0.00048439848,0.000033487202,0.000020517855],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99692345,0.0013560521,0.000613693,0.00049859216,0.00025506326,0.0003531526],"domain_scores_gemma":[0.9990815,0.00005781801,0.00013658052,0.0005755496,0.000052897587,0.000095667674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090547197,0.00040787,0.0020367734,0.00032980682,0.00004241672,0.000019323428,0.00033990387,0.0003414131,0.000054253705],"category_scores_gemma":[0.00008246753,0.00023800427,0.00071636774,0.0004750996,0.00020494251,0.000040070994,0.000052279698,0.00085275277,0.00014324748],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000376745,0.00019980295,0.00022624584,0.004426386,0.000060759747,0.000055091834,0.00040918918,9.609852e-7,9.568453e-9,0.00041689622,0.00077708357,0.9933899],"study_design_scores_gemma":[0.00087957113,0.00047408516,0.00046811826,0.0081520425,0.00014289629,0.00029272464,0.00021494615,0.000002769752,1.4593028e-8,0.000030773892,0.989105,0.00023706652],"about_ca_topic_score_codex":0.00001004105,"about_ca_topic_score_gemma":0.0000028122686,"teacher_disagreement_score":0.99315286,"about_ca_system_score_codex":0.00014892846,"about_ca_system_score_gemma":0.0007212564,"threshold_uncertainty_score":0.9705533},"labels":[],"label_agreement":null},{"id":"W1980420833","doi":"10.1016/j.ahj.2012.12.015","title":"Ambulance or in-catheterization laboratory administration of ticagrelor for primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: Rationale and design of the randomized, double-blind Administration of Ticagrelor in the cath Lab or in the Ambulance for New ST elevation myocardial Infarction to open the Coronary artery (ATLANTIC) study","year":2013,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto; Canadian Heart Research Centre; Southlake Regional Health Center","funders":"Servier; Société Française de Cardiologie; Fédération Française de Cardiologie; Institut National de la Santé et de la Recherche Médicale; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Ticagrelor; Percutaneous coronary intervention; Conventional PCI; Myocardial infarction; Internal medicine; Cardiology; Randomized controlled trial; Clinical endpoint; Thrombolysis; Prasugrel; Clopidogrel; Placebo; ST elevation; TIMI","score_opus":0.04479559503326706,"score_gpt":0.3230565785610634,"score_spread":0.2782609835277963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980420833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9524402,0.000108305016,0.028507201,0.0037783082,0.00014346206,0.01495659,0.000059099937,0.000004453007,0.0000023668576],"genre_scores_gemma":[0.995706,0.00021750462,0.0014433456,0.00071884046,0.00023713529,0.0014986416,0.00014004309,0.000019258876,0.000019233785],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99716944,0.00092792744,0.00096022355,0.00024858202,0.0005035995,0.00019021897],"domain_scores_gemma":[0.99746984,0.0011526264,0.0006053029,0.00029232958,0.00043090098,0.00004898772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030088045,0.0001877837,0.0006230636,0.00014250379,0.00016841711,0.000083059866,0.00023572445,0.000064078056,0.00001439486],"category_scores_gemma":[0.0004036348,0.0001008539,0.00022914431,0.0004900859,0.0001972506,0.00036077775,0.000028884084,0.00018594484,3.2744256e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8669951,0.0024572008,0.070713766,0.00038334835,0.001241606,0.000016539332,0.009966034,0.0028532643,0.013602698,0.00029939244,0.0013174347,0.03015363],"study_design_scores_gemma":[0.095542215,0.01115847,0.8739119,0.00042955662,0.00083031517,0.0009806573,0.012735768,0.0026996164,0.00047001409,0.00035056812,0.000613039,0.00027785893],"about_ca_topic_score_codex":0.0001212525,"about_ca_topic_score_gemma":0.00013837297,"teacher_disagreement_score":0.80319816,"about_ca_system_score_codex":0.000108909866,"about_ca_system_score_gemma":0.00077594275,"threshold_uncertainty_score":0.41127026},"labels":[],"label_agreement":null},{"id":"W1980847715","doi":"10.1161/strokeaha.109.564906","title":"Effect of Combined Aspirin and Extended-Release Dipyridamole Versus Clopidogrel on Functional Outcome and Recurrence in Acute, Mild Ischemic Stroke","year":2010,"lang":"en","type":"article","venue":"Stroke","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Dipyridamole; Clopidogrel; Aspirin; Stroke (engine); Cardiology; Ischemic stroke; Ticlopidine; Internal medicine; Platelet aggregation inhibitor; Anesthesia; Ischemia","score_opus":0.011692400739154533,"score_gpt":0.27790636302078814,"score_spread":0.26621396228163363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980847715","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971907,0.0008445661,0.0000161636,0.0000746652,0.0003709711,0.0003167999,0.00008754987,0.000025382133,0.0010731664],"genre_scores_gemma":[0.9991858,0.00021076702,0.00005784887,0.00005246881,0.000070113594,0.000022302975,0.00004157106,0.000015211804,0.00034391342],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99896806,0.000057901194,0.00021201577,0.0002920614,0.00027318456,0.00019678814],"domain_scores_gemma":[0.9992977,0.00018741954,0.00005888782,0.00027089377,0.000033292086,0.00015183169],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024888513,0.00018549054,0.0004139689,0.00011176902,0.000041560197,0.000009646732,0.000054092445,0.00011401446,0.000055679073],"category_scores_gemma":[0.00010410981,0.00015199198,0.00016766098,0.000081180864,0.00017915496,0.000060996794,0.000037586604,0.00037720826,0.00000675253],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027013471,0.0004102436,0.8107523,0.0003954496,0.0010444305,0.00014056916,0.000050464634,0.0000041539274,0.064645804,0.00036713705,0.00038614142,0.094789885],"study_design_scores_gemma":[0.031753976,0.0055904076,0.91450125,0.00018747301,0.00080644916,0.00006347487,0.000061590355,0.00012949349,0.044590216,0.000012417604,0.0019814146,0.00032183193],"about_ca_topic_score_codex":0.000015542319,"about_ca_topic_score_gemma":0.000009809644,"teacher_disagreement_score":0.10374901,"about_ca_system_score_codex":0.000013372859,"about_ca_system_score_gemma":0.000034917444,"threshold_uncertainty_score":0.6198053},"labels":[],"label_agreement":null},{"id":"W1980873144","doi":"10.1378/chest.13-0459","title":"Perioperative Management of Antiplatelet Therapy in Patients With a Coronary Stent Who Need Noncardiac Surgery","year":2013,"lang":"en","type":"review","venue":"CHEST Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University","funders":"British Mass Spectrometry Society","keywords":"Medicine; Discontinuation; Guideline; Clopidogrel; Perioperative; Coronary stent; Intensive care medicine; Stent; Platelet aggregation inhibitor; Antiplatelet drug; Elective surgery; Surgery; Aspirin; Internal medicine; Restenosis","score_opus":0.03204588355061454,"score_gpt":0.2719274851854765,"score_spread":0.23988160163486194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980873144","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0917849,0.9060868,0.000015684502,0.000010724921,0.00017358792,0.0016074049,0.000023619465,0.000011879551,0.00028542543],"genre_scores_gemma":[0.003337232,0.99581933,0.00014063173,0.000042684067,0.00016206331,0.00007908104,0.00013935371,0.000088558794,0.00019107443],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973864,0.0003148454,0.00087511505,0.00033630105,0.0007051494,0.00038221802],"domain_scores_gemma":[0.99852395,0.00007276827,0.00051618135,0.00042352552,0.00023668968,0.00022685854],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00047403935,0.000526936,0.0031674558,0.000352658,0.00007821322,0.000051291423,0.00017003657,0.00021004243,0.00021292358],"category_scores_gemma":[0.00000766788,0.0003238069,0.0016200461,0.00037663337,0.000128684,0.00015649063,0.000044103475,0.0006233186,0.00002235189],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000552744,0.00047498668,0.016937593,0.007814072,0.006631902,0.0011711342,0.000103140395,0.0000020239688,1.11949575e-7,0.0000034730535,0.0002692866,0.96603954],"study_design_scores_gemma":[0.007947723,0.000904073,0.15125291,0.057607643,0.0026598612,0.001001275,0.00032018236,9.027305e-7,0.0000037988364,0.0000020449886,0.77761877,0.0006807911],"about_ca_topic_score_codex":0.0000030796245,"about_ca_topic_score_gemma":1.2073895e-7,"teacher_disagreement_score":0.96535873,"about_ca_system_score_codex":0.0001631183,"about_ca_system_score_gemma":0.0003785071,"threshold_uncertainty_score":0.9999214},"labels":[],"label_agreement":null},{"id":"W1981268248","doi":"10.1053/j.jvca.2012.02.015","title":"Perioperative Management of Antiplatelet Agents in Patients Undergoing Cardiac Surgery","year":2012,"lang":"en","type":"review","venue":"Journal of Cardiothoracic and Vascular Anesthesia","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre","funders":"American College of Cardiology Foundation","keywords":"Medicine; Perioperative; Coronary artery disease; Percutaneous coronary intervention; Percutaneous; Revascularization; Adverse effect; Population; Cardiology; Internal medicine; Coronary artery bypass surgery; Intensive care medicine; Artery; Surgery; Myocardial infarction","score_opus":0.04205949291444828,"score_gpt":0.31561966735569424,"score_spread":0.273560174441246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981268248","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.037926864,0.9609875,0.00005186431,0.0000056801628,0.00015896543,0.00072430127,0.0000066425196,0.000007631901,0.00013054734],"genre_scores_gemma":[0.01969358,0.9796928,0.00019137246,0.000019532361,0.00022972484,0.000011535934,0.000044796016,0.00008023267,0.000036414956],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962846,0.00081157475,0.0013245356,0.000298437,0.00090368773,0.00037718378],"domain_scores_gemma":[0.9981528,0.00014209455,0.00077743415,0.00044283058,0.0002200091,0.00026481133],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019329138,0.00051686657,0.0051998766,0.0005669882,0.000057640736,0.00003224076,0.00014538612,0.00033683053,0.000019244897],"category_scores_gemma":[0.000022962195,0.00038661718,0.0048324373,0.00042477105,0.00009200102,0.00022421124,0.000043647728,0.000439385,0.000005074195],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017731634,0.00026382259,0.022031918,0.028296648,0.012729109,0.0013970984,0.000115179675,0.0000037416173,6.930212e-8,0.000022036666,0.0000683955,0.9348947],"study_design_scores_gemma":[0.0016809433,0.00026840385,0.046376973,0.03776926,0.023106102,0.001758781,0.00021342972,7.456721e-7,0.0000033143776,0.0000025762536,0.8882419,0.00057757524],"about_ca_topic_score_codex":0.0000021675755,"about_ca_topic_score_gemma":6.8074094e-8,"teacher_disagreement_score":0.9343171,"about_ca_system_score_codex":0.00013760694,"about_ca_system_score_gemma":0.00029447058,"threshold_uncertainty_score":0.99985856},"labels":[],"label_agreement":null},{"id":"W1981499783","doi":"10.1016/j.ijcard.2014.12.140","title":"Effect of esomeprazole on gastroduodenal erosions in patients at increased gastrointestinal risk treated with low-dose acetylsalicylic acid: A post-hoc analysis of the OBERON trial","year":2014,"lang":"en","type":"review","venue":"International Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Esomeprazole; Discontinuation; Internal medicine; Gastroenterology; Asymptomatic; Post-hoc analysis; Aspirin; Peptic ulcer; Lansoprazole; Gastric acid; Helicobacter pylori; Stomach","score_opus":0.007131447060545981,"score_gpt":0.28935285432085023,"score_spread":0.28222140726030426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981499783","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88357806,0.11506195,0.00005843084,0.000012702899,0.00022193616,0.00069767446,0.00032459805,0.0000049981336,0.000039649167],"genre_scores_gemma":[0.8100051,0.18913835,0.00002596513,0.000026968542,0.00045532777,0.00002396482,0.0002764923,0.000037909063,0.00000992143],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99477106,0.0023265795,0.0013321112,0.00030455418,0.0010285166,0.00023716812],"domain_scores_gemma":[0.9957658,0.00064635574,0.0022259988,0.00047509786,0.00074980914,0.0001369542],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001297298,0.00041268446,0.0040353346,0.0010570951,0.000034914403,0.000008239749,0.00052642846,0.00018674353,0.000029731327],"category_scores_gemma":[0.00081683503,0.0002208404,0.00423459,0.000518452,0.00023580917,0.00004387372,0.00010188771,0.00063826545,0.0000032651838],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.47654364,0.0008758577,0.2579844,0.0014266294,0.058902662,0.00047849075,0.000039952847,0.0025492331,0.00013040211,0.000012821424,0.00009713148,0.20095879],"study_design_scores_gemma":[0.29206207,0.09736995,0.359652,0.054459352,0.16077405,0.006384654,0.000033069875,0.000080988,0.00053175975,0.000005551,0.02762568,0.0010208554],"about_ca_topic_score_codex":0.000030962343,"about_ca_topic_score_gemma":0.000009260173,"teacher_disagreement_score":0.19993792,"about_ca_system_score_codex":0.0003289832,"about_ca_system_score_gemma":0.0003204844,"threshold_uncertainty_score":0.90056103},"labels":[],"label_agreement":null},{"id":"W1982497616","doi":"10.3810/hp.2014.08.1116","title":"Management of Acute Coronary Syndrome in the Hospital: A Focus on ACCF/AHA Guideline Updates to Oral Antiplatelet Therapy","year":2014,"lang":"en","type":"review","venue":"Hospital Practice","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"American College of Cardiology Foundation","keywords":"Prasugrel; Medicine; Ticagrelor; Clopidogrel; Acute coronary syndrome; P2Y12; Myocardial infarction; Guideline; Unstable angina; Aspirin; Intensive care medicine; Internal medicine; Cardiology; Chest pain; Percutaneous coronary intervention; Angina; Canadian Cardiovascular Society","score_opus":0.022285637544159922,"score_gpt":0.34533942028831455,"score_spread":0.32305378274415464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982497616","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004844787,0.98415244,0.0001062554,0.0030628752,0.00044817172,0.005135567,0.00010486377,0.00008134037,0.0020637088],"genre_scores_gemma":[0.019263351,0.9770018,0.0009852127,0.0015623192,0.0001357973,0.0003402305,0.0004024856,0.00014587841,0.00016295555],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99553317,0.0007109366,0.001249019,0.00085917185,0.0010915177,0.0005561802],"domain_scores_gemma":[0.9968179,0.00046940963,0.00071382243,0.001625252,0.00018754174,0.00018608145],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018413537,0.0007999241,0.0026493391,0.00028942648,0.000087537795,0.0000751977,0.0008047184,0.00033600494,0.00011072551],"category_scores_gemma":[0.00013672485,0.0005099035,0.0014384968,0.00083220523,0.000106147876,0.00031031366,0.00017889439,0.000755135,0.00037769042],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076317997,0.0019647696,0.00002882315,0.0025143796,0.009014584,0.012371339,0.00014393155,0.000002611017,1.5088877e-7,0.00063197734,0.0065093953,0.96605486],"study_design_scores_gemma":[0.0023041419,0.004640955,0.00083651,0.006998208,0.0059111333,0.001791159,0.00031737113,0.000001674196,0.0000025214172,0.00006734438,0.9765123,0.000616692],"about_ca_topic_score_codex":0.00003713882,"about_ca_topic_score_gemma":5.014357e-7,"teacher_disagreement_score":0.9700029,"about_ca_system_score_codex":0.00010132615,"about_ca_system_score_gemma":0.00012885217,"threshold_uncertainty_score":0.99973524},"labels":[],"label_agreement":null},{"id":"W1982661893","doi":"10.1016/s1098-3015(10)62692-7","title":"PCV51 SHORT AND LONG-TERM COST-EFFECTIVENESS OF EARLY AND SUSTAINED DUAL ORAL ANTIPLATELET THERAPY WITH CLOPIDROGREL FOLLOWING PERCUTANEOUS CORONARY INTERVENTION:A CANADIAN ECONOMIC ANALYSIS","year":2005,"lang":"en","type":"article","venue":"Value in Health","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Percutaneous coronary intervention; Medicine; Dual (grammatical number); Term (time); Cardiology; Intervention (counseling); Internal medicine; Intensive care medicine; Myocardial infarction; Nursing","score_opus":0.023288697709602253,"score_gpt":0.3016375212899182,"score_spread":0.278348823580316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982661893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859128,0.012675374,0.00008035201,0.000147482,0.000038359412,0.0010817307,0.000028844526,0.000019822788,0.000015227383],"genre_scores_gemma":[0.9973493,0.0022609914,0.00009996278,0.00011650553,0.000038269525,0.00001989677,0.00007784056,0.000025372578,0.0000118579455],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984413,0.0003560979,0.0003505381,0.00034755975,0.00015142445,0.00035308304],"domain_scores_gemma":[0.9992592,0.00009347617,0.00006452497,0.00022216923,0.000033900855,0.00032676797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008578625,0.00018947595,0.0007431608,0.000385491,0.00009288497,0.00002331726,0.00004868716,0.00008555682,0.000033072505],"category_scores_gemma":[0.0000073885276,0.0001658861,0.00025095398,0.00023971823,0.000102764185,0.00012203774,0.000015515665,0.00014255806,8.5875683e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017603778,0.000106487285,0.9368414,0.00026555854,0.0020668283,0.0010084935,0.00028108712,0.00150334,0.000023845074,0.000046357836,0.0000010066045,0.056095216],"study_design_scores_gemma":[0.0035487264,0.001246782,0.99182755,0.00035188592,0.0003488828,0.00094368437,0.00015183254,0.0012790051,0.000039480503,0.000008401798,0.00008328204,0.00017051195],"about_ca_topic_score_codex":0.037109405,"about_ca_topic_score_gemma":0.016253144,"teacher_disagreement_score":0.055924706,"about_ca_system_score_codex":0.00031752748,"about_ca_system_score_gemma":0.00042290526,"threshold_uncertainty_score":0.9693026},"labels":[],"label_agreement":null},{"id":"W1983666245","doi":"10.1016/j.cjca.2011.07.179","title":"243 Potential cross-reactivity between prasugrel and other antiplatelet agents","year":2011,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Toronto Public Health","funders":"","keywords":"Prasugrel; Medicine; Internal medicine; Clopidogrel; Aspirin","score_opus":0.04178077197537398,"score_gpt":0.27127389821097914,"score_spread":0.22949312623560517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983666245","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98888713,0.0018883663,0.001676598,0.000077874705,0.00036569717,0.00011508177,0.00005806884,0.000007132146,0.006924071],"genre_scores_gemma":[0.99828994,0.0001298908,0.00010426471,0.00027077002,0.0011075226,9.652249e-7,0.0000053500294,0.000023868091,0.00006743032],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989271,0.00015229534,0.0002836146,0.00016209066,0.0001387288,0.00033615276],"domain_scores_gemma":[0.99873567,0.000023612074,0.00013894524,0.00020029856,0.00014924296,0.00075224077],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047236352,0.00014741234,0.00064160203,0.00020515661,0.00010074515,0.000018798242,0.00011028189,0.00019276461,0.0001221964],"category_scores_gemma":[0.00007425629,0.00012498956,0.00041421276,0.00007555235,0.0003435831,0.000107587475,0.00001127492,0.00028099897,0.000014032835],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026032384,0.0000046038986,0.97491866,0.000019947769,0.001784168,0.0023485187,0.00016135932,0.000019270758,0.00027791446,0.00004772559,0.0012589067,0.01889858],"study_design_scores_gemma":[0.0019824828,0.00029998564,0.8644096,0.000034469227,0.0004914245,0.004565339,0.0000527469,0.000001637479,0.00038006733,0.00021951713,0.12743421,0.0001285108],"about_ca_topic_score_codex":0.00062436017,"about_ca_topic_score_gemma":0.000065567394,"teacher_disagreement_score":0.1261753,"about_ca_system_score_codex":0.000046062512,"about_ca_system_score_gemma":0.0005026328,"threshold_uncertainty_score":0.5096926},"labels":[],"label_agreement":null},{"id":"W1983778635","doi":"10.1002/pds.1716","title":"Investigation of an interaction between statins and clopidogrel after percutaneous coronary intervention: a cohort study","year":2009,"lang":"en","type":"article","venue":"Pharmacoepidemiology and Drug Safety","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Jewish General Hospital; Queen's University; McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; Clopidogrel; Percutaneous coronary intervention; Pharmacoepidemiology; Cohort; Internal medicine; Cardiology; Cohort study; Emergency medicine; Pharmacology; Aspirin; Myocardial infarction; Medical prescription","score_opus":0.022207824994304518,"score_gpt":0.33465251791344763,"score_spread":0.3124446929191431,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983778635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995941,0.0022676496,0.00037143537,0.0006313851,0.00007481877,0.0005831714,0.000023954286,0.000040392733,0.00006621811],"genre_scores_gemma":[0.9974099,0.0011224799,0.00028802635,0.0008793301,0.0001293117,0.000015015071,0.00011800398,0.00000848114,0.000029475756],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99798495,0.0010000309,0.00045611837,0.00031390527,0.00010101273,0.00014396722],"domain_scores_gemma":[0.99918807,0.00030508052,0.0001279816,0.00015062536,0.00005647675,0.00017176449],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014562319,0.00015101794,0.0005268641,0.00007288434,0.00007699561,0.0000040142377,0.000036265545,0.00006606761,0.00008401018],"category_scores_gemma":[0.000085032334,0.00012909659,0.00011871402,0.00006422351,0.00015728554,0.0001668395,0.000022821016,0.00020889525,0.000001961095],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002348086,0.00014101848,0.9166545,0.000050492617,0.00046976176,0.000102180085,0.00076977967,0.0000056174345,0.00026805015,0.000015621516,0.00005310047,0.07912175],"study_design_scores_gemma":[0.0020681033,0.00084614265,0.99397206,0.00006065475,0.00077630207,0.00052286196,0.00062756654,0.00024219579,0.00014334674,0.00034442177,0.0002822904,0.0001140418],"about_ca_topic_score_codex":0.000055540688,"about_ca_topic_score_gemma":0.000007510724,"teacher_disagreement_score":0.07900771,"about_ca_system_score_codex":0.000020535925,"about_ca_system_score_gemma":0.000018756138,"threshold_uncertainty_score":0.5264406},"labels":[],"label_agreement":null},{"id":"W1983822972","doi":"10.1111/j.1540-8191.2007.00402.x","title":"Does the Use of Preoperative Aspirin Increase the Risk of Bleeding in Patients Undergoing Coronary Artery Bypass Grafting Surgery? Systematic Review and Meta-Analysis","year":2007,"lang":"en","type":"review","venue":"Journal of Cardiac Surgery","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Aspirin; Fresh frozen plasma; Surgery; Blood transfusion; Blood product; Anesthesia; Packed red blood cells; Artery; Coronary artery bypass surgery; Randomized controlled trial; Platelet; Internal medicine","score_opus":0.07852392032375623,"score_gpt":0.3060750989269461,"score_spread":0.2275511786031899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983822972","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012116482,0.9858815,0.000019721572,0.000032020256,0.00016898093,0.0016261679,0.00014376534,0.0000043898913,0.000006979956],"genre_scores_gemma":[0.017632078,0.9819929,0.000019752715,0.00012910062,0.000082881874,0.000043711963,0.0000345115,0.000043756103,0.000021282138],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9886219,0.0055902326,0.0040773847,0.00027430608,0.0011491854,0.00028702727],"domain_scores_gemma":[0.973741,0.019359944,0.0053690225,0.0007226043,0.00066323037,0.0001442273],"candidate_categories":["metaepi_broad"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.014974765,0.0005158494,0.015822742,0.0008457797,0.00009700254,0.000044572553,0.00017446394,0.00017479328,0.000021567466],"category_scores_gemma":[0.0039286804,0.00019150722,0.018731492,0.0013009398,0.0001793074,0.00026734013,0.00007731176,0.0006603075,5.318591e-7],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009618457,0.00012163141,0.050729584,0.3510342,0.5831966,0.000103809085,0.000079965146,0.000016084601,4.766203e-8,0.000001113197,0.00022695512,0.014393885],"study_design_scores_gemma":[0.00012029735,0.00003635686,0.0053082816,0.086886175,0.904382,0.00015489782,0.00011448654,0.0000011559413,0.0000013322506,0.0000017958395,0.0027868412,0.00020640016],"about_ca_topic_score_codex":0.000031328316,"about_ca_topic_score_gemma":0.000004941541,"teacher_disagreement_score":0.32118544,"about_ca_system_score_codex":0.00009127656,"about_ca_system_score_gemma":0.00051727874,"threshold_uncertainty_score":0.9987884},"labels":[],"label_agreement":null},{"id":"W1983893864","doi":"10.1007/s11239-014-1090-5","title":"Efficacy and safety of cilostazol based triple antiplatelet treatment versus dual antiplatelet treatment in patients undergoing coronary stent implantation: an updated meta-analysis of the randomized controlled trials","year":2014,"lang":"en","type":"review","venue":"Journal of Thrombosis and Thrombolysis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Texas Association for Play Therapy","keywords":"Medicine; Cilostazol; Clopidogrel; Internal medicine; Aspirin; Cardiology; Stroke (engine); Myocardial infarction; Randomized controlled trial; Percutaneous coronary intervention; Coronary stent; Stent; Restenosis","score_opus":0.10678550049322177,"score_gpt":0.3696520605840979,"score_spread":0.2628665600908761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983893864","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.35987464,0.6351541,0.0000359258,0.000059461174,0.00021589323,0.0041261152,0.00050699397,0.000007963287,0.000018920831],"genre_scores_gemma":[0.30644125,0.6928387,0.00008719321,0.00001839619,0.00005222051,0.000048960035,0.00046514405,0.00003991647,0.000008195154],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9869849,0.0057660025,0.0053571505,0.00055574585,0.0010052072,0.0003309778],"domain_scores_gemma":[0.9874328,0.004804082,0.0063639055,0.0007564381,0.000394085,0.00024870492],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.004877508,0.0009468376,0.03870445,0.00121318,0.00014975622,0.000056209406,0.00019950159,0.000378746,0.00027508324],"category_scores_gemma":[0.00048398576,0.0004363463,0.018933289,0.0009962162,0.00031960328,0.00016006656,0.000048769132,0.00024154765,4.5070172e-7],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13822179,0.0024882539,0.00079510716,0.0009218536,0.81968933,0.000027806935,0.00018639855,0.00020577887,0.000013538737,0.00002167713,0.000010814005,0.037417654],"study_design_scores_gemma":[0.33934125,0.002688134,0.0043364414,0.00075986667,0.65143275,0.000022381055,0.00007571279,0.00008690931,0.000043816275,0.0000040454333,0.00095148926,0.00025723936],"about_ca_topic_score_codex":0.00007122254,"about_ca_topic_score_gemma":0.000039216815,"teacher_disagreement_score":0.20111945,"about_ca_system_score_codex":0.00024733247,"about_ca_system_score_gemma":0.0005809885,"threshold_uncertainty_score":0.99980885},"labels":[],"label_agreement":null},{"id":"W1984514918","doi":"10.1016/j.jacc.2003.10.071","title":"Clopidogrel inhibits platelet-leukocyte interactions and thrombin receptor agonist peptide-induced platelet activation in patients with an acute coronary syndrome","year":2004,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":177,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Clopidogrel; Medicine; Platelet; Platelet activation; Ex vivo; Agonist; Antiplatelet drug; Thrombin; Pharmacology; Aspirin; Internal medicine; Adenosine diphosphate; Endocrinology; Receptor; Biochemistry; Chemistry; In vitro; Platelet aggregation","score_opus":0.009133852522719895,"score_gpt":0.24589973528166983,"score_spread":0.23676588275894994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984514918","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99851537,0.000074320415,0.00015571887,0.00061111525,0.00017891114,0.0003705297,0.000040440256,0.000008917078,0.00004466072],"genre_scores_gemma":[0.99876475,0.0002047091,0.0006316304,0.0002572162,0.0000814849,0.0000053774565,0.000014194985,0.000026699126,0.00001395786],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985273,0.00024580862,0.00048225166,0.00019536851,0.00033614232,0.0002131478],"domain_scores_gemma":[0.9986395,0.00006991665,0.0006483937,0.0002855977,0.00022723223,0.00012930743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023219167,0.00019469568,0.0010262489,0.00020994357,0.00009116026,0.00000666953,0.00015168122,0.00006819108,0.0000071177847],"category_scores_gemma":[0.000047101974,0.00012981209,0.0003055946,0.00039445306,0.00037921037,0.0002505209,0.00004684866,0.00040964465,9.708776e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10113628,0.0025392545,0.75557005,0.00022927584,0.024181828,0.004600042,0.0009661632,0.020301515,0.06923512,0.00030982497,0.0014421172,0.019488508],"study_design_scores_gemma":[0.012083318,0.009587543,0.9570758,0.00042931942,0.00044861264,0.0098880045,0.0007180393,0.000008619924,0.008980291,0.00009048153,0.00045347397,0.00023649701],"about_ca_topic_score_codex":0.000024501998,"about_ca_topic_score_gemma":0.000005400231,"teacher_disagreement_score":0.20150574,"about_ca_system_score_codex":0.00020317618,"about_ca_system_score_gemma":0.00030357996,"threshold_uncertainty_score":0.5293583},"labels":[],"label_agreement":null},{"id":"W1984657534","doi":"10.1093/cvr/cvu108","title":"Purinergic receptors and atherosclerosis: emerging role for vessel wall P2Y12","year":2014,"lang":"en","type":"editorial","venue":"Cardiovascular Research","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"P2Y12; Prasugrel; Ticagrelor; Platelet; Cangrelor; Platelet activation; Clopidogrel; Purinergic receptor; Medicine; Pharmacology; Receptor; Internal medicine; Aspirin","score_opus":0.03006269055218852,"score_gpt":0.32376220449587684,"score_spread":0.2936995139436883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984657534","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019863527,0.4640781,0.001952438,0.00044610983,0.50312597,0.006885908,0.00024960042,0.0005537909,0.0028445825],"genre_scores_gemma":[0.011455931,0.07566858,0.00041049693,0.000072455994,0.9030993,0.0018071837,0.0015502234,0.0006562907,0.0052795243],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9913863,0.000989575,0.0005685802,0.0016510562,0.004035175,0.0013693025],"domain_scores_gemma":[0.99449176,0.00083819515,0.0000984939,0.0022659663,0.0016318293,0.00067374407],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0078120115,0.000692699,0.0022703288,0.0005845756,0.00061065005,0.00022791715,0.00054584123,0.0014113063,0.000068795904],"category_scores_gemma":[0.002006996,0.00063256297,0.0042922692,0.00054008065,0.00049644423,0.00012837863,0.0003174435,0.0019143427,0.00008786728],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000587306,0.00011683031,0.00008513014,0.0021777044,0.0128627075,0.000049703074,0.00016819572,0.000044542434,0.00017849848,0.000046837384,0.9243931,0.05928943],"study_design_scores_gemma":[0.0048842817,0.0004550704,0.00011485251,0.0008617086,0.0021880227,0.000030470494,0.00022572184,0.00009384018,0.00035010415,0.00017320641,0.99000835,0.00061438966],"about_ca_topic_score_codex":0.0001276979,"about_ca_topic_score_gemma":0.0000027674396,"teacher_disagreement_score":0.39997336,"about_ca_system_score_codex":0.0002632661,"about_ca_system_score_gemma":0.00061162654,"threshold_uncertainty_score":0.9998851},"labels":[],"label_agreement":null},{"id":"W1984694961","doi":"10.1016/s0002-8703(00)90069-3","title":"Chronic ischemic heart disease","year":2000,"lang":"sl","type":"article","venue":"American Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster Children's Hospital; Hamilton Health Sciences","funders":"","keywords":"Medicine; Internal medicine; Myocardial infarction; Blood pressure; Cohort; Body mass index; Cardiology; Angina; Unstable angina; Cholesterol; Cohort study; Proportional hazards model","score_opus":0.009872927413051454,"score_gpt":0.27403223072607014,"score_spread":0.2641593033130187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984694961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86598337,0.12321036,0.000050827257,0.00803593,0.00044586248,0.0003183581,0.000039837745,0.00007968581,0.001835784],"genre_scores_gemma":[0.9569641,0.0219616,0.00018240655,0.008012218,0.007849131,0.000012107111,0.000019560446,0.00010806041,0.00489085],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962184,0.0004693442,0.0006563152,0.0005399747,0.000982556,0.0011334218],"domain_scores_gemma":[0.99683356,0.00009559147,0.00015390317,0.000780097,0.00012756612,0.0020092642],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0005149194,0.0004945561,0.0011454832,0.00015720335,0.00054431957,0.00015465623,0.00025307757,0.00008774868,0.01803667],"category_scores_gemma":[0.00006612687,0.00044959332,0.0016874621,0.00055213884,0.0009076185,0.00026419543,0.000033209984,0.0011087978,0.0026315541],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025135437,0.000617592,0.08751491,0.00017681299,0.0022177144,0.0025115374,0.00027835273,0.0002985256,0.003393203,0.0000100474135,0.18509768,0.71537006],"study_design_scores_gemma":[0.00252986,0.0012623477,0.12792033,0.00072294316,0.0013541403,0.0054464783,0.00085506565,0.0001361751,0.0003384757,0.000031804728,0.85878533,0.00061707414],"about_ca_topic_score_codex":0.00009450166,"about_ca_topic_score_gemma":0.0000016546852,"teacher_disagreement_score":0.71475303,"about_ca_system_score_codex":0.00033476317,"about_ca_system_score_gemma":0.001583962,"threshold_uncertainty_score":0.99979556},"labels":[],"label_agreement":null},{"id":"W1984798494","doi":"10.1161/circulationaha.105.546697","title":"Should Aspirin Be Discontinued Before Coronary Artery Bypass Surgery?","year":2005,"lang":"en","type":"article","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Aspirin; Coronary artery bypass surgery; Artery; Surgery; Cardiology; Internal medicine","score_opus":0.036205848106881135,"score_gpt":0.26963471929088195,"score_spread":0.23342887118400082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984798494","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946598,0.0012304141,0.0011757589,0.0014941486,0.00013371852,0.00020538109,0.000008864874,0.00012643769,0.00096552196],"genre_scores_gemma":[0.99752825,0.000036408703,0.00006887517,0.0010380778,0.0005996787,0.000018606188,0.00039750666,0.00002772829,0.00028488084],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989809,0.000046801608,0.00023205938,0.00023287577,0.00030634992,0.00020103784],"domain_scores_gemma":[0.9994312,0.000031701155,0.00005721451,0.00031291432,0.00005410479,0.00011287879],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019310993,0.00013458761,0.00028385295,0.000082393984,0.000077504315,0.00002003268,0.000039415918,0.0001017545,0.0002635125],"category_scores_gemma":[0.000026340109,0.00012351062,0.00039946177,0.00012367837,0.000048092927,0.00020639856,0.000011187814,0.00010065606,0.00007383796],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016396143,0.0001545635,0.6519115,0.000048733313,0.00044219437,0.000110245106,0.00017790127,0.00021821019,0.002224512,0.00016746412,0.001246979,0.34313375],"study_design_scores_gemma":[0.0009115662,0.000021469743,0.9712243,0.000062455074,0.00021368398,0.00022255201,0.000043146014,0.0006257453,0.00042572877,0.00006251462,0.026046889,0.00013994976],"about_ca_topic_score_codex":0.0000044400444,"about_ca_topic_score_gemma":0.000011752173,"teacher_disagreement_score":0.3429938,"about_ca_system_score_codex":0.00006232635,"about_ca_system_score_gemma":0.00005721508,"threshold_uncertainty_score":0.50366163},"labels":[],"label_agreement":null},{"id":"W1985520875","doi":"10.1016/j.jacc.2008.08.047","title":"The ELAPSE (Evaluation of Long-Term Clopidogrel Antiplatelet and Systemic Anti-Inflammatory Effects) Study","year":2008,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; Vancouver General Hospital; University of British Columbia; St. Paul's Hospital; University of British Columbia Hospital","funders":"","keywords":"Medicine; Clopidogrel; Aspirin; Platelet; Internal medicine; Platelet activation; Arachidonic acid; Loading dose; Gastroenterology; Anesthesia; Pharmacology","score_opus":0.013235258064042302,"score_gpt":0.27025383361964705,"score_spread":0.25701857555560476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985520875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874205,0.011174587,0.00007317073,0.000107424436,0.00038152828,0.00076615135,0.000009242115,0.0000050243298,0.000062382715],"genre_scores_gemma":[0.99488264,0.004759275,0.000014569572,0.00003351538,0.00026633308,0.000007061399,4.770805e-7,0.000016443108,0.000019692596],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967635,0.0015163679,0.0006579279,0.00013855984,0.00074693625,0.00017667958],"domain_scores_gemma":[0.9973956,0.00039080653,0.0010590777,0.0004775958,0.0005990633,0.000077910496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021710414,0.00015648005,0.0012533512,0.0001161244,0.00015884943,0.0000028239904,0.00024404442,0.000051480914,0.0000015315181],"category_scores_gemma":[0.00030692032,0.00008475032,0.0006849457,0.00026895304,0.00094484934,0.00004874326,0.000066041655,0.00022084289,6.0133965e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015189003,0.00009241967,0.9809158,0.000114517505,0.004271975,0.00091322575,0.000129171,0.00036318993,0.0051758164,0.000012626591,0.00034272295,0.0061496277],"study_design_scores_gemma":[0.0043706326,0.0014279679,0.9712562,0.00018730998,0.002037639,0.018263474,0.00078154297,0.000025666432,0.0014595746,0.000013857206,0.00009302672,0.00008310838],"about_ca_topic_score_codex":0.0000027989204,"about_ca_topic_score_gemma":9.1593114e-7,"teacher_disagreement_score":0.017350249,"about_ca_system_score_codex":0.00005205023,"about_ca_system_score_gemma":0.0003596379,"threshold_uncertainty_score":0.34813368},"labels":[],"label_agreement":null},{"id":"W1985541943","doi":"10.1093/eurheartj/ehu262","title":"Applying novel methods to assess clinical outcomes: insights from the TRILOGY ACS trial","year":2014,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Alberta; Canadian VIGOUR Centre","funders":"Daiichi Sankyo Europe; University of Toronto; Eli Lilly and Company","keywords":"Medicine; Prasugrel; Hazard ratio; Randomized controlled trial; Clinical endpoint; Clinical trial; Internal medicine; Statistical significance; Revascularization; Acute coronary syndrome; Clopidogrel; Confidence interval; Myocardial infarction","score_opus":0.21967577645300984,"score_gpt":0.45010061567008414,"score_spread":0.2304248392170743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985541943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80320567,0.0008903229,0.18694131,0.0022895539,0.002647059,0.00084316015,0.0000047143812,0.00007009491,0.0031081238],"genre_scores_gemma":[0.91860044,0.00020801194,0.04058812,0.027552102,0.0125643695,0.000020120573,0.000011730712,0.000109650304,0.0003454355],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9944891,0.0038142852,0.0006752973,0.00030206543,0.0004405191,0.00027878647],"domain_scores_gemma":[0.9971741,0.0015498193,0.00014424005,0.00056400785,0.00010293096,0.00046493448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0050563063,0.00020154116,0.00071315427,0.00006744208,0.00032583918,0.00011868633,0.00028192234,0.00006776521,0.00011067066],"category_scores_gemma":[0.0018314585,0.00011528779,0.0009606319,0.00014662914,0.00007869278,0.000078637364,0.00009737024,0.00080954103,0.00026132265],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.044716775,0.0018835443,0.1716739,0.000027400836,0.006429745,0.00078266807,0.0011593794,0.00012233885,0.010640406,0.0007628469,0.05098551,0.7108155],"study_design_scores_gemma":[0.02673807,0.00058254495,0.28993937,0.000056200486,0.00031005588,0.00032310985,0.00010700071,0.000023407107,0.00008993038,0.000064163636,0.68162334,0.00014281245],"about_ca_topic_score_codex":0.000004350507,"about_ca_topic_score_gemma":9.383678e-7,"teacher_disagreement_score":0.7106727,"about_ca_system_score_codex":0.000022414355,"about_ca_system_score_gemma":0.000098724,"threshold_uncertainty_score":0.47012997},"labels":[],"label_agreement":null},{"id":"W1985989850","doi":"10.1016/s0140-6736(13)61840-1","title":"Cangrelor: a new CHAMPION for percutaneous coronary intervention","year":2013,"lang":"en","type":"letter","venue":"The Lancet","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"","keywords":"Prasugrel; Thienopyridine; Medicine; Clopidogrel; Conventional PCI; Percutaneous coronary intervention; Cangrelor; Myocardial infarction; Internal medicine; Ticagrelor; Cardiology; Randomized controlled trial; Aspirin; Acute coronary syndrome","score_opus":0.03416359685028918,"score_gpt":0.2767911925518894,"score_spread":0.2426275957016002,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985989850","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017444313,0.01792224,0.0011781016,0.9583077,0.0009847734,0.0023631162,0.00020064392,0.00023061386,0.0013685353],"genre_scores_gemma":[0.011400733,0.0022952994,0.00035913268,0.89510745,0.0416387,0.0001855525,0.00230006,0.00013576339,0.04657729],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.998872,0.00008017208,0.0001873665,0.00026033408,0.00026217016,0.00033797615],"domain_scores_gemma":[0.99899286,0.00007640635,0.000095017334,0.0007189771,0.000059256286,0.000057459332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015104434,0.0002297533,0.0007013792,0.00004083103,0.00007757498,0.000036473433,0.00024026824,0.00033186865,0.000636112],"category_scores_gemma":[0.000032767555,0.00014577525,0.00079394324,0.000045465506,0.00005844598,0.00003314864,0.000032356038,0.00062268804,0.00019466673],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040795346,0.000015669046,0.000042305262,0.00038376285,0.00079552253,0.00040373186,0.00008655257,9.713905e-7,0.00003759738,0.000009744647,0.95123804,0.046578173],"study_design_scores_gemma":[0.002090491,0.00024342099,0.00053323765,0.0003776282,0.0006689184,0.0022737507,0.00003135012,0.00003345435,0.00002490886,0.0005157996,0.9930291,0.00017794994],"about_ca_topic_score_codex":0.00012624453,"about_ca_topic_score_gemma":0.0000064941178,"teacher_disagreement_score":0.0632002,"about_ca_system_score_codex":0.00006265089,"about_ca_system_score_gemma":0.00008461756,"threshold_uncertainty_score":0.69649804},"labels":[],"label_agreement":null},{"id":"W1986249234","doi":"10.1371/journal.pone.0092078","title":"A Comparative Pharmacodynamic Study of Ticagrelor versus Clopidogrel and Ticagrelor in Patients Undergoing Primary Percutaneous Coronary Intervention: The CAPITAL RELOAD Study","year":2014,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"University of Ottawa","keywords":"Ticagrelor; Clopidogrel; Percutaneous coronary intervention; Medicine; Pharmacodynamics; Internal medicine; Cardiology; Aspirin; P2Y12; Platelet aggregation inhibitor; Myocardial infarction; Pharmacokinetics","score_opus":0.03152381227111124,"score_gpt":0.26523777439617297,"score_spread":0.23371396212506174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986249234","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99687314,0.0008123268,0.0000060722946,0.000040714753,0.00006801905,0.0018945866,0.0000061909236,0.00003065187,0.00026830874],"genre_scores_gemma":[0.999628,0.000112133865,0.000041406907,0.000044611752,0.000045538025,0.00003953695,0.000022776348,0.000019843084,0.000046158682],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982159,0.00036794404,0.00037152466,0.00030377784,0.00055731204,0.00018353465],"domain_scores_gemma":[0.9991104,0.00028530695,0.00010308425,0.00030987425,0.00010973141,0.00008158553],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026802236,0.00018372001,0.0006360745,0.00008471703,0.0000884255,0.000013014027,0.00011296581,0.000039727434,0.000041360512],"category_scores_gemma":[0.00006105682,0.00013743472,0.00011764362,0.00014847492,0.000118672186,0.000073159965,0.000100701836,0.00022262096,0.000013360997],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016948452,0.08608872,0.85408986,0.0005814122,0.010781598,0.00025246807,0.019305456,0.000027553513,0.00053729804,0.000023828665,0.000018431416,0.011344936],"study_design_scores_gemma":[0.028199323,0.016137347,0.93765694,0.00037676273,0.0024707825,0.000022015898,0.014321951,0.0005520206,0.000053926524,0.000014065365,0.000003956633,0.00019092768],"about_ca_topic_score_codex":0.00003207353,"about_ca_topic_score_gemma":0.00008841061,"teacher_disagreement_score":0.083567075,"about_ca_system_score_codex":0.00007535606,"about_ca_system_score_gemma":0.000033501627,"threshold_uncertainty_score":0.56044257},"labels":[],"label_agreement":null},{"id":"W1986579965","doi":"10.1378/chest.11-2294","title":"New Antithrombotic Drugs","year":2012,"lang":"en","type":"review","venue":"CHEST Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":531,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; McMaster University; Population Health Research Institute","funders":"Eisai; Sanofi; Bayer HealthCare; National Heart, Lung, and Blood Institute; Pfizer; Heart and Stroke Foundation of Canada; American College of Clinical Pharmacy; GlaxoSmithKline; Daiichi-Sankyo; McMaster University; Eli Lilly and Company; Bristol-Myers Squibb; American Society of Hematology","keywords":"Antithrombotic; Medicine; Intensive care medicine; Anticoagulant; Clinical Practice; Fibrinolytic agent; Thrombosis; Surgery; Internal medicine; Family medicine","score_opus":0.0645347768960622,"score_gpt":0.3386291739302689,"score_spread":0.27409439703420674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986579965","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000068083828,0.99612993,0.00066875276,0.000031469495,0.0007978506,0.0002517609,0.000003176426,0.000038143924,0.0020721168],"genre_scores_gemma":[0.000014752613,0.9913706,0.0008118303,0.000074458214,0.0054793563,0.0000029815537,0.000030830328,0.000084760504,0.0021303985],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984045,0.000111972964,0.00046782335,0.00018936349,0.00042620554,0.00040015014],"domain_scores_gemma":[0.99850225,0.00003765653,0.00026480484,0.0003790393,0.00005312841,0.000763137],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00037950987,0.00036735047,0.0019516,0.00015945129,0.000113321374,0.000067879,0.0001854523,0.0002856803,0.0016473185],"category_scores_gemma":[0.000024210192,0.00024916124,0.0025027967,0.00019926002,0.00004647624,0.00011069539,0.00003193262,0.00090656185,0.00085040095],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008252781,0.000050527244,0.000016721202,0.008683859,0.0017310296,0.0002473274,0.00003981082,3.627858e-8,1.4985247e-7,0.000017402635,0.0032519593,0.9859529],"study_design_scores_gemma":[0.0005947143,0.000046029323,0.000067510424,0.011044437,0.010653283,0.012539533,0.000018798932,6.472436e-8,9.286833e-7,0.000020410771,0.9647714,0.0002428706],"about_ca_topic_score_codex":0.0000015194958,"about_ca_topic_score_gemma":6.145284e-8,"teacher_disagreement_score":0.98571,"about_ca_system_score_codex":0.00011775269,"about_ca_system_score_gemma":0.001060887,"threshold_uncertainty_score":0.99999607},"labels":[],"label_agreement":null},{"id":"W1986593887","doi":"10.1159/000047592","title":"Antiplatelet Agents for Stroke Prevention","year":2000,"lang":"en","type":"review","venue":"Cerebrovascular Diseases","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Stroke (engine); Secondary prevention; Internal medicine; Intensive care medicine","score_opus":0.051991177938084894,"score_gpt":0.35431204390035725,"score_spread":0.30232086596227237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986593887","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011545114,0.9922153,0.00044408572,0.0000106836615,0.00031453575,0.0047454243,0.0012851899,0.00030903783,0.0005603177],"genre_scores_gemma":[0.000027184105,0.9850991,0.00019951903,0.0001132302,0.0010078786,0.0009936122,0.006919491,0.0002823199,0.005357658],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961364,0.00028531073,0.00089289487,0.0011923246,0.0007587753,0.000734241],"domain_scores_gemma":[0.9973195,0.00011467277,0.00029466514,0.001538487,0.00012753368,0.00060510286],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022809474,0.00096215407,0.003713248,0.00038671753,0.00024428262,0.00010687642,0.00037348655,0.0005686134,0.0014868631],"category_scores_gemma":[0.00009539654,0.0008039644,0.012010263,0.00036875723,0.00014180578,0.00015973618,0.00006720367,0.000315166,0.0003849049],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015858069,0.0005942955,0.00004733718,0.029318003,0.009715195,0.00008281948,0.0000059016243,0.0000025637723,7.590269e-8,0.000042145137,0.0042015156,0.9558316],"study_design_scores_gemma":[0.0031620478,0.00023941475,0.00008485848,0.0119423475,0.035606287,0.00029138278,0.0000109320645,0.0000067981928,0.0000023797415,0.000088801666,0.9478159,0.00074885425],"about_ca_topic_score_codex":0.0000034174911,"about_ca_topic_score_gemma":5.604452e-7,"teacher_disagreement_score":0.9550827,"about_ca_system_score_codex":0.00015185226,"about_ca_system_score_gemma":0.00081279577,"threshold_uncertainty_score":0.99944115},"labels":[],"label_agreement":null},{"id":"W1986849025","doi":"10.1161/circulationaha.107.187930","title":"2007 Chronic Angina Focused Update of the ACC/AHA 2002 Guidelines for the Management of Patients With Chronic Stable Angina","year":2007,"lang":"en","type":"article","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":526,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Douglas College","funders":"","keywords":"Medicine; Angina; Cardiology; Internal medicine; Intensive care medicine; Myocardial infarction","score_opus":0.02052531482063882,"score_gpt":0.26716665512283194,"score_spread":0.24664134030219312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986849025","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8842382,0.015126514,0.09749413,0.0002535174,0.00021949515,0.0022702275,0.000035959587,0.000028572094,0.00033341642],"genre_scores_gemma":[0.9989648,0.0002513425,0.00035306806,0.00008047022,0.00014047108,0.000022511746,0.000055165154,0.00002144634,0.00011076184],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9989801,0.000018170373,0.00027755828,0.00015187352,0.00036664685,0.00020563597],"domain_scores_gemma":[0.9989221,0.000026950303,0.00017015828,0.00046090622,0.00038912924,0.00003074152],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040922943,0.00011297165,0.00019448409,0.000047528974,0.00009421281,0.0000057744787,0.00011267685,0.0000460668,0.00010126249],"category_scores_gemma":[0.000012599434,0.000063838364,0.00022827453,0.00025460805,0.00007163421,0.000074702984,0.000022099472,0.000045250308,0.0000032810226],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002424422,0.0006516743,0.3979914,0.0029064275,0.0067241224,0.000010064268,0.0002450044,0.025729906,0.0015000431,0.0028408798,0.005952895,0.55302316],"study_design_scores_gemma":[0.0043834727,0.000121040575,0.97266895,0.0002793059,0.00094638893,0.0000017916727,0.000054035012,0.0022144224,0.0019148394,0.000049113856,0.017261326,0.00010530976],"about_ca_topic_score_codex":0.000010885958,"about_ca_topic_score_gemma":0.000006740431,"teacher_disagreement_score":0.5746775,"about_ca_system_score_codex":0.00011539401,"about_ca_system_score_gemma":0.00007184729,"threshold_uncertainty_score":0.2603253},"labels":[],"label_agreement":null},{"id":"W1987027612","doi":"10.1161/01.cir.0000051362.96946.15","title":"Early and Late Effects of Clopidogrel in Patients With Acute Coronary Syndromes","year":2003,"lang":"en","type":"article","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":303,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"Canadian Institutes of Health Research; McMaster University; Heart and Stroke Foundation of Canada; Sanofi; Hamilton Health Sciences; Bristol-Myers Squibb","keywords":"Medicine; Clopidogrel; Relative risk; Aspirin; Myocardial infarction; Internal medicine; Placebo; Refractory (planetary science); Cardiology; Acute coronary syndrome; Confidence interval","score_opus":0.004472699976012706,"score_gpt":0.2013304100661645,"score_spread":0.1968577100901518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987027612","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986269,0.000761403,0.00015321464,0.000003908656,0.00002683929,0.00031641166,0.0000011056648,0.000010785104,0.00009944222],"genre_scores_gemma":[0.9998123,0.00005805558,0.00006203067,0.000022428407,0.0000037117634,0.000005158838,0.000018041592,0.000008890137,0.000009358085],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99956936,0.00003721535,0.00008593934,0.00010470537,0.00013015888,0.00007264924],"domain_scores_gemma":[0.9997829,0.000017099548,0.000031989694,0.00010156107,0.000031391373,0.000035010667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000044004006,0.00006131486,0.00016037299,0.000052382107,0.000015209946,0.0000029759217,0.00001067796,0.000038599283,0.000006205571],"category_scores_gemma":[0.000011712185,0.00005039201,0.000040363153,0.00009650384,0.000031506963,0.00006652244,0.0000028765794,0.000036694266,0.0000016761026],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015809853,0.00007624213,0.99422467,0.00008757998,0.00021062573,0.000042547654,0.00008930309,0.000020889975,0.00022623639,0.000091428024,6.620143e-7,0.004771711],"study_design_scores_gemma":[0.0037873157,0.00016458929,0.99536395,0.00011888805,0.00016786925,0.000017316841,0.0000036469198,0.00001572427,0.00020261804,0.00008499588,0.000017051729,0.00005604879],"about_ca_topic_score_codex":0.00000374921,"about_ca_topic_score_gemma":2.558771e-7,"teacher_disagreement_score":0.004715662,"about_ca_system_score_codex":0.000012523569,"about_ca_system_score_gemma":0.000017475668,"threshold_uncertainty_score":0.20549265},"labels":[],"label_agreement":null},{"id":"W1987329984","doi":"10.1016/s0140-6736(12)61400-7","title":"Pharmacogenetic guidance for antiplatelet treatment – Authors' reply","year":2012,"lang":"en","type":"article","venue":"The Lancet","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"CYP2C19; Clopidogrel; Prasugrel; Pharmacogenomics; Medicine; Acute coronary syndrome; Allele; Pharmacogenetics; Scopus; Internal medicine; Aspirin; Population; Genotyping; Pharmacology; Myocardial infarction; MEDLINE; Genetics; Genotype; Biology; Gene","score_opus":0.057660236492697296,"score_gpt":0.3384509563736955,"score_spread":0.2807907198809982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987329984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96208686,0.029607266,0.0009272963,0.004293997,0.00041054116,0.0008059633,0.000059609763,0.00012062487,0.0016878737],"genre_scores_gemma":[0.9903153,0.0012296377,0.0005922479,0.0027855388,0.0036259936,0.0001219785,0.00003341628,0.000026675398,0.0012692075],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99912304,0.000063181076,0.00013594978,0.0001446018,0.00013804177,0.00039516555],"domain_scores_gemma":[0.99920744,0.000055682598,0.00004338721,0.0005389575,0.000031958953,0.00012259642],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039851514,0.00013424699,0.00038458535,0.000018174886,0.000113624985,0.000012741747,0.000108523884,0.000034662924,0.00010326712],"category_scores_gemma":[0.000029701312,0.000077683806,0.0002953838,0.00007580146,0.000052869815,0.00004443382,0.0000132422565,0.000054917095,0.00006928661],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009894328,0.0013758685,0.29378968,0.00051028887,0.0063727032,0.000098516335,0.0022871671,0.00008471757,0.035980225,0.0018155177,0.3488287,0.29896227],"study_design_scores_gemma":[0.005339787,0.00020943864,0.041458964,0.000039943774,0.0005644325,0.0001541505,0.00003504342,0.00006790431,0.028072996,0.00009068726,0.9238363,0.00013037879],"about_ca_topic_score_codex":0.000005024182,"about_ca_topic_score_gemma":4.6149017e-7,"teacher_disagreement_score":0.57500756,"about_ca_system_score_codex":0.000032242322,"about_ca_system_score_gemma":0.000029532546,"threshold_uncertainty_score":0.31678537},"labels":[],"label_agreement":null},{"id":"W1988143463","doi":"10.1136/bmj.39430.529549.be","title":"Aspirin “resistance” and risk of cardiovascular morbidity: systematic review and meta-analysis","year":2008,"lang":"en","type":"review","venue":"BMJ","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":705,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Toronto General Hospital; University Health Network","funders":"","keywords":"Medicine; Aspirin; Internal medicine; Odds ratio; Confidence interval; Meta-analysis; Acute coronary syndrome; Myocardial infarction","score_opus":0.07676824522354753,"score_gpt":0.3371925302022406,"score_spread":0.2604242849786931,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988143463","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000026337275,0.9950346,0.000118320946,0.000022880362,0.000013829287,0.004311365,0.00021975674,0.00002664054,0.0002500009],"genre_scores_gemma":[0.000006986862,0.9983697,0.00015089998,0.000074267184,0.000052118397,0.00052389596,0.000087174056,0.000047197085,0.00068777264],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9959503,0.001306825,0.001274002,0.0005748732,0.00069934496,0.00019468908],"domain_scores_gemma":[0.9970055,0.0001747364,0.0007844613,0.0017174018,0.0001392265,0.00017866955],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.0015812214,0.0005276261,0.019914586,0.00024694,0.00006862231,0.00001331124,0.00013049178,0.00021284577,0.00006907383],"category_scores_gemma":[0.000290468,0.00032407715,0.018595796,0.0006808973,0.0001531181,0.00004008748,0.00006285037,0.00024244128,0.000010029535],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000021082014,0.0000137262605,0.0000020428174,0.49916518,0.49729142,0.00009739896,0.0000037420516,4.3712873e-7,7.968552e-10,0.000003406052,0.0002713847,0.003149169],"study_design_scores_gemma":[0.00014493427,0.000014204862,0.00000553579,0.03402961,0.6734429,0.00037135405,0.00000344535,3.0223126e-7,7.16093e-8,0.0000019974736,0.2917952,0.00019047684],"about_ca_topic_score_codex":0.000041077135,"about_ca_topic_score_gemma":0.0000048873258,"teacher_disagreement_score":0.46513557,"about_ca_system_score_codex":0.000024856417,"about_ca_system_score_gemma":0.00012457579,"threshold_uncertainty_score":0.99992114},"labels":[],"label_agreement":null},{"id":"W1988248761","doi":"10.1007/bf03020000","title":"Platelet surface genes and the risk of bleeding after cardiac surgery","year":2007,"lang":"en","type":"article","venue":"Canadian Journal of Anesthesia/Journal canadien d anesthésie","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network","funders":"","keywords":"Platelet; Cardiac surgery; Medicine; Gene; Cardiology; Internal medicine; Surgery; Chemistry; Biochemistry","score_opus":0.00803669199327083,"score_gpt":0.20397259660120648,"score_spread":0.19593590460793564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988248761","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9447874,0.0533713,0.000032328862,0.001165209,0.0002900604,0.00018599998,0.000012255948,0.000005072952,0.00015039655],"genre_scores_gemma":[0.9937929,0.004982701,0.00017198025,0.00010197389,0.0007943123,9.601619e-7,0.0000027158871,0.00004952499,0.00010293581],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99711835,0.00031905543,0.001001266,0.00018630367,0.00060884416,0.00076620077],"domain_scores_gemma":[0.99578756,0.0005033635,0.0007556114,0.00028109527,0.00065678713,0.0020155632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006830167,0.00031186215,0.0012428757,0.00053801574,0.00038450587,0.00010510279,0.00023973499,0.00019318223,0.00010949132],"category_scores_gemma":[0.00027580085,0.00021098489,0.0012030574,0.00041094687,0.00071019516,0.00024769,0.000007648873,0.0007427909,0.0000026799844],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003902322,0.00003419761,0.38135365,0.00013563554,0.0027024746,0.5736577,0.0020226785,0.00014033515,0.000078547586,0.00014733768,0.0018651993,0.03395993],"study_design_scores_gemma":[0.0018182003,0.0002680634,0.09453435,0.0003522564,0.0011914924,0.88402355,0.0015591768,0.000009222321,0.00064326567,0.00013545276,0.015197337,0.00026760442],"about_ca_topic_score_codex":0.0050801565,"about_ca_topic_score_gemma":0.0020728703,"teacher_disagreement_score":0.3103659,"about_ca_system_score_codex":0.00022784343,"about_ca_system_score_gemma":0.002443008,"threshold_uncertainty_score":0.8603714},"labels":[],"label_agreement":null},{"id":"W1988395441","doi":"10.1016/j.jacc.2004.03.081","title":"A risk score to estimate the likelihood of coronary artery bypass surgery during the index hospitalization among patients with unstable angina and non–ST-segment elevation myocardial infarction","year":2004,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; TIMI; Cardiology; Myocardial infarction; Internal medicine; Unstable angina; Framingham Risk Score; Clopidogrel; ST segment; Odds ratio; Thrombolysis; Angina; Coronary artery bypass surgery; Cohort; Canadian Cardiovascular Society; Artery; Disease","score_opus":0.003102523239098175,"score_gpt":0.20690500987291977,"score_spread":0.20380248663382158,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988395441","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99532926,0.0002553299,0.0033715677,0.00038856769,0.00016989053,0.00041845307,0.000046837664,0.0000043704567,0.000015719366],"genre_scores_gemma":[0.99937165,0.00028610582,0.000064857464,0.00010556983,0.00013718425,0.000010708272,0.000003823616,0.000015899766,0.0000042016495],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986672,0.00024506002,0.00038735257,0.00011854261,0.00041046532,0.00017141856],"domain_scores_gemma":[0.9984117,0.000101548765,0.0007981707,0.00027860721,0.00034548854,0.00006444264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005097818,0.00013326271,0.0006281728,0.000121577104,0.00014310083,0.0000061051496,0.00011412169,0.00003783026,0.0000011258929],"category_scores_gemma":[0.000099194636,0.00006652712,0.00036155057,0.00042017337,0.0004035396,0.000100352685,0.000047833593,0.00016336261,1.4025034e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019356725,0.000043024746,0.9735566,0.000023613773,0.0016260332,0.000024472798,0.000078437064,0.020763204,0.00028966725,0.0000047463377,0.00010098987,0.0015535445],"study_design_scores_gemma":[0.001765965,0.00078680605,0.9955081,0.00015266724,0.00066253083,0.00030389352,0.00036836596,0.00002532258,0.00021468873,0.000043476954,0.000094811476,0.00007341985],"about_ca_topic_score_codex":0.00004935365,"about_ca_topic_score_gemma":0.000006947483,"teacher_disagreement_score":0.021951456,"about_ca_system_score_codex":0.00008919838,"about_ca_system_score_gemma":0.0002180957,"threshold_uncertainty_score":0.27128974},"labels":[],"label_agreement":null},{"id":"W1988726276","doi":"10.1161/circulationaha.110.939991","title":"Letter by Potter and Le Lorier Regarding Article, “Cardiovascular Outcomes and Mortality in Patients Using Clopidogrel With Proton Pump Inhibitors After Percutaneous Coronary Intervention or Acute Coronary Syndrome”","year":2010,"lang":"en","type":"letter","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Clopidogrel; Medicine; Acute coronary syndrome; Percutaneous coronary intervention; Pharmacoeconomics; Internal medicine; Pharmacoepidemiology; Medical prescription; Cardiology; Aspirin; Intensive care medicine; Myocardial infarction; Pharmacology","score_opus":0.010702573915539521,"score_gpt":0.23370931143700452,"score_spread":0.223006737521465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988726276","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99318624,0.0009746549,0.00033630177,0.002853706,0.00022549277,0.0023114793,0.000056771183,0.000049428185,0.0000059190074],"genre_scores_gemma":[0.977161,0.000068210844,0.00010334638,0.02140874,0.0002618371,0.00014181159,0.00070146256,0.00010931842,0.00004425874],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973207,0.00022271612,0.00051651365,0.00079451053,0.0007578045,0.0003877451],"domain_scores_gemma":[0.998982,0.000030475863,0.00017676022,0.00058820203,0.0001142635,0.000108287684],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00029178348,0.0004849361,0.0009587732,0.00021755458,0.000115511364,0.000088421846,0.00006471233,0.0008842165,0.00003766946],"category_scores_gemma":[0.000019796224,0.00038602907,0.00050054025,0.0001610923,0.00021512041,0.00042807628,0.00006952292,0.0012088099,0.0000029330413],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008188778,0.00012375791,0.98626965,0.00066265493,0.0030233597,0.005259127,0.00009133819,0.000015044191,0.00012511195,1.2148028e-7,0.00061466364,0.0029963183],"study_design_scores_gemma":[0.0045606447,0.00019603301,0.9821345,0.0006883277,0.0022122446,0.004003251,0.000018457993,0.00011651646,0.000049489514,0.000012705943,0.005488468,0.00051931094],"about_ca_topic_score_codex":0.00008653068,"about_ca_topic_score_gemma":0.0000062341487,"teacher_disagreement_score":0.018555034,"about_ca_system_score_codex":0.0001431637,"about_ca_system_score_gemma":0.000057923018,"threshold_uncertainty_score":0.99985915},"labels":[],"label_agreement":null},{"id":"W1989306687","doi":"10.1016/s0828-282x(10)70008-8","title":"The impact of treatment with omeprazole on the effectiveness of clopidogrel drug therapy during the first year after successful coronary stenting","year":2010,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Clopidogrel; Omeprazole; Myocardial infarction; Clinical endpoint; Internal medicine; Hazard ratio; Pharmacotherapy; Cardiology; Confidence interval; Randomized controlled trial","score_opus":0.0053870492724170565,"score_gpt":0.222552002669578,"score_spread":0.21716495339716094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989306687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99618256,0.0026315025,0.000008366803,0.00023951296,0.00017308697,0.00030904257,0.000018003459,0.000001926493,0.0004359683],"genre_scores_gemma":[0.99893266,0.00068586733,0.0000026772605,0.000023830367,0.00030430788,0.0000141392065,0.0000011253788,0.000016982325,0.000018402125],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989707,0.0003536976,0.00021417893,0.00009359122,0.00013684068,0.00023100468],"domain_scores_gemma":[0.99864066,0.0004950481,0.00016966545,0.00037451315,0.00017753712,0.00014260628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008470938,0.00013834311,0.00044466258,0.00007111765,0.00018845842,0.000012403872,0.00018914527,0.000056906734,0.000024171331],"category_scores_gemma":[0.000039164595,0.00005114548,0.0006846032,0.00010120519,0.00044968774,0.00003253083,0.0000068442023,0.00026561978,0.000001181687],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049049426,0.000011470188,0.9849942,0.000020821612,0.004314769,0.00018103488,0.00026361324,0.00086174114,0.0008980228,0.00006481492,0.000057032812,0.0034275602],"study_design_scores_gemma":[0.002157964,0.0011942479,0.9900493,0.000104127335,0.000199877,0.0006558565,0.0003427578,0.0000020395562,0.0013767,0.00003411383,0.003823675,0.000059342117],"about_ca_topic_score_codex":0.0007122058,"about_ca_topic_score_gemma":0.0007640934,"teacher_disagreement_score":0.0050551225,"about_ca_system_score_codex":0.00010094282,"about_ca_system_score_gemma":0.00067909097,"threshold_uncertainty_score":0.2085652},"labels":[],"label_agreement":null},{"id":"W1990473701","doi":"10.1038/sj.clpt.6100345","title":"Pharmacokinetics, Pharmacodynamics, and Safety of a Prostaglandin D2 Receptor Antagonist","year":2007,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Pharmacokinetics; Pharmacology; Pharmacodynamics; Antagonist; Tolerability; Medicine; Crossover study; Clinical pharmacology; Receptor antagonist; Chemistry; Placebo; Receptor; Adverse effect; Internal medicine","score_opus":0.039673737585190556,"score_gpt":0.3898679952633786,"score_spread":0.35019425767818807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990473701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98331344,0.008444453,0.0019718718,0.0026680394,0.0017812042,0.0010122344,0.000091562586,0.00011458136,0.00060259027],"genre_scores_gemma":[0.93769574,0.03494314,0.0009379631,0.024874961,0.0010847575,0.000010026225,0.00007571682,0.000062717016,0.00031499352],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974221,0.00026063458,0.0010600768,0.00047714188,0.00028995032,0.00049012515],"domain_scores_gemma":[0.9983289,0.0005175944,0.00026800676,0.00026847835,0.00021872867,0.0003982779],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016894306,0.0002983937,0.00083610276,0.00011455462,0.00012273609,0.000009587405,0.00017178062,0.00027487485,0.0004530783],"category_scores_gemma":[0.000018350758,0.00026061802,0.00048638333,0.0002285903,0.0011392582,0.000058276502,0.00008778219,0.00063106796,0.000023810957],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04800016,0.0045924075,0.30063224,0.0005682348,0.015334414,0.00047713186,0.0005620522,0.000015843723,0.37426078,0.00013308357,0.011825387,0.24359827],"study_design_scores_gemma":[0.042094577,0.002257276,0.09498211,0.000121988814,0.009440554,0.00028773077,0.00033851183,0.0011883484,0.11672976,0.000094441944,0.7316693,0.00079538126],"about_ca_topic_score_codex":0.0000032292176,"about_ca_topic_score_gemma":0.0000010477421,"teacher_disagreement_score":0.7198439,"about_ca_system_score_codex":0.00004660246,"about_ca_system_score_gemma":0.00014653405,"threshold_uncertainty_score":0.9999846},"labels":[],"label_agreement":null},{"id":"W1990651039","doi":"10.1016/j.ahj.2009.09.016","title":"Underutilization of clopidogrel and glycoprotein IIb/IIIa inhibitors in non–ST-elevation acute coronary syndrome patients: The Canadian Global Registry of Acute Coronary Events (GRACE) experience","year":2009,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Vancouver General Hospital; University of British Columbia; Surrey Memorial Hospital; Hamilton Health Sciences; McMaster University; Canadian Heart Research Centre; University of Alberta; St. Michael's Hospital","funders":"Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada; American Heart Association","keywords":"Medicine; Clopidogrel; Acute coronary syndrome; Internal medicine; Odds ratio; Cardiology; ST elevation; Population; Aspirin; Myocardial infarction","score_opus":0.008695378500523654,"score_gpt":0.2714112352902744,"score_spread":0.26271585678975073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990651039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998078,0.0005984465,0.00012227689,0.00062789273,0.000085786916,0.0004062569,0.000048594804,0.0000069369958,0.000025830928],"genre_scores_gemma":[0.9982661,0.0007443959,0.00022966326,0.0006664675,0.000028274628,0.0000060045595,0.00003738173,0.000010251767,0.000011444179],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99851644,0.00012666677,0.00043490232,0.00018646463,0.0004736891,0.00026181582],"domain_scores_gemma":[0.99906194,0.000018714762,0.00028370487,0.00024007262,0.00016184962,0.00023370865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020622558,0.00015407766,0.00041097982,0.000108536784,0.00015756694,0.000013328257,0.000110268134,0.000065749,0.000022518483],"category_scores_gemma":[0.000035247816,0.00012259246,0.00016520845,0.0004884266,0.0003416909,0.00017959965,0.000018746008,0.0002051735,9.332672e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005098211,0.000146054,0.9767878,0.000012971175,0.0002886811,0.00018747283,0.00036252363,0.000029783812,0.00041658306,0.000010766554,0.00018167018,0.021065842],"study_design_scores_gemma":[0.0013303821,0.0011761787,0.993407,0.00022907906,0.00016666943,0.002517669,0.00066910597,0.00006557511,0.00012697854,0.00008400251,0.0001179961,0.00010934145],"about_ca_topic_score_codex":0.0048754113,"about_ca_topic_score_gemma":0.00093413744,"teacher_disagreement_score":0.020956501,"about_ca_system_score_codex":0.00022625209,"about_ca_system_score_gemma":0.00039625342,"threshold_uncertainty_score":0.7370196},"labels":[],"label_agreement":null},{"id":"W1990853852","doi":"10.1016/j.cjca.2014.07.597","title":"PATTERNS OF ADP RECEPTOR INHIBITOR USE DURING THE INDEX HOSPITALIZATION IN PATIENTS WITH MYOCARDIAL INFARCTION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: INSIGHTS FROM THE CANADIAN OBSERVATIONAL ANTIPLATELET STUDY (COAPT)","year":2014,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Toronto Public Health","funders":"","keywords":"Medicine; Percutaneous coronary intervention; Clopidogrel; Prasugrel; Conventional PCI; Internal medicine; Myocardial infarction; Ticagrelor; Acute coronary syndrome; Cardiology; Aspirin; Coronary artery disease","score_opus":0.010593565656938853,"score_gpt":0.200885444352515,"score_spread":0.19029187869557615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990853852","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981894,0.00028040542,0.00024838062,0.00022802052,0.0005191291,0.00044841215,0.000058650858,0.0000036785775,0.000023934072],"genre_scores_gemma":[0.9990414,0.0000447243,0.000008622357,0.00017053496,0.00060613407,0.0000050355548,0.000095344076,0.000022190015,0.0000060277866],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99827576,0.0005431615,0.0004632296,0.00017027362,0.00031849052,0.00022907072],"domain_scores_gemma":[0.9986728,0.00015970867,0.00023391048,0.00026171486,0.00041041296,0.0002614953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029459168,0.00015966743,0.00046545258,0.00018776952,0.00022724931,0.000041443105,0.00016172594,0.00012401148,0.000025610203],"category_scores_gemma":[0.00020404853,0.00010291801,0.0002528653,0.00018753718,0.00011099411,0.00019976907,0.00001337743,0.0003388403,0.0000014604537],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049518445,0.000016320037,0.9927091,0.0000096022795,0.0009847798,0.00015359087,0.00057102175,0.0033370978,0.0000101023525,0.000017538074,0.000059958602,0.0016356822],"study_design_scores_gemma":[0.003335555,0.0007424403,0.99183863,0.00019410923,0.00019437574,0.00022372468,0.000825232,0.000018038052,0.000005681424,0.000019636496,0.0024927054,0.000109871115],"about_ca_topic_score_codex":0.062464505,"about_ca_topic_score_gemma":0.4126692,"teacher_disagreement_score":0.35020468,"about_ca_system_score_codex":0.00040897,"about_ca_system_score_gemma":0.0008909784,"threshold_uncertainty_score":0.94377863},"labels":[],"label_agreement":null},{"id":"W1991270018","doi":"10.1016/s0140-6736(12)60161-5","title":"Point-of-care genetic testing for personalisation of antiplatelet treatment (RAPID GENE): a prospective, randomised, proof-of-concept trial","year":2012,"lang":"en","type":"article","venue":"The Lancet","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":391,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Clopidogrel; Prasugrel; CYP2C19; Percutaneous coronary intervention; Conventional PCI; Pharmacogenetics; Internal medicine; Genotyping; Acute coronary syndrome; Prospective cohort study; Clinical endpoint; Randomized controlled trial; Aspirin; Genotype; Genetics; Myocardial infarction","score_opus":0.046823555741121715,"score_gpt":0.2899955717577107,"score_spread":0.24317201601658897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991270018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97907877,0.01621815,0.0008759866,0.00006521177,0.00011524305,0.0032236697,0.000099871475,0.000018506078,0.0003045865],"genre_scores_gemma":[0.99562466,0.000108855886,0.0028309973,0.000028318147,0.0011187362,0.00019592348,0.000043645836,0.000019575402,0.000029301531],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9990434,0.00010890942,0.00030234462,0.0001313762,0.00020096205,0.00021302074],"domain_scores_gemma":[0.99901605,0.00021415674,0.00022154844,0.0003342168,0.00016717467,0.000046877045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033576222,0.00013353016,0.00076454773,0.000034834182,0.00004902178,0.000003589648,0.00008542625,0.000051740048,0.00003036874],"category_scores_gemma":[0.00017194373,0.0000819693,0.00042653643,0.00011559681,0.00012002311,0.00004921648,0.000010665588,0.000042784697,4.924032e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.56297493,0.0014424907,0.07719954,0.0016315758,0.004499779,0.000009738321,0.019193465,0.0002456593,0.019287862,0.00030880418,0.0003591915,0.31284696],"study_design_scores_gemma":[0.49104467,0.005562232,0.025954764,0.00031325402,0.0021442845,0.00008082506,0.0014658743,0.00018792652,0.47189575,0.0001769935,0.00094727275,0.00022614641],"about_ca_topic_score_codex":0.000014783254,"about_ca_topic_score_gemma":4.8005427e-7,"teacher_disagreement_score":0.4526079,"about_ca_system_score_codex":0.000032443815,"about_ca_system_score_gemma":0.00008038371,"threshold_uncertainty_score":0.33426112},"labels":[],"label_agreement":null},{"id":"W1991304044","doi":"10.1016/s0140-6736(10)61313-x","title":"Response to antiplatelet treatment: from genes to outcome","year":2010,"lang":"en","type":"letter","venue":"The Lancet","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Clopidogrel; Myocardial infarction; Percutaneous coronary intervention; Guideline; Conventional PCI; Cardiology; Internal medicine; Acute coronary syndrome; Canadian Cardiovascular Society; Unstable angina; Aspirin; Angina","score_opus":0.04501325204191207,"score_gpt":0.3068182013313727,"score_spread":0.26180494928946063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991304044","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4085385,0.0014219864,0.000043295327,0.58757764,0.0004985278,0.0007245272,0.0007010135,0.00013260654,0.00036190884],"genre_scores_gemma":[0.016159436,0.0004520177,0.0006025715,0.9527344,0.020399163,0.00013308387,0.0005837909,0.00012647924,0.008809018],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99781847,0.00029736344,0.00029950656,0.0005415455,0.00047442905,0.00056869356],"domain_scores_gemma":[0.9971681,0.0002968837,0.00007179215,0.0022154236,0.000058296922,0.00018950723],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003840236,0.00045190664,0.0014760513,0.00012301779,0.0001279384,0.00007470592,0.0005224747,0.0007558968,0.00054371235],"category_scores_gemma":[0.00011365,0.00026720777,0.00064396195,0.0001844823,0.000063916406,0.000027369482,0.00008554635,0.0012264256,0.0018503736],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068364623,0.000038489277,0.0027191376,0.000032046675,0.0013725465,0.0025151812,0.00026625677,0.0000043355503,0.0036352454,0.0000017002901,0.9645084,0.018070161],"study_design_scores_gemma":[0.0025204443,0.00032528007,0.013363938,0.000096873635,0.0006224164,0.00010792167,0.000014318272,0.0000011040972,0.0015951553,0.000034721557,0.9809938,0.0003239965],"about_ca_topic_score_codex":0.00017132085,"about_ca_topic_score_gemma":0.000018201037,"teacher_disagreement_score":0.39237905,"about_ca_system_score_codex":0.00007722331,"about_ca_system_score_gemma":0.00009581862,"threshold_uncertainty_score":0.999978},"labels":[],"label_agreement":null},{"id":"W1991568796","doi":"10.1161/circresaha.113.300859","title":"Platelet microRNAs","year":2013,"lang":"en","type":"letter","venue":"Circulation Research","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College","funders":"","keywords":"Medicine; Clopidogrel; Aspirin; Prasugrel; Translational research; Pharmacology; Internal medicine; Pathology","score_opus":0.10358603303775511,"score_gpt":0.36624974516967645,"score_spread":0.26266371213192136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991568796","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15736029,0.011381316,0.00029935467,0.7974261,0.00055859325,0.0036645366,0.00005930762,0.00033481192,0.028915692],"genre_scores_gemma":[0.23412344,0.0016332378,0.00018527823,0.69721156,0.01838457,0.00051771314,0.0052286494,0.0003942844,0.042321246],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99623305,0.00041787152,0.00031560086,0.0005915763,0.001734742,0.00070716115],"domain_scores_gemma":[0.9978862,0.00018647261,0.000064696775,0.0009429246,0.00075580034,0.00016394124],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0007049061,0.00025844216,0.00053401693,0.0005560839,0.00022375294,0.00014477021,0.00022289297,0.0010476649,0.0037005607],"category_scores_gemma":[0.00013375017,0.00023352637,0.0005690605,0.000458383,0.00025564965,0.00010664563,0.00006735397,0.0029800131,0.0043516485],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032889635,0.000033162974,0.00086858805,0.0003812803,0.00054533215,0.0013582595,0.000035431316,0.000011013118,0.0004611053,0.000016757302,0.98407346,0.012182715],"study_design_scores_gemma":[0.0009979686,0.00005448682,0.010281477,0.00019766684,0.00008220455,0.0003136367,0.000022456816,0.00012974805,0.00022323687,0.00036388662,0.98709357,0.00023965375],"about_ca_topic_score_codex":0.000096474,"about_ca_topic_score_gemma":5.97179e-7,"teacher_disagreement_score":0.10021451,"about_ca_system_score_codex":0.00018470142,"about_ca_system_score_gemma":0.0003625961,"threshold_uncertainty_score":0.99932015},"labels":[],"label_agreement":null},{"id":"W1991835721","doi":"10.1016/j.athoracsur.2004.03.028","title":"Does Clopidogrel Increase Blood Loss Following Coronary Artery Bypass Surgery?","year":2004,"lang":"en","type":"article","venue":"The Annals of Thoracic Surgery","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":245,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre","funders":"","keywords":"Medicine; Clopidogrel; Coronary artery bypass surgery; Cardiology; Artery; Internal medicine; Surgery; Myocardial infarction","score_opus":0.04726731188019821,"score_gpt":0.32551217317859393,"score_spread":0.2782448612983957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991835721","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98236614,0.01229913,0.000062464846,0.0040614256,0.0006255168,0.00022201017,0.000031203075,0.00013101786,0.00020109935],"genre_scores_gemma":[0.99304956,0.003997854,0.00003643817,0.0020837458,0.0004405746,0.000028398088,0.00007956865,0.00005772624,0.00022611933],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99736226,0.00036302963,0.0006467847,0.00036827428,0.0007111948,0.000548465],"domain_scores_gemma":[0.99717516,0.0011887808,0.00023777806,0.0009679082,0.00015963771,0.00027071926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002536309,0.00032116525,0.0010779474,0.0002317206,0.0001868277,0.00002855283,0.00019389947,0.00014147922,0.00012358982],"category_scores_gemma":[0.00045629928,0.00017985226,0.0031508624,0.00044957077,0.0002577549,0.00022670008,0.00007403664,0.00022832547,0.00004764122],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011859214,0.0038426728,0.55381984,0.0015094504,0.027706498,0.03508004,0.0007041789,0.00016506907,0.0044061537,0.00019771334,0.009889852,0.35081935],"study_design_scores_gemma":[0.0044101723,0.0006256994,0.4739418,0.009864369,0.0138486,0.012607826,0.0021511985,0.000020091664,0.42832285,0.011331096,0.039210275,0.0036660114],"about_ca_topic_score_codex":0.00010109502,"about_ca_topic_score_gemma":0.0000051866605,"teacher_disagreement_score":0.4239167,"about_ca_system_score_codex":0.00001406193,"about_ca_system_score_gemma":0.0003698565,"threshold_uncertainty_score":0.7334162},"labels":[],"label_agreement":null},{"id":"W1992355666","doi":"10.1055/s-2005-869518","title":"Platelet Aggregation and Adenosine Diphosphate/Adenosine Triphosphate Receptors: A Historical Perspective","year":2005,"lang":"en","type":"review","venue":"Seminars in Thrombosis and Hemostasis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Adenylyl cyclase; P2Y12; Adenosine diphosphate; Adenosine; Platelet; Receptor; Chemistry; Adenosine triphosphate; Internal medicine; Endocrinology; Biochemistry; Biology; Medicine; Platelet aggregation","score_opus":0.04948052049927132,"score_gpt":0.3428839085987652,"score_spread":0.2934033880994939,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992355666","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014205213,0.99579424,0.000010353934,0.0007243807,0.00027670627,0.0013271088,0.00006989818,0.00008395268,0.0002928471],"genre_scores_gemma":[0.0003611345,0.9974748,0.0005652836,0.00018716473,0.000390817,0.00013683381,0.00019110304,0.00012814153,0.0005647028],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967924,0.00019084015,0.00088122627,0.0010926155,0.0004964242,0.0005465094],"domain_scores_gemma":[0.99846977,0.00018725482,0.00035376122,0.00050324335,0.0001281896,0.00035777572],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00046968804,0.00081550685,0.0034162165,0.0004193037,0.00018819957,0.00007938684,0.00014818617,0.0007036414,0.00025486542],"category_scores_gemma":[0.00012907496,0.0006875115,0.0007742426,0.0007448947,0.00023025047,0.00020623003,0.00012220326,0.0006940657,0.000017667971],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000120690995,0.00031152472,0.00020436387,0.0033446178,0.0009848339,0.000100806596,0.0005496631,2.1349197e-7,5.872606e-7,0.00012456006,0.0061389753,0.9881192],"study_design_scores_gemma":[0.0019232794,0.00038087677,0.0001949514,0.020914508,0.0031461602,0.00037414892,0.00041138718,0.0000057669163,0.00004293188,0.000069176815,0.9718351,0.000701756],"about_ca_topic_score_codex":0.00015777042,"about_ca_topic_score_gemma":0.0000108373615,"teacher_disagreement_score":0.9874174,"about_ca_system_score_codex":0.0015123438,"about_ca_system_score_gemma":0.00021342727,"threshold_uncertainty_score":0.9995576},"labels":[],"label_agreement":null},{"id":"W1992538223","doi":"10.1016/j.archger.2007.12.006","title":"Relationship between age and platelet activation in patients with stable and unstable angina","year":2008,"lang":"en","type":"article","venue":"Archives of Gerontology and Geriatrics","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Unstable angina; Platelet; Acute coronary syndrome; Medicine; Internal medicine; Platelet activation; Cardiology; P-selectin; Retrospective cohort study; Cohort; Myocardial infarction","score_opus":0.021030107792558057,"score_gpt":0.23274066228586746,"score_spread":0.2117105544933094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992538223","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973767,0.001379128,0.0006297061,0.000052809155,0.0000072747303,0.00018445544,0.0000073380124,0.000008643509,0.0003539804],"genre_scores_gemma":[0.99853927,0.0004344056,0.0008723175,0.000020650226,0.000014873207,0.000003088099,0.000049716164,0.000006554421,0.000059124857],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99947494,0.000051539533,0.00012478656,0.00015251266,0.00007002465,0.00012617135],"domain_scores_gemma":[0.9995586,0.000229795,0.000050999202,0.00009031709,0.000012235818,0.00005802812],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006173309,0.00008262,0.0002584383,0.00011919646,0.00008331945,0.0000029988864,0.000017869235,0.000060198043,0.00000234827],"category_scores_gemma":[0.0000371209,0.00006903156,0.000021450829,0.00008319677,0.0002185609,0.00009517027,0.000017948474,0.00009296828,1.3664706e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006581266,0.000046491357,0.9927341,0.000071953036,0.000056565208,0.000018469947,0.0006606851,0.0000021340343,0.000013537792,0.00024088255,0.000006923609,0.0054901754],"study_design_scores_gemma":[0.0031324553,0.00028084667,0.99558985,0.000022397102,0.000058539892,0.00001610954,0.000059690865,0.000005612014,0.00005951402,0.000538035,0.00016575429,0.00007120892],"about_ca_topic_score_codex":0.000036873083,"about_ca_topic_score_gemma":0.000008143675,"teacher_disagreement_score":0.0054189665,"about_ca_system_score_codex":0.000003947823,"about_ca_system_score_gemma":0.000025396868,"threshold_uncertainty_score":0.28150252},"labels":[],"label_agreement":null},{"id":"W1992920746","doi":"10.2165/00129784-200101060-00007","title":"Clopidogrel","year":2001,"lang":"fr","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Medicine; Clopidogrel; Pharmacotherapy; Internal medicine; Cardiology; Aspirin","score_opus":0.006937974988336916,"score_gpt":0.2398271040812727,"score_spread":0.23288912909293577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992920746","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2765086,0.6960417,0.015058269,0.0016089636,0.0042215413,0.0002497008,0.000012334734,0.000033061755,0.0062658167],"genre_scores_gemma":[0.7247837,0.26323202,0.0012123857,0.0007895988,0.007996969,0.0000044170074,0.000005789835,0.00011494995,0.001860118],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.994231,0.0010855655,0.0011276057,0.00042877093,0.002137146,0.0009899299],"domain_scores_gemma":[0.99619466,0.00017215405,0.0006503932,0.0011861392,0.0008136243,0.0009830251],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0029976536,0.00053627096,0.002693909,0.00039551838,0.0001462679,0.00007342236,0.00048747807,0.00017201091,0.00050703937],"category_scores_gemma":[0.00018714154,0.00049337663,0.010416782,0.0012612081,0.0013233017,0.00041566236,0.000073495845,0.00087461737,0.00033602116],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00086954626,0.0003270312,0.0029079923,0.00011341104,0.046476718,0.007179998,0.0007010962,0.002633307,0.00002458241,0.00020892406,0.0023356797,0.9362217],"study_design_scores_gemma":[0.0047926456,0.001489135,0.0039288015,0.0010368665,0.013518597,0.022377798,0.0045603514,0.000054784992,0.00017846358,0.000106471096,0.9474456,0.00051050435],"about_ca_topic_score_codex":0.00016676701,"about_ca_topic_score_gemma":5.255469e-7,"teacher_disagreement_score":0.9451099,"about_ca_system_score_codex":0.0003109218,"about_ca_system_score_gemma":0.0007281845,"threshold_uncertainty_score":0.9997518},"labels":[],"label_agreement":null},{"id":"W1993377665","doi":"10.4021/jnr.v2i5.142","title":"Utility of Antiplatelet Therapy With Ticlopidine in Patients Refractory to Clopidogrel for Intracranial Stenting: A Single Institution Experience","year":2012,"lang":"en","type":"article","venue":"Journal of Neurology Research","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Ticlopidine; Clopidogrel; Thienopyridine; Aspirin; Stroke (engine); Anesthesia; Internal medicine; Surgery","score_opus":0.09413128867276592,"score_gpt":0.36906271968195936,"score_spread":0.2749314310091934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993377665","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979871,0.0006036773,0.00033195716,0.00030723008,0.00016913004,0.00052920677,0.0000033299837,0.0000041794497,0.00006419772],"genre_scores_gemma":[0.9991019,0.00020082721,0.00025969042,0.00018247453,0.0002245992,0.000008774011,0.0000020854936,0.000012940235,0.000006719138],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981699,0.0003018407,0.0004096564,0.00014779184,0.00057662965,0.0003941711],"domain_scores_gemma":[0.9986444,0.00017271574,0.00014128012,0.00019433144,0.00065870915,0.00018854487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013900426,0.00009672889,0.00039998116,0.0003404405,0.000059159745,0.0000070486885,0.00013306012,0.00009843848,0.00002480734],"category_scores_gemma":[0.00042414982,0.000068503345,0.00013861568,0.00035544785,0.00022122292,0.00020551802,0.000031287716,0.00041236804,0.0000014473945],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03997247,0.0024800566,0.9168257,0.000053365977,0.00013018773,0.000106768886,0.00076821714,0.000009404631,0.009332734,0.000016784285,0.00009731046,0.030207014],"study_design_scores_gemma":[0.008448004,0.011561735,0.96712774,0.00007542,0.000023954242,0.00027424342,0.00011541383,0.000030022245,0.005424769,0.000014882416,0.006830368,0.00007347003],"about_ca_topic_score_codex":0.00000632865,"about_ca_topic_score_gemma":0.000002149091,"teacher_disagreement_score":0.05030203,"about_ca_system_score_codex":0.000020338852,"about_ca_system_score_gemma":0.00013416486,"threshold_uncertainty_score":0.27934852},"labels":[],"label_agreement":null},{"id":"W1993513406","doi":"10.1111/sdi.12338","title":"Clopidogrel Use in End‐Stage Kidney Disease","year":2014,"lang":"en","type":"review","venue":"Seminars in Dialysis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Department of Medicine, Ottawa Hospital","keywords":"Clopidogrel; Medicine; P2Y12; Percutaneous coronary intervention; Kidney disease; Internal medicine; Population; Acute coronary syndrome; Cardiology; Platelet activation; Pharmacology; Platelet; Aspirin; Myocardial infarction","score_opus":0.02802955502643215,"score_gpt":0.3144432339043473,"score_spread":0.28641367887791513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993513406","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006983691,0.9973673,0.000026985786,0.000043461805,0.0002212129,0.00093561364,0.00024392869,0.00005916403,0.00040394985],"genre_scores_gemma":[0.0002884727,0.99440277,0.00010518141,0.00041646362,0.0003477132,0.00026111832,0.0018022313,0.00011617487,0.0022598763],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964957,0.00061221584,0.00094236666,0.0008529656,0.000559965,0.0005367824],"domain_scores_gemma":[0.99731046,0.00032653025,0.00025041448,0.0013958657,0.000040224688,0.0006764873],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006645254,0.0006336658,0.003667026,0.00096987264,0.000040168434,0.000050526458,0.00030799618,0.00043043995,0.0006474217],"category_scores_gemma":[0.0010650804,0.00053754624,0.0029693919,0.0012476911,0.00014255581,0.00011441886,0.00011157066,0.0006165934,0.00015052277],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012692554,0.00030631147,0.008632699,0.014378796,0.0010051567,0.0020492868,0.000051771218,0.0000068727923,1.7487628e-7,0.0000469314,0.0017978424,0.97159725],"study_design_scores_gemma":[0.0010032617,0.000033217402,0.00043125995,0.030821348,0.0050291237,0.000019785539,0.000018971443,0.000015336364,6.4912786e-7,0.000019830672,0.96211183,0.00049539504],"about_ca_topic_score_codex":0.00010152074,"about_ca_topic_score_gemma":0.000044337936,"teacher_disagreement_score":0.9711018,"about_ca_system_score_codex":0.00027531097,"about_ca_system_score_gemma":0.00064656814,"threshold_uncertainty_score":0.9997076},"labels":[],"label_agreement":null},{"id":"W1993959174","doi":"10.1182/blood-2004-04-1425","title":"Quebec platelet syndrome: from the bench to the family","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Platelet; Internal medicine","score_opus":0.00929206201086894,"score_gpt":0.2174134825793148,"score_spread":0.20812142056844588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993959174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9849741,0.008900351,0.00032167547,0.0045710336,0.00012848357,0.00043851783,0.00003702686,0.00006475982,0.000564092],"genre_scores_gemma":[0.9925347,0.00024326751,0.00015250995,0.00641709,0.00030823622,0.000033819622,0.00003591004,0.000020603278,0.00025384108],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.999069,0.000046140587,0.00013438506,0.0002123505,0.0003270836,0.00021105834],"domain_scores_gemma":[0.99915916,0.00005639951,0.000023106531,0.00062001136,0.0000322629,0.00010907389],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015581839,0.0001317187,0.00021162385,0.00001755365,0.0001612463,0.000035788515,0.00021828349,0.000059738577,0.000096824726],"category_scores_gemma":[0.00003566368,0.0000666969,0.00026982388,0.00017845376,0.000057265224,0.000035664394,0.00004305714,0.00015474737,0.00039062114],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037068143,0.0136950305,0.085690096,0.000316904,0.050541256,0.030124208,0.030413397,0.0037110623,0.04891352,0.01663877,0.12560552,0.5906434],"study_design_scores_gemma":[0.008586349,0.00031999525,0.7487355,0.00019136003,0.0012629603,0.0008901047,0.0012485601,0.0000015276903,0.006966644,0.0005898718,0.2309143,0.00029286175],"about_ca_topic_score_codex":0.004619539,"about_ca_topic_score_gemma":0.00066734257,"teacher_disagreement_score":0.6630454,"about_ca_system_score_codex":0.000019055218,"about_ca_system_score_gemma":0.00013287694,"threshold_uncertainty_score":0.69833916},"labels":[],"label_agreement":null},{"id":"W1994058101","doi":"10.1160/th09-09-0617","title":"Advances in Understanding “High on-Treatment Platelet Reactivity”","year":2009,"lang":"en","type":"letter","venue":"Thrombosis and Haemostasis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Reactivity (psychology); Platelet; Medicine; Computational biology; Chemistry; Immunology; Biology; Pathology","score_opus":0.08320253691253922,"score_gpt":0.3197326454105934,"score_spread":0.23653010849805417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994058101","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.29098654,0.032604303,0.0002867952,0.6564148,0.00057403656,0.0027433573,0.00047079206,0.00034678244,0.015572583],"genre_scores_gemma":[0.46870652,0.23799664,0.0001669533,0.28993425,0.0017755164,0.00007624398,0.0009201299,0.00014335044,0.00028040272],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980035,0.00010820852,0.00029729368,0.000668266,0.00044646347,0.00047630884],"domain_scores_gemma":[0.9990954,0.00015455368,0.00011849176,0.0005005558,0.000022664704,0.000108342],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00012887841,0.0005417214,0.001323823,0.00028950445,0.00013863572,0.00005279899,0.000077443605,0.0005442326,0.00013612604],"category_scores_gemma":[0.000011986735,0.00041503896,0.0004260931,0.00020218518,0.00013284058,0.0001473112,0.000019371082,0.00067665766,0.000021752345],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012416115,0.0009527258,0.0020736519,0.00066846353,0.002575655,0.004621299,0.00052911177,0.00002084277,0.00005927506,0.0007468585,0.21736781,0.7691427],"study_design_scores_gemma":[0.0056575076,0.0015784971,0.0065495544,0.0013168746,0.00097473414,0.00012406403,0.00022126835,0.000006128649,0.0009005322,0.0027576904,0.979182,0.0007311192],"about_ca_topic_score_codex":0.00009926316,"about_ca_topic_score_gemma":0.000025755116,"teacher_disagreement_score":0.7684116,"about_ca_system_score_codex":0.00055000396,"about_ca_system_score_gemma":0.00008178889,"threshold_uncertainty_score":0.9998301},"labels":[],"label_agreement":null},{"id":"W1994107650","doi":"10.1159/000368361","title":"Should Aspirin Be Used for the Primary Prevention of Cardiovascular Disease in the General Population?","year":2014,"lang":"en","type":"letter","venue":"Medical Principles and Practice","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Aspirin; Medicine; Myocardial infarction; Stroke (engine); Population; Primary prevention; Disease; Intensive care medicine; Clinical trial; Randomized controlled trial; Internal medicine; Environmental health","score_opus":0.07965405195095232,"score_gpt":0.34387734281869126,"score_spread":0.26422329086773894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994107650","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013396077,0.04710263,0.00805274,0.92751,0.000301764,0.0029398075,0.000050238108,0.000033607623,0.0006131122],"genre_scores_gemma":[0.070109606,0.014382907,0.00071859563,0.90303373,0.007903481,0.000635445,0.0021926146,0.00011430987,0.0009093126],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956647,0.0012332198,0.00050748436,0.0004077197,0.0019153573,0.00027151575],"domain_scores_gemma":[0.99561745,0.0030187545,0.00023199587,0.00090560195,0.00010151396,0.00012466878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0052016177,0.0002564516,0.0006982701,0.000065146676,0.00014009456,0.000039582123,0.0002930546,0.00043697876,0.000054774933],"category_scores_gemma":[0.0025290577,0.00014126954,0.0010182003,0.00012749207,0.00019074955,0.00011167714,0.00007234578,0.0010746196,0.0000014267522],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010951516,0.0026045144,0.015278456,0.022585921,0.046058025,0.0062903934,0.0018419798,0.003368325,0.00001627563,0.005662482,0.4694177,0.41592443],"study_design_scores_gemma":[0.001821679,0.00013329319,0.011647426,0.0002776552,0.005116258,0.0001900201,0.000047177098,0.0006947039,0.0000011749524,0.00012752335,0.97977996,0.00016315344],"about_ca_topic_score_codex":0.00025219534,"about_ca_topic_score_gemma":0.000007201204,"teacher_disagreement_score":0.51036227,"about_ca_system_score_codex":0.00003570512,"about_ca_system_score_gemma":0.00026328347,"threshold_uncertainty_score":0.57608044},"labels":[],"label_agreement":null},{"id":"W1994283455","doi":"10.1016/s0992-5945(10)70401-3","title":"Prasugrel : une avancée dans la prise en charge du syndrome coronaire aigu traité par angioplastie","year":2010,"lang":"fr","type":"article","venue":"Option/Bio","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"World Federation of Science Journalists","funders":"","keywords":"Medicine","score_opus":0.004963403928189244,"score_gpt":0.21521862206683906,"score_spread":0.2102552181386498,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994283455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96682054,0.016899385,0.0016063395,0.0029610905,0.0042428835,0.00080773013,0.0002590621,0.00022403864,0.0061789467],"genre_scores_gemma":[0.97835875,0.004410983,0.00038712283,0.00027453585,0.0019182229,0.00008005341,0.00024553947,0.0001225866,0.014202215],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99713117,0.0002927279,0.00049565424,0.0006808627,0.0006104495,0.000789112],"domain_scores_gemma":[0.99810475,0.0001911914,0.0001701843,0.0007852592,0.00014887191,0.00059975317],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0006739764,0.0005326446,0.0007574327,0.00012700334,0.00033014824,0.00008933877,0.00029995246,0.00062485796,0.002463614],"category_scores_gemma":[0.00016455141,0.0005213742,0.0008576873,0.0003780416,0.000717087,0.00034368061,0.00006960058,0.00080276554,0.0021551782],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031262897,0.010820083,0.24906382,0.0036238544,0.015122295,0.03006212,0.016700584,0.0005210184,0.09637795,0.08845605,0.04167964,0.4444463],"study_design_scores_gemma":[0.005143453,0.00057082187,0.48563245,0.0007342524,0.0017884697,0.007474806,0.00052027596,0.00057009776,0.0014093134,0.00024907745,0.49508676,0.00082020886],"about_ca_topic_score_codex":0.00011862259,"about_ca_topic_score_gemma":0.00005909378,"teacher_disagreement_score":0.45340714,"about_ca_system_score_codex":0.00011903971,"about_ca_system_score_gemma":0.00037777465,"threshold_uncertainty_score":0.9997238},"labels":[],"label_agreement":null},{"id":"W1994844512","doi":"10.1016/j.ahj.2008.09.024","title":"Randomized trial comparing 600- with 300-mg loading dose of clopidogrel in patients with non–ST elevation acute coronary syndrome undergoing percutaneous coronary intervention: Results of the Platelet Responsiveness to Aspirin and Clopidogrel and Troponin Increment after Coronary intervention in Acute coronary Lesions (PRACTICAL) Trial","year":2008,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Clopidogrel; Aspirin; Percutaneous coronary intervention; Cardiology; Randomized controlled trial; Acute coronary syndrome; Internal medicine; Myocardial infarction","score_opus":0.018933743279249387,"score_gpt":0.28830759039358556,"score_spread":0.26937384711433615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994844512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99594903,0.00043142412,0.0002899442,0.0003044249,0.00016901102,0.0027980811,0.00003871698,0.000013362757,0.00000599695],"genre_scores_gemma":[0.9977665,0.00070528395,0.00115771,0.00013555143,0.00004502828,0.00007815329,0.000047547754,0.000042463762,0.000021776594],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9956394,0.0013764605,0.001378383,0.00045352447,0.00078049995,0.00037175434],"domain_scores_gemma":[0.9978806,0.00062103657,0.00073645485,0.00032656555,0.00020666631,0.0002286998],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013416833,0.00035015753,0.0015709029,0.0004293003,0.00019401997,0.000026336838,0.0001215234,0.00009583875,0.0000234618],"category_scores_gemma":[0.00017118632,0.00024771632,0.00041673792,0.00051123917,0.0007366056,0.00032076065,0.0001500423,0.0005949854,8.4897283e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7480255,0.00090772077,0.24389565,0.00005234079,0.0011387664,0.0023279812,0.0004976377,0.00009487857,0.00013167474,0.0000023880555,0.000014245916,0.0029112594],"study_design_scores_gemma":[0.4311782,0.010434509,0.5448946,0.0015161991,0.00041005193,0.010769105,0.0004871492,0.00009651101,0.00003269971,0.0000063780903,0.000009193568,0.00016543432],"about_ca_topic_score_codex":0.00020037404,"about_ca_topic_score_gemma":0.00011056343,"teacher_disagreement_score":0.31684726,"about_ca_system_score_codex":0.00025241918,"about_ca_system_score_gemma":0.00033885502,"threshold_uncertainty_score":0.9999975},"labels":[],"label_agreement":null},{"id":"W1994920995","doi":"10.1510/icvts.2009.214569","title":"Impact of clopidogrel use on mortality and major bleeding in patients undergoing coronary artery bypass surgery☆","year":2010,"lang":"en","type":"article","venue":"Interactive Cardiovascular and Thoracic Surgery","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Clopidogrel; Coronary artery bypass surgery; Cardiology; Surgery; Bypass surgery; Coronary artery disease; Internal medicine; Artery; Anesthesia; Myocardial infarction","score_opus":0.03344961661842058,"score_gpt":0.3088869966789736,"score_spread":0.27543738006055307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994920995","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968454,0.0020833968,0.000052090872,0.000010978182,0.0004985178,0.00030219325,0.000045746263,0.000036221747,0.00012541658],"genre_scores_gemma":[0.9986032,0.0010306153,0.00002169704,0.000057513273,0.00013211949,0.000021678778,0.000075195,0.00004709636,0.000010837818],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99770254,0.00033067205,0.0005063159,0.00055984216,0.00053247536,0.00036813677],"domain_scores_gemma":[0.9970277,0.0017922064,0.00014985134,0.0005783632,0.00021669018,0.00023517458],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011911996,0.0003519658,0.0013588435,0.00046788645,0.00007631477,0.000053186606,0.00004828149,0.0001830564,0.00003456304],"category_scores_gemma":[0.0007703672,0.0002987577,0.0022852165,0.00026910577,0.0001914068,0.00050035195,0.00006107007,0.00047866296,0.0000033646481],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017617586,0.0003142927,0.90863705,0.00015044792,0.009180688,0.0003864978,0.0000878654,0.000013162925,0.0002674414,0.0000042850215,0.000047275935,0.07914921],"study_design_scores_gemma":[0.00095080154,0.00012859875,0.9959013,0.00054984447,0.0008814991,0.0002627349,0.00007569741,0.000026290723,0.0008014469,0.000022344304,0.00011100411,0.00028846544],"about_ca_topic_score_codex":0.00025437272,"about_ca_topic_score_gemma":0.000022275024,"teacher_disagreement_score":0.087264195,"about_ca_system_score_codex":0.000074970325,"about_ca_system_score_gemma":0.0001640136,"threshold_uncertainty_score":0.9999465},"labels":[],"label_agreement":null},{"id":"W1995430571","doi":"10.1016/j.pharmthera.2006.05.011","title":"Aspirin resistance: Truth or dare","year":2006,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital du Sacré-Cœur de Montréal","funders":"","keywords":"Aspirin; Medicine; Resistance (ecology); Intensive care medicine; Disease; Population; Internal medicine; Biology; Environmental health","score_opus":0.11914217465125228,"score_gpt":0.4287936914252627,"score_spread":0.3096515167740104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995430571","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000028516917,0.9938517,0.00006112854,0.0001263152,0.0011549649,0.0013670705,0.0001597049,0.00023079908,0.0030197685],"genre_scores_gemma":[0.000024858067,0.9850032,0.00013260514,0.003116674,0.0014916968,0.00023005749,0.0005309792,0.00018722579,0.009282723],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971123,0.00047358245,0.0007249029,0.00067449006,0.00039676824,0.0006179982],"domain_scores_gemma":[0.9984771,0.00029115772,0.00031185866,0.0006058389,0.00011792244,0.00019614658],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00028302366,0.0007304037,0.002730464,0.00022412997,0.00016313084,0.00002731598,0.00035906734,0.0006408476,0.0011041785],"category_scores_gemma":[0.000003899969,0.00050930487,0.001790051,0.00047594018,0.0002713773,0.000049654773,0.00006587626,0.000852914,0.00024047167],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065390795,0.00039543436,0.0000061910055,0.014500836,0.010656029,0.0011766576,0.000021817019,6.4014495e-7,0.0000090782305,0.00003941729,0.010540957,0.96199906],"study_design_scores_gemma":[0.0020943917,0.0001458464,0.000008046614,0.0024939666,0.03820064,0.00036318268,0.000011425413,0.0000015439848,0.000030757492,0.000028234816,0.9561348,0.00048719507],"about_ca_topic_score_codex":0.0000016503668,"about_ca_topic_score_gemma":0.0000022416782,"teacher_disagreement_score":0.96151185,"about_ca_system_score_codex":0.00020438123,"about_ca_system_score_gemma":0.0009386629,"threshold_uncertainty_score":0.99980897},"labels":[],"label_agreement":null},{"id":"W1995460225","doi":"10.1002/clc.20964","title":"2011 ACCF/AHA Focused Update of the Guidelines for the Management of Patients With Unstable Angina/Non–ST‐Elevation Myocardial Infarction (Updating the 2007 Guideline): Highlights for the Clinician","year":2011,"lang":"en","type":"review","venue":"Clinical Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Guideline; Unstable angina; Myocardial infarction; Acute coronary syndrome; Internal medicine; Cardiology; Canadian Cardiovascular Society; Angina; ST elevation; Intensive care medicine","score_opus":0.11452807560708216,"score_gpt":0.39456066561185155,"score_spread":0.2800325900047694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995460225","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027819094,0.95379156,0.026661865,0.0017626833,0.003970365,0.012461393,0.0006865299,0.00004018809,0.00034725238],"genre_scores_gemma":[0.0010753555,0.9918644,0.0011508516,0.0013447251,0.0026486595,0.00097851,0.0006800964,0.00009863805,0.00015876204],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99479496,0.0008067656,0.0028650693,0.0006353645,0.00043704145,0.00046078482],"domain_scores_gemma":[0.991723,0.0025110573,0.001982941,0.001973906,0.0017341368,0.00007495437],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0059982557,0.0005094562,0.0027188684,0.00007107965,0.00039850536,0.000015551257,0.0009510586,0.00054093834,0.00003865212],"category_scores_gemma":[0.00073760736,0.00018881798,0.0043550907,0.00028936003,0.0007177922,0.00006287503,0.00024671794,0.00048066254,0.000008642443],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013778298,0.000112713074,0.002769482,0.0022380045,0.0195712,0.0000016821642,0.00001786872,0.00011029624,4.590005e-8,0.0013841658,0.06159128,0.91082543],"study_design_scores_gemma":[0.002915336,0.00051731296,0.010737552,0.0011454376,0.02113599,0.000008201247,0.000088328394,0.00006455614,4.921174e-7,0.00016264534,0.963005,0.0002191358],"about_ca_topic_score_codex":0.000030139248,"about_ca_topic_score_gemma":0.0000055056043,"teacher_disagreement_score":0.9106063,"about_ca_system_score_codex":0.000044444743,"about_ca_system_score_gemma":0.00041011718,"threshold_uncertainty_score":0.7699774},"labels":[],"label_agreement":null},{"id":"W1996019480","doi":"10.1097/00001756-200309150-00019","title":"Acetylsalicylic acid reduces perfusion deficit in ischemic injured brain in rats","year":2003,"lang":"en","type":"article","venue":"Neuroreport","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Perfusion; Stroke (engine); Anesthesia; Middle cerebral artery; Ischemia; Occlusion; Perfusion scanning; Cardiology; Internal medicine","score_opus":0.014470385599522882,"score_gpt":0.2691006221913443,"score_spread":0.2546302365918214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996019480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985161,0.0018459002,0.0000044485855,0.0004630373,0.00012953409,0.0003620577,0.0000014470712,0.000057346813,0.01197521],"genre_scores_gemma":[0.99808633,0.00032610307,0.00006492475,0.0010322836,0.0000511835,0.000031252515,0.00002292489,0.00003418526,0.00035082133],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99839985,0.00013666648,0.00041444143,0.0004222399,0.0003261997,0.00030057222],"domain_scores_gemma":[0.99933225,0.000028549624,0.00008166205,0.00041174574,0.00003124534,0.00011454868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045767447,0.00018427538,0.00039940578,0.00019450253,0.00003230631,0.000013036174,0.000070326525,0.00012020663,0.00013817815],"category_scores_gemma":[0.00033487045,0.00016915794,0.0002126958,0.00046209025,0.000051561925,0.00009334827,0.0000217142,0.0002830203,0.000024951962],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004084206,0.00039505458,0.2253255,0.000054643213,0.000045505465,0.004506178,0.00028212104,0.000014058455,0.7481086,0.00006163957,0.0022032706,0.018594969],"study_design_scores_gemma":[0.0045540687,0.00028544394,0.39539754,0.00023035263,0.0000873322,0.002677747,0.00035294963,0.000024884783,0.5322181,0.000101246,0.06362085,0.00044949653],"about_ca_topic_score_codex":0.000020188256,"about_ca_topic_score_gemma":0.000010458194,"teacher_disagreement_score":0.21589057,"about_ca_system_score_codex":0.000043699245,"about_ca_system_score_gemma":0.0002084178,"threshold_uncertainty_score":0.68980604},"labels":[],"label_agreement":null},{"id":"W1996056369","doi":"10.1016/j.ahj.2014.09.002","title":"Vorapaxar with or without clopidogrel after non–ST-segment elevation acute coronary syndromes: Results from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome trial","year":2014,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Clopidogrel; Internal medicine; Prasugrel; Myocardial infarction; Cardiology; Acute coronary syndrome; Stroke (engine); Ticagrelor; Interquartile range; Hazard ratio; Platelet aggregation inhibitor; Anesthesia; Aspirin; Confidence interval","score_opus":0.03194562231580365,"score_gpt":0.3418161774105404,"score_spread":0.3098705550947367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996056369","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98979473,0.00033117266,0.0038593728,0.0029572498,0.0009795699,0.0018293413,0.00020230626,0.000040751398,0.0000055223823],"genre_scores_gemma":[0.98782563,0.003286529,0.005929499,0.0012883653,0.000981692,0.000186015,0.00028088238,0.000069802336,0.00015159274],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9964068,0.00069671695,0.0011168451,0.0005895471,0.0007079957,0.00048207832],"domain_scores_gemma":[0.99801606,0.00038601283,0.0005305395,0.00058412366,0.00016589198,0.0003173699],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017922007,0.00035050037,0.0011728193,0.000103829865,0.00028929402,0.00007324297,0.00018822006,0.00012698468,0.00015387223],"category_scores_gemma":[0.00011580343,0.00021091277,0.0006514122,0.00032725747,0.0005564455,0.0002304674,0.000039306735,0.0006582061,0.000022230493],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.76031315,0.0018499007,0.17095254,0.00003066384,0.00737686,0.0009825799,0.00072600506,0.00016737645,0.0006634813,0.0000024799701,0.012735792,0.044199154],"study_design_scores_gemma":[0.11447251,0.038028147,0.8016243,0.0009930831,0.0030212444,0.02508126,0.0018645095,0.00091341336,0.00012488308,0.000039523868,0.0131234685,0.00071365904],"about_ca_topic_score_codex":0.00011088463,"about_ca_topic_score_gemma":0.000010864867,"teacher_disagreement_score":0.64584064,"about_ca_system_score_codex":0.00019014128,"about_ca_system_score_gemma":0.000498075,"threshold_uncertainty_score":0.8600773},"labels":[],"label_agreement":null},{"id":"W1997149933","doi":"10.1016/j.amjcard.2012.01.349","title":"Meta-Analysis of Randomized Controlled Trials on Effect of Cilostazol on Restenosis Rates and Outcomes After Percutaneous Coronary Intervention","year":2012,"lang":"en","type":"review","venue":"The American Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Cilostazol; Medicine; Percutaneous coronary intervention; Randomized controlled trial; Internal medicine; Restenosis; Aspirin; Relative risk; Clopidogrel; Confidence interval; Meta-analysis; Cardiology; Myocardial infarction; Adverse effect; Cochrane Library; Stent","score_opus":0.0694590473219525,"score_gpt":0.3784646936402463,"score_spread":0.3090056463182938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997149933","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.058673322,0.93910944,0.000059864535,0.00007392511,0.00012515803,0.0018301877,0.00007890822,0.0000039874412,0.000045200017],"genre_scores_gemma":[0.36821827,0.6314626,0.0000075399107,0.000059801056,0.00011244162,0.00008017533,0.000011024716,0.000021813465,0.000026389976],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9692873,0.026756069,0.00303342,0.00020674277,0.0005201,0.00019639687],"domain_scores_gemma":[0.97111773,0.021971578,0.0060287607,0.0005412032,0.00022949964,0.000111198795],"candidate_categories":["metaepi_broad"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.01879925,0.00051557546,0.06347895,0.00082933507,0.000026431348,0.0000072740118,0.00019736064,0.000133856,0.00010146117],"category_scores_gemma":[0.0021803938,0.00018930045,0.0607629,0.00030909738,0.0008479184,0.000023309225,0.000033469827,0.00040287763,0.0000019491256],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.24000986,0.000037151545,0.00012741693,0.00057278556,0.61468583,0.00013347968,0.000025977679,0.000032921413,0.000001423002,0.0000041728986,0.0000061196265,0.14436284],"study_design_scores_gemma":[0.04571278,0.0036003257,0.0003394903,0.0006780346,0.946116,0.0015099655,0.00004269177,9.962313e-7,0.0000035026576,0.0000075817443,0.0018571371,0.00013150608],"about_ca_topic_score_codex":0.0000072115254,"about_ca_topic_score_gemma":1.926604e-7,"teacher_disagreement_score":0.33143014,"about_ca_system_score_codex":0.00003842224,"about_ca_system_score_gemma":0.00006768359,"threshold_uncertainty_score":0.9504247},"labels":[],"label_agreement":null},{"id":"W1997163947","doi":"10.1016/j.cjca.2011.07.442","title":"533 Impact of clopidogrel on patients with ACS undergoing coronary bypass surgery: The practice study","year":2011,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Clopidogrel; Acute coronary syndrome; Blood product; Coronary artery bypass surgery; Tamponade; Context (archaeology); Surgery; Prospective cohort study; Blood transfusion; Artery; Myocardial infarction; Internal medicine","score_opus":0.02280232264300051,"score_gpt":0.253244520875823,"score_spread":0.2304421982328225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997163947","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99583447,0.00095258607,0.0000829217,0.00010476076,0.00023862346,0.00020464492,0.000015128526,0.0000031604795,0.0025636982],"genre_scores_gemma":[0.9993679,0.00011411153,0.000019323617,0.00021103409,0.00024732325,0.0000022217148,0.0000049642986,0.000020192032,0.000012930133],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985838,0.000485467,0.00031465062,0.00011560929,0.00024059013,0.00025987247],"domain_scores_gemma":[0.99815565,0.00040991837,0.00030055665,0.00030829417,0.00046541405,0.0003601711],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006747881,0.00014188675,0.0006411277,0.0001911255,0.000088133434,0.0000065132376,0.00013271741,0.00007498703,0.000030416946],"category_scores_gemma":[0.000405009,0.00007925169,0.0005178937,0.0001499693,0.0001801957,0.000100976504,0.000006946784,0.00028261152,0.0000038067762],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023438185,0.000051819494,0.9825713,0.00000811621,0.0055052554,0.0010350819,0.00041457938,0.00022285274,0.0000019351917,0.00001786044,0.0020057661,0.0058216094],"study_design_scores_gemma":[0.0020930746,0.0038802668,0.9876352,0.00006873618,0.0009575291,0.0010247906,0.0011512586,2.05281e-7,0.000007929564,0.000012943359,0.0030830973,0.00008497979],"about_ca_topic_score_codex":0.00091188826,"about_ca_topic_score_gemma":0.00036657375,"teacher_disagreement_score":0.0057366295,"about_ca_system_score_codex":0.00013294254,"about_ca_system_score_gemma":0.0022104227,"threshold_uncertainty_score":0.3921195},"labels":[],"label_agreement":null},{"id":"W1997519752","doi":"10.1016/j.amjcard.2013.11.052","title":"Association of Aspirin Dose and Vorapaxar Safety and Efficacy in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome (from the TRACER Trial)","year":2013,"lang":"en","type":"article","venue":"The American Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Merck","keywords":"Medicine; Hazard ratio; Internal medicine; Aspirin; Myocardial infarction; Cardiology; Confidence interval; Acute coronary syndrome; Placebo; Stroke (engine); Proportional hazards model","score_opus":0.005120502492045,"score_gpt":0.21997096785977702,"score_spread":0.21485046536773203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997519752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975971,0.0005765282,0.00018806203,0.0010450138,0.000051852436,0.000513188,0.000013576324,0.0000024326653,0.000012266191],"genre_scores_gemma":[0.9984404,0.0011551946,0.000052550466,0.0002469975,0.00007273013,0.0000055577825,0.000010163534,0.000009247695,0.0000071823124],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987335,0.00045256285,0.00033598076,0.00009847031,0.00025591152,0.00012358099],"domain_scores_gemma":[0.9988025,0.0002954803,0.0005487983,0.00016219703,0.00013919153,0.00005186735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006454655,0.00010023675,0.00066689553,0.0000459205,0.000039816277,0.000006971619,0.00007400723,0.00003530118,0.000007505971],"category_scores_gemma":[0.00005001824,0.000050025767,0.00013994573,0.00011879204,0.00020542275,0.00007013446,0.000019871772,0.00018090368,8.4219744e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.039070066,0.00010403921,0.85974616,0.0000059611875,0.0043377876,0.000035686437,0.00038210582,0.00014649611,0.00025184706,0.0000034877776,0.00010049672,0.0958159],"study_design_scores_gemma":[0.022822885,0.0035841423,0.97201735,0.00004655881,0.0007823322,0.00014479489,0.0003346896,0.0000066499515,0.000008172898,0.000028800403,0.00016937233,0.00005423518],"about_ca_topic_score_codex":0.000039271854,"about_ca_topic_score_gemma":9.7198e-7,"teacher_disagreement_score":0.11227124,"about_ca_system_score_codex":0.00005102011,"about_ca_system_score_gemma":0.000050369606,"threshold_uncertainty_score":0.20399916},"labels":[],"label_agreement":null},{"id":"W1997534509","doi":"10.1160/th09-02-0126","title":"Response to aspirin in healthy individuals","year":2009,"lang":"en","type":"article","venue":"Thrombosis and Haemostasis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame","funders":"","keywords":"Aspirin; Medicine; Platelet; Urinary system; Urine; Population; Antiplatelet drug; Internal medicine; Gastroenterology; Pharmacology; Clopidogrel","score_opus":0.048179876810959546,"score_gpt":0.3464716600524401,"score_spread":0.2982917832414806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997534509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97927797,0.0017144281,0.000041668533,0.01802108,0.000025158506,0.00037761085,0.000017099326,0.000045566725,0.00047941052],"genre_scores_gemma":[0.9845731,0.001146904,0.0006961397,0.01346911,0.000037764363,0.000011661313,0.000010829057,0.000011940494,0.000042524196],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9989072,0.00012084227,0.0002071,0.00027183836,0.00022750163,0.0002655286],"domain_scores_gemma":[0.9993788,0.00004630273,0.000025495641,0.0002677198,0.000027551267,0.00025410895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005918746,0.00013578347,0.00041448945,0.00018121097,0.0000716713,0.000023840248,0.00005352913,0.00007268346,0.000096505595],"category_scores_gemma":[0.000046879344,0.00011940993,0.00011976522,0.0003144709,0.00003428031,0.00006019688,0.000020726799,0.00009949091,0.000034496115],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0140172085,0.0009526664,0.13412629,0.000085331194,0.00044071174,0.0001322755,0.0026596664,0.000013880706,0.0051062764,0.00063414406,0.005549898,0.83628166],"study_design_scores_gemma":[0.0030820025,0.00138891,0.95880955,0.0001316076,0.00008517488,0.000024878304,0.00024624984,0.000003090887,0.001347239,0.00016697278,0.03455646,0.00015786657],"about_ca_topic_score_codex":0.000026689364,"about_ca_topic_score_gemma":0.0000058243268,"teacher_disagreement_score":0.83612376,"about_ca_system_score_codex":0.000037542977,"about_ca_system_score_gemma":0.000059665184,"threshold_uncertainty_score":0.48693958},"labels":[],"label_agreement":null},{"id":"W1997602267","doi":"10.1016/j.thromres.2012.04.006","title":"Aspirin response variability after major orthopedic surgery","year":2012,"lang":"en","type":"article","venue":"Thrombosis Research","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Hospital; Hamilton General Hospital; McMaster University","funders":"Hamilton Health Sciences","keywords":"Aspirin; Medicine; Orthopedic surgery; Platelet; Perioperative; Anesthesia; Prospective cohort study; Internal medicine; Surgery","score_opus":0.11246727086068427,"score_gpt":0.40304122980069573,"score_spread":0.2905739589400115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997602267","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99297535,0.0033763016,0.00010767993,0.000861368,0.00016292695,0.0005099878,0.000016422202,0.00009625571,0.0018937103],"genre_scores_gemma":[0.9973857,0.00055974966,0.00010877611,0.00029740194,0.0005550956,0.0001776147,0.00002199705,0.000045771787,0.00084788987],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99452806,0.0024952288,0.0002996294,0.00036320154,0.0013218868,0.0009920099],"domain_scores_gemma":[0.9965466,0.001550136,0.00002675322,0.0009895858,0.00029213345,0.0005947916],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.015537369,0.00017640938,0.00051282963,0.00031345242,0.0001910073,0.000034613404,0.00012510344,0.0001703876,0.00392882],"category_scores_gemma":[0.0014592379,0.00014336561,0.0005301142,0.0007294828,0.00032914974,0.00022712075,0.00014397281,0.0005159952,0.0011195925],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007926307,0.0010969191,0.96183145,0.00028910386,0.00070828025,0.000099787416,0.00038937977,3.1252299e-7,0.0044057523,0.00009213278,0.0066458457,0.016514704],"study_design_scores_gemma":[0.0006230168,0.00011573241,0.9500589,0.00010559491,0.00011362027,0.000042468844,0.00011824106,0.0000042730603,0.0017716414,0.0000741964,0.04681075,0.0001615933],"about_ca_topic_score_codex":0.000045252735,"about_ca_topic_score_gemma":0.000001876294,"teacher_disagreement_score":0.040164903,"about_ca_system_score_codex":0.00015348977,"about_ca_system_score_gemma":0.000367672,"threshold_uncertainty_score":0.99965817},"labels":[],"label_agreement":null},{"id":"W1998267695","doi":"10.1016/s0149-2918(04)90040-9","title":"Underuse of aspirin in type 2 diabetes mellitus: Prevalence and correlates of therapy in rural Canada","year":2004,"lang":"en","type":"article","venue":"Clinical Therapeutics","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute of Health Economics; University of Alberta","funders":"","keywords":"Medicine; Aspirin; Thienopyridine; Internal medicine; Population; Diabetes mellitus; Cohort; Type 2 Diabetes Mellitus; Type 2 diabetes; Logistic regression; Cohort study; Guideline; Clopidogrel; Environmental health","score_opus":0.0452454638835269,"score_gpt":0.3249693867348366,"score_spread":0.2797239228513097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998267695","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94780785,0.051640034,0.00000853078,0.00015073863,0.00010818716,0.000235907,0.000005586894,0.0000063632906,0.000036791203],"genre_scores_gemma":[0.93566,0.063728936,0.00007043951,0.0004898381,0.000022522247,0.0000024509309,0.0000040402583,0.000012642101,0.000009113155],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988083,0.000111751215,0.0005663055,0.00015314741,0.00019296123,0.00016749538],"domain_scores_gemma":[0.999231,0.00028690952,0.00010413033,0.00024649542,0.000065430366,0.00006604159],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041309375,0.00011476437,0.000511599,0.00004669668,0.000009614689,0.0000026029188,0.00008627562,0.000119207616,0.0000161966],"category_scores_gemma":[0.00005721897,0.00009256874,0.00012236334,0.0002129093,0.00024702228,0.000031914424,0.000018018172,0.00020264399,4.9953434e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005102683,0.00035517584,0.9399126,0.00013030645,0.00025352105,0.00001438663,0.00010571003,0.00008782889,0.0002502438,0.000165412,0.0000013209615,0.05821318],"study_design_scores_gemma":[0.005649048,0.00095247704,0.9875212,0.00060412474,0.00010286296,0.000003650565,0.00018384721,0.00009270342,0.0029465724,0.0014397202,0.0003720958,0.00013172033],"about_ca_topic_score_codex":0.0028436752,"about_ca_topic_score_gemma":0.0041556796,"teacher_disagreement_score":0.05808146,"about_ca_system_score_codex":0.000034233846,"about_ca_system_score_gemma":0.00039444622,"threshold_uncertainty_score":0.42988053},"labels":[],"label_agreement":null},{"id":"W1998846077","doi":"10.1016/j.cjca.2010.12.033","title":"The Use of Antiplatelet Therapy in the Outpatient Setting: Canadian Cardiovascular Society Guidelines Executive Summary","year":2011,"lang":"en","type":"review","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Université de Montréal; University of British Columbia; Montreal Heart Institute; Montreal Clinical Research Institute; St. Michael's Hospital; University of Alberta; Queen Elizabeth II Health Sciences Centre; Trillium Health Centre; St. Joseph’s Healthcare Hamilton; Centre Hospitalier de l’Université de Montréal; Women's College Hospital; McMaster University; Toronto General Hospital; University of Toronto","funders":"","keywords":"Medicine; Canadian Cardiovascular Society; Executive summary; Intensive care medicine; Family medicine; Internal medicine; Myocardial infarction; Finance","score_opus":0.13756425110916734,"score_gpt":0.30944524262647494,"score_spread":0.1718809915173076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998846077","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027859033,0.9965567,0.00006309941,0.00025310402,0.00080828636,0.0010922182,0.00021503349,0.000004108999,0.0007288532],"genre_scores_gemma":[0.0012763017,0.9966675,0.00008977272,0.000584307,0.0011281356,0.00003065266,0.00007913425,0.000071718394,0.0000724755],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9949478,0.0018329332,0.0015856678,0.0003492406,0.00043662646,0.00084772194],"domain_scores_gemma":[0.99599624,0.00049653347,0.00067549956,0.001151507,0.000943443,0.00073679385],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003477926,0.00054998545,0.003624655,0.0004888868,0.00029677674,0.00005415382,0.0008377449,0.0006943097,0.000008650094],"category_scores_gemma":[0.0005357142,0.00029597132,0.007972531,0.00051390595,0.000645761,0.00010007888,0.000023469664,0.0012493045,0.0000039185497],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007024469,0.000005526617,0.0007137127,0.00051909784,0.014509336,0.0017421088,0.00052147027,0.00015895082,6.962275e-8,0.00006839027,0.08952141,0.8921697],"study_design_scores_gemma":[0.00081091723,0.00029466255,0.00033640023,0.0024774668,0.0027315977,0.004193482,0.00038343415,0.0000014073108,5.0587676e-7,0.000021153863,0.988482,0.00026699234],"about_ca_topic_score_codex":0.042555854,"about_ca_topic_score_gemma":0.022202732,"teacher_disagreement_score":0.8989606,"about_ca_system_score_codex":0.00041088008,"about_ca_system_score_gemma":0.010374905,"threshold_uncertainty_score":0.9999492},"labels":[],"label_agreement":null},{"id":"W1998869090","doi":"10.1016/j.athoracsur.2012.07.086","title":"2012 Update to The Society of Thoracic Surgeons Guideline on Use of Antiplatelet Drugs in Patients Having Cardiac and Noncardiac Operations","year":2012,"lang":"en","type":"article","venue":"The Annals of Thoracic Surgery","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":294,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Guideline; Intensive care medicine; Cardiothoracic surgery; Cardiology; Medical emergency; Surgery; Pathology","score_opus":0.06812595295715602,"score_gpt":0.35741477958055196,"score_spread":0.28928882662339594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998869090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990621,0.006297774,0.00006834515,0.0019740134,0.00023069726,0.0005358169,0.00022447936,0.00001397141,0.000033905817],"genre_scores_gemma":[0.9935578,0.004923208,0.00015666777,0.0010339633,0.00011828186,0.000018803008,0.00010718686,0.000031322743,0.000052748077],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975222,0.0005739395,0.0007573415,0.00020504948,0.0005550128,0.00038645254],"domain_scores_gemma":[0.99772567,0.00074085814,0.00020603016,0.00078059844,0.0003974625,0.00014939749],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004130857,0.00021697028,0.0009057799,0.00015773492,0.00010798213,0.000015163394,0.00012716214,0.00009613003,0.000033302855],"category_scores_gemma":[0.00028843238,0.00013525272,0.0011061559,0.00050649047,0.00018022335,0.0003077734,0.00010780715,0.00017759402,0.0000075738],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025591217,0.0009075428,0.73152477,0.00036972715,0.0023890235,0.0000029404964,0.002389814,0.0010577227,0.0008567744,0.00005359567,0.065441765,0.19244722],"study_design_scores_gemma":[0.00036444154,0.00016845831,0.89608043,0.0012915881,0.00097097753,0.000009908509,0.0012231718,0.00020016551,0.059074268,0.000027590862,0.040086478,0.0005025314],"about_ca_topic_score_codex":0.0001622596,"about_ca_topic_score_gemma":0.000003702877,"teacher_disagreement_score":0.19194469,"about_ca_system_score_codex":0.000010693119,"about_ca_system_score_gemma":0.00008057668,"threshold_uncertainty_score":0.55154455},"labels":[],"label_agreement":null},{"id":"W1999272623","doi":"10.1016/s0151-9638(07)92527-2","title":"L’arrêt d’un traitement antiagrégant plaquettaire est-il nécessaire avant une chirurgie cutanée carcinologique ?","year":2007,"lang":"fr","type":"article","venue":"Annales de Dermatologie et de Vénéréologie","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Montréal","funders":"","keywords":"Medicine; Gynecology","score_opus":0.025457175414567376,"score_gpt":0.3107546215676668,"score_spread":0.28529744615309943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999272623","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7830606,0.15704241,0.019088281,0.030431196,0.002116442,0.0012309131,0.0002569416,0.0010079838,0.0057652346],"genre_scores_gemma":[0.9166628,0.067676,0.0028334414,0.010804467,0.0007431202,0.00010183978,0.0002860694,0.00017071169,0.0007215603],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.98988986,0.0016301693,0.0017110292,0.0015419415,0.0009658401,0.0042611416],"domain_scores_gemma":[0.9946304,0.0015748455,0.0005826682,0.0016456862,0.0003576656,0.001208716],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.004187509,0.0013856507,0.002145471,0.00051140366,0.00070861506,0.00021419108,0.0012013835,0.002024226,0.00049466814],"category_scores_gemma":[0.0014018273,0.0012928193,0.0017115179,0.0008550877,0.0020588185,0.00050249085,0.00041314703,0.0021250832,0.0005101749],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029070282,0.00347815,0.3210643,0.0026681072,0.0069620716,0.15974382,0.0041091847,0.0013630518,0.0048062494,0.018762778,0.031093288,0.44304198],"study_design_scores_gemma":[0.009667581,0.0018323701,0.4670094,0.0025732608,0.0036286956,0.04433995,0.013784345,0.0012750342,0.128358,0.009868014,0.31420675,0.003456584],"about_ca_topic_score_codex":0.00046003642,"about_ca_topic_score_gemma":0.00041971303,"teacher_disagreement_score":0.4395854,"about_ca_system_score_codex":0.00092326425,"about_ca_system_score_gemma":0.003309549,"threshold_uncertainty_score":0.9998894},"labels":[],"label_agreement":null},{"id":"W1999368002","doi":"10.1161/strokeaha.110.596643","title":"The Safety of Proton Pump Inhibitors and Clopidogrel in Patients After Stroke","year":2010,"lang":"en","type":"article","venue":"Stroke","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre; St. Michael's Hospital","funders":"","keywords":"Medicine; Clopidogrel; Stroke (engine); Odds ratio; Internal medicine; Cohort; Cohort study; Cardiology; Surgery; Aspirin","score_opus":0.0033888032226895527,"score_gpt":0.21424299614480607,"score_spread":0.21085419292211652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999368002","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977164,0.00049896,0.0000045210995,0.000096083466,0.00015740264,0.00070223375,0.00003707674,0.000010602046,0.0007767188],"genre_scores_gemma":[0.99922615,0.000250062,0.000032973705,0.000047602905,0.000089021305,0.00005462435,0.000007035459,0.000010854143,0.0002816833],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99925345,0.000032510834,0.00019194627,0.00013551684,0.00023076426,0.0001557899],"domain_scores_gemma":[0.99956894,0.000027470685,0.000043173597,0.00024269031,0.0000505041,0.00006721968],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018730877,0.00009069715,0.00018218059,0.000042069398,0.00004306622,0.000008699967,0.000047040667,0.00007052039,0.000030345152],"category_scores_gemma":[0.00004250603,0.00005843977,0.00013114868,0.00005318155,0.00014350079,0.00004327657,0.000030623494,0.00019870039,0.0000033093809],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013185189,0.00008772391,0.965259,0.00004109493,0.00011522862,0.0000060468988,0.00008701692,2.0127634e-7,0.0008204933,0.00004185426,0.000019472347,0.032203346],"study_design_scores_gemma":[0.0028671585,0.00019573302,0.9722675,0.00004513319,0.00006037986,0.0000023187451,0.00007280067,0.000004597533,0.0073553324,0.000020636477,0.017039709,0.00006870677],"about_ca_topic_score_codex":0.000013438459,"about_ca_topic_score_gemma":0.000024394354,"teacher_disagreement_score":0.03213464,"about_ca_system_score_codex":0.0000082834085,"about_ca_system_score_gemma":0.000032572767,"threshold_uncertainty_score":0.23831047},"labels":[],"label_agreement":null},{"id":"W1999452432","doi":"10.1016/j.jacc.2012.08.777","title":"TCT-736 Markedly Reduced Platelet Inhibition with Clopidogrel Given To Patients Undergoing Therapeutic Hypothermia Post Cardiac Arrest","year":2012,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Hypothermia; Clopidogrel; Platelet inhibition; Cardiology; Platelet; Internal medicine; Anesthesia; Myocardial infarction","score_opus":0.008953325805201423,"score_gpt":0.23494644202504728,"score_spread":0.22599311621984586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999452432","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99540776,0.0013593852,0.00023201651,0.0010187074,0.0007369541,0.0004539701,0.00008479071,0.000010808476,0.0006956364],"genre_scores_gemma":[0.9973837,0.00042546765,0.00043258365,0.00081006234,0.0008384402,0.000007587071,0.0000050335366,0.000043472755,0.000053666383],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99790865,0.0005746035,0.00047306163,0.00016262209,0.000502443,0.00037862975],"domain_scores_gemma":[0.99809486,0.00020764353,0.0006292411,0.00041268062,0.00041271467,0.00024285683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005041983,0.00022679007,0.0011830811,0.0001771667,0.00009581115,0.0000043200375,0.00018339582,0.00007099815,0.000010526101],"category_scores_gemma":[0.0001266403,0.00014002407,0.000876597,0.00044795976,0.0003437202,0.00011605982,0.000055947177,0.00027120486,0.000006109125],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027082399,0.0006000543,0.875481,0.00018997674,0.01507795,0.0004062743,0.00049337803,0.0013252065,0.038119983,0.00020022859,0.010996798,0.030026756],"study_design_scores_gemma":[0.0043208,0.0042114253,0.9645468,0.00035446673,0.0013509732,0.001640923,0.0011223513,0.0000014552778,0.0051969863,0.00005425911,0.016900966,0.00029861336],"about_ca_topic_score_codex":0.0000058625105,"about_ca_topic_score_gemma":0.0000016113232,"teacher_disagreement_score":0.08906578,"about_ca_system_score_codex":0.00013760792,"about_ca_system_score_gemma":0.00029382686,"threshold_uncertainty_score":0.5710016},"labels":[],"label_agreement":null},{"id":"W1999940036","doi":"10.1517/14740330902797081","title":"Antiplatelet therapy and coronary artery bypass graft surgery: perioperative safety and efficacy","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"University of Ottawa","keywords":"Medicine; Clopidogrel; Perioperative; Aspirin; Coronary artery disease; Regimen; Randomized controlled trial; Platelet aggregation inhibitor; Surgery; Ticlopidine; Artery; Anesthesia; Intensive care medicine; Internal medicine","score_opus":0.04322694386965911,"score_gpt":0.32378122526984554,"score_spread":0.28055428140018646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999940036","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00031823962,0.99538547,0.000029723744,0.0006855096,0.00061017845,0.0019840684,0.00014137792,0.00017545457,0.00066998636],"genre_scores_gemma":[0.00036292273,0.99552554,0.00006283882,0.0012931655,0.000855968,0.00006353211,0.0013259753,0.00014002465,0.00037003425],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99584395,0.00082091417,0.0010159861,0.0011861201,0.00057748647,0.00055556116],"domain_scores_gemma":[0.99757487,0.00075943524,0.00028464213,0.0008423638,0.000084768195,0.00045393646],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006985526,0.0010760155,0.0038858606,0.00030363805,0.0004328658,0.00008630303,0.00016586237,0.00048966834,0.00018395997],"category_scores_gemma":[0.00006304378,0.00078484067,0.0013899752,0.000304362,0.00031614405,0.00016872486,0.00007635363,0.0006753697,0.000042339292],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021619364,0.0003199576,0.000024989138,0.00067496137,0.0017608438,0.0002762068,0.00043932933,5.6868464e-7,0.0000010252697,0.00016258107,0.0021421046,0.9920355],"study_design_scores_gemma":[0.0036938977,0.00032881717,0.0019815653,0.00955516,0.00014666464,0.0016918239,0.000114089664,0.0000057695834,0.000004402621,0.0000029949017,0.98165876,0.0008160532],"about_ca_topic_score_codex":0.000008389657,"about_ca_topic_score_gemma":5.6890605e-7,"teacher_disagreement_score":0.99121946,"about_ca_system_score_codex":0.00012539655,"about_ca_system_score_gemma":0.00037250156,"threshold_uncertainty_score":0.9994603},"labels":[],"label_agreement":null},{"id":"W1999956795","doi":"10.1016/s0828-282x(07)70229-5","title":"The impact of bleeding in patients with acute coronary syndromes: How to optimize the benefits of treatment and minimize the risk","year":2007,"lang":"en","type":"review","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"GlaxoSmithKline; Bristol-Myers Squibb","keywords":"Medicine; Antithrombotic; Acute coronary syndrome; Revascularization; Cardiology; Internal medicine; Coronary artery disease; Intensive care medicine; Surgery; Myocardial infarction","score_opus":0.028824233355433618,"score_gpt":0.2847910626053941,"score_spread":0.2559668292499605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999956795","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.115061775,0.883668,0.00003377073,0.00007590412,0.00011601507,0.00074351864,0.00022248954,9.1560577e-7,0.00007758395],"genre_scores_gemma":[0.13843125,0.8613164,0.00003040622,0.000013894468,0.00014502485,0.000010326681,0.000010941566,0.00002505446,0.000016700544],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.998402,0.00042981998,0.0005124341,0.00015081871,0.00016581074,0.00033912275],"domain_scores_gemma":[0.9979352,0.00054301263,0.00056641153,0.00039227918,0.00021613478,0.00034699118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008107989,0.0002939953,0.0021451206,0.00025202718,0.00011798268,0.000014873441,0.0002678633,0.00016863072,0.000003826989],"category_scores_gemma":[0.000104023995,0.00010563784,0.001297023,0.00025108494,0.00036598265,0.000029786439,0.000016215692,0.0003398444,3.2129228e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000827388,0.00000972647,0.05126474,0.00020904173,0.02384978,0.00029052005,0.0002542415,0.0017119184,5.2682996e-8,0.000007538735,0.00040139374,0.92117363],"study_design_scores_gemma":[0.0075432705,0.009565704,0.5392776,0.008521256,0.025674408,0.010615754,0.00092046586,0.0000028905313,8.232692e-7,0.000013808841,0.3974083,0.00045570108],"about_ca_topic_score_codex":0.00052487286,"about_ca_topic_score_gemma":0.00018527472,"teacher_disagreement_score":0.92071795,"about_ca_system_score_codex":0.00034244874,"about_ca_system_score_gemma":0.0019062603,"threshold_uncertainty_score":0.43077862},"labels":[],"label_agreement":null},{"id":"W2000402404","doi":"10.1111/jth.12832","title":"Multiple daily doses of acetyl‐salicylic acid (ASA) overcome reduced platelet response to once‐daily ASA after coronary artery bypass graft surgery: a pilot randomized controlled trial","year":2014,"lang":"en","type":"article","venue":"Journal of Thrombosis and Haemostasis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; Population Health Research Institute; McMaster University; Hamilton General Hospital","funders":"Hamilton Health Sciences","keywords":"Medicine; Platelet; Aspirin; Quartile; Coronary artery bypass surgery; Anesthesia; Artery; Thromboxane B2; Randomized controlled trial; Salicylic acid; Surgery; Internal medicine; Confidence interval","score_opus":0.032459861320467985,"score_gpt":0.2909051286743202,"score_spread":0.25844526735385226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000402404","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98982173,0.0042355526,0.0003139382,0.0027129645,0.0006147285,0.0021698885,0.00006788952,0.000029767873,0.000033551936],"genre_scores_gemma":[0.9938529,0.0035726475,0.00056586886,0.0012457413,0.0004927576,0.00013311197,0.000012437507,0.00006259016,0.00006193408],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9942614,0.001993053,0.0018801194,0.00039084177,0.001011166,0.0004634571],"domain_scores_gemma":[0.99481463,0.0028303317,0.00081249536,0.0005443979,0.00043568003,0.00056248484],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0058654444,0.00048139598,0.0051929983,0.0005438383,0.00014368472,0.0000845274,0.00019974289,0.00019613878,0.00023164816],"category_scores_gemma":[0.0026918266,0.00033392067,0.0027308355,0.00030928125,0.0003077711,0.00029484625,0.000076031254,0.0003438889,0.000008809207],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94846815,0.0008509546,0.0013785482,0.00008998898,0.007552681,0.00015271467,0.00045868827,0.000017366836,0.033440847,0.0000056421604,0.0021637487,0.0054206657],"study_design_scores_gemma":[0.94669867,0.004338279,0.03012085,0.0007076094,0.0036518814,0.00047862998,0.00027728075,0.000063989704,0.011151238,0.00005021387,0.0020472193,0.00041416055],"about_ca_topic_score_codex":0.000028938903,"about_ca_topic_score_gemma":0.000006777433,"teacher_disagreement_score":0.0287423,"about_ca_system_score_codex":0.00007963006,"about_ca_system_score_gemma":0.00030999843,"threshold_uncertainty_score":0.9999113},"labels":[],"label_agreement":null},{"id":"W2000976136","doi":"10.1016/j.jacc.2009.09.012","title":"Management of Platelet-Directed Pharmacotherapy in Patients With Atherosclerotic Coronary Artery Disease Undergoing Elective Endoscopic Gastrointestinal Procedures","year":2009,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Pharmacotherapy; Percutaneous coronary intervention; Coronary artery disease; Cardiology; Percutaneous; Disease; Interventional cardiology; Intensive care medicine; Stent; Antiplatelet drug; Internal medicine; Clopidogrel; Myocardial infarction","score_opus":0.006184808722343763,"score_gpt":0.23471758527060138,"score_spread":0.22853277654825763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000976136","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99819124,0.00062722625,0.00034499652,0.00018478738,0.000046232082,0.00049335137,0.00001943247,0.0000087286135,0.00008403152],"genre_scores_gemma":[0.9985908,0.00045685543,0.00067865837,0.00017733172,0.000057110286,0.0000040787827,0.0000015966627,0.000015737189,0.000017779941],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986012,0.0002455857,0.0004275051,0.00014610766,0.00036541533,0.00021418606],"domain_scores_gemma":[0.9988058,0.000084279505,0.0005916174,0.00021110842,0.00020745187,0.00009970314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015907887,0.00016535184,0.00083600543,0.00015280025,0.000031807856,0.0000018196143,0.00017317513,0.000016487369,0.0000058188402],"category_scores_gemma":[0.000042421023,0.00010609725,0.0003824386,0.0003917262,0.00027801757,0.000053816955,0.00001726974,0.00017827534,2.1787838e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02301706,0.0004756175,0.9634865,0.00013814449,0.0022966766,0.0012858256,0.000029867071,0.0019690448,0.0021288968,0.00002977935,0.00014605503,0.0049965302],"study_design_scores_gemma":[0.007193537,0.003510363,0.9863998,0.0009360776,0.00042929006,0.0006160464,0.00016537875,0.00001464325,0.0005418697,0.000088672925,0.000022647293,0.00008163774],"about_ca_topic_score_codex":9.1522526e-7,"about_ca_topic_score_gemma":6.181958e-7,"teacher_disagreement_score":0.022913335,"about_ca_system_score_codex":0.00008793474,"about_ca_system_score_gemma":0.0002917319,"threshold_uncertainty_score":0.43265203},"labels":[],"label_agreement":null},{"id":"W2001319345","doi":"10.1023/b:thro.0000024050.78728.35","title":"Aspirin Use Post-Acute Coronary Syndromes: Intolerance, Bleeding and Discontinuation","year":2003,"lang":"en","type":"article","venue":"Journal of Thrombosis and Thrombolysis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"F. Hoffmann-La Roche","keywords":"Medicine; Aspirin; Discontinuation; Internal medicine; Acute coronary syndrome; Surgery; Myocardial infarction","score_opus":0.030681691163893823,"score_gpt":0.28528469481546037,"score_spread":0.2546030036515666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001319345","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932428,0.00542159,0.00050385384,0.00035826766,0.00015252722,0.00013432404,0.000008899471,0.000012852329,0.00016491394],"genre_scores_gemma":[0.9834411,0.015013596,0.0010685424,0.00031216606,0.000068724046,0.0000023024538,0.000006296206,0.00002319984,0.000064035],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998689,0.000097760254,0.00045269713,0.00020248613,0.00036264354,0.00019543913],"domain_scores_gemma":[0.9990421,0.000073338655,0.00026718792,0.00017545906,0.00022839778,0.00021350793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042974055,0.00019822203,0.0008039203,0.00018688933,0.00013990581,0.00010123428,0.000053322194,0.00009193543,0.00010367526],"category_scores_gemma":[0.00007295631,0.00014943194,0.00039542528,0.00019862593,0.0001376427,0.00063590816,0.000024524807,0.00019250262,0.000002176229],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000825551,0.0015748278,0.76338893,0.00039024712,0.029078979,0.00067136966,0.0025241573,0.000047841895,0.1370074,0.003194292,0.00082647434,0.060469933],"study_design_scores_gemma":[0.0029506893,0.0011269876,0.9824719,0.00040500058,0.0045561315,0.00240576,0.000995831,0.000049283066,0.0019243272,0.00020949788,0.0026426865,0.0002619209],"about_ca_topic_score_codex":0.000009800989,"about_ca_topic_score_gemma":0.000001920937,"teacher_disagreement_score":0.21908295,"about_ca_system_score_codex":0.000031487893,"about_ca_system_score_gemma":0.000058463826,"threshold_uncertainty_score":0.60936576},"labels":[],"label_agreement":null},{"id":"W2001895422","doi":"10.1016/s0735-1097(13)60006-6","title":"A PHARMACOGENOMIC APPROACH TO ANTIPLATELET THERAPY IN STEMI PATIENTS: REASSESSMENT OF ANTI-PLATELET THERAPY USING AN INDIVIDUALIZED STRATEGY IN PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION (THE RAPID STEMI STUDY)","year":2013,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Internal medicine; Cardiology; Myocardial infarction; Prasugrel; Platelet aggregation inhibitor; Pharmacogenomics; Clopidogrel; Platelet; Pharmacology","score_opus":0.02283141932588321,"score_gpt":0.2780783504130753,"score_spread":0.2552469310871921,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001895422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963768,0.00023600302,0.000111374684,0.00006548098,0.00013591832,0.0029478827,0.00006965666,0.00000533538,0.000051525956],"genre_scores_gemma":[0.9988934,0.000525285,0.00015512946,0.00020795091,0.00012263698,0.00004118885,0.000016357832,0.000036602192,0.0000014940291],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957535,0.0018327661,0.0010583663,0.0002800211,0.00076473685,0.00031059334],"domain_scores_gemma":[0.99741226,0.00010054361,0.0012524244,0.0004825989,0.00064505014,0.00010712301],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012324896,0.0002873177,0.0016045272,0.00046028357,0.00006945344,0.000013451446,0.00037619745,0.000075509866,0.000010816327],"category_scores_gemma":[0.00003208931,0.00016391082,0.0004053213,0.0010296358,0.00026511634,0.00024640263,0.000050412862,0.00035413203,3.1176234e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008007682,0.0016286038,0.94328153,0.000018060091,0.002746354,0.000014250384,0.0004292014,0.011133265,0.0030146993,0.0000027741999,0.000071838534,0.02965173],"study_design_scores_gemma":[0.019359728,0.0064211925,0.9701211,0.00006751027,0.00019255736,0.00006511667,0.0029679665,0.00007896523,0.00039241466,0.000008859706,0.00015635087,0.00016828184],"about_ca_topic_score_codex":0.00013420342,"about_ca_topic_score_gemma":0.0000019030499,"teacher_disagreement_score":0.029483447,"about_ca_system_score_codex":0.0001708193,"about_ca_system_score_gemma":0.00032557637,"threshold_uncertainty_score":0.66840893},"labels":[],"label_agreement":null},{"id":"W2001942881","doi":"10.1161/circinterventions.112.000063","title":"Effect on Platelet Reactivity From a Prasugrel Loading Dose After a Clopidogrel Loading Dose Compared With a Prasugrel Loading Dose Alone","year":2013,"lang":"en","type":"article","venue":"Circulation Cardiovascular Interventions","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada); Vancouver General Hospital","funders":"","keywords":"Prasugrel; Clopidogrel; Medicine; P2Y12; Loading dose; Maintenance dose; Thienopyridine; Acute coronary syndrome; Placebo; Internal medicine; Anesthesia; Aspirin; Myocardial infarction","score_opus":0.022969055206718225,"score_gpt":0.27368717203194914,"score_spread":0.25071811682523093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001942881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96442306,0.012897353,0.017013986,0.00013752893,0.0005380511,0.003674755,0.00009924243,0.00050651864,0.00070953154],"genre_scores_gemma":[0.9963346,0.00020178201,0.00053609937,0.00019875988,0.0006372378,0.0011599903,0.000599969,0.00020279258,0.00012877757],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.993773,0.0011410007,0.0010527537,0.0015293472,0.0015912228,0.00091267895],"domain_scores_gemma":[0.9960341,0.00038378278,0.0004004541,0.0021001508,0.00046428829,0.0006172179],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014784494,0.0009199279,0.002018805,0.00064233894,0.00049617805,0.00035473035,0.00030619054,0.0004312683,0.0007478283],"category_scores_gemma":[0.00026782652,0.00081725145,0.006178567,0.00091253,0.000265849,0.00093555986,0.00013382954,0.000889158,0.0008142181],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019156279,0.0077273613,0.1899373,0.0066838535,0.15765123,0.007158208,0.0044884714,0.025912495,0.05891901,0.00037025294,0.0024667825,0.51952875],"study_design_scores_gemma":[0.045615174,0.0026595935,0.88719106,0.014619509,0.01599538,0.0018852074,0.00067703694,0.0071075344,0.013435321,0.00039787812,0.007299711,0.0031166056],"about_ca_topic_score_codex":0.00070690544,"about_ca_topic_score_gemma":0.00003416691,"teacher_disagreement_score":0.69725376,"about_ca_system_score_codex":0.0005752559,"about_ca_system_score_gemma":0.00014510324,"threshold_uncertainty_score":0.99996376},"labels":[],"label_agreement":null},{"id":"W2002373284","doi":"10.1503/cmaj.1060153","title":"Atherothrombotic events and clopidogrel therapy","year":2007,"lang":"en","type":"letter","venue":"Canadian Medical Association Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Clopidogrel; Medicine; Internal medicine; Cardiology; Bioinformatics; Myocardial infarction; Biology","score_opus":0.010805064522831958,"score_gpt":0.24451241475473187,"score_spread":0.23370735023189992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002373284","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02908697,0.012374962,0.00007978543,0.95466816,0.0013970503,0.00037121822,0.0000379687,0.00003685985,0.0019470259],"genre_scores_gemma":[0.0027826384,0.010505087,0.000048734444,0.9673718,0.016797606,0.000005313958,0.00009076406,0.00006729787,0.0023307374],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960225,0.00024250905,0.00044517036,0.0002577093,0.0023270021,0.00070507627],"domain_scores_gemma":[0.9975869,0.00013944766,0.00023312769,0.00018263953,0.00031371939,0.0015441527],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0015840736,0.00027152456,0.0006239256,0.0003115249,0.00023859018,0.00006235927,0.00016320954,0.002086971,0.0040834057],"category_scores_gemma":[0.00039589003,0.00022879452,0.00048649657,0.00016476106,0.0000686372,0.00006156066,0.000009927352,0.003921634,0.00014538139],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017448165,0.000016135826,0.017385693,0.000028693266,0.0013948567,0.006435534,0.000055435205,6.564499e-8,5.7681024e-7,0.000002943118,0.9071494,0.067513235],"study_design_scores_gemma":[0.0020884853,0.00010021616,0.020464497,0.00025726832,0.00017345708,0.0033269895,0.00003359728,0.000004155617,0.0000016783019,0.000078294484,0.973254,0.00021732025],"about_ca_topic_score_codex":0.0005105875,"about_ca_topic_score_gemma":0.00048419702,"teacher_disagreement_score":0.06729592,"about_ca_system_score_codex":0.0007863141,"about_ca_system_score_gemma":0.0030679055,"threshold_uncertainty_score":0.9992085},"labels":[],"label_agreement":null},{"id":"W2003053831","doi":"10.1139/y02-111","title":"The influence of acetaldehyde and glycosaminoglycans upon Factor Xa- and Factor X-deficient plasma","year":2002,"lang":"en","type":"article","venue":"Canadian Journal of Physiology and Pharmacology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Partial thromboplastin time; Glycosaminoglycan; Chemistry; Heparin; Clotting time; Internal medicine; Biochemistry; Pharmacology; Coagulation; Medicine","score_opus":0.01484250158239058,"score_gpt":0.24641154821364178,"score_spread":0.2315690466312512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003053831","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9836956,0.015337837,0.0000019710346,0.0006071049,0.00018324074,0.000107472304,0.000036401307,0.0000021708283,0.00002815132],"genre_scores_gemma":[0.99335706,0.006050499,0.000008651794,0.00044014057,0.00009585709,0.0000016616552,9.511133e-7,0.0000067782257,0.0000383822],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9992606,0.00011381207,0.00021498377,0.00011889861,0.000061514824,0.00023019018],"domain_scores_gemma":[0.99915713,0.00015638882,0.00012780013,0.00007248174,0.0000877154,0.00039849698],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008802087,0.0001135306,0.0003314202,0.000092087204,0.00017320274,0.0000066838475,0.00007091313,0.000094348805,0.00029596782],"category_scores_gemma":[0.000030336014,0.00007665128,0.000082554674,0.000056680088,0.00058552803,0.00005671858,0.00001273606,0.00022715551,0.0000012464362],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000960985,0.00007669445,0.03208706,0.00026668247,0.0017064534,0.0003845487,0.0021519007,0.00014584024,0.9298504,0.00021378005,0.0010331423,0.031122504],"study_design_scores_gemma":[0.0056230873,0.0017112261,0.907814,0.00007490408,0.0006209024,0.0024837048,0.0003118893,0.00029696102,0.050939135,0.00024344136,0.029633082,0.00024766664],"about_ca_topic_score_codex":0.000111093505,"about_ca_topic_score_gemma":0.00017000081,"teacher_disagreement_score":0.87891126,"about_ca_system_score_codex":0.000017399883,"about_ca_system_score_gemma":0.00012998206,"threshold_uncertainty_score":0.32406402},"labels":[],"label_agreement":null},{"id":"W2003721825","doi":"10.1016/s0735-1097(13)61887-2","title":"IMPACT OF LOW–PROFILE SHEATHS ON VASCULAR COMPLICATION AND BLEEDING DURING TRANSFEMORAL TRANSCATHETER AORTIC VALVE REPLACEMENT","year":2013,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Complication; Cardiology; Valve replacement; Internal medicine; Surgery; Stenosis","score_opus":0.009352105823733147,"score_gpt":0.25952330876918206,"score_spread":0.2501712029454489,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003721825","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979719,0.0007922267,0.00038974974,0.00023413223,0.00006176073,0.0003875149,0.00002530141,0.000004388657,0.00013300772],"genre_scores_gemma":[0.999053,0.0005987433,0.00013817709,0.00004992128,0.00012141207,0.000007856919,0.0000010644072,0.000015682948,0.000014118618],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998737,0.00019958487,0.00046836093,0.00013280766,0.00029136208,0.00017092953],"domain_scores_gemma":[0.9989522,0.00006528542,0.00036649086,0.00031376744,0.0002022948,0.00009995002],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029741306,0.00013908159,0.0009625391,0.0001241686,0.00004732974,0.0000029286166,0.00012860009,0.000040149338,0.000028957584],"category_scores_gemma":[0.000028229295,0.0000847517,0.0022051067,0.00018116602,0.00032687513,0.000055991095,0.00001480628,0.00016169761,9.594249e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0072462466,0.0004398211,0.5610242,0.00048750537,0.023945028,0.000032820706,0.0004167564,0.0036884663,0.39299214,0.00007860813,0.0007087207,0.008939732],"study_design_scores_gemma":[0.0027607786,0.0028168173,0.98344296,0.00020737725,0.0010278908,0.00097127934,0.00031047052,0.00007368738,0.008205166,0.000043773856,0.00004224237,0.00009757597],"about_ca_topic_score_codex":0.000015882444,"about_ca_topic_score_gemma":1.0929736e-7,"teacher_disagreement_score":0.42241877,"about_ca_system_score_codex":0.000061294624,"about_ca_system_score_gemma":0.000085285654,"threshold_uncertainty_score":0.34560743},"labels":[],"label_agreement":null},{"id":"W2004495538","doi":"10.1016/j.cjca.2010.12.021","title":"Economic Evaluation of Clopidogrel Plus Aspirin for Secondary Prevention of Cardiovascular Events in Canada for Patients With Established Cardiovascular Disease: Results From the CHARISMA Trial","year":2011,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Bristol-Myers Squibb (Canada); McGill University; Université Laval","funders":"Sanofi","keywords":"Clopidogrel; Medicine; Aspirin; Life expectancy; Myocardial infarction; Internal medicine; Quality-adjusted life year; Disease; Stroke (engine); Cost effectiveness; Cardiology; Population; Environmental health","score_opus":0.033560448409573784,"score_gpt":0.2341714364903187,"score_spread":0.20061098808074493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004495538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9822899,0.011200701,0.0017174539,0.000036308626,0.0008599667,0.002581694,0.0012057069,0.0000016692537,0.0001066084],"genre_scores_gemma":[0.9986962,0.00018324745,0.00013852409,0.00002031038,0.0005254253,0.000055639324,0.00034895528,0.000027802358,0.000003895883],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99745774,0.0005558072,0.0008733238,0.00028741462,0.00051858823,0.00030709922],"domain_scores_gemma":[0.9974911,0.00017152347,0.00054131914,0.00065611355,0.0008202425,0.00031966576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027184281,0.00019208803,0.0013089534,0.0001776861,0.000058251477,0.0000038338553,0.00024416664,0.00011442989,0.0000144705355],"category_scores_gemma":[0.0005246837,0.00014543012,0.0018489067,0.000102976,0.00010710513,0.000117661104,0.0000105196505,0.00016247826,2.0189476e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.21961692,0.00011107972,0.2691152,0.00047711868,0.09491048,0.00011957034,0.0015082364,0.17389132,0.0000047960184,0.00007547553,0.0026957644,0.23747402],"study_design_scores_gemma":[0.18931374,0.0017714151,0.7727307,0.0003960061,0.013902408,0.000023778503,0.0006047167,0.00029249422,0.000078214915,0.00054637616,0.020043973,0.00029618453],"about_ca_topic_score_codex":0.30827203,"about_ca_topic_score_gemma":0.2120865,"teacher_disagreement_score":0.5036155,"about_ca_system_score_codex":0.00080429006,"about_ca_system_score_gemma":0.01715303,"threshold_uncertainty_score":0.9884188},"labels":[],"label_agreement":null},{"id":"W2004742061","doi":"10.2147/ceor.s51052","title":"Cost-effectiveness of ticagrelor versus clopidogrel in patients with acute coronary syndromes in Canada","year":2014,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital; University of Toronto; University Health Network; St. Paul's Hospital; McMaster University; Programs for Assessment of Technology in Health Research Institute; St. Joseph’s Healthcare Hamilton; AstraZeneca (Canada); University of Alberta Hospital; Alberta Hospital Edmonton","funders":"University of Toronto; Heart and Stroke Foundation of Canada","keywords":"Ticagrelor; Clopidogrel; Medicine; Acute coronary syndrome; Cardiology; Internal medicine; Aspirin; Intensive care medicine; Myocardial infarction","score_opus":0.06132080415009829,"score_gpt":0.37724270325244,"score_spread":0.31592189910234175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004742061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99864805,0.00017918386,0.000004455324,0.00007959027,0.00010793967,0.0007022313,0.000023158766,0.0000030762296,0.0002522908],"genre_scores_gemma":[0.9993172,0.00047351944,0.00003505583,0.000058558722,0.0000092919145,0.000032201027,0.000032781805,0.0000166563,0.000024679031],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99865675,0.00025581542,0.00030855724,0.00027159983,0.00021210052,0.0002951659],"domain_scores_gemma":[0.99807775,0.00137438,0.000044553795,0.0002854724,0.0000834623,0.00013440492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011154517,0.00011385889,0.0006105927,0.00015803723,0.000029619303,0.000008802125,0.00010045036,0.000062574065,0.000023947317],"category_scores_gemma":[0.00013050184,0.000089628185,0.00007766444,0.0001232484,0.00014680342,0.000053937154,0.0000674832,0.00026079043,0.0000037443785],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052195187,0.00012428686,0.9574733,0.00009956524,0.0003218888,0.000042072665,0.000019435838,0.000029676377,6.2508855e-7,0.00013944661,0.00000850662,0.036521703],"study_design_scores_gemma":[0.014834788,0.0006555259,0.98357713,0.000099686324,0.000036380996,0.0000031906764,0.00010674931,0.00018066753,0.000015476982,0.000047797384,0.00034592082,0.000096691045],"about_ca_topic_score_codex":0.034961037,"about_ca_topic_score_gemma":0.07531723,"teacher_disagreement_score":0.04035619,"about_ca_system_score_codex":0.00027403948,"about_ca_system_score_gemma":0.0006998475,"threshold_uncertainty_score":0.97146523},"labels":[],"label_agreement":null},{"id":"W2005011247","doi":"10.1016/s0828-282x(09)70527-6","title":"Dual antiplatelet therapy in patients requiring urgent coronary artery bypass grafting surgery: A position statement of the Canadian Cardiovascular Society","year":2009,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of Alberta; William Osler Health System; Sudbury Regional Hospital; University of Toronto; Sunnybrook Hospital; McMaster University; St. Michael's Hospital","funders":"Canadian Cardiovascular Society","keywords":"Medicine; Clopidogrel; Discontinuation; Acute coronary syndrome; Percutaneous coronary intervention; Cardiology; Myocardial infarction; Cardiac surgery; Internal medicine; Surgery","score_opus":0.017039230596815166,"score_gpt":0.22144352182633914,"score_spread":0.20440429122952397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005011247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922118,0.005477667,0.00007506074,0.0010556872,0.0005356827,0.00036466654,0.000040579227,0.0000042768474,0.00023455778],"genre_scores_gemma":[0.9980544,0.00072637846,0.000028950872,0.00079515314,0.00033381506,0.000002922376,0.00003369299,0.000019557063,0.0000051189195],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977276,0.00038595,0.00070466916,0.0002025,0.00041400865,0.0005653067],"domain_scores_gemma":[0.9983033,0.00003830497,0.00023187866,0.00036897618,0.0003437331,0.0007138222],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013676641,0.00020374781,0.00096930604,0.0003283417,0.00019120696,0.000019173032,0.00014448854,0.00018439263,0.000016381264],"category_scores_gemma":[0.00008562929,0.00016001477,0.001974684,0.00029528918,0.00016416413,0.000117154246,0.000008125021,0.00036290154,0.0000011386209],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046061823,0.000029100427,0.90749,0.000032193526,0.0065216487,0.0022324473,0.00065139553,0.0040501445,0.00022110567,0.000033091954,0.005143285,0.07313498],"study_design_scores_gemma":[0.0031359992,0.00039756554,0.9751201,0.00018286644,0.00030294457,0.001372828,0.00018157421,0.000009045064,0.00022554777,0.00006800467,0.01882813,0.00017536183],"about_ca_topic_score_codex":0.0073762857,"about_ca_topic_score_gemma":0.008349067,"teacher_disagreement_score":0.07295962,"about_ca_system_score_codex":0.0006865255,"about_ca_system_score_gemma":0.003543574,"threshold_uncertainty_score":0.99923366},"labels":[],"label_agreement":null},{"id":"W2005535293","doi":"10.1097/00005344-200401000-00019","title":"Effects of High Ticlopidine Doses on Platelet Function in Acute Coronary Syndrome Patients","year":2003,"lang":"en","type":"article","venue":"Journal of Cardiovascular Pharmacology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital du Sacré-Cœur de Montréal","funders":"","keywords":"Ticlopidine; Medicine; Platelet aggregation; Platelet; Percutaneous coronary intervention; Platelet activation; Acute coronary syndrome; Internal medicine; Platelet aggregation inhibitor; Coronary stent; Pharmacology; Cardiology; Anesthesia; Clopidogrel; Aspirin; Stent; Myocardial infarction","score_opus":0.005567818894684034,"score_gpt":0.23451594858728042,"score_spread":0.2289481296925964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005535293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97897243,0.018579643,0.0003554287,0.000032113294,0.0014567457,0.00049993605,0.0000044905414,0.0000116272095,0.000087583765],"genre_scores_gemma":[0.992821,0.006565365,0.00009075348,0.00032791542,0.00011951736,0.000012172909,0.000007637297,0.000032756863,0.000022919525],"study_design_codex":"meta_analysis","study_design_gemma":"observational","domain_scores_codex":[0.9975651,0.00062156573,0.000598063,0.00021816623,0.00071046053,0.00028662573],"domain_scores_gemma":[0.99893457,0.00015269217,0.00025100473,0.00022236985,0.00026799942,0.00017136571],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007241353,0.00022942189,0.0013001806,0.00038157316,0.00003636741,0.0000046925584,0.000109679415,0.00015819371,0.00011434375],"category_scores_gemma":[0.00008278271,0.00018875572,0.0016774484,0.0003104716,0.00008619004,0.00012881459,0.000018513247,0.0003919949,0.00001210923],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.061735578,0.016597277,0.11680134,0.004112386,0.3676513,0.111877106,0.0005024908,0.04298689,0.0500818,0.0006513616,0.007661239,0.21934122],"study_design_scores_gemma":[0.057436205,0.007736565,0.7832797,0.00039616122,0.014957842,0.0075869826,0.000033564465,0.000012749326,0.10679595,0.00017032953,0.02121384,0.0003800659],"about_ca_topic_score_codex":0.0000044060803,"about_ca_topic_score_gemma":9.1624585e-8,"teacher_disagreement_score":0.6664784,"about_ca_system_score_codex":0.000118599164,"about_ca_system_score_gemma":0.00013689185,"threshold_uncertainty_score":0.7697235},"labels":[],"label_agreement":null},{"id":"W2005742456","doi":"10.1007/s11936-013-0241-x","title":"Combination Aspirin and Clopidogrel for Secondary Prevention of Ischemic Stroke","year":2013,"lang":"en","type":"article","venue":"Current Treatment Options in Cardiovascular Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute of Neurological Disorders and Stroke","keywords":"Clopidogrel; Medicine; Aspirin; Antithrombotic; Stroke (engine); Minor stroke; Ischemic stroke; Cardiology; Clinical trial; Internal medicine; Secondary prevention; Platelet aggregation inhibitor; Intensive care medicine; Ischemia","score_opus":0.03191875644258772,"score_gpt":0.3060267999803999,"score_spread":0.27410804353781215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005742456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79523396,0.19569546,0.005068405,0.00023510397,0.00030578658,0.0025550069,0.000028530554,0.000041930718,0.000835821],"genre_scores_gemma":[0.9783812,0.019095805,0.00074614654,0.000016698606,0.00020578707,0.0008182706,0.00042665936,0.000026633272,0.00028279098],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99859875,0.000092368,0.00041118666,0.0003589531,0.00033077458,0.00020796512],"domain_scores_gemma":[0.9990875,0.000062204555,0.0000805088,0.0004721631,0.00017910692,0.00011853127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003749671,0.00022176717,0.0008027846,0.0002752713,0.000058181646,0.000007265289,0.00005086478,0.000088708126,0.00008478333],"category_scores_gemma":[0.000050422444,0.00017388751,0.00082573574,0.00019879045,0.00017876817,0.00013411089,0.00001854789,0.00010758286,0.000006082178],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011287894,0.0008144253,0.010229697,0.00058783125,0.0031595067,0.0000054936763,0.0001970959,0.000047515583,0.0010605638,0.00032697633,0.00061695,0.9828411],"study_design_scores_gemma":[0.09626252,0.006735572,0.5706922,0.0035778012,0.011634966,0.00035713558,0.0017049141,0.0016230375,0.004379341,0.0012554608,0.30092123,0.0008558195],"about_ca_topic_score_codex":0.00004399312,"about_ca_topic_score_gemma":0.0000023699088,"teacher_disagreement_score":0.9819853,"about_ca_system_score_codex":0.00012897085,"about_ca_system_score_gemma":0.000087158405,"threshold_uncertainty_score":0.70909274},"labels":[],"label_agreement":null},{"id":"W2006871457","doi":"10.1016/j.jpeds.2005.05.006","title":"Clopidogrel Use in Children","year":2005,"lang":"en","type":"article","venue":"The Journal of Pediatrics","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children; SickKids Foundation","funders":"","keywords":"Medicine; Clopidogrel; Dose; Regimen; Pediatrics; Adverse effect; Population; Retrospective cohort study; Aspirin; Surgery; Internal medicine","score_opus":0.010640256308922826,"score_gpt":0.2389949447298146,"score_spread":0.2283546884208918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006871457","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874056,0.011639806,0.00023003267,0.0004911454,0.00006340336,0.00008414594,0.0000017769254,0.00000550203,0.00007856585],"genre_scores_gemma":[0.98540586,0.011922676,0.00035702993,0.00046960948,0.0017325133,2.1118068e-7,0.0000010660341,0.000009914269,0.000101098005],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992154,0.000074473755,0.00025519347,0.00004012119,0.00029522635,0.000119554024],"domain_scores_gemma":[0.9995032,0.000075044816,0.00012039457,0.00014795733,0.000076432785,0.00007699555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005928942,0.00006751616,0.00018825439,0.000119427306,0.000026854017,0.000009647233,0.000103890816,0.00004214675,0.00003005789],"category_scores_gemma":[0.00009696551,0.000039752686,0.0001993743,0.00020577994,0.000027211496,0.00013011716,0.000014293645,0.0002500654,0.000016861619],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045695674,0.00018595804,0.97261816,0.0000145675995,0.00007770595,0.00004992153,0.00019663916,0.00057254353,0.00004691685,0.00002696166,0.003777447,0.02197621],"study_design_scores_gemma":[0.0028447893,0.00018142264,0.9892345,0.000017478511,0.0007423936,0.0017397219,0.000067339,0.000012903825,0.00011319789,0.000043677435,0.0049221776,0.000080370104],"about_ca_topic_score_codex":0.000007544919,"about_ca_topic_score_gemma":0.0000023551397,"teacher_disagreement_score":0.021895839,"about_ca_system_score_codex":0.000032137614,"about_ca_system_score_gemma":0.000084221836,"threshold_uncertainty_score":0.16210675},"labels":[],"label_agreement":null},{"id":"W2007385256","doi":"10.1182/blood-2014-05-574491","title":"Oxidized LDL activates blood platelets through CD36/NOX2–mediated inhibition of the cGMP/protein kinase G signaling cascade","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":171,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"British Heart Foundation","keywords":"CD36; Platelet activation; NADPH oxidase; Protein kinase C; Platelet; Chemistry; Signal transduction; Cell biology; Kinase; Reactive oxygen species; Internal medicine; Endocrinology; Biochemistry; Biology; Medicine; Receptor","score_opus":0.021207337023983402,"score_gpt":0.23848051120313346,"score_spread":0.21727317417915007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007385256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927637,0.0051718624,0.00006931628,0.0003235432,0.00009066091,0.00077160477,0.00003196706,0.00012066411,0.0006567101],"genre_scores_gemma":[0.9987032,0.00016519935,0.00037041618,0.00026393755,0.0002292795,0.00004689792,0.00006128912,0.00004946569,0.000110341214],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981031,0.00020021654,0.00039366612,0.00033657555,0.0006248841,0.00034157594],"domain_scores_gemma":[0.9988456,0.0000805417,0.00019811823,0.00053856795,0.00014555687,0.00019166114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029713666,0.00026650334,0.0005371105,0.00005411977,0.00010728499,0.000019521483,0.00014241357,0.0002081198,0.00008594382],"category_scores_gemma":[0.0002912728,0.00018759213,0.0005067272,0.0003908921,0.00017845842,0.0001588424,0.000068198075,0.00028264767,0.000021696618],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006325199,0.0013781993,0.0009447561,0.00014722208,0.0013265535,0.00038514665,0.00065415725,0.000021986476,0.9937005,0.00012827774,0.00007515769,0.00060551777],"study_design_scores_gemma":[0.01534053,0.00028905604,0.00058284047,0.00046893145,0.0012075454,0.0002470328,0.00037796528,0.000011618072,0.98008025,0.00042371912,0.000751413,0.00021909091],"about_ca_topic_score_codex":0.000065460736,"about_ca_topic_score_gemma":0.0000019452448,"teacher_disagreement_score":0.0147080105,"about_ca_system_score_codex":0.000019993608,"about_ca_system_score_gemma":0.0002263589,"threshold_uncertainty_score":0.76497847},"labels":[],"label_agreement":null},{"id":"W2009101920","doi":"10.3171/2012.8.jns12185","title":"Incidence of cerebral ischemic events after discontinuation of clopidogrel in patients with intracranial aneurysms treated with stent-assisted techniques","year":2012,"lang":"en","type":"article","venue":"Journal of neurosurgery","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Medicine; Clopidogrel; Discontinuation; Aspirin; Stent; Surgery; Stroke (engine); Cerebral infarction; Ticlopidine; Incidence (geometry); Aneurysm; Embolization; Anesthesia; Internal medicine; Ischemia","score_opus":0.00675319945593228,"score_gpt":0.21761755223201795,"score_spread":0.21086435277608567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009101920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99934095,0.00025721037,0.000069674534,0.00002163745,0.000063049476,0.00021379955,0.000008197845,0.0000073457168,0.000018140185],"genre_scores_gemma":[0.99955726,0.00005740305,0.00021828274,0.00004892054,0.000076253324,0.000004698977,0.0000070720885,0.000021203376,0.000008897484],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984917,0.00011142725,0.0005782933,0.000099129575,0.00054243795,0.00017699786],"domain_scores_gemma":[0.9988449,0.00004906166,0.0006005341,0.00016152738,0.00024194445,0.00010200969],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002742062,0.00014069997,0.00053993665,0.00027531604,0.00001111173,0.000004081767,0.000058347778,0.00005913082,0.000016518707],"category_scores_gemma":[0.000053432224,0.00009011402,0.00021075961,0.00031820848,0.00007336358,0.00033204813,0.000012925528,0.0001717205,2.70939e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008478608,0.0010361469,0.97675675,0.00007333096,0.00013276287,0.00012824565,0.00006415562,0.0000021817282,0.006061788,3.2802694e-7,0.000020556621,0.0072451355],"study_design_scores_gemma":[0.0024451574,0.0009699909,0.980052,0.0006893283,0.0002465689,0.0003000299,0.000023901895,0.0000018861228,0.015157159,6.950425e-7,0.000027231703,0.00008606936],"about_ca_topic_score_codex":0.000006526845,"about_ca_topic_score_gemma":0.000001033102,"teacher_disagreement_score":0.009095372,"about_ca_system_score_codex":0.000027369995,"about_ca_system_score_gemma":0.000069708236,"threshold_uncertainty_score":0.36747432},"labels":[],"label_agreement":null},{"id":"W2009376900","doi":"10.1159/000051041","title":"Hirulog-Like Peptide Reduces Balloon Catheter Injury Induced Neointima Formation in Rat Carotid Artery without Increase in Bleeding Tendency","year":2001,"lang":"en","type":"article","venue":"Journal of Vascular Research","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Fondation pour la Recherche Médicale; Manitoba Medical Service Foundation; Medical Research Council Canada; Heart and Stroke Foundation of Canada","keywords":"Neointima; Carotid arteries; Balloon; Balloon catheter; Medicine; Artery; Catheter; Cardiology; Internal medicine; Surgery; Stent; Restenosis","score_opus":0.044073576268715525,"score_gpt":0.34041096597090964,"score_spread":0.29633738970219414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009376900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960588,0.0022551685,0.000075821175,0.00030913224,0.00013890355,0.00053643336,0.0000010107161,0.000012945055,0.00061174214],"genre_scores_gemma":[0.9948564,0.0043250667,0.00020187948,0.00007654164,0.0003664178,0.000021218582,0.00000755159,0.000036307523,0.000108584245],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958406,0.00080357684,0.0008247268,0.00026282354,0.0016615448,0.0006066909],"domain_scores_gemma":[0.9985036,0.000091883005,0.00017462773,0.00037645997,0.0005362441,0.0003171603],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0051712077,0.0002100731,0.0006779739,0.0015739364,0.00010526786,0.000080196995,0.0002707269,0.00018048254,0.00011801284],"category_scores_gemma":[0.0003973405,0.00016967393,0.00062430376,0.00093798345,0.00009882441,0.0007845641,0.00008170336,0.0012953338,0.000026636111],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064811436,0.0028059683,0.53814584,0.0005595197,0.0016287959,0.007145921,0.0038927246,0.00019612808,0.37381536,0.000039443283,0.0012754174,0.06401377],"study_design_scores_gemma":[0.039106894,0.008896912,0.76278716,0.009671266,0.0009629336,0.019940268,0.015158215,0.0015215364,0.1313099,0.00116044,0.007909941,0.0015745376],"about_ca_topic_score_codex":0.00016531319,"about_ca_topic_score_gemma":0.00005208066,"teacher_disagreement_score":0.24250546,"about_ca_system_score_codex":0.00039359892,"about_ca_system_score_gemma":0.0003470873,"threshold_uncertainty_score":0.6919102},"labels":[],"label_agreement":null},{"id":"W2009662643","doi":"10.1016/j.cjca.2011.07.251","title":"329 First experience with the guideliner mother in child catheter for the treatment of complex coronary lesions","year":2011,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Alberta Hospital Edmonton","funders":"","keywords":"Medicine; Catheter; Internal medicine; Cardiology; Pediatrics; Radiology","score_opus":0.05976441093751458,"score_gpt":0.26352505348603844,"score_spread":0.20376064254852386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009662643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97378755,0.013193158,0.006081488,0.0031041815,0.00019824518,0.0006929984,0.00004555483,0.0000031458583,0.0028937045],"genre_scores_gemma":[0.99854547,0.0006091749,0.00012201912,0.00037431144,0.00025964805,0.000023151531,0.000002160969,0.000012318486,0.000051725554],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994083,0.000060217284,0.00020686678,0.00007857322,0.000070148,0.00017589299],"domain_scores_gemma":[0.9993536,0.00007307111,0.000081273836,0.0002408771,0.00011407461,0.00013708966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001463914,0.00009282378,0.00035126432,0.00006642272,0.00010326656,0.0000024774529,0.00013043254,0.000046480072,0.000062362946],"category_scores_gemma":[0.00001408575,0.000040902414,0.00035642102,0.000059500682,0.00032377883,0.000020274,0.0000024654578,0.000067209796,8.300846e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008211968,0.0002574148,0.75961876,0.000061007402,0.011945864,0.0029579184,0.038183667,0.010526878,0.00018163073,0.0012179062,0.02577128,0.14106567],"study_design_scores_gemma":[0.0030601996,0.0025258951,0.477316,0.000058927468,0.0004968243,0.002961742,0.002905687,0.000044579912,0.000103848135,0.00003629003,0.51039314,0.000096838674],"about_ca_topic_score_codex":0.000981628,"about_ca_topic_score_gemma":0.002894095,"teacher_disagreement_score":0.48462188,"about_ca_system_score_codex":0.000054234304,"about_ca_system_score_gemma":0.0002630376,"threshold_uncertainty_score":0.16679521},"labels":[],"label_agreement":null},{"id":"W2010691204","doi":"10.1056/nejmsa0803410","title":"Cardiovascular Outcomes after a Change in Prescription Policy for Clopidogrel","year":2008,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; McGill University Health Centre; Sunnybrook Health Science Centre; Statistics Canada; Institute for Clinical Evaluative Sciences; Dalhousie University; University Health Network; University of Toronto; Health Sciences Centre","funders":"","keywords":"Medicine; Clopidogrel; Percutaneous coronary intervention; Conventional PCI; Myocardial infarction; Ticagrelor; Population; Medical prescription; Aspirin; Internal medicine; Acute coronary syndrome; Emergency medicine; Cardiology","score_opus":0.03710606548780162,"score_gpt":0.2958151872061464,"score_spread":0.2587091217183448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010691204","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.940969,0.05012243,0.001694882,0.0060919067,0.0004546491,0.00049333717,0.0000037238597,0.000013702395,0.00015636718],"genre_scores_gemma":[0.9818894,0.007667849,0.0003716677,0.001603081,0.008194044,0.000020432688,0.000005285733,0.00002276676,0.00022546198],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99852836,0.00008549892,0.000448424,0.00013545717,0.00057652633,0.00022572125],"domain_scores_gemma":[0.99915075,0.00006743903,0.00011312964,0.00024067248,0.00016101373,0.00026697878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077190617,0.00016104714,0.00090229936,0.00039652924,0.000033258395,0.000002992451,0.000077736964,0.00006806268,0.000057018566],"category_scores_gemma":[0.000347,0.00010241492,0.0007170955,0.00020810722,0.00008804639,0.00012840085,0.000010057558,0.00019934418,0.0000021394555],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0075001186,0.00023426698,0.46112055,0.00022515834,0.0028783695,0.003853231,0.0045055104,0.000037397785,0.00018678678,0.00009648939,0.0024552182,0.5169069],"study_design_scores_gemma":[0.100773394,0.0011556727,0.6874485,0.00051880605,0.0007793551,0.0057707313,0.000089046705,0.000020203088,0.0000465665,0.00023130249,0.20303476,0.0001316475],"about_ca_topic_score_codex":0.00026455935,"about_ca_topic_score_gemma":0.000015279047,"teacher_disagreement_score":0.51677525,"about_ca_system_score_codex":0.00006471471,"about_ca_system_score_gemma":0.00019529459,"threshold_uncertainty_score":0.41763592},"labels":[],"label_agreement":null},{"id":"W2010940026","doi":"10.1136/bmj.e4558","title":"Prescribing proton pump inhibitors with clopidogrel","year":2012,"lang":"en","type":"letter","venue":"BMJ","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Clopidogrel; Computer science; Medicine; Pharmacology; Aspirin; Internal medicine","score_opus":0.02222621201545709,"score_gpt":0.2635527074404603,"score_spread":0.24132649542500317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010940026","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.043648206,0.016888037,0.00041317553,0.8936965,0.0019111139,0.016004581,0.00007931716,0.0008029209,0.026556147],"genre_scores_gemma":[0.031291474,0.0005076661,0.0007347409,0.86756426,0.076409265,0.0022058662,0.0014127095,0.00046704157,0.019406999],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99795014,0.00010722637,0.00029157594,0.00039054488,0.0007564685,0.00050403114],"domain_scores_gemma":[0.99885315,0.000027799448,0.00015487972,0.0007394018,0.000091442715,0.00013335749],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025231543,0.00036936917,0.00063197286,0.00011618701,0.00007395253,0.000032506458,0.00011541786,0.00060924434,0.0002555163],"category_scores_gemma":[0.000026329426,0.00026017788,0.0005134018,0.0001268903,0.00010521272,0.00009821908,0.000039666877,0.001112147,0.00019027766],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029136825,0.000058337882,0.006815545,0.0011378787,0.0013250503,0.0018187254,0.000073620184,8.9222385e-7,0.000032670065,0.000002839172,0.9821517,0.006291369],"study_design_scores_gemma":[0.0013594886,0.00019124788,0.0008493526,0.0010585053,0.0009555828,0.0007765268,0.00001984739,0.0000016813796,0.001214225,0.0000064114743,0.99319035,0.00037677688],"about_ca_topic_score_codex":0.000020037487,"about_ca_topic_score_gemma":4.98293e-7,"teacher_disagreement_score":0.074498154,"about_ca_system_score_codex":0.000056548106,"about_ca_system_score_gemma":0.00018960511,"threshold_uncertainty_score":0.99998504},"labels":[],"label_agreement":null},{"id":"W2011518374","doi":"10.1111/j.1540-8183.2009.00486.x","title":"Week‐Long High‐Maintenance Dose Clopidogrel Regimen Achieves Better Platelet Aggregation Inhibition than a Standard Loading Dose before Percutaneous Coronary Intervention: Results of a Double‐Blind, Randomized Clinical Trial","year":2009,"lang":"en","type":"article","venue":"Journal of Interventional Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Clopidogrel; Conventional PCI; Percutaneous coronary intervention; Regimen; Randomized controlled trial; Loading dose; Angiography; Internal medicine; Cardiology; Anesthesia; Aspirin; Myocardial infarction","score_opus":0.033192280250985334,"score_gpt":0.3352069113837219,"score_spread":0.3020146311327365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011518374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862976,0.0029401113,0.006177365,0.0018115616,0.0013270989,0.0011466286,0.0000813163,0.000029855062,0.00018846002],"genre_scores_gemma":[0.9955532,0.0007097514,0.0007644791,0.00021150694,0.0021825125,0.00001770416,0.000281518,0.00002662508,0.00025267754],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99362814,0.0015771108,0.0032380573,0.00041805173,0.0008013097,0.00033731025],"domain_scores_gemma":[0.9959332,0.00043597448,0.0020801644,0.00035924197,0.00097274804,0.00021868269],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0063836547,0.00034272735,0.0024574837,0.00040678168,0.00010378934,0.00003581161,0.00021049657,0.00042661373,0.00010392561],"category_scores_gemma":[0.0008951483,0.0002587144,0.005927286,0.00019896835,0.00051718036,0.00032381335,0.00004846495,0.0008322004,0.0000073497363],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94830877,0.000801325,0.0008817546,0.000090467845,0.0043198327,0.0032103793,0.000118446966,0.000084039886,0.00020473808,0.00042651087,0.0011103118,0.040443443],"study_design_scores_gemma":[0.93093914,0.021402126,0.01663721,0.0026281537,0.0017015449,0.021136515,0.00017783899,0.00003761055,0.00055910647,0.0038660318,0.0006459213,0.00026883182],"about_ca_topic_score_codex":0.000009916592,"about_ca_topic_score_gemma":0.000006265811,"teacher_disagreement_score":0.04017461,"about_ca_system_score_codex":0.0002011632,"about_ca_system_score_gemma":0.00019659068,"threshold_uncertainty_score":0.9999865},"labels":[],"label_agreement":null},{"id":"W2011668981","doi":"10.7326/0003-4819-135-2-200107170-00019","title":"Cocaine-Related Vasculitis Causing Upper-Limb Peripheral Vascular Disease","year":2001,"lang":"en","type":"letter","venue":"Annals of Internal Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Blood pressure; Vasculitis; Vascular disease; Internal medicine; Peripheral; Surgery; Disease; Cardiology","score_opus":0.029409072746992563,"score_gpt":0.3019148869201148,"score_spread":0.27250581417312225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011668981","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13588305,0.13847667,0.0009932054,0.71171397,0.002314685,0.0014033365,0.00018057103,0.00029954856,0.008734977],"genre_scores_gemma":[0.1162841,0.031515345,0.00005794514,0.82474744,0.013934799,0.000058722304,0.001351246,0.0003289542,0.011721463],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99448776,0.0003309561,0.0013756127,0.000909723,0.0019808193,0.00091510656],"domain_scores_gemma":[0.9964671,0.0001736735,0.00053498254,0.0013577446,0.00081724214,0.0006492483],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006555015,0.0008947728,0.00239559,0.0005779947,0.00010885512,0.000026448246,0.00039981835,0.00077344844,0.0036508485],"category_scores_gemma":[0.0005798558,0.0006968,0.0028914753,0.00043072132,0.0008371966,0.00014695716,0.00010558121,0.0020204955,0.000059890877],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012798095,0.00022031019,0.0029095258,0.0016658796,0.010428495,0.029442713,0.00026259554,0.000020265834,0.00017893316,0.000054174277,0.94090265,0.01263463],"study_design_scores_gemma":[0.0052731563,0.0012761093,0.0070164152,0.009562741,0.0032771644,0.0016143938,0.00010804661,0.0001382814,0.00020026063,0.0003734365,0.9704526,0.0007073609],"about_ca_topic_score_codex":0.0006655749,"about_ca_topic_score_gemma":0.0000028070747,"teacher_disagreement_score":0.11303346,"about_ca_system_score_codex":0.000086025786,"about_ca_system_score_gemma":0.00028182133,"threshold_uncertainty_score":0.9995483},"labels":[],"label_agreement":null},{"id":"W2012218367","doi":"10.1055/s-2002-34080","title":"State of the Art-A Journey through the World of Antithrombotic Therapy","year":2002,"lang":"en","type":"review","venue":"Seminars in Thrombosis and Hemostasis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton General Hospital","funders":"","keywords":"Medicine; Thienopyridine; Antithrombotic; Clopidogrel; Aspirin; Unstable angina; Intensive care medicine; Heparin; Myocardial infarction; Low molecular weight heparin; Thrombosis; Acute coronary syndrome; Cardiology; Internal medicine","score_opus":0.08915731536429666,"score_gpt":0.35560364768318165,"score_spread":0.266446332318885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012218367","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003473795,0.9929084,0.000004645493,0.00029099933,0.00015641584,0.0011746053,0.00010392148,0.000009331488,0.0018778397],"genre_scores_gemma":[0.0018145568,0.9970249,0.00011585142,0.0001778348,0.000055339362,0.00003359126,0.000017170894,0.0000652098,0.00069556053],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973829,0.00037577038,0.00094463484,0.00040003122,0.000559211,0.00033745606],"domain_scores_gemma":[0.99790865,0.000295842,0.0006165191,0.0010275039,0.0000841443,0.00006734159],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050200446,0.0004733767,0.0027409133,0.00015568596,0.00012579579,0.000022994029,0.00038494973,0.00016515046,0.00036509582],"category_scores_gemma":[0.00004041578,0.00023619019,0.0015620901,0.0011011234,0.00069853605,0.00007465313,0.00012279583,0.0005326397,0.000007909195],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024830033,0.00031970206,0.00065564585,0.0046586352,0.0018725899,0.000008588979,0.0006520105,0.0000025891818,0.000005356989,0.00008665998,0.004766182,0.98694724],"study_design_scores_gemma":[0.0008242795,0.00015396596,0.0015178426,0.031007646,0.0021769952,0.0000714474,0.00019233594,0.0000031228672,0.00022227468,0.00018720853,0.9633597,0.0002831643],"about_ca_topic_score_codex":0.000027385868,"about_ca_topic_score_gemma":0.00002108824,"teacher_disagreement_score":0.98666406,"about_ca_system_score_codex":0.000052369145,"about_ca_system_score_gemma":0.00014871338,"threshold_uncertainty_score":0.9631556},"labels":[],"label_agreement":null},{"id":"W2012343501","doi":"10.1161/circulationaha.111.029165","title":"Platelet Reactivity and Cardiovascular Outcomes After Percutaneous Coronary Intervention","year":2011,"lang":"en","type":"article","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":397,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"","keywords":"Medicine; Percutaneous coronary intervention; Cardiology; Internal medicine; Platelet; Percutaneous; Myocardial infarction","score_opus":0.020780774708676952,"score_gpt":0.23357517294168528,"score_spread":0.21279439823300833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012343501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920622,0.0045785457,0.0019610745,0.000015854564,0.00010184121,0.00031901314,0.000004882501,0.000085273285,0.00087129994],"genre_scores_gemma":[0.9993849,0.00019617757,0.00018048857,0.000081923456,0.0000490729,0.000020158865,0.00003248077,0.000021795342,0.00003302234],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991139,0.000074789365,0.00015964718,0.00027145917,0.0002421663,0.00013804817],"domain_scores_gemma":[0.9994591,0.000013901705,0.000033111864,0.000353189,0.000051110568,0.00008962022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021122396,0.00013527767,0.00032312327,0.00006792613,0.00005428596,0.000011388886,0.000027454898,0.00009862102,0.00023276011],"category_scores_gemma":[0.000025597528,0.00012171341,0.0005870324,0.00006276298,0.0000597592,0.00016358451,0.000020398704,0.00009415229,0.000028596702],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005328548,0.00015699017,0.8023982,0.00009192787,0.0015264765,0.00088755967,0.00044497824,0.000009863307,0.00054998224,0.000045586425,0.00000856393,0.19334702],"study_design_scores_gemma":[0.0011546407,0.000045498964,0.99452114,0.00004860282,0.00051527,0.0021832178,0.00010649379,0.00010014921,0.0002523976,0.00021439356,0.00072052993,0.00013764515],"about_ca_topic_score_codex":0.000055430337,"about_ca_topic_score_gemma":0.0000026592977,"teacher_disagreement_score":0.19320938,"about_ca_system_score_codex":0.000033176715,"about_ca_system_score_gemma":0.000013814005,"threshold_uncertainty_score":0.4963329},"labels":[],"label_agreement":null},{"id":"W2012988382","doi":"10.1055/s-0031-1291382","title":"Quebec Platelet Disorder: Update on Pathogenesis, Diagnosis, and Treatment","year":2011,"lang":"en","type":"review","venue":"Seminars in Thrombosis and Hemostasis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; McMaster University","funders":"Canadian Institutes of Health Research","keywords":"Pathogenesis; Medicine; Platelet; Intensive care medicine; Immunology","score_opus":0.06164073408527267,"score_gpt":0.3315595783117989,"score_spread":0.26991884422652623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012988382","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018322803,0.9796548,0.0000015647121,0.00008637075,0.000090402864,0.0013045234,0.00030434303,0.00004872486,0.00018647434],"genre_scores_gemma":[0.0005343376,0.99791616,0.00011203137,0.00019572713,0.00009482643,0.0005151992,0.00040514374,0.00010903712,0.000117561925],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99767935,0.00019404739,0.0005725641,0.0008836205,0.00022222662,0.00044818944],"domain_scores_gemma":[0.9987298,0.00015603116,0.00018416357,0.0006353548,0.000025140009,0.00026949914],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022422374,0.00078891916,0.0029396398,0.0002874302,0.00014693396,0.000049855622,0.000110622226,0.00047068016,0.00020076093],"category_scores_gemma":[0.000020096832,0.00057237945,0.00079443376,0.0002694362,0.00019766395,0.00006843661,0.00008268703,0.00024957606,0.000030364316],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053942706,0.0005749511,0.0023763953,0.0032047797,0.001233568,0.00012996461,0.00017549901,7.776922e-8,1.6797345e-7,0.0001402995,0.0006356601,0.9914747],"study_design_scores_gemma":[0.0012022954,0.0005783042,0.002535952,0.015762117,0.0031525667,0.0001091983,0.00012976734,5.628917e-7,0.000020097594,0.000022681015,0.9759308,0.00055565464],"about_ca_topic_score_codex":0.00080452615,"about_ca_topic_score_gemma":0.00050714554,"teacher_disagreement_score":0.99091905,"about_ca_system_score_codex":0.00018601854,"about_ca_system_score_gemma":0.00016182741,"threshold_uncertainty_score":0.9996728},"labels":[],"label_agreement":null},{"id":"W2013093342","doi":"10.1016/j.jacc.2012.08.764","title":"TCT-723 Transferring from Clopidogrel Loading Dose to Prasugrel Loading Dose in Acute Coronary Syndrome Patients: High on-Treatment Platelet Reactivity Analysis of the TRIPLET Trial","year":2012,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada); Hôpital du Sacré-Cœur de Montréal","funders":"","keywords":"Prasugrel; Medicine; Clopidogrel; Acute coronary syndrome; Loading dose; Internal medicine; Platelet; Cardiology; Aspirin; Myocardial infarction","score_opus":0.015922920389711315,"score_gpt":0.2689213109444139,"score_spread":0.2529983905547026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013093342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99690664,0.00048219092,0.00008869965,0.00039748332,0.00081492035,0.0007944034,0.00046424096,0.0000063316324,0.00004507159],"genre_scores_gemma":[0.998892,0.00048128917,0.00010543675,0.00021185873,0.0002375941,0.000015548863,0.000009283762,0.000026746085,0.00002023291],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969147,0.0009475016,0.0009031619,0.00024282113,0.00060356973,0.00038826905],"domain_scores_gemma":[0.99764514,0.0005367317,0.00083452737,0.0006468309,0.00014053409,0.0001962082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072668603,0.00029462198,0.0025495677,0.0004792903,0.00008308422,0.000004298668,0.00036542668,0.00010660237,0.000015579297],"category_scores_gemma":[0.00016132284,0.00016767008,0.0022873797,0.0013092662,0.000280625,0.000116733565,0.00007450595,0.00035010718,0.0000013474427],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14778629,0.0015275263,0.7645305,0.000028711918,0.05625818,0.0010603043,0.0007160799,0.0072975396,0.009584633,0.000039797356,0.00029954666,0.010870944],"study_design_scores_gemma":[0.027331552,0.0041027074,0.95568967,0.00017933518,0.008117439,0.00056452054,0.00037036513,0.00002063261,0.0027874932,0.000019946772,0.00062951323,0.00018684672],"about_ca_topic_score_codex":0.000114809045,"about_ca_topic_score_gemma":0.0000123611735,"teacher_disagreement_score":0.1911592,"about_ca_system_score_codex":0.0004354035,"about_ca_system_score_gemma":0.0002043942,"threshold_uncertainty_score":0.68373877},"labels":[],"label_agreement":null},{"id":"W2013254514","doi":"10.1016/j.ienj.2010.07.003","title":"What every emergency nurse needs to know about aspirin: An update","year":2010,"lang":"en","type":"article","venue":"International Emergency Nursing","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"British Columbia Institute of Technology; University of British Columbia","funders":"","keywords":"Aspirin; Emergency department; Medicine; Medical emergency; Emergency nursing; MEDLINE; Nursing; Internal medicine; Political science","score_opus":0.010974701304369573,"score_gpt":0.32352207422366197,"score_spread":0.3125473729192924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013254514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9559224,0.0032631964,0.0014211537,0.0035343964,0.026518371,0.0003171948,0.000018868448,0.00014913967,0.008855252],"genre_scores_gemma":[0.9885663,0.0034781953,0.0005599431,0.0005074873,0.0024285503,0.000031968648,0.00021115852,0.00006261654,0.004153773],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99806553,0.00004231557,0.00045945996,0.0004006729,0.0006742545,0.0003577379],"domain_scores_gemma":[0.9985778,0.00000635588,0.0000869859,0.0005208215,0.00038819842,0.00041988393],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022554891,0.0002534321,0.00027173897,0.00034825815,0.00013834427,0.00005430024,0.00034204987,0.00012962823,0.009198247],"category_scores_gemma":[0.000059654434,0.00025194418,0.0004381115,0.000361323,0.000057129,0.0009163497,0.000023232924,0.0003087001,0.0004796498],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012477743,0.0019704758,0.040576994,0.000059170947,0.0012815256,0.00015044068,0.0036903557,0.00020067678,0.08041667,0.008078474,0.042531997,0.8197954],"study_design_scores_gemma":[0.0028388554,0.00058335165,0.18937479,0.0013836788,0.0007267229,0.0005670673,0.0047029424,0.0015562718,0.012468436,0.004374014,0.7800026,0.0014212865],"about_ca_topic_score_codex":0.000022758331,"about_ca_topic_score_gemma":0.00002698041,"teacher_disagreement_score":0.81837416,"about_ca_system_score_codex":0.00006642764,"about_ca_system_score_gemma":0.00006537175,"threshold_uncertainty_score":0.99999326},"labels":[],"label_agreement":null},{"id":"W2013641304","doi":"10.1016/j.amjcard.2009.06.025","title":"Prevalence of Unresponsiveness to Aspirin and/or Clopidogrel in Patients With Stable Coronary Heart Disease","year":2009,"lang":"en","type":"article","venue":"The American Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital du Sacré-Cœur de Montréal","funders":"","keywords":"Clopidogrel; Aspirin; P2Y12; Medicine; Platelet; Adenosine diphosphate; Arachidonic acid; Coronary artery disease; Internal medicine; Platelet activation; Cardiology; Pharmacology; Platelet aggregation; Biochemistry; Chemistry; Enzyme","score_opus":0.00868001202825506,"score_gpt":0.25800081331207353,"score_spread":0.24932080128381848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013641304","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99710304,0.0015187915,0.0003169411,0.0007910058,0.00002760454,0.00021080152,0.0000102966305,0.0000033316978,0.000018205985],"genre_scores_gemma":[0.99814355,0.00037883787,0.00016506777,0.0012195961,0.00006426744,0.0000021159724,9.356128e-7,0.0000074439254,0.000018163593],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989074,0.00036373263,0.00023708353,0.00010884219,0.00022277454,0.00016017791],"domain_scores_gemma":[0.99917686,0.00011319195,0.00015921841,0.00022497046,0.00016355373,0.00016223367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037841278,0.00009771955,0.00062642904,0.00010368596,0.000022596996,0.0000024911697,0.0001024384,0.000014440092,0.000005475923],"category_scores_gemma":[0.00007884903,0.000052882755,0.0001370914,0.00020333103,0.00027780223,0.00004473293,0.000018465467,0.00011828146,7.41422e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.051311422,0.00007035607,0.91936415,0.000032446147,0.00022318058,0.00020001756,0.00007350782,0.00089257763,0.00011796471,0.000010169803,0.000059225727,0.02764497],"study_design_scores_gemma":[0.0018012704,0.00655017,0.9901497,0.00018051505,0.00024331405,0.0002999905,0.00012491873,0.0000013227262,0.000031000156,0.000039243845,0.0005137229,0.00006485811],"about_ca_topic_score_codex":0.0000030439212,"about_ca_topic_score_gemma":1.402178e-7,"teacher_disagreement_score":0.07078551,"about_ca_system_score_codex":0.000022549002,"about_ca_system_score_gemma":0.00017525983,"threshold_uncertainty_score":0.21564962},"labels":[],"label_agreement":null},{"id":"W2014670474","doi":"10.2478/acph-2014-0001","title":"Comparative bioavailability of two oral formulations of clopidogrel: Determination of clopidogrel and its carboxylic acid metabolite (SR26334) under fasting and fed conditions in healthy subjects","year":2014,"lang":"en","type":"article","venue":"Acta Pharmaceutica","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"inVentiv Health Clinical","funders":"","keywords":"Bioavailability; Clopidogrel; Bioequivalence; Metabolite; Crossover study; Pharmacology; Pharmacokinetics; Active metabolite; Chemistry; Ticlopidine; Medicine; Internal medicine; Aspirin","score_opus":0.06296090370604135,"score_gpt":0.38736786162805303,"score_spread":0.3244069579220117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014670474","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952779,0.0031467522,0.00043725688,0.00020785324,0.000039551174,0.000549104,0.000068903784,0.000016290951,0.00025643295],"genre_scores_gemma":[0.9987229,0.00056526606,0.00049950235,0.00011135778,0.000023303548,0.000014615161,0.000047639805,0.000011511511,0.000003892341],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99867284,0.00025752583,0.00046036704,0.00022053218,0.0002048041,0.00018390967],"domain_scores_gemma":[0.9990204,0.00026934876,0.00021067886,0.00017239607,0.00019950875,0.00012767721],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004522418,0.0001441416,0.00062177586,0.00018056644,0.000058454843,0.0000049097825,0.000045433673,0.000061792736,0.000024831095],"category_scores_gemma":[0.000099216646,0.00013387899,0.00010841719,0.00030085712,0.00024152473,0.00015183513,0.000036332345,0.00013305772,4.5513661e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041389614,0.0015541544,0.28521723,0.00320854,0.0013698466,0.0000067719366,0.0047402075,0.00005668662,0.6521228,0.009400605,0.000016668366,0.038167536],"study_design_scores_gemma":[0.016305182,0.0009571278,0.6396654,0.00033156198,0.0014643152,0.000050703755,0.00063845,0.028796585,0.30989996,0.001052984,0.00048133262,0.00035638252],"about_ca_topic_score_codex":0.00003369639,"about_ca_topic_score_gemma":0.000026096455,"teacher_disagreement_score":0.3544482,"about_ca_system_score_codex":0.000022203094,"about_ca_system_score_gemma":0.000079334364,"threshold_uncertainty_score":0.54594266},"labels":[],"label_agreement":null},{"id":"W2015168093","doi":"10.1016/j.jval.2013.03.1478","title":"Cost-effectiveness of ticagrelor versus generic clopidogrel in patients with acute coronary syndromes in Canada","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital; University Health Network; St. Paul's Hospital; McMaster University; Programs for Assessment of Technology in Health Research Institute; AstraZeneca (Canada); University of Alberta Hospital; Alberta Hospital Edmonton","funders":"","keywords":"Ticagrelor; Clopidogrel; Medicine; Acute coronary syndrome; Myocardial infarction; Quality-adjusted life year; Internal medicine; Stroke (engine); Emergency medicine; Cardiology; Aspirin; Cost effectiveness","score_opus":0.03387759758753904,"score_gpt":0.2694890968173862,"score_spread":0.23561149922984714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015168093","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965699,0.0015119604,0.000010783219,0.00008371397,0.00014624593,0.0016229321,0.000017466022,0.000006731057,0.000030294283],"genre_scores_gemma":[0.9991395,0.0004637072,0.00010539047,0.000119435565,0.000008250992,0.000097012635,0.00004530481,0.000017666156,0.0000037497723],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985272,0.00032715767,0.0003089598,0.00021337577,0.0003122383,0.00031103136],"domain_scores_gemma":[0.9993653,0.00016292621,0.0000708083,0.0002219369,0.000047547375,0.0001314305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026370466,0.00012708596,0.000508982,0.00013225456,0.000015428537,0.0000023517564,0.000067243986,0.00004253095,0.000029489831],"category_scores_gemma":[0.000023056658,0.00010428963,0.00004811779,0.00038307812,0.000038186532,0.00006199807,0.000017344475,0.00014678919,0.0000037820455],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023446572,0.00023292677,0.980442,0.0004343878,0.00015067372,0.00016322735,0.00007579064,0.002336517,0.0000031297939,0.000018087896,0.000022838425,0.013775773],"study_design_scores_gemma":[0.009895213,0.0007057827,0.9880591,0.00060526526,0.000022805834,0.000012294255,0.000105993626,0.00041010507,0.000021683127,0.000012207308,0.000051562853,0.000097998534],"about_ca_topic_score_codex":0.7317905,"about_ca_topic_score_gemma":0.076866,"teacher_disagreement_score":0.6549245,"about_ca_system_score_codex":0.00088072615,"about_ca_system_score_gemma":0.0018640708,"threshold_uncertainty_score":0.9399788},"labels":[],"label_agreement":null},{"id":"W2016437276","doi":"10.1016/j.ahj.2012.06.005","title":"Prior smoking status, clinical outcomes, and the comparison of ticagrelor with clopidogrel in acute coronary syndromes—Insights from the PLATelet inhibition and patient Outcomes (PLATO) trial","year":2012,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Bayer; Servier; Eisai; Daiichi-Sankyo; Regado Biosciences; Medicines Company; Boehringer Ingelheim; Schering-Plough; Medtronic; Johnson and Johnson; Meso Scale Diagnostics; Sanofi; Novartis; Merck; GlaxoSmithKline; Otsuka America; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; Roche; Astellas Pharma US; Pfizer; Abbott Laboratories; Portola Pharmaceuticals","keywords":"Ticagrelor; Medicine; Clopidogrel; Platelet inhibition; Internal medicine; Cardiology; Clinical trial; Acute coronary syndrome; Platelet; Platelet aggregation inhibitor; Aspirin; Intensive care medicine; Myocardial infarction","score_opus":0.03092289676265752,"score_gpt":0.3316381269638888,"score_spread":0.30071523020123125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016437276","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917794,0.005877185,0.000039299284,0.0014515168,0.00019672162,0.0006178164,0.000015578677,0.000010942771,0.000011537742],"genre_scores_gemma":[0.99615043,0.0017263546,0.00037756737,0.0015944155,0.00010707981,0.000011228711,0.000009738429,0.000020097772,0.0000030720328],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977041,0.00058621715,0.0007208019,0.00018281782,0.00049445545,0.00031164245],"domain_scores_gemma":[0.9979794,0.001123631,0.0003494549,0.00024381302,0.000051745847,0.00025195608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005520231,0.00019920732,0.0011135238,0.000060952545,0.00019067233,0.000033215532,0.000054719083,0.00006171443,0.000020015155],"category_scores_gemma":[0.000113684226,0.000090594345,0.0002981624,0.00014374095,0.00095864624,0.0001457769,0.000052745094,0.00060321094,0.0000015207602],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017941875,0.00029028475,0.9384968,0.0000043902737,0.0014270078,0.00006154393,0.0016414848,0.000001918683,0.0000062149265,0.000032284985,0.00014476254,0.039951377],"study_design_scores_gemma":[0.0363275,0.0012965004,0.9562248,0.00011499159,0.000518353,0.0007148449,0.0025127516,0.000024570547,0.00002250433,0.000033043474,0.0020882194,0.00012190761],"about_ca_topic_score_codex":0.00020390598,"about_ca_topic_score_gemma":0.000018203169,"teacher_disagreement_score":0.039829466,"about_ca_system_score_codex":0.000031538988,"about_ca_system_score_gemma":0.00010260732,"threshold_uncertainty_score":0.36943305},"labels":[],"label_agreement":null},{"id":"W2016476953","doi":"10.1016/j.jvs.2013.05.092","title":"Discontinuation of preoperative clopidogrel is unnecessary in peripheral arterial surgery","year":2013,"lang":"en","type":"article","venue":"Journal of Vascular Surgery","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Sacré-Cœur de Montréal","funders":"","keywords":"Medicine; Clopidogrel; Perioperative; Aspirin; Thromboelastometry; Carotid endarterectomy; Discontinuation; Surgery; Clinical endpoint; Abdominal surgery; Anesthesia; Prospective cohort study; Internal medicine; Coagulopathy; Randomized controlled trial","score_opus":0.015191613807186076,"score_gpt":0.24286753755457735,"score_spread":0.22767592374739126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016476953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99193615,0.0063797473,0.0004376195,0.0004019255,0.0005290394,0.0002329784,0.0000038634203,0.000007551571,0.00007114852],"genre_scores_gemma":[0.9963779,0.0026558733,0.0001410294,0.0002435369,0.0004870665,0.000010350627,0.000013579189,0.000024373314,0.000046296387],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976974,0.0002945312,0.0010009089,0.00016091726,0.0006143171,0.00023192677],"domain_scores_gemma":[0.998489,0.00027264815,0.00043601159,0.0002549616,0.00040531383,0.00014202906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012048252,0.00018052517,0.0011268965,0.0003732024,0.000031266678,0.000031644577,0.000071979935,0.000114894785,0.00073121255],"category_scores_gemma":[0.00024730273,0.00013895342,0.0017282289,0.000302032,0.00008873809,0.0005308065,0.000017249296,0.00020584797,0.000009166842],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010692376,0.0011641982,0.91685724,0.0002804532,0.002893096,0.000405022,0.001266019,0.000101913734,0.007102618,0.000014684752,0.011940069,0.056905422],"study_design_scores_gemma":[0.0017267253,0.00012353896,0.9895684,0.0008302402,0.00030155818,0.00022949396,0.0005451769,0.000088610854,0.0044777845,0.000080767735,0.0018162281,0.00021147645],"about_ca_topic_score_codex":0.000059512928,"about_ca_topic_score_gemma":0.0000036583876,"teacher_disagreement_score":0.07271113,"about_ca_system_score_codex":0.000053999876,"about_ca_system_score_gemma":0.00036468447,"threshold_uncertainty_score":0.8006265},"labels":[],"label_agreement":null},{"id":"W2016484478","doi":"10.1159/000108276","title":"Ticlopidine and Clopidogrel in Secondary Stroke Prevention","year":2007,"lang":"en","type":"article","venue":"Cerebrovascular Diseases","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Clopidogrel; Ticlopidine; Stroke (engine); Secondary prevention; Ischemic stroke; Internal medicine; Cardiology; Aspirin; Ischemia","score_opus":0.007311299507535367,"score_gpt":0.2553634663725993,"score_spread":0.24805216686506396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016484478","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9660886,0.029935393,0.0011570393,0.00010676517,0.00010216487,0.0004944022,0.000019160869,0.00010049444,0.001995974],"genre_scores_gemma":[0.9962908,0.0021925915,0.0003279176,0.00029735986,0.00022129824,0.00001818418,0.00010298316,0.000035319834,0.0005135588],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984666,0.00006900841,0.00031525397,0.00041345778,0.00036173192,0.0003739318],"domain_scores_gemma":[0.9990871,0.000050116363,0.00004918307,0.00041924632,0.000056097513,0.0003382447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003923841,0.00021208845,0.00042598534,0.0002180062,0.00007225248,0.000026010432,0.000070685724,0.00010579583,0.0002863963],"category_scores_gemma":[0.00008065697,0.00019630823,0.00051517726,0.00023381827,0.00012426764,0.00015427078,0.000050154453,0.0001735131,0.000026413585],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006526631,0.0007055229,0.5760333,0.00045084552,0.000988146,0.00033871172,0.000094141375,0.000005612602,0.0006686721,0.0005432284,0.00025769757,0.4192615],"study_design_scores_gemma":[0.005636149,0.00018210338,0.977396,0.0001760847,0.0005807668,0.00015911441,0.00027414353,0.00002330728,0.0012680391,0.0004702264,0.013582282,0.00025178478],"about_ca_topic_score_codex":0.000019788638,"about_ca_topic_score_gemma":0.000025428715,"teacher_disagreement_score":0.4190097,"about_ca_system_score_codex":0.000054937205,"about_ca_system_score_gemma":0.00012206876,"threshold_uncertainty_score":0.80052173},"labels":[],"label_agreement":null},{"id":"W2016782581","doi":"10.1177/1089253207311153","title":"Point-of-Care Platelet Function Testing","year":2007,"lang":"en","type":"review","venue":"Seminars in Cardiothoracic and Vascular Anesthesia","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Platelet; Platelet transfusion; Context (archaeology); Intensive care medicine; Point of care; Point-of-care testing; Stroke (engine); Platelet activation; Cardiopulmonary bypass; Revascularization; Internal medicine; Cardiology; Myocardial infarction; Immunology; Pathology","score_opus":0.03692951397568643,"score_gpt":0.33126236002777165,"score_spread":0.2943328460520852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016782581","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0024079566,0.99497354,0.00034001755,0.0000035748033,0.00007832033,0.0012523012,0.000007285658,0.00008224682,0.00085475796],"genre_scores_gemma":[0.0008809997,0.9972575,0.0010915902,0.00004866985,0.00027324195,0.00005903181,0.00018636048,0.00013882096,0.000063814354],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99691826,0.00034567047,0.0008665681,0.0007640553,0.0006153075,0.00049015717],"domain_scores_gemma":[0.9982515,0.00025696153,0.0002793824,0.00083093555,0.00016366916,0.00021757724],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012967583,0.00067423674,0.0037755335,0.0005949773,0.000091323185,0.000028406388,0.00015867688,0.0008035632,0.000019327395],"category_scores_gemma":[0.000104093226,0.0005754749,0.002424634,0.00093310967,0.00016926113,0.0000994549,0.000049643502,0.00064965937,0.000014749064],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000113650334,0.000051238694,0.0008635203,0.030784728,0.0012325845,0.0014602485,0.00011632236,0.000003657059,7.832036e-7,0.000028515908,0.000033759316,0.965311],"study_design_scores_gemma":[0.0007806018,0.00039003408,0.00073527,0.043347865,0.005828655,0.0052713817,0.00044268146,0.00000497087,0.0000070281053,0.000012185786,0.942585,0.0005943546],"about_ca_topic_score_codex":0.000014619562,"about_ca_topic_score_gemma":6.5827317e-7,"teacher_disagreement_score":0.9647166,"about_ca_system_score_codex":0.00013863225,"about_ca_system_score_gemma":0.00030487182,"threshold_uncertainty_score":0.9996697},"labels":[],"label_agreement":null},{"id":"W2017501956","doi":"10.1016/j.jacc.2007.01.097","title":"Lack of Evidence of a Clopidogrel–Statin Interaction in the CHARISMA Trial","year":2007,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":169,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Medicine; Clopidogrel; Atorvastatin; Statin; Placebo; Fluvastatin; Internal medicine; Population; Clinical endpoint; Hazard ratio; Pravastatin; Aspirin; Randomized controlled trial; Simvastatin; Pharmacology; Confidence interval; Cholesterol","score_opus":0.08300536404240397,"score_gpt":0.3777872770168705,"score_spread":0.29478191297446654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017501956","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959232,0.0015086752,0.000649321,0.0010021689,0.00033732897,0.00029352025,0.000009267218,0.0000013034116,0.0002752104],"genre_scores_gemma":[0.9982089,0.0010298943,0.00018283458,0.00020193505,0.00034874037,0.0000017518186,2.6677696e-7,0.0000066498847,0.000019048606],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9979415,0.00064540503,0.00079622807,0.000079793506,0.00040488315,0.00013220485],"domain_scores_gemma":[0.9973348,0.000785217,0.0012828249,0.00030204744,0.00025959132,0.000035531873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002535306,0.000089815665,0.0010010867,0.00016499162,0.00001830926,0.0000010549621,0.00027379964,0.000043584078,0.000007047047],"category_scores_gemma":[0.000642322,0.00004464736,0.00089764426,0.00047324802,0.00048624093,0.000051604704,0.000029934505,0.00026800908,3.381828e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6224979,0.0009414653,0.22446284,0.00056744943,0.0074836444,0.0015873235,0.0025314298,0.0019230654,0.05790763,0.0007499135,0.008356438,0.07099091],"study_design_scores_gemma":[0.061982993,0.025344653,0.81941754,0.0025248865,0.0031410265,0.010491354,0.029236367,0.00006617454,0.026791425,0.0007933226,0.01984581,0.00036445068],"about_ca_topic_score_codex":0.000025104326,"about_ca_topic_score_gemma":0.000004410864,"teacher_disagreement_score":0.5949547,"about_ca_system_score_codex":0.000037844948,"about_ca_system_score_gemma":0.00019804842,"threshold_uncertainty_score":0.18206665},"labels":[],"label_agreement":null},{"id":"W2018125855","doi":"10.1016/s0828-282x(09)70501-x","title":"Recommendations for advancing the care of Canadians living with refractory angina pectoris: A Canadian Cardiovascular Society position statement","year":2009,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Royal Jubilee Hospital; Montreal Heart Institute; St. Paul's Hospital; Alberta Health Services; McMaster University; Hamilton Health Sciences; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Position statement; Canadian Cardiovascular Society; Statement (logic); Angina; Refractory (planetary science); Position (finance); Physical therapy; Intensive care medicine; Family medicine; Gerontology; Cardiology; Myocardial infarction; Finance; Law","score_opus":0.010150697304648586,"score_gpt":0.23809405528488045,"score_spread":0.22794335798023185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018125855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7308517,0.1537411,0.06643974,0.0335904,0.0023975202,0.0036939306,0.0015461398,0.000046738118,0.007692697],"genre_scores_gemma":[0.99692845,0.00067668257,0.0007647379,0.0008586968,0.0006639734,0.000011241001,0.000052418618,0.000022623592,0.000021201819],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986071,0.00016059302,0.00036511561,0.00016626506,0.00018872468,0.00051219686],"domain_scores_gemma":[0.9978501,0.00008136518,0.00016317904,0.00034349968,0.0007401144,0.0008217305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069322187,0.00016631941,0.0006385509,0.00024636433,0.0003241055,0.00001795832,0.00015033918,0.00011371549,0.000015977352],"category_scores_gemma":[0.000090613816,0.00012531296,0.0011436418,0.00019793819,0.000113471,0.00010537725,0.000002726328,0.0002487789,4.941687e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008697095,0.000054369688,0.07975893,0.0008330894,0.054849934,0.002559752,0.038440526,0.08013573,0.0012388394,0.0015495981,0.23510092,0.50460863],"study_design_scores_gemma":[0.0018816278,0.0018162518,0.049710333,0.00051183783,0.0026759992,0.0016590074,0.017351555,0.000022055274,0.00010122373,0.00005962922,0.9239176,0.00029288034],"about_ca_topic_score_codex":0.08220653,"about_ca_topic_score_gemma":0.23104092,"teacher_disagreement_score":0.68881667,"about_ca_system_score_codex":0.0011518543,"about_ca_system_score_gemma":0.0064147487,"threshold_uncertainty_score":0.999218},"labels":[],"label_agreement":null},{"id":"W2019239868","doi":"10.1592/phco.27.8.1145","title":"Antiplatelet Therapy in Patients with Unstable Angina and Non–ST‐Segment‐Elevation Myocardial Infarction: Findings from the CRUSADE National Quality Improvement Initiative","year":2007,"lang":"en","type":"review","venue":"Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Guideline; Unstable angina; Percutaneous coronary intervention; Myocardial infarction; Intensive care medicine; Angina; Clopidogrel; Medical prescription; Specialty; Clinical trial; Canadian Cardiovascular Society; Internal medicine; Emergency medicine; Cardiology; Family medicine; Nursing","score_opus":0.045586181522098285,"score_gpt":0.36674517960882913,"score_spread":0.3211589980867309,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019239868","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4123949,0.585281,0.00003618311,0.0002993828,0.0002800575,0.0015747761,0.000090869515,0.000012750837,0.000030037601],"genre_scores_gemma":[0.08780083,0.9056767,0.000021951757,0.005297799,0.00092365034,0.00005938473,0.00011765414,0.00007606215,0.000025926349],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957269,0.0012985853,0.0011962017,0.0004103632,0.00091246696,0.0004554889],"domain_scores_gemma":[0.99711293,0.0009507658,0.001101411,0.00022353907,0.00043999866,0.0001713392],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003413614,0.00067674194,0.0016976454,0.00037707333,0.0005325383,0.00007091603,0.00036269566,0.00022724157,0.0003665548],"category_scores_gemma":[0.000010583113,0.0003587969,0.000523215,0.00044561477,0.00050192146,0.00036040627,0.000044980497,0.0012952937,0.0000020007756],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016265322,0.0016922125,0.02199192,0.00042752514,0.015637543,0.000050846644,0.0030664406,0.000013799282,0.0015405,0.000023978793,0.0050127287,0.9342772],"study_design_scores_gemma":[0.06345592,0.0029173384,0.05586044,0.0016087474,0.0025486697,0.00012830649,0.00038843197,0.0000066729376,0.0010659418,0.00024703273,0.870853,0.00091947376],"about_ca_topic_score_codex":0.00004487102,"about_ca_topic_score_gemma":0.0000037315071,"teacher_disagreement_score":0.9333577,"about_ca_system_score_codex":0.00020767972,"about_ca_system_score_gemma":0.0004649218,"threshold_uncertainty_score":0.9998864},"labels":[],"label_agreement":null},{"id":"W2019257461","doi":"10.1016/j.clinbiochem.2014.03.005","title":"Efficacy and safety of prasugrel in acute coronary syndrome patients","year":2014,"lang":"en","type":"review","venue":"Clinical Biochemistry","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Prasugrel; Medicine; Acute coronary syndrome; Internal medicine; Thrombosis; Adverse effect; Cardiology; Platelet; Intensive care medicine; Myocardial infarction","score_opus":0.03010802632832115,"score_gpt":0.36564861700220985,"score_spread":0.3355405906738887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019257461","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13278583,0.8663088,0.0000021726714,0.000007389553,0.000092706265,0.0005641647,0.000087035834,0.000017784916,0.00013410358],"genre_scores_gemma":[0.017383624,0.9815214,0.000044817327,0.000060255526,0.000077565775,0.000016867785,0.0006822993,0.000038663406,0.0001744904],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975314,0.00015645278,0.0012943055,0.0005699666,0.00024548813,0.00020234437],"domain_scores_gemma":[0.99820966,0.00045960545,0.00037741833,0.00066083303,0.000055531702,0.00023692839],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004967439,0.00032775308,0.0029322319,0.000043568078,0.00001883396,0.00000462083,0.00016422234,0.0007672866,0.000046611258],"category_scores_gemma":[0.00045843903,0.00025597413,0.0011244672,0.00013934118,0.0003295292,0.000014337488,0.00011971358,0.0005649578,0.000020439998],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004765321,0.00072566303,0.007073897,0.02014586,0.0019321745,0.00023713443,0.0000021235956,2.4898481e-8,8.0754967e-7,0.0000011224483,0.00020723032,0.96919745],"study_design_scores_gemma":[0.014274464,0.0011322601,0.06218917,0.060325082,0.010627236,0.00095223275,0.0000066593702,0.0000011889758,0.000016322785,0.00000793282,0.84964776,0.00081969437],"about_ca_topic_score_codex":5.533025e-7,"about_ca_topic_score_gemma":2.6563871e-8,"teacher_disagreement_score":0.9683777,"about_ca_system_score_codex":0.000034432327,"about_ca_system_score_gemma":0.0002451318,"threshold_uncertainty_score":0.9999893},"labels":[],"label_agreement":null},{"id":"W2019504426","doi":"10.1093/eurheartj/ehn417","title":"Effects of aspirin dose on ischaemic events and bleeding after percutaneous coronary intervention: insights from the PCI-CURE study","year":2008,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":135,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"European Society of Cardiology; Sanofi","keywords":"Medicine; Aspirin; Conventional PCI; Percutaneous coronary intervention; Myocardial infarction; Internal medicine; Hazard ratio; Stroke (engine); Cardiology; Confidence interval","score_opus":0.019300725531513574,"score_gpt":0.25763270376810693,"score_spread":0.23833197823659336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019504426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98593247,0.013210846,0.000015865813,0.0001166636,0.00021830149,0.00032660854,0.0000024102544,0.000016944317,0.00015991887],"genre_scores_gemma":[0.9977397,0.001117512,0.000026282725,0.00041882918,0.0005248625,0.0000019475347,0.0000024160202,0.000030580657,0.00013787978],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984471,0.0006271024,0.00024418577,0.00017717671,0.00037133548,0.00013305047],"domain_scores_gemma":[0.99943113,0.00011337029,0.00007526653,0.00019132017,0.000048319853,0.00014056671],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024809307,0.00014774837,0.00027700464,0.00005335881,0.00020049007,0.000015325537,0.00008697755,0.000024173432,0.00008289709],"category_scores_gemma":[0.000034260567,0.000092597955,0.00030922276,0.00006398446,0.000078527104,0.0000750935,0.000058899022,0.00038095858,0.000039890652],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009297712,0.0037263653,0.8121955,0.00021461581,0.004147721,0.11289365,0.014675926,0.000029072362,0.0127030285,0.000006966572,0.0028333443,0.027276102],"study_design_scores_gemma":[0.003523833,0.0018737641,0.97147924,0.0008490874,0.00030603848,0.019059677,0.0005046741,0.000005005559,0.00020270086,0.000016540429,0.0020790838,0.00010037057],"about_ca_topic_score_codex":0.000005005728,"about_ca_topic_score_gemma":7.610193e-7,"teacher_disagreement_score":0.15928373,"about_ca_system_score_codex":0.000019644032,"about_ca_system_score_gemma":0.000021556698,"threshold_uncertainty_score":0.3776035},"labels":[],"label_agreement":null},{"id":"W2019611014","doi":"10.1016/j.expneurol.2007.03.018","title":"Combination treatment with dipyridamole, aspirin, and tPA in an embolic model of stroke in rats","year":2007,"lang":"en","type":"article","venue":"Experimental Neurology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada","keywords":"Dipyridamole; Medicine; Aspirin; Antithrombotic; Tissue plasminogen activator; Perfusion; Combination therapy; Fibrinolytic agent; Anesthesia; Stroke (engine); Pharmacology; Cardiology; Internal medicine","score_opus":0.01634551105200225,"score_gpt":0.28283668931404826,"score_spread":0.266491178262046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019611014","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99781466,0.0013263315,0.0000519579,0.00003959127,0.000017937364,0.00027306564,0.0000026148398,0.000010810582,0.00046306103],"genre_scores_gemma":[0.9995188,0.00007105385,0.000054577715,0.0002858933,0.000011886281,0.000016550508,0.000013987246,0.000011967011,0.000015256795],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9993767,0.00004486785,0.00014620251,0.000189836,0.00009429197,0.00014811695],"domain_scores_gemma":[0.99975556,0.000012635344,0.000028978178,0.0001296663,0.000010393246,0.00006275505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007043972,0.00009975722,0.000248498,0.00012848702,0.0000127225685,0.0000023255357,0.000025492967,0.000054855085,0.000007907384],"category_scores_gemma":[0.0000011713131,0.000082447295,0.00003810736,0.000064291395,0.00008786987,0.00005717805,0.000011386479,0.000060022805,5.613176e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009657832,0.004209264,0.4425895,0.000023890247,0.00011143476,0.000814524,0.001989589,0.00067888945,0.5274923,0.00082264445,0.000001947896,0.011608199],"study_design_scores_gemma":[0.016268486,0.014145915,0.4885599,0.00002110709,0.000032342316,0.00017759141,0.0005284068,0.0055129896,0.47447097,0.000061322426,0.000047373545,0.00017357143],"about_ca_topic_score_codex":0.000052415577,"about_ca_topic_score_gemma":0.00007157522,"teacher_disagreement_score":0.05302132,"about_ca_system_score_codex":0.0000230584,"about_ca_system_score_gemma":0.000020337637,"threshold_uncertainty_score":0.3362103},"labels":[],"label_agreement":null},{"id":"W2021657358","doi":"10.1097/mca.0b013e32834e4ef1","title":"Pattern of liver enzyme elevations in acute ST-elevation myocardial infarction","year":2011,"lang":"en","type":"article","venue":"Coronary Artery Disease","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Internal medicine; Myocardial infarction; Hazard ratio; Cardiology; Creatine kinase; Alanine transaminase; Confidence interval; Aspartate transaminase; Heart failure; Transaminase; Clinical endpoint; Clinical trial; Enzyme","score_opus":0.022584582472750844,"score_gpt":0.23379573014402016,"score_spread":0.2112111476712693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021657358","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99642026,0.0008206636,0.0017181265,0.00006628592,0.000112827365,0.00042144195,0.00010362074,0.00003696384,0.0002998142],"genre_scores_gemma":[0.9984946,0.00047073135,0.000051887426,0.00040434778,0.00009623236,0.000053556763,0.0003265017,0.000018925371,0.000083196144],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989906,0.00008568155,0.00027288205,0.00023331612,0.00024443923,0.00017306747],"domain_scores_gemma":[0.9993035,0.00001863192,0.00006917969,0.0003410774,0.0000831908,0.00018439384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010514691,0.00013768212,0.00023486308,0.00015281147,0.000041131443,0.000004785434,0.000065126114,0.000055014356,0.0007303152],"category_scores_gemma":[0.00001684288,0.00013620724,0.0002784484,0.00016893749,0.00008035845,0.0002577349,0.000024224646,0.0000946099,0.000051850693],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022182402,0.0009266176,0.9171562,0.00010061307,0.0007783808,0.0007357691,0.00075669115,0.000021850852,0.0011364213,0.000083444786,0.00040806129,0.07567769],"study_design_scores_gemma":[0.0016385221,0.00016399802,0.9960322,0.000075066084,0.0005351374,0.000048542293,0.00007726681,0.00038254444,0.00020270821,0.00014999574,0.0005607223,0.0001333177],"about_ca_topic_score_codex":0.00002076555,"about_ca_topic_score_gemma":0.000005307097,"teacher_disagreement_score":0.07887596,"about_ca_system_score_codex":0.000038206443,"about_ca_system_score_gemma":0.00011520465,"threshold_uncertainty_score":0.79964393},"labels":[],"label_agreement":null},{"id":"W2023056589","doi":"10.1016/j.jacc.2014.09.038","title":"Vorapaxar, Combination Antiplatelet Therapy, and Stroke∗","year":2014,"lang":"en","type":"letter","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Stroke (engine); Cardiology; Platelet; Myocardial infarction; Ischemic stroke; Internal medicine; Platelet activation; Platelet aggregation; Clopidogrel; Platelet aggregation inhibitor; Aspirin; Pharmacology; Ischemia","score_opus":0.014831399129847687,"score_gpt":0.2461552198518997,"score_spread":0.23132382072205201,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023056589","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7566899,0.009074819,0.00035464275,0.23122315,0.0009555934,0.00052533625,0.00017131004,0.000014420137,0.0009908208],"genre_scores_gemma":[0.8377041,0.009301882,0.00018814753,0.14862086,0.0035961736,0.000004227684,0.0000137816905,0.0000644954,0.00050628936],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973913,0.0008823085,0.0006453348,0.00021182525,0.0006058236,0.0002634235],"domain_scores_gemma":[0.99709886,0.00028339773,0.0015650844,0.0005376023,0.00043768634,0.000077371114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069658906,0.00029399447,0.002325813,0.00027186365,0.00007190029,0.0000072366843,0.00034577204,0.0002964306,0.000009682468],"category_scores_gemma":[0.00011596239,0.00018277104,0.0015910915,0.00023934063,0.0009922473,0.000044315962,0.00006403325,0.0011770019,0.0000014468578],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002083131,0.00004514108,0.014990489,0.00016536162,0.008052243,0.002278421,0.000020921234,0.000033522734,0.0011274259,0.000049183243,0.9609892,0.010164957],"study_design_scores_gemma":[0.003811836,0.0022854484,0.019789949,0.00019548504,0.0011902219,0.015385682,0.00008087772,0.0000089221985,0.00044169783,0.00023869776,0.9563561,0.00021508647],"about_ca_topic_score_codex":0.000004659394,"about_ca_topic_score_gemma":1.4361119e-7,"teacher_disagreement_score":0.08260229,"about_ca_system_score_codex":0.00004767067,"about_ca_system_score_gemma":0.00024490306,"threshold_uncertainty_score":0.74531865},"labels":[],"label_agreement":null},{"id":"W2023099437","doi":"10.1055/s-2007-971814","title":"Platelet Function Testing: Quality Assurance","year":2007,"lang":"en","type":"review","venue":"Seminars in Thrombosis and Hemostasis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Quality assurance; Platelet; Medicine; Function (biology); Intensive care medicine; Pathology; Internal medicine; External quality assessment; Biology","score_opus":0.1676744590797424,"score_gpt":0.41105275312953654,"score_spread":0.24337829404979414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023099437","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025069516,0.99414426,0.00005736946,0.00003133811,0.0001898079,0.000777743,0.0000725966,0.00008232979,0.0021376293],"genre_scores_gemma":[0.0004292082,0.9980191,0.00071392837,0.00021386085,0.00019484665,0.000053460095,0.0001861042,0.00007603168,0.00011348857],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973417,0.00019640879,0.00085094996,0.00071011006,0.00044456104,0.00045625234],"domain_scores_gemma":[0.9983049,0.0005511683,0.00028819547,0.0005660644,0.00008680226,0.00020284757],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012142195,0.000537016,0.0028327333,0.00027735287,0.00012531449,0.000040626328,0.000115088194,0.0005666542,0.000104159844],"category_scores_gemma":[0.0002137138,0.0004457418,0.0007935901,0.0008052635,0.00015933775,0.00008519944,0.000065252505,0.0005614647,0.00002849447],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046946974,0.00015189775,0.0015251436,0.01336929,0.0006917244,0.00006120391,0.00003767503,1.8729743e-7,0.0000018720726,0.00004132632,0.0010821893,0.98299056],"study_design_scores_gemma":[0.000748619,0.00018288079,0.004657731,0.027058385,0.0017536284,0.00016876774,0.00010049886,0.000001305739,0.00001053433,0.000051363644,0.9647833,0.00048295665],"about_ca_topic_score_codex":0.000043990538,"about_ca_topic_score_gemma":0.0000096633,"teacher_disagreement_score":0.9825076,"about_ca_system_score_codex":0.00013822145,"about_ca_system_score_gemma":0.00021215295,"threshold_uncertainty_score":0.99979943},"labels":[],"label_agreement":null},{"id":"W2023161457","doi":"10.1016/j.ahj.2005.01.044","title":"Benefit of clopidogrel according to timing of percutaneous coronary intervention in patients with acute coronary syndromes: Further results from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study","year":2005,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Cardiovascular Society; McMaster University","funders":"","keywords":"Medicine; Clopidogrel; Conventional PCI; Percutaneous coronary intervention; Myocardial infarction; Aspirin; Cardiology; Internal medicine; Randomization; Loading dose; Angina; Unstable angina; Randomized controlled trial; Surgery","score_opus":0.015802448122042182,"score_gpt":0.28700235500861365,"score_spread":0.2711999068865715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023161457","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974069,0.0006824309,0.000054390708,0.00054267736,0.00009972879,0.0011189341,0.00007516774,0.000009178435,0.000010564525],"genre_scores_gemma":[0.9983844,0.00022636687,0.0010104985,0.00021531309,0.00006739725,0.000016260317,0.000026323894,0.000032008327,0.000021396847],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976894,0.0002632762,0.0007728984,0.00031322005,0.0006302513,0.00033094565],"domain_scores_gemma":[0.99893355,0.00010907527,0.0002784816,0.00035769973,0.00013981404,0.00018134742],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055999303,0.00021605972,0.00070384535,0.00024024093,0.000058966878,0.000011099392,0.0001890052,0.000034553497,0.0000475968],"category_scores_gemma":[0.0000468922,0.0001547937,0.00026607147,0.00054654817,0.00006270753,0.00012777024,0.00008547854,0.00031483234,0.000006566831],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008634977,0.0027830263,0.85576683,0.000012815768,0.00076441764,0.00020387114,0.0037143466,0.0016150904,0.000081461214,3.2328933e-7,0.00009764053,0.12632522],"study_design_scores_gemma":[0.0038438372,0.00635785,0.9800707,0.0014693295,0.000257705,0.0005168537,0.007009141,0.000044895365,0.000035346206,0.0000055513774,0.00022068231,0.00016807999],"about_ca_topic_score_codex":0.0005266814,"about_ca_topic_score_gemma":0.00020788844,"teacher_disagreement_score":0.12615713,"about_ca_system_score_codex":0.00022276537,"about_ca_system_score_gemma":0.000090541864,"threshold_uncertainty_score":0.63123035},"labels":[],"label_agreement":null},{"id":"W2024206888","doi":"10.1007/s40256-013-0018-3","title":"Pharmacokinetics and Pharmacodynamics of the Antiplatelet Combination Aspirin (Acetylsalicylic Acid) Plus Extended-Release Dipyridamole Are Not Altered by Coadministration with the Potent CYP2C19 Inhibitor Omeprazole","year":2013,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Celerion (Canada)","funders":"","keywords":"Omeprazole; Medicine; Proton-pump inhibitor; Pharmacology; Pharmacodynamics; Pharmacokinetics; Dipyridamole; Aspirin; Drug interaction; CYP2C19; Crossover study; Clopidogrel; Anesthesia; Internal medicine","score_opus":0.004512241784459435,"score_gpt":0.21755519109785537,"score_spread":0.21304294931339593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024206888","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98473585,0.008172095,0.003936451,0.0021513756,0.00017147181,0.00071777415,0.000037129717,0.000018117233,0.000059718062],"genre_scores_gemma":[0.9960936,0.0026805524,0.00011047199,0.0007514644,0.00024039633,0.00002875037,0.000015773965,0.000051002797,0.00002802554],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971002,0.00044547828,0.0005611365,0.0002722519,0.0013236022,0.00029735162],"domain_scores_gemma":[0.9977215,0.00006571501,0.00079687167,0.00057447003,0.00059536134,0.00024606814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007271917,0.00031366578,0.0009594146,0.00010314265,0.0001650696,0.00006770525,0.00028369005,0.000056853827,0.000013893343],"category_scores_gemma":[0.000033439283,0.00018250367,0.0011658291,0.0004431502,0.0007377977,0.0002355213,0.00006601789,0.00045294306,0.0000028634433],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054471493,0.0015577028,0.004843868,0.0006253248,0.039171375,0.00032066397,0.0022698103,0.0101624355,0.11510039,0.00010955498,0.0063106567,0.8140811],"study_design_scores_gemma":[0.0701625,0.0073673944,0.15262786,0.0019540687,0.030137219,0.010346467,0.022063255,0.012679852,0.6249765,0.00012037298,0.065219834,0.0023446693],"about_ca_topic_score_codex":0.000056800225,"about_ca_topic_score_gemma":7.4500804e-7,"teacher_disagreement_score":0.8117364,"about_ca_system_score_codex":0.00008568155,"about_ca_system_score_gemma":0.00020277983,"threshold_uncertainty_score":0.7442284},"labels":[],"label_agreement":null},{"id":"W2025798942","doi":"10.1007/s11239-013-0998-5","title":"Cangrelor for patients undergoing percutaneous coronary intervention: evidence from a meta-analysis of randomized trials","year":2013,"lang":"en","type":"review","venue":"Journal of Thrombosis and Thrombolysis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Medicine; Cangrelor; Percutaneous coronary intervention; Internal medicine; Clopidogrel; Myocardial infarction; Conventional PCI; Relative risk; TIMI; Cardiology; Randomized controlled trial; Prasugrel; Confidence interval","score_opus":0.24415101877041773,"score_gpt":0.41736220220514,"score_spread":0.17321118343472225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025798942","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006966094,0.98903465,0.0010653362,0.000071608694,0.00024010557,0.0021931939,0.00041238792,0.000009086559,0.000007523593],"genre_scores_gemma":[0.010033438,0.9874011,0.0019162057,0.00004244528,0.00019088935,0.00012343629,0.00019025146,0.000060049253,0.000042184707],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99139166,0.0024729846,0.004496623,0.00047590118,0.00091213966,0.00025071512],"domain_scores_gemma":[0.9823427,0.009947808,0.0058955834,0.0005776607,0.0009854268,0.00025078555],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.004894082,0.0006439571,0.033195373,0.0009150969,0.000101780926,0.000088523964,0.00030560698,0.00036263463,0.001742617],"category_scores_gemma":[0.003364246,0.00036520165,0.05669812,0.00064563734,0.00022391783,0.00026671216,0.00008335937,0.00030343773,0.0000030408337],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025336735,0.0004277727,0.000062328116,0.004892555,0.8647641,0.00001446488,0.00012002137,0.000005673579,0.00000441905,0.000007965768,0.00025556778,0.12691148],"study_design_scores_gemma":[0.018842509,0.0006138418,0.00018231728,0.0065028607,0.9672638,0.00006626808,0.00011031363,0.000024705498,0.0000040261484,0.0000901893,0.00599812,0.00030100407],"about_ca_topic_score_codex":0.00013243374,"about_ca_topic_score_gemma":0.00001367603,"teacher_disagreement_score":0.12661047,"about_ca_system_score_codex":0.00011699909,"about_ca_system_score_gemma":0.00028946667,"threshold_uncertainty_score":0.99988},"labels":[],"label_agreement":null},{"id":"W2026256733","doi":"10.1161/strokeaha.107.497271","title":"Antiplatelet Therapy for Secondary Prevention of Noncardioembolic Ischemic Stroke","year":2008,"lang":"en","type":"review","venue":"Stroke","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Aspirin; Clopidogrel; Dipyridamole; Stroke (engine); Cardiology; Internal medicine; Ticlopidine; Prasugrel; Anesthesia","score_opus":0.03488896007890335,"score_gpt":0.3230762856701135,"score_spread":0.28818732559121013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026256733","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001970547,0.98911566,0.00032224806,0.00000544785,0.00028123718,0.0027682832,0.0013330316,0.00007911122,0.004124452],"genre_scores_gemma":[0.0003042611,0.9934069,0.0003992523,0.000038083377,0.0007395303,0.00029191453,0.0012207263,0.00013870855,0.0034606345],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975927,0.00014071145,0.0008165281,0.0005704433,0.00045774312,0.00042188924],"domain_scores_gemma":[0.9982823,0.0001090525,0.00046851797,0.00082331174,0.00015656253,0.0001602322],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023039716,0.0005779984,0.003551003,0.00027743622,0.00009324247,0.000012939356,0.000242837,0.00053224346,0.00015963755],"category_scores_gemma":[0.00003140054,0.0004709616,0.0059524993,0.00018922359,0.00015322956,0.00008610145,0.00004008138,0.00044237744,0.000028365681],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002764917,0.000168245,0.000019055056,0.008088224,0.0067079198,0.000043163924,0.000021909247,2.611487e-7,0.00006773345,0.000009812575,0.0037923155,0.98080486],"study_design_scores_gemma":[0.0039882055,0.0005459437,0.000034643515,0.0043161246,0.0026082953,0.00068021065,0.000017647733,0.0000010133393,0.0005152464,0.000005318335,0.98692364,0.00036368993],"about_ca_topic_score_codex":0.0000035192559,"about_ca_topic_score_gemma":2.8872304e-7,"teacher_disagreement_score":0.98313135,"about_ca_system_score_codex":0.000058939262,"about_ca_system_score_gemma":0.00091385975,"threshold_uncertainty_score":0.9997742},"labels":[],"label_agreement":null},{"id":"W2026993092","doi":"10.3310/hta13310","title":"The effect of different treatment durations of clopidogrel in patients with non-ST-segment elevation acute coronary syndromes: a systematic review and value of information analysis","year":2009,"lang":"en","type":"review","venue":"Health Technology Assessment","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics","funders":"Health Technology Assessment Programme; National Institute for Health and Care Research","keywords":"Medicine; Clopidogrel; Percutaneous coronary intervention; Aspirin; Conventional PCI; Acute coronary syndrome; Internal medicine; Randomized controlled trial; Observational study; Stroke (engine); Myocardial infarction; MEDLINE; Coronary artery disease; Ticlopidine; Emergency medicine","score_opus":0.007741342285406925,"score_gpt":0.3264320055505357,"score_spread":0.3186906632651288,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026993092","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009644293,0.9796244,0.0005978396,0.00016463047,0.000015726253,0.009830712,0.00010114623,0.000017948076,0.0000033207718],"genre_scores_gemma":[0.030498367,0.96756816,0.00014400527,0.000025115496,0.0000014411323,0.0010371984,0.0007122757,0.000010513498,0.0000029366297],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99702066,0.00044783822,0.0017373089,0.00020327407,0.0003985026,0.00019243213],"domain_scores_gemma":[0.9970025,0.00017090862,0.0019636722,0.0006862387,0.00012512036,0.0000516053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061293476,0.00033673205,0.004596906,0.0007044402,0.00006862408,0.0000039197735,0.00011701208,0.00019574587,0.0000022158765],"category_scores_gemma":[0.000030735115,0.00016738092,0.0005093751,0.0010507923,0.00010881314,0.000056605088,0.000028292085,0.00018387829,3.1140033e-7],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000073305266,0.00037206148,0.013203066,0.6842741,0.012286327,0.0000028995555,0.000022397078,0.0000034946825,3.529478e-8,0.00020136111,0.0000044174326,0.28955656],"study_design_scores_gemma":[0.006953602,0.025381284,0.14880088,0.65475494,0.16222033,0.00009231026,0.00012438207,0.00007784277,0.0000055258715,0.000018454048,0.0011503162,0.00042011598],"about_ca_topic_score_codex":0.0000117660165,"about_ca_topic_score_gemma":0.000005429547,"teacher_disagreement_score":0.28913647,"about_ca_system_score_codex":0.00046272977,"about_ca_system_score_gemma":0.0003720231,"threshold_uncertainty_score":0.68255955},"labels":[],"label_agreement":null},{"id":"W2027057839","doi":"10.1016/s0828-282x(06)70960-6","title":"Effect of a prior authorization process on antiplatelet therapy and outcomes in patients prescribed clopidogrel following coronary stenting","year":2006,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"University of Alberta","keywords":"Medicine; Clopidogrel; Medical prescription; Ticagrelor; Stent; Internal medicine; Demographics; Prior authorization; Percutaneous coronary intervention; Emergency medicine; Aspirin; Myocardial infarction; Demography","score_opus":0.007086207797149561,"score_gpt":0.2418721572792805,"score_spread":0.23478594948213094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027057839","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974278,0.0016121987,0.00007189436,0.000044187345,0.00026265855,0.00034192053,0.000007872533,0.000004080856,0.00022734057],"genre_scores_gemma":[0.9996937,0.000067608045,0.000016161728,0.00004125083,0.00013453995,0.0000032750397,0.000015504062,0.000016621241,0.000011342431],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988466,0.00025710047,0.0003693514,0.00013110098,0.0001735611,0.00022231964],"domain_scores_gemma":[0.9993895,0.00009248355,0.00016178584,0.00010264162,0.00010319521,0.0001503613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051873305,0.0001363208,0.00075260265,0.00029957655,0.00005085749,0.000008336084,0.00006465559,0.0001144336,0.000002514239],"category_scores_gemma":[0.00012552005,0.00010311706,0.00034240517,0.00012209479,0.00006541434,0.0000756154,0.0000040222017,0.00015997974,3.5857585e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087777793,0.000010260454,0.96635705,0.00005027168,0.00044886378,0.0002592678,0.000062504936,0.00040160253,0.000086717904,0.000016029575,0.000032076186,0.031397566],"study_design_scores_gemma":[0.0076371976,0.0018809928,0.989054,0.00016981321,0.00015482088,0.00009062008,0.000028893859,0.000010183911,0.0004898062,0.000028055936,0.00036940817,0.0000862021],"about_ca_topic_score_codex":0.00011923928,"about_ca_topic_score_gemma":0.00003274447,"teacher_disagreement_score":0.031311363,"about_ca_system_score_codex":0.00004852696,"about_ca_system_score_gemma":0.00022104039,"threshold_uncertainty_score":0.42049918},"labels":[],"label_agreement":null},{"id":"W2028851695","doi":"10.1016/j.jstrokecerebrovasdis.2008.04.003","title":"Titrated Initiation of Acetylsalicylic Acid-Dipyridamole Therapy Reduces Adverse Effects and Improves Tolerance in Patients With Stroke","year":2008,"lang":"en","type":"article","venue":"Journal of Stroke and Cerebrovascular Diseases","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Ottawa; Trillium Health Centre","funders":"","keywords":"Dipyridamole; Medicine; Discontinuation; Adverse effect; Aspirin; Stroke (engine); Anesthesia; Headaches; Propranolol; Internal medicine; Surgery","score_opus":0.005100736387985622,"score_gpt":0.20159991364266477,"score_spread":0.19649917725467916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028851695","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9797173,0.019757185,0.00003022743,0.000024112009,0.000044574583,0.0003448479,0.000029140114,0.0000100081625,0.000042578307],"genre_scores_gemma":[0.9923724,0.0072652595,0.00011272492,0.00009846669,0.00008630604,0.000005747677,0.000015435146,0.00002116705,0.000022527247],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99863887,0.000101532576,0.00037184643,0.00019121006,0.0005120333,0.00018451683],"domain_scores_gemma":[0.9990726,0.00004129681,0.00026452093,0.00017374207,0.0002441408,0.00020366709],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011868191,0.00020226806,0.0006228114,0.00019814182,0.00006870305,0.00001134435,0.00006509171,0.000073427655,0.000015632437],"category_scores_gemma":[0.000046955698,0.00014400088,0.00031792917,0.0001578057,0.00019240908,0.00033454102,0.000015409181,0.00015157783,4.783474e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029304635,0.0007797691,0.9741277,0.00024752915,0.0014600857,0.00007303094,0.0002506821,0.000031624284,0.008904551,0.0000048370443,0.000041181134,0.011148512],"study_design_scores_gemma":[0.014525749,0.0015668395,0.9629728,0.00032160978,0.00045769243,0.00008475167,0.00021460967,0.000012495432,0.019577349,0.0000054880147,0.000114235336,0.00014637964],"about_ca_topic_score_codex":0.0000104419805,"about_ca_topic_score_gemma":0.0000012810588,"teacher_disagreement_score":0.012655039,"about_ca_system_score_codex":0.000022739223,"about_ca_system_score_gemma":0.00015386734,"threshold_uncertainty_score":0.5872186},"labels":[],"label_agreement":null},{"id":"W2029040054","doi":"10.1159/000324629","title":"Validity of Composite Outcomes in Meta-Analyses of Stroke Prevention Trials: The Case of Aspirin","year":2011,"lang":"en","type":"review","venue":"Cerebrovascular Diseases","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Aspirin; Relative risk; Stroke (engine); Myocardial infarction; Internal medicine; Placebo; Cardiology; Absolute risk reduction; Randomized controlled trial; Confidence interval; Pathology","score_opus":0.34675857275823047,"score_gpt":0.44642904437180525,"score_spread":0.09967047161357478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029040054","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010683129,0.98536086,0.00020109558,0.0000047746435,0.000095144365,0.0023773804,0.0011764547,0.000022879654,0.00007829748],"genre_scores_gemma":[0.027354574,0.97170323,0.00012201756,0.000009986632,0.000064262895,0.00020806739,0.00035175998,0.000071695315,0.0001143963],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99119985,0.0044462867,0.0028564013,0.0005761187,0.0006328104,0.00028855988],"domain_scores_gemma":[0.99425256,0.001128803,0.002155251,0.0019910068,0.00029316684,0.00017922607],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0027800759,0.00070355245,0.011837466,0.00052383984,0.000049983748,0.000011622226,0.00044124515,0.00029415908,0.00052053854],"category_scores_gemma":[0.00091716746,0.00037527754,0.02632621,0.00056381203,0.00040808917,0.00009827695,0.00013674823,0.0002903182,0.0000053799363],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033814032,0.003858699,0.0044840034,0.07454134,0.2721958,0.00045583173,0.00008528251,0.000026253681,0.00001427341,0.00021594249,0.00007392875,0.6437105],"study_design_scores_gemma":[0.004358001,0.00051531824,0.0032340568,0.008466389,0.92517245,0.00061458285,0.00020457334,0.0000052220016,0.0007077227,0.00029415524,0.05574579,0.00068172126],"about_ca_topic_score_codex":0.0004214764,"about_ca_topic_score_gemma":0.000027736767,"teacher_disagreement_score":0.6529767,"about_ca_system_score_codex":0.000047674916,"about_ca_system_score_gemma":0.00050850445,"threshold_uncertainty_score":0.99986994},"labels":[],"label_agreement":null},{"id":"W2029582166","doi":"10.1159/000215310","title":"Salicylate Antagonism of Acetylsalicylic Acid Inhibition of Platelet Aggregation in Male and Female Subjects: Influence of Citrate Concentration","year":2009,"lang":"en","type":"article","venue":"Haemostasis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Antagonism; Platelet; Platelet aggregation; Internal medicine; Chemistry; Aspirin; Endocrinology; Pharmacology; Medicine; Receptor","score_opus":0.01432367173965069,"score_gpt":0.26163943038462406,"score_spread":0.24731575864497338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029582166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99644166,0.0027465196,0.000080253994,0.00011065279,0.000013036211,0.000354685,0.000051252733,0.000013471184,0.00018846751],"genre_scores_gemma":[0.99681646,0.002768056,0.00017681562,0.0001318572,0.000015457606,0.0000041865464,0.000071542825,0.000008569652,0.000007063714],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99892914,0.0000715695,0.00043974209,0.00017972665,0.00023565147,0.00014414352],"domain_scores_gemma":[0.999359,0.00002429422,0.00023031121,0.000198205,0.0001321113,0.00005605544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023528283,0.000120780336,0.0004270501,0.00011059206,0.000021093998,0.0000048802535,0.00003427903,0.000101099286,0.000018767723],"category_scores_gemma":[0.00005707877,0.00011763639,0.00011191706,0.0003295359,0.00014105353,0.00018835314,0.000009068518,0.0000745055,8.3869605e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012806994,0.00028009145,0.03565787,0.00049170014,0.00016767622,0.00008622446,0.0016095722,0.00030599925,0.7919642,0.00055758905,0.000013084553,0.16758534],"study_design_scores_gemma":[0.0023060224,0.00031887816,0.1069128,0.00039172737,0.00008029152,0.00007661668,0.00020462934,0.000070194925,0.88933086,0.00019356592,0.000028407654,0.000086023676],"about_ca_topic_score_codex":0.00006232693,"about_ca_topic_score_gemma":0.000005783817,"teacher_disagreement_score":0.16749932,"about_ca_system_score_codex":0.000022090799,"about_ca_system_score_gemma":0.00006945561,"threshold_uncertainty_score":0.47970727},"labels":[],"label_agreement":null},{"id":"W2029920339","doi":"10.1016/j.ahj.2010.07.026","title":"Association between smoking, outcomes, and early clopidogrel use in patients with acute coronary syndrome: Insights from the Global Registry of Acute Coronary Events","year":2010,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Heart Research Centre; St. Michael's Hospital","funders":"Sanofi","keywords":"Medicine; Clopidogrel; Acute coronary syndrome; Internal medicine; Myocardial infarction; Cardiology; Aspirin","score_opus":0.008373253007348225,"score_gpt":0.24997584910183349,"score_spread":0.24160259609448526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029920339","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988589,0.00019563329,0.000016554177,0.0003483439,0.00014046842,0.00024608482,0.00017332892,0.000013535121,0.000007111815],"genre_scores_gemma":[0.9988477,0.00021239916,0.00033992087,0.0004285119,0.00006392012,0.000003471875,0.000052430445,0.000019338928,0.00003226578],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99833804,0.00017661562,0.00035072604,0.00020849478,0.0006843969,0.0002417348],"domain_scores_gemma":[0.9988377,0.00015222997,0.00036946993,0.0003146554,0.0001284296,0.00019749286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016995755,0.00018309175,0.0006214824,0.000047220183,0.00012312688,0.00003307432,0.00012945532,0.000092113674,0.000018842125],"category_scores_gemma":[0.000049011374,0.00011772086,0.00021372102,0.00023742505,0.00019993843,0.00023903085,0.000046758505,0.0005905211,0.000002151969],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005549853,0.00012914943,0.9921073,0.0000026228724,0.0044602063,0.0002471057,0.000082634484,5.324739e-7,0.000014248152,0.0000020981086,0.00018851417,0.0022106052],"study_design_scores_gemma":[0.0032189656,0.00076144683,0.99351585,0.00009341392,0.0012993998,0.00043872342,0.00004894149,8.48021e-7,0.000005808714,0.000055332403,0.00043049306,0.00013079695],"about_ca_topic_score_codex":0.0006207252,"about_ca_topic_score_gemma":0.000040190374,"teacher_disagreement_score":0.0031608064,"about_ca_system_score_codex":0.00011316583,"about_ca_system_score_gemma":0.00014123216,"threshold_uncertainty_score":0.48005176},"labels":[],"label_agreement":null},{"id":"W2030235009","doi":"10.1016/j.cjca.2014.07.745","title":"Superiority of Ticagrelor Over Clopidogrel in Patients After Cardiac Arrest Undergoing Therapeutic Hypothermia","year":2014,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Ticagrelor; Medicine; Clopidogrel; Conventional PCI; Percutaneous coronary intervention; P2Y12; Return of spontaneous circulation; Cardiology; Internal medicine; Anesthesia; Hypothermia; Loading dose; Cardiopulmonary resuscitation; Aspirin; Myocardial infarction; Resuscitation","score_opus":0.007496285214136697,"score_gpt":0.21311354204794888,"score_spread":0.20561725683381218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030235009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936144,0.003392744,0.00034731123,0.00010196578,0.0008762298,0.00013850034,0.00001813291,0.000003017948,0.0015077324],"genre_scores_gemma":[0.99877656,0.00022512516,0.00005054708,0.00027275502,0.00062872085,0.0000025333293,0.0000046142254,0.000022260847,0.000016903552],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99867433,0.00030585902,0.00039314193,0.00013662908,0.0001784519,0.00031157944],"domain_scores_gemma":[0.9990038,0.00010464103,0.00010848704,0.0002513388,0.00016311675,0.0003685733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042775058,0.00014185833,0.0008205207,0.00025175928,0.000029516448,0.000007529659,0.000107079744,0.0001553859,0.00004223003],"category_scores_gemma":[0.00014137034,0.00012027824,0.0006002256,0.00013203526,0.00019727145,0.00006307173,0.000007564501,0.00024179516,0.0000059252775],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034086892,0.000006908098,0.98442787,0.000042222266,0.00064669957,0.00007806412,0.000097438824,0.00007063289,0.000048327205,0.00008686967,0.00016845214,0.013985659],"study_design_scores_gemma":[0.0022001548,0.00039286833,0.9529837,0.00011130956,0.00025975515,0.000024411425,0.00004972317,0.00000395687,0.000042316384,0.00017357418,0.043649066,0.00010920161],"about_ca_topic_score_codex":0.00018764801,"about_ca_topic_score_gemma":0.00041974994,"teacher_disagreement_score":0.043480612,"about_ca_system_score_codex":0.0001180674,"about_ca_system_score_gemma":0.0007184571,"threshold_uncertainty_score":0.49048042},"labels":[],"label_agreement":null},{"id":"W2030325185","doi":"10.1159/000075298","title":"Recent Clinical Trial Results with Antiplatelet Therapy: Implications in Stroke Prevention","year":2004,"lang":"en","type":"review","venue":"Cerebrovascular Diseases","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Clopidogrel; Conventional PCI; Percutaneous coronary intervention; Internal medicine; Stroke (engine); Cardiology; Myocardial infarction; Aspirin; Clinical endpoint; Randomized controlled trial","score_opus":0.11136089986461128,"score_gpt":0.4021439598714671,"score_spread":0.29078306000685583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030325185","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022393889,0.9892915,0.00007723653,0.000107612286,0.00028992456,0.0069199367,0.0005349998,0.00021541817,0.00032400838],"genre_scores_gemma":[0.00021558847,0.99309903,0.00014793909,0.00010679095,0.0007808023,0.0008934758,0.0042090365,0.00019490786,0.00035240952],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9938625,0.0010268639,0.00200179,0.0015915897,0.0008416255,0.0006756079],"domain_scores_gemma":[0.9959945,0.00023026318,0.0006741315,0.0022850728,0.00021936405,0.0005966453],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00092027284,0.0009279791,0.003962285,0.0004686014,0.00015187365,0.00009897837,0.0004334611,0.0006779367,0.00016014847],"category_scores_gemma":[0.000322208,0.0006655782,0.005212054,0.0009752856,0.0002908848,0.00017321356,0.0000898388,0.0008169784,0.00010795938],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017408414,0.0030253113,0.0003274696,0.0038682392,0.0056455215,0.00016149553,0.000010529568,0.0000071548607,3.9600597e-8,0.000038603008,0.00019135533,0.9693159],"study_design_scores_gemma":[0.11288082,0.0014697283,0.0024163583,0.015651789,0.00723032,0.00021445201,0.000016037748,4.884713e-7,7.3939566e-7,0.00006385286,0.85937643,0.0006789574],"about_ca_topic_score_codex":0.000015849377,"about_ca_topic_score_gemma":0.000011944235,"teacher_disagreement_score":0.96863693,"about_ca_system_score_codex":0.00033321264,"about_ca_system_score_gemma":0.0032668686,"threshold_uncertainty_score":0.99957955},"labels":[],"label_agreement":null},{"id":"W2030370251","doi":"10.1016/s0009-9236(03)90529-7","title":"The Single‐Dose Pharmacokinetics of Clopidogrel in Healthy Adult Volunteers","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pharmaxis (Canada)","funders":"","keywords":"Pharmacokinetics; Clopidogrel; Medicine; Pharmacology; Internal medicine; Aspirin","score_opus":0.06607649872153568,"score_gpt":0.4036290090279938,"score_spread":0.33755251030645816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030370251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9737951,0.015907144,0.00016487647,0.006267894,0.0021584397,0.0007434566,0.000008118863,0.000051961695,0.0009029788],"genre_scores_gemma":[0.915179,0.030927291,0.000224825,0.053130396,0.00032565414,0.000026580841,0.0000059270947,0.000041476167,0.00013883442],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969099,0.00092117605,0.0010235278,0.0003534174,0.00029436706,0.0004976249],"domain_scores_gemma":[0.9980228,0.00091725856,0.00019871217,0.00038078972,0.00025810814,0.00022233256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001139839,0.00023393637,0.00064922177,0.00007410811,0.00011105277,0.000008420243,0.00023200597,0.00024336786,0.00012482898],"category_scores_gemma":[0.000089764915,0.0001707638,0.00057966803,0.00034227557,0.0008849566,0.000035625297,0.0000329092,0.0007120413,0.000029570592],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.057949696,0.021656686,0.42088985,0.0006323298,0.020172672,0.0007931578,0.0012218056,0.00052092934,0.05675936,0.0019706634,0.031661835,0.385771],"study_design_scores_gemma":[0.04610802,0.0057765194,0.058068205,0.00011389419,0.0048656105,0.00016905628,0.0006822059,0.0013309671,0.018188586,0.0005478226,0.8634852,0.00066392496],"about_ca_topic_score_codex":0.0000032302848,"about_ca_topic_score_gemma":0.0000048536563,"teacher_disagreement_score":0.83182335,"about_ca_system_score_codex":0.00005889141,"about_ca_system_score_gemma":0.00028474524,"threshold_uncertainty_score":0.69635457},"labels":[],"label_agreement":null},{"id":"W2030742513","doi":"10.1016/s0828-282x(07)70870-x","title":"Cost-effectiveness of clopidogrel in acute coronary syndromes in Canada: A long-term analysis based on the CURE trial","year":2007,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Myocardial infarction; Clopidogrel; Emergency medicine; Stroke (engine); Population; Heart failure; Health care; Intensive care medicine; Cause of death; Indirect costs; Disease; Internal medicine; Environmental health","score_opus":0.02881220311614878,"score_gpt":0.2818735674394495,"score_spread":0.25306136432330073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030742513","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99612063,0.0015639954,0.0009863324,0.0002807177,0.00031040917,0.0004914199,0.000035714627,0.000001133059,0.0002096498],"genre_scores_gemma":[0.99946207,0.00014367038,0.0000060366865,0.00022285379,0.00012503039,0.000007989873,0.0000176533,0.000010730912,0.0000039679007],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998203,0.0006184311,0.0004629638,0.00014037821,0.00023593377,0.0003392938],"domain_scores_gemma":[0.99860406,0.00053714623,0.00015415554,0.00025751686,0.00012734039,0.00031977752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018383801,0.00013795268,0.0010669553,0.00074311934,0.00003096616,0.0000037823231,0.00016813878,0.00011455986,0.000033555298],"category_scores_gemma":[0.00011483822,0.00009868819,0.0006526181,0.0006729452,0.00013157279,0.000027660966,0.0000049797245,0.0003615481,4.4553593e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014841516,0.000010733931,0.95728076,0.000027289707,0.0034679903,0.012033247,0.000026490334,0.008430655,0.000016979593,0.000022729584,0.00010171547,0.0037399193],"study_design_scores_gemma":[0.014955723,0.000478903,0.9819652,0.0001558535,0.0011685378,0.0005512642,0.00009766337,0.000029697061,0.000063056876,0.0000100996385,0.00043686855,0.000087120905],"about_ca_topic_score_codex":0.14189577,"about_ca_topic_score_gemma":0.76943094,"teacher_disagreement_score":0.62753516,"about_ca_system_score_codex":0.0008204207,"about_ca_system_score_gemma":0.005969858,"threshold_uncertainty_score":0.9996654},"labels":[],"label_agreement":null},{"id":"W2031246035","doi":"10.1016/j.giec.2011.07.005","title":"The Interaction Between Proton Pump Inhibitors and Clopidogrel and Upper Gastrointestinal Bleeding","year":2011,"lang":"en","type":"review","venue":"Gastrointestinal Endoscopy Clinics of North America","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster University Medical Centre; Health Sciences Centre","funders":"","keywords":"Clopidogrel; Medicine; Adverse effect; Proton-pump inhibitor; Upper gastrointestinal bleeding; Pharmacodynamics; Gastrointestinal bleeding; Aspirin; Peptic ulcer; Incidence (geometry); Internal medicine; Gastroenterology; Pharmacology; Intensive care medicine; Endoscopy; Pharmacokinetics","score_opus":0.03892271052220697,"score_gpt":0.3290272787407844,"score_spread":0.29010456821857744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031246035","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012999947,0.9827612,0.0009837997,0.00006047821,0.00017942002,0.0025449346,0.00010978217,0.00011195222,0.00024847596],"genre_scores_gemma":[0.0011521678,0.9886127,0.00912084,0.00003676737,0.0006018488,0.00015240134,0.00015866988,0.00011105839,0.000053513806],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99634737,0.00034007666,0.0015030806,0.00077176123,0.00041590052,0.0006218093],"domain_scores_gemma":[0.9956892,0.0016464894,0.0013529263,0.00059331505,0.00025518288,0.00046287413],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006392482,0.0007387039,0.0024140317,0.00023958634,0.00025804245,0.00006375078,0.00026769063,0.00009398182,0.000019838597],"category_scores_gemma":[0.0012147725,0.0005146042,0.001031358,0.0003567193,0.0010504962,0.00014752963,0.00024738582,0.0011749213,0.000018437691],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046174086,0.00008920506,0.11876014,0.0053311544,0.0004275815,0.00006458045,0.000022993527,3.5588005e-7,7.8431736e-7,0.000007376913,0.000045912046,0.87478817],"study_design_scores_gemma":[0.0017862107,0.006205559,0.012378157,0.060512856,0.0064875637,0.015958562,0.00026124256,0.000031320928,0.0000045228417,0.000037453105,0.8955731,0.00076347875],"about_ca_topic_score_codex":0.000049302285,"about_ca_topic_score_gemma":0.0000030500084,"teacher_disagreement_score":0.8955272,"about_ca_system_score_codex":0.00005846225,"about_ca_system_score_gemma":0.0003915004,"threshold_uncertainty_score":0.9997305},"labels":[],"label_agreement":null},{"id":"W2031612633","doi":"10.1592/phco.30.4.420","title":"Prolonged Infusion of Eptifibatide as Bridge Therapy Between Bare‐Metal Stent Insertion and Cardiovascular Surgery: Case Report and Review of the Literature","year":2010,"lang":"en","type":"review","venue":"Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services","funders":"","keywords":"Medicine; Eptifibatide; Clopidogrel; Myocardial infarction; Surgery; Stent; Aspirin; Coronary stent; Coronary artery disease; Angioplasty; Anesthesia; Cardiology; Percutaneous coronary intervention; Internal medicine; Restenosis","score_opus":0.04201689924318022,"score_gpt":0.3549312096058376,"score_spread":0.3129143103626574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031612633","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4000024,0.59783894,0.0000027002434,0.00023376258,0.0002911154,0.0015850179,0.000029615616,0.000009322384,0.0000071363565],"genre_scores_gemma":[0.045028295,0.9529825,0.000011149985,0.0010218264,0.0007455913,0.000047137368,0.00002946468,0.00009118467,0.00004286549],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9934542,0.0031193602,0.0019372479,0.0004344096,0.00072548783,0.00032930283],"domain_scores_gemma":[0.99602956,0.0007050294,0.0017978485,0.0006634274,0.0005509262,0.00025323514],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.006345046,0.0007190383,0.003919497,0.00035379382,0.00037805384,0.000028582517,0.0003520666,0.00034644673,0.00015307455],"category_scores_gemma":[0.00005477751,0.00037029773,0.0026243199,0.00045654897,0.0008079283,0.00020571974,0.000086624,0.0016390488,3.5485726e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013858338,0.00034451616,0.00087921397,0.018349743,0.016158177,0.003128931,0.0011486153,4.5090263e-7,0.0066828253,0.0000034189777,0.0013200543,0.95059824],"study_design_scores_gemma":[0.008735972,0.0009631675,0.0014217683,0.03509708,0.018495232,0.1574689,0.00007191542,0.0000011217277,0.010491852,0.00009023038,0.7664798,0.00068294455],"about_ca_topic_score_codex":0.000028045857,"about_ca_topic_score_gemma":0.0000011673483,"teacher_disagreement_score":0.9499153,"about_ca_system_score_codex":0.00003236938,"about_ca_system_score_gemma":0.0004501127,"threshold_uncertainty_score":0.9998749},"labels":[],"label_agreement":null},{"id":"W2031873044","doi":"10.1038/ajg.2009.667","title":"Management of Platelet-Directed Pharmacotherapy in Patients With Atherosclerotic Coronary Artery Disease Undergoing Elective Endoscopic Gastrointestinal Procedures","year":2009,"lang":"en","type":"review","venue":"The American Journal of Gastroenterology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Pharmacotherapy; Percutaneous coronary intervention; Coronary artery disease; Intensive care medicine; Percutaneous; Cardiology; Interventional cardiology; Disease; Platelet aggregation inhibitor; Stent; Internal medicine; Platelet; Myocardial infarction","score_opus":0.010768937383509456,"score_gpt":0.268176594382778,"score_spread":0.25740765699926854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031873044","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.62367916,0.37495008,0.0002860643,0.00004782323,0.0000395913,0.00096055644,0.000013415219,0.000017260292,0.0000060546276],"genre_scores_gemma":[0.25746706,0.7416353,0.00050204905,0.00022074662,0.000072506904,0.000021159398,0.000017734623,0.000055563392,0.000007835561],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9972741,0.0006690489,0.0008642245,0.00028561676,0.000446982,0.00046002964],"domain_scores_gemma":[0.99763095,0.000121039055,0.0015743629,0.0003205257,0.0001532863,0.00019984676],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025349943,0.00044896748,0.0025044929,0.00034002448,0.00004116398,0.0000092125665,0.00033731168,0.000027135397,0.000021398193],"category_scores_gemma":[0.00001941074,0.00026856235,0.0006997565,0.00034173724,0.00043704375,0.000063097614,0.00003167687,0.00054732646,0.0000016000713],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08348593,0.002200327,0.13896447,0.005021461,0.0093536675,0.0030451366,0.000083302046,0.0000985364,0.0000037213902,0.0000037221507,0.000047175585,0.7576925],"study_design_scores_gemma":[0.021140156,0.06365087,0.81904775,0.07744442,0.009609209,0.0068564,0.00020547371,0.000008071839,0.0000028012553,0.00003736091,0.001591196,0.00040626855],"about_ca_topic_score_codex":0.0000015502283,"about_ca_topic_score_gemma":0.0000021254145,"teacher_disagreement_score":0.75728625,"about_ca_system_score_codex":0.00015911566,"about_ca_system_score_gemma":0.00034350503,"threshold_uncertainty_score":0.99997663},"labels":[],"label_agreement":null},{"id":"W2032032737","doi":"10.1503/cmaj.060122","title":"Does sex affect how patients respond to ASA?","year":2006,"lang":"en","type":"review","venue":"Canadian Medical Association Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Aspirin; Randomized controlled trial; Primary prevention; Affect (linguistics); Disease; Alternative medicine; Internal medicine; Bioinformatics; Pathology; Psychology","score_opus":0.0099420292454802,"score_gpt":0.2725203556859617,"score_spread":0.2625783264404815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032032737","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005255662,0.9910607,0.000037237158,0.004211565,0.0017216314,0.0008441179,0.00025751296,0.000034853594,0.001306821],"genre_scores_gemma":[0.000102296355,0.9830852,0.000035354926,0.0039726538,0.0047496017,0.000030362893,0.0002878008,0.00007468082,0.007662038],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99528384,0.0006946009,0.00057216664,0.00033178288,0.0024205206,0.0006970764],"domain_scores_gemma":[0.9954003,0.00022462785,0.00036349392,0.00025725327,0.00038275516,0.0033715356],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017867456,0.00037116604,0.0016678515,0.00053589424,0.00025414387,0.00016658312,0.0002755216,0.0010558369,0.0014413767],"category_scores_gemma":[0.0021436098,0.00022273914,0.0014422454,0.0004495926,0.000029728813,0.000075710646,0.000021199063,0.001453793,0.00028060918],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007455621,0.000032974967,0.0016747849,0.00054430374,0.00087600935,0.0009089259,0.000017028466,5.665384e-8,7.983147e-9,0.0000028968639,0.18613741,0.8097981],"study_design_scores_gemma":[0.00091639196,0.00010443641,0.0012976475,0.0044787913,0.0010599608,0.00027577282,0.000022061366,5.5877933e-7,1.3977787e-7,0.0000062054296,0.99155575,0.0002822565],"about_ca_topic_score_codex":0.0002954921,"about_ca_topic_score_gemma":0.002132782,"teacher_disagreement_score":0.8095159,"about_ca_system_score_codex":0.0022176201,"about_ca_system_score_gemma":0.006310103,"threshold_uncertainty_score":0.9994714},"labels":[],"label_agreement":null},{"id":"W2032810702","doi":"10.1016/j.amjcard.2008.05.042","title":"Perioperative Bridging Therapy With Unfractionated Heparin or Low-Molecular-Weight Heparin in Patients With Mechanical Prosthetic Heart Valves on Long-Term Oral Anticoagulants (from the REGIMEN Registry)","year":2008,"lang":"en","type":"article","venue":"The American Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph's Hospital; Hamilton Health Sciences; Hamilton General Hospital","funders":"","keywords":"Heparin; Medicine; Perioperative; Regimen; Mechanical heart; Bridging (networking); Low molecular weight heparin; Surgery; Anesthesia; Intensive care medicine","score_opus":0.01380459713838553,"score_gpt":0.25779322963705575,"score_spread":0.24398863249867023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032810702","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969553,0.00052025926,0.0007108396,0.0011796845,0.00005924515,0.00049790833,0.0000071534255,0.000015919475,0.00005373756],"genre_scores_gemma":[0.9972667,0.0009654771,0.00013846061,0.0013435091,0.00018663163,0.000014124413,0.000015386302,0.000039571256,0.000030148298],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99749523,0.0009710414,0.000362592,0.0002856857,0.0005561615,0.00032929538],"domain_scores_gemma":[0.9985514,0.00018922414,0.00037477666,0.0005292062,0.00023222611,0.00012315947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037042686,0.00027618677,0.00114122,0.00008163633,0.000170728,0.000020177704,0.000259882,0.00005232434,0.00001553825],"category_scores_gemma":[0.00005313065,0.00011722297,0.00032478786,0.00034102923,0.00089816726,0.000078507364,0.000028655591,0.000542722,0.000003917686],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.050551396,0.0003102438,0.92808074,0.0000057002044,0.003514127,0.002439753,0.0004224221,0.0008693982,0.0009121031,0.000017591245,0.0001184566,0.012758062],"study_design_scores_gemma":[0.0062360205,0.0056143515,0.98198336,0.00022131113,0.00026665427,0.0038205683,0.00017502002,0.000016563741,0.0012143872,0.000007745679,0.00026095653,0.0001830709],"about_ca_topic_score_codex":0.000060350638,"about_ca_topic_score_gemma":0.000007111557,"teacher_disagreement_score":0.053902604,"about_ca_system_score_codex":0.00008032996,"about_ca_system_score_gemma":0.00037147343,"threshold_uncertainty_score":0.47802138},"labels":[],"label_agreement":null},{"id":"W2033254862","doi":"10.1136/bmj.b4351","title":"Coprescription of clopidogrel and proton pump inhibitors","year":2010,"lang":"en","type":"editorial","venue":"BMJ","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Clopidogrel; Medicine; Internal medicine; Aspirin","score_opus":0.00792104691341456,"score_gpt":0.2801084225929212,"score_spread":0.2721873756795066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033254862","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07436245,0.005315344,0.000030416399,0.00019792207,0.9150221,0.0032129653,0.0001276134,0.0000841597,0.0016470407],"genre_scores_gemma":[0.0098093795,0.0021460548,0.00012321028,0.000032211003,0.9858701,0.00019790548,0.00044427847,0.000055827306,0.0013210042],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.998553,0.000052808144,0.00031868846,0.0002705867,0.00066096196,0.00014395452],"domain_scores_gemma":[0.9990537,0.00006057828,0.00018173721,0.000392563,0.00020439176,0.000107040396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038175564,0.00019384734,0.00055918033,0.000091094145,0.000034065844,0.000013805454,0.000062810315,0.00084709557,0.000059364924],"category_scores_gemma":[0.00038571112,0.00016243054,0.0003122903,0.00006528856,0.00013810491,0.000046147885,0.000038316455,0.0005793455,0.000010844727],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060621434,0.00007703233,0.0006379628,0.0011917967,0.000392527,0.000040789128,0.00004824257,1.2268798e-7,0.0012688609,0.0000068003656,0.98532504,0.0104046],"study_design_scores_gemma":[0.0017724467,0.00023508753,0.00054655055,0.0005545631,0.00045417162,0.00002068279,0.000020033749,0.0000025050304,0.003502843,0.00003304945,0.9926995,0.00015856666],"about_ca_topic_score_codex":0.00004271682,"about_ca_topic_score_gemma":0.0000035748546,"teacher_disagreement_score":0.07084804,"about_ca_system_score_codex":0.000017078768,"about_ca_system_score_gemma":0.00026004456,"threshold_uncertainty_score":0.6623726},"labels":[],"label_agreement":null},{"id":"W2033401592","doi":"10.1097/ftd.0b013e3181757c59","title":"Assessment of VerifyNow P2Y12 Assay Accuracy in Evaluating Clopidogrel-Induced Platelet Inhibition","year":2008,"lang":"en","type":"article","venue":"Therapeutic Drug Monitoring","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Sacré-Cœur de Montréal; Université de Montréal","funders":"","keywords":"Clopidogrel; P2Y12; Medicine; Platelet; Internal medicine; Adenosine diphosphate; Thrombin; Coronary artery disease; Pharmacology; Cardiology; Platelet aggregation; Aspirin","score_opus":0.0663790918121313,"score_gpt":0.36503938341309816,"score_spread":0.29866029160096685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033401592","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954881,0.002167544,0.00024953397,0.00007805163,0.00042236946,0.00049851363,0.0000024813833,0.000084900435,0.001008518],"genre_scores_gemma":[0.9975621,0.0010325162,0.0007505983,0.00005757607,0.0004187129,0.000049300368,0.000014012333,0.000044382046,0.000070783455],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99779415,0.00028906894,0.0005044828,0.0003249567,0.00073099486,0.00035635082],"domain_scores_gemma":[0.99893445,0.00023464019,0.00017541632,0.00042325893,0.00012636551,0.00010586733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010307583,0.00023718078,0.00055804645,0.00019372089,0.00012443967,0.000012439922,0.000098450415,0.00011167064,0.000058361427],"category_scores_gemma":[0.00006440247,0.00022305653,0.00028995718,0.00036933378,0.00006638382,0.00019475745,0.00003815591,0.00036287718,0.000010077576],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004212885,0.00063610583,0.49280286,0.0002542883,0.00078827684,0.00044976184,0.0024645217,0.0004414883,0.27158326,0.00010254987,0.00001216854,0.23004343],"study_design_scores_gemma":[0.0055619543,0.0002789431,0.83652014,0.0007368883,0.00018989971,0.0002138479,0.0009113058,0.0008860754,0.1540129,0.00011158637,0.00025404675,0.0003223807],"about_ca_topic_score_codex":0.000069231995,"about_ca_topic_score_gemma":0.0000011717931,"teacher_disagreement_score":0.3437173,"about_ca_system_score_codex":0.00017487905,"about_ca_system_score_gemma":0.00025433733,"threshold_uncertainty_score":0.9095982},"labels":[],"label_agreement":null},{"id":"W2033877028","doi":"10.1503/cmaj.114-0028","title":"Not quite the full story on new antiplatelets","year":2014,"lang":"en","type":"letter","venue":"Canadian Medical Association Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital","funders":"","keywords":"Ticagrelor; Medicine; Perspective (graphical); Computer science; Data science; Internal medicine; Aspirin; Clopidogrel; Artificial intelligence","score_opus":0.011328396571759202,"score_gpt":0.22818756454952524,"score_spread":0.21685916797776603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033877028","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0045197224,0.0012536463,0.000086503605,0.9884253,0.0021922032,0.0002498748,0.000036151614,0.000037045407,0.0031995135],"genre_scores_gemma":[0.006223659,0.0008939521,0.000011886778,0.9356656,0.048416015,0.0000051770485,0.00012637005,0.00007404847,0.008583311],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9939103,0.0007443202,0.00048734588,0.00032713174,0.0036670924,0.00086382404],"domain_scores_gemma":[0.9964114,0.00049316924,0.00039814413,0.0004238063,0.00031773458,0.0019557592],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.0025170492,0.0003575412,0.00073623465,0.00028730268,0.0005404503,0.0001494009,0.0004581448,0.0020419413,0.005223773],"category_scores_gemma":[0.0015650005,0.00024713256,0.0009531205,0.00018195539,0.00008708808,0.000056635625,0.0000146136035,0.0084741395,0.0011796126],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004544404,0.000008866987,0.00024509602,0.000023165905,0.0011101601,0.007100708,0.000058877296,0.0000018089949,0.0000019634804,0.000013687209,0.9479427,0.043447565],"study_design_scores_gemma":[0.0016767052,0.00016563358,0.0015377451,0.00034425285,0.00037740418,0.0037696045,0.000030289231,0.000014299234,0.0000063057028,0.000035910205,0.9917779,0.00026394086],"about_ca_topic_score_codex":0.00052994495,"about_ca_topic_score_gemma":0.0008493302,"teacher_disagreement_score":0.05275976,"about_ca_system_score_codex":0.0012565529,"about_ca_system_score_gemma":0.0073780986,"threshold_uncertainty_score":0.9999981},"labels":[],"label_agreement":null},{"id":"W2034712190","doi":"10.1115/sbc2007-176446","title":"Platelet and Shear Stress Interactions Within Asymmetric Stenotic Arteries","year":2007,"lang":"en","type":"article","venue":"ASME 2007 Summer Bioengineering Conference","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Heart Institute","funders":"","keywords":"Platelet; Platelet activation; Cardiology; Shear stress; Platelet adhesion; Thrombosis; Internal medicine; Carotid arteries; Stenosis; Granule (geology); Medicine; Materials science; Composite material","score_opus":0.020935135931120317,"score_gpt":0.26250807628077244,"score_spread":0.24157294034965213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034712190","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94903964,0.0025035304,0.04546746,0.00012408986,0.00053105556,0.00026342485,0.000023766146,0.00019093559,0.0018560924],"genre_scores_gemma":[0.9975344,0.00032021277,0.0014133966,0.0001378492,0.00016366891,0.000006668335,0.000033223896,0.000030919273,0.00035965725],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99882454,0.000016038408,0.0002771783,0.00029137405,0.0002372543,0.00035364466],"domain_scores_gemma":[0.9992375,0.00007804892,0.000048150046,0.0002827023,0.000103649785,0.00024996971],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023830374,0.00022366723,0.00032735587,0.00028549146,0.00007697987,0.00005596596,0.0000782157,0.00008528244,0.00013618772],"category_scores_gemma":[0.000060772945,0.00020599905,0.000119975964,0.00030906952,0.000103153696,0.00015827175,0.000034651017,0.00025702824,0.00004144889],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026256437,0.0014111092,0.23627552,0.0023466367,0.006364734,0.004278967,0.0043930784,0.00208065,0.03740235,0.01322413,0.002349177,0.687248],"study_design_scores_gemma":[0.007957318,0.0011825523,0.78941894,0.0018753626,0.0011301641,0.002419998,0.004559829,0.01353579,0.09854853,0.00015686515,0.076952145,0.0022625215],"about_ca_topic_score_codex":0.00003874979,"about_ca_topic_score_gemma":0.000011780542,"teacher_disagreement_score":0.68498546,"about_ca_system_score_codex":0.000033697816,"about_ca_system_score_gemma":0.00004864039,"threshold_uncertainty_score":0.8400398},"labels":[],"label_agreement":null},{"id":"W2035301649","doi":"10.1001/jamaneurol.2013.601","title":"Association of Aspirin Resistance With Increased Stroke Severity and Infarct Size","year":2012,"lang":"en","type":"article","venue":"JAMA Neurology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Interquartile range; Medicine; Aspirin; Stroke (engine); Internal medicine; Cardiology; Prospective cohort study; Surrogate endpoint","score_opus":0.005010367128541977,"score_gpt":0.21173207948064718,"score_spread":0.2067217123521052,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035301649","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954948,0.0009660038,0.000020545753,0.0013473848,0.000036740174,0.00012885174,0.000015706608,0.000022559489,0.0019674213],"genre_scores_gemma":[0.99708766,0.00016283253,0.00009984829,0.0021884963,0.0001330273,0.0000063430234,0.0000058967576,0.000009850049,0.0003060603],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99925536,0.0001642425,0.00011050286,0.000115820556,0.00017614606,0.00017791361],"domain_scores_gemma":[0.9993971,0.00020666131,0.00008793734,0.00016005266,0.000057854293,0.00009041382],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002929563,0.000076130586,0.00024934288,0.0000266594,0.00002675284,0.0000038170815,0.000028486995,0.00012850514,0.000047016467],"category_scores_gemma":[0.0002211392,0.00006217819,0.00006528726,0.00006412375,0.000059402773,0.00008117752,0.000016024658,0.0001738118,0.0000028629709],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026906824,0.000104545565,0.99168205,0.00006963543,0.00032627795,0.000027449361,0.00006388079,5.409332e-7,0.0024897375,0.000085285676,0.00043429798,0.0020256315],"study_design_scores_gemma":[0.002388838,0.00024154932,0.96728855,0.000009757076,0.00019319505,0.000058167032,0.000008968476,0.0000036258502,0.0012971228,0.000021172753,0.028435469,0.000053559343],"about_ca_topic_score_codex":0.000024151845,"about_ca_topic_score_gemma":0.000016088958,"teacher_disagreement_score":0.02800117,"about_ca_system_score_codex":0.000010549137,"about_ca_system_score_gemma":0.000028963066,"threshold_uncertainty_score":0.25355527},"labels":[],"label_agreement":null},{"id":"W2035657173","doi":"10.1111/j.1527-3466.2000.tb00045.x","title":"Ridogrel: An Antiplatelet Agent with Antihypertensive Properties","year":2000,"lang":"en","type":"article","venue":"Cardiovascular Drug Reviews","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Thromboxane; Antithrombotic; Losartan; Pharmacology; Aspirin; Medicine; Thromboxane-A synthase; Platelet; Thromboxane A2; Thromboxane receptor; Ex vivo; In vivo; Angiotensin II; Receptor; Chemistry; Internal medicine; In vitro; Biochemistry; Biology","score_opus":0.02880990748899466,"score_gpt":0.23485040891820488,"score_spread":0.2060405014292102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035657173","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.61293477,0.38269114,0.00013639762,0.000097604105,0.00009038932,0.0016651702,0.0000062456447,0.0002032187,0.002175047],"genre_scores_gemma":[0.7572771,0.23687327,0.000902862,0.0017627649,0.0007055218,0.00023018086,0.00013005084,0.00016308579,0.0019551732],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99666494,0.0004587542,0.0005437594,0.0008933989,0.0008537772,0.0005853745],"domain_scores_gemma":[0.99707395,0.000008848883,0.000078121266,0.0021546038,0.0002276786,0.00045679833],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010428571,0.0005561368,0.0021253347,0.00010620795,0.00023646251,0.00007453572,0.00024651425,0.00012332769,0.0005752936],"category_scores_gemma":[0.000029982248,0.00035134683,0.0030378764,0.00045932436,0.00025708697,0.0003326919,0.000027822472,0.00030837388,0.0008781262],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084809575,0.0003816561,0.0020360716,0.0007956181,0.008334911,0.0024418395,0.00053406245,0.00044464695,0.00041048133,0.000013258753,0.0031151732,0.98064417],"study_design_scores_gemma":[0.0033701053,0.0002533026,0.003707311,0.00095420337,0.0037149282,0.003386099,0.00015744609,0.00007295314,0.0018290699,0.000005004193,0.98192245,0.0006271556],"about_ca_topic_score_codex":0.00004398733,"about_ca_topic_score_gemma":0.0000030697543,"teacher_disagreement_score":0.980017,"about_ca_system_score_codex":0.000053713477,"about_ca_system_score_gemma":0.000111724956,"threshold_uncertainty_score":0.9998998},"labels":[],"label_agreement":null},{"id":"W2035690940","doi":"10.1016/j.ijcard.2008.01.030","title":"The benefit of aspirin therapy in type 2 diabetes: What is the evidence?","year":2008,"lang":"en","type":"review","venue":"International Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut Universitaire de Cardiologie et de Pneumologie de Québec; Centre hospitalier universitaire de Québec; Université Laval","funders":"","keywords":"Medicine; Aspirin; Observational study; Diabetes mellitus; Type 2 diabetes; MEDLINE; Clinical trial; Type 1 diabetes; Intensive care medicine; Platelet aggregation inhibitor; Randomized controlled trial; Internal medicine; Endocrinology","score_opus":0.06318099061082277,"score_gpt":0.3618951607452851,"score_spread":0.29871417013446233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035690940","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003308545,0.99364007,0.000010161238,0.0007899635,0.0018624403,0.00026836895,0.0000065570002,0.0000027864405,0.000111097426],"genre_scores_gemma":[0.003980082,0.9941641,0.000007225692,0.00039532623,0.0013560664,0.000010643002,0.000007674134,0.000022407925,0.00005649148],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977339,0.00039550118,0.0009007135,0.00015061098,0.00064359145,0.00017566237],"domain_scores_gemma":[0.9971324,0.0010154707,0.00069263694,0.0003486136,0.00075970957,0.00005116772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008663857,0.00021710005,0.0015763687,0.00019699613,0.00004076825,0.00003269011,0.0007792224,0.00020041877,0.000027409025],"category_scores_gemma":[0.00020218497,0.000100490965,0.0022532833,0.00017837547,0.00026818382,0.00014197701,0.000058814898,0.0005260763,0.000010293518],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024258367,0.000016536524,0.000498745,0.00012754762,0.0060529425,0.00024423783,0.00005641675,0.000020075813,0.0000014075399,0.000041563806,0.00087373867,0.9918242],"study_design_scores_gemma":[0.00055841607,0.0003306603,0.0006517364,0.009634714,0.00041142377,0.002715756,0.000057540416,0.0000010349847,0.000008925477,0.0001455017,0.98539793,0.00008635161],"about_ca_topic_score_codex":0.0000025396212,"about_ca_topic_score_gemma":6.333958e-7,"teacher_disagreement_score":0.99173784,"about_ca_system_score_codex":0.00010374727,"about_ca_system_score_gemma":0.00049391924,"threshold_uncertainty_score":0.40979025},"labels":[],"label_agreement":null},{"id":"W2036310476","doi":"10.1016/j.amjcard.2008.07.019","title":"Relation Between Aspirin Dose, All-Cause Mortality, and Bleeding in Patients With Recent Cerebrovascular or Coronary Ischemic Events (from the BRAVO Trial)","year":2008,"lang":"en","type":"article","venue":"The American Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute; Université de Montréal; University of Alberta","funders":"","keywords":"Medicine; Aspirin; Hazard ratio; Internal medicine; Confidence interval; Myocardial infarction; Proportional hazards model; Stroke (engine); Cardiology; Placebo; Lower risk; Surgery; Pathology","score_opus":0.05352058188088669,"score_gpt":0.2935407493880327,"score_spread":0.24002016750714603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036310476","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976824,0.0011102594,0.00014628626,0.00047164562,0.000100959965,0.0004160533,0.0000067321753,0.000007445377,0.00005823209],"genre_scores_gemma":[0.9939721,0.005086449,0.000057670648,0.00034354205,0.00048527948,0.0000047871736,0.000022214861,0.000020251533,0.000007675437],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981591,0.0006096717,0.00042654306,0.00017015282,0.00042829727,0.00020621407],"domain_scores_gemma":[0.998746,0.00029477774,0.00040609602,0.0003321648,0.00012005518,0.00010093721],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007346887,0.0001600681,0.00081904174,0.000058881647,0.00008817392,0.0000051988304,0.00016992202,0.0000500608,0.000010541067],"category_scores_gemma":[0.00009254269,0.00007672689,0.0002605189,0.00022113264,0.0004240736,0.000088526795,0.000048371236,0.0003713741,0.0000017423862],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02022214,0.000036179328,0.96109563,0.0000035023,0.0066821286,0.00010945198,0.00019354142,0.00009450044,0.00002810625,0.0000015371688,0.00014125505,0.011392033],"study_design_scores_gemma":[0.02092058,0.0020633005,0.9721733,0.00007295342,0.0018196241,0.00052818435,0.00025210666,0.00000156341,0.000016932503,0.0000277982,0.0020260932,0.000097612436],"about_ca_topic_score_codex":0.000048686372,"about_ca_topic_score_gemma":0.0000025724269,"teacher_disagreement_score":0.011294421,"about_ca_system_score_codex":0.000062963794,"about_ca_system_score_gemma":0.00013758651,"threshold_uncertainty_score":0.31288314},"labels":[],"label_agreement":null},{"id":"W2036344615","doi":"10.1111/apt.12292","title":"Meta‐analysis: colonoscopic post‐polypectomy bleeding in patients on continued clopidogrel therapy","year":2013,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto","funders":"","keywords":"Medicine; Clopidogrel; Polypectomy; Colonoscopy; Internal medicine; Antithrombotic; Surgery; Relative risk; Aspirin; Colorectal cancer; Confidence interval; Cancer","score_opus":0.13149381803152568,"score_gpt":0.3822268265572356,"score_spread":0.2507330085257099,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036344615","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018368747,0.9761936,0.0000020263562,0.00026119355,0.00074226793,0.0040686596,0.00014104608,0.000104577055,0.000117883],"genre_scores_gemma":[0.0025613026,0.97769785,0.000054387703,0.016954597,0.00029786388,0.00086272927,0.0011834078,0.00014735124,0.00024052056],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9955966,0.0010254215,0.0010949656,0.0009519344,0.00054747076,0.0007835968],"domain_scores_gemma":[0.9980934,0.0003412414,0.0005123231,0.00064886274,0.0001578429,0.00024631308],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003692535,0.0010536275,0.0055351127,0.0009637855,0.00013607024,0.000040769046,0.00045463955,0.0005653233,0.0026484847],"category_scores_gemma":[2.9303183e-7,0.0007855618,0.0047995406,0.0010453773,0.0002057249,0.00012120764,0.0000826132,0.0009552087,0.00023987975],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006042368,0.0015639173,0.0011258806,0.00070845895,0.9049855,0.00009099128,0.00009376229,0.0000037821844,0.000019181734,0.000004823031,0.00016160937,0.090637855],"study_design_scores_gemma":[0.004354792,0.0009967831,0.00039960287,0.00021670191,0.642313,0.00000840645,0.00002128374,0.000004017133,0.000100788726,0.0000032587889,0.35112953,0.00045179372],"about_ca_topic_score_codex":0.00007096531,"about_ca_topic_score_gemma":0.000004307202,"teacher_disagreement_score":0.35096794,"about_ca_system_score_codex":0.0002703637,"about_ca_system_score_gemma":0.00025804798,"threshold_uncertainty_score":0.9994595},"labels":[],"label_agreement":null},{"id":"W2036470655","doi":"10.1161/01.atv.0000147304.67100.ee","title":"Gender Dependent Association of Thrombospondin-4 A387P Polymorphism With Myocardial Infarction","year":2004,"lang":"en","type":"letter","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. John’s Health Sciences Centre; Memorial University of Newfoundland","funders":"","keywords":"Thrombospondin; Myocardial infarction; Internal medicine; Thrombospondin 1; Association (psychology); Medicine; Polymorphism (computer science); Cardiology; Genetics; Psychology; Genotype; Biology; Angiogenesis; Matrix metalloproteinase; Gene","score_opus":0.023639491745358676,"score_gpt":0.251686042635636,"score_spread":0.2280465508902773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036470655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94218564,0.0019783867,0.0008988252,0.05209234,0.00069872325,0.0013208367,0.00024505836,0.00015430579,0.00042586014],"genre_scores_gemma":[0.88561195,0.018413408,0.0002911092,0.09296187,0.0015622649,0.00010591375,0.00088636734,0.00013136126,0.000035734047],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99719244,0.00031891014,0.00055107125,0.0007867145,0.0005820166,0.00056882686],"domain_scores_gemma":[0.9984701,0.00006777753,0.00044493095,0.00068506924,0.00020982079,0.0001222995],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0004084091,0.000553131,0.0016364203,0.00027016317,0.00016385161,0.00004053711,0.00014301085,0.0013817988,0.0001807839],"category_scores_gemma":[0.000024917686,0.00044104853,0.0009939024,0.00021153934,0.00027286386,0.00010556684,0.000076729455,0.0007916181,0.00002130669],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016914241,0.0009323979,0.78225434,0.0017270813,0.07043521,0.000014665825,0.001131403,0.000021269512,0.088712335,0.00036201076,0.0521707,0.0020694565],"study_design_scores_gemma":[0.004354145,0.0009061077,0.9341218,0.0003696791,0.0043710056,0.000014933773,0.000054891676,0.0000023736727,0.00026967085,0.000110088775,0.05487555,0.00054978486],"about_ca_topic_score_codex":0.00017834936,"about_ca_topic_score_gemma":0.000011130086,"teacher_disagreement_score":0.15186743,"about_ca_system_score_codex":0.00024385801,"about_ca_system_score_gemma":0.00022007081,"threshold_uncertainty_score":0.99991465},"labels":[],"label_agreement":null},{"id":"W2036731085","doi":"10.1111/j.1365-2796.2004.01324.x","title":"Cost‐effectiveness of clopidogrel in acute coronary syndromes in Sweden: a long‐term model based on the cure trial","year":2004,"lang":"en","type":"article","venue":"Journal of Internal Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Population Health Research Institute","funders":"","keywords":"Medicine; Clopidogrel; Cost effectiveness; Unstable angina; Angina; Quality-adjusted life year; Acute coronary syndrome; Clinical trial; Emergency medicine; Intensive care medicine; Internal medicine; Cardiology; Aspirin; Myocardial infarction","score_opus":0.040709026703612185,"score_gpt":0.3376672876684313,"score_spread":0.2969582609648191,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036731085","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98920417,0.0019495619,0.005651992,0.0019660424,0.00039685753,0.0006570141,0.0000046495556,0.0000048672864,0.00016485504],"genre_scores_gemma":[0.9980781,0.0008113345,0.00006539325,0.0007552782,0.0002323405,0.000014101187,0.0000027770886,0.000020022237,0.00002062635],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9978744,0.00025880584,0.0007599309,0.00015036752,0.000759408,0.00019713299],"domain_scores_gemma":[0.9987672,0.00035854717,0.00034346842,0.00024174775,0.00015606725,0.00013295001],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016331578,0.00019784832,0.00092976535,0.00040335854,0.00001824531,0.0000050294047,0.00024348283,0.00009905309,0.00007016013],"category_scores_gemma":[0.00022499442,0.00010800936,0.0004361979,0.00025238816,0.00018837187,0.000086821325,0.000020802321,0.0006265299,0.0000017625882],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7170987,0.00416382,0.18713157,0.0008055166,0.0034591903,0.027683567,0.0014473777,0.032158278,0.007644739,0.0004310922,0.00039022957,0.0175859],"study_design_scores_gemma":[0.3296954,0.016379295,0.6076858,0.03234432,0.0010170109,0.0050084535,0.00037573042,0.0025084685,0.0036175328,0.0010462952,0.00005312487,0.00026854285],"about_ca_topic_score_codex":0.000031240404,"about_ca_topic_score_gemma":0.000008671935,"teacher_disagreement_score":0.42055425,"about_ca_system_score_codex":0.00023297229,"about_ca_system_score_gemma":0.00031075208,"threshold_uncertainty_score":0.4404494},"labels":[],"label_agreement":null},{"id":"W2037723048","doi":"10.1016/j.ahj.2010.10.034","title":"Has the ClOpidogrel and Metoprolol in Myocardial Infarction Trial (COMMIT) of early β-blocker use in acute coronary syndromes impacted on clinical practice in Canada? Insights from the Global Registry of Acute Coronary Events (GRACE)","year":2011,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; Canadian VIGOUR Centre; Cégep de Sorel-Tracy; Canadian Heart Research Centre; University of Toronto; Surrey Memorial Hospital; St. Michael's Hospital","funders":"","keywords":"Medicine; Killip class; Internal medicine; Acute coronary syndrome; Myocardial infarction; Clopidogrel; Cardiology; ST elevation; TIMI; Odds ratio; Percutaneous coronary intervention","score_opus":0.0513770861922053,"score_gpt":0.32562099991625804,"score_spread":0.2742439137240527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037723048","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99685305,0.0010815285,0.0000047213907,0.001087422,0.00029274725,0.00059155276,0.00006572205,0.0000047171648,0.000018524097],"genre_scores_gemma":[0.99579793,0.0026570188,0.00022403573,0.0011722646,0.00011014441,0.000010333458,0.000009834746,0.000015322785,0.0000030898436],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965236,0.0014697078,0.0008875028,0.0002467933,0.0006051512,0.0002672099],"domain_scores_gemma":[0.99795645,0.00083589123,0.00050320366,0.00042734644,0.00010480545,0.00017232455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007507823,0.0001996366,0.00085440214,0.00007980828,0.000076663615,0.000016874123,0.0001806822,0.00009627925,0.000017043369],"category_scores_gemma":[0.00039760963,0.00012394633,0.00031855592,0.0004275019,0.00047796112,0.0002451087,0.000059195685,0.00085024297,8.759432e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06330831,0.0003829497,0.927236,0.0000025060306,0.0021695322,0.0009187601,0.0004937685,0.0000062578138,0.000026925836,0.000004587721,0.00027382286,0.0051765717],"study_design_scores_gemma":[0.0136736045,0.0024202703,0.9796094,0.00014366746,0.00065605517,0.0016299427,0.0011645367,0.000017844206,0.000013160529,0.00006781126,0.00049000775,0.00011371707],"about_ca_topic_score_codex":0.4112605,"about_ca_topic_score_gemma":0.049657606,"teacher_disagreement_score":0.36160287,"about_ca_system_score_codex":0.00022800076,"about_ca_system_score_gemma":0.0015181781,"threshold_uncertainty_score":0.9676837},"labels":[],"label_agreement":null},{"id":"W2038225144","doi":"10.1016/j.cgh.2008.12.019","title":"Low-Dose Aspirin Affects the Small Bowel Mucosa: Results of a Pilot Study With a Multidimensional Assessment","year":2008,"lang":"en","type":"article","venue":"Clinical Gastroenterology and Hepatology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":117,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Lactulose; Gastroenterology; Internal medicine; Aspirin; Colonoscopy; Capsule endoscopy; Calprotectin; Mannitol; Intestinal permeability; Inflammatory bowel disease","score_opus":0.05066277012749552,"score_gpt":0.32508185531206063,"score_spread":0.2744190851845651,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038225144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99728596,0.00024764537,0.0003060652,0.0011652492,0.0001426252,0.00073792547,0.000011587329,0.000029766761,0.00007314981],"genre_scores_gemma":[0.99663717,0.00038157793,0.00056544255,0.0022093256,0.000084745974,0.000047253292,0.000021120626,0.000015766529,0.000037600214],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99746776,0.0009498052,0.0005836294,0.00048729862,0.00017391834,0.00033760478],"domain_scores_gemma":[0.99849737,0.0005404546,0.00020843178,0.00047124157,0.00010109864,0.0001814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087580946,0.00020739173,0.0008847699,0.000058350557,0.00014384915,0.000002113535,0.00011101133,0.00010601322,0.000016028898],"category_scores_gemma":[0.00009873968,0.00012216384,0.00020765523,0.000062842984,0.001305501,0.000022453358,0.00011015887,0.00048143067,0.000004580589],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.042388838,0.0049895747,0.9488732,0.00003037238,0.0012436457,0.0013984857,0.000075019685,0.0000058428022,0.000060692226,0.000042357726,0.0002479221,0.00064401684],"study_design_scores_gemma":[0.022290148,0.050863594,0.9237762,0.00003955885,0.00042948523,0.0020096782,0.00012365026,0.00012971621,0.000022326469,0.000009717137,0.00023774043,0.0000681586],"about_ca_topic_score_codex":0.000032446605,"about_ca_topic_score_gemma":0.00026155377,"teacher_disagreement_score":0.04587402,"about_ca_system_score_codex":0.000010430289,"about_ca_system_score_gemma":0.00015004682,"threshold_uncertainty_score":0.4981697},"labels":[],"label_agreement":null},{"id":"W2038591467","doi":"10.1097/hpc.0000000000000030","title":"Pharmacodynamic and Clinical Implications of Switching Between P2Y12 Receptor Antagonists","year":2014,"lang":"en","type":"review","venue":"Critical Pathways in Cardiology A Journal of Evidence-Based Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Vancouver General Hospital; Sunnybrook Health Science Centre; St. Paul's Hospital; University of British Columbia; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Prasugrel; Ticagrelor; Medicine; P2Y12; Clopidogrel; Acute coronary syndrome; Pharmacodynamics; Aspirin; Cangrelor; Regimen; Pharmacology; Platelet aggregation inhibitor; Internal medicine; Myocardial infarction; Pharmacokinetics","score_opus":0.3023411432016327,"score_gpt":0.4935682816870773,"score_spread":0.1912271384854446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038591467","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026198125,0.98406714,0.009032263,0.0028036786,0.0007483484,0.00060219975,0.000051115534,0.000016567368,0.00005887735],"genre_scores_gemma":[0.113643184,0.88226223,0.00052954355,0.00039230488,0.0030673638,0.000018733703,0.000033654345,0.000050797422,0.000002199316],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9924793,0.0024766247,0.0034677659,0.00054878934,0.0005637315,0.00046378025],"domain_scores_gemma":[0.98435134,0.012761965,0.0009843096,0.000625642,0.0006194947,0.0006572622],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.007605838,0.0005235911,0.007761385,0.0006704039,0.00008042426,0.000008237229,0.0004134192,0.0007706948,0.00004381146],"category_scores_gemma":[0.011860373,0.00032641113,0.0022428008,0.00043073014,0.0017497775,0.00012982366,0.00007368245,0.0020437497,0.000005436899],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003544696,0.00011727421,0.011920091,0.016189273,0.0018714815,0.0005282312,0.00002226635,0.0000025093168,0.00008048855,0.00031560965,0.00040584028,0.96819246],"study_design_scores_gemma":[0.010733695,0.0077041555,0.01618772,0.35167715,0.044663806,0.006742986,0.00010502517,0.000029992476,0.000019420278,0.0016959932,0.5594341,0.0010059279],"about_ca_topic_score_codex":0.0000038749376,"about_ca_topic_score_gemma":3.5122943e-7,"teacher_disagreement_score":0.9671865,"about_ca_system_score_codex":0.00017159442,"about_ca_system_score_gemma":0.0014339077,"threshold_uncertainty_score":0.9999188},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"systematic_review","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"not_applicable","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"split"},{"id":"W2038789754","doi":"10.1161/circulationaha.112.105908","title":"Guided Antithrombotic Therapy: Current Status and Future Research Direction","year":2012,"lang":"en","type":"article","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Daiichi Sankyo Europe; Janssen Pharmaceuticals; National Center for Advancing Translational Sciences; Quest Diagnostics; Duke Clinical Research Institute; Daiichi-Sankyo; Medicines Company; Brigham and Women's Hospital; Abbott Vascular; St. Jude Medical; Medicure; Boston Scientific Corporation; National Institutes of Health; University of Florida; Alnylam Pharmaceuticals; Bayer HealthCare; Sanofi; GlaxoSmithKline; Edwards Lifesciences; Amgen; National Heart, Lung, and Blood Institute; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Medical school; Gerontology; Theology; Philosophy","score_opus":0.08658537196478518,"score_gpt":0.37388813119855235,"score_spread":0.2873027592337672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038789754","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9134043,0.08486632,0.00016699027,0.0001290606,0.00042035294,0.00031037678,0.0000011822939,0.000053346634,0.00064806145],"genre_scores_gemma":[0.9798734,0.018567935,0.000033843018,0.000035021207,0.0014060468,0.000011892247,0.000043433563,0.000015097109,0.000013292197],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99900794,0.00013559694,0.00010908625,0.00014778077,0.00033044326,0.0002691674],"domain_scores_gemma":[0.9994974,0.00002023847,0.000024669525,0.0001849357,0.00012177811,0.00015093935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004776702,0.00007847604,0.00014098514,0.00010717217,0.00014521541,0.000020573327,0.000017289989,0.000060667113,0.00008692792],"category_scores_gemma":[0.000023691751,0.00006608697,0.00008442012,0.00022909738,0.000054974145,0.00018037698,0.000009660704,0.00013590453,0.00002663775],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005828714,0.00012502485,0.62990165,0.000051412844,0.00009907837,0.0000011297,0.0003918272,0.0000037038265,0.0028550946,0.000563215,0.00023977547,0.36570978],"study_design_scores_gemma":[0.000825262,0.000022847196,0.89665836,0.00002796894,0.00004227669,0.000027610411,0.0001144598,0.00006109272,0.00033077988,0.000109850254,0.10171198,0.00006753393],"about_ca_topic_score_codex":0.000011562564,"about_ca_topic_score_gemma":3.3912102e-7,"teacher_disagreement_score":0.36564225,"about_ca_system_score_codex":0.00005790908,"about_ca_system_score_gemma":0.000037159727,"threshold_uncertainty_score":0.26949483},"labels":[],"label_agreement":null},{"id":"W2039419686","doi":"10.1016/j.cjca.2013.02.014","title":"Antiplatelet Therapy and Cardiac Surgery: Review of Recent Evidence and Clinical Implications","year":2013,"lang":"en","type":"review","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto; St. Michael's Hospital","funders":"Sanofi; Bayer; AstraZeneca; Bristol-Myers Squibb","keywords":"Medicine; Prasugrel; Ticagrelor; Clopidogrel; Perioperative; P2Y12; Cardiac surgery; Aspirin; Platelet inhibition; Anesthesia; Cardiology; Internal medicine","score_opus":0.19154440013038657,"score_gpt":0.39398576171982924,"score_spread":0.20244136158944268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039419686","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00033560753,0.99736655,0.000020866019,0.0007581525,0.00045817043,0.00081989093,0.000086318614,0.000003684545,0.0001507369],"genre_scores_gemma":[0.00027417243,0.99844927,0.000050434694,0.00027575018,0.0008445337,0.000017852914,0.00003771092,0.00003582197,0.000014480813],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99653953,0.0012622763,0.0014534784,0.00029089584,0.0001548709,0.00029896633],"domain_scores_gemma":[0.99615425,0.0010115239,0.0008343579,0.00050182355,0.00059536786,0.0009026959],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025695732,0.00030716954,0.0058313455,0.0003158302,0.000060909657,0.000015242475,0.00016235434,0.00039018044,0.00005383404],"category_scores_gemma":[0.0010312671,0.00021855866,0.0024057284,0.00024949116,0.0005009815,0.00008091573,0.000019313964,0.00052999996,0.0000046689565],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014060292,0.0000026279877,0.005319315,0.011713786,0.003422571,0.00008143598,0.000003070501,3.168092e-8,1.6833063e-7,0.000026093856,0.016691884,0.962725],"study_design_scores_gemma":[0.00017566324,0.00017547145,0.005590362,0.04842772,0.0036920859,0.0028424605,0.000004455989,2.0428413e-8,1.9633173e-7,0.000019193689,0.93890965,0.0001627303],"about_ca_topic_score_codex":0.00007695154,"about_ca_topic_score_gemma":0.000005667688,"teacher_disagreement_score":0.9625622,"about_ca_system_score_codex":0.000066122084,"about_ca_system_score_gemma":0.0039093588,"threshold_uncertainty_score":0.8912564},"labels":[],"label_agreement":null},{"id":"W2039445888","doi":"10.1503/cmaj.071592","title":"Mortality benefit from unrestricted access to clopidogrel: Too good to be true?","year":2008,"lang":"en","type":"review","venue":"Canadian Medical Association Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Clopidogrel; Thienopyridine; Percutaneous coronary intervention; Medicine; Randomized controlled trial; Thrombosis; Intensive care medicine; Platelet aggregation inhibitor; Cardiology; Internal medicine; Aspirin; Myocardial infarction","score_opus":0.04789590265397268,"score_gpt":0.3369743685430001,"score_spread":0.2890784658890274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039445888","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0030684818,0.9841774,0.00009965212,0.008031368,0.0015137503,0.000994539,0.0007701447,0.000060467682,0.001284201],"genre_scores_gemma":[0.00009761187,0.9698809,0.0000685747,0.024286047,0.004527466,0.000054986827,0.00050838967,0.00008219031,0.00049383065],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.994142,0.00038677873,0.0011560076,0.00052330573,0.0029380037,0.00085390254],"domain_scores_gemma":[0.9910281,0.00027489933,0.0004272543,0.00047494966,0.0005049412,0.007289903],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00079803413,0.0004923286,0.002274716,0.0005827664,0.0003424328,0.00021372396,0.0007276451,0.0012836051,0.0033827524],"category_scores_gemma":[0.0023629998,0.00042182754,0.0016159329,0.0011283171,0.000032717384,0.0001399356,0.0000672671,0.0017581843,0.00038950692],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012229456,0.000045092005,0.0025779663,0.00016782345,0.0027553325,0.002705179,0.000056124503,0.0000011078578,1.6418431e-8,0.000015134619,0.160627,0.831037],"study_design_scores_gemma":[0.0008150688,0.00007912072,0.013637201,0.0029718545,0.0014520887,0.0008737761,0.000023189994,0.0000014702132,2.0209507e-7,0.000016209655,0.9797236,0.00040623208],"about_ca_topic_score_codex":0.006409433,"about_ca_topic_score_gemma":0.011731842,"teacher_disagreement_score":0.8306308,"about_ca_system_score_codex":0.0025601075,"about_ca_system_score_gemma":0.010470566,"threshold_uncertainty_score":0.99982333},"labels":[],"label_agreement":null},{"id":"W2039629569","doi":"10.1161/circulationaha.105.602136","title":"Aspirin Use and Outcomes in a Community-Based Cohort of 7352 Patients Discharged After First Hospitalization for Heart Failure","year":2006,"lang":"en","type":"article","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; University of Calgary; Institute for Clinical Evaluative Sciences; University of Toronto; Toronto General Hospital; University of Alberta","funders":"","keywords":"Medicine; Aspirin; Hazard ratio; Internal medicine; Heart failure; Cardiology; Coronary artery disease; Angiotensin-converting enzyme; Medical prescription; Cohort; Blood pressure; Pharmacology; Confidence interval","score_opus":0.00900662226351483,"score_gpt":0.2303048443890834,"score_spread":0.22129822212556857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039629569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957174,0.00008688401,0.0031913742,0.00010858777,0.000021967313,0.0008184837,0.000033750657,0.000016954542,0.000004591782],"genre_scores_gemma":[0.9986491,0.000002650905,0.00024607635,0.000119126176,0.000013591951,0.000075249416,0.0008765254,0.000013730983,0.00000393349],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994067,0.00006308133,0.00020764832,0.00010037673,0.00013815449,0.00008405078],"domain_scores_gemma":[0.9995911,0.000056791825,0.00005444051,0.00017315256,0.00009878903,0.0000257062],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014884383,0.00008220239,0.00022043848,0.00008235044,0.000054883854,0.000013283768,0.000017609533,0.0000604422,0.000005998921],"category_scores_gemma":[0.000051191957,0.00007572829,0.00011939405,0.000089619265,0.000034456334,0.00013093806,0.0000059856047,0.0000492946,5.8047164e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012595228,0.0002677456,0.9986654,0.00019233477,0.000036562116,4.981132e-7,0.00005545562,0.00039100312,0.0001162098,0.00003220784,0.00002716384,0.00008947883],"study_design_scores_gemma":[0.002869776,0.000058864807,0.9954701,0.00010489652,0.00009767617,5.1630764e-7,0.000014207151,0.0006125909,0.00020777302,0.00007323295,0.00041362256,0.00007675803],"about_ca_topic_score_codex":0.000118883574,"about_ca_topic_score_gemma":0.000114592156,"teacher_disagreement_score":0.0031953023,"about_ca_system_score_codex":0.000028242679,"about_ca_system_score_gemma":0.000013890401,"threshold_uncertainty_score":0.308811},"labels":[],"label_agreement":null},{"id":"W2040550310","doi":"10.1378/chest.128.4_meetingabstracts.273s","title":"EFFECTS OF CLOPIDOGREL IN OFF-PUMP BEATING HEART SURGERY","year":2005,"lang":"en","type":"article","venue":"CHEST Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame","funders":"","keywords":"Medicine; Clopidogrel; Thrombus; Coronary artery bypass surgery; Acute coronary syndrome; Cardiology; Artery; Cardiac surgery; Incidence (geometry); Internal medicine; Surgery; Myocardial infarction","score_opus":0.010554822417891161,"score_gpt":0.24753957422270761,"score_spread":0.23698475180481646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040550310","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98279995,0.016195696,0.0001229444,0.00044984484,0.000113378526,0.00008886244,4.86853e-7,0.000011972442,0.00021685276],"genre_scores_gemma":[0.99642396,0.0019899788,0.00048458038,0.0003348037,0.0006830939,0.0000024417295,0.0000017834246,0.000014771023,0.00006460976],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991046,0.00007482806,0.00029536287,0.000091734524,0.00023894223,0.00019453345],"domain_scores_gemma":[0.99945474,0.00017640914,0.00008186099,0.000106242085,0.00004973365,0.00013099845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004984863,0.00009151076,0.00039151488,0.0001326589,0.000041895968,0.000010415753,0.000040600124,0.00005975107,0.00006480824],"category_scores_gemma":[0.00018146475,0.00007622689,0.0004097997,0.00013915912,0.000042776777,0.000088649045,0.000010069978,0.00024277068,0.000014121985],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048640824,0.0006699393,0.61805993,0.000930259,0.0005383836,0.00083865767,0.0005453862,0.00011517561,0.02075347,0.000016982225,0.0023914888,0.35465392],"study_design_scores_gemma":[0.0028759737,0.00010902264,0.89678544,0.0011171086,0.00017715068,0.0019005283,0.00011249118,0.00006994442,0.058549684,0.00003439104,0.03811434,0.00015394944],"about_ca_topic_score_codex":0.0000026906948,"about_ca_topic_score_gemma":9.5020846e-7,"teacher_disagreement_score":0.35449997,"about_ca_system_score_codex":0.000042153526,"about_ca_system_score_gemma":0.00012163131,"threshold_uncertainty_score":0.31084424},"labels":[],"label_agreement":null},{"id":"W2041379747","doi":"10.1016/s0828-282x(06)70255-0","title":"Biological basis and clinical implications of acetylsalicylic acid resistance","year":2006,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Skepticism; Intensive care medicine; Disease; Resistance (ecology); Internal medicine; Epistemology","score_opus":0.028036994547396964,"score_gpt":0.28711113495513757,"score_spread":0.2590741404077406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041379747","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97278816,0.016824082,0.0019671004,0.0026788672,0.00014857817,0.000101371836,0.000045169287,0.0000047572894,0.0054419045],"genre_scores_gemma":[0.99751425,0.0011578285,0.00033894525,0.00022012972,0.0006993865,0.0000013812706,0.000007741687,0.0000073069364,0.000053052765],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990141,0.00018012825,0.00044447396,0.00011813735,0.000062506835,0.00018069598],"domain_scores_gemma":[0.99903077,0.000085577034,0.00014881609,0.00019217002,0.00020329858,0.0003393546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004862151,0.00008059588,0.00060312153,0.0001209121,0.000050558414,0.000004625901,0.000087492626,0.000155068,0.000014896709],"category_scores_gemma":[0.00018298594,0.000062745996,0.0004853646,0.000108037035,0.000459511,0.000026832575,0.000006209895,0.00016549075,0.0000017022509],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022639829,0.000008709087,0.9676891,0.000020159874,0.00085554365,0.00019279459,0.000011542461,0.000019217985,0.0011456703,0.003629493,0.01355447,0.012646914],"study_design_scores_gemma":[0.0009399049,0.00019971357,0.8439178,0.000025881065,0.00023300157,0.0008465858,0.000028021486,2.812401e-7,0.00017382491,0.0011935182,0.15238284,0.000058638892],"about_ca_topic_score_codex":0.000102796475,"about_ca_topic_score_gemma":0.00043366197,"teacher_disagreement_score":0.13882837,"about_ca_system_score_codex":0.00003217562,"about_ca_system_score_gemma":0.00052260497,"threshold_uncertainty_score":0.25587073},"labels":[],"label_agreement":null},{"id":"W2041692547","doi":"10.1186/s13063-015-0724-z","title":"Influence of Morphine on Pharmacokinetics and Pharmacodynamics of Ticagrelor in Patients with Acute Myocardial Infarction (IMPRESSION): study protocol for a randomized controlled trial","year":2015,"lang":"en","type":"article","venue":"Trials","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Ticagrelor; Medicine; Pharmacodynamics; P2Y12; Prasugrel; Morphine; Myocardial infarction; Pharmacokinetics; Placebo; Pharmacology; Anesthesia; Internal medicine; Percutaneous coronary intervention","score_opus":0.03994860260227202,"score_gpt":0.38851159335276186,"score_spread":0.34856299075048985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041692547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6556925,0.000013547789,0.00006252685,0.000015879405,0.000047882928,0.34412497,0.000019401741,0.00000848372,0.000014809904],"genre_scores_gemma":[0.82857424,0.000014084342,0.00008068681,0.0000376965,0.00010323154,0.17115499,0.0000106638245,0.00001554735,0.000008828932],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99709046,0.00093346747,0.0011289677,0.000195631,0.0005255742,0.00012587498],"domain_scores_gemma":[0.99793905,0.00078364555,0.00062551023,0.00017565879,0.00037119995,0.00010493806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038653512,0.0001820397,0.0027480004,0.00015588837,0.000016901811,0.000006386951,0.00005519587,0.000058944293,0.0000090014955],"category_scores_gemma":[0.0014904102,0.00010316409,0.00039808635,0.00012879947,0.00010127959,0.00006280362,0.000018341978,0.0000845807,2.7626632e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9882544,0.0020158712,0.0025060934,0.00006565121,0.0039934,0.0000041807943,0.00018777854,0.0011513112,0.0005609654,0.0000066902385,0.000027670672,0.0012259663],"study_design_scores_gemma":[0.98581505,0.0058937436,0.0029416904,0.00012656569,0.0036543843,0.0000010068176,0.000025472778,0.0004975058,0.0008629822,0.00003851152,0.000045284807,0.00009780597],"about_ca_topic_score_codex":0.000010112622,"about_ca_topic_score_gemma":2.7322727e-7,"teacher_disagreement_score":0.17296997,"about_ca_system_score_codex":0.000020107964,"about_ca_system_score_gemma":0.00014350444,"threshold_uncertainty_score":0.42069095},"labels":[],"label_agreement":null},{"id":"W2041976702","doi":"10.1002/clc.20769","title":"Aspirin Use Is Associated With an Improved Long‐Term Survival in an Unselected Population Presenting With Unstable Angina","year":2010,"lang":"en","type":"article","venue":"Clinical Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute on Aging","keywords":"Medicine; Aspirin; Unstable angina; Myocardial infarction; Hazard ratio; Cohort; Population; Rochester Epidemiology Project; Angina; Confidence interval; Epidemiology; Stroke (engine); Cohort study; Internal medicine","score_opus":0.044127214571745794,"score_gpt":0.33951457145405367,"score_spread":0.2953873568823079,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041976702","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99860525,0.000062366154,0.00035603548,0.000039465405,0.00020334987,0.000500382,0.00001758848,0.000114367016,0.000101187106],"genre_scores_gemma":[0.9980579,0.000028278757,0.00018885643,0.00023820154,0.00042313978,0.000020508556,0.00090690405,0.000050483726,0.00008574346],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975468,0.00072210486,0.0004447198,0.0006121537,0.00021958088,0.0004546545],"domain_scores_gemma":[0.99842477,0.00024131588,0.00015047114,0.00065966934,0.00025425086,0.0002695252],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010476228,0.00022410574,0.0009357048,0.00009346594,0.000079213634,0.00003694013,0.00012334048,0.00042904736,0.00002774998],"category_scores_gemma":[0.0003973803,0.0001684794,0.00024902157,0.00030654247,0.00022493853,0.00024346076,0.000027288215,0.00068583345,0.00000285868],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002077092,0.0002437025,0.9933562,0.000013171547,0.00065806013,0.00037681288,0.000028490691,0.000045270277,0.00039702127,0.000014561472,0.000007852521,0.002781726],"study_design_scores_gemma":[0.0049439445,0.0020529297,0.9915684,0.00003289358,0.0003911568,0.00012682237,0.000022558821,0.00045724295,0.000040581723,0.000017803304,0.00011256225,0.00023309916],"about_ca_topic_score_codex":0.0001480657,"about_ca_topic_score_gemma":0.0014512513,"teacher_disagreement_score":0.0028668526,"about_ca_system_score_codex":0.000026118514,"about_ca_system_score_gemma":0.00017207427,"threshold_uncertainty_score":0.6870391},"labels":[],"label_agreement":null},{"id":"W2042402623","doi":"10.1038/tpj.2015.17","title":"A prospective randomized evaluation of a pharmacogenomic approach to antiplatelet therapy among patients with ST-elevation myocardial infarction: the RAPID STEMI study","year":2015,"lang":"en","type":"article","venue":"The Pharmacogenomics Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Heart Research Centre; University of Ottawa","funders":"University of Ottawa; Heart and Stroke Foundation of Canada","keywords":"Medicine; Prasugrel; Clopidogrel; Percutaneous coronary intervention; CYP2C19; Internal medicine; Myocardial infarction; Conventional PCI; Acute coronary syndrome; Cardiology; Clinical endpoint; Pharmacogenomics; Randomized controlled trial; Pharmacology","score_opus":0.04634402573124329,"score_gpt":0.29803349246836813,"score_spread":0.25168946673712483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042402623","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868593,0.0022375952,0.0010047946,0.00020548828,0.00037099098,0.008674924,0.000025029847,0.000025358155,0.00059650256],"genre_scores_gemma":[0.9978045,0.00061351946,0.00006373192,0.0003752628,0.0007032379,0.0003435086,0.000028326436,0.00005322005,0.000014679283],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99503714,0.0020868988,0.00064967695,0.00030411148,0.0016191857,0.00030296712],"domain_scores_gemma":[0.99706215,0.00012299308,0.00051141635,0.0003933651,0.0016409698,0.00026908703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009452542,0.00031148686,0.000763398,0.00017488295,0.00035560795,0.000087096414,0.00032384918,0.000048347658,0.00007343028],"category_scores_gemma":[0.00010203845,0.00015665588,0.00047007104,0.00044232633,0.00024808312,0.00021444305,0.00005499349,0.00047039014,0.000007129924],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5896702,0.0048508565,0.21981019,0.000028603932,0.034241933,0.000019077213,0.027811028,0.029782604,0.0033147477,0.000030000565,0.0013790544,0.08906172],"study_design_scores_gemma":[0.8124766,0.0017491784,0.15777698,0.00005517866,0.01030984,0.00040795477,0.0053442055,0.007985672,0.0019890277,0.00020634172,0.0011693793,0.00052964257],"about_ca_topic_score_codex":0.000018073477,"about_ca_topic_score_gemma":5.6733575e-7,"teacher_disagreement_score":0.22280642,"about_ca_system_score_codex":0.0003187745,"about_ca_system_score_gemma":0.00051432784,"threshold_uncertainty_score":0.63882416},"labels":[],"label_agreement":null},{"id":"W2042454514","doi":"10.1016/j.thromres.2004.05.004","title":"Clopidogrel does not induce fibrinolysis in healthy subjects","year":2004,"lang":"en","type":"article","venue":"Thrombosis Research","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; University of Alberta","funders":"","keywords":"Clopidogrel; Ticlopidine; Medicine; Thienopyridine; Myocardial infarction; Internal medicine; Unstable angina; Cardiology; Aspirin; Scopus; Pharmacology; MEDLINE; Chemistry","score_opus":0.1004578046065093,"score_gpt":0.405568358981551,"score_spread":0.30511055437504175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042454514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908864,0.0015456823,0.000023086826,0.0046134917,0.0000783478,0.00056706707,0.000008790168,0.00007230417,0.0022048273],"genre_scores_gemma":[0.99445003,0.004301145,0.00016813682,0.00055177545,0.00023776833,0.00006624759,0.0000180435,0.00003633499,0.00017050611],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99697745,0.00029177184,0.00028854344,0.00047889046,0.0011868206,0.0007765207],"domain_scores_gemma":[0.9987092,0.00013430753,0.000027909206,0.0006474612,0.0001855581,0.00029556119],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001279762,0.00016517047,0.0005098933,0.00050343265,0.0001856586,0.00003995668,0.00020242795,0.00016500684,0.00023330527],"category_scores_gemma":[0.00018843028,0.00012318723,0.00028301962,0.0011469857,0.00026225246,0.00012472253,0.00010857312,0.0006525281,0.00029638255],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015864946,0.008452708,0.47912937,0.003044327,0.004591912,0.0026451186,0.009929699,0.00041408627,0.26561773,0.012853251,0.0021630595,0.19529378],"study_design_scores_gemma":[0.009644973,0.0014581379,0.8742254,0.0005343231,0.00009266808,0.000052959833,0.0014299918,0.000014480964,0.1065566,0.0015510627,0.00404722,0.0003922248],"about_ca_topic_score_codex":0.0011290215,"about_ca_topic_score_gemma":0.00016741124,"teacher_disagreement_score":0.39509597,"about_ca_system_score_codex":0.00030953425,"about_ca_system_score_gemma":0.0004949423,"threshold_uncertainty_score":0.50234294},"labels":[],"label_agreement":null},{"id":"W2044838683","doi":"10.1016/j.cjca.2011.09.003","title":"The Association Between Prior Use of Aspirin and/or Warfarin and the In-hospital Management and Outcomes in Patients Presenting With Acute Coronary Syndromes: Insights From the Global Registry of Acute Coronary Events (GRACE)","year":2011,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"St. John’s Health Sciences Centre; Montreal Heart Institute; Canadian Heart Research Centre; University of Toronto; McGill University Health Centre; St. Michael's Hospital","funders":"Sanofi","keywords":"Medicine; Warfarin; Aspirin; Acute coronary syndrome; Guideline; Internal medicine; Percutaneous coronary intervention; Antithrombotic; Population; Intensive care medicine; Atrial fibrillation; Myocardial infarction","score_opus":0.01432189259818207,"score_gpt":0.22672814334521385,"score_spread":0.2124062507470318,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044838683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974795,0.0016320378,0.000016959923,0.00024750512,0.00008283063,0.00041350265,0.00007613414,0.0000011905247,0.00005031425],"genre_scores_gemma":[0.9985673,0.0012624561,0.000051089635,0.000048510763,0.00002371524,0.00000437952,0.000008813151,0.0000073641763,0.000026396763],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988364,0.00030271473,0.00036546166,0.00012305912,0.00019503714,0.00017732548],"domain_scores_gemma":[0.9990326,0.00024084191,0.00032995528,0.00019510594,0.00008680746,0.000114650225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033079018,0.0001172246,0.00056544633,0.000052847918,0.000078209014,0.000010721619,0.00013717012,0.000083426436,9.413353e-7],"category_scores_gemma":[0.00006858523,0.000055461504,0.00011887866,0.00008679089,0.0003118463,0.000099905985,0.00004825645,0.00017320337,8.1971514e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009940827,0.000009659427,0.98949695,0.0000131995785,0.0058339606,0.00040445675,0.0005026599,0.000004718972,2.2869784e-7,0.000047320224,0.000033429136,0.0026593606],"study_design_scores_gemma":[0.0047170226,0.00039848432,0.9923302,0.00010064129,0.0012312736,0.00012670031,0.00046712835,0.0000020671707,0.0000019692432,0.00026779156,0.00029727924,0.0000594391],"about_ca_topic_score_codex":0.0011270947,"about_ca_topic_score_gemma":0.0010185943,"teacher_disagreement_score":0.004602687,"about_ca_system_score_codex":0.000092432994,"about_ca_system_score_gemma":0.0001536506,"threshold_uncertainty_score":0.22616544},"labels":[],"label_agreement":null},{"id":"W2044849177","doi":"10.1503/cmaj.1060154","title":"Atherothrombotic events and clopidogrel therapy","year":2007,"lang":"en","type":"letter","venue":"Canadian Medical Association Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Clopidogrel; Medicine; Genotype; Cytochrome P450; Internal medicine; Bioinformatics; Aspirin; Biology; Genetics; Gene","score_opus":0.010805064522831958,"score_gpt":0.24451241475473187,"score_spread":0.23370735023189992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044849177","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02908697,0.012374962,0.00007978543,0.95466816,0.0013970503,0.00037121822,0.0000379687,0.00003685985,0.0019470259],"genre_scores_gemma":[0.0027826384,0.010505087,0.000048734444,0.9673718,0.016797606,0.000005313958,0.00009076406,0.00006729787,0.0023307374],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960225,0.00024250905,0.00044517036,0.0002577093,0.0023270021,0.00070507627],"domain_scores_gemma":[0.9975869,0.00013944766,0.00023312769,0.00018263953,0.00031371939,0.0015441527],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0015840736,0.00027152456,0.0006239256,0.0003115249,0.00023859018,0.00006235927,0.00016320954,0.002086971,0.0040834057],"category_scores_gemma":[0.00039589003,0.00022879452,0.00048649657,0.00016476106,0.0000686372,0.00006156066,0.000009927352,0.003921634,0.00014538139],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017448165,0.000016135826,0.017385693,0.000028693266,0.0013948567,0.006435534,0.000055435205,6.564499e-8,5.7681024e-7,0.000002943118,0.9071494,0.067513235],"study_design_scores_gemma":[0.0020884853,0.00010021616,0.020464497,0.00025726832,0.00017345708,0.0033269895,0.00003359728,0.000004155617,0.0000016783019,0.000078294484,0.973254,0.00021732025],"about_ca_topic_score_codex":0.0005105875,"about_ca_topic_score_gemma":0.00048419702,"teacher_disagreement_score":0.06729592,"about_ca_system_score_codex":0.0007863141,"about_ca_system_score_gemma":0.0030679055,"threshold_uncertainty_score":0.9992085},"labels":[],"label_agreement":null},{"id":"W2045036128","doi":"10.1517/13543784.2014.974803","title":"Ticagrelor for the treatment of peripheral arterial disease","year":2014,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Ticagrelor; Medicine; Clopidogrel; Intensive care medicine; Expert opinion; Clinical trial; Disease; Adverse effect; Arterial disease; Cardiology; Pharmacology; Internal medicine; Myocardial infarction; Vascular disease","score_opus":0.0663237658817336,"score_gpt":0.3664681768823458,"score_spread":0.3001444110006122,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045036128","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000020755513,0.9957109,0.0002746063,0.00073728623,0.001056498,0.0018376746,0.0002353676,0.000031862997,0.000095037634],"genre_scores_gemma":[0.000045128054,0.99231815,0.00021881862,0.0005556648,0.0034065503,0.0012795719,0.0018081167,0.00005606369,0.0003119175],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984157,0.00013847345,0.00047375815,0.00035673063,0.00043650018,0.00017884797],"domain_scores_gemma":[0.99845994,0.00048560175,0.00020148991,0.00050376833,0.000088108005,0.0002610939],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012217383,0.00036108054,0.0011388878,0.000073390496,0.00013943763,0.000020170632,0.00013059814,0.00013331336,0.00014801102],"category_scores_gemma":[0.00008541988,0.0002031744,0.0018138237,0.00009375917,0.00027977838,0.00002734094,0.000009508109,0.000071361785,0.000028455524],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047474558,0.0003734969,0.0000019017206,0.0022267106,0.0014385222,0.0000019415334,0.00025441428,0.000009874081,8.427565e-7,0.006615261,0.0068370127,0.9817653],"study_design_scores_gemma":[0.001585768,0.00046170168,0.000029972818,0.003487207,0.00037796912,0.00000790067,0.000020671652,0.000095592375,0.0000057792613,0.00018461481,0.9935486,0.00019425216],"about_ca_topic_score_codex":0.000004061068,"about_ca_topic_score_gemma":5.7114786e-8,"teacher_disagreement_score":0.98671156,"about_ca_system_score_codex":0.00012860112,"about_ca_system_score_gemma":0.00061169174,"threshold_uncertainty_score":0.82852113},"labels":[],"label_agreement":null},{"id":"W2045124661","doi":"10.1592/phco.30.3.275","title":"Drug Interaction Between Clopidogrel and Proton Pump Inhibitors","year":2010,"lang":"en","type":"review","venue":"Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Clopidogrel; Medicine; Aspirin; Observational study; Clinical trial; Intensive care medicine; Adverse effect; Internal medicine; Proton-pump inhibitor; Stroke (engine); MEDLINE; Drug; Acute coronary syndrome; Myocardial infarction; Pharmacology","score_opus":0.03874410229893858,"score_gpt":0.3880477371336679,"score_spread":0.3493036348347293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045124661","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12584251,0.8701363,0.000008062225,0.0006578844,0.0010588907,0.002174977,0.000017078459,0.00004143963,0.0000628417],"genre_scores_gemma":[0.009422522,0.98450655,0.000017799093,0.0011753218,0.004359607,0.000089017594,0.000019596235,0.00014016984,0.0002693961],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958368,0.0015829186,0.0012944989,0.0003910646,0.000455171,0.00043954692],"domain_scores_gemma":[0.99708956,0.00061008387,0.0014094122,0.0002942415,0.00020272534,0.00039395073],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0024797325,0.0007723882,0.0025167323,0.0005027806,0.0005160019,0.00006794816,0.0004171158,0.0003316623,0.0004993703],"category_scores_gemma":[0.000008542138,0.0004565447,0.0011664302,0.0002474682,0.00062266627,0.00029747127,0.00006296107,0.00283143,0.000007714139],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013668448,0.00032830227,0.00032023253,0.0020989454,0.0055972505,0.00009685107,0.0010543647,3.4247356e-7,0.003278234,0.0000061087485,0.004967868,0.9808847],"study_design_scores_gemma":[0.006759468,0.0004836444,0.000039383664,0.0016137228,0.005679732,0.0018255066,0.000099820245,0.0000015140974,0.005422413,0.0001024931,0.97754806,0.00042424296],"about_ca_topic_score_codex":0.000008879476,"about_ca_topic_score_gemma":9.572163e-7,"teacher_disagreement_score":0.9804604,"about_ca_system_score_codex":0.00006822879,"about_ca_system_score_gemma":0.0002667933,"threshold_uncertainty_score":0.99978864},"labels":[],"label_agreement":null},{"id":"W2047088941","doi":"10.1016/j.jacc.2004.11.051","title":"Long-term cost-effectiveness of clopidogrel given for up to one year in patients with acute coronary syndromes without ST-segment elevation","year":2005,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Clopidogrel; Medicine; Internal medicine; Acute coronary syndrome; Myocardial infarction; Cardiology; Confidence interval; Aspirin; Unstable angina; Stroke (engine)","score_opus":0.014172377746488211,"score_gpt":0.27992118045852704,"score_spread":0.2657488027120388,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047088941","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935583,0.0002355023,0.0045036594,0.00020230924,0.000113571325,0.0012188675,0.00014668673,0.0000028871964,0.000018203267],"genre_scores_gemma":[0.9987543,0.00017758487,0.0008065337,0.00008886839,0.000090010355,0.000026959102,0.000009020894,0.000018155366,0.000028557624],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99871486,0.0002961081,0.00037694158,0.00012612328,0.0003247849,0.00016116138],"domain_scores_gemma":[0.9987122,0.0001293826,0.0004782122,0.00023576335,0.00037106167,0.00007339994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045323712,0.00012189836,0.001065331,0.00015536828,0.000023877556,0.0000011345571,0.00015446424,0.000039045986,0.000004618119],"category_scores_gemma":[0.000050268707,0.00008060104,0.00040269163,0.00024540338,0.00019839752,0.000054955,0.00003446854,0.00011037313,4.6385117e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024292719,0.00016416477,0.9627748,0.00008789366,0.0032510844,0.000033598524,0.000031861768,0.0013809409,0.0008106658,0.000016727188,0.00017332671,0.0069821766],"study_design_scores_gemma":[0.007419723,0.0043776813,0.9852099,0.00034813763,0.0007510057,0.00022437354,0.000083421706,0.000003892895,0.001101296,0.00001208634,0.00038413637,0.000084340274],"about_ca_topic_score_codex":0.0000020160455,"about_ca_topic_score_gemma":0.0000015877985,"teacher_disagreement_score":0.022435063,"about_ca_system_score_codex":0.00014031574,"about_ca_system_score_gemma":0.00017987384,"threshold_uncertainty_score":0.32868153},"labels":[],"label_agreement":null},{"id":"W2047390896","doi":"10.3109/09537104.2012.711865","title":"Advances in monitoring of aspirin therapy","year":2012,"lang":"en","type":"review","venue":"Platelets","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; British Heart Foundation; Eli Lilly and Company","keywords":"Aspirin; Antithrombotic; Medicine; Platelet; Randomized controlled trial; Intensive care medicine; Clinical trial; Internal medicine","score_opus":0.07950739203623076,"score_gpt":0.36664074306030453,"score_spread":0.2871333510240738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047390896","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019764444,0.9957862,0.0000053377266,0.0000019248566,0.00031830286,0.0006292746,0.000010287131,0.000035095032,0.0012371498],"genre_scores_gemma":[0.0021730147,0.9970808,0.00008000962,0.0000068832155,0.00043274442,0.00006487693,0.00005007366,0.00006007737,0.00005153254],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984752,0.00010445433,0.0005247404,0.00026466715,0.00030796713,0.00032299643],"domain_scores_gemma":[0.9991432,0.000088729554,0.00020896867,0.0004101343,0.0000334237,0.00011556038],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026388594,0.00033815618,0.002098402,0.00023222182,0.000019357616,0.000005809728,0.0001399763,0.00027123204,0.00008416502],"category_scores_gemma":[0.000014036293,0.00025099702,0.00094498106,0.00029970187,0.000051834057,0.00013022477,0.000024798783,0.00032657487,0.0000548619],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005174407,0.00013399152,0.00087811507,0.010644708,0.00031928153,0.00012625573,0.000030431538,5.268909e-7,0.0000017016459,0.000011168738,0.0000022911984,0.98779976],"study_design_scores_gemma":[0.0007512075,0.00006834754,0.0002528967,0.01452954,0.00049549155,0.00017580413,0.000012314514,1.3138333e-7,0.0000652907,0.000009099006,0.9834241,0.00021577883],"about_ca_topic_score_codex":0.0000044702488,"about_ca_topic_score_gemma":3.3258019e-7,"teacher_disagreement_score":0.987584,"about_ca_system_score_codex":0.000052208437,"about_ca_system_score_gemma":0.0001196357,"threshold_uncertainty_score":0.9999942},"labels":[],"label_agreement":null},{"id":"W2047638404","doi":"10.1016/j.thromres.2009.02.002","title":"Evaluation of the platelet count drop method for assessment of platelet function in comparison with “gold standard” light transmission aggregometry","year":2009,"lang":"en","type":"article","venue":"Thrombosis Research","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital du Sacré-Cœur de Montréal","funders":"","keywords":"Clopidogrel; Platelet; Aspirin; Adenosine diphosphate; Medicine; Gold standard (test); Antiplatelet drug; Whole blood; Platelet aggregation; Platelet-rich plasma; Pharmacology; Platelet activation; Platelet-poor plasma; Internal medicine","score_opus":0.11636144609142936,"score_gpt":0.4590400771684635,"score_spread":0.34267863107703417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047638404","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96372604,0.0029547687,0.028767657,0.00084284577,0.000047373782,0.0024367846,0.0000283476,0.000016592254,0.0011796104],"genre_scores_gemma":[0.9968062,0.00043789044,0.0025259214,0.000034641685,0.00004385615,0.000068275665,0.00003080229,0.000020147634,0.00003225987],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9944852,0.0010161223,0.0004567927,0.0003141883,0.0034039193,0.0003237535],"domain_scores_gemma":[0.9977433,0.00023633428,0.00014497916,0.0004823903,0.0013050699,0.000087921086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009459193,0.00015383298,0.0006775159,0.00034214056,0.000101150945,0.00001508158,0.00016828498,0.00014158867,0.00013202641],"category_scores_gemma":[0.00012405877,0.00009554346,0.0002561934,0.001042393,0.00011293364,0.00009010635,0.000018608338,0.0003736802,6.6208986e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0075068525,0.0020667,0.012898821,0.00073949865,0.001798687,0.000005145945,0.0011964684,0.0035112705,0.23154263,0.00072036765,0.0017876012,0.73622596],"study_design_scores_gemma":[0.019388277,0.008007959,0.5624432,0.0020396137,0.001145442,0.000017268778,0.0014628543,0.05039616,0.34405708,0.0019245226,0.008812709,0.00030491082],"about_ca_topic_score_codex":0.000047677127,"about_ca_topic_score_gemma":0.000015981082,"teacher_disagreement_score":0.735921,"about_ca_system_score_codex":0.00029641725,"about_ca_system_score_gemma":0.000696244,"threshold_uncertainty_score":0.3896149},"labels":[],"label_agreement":null},{"id":"W2047649402","doi":"10.1046/j.1365-2141.2002.03492.x","title":"Antithrombotic effect of PMC, a potent α‐tocopherol analogue on platelet plug formation <i>in vivo</i>","year":2002,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Defence Medical Centre","funders":"National Science Council","keywords":"Medicine; Bleeding time; Aspirin; Platelet; Saline; Pharmacology; Thrombosis; In vivo; Anesthesia; Antithrombotic; Surgery; Internal medicine; Platelet aggregation","score_opus":0.00995421963956499,"score_gpt":0.23301067206485912,"score_spread":0.22305645242529412,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047649402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885016,0.010078343,0.00025434844,0.00019050844,0.00014787732,0.00033586132,0.000008854847,0.00001042397,0.0004721455],"genre_scores_gemma":[0.99598324,0.0036273615,0.00011409631,0.00016725447,0.0000635791,0.000005460366,0.0000032776193,0.000017176708,0.000018530583],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9983777,0.00027582963,0.000653981,0.00012581784,0.00033448538,0.00023223362],"domain_scores_gemma":[0.99920213,0.000116762145,0.00032355968,0.00014588436,0.00010233008,0.000109306864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039497184,0.00013838697,0.0010730217,0.00020570123,0.000037363807,0.000012027577,0.0001068783,0.0001327112,0.00026071872],"category_scores_gemma":[0.00012749448,0.00012835613,0.00047496028,0.00017879419,0.00009802356,0.00014331142,0.000012335243,0.00028529204,0.000018551053],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0075709173,0.003625077,0.039453506,0.0040128953,0.0040703057,0.61763215,0.0007976488,0.0022460395,0.01676861,0.00037680124,0.02332622,0.28011984],"study_design_scores_gemma":[0.021041922,0.0054504806,0.017313879,0.004638164,0.0006079092,0.8397799,0.00013695098,0.0005422425,0.10887454,0.00015733237,0.0011516099,0.00030507162],"about_ca_topic_score_codex":0.00001688481,"about_ca_topic_score_gemma":0.000010414554,"teacher_disagreement_score":0.27981478,"about_ca_system_score_codex":0.000037362544,"about_ca_system_score_gemma":0.000022620005,"threshold_uncertainty_score":0.5234211},"labels":[],"label_agreement":null},{"id":"W2047675956","doi":"10.1016/s1520-765x(01)90139-7","title":"Issues in discharge therapy after hospitalization for UA/NSTEMI","year":2001,"lang":"en","type":"article","venue":"European Heart Journal Supplements","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Unstable angina; Myocardial infarction; Aspirin; Intensive care medicine; Canadian Cardiovascular Society; Angina; Internal medicine","score_opus":0.03013074799605933,"score_gpt":0.3255495335349196,"score_spread":0.29541878553886025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047675956","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987855,0.008205105,0.0011393921,0.0014836726,0.00021814449,0.0006029938,0.000022879072,0.00002566219,0.00044710442],"genre_scores_gemma":[0.9892765,0.007106151,0.00043424973,0.0012461352,0.0007456902,0.000019529445,0.00007982266,0.000052844804,0.0010390311],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99869436,0.00019581494,0.0003400213,0.00018023932,0.0002869353,0.00030261412],"domain_scores_gemma":[0.99952173,0.0000130169,0.000055541597,0.00018025124,0.000077063865,0.00015240588],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006273914,0.00014500497,0.00024450422,0.00010809259,0.00010409215,0.000060956478,0.0000739817,0.000023171982,0.0012916471],"category_scores_gemma":[0.000023636852,0.00011414202,0.00030206374,0.00012413139,0.000020718675,0.00018075813,0.00001788181,0.00012374064,0.000074150295],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001235811,0.00034276923,0.96757054,0.000025816375,0.000254336,0.0004726218,0.00044156954,0.0000070191127,0.0007031993,0.000014253899,0.016085494,0.012846551],"study_design_scores_gemma":[0.004572752,0.0003674927,0.36691266,0.00012191326,0.000032931646,0.00034449386,0.00012154648,0.000012328406,0.00032535283,0.000043737804,0.62702304,0.00012172321],"about_ca_topic_score_codex":0.0000046943496,"about_ca_topic_score_gemma":0.000001939782,"teacher_disagreement_score":0.6109376,"about_ca_system_score_codex":0.000037269507,"about_ca_system_score_gemma":0.000023311062,"threshold_uncertainty_score":0.99962133},"labels":[],"label_agreement":null},{"id":"W2047885472","doi":"10.1016/j.ahj.2005.08.023","title":"A pharmacoepidemiology study of the interaction between atorvastatin and clopidogrel after percutaneous coronary intervention","year":2006,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame; Royal Victoria Regional Health Centre; McGill University Health Centre; Royal Victoria Hospital; Centre Hospitalier de l’Université de Montréal; McGill University","funders":"","keywords":"Medicine; Clopidogrel; Atorvastatin; Percutaneous coronary intervention; Conventional PCI; Internal medicine; Myocardial infarction; Loading dose; Cardiology; Unstable angina; Ticlopidine; Odds ratio","score_opus":0.01730070109310017,"score_gpt":0.32702505898266754,"score_spread":0.30972435788956737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047885472","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982635,0.0009293735,0.000130572,0.00032392345,0.00011630519,0.00020276292,0.000003916539,0.000009558387,0.000020084368],"genre_scores_gemma":[0.99916005,0.000112506306,0.00011810487,0.00027257172,0.00028701732,0.0000052992555,0.0000019822323,0.000011517816,0.00003096263],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99872935,0.00051161513,0.00033554036,0.00012150878,0.00017069482,0.00013126497],"domain_scores_gemma":[0.9994823,0.00010954266,0.0001650081,0.0001168936,0.000057457026,0.000068810674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032036172,0.000093107,0.00036212523,0.00005667683,0.000078913516,0.000008633255,0.000040006704,0.000019081916,0.00007977233],"category_scores_gemma":[0.000029602252,0.00006194752,0.00027795954,0.000101229656,0.00017384191,0.000053504715,0.000027873084,0.00025795677,0.00000259917],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057705335,0.0002643735,0.9552662,0.000012318137,0.00033588524,0.00011497963,0.00021162373,0.00001533543,0.0006118101,7.0583695e-7,0.00034394267,0.042245798],"study_design_scores_gemma":[0.0010298605,0.0012545537,0.9854555,0.00006774105,0.0003818324,0.0075671757,0.0022958035,0.000026962924,0.00008138034,0.000026217325,0.0017521591,0.000060807542],"about_ca_topic_score_codex":0.000315077,"about_ca_topic_score_gemma":0.000012803616,"teacher_disagreement_score":0.04218499,"about_ca_system_score_codex":0.000031470074,"about_ca_system_score_gemma":0.000023886441,"threshold_uncertainty_score":0.25261465},"labels":[],"label_agreement":null},{"id":"W2047888433","doi":"10.1160/th13-07-0581","title":"‘VASPFix’ for measurement of VASP phosphorylation in platelets and for monitoring effects of P2Y12 antagonists","year":2013,"lang":"en","type":"article","venue":"Thrombosis and Haemostasis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Medical Research Council","keywords":"P2Y12; Iloprost; Platelet; Prasugrel; Receptor; Clopidogrel; Phosphorylation; Pharmacology; Chemistry; Medicine; Internal medicine; Biochemistry; Platelet aggregation; Prostacyclin","score_opus":0.05079680462441154,"score_gpt":0.3076159874533074,"score_spread":0.2568191828288959,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047888433","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888852,0.008707456,0.0007570098,0.000117622716,0.00006476301,0.0014251879,0.000014670495,0.000009554495,0.000018487794],"genre_scores_gemma":[0.99481744,0.0034894382,0.0014572804,0.000021193078,0.00003777605,0.00014792974,0.000008900458,0.00001650587,0.0000035386122],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992173,0.000019993382,0.00024270522,0.00017835705,0.00019029957,0.00015134604],"domain_scores_gemma":[0.99944824,0.00010565687,0.000084868945,0.00013201093,0.00016393844,0.00006528159],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025854915,0.00011788732,0.00047533895,0.00006777466,0.000046694815,0.00000941984,0.000027658982,0.00006841829,0.0000059868207],"category_scores_gemma":[0.000056010802,0.000101999125,0.00014136877,0.0000711393,0.000063216496,0.000078672754,0.0000135993405,0.000033817807,2.2960226e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010518503,0.00056708197,0.19851682,0.00691219,0.0018467469,0.0000023959064,0.0013904519,0.000009465881,0.25807393,0.00025579406,0.0003292314,0.53104407],"study_design_scores_gemma":[0.0046818336,0.0004310738,0.44023255,0.00053822,0.0003792717,0.0000023937573,0.00022245431,0.00007879923,0.55285287,0.00023832603,0.00023708204,0.000105095496],"about_ca_topic_score_codex":0.000090282025,"about_ca_topic_score_gemma":0.0000023382804,"teacher_disagreement_score":0.530939,"about_ca_system_score_codex":0.000023456712,"about_ca_system_score_gemma":0.000025518702,"threshold_uncertainty_score":0.41594034},"labels":[],"label_agreement":null},{"id":"W2048562616","doi":"10.1016/s0735-1097(02)02831-0","title":"Short- and long-term oral antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention","year":2003,"lang":"en","type":"review","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Clopidogrel; Percutaneous coronary intervention; Aspirin; Antithrombotic; Myocardial infarction; Cardiology; Acute coronary syndrome; Ticlopidine; Internal medicine; Prasugrel","score_opus":0.028524603484318997,"score_gpt":0.3205755778339477,"score_spread":0.2920509743496287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048562616","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4382773,0.56105673,0.000010408595,0.00002681125,0.00016644977,0.0003819055,0.00006558214,0.0000032349008,0.000011601149],"genre_scores_gemma":[0.2871711,0.71255493,0.00004450412,0.000068744754,0.00006345038,0.0000049127416,0.000008328154,0.000035468565,0.000048531056],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9969747,0.0011886333,0.000977844,0.0002881729,0.00030327143,0.00026737945],"domain_scores_gemma":[0.9983498,0.00018281797,0.0008369364,0.0003795403,0.00011893969,0.00013199064],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00062817027,0.0004030414,0.004571023,0.00032324542,0.000053363434,0.000007725915,0.00025133416,0.00020100626,0.000014043177],"category_scores_gemma":[0.00003342255,0.0002506809,0.0019290831,0.000330479,0.0008767778,0.00006721625,0.00010183714,0.0005966508,5.255845e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017860433,0.000101056976,0.050269354,0.0015605313,0.010770443,0.024913292,0.000013843638,0.0000035172775,0.000018275763,0.000007168723,0.00019891512,0.91035753],"study_design_scores_gemma":[0.0023681272,0.0038065892,0.15530998,0.006127534,0.0059428257,0.75365376,0.000116838884,0.0000010326926,0.000002377316,0.000026970194,0.07228606,0.0003579295],"about_ca_topic_score_codex":0.0000016930779,"about_ca_topic_score_gemma":0.0000011047147,"teacher_disagreement_score":0.9099996,"about_ca_system_score_codex":0.00009674549,"about_ca_system_score_gemma":0.00023974164,"threshold_uncertainty_score":0.9999945},"labels":[],"label_agreement":null},{"id":"W2048688706","doi":"10.1016/j.jcjo.2011.06.004","title":"Clopidogrel therapy in ophthalmic procedures: a survey of subspecialty ophthalmologists and review of current guidelines","year":2011,"lang":"en","type":"article","venue":"Canadian Journal of Ophthalmology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Clopidogrel; Medicine; Subspecialty; Perioperative; Glaucoma; Emergency medicine; Intensive care medicine; Ophthalmology; Family medicine; Internal medicine; Myocardial infarction; Surgery","score_opus":0.17683638590823036,"score_gpt":0.36974562899120483,"score_spread":0.19290924308297447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048688706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6941144,0.3044324,0.0000034236361,0.000049675644,0.00021040843,0.00024865792,0.000029366061,0.0000010245054,0.00091066235],"genre_scores_gemma":[0.96488905,0.03472412,0.00020384544,0.000053260956,0.000073170726,0.0000048235274,0.000011250787,0.000019906518,0.000020562598],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977857,0.00036689514,0.0011433692,0.00019857255,0.00020806286,0.0002974046],"domain_scores_gemma":[0.99753445,0.00008540628,0.00058133405,0.0002869923,0.0011036188,0.0004081802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001566223,0.00019972386,0.0011431949,0.00042089666,0.000025625399,0.000002882489,0.0002336916,0.00013545087,0.00075656234],"category_scores_gemma":[0.0013576451,0.00015984771,0.00029820087,0.0004076091,0.00040525658,0.0000712852,0.000014973005,0.00024824633,0.0000012533062],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006898197,0.00019656027,0.9786569,0.002291817,0.00032053408,0.011034295,0.00022243282,9.4490593e-7,0.000050232866,0.000057314843,0.00035960748,0.0061195255],"study_design_scores_gemma":[0.0014641677,0.0012958072,0.8574327,0.0046540806,0.00007847894,0.1342984,0.000046027562,8.202808e-7,0.00024895635,0.00018324963,0.00016964684,0.00012766528],"about_ca_topic_score_codex":0.0045872834,"about_ca_topic_score_gemma":0.00020321336,"teacher_disagreement_score":0.2707747,"about_ca_system_score_codex":0.00005334326,"about_ca_system_score_gemma":0.0027603165,"threshold_uncertainty_score":0.82838273},"labels":[],"label_agreement":null},{"id":"W2048750724","doi":"10.1503/cmaj.060502","title":"Understanding clopidogrel efficacy in the presence of cytochrome P450 polymorphism","year":2006,"lang":"en","type":"letter","venue":"Canadian Medical Association Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Clopidogrel; CYP3A5; Genotype; CYP3A; Medicine; CYP2C19; Cytochrome P450; Polymorphism (computer science); Pharmacology; Bioinformatics; Internal medicine; Aspirin; Biology; Genetics; Gene; Metabolism","score_opus":0.028614040601272227,"score_gpt":0.2447701611337999,"score_spread":0.21615612053252767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048750724","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019092899,0.0030284866,0.00025219723,0.9722806,0.0005624396,0.00046854015,0.00007990982,0.000015195103,0.0042197183],"genre_scores_gemma":[0.29290274,0.0007236003,0.000024379151,0.69348764,0.011617308,0.000011663371,0.0002090598,0.000056799123,0.00096682884],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99514544,0.0005553505,0.00062243105,0.00020372166,0.0028753374,0.00059773395],"domain_scores_gemma":[0.9982616,0.0005423586,0.00035952125,0.00024553388,0.00015759906,0.00043344192],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019675165,0.00021361285,0.0005986998,0.0004040185,0.00016209671,0.00006087082,0.00038663537,0.0012559323,0.0011633761],"category_scores_gemma":[0.000795815,0.00015760453,0.00056230836,0.00039054535,0.00012264439,0.000062458836,0.000011186235,0.0037251622,0.00002830262],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010800863,0.000038380316,0.0042936504,0.00004849393,0.00041136748,0.008367186,0.00015756168,0.00000395742,0.0000027258163,0.00005236731,0.98529756,0.0013159344],"study_design_scores_gemma":[0.0025958032,0.00008642543,0.06606835,0.00078915537,0.00030716695,0.0018254113,0.00024014976,0.000023112303,0.0000021752448,0.00030162002,0.9275377,0.00022296814],"about_ca_topic_score_codex":0.001860626,"about_ca_topic_score_gemma":0.0021984659,"teacher_disagreement_score":0.27879298,"about_ca_system_score_codex":0.0015486709,"about_ca_system_score_gemma":0.003679025,"threshold_uncertainty_score":0.9997497},"labels":[],"label_agreement":null},{"id":"W2049185002","doi":"10.1016/j.cjca.2011.04.002","title":"Prasugrel as an Alternative for Clopidogrel-Associated Neutropenia","year":2011,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Fraser Health; Royal Columbian Hospital","funders":"","keywords":"Medicine; Clopidogrel; Prasugrel; Thienopyridine; Neutropenia; Ticlopidine; Acute coronary syndrome; Internal medicine; Cardiology; Aspirin; Myocardial infarction; Chemotherapy","score_opus":0.03834878362431105,"score_gpt":0.2681950048998236,"score_spread":0.22984622127551257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049185002","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9801815,0.0021322975,0.0032619329,0.00023117258,0.0009684889,0.00034856814,0.000048644637,0.000011349194,0.01281604],"genre_scores_gemma":[0.99774534,0.00016168777,0.00026633477,0.00057946704,0.0010472004,0.000006738909,0.000018673174,0.000026635627,0.00014791117],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99894655,0.00017578709,0.0002858806,0.00014514946,0.00011004845,0.00033659142],"domain_scores_gemma":[0.9983091,0.00003613952,0.00017055475,0.00019237038,0.00048579785,0.00080607773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004447012,0.000130676,0.000606662,0.00019899505,0.000088629255,0.000010202084,0.00017164106,0.00014643202,0.00007814046],"category_scores_gemma":[0.00022680173,0.00011036355,0.0005867762,0.0000852116,0.00015274428,0.00010803821,0.0000048484667,0.00019637092,0.000013500669],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014091192,0.00020244502,0.6116284,0.00019851912,0.04710607,0.022725312,0.009777754,0.0010800756,0.002165995,0.024652448,0.067322426,0.19904935],"study_design_scores_gemma":[0.0151935015,0.0104552945,0.3990105,0.00020681728,0.002977066,0.009111302,0.0013910284,0.000041214178,0.0018182595,0.008717831,0.5504292,0.0006479637],"about_ca_topic_score_codex":0.0008340012,"about_ca_topic_score_gemma":0.00055285875,"teacher_disagreement_score":0.4831068,"about_ca_system_score_codex":0.00012638904,"about_ca_system_score_gemma":0.0012910274,"threshold_uncertainty_score":0.4500495},"labels":[],"label_agreement":null},{"id":"W2049222615","doi":"10.1213/ane.0b013e318203f38d","title":"Antiplatelet Drugs","year":2011,"lang":"en","type":"review","venue":"Anesthesia & Analgesia","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":202,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Dalhousie University; University of Toronto; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Prasugrel; Perioperative; Cangrelor; Clopidogrel; Intensive care medicine; Ticagrelor; Aspirin; Drug; Cilostazol; Anesthesia; Pharmacology; Internal medicine","score_opus":0.0374753765423179,"score_gpt":0.3019103460123597,"score_spread":0.2644349694700418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049222615","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016602417,0.9943753,0.000019252762,0.000045355617,0.000053746124,0.000952607,0.00000542237,0.0002560126,0.0041262866],"genre_scores_gemma":[0.00010447454,0.9962637,0.000132221,0.00047658262,0.00046961254,0.00008939345,0.00035767013,0.00020949917,0.001896853],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971162,0.00026740154,0.00074011064,0.0008065071,0.00045177143,0.0006179873],"domain_scores_gemma":[0.99782765,0.00006525178,0.00032016216,0.0012841386,0.00009491158,0.0004078578],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00037788646,0.00085350533,0.0036448573,0.00037952958,0.00013604313,0.000046266407,0.00039461663,0.00068773906,0.0008809683],"category_scores_gemma":[0.0000135848895,0.0006496064,0.0036584018,0.0005985063,0.00017376897,0.000099586316,0.0000352439,0.0005723328,0.0018172468],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006508148,0.00015453037,0.000034447487,0.0082942005,0.0021533056,0.004494014,0.000053528107,2.5845232e-8,7.394879e-8,0.0007492689,0.0030632287,0.9809383],"study_design_scores_gemma":[0.0005422484,0.00014673585,0.00010419847,0.008353215,0.0077508264,0.010880965,0.000022079525,5.4309123e-7,0.0000023167868,0.00004308477,0.9715131,0.0006406684],"about_ca_topic_score_codex":0.000026527434,"about_ca_topic_score_gemma":3.8161383e-7,"teacher_disagreement_score":0.9802976,"about_ca_system_score_codex":0.000072869974,"about_ca_system_score_gemma":0.00048824985,"threshold_uncertainty_score":0.9995955},"labels":[],"label_agreement":null},{"id":"W2051297375","doi":"10.1111/j.1538-7836.2005.01640.x","title":"Enhanced antiplatelet effect of clopidogrel in patients whose platelets are least inhibited by aspirin: a randomized crossover trial","year":2005,"lang":"en","type":"article","venue":"Journal of Thrombosis and Haemostasis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McMaster University","funders":"Canada Research Chairs","keywords":"Clopidogrel; Aspirin; Platelet; Arachidonic acid; Medicine; Crossover study; Platelet activation; Pharmacology; Thromboxane; Thromboxane B2; Internal medicine; Placebo; Chemistry; Biochemistry; Pathology; Enzyme","score_opus":0.011377542439174233,"score_gpt":0.28435352650750434,"score_spread":0.2729759840683301,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051297375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942052,0.0041316384,0.000064412954,0.0003040438,0.00017592666,0.0009985869,0.00004663081,0.000010121216,0.0000634514],"genre_scores_gemma":[0.9949543,0.004434358,0.000111339185,0.00023062402,0.00018835883,0.00001010075,0.000022664379,0.000030856827,0.0000174213],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9973256,0.00035002557,0.0011462152,0.00024103897,0.0006453367,0.0002917625],"domain_scores_gemma":[0.9984472,0.00022279944,0.0006696857,0.00021785116,0.00023837805,0.00020412594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011070683,0.0003042921,0.0023848277,0.0002652383,0.00006757122,0.000040090217,0.000108224245,0.00019903675,0.00009990131],"category_scores_gemma":[0.0002765432,0.00021228494,0.0010044636,0.00026382413,0.00022177474,0.00028301554,0.00004054318,0.00032640935,0.000003939468],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.917391,0.0012755119,0.01307937,0.0002642116,0.0026397714,0.000038695143,0.00035452447,0.000054590582,0.0020576506,0.0000038919,0.0014717435,0.06136903],"study_design_scores_gemma":[0.91710645,0.0028216804,0.015573656,0.0010547101,0.0011390627,0.00003666792,0.000056640067,0.000044482375,0.061035514,0.0000070753754,0.0008795829,0.00024450585],"about_ca_topic_score_codex":0.000017480095,"about_ca_topic_score_gemma":0.0000039745496,"teacher_disagreement_score":0.061124526,"about_ca_system_score_codex":0.00006498097,"about_ca_system_score_gemma":0.000053932567,"threshold_uncertainty_score":0.8656729},"labels":[],"label_agreement":null},{"id":"W2051468622","doi":"10.1016/j.cjca.2015.04.019","title":"Current Evidence on Platelet P2Y12 Receptor Inhibitors: Is There Still a Role for Clopidogrel in 2015?","year":2015,"lang":"en","type":"review","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Prasugrel; Clopidogrel; Medicine; Ticagrelor; P2Y12; Percutaneous coronary intervention; Cardiology; Internal medicine; Aspirin; Myocardial infarction; Acute coronary syndrome; Platelet","score_opus":0.07141989344957655,"score_gpt":0.3523985692460148,"score_spread":0.28097867579643826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051468622","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00040808786,0.9957817,0.00007240244,0.00025097647,0.0019315716,0.0010396526,0.00030145998,0.0000068517206,0.00020726926],"genre_scores_gemma":[0.0015181656,0.9931829,0.00003809228,0.00014254161,0.0048479596,0.000059446014,0.0000690766,0.000077397555,0.00006443778],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971507,0.0005303199,0.0010030833,0.0003879972,0.00032175117,0.0006061585],"domain_scores_gemma":[0.99711996,0.00026883237,0.0005332032,0.0004837317,0.00046713604,0.0011271329],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00142526,0.00047739592,0.0036949415,0.00077428255,0.00004742412,0.000026050684,0.0003707775,0.00060006813,0.00005354935],"category_scores_gemma":[0.0005322628,0.0003590236,0.0025134068,0.0002827414,0.00016405973,0.00009360207,0.000016482125,0.0010127443,0.000065619606],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019327096,0.000007328357,0.0002671944,0.0021179398,0.0012126897,0.0003762345,0.00011186534,0.000016969769,1.8737238e-7,0.00001646404,0.09527513,0.90040475],"study_design_scores_gemma":[0.0012497202,0.00079278194,0.000059990285,0.026270606,0.0012863214,0.0011583215,0.000058853147,5.3448997e-7,0.0000017557966,0.000072122115,0.9687469,0.0003021021],"about_ca_topic_score_codex":0.00012195955,"about_ca_topic_score_gemma":0.000123844,"teacher_disagreement_score":0.9001026,"about_ca_system_score_codex":0.0007845729,"about_ca_system_score_gemma":0.007827471,"threshold_uncertainty_score":0.99988616},"labels":[],"label_agreement":null},{"id":"W2052614859","doi":"10.1016/j.jtcvs.2004.09.027","title":"Reasons for inability of clopidogrel to inhibit platelet aggregation early after coronary artery bypass surgery","year":2005,"lang":"en","type":"letter","venue":"Journal of Thoracic and Cardiovascular Surgery","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Hospital for Sick Children","keywords":"Clopidogrel; Medicine; Antiplatelet drug; P2Y12; Aspirin; Ticlopidine; Atorvastatin; Coronary artery bypass surgery; Platelet; Randomized controlled trial; Pharmacology; Cardiology; Platelet aggregation inhibitor; Internal medicine; Artery","score_opus":0.019130624262253117,"score_gpt":0.26461378145132475,"score_spread":0.24548315718907163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052614859","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8760986,0.10000139,0.0026642836,0.018982414,0.0011040514,0.0008759026,0.00020518443,0.000037771177,0.000030432362],"genre_scores_gemma":[0.9284242,0.01429514,0.0011355482,0.04307739,0.01189099,0.00019211246,0.0003110405,0.00028715414,0.00038643772],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9945265,0.0007087977,0.0017742087,0.00066674413,0.001677988,0.0006457582],"domain_scores_gemma":[0.99540216,0.0011747245,0.00082375214,0.0011117783,0.001092905,0.00039466406],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0047401176,0.00066500687,0.004063389,0.00096053584,0.00010380846,0.00006648285,0.00017126357,0.0010302798,0.000052580537],"category_scores_gemma":[0.0006400454,0.00057671964,0.010718483,0.00043048023,0.00023389432,0.0003632,0.00007577288,0.0012067505,0.000006636943],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006367383,0.00021591892,0.044740718,0.0034404716,0.024059493,0.007574992,0.00016078768,0.000048032107,0.000022085467,5.471398e-7,0.275127,0.6382426],"study_design_scores_gemma":[0.0012738375,0.00043300143,0.10037998,0.0048009595,0.010338761,0.010514188,0.0000973356,0.0000044852195,0.001103824,0.000074818774,0.86989725,0.0010815511],"about_ca_topic_score_codex":0.000016436297,"about_ca_topic_score_gemma":0.0000012842581,"teacher_disagreement_score":0.637161,"about_ca_system_score_codex":0.00015223467,"about_ca_system_score_gemma":0.0007466542,"threshold_uncertainty_score":0.9996684},"labels":[],"label_agreement":null},{"id":"W2053124554","doi":"10.1111/j.1538-7836.2006.01927.x","title":"Platelet function analyzer (PFA)‐100® closure time in the evaluation of platelet disorders and platelet function: reply to a rebuttal","year":2006,"lang":"en","type":"article","venue":"Journal of Thrombosis and Haemostasis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Regional Laboratory Medicine Program","funders":"","keywords":"Rebuttal; Platelet; Medicine; Function (biology); Closure (psychology); Platelet disorder; Internal medicine; Cardiology; Biology; Cell biology; Law","score_opus":0.03283090900181169,"score_gpt":0.3004219038630044,"score_spread":0.2675909948611927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053124554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891159,0.006986419,0.00025001197,0.0026457864,0.000120662306,0.0004914103,0.000023384473,0.000009768683,0.00035664087],"genre_scores_gemma":[0.9962339,0.0025600838,0.00014265551,0.00076271634,0.00022115912,0.000009637781,0.000026541491,0.000021568652,0.000021735359],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9975803,0.00028285093,0.0006911668,0.00025696933,0.0009681588,0.00022056556],"domain_scores_gemma":[0.99884933,0.000101706195,0.00035189683,0.0002683965,0.00031796476,0.00011070558],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023213993,0.00022087517,0.000679327,0.00031360812,0.00013144845,0.000053220425,0.0000900014,0.00012944482,0.00021220083],"category_scores_gemma":[0.00006987851,0.00015202172,0.0003509744,0.0004730322,0.00010465157,0.00024243162,0.000021939935,0.00026230028,0.0000046224054],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01156088,0.0016423599,0.07413059,0.0003624381,0.0057999776,0.00012601617,0.0023305204,0.0025025283,0.004327463,0.00022311258,0.043546736,0.8534474],"study_design_scores_gemma":[0.013638002,0.0031456929,0.9221375,0.0004965719,0.0036237,0.00076589163,0.002208795,0.000570474,0.0019829522,0.0016647493,0.04934366,0.00042201838],"about_ca_topic_score_codex":0.000119643766,"about_ca_topic_score_gemma":0.000048066366,"teacher_disagreement_score":0.8530254,"about_ca_system_score_codex":0.000055962464,"about_ca_system_score_gemma":0.000098220524,"threshold_uncertainty_score":0.6199266},"labels":[],"label_agreement":null},{"id":"W2053281372","doi":"10.1136/ebm.10.5.137","title":"Low dose aspirin lowered stroke risk but not risks of MI or cardiovascular deaths in women","year":2005,"lang":"en","type":"article","venue":"Evidence-Based Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Aspirin; Stroke (engine); Placebo; Internal medicine; IMG; Coronary artery disease; Physical therapy","score_opus":0.0694863246493535,"score_gpt":0.319278976236211,"score_spread":0.24979265158685748,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053281372","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95049655,0.044788692,0.001570356,0.0016090772,0.00020513058,0.00093913125,0.000044210672,0.000095253105,0.0002516137],"genre_scores_gemma":[0.98166686,0.014155066,0.000576045,0.0018358649,0.0010950967,0.00013690862,0.000019512901,0.00006160313,0.00045303753],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99555624,0.0004709101,0.00094083603,0.0006944061,0.0016220434,0.000715578],"domain_scores_gemma":[0.99692065,0.0006160126,0.00026070236,0.0014090871,0.00025802382,0.00053555216],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0029927935,0.00044786657,0.0017003838,0.00049075176,0.00008155353,0.000010749334,0.00031577772,0.00024315367,0.001348688],"category_scores_gemma":[0.0018891637,0.00032435864,0.0009516939,0.00067761034,0.00046314998,0.00024741018,0.000048092345,0.0005366734,0.00006422862],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03262892,0.0013406961,0.04113938,0.0019650254,0.0049231094,0.0025742985,0.0015111979,0.00863426,0.014711056,0.000016434251,0.0013211,0.88923454],"study_design_scores_gemma":[0.10154892,0.010865285,0.5604519,0.030375795,0.0074292524,0.0004229798,0.0039455583,0.0030674022,0.19217655,0.00006790378,0.08768566,0.0019627768],"about_ca_topic_score_codex":0.0007660365,"about_ca_topic_score_gemma":0.00004908185,"teacher_disagreement_score":0.88727176,"about_ca_system_score_codex":0.00035026466,"about_ca_system_score_gemma":0.0006881741,"threshold_uncertainty_score":0.99992085},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"not_applicable","genre":"commentary","about_ca_system":false,"about_ca_topic":false,"confidence":"medium"}],"label_agreement":"split"},{"id":"W2054113896","doi":"10.1038/ncpcardio1372","title":"Platelet ADP-receptor antagonists for cardiovascular disease: past, present and future","year":2008,"lang":"en","type":"review","venue":"Nature Clinical Practice Cardiovascular Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton General Hospital","funders":"","keywords":"Clopidogrel; Prasugrel; Thienopyridine; Medicine; Cangrelor; Aspirin; Cardiology; Dipyridamole; Stroke (engine); Internal medicine; Randomized controlled trial; Percutaneous coronary intervention; Pharmacology; Anesthesia; Myocardial infarction","score_opus":0.05084457865348018,"score_gpt":0.3999345695529619,"score_spread":0.34908999089948173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054113896","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000054312827,0.97928375,0.0009465321,0.0046687624,0.0055007264,0.008205667,0.00041510485,0.00035252172,0.0006215222],"genre_scores_gemma":[0.000009249241,0.90867704,0.0022952936,0.0017623304,0.08326139,0.0007898593,0.0024515446,0.0004918044,0.00026148223],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9848217,0.0030758614,0.0031013743,0.0035839747,0.004081424,0.0013356674],"domain_scores_gemma":[0.9852949,0.0045101545,0.0010030136,0.0053364225,0.0014493968,0.0024061045],"candidate_categories":["metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.006850413,0.0021773474,0.014067227,0.00050367555,0.0005882933,0.00008755344,0.00077955256,0.004171602,0.00010490277],"category_scores_gemma":[0.005478094,0.0015616812,0.034407955,0.0010377956,0.0014262155,0.00046759433,0.00033375196,0.006044383,0.000087541404],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012190816,0.00040283686,0.0000067739193,0.014647256,0.12598638,0.0034531422,0.000029441255,0.0000046165965,4.0724746e-8,0.00007931436,0.08145963,0.7727115],"study_design_scores_gemma":[0.009251042,0.0007016503,0.00007552181,0.0076689497,0.11702121,0.0072176,0.00011951336,0.000006259408,2.3704928e-7,0.000018939098,0.8566367,0.0012823635],"about_ca_topic_score_codex":0.000016528318,"about_ca_topic_score_gemma":1.2918841e-7,"teacher_disagreement_score":0.77517706,"about_ca_system_score_codex":0.00027600213,"about_ca_system_score_gemma":0.0014207287,"threshold_uncertainty_score":0.9990967},"labels":[],"label_agreement":null},{"id":"W2054324255","doi":"10.1016/j.pharmthera.2009.03.019","title":"Possibility of a rebound phenomenon following antiplatelet therapy withdrawal: A look at the clinical and pharmacological evidence","year":2009,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital du Sacré-Cœur de Montréal","funders":"","keywords":"Medicine; Discontinuation; Antiplatelet drug; Clopidogrel; Aspirin; Intensive care medicine; Coronary artery disease; Adverse effect; Cardiology; Internal medicine","score_opus":0.18953931495758358,"score_gpt":0.46842031270526946,"score_spread":0.2788809977476859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054324255","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.105356604,0.89018035,0.000018062632,0.0004232384,0.0006760786,0.0031103627,0.000030828458,0.00009833313,0.000106130814],"genre_scores_gemma":[0.012216703,0.98076177,0.00007295255,0.005807541,0.0006372493,0.00012984694,0.00003963377,0.00009415539,0.00024013134],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99340105,0.002558016,0.0016281264,0.0011214814,0.0005933327,0.0006980019],"domain_scores_gemma":[0.9961677,0.0018188915,0.0007590167,0.00079284696,0.00015457546,0.00030697693],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0028923547,0.0008775861,0.003966331,0.0001415285,0.00036130383,0.000040208437,0.0005712221,0.0007605853,0.00038215937],"category_scores_gemma":[0.000028703578,0.0005195349,0.0028505854,0.0004735977,0.0016783809,0.00012214945,0.0002364926,0.001404046,0.000030443012],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024866776,0.0008835365,0.0012742939,0.0016226583,0.017970761,0.00038361145,0.00015366128,6.2408117e-7,0.00036243134,0.0000050750427,0.0005021359,0.9743545],"study_design_scores_gemma":[0.0056288964,0.0016115813,0.0006779759,0.0024664248,0.036928494,0.00068035326,0.000033117718,0.000016475633,0.00021670116,0.000083091385,0.95106316,0.0005937058],"about_ca_topic_score_codex":0.0000054573293,"about_ca_topic_score_gemma":0.0000014593785,"teacher_disagreement_score":0.97376084,"about_ca_system_score_codex":0.00015703081,"about_ca_system_score_gemma":0.0007796835,"threshold_uncertainty_score":0.99972564},"labels":[],"label_agreement":null},{"id":"W2055153082","doi":"10.2147/ppa.s68423","title":"Southern Saskatchewan Ticagrelor Registry experience","year":2014,"lang":"en","type":"article","venue":"Patient Preference and Adherence","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Regina Qu'Appelle Health Region; St. Michael's Hospital; University of Saskatchewan","funders":"","keywords":"Ticagrelor; Medicine; Discontinuation; Acute coronary syndrome; Stroke (engine); Myocardial infarction; Cohort; Cardiogenic shock; Observational study; Emergency medicine; Internal medicine; Pediatrics","score_opus":0.024463313704273622,"score_gpt":0.23780188858307366,"score_spread":0.21333857487880004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055153082","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99334073,0.00078465446,0.0017439426,0.00004885852,0.000065240776,0.00021625544,0.000008801199,0.000076203214,0.0037153088],"genre_scores_gemma":[0.998049,0.00015418162,0.00042020594,0.0004004758,0.00006189507,0.00004366236,0.000014068639,0.000012629405,0.0008438705],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9988872,0.00005379423,0.00019074194,0.00036027958,0.00026963186,0.00023839937],"domain_scores_gemma":[0.999206,0.000038058686,0.00006914155,0.00040855142,0.000066025445,0.00021223557],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007800401,0.00016643944,0.0002531053,0.00002842467,0.000101526224,0.00003368206,0.0001000594,0.000074334974,0.00022660884],"category_scores_gemma":[0.00007120497,0.00012955506,0.00010388214,0.00009016622,0.00016891093,0.00009110481,0.000051008912,0.00013011256,0.000110018955],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005260662,0.00030397502,0.12106282,0.00023228057,0.00017418606,0.000038034595,0.013387394,0.0000061701385,0.0052745505,0.0004937954,0.00028509813,0.85821563],"study_design_scores_gemma":[0.021452254,0.014913232,0.48250452,0.005832486,0.0017651578,0.0012812353,0.13199148,0.004774105,0.08596493,0.009098549,0.23469335,0.005728708],"about_ca_topic_score_codex":0.0000622146,"about_ca_topic_score_gemma":0.000009532907,"teacher_disagreement_score":0.8524869,"about_ca_system_score_codex":0.000009524035,"about_ca_system_score_gemma":0.00005458799,"threshold_uncertainty_score":0.5283102},"labels":[],"label_agreement":null},{"id":"W2055408413","doi":"10.1503/cmaj.050871","title":"What is the role of dipyridamole in long-term secondary prevention after an ischemic stroke or transient ischemic attack?","year":2005,"lang":"en","type":"review","venue":"Canadian Medical Association Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Wellcome Trust","keywords":"Dipyridamole; Medicine; Stroke (engine); Secondary prevention; Ischemic stroke; Transient (computer programming); Myocardial infarction; Cardiology; Internal medicine; Term (time); Ischemia; Computer science","score_opus":0.012521073012051097,"score_gpt":0.29392467647629084,"score_spread":0.28140360346423976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055408413","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020564683,0.9771153,0.0000073271144,0.00080618385,0.00033242884,0.00054723746,0.000112053276,0.000008115775,0.0005066855],"genre_scores_gemma":[0.003803366,0.9918408,0.000010150105,0.001496895,0.0014334134,0.00005176576,0.00015503868,0.000048111102,0.0011604803],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99639136,0.00043940556,0.000995408,0.00029525108,0.0013793427,0.0004992532],"domain_scores_gemma":[0.9978307,0.000097950244,0.00047416787,0.00030753665,0.00017970022,0.0011099753],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015274612,0.0003179717,0.0012482714,0.00027540588,0.00009327319,0.000093430695,0.00031596798,0.0008479624,0.008593808],"category_scores_gemma":[0.00012114405,0.00021064143,0.0012467867,0.00027219616,0.00007313479,0.00035261296,0.000014910177,0.0017988189,0.000040657513],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005303314,0.00009208665,0.00097370654,0.0007315243,0.0009775874,0.0004110005,0.00027821917,1.9562911e-7,9.011013e-7,3.1004151e-7,0.0053911586,0.9910903],"study_design_scores_gemma":[0.0011750638,0.000090803114,0.0019248615,0.010329,0.0012123581,0.0011849155,0.00034167222,0.00000618855,0.0000065518752,9.940852e-7,0.98351836,0.00020920776],"about_ca_topic_score_codex":0.000090136156,"about_ca_topic_score_gemma":0.0053598303,"teacher_disagreement_score":0.9908811,"about_ca_system_score_codex":0.00097251,"about_ca_system_score_gemma":0.0070769256,"threshold_uncertainty_score":0.998552},"labels":[],"label_agreement":null},{"id":"W2056043590","doi":"10.1007/s00431-014-2485-1","title":"Monitoring aspirin therapy in children after interventional cardiac catheterization: laboratory measures, dose response, and clinical outcomes","year":2015,"lang":"en","type":"article","venue":"European Journal of Pediatrics","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Aspirin; Medicine; Urinary system; Platelet; Internal medicine; Cardiac catheterization; Gastroenterology; Urology; Anesthesia","score_opus":0.03655780556153559,"score_gpt":0.3059701733613137,"score_spread":0.2694123677997781,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056043590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9778958,0.021173155,0.00014486643,0.00010368094,0.00051590614,0.000111398214,0.000012145916,0.0000110511,0.000032022763],"genre_scores_gemma":[0.9921894,0.005789501,0.00033583638,0.00008837932,0.0015278504,8.79631e-7,0.000002795105,0.000029626039,0.0000357412],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972919,0.0013922697,0.00059615565,0.00013736334,0.00045560295,0.00012666317],"domain_scores_gemma":[0.99899477,0.000075181066,0.00020474044,0.00016555696,0.00029604224,0.00026369828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042442395,0.00012862089,0.0003709023,0.00019386203,0.000022062848,0.00003265079,0.000095536314,0.000039433282,0.0000068586814],"category_scores_gemma":[0.00038998036,0.00010043709,0.00041391613,0.00018729005,0.000054118693,0.00013484838,0.000036244208,0.00029447494,0.000008523452],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002584526,0.0001881907,0.9773458,0.0000069804846,0.00024243725,0.00040472916,0.00013770834,0.0000057544025,0.000015225797,5.699803e-7,0.000117871365,0.018950198],"study_design_scores_gemma":[0.004301849,0.0008839395,0.9922381,0.00005056374,0.00016624309,0.00006817851,0.00006450365,3.5038352e-7,0.000013913307,0.0000036126005,0.0021123951,0.000096350384],"about_ca_topic_score_codex":0.0000010561569,"about_ca_topic_score_gemma":6.6361764e-8,"teacher_disagreement_score":0.018853847,"about_ca_system_score_codex":0.000039339568,"about_ca_system_score_gemma":0.0001955803,"threshold_uncertainty_score":0.40957057},"labels":[],"label_agreement":null},{"id":"W2056100508","doi":"10.1097/mbc.0b013e3282f41e3e","title":"Quebec platelet disorder: features, pathogenesis and treatment","year":2008,"lang":"en","type":"review","venue":"Blood Coagulation & Fibrinolysis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Centre Hospitalier Universitaire Sainte-Justine; McMaster University Medical Centre; University of British Columbia; Health Sciences Centre; Canadian Blood Services","funders":"","keywords":"Pathogenesis; Medicine; Platelet; Intensive care medicine; Internal medicine","score_opus":0.024766411877909986,"score_gpt":0.27453250976352556,"score_spread":0.24976609788561557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056100508","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007660661,0.9905138,0.000037376234,0.000024452593,0.000059835165,0.0012259026,0.00014117346,0.00016900612,0.00016779402],"genre_scores_gemma":[0.00089117914,0.9942161,0.00014422426,0.000023130035,0.00037593947,0.0001867694,0.0016984602,0.0001109602,0.002353228],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976184,0.00019610177,0.0005988664,0.00078177784,0.00044326854,0.00036162234],"domain_scores_gemma":[0.9985042,0.00010003044,0.0002767627,0.0008004693,0.00006890067,0.00024963586],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000054922,0.0007335463,0.0027389405,0.0003346892,0.00026955185,0.00005593035,0.00009683226,0.00048785537,0.000087233915],"category_scores_gemma":[0.000017916836,0.0005659816,0.0021907873,0.00044733597,0.00015096716,0.000086800355,0.000053096035,0.00015757822,0.00004531096],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004808322,0.00024375485,0.0003455345,0.0016828352,0.0056513245,0.0003601335,0.000046351815,0.0000048283214,0.00000231137,0.000044816104,0.000100858924,0.99146914],"study_design_scores_gemma":[0.0019916603,0.00021577641,0.0041244035,0.0018810395,0.014485696,0.0027300608,0.000022409673,0.0000038418348,0.000020216266,0.0000022081745,0.9739785,0.0005441653],"about_ca_topic_score_codex":0.0007987269,"about_ca_topic_score_gemma":0.00020384505,"teacher_disagreement_score":0.990925,"about_ca_system_score_codex":0.000114745715,"about_ca_system_score_gemma":0.00036193282,"threshold_uncertainty_score":0.99967915},"labels":[],"label_agreement":null},{"id":"W2056191807","doi":"10.1111/j.1527-3466.2004.tb00130.x","title":"Therapeutic Potentials of Sarpogrelate in Cardiovascular Disease*","year":2004,"lang":"en","type":"review","venue":"Cardiovascular Drug Reviews","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Boniface Hospital","funders":"","keywords":"Medicine; Disease; Intensive care medicine; Internal medicine; Cardiology; Pharmacology","score_opus":0.048073908872342815,"score_gpt":0.30751698357133367,"score_spread":0.25944307469899086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056191807","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000014041732,0.98977274,0.00080166897,0.0000115043285,0.0005402174,0.008147049,0.000095219184,0.00012009215,0.0004974612],"genre_scores_gemma":[0.00015877414,0.9969743,0.0002216439,0.000056971072,0.0004912147,0.00096223195,0.000507222,0.0003627037,0.00026495778],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98891103,0.002871159,0.0031501183,0.0019755752,0.0020599344,0.0010321621],"domain_scores_gemma":[0.99193054,0.000103109225,0.00071018626,0.006353309,0.00021725254,0.00068557984],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_narrow","metaepi_broad"],"category_scores_codex":[0.005604972,0.0017283766,0.019125978,0.0009173593,0.000110604924,0.000050555213,0.00083356956,0.0006920134,0.00015089057],"category_scores_gemma":[0.00026874474,0.0013352705,0.06613799,0.0019462234,0.00038768537,0.00018912142,0.00022585194,0.0011994437,0.00042387354],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041525214,0.0002339421,0.000017903796,0.10833177,0.044287056,0.0011524444,0.00003861089,0.00025004538,1.7402287e-7,0.00006484779,0.00006298224,0.8455187],"study_design_scores_gemma":[0.0020994868,0.00003477164,0.00006771381,0.08549729,0.084965415,0.00049831986,0.000012052363,0.0000017242179,0.000002137406,0.0000821881,0.82577765,0.00096124713],"about_ca_topic_score_codex":0.00007009367,"about_ca_topic_score_gemma":0.000001062214,"teacher_disagreement_score":0.84455746,"about_ca_system_score_codex":0.00053982326,"about_ca_system_score_gemma":0.0014754703,"threshold_uncertainty_score":0.99954623},"labels":[],"label_agreement":null},{"id":"W2056592204","doi":"10.1017/s0317167100006685","title":"Progress in Clinical Neurosciences: The ‘Antiplatelet’ Agents and the Role of the Endothelium","year":2007,"lang":"en","type":"review","venue":"Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Saskatchewan","funders":"","keywords":"Ticlopidine; Dipyridamole; Aspirin; Clopidogrel; Endothelium; Medicine; Platelet; Mediator; Vasodilation; Pharmacology; Cardiology; Internal medicine","score_opus":0.06961771438703893,"score_gpt":0.35124422691595414,"score_spread":0.28162651252891524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056592204","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.34872207,0.6481759,0.0000010366804,0.0011811949,0.0009448723,0.0005400961,0.000009008132,0.0000043747655,0.00042146113],"genre_scores_gemma":[0.3047374,0.6931732,0.000049521288,0.0017198448,0.00028684232,0.0000054621255,1.400984e-7,0.00001361555,0.000013943652],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9906864,0.0042190775,0.0020248462,0.00060560124,0.0012876331,0.0011764307],"domain_scores_gemma":[0.9943244,0.0021139786,0.0018817051,0.00038593094,0.00027513597,0.0010188629],"candidate_categories":["sts","research_integrity"],"consensus_categories":["sts"],"category_scores_codex":[0.016567824,0.00047429002,0.0018584244,0.0006575265,0.002096882,0.00044074046,0.003520693,0.00034597673,0.000032751268],"category_scores_gemma":[0.0027262815,0.00017280318,0.0016014749,0.0023017218,0.035861637,0.00032067322,0.00018521892,0.0028001687,9.920593e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021358467,0.000066877525,0.4426325,0.00014817744,0.00010590916,0.003201886,0.00019226577,0.00004112771,9.7708615e-8,0.00089921337,0.000081929764,0.55241644],"study_design_scores_gemma":[0.001959606,0.025543403,0.13037352,0.0024858573,0.0013394969,0.11902855,0.0005809766,0.00034302298,0.000003707544,0.0053600674,0.7123973,0.00058451836],"about_ca_topic_score_codex":0.00038053174,"about_ca_topic_score_gemma":0.006444177,"teacher_disagreement_score":0.7123153,"about_ca_system_score_codex":0.00009413652,"about_ca_system_score_gemma":0.0054433336,"threshold_uncertainty_score":0.9995004},"labels":[],"label_agreement":null},{"id":"W2057237616","doi":"10.1159/000214310","title":"Platelet Interactions with the Endothelium and the Subendothelium: the Role of Thrombin and Prostacyclin","year":2009,"lang":"en","type":"article","venue":"Haemostasis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Platelet; Prostacyclin; Thrombin; Chemistry; Endothelium; Heparin; Aspirin; Platelet activation; Internal medicine; Endocrinology; Pharmacology; Biochemistry; Medicine","score_opus":0.0056606403012938004,"score_gpt":0.22620084712784208,"score_spread":0.2205402068265483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057237616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96716255,0.014109449,0.00007622218,0.015640153,0.000023465205,0.00080867944,0.000031268715,0.000028482782,0.0021197302],"genre_scores_gemma":[0.9961032,0.0021259198,0.00004788906,0.0014282229,0.00006237305,0.000025464204,0.0000057774146,0.000013683559,0.00018744668],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99916035,0.0001386899,0.00015188135,0.00016932041,0.00021920756,0.00016054149],"domain_scores_gemma":[0.9991642,0.0002261011,0.000079219644,0.00041086323,0.000069281734,0.00005030361],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003369193,0.00014058792,0.0002837454,0.000025917634,0.00022425619,0.00003810312,0.00009913105,0.000030381334,0.000038959737],"category_scores_gemma":[0.000039437407,0.000052818556,0.00012000594,0.0001559447,0.00057312206,0.000066462395,0.000026528189,0.00018795887,0.0000028023683],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007316394,0.00032807904,0.005956655,0.00006251591,0.0022857927,0.00006449376,0.011690442,0.000017073695,0.006862777,0.01576504,0.0017086301,0.9479421],"study_design_scores_gemma":[0.033791993,0.0018739705,0.09097626,0.0005544872,0.0039718025,0.0076073934,0.043879163,0.0008311663,0.45811483,0.011006904,0.34656268,0.00082935084],"about_ca_topic_score_codex":0.000056260647,"about_ca_topic_score_gemma":0.000023480083,"teacher_disagreement_score":0.94711274,"about_ca_system_score_codex":0.0000073379106,"about_ca_system_score_gemma":0.00003888549,"threshold_uncertainty_score":0.21538782},"labels":[],"label_agreement":null},{"id":"W2057281999","doi":"10.1038/ncpcardio0579","title":"Is antiplatelet therapy safe after intracerebral hemorrhage?","year":2006,"lang":"en","type":"article","venue":"Nature Clinical Practice Cardiovascular Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Intracerebral hemorrhage; Medicine; Anesthesia; Intensive care medicine; Subarachnoid hemorrhage","score_opus":0.020063372833131456,"score_gpt":0.34869612085215074,"score_spread":0.32863274801901926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057281999","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.36452937,0.5794017,0.002452054,0.02027838,0.0029610381,0.0017042991,0.000031901975,0.00039744138,0.028243866],"genre_scores_gemma":[0.9301711,0.018160904,0.0035967128,0.03633082,0.010535121,0.00006348895,0.00015008842,0.00014926022,0.0008425622],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.992618,0.0010859057,0.0015407801,0.001430058,0.0025113688,0.0008138901],"domain_scores_gemma":[0.9945012,0.0012251552,0.0003421045,0.0024142978,0.00093931064,0.00057794916],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.005711411,0.000726635,0.0024644108,0.00023344821,0.00019859403,0.000054724802,0.0003496143,0.0015280992,0.0013508844],"category_scores_gemma":[0.003651361,0.0005311584,0.0045696218,0.0008198214,0.00077683205,0.00054431404,0.00010082822,0.0034096758,0.0003473764],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02027028,0.0031054323,0.04275713,0.0004732982,0.03354475,0.03095773,0.00022195812,0.00004986511,0.00026825815,0.0005834239,0.12230441,0.7454635],"study_design_scores_gemma":[0.01678181,0.0008109243,0.14815617,0.00021301856,0.0050463835,0.0041720183,0.00018019986,0.00005138168,0.00029506406,0.00025858378,0.8234595,0.0005749491],"about_ca_topic_score_codex":0.00010017265,"about_ca_topic_score_gemma":0.0000015282944,"teacher_disagreement_score":0.7448885,"about_ca_system_score_codex":0.000092967544,"about_ca_system_score_gemma":0.00024383163,"threshold_uncertainty_score":0.99976814},"labels":[],"label_agreement":null},{"id":"W2057588675","doi":"10.5551/jat.5579","title":"Platelet Function Measured Using a Whole Blood Aggregometer Can Predict Bleeding Events","year":2011,"lang":"en","type":"article","venue":"Journal of Atherosclerosis and Thrombosis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Workers Compensation Board of British Columbia","funders":"","keywords":"Medicine; Platelet; Confidence interval; Internal medicine; Hazard ratio; Renal function; Whole blood; Proportional hazards model; Cardiology; Incidence (geometry); Gastroenterology","score_opus":0.07030675867711263,"score_gpt":0.2513136483657278,"score_spread":0.18100688968861517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057588675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969909,0.0017496179,0.00063539774,0.00005250261,0.00028293201,0.00015527564,0.000012368091,0.000020692607,0.000100283265],"genre_scores_gemma":[0.9965396,0.0020471714,0.0009122782,0.00017225949,0.0002658673,0.0000025296983,0.000002106585,0.000039053644,0.000019119656],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985241,0.00007940962,0.0004574834,0.0001940558,0.00049462327,0.00025028732],"domain_scores_gemma":[0.99897736,0.000019316612,0.0003561852,0.00018550424,0.0002074916,0.00025414815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005318859,0.00020907103,0.00060402526,0.00017066825,0.00014952975,0.00002874672,0.00008569039,0.00013165698,0.00013122227],"category_scores_gemma":[0.000033539203,0.00015904737,0.0005298089,0.00019367269,0.00007388417,0.00023896359,0.000028815393,0.0002192998,0.000002155338],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008764718,0.0012896473,0.58602196,0.0001796989,0.009276474,0.000032735927,0.0021785393,0.000012102797,0.3899533,0.000029586632,0.00016253856,0.009986957],"study_design_scores_gemma":[0.006717447,0.0020466032,0.9560222,0.0013293303,0.004628457,0.0005102842,0.00064648926,0.00006191621,0.027130453,0.00020191094,0.00041851017,0.000286388],"about_ca_topic_score_codex":0.0000347704,"about_ca_topic_score_gemma":0.0000021225633,"teacher_disagreement_score":0.37000024,"about_ca_system_score_codex":0.000041630843,"about_ca_system_score_gemma":0.00006730911,"threshold_uncertainty_score":0.6485763},"labels":[],"label_agreement":null},{"id":"W2057617175","doi":"10.1211/0022357022007","title":"Single oral dose study of two isosorbide-based aspirin prodrugs in the dog","year":2003,"lang":"en","type":"article","venue":"Journal of Pharmacy and Pharmacology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College","funders":"","keywords":"Aspirin; Pharmacology; Oral administration; Prodrug; Chemistry; Platelet; Medicine; Arachidonic acid; Antipyretic; Metabolite; Analgesic; Internal medicine; Biochemistry","score_opus":0.04579685353597562,"score_gpt":0.37436761860451817,"score_spread":0.32857076506854255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057617175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939305,0.004506069,0.000027304002,0.00044709648,0.00028087394,0.00047674894,0.0000019233062,0.000004468295,0.00032496807],"genre_scores_gemma":[0.99769276,0.00027669306,0.00007336627,0.0017559257,0.00016412427,0.000008645143,8.4427006e-7,0.000011097785,0.000016562979],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99809813,0.0008320663,0.0004787971,0.00012259356,0.0002832471,0.00018516106],"domain_scores_gemma":[0.99929106,0.00014926247,0.00023748583,0.00009679856,0.00012218006,0.00010319843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013260912,0.00013417254,0.00044792143,0.00013523416,0.000048211157,0.000008791992,0.000120802695,0.000025397294,0.00036444087],"category_scores_gemma":[0.000027231927,0.00008649237,0.00019278086,0.0002372261,0.00009509396,0.00009405757,0.0000107212645,0.00035850296,0.0000014894357],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011504772,0.021242501,0.51903874,0.00048956193,0.002682988,0.004500915,0.0060000056,0.00085595937,0.38604265,0.00010418524,0.0026900512,0.04484765],"study_design_scores_gemma":[0.2805592,0.011888809,0.10936449,0.00022746126,0.00782457,0.0048095966,0.005886917,0.00073893624,0.49710932,0.0005479294,0.08037285,0.0006699063],"about_ca_topic_score_codex":0.000024134168,"about_ca_topic_score_gemma":0.000004036532,"teacher_disagreement_score":0.40967426,"about_ca_system_score_codex":0.000021360584,"about_ca_system_score_gemma":0.00015746155,"threshold_uncertainty_score":0.39903718},"labels":[],"label_agreement":null},{"id":"W2058300302","doi":"10.1093/eurheartj/eht307.p239","title":"Clinical validation of BARC definitions of bleeding after an ACS in the TRACER trial","year":2013,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Interquartile range; Internal medicine; Hazard ratio; Confidence interval","score_opus":0.12533549445808906,"score_gpt":0.3567560205711544,"score_spread":0.23142052611306535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058300302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99651724,0.0003964595,0.00008612233,0.00037729237,0.00012381219,0.00022434568,0.0000021108312,0.0000049247783,0.0022676643],"genre_scores_gemma":[0.9982478,0.0004024414,0.000348632,0.0002882261,0.00067544426,0.0000031599463,0.000004150085,0.000012687575,0.000017483428],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981146,0.00097390043,0.00045949343,0.00008100533,0.00026609132,0.00010495046],"domain_scores_gemma":[0.9994526,0.00010084367,0.0000974004,0.00017147794,0.00009523537,0.00008245005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021521419,0.000061912906,0.00022169355,0.000070536305,0.00004170819,0.000027807675,0.000073792566,0.000026312633,0.00042492588],"category_scores_gemma":[0.00012576421,0.000039744064,0.0003193474,0.00009615541,0.00007300182,0.00018903763,0.000009936289,0.00027367668,0.000032553187],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.049804952,0.008205173,0.8192686,0.00030839283,0.0019264085,0.001123555,0.010431141,0.00013390582,0.015759975,0.00076001225,0.016086198,0.0761917],"study_design_scores_gemma":[0.020071248,0.0010417416,0.9728778,0.0002179663,0.00022346961,0.00045475268,0.0009266114,0.0000088144425,0.00064407266,0.00022543002,0.003223023,0.00008509018],"about_ca_topic_score_codex":0.000001751705,"about_ca_topic_score_gemma":3.9966685e-7,"teacher_disagreement_score":0.15360919,"about_ca_system_score_codex":0.00000536909,"about_ca_system_score_gemma":0.00004330528,"threshold_uncertainty_score":0.46526405},"labels":[],"label_agreement":null},{"id":"W2058387971","doi":"10.1016/s0014-5793(02)02434-1","title":"The hepoxilin analog PBT‐3 inhibits heparin‐activated platelet aggregation evoked by ADP","year":2002,"lang":"en","type":"article","venue":"FEBS Letters","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"Canadian Institutes of Health Research","keywords":"Chemistry; Platelet; Thromboxane; Thromboxane A2; Pharmacology; Thromboxane receptor; Receptor; Thromboxane B2; Antagonist; Aspirin; Mechanism of action; Platelet activation; Heparin; In vitro; Biochemistry; Internal medicine; Medicine","score_opus":0.009962302961676864,"score_gpt":0.21183450101231902,"score_spread":0.20187219805064216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058387971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98430914,0.0049085626,0.00022387762,0.008759879,0.00018147228,0.0004246572,0.000015474789,0.00015773857,0.0010191862],"genre_scores_gemma":[0.9907894,0.0012352698,0.000033474644,0.0064114407,0.00024292662,0.00003269479,0.00011922682,0.00003854838,0.0010969753],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99841905,0.00012799051,0.00028170212,0.0003282537,0.00045014606,0.00039288026],"domain_scores_gemma":[0.99912983,0.00009199336,0.00010080056,0.00046934246,0.00005227269,0.00015574202],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020899835,0.00022429787,0.00030387344,0.00006658609,0.00029302214,0.000060776212,0.00013511583,0.00010761588,0.00022980009],"category_scores_gemma":[0.00007503479,0.00016230327,0.00032788204,0.00030069525,0.00015040068,0.00013830935,0.000025632415,0.00026611626,0.00020936257],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010933467,0.00038101454,0.008846686,0.000085354346,0.0022302072,0.00052655186,0.00053297414,0.00012700303,0.31045663,0.00008388527,0.45813859,0.21749775],"study_design_scores_gemma":[0.009023884,0.00035658982,0.014028677,0.0002963695,0.00049760845,0.0004943374,0.00022240088,0.0015367607,0.4065553,0.00007400794,0.56603885,0.000875193],"about_ca_topic_score_codex":0.00004068107,"about_ca_topic_score_gemma":0.0000058448277,"teacher_disagreement_score":0.21662256,"about_ca_system_score_codex":0.00007725006,"about_ca_system_score_gemma":0.000015090099,"threshold_uncertainty_score":0.66185355},"labels":[],"label_agreement":null},{"id":"W2058807493","doi":"10.1111/ijs.12050","title":"Effect of Addition of Clopidogrel to Aspirin on Stroke Incidence: Meta-Analysis of Randomized Trials","year":2013,"lang":"en","type":"article","venue":"International Journal of Stroke","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; McMaster University","funders":"National Institute of Neurological Disorders and Stroke","keywords":"Medicine; Aspirin; Odds ratio; Clopidogrel; Confidence interval; Stroke (engine); Internal medicine; Randomized controlled trial","score_opus":0.042857637701068756,"score_gpt":0.36479282142247327,"score_spread":0.3219351837214045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058807493","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941627,0.0015769744,0.0024617473,0.00037935033,0.00022046274,0.00053661014,0.0003294389,0.000003391634,0.00032933077],"genre_scores_gemma":[0.99877846,0.00031983483,0.00039867833,0.00012432523,0.00017566151,0.000023225015,0.000027489486,0.000008947755,0.00014339236],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9956871,0.0009274367,0.0016933053,0.00011726161,0.0014835511,0.000091319576],"domain_scores_gemma":[0.9943876,0.0021650274,0.0016992308,0.00019234615,0.0014468877,0.00010890701],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004752127,0.00014957773,0.0037552156,0.0009795388,0.000009778565,0.000011379645,0.0002418092,0.0000680965,0.0021904726],"category_scores_gemma":[0.002582659,0.000090795744,0.0077847685,0.00020097385,0.00009384126,0.00012457719,0.000025082662,0.00013415556,0.000006706503],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.116702035,0.00038555881,0.0022260738,0.0000763379,0.8115719,0.000041796102,0.000122039084,0.0033036263,0.046375614,0.0002088614,0.0005492964,0.018436875],"study_design_scores_gemma":[0.10432261,0.0035629633,0.009273296,0.0002975619,0.46218592,0.000055707984,0.000105341496,0.00022065312,0.41934288,0.00014884312,0.00032105157,0.0001631653],"about_ca_topic_score_codex":0.000059821432,"about_ca_topic_score_gemma":0.0000013494874,"teacher_disagreement_score":0.37296727,"about_ca_system_score_codex":0.000038158792,"about_ca_system_score_gemma":0.000070661765,"threshold_uncertainty_score":0.99872166},"labels":[],"label_agreement":null},{"id":"W2058883281","doi":"10.1016/j.amjcard.2010.08.068","title":"Usefulness of Mean Platelet Volume as a Biomarker for Long-Term Outcomes After Percutaneous Coronary Intervention","year":2010,"lang":"en","type":"article","venue":"The American Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Percutaneous coronary intervention; Medicine; Term (time); Mean platelet volume; Cardiology; Internal medicine; Biomarker; Volume (thermodynamics); Percutaneous; Platelet; Myocardial infarction; Biology","score_opus":0.016513441110164517,"score_gpt":0.2886593617863304,"score_spread":0.2721459206761659,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058883281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950365,0.0007844497,0.0029610193,0.000415821,0.0004613802,0.00025213257,0.000019817124,0.000010381599,0.00005850185],"genre_scores_gemma":[0.9989569,0.0001552951,0.00014822997,0.00029190403,0.00028998396,0.000012299364,0.0000075065755,0.000027541826,0.00011033498],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986912,0.00025162904,0.00047066787,0.00013829216,0.0002308729,0.00021734528],"domain_scores_gemma":[0.9986038,0.00018489486,0.00046484603,0.00036200025,0.000272728,0.0001116869],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006933804,0.00016357478,0.0010622415,0.00011913269,0.000043718865,0.000007374635,0.00021219676,0.00006479698,0.00011742809],"category_scores_gemma":[0.00010421821,0.00009935062,0.0015822698,0.00009556085,0.0007189547,0.00005466053,0.000036197314,0.00027127386,0.000006842557],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020677939,0.00013306341,0.6376042,0.00009101692,0.0081666075,0.0026740944,0.00042206593,0.000025428977,0.008269582,0.00002156068,0.0003253257,0.32158917],"study_design_scores_gemma":[0.0020601018,0.002064917,0.9407316,0.00006433597,0.0011143569,0.05138997,0.00041007542,0.0000102034355,0.00048678016,0.0001251481,0.0014142888,0.00012821515],"about_ca_topic_score_codex":0.000009050554,"about_ca_topic_score_gemma":0.000003634122,"teacher_disagreement_score":0.32146093,"about_ca_system_score_codex":0.000020227888,"about_ca_system_score_gemma":0.0000783856,"threshold_uncertainty_score":0.40514007},"labels":[],"label_agreement":null},{"id":"W2060702221","doi":"10.1111/jgs.13271","title":"Regular Aspirin Use Does Not Reduce Risk of Cognitive Decline","year":2015,"lang":"en","type":"letter","venue":"Journal of the American Geriatrics Society","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institutes of Health; National Center for Advancing Translational Sciences; National Institute of Neurological Disorders and Stroke; U.S. Department of Health and Human Services","keywords":"Medicine; Aspirin; Cognition; Dementia; Stroke (engine); Cognitive decline; Cognitive test; Neuropsychology; Cohort; Recall; Gerontology; Physical therapy; Psychiatry; Internal medicine; Psychology","score_opus":0.020674032719030323,"score_gpt":0.27776115501121107,"score_spread":0.2570871222921807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060702221","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90058136,0.004432755,0.0005684519,0.09228594,0.0010445742,0.00046597648,0.0005616259,0.000021773612,0.000037516267],"genre_scores_gemma":[0.3178717,0.053056985,0.006990965,0.5939793,0.024292924,0.000012838759,0.0001443951,0.0003526815,0.0032982137],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958972,0.0006581821,0.0009800937,0.00029449852,0.0018060216,0.00036405018],"domain_scores_gemma":[0.99225795,0.00063294213,0.0045262123,0.00072626537,0.0016696531,0.0001869751],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0015779015,0.00040165053,0.0017787061,0.00011307509,0.000109867855,0.000045348406,0.0005404473,0.00035991977,0.000021941309],"category_scores_gemma":[0.0012569106,0.00022312465,0.0049158228,0.0006937097,0.0008413756,0.00012855283,0.00020386322,0.002479764,0.0000033860526],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017476118,0.00025036046,0.013953809,0.0002754343,0.011512194,0.00041556373,0.0006567691,0.000039340604,0.0006371781,7.615625e-7,0.9610476,0.009463393],"study_design_scores_gemma":[0.009304448,0.0022896607,0.048726015,0.0015737512,0.031233028,0.0019604987,0.002735239,0.00004245049,0.0050046197,0.00047549178,0.8955549,0.0010999001],"about_ca_topic_score_codex":0.000112964466,"about_ca_topic_score_gemma":6.3215896e-7,"teacher_disagreement_score":0.58270967,"about_ca_system_score_codex":0.00021240456,"about_ca_system_score_gemma":0.0010293373,"threshold_uncertainty_score":0.99982154},"labels":[],"label_agreement":null},{"id":"W2060742653","doi":"10.12968/hosp.2004.65.2.12057","title":"Antiplatelet agents in atherothrombotic diseases","year":2004,"lang":"en","type":"review","venue":"Hospital Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Aspirin; Myocardial infarction; Angina; Unstable angina; Coronary heart disease; Clopidogrel; Internal medicine; Cardiology; Canadian Cardiovascular Society; Intensive care medicine; Disease","score_opus":0.04341850013302493,"score_gpt":0.35127224335193286,"score_spread":0.3078537432189079,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060742653","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00076344743,0.9951868,0.000019384133,0.00017250059,0.00073191855,0.0022410974,0.000047484416,0.00014591817,0.0006914283],"genre_scores_gemma":[0.0018123823,0.99595666,0.000030279456,0.00018374865,0.00085189356,0.0001522163,0.0005251065,0.0001646422,0.00032309827],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967475,0.00013515321,0.00094782445,0.00080457825,0.0007612138,0.0006037153],"domain_scores_gemma":[0.99822295,0.000097271964,0.00026736743,0.00088845304,0.000058877296,0.00046511146],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021170173,0.00080485974,0.0043680356,0.00047374962,0.000058702135,0.000014832489,0.0002870778,0.00041938765,0.00084034016],"category_scores_gemma":[0.0002120344,0.00055424264,0.0013581408,0.0007753999,0.00038162654,0.000090695874,0.00007374393,0.00060648884,0.0003571574],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050025676,0.00076869846,0.0005141392,0.03792409,0.0014824718,0.005391554,0.00013010303,0.0000014031725,1.0498465e-7,0.00012831241,0.0010968324,0.95251226],"study_design_scores_gemma":[0.004971376,0.0010602522,0.0027646744,0.14066027,0.005606111,0.00045539593,0.000060354156,0.00000123785,2.311388e-7,0.00015120757,0.8436365,0.00063240103],"about_ca_topic_score_codex":0.000043521068,"about_ca_topic_score_gemma":0.0000013495071,"teacher_disagreement_score":0.95187986,"about_ca_system_score_codex":0.00034710008,"about_ca_system_score_gemma":0.00048759492,"threshold_uncertainty_score":0.9996909},"labels":[],"label_agreement":null},{"id":"W2061277785","doi":"10.1016/j.cjca.2012.08.020","title":"Personalized Cardiovascular Medicine: Status in 2012","year":2012,"lang":"en","type":"review","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Ottawa; McGill University","funders":"Canadian Institutes of Health Research; U.S. Food and Drug Administration; Cumberland Pharmaceuticals","keywords":"Medicine; Clopidogrel; Personalized medicine; Genetic testing; Pharmacogenetics; Warfarin; CYP2C19; Aspirin; Pharmacogenomics; Intensive care medicine; Antiplatelet drug; Precision medicine; Internal medicine; Bioinformatics; Pharmacology; Genetics; Atrial fibrillation; Pathology; Gene","score_opus":0.05516568838985138,"score_gpt":0.30411355131875695,"score_spread":0.24894786292890558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061277785","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000020593337,0.9922036,0.00027663668,0.00006489969,0.0015051784,0.00050256815,0.00004983581,0.000007313059,0.005369385],"genre_scores_gemma":[0.00094240136,0.9931281,0.00003703977,0.00011245392,0.005367568,0.000017826178,0.00008756324,0.000090340975,0.00021666927],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959606,0.0010877007,0.0011545109,0.00030886842,0.00044655235,0.0010417562],"domain_scores_gemma":[0.99656785,0.00014652284,0.00039050716,0.0006728839,0.0002652567,0.0019569641],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019130333,0.0005321534,0.007108527,0.0013797747,0.00006489394,0.000011336263,0.00030017924,0.0007393283,0.0003329968],"category_scores_gemma":[0.00025270795,0.00038982436,0.005874114,0.00048516676,0.00057288323,0.00012655342,0.000015874384,0.0011452256,0.000057005218],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044842483,0.0000034952807,0.0007998751,0.0032185144,0.011464499,0.0035631652,0.00010120396,0.000019333846,7.801919e-8,0.00009245359,0.0063594645,0.97433305],"study_design_scores_gemma":[0.001931985,0.00016215268,0.0005335222,0.0052137333,0.015172314,0.012836562,0.0000896166,7.053397e-8,3.9481346e-8,0.000017745719,0.96373796,0.00030431492],"about_ca_topic_score_codex":0.0006895665,"about_ca_topic_score_gemma":0.00018296145,"teacher_disagreement_score":0.97402877,"about_ca_system_score_codex":0.0006832987,"about_ca_system_score_gemma":0.005708674,"threshold_uncertainty_score":0.99992806},"labels":[],"label_agreement":null},{"id":"W2061452749","doi":"10.1055/s-2007-1002951","title":"Die computergestützte CTG-Analyse unter der Entbindung in Korrelation zu den Ergebnissen der Mikroblutuntersuchung","year":2007,"lang":"de","type":"article","venue":"Zeitschrift für Geburtshilfe und Neonatologie","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"TRIUMF","funders":"","keywords":"Computer science","score_opus":0.019215824605809007,"score_gpt":0.31525135419555,"score_spread":0.296035529589741,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061452749","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3930714,0.5604334,0.023992693,0.003284592,0.0058546327,0.0028124677,0.00006943521,0.0006055767,0.009875812],"genre_scores_gemma":[0.9821301,0.011780976,0.0012510192,0.0017965422,0.0015582433,0.000045661534,0.0005254509,0.000215461,0.00069656246],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99118507,0.00078231195,0.0021592854,0.0019246641,0.0014597031,0.0024889915],"domain_scores_gemma":[0.9953665,0.0010149169,0.0006038494,0.0016729545,0.00038936827,0.0009524259],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0023731655,0.0013943469,0.0021899433,0.0013184582,0.00044326822,0.00021953195,0.00090316136,0.0014910515,0.0005158033],"category_scores_gemma":[0.00044938814,0.0013215494,0.0017017942,0.0013067294,0.00065209286,0.0006656064,0.0004303046,0.0018055205,0.0011856253],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057111154,0.00221562,0.743891,0.00072293973,0.029656582,0.023692572,0.0033041013,0.0018799884,0.00061569345,0.0049786223,0.0051730094,0.17815875],"study_design_scores_gemma":[0.018461524,0.00085472246,0.39794785,0.0025500215,0.017978994,0.00038629124,0.002000125,0.0046619205,0.006507173,0.00028241402,0.5447831,0.0035858485],"about_ca_topic_score_codex":0.00035305915,"about_ca_topic_score_gemma":0.00034733035,"teacher_disagreement_score":0.58905864,"about_ca_system_score_codex":0.0002031483,"about_ca_system_score_gemma":0.00054211984,"threshold_uncertainty_score":0.9998807},"labels":[],"label_agreement":null},{"id":"W2062331418","doi":"10.1016/j.cjca.2014.07.242","title":"SHOULD DUAL ANTIPLATELET THERAPY BE USED AFTER CORONARY ARTERY BYPASS SURGERY? A META-ANALYSIS OF 4662 PATIENTS FROM RANDOMIZED CONTROLLED TRIALS","year":2014,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Toronto Public Health","funders":"","keywords":"Medicine; Randomized controlled trial; Meta-analysis; Coronary artery bypass surgery; Internal medicine; Cardiology; Artery","score_opus":0.08085568849265815,"score_gpt":0.28583569630360456,"score_spread":0.2049800078109464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062331418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97129565,0.02433837,0.0015764049,0.0008020959,0.00061103,0.0007304531,0.00043488241,0.0000078358225,0.00020327474],"genre_scores_gemma":[0.9966398,0.0009629275,0.00004333166,0.0014399753,0.000605297,0.000055418677,0.00017987029,0.00003385744,0.00003955986],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9894523,0.0067926683,0.0024642113,0.000295472,0.00057041366,0.00042491636],"domain_scores_gemma":[0.9905505,0.006209203,0.0013464647,0.00051638304,0.000685599,0.00069184887],"candidate_categories":["metaepi_broad"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.009965545,0.00038403767,0.021040509,0.0011829714,0.00006220772,0.000028186314,0.00015907294,0.0003214347,0.0009082204],"category_scores_gemma":[0.002965011,0.00023094192,0.025163567,0.00033231662,0.0003874895,0.000100903,0.000009057088,0.00029276725,0.0000032037076],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15426838,0.00002460192,0.05218543,0.0000070018773,0.78861076,0.00063439505,0.00012929688,0.00045691567,0.00010384699,0.00001267847,0.0016381405,0.0019285287],"study_design_scores_gemma":[0.3058998,0.00037425946,0.07046878,0.00002145778,0.6083997,0.0001730832,0.00005761817,0.000049013368,0.00014880276,0.00011209263,0.013978709,0.00031670032],"about_ca_topic_score_codex":0.00044937743,"about_ca_topic_score_gemma":0.000306825,"teacher_disagreement_score":0.1802111,"about_ca_system_score_codex":0.00005303181,"about_ca_system_score_gemma":0.00078920636,"threshold_uncertainty_score":0.99443763},"labels":[],"label_agreement":null},{"id":"W2062930220","doi":"10.1160/th10-10-0633","title":"Clopidogrel in acute coronary syndromes: Where are we now?","year":2011,"lang":"en","type":"review","venue":"Thrombosis and Haemostasis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Clopidogrel; Cardiology; Internal medicine; Myocardial infarction; Acute coronary syndrome; Platelet; Thrombosis; Intensive care medicine","score_opus":0.13747941215541093,"score_gpt":0.36386412063036216,"score_spread":0.22638470847495124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062930220","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00097616756,0.9964574,0.0000070369724,0.0002791664,0.00016187444,0.0010983007,0.00034018507,0.00008861797,0.00059127295],"genre_scores_gemma":[0.00012149019,0.9985455,0.000160743,0.00014807777,0.00010049685,0.00013319316,0.0002464822,0.00012613027,0.00041784273],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976443,0.00019023304,0.00065391307,0.0007424261,0.00029208098,0.00047702526],"domain_scores_gemma":[0.998557,0.000064386535,0.00027386236,0.00076429104,0.000053068663,0.00028742058],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023065563,0.0006968671,0.0038213935,0.0002871739,0.000110861976,0.000037980924,0.00021052622,0.0005667414,0.0007539948],"category_scores_gemma":[0.0000053990993,0.0005325423,0.0013664949,0.0004163172,0.00020746,0.000113774935,0.00013469024,0.0005229429,0.00021059682],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006319334,0.0002385063,0.0012974388,0.016382169,0.0050280266,0.0005780683,0.00012292553,2.2721217e-8,9.470876e-8,0.00004983037,0.0072782533,0.9689615],"study_design_scores_gemma":[0.0012459041,0.000180381,0.0031374912,0.034143005,0.009348885,0.0009409661,0.0001450652,4.4120318e-7,6.470718e-7,0.000030337498,0.9502801,0.0005468363],"about_ca_topic_score_codex":0.00003145992,"about_ca_topic_score_gemma":0.000031378502,"teacher_disagreement_score":0.9684146,"about_ca_system_score_codex":0.00009783576,"about_ca_system_score_gemma":0.00020438373,"threshold_uncertainty_score":0.9997126},"labels":[],"label_agreement":null},{"id":"W2063000521","doi":"10.1111/j.1365-2036.2006.02829.x","title":"The prevalence of risk factors for gastrointestinal complications and use of gastroprotection among persons hospitalized for cardiovascular disease","year":2006,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Aspirin; Proton-pump inhibitor; Internal medicine; Gastrointestinal disease; Disease; Gastrointestinal bleeding; Risk factor; Intensive care medicine","score_opus":0.02690421751039171,"score_gpt":0.2776513275388849,"score_spread":0.25074711002849315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063000521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9721029,0.0060091554,0.018717926,0.00017282323,0.00008017144,0.0019437594,0.0009479446,0.000023606439,0.0000017284486],"genre_scores_gemma":[0.99596024,0.0014823017,0.0019496286,0.00012482094,0.00006569272,0.00025287535,0.000112267124,0.000024376055,0.000027805236],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99901736,0.0001268712,0.00025936088,0.00022925447,0.0001594395,0.00020773557],"domain_scores_gemma":[0.9989331,0.00040900905,0.00016480991,0.0002631478,0.00015431947,0.000075651216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020465652,0.00015409019,0.0002766099,0.00004267619,0.00025711415,0.000008404119,0.00008022859,0.000030104398,0.000006903605],"category_scores_gemma":[0.0000029484502,0.00011731232,0.0007285316,0.0000633196,0.000489749,0.000071972536,0.00001843515,0.000078845456,9.734059e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039908867,0.0006681761,0.9396389,0.000510633,0.028826255,0.0000034695454,0.00015392964,0.001503492,0.022007195,0.00009425102,0.00014516631,0.0024576543],"study_design_scores_gemma":[0.0051180082,0.00077385985,0.9178666,0.00007033092,0.059245113,0.000021582744,0.00020448776,0.0028495982,0.010003249,0.00022134832,0.003463403,0.00016243508],"about_ca_topic_score_codex":0.0001379732,"about_ca_topic_score_gemma":0.0000020736743,"teacher_disagreement_score":0.03041886,"about_ca_system_score_codex":0.000026748867,"about_ca_system_score_gemma":0.000042738655,"threshold_uncertainty_score":0.47838575},"labels":[],"label_agreement":null},{"id":"W2063870679","doi":"10.1016/j.cjca.2013.07.435","title":"Underutilization of Newer Guideline-Recommended Oral Antiplatelet Therapy: Insights From the Canadian Acute Coronary Syndrome (ACS) Reflective","year":2013,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Toronto Public Health","funders":"","keywords":"Medicine; Acute coronary syndrome; Guideline; Intensive care medicine; Audit; Clinical trial; Psychological intervention; Myocardial infarction; Internal medicine; Pathology; Nursing","score_opus":0.024503484423735945,"score_gpt":0.2631275802094067,"score_spread":0.23862409578567073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063870679","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842496,0.008638294,0.0007588673,0.003496851,0.0007270121,0.00044133415,0.0000942588,0.000008112754,0.0015856783],"genre_scores_gemma":[0.99549496,0.00088996015,0.00016767722,0.0028971967,0.00034150228,0.0000060465563,0.00012335624,0.000032351923,0.000046955865],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981844,0.00040904366,0.0005986541,0.00019579189,0.00021963984,0.0003924757],"domain_scores_gemma":[0.9976922,0.00010170364,0.00023989953,0.00038251054,0.00077908474,0.0008045802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029959079,0.00021730103,0.0008470759,0.00030683877,0.0002171059,0.000031831427,0.00028723635,0.00026164355,0.00029565356],"category_scores_gemma":[0.000087307424,0.00014878112,0.00050636625,0.00026445845,0.00025687047,0.00017093123,0.000011138656,0.0003689799,0.000021533293],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016801286,0.000048410737,0.49535805,0.000036559104,0.04465005,0.011628773,0.002758499,0.003112416,0.0055595795,0.0013712199,0.33319736,0.100598946],"study_design_scores_gemma":[0.0048404527,0.0009909951,0.80219144,0.00013002253,0.0009551227,0.00662167,0.0008709192,0.000050116592,0.0005903322,0.0032563186,0.17916164,0.00034099547],"about_ca_topic_score_codex":0.13575017,"about_ca_topic_score_gemma":0.1477632,"teacher_disagreement_score":0.30683336,"about_ca_system_score_codex":0.00030876423,"about_ca_system_score_gemma":0.003480986,"threshold_uncertainty_score":0.87000495},"labels":[],"label_agreement":null},{"id":"W2064267796","doi":"10.1038/nrcardio.2010.101","title":"New antithrombotic agents—insights from clinical trials","year":2010,"lang":"en","type":"review","venue":"Nature Reviews Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; University of British Columbia; McMaster University; Hamilton General Hospital","funders":"","keywords":"Medicine; Antithrombotic; Clinical trial; Intensive care medicine; Fibrinolytic agent; Internal medicine","score_opus":0.20925118518574015,"score_gpt":0.5033893335698135,"score_spread":0.2941381483840734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064267796","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000051634433,0.9858726,0.0006261278,0.000055800487,0.006795179,0.004507917,0.00011496068,0.00012360667,0.0018986108],"genre_scores_gemma":[0.0000032171563,0.97851706,0.0015337674,0.0009611722,0.016336007,0.000119206394,0.0018533351,0.00015072947,0.0005255074],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98319757,0.010348639,0.0039021748,0.0015442953,0.00047316914,0.000534148],"domain_scores_gemma":[0.9928443,0.0020823262,0.0016302903,0.0025397527,0.00012803242,0.00077532383],"candidate_categories":["metaepi_narrow","metaepi_broad","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_broad","research_integrity"],"category_scores_codex":[0.0052991416,0.0011677924,0.02707359,0.00025274372,0.00009641149,0.000037634472,0.00064005185,0.007091573,0.000704407],"category_scores_gemma":[0.005758141,0.00069414545,0.02157619,0.00047235689,0.0002173777,0.000064109416,0.00014718078,0.006651298,0.0017617968],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004262429,0.0000359913,0.000029427261,0.0041960394,0.0063477876,0.0005943092,0.000003324466,3.555366e-8,6.6745076e-7,0.00015764708,0.05846063,0.9301315],"study_design_scores_gemma":[0.0013484332,0.00012689298,0.00013409456,0.012865332,0.03655933,0.0008570441,0.0000015652442,1.9885911e-7,2.7854395e-7,0.0001561142,0.9473691,0.00058162434],"about_ca_topic_score_codex":0.000007395526,"about_ca_topic_score_gemma":0.0000032462956,"teacher_disagreement_score":0.9295499,"about_ca_system_score_codex":0.00007781464,"about_ca_system_score_gemma":0.0015414521,"threshold_uncertainty_score":0.999551},"labels":[],"label_agreement":null},{"id":"W2064415351","doi":"10.14740/cr307w","title":"Impact of Grapefruit Juice on the Antiplatelet Activity of Loading and Maintenance Doses of Clopidogrel in Healthy Volunteers","year":2014,"lang":"en","type":"article","venue":"Cardiology Research","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Clopidogrel; Grapefruit juice; Medicine; Maintenance dose; P2Y12; Loading dose; Confidence interval; Pharmacology; Anesthesia; Internal medicine; Aspirin; Pharmacokinetics","score_opus":0.05851903459463858,"score_gpt":0.38440629081027106,"score_spread":0.32588725621563247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064415351","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965004,0.0017325652,0.000081245074,0.00024942964,0.000033719884,0.00038727658,0.000018868463,0.0000059142158,0.0009906235],"genre_scores_gemma":[0.99777555,0.002083587,0.000010935466,0.000030208648,0.000053608575,0.0000124720855,0.0000031174175,0.000012655637,0.000017884098],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977533,0.0010277363,0.00024858947,0.00025177162,0.00034449704,0.0003741104],"domain_scores_gemma":[0.99804604,0.0010560986,0.00007869196,0.00047969967,0.00025239974,0.0000870513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028783178,0.00011689361,0.0008831119,0.00026870435,0.000052319756,0.0000025839106,0.00014679336,0.00013364218,0.0000112487805],"category_scores_gemma":[0.00080611504,0.000073120056,0.0003673024,0.00041992354,0.0010072141,0.000033267832,0.00006520224,0.0004323944,0.0000020064108],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011159042,0.00017289577,0.9186442,0.00048035948,0.0012869076,0.000050827093,0.00034668492,0.00018079756,0.047094863,0.0010445876,0.00050970516,0.019029148],"study_design_scores_gemma":[0.0024985538,0.0029876225,0.9865204,0.00027164025,0.000049239992,0.00009601466,0.00022911814,0.000177077,0.006652251,0.00020942738,0.00022866193,0.00007997067],"about_ca_topic_score_codex":0.000250367,"about_ca_topic_score_gemma":0.0000061558385,"teacher_disagreement_score":0.06787624,"about_ca_system_score_codex":0.00004478339,"about_ca_system_score_gemma":0.00013845642,"threshold_uncertainty_score":0.37111223},"labels":[],"label_agreement":null},{"id":"W2064771381","doi":"10.4212/cjhp.v64i6.1090","title":"Anticoagulation Therapy: A Point-of-Care Guide","year":2011,"lang":"en","type":"article","venue":"The Canadian Journal of Hospital Pharmacy","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Point of care; Medicine; Point (geometry); Intensive care medicine; Nursing; Mathematics","score_opus":0.03117453113887647,"score_gpt":0.27847209144244445,"score_spread":0.24729756030356798,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064771381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.974812,0.019510044,0.000066760316,0.00071830966,0.0004039136,0.00022196911,0.0000061997384,0.0000057475404,0.0042550974],"genre_scores_gemma":[0.9985219,0.00059954106,0.00014697804,0.00041481532,0.00024189785,0.0000010810469,0.000002903142,0.000018376304,0.000052463132],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99917394,0.000058610094,0.00030075535,0.00006898353,0.00021852218,0.0001791608],"domain_scores_gemma":[0.9989151,0.000014747056,0.00017978427,0.00018937621,0.00037064936,0.00033034533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025860855,0.00010383813,0.000254576,0.00012004648,0.000105392515,0.000014055498,0.00018161228,0.00002567427,0.000497404],"category_scores_gemma":[0.0000373057,0.000066960565,0.0004183569,0.00012776717,0.00014983615,0.00014780756,0.0000054991883,0.00016221436,0.000009531983],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029761589,0.00044912004,0.56176025,0.00018904771,0.00603661,0.0031549523,0.04045965,0.000050933893,0.002945302,0.0015738888,0.014363977,0.36604014],"study_design_scores_gemma":[0.02130663,0.0056766993,0.665567,0.00080729014,0.002448812,0.0022039863,0.0074603697,0.000069727255,0.10404911,0.002662807,0.18692331,0.000824266],"about_ca_topic_score_codex":0.0029678047,"about_ca_topic_score_gemma":0.00040259107,"teacher_disagreement_score":0.36521587,"about_ca_system_score_codex":0.000057333327,"about_ca_system_score_gemma":0.0008535712,"threshold_uncertainty_score":0.5446225},"labels":[],"label_agreement":null},{"id":"W2065676805","doi":"10.1159/000048951","title":"Trial of Invasive versus Medical Therapy in the Elderly (TIME)","year":2001,"lang":"en","type":"article","venue":"Heart Drug","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Revascularization; Clinical endpoint; Myocardial infarction; Internal medicine; Coronary artery disease; Angina; Cardiology; Canadian Cardiovascular Society; Percutaneous coronary intervention; Acute coronary syndrome; Randomized controlled trial; Percutaneous; Surgery","score_opus":0.023970524056547586,"score_gpt":0.2939299701523684,"score_spread":0.2699594460958208,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065676805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906095,0.0019755661,0.0000046178484,0.003697498,0.00016222596,0.00048739833,0.0000012817756,0.000018519988,0.0030433426],"genre_scores_gemma":[0.99577314,0.0025808031,0.000015160605,0.0010563384,0.00033222363,0.000023288838,0.000009610902,0.000010424637,0.00019902119],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9986889,0.00021418493,0.0001982084,0.00013446072,0.000602423,0.0001618699],"domain_scores_gemma":[0.9992508,0.0003062183,0.000026129317,0.0003024966,0.000035105957,0.000079215584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066149206,0.00008976691,0.00029411676,0.000049516584,0.000032687116,0.00000636985,0.00011015777,0.00006919263,0.0008650838],"category_scores_gemma":[0.00017643819,0.000055644767,0.00029846912,0.0001868919,0.00008108087,0.000036112102,0.000009989319,0.00016541033,0.000073596966],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5183289,0.0049812365,0.013513434,0.000115800074,0.0018329144,0.002664427,0.00654224,0.000011849322,0.002193771,0.0005221853,0.061812866,0.38748038],"study_design_scores_gemma":[0.5160259,0.008597383,0.022350438,0.0003850807,0.00025158943,0.0006666287,0.0026286694,0.000065087675,0.0040690494,0.00036586888,0.4441785,0.00041581396],"about_ca_topic_score_codex":0.00006239188,"about_ca_topic_score_gemma":0.000021858337,"teacher_disagreement_score":0.38706458,"about_ca_system_score_codex":0.000010954624,"about_ca_system_score_gemma":0.00020208243,"threshold_uncertainty_score":0.94720614},"labels":[],"label_agreement":null},{"id":"W2066789797","doi":"10.1371/journal.pone.0067314","title":"Human Thromboxane A2 Receptor Genetic Variants: In Silico, In Vitro and “In Platelet” Analysis","year":2013,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"National Heart, Lung, and Blood Institute; American Heart Association","keywords":"In silico; Platelet; Platelet activation; Biology; Phenotype; Gene; Genetics; Immunology","score_opus":0.02419919068885685,"score_gpt":0.22922352595530737,"score_spread":0.20502433526645053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066789797","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961248,0.0028501244,0.0000085562,0.0002025478,0.000007930984,0.0005307504,0.000006695264,0.000024842408,0.00024374457],"genre_scores_gemma":[0.9980026,0.00089380087,0.00057865464,0.00020184068,0.000052677802,0.00007523565,0.000044843488,0.000020707219,0.00012966694],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986596,0.00011064879,0.00032750133,0.0003405867,0.00027331486,0.0002883356],"domain_scores_gemma":[0.9994556,0.00003169681,0.000041473522,0.00032410314,0.00003248322,0.00011465001],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018373926,0.00015470074,0.0007317469,0.00043407464,0.000025672065,0.000020746978,0.00007277318,0.00011039703,0.00087861915],"category_scores_gemma":[0.000040296658,0.00014639816,0.0001311919,0.00070942735,0.00005899541,0.00009601872,0.000028770464,0.00019500579,0.00005809817],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029891808,0.003303647,0.38101456,0.00022076271,0.0033097637,0.00027773806,0.0004958402,0.000057736615,0.60513043,0.000008641451,0.00003758168,0.005844368],"study_design_scores_gemma":[0.0032182222,0.00009544565,0.97317666,0.00018597674,0.0006164668,0.00000520809,0.00015335904,0.00074313337,0.021513645,0.000091750415,0.000015632713,0.00018453113],"about_ca_topic_score_codex":0.0005957999,"about_ca_topic_score_gemma":0.00016599617,"teacher_disagreement_score":0.5921621,"about_ca_system_score_codex":0.0000579477,"about_ca_system_score_gemma":0.000023336273,"threshold_uncertainty_score":0.96202636},"labels":[],"label_agreement":null},{"id":"W2067385539","doi":"10.1016/j.cjca.2014.09.011","title":"Increased Uptake of Guideline-Recommended Oral Antiplatelet Therapy: Insights from the Canadian Acute Coronary Syndrome Reflective","year":2014,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of Alberta; Vancouver General Hospital; Southlake Regional Health Center; University of British Columbia; Montreal Heart Institute; Credit Valley Hospital; Institut universitaire de cardiologie et de pneumologie de Québec; Trillium Health Centre; Université de Montréal; University of Saskatchewan; University of Toronto; Royal University Hospital; Health Sciences Centre; St. Michael's Hospital; Sunnybrook Health Science Centre; Oakville-Trafalgar Memorial Hospital; Hamilton Health Sciences; McMaster University; Canadian Heart Research Centre; London Health Sciences Centre","funders":"","keywords":"Medicine; Prasugrel; Ticagrelor; Acute coronary syndrome; Clopidogrel; Percutaneous coronary intervention; Unstable angina; Conventional PCI; Internal medicine; Cardiology; Myocardial infarction; Guideline; Observational study","score_opus":0.019824283792189076,"score_gpt":0.2577726843845104,"score_spread":0.2379484005923213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067385539","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879985,0.0064920015,0.00041432932,0.001838439,0.0006651501,0.0002754679,0.00017851956,0.000008556199,0.0021290453],"genre_scores_gemma":[0.9950096,0.000530833,0.00028033397,0.003431528,0.0005644717,0.000003881592,0.00012285051,0.00003674348,0.000019740988],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99768156,0.00063989096,0.0007390349,0.00022716691,0.0002537926,0.00045857916],"domain_scores_gemma":[0.9973642,0.0001715035,0.00028216906,0.00050217763,0.0005637999,0.0011161143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007860984,0.00025558297,0.0011749159,0.00033669986,0.00025303796,0.000022830727,0.0003826293,0.00028128392,0.00012287653],"category_scores_gemma":[0.00019856257,0.0001758568,0.0007660679,0.00024647295,0.00030666857,0.000093302006,0.0000123536065,0.00048415136,0.000011603126],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059716967,0.00006283091,0.5249418,0.000047492656,0.06327516,0.026855819,0.0023376583,0.001641495,0.005935671,0.0017958485,0.17965926,0.18747526],"study_design_scores_gemma":[0.0047758245,0.0010481009,0.5617115,0.000095168,0.0008845474,0.006764224,0.00026070548,0.000027921116,0.00034163907,0.001075142,0.42277706,0.00023817107],"about_ca_topic_score_codex":0.11465857,"about_ca_topic_score_gemma":0.1967426,"teacher_disagreement_score":0.24311778,"about_ca_system_score_codex":0.0002647865,"about_ca_system_score_gemma":0.004133139,"threshold_uncertainty_score":0.891237},"labels":[],"label_agreement":null},{"id":"W2067435040","doi":"10.1016/j.thromres.2007.04.009","title":"Identification of platelet hyper-reactivity measured with a portable device immediately after percutaneous coronary intervention predicts in stent thrombosis","year":2007,"lang":"en","type":"article","venue":"Thrombosis Research","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Medicine; Cardiology; Percutaneous coronary intervention; Internal medicine; Conventional PCI; Myocardial infarction; Thrombosis; Hazard ratio; Stent; Unstable angina; Confidence interval","score_opus":0.06218266555877923,"score_gpt":0.35508753623409606,"score_spread":0.29290487067531684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067435040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959142,0.0018775242,0.0002457288,0.00013476262,0.0000681734,0.0011701706,0.000033252654,0.000051665902,0.0005045299],"genre_scores_gemma":[0.9986219,0.0008764227,0.00007919617,0.000033052736,0.00006914334,0.00008967364,0.0000755193,0.000051238567,0.00010388654],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99587756,0.00039074902,0.0006737442,0.0005457156,0.0018455507,0.00066667923],"domain_scores_gemma":[0.9980799,0.00022542177,0.00014573577,0.0006640561,0.00065179076,0.00023311969],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043698982,0.000232112,0.00065102766,0.0005188565,0.000101914484,0.00003386365,0.00019816136,0.00019800705,0.0002518028],"category_scores_gemma":[0.0001777533,0.00019462562,0.00029004354,0.0009334861,0.00034860923,0.00029448463,0.0000810444,0.0005380779,0.000042756645],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011347312,0.004433276,0.46938753,0.001149211,0.001597827,0.0011072455,0.0020545397,0.00005009998,0.45893455,0.000027764745,0.00013987314,0.049770784],"study_design_scores_gemma":[0.0024985585,0.00086454925,0.9277925,0.00058844517,0.00018597655,0.00030444047,0.0016798908,0.00008413998,0.065529585,0.000033524957,0.00024778442,0.00019062584],"about_ca_topic_score_codex":0.0005833735,"about_ca_topic_score_gemma":0.000474068,"teacher_disagreement_score":0.45840496,"about_ca_system_score_codex":0.00031315687,"about_ca_system_score_gemma":0.00020397986,"threshold_uncertainty_score":0.7936602},"labels":[],"label_agreement":null},{"id":"W2069363135","doi":"10.1073/pnas.111150798","title":"Platelets modulate gastric ulcer healing: Role of endostatin and vascular endothelial growth factor release","year":2001,"lang":"en","type":"article","venue":"Proceedings of the National Academy of Sciences","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":245,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Ticlopidine; Endostatin; Medicine; Angiogenesis; Aspirin; Platelet; Pharmacology; Vascular endothelial growth factor; Wound healing; Internal medicine; Umbilical vein; Immunology; Chemistry; VEGF receptors; Clopidogrel; Biochemistry; In vitro","score_opus":0.022182692799912272,"score_gpt":0.270339936920636,"score_spread":0.24815724412072374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069363135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968427,0.0014896658,0.0000037665343,0.00045285668,0.000008534629,0.00022810108,0.000032784134,0.000010840085,0.0009307947],"genre_scores_gemma":[0.9980435,0.0011919175,0.00050585193,0.00014118876,0.00006972732,0.0000047441695,3.7313131e-7,0.000006618023,0.000036126297],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981424,0.000010341923,0.00031672235,0.00022563181,0.001142915,0.00016194496],"domain_scores_gemma":[0.9992771,0.00008138732,0.00027740194,0.000012445354,0.00027649626,0.00007518402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005525969,0.00011136739,0.00028561836,0.00017656013,0.00010605414,0.000009564899,0.00022952033,0.000070685164,0.000026147296],"category_scores_gemma":[0.00041454405,0.00007426175,0.00021062115,0.00051744696,0.000559044,0.00021919975,0.00005522875,0.00012645229,5.608444e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004228054,0.00022714946,0.13638622,0.0003299122,0.00038352422,2.6440043e-7,0.0005357997,0.00012452672,0.8435102,0.009912174,0.00007174296,0.00809567],"study_design_scores_gemma":[0.0020202042,0.0002290156,0.46505043,0.00026629312,0.0001525438,0.0001502912,0.00039540016,0.0014498533,0.5137647,0.015778374,0.00058701873,0.00015587927],"about_ca_topic_score_codex":0.000015000531,"about_ca_topic_score_gemma":1.9149754e-8,"teacher_disagreement_score":0.3297455,"about_ca_system_score_codex":0.000015983647,"about_ca_system_score_gemma":0.000045093595,"threshold_uncertainty_score":0.30283064},"labels":[],"label_agreement":null},{"id":"W2069469642","doi":"10.1016/s0735-1097(13)61596-x","title":"NON-ADHERENCE WITH CLOPIDOGREL AFTER CORONARY STENTING IS ASSOCIATED WITH INCREASED MORTALITY AND MYOCARDIAL INFARCTION","year":2013,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Victoria Heart Institute Foundation","funders":"","keywords":"Medicine; Clopidogrel; Myocardial infarction; Internal medicine; Coronary stenting; Cardiology; Stent","score_opus":0.009923273015738065,"score_gpt":0.23684501239857286,"score_spread":0.2269217393828348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069469642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99858135,0.00041890144,0.00013380597,0.00021610841,0.0000785172,0.00030933297,0.000030848685,0.000005788468,0.00022532028],"genre_scores_gemma":[0.9988659,0.00022396911,0.00014102632,0.00054713414,0.00017247254,0.000012646887,0.0000014901161,0.000015876647,0.000019471281],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987311,0.00025356628,0.0003193605,0.00014065969,0.0003727827,0.00018257403],"domain_scores_gemma":[0.9985875,0.00008865553,0.0006160721,0.0002498719,0.0003441362,0.00011380353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029929218,0.00014894307,0.0009342993,0.000071289214,0.000059437476,0.0000062325776,0.00010080458,0.00005191848,0.000014389888],"category_scores_gemma":[0.00005989254,0.00008220406,0.00038454938,0.00026653847,0.00068632874,0.00010212033,0.000040431998,0.00022671666,6.57626e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001969841,0.000032460448,0.99040604,0.000017322142,0.0047427504,0.0002564845,0.000034484357,0.00004356118,0.0011169902,0.0000015007604,0.000342881,0.0010357153],"study_design_scores_gemma":[0.002525709,0.0019108477,0.9903515,0.00016314512,0.0012458584,0.0028283906,0.000483959,0.000025864865,0.00019373522,0.00001910218,0.00015179401,0.000100099765],"about_ca_topic_score_codex":0.00008900524,"about_ca_topic_score_gemma":0.0000041348926,"teacher_disagreement_score":0.0034968923,"about_ca_system_score_codex":0.00003820803,"about_ca_system_score_gemma":0.00022553372,"threshold_uncertainty_score":0.33521843},"labels":[],"label_agreement":null},{"id":"W2069673992","doi":"10.1159/000297961","title":"Preliminary Evidence of a High Risk of Bleeding on Aspirin plus Clopidogrel in Aspirin-Naïve Patients in the Acute Phase after TIA or Minor Ischaemic Stroke","year":2010,"lang":"en","type":"article","venue":"Cerebrovascular Diseases","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; National Institute for Health and Care Research","keywords":"Aspirin; Medicine; Clopidogrel; Stroke (engine); Internal medicine; Randomized controlled trial; Gastroenterology; Anesthesia","score_opus":0.012118606955657805,"score_gpt":0.27749016180232583,"score_spread":0.265371554846668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069673992","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993395,0.004568563,0.000041132585,0.00006148104,0.00019551604,0.0013856256,0.00028960992,0.000028695014,0.000034426765],"genre_scores_gemma":[0.9972432,0.0019112012,0.00012370598,0.00019080844,0.0001393795,0.00020802816,0.00009187574,0.00004828492,0.000043479282],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99700624,0.00031132463,0.0006957685,0.00058649265,0.00096595625,0.00043422676],"domain_scores_gemma":[0.9978475,0.00032405564,0.00027649768,0.001181829,0.00016915707,0.00020096319],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000497558,0.00038409303,0.0008950194,0.0003651944,0.000055283974,0.000020200074,0.00041700684,0.00018111891,0.00019686599],"category_scores_gemma":[0.00041471038,0.000258028,0.0009864324,0.00050346943,0.0003022858,0.00024609923,0.00011292093,0.0005098496,0.000016072667],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0228359,0.004326202,0.92975307,0.0013792751,0.0021575235,0.00044029029,0.0009327576,0.00015236164,0.00078260014,0.000042697236,0.00010501316,0.03709233],"study_design_scores_gemma":[0.015579527,0.0027733753,0.9719291,0.0022791945,0.003060248,0.00003383425,0.00033453648,0.00016214023,0.003266398,0.00006192585,0.00018281794,0.0003369489],"about_ca_topic_score_codex":0.00038602808,"about_ca_topic_score_gemma":0.00013020051,"teacher_disagreement_score":0.042176004,"about_ca_system_score_codex":0.00006364057,"about_ca_system_score_gemma":0.0002755645,"threshold_uncertainty_score":0.9999872},"labels":[],"label_agreement":null},{"id":"W2069886756","doi":"10.1016/s0049-3848(03)00180-4","title":"Oral anticoagulants in patients with coronary artery disease: an inexpensive and effective strategy","year":2003,"lang":"en","type":"review","venue":"Thrombosis Research","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Coronary artery disease; Cardiology; Internal medicine","score_opus":0.11383836100664449,"score_gpt":0.42008655799289124,"score_spread":0.3062481969862467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069886756","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21823561,0.7779982,0.0000016945523,0.0000044338904,0.00002745278,0.0034812605,0.00008930489,0.000024444595,0.00013759764],"genre_scores_gemma":[0.08203689,0.9167857,0.000015242729,0.000029439152,0.000055369506,0.00028146498,0.0006557675,0.00009768199,0.00004242453],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9950355,0.0019312284,0.0003634688,0.0008426362,0.0011384477,0.0006887122],"domain_scores_gemma":[0.9980439,0.00023204536,0.00007775423,0.00075018057,0.00033078907,0.00056534016],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007851483,0.0004821088,0.0023287488,0.00052640506,0.00014241478,0.000072344046,0.0001720821,0.00025649904,0.00011368812],"category_scores_gemma":[0.0000708089,0.00033557884,0.00028781258,0.00067435484,0.00048768896,0.00020035954,0.00009019037,0.0008798778,0.0000433507],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010579323,0.0014924906,0.0702398,0.010067476,0.002336372,0.0009195163,0.00006686157,8.705995e-7,5.6218107e-7,0.00003856801,0.00013838775,0.91364115],"study_design_scores_gemma":[0.005301172,0.0030790109,0.934,0.01639808,0.0018706801,0.00007864973,0.00013634129,0.000004220272,8.904903e-7,0.000055891178,0.038397804,0.00067726837],"about_ca_topic_score_codex":0.000026138265,"about_ca_topic_score_gemma":0.000008705037,"teacher_disagreement_score":0.91296387,"about_ca_system_score_codex":0.00018378225,"about_ca_system_score_gemma":0.0006021263,"threshold_uncertainty_score":0.99990964},"labels":[],"label_agreement":null},{"id":"W2069955925","doi":"10.1016/j.ahj.2009.01.002","title":"Temporal trends and patterns of early clopidogrel use across the spectrum of acute coronary syndromes","year":2009,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cégep de Lévis; McMaster University; Montreal Heart Institute; Canadian Heart Research Centre; St. John’s Health Sciences Centre; St. Michael's Hospital","funders":"","keywords":"Clopidogrel; Medicine; Acute coronary syndrome; Internal medicine; Cardiology; Myocardial infarction; Unstable angina; ST elevation","score_opus":0.018504039874182865,"score_gpt":0.3030211150367397,"score_spread":0.2845170751625568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069955925","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970073,0.0010089906,0.00008015733,0.0017281703,0.000045476972,0.00006221708,0.000041606083,0.000009895424,0.00001618091],"genre_scores_gemma":[0.9974807,0.0015968217,0.00016762351,0.0005255015,0.000095240524,6.736185e-7,0.000004078268,0.000011251259,0.00011813086],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99898267,0.000094132905,0.0002773275,0.00011671495,0.00030458294,0.00022455298],"domain_scores_gemma":[0.999371,0.000043411434,0.00016872413,0.00022505438,0.000047245332,0.00014455701],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002024657,0.00011839105,0.00049225945,0.00006830467,0.000095772484,0.000023004372,0.0000760945,0.000026252426,0.00005261804],"category_scores_gemma":[0.00000805413,0.000075583215,0.0003849413,0.00019137085,0.00031809622,0.00011542866,0.000018318,0.00021377747,0.0000010449304],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005119241,0.00009945691,0.93103874,0.0000067825977,0.00077487534,0.00024301524,0.00041944007,0.0000014438905,0.00061446126,0.000009800651,0.00020529889,0.066074766],"study_design_scores_gemma":[0.00080518227,0.0022370159,0.9878846,0.00007280995,0.00026186893,0.006916686,0.00038376378,0.000004595511,0.000411393,0.000024598987,0.0009213796,0.00007611124],"about_ca_topic_score_codex":0.00015868156,"about_ca_topic_score_gemma":0.0000030474646,"teacher_disagreement_score":0.06599865,"about_ca_system_score_codex":0.0000116687015,"about_ca_system_score_gemma":0.000049434948,"threshold_uncertainty_score":0.3082194},"labels":[],"label_agreement":null},{"id":"W2070248682","doi":"10.1016/j.jtcvs.2013.10.011","title":"Clinical, biochemical, and genetic predictors of coronary artery bypass graft failure","year":2013,"lang":"en","type":"article","venue":"Journal of Thoracic and Cardiovascular Surgery","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; Toronto General Hospital; University of Toronto; Hamilton Health Sciences; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Internal medicine; Odds ratio; Cardiology; Diabetes mellitus; Artery; Coronary artery disease; Confidence interval; Surgery; Endocrinology","score_opus":0.01455671849878285,"score_gpt":0.26539919024701564,"score_spread":0.25084247174823276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070248682","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8504314,0.14826202,0.00066697923,0.00012458544,0.00026450073,0.00020741441,0.000005098537,0.000013519119,0.000024492458],"genre_scores_gemma":[0.9622352,0.036344178,0.0007015882,0.00012977248,0.00052465696,0.0000061469573,0.000005143758,0.00003087286,0.000022424814],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974859,0.0003436372,0.0009795483,0.0002738792,0.000671055,0.00024598124],"domain_scores_gemma":[0.99818546,0.0002572989,0.0003081883,0.00047038816,0.00035774155,0.0004209441],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013352851,0.00023375476,0.0015668209,0.00020196776,0.00005909722,0.000033430922,0.00008872701,0.00021944783,0.000057534],"category_scores_gemma":[0.00018730074,0.0001768976,0.0028605761,0.00017674225,0.00039260683,0.00020072053,0.00004379613,0.0003194169,0.000004062714],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060124445,0.00029847602,0.6302392,0.0007286474,0.02526045,0.0014685352,0.00007958614,0.000016366075,0.0028434603,0.0000014748501,0.01260424,0.32585832],"study_design_scores_gemma":[0.0016800903,0.00043624293,0.95532125,0.0008630904,0.007219225,0.01713855,0.0005411649,0.000028534423,0.0027232068,0.00011628837,0.013527365,0.0004049809],"about_ca_topic_score_codex":0.00000645161,"about_ca_topic_score_gemma":1.14007705e-7,"teacher_disagreement_score":0.32545334,"about_ca_system_score_codex":0.000011529108,"about_ca_system_score_gemma":0.00015265841,"threshold_uncertainty_score":0.7213675},"labels":[],"label_agreement":null},{"id":"W2070815436","doi":"10.1016/s0002-9149(01)01632-0","title":"Oral glycoprotein IIb/IIIa antagonism in patients with coronary artery disease","year":2001,"lang":"en","type":"article","venue":"The American Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"National Center for Research Resources","keywords":"Medicine; Aspirin; Coronary artery disease; Antiplatelet drug; Concomitant; Platelet; Internal medicine; Platelet aggregation inhibitor; Pharmacodynamics; Fibrinogen; Antagonism; Pharmacology; Population; Cardiology; Gastroenterology; Pharmacokinetics; Clopidogrel; Receptor","score_opus":0.00744214247318568,"score_gpt":0.230986086811995,"score_spread":0.22354394433880934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070815436","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99715054,0.001087808,0.00067291834,0.0006051552,0.00009935207,0.0002268135,0.0000065810054,0.000009933249,0.00014091087],"genre_scores_gemma":[0.9981643,0.00054783584,0.00007315749,0.0008539762,0.00030434088,0.0000054658985,0.000008972697,0.000020667485,0.00002128909],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99859464,0.00038872595,0.00029707272,0.00013736593,0.000313147,0.0002690508],"domain_scores_gemma":[0.9990553,0.000051446983,0.00024316441,0.00032062305,0.0001304838,0.00019896058],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035713325,0.00015291604,0.0007821547,0.000112563925,0.000050053197,0.000006788138,0.0001575607,0.000024661584,0.000018773122],"category_scores_gemma":[0.000030404011,0.0000858888,0.0003633906,0.00022813916,0.00054144446,0.00007407109,0.000024847319,0.0002751597,0.000007581931],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023955442,0.00009058848,0.9006397,0.000005300898,0.0010052933,0.0035398023,0.00005161443,0.0003467718,0.00005806639,0.000009484379,0.00012270332,0.070175245],"study_design_scores_gemma":[0.0047901026,0.0025241068,0.9856512,0.000049054517,0.00038463913,0.0025532611,0.00019045615,0.000004624367,0.000010455996,0.0000972436,0.0036349997,0.00010985368],"about_ca_topic_score_codex":0.000007106957,"about_ca_topic_score_gemma":5.330063e-7,"teacher_disagreement_score":0.08501151,"about_ca_system_score_codex":0.000048535665,"about_ca_system_score_gemma":0.00015660615,"threshold_uncertainty_score":0.35024437},"labels":[],"label_agreement":null},{"id":"W2073222500","doi":"10.3109/07853890.2014.902636","title":"Myocardial infarction and gastro-intestinal bleeding risks associated with aspirin use among elderly individuals with type 2 diabetes","year":2014,"lang":"en","type":"article","venue":"Annals of Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval; Université du Québec à Rimouski","funders":"","keywords":"Aspirin; Medicine; Myocardial infarction; Internal medicine; Diabetes mellitus; Cohort; Odds ratio; Cohort study; Population; Endocrinology","score_opus":0.04732955425765454,"score_gpt":0.288690790331574,"score_spread":0.2413612360739195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073222500","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973513,0.00097464595,0.00020217874,0.00075199927,0.000049570826,0.00025272125,0.0000051890515,0.00005928922,0.00035313584],"genre_scores_gemma":[0.9981961,0.00041133622,0.00014438074,0.00079463853,0.00028886565,0.0000086706805,0.00006614355,0.000030195219,0.000059631064],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984575,0.00012842145,0.00026080234,0.0002623813,0.00058512,0.00030579898],"domain_scores_gemma":[0.9986811,0.00023631513,0.00020459827,0.00022678502,0.0004238541,0.000227327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088102894,0.00021349522,0.0006418918,0.00016051854,0.00007558097,0.000016202,0.000058465255,0.000088466775,0.000036829664],"category_scores_gemma":[0.0007023354,0.00013803384,0.0000793139,0.00030233886,0.0005435877,0.00018143887,0.000019684067,0.00021376542,0.0000014680342],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005012395,0.000069883434,0.9791013,0.000065488704,0.0015420092,0.000017200018,0.00014422726,0.000026658989,0.0007839899,0.000030937266,0.0007563494,0.01696072],"study_design_scores_gemma":[0.0044809245,0.007361118,0.9822153,0.0020736728,0.00090789207,0.00004537786,0.00016737086,0.00010575237,0.00097458536,0.000037972015,0.0014740053,0.00015602114],"about_ca_topic_score_codex":0.00010617711,"about_ca_topic_score_gemma":0.000010496036,"teacher_disagreement_score":0.016804697,"about_ca_system_score_codex":0.000008312496,"about_ca_system_score_gemma":0.00004286894,"threshold_uncertainty_score":0.56288564},"labels":[],"label_agreement":null},{"id":"W2073454694","doi":"10.1160/th04-02-0078","title":"Comparison of two methods to assess variability of platelet response to anti-platelet therapies in patients with acute coronary syndrome undergoing angioplasty","year":2004,"lang":"en","type":"article","venue":"Thrombosis and Haemostasis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Abciximab; Medicine; Platelet; Platelet activation; Internal medicine; Clopidogrel; Cardiology; Angioplasty; Hematology; P-selectin; Acute coronary syndrome; Percutaneous coronary intervention; Myocardial infarction","score_opus":0.05211372176848361,"score_gpt":0.37591315209583054,"score_spread":0.3237994303273469,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073454694","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99271864,0.00024965918,0.005656183,0.0002794988,0.00004288861,0.00088013033,0.0001223246,0.0000294072,0.000021278738],"genre_scores_gemma":[0.9688378,0.00012263829,0.030790756,0.00015776207,0.0000055604046,0.000019167966,0.000031138898,0.00003268237,0.0000025207537],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979153,0.00042439476,0.0005227643,0.00042486156,0.0004093444,0.000303327],"domain_scores_gemma":[0.99865586,0.0003600721,0.00014435273,0.0004776878,0.00015555817,0.00020650064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010756357,0.0002689711,0.0013027855,0.00024093699,0.00007530269,0.000015639978,0.000118324875,0.00009840472,0.000047838657],"category_scores_gemma":[0.000080891135,0.00021447372,0.00017605435,0.00058203156,0.00015013717,0.00012701582,0.000083384,0.0001382019,0.0000020107552],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010149659,0.0013913728,0.95786595,0.0002014034,0.0024630183,0.00005495649,0.0025658794,0.00085799297,0.0070107672,0.00009967219,0.00001604087,0.017323263],"study_design_scores_gemma":[0.0075025577,0.0022629763,0.9597583,0.00045278048,0.00036694482,0.000033694752,0.0004822852,0.000006578364,0.028741717,0.000102329905,0.000055553053,0.00023430043],"about_ca_topic_score_codex":0.000091129805,"about_ca_topic_score_gemma":0.00002244406,"teacher_disagreement_score":0.025134573,"about_ca_system_score_codex":0.000086561704,"about_ca_system_score_gemma":0.0001593737,"threshold_uncertainty_score":0.87459844},"labels":[],"label_agreement":null},{"id":"W2073607102","doi":"10.1016/j.cjca.2013.07.383","title":"Dual Antiplatelet Patterns in Patients With Myocardial Infarction Undergoing Percutaneous Coronary Intervention: Insights From the Prospective Canadian Observational Antiplatelet Study (COAPT)","year":2013,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Toronto Public Health","funders":"","keywords":"Medicine; Percutaneous coronary intervention; Clopidogrel; Acute coronary syndrome; Conventional PCI; Observational study; P2Y12; Internal medicine; Cardiology; Myocardial infarction; Aspirin; Platelet aggregation inhibitor","score_opus":0.011718842172991609,"score_gpt":0.20949715930214652,"score_spread":0.19777831712915492,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073607102","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967916,0.00071229076,0.000087672095,0.00043477188,0.0005747175,0.0010109735,0.000085821586,0.000008057189,0.0002940942],"genre_scores_gemma":[0.9985398,0.00006452691,0.000021393043,0.00040657647,0.000764564,0.000017183267,0.00013904412,0.000033528187,0.000013400214],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979746,0.00041303618,0.000530872,0.00029049028,0.00035665775,0.00043438716],"domain_scores_gemma":[0.9982192,0.00014581232,0.0001862802,0.00029501918,0.0005569208,0.0005968034],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023010011,0.00025719905,0.00071971177,0.00035751978,0.00023694539,0.000070237686,0.00018293338,0.00016735286,0.00014500516],"category_scores_gemma":[0.00010520596,0.00018285924,0.00034774395,0.00025135116,0.00016165827,0.00030691607,0.000016721957,0.0005443602,0.000019712157],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045245784,0.000029761264,0.9886749,0.0000059433446,0.0022491014,0.0027939582,0.0005756778,0.0008039695,0.00000694425,0.000017869765,0.00041795865,0.00397147],"study_design_scores_gemma":[0.0053950897,0.0013838018,0.9867361,0.00014418921,0.0002971125,0.0017964857,0.0018685574,0.000010570505,0.000002409103,0.000120328536,0.002046443,0.00019891569],"about_ca_topic_score_codex":0.108412266,"about_ca_topic_score_gemma":0.29951984,"teacher_disagreement_score":0.19110759,"about_ca_system_score_codex":0.0006274641,"about_ca_system_score_gemma":0.0019131524,"threshold_uncertainty_score":0.8975249},"labels":[],"label_agreement":null},{"id":"W2074111487","doi":"10.1016/j.ijcard.2010.02.025","title":"Heterogeneity in platelet cyclooxygenase inhibition by aspirin in coronary artery disease","year":2010,"lang":"en","type":"article","venue":"International Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital du Sacré-Cœur de Montréal","funders":"","keywords":"Aspirin; Medicine; Platelet; Cyclooxygenase; Thromboxane; Pharmacology; Epinephrine; Platelet activation; Arachidonic acid; Adenosine diphosphate; Thromboxane A2; Antiplatelet drug; Coronary artery disease; Internal medicine; Biochemistry; Platelet aggregation; Enzyme; Chemistry; Clopidogrel","score_opus":0.009112097722822765,"score_gpt":0.2704330489283201,"score_spread":0.2613209512054973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074111487","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964971,0.0011368654,0.00034634603,0.00075153593,0.00088559475,0.000116318515,0.000041734394,0.0000076003826,0.00021693086],"genre_scores_gemma":[0.9980935,0.00051936664,0.000055927456,0.000579386,0.00064042915,0.000006560525,0.00007998525,0.000012790122,0.000012047461],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987295,0.00012790311,0.000466966,0.00015859806,0.0003511587,0.00016587338],"domain_scores_gemma":[0.99934113,0.000053181593,0.0001314481,0.0001388855,0.00016957762,0.00016575503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004355457,0.0001222524,0.0004004634,0.00029084203,0.000011898122,0.000011207933,0.00013247199,0.00011421935,0.000047103516],"category_scores_gemma":[0.00010072502,0.000109100685,0.00038996173,0.000071505994,0.00009369484,0.00014999972,0.00003134937,0.00046207284,0.000010430777],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056539746,0.00032898466,0.86747086,0.000020500831,0.0010599049,0.033663634,0.00004687826,0.0007805046,0.06089839,0.00011045635,0.0013067051,0.028659202],"study_design_scores_gemma":[0.007523395,0.00020566683,0.9593505,0.00012595793,0.00006858566,0.010083606,0.000039163624,0.00005765049,0.004689009,0.0005817627,0.01711077,0.0001639114],"about_ca_topic_score_codex":0.000005542017,"about_ca_topic_score_gemma":0.000015014327,"teacher_disagreement_score":0.09187966,"about_ca_system_score_codex":0.00007490231,"about_ca_system_score_gemma":0.00013424626,"threshold_uncertainty_score":0.44489968},"labels":[],"label_agreement":null},{"id":"W2074207945","doi":"10.1371/journal.pone.0104491","title":"Impact of Aspirin and Clopidogrel Interruption on Platelet Function in Patients Undergoing Major Vascular Surgery","year":2014,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"Institut National de la Santé et de la Recherche Médicale","keywords":"Clopidogrel; Aspirin; Medicine; Platelet; Anesthesia; Perioperative; Platelet activation; Antiplatelet drug; Pharmacology; Internal medicine","score_opus":0.030693261561595693,"score_gpt":0.2425175684024947,"score_spread":0.211824306840899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074207945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991117,0.00031292727,0.00013042962,0.000016304555,0.000030062061,0.00023673801,0.0000034929012,0.000025808245,0.00013250369],"genre_scores_gemma":[0.9994031,0.00031267133,0.00003589208,0.00007081304,0.000067139554,0.00000793584,0.00006999293,0.00001897378,0.000013446236],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990582,0.00009205606,0.0002170874,0.00018550312,0.00030217174,0.00014499563],"domain_scores_gemma":[0.9994958,0.000099452205,0.000069863134,0.00020566874,0.00005588357,0.00007334063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026265738,0.00011686455,0.0004037665,0.00018656293,0.000022439857,0.000007134801,0.000022674765,0.000076009295,0.00004210845],"category_scores_gemma":[0.000124949,0.000099219425,0.0002482841,0.00011777728,0.000030401367,0.00007443684,0.0000139322165,0.0001030295,0.000012891601],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014314292,0.0017136321,0.9672908,0.0003341589,0.0013694742,0.0000033701467,0.000042739455,0.000019663552,0.00080654793,0.000018541356,0.00002189367,0.026947735],"study_design_scores_gemma":[0.0032532627,0.0012066566,0.99279296,0.0009906873,0.00026769753,0.0000010957165,0.000010971323,0.00015181143,0.0011507425,0.000056461537,0.000017082226,0.00010058219],"about_ca_topic_score_codex":0.0000270205,"about_ca_topic_score_gemma":0.0000056203544,"teacher_disagreement_score":0.026847152,"about_ca_system_score_codex":0.000054334745,"about_ca_system_score_gemma":0.00002903914,"threshold_uncertainty_score":0.4046051},"labels":[],"label_agreement":null},{"id":"W2074469810","doi":"10.1016/j.jval.2012.08.1742","title":"PSY19 A Cost-Consequence Analysis of Patient Self-Management Versus Physician-Managed Monitoring of Long-Term Oral Anticoagulation Therapy in Canada","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Montreal Heart Institute; Université de Montréal","funders":"","keywords":"Medicine; Context (archaeology); Pharmacist; Health care; Quality of life (healthcare); Perspective (graphical); Pharmacy; Family medicine; Nursing","score_opus":0.04092273519297076,"score_gpt":0.3086628603900941,"score_spread":0.26774012519712337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074469810","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945225,0.0044702007,0.000059058577,0.000044044667,0.00019851945,0.00065415807,0.00000622361,0.000009804395,0.000035459892],"genre_scores_gemma":[0.9968583,0.0027528496,0.00023761872,0.00007280503,0.000026908529,0.000020853551,0.000018959385,0.000010560644,0.0000011178533],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998459,0.0002264264,0.00045765613,0.00016244703,0.00040193452,0.00029254332],"domain_scores_gemma":[0.9992912,0.00007616646,0.00019910082,0.0002950965,0.000040995794,0.000097437485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038480532,0.000114869865,0.00054488715,0.00031468074,0.000023239027,0.0000024048977,0.00006350131,0.000027562312,0.0000061504475],"category_scores_gemma":[0.000010249565,0.00010974148,0.00015394279,0.00096846634,0.000023172119,0.00007337392,0.000014155637,0.00008590403,3.638136e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005499227,0.00032756475,0.92063105,0.00028717273,0.001349759,0.000043663596,0.00073239015,0.015317647,0.000051615894,0.000043657506,0.0000017309127,0.060663853],"study_design_scores_gemma":[0.00234453,0.00015243114,0.9940769,0.000275065,0.00029358588,0.0000011393603,0.0005809884,0.0012531286,0.00091596326,0.0000037586508,0.00001674902,0.000085748215],"about_ca_topic_score_codex":0.35663775,"about_ca_topic_score_gemma":0.018640617,"teacher_disagreement_score":0.33799714,"about_ca_system_score_codex":0.00059165293,"about_ca_system_score_gemma":0.00034716178,"threshold_uncertainty_score":0.9992666},"labels":[],"label_agreement":null},{"id":"W2075102176","doi":"10.2147/vhrm.2006.2.4.379","title":"Clinical update on the therapeutic use of clopidogrel: treatment of acute ST-segment elevation myocardial infarction (STEMI)","year":2006,"lang":"en","type":"review","venue":"Vascular Health and Risk Management","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Canadian Institutes of Health Research; Hamilton Health Sciences; Sanofi; McMaster University; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Clopidogrel; Cardiology; Percutaneous coronary intervention; Internal medicine; Myocardial infarction; Aspirin; Thrombus; Ticlopidine","score_opus":0.06356072955798536,"score_gpt":0.3606762692281438,"score_spread":0.2971155396701584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075102176","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011058111,0.9932528,0.000942724,0.00007341537,0.00026503185,0.004131189,0.00015882464,0.000025031015,0.000045170353],"genre_scores_gemma":[0.00007800522,0.9981618,0.0002753325,0.00028484524,0.00022049721,0.00018945531,0.0006580533,0.00004857721,0.00008343912],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960969,0.0011474276,0.0013151347,0.00052114413,0.0006116864,0.00030771724],"domain_scores_gemma":[0.9977231,0.00015859857,0.0009137412,0.0009551499,0.00006785138,0.00018156922],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00111249,0.00043465398,0.0021978084,0.00023064711,0.0001507641,0.000019817144,0.00009660901,0.00020239591,0.000015351861],"category_scores_gemma":[0.000009206246,0.0002423545,0.00230011,0.00028463057,0.00012595141,0.000038698112,0.00004094525,0.0002154315,0.000009703331],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017947305,0.00053384155,0.0009101582,0.0055612037,0.019773412,0.0000100121915,0.000026029205,0.000013543095,7.398562e-9,0.00043806416,0.00042445137,0.9721298],"study_design_scores_gemma":[0.001860507,0.0015031699,0.0019307912,0.002751993,0.015883232,0.000009292797,0.000030424912,0.000019789328,2.5732567e-7,0.000025008847,0.9758121,0.0001734851],"about_ca_topic_score_codex":0.00013863108,"about_ca_topic_score_gemma":0.0000028806262,"teacher_disagreement_score":0.9753876,"about_ca_system_score_codex":0.00016981854,"about_ca_system_score_gemma":0.00021367396,"threshold_uncertainty_score":0.98829293},"labels":[],"label_agreement":null},{"id":"W2075309064","doi":"10.1177/107424840501000302","title":"Review of Antiplatelet Therapy in Secondary Prevention of Cerebrovascular Events: A Need for Direct Comparisons Between Antiplatelet Agents","year":2005,"lang":"en","type":"review","venue":"Journal of Cardiovascular Pharmacology and Therapeutics","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Secondary prevention; Cardiology; Aspirin; Intensive care medicine; Internal medicine; Platelet aggregation inhibitor","score_opus":0.07889448075938914,"score_gpt":0.393336780181643,"score_spread":0.3144422994222538,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075309064","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0033683004,0.9923704,0.00062095176,0.00005471872,0.00039830452,0.0029601639,0.00014123475,0.00001299892,0.00007288537],"genre_scores_gemma":[0.0031223455,0.9951961,0.0004252057,0.00029697953,0.0006268777,0.000057016645,0.0001478834,0.00010909569,0.000018470384],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99404144,0.001591874,0.0027165737,0.00045808085,0.00073734095,0.00045470268],"domain_scores_gemma":[0.99635667,0.0003303705,0.0019311496,0.0005911089,0.00059575215,0.00019494748],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004087998,0.00070146116,0.008705177,0.0007205751,0.00006846271,0.000008457463,0.00040196534,0.0006433158,0.00008178153],"category_scores_gemma":[0.00004032981,0.0005554555,0.009897676,0.0006190576,0.00023494072,0.00017696324,0.00006765729,0.0009701155,0.0000013098801],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004969079,0.0005499824,0.00023660512,0.058050424,0.085969105,0.00006994664,0.00004197477,0.000018638508,0.00001112107,0.0000027627307,0.00053730357,0.85401523],"study_design_scores_gemma":[0.010993593,0.0010253472,0.00034609964,0.045775004,0.04765863,0.0010211772,0.00002071244,0.0000056132153,0.00021361125,0.000018557519,0.8925356,0.0003860529],"about_ca_topic_score_codex":0.000003638911,"about_ca_topic_score_gemma":2.7782514e-7,"teacher_disagreement_score":0.8919983,"about_ca_system_score_codex":0.00010173379,"about_ca_system_score_gemma":0.0008101746,"threshold_uncertainty_score":0.9996897},"labels":[],"label_agreement":null},{"id":"W2075493942","doi":"10.1007/s11239-012-0750-6","title":"Atopaxar and its effects on markers of platelet activation and inflammation: results from the LANCELOT CAD program","year":2012,"lang":"en","type":"article","venue":"Journal of Thrombosis and Thrombolysis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Eisai Incorporated","keywords":"Medicine; Placebo; Randomization; Internal medicine; Inflammation; Hematology; Biomarker; Randomized controlled trial; Antagonist; Platelet; Gastroenterology; Receptor; Immunology; Pathology; Biology","score_opus":0.021257030030658305,"score_gpt":0.28041558241433473,"score_spread":0.2591585523836764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075493942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99286693,0.0055026948,0.000016417362,0.0011404975,0.00008200485,0.00026758594,0.000015205422,0.000009106002,0.00009955079],"genre_scores_gemma":[0.9909604,0.008274814,0.00019595723,0.00012876837,0.00040932855,0.000004332898,0.000009858865,0.000011838672,0.000004677195],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99892044,0.00012533477,0.00035441923,0.00012094569,0.0003373874,0.00014148462],"domain_scores_gemma":[0.99889654,0.0003632213,0.00035329958,0.00015003502,0.00010538981,0.00013150644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057364674,0.00014019485,0.0005291573,0.000063895044,0.000101392776,0.000027509997,0.00004872237,0.00008441537,0.000011270762],"category_scores_gemma":[0.00015581619,0.00008464873,0.00016623628,0.00012706337,0.000080162805,0.00024669408,0.000025887024,0.00016304509,7.3000984e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00703464,0.0011359955,0.2580944,0.0009357988,0.016762165,0.00002838778,0.0069065266,0.000024579485,0.1193025,0.0009476675,0.0019123687,0.586915],"study_design_scores_gemma":[0.003138594,0.00069581054,0.9379026,0.0005672982,0.0009580551,0.000036748886,0.0003633107,0.000041873067,0.05424245,0.00007201978,0.0018769564,0.00010426892],"about_ca_topic_score_codex":0.000016372629,"about_ca_topic_score_gemma":0.0000010203556,"teacher_disagreement_score":0.6798082,"about_ca_system_score_codex":0.000016159918,"about_ca_system_score_gemma":0.00002105045,"threshold_uncertainty_score":0.34518752},"labels":[],"label_agreement":null},{"id":"W2075984299","doi":"10.1097/hco.0b013e328356ae95","title":"The aspirin controversy in primary prevention","year":2012,"lang":"en","type":"review","venue":"Current Opinion in Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton General Hospital; Population Health Research Institute; McMaster University","funders":"American Heart Association","keywords":"Aspirin; Medicine; Antithrombotic; Stroke (engine); Myocardial infarction; Meta-analysis; Primary prevention; Disease; Placebo; Internal medicine; Intensive care medicine; Cardiology; Alternative medicine; Pathology","score_opus":0.12797118201989202,"score_gpt":0.4120987805047541,"score_spread":0.28412759848486213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075984299","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000017897732,0.9906882,0.000091907146,0.000023153041,0.006860058,0.0015111167,0.000019931118,0.000025652653,0.0007620753],"genre_scores_gemma":[0.000089672925,0.9966961,0.0000045249285,0.000010934742,0.001953169,0.0004337684,0.0007239725,0.00003506714,0.000052752115],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971682,0.0010371907,0.0007169566,0.00039179708,0.00022022046,0.0004656574],"domain_scores_gemma":[0.99880695,0.0003021889,0.00020688969,0.0005562658,0.000033421242,0.00009427313],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010929918,0.0003387993,0.0022206875,0.00020783673,0.00005070879,0.000011731149,0.00019048949,0.0003733835,0.000013508794],"category_scores_gemma":[0.00006186736,0.000224081,0.0015671361,0.00026143514,0.00014204187,0.000052271964,0.00008906278,0.0007446351,0.00007756807],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006610388,0.00006458013,0.0011990295,0.009231396,0.0003953205,0.000007642606,0.00000831372,0.0000014793138,3.100988e-8,0.0002143498,0.0006042519,0.9882075],"study_design_scores_gemma":[0.0013703336,0.000066833054,0.002819527,0.009865602,0.00056764606,0.0002220559,0.000010470455,5.322924e-7,1.9459232e-8,0.000052054416,0.98482543,0.00019950658],"about_ca_topic_score_codex":0.000002160747,"about_ca_topic_score_gemma":7.4827824e-7,"teacher_disagreement_score":0.988008,"about_ca_system_score_codex":0.00032535128,"about_ca_system_score_gemma":0.0004045893,"threshold_uncertainty_score":0.9137758},"labels":[],"label_agreement":null},{"id":"W2076188495","doi":"10.1067/mlc.2002.121855","title":"A new method for measuring inhibition of platelet function by nonsteroidal antiinflammatory drugs","year":2002,"lang":"en","type":"article","venue":"Journal of Laboratory and Clinical Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency","funders":"","keywords":"Aspirin; Platelet; Medicine; Agonist; Pharmacology; Prostaglandin; Chemistry; Internal medicine; Receptor","score_opus":0.029034260815960427,"score_gpt":0.3240754321480436,"score_spread":0.29504117133208313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076188495","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93878156,0.021807678,0.0371173,0.0013587418,0.00051790563,0.00024899028,0.0000145623635,0.00001448147,0.00013876882],"genre_scores_gemma":[0.9876094,0.005416026,0.0033658077,0.0013496128,0.0020912252,0.0000023497914,0.0000057716857,0.00002720454,0.00013262837],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980053,0.00019678942,0.0010838903,0.00016013463,0.0004153811,0.00013854823],"domain_scores_gemma":[0.99807113,0.00043072627,0.00056992733,0.00014439727,0.00043606074,0.00034773204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019180054,0.00014076346,0.0008392646,0.00010986641,0.000049449452,0.00000555254,0.000046399775,0.00016265328,0.00016863534],"category_scores_gemma":[0.0005112939,0.0001004548,0.00032222812,0.00016869872,0.00014284441,0.00015601318,0.000009870909,0.00030323575,0.0000013897036],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011261777,0.00088655646,0.01673262,0.0009219598,0.004125549,0.00024703404,0.0008076135,0.0000072122675,0.10028056,0.00022693354,0.082348175,0.782154],"study_design_scores_gemma":[0.19197902,0.044065606,0.05749814,0.011008705,0.015684718,0.0018204672,0.0052646296,0.001315915,0.08904193,0.002014619,0.5789,0.0014062506],"about_ca_topic_score_codex":0.0000018277491,"about_ca_topic_score_gemma":3.5833284e-7,"teacher_disagreement_score":0.7807478,"about_ca_system_score_codex":0.000013731331,"about_ca_system_score_gemma":0.0000918967,"threshold_uncertainty_score":0.4096428},"labels":[],"label_agreement":null},{"id":"W2076238851","doi":"10.1136/heartjnl-2012-302920v.8","title":"REVERSAL OF THE ANTI-PLATELET EFFECTS OF ASPIRIN AND CLOPIDOGREL","year":2012,"lang":"en","type":"article","venue":"Heart","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Clopidogrel; Aspirin; Medicine; Platelet; Cohort; Internal medicine; Anesthesia; Ticlopidine; Blood sampling; Gastroenterology; Cardiology","score_opus":0.006189453920655984,"score_gpt":0.2321123430616397,"score_spread":0.2259228891409837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076238851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912164,0.007979824,0.000015383515,0.00013101102,0.00013957887,0.00019368646,0.000002173755,0.000008557703,0.00031338367],"genre_scores_gemma":[0.999242,0.0002528431,0.00008763719,0.00023649956,0.000085840344,0.0000021518629,0.0000012984972,0.000007575276,0.00008416569],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99952585,0.000051394964,0.00009880761,0.000062458865,0.00014587758,0.00011560241],"domain_scores_gemma":[0.9996402,0.000042004733,0.00002993866,0.00020490923,0.000021775795,0.00006111657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013969599,0.00005779158,0.00022882645,0.000019399315,0.000021272997,0.0000011832215,0.000025843154,0.000043634445,0.0000202015],"category_scores_gemma":[0.000034881774,0.00003695388,0.00016287819,0.00007360268,0.00009851288,0.00003438493,0.000022431264,0.000058617945,0.0000049561304],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013298131,0.00021920844,0.92248535,0.00108293,0.0003708464,0.0000084828425,0.00030167378,8.696119e-7,0.06306881,0.0003136909,0.0021788492,0.009836328],"study_design_scores_gemma":[0.0010756596,0.00008954174,0.82615936,0.00019995446,0.00014065848,0.00010400002,0.000025084122,0.000001771691,0.15044008,0.0000107383785,0.021708181,0.000044991444],"about_ca_topic_score_codex":0.000011092118,"about_ca_topic_score_gemma":1.898365e-7,"teacher_disagreement_score":0.09632599,"about_ca_system_score_codex":0.0000035572928,"about_ca_system_score_gemma":0.000018942908,"threshold_uncertainty_score":0.15069354},"labels":[],"label_agreement":null},{"id":"W2076482318","doi":"10.1016/j.jacc.2007.03.025","title":"Patients With Prior Myocardial Infarction, Stroke, or Symptomatic Peripheral Arterial Disease in the CHARISMA Trial","year":2007,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":804,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"Sanofi","keywords":"Medicine; Clopidogrel; Aspirin; Myocardial infarction; Internal medicine; Hazard ratio; Stroke (engine); Placebo; Cardiology; Population; Confidence interval","score_opus":0.007646570878303793,"score_gpt":0.24634197210572809,"score_spread":0.2386954012274243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076482318","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99730855,0.00015469245,0.00032959436,0.00059715606,0.00067481474,0.00076230994,0.00005276764,0.0000049759587,0.00011511998],"genre_scores_gemma":[0.99795455,0.000082972205,0.00009714003,0.0005030185,0.001301089,0.000009408698,0.0000025689915,0.000016267586,0.00003299099],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99778014,0.0005537678,0.00061618414,0.00013289001,0.0006596805,0.00025735018],"domain_scores_gemma":[0.9984064,0.00020336626,0.0006385567,0.00038390275,0.00024026325,0.00012749818],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009633197,0.00016744129,0.0009738124,0.00014270905,0.000083426414,0.000007271733,0.00028583422,0.000047111622,0.000014299435],"category_scores_gemma":[0.00024638523,0.00007638683,0.0007924818,0.000402818,0.00051430846,0.00007214997,0.000030865103,0.0002726879,6.275888e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.48138735,0.0004216592,0.5071035,0.00004127544,0.0030166872,0.0007948855,0.0002512331,0.00038739343,0.00016735957,0.00003801749,0.0013862355,0.00500439],"study_design_scores_gemma":[0.041747145,0.003603122,0.9474361,0.00007019119,0.0008959961,0.0005333187,0.00076965336,0.0000065177705,0.000017326915,0.000023904659,0.0047893184,0.00010740688],"about_ca_topic_score_codex":0.0000060910616,"about_ca_topic_score_gemma":0.000003538693,"teacher_disagreement_score":0.44033256,"about_ca_system_score_codex":0.00008496322,"about_ca_system_score_gemma":0.00045447724,"threshold_uncertainty_score":0.31149647},"labels":[],"label_agreement":null},{"id":"W2076572320","doi":"10.1016/s1063-4584(07)61665-3","title":"29 IN VIVO DIFFERENTIATION OF NORMAL HYALINE CARTILAGE AND REPARATIVE TISSUE IN PATIENTS AFTER DIFFERENT CARTILAGE REPAIR PROCEDURES – CARTILAGE T2 ASSESSMENT AT 3 TESLA","year":2007,"lang":"en","type":"article","venue":"Osteoarthritis and Cartilage","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Cartilage; Hyaline cartilage; In vivo; Pathology; Medicine; Knee cartilage; Anatomy; Articular cartilage; Biology; Osteoarthritis","score_opus":0.004560355273698685,"score_gpt":0.23803564417417547,"score_spread":0.23347528890047678,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076572320","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99118125,0.005764617,0.000018749966,0.00003966811,0.00011848085,0.0012786573,0.00013719503,0.000061391875,0.0013999651],"genre_scores_gemma":[0.99819386,0.00064116163,0.000060559832,0.0001451374,0.00008481167,0.00013508089,0.00010959323,0.00005111544,0.00057865505],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99685,0.00018990801,0.00094364496,0.0007315546,0.0006462182,0.00063866057],"domain_scores_gemma":[0.99879956,0.00007831888,0.00020980596,0.00046167776,0.00014131983,0.0003093],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00049954886,0.0004614062,0.00097451126,0.00029817052,0.0001098766,0.000037220503,0.000073822244,0.00024167963,0.0002037363],"category_scores_gemma":[0.0000638639,0.00041727984,0.000267459,0.00028296464,0.00023524222,0.00025411873,0.00015481157,0.000246257,0.000002586043],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026863737,0.00063689915,0.7407258,0.0005259354,0.000028331579,0.0006127861,0.0022112834,0.000003733164,0.24848376,0.000038667768,0.00012243364,0.003923954],"study_design_scores_gemma":[0.0074641122,0.0014655064,0.6462285,0.00054512796,0.0001758977,0.00003827793,0.0005411262,0.000009138461,0.34252158,0.000019932673,0.0006022207,0.00038857188],"about_ca_topic_score_codex":0.000026315121,"about_ca_topic_score_gemma":0.0028165753,"teacher_disagreement_score":0.09449734,"about_ca_system_score_codex":0.00015671153,"about_ca_system_score_gemma":0.00006319215,"threshold_uncertainty_score":0.9998279},"labels":[],"label_agreement":null},{"id":"W2076813102","doi":"10.1016/j.aaen.2005.02.003","title":"What every emergency nurse needs to know about aspirin","year":2005,"lang":"en","type":"review","venue":"Accident and Emergency Nursing","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"British Columbia Institute of Technology","funders":"","keywords":"Aspirin; Medicine; Emergency department; Health care; Need to know; Medical emergency; Intensive care medicine; Nursing; Computer science; Political science; Computer security","score_opus":0.0315194936837958,"score_gpt":0.3669753751265359,"score_spread":0.3354558814427401,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076813102","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002072313,0.9880298,0.00007290303,0.00023055587,0.00657955,0.0013271087,0.00000674734,0.00012885912,0.0015522009],"genre_scores_gemma":[0.00031208157,0.98889077,0.00006321201,0.000078358,0.002608109,0.000105328094,0.0001962453,0.00015348467,0.007592421],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966581,0.00015086393,0.0011307572,0.00074065675,0.00058711664,0.00073253416],"domain_scores_gemma":[0.9981587,0.000015499998,0.00024648977,0.00081345375,0.00013160784,0.0006342325],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00031721246,0.0008045236,0.0021285503,0.0006434383,0.00025445138,0.00007624055,0.00028188253,0.0004300533,0.002488643],"category_scores_gemma":[0.000038568316,0.0007016144,0.0019308175,0.0009478045,0.000053830587,0.00056943565,0.000052966698,0.00044300134,0.00046464556],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005506248,0.0001793854,0.00037048003,0.0021986102,0.0007891871,0.000047722857,0.0006062105,0.00000114831,0.000002013449,0.000036660687,0.021664463,0.97404903],"study_design_scores_gemma":[0.00037413382,0.00013534594,0.0006460049,0.038809985,0.0051884796,0.00024728736,0.00079420704,0.000001973523,0.0000025484605,0.000042961776,0.95302016,0.0007369317],"about_ca_topic_score_codex":0.000012769326,"about_ca_topic_score_gemma":0.000008959646,"teacher_disagreement_score":0.97331214,"about_ca_system_score_codex":0.00018110845,"about_ca_system_score_gemma":0.00016694517,"threshold_uncertainty_score":0.9995435},"labels":[],"label_agreement":null},{"id":"W2077411564","doi":"10.1006/bbrc.2001.5012","title":"Novel Platelet Antiaggregating Substances","year":2001,"lang":"en","type":"article","venue":"Biochemical and Biophysical Research Communications","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"","keywords":"Arachidonic acid; Platelet; Chemistry; Thromboxane A2; Platelet aggregation; Pharmacology; Thromboxane; Mechanism of action; IC50; Thromboxane B2; Platelet-rich plasma; In vitro; Biochemistry; Medicine; Receptor; Internal medicine","score_opus":0.101990614821519,"score_gpt":0.38292786350482044,"score_spread":0.28093724868330144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077411564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98294127,0.009385673,0.00017278585,0.003954219,0.000009213422,0.000220493,0.000012088809,0.000056354304,0.0032478864],"genre_scores_gemma":[0.98665965,0.01091434,0.0018463966,0.0001340561,0.00012803456,0.000032250562,0.00006245266,0.000011667004,0.00021116759],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987482,0.00008733095,0.00017139933,0.00023700333,0.00045087584,0.00030520023],"domain_scores_gemma":[0.9983319,0.00035281124,0.000024935123,0.00082009705,0.00022363199,0.00024661468],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035849572,0.00010018294,0.00021843171,0.0000649542,0.00034586946,0.00004314184,0.00029694082,0.00008158568,0.000029201836],"category_scores_gemma":[0.0002670746,0.00007808526,0.00014609087,0.0005088345,0.00092792365,0.00006322027,0.00019977192,0.00041955765,0.0000330139],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018852044,0.0005817723,0.0012575195,0.000036741618,0.000115646515,0.000010814543,0.00003824843,6.336919e-8,0.93891066,0.0047122133,0.00041528168,0.053732537],"study_design_scores_gemma":[0.007954378,0.00086806435,0.1019323,0.0009978832,0.00022714354,0.0007072186,0.0013904216,0.0025108585,0.57570076,0.0044575883,0.3022046,0.0010487599],"about_ca_topic_score_codex":0.000043547137,"about_ca_topic_score_gemma":0.0000024476471,"teacher_disagreement_score":0.36320984,"about_ca_system_score_codex":0.00002338012,"about_ca_system_score_gemma":0.00005838979,"threshold_uncertainty_score":0.34189734},"labels":[],"label_agreement":null},{"id":"W2077429173","doi":"10.1016/j.ahj.2007.06.001","title":"Preliminary experience with intravenous P2Y12 platelet receptor inhibition as an adjunct to reduced-dose alteplase during acute myocardial infarction: Results of the Safety, Tolerability and Effect on Patency in Acute Myocardial Infarction (STEP-AMI) angiographic trial","year":2007,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Cangrelor; TIMI; P2Y12; Myocardial infarction; Internal medicine; Cardiology; Clopidogrel; Anesthesia; Thrombolysis; Aspirin","score_opus":0.007624799264455014,"score_gpt":0.26878978336179143,"score_spread":0.2611649840973364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077429173","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970315,0.00012178246,0.000049826733,0.0005776933,0.00053374085,0.0015577583,0.00003672789,0.000037035694,0.000053954253],"genre_scores_gemma":[0.9979547,0.00055792613,0.00017789126,0.0004491045,0.000740996,0.000048910188,0.000026854703,0.00003785219,0.000005719019],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9965021,0.00075290474,0.00082279067,0.00055425416,0.0008529496,0.00051499926],"domain_scores_gemma":[0.99832237,0.00016975756,0.00032044345,0.0005351199,0.000171459,0.00048088058],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015555398,0.0003493881,0.0008841254,0.00042967228,0.0003646853,0.000043615953,0.00010855367,0.00012345937,0.000016609834],"category_scores_gemma":[0.00017823427,0.00024846656,0.0005426864,0.0010819323,0.0005018385,0.0003115259,0.00005631337,0.0006882659,0.0000035214398],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7995902,0.00084107154,0.056997295,0.000038151677,0.001704908,0.0005632357,0.0040016677,0.00026400617,0.045659356,0.0000034837203,0.000116913514,0.09021974],"study_design_scores_gemma":[0.033239145,0.03601547,0.9054827,0.00040479176,0.00046158317,0.0051215244,0.0010293073,0.000010512328,0.017505169,0.000009420522,0.00038550378,0.0003348781],"about_ca_topic_score_codex":0.00032848585,"about_ca_topic_score_gemma":0.000018703613,"teacher_disagreement_score":0.8484854,"about_ca_system_score_codex":0.00019283117,"about_ca_system_score_gemma":0.00019939247,"threshold_uncertainty_score":0.9999968},"labels":[],"label_agreement":null},{"id":"W2077732062","doi":"10.1016/j.ahj.2009.10.008","title":"Standardized reporting of bleeding complications for clinical investigations in acute coronary syndromes: A proposal from the Academic Bleeding Consensus (ABC) Multidisciplinary Working Group","year":2009,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Antithrombotic; Clinical trial; Intensive care medicine; Clinical endpoint; MEDLINE; Internal medicine","score_opus":0.1172678740045676,"score_gpt":0.4150230725337798,"score_spread":0.2977551985292122,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077732062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856594,0.0020012243,0.0024303005,0.00891781,0.00013833598,0.00073192624,0.00003320559,0.000042341282,0.00004541032],"genre_scores_gemma":[0.96664536,0.0011066413,0.031023394,0.0007866249,0.00035318919,0.000024088493,0.00003090277,0.000024310295,0.000005506919],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99665964,0.00028078153,0.001982582,0.00031204597,0.00041211018,0.00035286703],"domain_scores_gemma":[0.9968018,0.001038241,0.0014394103,0.00028643172,0.00018501528,0.00024913368],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002777314,0.00018274735,0.00093801226,0.000119708195,0.00045132323,0.00002984839,0.00015804078,0.00008854594,0.000008433591],"category_scores_gemma":[0.001070229,0.0001356599,0.00066034024,0.00044793455,0.00066408736,0.000088195215,0.000041334115,0.00090646057,0.0000011221151],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00095078896,0.00017207826,0.9630313,0.0000123805885,0.000890079,0.00017191542,0.00067999033,0.00006722923,0.009520397,0.00016532192,0.0007748143,0.023563702],"study_design_scores_gemma":[0.002715516,0.00079799356,0.9833566,0.0011461882,0.00070372724,0.0035925088,0.0038139985,0.0010129478,0.00016161814,0.0018549807,0.00066121353,0.00018273387],"about_ca_topic_score_codex":0.000036574045,"about_ca_topic_score_gemma":0.0000039257043,"teacher_disagreement_score":0.028593095,"about_ca_system_score_codex":0.00009349822,"about_ca_system_score_gemma":0.000503291,"threshold_uncertainty_score":0.553205},"labels":[],"label_agreement":null},{"id":"W2078427919","doi":"10.1177/171516350413700904","title":"Patient Tool in Combination Antiplatelet Rx","year":2004,"lang":"en","type":"article","venue":"Canadian Pharmacists Journal / Revue des Pharmaciens du Canada","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Acute coronary syndrome; Reimbursement; Medicine; Intensive care medicine; Medical emergency; Family medicine; Internal medicine; Health care; Myocardial infarction","score_opus":0.014900762652396857,"score_gpt":0.23971465287749183,"score_spread":0.22481389022509496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078427919","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99535435,0.002100742,0.00010701278,0.00021844449,0.0009957567,0.00045090815,0.00010666193,0.00002474428,0.0006413843],"genre_scores_gemma":[0.9911353,0.0049695964,0.00012848238,0.003228348,0.0003310726,0.000014052133,0.00005902913,0.000048559396,0.00008554236],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9976588,0.00010228234,0.00054707885,0.00033132476,0.0005345184,0.00082601985],"domain_scores_gemma":[0.9980633,0.000026542266,0.00013828072,0.00023135134,0.00032624687,0.0012142357],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036755545,0.00030591062,0.00044694656,0.00045702409,0.00039304164,0.00009402349,0.0002007907,0.00007331579,0.00045895643],"category_scores_gemma":[0.000095851225,0.00031843327,0.00027092762,0.000639456,0.00012041906,0.00030944293,0.000018693188,0.00060218456,0.000018462464],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008004578,0.0003994212,0.011197233,0.0003175976,0.0007979959,0.5791302,0.0016472884,0.0068467692,0.0039132936,0.00030579776,0.00534448,0.3892995],"study_design_scores_gemma":[0.017483499,0.0002309515,0.0009826523,0.00014677562,0.00030275172,0.9136271,0.000037632537,0.00060407666,0.010059413,0.00048429662,0.055211272,0.0008295808],"about_ca_topic_score_codex":0.01388178,"about_ca_topic_score_gemma":0.02717487,"teacher_disagreement_score":0.38846993,"about_ca_system_score_codex":0.003124067,"about_ca_system_score_gemma":0.004541343,"threshold_uncertainty_score":0.99992675},"labels":[],"label_agreement":null},{"id":"W2078541011","doi":"10.1016/j.cjca.2010.12.015","title":"The Use of Antiplatelet Therapy in the Outpatient Setting: Canadian Cardiovascular Society Guidelines","year":2011,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":119,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of Alberta Hospital; Université de Montréal; St. Michael's Hospital; University of Alberta; Thrombosis and Atherosclerosis Research Institute; Queen Elizabeth II Health Sciences Centre; Trillium Health Centre; St. Joseph’s Healthcare Hamilton; Women's College Hospital; Centre hospitalier universitaire de Québec; University of British Columbia; Montreal Clinical Research Institute; Montreal Heart Institute; Centre Hospitalier de l’Université de Montréal; McMaster University; Toronto General Hospital; University of Toronto","funders":"National Heart, Lung, and Blood Institute; Université de Montréal; European Society of Cardiology; Hamilton Health Sciences; American Stroke Association; Cardiac Society of Australia and New Zealand; Université Laval; American Society for Gastrointestinal Endoscopy; McMaster University; University of Toronto; American College of Cardiology Foundation; American Diabetes Association; American Heart Association; European Association for the Study of Diabetes; Heart Failure Society of America; McGill University Health Centre; McGill University; National Heart Foundation of Australia; American College of Gastroenterology","keywords":"Medicine; Clopidogrel; Intensive care medicine; Coronary artery disease; Percutaneous coronary intervention; Kidney disease; Diabetes mellitus; Perioperative; Stroke (engine); Internal medicine; Myocardial infarction; Surgery","score_opus":0.11077024591479029,"score_gpt":0.2628150623661348,"score_spread":0.1520448164513445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078541011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.950886,0.043675527,0.0005012752,0.0020531265,0.0008113338,0.00059333874,0.00005298911,0.000005548019,0.0014208471],"genre_scores_gemma":[0.9912873,0.006383547,0.00028117295,0.0014727935,0.0005175904,0.000006663103,0.0000075174294,0.00002310489,0.000020308835],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99776685,0.00054626964,0.0006714213,0.00016366938,0.00032051522,0.00053124886],"domain_scores_gemma":[0.9978788,0.0001436609,0.00018524846,0.0006293721,0.00068263296,0.0004803204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022654154,0.00019061982,0.00074719545,0.00019928909,0.0002204798,0.00002638325,0.00039104826,0.00019481608,0.000015243602],"category_scores_gemma":[0.0003520758,0.000107571315,0.0019345209,0.00027138385,0.00040227897,0.000091672635,0.000008701039,0.00042454613,0.000002552097],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00095467607,0.000030327365,0.4736567,0.000067456785,0.021081455,0.0060514025,0.010079172,0.0068110772,0.00008734339,0.0007337715,0.14586678,0.33457983],"study_design_scores_gemma":[0.0015105888,0.00038888605,0.11430149,0.00006230199,0.00033172252,0.0021230753,0.0013669563,0.000020873458,0.000087596236,0.00008556902,0.8795858,0.00013512358],"about_ca_topic_score_codex":0.06442087,"about_ca_topic_score_gemma":0.03591487,"teacher_disagreement_score":0.73371905,"about_ca_system_score_codex":0.0001271582,"about_ca_system_score_gemma":0.002484002,"threshold_uncertainty_score":0.9816772},"labels":[],"label_agreement":null},{"id":"W2078643136","doi":"10.1016/s0002-9149(01)01735-0","title":"Comparison of two aspirin doses on ischemic stroke in post-myocardial infarction patients in the warfarin (Coumadin) Aspirin Reinfarction Study (CARS)","year":2001,"lang":"en","type":"article","venue":"The American Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Aspirin; Medicine; Warfarin; Myocardial infarction; Cardiology; Stroke (engine); Anesthesia; Internal medicine; Atrial fibrillation","score_opus":0.024156495498328084,"score_gpt":0.3315784791193295,"score_spread":0.30742198362100137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078643136","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99766713,0.00038071847,0.000089058194,0.00038552991,0.00021928559,0.00049361656,0.0000055299165,0.0000072914345,0.0007518475],"genre_scores_gemma":[0.9986276,0.00043689477,0.000014183866,0.00050324976,0.00037030858,0.000013831912,0.000009357379,0.000018100029,0.000006486522],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967288,0.0014414645,0.0007698066,0.00019480991,0.0005840807,0.00028107647],"domain_scores_gemma":[0.9984019,0.0002633942,0.00060451165,0.00043717778,0.00023017619,0.00006285545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015316213,0.00020258494,0.0011890006,0.00034961913,0.000056790723,0.00000982729,0.0002975534,0.000051442352,0.000007550152],"category_scores_gemma":[0.00012553071,0.000121575744,0.000558207,0.0004902736,0.00033801666,0.00008629914,0.000038609043,0.0006799643,0.0000046495225],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056076995,0.0004315924,0.91804945,0.0000053557046,0.0009674411,0.000093185634,0.0010486519,0.0060984828,0.0014260291,0.000008218541,0.000095969204,0.06616791],"study_design_scores_gemma":[0.0051557836,0.0077628302,0.9775402,0.00005755973,0.00040370636,0.00041996213,0.006708122,0.000026013953,0.00020104436,0.000019706295,0.0015995519,0.00010550998],"about_ca_topic_score_codex":0.0003425222,"about_ca_topic_score_gemma":0.00003634657,"teacher_disagreement_score":0.066062406,"about_ca_system_score_codex":0.00011504096,"about_ca_system_score_gemma":0.00009596858,"threshold_uncertainty_score":0.4957715},"labels":[],"label_agreement":null},{"id":"W2078686545","doi":"10.1016/j.ahj.2010.10.017","title":"A Comparison of prasugrel at the time of percutaneous Coronary intervention or as pretreatment at the time of diagnosis in patients with non–ST-segment elevation myocardial infarction: Design and rationale for the ACCOAST study","year":2011,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute; Université de Montréal","funders":"Daiichi Sankyo Europe; Daiichi-Sankyo","keywords":"Prasugrel; Medicine; Thienopyridine; Myocardial infarction; Percutaneous coronary intervention; Conventional PCI; Cardiology; Internal medicine; TIMI; Clopidogrel; Thrombolysis","score_opus":0.02760272333548789,"score_gpt":0.292227135428638,"score_spread":0.2646244120931501,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078686545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99682707,0.0005032299,0.00045981412,0.0001827865,0.000023176643,0.0019788535,0.000017323346,0.0000023600358,0.0000053830195],"genre_scores_gemma":[0.9993349,0.00015619432,0.00022095865,0.0000728978,0.000025310123,0.000104337865,0.000013069164,0.000010872184,0.00006149798],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987734,0.0002900498,0.0003482468,0.00010922509,0.0003820411,0.00009705348],"domain_scores_gemma":[0.9989162,0.0003699706,0.00033197834,0.00017273592,0.00017238369,0.000036699716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004648806,0.000102108184,0.00034695677,0.000042539104,0.00014797428,0.0000060533666,0.00005817153,0.000017214572,0.00028942246],"category_scores_gemma":[0.000043417785,0.000046249766,0.00017100277,0.000119112476,0.00024961948,0.000050303264,0.000034298584,0.000077914454,0.0000023680282],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01175231,0.0015166787,0.95741016,0.000015205994,0.0015541366,0.0000045122038,0.0044022785,0.00039665715,0.0002302422,3.194666e-7,0.0004991586,0.022218326],"study_design_scores_gemma":[0.0028184652,0.0126003185,0.9787291,0.0000988299,0.00077544246,0.00023378128,0.0035589833,0.00031243992,0.0007202592,0.000004324994,0.00009247126,0.00005554168],"about_ca_topic_score_codex":0.00011461868,"about_ca_topic_score_gemma":0.000019891733,"teacher_disagreement_score":0.022162784,"about_ca_system_score_codex":0.00008478277,"about_ca_system_score_gemma":0.00007235453,"threshold_uncertainty_score":0.3168973},"labels":[],"label_agreement":null},{"id":"W2078838541","doi":"10.1016/s0755-4982(06)74662-0","title":"Absence de bénéfice significatif de l’adjonction d’aspirine au clopidogrel en prévention secondaire après un accident ischémique cerebral","year":2006,"lang":"fr","type":"review","venue":"La Presse Médicale","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ste. Anne's Hospital","funders":"","keywords":"Medicine; Clopidogrel; Gynecology; Internal medicine; Aspirin","score_opus":0.024955088048952998,"score_gpt":0.2818828834386916,"score_spread":0.2569277953897386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078838541","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020126775,0.943005,0.025210978,0.00031328422,0.0009599223,0.0021241168,0.000119858756,0.0002742863,0.007865774],"genre_scores_gemma":[0.06629607,0.91255355,0.0010683525,0.00034242924,0.0045380946,0.0006830555,0.0011211248,0.0002374844,0.013159865],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9927335,0.0025649043,0.0013276779,0.0012093058,0.00084195536,0.001322666],"domain_scores_gemma":[0.9965055,0.000592872,0.0006598059,0.0012706297,0.00017325913,0.0007979053],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0023064364,0.00096232834,0.0019997065,0.00020691489,0.00037159264,0.00015604512,0.0006756812,0.001503028,0.0032717884],"category_scores_gemma":[0.00033806218,0.00092223834,0.002275679,0.00048419918,0.00048443908,0.00032959742,0.00020551239,0.0016040272,0.0005927681],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021922756,0.0015006877,0.013742481,0.023799561,0.0023968313,0.0010532412,0.00037513277,0.00019211229,0.00021829239,0.0018901229,0.00420092,0.9504114],"study_design_scores_gemma":[0.0023469864,0.0002289309,0.04883739,0.014978993,0.005277267,0.0015088018,0.00013844801,0.0002408712,0.0009208649,0.0005984169,0.92395806,0.0009649915],"about_ca_topic_score_codex":0.0005435537,"about_ca_topic_score_gemma":0.00006373717,"teacher_disagreement_score":0.9494464,"about_ca_system_score_codex":0.0009831853,"about_ca_system_score_gemma":0.0017911887,"threshold_uncertainty_score":0.99979323},"labels":[],"label_agreement":null},{"id":"W2078960594","doi":"10.1016/j.ahj.2014.11.002","title":"Balancing the risks of bleeding and stent thrombosis: A decision analytic model to compare durations of dual antiplatelet therapy after drug-eluting stents","year":2014,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"National Heart, Lung, and Blood Institute; Abbott Laboratories; Abbott Vascular; St. Jude Medical; Biotronik; Medtronic; National Institutes of Health; Cordis; Boston Scientific Corporation; Gilead Sciences; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Aspirin; Internal medicine; Myocardial infarction; Acute coronary syndrome; Cardiology; Population; Stroke (engine); Stent; Adverse effect; Relative risk; Confidence interval","score_opus":0.05357831437364011,"score_gpt":0.34326572630173374,"score_spread":0.28968741192809366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078960594","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904614,0.0012821009,0.007500106,0.00045129118,0.00004902151,0.00020657717,0.000007715625,0.000009497904,0.0000322924],"genre_scores_gemma":[0.99658155,0.00088111317,0.0018013085,0.00059018424,0.000116205694,0.000005212755,0.0000012564101,0.000018448343,0.000004687007],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985097,0.00014608669,0.00045492768,0.00017105574,0.00048710924,0.0002310937],"domain_scores_gemma":[0.9989907,0.00017696481,0.00020814587,0.00024124575,0.00019746128,0.00018543983],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007603122,0.00014316784,0.0006040662,0.00013915161,0.00018266555,0.00003098724,0.000075246324,0.000016640992,0.000019014169],"category_scores_gemma":[0.00007832975,0.00009216528,0.00031117475,0.00028224126,0.0001788239,0.00008908461,0.000040689432,0.00020094767,0.0000016012478],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016412417,0.00027998272,0.87810034,0.00005944757,0.0016847707,0.000021250133,0.0039696987,0.017753018,0.021574149,0.000027050082,0.0005078138,0.07438123],"study_design_scores_gemma":[0.002221617,0.0005761502,0.9464114,0.000687921,0.00048851746,0.00057121046,0.004699435,0.04174993,0.002019545,0.00007739063,0.00029357598,0.00020331812],"about_ca_topic_score_codex":0.00007513513,"about_ca_topic_score_gemma":0.0000071417776,"teacher_disagreement_score":0.07417792,"about_ca_system_score_codex":0.000023291203,"about_ca_system_score_gemma":0.00006488152,"threshold_uncertainty_score":0.3758391},"labels":[],"label_agreement":null},{"id":"W2079442065","doi":"10.4330/wjc.v3.i5.153","title":"Clinical evidence of interaction between clopidogrel and proton pump inhibitors","year":2011,"lang":"en","type":"article","venue":"World Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Cardiovascular Society; American Heart Association","keywords":"Clopidogrel; Medicine; Aspirin; Acute coronary syndrome; Percutaneous coronary intervention; Internal medicine; Proton-pump inhibitor; Platelet aggregation inhibitor; Adverse effect; Cardiology; Myocardial infarction; Intensive care medicine","score_opus":0.09421746713001392,"score_gpt":0.3637108422095402,"score_spread":0.2694933750795263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079442065","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902406,0.0070339716,0.0008229637,0.0001650283,0.0004598841,0.00022119847,9.175411e-7,0.0000065689155,0.0010489149],"genre_scores_gemma":[0.9945976,0.0037050524,0.00032030733,0.00006528651,0.001264513,0.0000028608247,6.2779145e-7,0.000009225063,0.000034495766],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985657,0.00034121829,0.0006838334,0.00011967738,0.00017282214,0.00011675213],"domain_scores_gemma":[0.9989147,0.00020788379,0.00037878202,0.00016004634,0.00020556254,0.00013299378],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012420011,0.00009341936,0.00080750807,0.00018084397,0.000020665448,0.0000027387862,0.000070343696,0.00008731475,0.000025859716],"category_scores_gemma":[0.00021231383,0.00006903973,0.0006108793,0.00010965074,0.0002213646,0.00012679273,0.000029462746,0.0003385939,0.0000026905716],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016728899,0.0000256194,0.93083024,0.00009415109,0.001218588,0.0001430936,0.00008280554,0.0000019264785,0.00027165803,0.000024136752,0.0002864421,0.06534846],"study_design_scores_gemma":[0.002048149,0.0020827537,0.9573408,0.0009557166,0.001191796,0.0015250965,0.00014020057,0.0000015148064,0.004242782,0.00026478907,0.030099973,0.00010643263],"about_ca_topic_score_codex":0.0000035418093,"about_ca_topic_score_gemma":5.672812e-7,"teacher_disagreement_score":0.06524203,"about_ca_system_score_codex":0.000016112313,"about_ca_system_score_gemma":0.00007876346,"threshold_uncertainty_score":0.28153583},"labels":[],"label_agreement":null},{"id":"W2080041203","doi":"10.1161/circulationaha.112.121665","title":"Response to Letter Regarding Article, “Association of Proton Pump Inhibitor Use on Cardiovascular Outcomes With Clopidogrel and Ticagrelor: Insights From PLATO”","year":2012,"lang":"en","type":"article","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Southlake Regional Health Center; University of Toronto; Canadian Heart Research Centre; St. Michael's Hospital","funders":"","keywords":"Clopidogrel; Ticagrelor; Medicine; Classics; Library science; Art history; Internal medicine; History; Computer science; Aspirin","score_opus":0.015518044452460295,"score_gpt":0.23070470235406354,"score_spread":0.21518665790160324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080041203","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99690735,0.00048626887,0.0010096943,0.0004062425,0.00009212387,0.0009989687,0.000007756216,0.000049328875,0.000042283264],"genre_scores_gemma":[0.99879664,0.000017617442,0.00023803467,0.0005945041,0.00022209997,0.00005228434,0.000023164062,0.000028153405,0.000027486527],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984863,0.00021994521,0.00023168881,0.00024377466,0.0006169477,0.00020137551],"domain_scores_gemma":[0.9990455,0.00019110582,0.000092498056,0.00039324965,0.000116237374,0.00016140872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004290815,0.00015564826,0.00042370497,0.00013182043,0.000071655464,0.000027203801,0.000028002687,0.00012156336,0.000008099741],"category_scores_gemma":[0.0002967208,0.00012057383,0.0002560717,0.00018121478,0.000027410784,0.00031838627,0.000016378266,0.00010492601,0.000020507192],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002322276,0.00010425835,0.98124516,0.000038101873,0.0014323131,0.0000113989045,0.00080947956,0.0003458925,0.011705368,0.000053258984,0.000054091797,0.0018784087],"study_design_scores_gemma":[0.002677491,0.000095302414,0.9740486,0.00016293499,0.0005683295,0.000007649111,0.000059223785,0.00007061639,0.01614647,0.000018597591,0.0059877583,0.00015702486],"about_ca_topic_score_codex":0.000024766874,"about_ca_topic_score_gemma":0.0000013457704,"teacher_disagreement_score":0.0071965493,"about_ca_system_score_codex":0.00013718814,"about_ca_system_score_gemma":0.0000257468,"threshold_uncertainty_score":0.4916858},"labels":[],"label_agreement":null},{"id":"W2081239343","doi":"10.1016/j.cjca.2013.09.016","title":"Platelet Reactivity Measurements Reveal Patient Noncompliance During Ticagrelor Maintenance Therapy","year":2013,"lang":"en","type":"letter","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Ticagrelor; Medicine; Prasugrel; Clopidogrel; Acute coronary syndrome; Percutaneous coronary intervention; Internal medicine; Cardiology; P2Y12; Platelet; Conventional PCI; Loading dose; Coronary artery disease; Myocardial infarction","score_opus":0.036101061066942844,"score_gpt":0.23375073305146438,"score_spread":0.19764967198452155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081239343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7503894,0.028682826,0.00052313524,0.20023933,0.0054840813,0.0018770177,0.00024788512,0.0000480988,0.012508238],"genre_scores_gemma":[0.8181805,0.002210221,0.00021658154,0.1627209,0.0152646,0.000038014838,0.00009682381,0.00017104408,0.0011013196],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970532,0.00042527128,0.0006975267,0.00039509826,0.0005517307,0.0008771875],"domain_scores_gemma":[0.9973356,0.00006452513,0.0005518143,0.0006249262,0.0007353854,0.0006877121],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00039144288,0.00045619847,0.001766109,0.00037643337,0.00015588099,0.000038524962,0.00033604546,0.00081209285,0.00011596199],"category_scores_gemma":[0.00014570625,0.00036998396,0.0013621454,0.0001398837,0.00029777072,0.00012482719,0.000015833104,0.002149444,0.00007949641],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035532718,0.0000052926625,0.004139171,0.00012459242,0.0037182756,0.013645627,0.00006412023,0.00005476048,0.0005970155,9.049875e-7,0.94422156,0.033073355],"study_design_scores_gemma":[0.002537659,0.00044875537,0.021786949,0.00049322867,0.0002799135,0.010133206,0.000024012848,6.527225e-7,0.0005405826,0.000045765188,0.96335465,0.00035460948],"about_ca_topic_score_codex":0.00041208786,"about_ca_topic_score_gemma":0.000034618723,"teacher_disagreement_score":0.067791104,"about_ca_system_score_codex":0.0006094699,"about_ca_system_score_gemma":0.001802841,"threshold_uncertainty_score":0.9998752},"labels":[],"label_agreement":null},{"id":"W2082043630","doi":"10.1111/jth.12231","title":"Recommendations for the standardization of light transmission aggregometry: a consensus of the working party from the platelet physiology subcommittee of SSC/ISTH","year":2013,"lang":"en","type":"article","venue":"Journal of Thrombosis and Haemostasis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":547,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Regional Laboratory Medicine Program; McMaster University","funders":"British Heart Foundation","keywords":"Standardization; Medicine; Presentation (obstetrics); Psychological intervention; Consensus conference; MEDLINE; Protocol (science); Systematic review; Computer science; Medical physics; Alternative medicine; Pathology; Surgery; Political science; Nursing; Internal medicine","score_opus":0.054455971798608345,"score_gpt":0.2970151790106052,"score_spread":0.24255920721199686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082043630","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9645929,0.010270678,0.0029938146,0.021374917,0.00014973755,0.00047125507,0.00011583534,0.000002678577,0.000028238814],"genre_scores_gemma":[0.99008286,0.008809153,0.0007600683,0.00023413368,0.00008314314,0.0000053636923,0.000008290981,0.000011097474,0.0000059045938],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9988303,0.000178508,0.00053766696,0.00008883514,0.0002600574,0.000104600374],"domain_scores_gemma":[0.9979985,0.0006828635,0.0006925104,0.00025295708,0.0003286507,0.00004452612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049882644,0.00010562463,0.00053295126,0.00004413025,0.00016590841,0.000011496525,0.00015626237,0.000068958514,0.00014099949],"category_scores_gemma":[0.00010375878,0.000045871846,0.00052739365,0.00020794466,0.00020573886,0.000042414416,0.000024922849,0.00013761023,1.3481474e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033105174,0.0008627763,0.0301151,0.0004412605,0.013104225,0.0000020169825,0.0067499066,0.00030620894,0.15887564,0.0004429726,0.07715626,0.7086331],"study_design_scores_gemma":[0.009924126,0.0010820021,0.46855736,0.0027201585,0.0044689835,0.00006850545,0.0073394235,0.00039854576,0.35451263,0.00313809,0.14752986,0.0002603228],"about_ca_topic_score_codex":0.00006806696,"about_ca_topic_score_gemma":0.000005472852,"teacher_disagreement_score":0.7083728,"about_ca_system_score_codex":0.0000140972725,"about_ca_system_score_gemma":0.00007530653,"threshold_uncertainty_score":0.18705997},"labels":[],"label_agreement":null},{"id":"W2082149672","doi":"10.1056/nejmoa1008410","title":"Effects of<i>CYP2C19</i>Genotype on Outcomes of Clopidogrel Treatment","year":2010,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":535,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"Medicines Company; Eisai; Sanofi; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Clopidogrel; Medicine; CYP2C19; Internal medicine; Hazard ratio; Placebo; Confidence interval; Cardiology; Gastroenterology; Myocardial infarction; Pathology","score_opus":0.00844415188513664,"score_gpt":0.26537457889680705,"score_spread":0.2569304270116704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082149672","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907094,0.006155847,0.0001472122,0.0013415546,0.0008632046,0.00017594203,0.0000018259137,0.0000071982704,0.0005977975],"genre_scores_gemma":[0.9949782,0.002595525,0.00031687287,0.00021127693,0.001614032,8.1028463e-7,0.000002336292,0.00001581226,0.0002651189],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9987176,0.000060726426,0.0004730201,0.00009475357,0.00052223325,0.0001316311],"domain_scores_gemma":[0.99870217,0.00032708055,0.0003200099,0.00022679956,0.00016643171,0.00025752027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037925472,0.0001615467,0.0009431729,0.00013929355,0.000019299105,0.0000014319652,0.0000883237,0.00007719088,0.00013164828],"category_scores_gemma":[0.00022702197,0.00008555264,0.00038235466,0.00011100014,0.00012297313,0.00003009856,0.000006499869,0.00023123024,0.000002908681],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006242058,0.00091941847,0.07790037,0.00036515668,0.0042782193,0.0010285767,0.0010149069,0.00001548155,0.093510196,0.0005370462,0.0011661616,0.8130224],"study_design_scores_gemma":[0.22252902,0.022235945,0.5570139,0.0018020167,0.004871207,0.0015025786,0.00014747269,0.000006280424,0.110592104,0.0005206613,0.07855728,0.00022147769],"about_ca_topic_score_codex":0.000043683922,"about_ca_topic_score_gemma":0.000004356232,"teacher_disagreement_score":0.81280094,"about_ca_system_score_codex":0.000016440224,"about_ca_system_score_gemma":0.00015672622,"threshold_uncertainty_score":0.34887353},"labels":[],"label_agreement":null},{"id":"W2084005748","doi":"10.1001/archinte.165.7.784","title":"Bleeding Complications Associated With Combinations of Aspirin, Thienopyridine Derivatives, and Warfarin in Elderly Patients Following Acute Myocardial Infarction","year":2005,"lang":"en","type":"article","venue":"Archives of Internal Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":188,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Jewish General Hospital","funders":"","keywords":"Thienopyridine; Medicine; Aspirin; Warfarin; Clopidogrel; Myocardial infarction; Population; Internal medicine; Anticoagulant drug; Antiplatelet drug; Anticoagulant; Odds ratio; Anesthesia; Cardiology; Atrial fibrillation","score_opus":0.009763824273190093,"score_gpt":0.25670765254675254,"score_spread":0.24694382827356245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084005748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936248,0.0005259526,0.0018008889,0.00076393114,0.00004085422,0.00028716645,0.000011818114,0.00001671601,0.002927884],"genre_scores_gemma":[0.99894315,0.00027105518,0.00045404938,0.00016702845,0.000037457354,0.000012839377,0.00006680193,0.000013172299,0.000034462613],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989849,0.000056088207,0.00036957083,0.00016693705,0.00028755688,0.0001349711],"domain_scores_gemma":[0.9993169,0.00020491752,0.00017226858,0.0001404354,0.00008530761,0.000080178754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013577021,0.0001236224,0.00042850594,0.0002916691,0.000042040483,0.0000028879303,0.00007876081,0.00003160378,0.000008093582],"category_scores_gemma":[0.0001574877,0.000094707204,0.000112769056,0.00020841451,0.00027373884,0.00010548339,0.000035042558,0.00015160405,3.5102917e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092658505,0.0010254817,0.8892392,0.000065903005,0.003348334,0.000014533692,0.0034074364,0.00005264989,0.015540772,0.00091991306,0.000043316057,0.08541586],"study_design_scores_gemma":[0.011159086,0.0017135891,0.98196393,0.001837195,0.0004239036,0.000016404634,0.00029913927,0.0004749647,0.001537743,0.00026296003,0.00022091069,0.00009016244],"about_ca_topic_score_codex":0.00010131776,"about_ca_topic_score_gemma":0.000022677072,"teacher_disagreement_score":0.092724726,"about_ca_system_score_codex":0.00002383005,"about_ca_system_score_gemma":0.000027752603,"threshold_uncertainty_score":0.38620475},"labels":[],"label_agreement":null},{"id":"W2084275747","doi":"10.1016/j.plefa.2012.08.007","title":"The combination of EPA+DHA and low-dose aspirin ingestion reduces platelet function acutely whereas each alone may not in healthy humans","year":2012,"lang":"en","type":"article","venue":"Prostaglandins Leukotrienes and Essential Fatty Acids","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Center for Research Resources; National Heart, Lung, and Blood Institute; Albany College of Pharmacy and Health Sciences","keywords":"Ingestion; Aspirin; Platelet; Medicine; Pharmacology; Internal medicine","score_opus":0.01646108971639503,"score_gpt":0.2709567458825479,"score_spread":0.2544956561661529,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084275747","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98739845,0.010525088,0.00027574808,0.0007549752,0.00031896133,0.0005895835,0.000017476195,0.000029347253,0.00009036109],"genre_scores_gemma":[0.99237937,0.0069950023,0.00003499038,0.00008141269,0.0002220644,0.000043228483,0.00016615435,0.00002204691,0.00005576164],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99852645,0.00013124831,0.0003772563,0.00027428346,0.000327336,0.00036339255],"domain_scores_gemma":[0.99933046,0.00007406689,0.0001433171,0.00020131859,0.00008549788,0.00016532095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007025701,0.00020731807,0.00039085074,0.00013644756,0.00030206592,0.000055325258,0.000057170408,0.0001571991,0.000012987933],"category_scores_gemma":[0.00004316276,0.00015307456,0.00010857466,0.00022831428,0.00023064416,0.0002715755,0.0000526203,0.00019761453,0.0000026454654],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027512368,0.0012838952,0.66052485,0.00096702983,0.00094281504,0.00003837595,0.0027924536,0.000025682593,0.02696866,0.006669118,0.00008223348,0.27219254],"study_design_scores_gemma":[0.011448797,0.0014613168,0.9221538,0.00035955646,0.00046532467,0.00016070655,0.0010343929,0.00019648085,0.055014282,0.0002829842,0.007039876,0.00038249826],"about_ca_topic_score_codex":0.00014046744,"about_ca_topic_score_gemma":0.00004865552,"teacher_disagreement_score":0.27181002,"about_ca_system_score_codex":0.000042822914,"about_ca_system_score_gemma":0.000060098304,"threshold_uncertainty_score":0.62422},"labels":[],"label_agreement":null},{"id":"W2084386314","doi":"10.1016/j.jacc.2012.08.580","title":"TCT-546 Timing of Access Site Bleeding After Transfemoral Coronary Intervention","year":2012,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Intervention (counseling); Cardiology; Internal medicine; Percutaneous coronary intervention; Nursing; Myocardial infarction","score_opus":0.02447610419439818,"score_gpt":0.29761482430489344,"score_spread":0.2731387201104953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084386314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930242,0.004384895,0.0013750881,0.00025394376,0.00043486702,0.00014019026,0.00003916694,0.0000039689526,0.00034372322],"genre_scores_gemma":[0.9986312,0.00046745446,0.00019734469,0.0001421369,0.0004957741,0.0000027412136,0.0000011774663,0.000015457883,0.000046754012],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986153,0.0002950952,0.0005183493,0.00007895435,0.0002904264,0.00020183879],"domain_scores_gemma":[0.998883,0.00007602746,0.000532627,0.00021759009,0.00019273016,0.00009803482],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064142415,0.00011735571,0.00096809765,0.0001382609,0.00003006755,0.0000023001437,0.00020506849,0.00004631203,0.000043335196],"category_scores_gemma":[0.000051520918,0.00007777025,0.0015055719,0.000249251,0.00037849197,0.00017453411,0.000061059756,0.00019075959,9.669101e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0076545333,0.00016636265,0.9604099,0.00019117477,0.0038091962,0.00033493503,0.00018501877,0.00026115964,0.01262859,0.000031358726,0.0012373892,0.013090406],"study_design_scores_gemma":[0.0026308575,0.0011131174,0.9755557,0.000375159,0.0019090803,0.0075564,0.00087092945,0.00002130937,0.0066359267,0.00004277273,0.00316467,0.00012403599],"about_ca_topic_score_codex":0.000004801094,"about_ca_topic_score_gemma":5.464548e-7,"teacher_disagreement_score":0.015145866,"about_ca_system_score_codex":0.000043047818,"about_ca_system_score_gemma":0.00006802003,"threshold_uncertainty_score":0.3171379},"labels":[],"label_agreement":null},{"id":"W2084628897","doi":"10.1016/s0002-8703(03)00260-6","title":"Effects of clopidogrel and aspirin combination versus aspirin alone on platelet aggregation and major receptor expression in patients with heart failure: the Plavix Use for Treatment Of Congestive Heart Failure (PLUTO-CHF) trial","year":2003,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"","keywords":"Medicine; Clopidogrel; Aspirin; Platelet activation; Heart failure; Cardiology; Internal medicine; Platelet; Ejection fraction; Population; Antithrombotic","score_opus":0.011838788819563266,"score_gpt":0.25740497313473953,"score_spread":0.24556618431517627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084628897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99715537,0.0004521213,0.00006264835,0.00051649095,0.00010729724,0.0016787066,0.000017902137,0.000007931911,0.0000015596381],"genre_scores_gemma":[0.99771816,0.00018972115,0.0018192597,0.00010069168,0.000058999878,0.000058370024,0.000025001349,0.000023202885,0.0000065895497],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985519,0.00035520364,0.00031752832,0.00022685516,0.00034514428,0.00020333851],"domain_scores_gemma":[0.9987062,0.00061919936,0.00023220554,0.0001585542,0.00014829196,0.00013553305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024409189,0.00019952594,0.00065274443,0.00013277777,0.00011799575,0.000024615483,0.00002815332,0.00006515227,0.000007305782],"category_scores_gemma":[0.00017241802,0.00012788718,0.00015953113,0.00017854806,0.00027281934,0.00014174943,0.000007204515,0.00012801483,7.197776e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.33492497,0.0047889436,0.59932256,0.0003158657,0.0016249154,0.000022887301,0.0014793571,0.000113850976,0.010292775,0.00010402494,0.001970277,0.045039587],"study_design_scores_gemma":[0.28591433,0.06956182,0.51685876,0.0013075559,0.00057855435,0.000108191125,0.0008093369,0.000028258357,0.10840709,0.00003384445,0.016013011,0.00037924192],"about_ca_topic_score_codex":0.000039166094,"about_ca_topic_score_gemma":0.0000107582955,"teacher_disagreement_score":0.09811431,"about_ca_system_score_codex":0.000077654084,"about_ca_system_score_gemma":0.00009159082,"threshold_uncertainty_score":0.5215088},"labels":[],"label_agreement":null},{"id":"W2084949838","doi":"10.1136/ebm.11.3.82","title":"Addition of clopidogrel to aspirin, but not early use of metoprolol, improved overall outcome in acute myocardial infarction","year":2006,"lang":"en","type":"letter","venue":"Evidence-Based Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Medicine; Clopidogrel; Myocardial infarction; Percutaneous coronary intervention; Aspirin; Metoprolol; Internal medicine; Placebo; Cardiology; Emergency medicine","score_opus":0.05945500929074134,"score_gpt":0.29873486185199877,"score_spread":0.23927985256125744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084949838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7476682,0.0029828176,0.0019971556,0.24224132,0.0012367446,0.0031580264,0.0005327279,0.000120357705,0.00006262479],"genre_scores_gemma":[0.5182111,0.0011461998,0.0011688384,0.46841168,0.0068676746,0.0003426796,0.002243208,0.00019058282,0.0014179831],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9948987,0.0003828014,0.0016700648,0.00079546776,0.0016800875,0.0005728951],"domain_scores_gemma":[0.99659073,0.0007136424,0.0007196702,0.0011491866,0.0006182949,0.00020847298],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00092728913,0.00064162834,0.0024366807,0.0011557826,0.000039949326,0.00001512962,0.00026860947,0.0009139773,0.00027435474],"category_scores_gemma":[0.00082743785,0.00052622054,0.0010550235,0.000662506,0.00037711306,0.00035231118,0.000057011886,0.0013384394,0.000019894178],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017340835,0.000566792,0.11836626,0.0061961887,0.0060032043,0.0031003684,0.00027399318,0.00052790926,0.06712704,0.00002474654,0.7513003,0.029172385],"study_design_scores_gemma":[0.016639287,0.008516441,0.67396855,0.01839433,0.007979714,0.00008784431,0.000024868872,0.00018966543,0.010899984,0.000059943864,0.26205632,0.0011830587],"about_ca_topic_score_codex":0.003328259,"about_ca_topic_score_gemma":0.000019721647,"teacher_disagreement_score":0.5556023,"about_ca_system_score_codex":0.00027175673,"about_ca_system_score_gemma":0.0004429016,"threshold_uncertainty_score":0.99971896},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"editorial","about_ca_system":false,"about_ca_topic":false,"confidence":"high"},{"model":"gpt","categories":[],"domain":null,"study_design":"observational","genre":"commentary","about_ca_system":false,"about_ca_topic":false,"confidence":"medium"}],"label_agreement":"split"},{"id":"W2084987285","doi":"10.1016/s0828-282x(07)71016-4","title":"Safety of the cardiac triple therapy: The experience of the Quebec Heart Institute","year":2007,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Clopidogrel; Warfarin; Internal medicine; Acute coronary syndrome; Cardiology; Aspirin; Atrial fibrillation; Myocardial infarction","score_opus":0.013859901058805954,"score_gpt":0.2429172958091649,"score_spread":0.22905739475035897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084987285","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9802517,0.012824943,0.00044428054,0.0018833908,0.002056233,0.00032451356,0.000022492648,0.0000022267807,0.0021901608],"genre_scores_gemma":[0.9980426,0.00047364394,0.000012258257,0.0006498212,0.0006110782,0.0000018683171,8.138433e-7,0.000010508555,0.00019745252],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99858236,0.0003245982,0.00045557015,0.000097275886,0.00027175862,0.0002684267],"domain_scores_gemma":[0.99864453,0.0000891154,0.00022901228,0.0005737421,0.00025588385,0.00020771296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011423348,0.00011728842,0.0006057366,0.00007362235,0.00017862681,0.00000539646,0.00041062786,0.000106624735,0.000018443852],"category_scores_gemma":[0.00019041242,0.000053524647,0.001314443,0.00028489536,0.0011107518,0.000054352593,0.000019351686,0.00030013663,7.8166164e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019195089,0.00002232553,0.8805934,0.00005586407,0.0052915523,0.00016567078,0.0066213333,0.0019981952,0.012137931,0.0029077108,0.01651942,0.07176706],"study_design_scores_gemma":[0.0007604251,0.00007023229,0.5100189,0.000052353655,0.00014140067,0.00038122587,0.00082314323,4.42584e-7,0.004082747,0.00003672571,0.48358354,0.0000488784],"about_ca_topic_score_codex":0.005280868,"about_ca_topic_score_gemma":0.0050418745,"teacher_disagreement_score":0.4670641,"about_ca_system_score_codex":0.000094975636,"about_ca_system_score_gemma":0.0019461239,"threshold_uncertainty_score":0.79831284},"labels":[],"label_agreement":null},{"id":"W2085123525","doi":"10.1016/j.cgh.2011.05.020","title":"Low Doses of Acetylsalicylic Acid Increase Risk of Gastrointestinal Bleeding in a Meta-Analysis","year":2011,"lang":"en","type":"review","venue":"Clinical Gastroenterology and Hepatology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":153,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Internal medicine; Clopidogrel; Aspirin; Odds ratio; Relative risk; Adverse effect; Confidence interval; Meta-analysis; Gastrointestinal bleeding; Randomized controlled trial; Gastroenterology","score_opus":0.13425689879310324,"score_gpt":0.3887831595638887,"score_spread":0.25452626077078544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085123525","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12855609,0.87039137,0.0003417046,0.000023483504,0.000051227456,0.00043386506,0.00014803646,0.000016338201,0.000037909693],"genre_scores_gemma":[0.11246286,0.8864213,0.0007282227,0.00015173602,0.00005291102,0.00005819474,0.00008465909,0.000028655126,0.000011454838],"study_design_codex":"observational","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9937099,0.0024616288,0.0024584653,0.0007603643,0.00013707194,0.0004725555],"domain_scores_gemma":[0.99659,0.0008098856,0.0015022837,0.0006970818,0.00012821547,0.00027253854],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018986055,0.0005068674,0.0119296955,0.00069451565,0.00002973338,0.0000027044975,0.00026187423,0.0005559295,0.00035005077],"category_scores_gemma":[0.0006274608,0.00036104847,0.0079871435,0.00038973015,0.0013025865,0.000035128065,0.00018916793,0.0009926157,0.000006008218],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002599597,0.0011342675,0.7056955,0.0054522688,0.2526316,0.0003667998,0.00002046604,5.8950434e-7,7.4427817e-7,0.00007635427,0.00003052591,0.03199128],"study_design_scores_gemma":[0.003137258,0.003745377,0.020567313,0.001062148,0.96062213,0.002515846,0.000029602405,0.0000180982,0.0000031219784,0.00007779108,0.007996004,0.00022532417],"about_ca_topic_score_codex":0.000109736415,"about_ca_topic_score_gemma":0.00016702767,"teacher_disagreement_score":0.7079905,"about_ca_system_score_codex":0.000015051574,"about_ca_system_score_gemma":0.0001939598,"threshold_uncertainty_score":0.9998841},"labels":[],"label_agreement":null},{"id":"W2085141917","doi":"10.1161/circulationaha.110.957373","title":"Effect of Timing of Chronic Preoperative Aspirin Discontinuation on Morbidity and Mortality in Coronary Artery Bypass Surgery","year":2011,"lang":"en","type":"article","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Discontinuation; Aspirin; Propensity score matching; Myocardial infarction; Coronary artery bypass surgery; Stroke (engine); Surgery; Artery; Adverse effect; Canadian Cardiovascular Society; Anesthesia; Angina; Internal medicine","score_opus":0.04359485321950213,"score_gpt":0.2859146001112998,"score_spread":0.2423197468917977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085141917","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99852693,0.00055242004,0.0003023132,0.0000031251514,0.000044899454,0.00029483825,0.0000043409755,0.000009473714,0.0002616659],"genre_scores_gemma":[0.99983555,0.000047139078,0.000005816656,0.0000060723323,0.000029993476,0.000013815701,0.000051751656,0.000007131195,0.0000027255774],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99923825,0.00018123315,0.00021941937,0.00014112392,0.00014729278,0.00007265783],"domain_scores_gemma":[0.9995971,0.00009678958,0.00009236605,0.00015411516,0.000032971184,0.000026656326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047946558,0.00008011273,0.00030380077,0.00007784571,0.000015309726,0.0000018387528,0.000015314803,0.000051442523,0.0000316507],"category_scores_gemma":[0.000047064717,0.00006895952,0.000115358875,0.000081712904,0.00005998211,0.00010395139,0.000006792038,0.00005208298,0.0000010224329],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003403432,0.00012736834,0.96175045,0.00022213931,0.00015101282,0.00001383798,0.00025506123,0.00009074755,0.0049185967,0.000025199715,0.0000016653963,0.032103576],"study_design_scores_gemma":[0.0008383697,0.00025607058,0.9693855,0.00025455246,0.0001408071,0.000008618751,0.000016727196,0.001267017,0.027755603,0.000021324386,7.8396243e-7,0.00005459355],"about_ca_topic_score_codex":0.0000585988,"about_ca_topic_score_gemma":0.000014426748,"teacher_disagreement_score":0.03204898,"about_ca_system_score_codex":0.00003797128,"about_ca_system_score_gemma":0.000038518327,"threshold_uncertainty_score":0.28120875},"labels":[],"label_agreement":null},{"id":"W2085190889","doi":"10.1016/j.jacc.2005.01.034","title":"Resistance to clopidogrel: A review of the evidence","year":2005,"lang":"en","type":"review","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":520,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital du Sacré-Cœur de Montréal","funders":"","keywords":"Clopidogrel; Medicine; Platelet; Antiplatelet drug; Acute coronary syndrome; Cardiology; P2Y12; Internal medicine; Pharmacology; Aspirin; Myocardial infarction","score_opus":0.038522489922450436,"score_gpt":0.35212126452020354,"score_spread":0.3135987745977531,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085190889","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013106233,0.9954547,0.000043680666,0.0024245337,0.00042996023,0.0009797136,0.00010354198,0.000003729188,0.00042907152],"genre_scores_gemma":[0.00060281676,0.99638206,0.00028352212,0.0013342287,0.0008403639,0.0000154245,5.732033e-7,0.000036536425,0.0005044602],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955692,0.0017339801,0.0015032386,0.0002171122,0.0007426773,0.00023374535],"domain_scores_gemma":[0.994317,0.00051225873,0.0031898802,0.0012793129,0.0005698715,0.00013169608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015822405,0.00031272642,0.0059533506,0.00014320323,0.000051647214,0.0000018886137,0.0011087916,0.00010355671,0.000014925083],"category_scores_gemma":[0.001531558,0.00014729834,0.006717432,0.0012405687,0.0006728904,0.000034926907,0.0001900221,0.00055745867,0.0000034339707],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089821976,0.00006227095,0.00034210252,0.07526649,0.008957202,0.00031432684,0.000014556303,0.000022347318,0.000010528545,0.00011046302,0.1267332,0.7872683],"study_design_scores_gemma":[0.00018760539,0.00025235701,0.00034629102,0.18646201,0.0061287438,0.0028993178,0.000015758,2.8727376e-8,0.0000043069963,0.0000074853124,0.8035931,0.000102959944],"about_ca_topic_score_codex":0.0000014442016,"about_ca_topic_score_gemma":0.0000012219296,"teacher_disagreement_score":0.78716534,"about_ca_system_score_codex":0.00015461262,"about_ca_system_score_gemma":0.0015141496,"threshold_uncertainty_score":0.677471},"labels":[],"label_agreement":null},{"id":"W2086017072","doi":"10.1111/ijs.12419","title":"Effect of Addition of Clopidogrel to Aspirin on Subdural Hematoma: Meta-Analysis of Randomized Clinical Trials","year":2014,"lang":"en","type":"review","venue":"International Journal of Stroke","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Clopidogrel; Aspirin; Hematoma; Stroke (engine); Randomized controlled trial; Anesthesia; Internal medicine; Surgery","score_opus":0.16095925171892408,"score_gpt":0.5093533115348473,"score_spread":0.3483940598159232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086017072","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0075170244,0.9873328,0.002116411,0.00008351977,0.00071201124,0.0011609091,0.0009107587,0.000005177818,0.00016138905],"genre_scores_gemma":[0.044990648,0.95356584,0.00020953166,0.0000717095,0.00077390386,0.00003704742,0.00022560956,0.00003150844,0.00009420198],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98597497,0.0061768466,0.005772956,0.00022267707,0.0017370624,0.000115499206],"domain_scores_gemma":[0.98107946,0.010380514,0.0068698125,0.00034891328,0.0011549032,0.00016638692],"candidate_categories":["metaepi_broad"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.023667691,0.00034521948,0.021073863,0.0014752281,0.000009364102,0.0000106973,0.0004353377,0.00025297917,0.00063627504],"category_scores_gemma":[0.0074284403,0.00019092568,0.045935377,0.00029068545,0.00015325959,0.00005077653,0.00004136081,0.00038150235,0.000006596751],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.043396425,0.00026414057,0.00002410012,0.0019427659,0.6822303,0.0000517248,0.000007646519,0.000047196234,0.000006992967,0.00010932363,0.00020179883,0.27171758],"study_design_scores_gemma":[0.0468547,0.0017649994,0.000024441444,0.004392527,0.89770424,0.000118367265,0.000004570726,0.000013715876,0.0005111711,0.0000147453875,0.048454564,0.00014193852],"about_ca_topic_score_codex":0.0000064485084,"about_ca_topic_score_gemma":5.9755286e-7,"teacher_disagreement_score":0.27157563,"about_ca_system_score_codex":0.000052224997,"about_ca_system_score_gemma":0.0002104016,"threshold_uncertainty_score":0.99345934},"labels":[],"label_agreement":null},{"id":"W2086890457","doi":"10.1378/chest.08-0685","title":"The Primary and Secondary Prevention of Coronary Artery Disease","year":2008,"lang":"en","type":"article","venue":"CHEST Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":249,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; McMaster University Medical Centre","funders":"","keywords":"Medicine; Clopidogrel; Aspirin; Antithrombotic; Percutaneous coronary intervention; Conventional PCI; Internal medicine; Coronary artery disease; Acute coronary syndrome; Myocardial infarction; Cardiology; Warfarin; Atrial fibrillation","score_opus":0.01496226565948641,"score_gpt":0.23245553034698094,"score_spread":0.21749326468749453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086890457","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96481735,0.03383942,0.00027067817,0.0002634701,0.00008280075,0.00009402832,0.0000025925144,0.000007947771,0.0006217431],"genre_scores_gemma":[0.9846666,0.014292011,0.00010012982,0.00015642462,0.00020158966,0.0000022645822,0.0000069146317,0.000008680313,0.00056538417],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99942863,0.000050195224,0.0001622023,0.00007018031,0.00018889658,0.000099881334],"domain_scores_gemma":[0.99955153,0.0000322743,0.000068204026,0.00012969605,0.00004769822,0.0001705896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019054118,0.000064712476,0.00014617381,0.000024081464,0.00022544166,0.000009060886,0.00004170087,0.000023933348,0.000053797503],"category_scores_gemma":[0.00002072065,0.000041340816,0.0002107692,0.000034667497,0.00018837396,0.000085422165,0.000015200478,0.000159596,0.0000026585285],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049530524,0.00066889287,0.30827993,0.0006594684,0.0021482548,0.0051691155,0.00059684267,0.000005869526,0.003979289,0.00013570012,0.006722362,0.66668123],"study_design_scores_gemma":[0.0014938388,0.00013046451,0.9761472,0.000084827,0.00016844893,0.0075107315,0.000078546225,0.0000061054484,0.00017940936,0.00032553732,0.01382541,0.000049485992],"about_ca_topic_score_codex":1.5412897e-7,"about_ca_topic_score_gemma":8.976438e-8,"teacher_disagreement_score":0.66786724,"about_ca_system_score_codex":0.00001528093,"about_ca_system_score_gemma":0.00024468653,"threshold_uncertainty_score":0.17339379},"labels":[],"label_agreement":null},{"id":"W2086993538","doi":"10.1161/circinterventions.108.846741","title":"Bleeding in Patients Undergoing Percutaneous Coronary Intervention","year":2009,"lang":"en","type":"article","venue":"Circulation Cardiovascular Interventions","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":299,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Percutaneous coronary intervention; Percutaneous; Myocardial infarction; Conventional PCI; Cardiology; Surgery; Internal medicine; Radiology","score_opus":0.020072051190003232,"score_gpt":0.26850028897317674,"score_spread":0.2484282377831735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086993538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9738922,0.008500198,0.014597539,0.00009551375,0.00028694962,0.0007936961,0.000007670766,0.0001669346,0.0016593047],"genre_scores_gemma":[0.99885774,0.00023648796,0.00026970898,0.00011376641,0.000113978924,0.000018899163,0.00026740175,0.0000300796,0.000091966154],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99782693,0.00019044545,0.00061851507,0.00046243743,0.00058927975,0.00031240596],"domain_scores_gemma":[0.9989873,0.000026794287,0.0000927597,0.0005626884,0.00019370107,0.00013673291],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005423638,0.00022951736,0.00056072295,0.00039559335,0.00013762791,0.00005366039,0.00010610768,0.00014252264,0.00019848821],"category_scores_gemma":[0.00012858256,0.00025036267,0.0044595064,0.00043318633,0.000043468222,0.00030032964,0.000028592603,0.0002306928,0.000065147455],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005667152,0.0029779673,0.5204992,0.000789924,0.006639581,0.00074661477,0.00034243372,0.014186537,0.00032710878,0.0013072152,0.00019610822,0.45142058],"study_design_scores_gemma":[0.005243066,0.00037031513,0.98955137,0.0012554518,0.001005496,0.00051169266,0.00017327309,0.00047670025,0.000036155645,0.00051676895,0.000587823,0.0002718945],"about_ca_topic_score_codex":0.000012353597,"about_ca_topic_score_gemma":0.0000065454783,"teacher_disagreement_score":0.46905214,"about_ca_system_score_codex":0.00030389414,"about_ca_system_score_gemma":0.00004242521,"threshold_uncertainty_score":0.9999949},"labels":[],"label_agreement":null},{"id":"W2087200187","doi":"10.1503/cmaj.1070122","title":"Combined antithrombotic therapy","year":2007,"lang":"en","type":"letter","venue":"Canadian Medical Association Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Antithrombotic; Medicine; Randomized controlled trial; Coronary artery disease; Intensive care medicine; Surgery; Internal medicine","score_opus":0.011008820089622522,"score_gpt":0.2420165682605195,"score_spread":0.23100774817089698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087200187","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0092216125,0.0041702576,0.00008389475,0.9777596,0.0022504414,0.00032201447,0.000038361246,0.000055917637,0.0060978997],"genre_scores_gemma":[0.0028106493,0.0042263735,0.000039357335,0.9681204,0.021172896,0.0000040920677,0.00022341855,0.00007573578,0.003327066],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99465615,0.00026773178,0.00056393864,0.00027041312,0.0033368915,0.0009048917],"domain_scores_gemma":[0.99692744,0.00016181868,0.0002935268,0.00026247354,0.0005990973,0.0017556293],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0018597026,0.00030864897,0.0007919039,0.000450663,0.0002791247,0.000115757175,0.00027299477,0.0026171298,0.012147842],"category_scores_gemma":[0.0005978807,0.00026410917,0.0008747882,0.0002890952,0.000082487844,0.000070723974,0.000008961114,0.0056354348,0.00053121906],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028026363,0.000025562633,0.0071388935,0.000024502942,0.0016702418,0.021894602,0.000027671947,1.6582746e-7,9.671609e-7,0.0000047946864,0.94612646,0.023058131],"study_design_scores_gemma":[0.0028856553,0.00016037792,0.009614831,0.0002298522,0.00020509452,0.0022811252,0.000030846593,0.0000069603207,0.0000061821383,0.00004549436,0.9842693,0.00026427797],"about_ca_topic_score_codex":0.0006572825,"about_ca_topic_score_gemma":0.00048682382,"teacher_disagreement_score":0.038142864,"about_ca_system_score_codex":0.0012269662,"about_ca_system_score_gemma":0.0063985744,"threshold_uncertainty_score":0.9999811},"labels":[],"label_agreement":null},{"id":"W2087385591","doi":"10.1016/s0140-6736(05)72319-9","title":"Treatment and secondary prevention of stroke","year":2000,"lang":"en","type":"letter","venue":"The Lancet","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Deep River Science Academy","funders":"","keywords":"Medicine; Stroke (engine); Aspirin; Randomized controlled trial; Relative risk; Scopus; Clinical trial; Secondary prevention; MEDLINE; Physical therapy; Pediatrics; Internal medicine; Confidence interval","score_opus":0.02209868484230131,"score_gpt":0.26420247823488857,"score_spread":0.24210379339258725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087385591","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.33808297,0.073228195,0.000024591289,0.5489835,0.00020725785,0.0013212904,0.00075372757,0.00010241573,0.03729603],"genre_scores_gemma":[0.120977215,0.096526064,0.00028347594,0.6587344,0.029617138,0.0001491792,0.0022655868,0.00015497867,0.091292],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99943656,0.00007665301,0.000110117384,0.00012941172,0.00012126765,0.00012601672],"domain_scores_gemma":[0.99946505,0.000026146767,0.0000509435,0.0004292789,0.000011244386,0.000017355866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005902673,0.0001230082,0.00056477595,0.000025373129,0.000027013708,0.000006852717,0.00006048395,0.0001452881,0.00042204393],"category_scores_gemma":[0.0000021650937,0.000069979586,0.00026872897,0.000023269098,0.000074817515,0.000014279502,0.0000082331535,0.000262479,0.000011376663],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005850798,0.00005290473,0.00045083396,0.0004140159,0.0024454698,0.00021125052,0.00012169301,6.845787e-7,0.00007598598,0.00001007182,0.70989704,0.28573495],"study_design_scores_gemma":[0.0023050976,0.00029522958,0.0024753932,0.00010700482,0.000780323,0.00015318967,0.000010033549,0.0000014291959,0.00023629269,0.00012336184,0.9934459,0.00006676307],"about_ca_topic_score_codex":0.000011571639,"about_ca_topic_score_gemma":7.135365e-7,"teacher_disagreement_score":0.2856682,"about_ca_system_score_codex":0.000015006583,"about_ca_system_score_gemma":0.000055308195,"threshold_uncertainty_score":0.4621085},"labels":[],"label_agreement":null},{"id":"W2088169063","doi":"10.1161/circulationaha.113.001433","title":"Letter by Wallace and Chan Regarding Article, “Drug Resistance and Pseudoresistance: An Unintended Consequence of Enteric Coating Aspirin”","year":2013,"lang":"en","type":"letter","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"","keywords":"Enteric coating; Aspirin; Medicine; Enteric coated; Internal medicine; Pharmacology; Dosage form","score_opus":0.013184401167859433,"score_gpt":0.2328270795121267,"score_spread":0.21964267834426726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088169063","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90372807,0.0075541567,0.0011225846,0.08651854,0.00009404616,0.00064819417,0.000033606433,0.00007009696,0.0002307185],"genre_scores_gemma":[0.93155366,0.00042823397,0.00030987652,0.06576672,0.0004462913,0.000029470935,0.00034846476,0.00005326446,0.0010640048],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99839914,0.00016913135,0.0003491259,0.0004748118,0.00035950996,0.00024828335],"domain_scores_gemma":[0.9990246,0.000058271624,0.0002581014,0.0004022136,0.00016663718,0.00009016342],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019231495,0.00024823606,0.000517677,0.00009362403,0.00009576527,0.000053845106,0.00006756011,0.0002444929,0.000030526102],"category_scores_gemma":[0.000048512728,0.00021838998,0.0001206045,0.00011475407,0.00026484395,0.00020402909,0.00002422634,0.00038466902,0.0000033251815],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005004735,0.000106108855,0.034817427,0.006330029,0.0014658509,0.0012048063,0.0011985338,0.00001518699,0.21024907,0.00012381493,0.7340967,0.00989199],"study_design_scores_gemma":[0.013559784,0.00026898246,0.1952687,0.010207337,0.0034756134,0.0019410528,0.00071041065,0.00296235,0.0195632,0.0023054215,0.7467027,0.003034473],"about_ca_topic_score_codex":0.000034324286,"about_ca_topic_score_gemma":0.0000041800317,"teacher_disagreement_score":0.19068587,"about_ca_system_score_codex":0.00007550836,"about_ca_system_score_gemma":0.000036370926,"threshold_uncertainty_score":0.8905685},"labels":[],"label_agreement":null},{"id":"W2089890915","doi":"10.1007/s11239-012-0762-2","title":"Relation between clopidogrel active metabolite levels and different platelet aggregation methods in patients receiving clopidogrel and aspirin","year":2012,"lang":"en","type":"article","venue":"Journal of Thrombosis and Thrombolysis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; Hamilton Health Sciences; McMaster University Medical Centre; Hamilton Regional Laboratory Medicine Program; Population Health Research Institute; McMaster University","funders":"Sanofi","keywords":"Clopidogrel; Medicine; Platelet; Pharmacology; Aspirin; Active metabolite; Ticlopidine; Prodrug; Platelet aggregation inhibitor; Metabolite; P2Y12; Internal medicine; Pharmacokinetics","score_opus":0.044024308992007266,"score_gpt":0.3433982250634227,"score_spread":0.29937391607141545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089890915","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99009526,0.008014748,0.0011972289,0.00021490573,0.00017529336,0.00022159802,0.000011546751,0.000009335297,0.000060113864],"genre_scores_gemma":[0.9888727,0.006855295,0.0038956348,0.00007233517,0.00025400677,0.0000034168706,0.000015517087,0.000024742938,0.000006349079],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981321,0.00038040467,0.00062792376,0.00021634618,0.00036781805,0.00027540163],"domain_scores_gemma":[0.99875027,0.00023202009,0.00045215568,0.00015701007,0.00013293637,0.0002755856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009946628,0.00024468717,0.0010796372,0.0003255954,0.000115929295,0.00004424292,0.00005034081,0.0001741982,0.000021721931],"category_scores_gemma":[0.00013136557,0.0001841009,0.00025318802,0.00023611664,0.00011012197,0.00065745896,0.00006151912,0.0003271408,6.1046416e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008797043,0.00015579055,0.7565218,0.00006678399,0.0012825264,0.0000010493438,0.00093145133,0.0000012188651,0.000893497,0.00004879795,0.000008136111,0.24000095],"study_design_scores_gemma":[0.0031124316,0.00027724027,0.9901564,0.00030990125,0.0015031364,0.000021657519,0.00026279897,0.000021138361,0.0035065874,0.00029543292,0.00034822288,0.0001850349],"about_ca_topic_score_codex":0.000013430177,"about_ca_topic_score_gemma":0.0000016588191,"teacher_disagreement_score":0.2398159,"about_ca_system_score_codex":0.00006703184,"about_ca_system_score_gemma":0.000021083977,"threshold_uncertainty_score":0.75074166},"labels":[],"label_agreement":null},{"id":"W2090135582","doi":"10.1007/s11302-011-9227-x","title":"Historical perspective on ADP-induced platelet activation","year":2011,"lang":"en","type":"article","venue":"Purinergic Signalling","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; Canada Research Chairs; University of Toronto","funders":"","keywords":"Platelet; Hemostasis; Adenosine diphosphate; P2Y12; Medicine; Platelet aggregation; P2Y receptor; Receptor; Chemistry; Purinergic receptor; Internal medicine","score_opus":0.04830850259986155,"score_gpt":0.2588032566583726,"score_spread":0.21049475405851106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090135582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97379297,0.00083500217,0.0013695005,0.00021935748,0.00016023584,0.0002493694,6.23338e-7,0.00015924293,0.023213694],"genre_scores_gemma":[0.9982469,0.00009339987,0.00025768141,0.00028974813,0.00043329247,0.000026288017,0.0000054235866,0.00003294482,0.0006143371],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99885774,0.000046106397,0.00018910896,0.00032963083,0.00034152588,0.00023586396],"domain_scores_gemma":[0.9993899,0.000040901836,0.0000652206,0.00022620034,0.00012289885,0.00015489751],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014631932,0.0001780701,0.0003098175,0.00013624056,0.00009274146,0.000008722712,0.00008005986,0.00010034551,0.00041801645],"category_scores_gemma":[0.000059394722,0.00015217198,0.00032750788,0.00017423004,0.000018221413,0.00008228746,0.000014614619,0.00022744609,0.000069281356],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.039705478,0.012033687,0.019378139,0.000681765,0.013318826,0.0074769473,0.025295282,0.0019145556,0.52450776,0.11671752,0.010049073,0.22892095],"study_design_scores_gemma":[0.012583538,0.003964918,0.03634232,0.0007212101,0.0008873309,0.0004245527,0.0028716489,0.00073965616,0.9049214,0.0054495316,0.02952079,0.0015731128],"about_ca_topic_score_codex":0.00015065345,"about_ca_topic_score_gemma":4.9436574e-7,"teacher_disagreement_score":0.38041362,"about_ca_system_score_codex":0.00048475846,"about_ca_system_score_gemma":0.00006147159,"threshold_uncertainty_score":0.6205393},"labels":[],"label_agreement":null},{"id":"W2090245176","doi":"10.1016/s0735-1097(13)61193-6","title":"SAME-DAY DISCHARGE COMPARED TO OVERNIGHT HOSPITALIZATION AFTER UNCOMPLICATED PCI: A SYSTEMATIC REVIEW AND META-ANALYSIS","year":2013,"lang":"en","type":"review","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"","keywords":"Medicine; Conventional PCI; Meta-analysis; Emergency medicine; Internal medicine; Cardiology; Myocardial infarction","score_opus":0.034469779661474825,"score_gpt":0.3135777314383108,"score_spread":0.279107951776836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090245176","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013513824,0.9950301,0.0007636925,0.0006310793,0.0000654893,0.002880111,0.00045245333,0.000007119302,0.000034831806],"genre_scores_gemma":[0.0033598032,0.99485993,0.00013510892,0.0009342273,0.000090745445,0.00023420276,0.00001679172,0.000042702446,0.00032648287],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99472785,0.0024081743,0.0017941581,0.00030660874,0.00053485966,0.00022836123],"domain_scores_gemma":[0.9949531,0.0002883964,0.0029871552,0.0010162923,0.0005280172,0.00022704262],"candidate_categories":["metaepi_broad"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.0010737866,0.0004657291,0.019857505,0.0003806711,0.00004738384,0.000010902232,0.00044089774,0.00010287603,0.00007458953],"category_scores_gemma":[0.00033201507,0.00022162282,0.011324491,0.0015591519,0.000277396,0.000051565097,0.00012837346,0.00028628093,0.000009525513],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000776541,0.000046775927,0.00010332384,0.2552494,0.7392863,0.00012669299,0.000016342588,0.000024818011,9.594378e-7,0.000018990002,0.0044549727,0.00059377967],"study_design_scores_gemma":[0.0002051689,0.00020160056,0.00014801839,0.013549434,0.89266026,0.0017820146,0.00003445055,0.0000016099712,3.449467e-7,0.0000066151015,0.091204524,0.00020593606],"about_ca_topic_score_codex":0.000006274552,"about_ca_topic_score_gemma":0.0000011369664,"teacher_disagreement_score":0.24169996,"about_ca_system_score_codex":0.00009854393,"about_ca_system_score_gemma":0.00020743134,"threshold_uncertainty_score":0.9985769},"labels":[],"label_agreement":null},{"id":"W2090347422","doi":"10.1055/s-0029-1145258","title":"Determinants of Bleeding Risk in Patients on Antithrombotic and Antifibrinolytic Drugs","year":2008,"lang":"en","type":"review","venue":"Seminars in Thrombosis and Hemostasis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton General Hospital","funders":"","keywords":"Antithrombotic; Medicine; Antifibrinolytic; Drug class; Aspirin; Intensive care medicine; Drug; Fibrinolytic agent; Surgery; Internal medicine; Pharmacology; Tranexamic acid","score_opus":0.035993886033923755,"score_gpt":0.32542483596635413,"score_spread":0.28943094993243035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090347422","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.45531183,0.54400015,1.2955766e-7,0.0000020164969,0.000048472968,0.00048153594,0.00005611752,0.0000078450485,0.00009191723],"genre_scores_gemma":[0.08750346,0.91225225,0.00007491347,0.00002079695,0.000026185571,0.00001704796,0.00003645112,0.000057895268,0.000010983583],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9976416,0.00015346128,0.0008105349,0.0006390844,0.0003786827,0.00037662248],"domain_scores_gemma":[0.998859,0.00019407913,0.0003565225,0.00041784788,0.00004154259,0.00013103476],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00027463923,0.00049145514,0.0031200533,0.0005308306,0.000083056635,0.000017476757,0.0001042223,0.00034146637,0.000015313557],"category_scores_gemma":[0.000072181305,0.00040923027,0.0004702911,0.0004753257,0.0002691455,0.000081480655,0.00010051057,0.00039147382,0.0000039714027],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003775317,0.00028673353,0.23599747,0.0071095666,0.00024669562,0.000035358247,0.00027616462,2.4081868e-7,3.5401905e-7,0.0000030062579,0.000058904876,0.75594777],"study_design_scores_gemma":[0.0073621175,0.0018338112,0.7011568,0.23304178,0.0052341176,0.00020047426,0.00061622966,0.000041102172,0.00016870088,0.000041884028,0.048655998,0.0016469676],"about_ca_topic_score_codex":0.00007230247,"about_ca_topic_score_gemma":0.00000558933,"teacher_disagreement_score":0.7543008,"about_ca_system_score_codex":0.00008897545,"about_ca_system_score_gemma":0.000092245726,"threshold_uncertainty_score":0.99983597},"labels":[],"label_agreement":null},{"id":"W2090459945","doi":"10.3821/1913-701x-143.4.192","title":"Patient Self-Medication with ASA 81 mg","year":2010,"lang":"en","type":"article","venue":"Canadian Pharmacists Journal / Revue des Pharmaciens du Canada","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Regina Qu'Appelle Health Region","funders":"","keywords":"Medicine; Stroke (engine); Diabetes mellitus; Blood pressure; Family history; Pharmacy; Coronary heart disease; Framingham Risk Score; Heart disease; Internal medicine; Disease; High cholesterol; Physical therapy; Emergency medicine; Cholesterol; Family medicine","score_opus":0.008059912752992091,"score_gpt":0.2212773528486694,"score_spread":0.2132174400956773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090459945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940977,0.00116678,0.0000923773,0.00025031445,0.001567307,0.00041723676,0.0001269945,0.000055794775,0.0022254828],"genre_scores_gemma":[0.99159086,0.0028122044,0.000460994,0.003627205,0.0011422841,0.000021318667,0.00005873983,0.00006269465,0.00022370386],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99767166,0.00008760497,0.00039898767,0.00035896755,0.0006882703,0.000794528],"domain_scores_gemma":[0.995583,0.000037613136,0.00018235373,0.000359126,0.0005463991,0.003291538],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00035763587,0.00032618575,0.0003875382,0.0002766329,0.00065633986,0.000102878745,0.00026112728,0.00008061895,0.0017260475],"category_scores_gemma":[0.00006975188,0.00028406244,0.0002275268,0.00042891855,0.00018960348,0.00024061924,0.000016327262,0.0009800952,0.000027866168],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011023228,0.00038892,0.020873412,0.0005199014,0.0034848738,0.33328667,0.002284312,0.00028621109,0.018070864,0.000112016714,0.075886115,0.5437044],"study_design_scores_gemma":[0.0031962714,0.000114248134,0.00029090117,0.000027042623,0.0005371315,0.6198015,0.000016587604,0.00057199644,0.0036584144,0.000013524229,0.37137446,0.00039791127],"about_ca_topic_score_codex":0.005926375,"about_ca_topic_score_gemma":0.037021637,"teacher_disagreement_score":0.54330647,"about_ca_system_score_codex":0.00088675105,"about_ca_system_score_gemma":0.006372424,"threshold_uncertainty_score":0.99996114},"labels":[],"label_agreement":null},{"id":"W2092078602","doi":"10.1161/strokeaha.110.584151","title":"Rapid Change in Prescribing Behavior in Hospitals Participating in Get With The Guidelines–Stroke After Release of the Management of Atherothrombosis With Clopidogrel in High-Risk Patients (MATCH) Clinical Trial Results","year":2010,"lang":"en","type":"article","venue":"Stroke","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Institute of Neurological Disorders and Stroke; Canadian Institutes of Health Research","keywords":"Medicine; Clopidogrel; Stroke (engine); Aspirin; Antithrombotic; Medical prescription; Guideline; Clinical trial; Emergency medicine; Randomized controlled trial; Ischemic stroke; Internal medicine; Intensive care medicine; Physical therapy; Cardiology; Ischemia","score_opus":0.04078810254022831,"score_gpt":0.31967535465784386,"score_spread":0.27888725211761556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092078602","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964816,0.00026648692,0.0000036092426,0.00023794016,0.00014534296,0.0026916016,0.00012590396,0.000008326042,0.000039210117],"genre_scores_gemma":[0.9978695,0.00035485925,0.00044723542,0.00009009805,0.00009085108,0.0010880635,0.000012229662,0.00002823163,0.000018934903],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99737394,0.00034786243,0.0010774176,0.00035782438,0.0005244175,0.00031853953],"domain_scores_gemma":[0.99868864,0.00009865615,0.00037741064,0.000681288,0.000093864306,0.00006013862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015124928,0.0002007857,0.0006134451,0.00012340101,0.000025286954,0.000008555328,0.00020047625,0.00012259482,0.000020683847],"category_scores_gemma":[0.00014060893,0.00011036233,0.00021384186,0.0003295273,0.00020753614,0.00008988419,0.000089078836,0.0005066662,7.601676e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026385566,0.00094461144,0.94208664,0.00005638538,0.00016722795,0.000054974702,0.00092750246,0.000032304622,0.000023801464,0.000005948706,0.000009051636,0.029305989],"study_design_scores_gemma":[0.060247134,0.0011814208,0.93649113,0.00076127006,0.0003355318,7.2853976e-7,0.0004967138,0.000043510772,0.00025939854,0.0000028212428,0.000061526116,0.00011879471],"about_ca_topic_score_codex":0.0014860665,"about_ca_topic_score_gemma":0.0029746399,"teacher_disagreement_score":0.033861566,"about_ca_system_score_codex":0.00003072275,"about_ca_system_score_gemma":0.000050230236,"threshold_uncertainty_score":0.4500445},"labels":[],"label_agreement":null},{"id":"W2093561137","doi":"10.1080/09537100801989857","title":"Effects of aspirin and clopidogrel in healthy men measured by platelet aggregation and PFA-100","year":2008,"lang":"en","type":"article","venue":"Platelets","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of British Columbia","funders":"","keywords":"Clopidogrel; Aspirin; Platelet; Arachidonic acid; Medicine; Platelet aggregation; Epinephrine; Antiplatelet drug; Internal medicine; Pharmacology; Chemistry; Biochemistry","score_opus":0.010672312199521592,"score_gpt":0.235054379695817,"score_spread":0.2243820674962954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093561137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96885556,0.030013645,0.00004513924,0.00018119682,0.000041910847,0.000549782,0.000007848201,0.000036572,0.0002683464],"genre_scores_gemma":[0.98860675,0.010869781,0.00010361493,0.00025064638,0.000041598665,0.00002058375,0.000034002333,0.000022678209,0.000050319144],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9987893,0.00009403142,0.00028015618,0.000293759,0.00029943325,0.00024331691],"domain_scores_gemma":[0.99942714,0.00010997019,0.00008458396,0.00016266547,0.000043115168,0.00017253101],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022044282,0.00017720778,0.00051835296,0.00012838864,0.00006862534,0.000006220541,0.000041344843,0.00014217748,0.000009756614],"category_scores_gemma":[0.00006350538,0.00016161546,0.000082095044,0.00017458154,0.00014260247,0.000098777986,0.000023547027,0.00015666719,0.0000041938474],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012313372,0.0015961505,0.21219958,0.004913189,0.001829404,0.004547356,0.004434784,0.000026240967,0.061001837,0.00020648021,0.004890264,0.69204134],"study_design_scores_gemma":[0.04424087,0.003162129,0.6550766,0.0014429394,0.00039359427,0.0036707087,0.00019434182,0.0006598119,0.2711623,0.0003252171,0.018695293,0.0009761778],"about_ca_topic_score_codex":0.000102892955,"about_ca_topic_score_gemma":0.0000054228376,"teacher_disagreement_score":0.69106513,"about_ca_system_score_codex":0.000029302244,"about_ca_system_score_gemma":0.000057653855,"threshold_uncertainty_score":0.65904874},"labels":[],"label_agreement":null},{"id":"W2093842971","doi":"10.14740/cr322w","title":"Incidence of Gastrointestinal Bleeding After Percutaneous Coronary Intervention: A Single Center Experience","year":2014,"lang":"en","type":"article","venue":"Cardiology Research","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Percutaneous coronary intervention; Myocardial infarction; Internal medicine; Incidence (geometry); Gastrointestinal bleeding; Killip class; Cardiology; Univariate analysis; Single Center; GI bleeding; Surgery; Multivariate analysis; Endoscopy","score_opus":0.044252314427967725,"score_gpt":0.3439352758517181,"score_spread":0.2996829614237504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093842971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992829,0.0015885642,0.0024121746,0.00007936208,0.00008482194,0.00021647441,0.0000051979655,0.00003060147,0.0027538028],"genre_scores_gemma":[0.9988982,0.000073093775,0.0003991599,0.000059890506,0.0002642376,0.00004438355,0.000011431284,0.000016849599,0.00023273799],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980584,0.000489806,0.00024490515,0.00033863875,0.00044557443,0.0004227123],"domain_scores_gemma":[0.9988049,0.00019156399,0.00003434929,0.00041370364,0.0003989782,0.00015645755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095906184,0.00011747683,0.00048096423,0.00014458127,0.00007949303,0.000011242781,0.00017026324,0.0000734963,0.00023750396],"category_scores_gemma":[0.00045485134,0.00010174662,0.000408427,0.0001776113,0.000796789,0.00006570613,0.00015975162,0.0003304588,0.000047672125],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026961402,0.00019092926,0.93142503,0.00021667963,0.00026701373,0.0035819637,0.00043242905,0.000018680154,0.04559322,0.00007800371,0.00031293213,0.015186962],"study_design_scores_gemma":[0.005143982,0.0086746765,0.722142,0.0027819462,0.0002520817,0.23784001,0.0047630877,0.0004901496,0.0062780282,0.00044172088,0.010653301,0.00053901365],"about_ca_topic_score_codex":0.000008808534,"about_ca_topic_score_gemma":0.0000010987496,"teacher_disagreement_score":0.23425804,"about_ca_system_score_codex":0.000062456595,"about_ca_system_score_gemma":0.000046261186,"threshold_uncertainty_score":0.41491067},"labels":[],"label_agreement":null},{"id":"W2093910554","doi":"10.1016/j.ijcard.2009.01.037","title":"Platelet count, not oxidative stress, may contribute to inadequate platelet inhibition by aspirin","year":2009,"lang":"en","type":"article","venue":"International Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital du Sacré-Cœur de Montréal","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada","keywords":"Aspirin; Medicine; Platelet; Urinary system; Internal medicine; Oxidative stress; Platelet activation; Gastroenterology","score_opus":0.012565261242398986,"score_gpt":0.2852774398207712,"score_spread":0.2727121785783722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093910554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9750883,0.0012459818,0.013027486,0.008194888,0.0006736683,0.0002339922,0.00035409993,0.000019619096,0.0011619567],"genre_scores_gemma":[0.9933177,0.0009128332,0.00015207811,0.003914894,0.0013088686,0.0000042059355,0.00025569322,0.0000149332645,0.000118760116],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99807334,0.00015492296,0.00057794893,0.00021377139,0.00071533,0.00026470475],"domain_scores_gemma":[0.9983331,0.00008802154,0.00029151383,0.00015674032,0.0008971322,0.00023346614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000515235,0.00020058875,0.00070636306,0.00024296521,0.000042979485,0.000035633617,0.00021432182,0.00016062683,0.00008755164],"category_scores_gemma":[0.00017956548,0.00017041073,0.00052752707,0.000106232095,0.00007611889,0.00019422662,0.000031280302,0.0003454083,0.000057791603],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033336174,0.0007018794,0.014022856,0.00004752858,0.018871576,0.026783278,0.0005792992,0.0070924163,0.18290749,0.004089392,0.1493897,0.56217843],"study_design_scores_gemma":[0.016875695,0.0038885134,0.039599307,0.00048827496,0.00043616013,0.012860676,0.00022974254,0.000040921826,0.26677328,0.0012687133,0.6569857,0.0005529946],"about_ca_topic_score_codex":0.0000056922827,"about_ca_topic_score_gemma":8.1740444e-7,"teacher_disagreement_score":0.5616254,"about_ca_system_score_codex":0.00018952129,"about_ca_system_score_gemma":0.00013222396,"threshold_uncertainty_score":0.6949148},"labels":[],"label_agreement":null},{"id":"W2094630703","doi":"10.3821/1913-701x-142.4.200","title":"Does an Aspirin a Day Keep the Doctor Away?","year":2009,"lang":"en","type":"article","venue":"Canadian Pharmacists Journal / Revue des Pharmaciens du Canada","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Aspirin; Medicine; Internal medicine","score_opus":0.0200248429371385,"score_gpt":0.2672063727138738,"score_spread":0.24718152977673533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094630703","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911424,0.0029714596,0.000112192065,0.001044138,0.0020496524,0.0005494297,0.00024236659,0.000057189784,0.0018312006],"genre_scores_gemma":[0.9764681,0.0046995096,0.000061054554,0.014830289,0.0025020314,0.00001044218,0.000050340168,0.00004880275,0.0013294198],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99709404,0.00029542457,0.0004910512,0.00042325776,0.0006430705,0.0010531453],"domain_scores_gemma":[0.9956036,0.000056216715,0.00015107349,0.0005173685,0.00040421984,0.0032675161],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008010976,0.00040485914,0.000489495,0.00023250692,0.0011214217,0.0002385571,0.00060488476,0.00007308794,0.0013791773],"category_scores_gemma":[0.0000932129,0.00024867334,0.0004448814,0.00050677033,0.0002198314,0.00039197388,0.00001679809,0.0007853998,0.000019912693],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005210994,0.00017862736,0.0027888084,0.00011901604,0.0011343069,0.18863882,0.0014270502,0.00047178782,0.0049363202,0.00015870565,0.018645318,0.78098017],"study_design_scores_gemma":[0.0042205513,0.00022170549,0.00085554534,0.000050678573,0.0008117362,0.50400066,0.000042495823,0.0010689026,0.0039056402,0.00024307401,0.48385268,0.0007263168],"about_ca_topic_score_codex":0.00750522,"about_ca_topic_score_gemma":0.03244109,"teacher_disagreement_score":0.7802538,"about_ca_system_score_codex":0.0011984914,"about_ca_system_score_gemma":0.0039025615,"threshold_uncertainty_score":0.99999654},"labels":[],"label_agreement":null},{"id":"W2094927424","doi":"10.1016/j.cjca.2012.07.743","title":"903 The Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes (TRILOGY ACS) Trial","year":2012,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Toronto Public Health","funders":"","keywords":"Medicine; Prasugrel; Clopidogrel; Myocardial infarction; Internal medicine; Unstable angina; Aspirin; Clinical endpoint; Cardiology; Revascularization; TIMI; Randomized controlled trial; Acute coronary syndrome; Percutaneous coronary intervention","score_opus":0.021030391284627515,"score_gpt":0.2632095992098653,"score_spread":0.24217920792523778,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094927424","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9799454,0.003822436,0.0030045833,0.009850559,0.0014901179,0.00082336366,0.00007087856,0.000011964764,0.0009806717],"genre_scores_gemma":[0.99113595,0.00022180754,0.000102736914,0.005062493,0.0032716247,0.000024407933,0.000035962938,0.000029471412,0.00011551593],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.997696,0.00056529196,0.0005007675,0.00017930294,0.00034421243,0.00071446376],"domain_scores_gemma":[0.9977235,0.00014812361,0.00013274963,0.00039171433,0.00019186924,0.0014120392],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014788561,0.00021912367,0.0007707387,0.0002645592,0.00024743043,0.000030357052,0.00031892676,0.00037222327,0.00016375791],"category_scores_gemma":[0.00022690374,0.00012843446,0.0005988363,0.00028916154,0.00027272463,0.000114415736,0.000033753186,0.0008754717,0.00007179433],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08024896,0.00010857847,0.015009821,0.00009041033,0.03340809,0.030215178,0.0041254736,0.014225638,0.0029088946,0.0041373656,0.5758432,0.23967838],"study_design_scores_gemma":[0.022784846,0.005619629,0.10443864,0.00009386441,0.0021352055,0.0371334,0.0011869969,0.000007044913,0.00033973213,0.00020314727,0.82563734,0.00042017162],"about_ca_topic_score_codex":0.00013678518,"about_ca_topic_score_gemma":0.00011608912,"teacher_disagreement_score":0.24979411,"about_ca_system_score_codex":0.00015023866,"about_ca_system_score_gemma":0.0009558104,"threshold_uncertainty_score":0.52374053},"labels":[],"label_agreement":null},{"id":"W2096451143","doi":"10.1161/circulationaha.110.958041","title":"Upstream Clopidogrel Use and the Efficacy and Safety of Early Eptifibatide Treatment in Patients With Acute Coronary Syndrome","year":2011,"lang":"en","type":"article","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Eptifibatide; Clopidogrel; Medicine; Acute coronary syndrome; Myocardial infarction; Internal medicine; Cardiology; Odds ratio; Anesthesia; Percutaneous coronary intervention","score_opus":0.015499976637070454,"score_gpt":0.21396290799152748,"score_spread":0.19846293135445703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096451143","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988953,0.0003010756,0.00006037683,0.000010104966,0.000011751198,0.00066074386,0.000009452388,0.000008365492,0.0000428449],"genre_scores_gemma":[0.9996479,0.00019772346,0.00006309064,0.000014764065,0.0000042894044,0.000010459283,0.000043355074,0.0000090399535,0.000009380759],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99951136,0.000054601343,0.00012912929,0.00012601123,0.00010786546,0.00007103381],"domain_scores_gemma":[0.9996703,0.00004497063,0.00005044591,0.0001635037,0.000033118704,0.000037637103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006265156,0.00008310904,0.00020302876,0.000037935715,0.00003265755,0.000005491345,0.000015398247,0.00003380077,0.000009375319],"category_scores_gemma":[0.000007995195,0.000048644248,0.00004666045,0.000061856525,0.00013030258,0.00009800586,0.000007184978,0.000030014007,8.4409646e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045788125,0.00015886643,0.9846709,0.000011970705,0.00046133698,0.00002544163,0.00092034676,0.000008215125,0.0000095584355,0.000090434056,2.7844658e-7,0.009063865],"study_design_scores_gemma":[0.013043431,0.00039926794,0.98587716,0.000067114604,0.00039395323,0.00004678221,0.000026809617,0.000023195807,0.0000220566,0.00004177262,0.000005670558,0.00005279326],"about_ca_topic_score_codex":0.0001020426,"about_ca_topic_score_gemma":0.0000038634616,"teacher_disagreement_score":0.009011072,"about_ca_system_score_codex":0.000020604019,"about_ca_system_score_gemma":0.000017903883,"threshold_uncertainty_score":0.1983655},"labels":[],"label_agreement":null},{"id":"W2096945996","doi":"10.1373/clinchem.2009.137471","title":"Long-Term Aspirin and Clopidogrel Response Evaluated by Light Transmission Aggregometry, VerifyNow, and Thrombelastography in Patients Undergoing Percutaneous Coronary Intervention","year":2010,"lang":"en","type":"article","venue":"Clinical Chemistry","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Canadian Blood Services; Vancouver General Hospital","funders":"Canadian Blood Services","keywords":"Aspirin; Medicine; Clopidogrel; Percutaneous coronary intervention; P2Y12; Thrombelastography; Platelet; Internal medicine; Myocardial infarction; Conventional PCI; Loading dose; Anesthesia; Cardiology","score_opus":0.010226461728387823,"score_gpt":0.3042059203592234,"score_spread":0.2939794586308356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096945996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99481565,0.004540113,0.000035012064,0.00015862357,0.0001028124,0.00023836695,0.000009953878,0.000044427874,0.00005506337],"genre_scores_gemma":[0.99753124,0.0019618038,0.00005188035,0.00009746827,0.0000560452,0.0000040221867,0.0001166737,0.000026021204,0.00015486842],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99844664,0.0001490874,0.00048513553,0.00046323857,0.0002529979,0.00020292311],"domain_scores_gemma":[0.9990291,0.00025557863,0.00009539668,0.00027821623,0.00005728062,0.00028445284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000658606,0.00019448472,0.00040848274,0.00004703885,0.000060267663,0.00002229258,0.00007408628,0.00037135376,0.00015362079],"category_scores_gemma":[0.00027754373,0.00017489996,0.00030063916,0.00014201213,0.00024388841,0.000060406703,0.000046272326,0.00057749305,0.0000030934918],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006271526,0.0008253608,0.85822684,0.00035830922,0.00020533372,0.0001712334,0.00004318659,1.2737547e-7,0.021640252,1.5715034e-7,0.00009531231,0.11216236],"study_design_scores_gemma":[0.008902459,0.0009001115,0.9836495,0.000831096,0.00025170186,0.00035077796,0.00003669934,0.000040350085,0.0038819893,0.000019861567,0.00089527725,0.00024018313],"about_ca_topic_score_codex":0.0000015741632,"about_ca_topic_score_gemma":0.0000019234242,"teacher_disagreement_score":0.12542266,"about_ca_system_score_codex":0.000017834638,"about_ca_system_score_gemma":0.00005059243,"threshold_uncertainty_score":0.7132214},"labels":[],"label_agreement":null},{"id":"W2097019666","doi":"10.1152/physiolgenomics.00090.2010","title":"Aspirin resistance with genetic dyslipidemia: contribution of vascular thromboxane generation","year":2010,"lang":"en","type":"article","venue":"Physiological Genomics","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Society for Exercise Physiology","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Medical College of Wisconsin; Centre International de Recherche sur le Cancer; American Heart Association","keywords":"Aspirin; Medicine; Thromboxane; Internal medicine; Thromboxane A2; Pharmacology; Platelet; Vascular disease; Endocrinology","score_opus":0.015630592272634615,"score_gpt":0.2404755243518645,"score_spread":0.2248449320792299,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097019666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99426603,0.001257925,0.0038361992,0.00006392079,0.00007863836,0.00032373169,0.000010151208,0.00003631912,0.00012706468],"genre_scores_gemma":[0.9951409,0.0004182516,0.003639165,0.00021481978,0.0004139091,0.00001827141,0.0001141579,0.000013375077,0.000027146038],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99908924,0.000058772348,0.00022307318,0.00026956171,0.00017443829,0.0001848871],"domain_scores_gemma":[0.9992681,0.000023358927,0.00009404769,0.00036905738,0.0001513728,0.000094041694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001592836,0.00013783854,0.0004167635,0.000022540717,0.000064529624,0.0000067971487,0.000079601414,0.00014597696,0.000075778655],"category_scores_gemma":[0.00005428947,0.000093644114,0.00022747973,0.00009823924,0.00018085788,0.000031659325,0.000021028509,0.00021301505,0.000013094156],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030041012,0.00014318051,0.0016511353,0.00003237799,0.00026657223,0.0000118331045,0.000018544868,0.0003062688,0.9945175,0.0010260956,0.00008948144,0.0016366036],"study_design_scores_gemma":[0.0049735587,0.0010633398,0.7870333,0.00006421085,0.0007421491,0.000038632978,0.000045925444,0.0009792502,0.18618062,0.0016498601,0.016750999,0.00047811976],"about_ca_topic_score_codex":0.0000029406417,"about_ca_topic_score_gemma":0.000008737942,"teacher_disagreement_score":0.80833685,"about_ca_system_score_codex":0.000023318851,"about_ca_system_score_gemma":0.00006078287,"threshold_uncertainty_score":0.3818696},"labels":[],"label_agreement":null},{"id":"W2098276516","doi":"10.1254/jphs.93.381","title":"Platelets and Anti-platelet Therapy","year":2003,"lang":"en","type":"review","venue":"Journal of Pharmacological Sciences","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Platelet; Medicine; Thrombus; Thrombin; Pharmacology; Fibrin; Platelet activation; Receptor; Thromboxane A2; Thrombosis; Thromboxane; Internal medicine; Immunology","score_opus":0.12525692734469338,"score_gpt":0.41752187989628536,"score_spread":0.292264952551592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098276516","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01342811,0.98504233,0.000010450424,0.00007789629,0.00038625288,0.00037676477,0.000006213616,0.000012884491,0.00065912335],"genre_scores_gemma":[0.00089088554,0.9979379,0.00022066562,0.00048058535,0.0003919008,0.000004726296,0.0000015372401,0.000013227377,0.000058571743],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976913,0.00036323676,0.0006958236,0.00028954883,0.0006393618,0.00032078437],"domain_scores_gemma":[0.9986839,0.00021359941,0.000584324,0.0000805318,0.00009801204,0.00033960512],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014674338,0.000321935,0.0020750747,0.00021391318,0.0001756428,0.00006822125,0.0002794634,0.00024028754,0.0007722442],"category_scores_gemma":[0.000053681204,0.00015983755,0.001125176,0.00046515604,0.00056585716,0.00013276299,0.000032970842,0.0005812855,0.000016680493],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051416617,0.00018182246,0.000033315322,0.00046460328,0.001147204,0.0013172729,0.0000073741194,0.0000012134241,0.000040026487,0.000022270628,0.0011691313,0.99556434],"study_design_scores_gemma":[0.0012107498,0.0007668385,0.000031043295,0.0012874423,0.0014851629,0.0085236905,0.0000149869775,0.0000011529861,0.0000567831,0.000044807064,0.9863848,0.00019251279],"about_ca_topic_score_codex":4.167607e-7,"about_ca_topic_score_gemma":1.558292e-8,"teacher_disagreement_score":0.9953718,"about_ca_system_score_codex":0.00003928658,"about_ca_system_score_gemma":0.0004355803,"threshold_uncertainty_score":0.8455532},"labels":[],"label_agreement":null},{"id":"W2098590339","doi":"10.25011/cim.v33i6.14588","title":"A survey evaluating surgeons’ peri-operative usage of acetyl-salicylic acid (ASA) and their willingness to enroll their patients in a perioperative ASA randomized controlled trial","year":2010,"lang":"en","type":"article","venue":"Clinical and investigative medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Institute of Nutrition, Metabolism and Diabetes; University of Toronto; McMaster University","funders":"Canadian Institutes of Health Research; Hamilton Health Sciences","keywords":"Medicine; Perioperative; Orthopedic surgery; Randomized controlled trial; Vascular surgery; Placebo; Surgery; Alternative medicine","score_opus":0.1053838450853346,"score_gpt":0.36965955589669447,"score_spread":0.26427571081135987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098590339","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98977375,0.0016039868,0.00007649592,0.0019339918,0.00053430407,0.0058110654,0.000048241316,0.000023949979,0.000194221],"genre_scores_gemma":[0.99654627,0.0007416054,0.00013450475,0.0016106016,0.00032628872,0.00042991363,0.000077122946,0.00003269809,0.0001009966],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9925863,0.0040800045,0.0018229232,0.0007131992,0.0004493154,0.00034823472],"domain_scores_gemma":[0.99370235,0.004063947,0.0004297506,0.00037647525,0.00076515257,0.00066230795],"candidate_categories":["metaresearch","metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.011414702,0.00050129194,0.0047562844,0.00016564627,0.00015537877,0.00002398885,0.00013493658,0.00025373767,0.00013072972],"category_scores_gemma":[0.0331466,0.00026155374,0.0005145992,0.0004146809,0.0079185,0.00015318286,0.00010401662,0.0007613053,0.0000020917657],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6889902,0.00068583,0.27645916,0.00007491732,0.0015990154,0.000010861395,0.013574105,0.0000026270181,0.007274274,0.00026852862,0.00004169811,0.011018823],"study_design_scores_gemma":[0.72457176,0.0041977903,0.26686805,0.00046044588,0.0003056558,0.0000048694515,0.0010916269,0.00083317753,0.0009354266,0.00041116742,0.00007422221,0.0002458077],"about_ca_topic_score_codex":0.00025260358,"about_ca_topic_score_gemma":0.00026515702,"teacher_disagreement_score":0.03558158,"about_ca_system_score_codex":0.000015218118,"about_ca_system_score_gemma":0.00033094332,"threshold_uncertainty_score":0.99998367},"labels":[],"label_agreement":null},{"id":"W2098925693","doi":"10.1016/j.ahj.2014.04.011","title":"Impact of smoking status on platelet function and clinical outcomes with prasugrel vs. clopidogrel in patients with acute coronary syndromes managed without revascularization: Insights from the TRILOGY ACS trial","year":2014,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Prasugrel; Medicine; Clopidogrel; Cardiology; Internal medicine; Revascularization; Clinical trial; Platelet; Myocardial infarction; Intensive care medicine","score_opus":0.015271233638290551,"score_gpt":0.29751542418150395,"score_spread":0.2822441905432134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098925693","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99834967,0.00021749896,0.00049683574,0.00014388996,0.00013063816,0.00061853835,0.000010807109,0.000016622962,0.000015478723],"genre_scores_gemma":[0.99828374,0.0005997204,0.00022687156,0.0006344912,0.00016410637,0.0000068781624,0.000044238936,0.00003349969,0.0000064480023],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976481,0.0007099826,0.0005021406,0.00028961635,0.000589269,0.00026087463],"domain_scores_gemma":[0.9985722,0.00038811535,0.0003692343,0.0003469797,0.000121072735,0.00020240733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039976917,0.00023407246,0.0009939794,0.00012656368,0.00014009526,0.00003283813,0.00007529643,0.00007426088,0.00001983833],"category_scores_gemma":[0.00011190586,0.00011845179,0.00033610757,0.0002678182,0.00039002925,0.00013655737,0.000021678623,0.0005314615,0.0000015576231],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08826975,0.00035966377,0.892023,0.0000046570053,0.004081217,0.000049710223,0.00008355901,0.000053923846,0.0000018028976,0.0000061363157,0.000044864817,0.015021694],"study_design_scores_gemma":[0.055606592,0.017988646,0.9246889,0.00017030502,0.00093061087,0.00014191252,0.0000863649,0.000023098604,0.0000015165664,0.000027169608,0.00019193809,0.00014298852],"about_ca_topic_score_codex":0.00017832764,"about_ca_topic_score_gemma":0.000019825518,"teacher_disagreement_score":0.032665838,"about_ca_system_score_codex":0.000062829415,"about_ca_system_score_gemma":0.00018699438,"threshold_uncertainty_score":0.48303238},"labels":[],"label_agreement":null},{"id":"W2099380661","doi":"10.1161/atvbaha.108.176388","title":"G-Protein–Coupled Receptors as Signaling Targets for Antiplatelet Therapy","year":2008,"lang":"en","type":"review","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":129,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Heart Research Centre; McMaster University Medical Centre; St. Michael's Hospital","funders":"School of Medicine, Duke University; Institut National de la Santé et de la Recherche Médicale; Regado Biosciences; Duke Clinical Research Institute; Daiichi-Sankyo; Medicines Company; Eisai; Thomas Jefferson University; Cleveland Clinic Foundation; Cleveland Clinic; McMaster University; Momenta Pharmaceuticals; Daiichi Sankyo Europe; Sanofi; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"G protein-coupled receptor; Protease-activated receptor; Receptor; Thrombin; Cell biology; Signal transduction; Phospholipase C; Platelet; Platelet activation; Thromboxane; Chemistry; Pharmacology; Biology; Biochemistry; Immunology","score_opus":0.07514346557610437,"score_gpt":0.3376267490991301,"score_spread":0.26248328352302575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099380661","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03867438,0.95705104,0.00039715687,0.000052976095,0.00035117584,0.0032198853,0.00007627565,0.00014709568,0.000029996045],"genre_scores_gemma":[0.0028759055,0.9935822,0.0006650998,0.00036283696,0.0005211452,0.00080235774,0.0009804256,0.0001924798,0.000017559014],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965213,0.0003891901,0.0008827825,0.001211024,0.00024602504,0.00074965705],"domain_scores_gemma":[0.99818456,0.00015935213,0.0003654366,0.00082237093,0.00014570766,0.00032258072],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00041778668,0.0009612212,0.004180483,0.00026400763,0.00045125338,0.00005876706,0.00025609066,0.000985045,0.00024528633],"category_scores_gemma":[0.00006407574,0.00071722467,0.003693575,0.0002872783,0.00038415877,0.00008968783,0.00008889395,0.00036434064,0.00006627725],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009356275,0.0007838861,0.00044864087,0.0076627303,0.024603024,0.0000050877316,0.0002704081,4.8790787e-7,0.00692451,0.00034881601,0.00081189646,0.958047],"study_design_scores_gemma":[0.0031033396,0.001199764,0.000816851,0.004407243,0.001798259,0.00003793078,0.000030300876,0.000007138764,0.00006386455,0.000040681814,0.9876587,0.00083593087],"about_ca_topic_score_codex":0.000031460648,"about_ca_topic_score_gemma":0.0000010774622,"teacher_disagreement_score":0.9868468,"about_ca_system_score_codex":0.0000599911,"about_ca_system_score_gemma":0.00023396504,"threshold_uncertainty_score":0.9995279},"labels":[],"label_agreement":null},{"id":"W2099409915","doi":"10.1161/circulationaha.106.612812","title":"Adverse Impact of Bleeding on Prognosis in Patients With Acute Coronary Syndromes","year":2006,"lang":"en","type":"article","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1341,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Hazard ratio; Internal medicine; Acute coronary syndrome; Unstable angina; Stroke (engine); Incidence (geometry); Clopidogrel; Proportional hazards model; Antithrombotic; Diabetes mellitus; Cardiology; Angina; Aspirin; Myocardial infarction; Confidence interval","score_opus":0.008928021555640786,"score_gpt":0.23913860664203904,"score_spread":0.23021058508639825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099409915","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991979,0.00007497403,0.00004430946,0.000006199528,0.000015393583,0.0003508714,0.000007298756,0.000019500552,0.00028356252],"genre_scores_gemma":[0.9997607,0.000006491328,0.00003003248,0.000007828023,0.000017738588,0.000007993586,0.00015219628,0.000011454267,0.0000055816467],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99943537,0.000016407832,0.00012407685,0.00011717157,0.00021233028,0.00009463903],"domain_scores_gemma":[0.9997613,0.000009305341,0.000053469776,0.000097095886,0.00005190626,0.000026958265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000045348053,0.00007810327,0.00017162944,0.00009929452,0.000018261804,0.0000023611135,0.000018335259,0.00003929018,0.00003137207],"category_scores_gemma":[0.0000038312846,0.00005918003,0.00014448387,0.00015833457,0.000022627572,0.00008385017,0.0000033970655,0.000041352203,0.000004008794],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006319711,0.0002835861,0.99392,0.000021867403,0.00029488446,0.000037141846,0.000025070774,0.0024228275,0.00019093964,0.000022508983,0.000010026251,0.0021391225],"study_design_scores_gemma":[0.0028389802,0.00033521224,0.9960775,0.00014635117,0.00017599996,0.000015231413,0.000009976435,0.0001627728,0.00014821674,0.000023358802,0.0000022539232,0.00006419676],"about_ca_topic_score_codex":0.0000319768,"about_ca_topic_score_gemma":8.107105e-7,"teacher_disagreement_score":0.0022600547,"about_ca_system_score_codex":0.00007788087,"about_ca_system_score_gemma":0.000033745153,"threshold_uncertainty_score":0.24132916},"labels":[],"label_agreement":null},{"id":"W2099543072","doi":"10.1177/2042098612451267","title":"Acetylsalicylic acid for primary prevention of cardiovascular diseases in older patients with diabetes: do the benefits overcome the risks?","year":2012,"lang":"en","type":"review","venue":"Therapeutic Advances in Drug Safety","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec; Université du Québec à Rimouski","funders":"","keywords":"Medicine; Diabetes mellitus; Primary prevention; Intensive care medicine; Secondary prevention; Disease; Internal medicine; Endocrinology","score_opus":0.024539556583118998,"score_gpt":0.305003854526432,"score_spread":0.28046429794331296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099543072","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0031899798,0.98989105,0.00031492664,0.000026083508,0.00019104201,0.005989154,0.00027437223,0.000030256331,0.00009310367],"genre_scores_gemma":[0.032155395,0.96583533,0.0000518537,0.0001143527,0.00020864866,0.0010873285,0.00040196086,0.0001158714,0.000029249402],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99628866,0.0008371925,0.0009128692,0.0005590142,0.0008033647,0.00059891545],"domain_scores_gemma":[0.997245,0.00059965043,0.00049019326,0.0014535427,0.000116731026,0.00009485711],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011906977,0.0006361488,0.0027552713,0.00016752849,0.00013377446,0.000017954433,0.00053169724,0.00019057728,0.000027256148],"category_scores_gemma":[0.000033894157,0.00031589082,0.0022654675,0.0006705211,0.00034144873,0.00032119866,0.00009791468,0.0004533887,0.000003665366],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041000303,0.00054319185,0.0044782683,0.009212321,0.0031474065,0.0000013068351,0.00015428741,0.00022880589,3.6417177e-8,0.00011977115,0.0000017653872,0.98170286],"study_design_scores_gemma":[0.004701894,0.00016433069,0.04851957,0.013210843,0.012269943,0.000005041846,0.00011397415,0.0000026190983,0.0000021894753,0.0002227632,0.9202852,0.00050163217],"about_ca_topic_score_codex":0.0000063703374,"about_ca_topic_score_gemma":0.0000086258915,"teacher_disagreement_score":0.98120123,"about_ca_system_score_codex":0.00022992196,"about_ca_system_score_gemma":0.00023468226,"threshold_uncertainty_score":0.9999293},"labels":[],"label_agreement":null},{"id":"W2099647468","doi":"10.1067/mhj.2001.111262","title":"Active-control trials: How would a new agent compare with placebo? A method illustrated with clopidogrel, aspirin, and placebo","year":2001,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Placebo; Medicine; Aspirin; Clopidogrel; Odds ratio; Stroke (engine); Internal medicine; Confidence interval; Randomized controlled trial; Myocardial infarction; Anesthesia; Cardiology; Pathology","score_opus":0.049109415277313336,"score_gpt":0.3348498403598773,"score_spread":0.285740425082564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099647468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9333095,0.0029275727,0.05456038,0.0075477273,0.00007084898,0.0010988148,0.000019143698,0.00009401791,0.00037197745],"genre_scores_gemma":[0.9845744,0.001059137,0.010664984,0.0025266916,0.0007407287,0.000026461572,0.000009438543,0.000061222956,0.00033698665],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973034,0.00088372966,0.00034621655,0.00036674095,0.0006005584,0.00049931643],"domain_scores_gemma":[0.9980491,0.00030140925,0.0003308803,0.00028500616,0.00018460343,0.00084903755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010407828,0.00035129645,0.0014925749,0.00016834732,0.00023084568,0.00013488642,0.00008719385,0.00007770246,0.00020792852],"category_scores_gemma":[0.00011565027,0.00021870057,0.0003596521,0.00044907245,0.00032398742,0.00018294445,0.000013232623,0.00086756406,0.0000148232775],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15661651,0.0005180582,0.20332323,0.0000711617,0.012396945,0.004728949,0.0011494728,0.00078292785,0.0023972446,0.000016281545,0.012133389,0.60586584],"study_design_scores_gemma":[0.11110302,0.015513958,0.2008612,0.0013147341,0.006928859,0.11399137,0.015078203,0.0011676202,0.0013765094,0.000042763342,0.5310658,0.0015559512],"about_ca_topic_score_codex":0.00011735865,"about_ca_topic_score_gemma":0.00003028493,"teacher_disagreement_score":0.6043099,"about_ca_system_score_codex":0.000076205964,"about_ca_system_score_gemma":0.0005640139,"threshold_uncertainty_score":0.89183503},"labels":[],"label_agreement":null},{"id":"W2099717909","doi":"10.1345/aph.1q692","title":"Use of Aspirin and Clopidogrel After Coronary Artery Bypass Graft Surgery","year":2012,"lang":"en","type":"review","venue":"Annals of Pharmacotherapy","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; University Health Network; Western University","funders":"","keywords":"Medicine; Observational study; Clopidogrel; Aspirin; Acute coronary syndrome; Randomized controlled trial; Internal medicine; Subgroup analysis; Coronary artery bypass surgery; Cardiology; Clinical trial; Surgery; Meta-analysis; Artery; Myocardial infarction","score_opus":0.26156245635913833,"score_gpt":0.40676857646073356,"score_spread":0.14520612010159523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099717909","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015565359,0.98310167,0.0000126998275,0.00005612278,0.00021663036,0.0007545581,0.00023650506,0.000033323915,0.000023160066],"genre_scores_gemma":[0.0055647227,0.9924363,0.000045849712,0.0010190061,0.00040653592,0.0000872076,0.00013217841,0.00011388958,0.00019431149],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997598,0.0003404726,0.0008862378,0.00036307517,0.00041153995,0.00040066696],"domain_scores_gemma":[0.998233,0.0003476656,0.00047605584,0.00050431123,0.00015457981,0.00028435106],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005103956,0.00051032624,0.002874839,0.0003363864,0.000026086847,0.000012658385,0.0001079375,0.00027101388,0.0005349996],"category_scores_gemma":[0.000010502582,0.00040031207,0.002314328,0.00023877062,0.0002479816,0.00021641742,0.000034006738,0.00026428682,0.000015441152],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006775599,0.00038685757,0.0018171615,0.014959623,0.0068268054,0.00015709003,0.000041154784,8.967118e-8,0.00012422967,0.0000052743135,0.0023552882,0.97264886],"study_design_scores_gemma":[0.00058298017,0.000113329166,0.0013935908,0.006528029,0.0030909006,0.00033202805,0.000003053286,5.936518e-7,0.0006646436,0.000007077086,0.9869326,0.0003511755],"about_ca_topic_score_codex":0.000011513875,"about_ca_topic_score_gemma":4.6383948e-7,"teacher_disagreement_score":0.9845773,"about_ca_system_score_codex":0.000009102122,"about_ca_system_score_gemma":0.00019027703,"threshold_uncertainty_score":0.99984485},"labels":[],"label_agreement":null},{"id":"W2099852184","doi":"10.1161/strokeaha.112.656173","title":"Effect of Addition of Clopidogrel to Aspirin on Mortality","year":2012,"lang":"en","type":"review","venue":"Stroke","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of British Columbia","funders":"National Institute of Neurological Disorders and Stroke","keywords":"Medicine; Clopidogrel; Aspirin; Stroke (engine); Cardiology; Internal medicine","score_opus":0.044818004776451856,"score_gpt":0.3715435029480006,"score_spread":0.3267254981715487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099852184","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0071277497,0.98870134,0.0000197058,0.0000017588105,0.00018956157,0.0010343809,0.00066540996,0.000019830364,0.0022402823],"genre_scores_gemma":[0.006999799,0.99184763,0.00001710969,0.000018989005,0.00036583713,0.00007586315,0.00044354988,0.000033686654,0.00019751322],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99861073,0.00025991528,0.00038147264,0.00020046129,0.00037914075,0.00016830233],"domain_scores_gemma":[0.9989555,0.00011563925,0.00019958388,0.00055242697,0.000041349318,0.00013548523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044755585,0.0002473486,0.0019149961,0.00013268559,0.000013145256,0.0000018276082,0.000088955356,0.00018574252,0.00024379898],"category_scores_gemma":[0.000048041424,0.0001711085,0.0017143043,0.00013523425,0.000047574664,0.00001848414,0.000023717688,0.00016672308,0.000079815785],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013112716,0.00008376211,0.0001606333,0.028582972,0.0017203011,0.00000906069,0.0000057102993,2.510006e-7,0.000004309655,0.00003637692,0.00016770714,0.9690978],"study_design_scores_gemma":[0.0006081802,0.0015739903,0.0005666607,0.013759713,0.00947841,0.000014935726,0.0000022427453,7.1638e-8,0.00050475565,0.000001024468,0.9733437,0.00014634564],"about_ca_topic_score_codex":0.000010144363,"about_ca_topic_score_gemma":5.931519e-7,"teacher_disagreement_score":0.97317594,"about_ca_system_score_codex":0.00003430093,"about_ca_system_score_gemma":0.00007225971,"threshold_uncertainty_score":0.6977602},"labels":[],"label_agreement":null},{"id":"W2099914119","doi":"10.2217/pgs.12.84","title":"Overcoming Obstacles in Pharmacogenomic Strategies for Antiplatelet Drugs: Are we Rapid Enough?","year":2012,"lang":"en","type":"editorial","venue":"Pharmacogenomics","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Abbott Vascular; Sanofi","keywords":"MEDLINE; Medicine; Pharmacogenomics; Clopidogrel; Library science; Internal medicine; Aspirin; Pharmacology; Computer science; Political science","score_opus":0.030896290174477172,"score_gpt":0.32085314992630515,"score_spread":0.289956859751828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099914119","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11690502,0.21476157,0.00039901998,0.00031438266,0.6578744,0.0041238214,0.004454848,0.00035250915,0.00081442425],"genre_scores_gemma":[0.13089229,0.13793966,0.0005537715,0.00041894108,0.72606665,0.00041940896,0.0027809641,0.0005333848,0.00039490536],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954438,0.00020877057,0.001084514,0.0010726638,0.0008088922,0.0013813113],"domain_scores_gemma":[0.99710774,0.0008145536,0.0006138114,0.0006782384,0.00028110668,0.00050451636],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001063547,0.001091831,0.002060267,0.0005075751,0.00023038387,0.00017100522,0.0005616403,0.0009501005,0.00035576048],"category_scores_gemma":[0.00008654396,0.0011367352,0.0015148411,0.00027738477,0.00017617509,0.0004674965,0.00015492167,0.0013868642,0.000087965534],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0070304405,0.00088236894,0.0002684712,0.0038151562,0.0049767,0.00042012628,0.001687945,0.00024187825,0.018912852,0.000042457857,0.91367483,0.048046764],"study_design_scores_gemma":[0.013202176,0.00010611673,0.000022034063,0.0005472748,0.0026324994,0.000042350555,0.0011493714,0.00021335832,0.0056028324,0.00011834264,0.9752366,0.0011270541],"about_ca_topic_score_codex":0.000039835693,"about_ca_topic_score_gemma":0.000005422032,"teacher_disagreement_score":0.076821916,"about_ca_system_score_codex":0.000633784,"about_ca_system_score_gemma":0.0012994874,"threshold_uncertainty_score":0.99910825},"labels":[],"label_agreement":null},{"id":"W2100209149","doi":"10.1056/nejmoa060989","title":"Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events","year":2006,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2827,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Aspirin; Clopidogrel; Cardiology; Platelet aggregation inhibitor; Internal medicine","score_opus":0.027272164513522514,"score_gpt":0.296974711625172,"score_spread":0.26970254711164954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100209149","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9628264,0.024607506,0.00875896,0.0026928573,0.00052498275,0.00037769612,0.0000023542386,0.0000066762905,0.00020259863],"genre_scores_gemma":[0.9945536,0.0016982895,0.0004455831,0.00009212817,0.002827974,0.0000024011488,0.0000070362407,0.000015099562,0.0003578796],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9988986,0.00006430199,0.00043015328,0.000091404334,0.00038746922,0.00012806339],"domain_scores_gemma":[0.9990525,0.00027106347,0.0002759866,0.00014987795,0.00014585766,0.000104662264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085120933,0.000113667695,0.00048729955,0.00007958739,0.000046085253,0.0000030243777,0.00007554924,0.000050473205,0.000051802275],"category_scores_gemma":[0.000119402546,0.000062316256,0.00022596147,0.00009454116,0.0001127527,0.000050990853,0.0000098830515,0.00013128272,6.3743056e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017311867,0.00042585938,0.020692885,0.00047475123,0.0028953329,0.00009585942,0.00047457937,0.00024811714,0.008105157,0.0007730367,0.004419348,0.9440832],"study_design_scores_gemma":[0.50123686,0.018582253,0.3051802,0.0034714753,0.0078096115,0.0022665954,0.0006403036,0.00023154006,0.0034631877,0.0071839523,0.14961123,0.0003227885],"about_ca_topic_score_codex":0.000056034205,"about_ca_topic_score_gemma":0.000017576042,"teacher_disagreement_score":0.9437604,"about_ca_system_score_codex":0.000017830798,"about_ca_system_score_gemma":0.00009065935,"threshold_uncertainty_score":0.2541183},"labels":[],"label_agreement":null},{"id":"W2102338684","doi":"10.1007/s00228-015-1949-1","title":"The impact of switching P2Y12 receptor inhibitor therapy during index hospitalization: a systematic review","year":2015,"lang":"en","type":"review","venue":"European Journal of Clinical Pharmacology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Clopidogrel; P2Y12; Medicine; Odds ratio; Mace; Acute coronary syndrome; Internal medicine; Confidence interval; Cardiology; Myocardial infarction; Percutaneous coronary intervention","score_opus":0.09233038123619429,"score_gpt":0.47012471673754946,"score_spread":0.37779433550135516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102338684","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016236522,0.9946195,0.000047611902,0.00009493755,0.0017175993,0.0017246295,0.000008540518,0.000016653325,0.0001469127],"genre_scores_gemma":[0.0015245983,0.9945502,0.000014537181,0.00024471313,0.0034794784,0.000010580399,0.000008708636,0.00010414415,0.0000630016],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9846111,0.009125484,0.005100397,0.00025763284,0.0006215589,0.00028384355],"domain_scores_gemma":[0.9919495,0.0009043257,0.00540513,0.0004764807,0.0008032896,0.00046130456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012241381,0.00044769776,0.0064001516,0.00010491688,0.0000956498,0.000024186515,0.0006363615,0.0001420029,0.0001573366],"category_scores_gemma":[0.0015198251,0.00021441083,0.006317567,0.00034268442,0.00017912309,0.000096524316,0.00009427977,0.0014321584,0.000054480133],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012672333,0.0006629823,0.00011324973,0.48681188,0.023774954,0.0012650342,0.00007130763,0.0000064970245,0.000005893141,0.0000014724213,0.019725615,0.46629387],"study_design_scores_gemma":[0.006311263,0.0026037141,0.0002728844,0.53464717,0.014766836,0.002209382,0.000019628276,0.0000026860498,0.0000022130798,0.0000032321898,0.43882117,0.00033981187],"about_ca_topic_score_codex":5.1040917e-7,"about_ca_topic_score_gemma":1.5672626e-8,"teacher_disagreement_score":0.46595407,"about_ca_system_score_codex":0.00010642339,"about_ca_system_score_gemma":0.001026192,"threshold_uncertainty_score":0.87434196},"labels":[],"label_agreement":null},{"id":"W2102838512","doi":"10.1182/blood-2014-01-512723","title":"Role of phenotypic and genetic testing in managing clopidogrel therapy","year":2014,"lang":"en","type":"review","venue":"Blood","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; McMaster University; Population Health Research Institute","funders":"","keywords":"Prasugrel; Clopidogrel; Ticagrelor; P2Y12; Medicine; CYP2C19; Loading dose; Intensive care medicine; Internal medicine; Pharmacology; Aspirin","score_opus":0.024679709816329835,"score_gpt":0.27450379482731974,"score_spread":0.2498240850109899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102838512","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0116186375,0.98721206,0.00001083962,0.0000025196691,0.000019164896,0.000487072,0.0000030790075,0.000023641494,0.00062300643],"genre_scores_gemma":[0.0029127432,0.99627626,0.0005093824,0.000025673586,0.00017031227,0.00003047632,0.000012747529,0.000044881835,0.000017547802],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989451,0.00010960129,0.0003575787,0.00026653337,0.00014856328,0.00017263464],"domain_scores_gemma":[0.999358,0.00009462824,0.0001401149,0.0003183739,0.000025725643,0.000063145606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014964199,0.0002236111,0.0013795878,0.00014818137,0.000020919111,0.000007601632,0.000082578365,0.00013313933,0.000011038552],"category_scores_gemma":[0.00003628428,0.00017458634,0.00034905007,0.00021296334,0.00004882129,0.000013534266,0.000028720475,0.00016495219,0.0000051018105],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008354272,0.00012045899,0.0021641625,0.007307062,0.00053568126,0.000041673142,0.000021497151,3.5864e-7,0.000007960529,0.000012517672,0.000001230743,0.98977906],"study_design_scores_gemma":[0.007395084,0.0004791929,0.013465177,0.04506084,0.0068747927,0.0011466849,0.00004666397,0.000026520887,0.000033031632,0.00041170447,0.9243601,0.0007001851],"about_ca_topic_score_codex":0.000014938677,"about_ca_topic_score_gemma":8.8624535e-7,"teacher_disagreement_score":0.9890789,"about_ca_system_score_codex":0.0000071389272,"about_ca_system_score_gemma":0.00008179569,"threshold_uncertainty_score":0.71194243},"labels":[],"label_agreement":null},{"id":"W2102860654","doi":"10.1016/j.ahj.2010.07.035","title":"Randomized trial of aspirin and clopidogrel versus aspirin alone for the prevention of coronary artery bypass graft occlusion: the Preoperative Aspirin and Postoperative Antiplatelets in Coronary Artery Bypass Grafting study","year":2010,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Population Health Research Institute; McMaster University","funders":"Johnson and Johnson; Sanofi","keywords":"Medicine; Clopidogrel; Aspirin; Placebo; Myocardial infarction; Cardiology; Stroke (engine); Randomized controlled trial; Artery; Surgery; Platelet aggregation inhibitor; Anesthesia; Internal medicine; Coronary artery bypass surgery","score_opus":0.023129869863531514,"score_gpt":0.31693097748149784,"score_spread":0.29380110761796635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102860654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99164826,0.0021664766,0.00021222695,0.0011754762,0.0004566005,0.0042834296,0.0000186768,0.000013178478,0.00002567016],"genre_scores_gemma":[0.9980046,0.00090161344,0.0003530405,0.00025400118,0.00028093264,0.0001293217,0.000013129609,0.00003259767,0.00003072057],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99667436,0.0011646397,0.00093868084,0.0003608992,0.0005259036,0.0003355245],"domain_scores_gemma":[0.9970981,0.0016560871,0.00047093778,0.00036670128,0.00025573306,0.00015247596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028500906,0.00031488025,0.0014310543,0.00015684846,0.00038992413,0.000051509065,0.00015620608,0.00008540667,0.00002667603],"category_scores_gemma":[0.00028397754,0.00018534598,0.00052432873,0.00026252793,0.0012031883,0.00021598749,0.0001069181,0.0007138587,7.937766e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8806028,0.0014250287,0.04721726,0.000051917494,0.0044736764,0.00029286538,0.004214955,0.00004574536,0.0072584026,0.000032150034,0.00008287018,0.054302365],"study_design_scores_gemma":[0.7674079,0.013071938,0.2025922,0.00025982806,0.0015692485,0.0036292325,0.009152571,0.0006313141,0.0010306479,0.00008568653,0.0002459806,0.0003234471],"about_ca_topic_score_codex":0.00008150193,"about_ca_topic_score_gemma":0.00011728282,"teacher_disagreement_score":0.15537493,"about_ca_system_score_codex":0.000026651258,"about_ca_system_score_gemma":0.00023850439,"threshold_uncertainty_score":0.755819},"labels":[],"label_agreement":null},{"id":"W2102951688","doi":"10.1001/jama.2012.50788","title":"Association of Clopidogrel Pretreatment With Mortality, Cardiovascular Events, and Major Bleeding Among Patients Undergoing Percutaneous Coronary Intervention","year":2012,"lang":"en","type":"review","venue":"JAMA","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":201,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Clopidogrel; Observational study; Percutaneous coronary intervention; Conventional PCI; Randomized controlled trial; Internal medicine; Jadad scale; Aspirin; Myocardial infarction; Cochrane Library","score_opus":0.019981246014615612,"score_gpt":0.26887674347683993,"score_spread":0.2488954974622243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102951688","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11782752,0.8804596,0.000051773826,0.000003548093,0.00014625172,0.0012630762,0.000060630064,0.00003580561,0.00015176355],"genre_scores_gemma":[0.10110446,0.89771545,0.00007133334,0.0000068895656,0.00019340357,0.00005754396,0.00053948164,0.000065908294,0.00024554113],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9976816,0.00031346793,0.00053001335,0.0003854318,0.0008031129,0.0002863417],"domain_scores_gemma":[0.9986733,0.00009979008,0.0005001944,0.0004156669,0.00016196701,0.00014908519],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005566203,0.00038626406,0.0018057533,0.00013164384,0.000072608935,0.000023373024,0.000078010366,0.0003656665,0.000041176914],"category_scores_gemma":[0.000058738242,0.00028913934,0.0018586772,0.00015739223,0.00004612814,0.00017695528,0.0000728219,0.00025003086,0.000006348465],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006887343,0.0002993742,0.22584578,0.01776365,0.029027782,0.00008510151,0.000063735875,0.0000013375383,5.5416066e-8,0.0000041835997,0.000020466983,0.72681963],"study_design_scores_gemma":[0.013594054,0.0020764035,0.44094247,0.08491101,0.2130939,0.0016248039,0.00023005002,0.000009138961,0.000005186099,0.000024978004,0.24222213,0.0012658681],"about_ca_topic_score_codex":0.00007513372,"about_ca_topic_score_gemma":0.000017289572,"teacher_disagreement_score":0.7255538,"about_ca_system_score_codex":0.0004679761,"about_ca_system_score_gemma":0.00008940198,"threshold_uncertainty_score":0.9999561},"labels":[],"label_agreement":null},{"id":"W2103043514","doi":"10.1093/eurheartj/ehr143","title":"Implications of variability in definition and reporting of major bleeding in randomized trials of oral P2Y12 inhibitors for acute coronary syndromes","year":2011,"lang":"en","type":"review","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton General Hospital; Population Health Research Institute; Université de Montréal; Montreal Heart Institute; University of Alberta Hospital; Alberta Hospital Edmonton; St. Michael's Hospital; McMaster University; Hamilton Health Sciences","funders":"Korea Electrotechnology Research Institute; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; P2Y12; Randomized controlled trial; Acute coronary syndrome; Intensive care medicine; Clopidogrel; Internal medicine; Major bleeding; Aspirin; Myocardial infarction","score_opus":0.2738449562290249,"score_gpt":0.42279581695213503,"score_spread":0.14895086072311015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103043514","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.054338805,0.9428314,0.00039751796,0.00002135523,0.000115432,0.0018857394,0.00006836941,0.000006466561,0.0003349107],"genre_scores_gemma":[0.071731485,0.9262634,0.0018111947,0.0000070728734,0.000077791825,0.000025472918,0.000041507017,0.00003652025,0.0000055663086],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9904808,0.0039499206,0.0050595133,0.00020347106,0.00015351374,0.00015277404],"domain_scores_gemma":[0.9934594,0.0015266284,0.0045466917,0.00022069433,0.00016373757,0.00008285442],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.04074828,0.00019364175,0.0058589126,0.00037822907,0.0000320733,0.000005756392,0.000069299946,0.00008984072,0.00004088815],"category_scores_gemma":[0.0075312676,0.00013892665,0.002106078,0.00020759438,0.00014239048,0.000071352486,0.000037055623,0.00029924908,3.6735807e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018516967,0.0007106613,0.02415592,0.02567952,0.0075164023,0.00025423465,0.00046558338,0.0000012281022,0.00034326548,0.0004654492,0.0001473557,0.9217434],"study_design_scores_gemma":[0.3867434,0.0022727938,0.1575419,0.24783066,0.079815164,0.044056486,0.00046608225,0.000015932072,0.0004775531,0.005485092,0.07362748,0.0016674498],"about_ca_topic_score_codex":0.000007099934,"about_ca_topic_score_gemma":4.772227e-7,"teacher_disagreement_score":0.92007595,"about_ca_system_score_codex":0.0000361091,"about_ca_system_score_gemma":0.000266275,"threshold_uncertainty_score":0.9877515},"labels":[],"label_agreement":null},{"id":"W2103481781","doi":"10.1503/cmaj.082001","title":"A population-based study of the drug interaction between proton pump inhibitors and clopidogrel","year":2009,"lang":"en","type":"article","venue":"Canadian Medical Association Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":765,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research; Ontario Ministry of Health and Long-Term Care; Institute for Clinical Evaluative Sciences; Heart and Stroke Foundation of Canada","keywords":"Clopidogrel; Medicine; Myocardial infarction; Pantoprazole; Percutaneous coronary intervention; Internal medicine; Odds ratio; Confidence interval; Population; Cardiology; Proton-pump inhibitor; Concomitant; Omeprazole","score_opus":0.006796539008106614,"score_gpt":0.24864833292814942,"score_spread":0.2418517939200428,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103481781","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99001575,0.000106055864,0.000009819031,0.009128696,0.0001925252,0.0004392751,0.0000039523975,0.000007680759,0.00009625654],"genre_scores_gemma":[0.99752,0.000014922203,0.00000575489,0.0017321075,0.0006734434,0.000004725066,0.000005998456,0.000005913485,0.000037076934],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998266,0.0002240736,0.0003181362,0.000095517156,0.0009381284,0.0001581656],"domain_scores_gemma":[0.99898046,0.00006403095,0.00019193479,0.00009351704,0.00016120677,0.00050883496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008134124,0.000077518605,0.00022363763,0.000110501416,0.00018239462,0.00002645287,0.00006649355,0.00011571579,0.00013434222],"category_scores_gemma":[0.0004848379,0.000054496457,0.00014276484,0.00018039231,0.000012352111,0.000066696324,0.0000040443038,0.00045090148,0.0000020187467],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020756715,0.00007137546,0.96288055,0.0000076793,0.00014419424,0.000024464342,0.00023173518,0.0000060528446,0.0000028741968,0.0000035678145,0.0006293732,0.035977356],"study_design_scores_gemma":[0.0019061405,0.00015800346,0.990654,0.00013376212,0.00014171381,0.000037549486,0.0006046481,0.000050468796,0.000051203006,0.000043947788,0.006161388,0.000057194848],"about_ca_topic_score_codex":0.0014853328,"about_ca_topic_score_gemma":0.0023258515,"teacher_disagreement_score":0.03592016,"about_ca_system_score_codex":0.0003149924,"about_ca_system_score_gemma":0.00068844826,"threshold_uncertainty_score":0.22453889},"labels":[],"label_agreement":null},{"id":"W2104790415","doi":"10.1161/01.str.0000209620.44017.97","title":"The Risks and Safety of Clopidogrel in Pediatric Arterial Ischemic Stroke","year":2006,"lang":"en","type":"article","venue":"Stroke","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Heart and Stroke Foundation of Canada","keywords":"Clopidogrel; Medicine; Aspirin; Tolerability; Stroke (engine); Anesthesia; Platelet aggregation inhibitor; Prospective cohort study; Adverse effect; Internal medicine","score_opus":0.009578575303783485,"score_gpt":0.24063952014526116,"score_spread":0.23106094484147768,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104790415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859986,0.008097002,0.00005629815,0.00009739897,0.00011220218,0.00018516893,0.00004400071,0.000014682929,0.0053946935],"genre_scores_gemma":[0.99531734,0.0035356798,0.00005504813,0.000020457102,0.00048087677,0.0000069254334,0.000012980123,0.000009633997,0.0005610597],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99926317,0.00003745899,0.00021706926,0.00013420853,0.00018049429,0.00016759928],"domain_scores_gemma":[0.9996332,0.00005344914,0.000053349595,0.00019416319,0.00002584802,0.000039991188],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017712543,0.00009014415,0.00021290983,0.000047118105,0.0000520326,0.000008768413,0.000051169256,0.00006052887,0.000019604182],"category_scores_gemma":[0.000018689534,0.000063080406,0.00014923574,0.00007655373,0.000087221066,0.00002908228,0.000020328005,0.000107429405,0.0000036875088],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028674332,0.0001823565,0.94432306,0.00012149356,0.00027210833,0.000056820998,0.00007982433,0.00002181896,0.012503146,0.00048169994,0.0024057734,0.036684472],"study_design_scores_gemma":[0.005074775,0.000111504065,0.9661043,0.000021727908,0.00026534376,0.000028287683,0.00012066731,0.000023206307,0.0032167141,0.000056487177,0.02486926,0.000107705055],"about_ca_topic_score_codex":0.000070455404,"about_ca_topic_score_gemma":0.000024807718,"teacher_disagreement_score":0.036576767,"about_ca_system_score_codex":0.000012202032,"about_ca_system_score_gemma":0.000044785495,"threshold_uncertainty_score":0.25723442},"labels":[],"label_agreement":null},{"id":"W2104806055","doi":"10.1161/jaha.113.000669","title":"Delay in Filling First Clopidogrel Prescription After Coronary Stenting Is Associated With an Increased Risk of Death and Myocardial Infarction","year":2014,"lang":"en","type":"article","venue":"Journal of the American Heart Association","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Providence Health Care; Victoria Heart Institute Foundation","funders":"","keywords":"Medicine; Hazard ratio; Interquartile range; Clopidogrel; Myocardial infarction; Internal medicine; Cardiology; Proportional hazards model; Confidence interval; Percutaneous coronary intervention; Stent","score_opus":0.006632793280766376,"score_gpt":0.22381615946137237,"score_spread":0.217183366180606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104806055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99923587,0.00021154022,0.00014402402,0.00017438938,0.000065383494,0.00013948204,0.000009156372,0.000006725956,0.00001342521],"genre_scores_gemma":[0.9989138,0.00030235018,0.00023256276,0.00037882075,0.00014334124,0.0000031178147,0.0000035149974,0.00001314019,0.000009315923],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99838215,0.0005997953,0.00032785177,0.00009961538,0.00045667432,0.0001338916],"domain_scores_gemma":[0.9986247,0.00018156155,0.0007806503,0.00011830044,0.00022950058,0.000065303415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014403561,0.000092263515,0.00047642895,0.00009612808,0.00007821096,0.000015851187,0.000040697047,0.000052938765,0.000004651747],"category_scores_gemma":[0.0005124137,0.00006449324,0.00025283737,0.0002088924,0.00004454232,0.00018796336,0.000013566103,0.00022517699,2.975924e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001121297,0.000093478695,0.99536026,0.000009218839,0.0006558058,0.0000031640302,0.00028759564,0.00023364821,0.00033855578,6.6706116e-7,0.000042945292,0.001853385],"study_design_scores_gemma":[0.0018155542,0.0007527587,0.9945116,0.00021924509,0.00065077766,0.00005290455,0.00015596156,0.0014388642,0.00011081332,0.000028184628,0.0001946226,0.00006871],"about_ca_topic_score_codex":0.0003344019,"about_ca_topic_score_gemma":0.000053612875,"teacher_disagreement_score":0.001784675,"about_ca_system_score_codex":0.00021017995,"about_ca_system_score_gemma":0.00005472268,"threshold_uncertainty_score":0.26299578},"labels":[],"label_agreement":null},{"id":"W2105046003","doi":"10.24908/pceea.v0i0.3871","title":"MODEL ASSISTED DESIGN AND SIMULATION OF A PHARMACEUTICAL BATCH PROCESS; MANUFACTURING OF CLOPIDOGREL BISULFATE","year":2011,"lang":"en","type":"article","venue":"Proceedings of the Canadian Engineering Education Association (CEEA)","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Process engineering; Solubility; Acetone; Clopidogrel; Fourier transform infrared spectroscopy; Simulation software; Chemical engineering; Materials science; Computer science; Engineering; Software; Chemistry; Organic chemistry; Aspirin","score_opus":0.032518154788249244,"score_gpt":0.26417743408002303,"score_spread":0.2316592792917738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105046003","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99763465,0.00022300362,0.00087062037,0.00019699277,0.00010422541,0.00040749137,0.00000893543,0.000023003708,0.00053110614],"genre_scores_gemma":[0.99759126,0.000038287242,0.0021233843,0.00005129746,0.000029796973,0.00001702228,0.0000033998087,0.00001940765,0.00012612113],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991943,0.0000074281875,0.00026313652,0.00012550243,0.00025916917,0.00015043179],"domain_scores_gemma":[0.99903506,0.000031656822,0.00026375937,0.00006877437,0.0004550563,0.00014568112],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003408148,0.00010349702,0.00022269358,0.0001876788,0.00004567796,0.000008270691,0.000083903455,0.00010758546,0.000014173112],"category_scores_gemma":[0.0002915075,0.00009514926,0.00010942484,0.00019722976,0.000026492666,0.00011736947,0.000009303521,0.00010847721,3.6755216e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090137555,0.0016107602,0.5135116,0.012481575,0.0051661646,0.0000015449621,0.021775,0.3113934,0.07921728,0.0044476967,0.0018847316,0.04760887],"study_design_scores_gemma":[0.0015141831,0.00008949756,0.4304091,0.00072182785,0.0009432985,0.000013564454,0.00045957972,0.3468141,0.21770068,0.00052435393,0.0004801441,0.0003296844],"about_ca_topic_score_codex":0.0003760948,"about_ca_topic_score_gemma":0.000032943204,"teacher_disagreement_score":0.13848339,"about_ca_system_score_codex":0.00024298507,"about_ca_system_score_gemma":0.00042016225,"threshold_uncertainty_score":0.38800743},"labels":[],"label_agreement":null},{"id":"W2105117811","doi":"10.4212/cjhp.v63i1.869","title":"Clopidogrel and Proton Pump Inhibitors: A New Drug Interaction?","year":2010,"lang":"en","type":"article","venue":"The Canadian Journal of Hospital Pharmacy","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Providence Health Care; Kelowna General Hospital; Eagle Ridge Hospital; St. Paul's Hospital","funders":"","keywords":"CYP2C19; Clopidogrel; Prodrug; CYP3A4; Pharmacology; Cytochrome P450; Isozyme; Chemistry; CYP2D6; CYP2B6; Drug; Drug interaction; Medicine; Enzyme; Biochemistry; Aspirin","score_opus":0.009730311454626205,"score_gpt":0.269886882424192,"score_spread":0.2601565709695658,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105117811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9831842,0.0023115596,0.0000067633905,0.012212772,0.0012315689,0.0003747366,0.000003229299,0.0000072848675,0.0006678458],"genre_scores_gemma":[0.99699306,0.00019068371,0.000045647645,0.0007130588,0.0017165028,0.0000036408326,0.0000014579148,0.00001754923,0.00031839605],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99927586,0.000034517798,0.00022006413,0.00008898547,0.00018998604,0.00019058133],"domain_scores_gemma":[0.99875504,0.000023469354,0.00012060719,0.00014467613,0.0001314816,0.0008247052],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029440972,0.00011248747,0.00019421101,0.000110151355,0.00016406628,0.00008183293,0.00012326357,0.000026295927,0.000308592],"category_scores_gemma":[0.00006828395,0.00007370474,0.00022535257,0.000097428354,0.00014170825,0.00023279618,0.000009706147,0.00061470486,0.000017850305],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017447551,0.00039873764,0.26408666,0.00026189216,0.0041965023,0.004378484,0.012377167,0.000020594242,0.0066544767,0.0007096411,0.17632665,0.5288444],"study_design_scores_gemma":[0.0051541496,0.0005176135,0.021914048,0.0002411337,0.00067315204,0.003976564,0.0006969484,0.000033920856,0.021635305,0.0010072772,0.94384766,0.00030222756],"about_ca_topic_score_codex":0.004557652,"about_ca_topic_score_gemma":0.0025336805,"teacher_disagreement_score":0.767521,"about_ca_system_score_codex":0.000039597995,"about_ca_system_score_gemma":0.0011164004,"threshold_uncertainty_score":0.6889837},"labels":[],"label_agreement":null},{"id":"W2105210342","doi":"10.1016/s0140-6736(15)60263-x","title":"Mortality in patients treated with extended duration dual antiplatelet therapy after drug-eluting stent implantation: a pairwise and Bayesian network meta-analysis of randomised trials","year":2015,"lang":"en","type":"review","venue":"The Lancet","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":394,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Sacré-Cœur de Montréal","funders":"","keywords":"Medicine; Meta-analysis; Drug-eluting stent; Internal medicine; Bayesian network; Randomized controlled trial; Stent; Pairwise comparison; Drug; Cardiology; Pharmacology; Statistics; Restenosis; Mathematics","score_opus":0.1336524775581952,"score_gpt":0.35838239160006446,"score_spread":0.22472991404186926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105210342","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08438383,0.9120445,0.000029841845,0.000031108026,0.000027978096,0.003095719,0.0003165721,0.000028030743,0.00004240398],"genre_scores_gemma":[0.08453025,0.91342205,0.000048309124,0.00009981295,0.0002639844,0.00038103943,0.001190473,0.0000380932,0.000026003061],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99435,0.002964145,0.0013769789,0.0004270297,0.0005745899,0.00030725874],"domain_scores_gemma":[0.99751085,0.00042564105,0.0010354638,0.0007676812,0.00015959903,0.00010078183],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00513689,0.00046494484,0.01010447,0.00019783711,0.00005609047,0.00003963152,0.00011901236,0.00015311064,0.00009462576],"category_scores_gemma":[0.00008011976,0.00021647172,0.0024805407,0.0008676282,0.00009779216,0.00007155804,0.000024500487,0.0002225702,0.0000010728262],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.036933724,0.00033860645,0.015918477,0.002410535,0.660246,0.00017395928,0.00044353362,0.00009365957,2.3743763e-7,0.000008073586,0.00026389616,0.28316927],"study_design_scores_gemma":[0.055057798,0.00030445828,0.0374009,0.0011593511,0.8845035,0.00003983984,0.0000509805,0.00006734441,0.0000030178433,0.00002232992,0.020887986,0.0005025006],"about_ca_topic_score_codex":0.000051242896,"about_ca_topic_score_gemma":0.000038206785,"teacher_disagreement_score":0.28266677,"about_ca_system_score_codex":0.000037274727,"about_ca_system_score_gemma":0.00013398207,"threshold_uncertainty_score":0.88274604},"labels":[],"label_agreement":null},{"id":"W2106496789","doi":"10.1186/s13643-015-0078-3","title":"Investigating the effectiveness of different aspirin dosing regimens and the timing of aspirin intake in primary and secondary prevention of cardiovascular disease: protocol for a systematic review","year":2015,"lang":"en","type":"review","venue":"Systematic Reviews","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"NIHR School for Primary Care Research; National Institute for Health and Care Research","keywords":"Medicine; Aspirin; Dosing; Intensive care medicine; Systematic review; Population; Data extraction; Medical prescription; Evening; MEDLINE; Internal medicine; Pharmacology; Environmental health","score_opus":0.07602158357894793,"score_gpt":0.3604116233740559,"score_spread":0.28439003979510796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106496789","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000018633771,0.617773,0.00022486813,0.000003294535,0.000015663436,0.38191777,0.00001101063,0.00000513453,0.000030623676],"genre_scores_gemma":[0.00004657211,0.6620387,0.000067409776,0.000012532092,0.000020568776,0.33773404,0.00003005459,0.000040391125,0.000009735121],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.97875655,0.015627662,0.004213279,0.00045532742,0.00074491906,0.00020225254],"domain_scores_gemma":[0.9920099,0.00232375,0.0036656247,0.0016464939,0.00023472948,0.00011951288],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.031905893,0.00060761225,0.015301511,0.00014154194,0.000056153465,0.00001937024,0.0002848861,0.00013766947,0.0000017410504],"category_scores_gemma":[0.0031950271,0.00025148032,0.003503692,0.00037138668,0.00035317685,0.000072692594,0.00013616956,0.00026755282,5.4713587e-7],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007044848,0.000063141764,0.000005417957,0.9696154,0.0037637074,0.0000024398896,0.000095878604,7.5212245e-7,7.151419e-7,0.00011951474,0.0000061936844,0.026256412],"study_design_scores_gemma":[0.0026500996,0.000122066056,0.000015556134,0.9596474,0.032685507,0.00012122038,0.000043745542,0.000023803275,0.000002068917,0.000117340955,0.0043770475,0.00019414243],"about_ca_topic_score_codex":0.000007400421,"about_ca_topic_score_gemma":5.3845116e-7,"teacher_disagreement_score":0.044265676,"about_ca_system_score_codex":0.00011752665,"about_ca_system_score_gemma":0.00039541305,"threshold_uncertainty_score":0.99999374},"labels":[],"label_agreement":null},{"id":"W2107190458","doi":"10.25011/cim.v34i4.15362","title":"The effect of the duration of clopidogrel use on hsCRP levels after stenting the target vessel in patients with acute coronary syndrome","year":2011,"lang":"en","type":"article","venue":"Clinical and investigative medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Clopidogrel; Medicine; Acute coronary syndrome; Internal medicine; Coronary stenting; Stent; Cardiology; Loading dose; Aspirin; Myocardial infarction; Restenosis","score_opus":0.06271590400649903,"score_gpt":0.2793786274318836,"score_spread":0.21666272342538456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107190458","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975638,0.00050973304,0.00001230324,0.0009987553,0.00014751645,0.0007054059,0.000011366665,0.000005430435,0.000045695986],"genre_scores_gemma":[0.99911124,0.000112779315,0.00003829803,0.0005900913,0.000037709866,0.000024235325,0.00000725727,0.0000110532,0.00006735546],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982506,0.0005616717,0.00052734034,0.000189124,0.00034062492,0.00013061179],"domain_scores_gemma":[0.9986796,0.00055898057,0.0002431851,0.0003331821,0.00010046513,0.000084635874],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0009675533,0.00014659631,0.00047802905,0.00002495832,0.00008366809,0.000003090205,0.00011048377,0.000064274864,0.000017827193],"category_scores_gemma":[0.00078735483,0.000048780515,0.0001363628,0.00017662709,0.005347071,0.00008108585,0.00004759253,0.00027906403,9.042185e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021592758,0.00008223457,0.9947027,0.00004862535,0.0004911812,0.000020606303,0.0004233135,5.755203e-7,0.000033269618,0.00014651941,0.00005660909,0.001835088],"study_design_scores_gemma":[0.004523462,0.0046209455,0.98820895,0.0008499344,0.00041226772,0.000010948978,0.000094931405,0.000013990984,0.0006398184,0.00048354166,0.00008430107,0.00005691304],"about_ca_topic_score_codex":0.000022775706,"about_ca_topic_score_gemma":0.000002613972,"teacher_disagreement_score":0.0064937565,"about_ca_system_score_codex":0.0000064832643,"about_ca_system_score_gemma":0.00003788997,"threshold_uncertainty_score":0.9973598},"labels":[],"label_agreement":null},{"id":"W2107367876","doi":"10.12927/hcq.2013.20875","title":"ICES Report: New Findings Highlight Potential Risks of Common Drug Combination in Cardiac Patients","year":2009,"lang":"en","type":"article","venue":"Healthcare Quarterly","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; University of Toronto; St. Michael's Hospital; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences","funders":"Canadian Institutes of Health Research; Ontario Ministry of Health and Long-Term Care","keywords":"Medicine; Intensive care medicine; Drug; Best practice; Risk analysis (engineering); Pharmacology; Political science","score_opus":0.01618634368382427,"score_gpt":0.30516969680992345,"score_spread":0.2889833531260992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107367876","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99271214,0.002396022,0.000042917585,0.0036812958,0.000341267,0.00056770555,0.000016213015,0.000051061932,0.00019136304],"genre_scores_gemma":[0.9989102,0.0001760625,0.00005054694,0.00031667805,0.00013081437,0.0000063549996,0.00027277533,0.000014823511,0.00012174683],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982093,0.00017937663,0.0005620842,0.00028581166,0.00049700984,0.0002664],"domain_scores_gemma":[0.99907553,0.00002194977,0.00017783233,0.0003709111,0.00014894687,0.00020480865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030084734,0.00016071985,0.000582422,0.00017267921,0.00006051826,0.000013799209,0.00007722463,0.00011961777,0.000018266812],"category_scores_gemma":[0.000012022702,0.00015224068,0.00032446155,0.00021522211,0.0000286619,0.00013919002,0.0000043379514,0.00018684007,0.000009418124],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081677677,0.0010813873,0.6081696,0.0003486801,0.00019551508,0.0005170478,0.0035408027,0.0000040792243,0.00024993648,0.0007220597,0.0026788565,0.38167527],"study_design_scores_gemma":[0.0027539562,0.0015090321,0.9923524,0.00023970408,0.00009877679,0.00002842828,0.00042068763,0.000011669025,0.00040013122,0.00066950027,0.0013734949,0.00014220043],"about_ca_topic_score_codex":0.0017743917,"about_ca_topic_score_gemma":0.000065931425,"teacher_disagreement_score":0.38418284,"about_ca_system_score_codex":0.000076975746,"about_ca_system_score_gemma":0.0001705427,"threshold_uncertainty_score":0.6208195},"labels":[],"label_agreement":null},{"id":"W2107413660","doi":"10.1373/clinchem.2015.238105","title":"Clopidogrel and CYP2C19: Pharmacogenetic Testing Ready for Clinical Prime Time?","year":2015,"lang":"en","type":"article","venue":"Clinical Chemistry","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; University Health Network; Western University; Mount Sinai Hospital; University of Toronto","funders":"Eli Lilly and Company","keywords":"CYP2C19; Clopidogrel; Pharmacogenetics; Medicine; Prime (order theory); Internal medicine; Pharmacology; Biology; Genotype; Aspirin; Mathematics; Genetics; Gene","score_opus":0.2920167579993943,"score_gpt":0.47091503935825774,"score_spread":0.17889828135886343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107413660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98985523,0.0060221287,0.0001339756,0.0004432675,0.0001784002,0.00035618126,0.000022081296,0.00012010191,0.0028686111],"genre_scores_gemma":[0.98281366,0.0013237342,0.0049166037,0.002012126,0.004302096,0.00003258954,0.00016169749,0.00007525001,0.0043622483],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99823403,0.000078446115,0.0007268752,0.00049131777,0.00021159012,0.00025771884],"domain_scores_gemma":[0.9976662,0.00083815464,0.00013441536,0.00038834725,0.00023953324,0.0007333961],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015735837,0.00017569552,0.00061730837,0.000008800121,0.00004945795,0.000017654525,0.0001067587,0.0002801002,0.000049786307],"category_scores_gemma":[0.0033031444,0.00015259632,0.00041973637,0.00007550276,0.0003132049,0.000030418807,0.00006660875,0.00031090432,0.00006228457],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031063242,0.0014104812,0.5821844,0.000518575,0.0016563298,0.00021642484,0.00002706533,0.000002243147,0.005791858,0.000004051435,0.054488607,0.3505937],"study_design_scores_gemma":[0.06068881,0.0029299555,0.06452802,0.00072214985,0.0057109725,0.0012666022,0.000200031,0.0052171047,0.03939135,0.00074260175,0.81694525,0.0016571329],"about_ca_topic_score_codex":5.039191e-7,"about_ca_topic_score_gemma":1.7112255e-8,"teacher_disagreement_score":0.76245666,"about_ca_system_score_codex":0.00001568637,"about_ca_system_score_gemma":0.00030069076,"threshold_uncertainty_score":0.6222697},"labels":[],"label_agreement":null},{"id":"W2107739388","doi":"10.1503/cmaj.070586","title":"Restrictive access to clopidogrel and mortality following coronary stent implantation","year":2008,"lang":"en","type":"article","venue":"Canadian Medical Association Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Clopidogrel; Medicine; Medical prescription; Percutaneous coronary intervention; Hazard ratio; Internal medicine; Antiplatelet drug; Confidence interval; Cardiology; Emergency medicine; Myocardial infarction; Pharmacology","score_opus":0.020724447016243402,"score_gpt":0.28729725075485496,"score_spread":0.2665728037386116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107739388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99351156,0.0006066803,0.00022266673,0.004320642,0.00040477837,0.00017349335,0.000015620955,0.000014826367,0.0007297423],"genre_scores_gemma":[0.9894975,0.00096976245,0.000045547287,0.008719719,0.00063456886,0.0000061273404,0.000017836757,0.000010149593,0.000098798555],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981641,0.00011749785,0.0002445053,0.00014225632,0.0010495285,0.0002821089],"domain_scores_gemma":[0.997878,0.000062476225,0.000075708056,0.000076421486,0.00016108045,0.0017463245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062172225,0.00009089754,0.00023295889,0.00013607387,0.00032767464,0.00004329144,0.000081853446,0.00016758079,0.00025542156],"category_scores_gemma":[0.00049824815,0.000082119346,0.00017986842,0.00018815548,0.000022435614,0.00016888845,0.000013976382,0.00035536726,0.000021732534],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037987484,0.000020173273,0.9576509,0.0000054333636,0.00060192624,0.0043297433,0.00024250732,0.0000035196417,0.000006636151,0.000013706551,0.010699843,0.02638765],"study_design_scores_gemma":[0.0013085522,0.000074854404,0.9763028,0.00005664242,0.00012543006,0.0027991196,0.00019314131,0.000019567198,0.000010953432,0.000034626908,0.018984273,0.00009005524],"about_ca_topic_score_codex":0.0011466885,"about_ca_topic_score_gemma":0.0019593537,"teacher_disagreement_score":0.026297595,"about_ca_system_score_codex":0.00047758807,"about_ca_system_score_gemma":0.0016413544,"threshold_uncertainty_score":0.33487296},"labels":[],"label_agreement":null},{"id":"W2108528869","doi":"10.1182/blood-2013-08-520387","title":"Characterization of multiple platelet activation pathways in patients with bleeding as a high-throughput screening option: use of 96-well Optimul assay","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; British Heart Foundation; Wellcome Trust","keywords":"Platelet; Ristocetin; Medicine; Platelet activation; Aspirin; Population; Internal medicine; Predictive value; Bleeding time; Thromboxane; Epinephrine; Thrombin; Gastroenterology; Immunology; Platelet aggregation","score_opus":0.013769538362478415,"score_gpt":0.20107176207462385,"score_spread":0.18730222371214544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108528869","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98581487,0.0000140779575,0.013627943,0.000015205248,0.000027200818,0.00041475275,0.000017641747,0.000029520317,0.000038783433],"genre_scores_gemma":[0.99710053,0.000029532172,0.0022784022,0.000044368917,0.000063391366,0.000011505461,0.00043524944,0.000026415575,0.000010599525],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988947,0.000082088925,0.00029812285,0.00021413028,0.00036104687,0.00014991773],"domain_scores_gemma":[0.9992447,0.0000768995,0.00021627748,0.00023340159,0.0001731836,0.000055560864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020415887,0.00013822583,0.00036806325,0.000127925,0.000034203083,0.000011336745,0.000048788406,0.00009562307,0.000024634695],"category_scores_gemma":[0.00010581902,0.00011876174,0.000097353084,0.00022212781,0.000039581286,0.00032892966,0.000020616506,0.000092708535,0.0000026705418],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021193877,0.0017276373,0.8192788,0.00024145955,0.0005931379,0.000009117569,0.00034499486,0.0007900623,0.16330694,0.0001586773,0.0000019842068,0.011427795],"study_design_scores_gemma":[0.012263821,0.0006693528,0.69530064,0.0005469278,0.00018221306,0.000004318476,0.000033867815,0.00079055777,0.28991178,0.000006728604,0.00015334807,0.00013648446],"about_ca_topic_score_codex":0.000061734114,"about_ca_topic_score_gemma":0.0000014909159,"teacher_disagreement_score":0.12660483,"about_ca_system_score_codex":0.000013512394,"about_ca_system_score_gemma":0.00002842422,"threshold_uncertainty_score":0.48429632},"labels":[],"label_agreement":null},{"id":"W2108655930","doi":"10.5114/kitp.2013.34297","title":"Aspirin versus clopidogrel after surgical offpump coronary revascularization – a prospective, randomized, head-to-head pilot trial","year":2013,"lang":"en","type":"article","venue":"Polish Journal of Cardio-Thoracic Surgery","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Aspirin; Clopidogrel; Randomized controlled trial; Revascularization; Prospective cohort study; Internal medicine; Cardiothoracic surgery; Cardiac surgery; Surgery; Cardiology; Myocardial infarction","score_opus":0.033876537120704084,"score_gpt":0.3187181486141367,"score_spread":0.2848416114934326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108655930","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.977581,0.014575492,0.0009270732,0.0005982063,0.0027503872,0.002268932,0.000017228467,0.00007074258,0.0012109368],"genre_scores_gemma":[0.9923606,0.0025009408,0.0002966167,0.00040313182,0.003865107,0.00025121967,0.000035426896,0.00009164788,0.00019530376],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9939579,0.0017797339,0.0015169383,0.00045236715,0.0015976542,0.0006954022],"domain_scores_gemma":[0.99577063,0.0011446049,0.00050748285,0.0006027169,0.0010989922,0.00087557436],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004814512,0.00046605352,0.002939612,0.0006386273,0.00012052114,0.0001320243,0.00017978295,0.0002284176,0.0004659694],"category_scores_gemma":[0.0013416524,0.00036727882,0.004326516,0.0006502016,0.00025661197,0.00057871215,0.000067843765,0.00057830376,0.00014154796],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.91807234,0.00048564235,0.016698696,0.00014677018,0.0048370445,0.0021499544,0.00010069255,0.00007035695,0.000046071476,0.000021448697,0.0017929677,0.055578016],"study_design_scores_gemma":[0.85948795,0.0029321588,0.08637148,0.001673251,0.0060004597,0.0078286845,0.00019495824,0.00004151281,0.0007578627,0.00032096397,0.033219833,0.0011708703],"about_ca_topic_score_codex":0.00007172126,"about_ca_topic_score_gemma":0.000002592469,"teacher_disagreement_score":0.069672786,"about_ca_system_score_codex":0.00024166895,"about_ca_system_score_gemma":0.000638223,"threshold_uncertainty_score":0.9998779},"labels":[],"label_agreement":null},{"id":"W2109535341","doi":"10.1517/17425255.2012.712684","title":"Pharmacokinetic and clinical evaluation of esomeprazole and ASA for the prevention of gastroduodenal ulcers in cardiovascular patients","year":2012,"lang":"en","type":"review","venue":"Expert Opinion on Drug Metabolism & Toxicology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Esomeprazole; Medicine; Aspirin; Proton-pump inhibitor; Pharmacokinetics; Adverse effect; Internal medicine; Primary prevention; Lansoprazole; Incidence (geometry); Intensive care medicine; Gastroenterology; Omeprazole; Disease","score_opus":0.09234133826754146,"score_gpt":0.4225028711945722,"score_spread":0.33016153292703077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109535341","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010097436,0.98529375,0.00008742102,0.000035719157,0.0011516757,0.0032616383,0.000042327305,0.000007345001,0.000022691633],"genre_scores_gemma":[0.013987267,0.9845966,0.000107397376,0.000052887757,0.0006126325,0.000448695,0.00014684831,0.000037908194,0.000009759368],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961393,0.001620886,0.0009535561,0.0004466853,0.0005907486,0.00024881354],"domain_scores_gemma":[0.99834734,0.0004357618,0.00043508876,0.00046232156,0.0002075261,0.000111960384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036587873,0.0003069216,0.0023711224,0.00022634082,0.000044279448,0.000005114043,0.00012341014,0.00026740946,0.000044829372],"category_scores_gemma":[0.00024717674,0.00020826393,0.0014624418,0.00016266637,0.00024075784,0.00006156338,0.00006299842,0.00026313832,0.0000011316711],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027398457,0.0004914434,0.00016601564,0.0012144023,0.002768903,3.314115e-7,0.000113908194,0.000011183487,0.0000025500356,0.000038169295,0.00009794605,0.9948212],"study_design_scores_gemma":[0.008132451,0.00030082423,0.011198855,0.0014766037,0.006639,0.00002002108,0.00006928333,0.0001170883,0.000034328074,0.000019937586,0.9717968,0.00019477936],"about_ca_topic_score_codex":0.000007858908,"about_ca_topic_score_gemma":0.0000010712856,"teacher_disagreement_score":0.9946264,"about_ca_system_score_codex":0.000041463605,"about_ca_system_score_gemma":0.00021238183,"threshold_uncertainty_score":0.84927565},"labels":[],"label_agreement":null},{"id":"W2109577952","doi":"10.1056/nejmoa1205512","title":"Prasugrel versus Clopidogrel for Acute Coronary Syndromes without Revascularization","year":2012,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":871,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital; University of Alberta","funders":"Genentech; Servier; Astellas Pharma; Regado Biosciences; Medicines Company; Amarin Corporation; Eisai; Boston VA Research Institute; Boston Scientific Corporation; Helsinn; Janssen Pharmaceuticals; Gilead Sciences; GlaxoSmithKline; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; Amylin Pharmaceuticals; Pfizer; Daiichi Sankyo Europe; Sanofi; Regeneron Pharmaceuticals; Abbott Laboratories","keywords":"Prasugrel; Clopidogrel; Medicine; Cardiology; Internal medicine; Revascularization; Acute coronary syndrome; Myocardial infarction","score_opus":0.03414270373853988,"score_gpt":0.3242639092236171,"score_spread":0.2901212054850772,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109577952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91311234,0.042016484,0.036569957,0.0039474764,0.0031123667,0.0005923744,0.0000062430668,0.00003693186,0.0006058537],"genre_scores_gemma":[0.98471135,0.0046633035,0.0022151757,0.00047113563,0.007335809,0.0000039793636,0.00003522824,0.00003405243,0.0005299772],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985453,0.00008194762,0.0004318742,0.00010962883,0.0005632536,0.00026802934],"domain_scores_gemma":[0.9986672,0.00015628104,0.00025462487,0.00020415607,0.00024378453,0.00047396915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009991971,0.00017073308,0.00066450814,0.00014561546,0.00006396012,0.000005827296,0.00009122014,0.000092954004,0.00014563974],"category_scores_gemma":[0.00033832647,0.000110678404,0.0003362037,0.0001370592,0.00008726037,0.00020011104,0.000011501437,0.00020615142,0.0000046416076],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.043362133,0.00052959705,0.17707944,0.00035088454,0.01671023,0.0006251929,0.0022037474,0.000053885346,0.0044389726,0.0009803553,0.026011568,0.727654],"study_design_scores_gemma":[0.39193854,0.0098485155,0.14727862,0.0013688329,0.016267573,0.021226808,0.0005023668,0.00008773369,0.0007461869,0.00037120367,0.40994936,0.00041426474],"about_ca_topic_score_codex":0.0000050099984,"about_ca_topic_score_gemma":7.186933e-7,"teacher_disagreement_score":0.7272397,"about_ca_system_score_codex":0.000048359896,"about_ca_system_score_gemma":0.0001633842,"threshold_uncertainty_score":0.45133343},"labels":[],"label_agreement":null},{"id":"W2110112177","doi":"10.1136/eb-2012-100951","title":"Low-dose aspirin is associated with an increased risk of haemorrhage; but not in people with diabetes who have a high baseline rate of bleeding","year":2012,"lang":"en","type":"letter","venue":"Evidence-Based Nursing","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Aspirin; Medicine; Diabetes mellitus; Low dose aspirin; Major bleeding; Baseline (sea); Intensive care medicine; Internal medicine; Endocrinology; Myocardial infarction","score_opus":0.019519427499079093,"score_gpt":0.2523709947840942,"score_spread":0.2328515672850151,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110112177","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98163223,0.0037040599,0.00058789627,0.0122711435,0.00011299628,0.0012049199,0.00037853356,0.00008179471,0.000026432419],"genre_scores_gemma":[0.96049476,0.00019388877,0.0005438674,0.036662295,0.00090389914,0.00006623095,0.00084938953,0.00018889939,0.000096764175],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.994407,0.0017085776,0.00089862494,0.00084281014,0.0012253467,0.00091763015],"domain_scores_gemma":[0.9953212,0.0014942605,0.0011819708,0.0010544984,0.00062120217,0.0003268691],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0027643144,0.0007795044,0.0023930792,0.0007225435,0.00012378537,0.0000461118,0.00031731115,0.00068946334,0.00021546143],"category_scores_gemma":[0.0008636492,0.00061846076,0.0005571957,0.00084209786,0.00051895744,0.0005463994,0.000022956436,0.0015024297,0.0000035397388],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025065795,0.0039002977,0.8775383,0.009584819,0.0074821436,0.0030888312,0.0028131139,0.0018787471,0.011044016,0.00000338524,0.020294296,0.037306245],"study_design_scores_gemma":[0.025421666,0.0074803904,0.46480295,0.22431177,0.018181346,0.000068162204,0.00083347934,0.011407968,0.24445064,0.000040103616,0.0003624899,0.0026390355],"about_ca_topic_score_codex":0.0013273174,"about_ca_topic_score_gemma":0.000070355105,"teacher_disagreement_score":0.41273537,"about_ca_system_score_codex":0.000395226,"about_ca_system_score_gemma":0.0009475437,"threshold_uncertainty_score":0.9996267},"labels":[],"label_agreement":null},{"id":"W2110401890","doi":"10.1016/j.ahj.2010.04.008","title":"Rationale and design of the randomized, double-blind trial testing INtraveNous and Oral administration of elinogrel, a selective and reversible P2Y12-receptor inhibitor, versus clopidogrel to eVAluate Tolerability and Efficacy in nonurgent Percutaneous Coronary Interventions patients (INNOVATE-PCI)","year":2010,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Sunnybrook Health Science Centre; Health Sciences Centre; University of Toronto","funders":"","keywords":"Medicine; Clopidogrel; P2Y12; Tolerability; Conventional PCI; Percutaneous coronary intervention; Aspirin; Loading dose; Randomized controlled trial; Adverse effect; Pharmacology; Anesthesia; Internal medicine; Cardiology; Myocardial infarction","score_opus":0.06444363554676172,"score_gpt":0.3405980648573348,"score_spread":0.2761544293105731,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110401890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971853,0.00032373212,0.00011945147,0.00025868224,0.00018247732,0.0019108122,0.0000106516545,0.000004309645,0.0000045789725],"genre_scores_gemma":[0.99638426,0.00016735648,0.0032933115,0.00004474201,0.00007360815,0.000020150812,0.0000053459007,0.000008401934,0.0000028156621],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99847406,0.0003962855,0.0005299005,0.00019761837,0.00026666542,0.00013549572],"domain_scores_gemma":[0.9986958,0.00051677396,0.00023324607,0.00010676589,0.00031135115,0.00013607404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012183612,0.00012696827,0.00058319606,0.00009105738,0.00013090634,0.000025196548,0.00003503045,0.00004558115,0.000014753743],"category_scores_gemma":[0.0007988148,0.00009474027,0.00012674466,0.00026704016,0.00050121784,0.0000811981,0.000037594313,0.00030524292,2.007141e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8957632,0.00086601876,0.067598194,0.00007157966,0.000410709,0.000009097671,0.001091389,0.000056388188,0.006470089,0.000008240005,0.00003924783,0.027615806],"study_design_scores_gemma":[0.7508848,0.012080753,0.23092528,0.0005436797,0.0008439795,0.0016755707,0.000800069,0.00047876907,0.0013646688,0.000053195876,0.000079888516,0.00026934614],"about_ca_topic_score_codex":0.00007167979,"about_ca_topic_score_gemma":0.000017297465,"teacher_disagreement_score":0.16332708,"about_ca_system_score_codex":0.000028390068,"about_ca_system_score_gemma":0.00023622495,"threshold_uncertainty_score":0.3863396},"labels":[],"label_agreement":null},{"id":"W2110551412","doi":"10.1016/s0735-1097(12)60477-x","title":"THE EVALUATION OF ADMINISTERING A FIXED BOLUS OF UNFRACTIONATED HEPARIN PRIOR TO PRIMARY PERCUTANEOUS CORONARY INTERVENTION","year":2012,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Percutaneous coronary intervention; Heparin; Bolus (digestion); Cardiology; Internal medicine; Myocardial infarction","score_opus":0.02411536040978728,"score_gpt":0.31391850200701094,"score_spread":0.28980314159722365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110551412","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949685,0.0031601537,0.00027975236,0.00041495904,0.00040519045,0.0003440332,0.000025580277,0.0000029437585,0.00039890577],"genre_scores_gemma":[0.99904656,0.00038161682,0.00022826638,0.00009657274,0.00016897709,0.000004867151,0.0000018299186,0.000011599899,0.000059702834],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99782765,0.0007588884,0.0006127588,0.00007409397,0.0005792598,0.00014732165],"domain_scores_gemma":[0.9978071,0.00021916324,0.00095912005,0.00029636768,0.00064077246,0.00007749108],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018514522,0.00009641478,0.00074587896,0.000097908334,0.00005593693,0.0000014744023,0.00018247934,0.000039200648,0.000013341311],"category_scores_gemma":[0.00040446108,0.000058448742,0.0008496557,0.0002413564,0.00028460435,0.00005361361,0.00007047886,0.00014015485,6.4153744e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.046944797,0.00083079276,0.23064286,0.00043466612,0.015651844,0.0002445731,0.0006272771,0.0064898324,0.21002553,0.00013858864,0.004315461,0.48365378],"study_design_scores_gemma":[0.0020345908,0.0019715053,0.9683967,0.00023337873,0.0020762263,0.012734996,0.0013762839,0.00008703635,0.0037580044,0.000042696844,0.007197826,0.00009073434],"about_ca_topic_score_codex":0.000008882783,"about_ca_topic_score_gemma":0.0000015156027,"teacher_disagreement_score":0.73775387,"about_ca_system_score_codex":0.00013894138,"about_ca_system_score_gemma":0.00028121474,"threshold_uncertainty_score":0.23834705},"labels":[],"label_agreement":null},{"id":"W2112433293","doi":"","title":"Proton pump inhibitors and clopidogrel: Evidence of a Pharmacological interaction of great clinical impact","year":2010,"lang":"en","type":"article","venue":"Revista Colombiana de Gastroenterología","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Clopidogrel; Thienopyridine; CYP2C19; Medicine; Ticlopidine; Esomeprazole; Pharmacology; Acute coronary syndrome; Antithrombotic; Lansoprazole; Proton-pump inhibitor; Antiplatelet drug; Omeprazole; Internal medicine; Cardiology; Aspirin; Myocardial infarction; Cytochrome P450","score_opus":0.034273045830587434,"score_gpt":0.37430275561257265,"score_spread":0.3400297097819852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112433293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975556,0.0008976286,0.0001470018,0.00021306101,0.000121500016,0.0009933941,0.000011205615,0.000038267557,0.000022317328],"genre_scores_gemma":[0.9972291,0.0020042611,0.00032872136,0.0002103351,0.00014850659,0.000047433914,0.0000066912535,0.000015000354,0.00000994646],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981524,0.0003355162,0.00066100253,0.0003242046,0.00023563816,0.00029128976],"domain_scores_gemma":[0.99878097,0.00017742295,0.00033730493,0.00029676742,0.00015538791,0.00025213364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010902854,0.00018840033,0.00076047785,0.000093185234,0.00003382564,0.000017180035,0.00012428638,0.00017626103,0.00016995087],"category_scores_gemma":[0.00051601353,0.00014189428,0.0006336855,0.00012950283,0.00046332958,0.00012186579,0.000076460645,0.0005037785,0.0000025496115],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00584042,0.0003879181,0.9374268,0.00033933794,0.0006414045,0.00006656714,0.00002769543,0.0000022357192,0.044513885,0.000010398158,0.0002707749,0.0104725575],"study_design_scores_gemma":[0.0039733453,0.0089689735,0.97074854,0.0007938234,0.0012631562,0.0007387288,0.00006360036,0.00023680694,0.011690202,0.000018858613,0.0013717312,0.00013222935],"about_ca_topic_score_codex":0.00002651613,"about_ca_topic_score_gemma":0.0000052650275,"teacher_disagreement_score":0.03332174,"about_ca_system_score_codex":0.000039187835,"about_ca_system_score_gemma":0.000099298275,"threshold_uncertainty_score":0.5786281},"labels":[],"label_agreement":null},{"id":"W2112592426","doi":"10.1016/s0003-4975(01)02599-1","title":"Sarpogrelate inhibits serotonin-induced proliferation of porcine coronary artery smooth muscle cells: implications for long-term graft patency","year":2001,"lang":"en","type":"article","venue":"The Annals of Thoracic Surgery","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; St. Boniface Hospital","funders":"","keywords":"Serotonin; Medicine; Cell growth; Vascular smooth muscle; Angiotensin II; Endocrinology; Internal medicine; Biology; Receptor; Biochemistry","score_opus":0.11523706380940707,"score_gpt":0.36396853272019375,"score_spread":0.24873146891078668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112592426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916248,0.0036277699,0.00057860947,0.0026371586,0.00011930932,0.0012189703,0.000050032206,0.000054341075,0.000089058914],"genre_scores_gemma":[0.9955743,0.0032792834,0.000037390957,0.00046419952,0.00015071864,0.00014746335,0.00018736134,0.00003971719,0.0001195861],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9983946,0.0001619143,0.0006149647,0.00026286457,0.00025968117,0.0003059895],"domain_scores_gemma":[0.99810725,0.00031533357,0.00034587475,0.0006824013,0.0004313632,0.0001177709],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010698581,0.00020417543,0.000603394,0.00016565512,0.00012700337,0.000011125962,0.00012558022,0.0001150098,0.000060393882],"category_scores_gemma":[0.00008533459,0.00015050663,0.00075575145,0.00034639667,0.00010817844,0.00016094316,0.00003080571,0.00011558118,0.0000071844443],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003627348,0.0011854407,0.3638344,0.0008290911,0.001334498,0.00006524641,0.00033402015,0.00005445081,0.12428104,0.000066911794,0.0015729571,0.5028146],"study_design_scores_gemma":[0.00041644898,0.0002479854,0.81122667,0.0004777049,0.00042320206,0.00011793182,0.00005626615,0.000046446647,0.18580613,0.0005032688,0.000469893,0.00020804306],"about_ca_topic_score_codex":0.000007400202,"about_ca_topic_score_gemma":0.0000029606617,"teacher_disagreement_score":0.5026065,"about_ca_system_score_codex":0.000009704687,"about_ca_system_score_gemma":0.00014834167,"threshold_uncertainty_score":0.61374825},"labels":[],"label_agreement":null},{"id":"W2112697651","doi":"10.1093/eurheartj/sul051","title":"Clopidogrel in non-ST-segment elevation acute coronary syndromes","year":2006,"lang":"en","type":"article","venue":"European Heart Journal Supplements","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Clopidogrel; Aspirin; Percutaneous coronary intervention; Acute coronary syndrome; Cardiology; Myocardial infarction; Internal medicine; Regimen; Loading dose; Stroke (engine); Anesthesia","score_opus":0.01932776898548623,"score_gpt":0.28593240307784895,"score_spread":0.26660463409236274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112697651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958173,0.0010010883,0.00067778875,0.00066310377,0.00024497777,0.00034948473,0.00003704369,0.000028737752,0.0011804994],"genre_scores_gemma":[0.99611926,0.00070349924,0.0009246258,0.00070081104,0.0004353984,0.000004813461,0.00024100595,0.000044777415,0.0008258346],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982023,0.00022471401,0.00048654072,0.00021366964,0.0005079665,0.00036477987],"domain_scores_gemma":[0.99946547,0.000014520378,0.00009280264,0.00020938374,0.000062874606,0.00015493468],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00064741255,0.00017739915,0.0002939906,0.00017094717,0.00014547269,0.000050037605,0.0000981579,0.000028189768,0.001002706],"category_scores_gemma":[0.000007994266,0.00015448306,0.0002926923,0.00016743188,0.00003065001,0.00016392622,0.000045389694,0.00027190743,0.0002212061],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036915994,0.00051080197,0.9242393,0.000033498833,0.00056561327,0.0056515504,0.00007922302,0.00006809547,0.0032977678,0.000018896539,0.05475082,0.010415306],"study_design_scores_gemma":[0.004163353,0.00033805048,0.8706021,0.00014308859,0.00014178595,0.0030005218,0.00006110111,0.000020663882,0.0002922152,0.00004100561,0.12104632,0.00014980584],"about_ca_topic_score_codex":0.000017679951,"about_ca_topic_score_gemma":0.0000028897568,"teacher_disagreement_score":0.0662955,"about_ca_system_score_codex":0.00011417933,"about_ca_system_score_gemma":0.00005103718,"threshold_uncertainty_score":0.99991053},"labels":[],"label_agreement":null},{"id":"W2113522678","doi":"10.1093/eurheartj/ehs059","title":"The relationship between CYP2C19 polymorphisms and ischaemic and bleeding outcomes in stable outpatients: the CHARISMA genetics study","year":2012,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Sanofi","keywords":"Clopidogrel; Medicine; CYP2C19; Internal medicine; Aspirin; Genotyping; Gastroenterology; Genotype; Cardiology; Genetics","score_opus":0.07838229891284965,"score_gpt":0.31750293677929303,"score_spread":0.2391206378664434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113522678","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9840024,0.014345182,0.000028575407,0.0009396922,0.00012328816,0.0002778779,0.0000019809372,0.000010651844,0.00027035247],"genre_scores_gemma":[0.9985248,0.0004733474,0.000033619865,0.00017189,0.00042260648,0.0000018922922,0.0000010249303,0.000023800874,0.00034705],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99857646,0.0005201253,0.000255336,0.000104274164,0.00027143813,0.00027238336],"domain_scores_gemma":[0.99923086,0.0003107279,0.00007053636,0.00018537791,0.000027248327,0.00017527524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020922052,0.00011443718,0.00020160626,0.000060050534,0.00058079814,0.00009214888,0.000076356766,0.000020828864,0.000014712346],"category_scores_gemma":[0.00016461112,0.00006136293,0.00007950748,0.00009205802,0.00008819703,0.00013589789,0.0000705271,0.00042213805,0.000020187834],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002996857,0.000055106062,0.9947447,0.0000036627855,0.00012742319,0.000016435995,0.0016242128,0.0000010061138,0.000018419041,0.000018717725,0.00013414831,0.0032262015],"study_design_scores_gemma":[0.0012687807,0.00016463689,0.99038774,0.00004038832,0.00014573002,0.00029350637,0.001886049,0.00000422615,0.000008356224,0.00001963062,0.0057088337,0.00007212229],"about_ca_topic_score_codex":0.0000047880667,"about_ca_topic_score_gemma":8.2519153e-7,"teacher_disagreement_score":0.01452237,"about_ca_system_score_codex":0.000019358384,"about_ca_system_score_gemma":0.000018859215,"threshold_uncertainty_score":0.44670883},"labels":[],"label_agreement":null},{"id":"W2113568077","doi":"10.1111/jth.12829","title":"Active metabolite concentration of clopidogrel in patients taking different doses of aspirin: results of the interaction trial","year":2014,"lang":"en","type":"article","venue":"Journal of Thrombosis and Haemostasis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Thrombosis and Atherosclerosis Research Institute; Population Health Research Institute; McMaster University","funders":"Daiichi Sankyo Europe; Daiichi-Sankyo; Janssen Biotech; Sanofi; GlaxoSmithKline","keywords":"Clopidogrel; Aspirin; Medicine; Metabolite; Pharmacokinetics; Randomized controlled trial; Ticlopidine; Active metabolite; Geometric mean; Pharmacology; Internal medicine; Anesthesia","score_opus":0.038709528345119815,"score_gpt":0.3105752629133709,"score_spread":0.2718657345682511,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113568077","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99884397,0.00040163333,0.000046220877,0.0001284267,0.00025692987,0.00021933827,0.00002577555,0.0000010055397,0.000076707205],"genre_scores_gemma":[0.9986332,0.0012006613,0.000047520072,0.000030907995,0.00007516216,9.2016484e-7,0.000004938366,0.0000054034,0.0000012529654],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99865603,0.00018501931,0.0006648806,0.00007805446,0.00034280945,0.00007320377],"domain_scores_gemma":[0.99858135,0.000087683096,0.0009194298,0.00013217045,0.00024143337,0.000037920265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032093195,0.0000856615,0.0005929801,0.00007348881,0.00002232806,0.0000051864686,0.000059242753,0.00004934539,0.0000092292685],"category_scores_gemma":[0.00022174435,0.000050777737,0.00035732787,0.00010651109,0.000080593236,0.0001133161,0.00002069901,0.00011327898,4.5642647e-8],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1578869,0.0032904241,0.3237937,0.0005500845,0.004290904,0.0000015623876,0.0041081035,0.0002604327,0.017883584,0.00027310938,0.00012303558,0.48753816],"study_design_scores_gemma":[0.04010164,0.0012072262,0.8395795,0.00064157625,0.00069299806,0.000002589187,0.000395957,0.000043823744,0.1170496,0.000039797844,0.0001950157,0.000050273593],"about_ca_topic_score_codex":0.000039285213,"about_ca_topic_score_gemma":0.000005639349,"teacher_disagreement_score":0.5157858,"about_ca_system_score_codex":0.000024320503,"about_ca_system_score_gemma":0.000031242987,"threshold_uncertainty_score":0.2070656},"labels":[],"label_agreement":null},{"id":"W2114803960","doi":"10.1177/1076029610384114","title":"An Anti-von Willebrand Factor Aptamer Reduces Platelet Adhesion Among Patients Receiving Aspirin and Clopidogrel in an Ex Vivo Shear-Induced Arterial Thrombosis","year":2010,"lang":"en","type":"article","venue":"Clinical and Applied Thrombosis/Hemostasis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Abciximab; Von Willebrand factor; Platelet; Medicine; Ex vivo; Clopidogrel; Aspirin; Ticlopidine; Internal medicine; Antithrombotic; Glycoprotein Ib; Cardiology; Pharmacology; In vivo; Percutaneous coronary intervention; Myocardial infarction; Biology","score_opus":0.041971588271797346,"score_gpt":0.3318868669750676,"score_spread":0.2899152787032702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114803960","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978447,0.00007939948,0.000007030911,0.00012542946,0.0005509194,0.00096378726,0.00006462702,0.00012551538,0.00023859441],"genre_scores_gemma":[0.99715656,0.0011089056,0.00046991595,0.00045408163,0.00054681074,0.000039393344,0.00013636933,0.00008290419,0.0000050450935],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964899,0.00022068294,0.0009935052,0.0012334705,0.00047810958,0.0005843537],"domain_scores_gemma":[0.99802977,0.00021051418,0.00023500845,0.00068234577,0.000093868766,0.0007485198],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00065053126,0.0005323192,0.0014451772,0.00015209653,0.0002749953,0.00013358079,0.00020412839,0.0006836741,0.00025553475],"category_scores_gemma":[0.00009529572,0.00044423473,0.000304617,0.00027178467,0.0006674539,0.0004708631,0.000113072965,0.00081258884,0.0000128823995],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007536685,0.0015923552,0.6888428,0.000090168985,0.00031897743,0.000010226183,0.00047802195,7.2457766e-7,0.11839374,0.000029929726,0.000053880893,0.18943551],"study_design_scores_gemma":[0.0071325707,0.00087848946,0.95604604,0.00018124882,0.00025452915,0.0000052425053,0.0003880287,0.000055992008,0.034039803,0.00011447853,0.0003402646,0.0005633101],"about_ca_topic_score_codex":0.000045830795,"about_ca_topic_score_gemma":0.000058894944,"teacher_disagreement_score":0.26720327,"about_ca_system_score_codex":0.000017821587,"about_ca_system_score_gemma":0.000067472916,"threshold_uncertainty_score":0.9998009},"labels":[],"label_agreement":null},{"id":"W2114838942","doi":"10.1161/jaha.114.001652","title":"<i>CYP2C19</i> Metabolizer Status and Clopidogrel Efficacy in the Secondary Prevention of Small Subcortical Strokes (SPS3) Study","year":2015,"lang":"en","type":"article","venue":"Journal of the American Heart Association","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute of Neurological Disorders and Stroke; National Institute of General Medical Sciences","keywords":"Clopidogrel; Medicine; CYP2C19; Odds ratio; Internal medicine; Stroke (engine); Aspirin; Cohort","score_opus":0.021640271093501823,"score_gpt":0.29947043377417876,"score_spread":0.27783016268067695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114838942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970582,0.0016961294,0.00002664752,0.0007355345,0.00011267191,0.00031136826,0.0000030704014,0.000003600547,0.000052772775],"genre_scores_gemma":[0.9990035,0.0002972363,0.00013766182,0.00035563557,0.00015344733,0.0000027372225,8.2953704e-7,0.000008272038,0.00004065858],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978391,0.00091284636,0.0004107806,0.000081820406,0.0006021838,0.00015326019],"domain_scores_gemma":[0.9988994,0.00021243263,0.00044235532,0.00016422074,0.0001990725,0.000082510036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020494892,0.000084338,0.00054526783,0.000070578215,0.000037069058,0.000017622244,0.00008505118,0.00002818367,0.0000039669976],"category_scores_gemma":[0.00056647795,0.000047673177,0.0003482564,0.00027887072,0.00005792361,0.00008135112,0.000023392555,0.00027521278,8.2959997e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005456939,0.0007521227,0.98720324,0.00000755161,0.0005134349,0.000006485153,0.0011462985,0.00002024788,0.0003059976,0.000009924294,0.00043476222,0.009054215],"study_design_scores_gemma":[0.0031679648,0.0010199547,0.98920333,0.00003182343,0.0006204891,0.00004362086,0.0038595314,0.000010417026,0.000120696044,0.00006531761,0.0018103683,0.000046489393],"about_ca_topic_score_codex":0.000069499125,"about_ca_topic_score_gemma":0.000017746595,"teacher_disagreement_score":0.009007726,"about_ca_system_score_codex":0.000101155114,"about_ca_system_score_gemma":0.00022857318,"threshold_uncertainty_score":0.19440559},"labels":[],"label_agreement":null},{"id":"W2115055700","doi":"10.1161/01.str.0000236037.87109.fc","title":"CHARISMA","year":2006,"lang":"en","type":"article","venue":"Stroke","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials","funders":"","keywords":"Medicine; Medical school; Charisma; Library science; Theology; Philosophy; Medical education","score_opus":0.006805139166795887,"score_gpt":0.22542599054031512,"score_spread":0.21862085137351922,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115055700","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93470055,0.0023906443,0.0005327374,0.00020626915,0.00007473087,0.00008523877,0.000008525438,0.00007378028,0.0619275],"genre_scores_gemma":[0.9902061,0.000053558564,0.00014866947,0.00019416068,0.00034624877,0.000004318434,0.00002046658,0.0000075868093,0.00901887],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996228,0.0000074869804,0.000058907546,0.0000853069,0.0001231892,0.000102311074],"domain_scores_gemma":[0.99979264,0.000003855628,0.000009881433,0.00013994699,0.00001711475,0.00003658674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000035395988,0.00004833637,0.00010182783,0.000022572265,0.000028133632,0.0000054421726,0.000022469616,0.00002893512,0.00027842712],"category_scores_gemma":[0.0000030596602,0.000039755385,0.00016879501,0.00003578809,0.000023501594,0.00001918134,0.000005458763,0.000044315402,0.00013327018],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010330225,0.0009975443,0.5353563,0.0001864013,0.0019616222,0.0016805768,0.00013788059,0.00004747056,0.0904864,0.020772764,0.07963978,0.26770025],"study_design_scores_gemma":[0.0032817111,0.00016401868,0.4666054,0.000033850763,0.0003476899,0.00019163746,0.00008796368,0.00004466896,0.026470928,0.0005753656,0.50200504,0.00019174302],"about_ca_topic_score_codex":0.000023739916,"about_ca_topic_score_gemma":0.0000010519018,"teacher_disagreement_score":0.42236525,"about_ca_system_score_codex":0.0000075643306,"about_ca_system_score_gemma":0.00001768198,"threshold_uncertainty_score":0.30485818},"labels":[],"label_agreement":null},{"id":"W2115371613","doi":"10.1160/th14-03-0265","title":"Insights into the role of thrombin in the pathogenesis of recurrent ischaemia after acute coronary syndrome","year":2014,"lang":"en","type":"review","venue":"Thrombosis and Haemostasis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute","funders":"Canada Research Chairs; Bayer HealthCare; Janssen Scientific Affairs; McMaster University","keywords":"Medicine; Rivaroxaban; Acute coronary syndrome; Aspirin; Cardiology; Myocardial infarction; Internal medicine; Von Willebrand factor; Discovery and development of direct thrombin inhibitors; Clopidogrel; Dabigatran; Thrombus; Thrombosis; Stroke (engine); Antiplatelet drug; Thrombin; Warfarin; Platelet; Atrial fibrillation","score_opus":0.03179600111663118,"score_gpt":0.31392873823501527,"score_spread":0.2821327371183841,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115371613","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1893108,0.80940497,0.0000038204757,0.000058547266,0.000058664595,0.0009980721,0.00006738428,0.000009609565,0.000088122004],"genre_scores_gemma":[0.22290848,0.7766229,0.00003584906,0.00009188455,0.000032206703,0.00017740068,0.00008526545,0.000040355335,0.000005655763],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973616,0.00063872297,0.00081116694,0.0004286344,0.0005209568,0.00023889166],"domain_scores_gemma":[0.99826,0.00023317228,0.00037208013,0.0009785212,0.000074572716,0.000081608385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051372184,0.00046308292,0.0028175104,0.00016705978,0.00009313591,0.000016992719,0.00035814624,0.00028767475,0.00007331077],"category_scores_gemma":[0.000019023475,0.00022928826,0.0012516085,0.0004540861,0.0004181191,0.000058836576,0.00014016344,0.0003292727,0.0000082880615],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011020885,0.0002662634,0.00049494155,0.006443644,0.0029949406,0.00005942685,0.0017966998,1.0578229e-7,0.00001959631,0.00024563647,0.00007838447,0.9874902],"study_design_scores_gemma":[0.001981812,0.0012727185,0.07639221,0.028009515,0.026963985,0.0008719958,0.0016439498,0.0000067150363,0.00013954296,0.000888459,0.8609686,0.0008605037],"about_ca_topic_score_codex":0.000068250854,"about_ca_topic_score_gemma":0.000019075844,"teacher_disagreement_score":0.98662966,"about_ca_system_score_codex":0.00003718385,"about_ca_system_score_gemma":0.00014789481,"threshold_uncertainty_score":0.9350104},"labels":[],"label_agreement":null},{"id":"W2115558889","doi":"10.1016/j.amjcard.2014.05.054","title":"Usefulness and Safety of Vorapaxar in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention (from the TRACER Trial)","year":2014,"lang":"en","type":"article","venue":"The American Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Merck; AstraZeneca","keywords":"Percutaneous coronary intervention; Medicine; Cardiology; Acute coronary syndrome; Internal medicine; Myocardial infarction","score_opus":0.0069200881485369245,"score_gpt":0.22406924132805733,"score_spread":0.2171491531795204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115558889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99326193,0.0004897247,0.0054702256,0.0002550125,0.00011836563,0.00037305546,0.000015028607,0.0000040753057,0.000012554209],"genre_scores_gemma":[0.9990268,0.0005656419,0.000089207715,0.00018635548,0.000089316876,0.0000045446955,0.000017897959,0.00001586621,0.0000044129783],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982221,0.0007741923,0.00044644164,0.00013216787,0.00028186603,0.00014324633],"domain_scores_gemma":[0.9986297,0.00041096477,0.00053860305,0.00024868528,0.00011939976,0.000052641117],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007877478,0.00013317289,0.00077992055,0.00006259324,0.000058847112,0.0000059195354,0.00013350515,0.000036156227,0.000009885518],"category_scores_gemma":[0.0000484659,0.00007002707,0.00029347267,0.00012643203,0.00041485988,0.000065829096,0.0000301308,0.00021875287,6.1446093e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18832481,0.00020597749,0.6419368,0.00003267487,0.0061592404,0.00044817897,0.0007174523,0.0014479952,0.00031012535,0.000022065811,0.00004065838,0.16035402],"study_design_scores_gemma":[0.018606575,0.0079496205,0.9674182,0.0002012929,0.0010125568,0.0035578634,0.0009556405,0.000025727633,0.000013870075,0.00008110716,0.000094558134,0.00008296627],"about_ca_topic_score_codex":0.000022200567,"about_ca_topic_score_gemma":0.0000036063605,"teacher_disagreement_score":0.3254814,"about_ca_system_score_codex":0.000056440218,"about_ca_system_score_gemma":0.00006598308,"threshold_uncertainty_score":0.2855621},"labels":[],"label_agreement":null},{"id":"W2116051185","doi":"10.1378/chest.11-2306","title":"Primary and Secondary Prevention of Cardiovascular Disease","year":2012,"lang":"en","type":"article","venue":"CHEST Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":472,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Heart, Lung, and Blood Institute; Sanofi; Bristol-Myers Squibb","keywords":"Medicine; Clopidogrel; Prasugrel; Aspirin; Percutaneous coronary intervention; Antithrombotic; Ticagrelor; Coronary artery disease; Internal medicine; Conventional PCI; Acute coronary syndrome; Cardiology; Guideline; Stent; Myocardial infarction; Surgery","score_opus":0.01697712523490647,"score_gpt":0.24125187670600412,"score_spread":0.22427475147109766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116051185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8155385,0.1811781,0.0019527699,0.000046775727,0.00012183248,0.0001034278,0.000003104657,0.000010575504,0.0010448752],"genre_scores_gemma":[0.9916082,0.007112004,0.00047433723,0.00007625325,0.00056311104,0.0000026827115,0.000010408688,0.000014168214,0.00013885333],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99923235,0.000067187066,0.0001671978,0.00008164823,0.00028834006,0.00016327458],"domain_scores_gemma":[0.9992993,0.000010774775,0.000055818553,0.00019727899,0.000053941792,0.0003829113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005121954,0.00008598219,0.00028465243,0.000053588472,0.000062156236,0.000010034394,0.00003385367,0.00003855819,0.00012096508],"category_scores_gemma":[0.000027598375,0.00006963772,0.0006311685,0.000053984684,0.000071324204,0.00019618566,0.000019355586,0.00016318883,0.000004614885],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010584804,0.0008156932,0.15718377,0.0020068935,0.010402211,0.00031119052,0.0004831738,0.000030035339,0.0020531781,0.00017515334,0.00089606456,0.8245842],"study_design_scores_gemma":[0.002608251,0.00010178201,0.87587845,0.00020167863,0.002494305,0.0015571901,0.00011575797,0.000005548954,0.0010655029,0.00016254514,0.11568413,0.00012482682],"about_ca_topic_score_codex":7.5083483e-7,"about_ca_topic_score_gemma":1.26034205e-8,"teacher_disagreement_score":0.8244593,"about_ca_system_score_codex":0.000023535395,"about_ca_system_score_gemma":0.0001263438,"threshold_uncertainty_score":0.28397435},"labels":[],"label_agreement":null},{"id":"W2116202999","doi":"10.1016/j.cjca.2011.06.003","title":"Use of Clopidogrel Post-Coronary Artery Bypass Surgery in Canadian Patients With Acute Coronary Syndromes","year":2011,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; McMaster University; Canadian Heart Research Centre; Montreal Heart Institute; Population Health Research Institute; Hamilton Health Sciences; University of Toronto; St. Michael's Hospital","funders":"University of Massachusetts Medical School; Heart and Stroke Foundation of Canada; Servier; Sanofi; Bristol-Myers Squibb","keywords":"Medicine; Clopidogrel; Cardiology; Internal medicine; Coronary artery bypass surgery; Acute coronary syndrome; Artery; Myocardial infarction","score_opus":0.024281734960660935,"score_gpt":0.20454527358928254,"score_spread":0.1802635386286216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116202999","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972413,0.0014034901,0.000023411261,0.0001315423,0.00041736133,0.00016027917,0.00017907695,0.000003870449,0.0004396253],"genre_scores_gemma":[0.99894905,0.0002471844,0.000093784714,0.00046261534,0.00010616336,0.0000035337437,0.00007051431,0.00003173184,0.00003544866],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983504,0.00020372972,0.0004986665,0.0001771772,0.00018876414,0.0005812862],"domain_scores_gemma":[0.9977358,0.00008600534,0.00018139923,0.00030083238,0.0004278403,0.0012681397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029815655,0.00019825649,0.0009991993,0.00089693663,0.00005214218,0.0000071467744,0.00013773749,0.00018893609,0.00009140889],"category_scores_gemma":[0.0000854849,0.00016421828,0.0004928673,0.00020856934,0.00028634022,0.00021064357,0.0000072756266,0.0002825789,0.000005729202],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008543403,0.000012013437,0.9696227,0.000019470799,0.0026404748,0.018266445,0.00014288381,0.00003485031,0.000009655092,0.000016106686,0.0013291538,0.0070519205],"study_design_scores_gemma":[0.0012709879,0.000690796,0.97805494,0.00014312488,0.0004946159,0.008672025,0.00008579539,6.626599e-7,0.00001564434,0.000014506546,0.01039295,0.00016397801],"about_ca_topic_score_codex":0.08702853,"about_ca_topic_score_gemma":0.17017382,"teacher_disagreement_score":0.0831453,"about_ca_system_score_codex":0.00024518353,"about_ca_system_score_gemma":0.0052186744,"threshold_uncertainty_score":0.9257704},"labels":[],"label_agreement":null},{"id":"W2116481772","doi":"10.1111/j.1538-7836.2007.02499.x","title":"Combined antiplatelet and anticoagulant therapy: clinical benefits and risks","year":2007,"lang":"en","type":"review","venue":"Journal of Thrombosis and Haemostasis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences; Hamilton General Hospital","funders":"","keywords":"Anticoagulant therapy; Medicine; Intensive care medicine; Anticoagulant; Internal medicine","score_opus":0.4128427458046052,"score_gpt":0.4793734588441787,"score_spread":0.06653071303957347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116481772","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12903869,0.8700102,0.000014782767,0.00014192816,0.00022783875,0.000464029,0.000048928177,0.000013151883,0.00004044286],"genre_scores_gemma":[0.0053214077,0.993474,0.000365581,0.00030186505,0.0004388492,0.0000023450498,0.000020025765,0.000067748406,0.000008156582],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99703074,0.00026954152,0.0014852987,0.00041087094,0.00047420512,0.00032933737],"domain_scores_gemma":[0.99761945,0.00041108773,0.0009212391,0.00032619515,0.00019698538,0.0005250569],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018375431,0.0005228151,0.004443189,0.0003328658,0.00016631835,0.000109335226,0.0001264871,0.00054121023,0.00004188012],"category_scores_gemma":[0.00008711183,0.0003404084,0.0013277661,0.00020904926,0.00036271624,0.00013234175,0.00009502462,0.0007650659,0.0000024567662],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003580671,0.00025261124,0.0050411583,0.0024571153,0.005846234,0.00021305107,0.000038023103,5.6251757e-8,6.783305e-7,0.00003808243,0.00055354915,0.98520136],"study_design_scores_gemma":[0.007454024,0.0020652334,0.03287085,0.01710311,0.011198898,0.0040618777,0.00008919541,0.0000029908374,0.000012106384,0.000036641875,0.9245504,0.00055466],"about_ca_topic_score_codex":0.000010150349,"about_ca_topic_score_gemma":8.3917394e-7,"teacher_disagreement_score":0.98464674,"about_ca_system_score_codex":0.000023210072,"about_ca_system_score_gemma":0.00018770981,"threshold_uncertainty_score":0.9999048},"labels":[],"label_agreement":null},{"id":"W2117034502","doi":"10.1503/cmaj.114-0015","title":"Clopidogrel and proton pump inhibitors","year":2014,"lang":"en","type":"letter","venue":"Canadian Medical Association Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Clopidogrel; Drug; Randomized controlled trial; Medicine; Pharmacology; Clinical trial; Cardiology; Computer science; Internal medicine; Aspirin","score_opus":0.006412119653015035,"score_gpt":0.2180758632068556,"score_spread":0.21166374355384057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117034502","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008293733,0.0020091815,0.000033777193,0.98546356,0.0010260778,0.00046386986,0.000022725952,0.00003200437,0.0026550835],"genre_scores_gemma":[0.004050265,0.001568337,0.000021992999,0.960164,0.032084335,0.000024982655,0.00012188893,0.0000572205,0.0019069733],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99624175,0.00030723508,0.0004564167,0.00026158767,0.0021312311,0.00060178264],"domain_scores_gemma":[0.9974259,0.00010867942,0.00026412914,0.00017218251,0.000331177,0.0016979118],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.001422595,0.00025023674,0.0006123769,0.00027809697,0.0002401314,0.00011786471,0.00013622944,0.0020907214,0.0019195426],"category_scores_gemma":[0.00090204796,0.00021414134,0.00043772842,0.00012962871,0.00007903201,0.000062043786,0.000012835443,0.004183359,0.00014391557],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008586749,0.000006879913,0.0121976575,0.00011163942,0.0006473685,0.0047068507,0.000031832074,6.2990395e-8,4.0980999e-7,0.0000038078513,0.95666635,0.025618577],"study_design_scores_gemma":[0.0013273066,0.00008745404,0.0017241935,0.00041470237,0.00026908529,0.0042026024,0.000022552302,0.000012711208,0.0000059498166,0.000059029422,0.99165803,0.00021640067],"about_ca_topic_score_codex":0.0005183266,"about_ca_topic_score_gemma":0.00034532876,"teacher_disagreement_score":0.034991685,"about_ca_system_score_codex":0.00069088984,"about_ca_system_score_gemma":0.0033124893,"threshold_uncertainty_score":0.99920475},"labels":[],"label_agreement":null},{"id":"W2117263944","doi":"10.1345/aph.1k566","title":"Single Antiplatelet Therapy for Patients with Previous Gastrointestinal Bleeds","year":2008,"lang":"en","type":"article","venue":"Annals of Pharmacotherapy","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Capital District Health Authority; University of British Columbia","funders":"","keywords":"Medicine; Aspirin; Clopidogrel; Internal medicine; Gastrointestinal bleeding; Bleed; Clinical trial; Randomized controlled trial; Gastroenterology; Surgery","score_opus":0.054713373585104544,"score_gpt":0.313214655870963,"score_spread":0.25850128228585845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117263944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99315274,0.0040200627,0.0009887653,0.00025927986,0.000047866895,0.0011498859,0.000054710526,0.00008026345,0.00024640004],"genre_scores_gemma":[0.9898119,0.0058396044,0.0016475982,0.0021174375,0.0001889539,0.00005105635,0.00007587741,0.00007023974,0.0001973261],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99858063,0.000049993097,0.00030130183,0.00029391085,0.00039785245,0.00037631075],"domain_scores_gemma":[0.9988117,0.00006366801,0.00016025937,0.00027870905,0.0005094681,0.00017615699],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015104278,0.0002580421,0.00051586266,0.00011172618,0.000111759065,0.000008212718,0.00012435213,0.000042076237,0.00021567986],"category_scores_gemma":[0.000009408012,0.0001920749,0.00045405194,0.00019709382,0.0001813777,0.00013194182,0.000007029258,0.000095721975,0.00000550439],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.059721135,0.010777235,0.48041624,0.0003282483,0.005829949,0.000230257,0.0009340079,0.0000704373,0.263212,0.000052866308,0.0138014695,0.16462615],"study_design_scores_gemma":[0.04518634,0.016132833,0.0971574,0.00043442176,0.00026720355,0.00059110735,0.00004361298,0.00007094118,0.76061976,0.000075369884,0.078769505,0.0006515382],"about_ca_topic_score_codex":0.000006058889,"about_ca_topic_score_gemma":1.4793534e-7,"teacher_disagreement_score":0.49740773,"about_ca_system_score_codex":0.000011138933,"about_ca_system_score_gemma":0.000091658,"threshold_uncertainty_score":0.78325874},"labels":[],"label_agreement":null},{"id":"W2117950068","doi":"10.1186/s12893-015-0096-z","title":"Should dual antiplatelet therapy be used in patients following coronary artery bypass surgery? A meta-analysis of randomized controlled trials","year":2015,"lang":"en","type":"review","venue":"BMC Surgery","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa; Canadian Respiratory Research Network; McMaster University; Population Health Research Institute; University of Toronto; St. Michael's Hospital","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Clopidogrel; Aspirin; Prasugrel; Ticagrelor; Randomized controlled trial; Acute coronary syndrome; Internal medicine; Cardiology; Platelet aggregation inhibitor; Surgery; Myocardial infarction","score_opus":0.3555284585887374,"score_gpt":0.39651450203654837,"score_spread":0.04098604344781098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117950068","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.027623914,0.9646233,0.00003759601,0.00002712185,0.00079993316,0.0063422457,0.000417141,0.000084436164,0.000044330707],"genre_scores_gemma":[0.014200537,0.9793015,0.000025150926,0.00021834108,0.00018851632,0.0017808184,0.003937165,0.00017807001,0.00016987369],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9675962,0.019715026,0.00841437,0.0010674126,0.0024643703,0.0007426692],"domain_scores_gemma":[0.94028443,0.053427234,0.0040758285,0.0014341198,0.0004067632,0.00037159564],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"category_scores_codex":[0.057040542,0.0014525655,0.12152041,0.003864955,0.00006531621,0.000069301306,0.00022281782,0.00091618625,0.00071060576],"category_scores_gemma":[0.01007496,0.00084601814,0.16311707,0.0023726667,0.0001915466,0.00019493801,0.00006279836,0.0005013222,0.000011774799],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.111776896,0.0008749891,0.0059009753,0.0016615608,0.82377255,0.00057749945,0.000037235022,0.000009230746,2.529731e-7,0.0000019857143,0.0012794783,0.054107375],"study_design_scores_gemma":[0.16824354,0.00003950589,0.00025634,0.0011830672,0.77713305,0.00002283839,0.000018994488,0.000009842335,0.0000014311803,0.0000042852553,0.05239503,0.000692081],"about_ca_topic_score_codex":0.00004343931,"about_ca_topic_score_gemma":0.000009670189,"teacher_disagreement_score":0.056466643,"about_ca_system_score_codex":0.00013237598,"about_ca_system_score_gemma":0.0020897484,"threshold_uncertainty_score":0.9998224},"labels":[],"label_agreement":null},{"id":"W2117976231","doi":"10.1093/eurheartj/ehn104","title":"The effect of pre-operative aspirin on bleeding, transfusion, myocardial infarction, and mortality in coronary artery bypass surgery: a systematic review of randomized and observational studies","year":2008,"lang":"en","type":"review","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":152,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton General Hospital","funders":"","keywords":"Medicine; Aspirin; Observational study; Myocardial infarction; Artery; Coronary artery bypass surgery; Randomized controlled trial; Surgery; Bypass grafting; Cardiology; Internal medicine","score_opus":0.07481222521044474,"score_gpt":0.3640514197773719,"score_spread":0.28923919456692715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117976231","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.027080271,0.97026247,0.000003836007,0.00006629183,0.0001613449,0.0023591057,0.000013474781,0.0000069221805,0.0000462777],"genre_scores_gemma":[0.0021722212,0.9973839,0.000005040512,0.000118960896,0.00017108362,0.00007350125,0.000017475944,0.00003252423,0.000025310817],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9887293,0.00857406,0.0017350689,0.00022750293,0.00057887245,0.0001551782],"domain_scores_gemma":[0.99527365,0.003486229,0.00068718084,0.0002450043,0.0002073249,0.000100640864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009090989,0.00034459826,0.0061502946,0.00015166549,0.0001784911,0.000018642793,0.000070334296,0.00005662442,0.0000061308638],"category_scores_gemma":[0.0017237354,0.00017430387,0.0017524253,0.00016373777,0.0003843794,0.000074060015,0.000030258523,0.00045617146,0.0000012148168],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059596132,0.00007244061,0.006940465,0.94037294,0.017802427,0.00033390668,0.0003186518,0.0000016374032,0.0000011690022,0.000010627801,0.00087675,0.027309367],"study_design_scores_gemma":[0.0147789875,0.0005128311,0.017497325,0.9374391,0.01025555,0.0075213276,0.000031335654,0.0000015543354,0.0000012766961,0.0000028469196,0.011745514,0.00021238245],"about_ca_topic_score_codex":0.0000017739014,"about_ca_topic_score_gemma":5.940508e-7,"teacher_disagreement_score":0.027121406,"about_ca_system_score_codex":0.000040952353,"about_ca_system_score_gemma":0.00017505928,"threshold_uncertainty_score":0.7107906},"labels":[],"label_agreement":null},{"id":"W2118534378","doi":"10.1016/j.jacc.2010.11.024","title":"Clopidogrel–Drug Interactions","year":2011,"lang":"en","type":"review","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":227,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Otsuka America; Medicines Company; Medicure; Arena Pharmaceuticals; Eisai; Schering-Plough; Sanofi; Novartis; GlaxoSmithKline","keywords":"Clopidogrel; Medicine; P2Y12; Pharmacology; Pharmacodynamics; Prodrug; Drug; Atorvastatin; Antiplatelet drug; Drug interaction; Omeprazole; Adverse effect; CYP2C19; Active metabolite; Pharmacokinetics; Internal medicine; Cytochrome P450; Aspirin; Metabolism","score_opus":0.03307971435127868,"score_gpt":0.32427638420487076,"score_spread":0.29119666985359205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118534378","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00060124294,0.9953973,0.000091229944,0.000112367554,0.0011392114,0.00032904113,0.000112726884,0.0000068287372,0.002210045],"genre_scores_gemma":[0.0025093802,0.99524903,0.00019301436,0.00010866282,0.0011939352,0.000007494044,0.000003025928,0.00004225503,0.00069321244],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974957,0.00087479316,0.0009934533,0.00016411301,0.0002663923,0.00020552424],"domain_scores_gemma":[0.99641347,0.00024694923,0.0022655453,0.00063413347,0.00030779137,0.00013212634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049809745,0.00028788406,0.004684371,0.00029788393,0.00005480271,0.0000023487628,0.00049017963,0.000067784094,0.00003830805],"category_scores_gemma":[0.00015592575,0.00015849994,0.0066509824,0.00051068945,0.00062910566,0.000040718474,0.00010106329,0.00073186285,0.0000106365205],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006706013,0.000098280856,0.0005321241,0.002736491,0.020778293,0.0009831222,0.00002256171,0.000007693343,0.0000031352083,0.00022837505,0.03750439,0.9364349],"study_design_scores_gemma":[0.0003881838,0.00026346932,0.00024860058,0.0035876143,0.008613564,0.023990726,0.00009416356,1.3598549e-7,0.0000029750092,0.000042527547,0.9626427,0.0001253345],"about_ca_topic_score_codex":0.0000050132844,"about_ca_topic_score_gemma":8.6024573e-7,"teacher_disagreement_score":0.9363096,"about_ca_system_score_codex":0.00010307709,"about_ca_system_score_gemma":0.0008484553,"threshold_uncertainty_score":0.6707694},"labels":[],"label_agreement":null},{"id":"W2118782261","doi":"10.1161/strokeaha.110.593582","title":"The Use of Platelet Function Assays May Help to Determine Appropriate Antiplatelet Treatment Options in a Patient With Recurrent Stroke on Baby Aspirin","year":2010,"lang":"en","type":"letter","venue":"Stroke","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Aspirin; Stroke (engine); Platelet; Intensive care medicine; Platelet aggregation inhibitor; Internal medicine","score_opus":0.0316050986562318,"score_gpt":0.2477007554760952,"score_spread":0.21609565681986342,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118782261","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9713725,0.0006689544,0.00021211599,0.02222368,0.00085363025,0.0029599173,0.0012823958,0.00008301426,0.00034379202],"genre_scores_gemma":[0.8510199,0.0066512856,0.0031093026,0.10887393,0.005757657,0.0028000777,0.0061165784,0.00075949257,0.014911734],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99669796,0.0002529202,0.0006600324,0.00076644565,0.0009578566,0.0006648048],"domain_scores_gemma":[0.9978312,0.00023288907,0.00032092526,0.0012521181,0.00017670289,0.00018611256],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021187206,0.0006690475,0.0010398717,0.00041407015,0.00016512831,0.00008038204,0.00018345249,0.00079454883,0.0000691321],"category_scores_gemma":[0.00005019332,0.00040673936,0.0006717161,0.00024844173,0.00015257853,0.000087434375,0.000054276337,0.0018371957,0.000048970025],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016590035,0.0014445193,0.0019785732,0.00035992096,0.005436768,0.0054382766,0.00032280924,0.00087739155,0.0028809384,0.000040529423,0.063659616,0.90097064],"study_design_scores_gemma":[0.0043035885,0.0087122535,0.0023096055,0.00068959745,0.00082742644,0.00025564682,0.00006231078,0.00006994006,0.0028450873,0.000006583036,0.97943425,0.00048371346],"about_ca_topic_score_codex":0.00012398446,"about_ca_topic_score_gemma":0.00019473983,"teacher_disagreement_score":0.91577464,"about_ca_system_score_codex":0.00023431535,"about_ca_system_score_gemma":0.00020545333,"threshold_uncertainty_score":0.9998385},"labels":[],"label_agreement":null},{"id":"W2119335129","doi":"10.1161/circulationaha.108.846014","title":"Response to Letter Regarding Article, “Incomplete Inhibition of Thromboxane Biosynthesis by Acetylsalicylic Acid: Determinants and Effect on Cardiovascular Risk”","year":2009,"lang":"en","type":"letter","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Classics; History","score_opus":0.011948441110092058,"score_gpt":0.2405072400483567,"score_spread":0.22855879893826464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119335129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97563857,0.0022861664,0.0006415633,0.019900627,0.00010152376,0.001200412,0.00010042644,0.000089033,0.000041676954],"genre_scores_gemma":[0.93729234,0.00015927725,0.00006787756,0.061353914,0.00079403725,0.000044215718,0.00018570681,0.00008517473,0.00001743623],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.996314,0.0011784675,0.00047737994,0.0007525355,0.00088227115,0.0003953513],"domain_scores_gemma":[0.9982575,0.00029326483,0.00023591543,0.0009770246,0.0001014537,0.00013479893],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013245114,0.00046315623,0.0012914393,0.0003825593,0.00014842473,0.000043430824,0.00008244861,0.0006230368,0.00002108728],"category_scores_gemma":[0.00039430792,0.0004217277,0.0010852717,0.00030002583,0.000097373864,0.00011613294,0.000030458084,0.0005827982,0.00003995211],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0075726532,0.00018644142,0.03309984,0.0016287623,0.006288485,0.0016141635,0.00040384338,0.00028482132,0.52135515,0.0000018533113,0.20545183,0.22211215],"study_design_scores_gemma":[0.007496099,0.0018066799,0.44408333,0.0033433107,0.0069292677,0.00041507103,0.000019122748,0.00016764502,0.3050167,0.000070643415,0.22928342,0.0013687228],"about_ca_topic_score_codex":0.000024859144,"about_ca_topic_score_gemma":4.840811e-7,"teacher_disagreement_score":0.41098347,"about_ca_system_score_codex":0.00014864125,"about_ca_system_score_gemma":0.000032697168,"threshold_uncertainty_score":0.99982345},"labels":[],"label_agreement":null},{"id":"W2119345183","doi":"10.1053/j.ajkd.2007.07.007","title":"Aspirin Prescription and Outcomes in Hemodialysis Patients: The Dialysis Outcomes and Practice Patterns Study (DOPPS)","year":2007,"lang":"en","type":"article","venue":"American Journal of Kidney Diseases","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":126,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Aspirin; Internal medicine; Medical prescription; Hemodialysis; Dialysis; Myocardial infarction; Stroke (engine); Coronary artery disease; Clopidogrel; Odds ratio; Proportional hazards model; Cardiology","score_opus":0.007532472929136792,"score_gpt":0.28236796628508903,"score_spread":0.27483549335595225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119345183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99628854,0.0010265601,0.00026202,0.0019162577,0.0000773632,0.00034813705,0.000031314066,0.000010769945,0.00003902061],"genre_scores_gemma":[0.9947041,0.0007870129,0.000089006855,0.004287271,0.00008061554,0.0000068586114,0.000008940773,0.000018674287,0.00001751689],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979847,0.00043006561,0.00055188633,0.00020750698,0.0006044214,0.00022140594],"domain_scores_gemma":[0.9977331,0.0006717933,0.00045468015,0.00027087567,0.00021081019,0.00065870717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000875035,0.00020031657,0.000770995,0.0002605143,0.0000883278,0.000053362546,0.000106452026,0.000022603863,0.00001776604],"category_scores_gemma":[0.003441867,0.000119925106,0.00035584206,0.00029145658,0.00022364872,0.00032578455,0.00004929691,0.00016927959,9.613656e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012948278,0.0015280893,0.919519,0.000019092196,0.001756713,0.00017263698,0.00085724326,0.000003591201,0.000009698563,0.0000020916266,0.00007252937,0.07476449],"study_design_scores_gemma":[0.003954783,0.0009643044,0.9793949,0.00005759518,0.0030303954,0.000053986274,0.011723901,0.0000036741592,0.000006925038,0.000011728571,0.00066953414,0.00012826128],"about_ca_topic_score_codex":0.00018982956,"about_ca_topic_score_gemma":0.00001547098,"teacher_disagreement_score":0.07463623,"about_ca_system_score_codex":0.00004718303,"about_ca_system_score_gemma":0.00011514722,"threshold_uncertainty_score":0.4890404},"labels":[],"label_agreement":null},{"id":"W2119897760","doi":"10.1016/j.ejcts.2008.03.052","title":"Effect of clopidogrel on bleeding and transfusions after off-pump coronary artery bypass graft surgery: impact of discontinuation prior to surgery","year":2008,"lang":"en","type":"article","venue":"European Journal of Cardio-Thoracic Surgery","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Notre-Dame; Montreal Heart Institute","funders":"","keywords":"Medicine; Clopidogrel; Discontinuation; Unstable angina; Aspirin; Myocardial infarction; Surgery; Anesthesia; Coronary artery bypass surgery; Off-pump coronary artery bypass; Cardiac surgery; Artery; Angina; Percutaneous coronary intervention; Acute coronary syndrome; Platelet; Blood transfusion; Cardiology; Internal medicine; Bypass grafting","score_opus":0.019201439051662297,"score_gpt":0.277479889658535,"score_spread":0.2582784506068727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119897760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99029464,0.008086044,0.00040492846,0.00010893296,0.0005488213,0.0003317503,0.000042394324,0.000026443893,0.00015603179],"genre_scores_gemma":[0.99306756,0.0061488524,0.00003294334,0.000070314825,0.00053651794,0.0000053640756,0.000014464632,0.00009219363,0.000031764306],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9940696,0.0028435856,0.0013997558,0.00032046036,0.0009423597,0.0004242614],"domain_scores_gemma":[0.995241,0.0028342607,0.00062540284,0.00043444926,0.0003545687,0.0005103351],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.008482082,0.0004056123,0.0022330747,0.000973796,0.00011068076,0.000019201278,0.000095908865,0.00007645274,0.000058620728],"category_scores_gemma":[0.0007995688,0.00030200742,0.0038726807,0.00052027724,0.00020675472,0.00028108747,0.000033281616,0.0003337077,0.000008368928],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017640576,0.0002623485,0.5798297,0.00031116774,0.0036003632,0.008251504,0.00051324884,0.000201785,0.0027076686,2.4680207e-7,0.0019834132,0.38469797],"study_design_scores_gemma":[0.0008277611,0.0013378463,0.98215073,0.0020049699,0.0013971986,0.0062786294,0.000081826714,0.000010620089,0.0048438767,7.94004e-7,0.0007333186,0.00033240556],"about_ca_topic_score_codex":0.000004308776,"about_ca_topic_score_gemma":2.952677e-7,"teacher_disagreement_score":0.40232107,"about_ca_system_score_codex":0.00007478141,"about_ca_system_score_gemma":0.000328102,"threshold_uncertainty_score":0.9999432},"labels":[],"label_agreement":null},{"id":"W2120275267","doi":"10.1016/j.ahj.2010.04.022","title":"Study design and rationale of a comparison of prasugrel and clopidogrel in medically managed patients with unstable angina/non–ST-segment elevation myocardial infarction: The TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes (TRILOGY ACS) trial","year":2010,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":123,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Prasugrel; Medicine; Clopidogrel; Thienopyridine; Myocardial infarction; Internal medicine; Cardiology; Unstable angina; Percutaneous coronary intervention; Acute coronary syndrome; Aspirin; Randomized controlled trial; Angina","score_opus":0.016212750482453468,"score_gpt":0.2857078447831658,"score_spread":0.26949509430071233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120275267","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894265,0.000111059875,0.0060662683,0.0017840614,0.000096256095,0.002486787,0.000014335204,0.000007825698,0.0000069094276],"genre_scores_gemma":[0.9963703,0.00010414915,0.0027207963,0.0005715137,0.00010948824,0.00007266719,0.000029980632,0.00001584471,0.0000052368982],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99772066,0.00046345612,0.0005496665,0.00023098728,0.00080394343,0.00023128385],"domain_scores_gemma":[0.9989204,0.00022399382,0.0002437614,0.0002044442,0.00020083702,0.00020656263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013791937,0.00016812685,0.0005935332,0.00019680707,0.00017773734,0.000030847154,0.000090551155,0.000084112944,0.00003403368],"category_scores_gemma":[0.00011117152,0.00010170846,0.000081399,0.00044795993,0.00036789538,0.00011891213,0.00005105983,0.0006611383,7.7788087e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10923771,0.0034807748,0.7248904,0.00007359455,0.0053156666,0.00033547284,0.0066999374,0.0050236043,0.004092587,0.00009940923,0.0038899388,0.13686086],"study_design_scores_gemma":[0.021365458,0.015239825,0.95827407,0.00008069157,0.0004655952,0.00038194278,0.0029865298,0.00028597738,0.00011960081,0.000026256872,0.0006238738,0.00015017469],"about_ca_topic_score_codex":0.00006843968,"about_ca_topic_score_gemma":0.000023748195,"teacher_disagreement_score":0.23338364,"about_ca_system_score_codex":0.00003177161,"about_ca_system_score_gemma":0.0002416297,"threshold_uncertainty_score":0.41475508},"labels":[],"label_agreement":null},{"id":"W2120887783","doi":"10.1186/1475-2840-10-25","title":"Aspirin effect on the incidence of major adverse cardiovascular events in patients with diabetes mellitus: a systematic review and meta-analysis","year":2011,"lang":"en","type":"review","venue":"Cardiovascular Diabetology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Division of Materials Research; Canadian Institutes of Health Research; Alberta Innovates","keywords":"Medicine; Angiology; Diabetes mellitus; Meta-analysis; Aspirin; Incidence (geometry); Internal medicine; Adverse effect; Intensive care medicine; Systematic review; MEDLINE; Endocrinology","score_opus":0.023175798601107647,"score_gpt":0.25486979203770777,"score_spread":0.23169399343660013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120887783","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0027048886,0.98566055,0.000037751957,0.000009656532,0.000048036534,0.011351671,0.00010050845,0.00004057341,0.000046345816],"genre_scores_gemma":[0.005780818,0.990429,0.000027063585,0.00020241582,0.0000233927,0.0031670972,0.00022015904,0.00013499653,0.000015052146],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98889583,0.005860035,0.0017052549,0.0014479801,0.0013488324,0.000742091],"domain_scores_gemma":[0.9931201,0.0007811246,0.0007485416,0.0047776084,0.00031911928,0.00025355292],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_narrow","metaepi_broad"],"category_scores_codex":[0.005571801,0.0013269696,0.03181338,0.00080234377,0.00009490275,0.000009199975,0.00067081884,0.0005698367,0.00008969529],"category_scores_gemma":[0.0005684855,0.0006769239,0.03672712,0.0019531497,0.0004140012,0.000099560944,0.00020102941,0.0007622375,0.000044916796],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002277666,0.00009861221,0.00083848846,0.39926505,0.59480345,0.00004928083,0.000011867871,0.000007179718,4.1994594e-9,0.000017277947,0.000002351264,0.0048836614],"study_design_scores_gemma":[0.0013322334,0.00042431738,0.0009685211,0.046691082,0.9432519,0.000030300118,0.0000054461743,4.571945e-7,0.0000021232538,0.000005055077,0.006704684,0.0005838638],"about_ca_topic_score_codex":0.000028402439,"about_ca_topic_score_gemma":0.000003441704,"teacher_disagreement_score":0.352574,"about_ca_system_score_codex":0.00013131578,"about_ca_system_score_gemma":0.00016702249,"threshold_uncertainty_score":0.99994814},"labels":[],"label_agreement":null},{"id":"W2121627749","doi":"10.1016/j.jval.2013.01.013","title":"Health-Related Quality of Life of Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes—Results from the PLATO Trial","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Ticagrelor; Clopidogrel; Medicine; Acute coronary syndrome; Myocardial infarction; Quality of life (healthcare); Stroke (engine); Internal medicine; Population; Emergency medicine","score_opus":0.053571034764102334,"score_gpt":0.3010175903735779,"score_spread":0.24744655560947557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121627749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923973,0.0027090998,0.00000694416,0.0020479066,0.00027679044,0.002269828,0.00023991529,0.000018894985,0.000033308366],"genre_scores_gemma":[0.99850523,0.00064786815,0.00015807737,0.00037251078,0.000035257173,0.000026204947,0.00022547344,0.00002085131,0.000008542758],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964549,0.0008695156,0.0014608196,0.00030207552,0.0005823602,0.0003303107],"domain_scores_gemma":[0.99781615,0.0007360525,0.00058635033,0.0005486004,0.00008701215,0.0002258424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011840079,0.0001691647,0.0010558809,0.00008971133,0.0000438505,0.000004081423,0.00014203509,0.000111605645,0.00004804387],"category_scores_gemma":[0.00030099452,0.00011164844,0.00018040494,0.00037058824,0.00014046075,0.000071924056,0.000032097472,0.00028068246,0.000012031057],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.44846022,0.0026556992,0.5211498,0.00053277623,0.0021513975,0.000027729902,0.0033510665,0.00089565123,0.0000032975922,0.00028278842,0.0007866956,0.019702865],"study_design_scores_gemma":[0.1405937,0.002867248,0.8554451,0.000474127,0.000042387554,0.0000018377397,0.00022824368,0.00013960151,0.000002744878,0.000066839,0.00004532709,0.000092831964],"about_ca_topic_score_codex":0.036638487,"about_ca_topic_score_gemma":0.00011626138,"teacher_disagreement_score":0.3342953,"about_ca_system_score_codex":0.00013229845,"about_ca_system_score_gemma":0.00094956637,"threshold_uncertainty_score":0.96977663},"labels":[],"label_agreement":null},{"id":"W2123601427","doi":"10.1016/j.ahj.2015.07.017","title":"Impact of prasugrel pretreatment and timing of coronary artery bypass grafting on clinical outcomes of patients with non-ST-segment elevation myocardial infarction: From the A Comparison of Prasugrel at PCI or Time of Diagnosis of Non–ST-Elevation Myocardial Infarction (ACCOAST) study","year":2015,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"Daiichi-Sankyo; Daiichi Sankyo Europe; Eli Lilly and Company","keywords":"Medicine; Prasugrel; Cardiology; Myocardial infarction; Internal medicine; TIMI; Percutaneous coronary intervention; Conventional PCI; Hazard ratio; Clinical endpoint; Revascularization; Randomization; Coronary artery disease; Randomized controlled trial; Confidence interval","score_opus":0.04430944616204498,"score_gpt":0.35424903213227393,"score_spread":0.30993958597022897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123601427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99820817,0.00013748197,0.00021931532,0.000063556094,0.00010313462,0.0010866836,0.00016949007,0.0000052910846,0.000006896136],"genre_scores_gemma":[0.99914044,0.00017290445,0.00041330463,0.000038439153,0.00010449025,0.000024058767,0.00008030413,0.000023755445,0.0000023277075],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99662864,0.0004913249,0.0013647452,0.00023394825,0.0011033562,0.00017798731],"domain_scores_gemma":[0.9961282,0.0007007467,0.0019602533,0.0003450007,0.00071938126,0.00014643866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008764145,0.00023822344,0.001474646,0.00016500388,0.000067504094,0.0000063737907,0.00008384809,0.00007024912,0.000032804226],"category_scores_gemma":[0.000289634,0.00014717459,0.0005505765,0.00030652026,0.00038818983,0.0001468731,0.000057112044,0.00022040683,5.6830623e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0097613055,0.0026846584,0.9602162,0.000027898728,0.007264054,0.0000025279676,0.0020807108,0.00072820135,0.00046448404,1.230257e-7,0.00027112622,0.01649871],"study_design_scores_gemma":[0.0077825384,0.022704566,0.96437746,0.0002825806,0.0017221683,0.000018908104,0.002259663,0.0003007646,0.00042606192,0.0000018131794,0.000011583402,0.00011188793],"about_ca_topic_score_codex":0.0006950347,"about_ca_topic_score_gemma":0.000014223786,"teacher_disagreement_score":0.020019908,"about_ca_system_score_codex":0.00014328976,"about_ca_system_score_gemma":0.00032044834,"threshold_uncertainty_score":0.6001606},"labels":[],"label_agreement":null},{"id":"W2123722811","doi":"10.1016/j.ahj.2010.09.001","title":"Patterns of discharge antiplatelet therapy and late outcomes among 8,582 patients with bleeding during acute coronary syndrome: A pooled analysis from PURSUIT, PARAGON-A, PARAGON-B, and SYNERGY","year":2010,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"","keywords":"Medicine; Hazard ratio; Acute coronary syndrome; Percutaneous coronary intervention; Confidence interval; Myocardial infarction; Internal medicine; Stroke (engine); Propensity score matching; Randomized controlled trial; Cardiology","score_opus":0.005810309261934231,"score_gpt":0.23319476879128415,"score_spread":0.2273844595293499,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123722811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987478,0.00059548335,0.000058899775,0.00013805451,0.00008294401,0.00023779461,0.00010647981,0.00002899188,0.0000035039823],"genre_scores_gemma":[0.99716914,0.002186116,0.0002796219,0.00018099484,0.000051381427,0.000008596783,0.000047998623,0.00004490289,0.00003125819],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981034,0.00010637522,0.00043572162,0.0003879352,0.0005561112,0.000410454],"domain_scores_gemma":[0.9987018,0.00009660856,0.00033348645,0.00032943944,0.00011260337,0.00042606934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020842475,0.00032608863,0.0012690338,0.00029691882,0.00023733074,0.000080198275,0.000113603994,0.00007417449,0.0001127466],"category_scores_gemma":[0.0000159698,0.00022475749,0.00042333952,0.0003593829,0.00033186062,0.00027472433,0.00005497602,0.000474238,9.956115e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084735657,0.0001825596,0.9773546,0.000014044313,0.012804861,0.00047879995,0.00022137293,0.00000955724,0.0032431497,0.0000010560822,0.000003743998,0.0048388974],"study_design_scores_gemma":[0.0041870833,0.0006151709,0.990311,0.00010640238,0.0028215616,0.0007597837,0.00021141686,0.00006184411,0.0006181327,0.000006747834,0.00002919738,0.00027164747],"about_ca_topic_score_codex":0.00046195337,"about_ca_topic_score_gemma":0.00003523725,"teacher_disagreement_score":0.012956411,"about_ca_system_score_codex":0.000015036958,"about_ca_system_score_gemma":0.000044125598,"threshold_uncertainty_score":0.9165344},"labels":[],"label_agreement":null},{"id":"W2123862033","doi":"10.1590/s2179-83972009000400005","title":"Hiporresponsividade à terapia antiplaquetária","year":2009,"lang":"pt","type":"article","venue":"Revista Brasileira de Cardiologia Invasiva","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Medicine; Cardiology; Intensive care medicine","score_opus":0.023966436666229867,"score_gpt":0.2794953428498115,"score_spread":0.2555289061835816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123862033","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88488346,0.10358693,0.003674253,0.00044088325,0.0008924916,0.0018045506,0.00022288445,0.00058889226,0.0039056751],"genre_scores_gemma":[0.9826447,0.006548,0.00025751156,0.005567429,0.002613671,0.000040818064,0.00028567447,0.00013355915,0.0019086681],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9923102,0.001945207,0.0013050905,0.0015746098,0.0009668721,0.0018979906],"domain_scores_gemma":[0.99502826,0.0005901792,0.00045805305,0.0024719504,0.0003626253,0.0010889214],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0023039153,0.001252527,0.002949236,0.0004588114,0.00043889854,0.00040455183,0.0008896817,0.001104813,0.0006379074],"category_scores_gemma":[0.0018653894,0.0011610854,0.003415713,0.0009989102,0.00044662302,0.00033478058,0.00014573791,0.0013258915,0.00087873783],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004897132,0.0008340938,0.7959466,0.0013423715,0.006317197,0.014502409,0.0009439858,0.00022909828,0.030296547,0.0046523036,0.084859826,0.05517843],"study_design_scores_gemma":[0.0047787875,0.0017333234,0.9417316,0.0020401732,0.0031228862,0.0037323437,0.0006627694,0.00008341634,0.0022857657,0.00007272097,0.03814748,0.001608779],"about_ca_topic_score_codex":0.000014507023,"about_ca_topic_score_gemma":6.7547955e-7,"teacher_disagreement_score":0.14578494,"about_ca_system_score_codex":0.0005309073,"about_ca_system_score_gemma":0.0011925155,"threshold_uncertainty_score":0.9998992},"labels":[],"label_agreement":null},{"id":"W2124278276","doi":"10.1016/j.ahj.2010.10.037","title":"Clopidogrel loading dose and bleeding outcomes in patients undergoing urgent coronary artery bypass grafting","year":2011,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Victoria Heart Institute Foundation; Royal Jubilee Hospital","funders":"","keywords":"Medicine; Bypass grafting; Clopidogrel; Artery; Cardiology; Internal medicine; Myocardial infarction","score_opus":0.024708544695760237,"score_gpt":0.26379307882862585,"score_spread":0.23908453413286562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124278276","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99842966,0.0007671957,0.00006846582,0.00016906329,0.00019486784,0.00014399724,0.0000012763214,0.000027254107,0.0001982229],"genre_scores_gemma":[0.99713933,0.00065745634,0.0010792102,0.000962851,0.00011058421,0.0000034985314,0.0000020762077,0.000026884109,0.000018089613],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99868846,0.00009812075,0.00034752695,0.00020220218,0.00029699827,0.00036667692],"domain_scores_gemma":[0.99925673,0.00008050314,0.000120465615,0.00013177936,0.000051237756,0.00035929662],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031226376,0.00016730803,0.00048971485,0.00019056798,0.00016368447,0.000029235694,0.000052456446,0.0000337296,0.00008303036],"category_scores_gemma":[0.000077328026,0.00014118182,0.00024228895,0.00016643075,0.00013539591,0.0001826665,0.00003961362,0.00031172516,0.000008776023],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027648383,0.00016442532,0.9791182,0.000013794397,0.00039729153,0.00024437474,0.0005320632,0.0000023147534,0.00010557401,0.0000077528,0.00006113453,0.019076578],"study_design_scores_gemma":[0.0026203457,0.00059812993,0.993845,0.00017623007,0.000120435005,0.0009240529,0.0012163647,0.000024990144,0.00005437805,0.000047423382,0.00020993326,0.0001627283],"about_ca_topic_score_codex":0.00003400594,"about_ca_topic_score_gemma":0.0000036567083,"teacher_disagreement_score":0.018913848,"about_ca_system_score_codex":0.00007623575,"about_ca_system_score_gemma":0.00009337632,"threshold_uncertainty_score":0.57572275},"labels":[],"label_agreement":null},{"id":"W2124817426","doi":"10.1503/cmaj.130033","title":"New antiplatelet agents for cardiovascular disease","year":2013,"lang":"en","type":"review","venue":"Canadian Medical Association Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital","funders":"","keywords":"Clopidogrel; Medicine; Aspirin; Platelet aggregation inhibitor; Intensive care medicine; Disease; Medical therapy; Ticlopidine; Cardiology; Internal medicine","score_opus":0.029950895654486304,"score_gpt":0.2913437052474674,"score_spread":0.26139280959298106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124817426","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000009212224,0.99466604,0.0010178345,0.0009816954,0.00135467,0.0014280861,0.00017680616,0.00003681429,0.0003288528],"genre_scores_gemma":[0.000003805741,0.98611516,0.00025926685,0.0019586913,0.007249779,0.00008908401,0.00036675142,0.00011234111,0.0038451133],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99494284,0.00033885738,0.00088956696,0.0004471449,0.0024957724,0.0008857913],"domain_scores_gemma":[0.9907571,0.00016749388,0.00035578993,0.00048172267,0.0004578841,0.007780004],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017083179,0.00048277323,0.0024657063,0.00038074993,0.00031923782,0.00018210734,0.00037058687,0.0011108019,0.005915525],"category_scores_gemma":[0.0015224904,0.0003888889,0.007705513,0.0003178029,0.00003208399,0.00012717782,0.00002178139,0.0012928575,0.0006969079],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008246301,0.000015692349,0.000046465488,0.0013511273,0.010773903,0.0012540248,0.0000066217117,7.9111624e-7,1.8778923e-9,0.000028459115,0.2323472,0.75416744],"study_design_scores_gemma":[0.0017868681,0.0000414522,0.000047184734,0.0050511374,0.009171108,0.0013653176,0.000012570932,0.000010150384,3.0523278e-8,0.000051883435,0.98208904,0.00037327484],"about_ca_topic_score_codex":0.00062183733,"about_ca_topic_score_gemma":0.000110301764,"teacher_disagreement_score":0.7537942,"about_ca_system_score_codex":0.0014028255,"about_ca_system_score_gemma":0.019402262,"threshold_uncertainty_score":0.9998563},"labels":[],"label_agreement":null},{"id":"W2125043491","doi":"10.1056/nejmoa1407024","title":"Prehospital Ticagrelor in ST-Segment Elevation Myocardial Infarction","year":2014,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":651,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Canadian Heart Research Centre; Southlake Regional Health Center; University of Toronto","funders":"","keywords":"Ticagrelor; Elevation (ballistics); Myocardial infarction; Cardiology; Medicine; Internal medicine; ST segment; Acute coronary syndrome; Engineering","score_opus":0.008881746145355036,"score_gpt":0.2441208986101834,"score_spread":0.23523915246482838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125043491","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98314905,0.0019275108,0.007821781,0.005283012,0.00069475436,0.00016658344,6.9863876e-7,0.000011861871,0.00094476744],"genre_scores_gemma":[0.9925469,0.00081837253,0.00026494754,0.00064249535,0.0055881883,0.0000012146332,0.000008810142,0.000012055258,0.00011702928],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986483,0.00011871877,0.00043259532,0.00010234068,0.00055304455,0.00014500016],"domain_scores_gemma":[0.9992773,0.00008659941,0.00016060173,0.00013270526,0.00012944874,0.00021333683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011308724,0.000111879934,0.0004360084,0.00020021535,0.000023620616,0.0000056292215,0.000055986442,0.00005989356,0.00016523991],"category_scores_gemma":[0.0003849744,0.00007471045,0.00015114875,0.00015091825,0.000052075407,0.00009845312,0.000007862651,0.0002495322,0.000005377757],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002512602,0.00013843,0.08549666,0.00004850032,0.0004884421,0.0001330075,0.0007752628,0.00019862391,0.0025020733,0.00031946567,0.0040358426,0.90335107],"study_design_scores_gemma":[0.12599574,0.0055374186,0.59963727,0.00082172133,0.0007159744,0.0016309912,0.0002794091,0.0002588933,0.00031766898,0.0012602456,0.2633673,0.00017734621],"about_ca_topic_score_codex":0.000022627435,"about_ca_topic_score_gemma":0.000003570365,"teacher_disagreement_score":0.90317374,"about_ca_system_score_codex":0.00005852752,"about_ca_system_score_gemma":0.00009819351,"threshold_uncertainty_score":0.30466035},"labels":[],"label_agreement":null},{"id":"W2125802847","doi":"10.1016/j.athoracsur.2009.10.051","title":"Clopidogrel Increases Blood Transfusion and Hemorrhagic Complications in Patients Undergoing Cardiac Surgery","year":2010,"lang":"en","type":"article","venue":"The Annals of Thoracic Surgery","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":111,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Clopidogrel; Blood transfusion; Cardiology; Surgery; Internal medicine; Anesthesia; Myocardial infarction","score_opus":0.04129036141958963,"score_gpt":0.31213796310478736,"score_spread":0.2708476016851977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125802847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941709,0.0041454406,0.000009907418,0.0009837697,0.00014893647,0.00028644962,0.000032263386,0.000035664852,0.00018667201],"genre_scores_gemma":[0.9924449,0.006873981,0.000028053331,0.00041967767,0.00008877664,0.000019711291,0.00008663548,0.000022469723,0.000015792915],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985988,0.00025815342,0.0003834783,0.00022311856,0.00029555484,0.00024086324],"domain_scores_gemma":[0.9973854,0.0017372438,0.00011731252,0.00049504125,0.0001410608,0.00012396714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013822052,0.00015669763,0.00061128923,0.00021319809,0.00011991274,0.000014612655,0.00007364872,0.000087699416,0.00003667911],"category_scores_gemma":[0.00042130228,0.00011676614,0.0005561766,0.00032855073,0.00018031805,0.00010235991,0.00003138506,0.00020264638,0.000004904169],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000467004,0.00049675064,0.89511794,0.00021065363,0.0002929506,0.000011742468,0.000064109925,0.0000014306595,0.000732741,0.000028085919,0.00059793494,0.10197867],"study_design_scores_gemma":[0.00019471206,0.0000364105,0.98811144,0.00033757166,0.00027824772,0.000029463288,0.00009688229,0.000011307825,0.009828333,0.00023022847,0.0006754846,0.00016991646],"about_ca_topic_score_codex":0.00013681773,"about_ca_topic_score_gemma":0.000022752325,"teacher_disagreement_score":0.10180875,"about_ca_system_score_codex":0.0000031600657,"about_ca_system_score_gemma":0.00012455648,"threshold_uncertainty_score":0.4761585},"labels":[],"label_agreement":null},{"id":"W2126110249","doi":"10.1161/01.cir.0000029926.71825.e2","title":"Benefit of Clopidogrel in Patients With Acute Coronary Syndromes Without ST-Segment Elevation in Various Risk Groups","year":2002,"lang":"en","type":"article","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":229,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Population Health Research Institute","funders":"Sanofi; American Heart Association","keywords":"Medicine; TIMI; Clopidogrel; Internal medicine; Myocardial infarction; Aspirin; Cardiology; Framingham Risk Score; Relative risk; Acute coronary syndrome; Confidence interval; Population; Placebo; Stroke (engine); Unstable angina; Thrombolysis","score_opus":0.009634159535055175,"score_gpt":0.21249980158076617,"score_spread":0.202865642045711,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126110249","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973399,0.0005433676,0.0013636844,0.000017292694,0.00003651433,0.00059311546,0.000016438971,0.000021140017,0.00006853214],"genre_scores_gemma":[0.99926937,0.00023002947,0.00020941504,0.000032486085,0.000015499625,0.000020689757,0.00019518274,0.000017430159,0.000009887961],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990047,0.000046751204,0.0002665205,0.0002046335,0.0003395426,0.00013781725],"domain_scores_gemma":[0.9995361,0.000015312968,0.00012372195,0.00021344572,0.0000695085,0.000041918764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000116914845,0.00011486926,0.00027751084,0.00016637397,0.000026185082,0.0000051755856,0.000035693298,0.000074664065,0.00007375579],"category_scores_gemma":[0.000011493456,0.00010213126,0.000078843,0.0002700323,0.000030318233,0.00013620892,0.000008514662,0.00009827117,0.0000063211332],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003400283,0.00042293832,0.9667593,0.000037677244,0.00021997976,0.00002536015,0.00027318185,0.0016030499,0.000035936973,0.00005864597,0.000003405723,0.030220496],"study_design_scores_gemma":[0.0056079593,0.00021578324,0.9909577,0.00014631817,0.00019833981,0.000016177579,0.000030417996,0.0025218676,0.000020591478,0.00015909705,0.000016128239,0.000109648005],"about_ca_topic_score_codex":0.00004266244,"about_ca_topic_score_gemma":0.000016967351,"teacher_disagreement_score":0.030110847,"about_ca_system_score_codex":0.00011148603,"about_ca_system_score_gemma":0.000015177555,"threshold_uncertainty_score":0.4164792},"labels":[],"label_agreement":null},{"id":"W2126298629","doi":"10.1016/s0140-6736(13)61451-8","title":"Prasugrel versus clopidogrel for patients with unstable angina or non-ST-segment elevation myocardial infarction with or without angiography: a secondary, prespecified analysis of the TRILOGY ACS trial","year":2013,"lang":"en","type":"article","venue":"The Lancet","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Daiichi-Sankyo; Daiichi Sankyo Europe; Eli Lilly and Company","keywords":"Medicine; Clopidogrel; Prasugrel; Cardiology; Internal medicine; Myocardial infarction; Unstable angina; Coronary angiography; Angina","score_opus":0.02392406723887526,"score_gpt":0.2658834400548996,"score_spread":0.24195937281602437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126298629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935234,0.00015857129,0.001632126,0.00040174642,0.00022185604,0.0036326284,0.00014309192,0.000033024327,0.00025353316],"genre_scores_gemma":[0.99785817,0.00010907354,0.00040836766,0.00026116762,0.00051635085,0.00043110858,0.0002035043,0.000026140991,0.00018610989],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99866563,0.000120861776,0.00024827904,0.00024897023,0.00043606872,0.00028017728],"domain_scores_gemma":[0.9986156,0.00014832204,0.0002391521,0.00067495287,0.00026641798,0.00005553348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027090844,0.00018795634,0.0007676373,0.00015207742,0.00013892146,0.000030618845,0.00017577698,0.00007659455,0.00013103009],"category_scores_gemma":[0.000047258916,0.00007785125,0.0004920736,0.0009883508,0.00014304405,0.00012189853,0.000024493223,0.00012350026,0.0000017649623],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.734283,0.0004653739,0.22087577,0.00011082885,0.026671173,0.0000015509019,0.00048147468,0.0003705776,0.000085020154,0.00006842218,0.0052527837,0.011334033],"study_design_scores_gemma":[0.19554773,0.0071567185,0.7675381,0.00009171558,0.012444624,0.0000035630767,0.00034994108,0.0003946396,0.00016919778,0.00002166974,0.01603099,0.00025116996],"about_ca_topic_score_codex":0.00011471184,"about_ca_topic_score_gemma":0.00008350949,"teacher_disagreement_score":0.5466623,"about_ca_system_score_codex":0.00003943516,"about_ca_system_score_gemma":0.00021444554,"threshold_uncertainty_score":0.3174682},"labels":[],"label_agreement":null},{"id":"W2126452917","doi":"10.1161/hc0302.102609","title":"Antioxidative Properties of Acetylsalicylic Acid on Vascular Tissues From Normotensive and Spontaneously Hypertensive Rats","year":2002,"lang":"en","type":"article","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":154,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"WSP (Canada)","funders":"Medical Research Council; Medical Research Council Canada","keywords":"Medicine; Oxidative stress; Internal medicine; Superoxide; Endocrinology; Angiotensin II; Aorta; Aspirin; Endothelial dysfunction; In vivo; NAD+ kinase; NADPH oxidase; NAD(P)H oxidase; Pharmacology; Blood pressure; Biochemistry; Enzyme; Chemistry","score_opus":0.02809339188988025,"score_gpt":0.2181503882285487,"score_spread":0.19005699633866846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126452917","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9828193,0.016108528,0.00013621953,0.00019446855,0.000051610114,0.00042174582,0.000012384677,0.00004652614,0.00020921446],"genre_scores_gemma":[0.9980792,0.0012565559,0.000085019754,0.00035824344,0.00011675933,0.00000794118,0.000044911532,0.00002268189,0.00002868095],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99902284,0.000077862474,0.0001915147,0.00027847037,0.00029760628,0.00013172036],"domain_scores_gemma":[0.9992747,0.000025458994,0.000082879735,0.00028754657,0.00025232462,0.00007711317],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005891126,0.00015787296,0.0004173319,0.00008095777,0.000070238595,0.000013024226,0.000036446283,0.00009574761,0.00008766472],"category_scores_gemma":[0.000099959005,0.00012961407,0.00018171094,0.00011348222,0.00011829178,0.000104152445,0.0000134014435,0.00008372319,0.000041052743],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004801383,0.0002675103,0.015749918,0.00014797032,0.001883516,0.00040918676,0.0037739892,0.0001547897,0.93605715,0.00015187077,0.00017080516,0.040753182],"study_design_scores_gemma":[0.004530909,0.000479074,0.5216381,0.0009423971,0.0014119903,0.00050129835,0.001628887,0.0035963184,0.46293798,0.00022380131,0.0015591272,0.0005501426],"about_ca_topic_score_codex":0.000056192996,"about_ca_topic_score_gemma":0.0000020897598,"teacher_disagreement_score":0.50588816,"about_ca_system_score_codex":0.000026729156,"about_ca_system_score_gemma":0.00001369867,"threshold_uncertainty_score":0.52855086},"labels":[],"label_agreement":null},{"id":"W2126896835","doi":"10.1517/13543784.9.3.457","title":"Platelet substitutes and novel platelet products","year":2000,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Queen's University","funders":"","keywords":"Platelet; Business; Chemistry; Medicine; Internal medicine","score_opus":0.06310912037077193,"score_gpt":0.3306338903687579,"score_spread":0.26752476999798597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126896835","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014812761,0.9956774,0.000013727388,0.0006935885,0.0005788211,0.0012385864,0.00018327785,0.0001515113,0.0013149717],"genre_scores_gemma":[0.000029022338,0.99156487,0.000682015,0.0014350951,0.0018985231,0.0002668985,0.0034882512,0.00010762775,0.0005276749],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99712265,0.00012284725,0.00066388684,0.0009270318,0.00079844956,0.00036513992],"domain_scores_gemma":[0.99849045,0.00020335248,0.00020901645,0.0005809417,0.00010209604,0.0004141703],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002490311,0.0006846728,0.0016515291,0.00031193148,0.00021539512,0.00006848086,0.00018398986,0.00043447185,0.00025227922],"category_scores_gemma":[0.00014375117,0.0005481132,0.00059332524,0.00039576727,0.00043510896,0.00015554867,0.000045197794,0.00052144856,0.00025197104],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000111819165,0.00021685699,0.0000017652147,0.0036220746,0.0009660956,0.00003939551,0.00019801472,0.0000060850666,0.0000045375355,0.0061978586,0.014330016,0.97430545],"study_design_scores_gemma":[0.0013071133,0.00011315613,0.00001701346,0.011582191,0.00008084073,0.0006477366,0.000018126277,0.000009271667,0.00008440639,0.00015514153,0.98544055,0.0005444345],"about_ca_topic_score_codex":0.000011555269,"about_ca_topic_score_gemma":8.760753e-8,"teacher_disagreement_score":0.973761,"about_ca_system_score_codex":0.00010642375,"about_ca_system_score_gemma":0.00089499325,"threshold_uncertainty_score":0.999697},"labels":[],"label_agreement":null},{"id":"W2127160975","doi":"10.1016/j.jacc.2013.10.048","title":"Vorapaxar in Acute Coronary Syndrome Patients Undergoing Coronary Artery Bypass Graft Surgery","year":2013,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"","keywords":"Medicine; Cardiology; Internal medicine; Myocardial infarction; Acute coronary syndrome; Hazard ratio; Stroke (engine); Perioperative; Revascularization; Clinical endpoint; Anesthesia; Confidence interval; Clinical trial","score_opus":0.008514318855415266,"score_gpt":0.2236930524200404,"score_spread":0.21517873356462514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127160975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99690306,0.0012719622,0.000059150705,0.00074630446,0.00052760757,0.00034076496,0.00003965753,0.000008035874,0.00010347729],"genre_scores_gemma":[0.99771327,0.00135133,0.00011357113,0.0006075272,0.00009987758,0.000008782091,0.0000047940475,0.000027632877,0.00007320125],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977488,0.000570394,0.0007512533,0.00017235275,0.0004406082,0.00031658215],"domain_scores_gemma":[0.9979832,0.00045302074,0.0007493623,0.00039860306,0.00027284533,0.00014296635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042890862,0.00019930948,0.0016040469,0.00027728433,0.000053834203,0.000004274592,0.00025412004,0.00007597327,0.000029398963],"category_scores_gemma":[0.00012906642,0.0001357988,0.0012883772,0.00044394808,0.0005095207,0.00015160971,0.00008335563,0.00031669778,0.000008378593],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012390232,0.00012545526,0.9817217,0.000034767603,0.0038496782,0.0034153224,0.000017114307,0.00021439785,0.00038294937,0.0000072360717,0.006283317,0.0027090379],"study_design_scores_gemma":[0.0020774102,0.00105095,0.9768962,0.00017428797,0.00055164285,0.018005066,0.0003383986,0.000009843104,0.00005422878,0.00015051552,0.00055944634,0.00013197868],"about_ca_topic_score_codex":0.000008238041,"about_ca_topic_score_gemma":0.0000017919724,"teacher_disagreement_score":0.014589743,"about_ca_system_score_codex":0.000113789916,"about_ca_system_score_gemma":0.00039171212,"threshold_uncertainty_score":0.5537714},"labels":[],"label_agreement":null},{"id":"W2127231760","doi":"10.1111/j.1540-8183.2009.00431.x","title":"Determining the In‐Hospital Cost of Bleeding in Patients Undergoing Percutaneous Coronary Intervention","year":2009,"lang":"en","type":"article","venue":"Journal of Interventional Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Medicine; Conventional PCI; Percutaneous coronary intervention; TIMI; Major bleeding; Emergency medicine; Incidence (geometry); Cost database; Surgery; Intensive care medicine; Myocardial infarction; Cardiology","score_opus":0.010966169373677274,"score_gpt":0.2707869523119889,"score_spread":0.2598207829383116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127231760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974269,0.0012716221,0.0003700404,0.00017616541,0.00034886185,0.00018035473,0.000004139838,0.0000031162454,0.00021875395],"genre_scores_gemma":[0.99955547,0.00014101804,0.00006532987,0.000067183,0.00013590761,0.00000159785,0.000012906235,0.000007616166,0.000012983822],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984907,0.00019574596,0.00077313045,0.00010986921,0.0002741952,0.00015636445],"domain_scores_gemma":[0.99915355,0.00011617929,0.00034261393,0.00009775203,0.00024563048,0.00004424831],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064155186,0.00010742322,0.00050610985,0.00023479517,0.000024212397,0.000006890374,0.00012565897,0.000081579594,0.000036705023],"category_scores_gemma":[0.00023726105,0.0000788605,0.001054357,0.000113291935,0.00006865168,0.00012009857,0.000026798214,0.00028900482,0.0000014519945],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012964432,0.00075547287,0.9626265,0.000059701528,0.0005036648,0.0006221777,0.00012884224,0.00065254327,0.00009608184,0.00010410334,0.00010621468,0.03304824],"study_design_scores_gemma":[0.004509226,0.004564412,0.9875569,0.00092927413,0.00013061149,0.0014052736,0.0003472925,0.000032034437,0.00003419851,0.00034326845,0.00007824769,0.00006927327],"about_ca_topic_score_codex":0.0000021197109,"about_ca_topic_score_gemma":0.0000038726057,"teacher_disagreement_score":0.032978963,"about_ca_system_score_codex":0.00014601303,"about_ca_system_score_gemma":0.000052900632,"threshold_uncertainty_score":0.3215838},"labels":[],"label_agreement":null},{"id":"W2128123374","doi":"","title":"Comparaison des doses de clopidogrel et d’aspirine dans le syndrome coronarien aigu, étude CURRENT-OASIS 7","year":2012,"lang":"fr","type":"article","venue":"","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut universitaire de cardiologie et de pneumologie de Québec","funders":"","keywords":"Medicine","score_opus":0.0339830575095795,"score_gpt":0.31681523644546605,"score_spread":0.2828321789358865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128123374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.696642,0.28284883,0.013588165,0.00090430793,0.0014492237,0.00038556498,0.00005326067,0.00016471632,0.003963948],"genre_scores_gemma":[0.9762175,0.017978787,0.0011888804,0.00075460866,0.00091323134,0.000048032056,0.00013394469,0.00008935898,0.0026756693],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996528,0.00053379027,0.00049748976,0.00043891638,0.00054285827,0.001458913],"domain_scores_gemma":[0.997956,0.00017752287,0.000114664625,0.00065470475,0.00010836477,0.0009887473],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000983235,0.00051877165,0.00089825597,0.0001226266,0.0003085741,0.00006409521,0.00028633812,0.00022733552,0.0020264764],"category_scores_gemma":[0.00009058801,0.00048317402,0.0008466966,0.000373063,0.0008350302,0.00063163566,0.00014247351,0.00045943167,0.00078943925],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040618854,0.0039914367,0.7459023,0.0011447319,0.0026963525,0.00038014408,0.004483874,0.00014075355,0.0007554719,0.02487446,0.003821924,0.21140239],"study_design_scores_gemma":[0.004106076,0.00042492137,0.7887444,0.00093688053,0.0015543883,0.002873478,0.0032580511,0.00018955984,0.0021643373,0.00022685256,0.19485162,0.00066944165],"about_ca_topic_score_codex":0.0011744165,"about_ca_topic_score_gemma":0.00014201897,"teacher_disagreement_score":0.27957553,"about_ca_system_score_codex":0.0002607387,"about_ca_system_score_gemma":0.00037184282,"threshold_uncertainty_score":0.99998856},"labels":[],"label_agreement":null},{"id":"W2128828314","doi":"10.1161/circinterventions.109.928721","title":"Incidence, Predictors, and Prognostic Implications of Hospitalization for Late Bleeding After Percutaneous Coronary Intervention for Patients Older Than 65 Years","year":2010,"lang":"en","type":"article","venue":"Circulation Cardiovascular Interventions","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre; Western University","funders":"Canadian Institutes of Health Research; Ontario Ministry of Health and Long-Term Care","keywords":"Medicine; Conventional PCI; Percutaneous coronary intervention; Myocardial infarction; Hazard ratio; Internal medicine; Incidence (geometry); Gastrointestinal bleeding; Proportional hazards model; Cardiology; Surgery; Confidence interval","score_opus":0.010055346599412237,"score_gpt":0.25836624424372534,"score_spread":0.2483108976443131,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128828314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8960016,0.0022356675,0.09838534,0.000031762356,0.00035037613,0.00268203,0.00022521503,0.000068235044,0.000019773268],"genre_scores_gemma":[0.99653476,0.00012864148,0.0012510098,0.000016871429,0.00013171791,0.000784823,0.0010584294,0.000050067873,0.000043672964],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99850744,0.00005680102,0.000541092,0.00040363584,0.000285556,0.00020550226],"domain_scores_gemma":[0.99854463,0.000074944655,0.00016962292,0.00044100583,0.0006525682,0.0001172088],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043982774,0.00018103894,0.00042706422,0.00021456114,0.0001343947,0.00004058013,0.0000842464,0.0001631526,0.000050243743],"category_scores_gemma":[0.00024331427,0.00019441755,0.0026231534,0.00018920159,0.0001176273,0.00023581575,0.0000314524,0.00010945245,0.0000019250624],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000250508,0.0006916207,0.9528853,0.0015936155,0.0043597296,0.000006082522,0.00040882942,0.00030372257,0.0009032954,0.00053595915,0.000065226974,0.037996095],"study_design_scores_gemma":[0.0027536612,0.0002957231,0.9911285,0.00056192407,0.0028925156,0.00011187065,0.00006374421,0.00075817626,0.00006281494,0.0005443897,0.00063830515,0.00018835936],"about_ca_topic_score_codex":0.000008602935,"about_ca_topic_score_gemma":0.000010505852,"teacher_disagreement_score":0.100533165,"about_ca_system_score_codex":0.00004218259,"about_ca_system_score_gemma":0.000032629974,"threshold_uncertainty_score":0.79281175},"labels":[],"label_agreement":null},{"id":"W2128928935","doi":"10.1503/cmaj.060664","title":"Increased risk of atherothrombotic events associated with cytochrome P450 3A5 polymorphism in patients taking clopidogrel","year":2006,"lang":"en","type":"article","venue":"Canadian Medical Association Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":204,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Clopidogrel; Medicine; Cytochrome P450; Bioinformatics; Ticlopidine; Internal medicine; Myocardial infarction; Biology; Metabolism","score_opus":0.0038450671122195993,"score_gpt":0.19590363807964534,"score_spread":0.19205857096742573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128928935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982059,0.00034016874,0.00006126287,0.00048933306,0.00009593105,0.00024166542,0.000056572593,0.0000149320485,0.0004942556],"genre_scores_gemma":[0.9986295,0.00008119307,0.000041938805,0.00074691634,0.00032620569,0.000005251464,0.00007686516,0.000028501952,0.00006361827],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966018,0.00040654754,0.0005640836,0.00017590656,0.0017640162,0.00048760552],"domain_scores_gemma":[0.9979737,0.00012770075,0.0006368569,0.00013370608,0.00037366702,0.0007543894],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013899903,0.00016893182,0.00052363495,0.00029495754,0.00014593672,0.00001793038,0.00012899807,0.00034553997,0.0009790391],"category_scores_gemma":[0.0014492855,0.00014184548,0.00025641973,0.00042989018,0.00005668941,0.00009926281,0.0000083887,0.000688537,0.000016028149],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008844313,0.0002493948,0.99463767,0.000008783056,0.00066316046,0.00027115876,0.000050390267,0.000020996691,0.000013971242,0.000022485168,0.0006506105,0.003322919],"study_design_scores_gemma":[0.008361825,0.00021066569,0.9896152,0.0004561994,0.00024943752,0.00005639691,0.000048227765,0.00006697436,0.000015496704,0.000110403984,0.0006633262,0.00014585197],"about_ca_topic_score_codex":0.009556621,"about_ca_topic_score_gemma":0.0141972415,"teacher_disagreement_score":0.008273382,"about_ca_system_score_codex":0.0012121644,"about_ca_system_score_gemma":0.0017757328,"threshold_uncertainty_score":0.9999342},"labels":[],"label_agreement":null},{"id":"W2129745430","doi":"10.1017/s1481803500012896","title":"The role of clopidogrel in the emergency department","year":2005,"lang":"en","type":"article","venue":"Canadian Journal of Emergency Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Fraser Health; Burnaby Hospital; London Health Sciences Centre","funders":"","keywords":"Medicine; Clopidogrel; Intensive care medicine; Emergency department; Acute coronary syndrome; Disease; Emergency medicine; Medical emergency; Aspirin; Myocardial infarction; Internal medicine","score_opus":0.030297815147058607,"score_gpt":0.30170035838826353,"score_spread":0.27140254324120494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129745430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79497653,0.18318698,0.000026223692,0.010459648,0.0020809856,0.0002942031,0.0000065908357,0.0000028281188,0.00896598],"genre_scores_gemma":[0.98169297,0.016328344,0.000015424712,0.00017714126,0.0014789294,0.000005138822,0.0000036313068,0.000012401732,0.00028599717],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981577,0.00013195816,0.000874942,0.0000913608,0.00044346036,0.00030059417],"domain_scores_gemma":[0.99878746,0.000039892046,0.00025343287,0.00031444806,0.00023597552,0.00036880575],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012032851,0.0001296456,0.00035048067,0.00016276812,0.00012943955,0.000001814795,0.00030553996,0.000050160805,0.001988444],"category_scores_gemma":[0.00025973548,0.00006483368,0.0003351885,0.00038442435,0.00012390071,0.000059357604,0.000004773843,0.0002468871,0.000007491463],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052392884,0.00024282574,0.5157286,0.00009499332,0.0015930836,0.000425187,0.007153692,0.00008898091,0.00078407745,0.004462753,0.14240347,0.32649842],"study_design_scores_gemma":[0.0011678819,0.00046739983,0.13488787,0.00013788641,0.00031043234,0.00012864993,0.0030062906,0.000021603631,0.000098521625,0.0007198266,0.85897005,0.00008360599],"about_ca_topic_score_codex":0.00090503163,"about_ca_topic_score_gemma":0.010665065,"teacher_disagreement_score":0.71656656,"about_ca_system_score_codex":0.000061248975,"about_ca_system_score_gemma":0.00048087531,"threshold_uncertainty_score":0.9989239},"labels":[],"label_agreement":null},{"id":"W2131470908","doi":"10.1016/s0735-1097(01)01713-2","title":"Meta-analysis of randomized and registry comparisons of ticlopidine with clopidogrel after stenting","year":2002,"lang":"en","type":"review","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":365,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"","keywords":"Ticlopidine; Clopidogrel; Medicine; Tolerability; Mace; Internal medicine; Randomized controlled trial; Adverse effect; Cardiology; Percutaneous coronary intervention; Loading dose; Clinical endpoint; Anesthesia; Myocardial infarction","score_opus":0.054100163930527766,"score_gpt":0.30952802525451883,"score_spread":0.2554278613239911,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131470908","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0074103116,0.99101514,0.00044614542,0.00009524644,0.00005743262,0.0005461705,0.00024368335,0.0000023517975,0.00018352112],"genre_scores_gemma":[0.08989702,0.9090415,0.00072830974,0.000032282856,0.00010559879,0.000016164107,0.000003909892,0.00002617188,0.00014904789],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99530756,0.0018656331,0.001901214,0.00020669904,0.0005390978,0.0001798163],"domain_scores_gemma":[0.9920874,0.0009242696,0.0057076532,0.0006955461,0.0004872272,0.00009786155],"candidate_categories":["metaepi_broad"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.0015624844,0.0003360539,0.022455242,0.0005160903,0.000026702008,0.0000026193247,0.00029005835,0.000115582734,0.0000327807],"category_scores_gemma":[0.00022532397,0.0001586116,0.0167298,0.0009427977,0.0016652574,0.000025554304,0.00007993124,0.0003675511,1.556872e-7],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013423011,0.00006813342,0.001124055,0.0027554817,0.97430974,0.00024999827,0.000019674417,0.0001473064,0.0000023559676,0.000022778086,0.0003551311,0.007522306],"study_design_scores_gemma":[0.010495544,0.00039223905,0.00030252317,0.0009772155,0.91056037,0.0021932733,0.00012723582,0.000010026363,0.0000041821845,0.0000035099497,0.074795604,0.00013828557],"about_ca_topic_score_codex":0.000008237166,"about_ca_topic_score_gemma":0.0000012491977,"teacher_disagreement_score":0.08248671,"about_ca_system_score_codex":0.000027052107,"about_ca_system_score_gemma":0.0002404416,"threshold_uncertainty_score":0.9931174},"labels":[],"label_agreement":null},{"id":"W2131849932","doi":"10.18433/j3mp4z","title":"Efficacy and Safety of Platelet Inhibitors","year":2013,"lang":"en","type":"review","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Adverse effect; Intensive care medicine; Clinical trial; Novelty; Pharmacodynamics; Disease; Pharmacology; Pharmacogenetics; Drug; Pharmacokinetics; Internal medicine; Psychology","score_opus":0.10714641465103818,"score_gpt":0.43300134389501543,"score_spread":0.32585492924397724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131849932","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0065430994,0.991611,0.000020808598,0.00017082329,0.00044905726,0.00071646273,0.00001368438,0.000013008843,0.00046205465],"genre_scores_gemma":[0.0043189093,0.99448895,0.0002562469,0.00015275304,0.00071029994,0.0000051557527,0.000003045037,0.000026042297,0.000038582777],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99646413,0.00033052434,0.0014287652,0.000316395,0.0010661968,0.00039399674],"domain_scores_gemma":[0.997695,0.0004656217,0.0008309983,0.00014877066,0.00019703062,0.0006625321],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016017366,0.00039632004,0.0023084525,0.00036093054,0.00013275696,0.000052744468,0.00038819865,0.000121499856,0.00068231596],"category_scores_gemma":[0.00015411203,0.00023874493,0.0013115025,0.00063126243,0.0010124395,0.0003011216,0.00010763167,0.00079250196,0.000021446913],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003086665,0.00022543648,0.000060266033,0.0047498005,0.0010895465,0.00016957414,0.000028879875,0.0000019210738,0.000096537915,0.00003561574,0.0006577769,0.992576],"study_design_scores_gemma":[0.0037502337,0.00028592828,0.000014387168,0.0059271073,0.0039102403,0.0026074138,0.000024120569,0.000027505623,0.0007633444,0.000011069103,0.9824514,0.00022725145],"about_ca_topic_score_codex":0.0000038144706,"about_ca_topic_score_gemma":4.0378037e-8,"teacher_disagreement_score":0.99234873,"about_ca_system_score_codex":0.0000576434,"about_ca_system_score_gemma":0.0007124643,"threshold_uncertainty_score":0.97357357},"labels":[],"label_agreement":null},{"id":"W2132239648","doi":"10.1517/14656566.2014.853039","title":"An aspirin a day? Aspirin use across a spectrum of risk: cardiovascular disease, cancers and bleeds","year":2013,"lang":"en","type":"editorial","venue":"Expert Opinion on Pharmacotherapy","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Aspirin; Primary prevention; Disease; Secondary prevention; Intensive care medicine; Context (archaeology); Adverse effect; Platelet aggregation inhibitor; Population; Internal medicine; Environmental health","score_opus":0.02116803437083587,"score_gpt":0.33934537443845597,"score_spread":0.3181773400676201,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132239648","genre_codex":"editorial","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08773152,0.37060684,0.00055789674,0.00024368158,0.5332555,0.003428038,0.0035232236,0.00048331704,0.0001699471],"genre_scores_gemma":[0.025606876,0.5294756,0.0001163385,0.0006748706,0.44146988,0.0004254357,0.0016690115,0.00039574676,0.00016623612],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99427974,0.0006921776,0.0007199451,0.0014138321,0.0021005976,0.00079369405],"domain_scores_gemma":[0.99617875,0.00032256008,0.00038510468,0.0018537206,0.00028783697,0.00097203907],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00081686786,0.0009844599,0.0018830177,0.0002750684,0.00028350868,0.0001641797,0.00043344987,0.0006586469,0.0003350987],"category_scores_gemma":[0.00007954631,0.0008627692,0.0018817396,0.0003194436,0.0003950708,0.0004234145,0.00006225187,0.0010773833,0.0000277212],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01258927,0.0015711606,0.0014223127,0.0008560983,0.033361223,0.0002977853,0.0030681398,0.00094550004,0.001247447,0.000041455427,0.7206706,0.223929],"study_design_scores_gemma":[0.010368986,0.0008122448,0.0011214011,0.0010469264,0.0004535872,0.000011625979,0.00015022265,0.00022373232,0.002412769,0.000023884397,0.98248774,0.0008868634],"about_ca_topic_score_codex":0.002150916,"about_ca_topic_score_gemma":0.000008528825,"teacher_disagreement_score":0.26181716,"about_ca_system_score_codex":0.00028763094,"about_ca_system_score_gemma":0.0005884877,"threshold_uncertainty_score":0.9993823},"labels":[],"label_agreement":null},{"id":"W2132247347","doi":"10.1016/s1474-4422(07)70250-8","title":"Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial","year":2007,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":558,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Canadian Institutes of Health Research; Sanofi","keywords":"Medicine; Stroke (engine); Clopidogrel; Placebo; Aspirin; Internal medicine; Relative risk; Randomized controlled trial; Absolute risk reduction; Surgery; Anesthesia; Confidence interval","score_opus":0.03280484385702336,"score_gpt":0.3193459786047938,"score_spread":0.28654113474777043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132247347","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897849,0.0007470144,0.0025966861,0.0020794382,0.00027376437,0.0029991956,0.000016802729,0.000026314783,0.0014758754],"genre_scores_gemma":[0.9971804,0.00026578875,0.0000753124,0.001846912,0.0003797425,0.00009859488,0.000003624672,0.000014404356,0.00013522748],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99836665,0.000380744,0.00039627962,0.00026415117,0.0002626936,0.00032947917],"domain_scores_gemma":[0.9989379,0.00037599352,0.0001175302,0.00038654727,0.000053220443,0.00012878652],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013422801,0.00015847228,0.0010099278,0.00006764582,0.000049154554,0.000007988288,0.0001410003,0.000057330675,0.00004360616],"category_scores_gemma":[0.00007249963,0.00009975049,0.00025666444,0.0000896131,0.00013378686,0.000024743824,0.000032864617,0.00024922445,0.0000045634197],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9748735,0.00049728993,0.0016601902,0.000053127857,0.00071081147,0.00008742165,0.0004164171,0.000064586755,0.010271556,0.0000934424,0.00044365,0.010828021],"study_design_scores_gemma":[0.8845586,0.013646825,0.09371831,0.00005313681,0.00078690593,0.00017193962,0.0000456403,0.00020871656,0.0009500434,0.000023410728,0.005658322,0.00017810115],"about_ca_topic_score_codex":0.000008405615,"about_ca_topic_score_gemma":0.000008938741,"teacher_disagreement_score":0.09205812,"about_ca_system_score_codex":0.000007756107,"about_ca_system_score_gemma":0.000054716656,"threshold_uncertainty_score":0.4067707},"labels":[],"label_agreement":null},{"id":"W2132569473","doi":"10.1111/j.1440-1746.2010.06366.x","title":"Proton pump inhibitor and clopidogrel interaction: The case for watchful waiting","year":2010,"lang":"en","type":"review","venue":"Journal of Gastroenterology and Hepatology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Clopidogrel; Medicine; Proton-pump inhibitor; Watchful waiting; Adverse effect; Intensive care medicine; Aspirin; Internal medicine; Cancer","score_opus":0.032947387904120565,"score_gpt":0.33116822455924794,"score_spread":0.2982208366551274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132569473","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16312957,0.83401453,0.00016125233,0.0010917141,0.0006692738,0.00090527284,0.000013211832,0.0000068700583,0.000008335347],"genre_scores_gemma":[0.018488739,0.97966236,0.00016523892,0.0004787673,0.0010670983,0.00008275295,0.00001025086,0.00002804541,0.000016733384],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99838275,0.00032000677,0.000728398,0.00021889913,0.0000757681,0.00027418192],"domain_scores_gemma":[0.9985691,0.0002570876,0.00070269144,0.00017690274,0.00014665372,0.0001476065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064628077,0.00026877096,0.0018446748,0.00015839588,0.00016801115,0.000020419731,0.00008681496,0.0004106399,0.000018476525],"category_scores_gemma":[0.000097130716,0.00015272744,0.00076079665,0.00003689854,0.00033430426,0.00006913359,0.000055543038,0.0011047068,9.544103e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003069538,0.00014039634,0.008600391,0.008310429,0.0027471168,0.006703535,0.00010418327,7.045567e-8,0.000002218569,0.00007611462,0.00047375794,0.9697722],"study_design_scores_gemma":[0.0013525704,0.0015972108,0.000026316953,0.0010239654,0.0026384634,0.37017462,0.00007333921,0.000010753998,0.0000015869988,0.00003340518,0.62301296,0.000054802793],"about_ca_topic_score_codex":0.0000027103622,"about_ca_topic_score_gemma":0.000019595553,"teacher_disagreement_score":0.96971744,"about_ca_system_score_codex":0.000020550859,"about_ca_system_score_gemma":0.00011278156,"threshold_uncertainty_score":0.62280446},"labels":[],"label_agreement":null},{"id":"W2132802124","doi":"","title":"Antiplaquettaires pour le syndrome coronarien aigu, lequel choisir?","year":2012,"lang":"fr","type":"article","venue":"","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Gynecology; Medicine","score_opus":0.01809582253315033,"score_gpt":0.2593911924609286,"score_spread":0.24129536992777828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132802124","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6033443,0.3512915,0.003612179,0.0057129916,0.0034642108,0.00054468325,0.000049531674,0.00023133088,0.031749252],"genre_scores_gemma":[0.92784315,0.004511893,0.0006748856,0.0017862519,0.0020483218,0.000022613345,0.00006843976,0.000094856136,0.062949575],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968614,0.00027190032,0.00045018658,0.0004395611,0.0005687751,0.001408152],"domain_scores_gemma":[0.9979895,0.00013661817,0.00009773295,0.0007634416,0.00010680559,0.00090595527],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00069634797,0.00046993414,0.0008067439,0.00012225307,0.0002358121,0.00005739469,0.00024231497,0.0003830648,0.005702256],"category_scores_gemma":[0.00009321342,0.00043461382,0.0008826881,0.0002796462,0.0003900451,0.00075093674,0.00010389878,0.00038037324,0.004221189],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001113794,0.007389141,0.36794615,0.002082065,0.012225034,0.0051456196,0.002274172,0.00013146385,0.0074267723,0.12330981,0.14503314,0.32592285],"study_design_scores_gemma":[0.006402273,0.00041607235,0.49982518,0.0007926954,0.0016604027,0.00925868,0.003693403,0.00021763112,0.0051730466,0.0005067153,0.4710329,0.0010210099],"about_ca_topic_score_codex":0.0008473946,"about_ca_topic_score_gemma":0.000010551217,"teacher_disagreement_score":0.3467796,"about_ca_system_score_codex":0.00014301622,"about_ca_system_score_gemma":0.00062184595,"threshold_uncertainty_score":0.9998106},"labels":[],"label_agreement":null},{"id":"W2134322421","doi":"10.1056/nejmoa1109719","title":"Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes","year":2011,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":753,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Thrombin; Antagonist; Cardiology; Medicine; Internal medicine; Receptor antagonist; Receptor; Pharmacology; Platelet","score_opus":0.02951225523606125,"score_gpt":0.2674083577149176,"score_spread":0.23789610247885637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134322421","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9837568,0.0115883555,0.00049207377,0.0015098554,0.0007717483,0.00015084638,0.0000033368674,0.00001725612,0.001709759],"genre_scores_gemma":[0.9902606,0.006590577,0.0009155463,0.00061845576,0.0012334916,9.596083e-7,0.000008806886,0.000024254268,0.0003472879],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9984731,0.000104974206,0.00054226385,0.00014344082,0.00050490594,0.00023130848],"domain_scores_gemma":[0.99903506,0.00005629981,0.00020588958,0.00021188226,0.00011529983,0.00037555012],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006994507,0.00018242653,0.0007929314,0.00023472341,0.00003689657,0.0000044264484,0.00014713511,0.000082462,0.0019645223],"category_scores_gemma":[0.000079743906,0.00011747021,0.00023712406,0.00020893243,0.00018334424,0.0001281517,0.000016481124,0.0003603938,0.00001683019],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02561276,0.0014767982,0.39964798,0.00025366034,0.0075800144,0.036439084,0.009684724,0.000039420476,0.021261897,0.00050386455,0.032934655,0.46456516],"study_design_scores_gemma":[0.25486282,0.012361689,0.58577424,0.002759619,0.0031102279,0.070293956,0.0019728174,0.000034210876,0.0041954764,0.0012678469,0.06282429,0.0005428002],"about_ca_topic_score_codex":0.0000768036,"about_ca_topic_score_gemma":0.000005799112,"teacher_disagreement_score":0.46402234,"about_ca_system_score_codex":0.00004321355,"about_ca_system_score_gemma":0.00021249824,"threshold_uncertainty_score":0.9989478},"labels":[],"label_agreement":null},{"id":"W2134834771","doi":"10.1016/j.cjca.2014.07.596","title":"BLEEDING AND ISCHEMIC EVENTS IN CANADIAN PATIENTS WITH MYOCARDIAL INFARCTION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: INSIGHTS FROM THE CANADIAN OBSERVATIONAL ANTIPLATELET STUDY (COAPT) AT 1 YEAR","year":2014,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Toronto Public Health","funders":"","keywords":"Medicine; Clopidogrel; Percutaneous coronary intervention; Prasugrel; Internal medicine; Mace; Ticagrelor; Myocardial infarction; Cardiogenic shock; Cardiology; Conventional PCI; Population","score_opus":0.012996200337421807,"score_gpt":0.21419088408123318,"score_spread":0.2011946837438114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134834771","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99699336,0.0009592821,0.000016487873,0.0004312649,0.00039545135,0.00033093913,0.000039551465,0.0000035326013,0.0008301467],"genre_scores_gemma":[0.9988587,0.00006381609,0.000016886012,0.00041101195,0.0005093374,0.0000039397314,0.00009465822,0.000023915813,0.000017734337],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99851066,0.0002888696,0.0003382527,0.00021840156,0.00023984672,0.00040398436],"domain_scores_gemma":[0.9983649,0.00012320832,0.00011446097,0.00019309338,0.00022715743,0.0009771293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003740658,0.00017885811,0.00048236246,0.00035276206,0.000342798,0.000025853407,0.00013882901,0.00015037732,0.000038069593],"category_scores_gemma":[0.00015791168,0.00013853134,0.00016193047,0.0001650273,0.00012561741,0.000131465,0.000014072194,0.00034834936,0.000006315991],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002178918,0.0000054191196,0.99539816,0.000005110559,0.000920143,0.00053757156,0.00033612573,0.0004859199,0.000013277609,0.000022703265,0.0003655821,0.0016920858],"study_design_scores_gemma":[0.0029771419,0.0005411748,0.96620303,0.0001038666,0.00028585776,0.0011503424,0.00049955334,0.000020706815,0.0000014289394,0.000045069955,0.028028993,0.00014280668],"about_ca_topic_score_codex":0.6656795,"about_ca_topic_score_gemma":0.98785406,"teacher_disagreement_score":0.32217455,"about_ca_system_score_codex":0.0011501295,"about_ca_system_score_gemma":0.0025199186,"threshold_uncertainty_score":0.5649144},"labels":[],"label_agreement":null},{"id":"W2134918607","doi":"10.1002/lsm.1069","title":"Fluorescence spectroscopic analysis of circulating platelet activation during coronary angioplasty","year":2001,"lang":"en","type":"article","venue":"Lasers in Surgery and Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"London Health Sciences Centre","keywords":"Platelet activation; Platelet; Thrombus; Chemistry; Biophysics; Internal medicine; Medicine; Cardiology; Biology","score_opus":0.016674292260075014,"score_gpt":0.26017435204091516,"score_spread":0.24350005978084013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134918607","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99816614,0.0010706588,0.00010064963,0.00017670069,0.00006669574,0.00012924288,0.0000023993664,0.000024751564,0.00026275095],"genre_scores_gemma":[0.9975698,0.002046248,0.000037248075,0.00011837854,0.00008607616,0.0000051790976,0.00006810444,0.000009487562,0.00005946133],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989231,0.00005460066,0.00033548597,0.00022864547,0.0002589479,0.00019920708],"domain_scores_gemma":[0.9993357,0.00023820161,0.000097319484,0.00019057648,0.00003525886,0.000102932056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032913324,0.00012531724,0.0006997859,0.00049552455,0.00005021462,0.0000023851605,0.00002715629,0.000065012064,0.00021525632],"category_scores_gemma":[0.00015160881,0.00010452275,0.00018504541,0.0010401125,0.00013847735,0.00008760198,0.000012421539,0.00011071901,6.7127826e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065508485,0.00006638755,0.9607089,0.00012064014,0.00088539155,0.00055075367,0.00021875408,0.00011733433,0.027364226,0.00001554223,0.000024788109,0.00927218],"study_design_scores_gemma":[0.0012473823,0.000052633735,0.98979515,0.0005242506,0.00058450334,0.000108267755,0.00038878724,0.0003820511,0.006709058,0.00001615361,0.00010114568,0.00009059289],"about_ca_topic_score_codex":0.0000780352,"about_ca_topic_score_gemma":0.000013432403,"teacher_disagreement_score":0.029086256,"about_ca_system_score_codex":0.00002641207,"about_ca_system_score_gemma":0.000033251537,"threshold_uncertainty_score":0.42623138},"labels":[],"label_agreement":null},{"id":"W2135780868","doi":"10.1056/nejmoa020798","title":"Aspirin and Mortality from Coronary Bypass Surgery","year":2002,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":677,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Texas Health Science Center at San Antonio; Karl-Franzens-Universität Graz; Rheinische Friedrich-Wilhelms-Universität Bonn; Institut de Cardiologie de Montréal; Julius-Maximilians-Universität Würzburg; Universität Heidelberg; York University; University of Arkansas for Medical Sciences; Texas Heart Institute; University of Ottawa; Thomas Jefferson University; Yale University; University of Washington; Faculty of Medicine Siriraj Hospital, Mahidol University; University of Toronto; University of Rochester; Emory University; Massachusetts General Hospital; University of Alberta; U.S. Department of Veterans Affairs","keywords":"Medicine; Aspirin; Bypass surgery; Cardiology; Surgery; Internal medicine; Coronary artery bypass surgery; Artery","score_opus":0.04302693633568632,"score_gpt":0.2642442064293876,"score_spread":0.2212172700937013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135780868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9495364,0.045972526,0.0002223846,0.0030548703,0.0004107465,0.000047804042,0.000003846192,0.0000127808435,0.00073864055],"genre_scores_gemma":[0.9857899,0.008517613,0.00008856592,0.0010536738,0.004217706,3.792959e-7,0.0000082720335,0.000013729,0.00031018804],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9987079,0.000100877936,0.00042481045,0.0001225915,0.00049849384,0.00014530713],"domain_scores_gemma":[0.998863,0.00027764143,0.00017179029,0.00017939025,0.00008941631,0.00041878645],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006002174,0.00013338929,0.0006738294,0.00010289645,0.00003607241,0.000006134402,0.000053411044,0.00006123305,0.0013077427],"category_scores_gemma":[0.0001849736,0.00008605798,0.00019379784,0.00009125642,0.00012553837,0.00008678802,0.000011542093,0.00023712733,0.000006397146],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068350194,0.00009266726,0.36916363,0.00003640501,0.0011555442,0.002957405,0.00032466417,0.0000025856848,0.00094407616,0.000012356444,0.018810442,0.6058167],"study_design_scores_gemma":[0.041095007,0.0007323309,0.8285171,0.0006853971,0.0013266326,0.005134396,0.00014001681,0.000041000098,0.00019074393,0.00041944967,0.121573195,0.0001447654],"about_ca_topic_score_codex":0.000098636934,"about_ca_topic_score_gemma":0.000007944524,"teacher_disagreement_score":0.60567194,"about_ca_system_score_codex":0.00001686187,"about_ca_system_score_gemma":0.0000507664,"threshold_uncertainty_score":0.9996052},"labels":[],"label_agreement":null},{"id":"W2136228924","doi":"10.1056/nejmoa0908628","title":"Platelet Inhibition with Cangrelor in Patients Undergoing PCI","year":2009,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":618,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Heart Research Centre; St. Michael's Hospital","funders":"","keywords":"Cangrelor; P2Y12; Medicine; Adenosine diphosphate; Adenosine; Conventional PCI; Platelet; Adenosine triphosphate; Pharmacology; Anesthesia; Internal medicine; Cardiology; Platelet aggregation; Myocardial infarction","score_opus":0.007796642200202356,"score_gpt":0.22693813854739375,"score_spread":0.2191414963471914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136228924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99345976,0.0017757181,0.00037840632,0.0032838879,0.00011362318,0.00012775854,5.799409e-7,0.000009042673,0.0008512284],"genre_scores_gemma":[0.99667287,0.0006161378,0.00018913353,0.001203225,0.0012314339,2.5859725e-7,0.000009481727,0.000010013098,0.000067423105],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9988454,0.000052209278,0.00034328303,0.000095334006,0.00050514564,0.00015860132],"domain_scores_gemma":[0.9993298,0.00005413687,0.00015875736,0.00010359736,0.00012893777,0.0002247601],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003601411,0.00012038166,0.00043513783,0.00021210813,0.00002510168,0.000004879951,0.000038645623,0.000048244852,0.000080256264],"category_scores_gemma":[0.000117896656,0.000071464565,0.00007934484,0.0001939298,0.000040062852,0.00010738433,0.000003092429,0.0002474003,0.0000019225868],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010676093,0.00032497584,0.11554801,0.00005167178,0.00031342366,0.0025381283,0.00092025014,0.00015376919,0.0004703916,0.00009312205,0.0034797178,0.8654305],"study_design_scores_gemma":[0.4257013,0.014323783,0.53771,0.0032300027,0.00039368594,0.0031465346,0.00029038248,0.000012234871,0.00072049984,0.0006926443,0.013584898,0.00019404858],"about_ca_topic_score_codex":0.000020172885,"about_ca_topic_score_gemma":0.000025040867,"teacher_disagreement_score":0.8652364,"about_ca_system_score_codex":0.0000592411,"about_ca_system_score_gemma":0.00018116433,"threshold_uncertainty_score":0.29142404},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"split"},{"id":"W2136229214","doi":"10.1097/01.hjr.0000152239.28456.36","title":"The cost-effectiveness of the use of clopidogrel in acute coronary syndromes in five countries based upon the CURE study","year":2004,"lang":"en","type":"article","venue":"European Journal of Cardiovascular Prevention & Rehabilitation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"European Society of Cardiology","keywords":"Clopidogrel; Medicine; Euros; Unstable angina; Emergency medicine; Cost effectiveness; Health economics; Myocardial infarction; Internal medicine; Public health","score_opus":0.024435170655226823,"score_gpt":0.27699803902267817,"score_spread":0.25256286836745134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136229214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98673874,0.0076847156,0.0029888165,0.00027736873,0.000199832,0.0020850487,0.00000634879,0.000005398956,0.000013711271],"genre_scores_gemma":[0.99881643,0.0008931959,0.00018365875,0.000016436908,0.00002947645,0.00002372686,0.0000038423,0.000024105178,0.0000091052525],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99043953,0.0074854125,0.0008285365,0.00017513403,0.0009261234,0.00014528376],"domain_scores_gemma":[0.99760675,0.00079806306,0.00041881765,0.0006500963,0.0004874299,0.00003886208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009067611,0.00015988952,0.00060145865,0.00015151249,0.0001010523,0.000022918,0.00024747622,0.000035231726,0.0000033588303],"category_scores_gemma":[0.0005668681,0.000086507855,0.0018594336,0.00048114252,0.00028173006,0.00023855513,0.000043266828,0.00030150235,0.0000011467348],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010966579,0.0032850606,0.2528507,0.001019446,0.01732172,0.0007614892,0.0067345807,0.61238575,0.0005341346,0.00036160543,0.000050306233,0.093728594],"study_design_scores_gemma":[0.009712285,0.0018798322,0.9807797,0.0015697769,0.0014260946,0.0001791385,0.0017448256,0.00004051148,0.0002221817,0.0001602792,0.00219762,0.000087742046],"about_ca_topic_score_codex":0.000022999206,"about_ca_topic_score_gemma":0.000013669349,"teacher_disagreement_score":0.727929,"about_ca_system_score_codex":0.00014808662,"about_ca_system_score_gemma":0.00024091922,"threshold_uncertainty_score":0.35276878},"labels":[],"label_agreement":null},{"id":"W2137474883","doi":"10.1161/circulationaha.113.008227","title":"Impact of Clopidogrel Plus Aspirin Versus Aspirin Alone on the Progression of Native Coronary Artery Disease After Bypass Surgery","year":2014,"lang":"en","type":"article","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Aspirin; Clopidogrel; Coronary artery disease; Cardiology; Coronary artery bypass surgery; Surgery; Internal medicine; Disease; Artery; Bypass surgery","score_opus":0.027205880794554105,"score_gpt":0.2940678693038584,"score_spread":0.2668619885093043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137474883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977617,0.00089282054,0.00040449956,0.000102926184,0.00014919683,0.00037950554,0.000022045357,0.000027550988,0.00025974918],"genre_scores_gemma":[0.9995332,0.000036701385,0.000010095926,0.00006228249,0.0001411531,0.00004342954,0.0001422193,0.000022014576,0.000008924591],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99866146,0.00021403044,0.000289756,0.00021259459,0.00046324104,0.00015890271],"domain_scores_gemma":[0.99880034,0.00032181374,0.00018313258,0.00043291264,0.00014342056,0.00011837496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003562849,0.00015751562,0.00037094104,0.00010815971,0.000046158428,0.0000066328766,0.00005485246,0.0000717848,0.00009844612],"category_scores_gemma":[0.00015827846,0.000103486615,0.00064246915,0.0001768173,0.0001397492,0.0000866046,0.000018395831,0.000098835895,0.000012114439],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015331634,0.00046168047,0.900308,0.00023871957,0.001162347,0.000058904447,0.00018392931,0.0011559749,0.0012282267,0.0002084429,0.00013244925,0.07952965],"study_design_scores_gemma":[0.002053121,0.00029212597,0.9950765,0.0004331412,0.00026820236,0.000007553256,0.00001999635,0.0011429932,0.0004323021,0.00006858477,0.00009685695,0.00010865562],"about_ca_topic_score_codex":0.000008361806,"about_ca_topic_score_gemma":8.5950313e-7,"teacher_disagreement_score":0.09476843,"about_ca_system_score_codex":0.000069799076,"about_ca_system_score_gemma":0.00015825882,"threshold_uncertainty_score":0.42200616},"labels":[],"label_agreement":null},{"id":"W2138058610","doi":"10.1161/circulationaha.108.791061","title":"Greater Clinical Benefit of More Intensive Oral Antiplatelet Therapy With Prasugrel in Patients With Diabetes Mellitus in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel–Thrombolysis in Myocardial Infarction 38","year":2008,"lang":"en","type":"article","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":757,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Prasugrel; Medicine; Clopidogrel; Internal medicine; TIMI; Myocardial infarction; Cardiology; Diabetes mellitus; Hazard ratio; Stroke (engine); Thrombolysis; Endocrinology; Confidence interval","score_opus":0.0357255022373527,"score_gpt":0.2852329244042375,"score_spread":0.24950742216688476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138058610","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958883,0.0002380252,0.00031620776,0.0002812334,0.000060842638,0.0031714637,0.000013471607,0.000020066265,0.000010407167],"genre_scores_gemma":[0.9985026,0.0001620072,0.000117619726,0.00070789177,0.000035822522,0.00020644612,0.00022287601,0.000043660955,0.0000010862265],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971705,0.0003219583,0.0008231655,0.0005401622,0.0007619094,0.00038232634],"domain_scores_gemma":[0.99886,0.00013000237,0.0002747777,0.0003905002,0.0002733649,0.000071337825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078174553,0.00034247994,0.0009922261,0.00046191295,0.000054313325,0.000025942969,0.00009383102,0.00019880099,0.000008212235],"category_scores_gemma":[0.00004532617,0.00021213846,0.0001688482,0.00093243545,0.00016004803,0.00033114591,0.000017837378,0.0003801744,0.0000011416836],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026698593,0.0009154211,0.95541567,0.00002467635,0.00048128612,0.000050047212,0.0017973285,0.005633873,0.00033378197,0.000005579612,0.000003336902,0.008640407],"study_design_scores_gemma":[0.075252764,0.0024392642,0.91989213,0.00034118965,0.00009822531,0.0000068872296,0.0007974325,0.00027763948,0.0006067369,0.000016379883,0.0000074496797,0.00026387552],"about_ca_topic_score_codex":0.0001975976,"about_ca_topic_score_gemma":0.00009872804,"teacher_disagreement_score":0.04855417,"about_ca_system_score_codex":0.00020258692,"about_ca_system_score_gemma":0.000112130154,"threshold_uncertainty_score":0.8650755},"labels":[],"label_agreement":null},{"id":"W2138604875","doi":"10.1038/clpt.2009.98","title":"New Antithrombotic Drugs","year":2009,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Antithrombotic; Hemostasis; Medicine; Thrombosis; Intensive care medicine; Fibrinolytic agent; Platelet; Pharmacology; Internal medicine","score_opus":0.15986582646157363,"score_gpt":0.4988658099130718,"score_spread":0.3389999834514982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138604875","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000030153064,0.9937995,0.00026468936,0.0008807529,0.0025771563,0.0013809721,0.000014935799,0.00023709038,0.00081476354],"genre_scores_gemma":[0.000006023957,0.9519701,0.00054023345,0.041120626,0.004242153,0.000019503963,0.00011885343,0.00012954742,0.0018529856],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99581003,0.00087493093,0.001474793,0.0008484999,0.00037439424,0.00061733974],"domain_scores_gemma":[0.9974317,0.000635959,0.00044215834,0.0007557872,0.00010033761,0.0006340891],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00066657766,0.00073424424,0.0046151415,0.00016454364,0.00010912984,0.000026792866,0.0004740638,0.0012108182,0.0011750464],"category_scores_gemma":[0.000012727438,0.0005628977,0.0045720995,0.00040494135,0.00036002052,0.00005108071,0.00008202987,0.0017719218,0.0010748262],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014174478,0.00051583623,0.000015570864,0.0016379977,0.010714549,0.00027748314,0.000014273908,2.8157874e-7,9.87579e-7,0.000008155389,0.03958672,0.9470864],"study_design_scores_gemma":[0.0028422768,0.00061907625,0.000057291563,0.001987784,0.057561055,0.00025503128,0.0000055089804,0.0000042224724,0.0000026079883,0.000058490987,0.9361363,0.00047035684],"about_ca_topic_score_codex":0.0000012793421,"about_ca_topic_score_gemma":1.1480617e-7,"teacher_disagreement_score":0.94661605,"about_ca_system_score_codex":0.00009438071,"about_ca_system_score_gemma":0.0016660747,"threshold_uncertainty_score":0.99973804},"labels":[],"label_agreement":null},{"id":"W2138696762","doi":"10.1161/01.cir.103.21.2572","title":"Point-of-Care Measured Platelet Inhibition Correlates With a Reduced Risk of an Adverse Cardiac Event After Percutaneous Coronary Intervention","year":2001,"lang":"en","type":"article","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":359,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Mace; Percutaneous coronary intervention; Conventional PCI; Internal medicine; Myocardial infarction; Cardiology; Platelet; Loading dose; Odds ratio","score_opus":0.00686730293768508,"score_gpt":0.22747195385924973,"score_spread":0.22060465092156464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138696762","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99530303,0.002563521,0.0011853677,0.00000989108,0.00010314964,0.0006447016,0.000040073755,0.000051267136,0.00009896847],"genre_scores_gemma":[0.9989591,0.00024452395,0.00014314248,0.000011134817,0.00006322863,0.000024219802,0.0005156095,0.000029332736,0.000009713534],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986802,0.00019331662,0.000346363,0.00025384818,0.00039032914,0.00013597729],"domain_scores_gemma":[0.9990464,0.000019440227,0.00021847396,0.00032280455,0.00030429868,0.00008859982],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020901575,0.00015629147,0.0003742294,0.00012025916,0.000047528,0.000004771833,0.000030328958,0.0001222802,0.00011422998],"category_scores_gemma":[0.000031751275,0.00013944687,0.00046523448,0.0001802228,0.00008068161,0.00020500053,0.000009617824,0.000116017814,0.0000064561486],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020882986,0.0009040853,0.7248559,0.00077801675,0.0024153055,0.0010121932,0.0043726726,0.009693169,0.045872897,0.000031726486,0.000011413465,0.18916965],"study_design_scores_gemma":[0.003358009,0.00085425226,0.9812869,0.000884384,0.0013699171,0.0012388512,0.0022691586,0.0009607619,0.007402438,0.00008744729,0.00006909435,0.00021883001],"about_ca_topic_score_codex":0.00003908354,"about_ca_topic_score_gemma":0.0000093136705,"teacher_disagreement_score":0.25643095,"about_ca_system_score_codex":0.000091960814,"about_ca_system_score_gemma":0.000050411796,"threshold_uncertainty_score":0.5686478},"labels":[],"label_agreement":null},{"id":"W2139734600","doi":"10.1503/cmaj.1031185","title":"Current and future concepts in stroke prevention","year":2004,"lang":"en","type":"review","venue":"Canadian Medical Association Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Royal Alexandra Hospital; University of Alberta Hospital","funders":"","keywords":"Medicine; Stroke (engine); Carotid endarterectomy; Intensive care medicine; Psychological intervention; Population; Internal medicine; Carotid arteries","score_opus":0.013732090785019954,"score_gpt":0.31963275562305776,"score_spread":0.3059006648380378,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139734600","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012598725,0.9974081,0.0000105494255,0.0009886544,0.00086662703,0.00032063306,0.000037745,0.000008246894,0.0002334762],"genre_scores_gemma":[0.000043878386,0.9955993,0.000013293927,0.00032670342,0.003763381,0.000012950479,0.000076276476,0.000022288423,0.00014188132],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99758595,0.00030849132,0.00054306316,0.00019519753,0.0010096483,0.0003576764],"domain_scores_gemma":[0.9980483,0.000046469224,0.00026140807,0.000096475174,0.000113251255,0.0014340807],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010952196,0.00020833054,0.0010353856,0.0002992949,0.00009439643,0.00004935444,0.000094984796,0.0007199214,0.0011229502],"category_scores_gemma":[0.0002460048,0.00016971867,0.0006342913,0.00020225257,0.00003296646,0.00006444996,0.00000902902,0.0017131635,0.000039695897],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000030284355,0.000026364525,0.00041434573,0.0013696487,0.00036341246,0.00059669086,0.000032590615,4.959386e-8,2.1733593e-9,0.00005204447,0.0015114294,0.9956304],"study_design_scores_gemma":[0.0013246222,0.00004064081,0.00069122313,0.013474419,0.0005822227,0.0014814807,0.00006256281,6.0946735e-7,1.2917683e-8,0.000036106336,0.98216367,0.00014244317],"about_ca_topic_score_codex":0.00011217147,"about_ca_topic_score_gemma":0.0014873229,"teacher_disagreement_score":0.9954879,"about_ca_system_score_codex":0.0017056678,"about_ca_system_score_gemma":0.010219633,"threshold_uncertainty_score":0.99979013},"labels":[],"label_agreement":null},{"id":"W2140261980","doi":"10.1093/eurheartj/ehm226","title":"A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease","year":2007,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":524,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital du Sacré-Cœur de Montréal","funders":"","keywords":"Medicine; Aspirin; Coronary artery disease; Internal medicine; Cardiology; Platelet; Disease","score_opus":0.024091341320437117,"score_gpt":0.27605279107910946,"score_spread":0.25196144975867235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140261980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99695283,0.0018631157,0.00039880342,0.00007225258,0.000065399414,0.00034174236,0.000014670637,0.000008880142,0.00028232843],"genre_scores_gemma":[0.9991604,0.000027240882,0.00028442492,0.00019723494,0.00008619206,0.0000011500857,0.0000049447203,0.00002287592,0.00021554889],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99855703,0.00020158227,0.00040787502,0.00015022731,0.00046981915,0.00021349237],"domain_scores_gemma":[0.99913865,0.00007081196,0.00015362214,0.00028240393,0.00014198267,0.00021250462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008307013,0.00011705714,0.00027936537,0.00010501918,0.00007009994,0.0000102705,0.00009868949,0.000014793188,0.00006762683],"category_scores_gemma":[0.000060581693,0.00007692964,0.00012089444,0.0001991244,0.000074074975,0.00009407846,0.000025816202,0.00020443213,0.00000903986],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0098246485,0.00043324856,0.9838568,0.00022214976,0.000097248805,0.00024701896,0.00017280798,0.00007773037,0.00044026162,0.0000024326425,0.00046395208,0.0041617285],"study_design_scores_gemma":[0.002462207,0.0009086709,0.992133,0.0007623614,0.00012693524,0.000050936454,0.000052480504,0.0000053388458,0.0003405124,0.0000037903071,0.0030711433,0.000082614024],"about_ca_topic_score_codex":9.899134e-7,"about_ca_topic_score_gemma":0.0000093665485,"teacher_disagreement_score":0.008276237,"about_ca_system_score_codex":0.00003009313,"about_ca_system_score_gemma":0.000059401737,"threshold_uncertainty_score":0.31370994},"labels":[],"label_agreement":null},{"id":"W2141210626","doi":"10.1111/j.1572-0241.2008.01995.x","title":"Efficacy of Esomeprazole (20 mg Once Daily) for Reducing the Risk of Gastroduodenal Ulcers Associated With Continuous Use of Low-Dose Aspirin","year":2008,"lang":"en","type":"article","venue":"The American Journal of Gastroenterology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":209,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"AstraZeneca","keywords":"Esomeprazole; Medicine; Heartburn; Gastroenterology; Internal medicine; Aspirin; Placebo; Population; Proton-pump inhibitor; Adverse effect; Reflux","score_opus":0.013937976018262795,"score_gpt":0.23670350013856778,"score_spread":0.22276552412030498,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141210626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956948,0.00027725557,0.0032741553,0.00035233246,0.00005362971,0.0002884266,0.000049142724,0.0000057425596,0.0000044954395],"genre_scores_gemma":[0.9984249,0.0004070788,0.0007887708,0.00022752612,0.00009958353,0.000003703894,0.000005733338,0.000025784428,0.00001692801],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978258,0.00058787613,0.00071877183,0.000149506,0.000388729,0.00032932128],"domain_scores_gemma":[0.99613005,0.00052556297,0.0023641302,0.00041351907,0.00046475301,0.000101997284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008753587,0.00017664177,0.0012365639,0.00012038664,0.000081213504,0.0000035941753,0.00029145274,0.000028065246,0.00000908719],"category_scores_gemma":[0.00037256934,0.000096281496,0.0006701572,0.00020636946,0.0017161685,0.0000701905,0.000035321194,0.00031748653,2.3153866e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18616383,0.0013168971,0.752383,0.00006052475,0.011080376,0.00014810568,0.0018845854,0.017940065,0.021637663,0.000005845137,0.00047743338,0.006901666],"study_design_scores_gemma":[0.014427357,0.033201523,0.9406002,0.0005676338,0.0023897,0.002435169,0.0014730896,0.0002516699,0.0044602063,0.000008498451,0.000088841545,0.000096120944],"about_ca_topic_score_codex":0.00005456671,"about_ca_topic_score_gemma":0.000008274692,"teacher_disagreement_score":0.18821718,"about_ca_system_score_codex":0.00003426507,"about_ca_system_score_gemma":0.00014520179,"threshold_uncertainty_score":0.6323294},"labels":[],"label_agreement":null},{"id":"W2141358924","doi":"10.1056/nejmoa1500857","title":"Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction","year":2015,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1970,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Ticagrelor; Term (time); Myocardial infarction; Medicine; Cardiology; Internal medicine; Percutaneous coronary intervention","score_opus":0.023550366117892612,"score_gpt":0.2528091807199831,"score_spread":0.2292588146020905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141358924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973647,0.0011097558,0.00044395577,0.0005537368,0.00027310025,0.00016827998,0.0000012549897,0.0000047343337,0.00008050562],"genre_scores_gemma":[0.99811554,0.0002619039,0.00019349279,0.00019827302,0.0011583244,4.2836982e-7,0.000008818845,0.000012629235,0.00005061049],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99861246,0.000084280284,0.00039865205,0.000082833,0.0007001863,0.000121610436],"domain_scores_gemma":[0.99889636,0.000060992235,0.00021319202,0.00014493511,0.00037268375,0.00031186538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047999053,0.00010776091,0.0005313801,0.00020032325,0.000010567099,0.0000039807514,0.00005037774,0.000050776565,0.00004291921],"category_scores_gemma":[0.0003094376,0.000062024286,0.00010112339,0.00016824875,0.00009100724,0.00014811079,0.000008674476,0.00019679758,0.0000013655956],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009736594,0.00015856627,0.8415199,0.000028461,0.00042732575,0.00017128533,0.0004404504,0.0000475,0.00005239954,0.0000052783807,0.0005933639,0.14681888],"study_design_scores_gemma":[0.10609181,0.0034192225,0.8851884,0.0005997868,0.00047302913,0.00028850895,0.00004105858,0.000003315485,0.00004827802,0.000016470585,0.0037713666,0.00005872925],"about_ca_topic_score_codex":0.000033130316,"about_ca_topic_score_gemma":0.0000069402504,"teacher_disagreement_score":0.14676015,"about_ca_system_score_codex":0.000044131008,"about_ca_system_score_gemma":0.00022193551,"threshold_uncertainty_score":0.2529277},"labels":[],"label_agreement":null},{"id":"W2141653128","doi":"10.1093/eurheartj/ehn419","title":"Comparison of four tests to assess inhibition of platelet function by clopidogrel in stable coronary artery disease patients","year":2008,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":144,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Clopidogrel; Medicine; P2Y12; Platelet; Coronary artery disease; Internal medicine; Cardiology; Adenosine diphosphate; Pharmacology; Antiplatelet drug; Aspirin; Platelet aggregation","score_opus":0.06633299385524856,"score_gpt":0.3003798483734112,"score_spread":0.23404685451816265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141653128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997718,0.00096656365,0.0005376842,0.00006972765,0.00015073988,0.00023091087,0.000028441325,0.000014239161,0.00028373764],"genre_scores_gemma":[0.99917424,0.00016662375,0.00013653097,0.00024986928,0.00012102901,0.0000015601972,0.000057481702,0.00002755315,0.0000650938],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99841386,0.00031321135,0.00047094288,0.00015329894,0.00045736117,0.0001913404],"domain_scores_gemma":[0.99920386,0.00003377142,0.00014629416,0.00017143878,0.00015588131,0.00028874344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034742313,0.00012423132,0.00038072618,0.0001576994,0.00008037885,0.000007942011,0.000046208745,0.000026175081,0.00008546813],"category_scores_gemma":[0.00006466803,0.00011346279,0.00020446224,0.00018592765,0.000051155974,0.00015132793,0.00002566413,0.00022463204,0.00002592461],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016762398,0.0008757863,0.9740231,0.000055649532,0.00009719451,0.00040312257,0.00014207604,0.0002011984,0.004599853,0.0000012713884,0.014500662,0.0034238626],"study_design_scores_gemma":[0.0028887924,0.0008697337,0.9888926,0.00032455724,0.000059470316,0.00026474512,0.00006266627,0.000028747161,0.0013028521,0.0000053535637,0.0051979423,0.000102525955],"about_ca_topic_score_codex":0.0000021863796,"about_ca_topic_score_gemma":5.4727855e-7,"teacher_disagreement_score":0.01486953,"about_ca_system_score_codex":0.000039870236,"about_ca_system_score_gemma":0.00007883118,"threshold_uncertainty_score":0.46268782},"labels":[],"label_agreement":null},{"id":"W2142021807","doi":"10.1056/nejmoa1200933","title":"Vorapaxar in the Secondary Prevention of Atherothrombotic Events","year":2012,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":941,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Secondary prevention; Medicine; Business; Cardiology; Internal medicine","score_opus":0.024509523199422803,"score_gpt":0.29541606064489967,"score_spread":0.2709065374454769,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142021807","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9773306,0.019285304,0.0006429139,0.0014243906,0.0003114862,0.00015581383,5.555017e-7,0.0000026200826,0.0008462815],"genre_scores_gemma":[0.99603087,0.0011811609,0.00012421398,0.00033237253,0.00221012,7.213016e-7,0.0000025344402,0.00000856916,0.00010945741],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986848,0.00022578459,0.0004168893,0.000048774993,0.00048260673,0.0001411299],"domain_scores_gemma":[0.9993285,0.000099526915,0.00022578065,0.00015229321,0.000065530345,0.0001283776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002023631,0.000087336724,0.00042235735,0.00011887792,0.000016729688,0.0000012346242,0.00009824825,0.000042468975,0.00034497792],"category_scores_gemma":[0.00013500216,0.00004501757,0.0001927971,0.00015717793,0.000059928538,0.00010642251,0.0000061636038,0.00024780468,0.0000025427541],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021178315,0.0007857411,0.1897571,0.00023072446,0.00095505407,0.00015421152,0.008275909,0.000015062218,0.004284437,0.00030388276,0.0034074984,0.78971255],"study_design_scores_gemma":[0.07959303,0.0027160451,0.85445356,0.0015621899,0.0010684269,0.0038671463,0.0018616935,0.0000048845704,0.0005728227,0.0016916653,0.05250334,0.00010518146],"about_ca_topic_score_codex":0.000016271084,"about_ca_topic_score_gemma":0.0000030144743,"teacher_disagreement_score":0.78960735,"about_ca_system_score_codex":0.000016662385,"about_ca_system_score_gemma":0.00010663867,"threshold_uncertainty_score":0.37772664},"labels":[],"label_agreement":null},{"id":"W2143795636","doi":"10.1016/j.ahj.2005.02.044","title":"Long-term cost-effectiveness of early and sustained clopidogrel therapy for up to 1 year in patients undergoing percutaneous coronary intervention after presenting with acute coronary syndromes without ST-segment elevation","year":2005,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Clopidogrel; Medicine; Conventional PCI; Percutaneous coronary intervention; Aspirin; Internal medicine; Cost effectiveness; Cardiology; Surgery; Myocardial infarction","score_opus":0.013642784716054788,"score_gpt":0.29962879687257643,"score_spread":0.28598601215652164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143795636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99480945,0.00041938023,0.003182135,0.000072251714,0.000045034543,0.0014441345,0.000012451838,0.0000128022875,0.0000023848013],"genre_scores_gemma":[0.9983667,0.00034655072,0.00096053845,0.000110692126,0.000053384076,0.00006826575,0.000023344997,0.000032453885,0.000038039023],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99878454,0.00019078051,0.00027612573,0.00020978408,0.00029305226,0.00024573525],"domain_scores_gemma":[0.99933696,0.00009997362,0.00012787154,0.00012485046,0.00017794927,0.00013239935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031396764,0.00015301799,0.00041432653,0.00015606644,0.00006744761,0.000028364046,0.00004489881,0.000031268602,0.00002539526],"category_scores_gemma":[0.000019536124,0.00012457503,0.00017261694,0.0001366708,0.00009527957,0.00017603893,0.000022430615,0.00013220175,9.5352834e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01773841,0.0002543502,0.932994,0.00009904718,0.0006685063,0.00012834487,0.0003512103,0.00003987963,0.00030610216,0.0000016883971,0.000006054866,0.04741241],"study_design_scores_gemma":[0.00586774,0.005649131,0.98556674,0.0005554829,0.0001521924,0.0014538243,0.00037465905,0.000025315774,0.00017567613,0.000006265796,0.000036388865,0.000136569],"about_ca_topic_score_codex":0.0000142561175,"about_ca_topic_score_gemma":0.000009121535,"teacher_disagreement_score":0.052572757,"about_ca_system_score_codex":0.00014115142,"about_ca_system_score_gemma":0.00008971201,"threshold_uncertainty_score":0.5080022},"labels":[],"label_agreement":null},{"id":"W2144206796","doi":"10.1016/s0140-6736(10)61088-4","title":"Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial","year":2010,"lang":"en","type":"article","venue":"The Lancet","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":824,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Population Health Research Institute; Université de Montréal; Montreal Heart Institute; University of Toronto; Hamilton Health Sciences; McMaster University","funders":"Sanofi; Bristol-Myers Squibb","keywords":"Medicine; Clopidogrel; Percutaneous coronary intervention; Aspirin; Conventional PCI; Loading dose; Maintenance dose; Myocardial infarction; Randomized controlled trial; Internal medicine; Cardiology","score_opus":0.0431597706418513,"score_gpt":0.3324374110726355,"score_spread":0.28927764043078424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144206796","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845612,0.002852543,0.00008069373,0.00042012677,0.007591531,0.003788542,0.00049410143,0.00014548654,0.00006577422],"genre_scores_gemma":[0.9938737,0.0025104494,0.00024718465,0.00006674448,0.0023462442,0.00028119143,0.000513388,0.00007765485,0.00008345705],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9971096,0.00030895008,0.0006549393,0.0006154267,0.0006437898,0.00066732976],"domain_scores_gemma":[0.99751776,0.0011077423,0.00025742446,0.0007814086,0.00010317784,0.00023250715],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011716187,0.00047455687,0.0014351833,0.00017007256,0.0002565924,0.000129724,0.00037446586,0.0002653799,0.0001604756],"category_scores_gemma":[0.0002968066,0.00036422754,0.0007377756,0.00020986985,0.00028465496,0.00024620118,0.00015932837,0.00071019714,0.000015515134],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.93976843,0.00045914616,0.0014488676,0.00027576383,0.0030044843,0.00038505404,0.00050858076,0.000014558509,0.00061050034,0.00023971856,0.00084861816,0.052436255],"study_design_scores_gemma":[0.9719093,0.0049690087,0.012722327,0.00043334122,0.002529244,0.0004948907,0.00032948446,0.0000708174,0.00019484262,0.00041728982,0.0054067257,0.00052275724],"about_ca_topic_score_codex":0.000059196405,"about_ca_topic_score_gemma":0.00019774586,"teacher_disagreement_score":0.0519135,"about_ca_system_score_codex":0.00014896618,"about_ca_system_score_gemma":0.00030697687,"threshold_uncertainty_score":0.99988097},"labels":[],"label_agreement":null},{"id":"W2144667981","doi":"10.1016/j.thromres.2007.03.006","title":"Antiplatelet therapy for primary and secondary prevention in Jordanian patients with diabetes mellitus","year":2007,"lang":"en","type":"article","venue":"Thrombosis Research","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Heart and Stroke Foundation of Canada; American Heart Association","keywords":"Medicine; Aspirin; Internal medicine; Diabetes mellitus; Clopidogrel; Odds ratio; Antiplatelet drug; Medical prescription; Platelet aggregation inhibitor; Myocardial infarction; Observational study; Emergency medicine","score_opus":0.03485102396456767,"score_gpt":0.3391501432293353,"score_spread":0.3042991192647676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144667981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920172,0.0051655713,0.00013147692,0.00010809488,0.000024730816,0.0016067636,0.000014804244,0.00002790843,0.0009034386],"genre_scores_gemma":[0.99652433,0.0024969298,0.00045146153,0.00013923872,0.00007280813,0.00006441488,0.00013276469,0.000037306392,0.00008074196],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981308,0.00014605538,0.00021944342,0.00034907123,0.00059440633,0.00056024775],"domain_scores_gemma":[0.9990801,0.00022913265,0.000032661206,0.00027525655,0.00022776736,0.00015505556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020284655,0.00014357174,0.0003781512,0.0002950486,0.00014391709,0.000033535114,0.00008432542,0.000110952096,0.00007772285],"category_scores_gemma":[0.000039510003,0.00010953531,0.00011163307,0.00037623197,0.00021210295,0.0001552319,0.000035487905,0.00030860375,0.0000054563716],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029106012,0.00095737993,0.60273194,0.00033888154,0.00053387205,0.000014690988,0.0002857314,5.5859545e-7,0.0038475548,0.00009594061,0.00020797401,0.38807487],"study_design_scores_gemma":[0.008620141,0.0016514605,0.97975147,0.00019075503,0.000028411281,0.0000015560472,0.00013353543,0.0000065524328,0.0055399938,0.00027118798,0.0036692386,0.00013570071],"about_ca_topic_score_codex":0.000012570159,"about_ca_topic_score_gemma":0.000017770806,"teacher_disagreement_score":0.38793918,"about_ca_system_score_codex":0.00007282139,"about_ca_system_score_gemma":0.00012311191,"threshold_uncertainty_score":0.44667202},"labels":[],"label_agreement":null},{"id":"W2144986407","doi":"10.1161/circulationaha.112.000627","title":"The Power of More Than One","year":2013,"lang":"en","type":"letter","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Power (physics)","score_opus":0.016800094564517337,"score_gpt":0.2388831693354391,"score_spread":0.22208307477092176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144986407","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.43212056,0.019875754,0.0011432001,0.5373207,0.0008306832,0.0020571135,0.000035902915,0.00014610484,0.0064699766],"genre_scores_gemma":[0.9093422,0.000346149,0.000022407576,0.08745088,0.0014733222,0.000031595137,0.00046990867,0.00004802606,0.0008155083],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99897194,0.000055239438,0.00020365595,0.00016759105,0.00045123315,0.00015031478],"domain_scores_gemma":[0.9990966,0.000052661642,0.00012882678,0.0005444957,0.0001488276,0.000028636261],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010704632,0.00013081402,0.00029609184,0.000048396792,0.00006887351,0.000016836128,0.00008201528,0.00032920038,0.00018436958],"category_scores_gemma":[0.000031689615,0.00009051892,0.00043840543,0.000080480466,0.00010516927,0.000039088893,0.000012276709,0.00035481798,0.00006723591],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000099956575,0.00008071429,0.017815784,0.0005533323,0.003172285,0.000112508824,0.0003579117,0.0000275105,0.00093968963,0.00016870508,0.95306605,0.023605546],"study_design_scores_gemma":[0.00071868254,0.00003501022,0.37573323,0.00025308214,0.000662393,0.000047669742,0.00005817751,0.000056527784,0.00019141368,0.0003726259,0.6216876,0.00018361429],"about_ca_topic_score_codex":0.000013783098,"about_ca_topic_score_gemma":1.8054698e-7,"teacher_disagreement_score":0.47722164,"about_ca_system_score_codex":0.00002934786,"about_ca_system_score_gemma":0.000057142075,"threshold_uncertainty_score":0.36912546},"labels":[],"label_agreement":null},{"id":"W2145805794","doi":"10.1016/j.farma.2009.08.002","title":"Resistencia a la aspirina: prevalencia, mecanismos de acción y asociación con eventos tromboembólicos. Revisión narrativa","year":2010,"lang":"es","type":"review","venue":"Farmacia Hospitalaria","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Aspirin; Medicine; Platelet aggregation inhibitor; Platelet aggregation; Epidemiology; Population; MEDLINE; Intensive care medicine; Internal medicine; Platelet","score_opus":0.015760116653903113,"score_gpt":0.31782601908764485,"score_spread":0.30206590243374176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145805794","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.028174628,0.95248175,0.0001710212,0.00043252157,0.002176662,0.0063786935,0.00069159514,0.0005220089,0.008971135],"genre_scores_gemma":[0.047071427,0.94258714,0.00040108035,0.00070816063,0.003414795,0.0010825798,0.0008042814,0.0006014814,0.0033290263],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9873103,0.0032924234,0.0025556497,0.0024036097,0.0021601308,0.0022778756],"domain_scores_gemma":[0.99245846,0.0006731944,0.0018054893,0.0028269081,0.0007251317,0.0015107964],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.0038781918,0.0025685376,0.006720844,0.00053933647,0.0008489737,0.00046294028,0.0017585389,0.0035521702,0.0028902842],"category_scores_gemma":[0.0016438768,0.0023669885,0.006718571,0.0011952958,0.0007050731,0.00049157813,0.0004764281,0.0047419723,0.0015593779],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062915916,0.0017077551,0.006751939,0.040013872,0.014539482,0.0031100304,0.0014963938,0.0000018260496,0.00062976975,0.0059410585,0.007576863,0.9176018],"study_design_scores_gemma":[0.0046201483,0.0008344724,0.015762165,0.021623217,0.018546019,0.0010083333,0.0002884928,0.000015943295,0.00016421004,0.00032047537,0.9344148,0.0024017468],"about_ca_topic_score_codex":0.00009975877,"about_ca_topic_score_gemma":0.000011402396,"teacher_disagreement_score":0.9268379,"about_ca_system_score_codex":0.00091617485,"about_ca_system_score_gemma":0.0040170797,"threshold_uncertainty_score":0.99921805},"labels":[],"label_agreement":null},{"id":"W2145810686","doi":"10.1093/eurheartj/ehp295","title":"Personalized medicine and antiplatelet therapy: ready for prime time?","year":2009,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Pharmacogenetics; Personalized medicine; Intensive care medicine; Aspirin; Drug; Antiplatelet drug; Pharmacology; Pharmacotherapy; Precision medicine; Pharmacogenomics; Combination therapy; P2Y12; Bioinformatics; Internal medicine; Clopidogrel","score_opus":0.06872503569603725,"score_gpt":0.3310418721325588,"score_spread":0.2623168364365216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145810686","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9411114,0.036179557,0.0010117063,0.011290139,0.00018713558,0.0006324411,0.0000096231115,0.00012838999,0.009449616],"genre_scores_gemma":[0.97257006,0.008441387,0.001774699,0.010585094,0.0030185354,0.0000018837029,0.000041966832,0.00007955086,0.0034867937],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99871457,0.00023897248,0.00025480727,0.00021653771,0.0002954538,0.00027963548],"domain_scores_gemma":[0.9992283,0.000061697516,0.00007807164,0.00019854728,0.000118306474,0.0003150576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011691555,0.00018246844,0.0004466483,0.00010379367,0.00024481348,0.000043108714,0.00007110445,0.00003728725,0.00038357414],"category_scores_gemma":[0.00008859229,0.0001270743,0.00027099132,0.00008443285,0.00012602183,0.0000963656,0.000009035832,0.00023063355,0.00006160338],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010598077,0.0006415911,0.008053367,0.00007704466,0.002076115,0.0025601466,0.0023330399,0.0000041653716,0.18887262,0.00052768853,0.24210106,0.5421551],"study_design_scores_gemma":[0.014808872,0.0030992043,0.10022502,0.0003101836,0.00022994242,0.012296673,0.00011614303,0.0000594415,0.0009886975,0.0001923411,0.86741185,0.00026164792],"about_ca_topic_score_codex":4.9439376e-7,"about_ca_topic_score_gemma":1.6100554e-8,"teacher_disagreement_score":0.6253108,"about_ca_system_score_codex":0.000015666657,"about_ca_system_score_gemma":0.000046412413,"threshold_uncertainty_score":0.5181939},"labels":[],"label_agreement":null},{"id":"W2145834923","doi":"10.1378/chest.08-0673","title":"New Antithrombotic Drugs","year":2008,"lang":"en","type":"article","venue":"CHEST Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":261,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Antithrombotic; Medicine; Anticoagulant; Intensive care medicine; Fibrinolytic agent; Pharmacology; Surgery; Internal medicine","score_opus":0.020130878648901066,"score_gpt":0.24828864492477026,"score_spread":0.2281577662758692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145834923","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97924256,0.008092696,0.0061410232,0.0006336965,0.00028530913,0.00006917295,4.6165601e-7,0.000044761036,0.0054903124],"genre_scores_gemma":[0.9894352,0.0037626817,0.002516983,0.00047823437,0.0012392044,4.0043304e-7,0.0000022782594,0.000018318815,0.002546681],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9992897,0.000021394844,0.00013982928,0.000092904855,0.0002785787,0.00017760998],"domain_scores_gemma":[0.9994087,0.000010475917,0.00004060311,0.00015184835,0.000050432565,0.00033789815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010527347,0.00008943583,0.00022383676,0.00005217971,0.00016408497,0.000015834024,0.000063509004,0.000045476634,0.0008255247],"category_scores_gemma":[0.000023011276,0.000069349255,0.0003382359,0.00009930893,0.00005378806,0.00008837959,0.00000930524,0.00022274833,0.00019090253],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013400842,0.0009497415,0.31330922,0.0003582989,0.0050530317,0.022045184,0.0057739615,0.00009265776,0.013579072,0.0005049617,0.26500142,0.37199238],"study_design_scores_gemma":[0.0073759556,0.00035222265,0.6211661,0.00021995997,0.0005154906,0.060572546,0.00039117932,0.000022572563,0.006759721,0.000439489,0.30186075,0.00032399205],"about_ca_topic_score_codex":0.000003418152,"about_ca_topic_score_gemma":9.460625e-8,"teacher_disagreement_score":0.3716684,"about_ca_system_score_codex":0.000028514674,"about_ca_system_score_gemma":0.00029345544,"threshold_uncertainty_score":0.9038916},"labels":[],"label_agreement":null},{"id":"W2145926981","doi":"10.1111/ijcp.12634","title":"Should patients prescribed long-term low-dose aspirin receive proton pump inhibitors? A systematic review and meta-analysis","year":2015,"lang":"en","type":"review","venue":"International Journal of Clinical Practice","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"ZonMw; American College of Cardiology Foundation","keywords":"Medicine; Aspirin; Observational study; Meta-analysis; Relative risk; Internal medicine; Adverse effect; Proton-pump inhibitor; Randomized controlled trial; Cohort study; MEDLINE; Systematic review; Confidence interval","score_opus":0.24471596371937396,"score_gpt":0.5161803909949545,"score_spread":0.2714644272755805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145926981","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000038515533,0.99393845,0.00008520947,0.0009321716,0.00053468585,0.004132088,0.00007787654,0.000014258378,0.00024672048],"genre_scores_gemma":[0.0001280362,0.9958085,0.00020220786,0.002531946,0.0006522961,0.00017684583,0.00014836191,0.00005419919,0.00029764324],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98745507,0.0035022837,0.005607871,0.00050353305,0.0027266855,0.00020455131],"domain_scores_gemma":[0.98343027,0.0026912955,0.007901156,0.0006405403,0.004785196,0.00055156933],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.00938132,0.0005424762,0.011594288,0.00042355832,0.000035231813,0.00014145912,0.00063611084,0.00041973687,0.00022500906],"category_scores_gemma":[0.02220439,0.00032298942,0.011020323,0.00040820875,0.00012356415,0.0007386692,0.00017256955,0.0015578668,0.000055689845],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054448773,0.0013423689,0.00011206154,0.3055141,0.64344645,0.0012864148,0.000015004389,5.4514953e-7,5.2583173e-9,0.0000044748863,0.0005147779,0.047219303],"study_design_scores_gemma":[0.0012274785,0.00034845475,0.00005941911,0.061026398,0.7532513,0.0012454222,0.000005938534,7.3856853e-7,1.5241436e-7,0.000006995911,0.18260962,0.00021807378],"about_ca_topic_score_codex":0.0000043840646,"about_ca_topic_score_gemma":6.853398e-7,"teacher_disagreement_score":0.24448769,"about_ca_system_score_codex":0.00015119201,"about_ca_system_score_gemma":0.00081147114,"threshold_uncertainty_score":0.9999222},"labels":[],"label_agreement":null},{"id":"W2147195562","doi":"10.1161/01.cir.0000013777.21160.07","title":"Aspirin-Resistant Thromboxane Biosynthesis and the Risk of Myocardial Infarction, Stroke, or Cardiovascular Death in Patients at High Risk for Cardiovascular Events","year":2002,"lang":"en","type":"article","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1053,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Population Health Research Institute; Hamilton Health Sciences; Princess Margaret Cancer Centre; Hamilton General Hospital","funders":"Heart and Stroke Foundation of Canada","keywords":"Medicine; Aspirin; Myocardial infarction; Internal medicine; Stroke (engine); Cardiology; Quartile; Odds ratio; Thromboxane; Population; Confidence interval; Platelet","score_opus":0.015292504800787355,"score_gpt":0.21152885348599246,"score_spread":0.1962363486852051,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147195562","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9816734,0.014050746,0.0019008728,0.000030197794,0.00016632037,0.0018998357,0.00018396806,0.000035710516,0.000058912796],"genre_scores_gemma":[0.99330974,0.0060655163,0.00016524024,0.000029973673,0.00016179873,0.00012143523,0.00007979931,0.000044645705,0.000021873973],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99729997,0.0005865221,0.00051411905,0.00048581234,0.0008200425,0.0002935369],"domain_scores_gemma":[0.9983507,0.00022807549,0.00021332868,0.00087733904,0.00022806306,0.00010253313],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013015041,0.0002687488,0.0010551949,0.00016816183,0.0002595716,0.000015085328,0.00009709811,0.00017596254,0.00004628866],"category_scores_gemma":[0.00046136184,0.00018639676,0.0024743755,0.00027194977,0.00015536178,0.00012677474,0.000045977962,0.00015041481,0.000006986707],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026101577,0.00018642178,0.9402831,0.0001697736,0.017506987,0.0000054156094,0.00023225897,0.00539478,0.000037789854,0.00007352247,0.000023734143,0.03347602],"study_design_scores_gemma":[0.01688684,0.00013863522,0.97162676,0.00008877612,0.0075650266,0.000010528721,0.000045324872,0.0009768775,0.0001730425,0.00021723949,0.002058412,0.0002125666],"about_ca_topic_score_codex":0.0004997458,"about_ca_topic_score_gemma":0.000015939087,"teacher_disagreement_score":0.033263452,"about_ca_system_score_codex":0.00015928246,"about_ca_system_score_gemma":0.000027795746,"threshold_uncertainty_score":0.76010394},"labels":[],"label_agreement":null},{"id":"W2147326598","doi":"10.1016/j.amjcard.2009.04.013","title":"Usefulness of Pretreatment With High-Dose Clopidogrel in Patients Undergoing Primary Angioplasty for ST-Elevation Myocardial Infarction","year":2009,"lang":"en","type":"article","venue":"The American Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Primary angioplasty; Clopidogrel; Medicine; Myocardial infarction; Cardiology; Internal medicine; Angioplasty; Percutaneous coronary intervention","score_opus":0.008898758150131317,"score_gpt":0.23024122010996548,"score_spread":0.22134246195983415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147326598","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993278,0.00030877956,0.0056207883,0.00026635945,0.00011165212,0.00035385194,0.000009702971,0.0000057706134,0.00004504],"genre_scores_gemma":[0.99868625,0.00034948843,0.0003892454,0.0002576337,0.00027384982,0.000007728337,0.000021589954,0.000011043508,0.0000031576349],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99890137,0.00023987934,0.0003392429,0.000108536704,0.00024910903,0.00016184628],"domain_scores_gemma":[0.998915,0.00016131319,0.00045315127,0.0001804786,0.00023830708,0.000051720133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003996808,0.000117962154,0.00073716574,0.0001367747,0.000035987014,0.0000032433375,0.0000724275,0.000034021512,0.000001102067],"category_scores_gemma":[0.00005380637,0.00007110542,0.00034003085,0.0002114801,0.00017418027,0.00007484216,0.000007985561,0.00012889683,2.4019437e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025614254,0.00017708236,0.7780804,0.000035758178,0.0028349308,0.000032897184,0.00024759397,0.006892715,0.00033030487,0.00010755585,0.00013661047,0.18550986],"study_design_scores_gemma":[0.006506601,0.009396745,0.9824555,0.00008464718,0.0005733234,0.00017303626,0.00017355263,0.000005069623,0.00012524045,0.00018497353,0.00024871225,0.00007258321],"about_ca_topic_score_codex":0.0000055159353,"about_ca_topic_score_gemma":6.787159e-7,"teacher_disagreement_score":0.20437509,"about_ca_system_score_codex":0.00010849747,"about_ca_system_score_gemma":0.00017411062,"threshold_uncertainty_score":0.28995952},"labels":[],"label_agreement":null},{"id":"W2147800731","doi":"10.1378/chest.11-2298","title":"Perioperative Management of Antithrombotic Therapy","year":2012,"lang":"en","type":"article","venue":"CHEST Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1641,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Center for Advancing Translational Sciences; Sanofi; National Center for Research Resources; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; Pfizer","keywords":"Medicine; Antithrombotic; Perioperative; Warfarin; Atrial fibrillation; Vitamin K antagonist; Guideline; Surgery; Thrombosis; Bridging (networking); Stent; Cardiology","score_opus":0.0313881980672498,"score_gpt":0.2908428595477427,"score_spread":0.2594546614804929,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147800731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9715555,0.02176951,0.0010752801,0.00010275337,0.00018146691,0.00011621423,7.4535797e-7,0.000010219032,0.0051883347],"genre_scores_gemma":[0.98776835,0.010126033,0.0013636601,0.000120441466,0.00030231298,0.0000020231864,0.0000016898207,0.000011908969,0.0003035788],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993789,0.000034815064,0.00014334769,0.00005680846,0.00021389824,0.00017220248],"domain_scores_gemma":[0.999613,0.00000581438,0.00005183896,0.00012746219,0.000057174522,0.00014471613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023830004,0.00008102041,0.00021150985,0.00003810749,0.000067594054,0.000011058257,0.000049770326,0.000028588218,0.00048453547],"category_scores_gemma":[0.000003258228,0.000056285273,0.00024377178,0.00007802428,0.00006287838,0.00011259861,0.000009804687,0.00011290726,0.000024972423],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017000274,0.0034164402,0.49915078,0.0010092421,0.013990812,0.00089537207,0.006679632,0.000041325537,0.03258367,0.004693944,0.0016061609,0.4342326],"study_design_scores_gemma":[0.0043857736,0.00028516335,0.9225868,0.00025418313,0.00035048614,0.0015536823,0.0019762756,0.0000059686413,0.020399189,0.000035445,0.048021257,0.00014580849],"about_ca_topic_score_codex":4.3926164e-7,"about_ca_topic_score_gemma":1.5336505e-8,"teacher_disagreement_score":0.43408677,"about_ca_system_score_codex":0.000020398946,"about_ca_system_score_gemma":0.000025695643,"threshold_uncertainty_score":0.53053236},"labels":[],"label_agreement":null},{"id":"W2148363808","doi":"10.1016/j.ahj.2009.02.012","title":"Evaluation of individualized clopidogrel therapy after drug-eluting stent implantation in patients with high residual platelet reactivity: Design and rationale of the GRAVITAS trial","year":2009,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":123,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"","keywords":"Medicine; Clopidogrel; Percutaneous coronary intervention; Internal medicine; Conventional PCI; Cardiology; Acute coronary syndrome; Loading dose; Myocardial infarction; Clinical endpoint; Platelet aggregation inhibitor; Aspirin; Randomized controlled trial","score_opus":0.026233255699765767,"score_gpt":0.28904788736983095,"score_spread":0.2628146316700652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148363808","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980855,0.0005719104,0.00006529215,0.00025974712,0.000042486387,0.0009570364,0.000008493339,0.0000034158309,0.000006106958],"genre_scores_gemma":[0.99863434,0.00018871551,0.00088985794,0.00018231716,0.000071904455,0.000012878103,0.000010320222,0.000008185674,0.0000014751416],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9975086,0.0008898523,0.00032257012,0.0001223391,0.0010306595,0.00012598008],"domain_scores_gemma":[0.9991319,0.00011113061,0.00030001492,0.00012833976,0.00027848672,0.00005008902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017422278,0.00010058956,0.000355033,0.00010962038,0.000060671155,0.000012307265,0.000037681384,0.000025049887,0.000014857206],"category_scores_gemma":[0.00007488488,0.00006301077,0.0001032909,0.00021179895,0.00011696653,0.00010810139,0.000006222255,0.00015149337,1.685345e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10962695,0.0009966621,0.39378583,0.000012760552,0.0007360802,0.000010499095,0.0017676656,0.00069673354,0.0016150875,0.0000086899645,0.00009408649,0.49064893],"study_design_scores_gemma":[0.04143112,0.0017391234,0.9534371,0.00011288134,0.00024458734,0.000059325976,0.00019588009,0.000023317305,0.00243714,0.00021834321,0.00002956545,0.0000716412],"about_ca_topic_score_codex":0.000039834347,"about_ca_topic_score_gemma":0.0000030051137,"teacher_disagreement_score":0.5596512,"about_ca_system_score_codex":0.000041282095,"about_ca_system_score_gemma":0.00026487038,"threshold_uncertainty_score":0.25695044},"labels":[],"label_agreement":null},{"id":"W2148737731","doi":"10.1161/circulationaha.110.978007","title":"Aspirin Plus Clopidogrel Versus Aspirin Alone After Coronary Artery Bypass Grafting","year":2010,"lang":"en","type":"article","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":219,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute; University of Ottawa","funders":"","keywords":"Medicine; Aspirin; Clopidogrel; Intravascular ultrasound; Cardiology; Internal medicine; Placebo; Coronary artery disease; Intimal hyperplasia; Artery; Surgery; Pathology","score_opus":0.017025895520080877,"score_gpt":0.2560195213459512,"score_spread":0.2389936258258703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148737731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99494517,0.00093848247,0.0011463613,0.00015216584,0.00093453535,0.0003581515,0.0000061789397,0.00014999943,0.0013689772],"genre_scores_gemma":[0.99836254,0.000030841627,0.0002534447,0.0003000211,0.0007133436,0.000044564385,0.00019330005,0.000037888265,0.000064047854],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987886,0.00004388864,0.00024198901,0.00032038515,0.0003464449,0.0002586978],"domain_scores_gemma":[0.9992064,0.000042194282,0.00006586596,0.00044348213,0.000087521126,0.00015450771],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019899342,0.00017604291,0.00027373078,0.000092166854,0.000096944605,0.000029213454,0.00006312876,0.0001722358,0.00029902437],"category_scores_gemma":[0.000038898637,0.00017437786,0.00031407241,0.00015253361,0.000080547565,0.00017228103,0.000025936668,0.0002814395,0.00021120276],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053127874,0.00031836002,0.7264653,0.00025068477,0.0017242419,0.0011828219,0.00053616206,0.000420319,0.040695228,0.0004619723,0.00020953645,0.2224226],"study_design_scores_gemma":[0.006328394,0.00008223363,0.98518515,0.00006942452,0.00035246924,0.00026755128,0.000054113538,0.001145664,0.00059504766,0.00010305451,0.0055740196,0.0002428874],"about_ca_topic_score_codex":0.0000103441125,"about_ca_topic_score_gemma":0.000016312699,"teacher_disagreement_score":0.25871986,"about_ca_system_score_codex":0.00005982033,"about_ca_system_score_gemma":0.000087345274,"threshold_uncertainty_score":0.7110923},"labels":[],"label_agreement":null},{"id":"W2149863735","doi":"10.1186/1468-6708-6-15","title":"The clopidogrel after surgery for coronary artery disease (CASCADE) randomized controlled trial: clopidogrel and aspirin versus aspirin alone after coronary bypass surgery [NCT00228423]","year":2005,"lang":"en","type":"article","venue":"Current Controlled Trials in Cardiovascular Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Physicians' Services Incorporated Foundation; Boston Scientific Corporation; Sanofi; Bristol-Myers Squibb","keywords":"Medicine; Clopidogrel; Aspirin; Intimal hyperplasia; Cardiology; Surgery; Coronary artery bypass surgery; Coronary artery disease; Intravascular ultrasound; Internal medicine; Artery","score_opus":0.04364814432407861,"score_gpt":0.31337962595932095,"score_spread":0.26973148163524235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149863735","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.37934285,0.5877866,0.0011848302,0.0029863426,0.0075030294,0.020887533,0.00008209089,0.00016691467,0.000059772552],"genre_scores_gemma":[0.87884617,0.082520165,0.000058034595,0.00078553107,0.008446113,0.028622424,0.000324407,0.00020092449,0.00019624359],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.97702324,0.01046093,0.00663452,0.0017065625,0.002605066,0.0015696652],"domain_scores_gemma":[0.94138473,0.053393036,0.0013641337,0.0021380514,0.00060955674,0.0011105164],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"category_scores_codex":[0.057908505,0.0015776455,0.025226602,0.0010351918,0.00040350223,0.00014702986,0.000354058,0.0005120698,0.00019575554],"category_scores_gemma":[0.022335073,0.0009192482,0.024827162,0.0005885782,0.0015362807,0.0003494711,0.00015272837,0.00091044133,0.00002815049],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7928208,0.0006290564,0.0016458386,0.00043573926,0.03546203,0.0008251077,0.00007809507,0.000048971528,0.0000057942393,0.000045865607,0.0013581654,0.16664453],"study_design_scores_gemma":[0.8967572,0.00046077018,0.00818304,0.0018707392,0.034138076,0.00015256404,0.000106819156,0.00055617385,0.000006756635,0.00011825566,0.05676154,0.0008880881],"about_ca_topic_score_codex":0.00002000484,"about_ca_topic_score_gemma":0.00002370198,"teacher_disagreement_score":0.5052665,"about_ca_system_score_codex":0.00036393048,"about_ca_system_score_gemma":0.0012563337,"threshold_uncertainty_score":0.99969715},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W2150443278","doi":"10.1007/s11886-010-0120-y","title":"Aspirin for Acute Coronary Syndromes: Have We Learned the Correct Dose Yet?","year":2010,"lang":"en","type":"review","venue":"Current Cardiology Reports","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Population Health Research Institute","funders":"","keywords":"Aspirin; Medicine; Placebo; Randomized controlled trial; Acute coronary syndrome; Observational study; Internal medicine; Myocardial infarction; Pathology","score_opus":0.10019534899786278,"score_gpt":0.4043416895422101,"score_spread":0.3041463405443473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150443278","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00038127814,0.985322,0.00018711963,0.00006887655,0.009131587,0.004156786,0.00014599824,0.00022243304,0.00038393564],"genre_scores_gemma":[0.00034651728,0.99320525,0.000027986634,0.00006265357,0.0013693342,0.0013960252,0.0023248694,0.0001493479,0.0011180046],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960605,0.00047828953,0.0011702268,0.0011905014,0.00040789228,0.00069262076],"domain_scores_gemma":[0.9961653,0.00043360837,0.000808697,0.002102898,0.00020541449,0.00028412347],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011777243,0.0008497397,0.0049046767,0.00014127436,0.00025556542,0.000032884018,0.00031109556,0.00095558696,0.00006124494],"category_scores_gemma":[0.00027681902,0.00051430473,0.0062928475,0.00018264272,0.0005046443,0.000052875166,0.00016626695,0.0015998884,0.00006383086],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000090823814,0.00006207326,0.00032351442,0.004568778,0.008376475,0.006293622,0.00002828886,0.0000011536856,7.025167e-7,0.000008910476,0.01141599,0.9688297],"study_design_scores_gemma":[0.0005709513,0.00026059395,0.00013451684,0.0047819023,0.021647908,0.1056232,0.000022925462,0.0000014344754,6.963802e-7,0.000107989996,0.8663942,0.00045367458],"about_ca_topic_score_codex":0.000001741053,"about_ca_topic_score_gemma":7.435551e-7,"teacher_disagreement_score":0.968376,"about_ca_system_score_codex":0.00010739422,"about_ca_system_score_gemma":0.0010637854,"threshold_uncertainty_score":0.9997308},"labels":[],"label_agreement":null},{"id":"W2151067537","doi":"10.1139/cjc-2014-0429","title":"A combination of pharmacophore modeling, molecular docking, and virtual screening for P2Y<sub>12</sub> receptor antagonists from Chinese herbs","year":2014,"lang":"en","type":"article","venue":"Canadian Journal of Chemistry","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Natural Science Foundation of China","keywords":"Pharmacophore; Chemistry; Virtual screening; Docking (animal); Stereochemistry; Combinatorial chemistry; Protein–ligand docking; Receptor; Computational biology; Biochemistry","score_opus":0.007664845837476574,"score_gpt":0.2306364495852247,"score_spread":0.22297160374774813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151067537","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98784804,0.0038478032,0.0078198,0.00015436305,0.00009160456,0.00009958416,0.000055753888,0.000005113426,0.000077942546],"genre_scores_gemma":[0.99897677,0.00017529952,0.00027504828,0.0001633295,0.000302215,0.0000019299366,0.00006921841,0.00002612666,0.000010078168],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991433,0.00002654583,0.00030998277,0.00014014183,0.00019989084,0.00018015261],"domain_scores_gemma":[0.99889016,0.00003115821,0.00018312226,0.0001369986,0.0002339444,0.00052458665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023979165,0.00014357475,0.00037497323,0.000058514783,0.00007045514,0.000023017183,0.000099015655,0.000101804755,0.000045439625],"category_scores_gemma":[0.00014772419,0.0001348547,0.00028129597,0.00006164043,0.0000768619,0.000069764516,0.0000071207637,0.00017150042,3.323303e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000469673,0.000039091363,0.004866688,0.0001907948,0.00070683815,0.00008690486,0.00028878468,0.0010530753,0.96404296,0.000007463497,0.00040779085,0.027839921],"study_design_scores_gemma":[0.008011207,0.00025298953,0.001127747,0.0006641392,0.00045968295,0.00028465354,0.00027971977,0.014194893,0.97244304,0.00026911357,0.0017364299,0.00027635793],"about_ca_topic_score_codex":0.00014856795,"about_ca_topic_score_gemma":0.00003404368,"teacher_disagreement_score":0.027563564,"about_ca_system_score_codex":0.000046024066,"about_ca_system_score_gemma":0.00036298163,"threshold_uncertainty_score":0.54992145},"labels":[],"label_agreement":null},{"id":"W2151474309","doi":"10.1136/ebmed.2011.100263","title":"Patients treated with aspirin after a first myocardial infarction who also receive a proton pump inhibitor have a higher incidence of cardiovascular events","year":2011,"lang":"en","type":"letter","venue":"Evidence-Based Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre","funders":"","keywords":"Aspirin; Medicine; Proton-pump inhibitor; Myocardial infarction; Incidence (geometry); Internal medicine; Adverse effect; Cardiology; Propensity score matching","score_opus":0.02308518445512036,"score_gpt":0.23915964319675403,"score_spread":0.21607445874163367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151474309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8244333,0.052389074,0.00054330146,0.09953187,0.0016878814,0.01994937,0.00026050734,0.0004637348,0.00074094237],"genre_scores_gemma":[0.8338544,0.007405599,0.0001562934,0.13819753,0.011796922,0.0051356605,0.0013373006,0.0004914779,0.0016248537],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9921063,0.00076315406,0.0012370023,0.0014737878,0.0035577202,0.00086203794],"domain_scores_gemma":[0.9949881,0.00030102624,0.00075964135,0.0020787914,0.001463188,0.00040927247],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001027461,0.0011845188,0.0031547074,0.000767828,0.00013943712,0.000019237505,0.000403504,0.0011922582,0.0008149731],"category_scores_gemma":[0.00047101532,0.00083194015,0.001882007,0.00075054506,0.0008114289,0.00043190742,0.00008991509,0.0016746635,0.00005303186],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031396482,0.0008686479,0.7771577,0.013110576,0.021402052,0.006166639,0.0009887407,0.00011229255,0.000058190835,8.7496437e-7,0.13547815,0.013259619],"study_design_scores_gemma":[0.017222412,0.008558907,0.29259464,0.06865483,0.014805086,0.00011036382,0.00003462952,0.000017038445,0.0015158402,0.000014965939,0.5952495,0.0012217768],"about_ca_topic_score_codex":0.0014501765,"about_ca_topic_score_gemma":0.000015192178,"teacher_disagreement_score":0.48456308,"about_ca_system_score_codex":0.00048527005,"about_ca_system_score_gemma":0.00068412523,"threshold_uncertainty_score":0.99941313},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"observational","genre":"editorial","about_ca_system":false,"about_ca_topic":false,"confidence":"medium"},{"model":"gpt","categories":[],"domain":null,"study_design":"not_applicable","genre":"commentary","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"split"},{"id":"W2152482321","doi":"10.1160/th13-09-0747","title":"Transferring from clopidogrel loading dose to prasugrel loading dose in acute coronary syndrome patients","year":2014,"lang":"en","type":"article","venue":"Thrombosis and Haemostasis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Sacré-Cœur de Montréal","funders":"","keywords":"Prasugrel; Clopidogrel; Medicine; Acute coronary syndrome; Loading dose; CYP2C19; Maintenance dose; Percutaneous coronary intervention; P2Y12; Internal medicine; Pharmacology; Anesthesia; Aspirin; Myocardial infarction","score_opus":0.02930765278176066,"score_gpt":0.2840907112301088,"score_spread":0.25478305844834814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152482321","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99716187,0.0009248051,0.00032567393,0.00040499374,0.0001689259,0.00061310624,0.00008938846,0.00008664275,0.00022460443],"genre_scores_gemma":[0.99631405,0.0015977242,0.00073190936,0.001072645,0.000060481652,0.00003572874,0.00010842418,0.00005715109,0.00002187559],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980822,0.00010784842,0.00039206917,0.0005752879,0.000385654,0.00045691337],"domain_scores_gemma":[0.9990367,0.00008906259,0.000051961662,0.00040206997,0.000052290347,0.00036791418],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026248235,0.00032073856,0.0008128577,0.0001983459,0.00016520267,0.000053853983,0.00012931117,0.00015001842,0.00016114439],"category_scores_gemma":[0.000027159673,0.00029537966,0.0002628721,0.00030152424,0.000077103854,0.00020366996,0.00007167513,0.00021355221,0.000053990996],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012776278,0.00067543186,0.7673206,0.0001796792,0.0021944775,0.00021275529,0.0027281602,0.000033929475,0.004549937,0.00013188054,0.0003643258,0.22033124],"study_design_scores_gemma":[0.0064518014,0.0005428819,0.98791283,0.0006272055,0.0007464438,0.000039376755,0.0002114544,0.00012483983,0.0017506701,0.00010927823,0.0010783424,0.0004048738],"about_ca_topic_score_codex":0.00021285728,"about_ca_topic_score_gemma":0.000028719009,"teacher_disagreement_score":0.22059228,"about_ca_system_score_codex":0.00008407278,"about_ca_system_score_gemma":0.00003355128,"threshold_uncertainty_score":0.9999498},"labels":[],"label_agreement":null},{"id":"W2152813238","doi":"10.1161/circulationaha.110.000786","title":"Safety and Tolerability of Atopaxar in the Treatment of Patients With Acute Coronary Syndromes","year":2011,"lang":"en","type":"article","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":151,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Medicine; Placebo; Tolerability; Myocardial infarction; Internal medicine; Stroke (engine); Angina; Anesthesia; Unstable angina; Clopidogrel; Cardiology; Adverse effect","score_opus":0.018311825279201537,"score_gpt":0.22844262335093596,"score_spread":0.21013079807173443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152813238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989128,0.00047644431,0.00010214936,0.0000066795046,0.000007740467,0.00034130382,0.000009388966,0.0000035147964,0.00013995373],"genre_scores_gemma":[0.99972624,0.00017732797,0.000039316976,0.000008792161,0.0000030182866,0.0000047133203,0.0000361413,0.0000031582715,0.0000013111653],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99961615,0.000039968465,0.00011969826,0.000076221215,0.00010686007,0.000041090385],"domain_scores_gemma":[0.99974334,0.000014548336,0.000043755033,0.00015010538,0.000033727443,0.0000144931855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000058887104,0.0000469446,0.00016688927,0.000020166997,0.000013238387,6.631152e-7,0.000015238954,0.000021584907,0.000019936491],"category_scores_gemma":[0.0000024791907,0.000027233707,0.000053937754,0.000058016765,0.000058004047,0.000033200293,0.0000018246176,0.000013106475,2.493092e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080967974,0.00045172882,0.98275125,0.000025218822,0.00019132045,0.000008101896,0.0015260988,0.000006318573,0.000019056426,0.0000607236,1.6911711e-7,0.014150311],"study_design_scores_gemma":[0.0019784635,0.00039416846,0.99702394,0.000021228207,0.00020934545,0.000012395134,0.000100533056,0.000019501642,0.00012210563,0.00006599251,0.000025312163,0.00002699264],"about_ca_topic_score_codex":0.000021619926,"about_ca_topic_score_gemma":0.0000021175806,"teacher_disagreement_score":0.014272689,"about_ca_system_score_codex":0.000016696504,"about_ca_system_score_gemma":0.000014623291,"threshold_uncertainty_score":0.111055836},"labels":[],"label_agreement":null},{"id":"W2154701937","doi":"10.2174/092986607782110202","title":"The Molecular Nature and Consequences of Lipoprotein (A)s Association with Platelets","year":2007,"lang":"en","type":"review","venue":"Protein and Peptide Letters","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cape Breton University","funders":"","keywords":"Platelet; Fibrinolysis; Fibrinogen; Chemistry; Lipoprotein(a); Apolipoprotein B; Endocrinology; Internal medicine; Plasmin; Platelet activation; Biochemistry; Biology; Cholesterol; Medicine","score_opus":0.012145365475224787,"score_gpt":0.27672529867212814,"score_spread":0.26457993319690337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154701937","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015594254,0.9816209,0.000052474265,0.00083362387,0.000024502036,0.0016711428,0.000014417474,0.000022391449,0.00016627145],"genre_scores_gemma":[0.002131168,0.99656457,0.000286462,0.0006078451,0.00009400606,0.000105619896,0.00002784487,0.000034440596,0.00014806452],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985471,0.00016381971,0.00031079917,0.00029685727,0.00043316119,0.0002482968],"domain_scores_gemma":[0.9991256,0.00014109,0.00032944215,0.00025145774,0.000058470698,0.00009393072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006129005,0.00029227772,0.0009495877,0.00008202849,0.000116320436,0.000045679873,0.0000840876,0.0003607557,0.0000057080692],"category_scores_gemma":[0.000078631,0.00016360903,0.00029135233,0.00015686832,0.0003058907,0.000038640992,0.000025731504,0.0006372415,0.000001827564],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015452529,0.00001641716,0.000091413975,0.008639834,0.0019731624,0.00037382016,0.00003246104,1.5205597e-7,0.0005574077,0.00032518638,0.00013183468,0.9877038],"study_design_scores_gemma":[0.00066161936,0.00015161357,0.00006193119,0.010330173,0.0012391041,0.00041364893,0.000023336648,2.7455934e-7,0.0012290125,0.000041162355,0.9855875,0.0002606671],"about_ca_topic_score_codex":0.000031095744,"about_ca_topic_score_gemma":0.0000036260828,"teacher_disagreement_score":0.9874431,"about_ca_system_score_codex":0.000043566575,"about_ca_system_score_gemma":0.00009642108,"threshold_uncertainty_score":0.6671783},"labels":[],"label_agreement":null},{"id":"W2155242348","doi":"10.1177/2048872614527838","title":"Vorapaxar, a platelet thrombin-receptor antagonist, in medically managed patients with non-ST-segment elevation acute coronary syndrome: results from the TRACER trial","year":2014,"lang":"en","type":"article","venue":"European Heart Journal Acute Cardiovascular Care","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Cardiology; Acute coronary syndrome; Internal medicine; Elevation (ballistics); Antagonist; Platelet; Platelet activation; ST elevation; Thrombin; Receptor antagonist; Receptor; Electrocardiography; Myocardial infarction; Engineering","score_opus":0.010722257029012075,"score_gpt":0.2265749162038676,"score_spread":0.21585265917485552,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155242348","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882873,0.004195585,0.0034089107,0.0005915579,0.0008084285,0.0018563147,0.00041057574,0.00008609603,0.00035519328],"genre_scores_gemma":[0.9925654,0.0021984524,0.0009886237,0.0013502216,0.0010159346,0.000029675131,0.0016320281,0.0001651603,0.000054500655],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.993312,0.0019789755,0.0009805053,0.00082529744,0.0022432501,0.0006599776],"domain_scores_gemma":[0.997343,0.000156157,0.00027393195,0.0013149645,0.0004386335,0.00047331877],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0024970255,0.00057131867,0.0013352094,0.00016834108,0.0005074751,0.00019294399,0.0004620332,0.00015856173,0.00010593706],"category_scores_gemma":[0.00015069135,0.00037220854,0.0022399009,0.0004350041,0.00021559677,0.00029544768,0.00012724388,0.0011633224,0.00010252486],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.34321758,0.0035669324,0.07921571,0.00042216884,0.18481468,0.052274235,0.013491291,0.013687095,0.0009097479,0.000014182886,0.055610158,0.2527762],"study_design_scores_gemma":[0.22724444,0.0038851688,0.62836117,0.001084908,0.00668407,0.003707159,0.0011322774,0.00010898238,0.00014851656,0.0000062857093,0.12669253,0.00094450446],"about_ca_topic_score_codex":0.000024953939,"about_ca_topic_score_gemma":0.0000028611219,"teacher_disagreement_score":0.5491454,"about_ca_system_score_codex":0.00024950886,"about_ca_system_score_gemma":0.00019637216,"threshold_uncertainty_score":0.999873},"labels":[],"label_agreement":null},{"id":"W2155676376","doi":"10.1016/j.jemermed.2007.10.019","title":"Do Patients with Acute Myocardial Infarction Benefit from Treatment with Clopidogrel?","year":2008,"lang":"en","type":"review","venue":"Journal of Emergency Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Clopidogrel; Medicine; Myocardial infarction; Intensive care medicine; Percutaneous; Cardiology; Fibrinolytic therapy; Audience measurement; Internal medicine; Psychological intervention; Emergency department; Acute coronary syndrome; Platelet aggregation inhibitor; Platelet","score_opus":0.03720660136597693,"score_gpt":0.3221140054589338,"score_spread":0.2849074040929569,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155676376","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010024669,0.98674643,0.000086193184,0.00007107364,0.0017471514,0.0008081898,0.00007260355,0.000019476025,0.0004242116],"genre_scores_gemma":[0.00024197059,0.99477315,0.0001277118,0.0000362587,0.004039653,0.000024810115,0.00036337436,0.00009961035,0.00029347613],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964777,0.00012066937,0.0013671796,0.00037154296,0.001351273,0.00031161716],"domain_scores_gemma":[0.9969682,0.00005565389,0.0013574444,0.0005360067,0.00063785777,0.0004448413],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00013204172,0.0006942097,0.0037034089,0.00038975858,0.00010412544,0.00000434556,0.00017170078,0.00025628397,0.0011984345],"category_scores_gemma":[0.000027010248,0.0003240603,0.0015876234,0.0005024825,0.00011948414,0.00013281457,0.000015791551,0.00048058934,0.00001759952],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021284642,0.00056452333,0.0066494923,0.0007149398,0.03926205,0.0010049297,0.00021247692,0.000002897496,3.836281e-7,0.0000034880252,0.0041364455,0.9453199],"study_design_scores_gemma":[0.007889542,0.010104794,0.0048310813,0.012821996,0.03210458,0.0011143088,0.000034610403,2.1201178e-7,3.1417775e-7,0.000009113737,0.9307672,0.0003222485],"about_ca_topic_score_codex":0.00005561013,"about_ca_topic_score_gemma":0.00000443648,"teacher_disagreement_score":0.94499767,"about_ca_system_score_codex":0.00027187009,"about_ca_system_score_gemma":0.0005987665,"threshold_uncertainty_score":0.99992114},"labels":[],"label_agreement":null},{"id":"W2155707631","doi":"10.1161/circulationaha.112.092239","title":"Response to Letters Regarding Article, “Platelet Reactivity and Cardiovascular Outcomes After Percutaneous Coronary Intervention: A Time-Dependent Analysis of the Gauging Responsiveness With a VerifyNow P2Y12 Assay: Impact on Thrombosis and Safety (GRAVITAS) Trial”","year":2012,"lang":"en","type":"article","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"","keywords":"Medicine; Percutaneous coronary intervention; P2Y12; Thrombosis; Internal medicine; Myocardial infarction","score_opus":0.013301167492545812,"score_gpt":0.2701438297930641,"score_spread":0.25684266230051833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155707631","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967373,0.0007616886,0.0011697201,0.0003189721,0.00005550555,0.00088060007,0.000033810433,0.000028513085,0.000013906341],"genre_scores_gemma":[0.999626,0.00003386064,0.000044982844,0.00017890809,0.000034714252,0.00003106848,0.000014764683,0.000026975995,0.000008735093],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975272,0.0010297081,0.00028088278,0.00033776317,0.00058070756,0.00024374982],"domain_scores_gemma":[0.9986765,0.00033413814,0.000107330416,0.000639919,0.00008073401,0.00016139311],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002124052,0.00022351921,0.00076539983,0.00026941934,0.00013622158,0.00003143003,0.000051306728,0.000084452695,0.00004930932],"category_scores_gemma":[0.00020458174,0.00014755563,0.00093861384,0.0005007679,0.00008862658,0.00020058893,0.00004830013,0.0001326006,0.0000028720697],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12372526,0.00019870646,0.8257508,0.000046768615,0.013377326,0.000080720034,0.0007881959,0.0055614924,0.021314183,0.0000032482,0.000004531323,0.009148751],"study_design_scores_gemma":[0.0072013014,0.00019223146,0.9856148,0.00018798304,0.0052190498,0.00027162678,0.00016304532,0.0002584191,0.00067133177,0.0000023444795,0.00004131986,0.00017654702],"about_ca_topic_score_codex":0.0000507834,"about_ca_topic_score_gemma":0.0000039231586,"teacher_disagreement_score":0.15986398,"about_ca_system_score_codex":0.00016566983,"about_ca_system_score_gemma":0.00003221327,"threshold_uncertainty_score":0.60171443},"labels":[],"label_agreement":null},{"id":"W2156506897","doi":"10.1161/circulationaha.104.502815","title":"Randomized Comparison of Prasugrel (CS-747, LY640315), a Novel Thienopyridine P2Y <sub>12</sub> Antagonist, With Clopidogrel in Percutaneous Coronary Intervention","year":2005,"lang":"en","type":"article","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":380,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Health Centre","funders":"Eli Lilly and Company","keywords":"Prasugrel; Medicine; Clopidogrel; Thienopyridine; Percutaneous coronary intervention; Internal medicine; TIMI; Cardiology; Myocardial infarction; Ticlopidine; Anesthesia","score_opus":0.018205138269022147,"score_gpt":0.27273357665322956,"score_spread":0.2545284383842074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156506897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98190635,0.0035464817,0.012596651,0.00019249244,0.00008349811,0.0011909937,0.000011604146,0.00007412322,0.00039779657],"genre_scores_gemma":[0.9985884,0.00027794106,0.00053221494,0.00008498801,0.00015007409,0.000037131358,0.00027195804,0.000039103,0.000018221306],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99805886,0.00017210926,0.0006967573,0.00035215917,0.00047981113,0.00024031827],"domain_scores_gemma":[0.99901766,0.000108427754,0.00029881214,0.0003332429,0.00014539457,0.00009647579],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056907657,0.00023671574,0.00094604824,0.00023244416,0.00006878707,0.00001780647,0.00007856677,0.00015204152,0.000052406504],"category_scores_gemma":[0.00008616795,0.00020175987,0.00047877477,0.00027103833,0.00019257992,0.00018722216,0.000020604872,0.00020884801,0.000014923443],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.23321699,0.005035038,0.30378044,0.0009884583,0.0025185584,0.00029452768,0.0033093444,0.02466669,0.25530273,0.00083284517,0.00014773176,0.16990666],"study_design_scores_gemma":[0.4134815,0.00082026253,0.4464543,0.0018217638,0.0021966528,0.003041583,0.0010085517,0.09449753,0.035095338,0.00014455918,0.0006069877,0.00083098083],"about_ca_topic_score_codex":0.000042566673,"about_ca_topic_score_gemma":0.00005722719,"teacher_disagreement_score":0.22020738,"about_ca_system_score_codex":0.0001482427,"about_ca_system_score_gemma":0.00008215769,"threshold_uncertainty_score":0.8227529},"labels":[],"label_agreement":null},{"id":"W2156645533","doi":"10.1007/bf03022257","title":"Antiplatelet agents and perioperative bleeding","year":2006,"lang":"en","type":"review","venue":"Canadian Journal of Anesthesia/Journal canadien d anesthésie","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Clopidogrel; Abciximab; Discontinuation; Context (archaeology); Perioperative; Ticlopidine; Aspirin; Intensive care medicine; Surgery; Internal medicine; Myocardial infarction; Percutaneous coronary intervention","score_opus":0.024945023519498087,"score_gpt":0.269253919331261,"score_spread":0.24430889581176293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156645533","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.026045622,0.9721076,0.0000056995327,0.00035587075,0.00033557016,0.00046058762,0.000022102246,0.000011276695,0.0006556852],"genre_scores_gemma":[0.00530587,0.9913329,0.00016399562,0.00009041854,0.0019134806,0.0000054478146,0.000046041234,0.00018010313,0.00096172484],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99579024,0.00033834504,0.0016138158,0.0004280616,0.00071437366,0.0011151796],"domain_scores_gemma":[0.9939014,0.00008644117,0.0012089196,0.0003500505,0.00068334973,0.0037698534],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013001978,0.00088532426,0.0037023663,0.0016478406,0.0007079711,0.0004943792,0.00050202024,0.0006501465,0.00025859114],"category_scores_gemma":[0.00012608679,0.0006969854,0.0020134936,0.0006103449,0.00042250875,0.00040246348,0.000013300209,0.0018592164,0.000019810304],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046766138,0.000025427116,0.00027199427,0.0018350251,0.0013188745,0.7329776,0.00022975323,0.0000064724677,1.4312275e-7,0.00005654414,0.0036814578,0.2595499],"study_design_scores_gemma":[0.0006491298,0.00038071824,0.00013162325,0.0062242066,0.0022342403,0.5100593,0.000120023265,0.0000014290182,3.6990284e-7,0.000009850783,0.47985387,0.0003352409],"about_ca_topic_score_codex":0.0017613762,"about_ca_topic_score_gemma":0.0009701888,"teacher_disagreement_score":0.4761724,"about_ca_system_score_codex":0.0010223422,"about_ca_system_score_gemma":0.010809143,"threshold_uncertainty_score":0.99954814},"labels":[],"label_agreement":null},{"id":"W2157163846","doi":"10.1001/jama.292.15.1867","title":"Oral Antiplatelet Therapy in Cerebrovascular Disease, Coronary Artery Disease, and Peripheral Arterial Disease","year":2004,"lang":"en","type":"review","venue":"JAMA","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":183,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences; Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Medicine; Arterial disease; Cardiology; Coronary artery disease; Disease; Vascular disease; Internal medicine; Peripheral","score_opus":0.02404446166462724,"score_gpt":0.2822126868796644,"score_spread":0.25816822521503713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157163846","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.029863346,0.96559113,0.000028938612,0.00019322454,0.00049557316,0.0030179447,0.0005623779,0.00018153508,0.000065952925],"genre_scores_gemma":[0.01315547,0.98149294,0.000047695918,0.00056522276,0.0012775863,0.000430603,0.0024686935,0.00025039417,0.00031140517],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.995301,0.00054604287,0.00095571665,0.001427514,0.0008987878,0.0008709389],"domain_scores_gemma":[0.99631476,0.00007499139,0.00023543951,0.0014212937,0.00009423065,0.0018592776],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00035014542,0.0012168557,0.003172657,0.00037001137,0.00017086267,0.00023213292,0.00034077704,0.00042001635,0.0007902458],"category_scores_gemma":[0.00009742108,0.0009856282,0.0027756381,0.00042516954,0.00038717684,0.00039441878,0.00014283952,0.00074448145,0.00009295138],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053481096,0.0010111051,0.004311876,0.019076874,0.003168382,0.013487598,0.000048714675,0.000009434785,6.0608716e-7,0.00008506489,0.0005776676,0.95287454],"study_design_scores_gemma":[0.015262116,0.0002332595,0.11794457,0.024599783,0.005117235,0.00045857186,0.000019342062,0.000019538395,2.0446664e-7,0.00033131836,0.83463836,0.0013756987],"about_ca_topic_score_codex":0.00001647458,"about_ca_topic_score_gemma":0.000002640433,"teacher_disagreement_score":0.95149887,"about_ca_system_score_codex":0.00029277132,"about_ca_system_score_gemma":0.0017817226,"threshold_uncertainty_score":0.9992594},"labels":[],"label_agreement":null},{"id":"W2157284846","doi":"10.1007/s11910-010-0162-y","title":"Current Status of Antiplatelet Agents to Prevent Stroke","year":2010,"lang":"en","type":"review","venue":"Current Neurology and Neuroscience Reports","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute of Neurological Disorders and Stroke; Sanofi","keywords":"Aspirin; Dipyridamole; Medicine; Clopidogrel; Stroke (engine); Neurology; Cardiology; Ischemic stroke; Vascular disease; Intensive care medicine; Internal medicine; Ischemia","score_opus":0.05889108693012801,"score_gpt":0.37598398489332746,"score_spread":0.31709289796319945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157284846","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0561456,0.9372444,0.000035063607,0.000022729231,0.0049047833,0.0014824134,0.000076396565,0.000049566162,0.000039046743],"genre_scores_gemma":[0.0048779286,0.9945991,0.0000068125732,0.00013716637,0.00017868707,0.000074594034,0.000047945272,0.000044693177,0.00003308134],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960809,0.00024675464,0.0010205356,0.0012809136,0.00060173066,0.00076921785],"domain_scores_gemma":[0.9974518,0.00007714438,0.00066984154,0.00094313984,0.00008986281,0.00076822535],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042551637,0.000536115,0.0020480927,0.0003254753,0.00013715122,0.000025996093,0.00020049856,0.00027377455,0.000025295101],"category_scores_gemma":[0.00039893665,0.00041927095,0.00086983875,0.0004554035,0.00044700314,0.00008595043,0.00026362983,0.0011924856,0.000007161898],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046884004,0.00050057145,0.0015809827,0.0043429565,0.00003750923,0.0013837662,0.00001709757,0.0000010824872,0.000057328703,0.00000984176,0.00024147787,0.9917805],"study_design_scores_gemma":[0.00020281553,0.00047910694,0.0025944544,0.0017385744,0.00094326516,0.0066482984,5.956089e-7,0.000003474064,0.000049849976,0.00000974204,0.9870511,0.00027869802],"about_ca_topic_score_codex":0.0000019644954,"about_ca_topic_score_gemma":5.6229817e-7,"teacher_disagreement_score":0.9915018,"about_ca_system_score_codex":0.000014056986,"about_ca_system_score_gemma":0.0007205984,"threshold_uncertainty_score":0.9998259},"labels":[],"label_agreement":null},{"id":"W2157424947","doi":"","title":"Family practice patients' use of acetylsalicylic acid for cardiovascular disease prevention.","year":2013,"lang":"en","type":"article","venue":"PubMed","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Primary prevention; Family medicine; Secondary prevention; Adverse effect; Disease; Alternative medicine; Internal medicine","score_opus":0.04034935566475528,"score_gpt":0.2461126234683076,"score_spread":0.2057632678035523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157424947","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96503794,0.018631553,0.0071279462,0.00040062654,0.0002517295,0.007996102,0.00008994631,0.00010875781,0.0003553895],"genre_scores_gemma":[0.99063945,0.000786052,0.0012473381,0.00067770685,0.00016315894,0.0057042977,0.00013967296,0.000044289038,0.00059806416],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99839824,0.00013146397,0.0002928459,0.00031543343,0.00052013696,0.00034184876],"domain_scores_gemma":[0.9981922,0.00010119623,0.00010728033,0.00071516674,0.00052932644,0.00035484837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034674467,0.00016650205,0.00043763357,0.00007804353,0.000058884336,0.00003560769,0.00008887508,0.00006935116,0.000021670263],"category_scores_gemma":[0.0011030046,0.00014349568,0.0017276952,0.00016360368,0.00007152933,0.0005679831,0.000034549666,0.00007333076,0.000017471837],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019601677,0.0017432624,0.02202739,0.00059607276,0.014884325,0.00001913436,0.000065916436,0.00012077915,0.00008554027,0.0002970068,0.009183048,0.94901735],"study_design_scores_gemma":[0.0048272517,0.00010288824,0.76351726,0.00003691861,0.0041401256,0.000006178227,0.00006841655,0.00003117293,0.00042005238,0.00016264796,0.22647259,0.00021451143],"about_ca_topic_score_codex":0.000052089854,"about_ca_topic_score_gemma":1.5379257e-7,"teacher_disagreement_score":0.9488028,"about_ca_system_score_codex":0.000039257604,"about_ca_system_score_gemma":0.000064630774,"threshold_uncertainty_score":0.5851584},"labels":[],"label_agreement":null},{"id":"W2158389123","doi":"10.1503/cmaj.090251","title":"The drug-drug interaction between proton pump inhibitors and clopidogrel","year":2009,"lang":"en","type":"letter","venue":"Canadian Medical Association Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Clopidogrel; Drug; Myocardial infarction; Medicine; Drug interaction; Aspirin; Randomized controlled trial; Pharmacology; Proton-pump inhibitor; Platelet aggregation inhibitor; Clinical trial; Cardiology; Internal medicine","score_opus":0.006222158780328278,"score_gpt":0.23369045065677632,"score_spread":0.22746829187644804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158389123","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.028666627,0.0030352434,0.000008787777,0.96520346,0.0013007018,0.0006061094,0.000030376828,0.0000307327,0.0011179766],"genre_scores_gemma":[0.028527709,0.0071980623,0.000015095636,0.8942098,0.06398394,0.000046993588,0.00027863405,0.000083211395,0.0056565814],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959283,0.0004925381,0.00059485156,0.00026247415,0.0020882734,0.0006335596],"domain_scores_gemma":[0.9975041,0.00033988612,0.00040732697,0.00019572632,0.00034544038,0.0012075243],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.002044886,0.00027253255,0.00053688936,0.00022345124,0.00066045305,0.0002574133,0.00019897842,0.0010030495,0.00034990866],"category_scores_gemma":[0.0008078702,0.00019389846,0.0004759617,0.00016963536,0.00009325046,0.0001234603,0.000015170877,0.005268455,0.0000660905],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013203143,0.000005885428,0.013924295,0.00003428271,0.000658256,0.001232492,0.00008560105,9.19542e-8,1.816796e-7,0.0000018003664,0.86456865,0.11947528],"study_design_scores_gemma":[0.0009414963,0.00004680392,0.007669425,0.00043854816,0.00034437238,0.0008926562,0.00015228537,0.0000059074064,0.000011235944,0.000107873486,0.989193,0.00019638166],"about_ca_topic_score_codex":0.0008283729,"about_ca_topic_score_gemma":0.0013824058,"teacher_disagreement_score":0.12462439,"about_ca_system_score_codex":0.0011195253,"about_ca_system_score_gemma":0.0025387057,"threshold_uncertainty_score":0.99702644},"labels":[],"label_agreement":null},{"id":"W2158634694","doi":"10.1177/1479164114546854","title":"The clinical burden of type 2 diabetes in patients with acute coronary syndromes: Prognosis and implications for short- and long-term management","year":2014,"lang":"en","type":"review","venue":"Diabetes and Vascular Disease Research","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital; University of Manitoba","funders":"European Association for the Study of Diabetes","keywords":"Medicine; Acute coronary syndrome; Lixisenatide; Alogliptin; Intensive care medicine; Type 2 diabetes; Type 2 Diabetes Mellitus; Diabetes mellitus; Population; Internal medicine; Insulin resistance; Liraglutide; Insulin; Myocardial infarction; Endocrinology","score_opus":0.0682991647252024,"score_gpt":0.4006491304565973,"score_spread":0.33234996573139486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158634694","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3562371,0.6406277,0.0000022987704,0.000037761172,0.000013613208,0.002983005,0.00008719223,0.000008146384,0.0000031688428],"genre_scores_gemma":[0.06786873,0.93051434,0.000024510042,0.000013985982,0.00004549356,0.00095297163,0.00050654134,0.00005535917,0.000018080606],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99745476,0.00044553867,0.0005046239,0.00063757633,0.00044830024,0.0005092146],"domain_scores_gemma":[0.9979539,0.0006180648,0.00008441237,0.00065699144,0.00026242415,0.0004242015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014555209,0.00030297815,0.0013350389,0.00020460703,0.00023235926,0.00007795791,0.0001816656,0.00014637616,0.0000038114508],"category_scores_gemma":[0.000094133626,0.00018120714,0.00048643292,0.0003154106,0.00062176626,0.000055107266,0.00023288815,0.00027312041,9.4568884e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008142608,0.00016031423,0.45228368,0.013998502,0.004013786,0.000005505652,0.0000039686265,6.1680204e-8,2.2796586e-8,0.00004838379,0.00002566318,0.52937865],"study_design_scores_gemma":[0.0017846302,0.00075474335,0.9351813,0.007921105,0.0064183595,0.0000013661825,0.000011701486,0.000020664169,6.7293065e-8,0.000067044275,0.047596138,0.00024283859],"about_ca_topic_score_codex":7.89114e-7,"about_ca_topic_score_gemma":6.6360906e-7,"teacher_disagreement_score":0.5291358,"about_ca_system_score_codex":0.000025941064,"about_ca_system_score_gemma":0.00014080871,"threshold_uncertainty_score":0.73894125},"labels":[],"label_agreement":null},{"id":"W2159382450","doi":"10.1016/j.cjca.2013.07.001","title":"Focused 2012 Update of the Canadian Cardiovascular Society Guidelines for the Use of Antiplatelet Therapy","year":2013,"lang":"en","type":"review","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"McMaster University; Vancouver General Hospital; St. Michael's Hospital; Libin Cardiovascular Institute of Alberta; Centre Hospitalier de l’Université de Montréal; St. Joseph’s Healthcare Hamilton; Montreal Heart Institute; University of British Columbia; Humber River Regional Hospital; Alberta Health Services; University of Toronto; Université de Montréal","funders":"","keywords":"Medicine; Canadian Cardiovascular Society; Intensive care medicine; Internal medicine; Myocardial infarction","score_opus":0.21303183059514588,"score_gpt":0.3319881479623654,"score_spread":0.11895631736721954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159382450","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016211123,0.9943845,0.00093795534,0.00074133213,0.0012434178,0.0018895764,0.00057926466,0.0000038342814,0.00005796692],"genre_scores_gemma":[0.0010190842,0.99586964,0.0004893009,0.0005940834,0.0017263974,0.000047549915,0.000049111983,0.00009616221,0.00010868371],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964248,0.00064144237,0.0015091636,0.00029526296,0.00045548985,0.00067383714],"domain_scores_gemma":[0.9942334,0.00038115957,0.00096906297,0.0013750194,0.0023040455,0.0007372659],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0017848087,0.0005124669,0.004473124,0.00032647632,0.00030270973,0.000040720042,0.0008623236,0.0007343562,0.00005191333],"category_scores_gemma":[0.0005133591,0.000263786,0.014315446,0.00041469155,0.0007730044,0.00012842732,0.00002716627,0.00068702886,0.0000041112803],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003562006,0.0000028103004,0.00014394369,0.0011823925,0.03176494,0.000060947255,0.00003953734,0.00056635257,9.921442e-7,0.000051600106,0.12973352,0.8364173],"study_design_scores_gemma":[0.0012650434,0.00012390279,0.00018258273,0.0018041863,0.00822164,0.0016979589,0.000029748047,0.000008136476,0.0000074759396,0.0000235262,0.98640186,0.00023395973],"about_ca_topic_score_codex":0.035734676,"about_ca_topic_score_gemma":0.018739797,"teacher_disagreement_score":0.8566683,"about_ca_system_score_codex":0.00027343363,"about_ca_system_score_gemma":0.012056363,"threshold_uncertainty_score":0.99998146},"labels":[],"label_agreement":null},{"id":"W2160809781","doi":"10.1016/j.jcjd.2013.07.017","title":"Prise en charge des syndromes coronariens aigus","year":2013,"lang":"fr","type":"article","venue":"Canadian Journal of Diabetes","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Gynecology","score_opus":0.011476484834804606,"score_gpt":0.21223305517409533,"score_spread":0.20075657033929073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160809781","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6898018,0.30599067,0.000017440914,0.0014701027,0.0016665282,0.0001974732,0.000053091062,0.0000065271497,0.00079636107],"genre_scores_gemma":[0.99119556,0.0018818111,0.00019662913,0.0007263403,0.0014268879,0.0000073456936,0.0000099688095,0.000054753586,0.0045006787],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977295,0.00023724519,0.00051176205,0.00017808027,0.00029967848,0.0010437275],"domain_scores_gemma":[0.99630207,0.00015709638,0.00020110463,0.00028569018,0.00046036745,0.00259365],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00053527334,0.00028369078,0.0007154212,0.00031734808,0.00021940989,0.00015802433,0.00028525456,0.0002251034,0.011162871],"category_scores_gemma":[0.00040722793,0.00025952313,0.00070531556,0.00023660512,0.00063604297,0.0005198153,0.000012643543,0.0004398381,0.0008697122],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008447566,0.000117384436,0.6257018,0.0005514374,0.0035233519,0.0011594107,0.0019102306,0.00002571762,0.00043117392,0.00047021973,0.031265244,0.3348356],"study_design_scores_gemma":[0.003045094,0.0012417204,0.7218014,0.0035309722,0.0019043542,0.0008103873,0.0016782009,0.00013271302,0.0012648099,0.0016078313,0.2623631,0.000619434],"about_ca_topic_score_codex":0.0013531139,"about_ca_topic_score_gemma":0.0004823998,"teacher_disagreement_score":0.33421615,"about_ca_system_score_codex":0.00038999546,"about_ca_system_score_gemma":0.0021801475,"threshold_uncertainty_score":0.9999857},"labels":[],"label_agreement":null},{"id":"W2161872374","doi":"10.1016/j.ahj.2009.10.010","title":"Safety and feasibility of adjunctive antiplatelet therapy with intravenous elinogrel, a direct-acting and reversible P2Y12 ADP-receptor antagonist, before primary percutaneous intervention in patients with ST-elevation myocardial infarction: The Early Rapid ReversAl of Platelet ThromboSis with Intravenous Elinogrel before PCI to Optimize REperfusion in Acute Myocardial Infarction (ERASE MI) pilot trial","year":2009,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; P2Y12; Percutaneous coronary intervention; Cardiology; Myocardial infarction; Internal medicine; Antagonist; Anesthesia; Percutaneous; Receptor","score_opus":0.011609996221470558,"score_gpt":0.25178611706825077,"score_spread":0.24017612084678022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161872374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966164,0.0002726716,0.00022847013,0.00048529785,0.00011331627,0.0021522332,0.000084537,0.00002516545,0.000021911324],"genre_scores_gemma":[0.99616915,0.0015285098,0.0016118122,0.0003329018,0.00019289026,0.000014986915,0.000107025204,0.0000404605,0.0000022552447],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968398,0.0005712966,0.00086126506,0.00052515086,0.0007842504,0.00041823756],"domain_scores_gemma":[0.99831206,0.00009863374,0.0006046228,0.00034659408,0.0004186331,0.0002194448],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010390183,0.00039353667,0.0012436995,0.00036373283,0.00026936174,0.0000553754,0.00010045693,0.00011430464,0.000024747073],"category_scores_gemma":[0.00006627554,0.00026498287,0.00023282782,0.00081547094,0.0004940427,0.00041356066,0.00003706008,0.0006898745,3.4009165e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.40910742,0.0013312877,0.4184228,0.00004994204,0.0015813671,0.000077053606,0.004207549,0.0004123599,0.0013042965,0.0000011305302,0.000027768416,0.16347703],"study_design_scores_gemma":[0.042709813,0.06886003,0.8846256,0.00064526306,0.00041096864,0.0009280644,0.0011458069,0.000040921157,0.00022473572,0.0000063679126,0.00010642298,0.00029601992],"about_ca_topic_score_codex":0.0006038958,"about_ca_topic_score_gemma":0.00007378171,"teacher_disagreement_score":0.4662028,"about_ca_system_score_codex":0.00028058264,"about_ca_system_score_gemma":0.0002677559,"threshold_uncertainty_score":0.9999802},"labels":[],"label_agreement":null},{"id":"W2162012946","doi":"10.1186/1741-7015-8-81","title":"The potential interaction between clopidogrel and proton pump inhibitors: a systematic review","year":2010,"lang":"en","type":"review","venue":"BMC Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Clopidogrel; MEDLINE; Meta-analysis; Publication bias; Internal medicine; Intensive care medicine; Aspirin","score_opus":0.03681056357003266,"score_gpt":0.3469760829051806,"score_spread":0.31016551933514797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162012946","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00001358491,0.9876118,0.00011798957,0.0003452203,0.0006162078,0.011043934,0.000008515679,0.000075602395,0.00016715108],"genre_scores_gemma":[0.000022507707,0.99474204,0.000019369663,0.00020098765,0.0030089417,0.0013320934,0.00017777142,0.00007328131,0.00042301425],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99639827,0.0006657021,0.0014167412,0.00049810053,0.0007222391,0.0002989767],"domain_scores_gemma":[0.99724627,0.00053243537,0.000753853,0.0010529275,0.00013840476,0.00027612157],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0020934858,0.0005404808,0.0043848455,0.00013758359,0.00019681432,0.000033086446,0.00022174857,0.00035646756,0.000052011823],"category_scores_gemma":[0.0012836927,0.00025057636,0.0010840313,0.00028045906,0.00029288157,0.00006481457,0.00007374631,0.0009352003,0.000062477055],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015589847,0.000014702138,0.0000068891313,0.757789,0.00072197587,0.000030253505,0.000010068666,1.8344166e-9,3.3440602e-7,0.0000073634774,0.0005462592,0.24085753],"study_design_scores_gemma":[0.00041919944,0.00011846103,0.000005311491,0.48869643,0.017727025,0.0007899286,0.000024852856,6.6296957e-7,3.8228438e-7,0.00000632895,0.49208233,0.0001291126],"about_ca_topic_score_codex":0.000010916789,"about_ca_topic_score_gemma":0.0000018241477,"teacher_disagreement_score":0.49153605,"about_ca_system_score_codex":0.000059776434,"about_ca_system_score_gemma":0.00026715986,"threshold_uncertainty_score":0.99999464},"labels":[],"label_agreement":null},{"id":"W2162084532","doi":"10.1161/circulationaha.108.844050","title":"Response to Letter Regarding Article, “Greater Clinical Benefit of More Intensive Oral Antiplatelet Therapy With Prasugrel in Patients With Diabetes Mellitus in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel: Thrombolysis in Myocardial Infarction 38”","year":2009,"lang":"en","type":"article","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Prasugrel; TIMI; Myocardial infarction; Diabetes mellitus; Thrombolysis; Acute coronary syndrome; Clinical trial; Internal medicine","score_opus":0.026472256168961688,"score_gpt":0.2917631940775527,"score_spread":0.265290937908591,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162084532","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99383944,0.000096865464,0.0005734386,0.002140037,0.000047994043,0.0032654298,0.000008023802,0.000022700224,0.000006041168],"genre_scores_gemma":[0.9955369,0.00002453275,0.00019996574,0.0039570625,0.000037131394,0.00014092158,0.00006634022,0.000036138576,9.680764e-7],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970254,0.00051447883,0.0007866906,0.0005494153,0.0007121995,0.00041186524],"domain_scores_gemma":[0.9988681,0.00017954416,0.00021265604,0.00041679837,0.00023905277,0.000083850995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015594999,0.00032000383,0.000871388,0.0005311305,0.00004479823,0.000051409683,0.000092574206,0.00016581091,0.0000047175117],"category_scores_gemma":[0.000095606345,0.00020134085,0.00014946537,0.0010450151,0.00007315777,0.0003406952,0.000015810816,0.00034313937,0.0000013104165],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09927757,0.00066161255,0.87154853,0.000011531432,0.0002912969,0.000039619823,0.0018066234,0.008956964,0.003546439,0.000004911838,0.00000800123,0.013846872],"study_design_scores_gemma":[0.061955914,0.0035444072,0.93076897,0.000456613,0.00008933217,0.0000030449512,0.0006965495,0.0002388805,0.001944482,0.000022691214,0.000014292106,0.00026482396],"about_ca_topic_score_codex":0.000061585866,"about_ca_topic_score_gemma":0.000045880588,"teacher_disagreement_score":0.05922041,"about_ca_system_score_codex":0.00023376818,"about_ca_system_score_gemma":0.00007064077,"threshold_uncertainty_score":0.82104415},"labels":[],"label_agreement":null},{"id":"W2162886638","doi":"10.1016/s0140-6736(01)05701-4","title":"Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study","year":2001,"lang":"en","type":"article","venue":"The Lancet","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2808,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"","keywords":"Conventional PCI; Medicine; Clopidogrel; Percutaneous coronary intervention; Myocardial infarction; Aspirin; Internal medicine; Cardiology; Clinical endpoint; Acute coronary syndrome; Thienopyridine; Placebo; Surgery; Randomized controlled trial","score_opus":0.009913633990753016,"score_gpt":0.24976536345661912,"score_spread":0.2398517294658661,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162886638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98838556,0.009863841,0.000018364764,0.00021572669,0.000037160404,0.0013731102,0.000004153204,0.00002051697,0.00008158968],"genre_scores_gemma":[0.99606156,0.0035121785,0.0000066358552,0.00018975511,0.000057658242,0.000040267325,0.000017111017,0.000016387707,0.00009846027],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99908787,0.00020931789,0.00014038301,0.00016647796,0.00023722733,0.00015871236],"domain_scores_gemma":[0.9994226,0.000120158,0.00006089379,0.00033860476,0.00002502473,0.00003270441],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016615614,0.00013864692,0.00036419745,0.000020801732,0.00006450847,0.000013706417,0.000111044305,0.00003066787,0.000016579706],"category_scores_gemma":[0.000009329462,0.00006582345,0.000104380146,0.00010230152,0.00008513808,0.00003393338,0.00002745798,0.00010754483,0.0000014524319],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004435448,0.0013467402,0.96812767,0.000095425035,0.00093657686,0.00040346326,0.0006983236,0.0000035077917,0.000042164997,0.000003830174,0.00011864699,0.023788234],"study_design_scores_gemma":[0.016671097,0.0047977096,0.977123,0.0003626894,0.00025173326,0.00019945805,0.0003087573,0.000004274422,0.00009554907,0.0000119054275,0.000093090704,0.000080691745],"about_ca_topic_score_codex":0.000024905727,"about_ca_topic_score_gemma":0.00006269031,"teacher_disagreement_score":0.023707543,"about_ca_system_score_codex":0.000037312515,"about_ca_system_score_gemma":0.000015996213,"threshold_uncertainty_score":0.26842025},"labels":[],"label_agreement":null},{"id":"W2163986031","doi":"10.1016/j.jacc.2011.02.040","title":"Impact of Insulin Receptor Substrate-1 Genotypes on Platelet Reactivity and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease","year":2011,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Regione del Veneto; Medicines Company; Medicure; Eisai; Schering-Plough; Daiichi Sankyo Europe; Sanofi; Baxter International; GlaxoSmithKline; Otsuka America; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Mace; Internal medicine; Coronary artery disease; Hazard ratio; Clopidogrel; Aspirin; Odds ratio; Population; Gastroenterology; Type 2 diabetes; Type 2 Diabetes Mellitus; Diabetes mellitus; Cardiology; Endocrinology; Confidence interval; Myocardial infarction; Percutaneous coronary intervention","score_opus":0.010294739783799859,"score_gpt":0.2219516339473619,"score_spread":0.21165689416356204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163986031","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950573,0.0044489237,0.0000041165486,0.000022688939,0.000072313276,0.00025253915,0.00010146923,0.0000029004348,0.000037748552],"genre_scores_gemma":[0.9979546,0.0018834117,0.000072380884,0.000030937925,0.000035735316,0.0000018031752,0.0000024665328,0.00001597177,0.0000027015672],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987193,0.00034057762,0.00032783818,0.00015582104,0.00028894833,0.00016756186],"domain_scores_gemma":[0.99886394,0.00011253092,0.00035353476,0.0003433541,0.00018987038,0.00013675848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033817254,0.0001699923,0.001368562,0.00013773533,0.000025212052,0.0000016836651,0.00009860934,0.000044979788,0.000005407375],"category_scores_gemma":[0.00010059114,0.00009474524,0.00061884656,0.00019814781,0.0005412626,0.000066361245,0.000032734264,0.00018172666,2.6218592e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011695323,0.00018111615,0.9760989,0.000032203876,0.00564445,0.00015232737,0.00004132909,0.00011600076,0.00017830142,0.0000040412997,0.000028057917,0.005827972],"study_design_scores_gemma":[0.0029578838,0.003694007,0.99199057,0.00008350497,0.0006362555,0.00008705552,0.00007896287,0.0000019025053,0.0002791075,0.00003400742,0.00006179819,0.000094950155],"about_ca_topic_score_codex":0.00001709188,"about_ca_topic_score_gemma":9.1395e-7,"teacher_disagreement_score":0.015891688,"about_ca_system_score_codex":0.000036421883,"about_ca_system_score_gemma":0.00016843999,"threshold_uncertainty_score":0.3863599},"labels":[],"label_agreement":null},{"id":"W2165026522","doi":"10.1016/j.amjmed.2013.09.019","title":"Prevalence of High On-treatment Platelet Reactivity in Diabetic Patients Treated with Aspirin","year":2013,"lang":"en","type":"review","venue":"The American Journal of Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Aspirin; Diabetes mellitus; Internal medicine; Confidence interval; Relative risk; Clinical trial; Randomized controlled trial; Endocrinology","score_opus":0.02259604031676341,"score_gpt":0.2914793414981795,"score_spread":0.26888330118141607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165026522","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4448251,0.5543182,0.000003212564,0.00010294483,0.000038888917,0.0006365665,0.000013557924,0.0000047767,0.00005677193],"genre_scores_gemma":[0.17209677,0.8274584,0.000021149603,0.00008120394,0.00018971192,0.000023545099,0.000013104765,0.00003543266,0.0000806817],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99727863,0.00058476254,0.0008826878,0.00022820265,0.00077176956,0.0002539541],"domain_scores_gemma":[0.99662966,0.00047758062,0.00190799,0.0005918232,0.00020266288,0.00019030763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005013954,0.00045094264,0.003918979,0.00033947898,0.000025728255,0.0000035045634,0.00026006813,0.000062806204,0.00008325309],"category_scores_gemma":[0.00009889454,0.00017713816,0.000548243,0.0005275821,0.0008501912,0.00004613662,0.000017477285,0.0004624926,0.000008585379],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010483679,0.0005804333,0.002804926,0.002365422,0.0019626534,0.00025198836,0.00007620779,0.0000038025578,0.0000020223981,0.0000032970256,0.00006108236,0.9908398],"study_design_scores_gemma":[0.036971368,0.146373,0.15501295,0.3040086,0.038855903,0.0036555415,0.00042746591,0.000003666324,0.00019145051,0.000041325835,0.3132594,0.0011993342],"about_ca_topic_score_codex":0.00021842425,"about_ca_topic_score_gemma":0.0000011670056,"teacher_disagreement_score":0.9896405,"about_ca_system_score_codex":0.00024874092,"about_ca_system_score_gemma":0.00027390316,"threshold_uncertainty_score":0.72234845},"labels":[],"label_agreement":null},{"id":"W2165123288","doi":"10.1160/th10-11-0749","title":"Why an aspirin a day no longer keeps the doctor away …","year":2010,"lang":"en","type":"letter","venue":"Thrombosis and Haemostasis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; British Heart Foundation","keywords":"Aspirin; Medicine; Internal medicine; Cardiology","score_opus":0.046962521177329734,"score_gpt":0.3029663587263298,"score_spread":0.2560038375490001,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165123288","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20181134,0.0075998087,0.00011285327,0.7799585,0.0016252018,0.0020048989,0.000623194,0.00034545007,0.005918762],"genre_scores_gemma":[0.0073763067,0.005777138,0.0002524174,0.9754182,0.0077609248,0.00011565231,0.00115479,0.00019672394,0.0019478181],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99722785,0.00027838573,0.00038138434,0.0007870424,0.0007323453,0.0005930151],"domain_scores_gemma":[0.99772906,0.00013793213,0.00015167947,0.0015362634,0.00020495417,0.00024008554],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00048814347,0.00060526,0.0011399554,0.00012289692,0.00039059462,0.00019748574,0.0003468525,0.0014014255,0.002642717],"category_scores_gemma":[0.000040709605,0.0003824012,0.0008001486,0.00017873636,0.0005157666,0.000160276,0.0001101904,0.0027786745,0.00021731299],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008694491,0.00012035878,0.00053154584,0.00027575748,0.0020345745,0.00023787296,0.00032992012,1.3614378e-7,0.00027220353,0.00002353583,0.962638,0.03344912],"study_design_scores_gemma":[0.0012713615,0.00027032508,0.0059982575,0.00021513637,0.002205785,0.00011916723,0.000062537736,0.000007828615,0.0003978316,0.00005222014,0.9888923,0.00050723524],"about_ca_topic_score_codex":0.00019912315,"about_ca_topic_score_gemma":0.000038316626,"teacher_disagreement_score":0.19545974,"about_ca_system_score_codex":0.000033844484,"about_ca_system_score_gemma":0.000115210714,"threshold_uncertainty_score":0.999895},"labels":[],"label_agreement":null},{"id":"W2166268102","doi":"10.1161/jaha.114.001505","title":"Efficacy and Safety of Vorapaxar as Approved for Clinical Use in the United States","year":2015,"lang":"en","type":"article","venue":"Journal of the American Heart Association","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Medicine; Intensive care medicine; Safety profile; Adverse effect; Internal medicine","score_opus":0.053695344002935456,"score_gpt":0.35750634851350244,"score_spread":0.303811004510567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166268102","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955645,0.0002863558,0.000102931095,0.0036882162,0.000076480086,0.00026512853,0.0000057360353,0.0000025382212,0.000008122642],"genre_scores_gemma":[0.9966585,0.00084420305,0.00026902006,0.0020370823,0.0001434532,0.0000016433592,0.000004188797,0.0000069929238,0.000034896428],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984776,0.0006280805,0.00039849215,0.000056654564,0.00034752316,0.00009169447],"domain_scores_gemma":[0.9978662,0.0011294113,0.00052136753,0.00012793083,0.00029552443,0.000059554724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031319738,0.000055769517,0.00043124636,0.000056249704,0.000031248546,0.000013156108,0.00007053396,0.000031041942,7.663805e-7],"category_scores_gemma":[0.002922083,0.000030053241,0.0003191677,0.00026394794,0.00008316178,0.000061562525,0.000011461644,0.00016444111,4.277844e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044553606,0.00028891844,0.9824591,0.000010379426,0.00060837186,0.000002909517,0.0008181328,0.00015774698,0.00010424875,0.000017786146,0.0074527445,0.0036242728],"study_design_scores_gemma":[0.0047568316,0.0010150216,0.9569372,0.000058070338,0.00033388555,0.000038824517,0.001513354,0.00019510568,0.00006156694,0.00014693844,0.03490032,0.000042896525],"about_ca_topic_score_codex":0.00010594647,"about_ca_topic_score_gemma":0.000004737586,"teacher_disagreement_score":0.027447574,"about_ca_system_score_codex":0.0000678164,"about_ca_system_score_gemma":0.000115655224,"threshold_uncertainty_score":0.34982172},"labels":[],"label_agreement":null},{"id":"W2167140116","doi":"10.7326/0003-4819-150-6-200903170-00006","title":"Aspirin to Prevent Cardiovascular Disease: The Association of Aspirin Dose and Clopidogrel With Thrombosis and Bleeding","year":2009,"lang":"en","type":"article","venue":"Annals of Internal Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":182,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Aspirin; Hazard ratio; Clopidogrel; Internal medicine; Interquartile range; Myocardial infarction; Stroke (engine); Placebo; Clinical endpoint; Incidence (geometry); Randomized controlled trial; Confidence interval","score_opus":0.03300128050591339,"score_gpt":0.31188307408136,"score_spread":0.2788817935754466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167140116","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9655926,0.022248354,0.00025169787,0.010899817,0.00004916534,0.0004041101,0.000010915462,0.000014168313,0.0005291522],"genre_scores_gemma":[0.9918813,0.005684233,0.000053808744,0.0020411722,0.00021330261,0.000007872789,0.0000037681768,0.000011385729,0.00010312923],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99852794,0.000076784934,0.00030892759,0.00022337404,0.0006850166,0.00017793536],"domain_scores_gemma":[0.9989846,0.00008043982,0.00014355841,0.0003031892,0.00026385428,0.00022437164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087045226,0.00015554392,0.00059858075,0.000099461555,0.000038041842,0.0000059871563,0.00008868733,0.000044843728,0.000016070875],"category_scores_gemma":[0.00016370803,0.00008881608,0.0002324913,0.00016757385,0.00012585691,0.00006622032,0.00003203158,0.000117650394,7.8276844e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006470272,0.0010870938,0.37807435,0.0015943103,0.027800946,0.00020875597,0.0046394616,0.0002610747,0.009242786,0.0018760463,0.007927974,0.56081694],"study_design_scores_gemma":[0.002584267,0.0030284857,0.97128993,0.0033908642,0.0018640341,0.000044765166,0.0004589891,0.00003204015,0.0031266618,0.00025775825,0.013770852,0.00015133746],"about_ca_topic_score_codex":0.0001155834,"about_ca_topic_score_gemma":0.000003288424,"teacher_disagreement_score":0.5932156,"about_ca_system_score_codex":0.000015138525,"about_ca_system_score_gemma":0.000029859519,"threshold_uncertainty_score":0.36218145},"labels":[],"label_agreement":null},{"id":"W2168027888","doi":"10.1016/j.ijcard.2015.06.016","title":"A pharmacodynamic comparison of a personalized strategy for anti-platelet therapy versus ticagrelor in achieving a therapeutic window","year":2015,"lang":"en","type":"review","venue":"International Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Heart Research Centre; University of Ottawa","funders":"Canadian Institutes of Health Research; Canadian HIV Trials Network, Canadian Institutes of Health Research","keywords":"Ticagrelor; Prasugrel; Medicine; P2Y12; Clopidogrel; Internal medicine; Therapeutic window; Pharmacodynamics; Odds ratio; Aspirin; Cardiology; Pharmacology; Pharmacokinetics","score_opus":0.18278574577667997,"score_gpt":0.47156749022970545,"score_spread":0.2887817444530255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168027888","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008277782,0.98802406,0.0012188951,0.000067347755,0.0013449753,0.00073544105,0.00009364601,0.0000089045425,0.00022897364],"genre_scores_gemma":[0.12088681,0.87778157,0.00009414605,0.000035761186,0.0010012933,0.000027835087,0.0001072175,0.0000468347,0.000018548904],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99709034,0.00048189156,0.0012906042,0.0002487251,0.00063131034,0.00025714625],"domain_scores_gemma":[0.99736875,0.00047619178,0.0010333814,0.0001855999,0.0008129155,0.00012317605],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010121446,0.00035938233,0.0038747974,0.0005828724,0.000018828106,0.000017918665,0.00047790387,0.00032059965,0.000032825264],"category_scores_gemma":[0.00010544235,0.0002641175,0.0026940824,0.00016213092,0.00017586326,0.00008492413,0.00003267004,0.0005686276,0.0000034990894],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006378306,0.00015595776,0.00031202578,0.00080597005,0.01722289,0.00040159014,0.00009749022,0.0002464473,0.00005350804,0.00010925674,0.00012967736,0.9740869],"study_design_scores_gemma":[0.01911316,0.0014156993,0.00019817757,0.0031751313,0.0026799792,0.0026424895,0.00018102207,0.00008797418,0.00001381115,0.000064500724,0.9701618,0.00026626067],"about_ca_topic_score_codex":0.0000028274267,"about_ca_topic_score_gemma":5.236851e-7,"teacher_disagreement_score":0.9738206,"about_ca_system_score_codex":0.00025061925,"about_ca_system_score_gemma":0.0010491243,"threshold_uncertainty_score":0.9999811},"labels":[],"label_agreement":null},{"id":"W2168637682","doi":"10.1093/ejcts/ezs369","title":"Combined clopidogrel and aspirin treatment up to surgery increases the risk of postoperative myocardial infarction, blood loss and reoperation for bleeding in patients undergoing coronary artery bypass grafting†","year":2012,"lang":"en","type":"article","venue":"European Journal of Cardio-Thoracic Surgery","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; British Heart Foundation; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute for Health and Care Research","keywords":"Medicine; Clopidogrel; Aspirin; Myocardial infarction; Surgery; Artery; Incidence (geometry); Anesthesia; Coronary artery bypass surgery; Cardiology; Internal medicine","score_opus":0.01888752737780444,"score_gpt":0.2512808119835113,"score_spread":0.23239328460570688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168637682","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935423,0.004993791,0.00023143919,0.00018898759,0.0005030033,0.00045932928,0.000028995932,0.000011759681,0.00004037977],"genre_scores_gemma":[0.9952424,0.003935943,0.00009654251,0.00018788567,0.00044274324,0.000009668623,0.00002891303,0.00004364878,0.00001225247],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965077,0.0018285918,0.00080013275,0.00019445192,0.00036234866,0.00030678703],"domain_scores_gemma":[0.9973478,0.0014447131,0.00039247383,0.00019920849,0.0003517308,0.00026407707],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0049283537,0.00024267391,0.0008726727,0.0003253134,0.00018551928,0.00004218653,0.000046566136,0.000042840846,0.000003415559],"category_scores_gemma":[0.00083089323,0.00017073487,0.00061750785,0.00021638344,0.00010667659,0.00032985705,0.00003837775,0.00016074303,0.0000010958919],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033306025,0.00020867251,0.9396522,0.000053576223,0.0025419805,0.00012395556,0.00092589954,0.00006865228,0.000105779836,0.0000036403835,0.00021229466,0.052772712],"study_design_scores_gemma":[0.002513766,0.0009076356,0.99150497,0.0004603719,0.0014228293,0.0008113817,0.000737522,0.000005992982,0.0006189374,0.0000049750606,0.00082449557,0.0001871335],"about_ca_topic_score_codex":0.000011315474,"about_ca_topic_score_gemma":0.0000017300897,"teacher_disagreement_score":0.05258558,"about_ca_system_score_codex":0.00007194153,"about_ca_system_score_gemma":0.00014825654,"threshold_uncertainty_score":0.69623655},"labels":[],"label_agreement":null},{"id":"W2169423399","doi":"10.1378/chest.125.5.1616","title":"Dosing Practices and Risk Factors for Bleeding in Patients Receiving Enoxaparin for the Treatment of an Acute Coronary Syndrome","year":2004,"lang":"en","type":"article","venue":"CHEST Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Dosing; Clopidogrel; Odds ratio; Acute coronary syndrome; Enoxaparin sodium; Internal medicine; Retrospective cohort study; Aspirin; Myocardial infarction; Low molecular weight heparin; Thrombosis","score_opus":0.03070477008590523,"score_gpt":0.2968270174928856,"score_spread":0.2661222474069804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169423399","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963227,0.0023465573,0.0006425341,0.00005633436,0.00010561383,0.0005007915,0.000015433261,0.000005752518,0.0000042664524],"genre_scores_gemma":[0.9927124,0.005960323,0.0011987368,0.000010008248,0.00007071974,0.0000142349,0.000011453235,0.000015231295,0.000006942637],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99939024,0.000027726415,0.0001916889,0.00011401858,0.00012476061,0.00015156386],"domain_scores_gemma":[0.99927264,0.00020979613,0.0002828234,0.000093619274,0.00005569054,0.000085406704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026234906,0.00010191087,0.00024626244,0.000055050605,0.00019184283,0.0000310413,0.000044448512,0.000043512,0.0000032880869],"category_scores_gemma":[0.00010109665,0.00006197635,0.00017362389,0.000047791156,0.00004039308,0.00020916501,0.0000051038996,0.00008198761,9.112063e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018033178,0.00087409565,0.90562654,0.00008792321,0.0020487863,0.00004853609,0.0030792807,0.00021858988,0.00041409794,0.0000053966614,0.0000021479727,0.08579129],"study_design_scores_gemma":[0.00852536,0.0035161874,0.98247427,0.00015119703,0.0013057593,0.00035319815,0.0013020315,0.00007646998,0.0017688663,0.000111574096,0.00033828002,0.0000768042],"about_ca_topic_score_codex":0.000028269991,"about_ca_topic_score_gemma":0.000006884778,"teacher_disagreement_score":0.08571448,"about_ca_system_score_codex":0.00010107931,"about_ca_system_score_gemma":0.000057427125,"threshold_uncertainty_score":0.25273222},"labels":[],"label_agreement":null},{"id":"W2170016296","doi":"10.1016/s1499-2671(09)33211-6","title":"Cross-sectional survey of aspirin use and dose in albertans with diabetes","year":2009,"lang":"en","type":"article","venue":"Canadian Journal of Diabetes","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Aspirin; Medicine; Diabetes mellitus; Low dose aspirin; Cross-sectional study; Internal medicine; Endocrinology; Pathology","score_opus":0.01996498362225373,"score_gpt":0.24328705092583733,"score_spread":0.2233220673035836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170016296","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99577034,0.003931316,0.0000016183395,0.00007173696,0.00004583422,0.00008187039,0.000036308367,0.000002003145,0.000058990856],"genre_scores_gemma":[0.9995308,0.000028424925,0.000054772925,0.00028038543,0.000046336285,6.5609646e-7,0.000012718323,0.000010382972,0.00003552951],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99909043,0.00007572238,0.0002985482,0.00010860524,0.00017321909,0.00025347996],"domain_scores_gemma":[0.9989153,0.00012996566,0.000114016715,0.00012112867,0.00027375302,0.00044583518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045720825,0.00010990396,0.0003743178,0.00027295903,0.000039619033,0.000047437014,0.00006678269,0.000066104534,0.000057070687],"category_scores_gemma":[0.00024214004,0.0000865893,0.000112146205,0.0002205689,0.00016128868,0.00021472023,0.0000023781213,0.00015685287,6.6646794e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045560322,0.000032416094,0.996426,0.000023369015,0.00021019543,0.000036248253,0.00004493532,0.00005419516,0.00035562878,0.0000126772975,0.000024673656,0.0027341174],"study_design_scores_gemma":[0.0017780951,0.00059157505,0.9964237,0.00017821125,0.000046762583,0.000015241607,0.000011759505,0.000015312398,0.000619683,0.000039354665,0.0001884347,0.00009182739],"about_ca_topic_score_codex":0.000838695,"about_ca_topic_score_gemma":0.009489473,"teacher_disagreement_score":0.008650778,"about_ca_system_score_codex":0.000045980403,"about_ca_system_score_gemma":0.00057234435,"threshold_uncertainty_score":0.5295348},"labels":[],"label_agreement":null},{"id":"W2171130122","doi":"10.1111/jth.12282","title":"Periprocedural antiplatelet therapy: recommendations for standardized reporting in patients on antiplatelet therapy: communication from the SSC of the ISTH","year":2013,"lang":"en","type":"article","venue":"Journal of Thrombosis and Haemostasis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University; St. Joseph's Hospital","funders":"","keywords":"Prasugrel; Clopidogrel; Medicine; Ticagrelor; P2Y12; Aspirin; Internal medicine; Platelet; Anticoagulant therapy; Platelet aggregation inhibitor; Cangrelor; Intensive care medicine","score_opus":0.07132745156482706,"score_gpt":0.3260375890484786,"score_spread":0.25471013748365157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171130122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863433,0.003136039,0.000041967727,0.009320319,0.0001296347,0.00088691403,0.000080699094,0.000006652229,0.000054455424],"genre_scores_gemma":[0.98239946,0.015533057,0.00062047126,0.0012937278,0.00006690299,0.00001852937,0.00003652175,0.000024476829,0.000006848323],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99791497,0.00023130668,0.0011228863,0.00015803358,0.00039426927,0.0001785075],"domain_scores_gemma":[0.9971354,0.00029331824,0.0015697425,0.0004693698,0.00046830726,0.00006384464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010303967,0.0001781345,0.00067225774,0.00007046282,0.00027759164,0.00006526716,0.00023296951,0.00008712699,0.00012230284],"category_scores_gemma":[0.00029273416,0.000092132825,0.00054343115,0.00019958925,0.00014157726,0.00020467734,0.0000427713,0.0002682314,6.785728e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004730218,0.0012735042,0.6282491,0.00006064308,0.0033609923,0.0000028178417,0.0041840416,0.000025997984,0.0028591498,0.00011210101,0.020626469,0.33451495],"study_design_scores_gemma":[0.01200354,0.0007019742,0.9647678,0.00066085794,0.0001967821,0.000016889364,0.0016430588,0.000039642055,0.009643289,0.0006312916,0.009543367,0.00015149171],"about_ca_topic_score_codex":0.00014166288,"about_ca_topic_score_gemma":0.000008287569,"teacher_disagreement_score":0.3365187,"about_ca_system_score_codex":0.000046404708,"about_ca_system_score_gemma":0.00009372811,"threshold_uncertainty_score":0.37570676},"labels":[],"label_agreement":null},{"id":"W2171267144","doi":"10.1016/s0828-282x(07)70744-4","title":"The effect of acetylsalicylic acid resistance on prognosis of patients who have developed acute coronary syndrome during acetylsalicylic acid therapy","year":2007,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine; Acute coronary syndrome; Myocardial infarction; Coronary artery disease; Hazard ratio; Cardiology; Revascularization; Aspirin; Prospective cohort study; Confidence interval","score_opus":0.009145161246392594,"score_gpt":0.240344284451683,"score_spread":0.2311991232052904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171267144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888105,0.009309029,0.00008632626,0.00023070049,0.00028393825,0.00055755605,0.000056678546,0.0000069572015,0.0006583256],"genre_scores_gemma":[0.9976866,0.0017889193,0.00003634317,0.00011779943,0.00018399073,0.00001191034,0.000013601476,0.00004398233,0.000116838746],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99754035,0.00044765702,0.000771577,0.00022763562,0.0004262,0.0005866022],"domain_scores_gemma":[0.9978903,0.00021741539,0.0004988493,0.00044428135,0.00042549588,0.00052363507],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013144573,0.00028663667,0.001279826,0.0003391737,0.00020168697,0.00001121836,0.0003622892,0.00022576057,0.000011412173],"category_scores_gemma":[0.00023499991,0.00019218169,0.00089390134,0.0002816454,0.00047289682,0.00008083595,0.00001865406,0.00038069414,0.0000028135769],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011533766,0.00002068901,0.94950694,0.00017488925,0.008698845,0.0019720634,0.0003654059,0.00004295789,0.004329588,0.000046678146,0.0012554206,0.02205275],"study_design_scores_gemma":[0.00529336,0.0025659017,0.92015356,0.00028370976,0.0004304735,0.0009843132,0.00008935333,3.247564e-7,0.059232697,0.000014489546,0.010782229,0.00016957421],"about_ca_topic_score_codex":0.000038188977,"about_ca_topic_score_gemma":0.00021845002,"teacher_disagreement_score":0.05490311,"about_ca_system_score_codex":0.00020558915,"about_ca_system_score_gemma":0.0006233944,"threshold_uncertainty_score":0.7836942},"labels":[],"label_agreement":null},{"id":"W2171508983","doi":"10.1503/cmaj.070186","title":"Drug drug interactions between antithrombotic medications and the risk of gastrointestinal bleeding","year":2007,"lang":"en","type":"article","venue":"Canadian Medical Association Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":246,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Clopidogrel; Warfarin; Antithrombotic; Aspirin; Drug; Gastrointestinal bleeding; Internal medicine; Population; Antiplatelet drug; Confidence interval; Medical prescription; Retrospective cohort study; Pharmacology; Atrial fibrillation","score_opus":0.0061064668683975965,"score_gpt":0.24548240097849297,"score_spread":0.23937593411009536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171508983","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9716459,0.0010547203,0.0032744803,0.02158493,0.00027417543,0.00017045526,0.000023970068,0.000015660273,0.0019557222],"genre_scores_gemma":[0.99672437,0.000584884,0.00032433926,0.0009270341,0.0012044638,0.0000016178143,0.000008474187,0.0000105000145,0.0002143034],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979579,0.00021253838,0.00045871883,0.00010656079,0.0009628308,0.00030145573],"domain_scores_gemma":[0.9972701,0.0008888217,0.0003039331,0.00010770797,0.0003399094,0.0010895132],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005151648,0.00009359349,0.00031534888,0.0001765915,0.0003799893,0.000029761393,0.00011476669,0.000051441875,0.0006376261],"category_scores_gemma":[0.0023212063,0.000064882784,0.00023590717,0.0002280317,0.00022968616,0.000086916356,0.000012546547,0.0009030163,0.000014069732],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004332993,0.000025303396,0.96952325,0.000014037545,0.0009805869,0.00011638329,0.0005971328,0.0000022006666,0.000008718617,0.00034361394,0.008295941,0.020049525],"study_design_scores_gemma":[0.0040405467,0.000029671934,0.96557975,0.00042238794,0.0011379382,0.0024035776,0.0029935,0.00018088795,0.00003937858,0.00040110596,0.0226632,0.0001080655],"about_ca_topic_score_codex":0.002206844,"about_ca_topic_score_gemma":0.006778437,"teacher_disagreement_score":0.025078498,"about_ca_system_score_codex":0.00023186473,"about_ca_system_score_gemma":0.0009944779,"threshold_uncertainty_score":0.6981559},"labels":[],"label_agreement":null},{"id":"W2172413667","doi":"","title":"Acide acétylsalicylique à faible dose en prévention primaire des maladies cardiovasculaires: Éviter de mal interpréter les recommandations.","year":2015,"lang":"fr","type":"article","venue":"PubMed Central","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"North York General Hospital","funders":"","keywords":"Medicine; Gynecology","score_opus":0.02474680128046936,"score_gpt":0.2596411953814459,"score_spread":0.23489439410097657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2172413667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82687724,0.13955992,0.021667585,0.002052147,0.0045756283,0.001401025,0.0001113984,0.00023199162,0.003523054],"genre_scores_gemma":[0.96496093,0.015118286,0.0023655558,0.000450782,0.0046367445,0.000467259,0.00030201243,0.00012122423,0.011577188],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99471915,0.0010559729,0.0005590231,0.00058620796,0.00059636094,0.0024832645],"domain_scores_gemma":[0.9974461,0.00009149392,0.00012707751,0.0006600042,0.00018866471,0.0014866447],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0023570664,0.0004973771,0.000759695,0.00019735249,0.00023786144,0.00019014094,0.00029568476,0.0004265559,0.00056924456],"category_scores_gemma":[0.00055335043,0.00048482907,0.0013858962,0.00030512476,0.00054722297,0.00077436375,0.00014334735,0.00050745724,0.0001314242],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014444012,0.0005973986,0.31087437,0.0013951109,0.0054656337,0.0006438688,0.0066880607,0.00061714865,0.000079231526,0.00061797234,0.013526564,0.65805024],"study_design_scores_gemma":[0.005358654,0.00020107771,0.7038138,0.0015743654,0.0023479094,0.0011410638,0.0025940863,0.00026888523,0.0022487273,0.0010731719,0.2787196,0.0006586547],"about_ca_topic_score_codex":0.00032337298,"about_ca_topic_score_gemma":0.00028729916,"teacher_disagreement_score":0.6573916,"about_ca_system_score_codex":0.0018059221,"about_ca_system_score_gemma":0.0007293261,"threshold_uncertainty_score":0.9997603},"labels":[],"label_agreement":null},{"id":"W2172566340","doi":"10.1016/j.bmcl.2004.06.079","title":"Pyridoxine as a template for the design of antiplatelet agents","year":2004,"lang":"en","type":"article","venue":"Bioorganic & Medicinal Chemistry Letters","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CanAm Bioresearch (Canada)","funders":"","keywords":"Pyridoxine; Chemistry; Pharmacology; Combinatorial chemistry; Biochemistry; Medicine","score_opus":0.024722341153428876,"score_gpt":0.2664363320021246,"score_spread":0.24171399084869571,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2172566340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9462821,0.0027814913,0.0404823,0.00921547,0.00017349815,0.0008628363,0.000020792699,0.00007816467,0.0001033575],"genre_scores_gemma":[0.9949002,0.0005021286,0.0005668487,0.0032909405,0.0005205195,0.000035983016,0.000044892047,0.00004595945,0.00009249042],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984576,0.000022039092,0.00035192157,0.00032102858,0.0004998932,0.00034748227],"domain_scores_gemma":[0.9989728,0.0001318782,0.0001399549,0.00049603457,0.0000840788,0.00017528226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040272347,0.00025082467,0.00045917855,0.000031196196,0.00012185755,0.000010492632,0.00024395312,0.000113079506,0.00033133125],"category_scores_gemma":[0.00017288435,0.00016857908,0.0003579776,0.00021878282,0.00029520527,0.00004155409,0.000029249653,0.0001883403,0.000020523465],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011230278,0.00012290303,0.00016606686,0.0003275433,0.001059949,0.00031112978,0.00016100529,0.0001501792,0.99191266,0.000010038692,0.0032179256,0.0014375782],"study_design_scores_gemma":[0.009126733,0.00021702862,0.0014750649,0.00040100474,0.0011617359,0.0016541447,0.00031303335,0.00005539061,0.975793,0.00007276114,0.0094638225,0.0002662895],"about_ca_topic_score_codex":0.000025570076,"about_ca_topic_score_gemma":1.0032976e-7,"teacher_disagreement_score":0.04861815,"about_ca_system_score_codex":0.00007681783,"about_ca_system_score_gemma":0.00020479009,"threshold_uncertainty_score":0.6874455},"labels":[],"label_agreement":null},{"id":"W2182760934","doi":"10.1017/s148180350000960x","title":"Underutilization of acetylsalicylic acid for acute coronary syndromes in the emergency department","year":2004,"lang":"en","type":"article","venue":"Canadian Journal of Emergency Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal General Hospital; Jewish General Hospital; McGill University Health Centre; McGill University; Queen's University","funders":"Jewish General Hospital","keywords":"Medicine; Emergency department; Acute coronary syndrome; Medical emergency; Emergency medicine; Aspirin; Intensive care medicine; Internal medicine; Myocardial infarction; Psychiatry","score_opus":0.07195071614165281,"score_gpt":0.3481399602276034,"score_spread":0.2761892440859506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2182760934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9636069,0.026763538,0.0019164912,0.004698304,0.0019927854,0.0005751526,0.00003197906,0.000004051975,0.00041080298],"genre_scores_gemma":[0.9920721,0.0071640806,0.00006992348,0.00020019736,0.000333583,0.000013105654,0.000039927687,0.000019001522,0.00008804639],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983924,0.00006265146,0.0008040598,0.00012258593,0.00034618194,0.00027212652],"domain_scores_gemma":[0.9988609,0.0000172271,0.0002622526,0.00023840091,0.00028106317,0.00034018015],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006090762,0.0001513935,0.0004890575,0.00028564228,0.000078211604,0.0000012970127,0.00020309287,0.00007076101,0.0009290607],"category_scores_gemma":[0.00017732504,0.00009881864,0.00035549112,0.0004507767,0.00009096408,0.0000882691,0.0000038572416,0.00013647508,0.0000017450401],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045129503,0.0017716829,0.7093052,0.002367991,0.020154962,0.0064751357,0.028409675,0.0015284964,0.017228171,0.021719687,0.13368048,0.05284552],"study_design_scores_gemma":[0.020950124,0.008336817,0.8732081,0.0017930559,0.0062730624,0.0026256305,0.007979976,0.000037852562,0.0017510625,0.011455301,0.06497945,0.00060953863],"about_ca_topic_score_codex":0.00045482873,"about_ca_topic_score_gemma":0.0027016578,"teacher_disagreement_score":0.16390288,"about_ca_system_score_codex":0.000114841445,"about_ca_system_score_gemma":0.00080297363,"threshold_uncertainty_score":0.9999842},"labels":[],"label_agreement":null},{"id":"W2183039121","doi":"10.1093/eurheartj/ehv611","title":"Ascertainment, classification, and impact of neoplasm detection during prolonged treatment with dual antiplatelet therapy with prasugrel vs. clopidogrel following acute coronary syndrome","year":2015,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute","keywords":"Medicine; Prasugrel; Acute coronary syndrome; Clopidogrel; Incidence (geometry); Internal medicine; Cardiology; Aspirin; Myocardial infarction","score_opus":0.03279786181950884,"score_gpt":0.28506204030941884,"score_spread":0.25226417848991,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2183039121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970294,0.00204488,0.000121212994,0.00011638341,0.00006140155,0.0004654142,0.000005627453,0.00004745557,0.00010821064],"genre_scores_gemma":[0.9979597,0.0014219913,0.00029273037,0.000037576472,0.00011116664,0.000006317156,0.000010763728,0.000064904954,0.0000948915],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99843603,0.00032145766,0.00026727573,0.00026035128,0.00043659876,0.00027828073],"domain_scores_gemma":[0.99906516,0.00002039845,0.00017748805,0.00024896994,0.00011714162,0.0003708197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042766525,0.0002587651,0.0004634029,0.00013530749,0.00020578357,0.000053922027,0.000047125377,0.000042013016,0.000011419978],"category_scores_gemma":[0.000008833031,0.00015501319,0.00028281636,0.00016777082,0.0000926826,0.00021957983,0.000013855018,0.00022288025,0.0000070093524],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013305973,0.00041176504,0.9455067,0.000022434204,0.0065867193,0.0073988005,0.0008909073,0.00010033674,0.015172708,5.6418196e-7,0.00004325884,0.010559865],"study_design_scores_gemma":[0.0132361045,0.012241473,0.9041581,0.00019571884,0.00044941084,0.06757096,0.00022236425,0.00004026863,0.0013532465,0.0000013590015,0.00035799536,0.0001729515],"about_ca_topic_score_codex":0.0000085929405,"about_ca_topic_score_gemma":0.0000017943685,"teacher_disagreement_score":0.060172163,"about_ca_system_score_codex":0.00014963724,"about_ca_system_score_gemma":0.00021708552,"threshold_uncertainty_score":0.63212544},"labels":[],"label_agreement":null},{"id":"W2183929156","doi":"10.9778/cmajo.20140078","title":"Trends in the coprescription of proton pump inhibitors with clopidogrel: an ecological analysis","year":2015,"lang":"en","type":"article","venue":"CMAJ Open","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Institute for Clinical Evaluative Sciences; McMaster University; Sunnybrook Hospital; University of Toronto","funders":"","keywords":"Clopidogrel; Ecology; Medicine; Environmental science; Internal medicine; Biology; Aspirin","score_opus":0.05269980685740805,"score_gpt":0.32679774079607976,"score_spread":0.2740979339386717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2183929156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99496925,0.00017182849,0.0000604215,0.00023979234,0.000017604809,0.0007738614,0.0000036978188,0.000012843119,0.0037507028],"genre_scores_gemma":[0.99926615,0.000018698109,0.00008171783,0.00020238734,0.000054102908,0.0001389582,0.00009137996,0.000006872366,0.00013973733],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990571,0.00021116967,0.00016205036,0.00017881232,0.00027743555,0.000113388465],"domain_scores_gemma":[0.9994298,0.000011514073,0.000055798482,0.00035475352,0.000062450345,0.00008566132],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066324,0.00008454592,0.0003372648,0.00014477276,0.000025349565,0.000031879274,0.0002054059,0.00005841897,0.00011972623],"category_scores_gemma":[0.000019372841,0.000044423337,0.00015022153,0.0007819015,0.000075924596,0.00015141595,0.000038505827,0.00008940759,0.0000040431078],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024807195,0.0014135136,0.96071035,0.0000297508,0.0013138585,0.00016295735,0.0020448202,0.00028179356,0.00016005214,0.00017612746,0.00075604033,0.030469997],"study_design_scores_gemma":[0.004115691,0.0018008951,0.9806183,0.000039602328,0.0012685896,0.000028522056,0.0022266794,0.00020883966,0.001342104,0.00007191119,0.008149278,0.00012959786],"about_ca_topic_score_codex":0.00041048357,"about_ca_topic_score_gemma":0.0002839621,"teacher_disagreement_score":0.0303404,"about_ca_system_score_codex":0.000024706702,"about_ca_system_score_gemma":0.00005539184,"threshold_uncertainty_score":0.18115312},"labels":[],"label_agreement":null},{"id":"W2186081485","doi":"10.2310/8000.2014.141510","title":"Clopidogrel with aspirin versus aspirin alone in prevention of stroke following transient ischemic attack or acute minor stroke","year":2015,"lang":"en","type":"letter","venue":"Canadian Journal of Emergency Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Aspirin; Medicine; Clopidogrel; Minor stroke; Stroke (engine); Cardiology; Internal medicine; Ischemic stroke; Platelet aggregation inhibitor; Anesthesia; Ischemia","score_opus":0.09630481529531806,"score_gpt":0.34208321873691294,"score_spread":0.24577840344159488,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2186081485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8755946,0.039296918,0.0002739855,0.06874411,0.01012405,0.0012363605,0.0002665012,0.000017334938,0.004446099],"genre_scores_gemma":[0.7885564,0.019095495,0.0021817316,0.049840853,0.044488814,0.00014458531,0.003103153,0.0011418783,0.0914471],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958236,0.00018336021,0.0015741746,0.00039267045,0.0013214367,0.00070474553],"domain_scores_gemma":[0.9971279,0.0000523123,0.0007789708,0.00053668086,0.00056420785,0.00093992037],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00085602363,0.00054163777,0.0019303575,0.0010551412,0.00005331981,0.000005115818,0.0003793012,0.00054406014,0.0014934216],"category_scores_gemma":[0.00015959427,0.00038478017,0.0010291317,0.0005550266,0.00018908954,0.00016328503,0.000010271666,0.0016259435,0.0000062620434],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004427552,0.00009113016,0.0049986183,0.00085969357,0.008914325,0.018431224,0.00074779266,0.000039505525,0.00067353726,7.8848075e-7,0.9559175,0.0048983693],"study_design_scores_gemma":[0.022347696,0.0072400332,0.0016027294,0.005313065,0.0076872874,0.0004737831,0.0006722322,0.0000068319046,0.00019894965,0.0000035378457,0.9539608,0.00049306266],"about_ca_topic_score_codex":0.0017057861,"about_ca_topic_score_gemma":0.01136524,"teacher_disagreement_score":0.08703825,"about_ca_system_score_codex":0.00040548318,"about_ca_system_score_gemma":0.0046611014,"threshold_uncertainty_score":0.9998604},"labels":[],"label_agreement":null},{"id":"W2187596630","doi":"","title":"Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events. Eikelboom JW, Hirsh J, Weitz J, Johnston M, Yi Q, Yusuf S. Circulation 2002; 105: 1650- 1655.","year":2002,"lang":"en","type":"article","venue":"","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":288,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Aspirin; Stroke (engine); Internal medicine; Myocardial infarction; Population; Quartile; Odds ratio; Risk factor; Randomization; Randomized controlled trial; Surgery; Confidence interval","score_opus":0.012932286778017497,"score_gpt":0.20710964898854814,"score_spread":0.19417736221053064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2187596630","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.963142,0.029427266,0.0023396157,0.00009888911,0.00034195874,0.0035605244,0.00047477448,0.000107585285,0.00050738716],"genre_scores_gemma":[0.97406495,0.024259267,0.00046874007,0.00010842278,0.0003053258,0.00025197255,0.00011267112,0.000110978006,0.0003177005],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99429625,0.0011464448,0.0010967987,0.0010378776,0.0017062344,0.00071640743],"domain_scores_gemma":[0.9966243,0.00045985825,0.00040059024,0.0017812257,0.00045244413,0.0002816028],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0024818506,0.00066236063,0.0023653898,0.00038768732,0.0004912172,0.000040809482,0.00025762676,0.00039339977,0.00040836094],"category_scores_gemma":[0.00065496966,0.00044766435,0.0051273825,0.000549733,0.0003721199,0.00027099848,0.00013911488,0.00036605823,0.00003007002],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012047263,0.0011404834,0.8042831,0.00066058314,0.08546888,0.000049609283,0.0006244461,0.006377647,0.00009794728,0.00031939862,0.0008466802,0.088084005],"study_design_scores_gemma":[0.032760132,0.0005959571,0.926015,0.00020494676,0.016789543,0.000040006464,0.00015908782,0.0009790235,0.0006148019,0.00018682728,0.020988815,0.0006658214],"about_ca_topic_score_codex":0.0025583021,"about_ca_topic_score_gemma":0.00011701581,"teacher_disagreement_score":0.12173198,"about_ca_system_score_codex":0.0003264589,"about_ca_system_score_gemma":0.000080253165,"threshold_uncertainty_score":0.9997975},"labels":[],"label_agreement":null},{"id":"W2192383112","doi":"10.1038/nrneph.2015.196","title":"Net benefit of ticagrelor in patients with chronic kidney disease","year":2015,"lang":"en","type":"review","venue":"Nature Reviews Nephrology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Population Health Research Institute","funders":"","keywords":"Medicine; Ticagrelor; Kidney disease; Intensive care medicine; Internal medicine; Aspirin; Clopidogrel","score_opus":0.015580089725553165,"score_gpt":0.2999967795557708,"score_spread":0.2844166898302176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2192383112","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009306382,0.9956266,0.000003377202,0.000064880056,0.00016767396,0.0036634286,0.00016862407,0.000024478437,0.00018785053],"genre_scores_gemma":[0.00004614926,0.9961044,0.000078719066,0.0011767831,0.00034728955,0.00020493905,0.0018488538,0.00008297213,0.00010985567],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970528,0.00042507437,0.0009693525,0.0006462618,0.00046241115,0.00044409066],"domain_scores_gemma":[0.99747765,0.000056667024,0.00055668264,0.001111664,0.0001986118,0.00059869915],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005062743,0.0006367314,0.005269936,0.00030079242,0.000021958445,0.0000056974536,0.0003013475,0.0010100504,0.00023060314],"category_scores_gemma":[0.00022186457,0.00038504007,0.0013479643,0.0006347724,0.00017472041,0.00005541333,0.00007627677,0.0013203112,0.00009980973],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048641014,0.00028851794,0.00091329945,0.037864838,0.00085408863,0.00009721729,0.000005014911,3.9386435e-7,1.9146716e-8,0.00011803004,0.005363039,0.9540091],"study_design_scores_gemma":[0.0027515974,0.00051632,0.0016512696,0.02215951,0.0061639743,0.00003315549,2.6408102e-7,5.655405e-7,2.7740192e-8,0.000022419894,0.96638536,0.00031553657],"about_ca_topic_score_codex":0.0000027253072,"about_ca_topic_score_gemma":0.0000045579677,"teacher_disagreement_score":0.9610223,"about_ca_system_score_codex":0.00023548857,"about_ca_system_score_gemma":0.001471792,"threshold_uncertainty_score":0.99986017},"labels":[],"label_agreement":null},{"id":"W2195676387","doi":"10.1016/j.cjca.2015.11.023","title":"Effect of Modifying Antiplatelet Treatment to Ticagrelor in High-Risk Coronary Patients With Low Response to Clopidogrel (MATTIS)","year":2015,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Ticagrelor; Medicine; Clopidogrel; Internal medicine; Cardiology; Aspirin; Prasugrel","score_opus":0.007961435632698481,"score_gpt":0.23516941509763797,"score_spread":0.22720797946493948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2195676387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99769235,0.00074902107,0.0003774225,0.0002298011,0.00027277245,0.00052322674,0.00006822554,0.0000044448157,0.00008273546],"genre_scores_gemma":[0.9993647,0.000051789353,0.00019914542,0.00014056708,0.00017672936,0.000009278331,0.000011654108,0.000025636515,0.000020528283],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99814314,0.0007185864,0.00036529065,0.00018321168,0.00023019516,0.00035959037],"domain_scores_gemma":[0.99792045,0.00018256708,0.00012183952,0.00027796262,0.00025691438,0.001240288],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009371256,0.00019344167,0.0010297234,0.0005375234,0.000035436653,0.00000697722,0.00011532345,0.00011392149,0.0000076250635],"category_scores_gemma":[0.0003792018,0.0001354553,0.0002632056,0.00025853465,0.00008651506,0.000052520725,0.000010324623,0.00016064043,0.000015848944],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0322809,0.000018408644,0.8919485,0.000028251927,0.001116381,0.0027278338,0.0003794745,0.011452842,0.00007143953,0.0000034579718,0.0006617461,0.05931073],"study_design_scores_gemma":[0.016117346,0.022862742,0.9469857,0.0002884162,0.00054706424,0.00073780207,0.00009648099,0.0000060211337,0.00062820804,0.000009191847,0.011532821,0.00018817883],"about_ca_topic_score_codex":0.00082450773,"about_ca_topic_score_gemma":0.00034639062,"teacher_disagreement_score":0.05912255,"about_ca_system_score_codex":0.00040365322,"about_ca_system_score_gemma":0.0010428622,"threshold_uncertainty_score":0.5523706},"labels":[],"label_agreement":null},{"id":"W2196185731","doi":"10.1016/j.thromres.2015.10.040","title":"Is platelet transfusion the solution to reverse platelet inhibition in patients on triple antiplatelet therapy?","year":2015,"lang":"en","type":"letter","venue":"Thrombosis Research","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Medicine; Prasugrel; Clopidogrel; Aspirin; Internal medicine; Acute coronary syndrome; Myocardial infarction; Percutaneous coronary intervention; Cardiology; Antiplatelet drug; Coronary artery disease; Stroke (engine)","score_opus":0.12082728665355699,"score_gpt":0.3656233201360255,"score_spread":0.2447960334824685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2196185731","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7368444,0.0008371808,0.000011143549,0.2554968,0.00039399482,0.0045883744,0.0002909692,0.000099070894,0.0014380547],"genre_scores_gemma":[0.44723815,0.018108504,0.000048922815,0.524285,0.003655256,0.0006864854,0.003701586,0.00041704578,0.0018589929],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9907253,0.0015841444,0.00076295336,0.0012597801,0.004218799,0.0014490702],"domain_scores_gemma":[0.9968391,0.00029386877,0.0001277452,0.0015746462,0.00084207405,0.000322545],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0033699055,0.0006874851,0.0012771788,0.0012615582,0.00047537033,0.00013644867,0.0004329026,0.0013870546,0.0007900449],"category_scores_gemma":[0.00021844095,0.00049217604,0.00071808044,0.0017799456,0.00034466878,0.00019992686,0.00015599828,0.004572483,0.0011433621],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003666699,0.0006185112,0.00047724904,0.00016960202,0.0005129171,0.000519519,0.0013029905,0.000010610568,0.0006058857,0.0000036632619,0.97154254,0.020569842],"study_design_scores_gemma":[0.012254294,0.0030038576,0.009360069,0.0011730134,0.00007763377,0.000034180506,0.00017971208,0.000026044983,0.0068241265,0.00015079863,0.96627766,0.00063860393],"about_ca_topic_score_codex":0.00070908276,"about_ca_topic_score_gemma":0.0000308923,"teacher_disagreement_score":0.28960624,"about_ca_system_score_codex":0.0007670176,"about_ca_system_score_gemma":0.0004489072,"threshold_uncertainty_score":0.99990934},"labels":[],"label_agreement":null},{"id":"W2198317996","doi":"10.1016/j.jcin.2015.08.032","title":"Is There an Ideal Level of Platelet P2Y12-Receptor Inhibition in Patients Undergoing Percutaneous Coronary Intervention?","year":2015,"lang":"en","type":"article","venue":"JACC: Cardiovascular Interventions","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Sacré-Cœur de Montréal","funders":"Janssen Pharmaceuticals; Abbott Vascular; Covidien; Regado Biosciences; Medicines Company; Cordis; Boston Scientific Corporation; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; CSL Behring; Cardiovascular Research Foundation; Medtronic; Sanofi; Merck","keywords":"Medicine; Percutaneous coronary intervention; Clopidogrel; Hazard ratio; Internal medicine; P2Y12; Confidence interval; Stent; Incidence (geometry); Drug-eluting stent; Cardiology; Adverse effect; Thrombosis; Surgery; Myocardial infarction","score_opus":0.0782567787641679,"score_gpt":0.30808384118475,"score_spread":0.22982706242058212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2198317996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9827779,0.010924858,0.0040847617,0.00006550737,0.00037850672,0.00086989964,0.00027667527,0.00008999122,0.0005318832],"genre_scores_gemma":[0.99768335,0.00036802184,0.0005722438,0.00008365136,0.00012824738,0.000053325573,0.00076944375,0.00007190287,0.0002698254],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99665546,0.000498798,0.000913135,0.0005744817,0.000981382,0.0003767588],"domain_scores_gemma":[0.9980557,0.000036575806,0.0001839167,0.0009348953,0.00048157456,0.00030736177],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010312475,0.0003345804,0.0009464959,0.00037326946,0.00008687761,0.00004159677,0.00016054907,0.00022597259,0.000555596],"category_scores_gemma":[0.00015109558,0.00033245914,0.004749565,0.000394643,0.00013270149,0.00043239642,0.00012184992,0.00031742235,0.000117458134],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007673067,0.022677489,0.4992523,0.0064907614,0.057428256,0.004324582,0.0071240626,0.008571202,0.0008100644,0.0011983538,0.012258454,0.3721914],"study_design_scores_gemma":[0.05099996,0.0071371305,0.89751893,0.00891929,0.004905542,0.0023868615,0.007927953,0.00043491874,0.0053484826,0.0013182892,0.011357256,0.0017453916],"about_ca_topic_score_codex":0.00029103717,"about_ca_topic_score_gemma":0.00012241628,"teacher_disagreement_score":0.39826664,"about_ca_system_score_codex":0.00028226912,"about_ca_system_score_gemma":0.00014882513,"threshold_uncertainty_score":0.99991274},"labels":[],"label_agreement":null},{"id":"W2198723167","doi":"10.9734/bjmmr/2015/19433","title":"Benefit and Safety of Dual Antiplatelet Therapy after Coronary Artery Bypass Grafting for Off-pump CABG: A Systematic Review and Meta-analysis","year":2015,"lang":"en","type":"review","venue":"British Journal of Medicine and Medical Research","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Aspirin; Cochrane Library; Randomized controlled trial; Internal medicine; Meta-analysis; Stroke (engine); Observational study; Revascularization; Surgery; Cardiology; Myocardial infarction","score_opus":0.15029110683418145,"score_gpt":0.42414586282171757,"score_spread":0.2738547559875361,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2198723167","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00053170027,0.99528056,0.000048574537,0.001236247,0.000040301224,0.0026791294,0.00014418368,0.000006192212,0.00003313228],"genre_scores_gemma":[0.00072667067,0.9976511,0.000052379644,0.00073323026,0.00033107406,0.00016029982,0.0000746069,0.00005201838,0.00021863608],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9919272,0.0014165732,0.002502881,0.00048633877,0.0031653463,0.00050167105],"domain_scores_gemma":[0.9940074,0.0020335303,0.0007943497,0.00038138268,0.0015097533,0.001273594],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.019936852,0.0004345175,0.0122852465,0.000677568,0.00012958967,0.000038385828,0.0002345719,0.00042582373,0.0004039171],"category_scores_gemma":[0.0042143217,0.0002676525,0.0022078464,0.0007319935,0.001053346,0.00011289937,0.00013101616,0.0012820993,6.483747e-7],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039775873,0.000104928375,0.000008742263,0.3612946,0.15364192,0.004575559,0.00007687707,1.6648361e-8,1.4611078e-7,0.0000063476773,0.0012973668,0.47859573],"study_design_scores_gemma":[0.0050582574,0.0013938025,0.000055428223,0.22744207,0.5574458,0.0562694,0.00021389802,0.0000041808853,1.8066356e-7,0.00004846159,0.15182962,0.00023886593],"about_ca_topic_score_codex":0.000034263398,"about_ca_topic_score_gemma":0.000011922244,"teacher_disagreement_score":0.47835687,"about_ca_system_score_codex":0.00004684888,"about_ca_system_score_gemma":0.0007742069,"threshold_uncertainty_score":0.9999776},"labels":[],"label_agreement":null},{"id":"W2199413880","doi":"10.1177/1533317515619480","title":"Simple Neuropsychological Tests May Identify Participants in Whom Aspirin Use Is Associated With Lower Dementia Incidence","year":2015,"lang":"en","type":"article","venue":"American Journal of Alzheimer s Disease & Other Dementias®","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research","keywords":"Dementia; Neuropsychology; Incidence (geometry); Vascular dementia; Aspirin; Odds ratio; Cognition; Confidence interval; Psychology; Medicine; Psychiatry; Clinical psychology; Disease; Internal medicine","score_opus":0.06636473755571795,"score_gpt":0.3416836889458936,"score_spread":0.2753189513901757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2199413880","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99406904,0.004680068,0.00032703497,0.00035687967,0.000136174,0.0003216086,0.00002431088,0.00003393243,0.00005092765],"genre_scores_gemma":[0.99534005,0.000103272825,0.00017994568,0.004149148,0.00010423557,0.000015454145,0.000010795878,0.000069812115,0.000027298207],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99661666,0.0004647262,0.0007577258,0.0004096587,0.0011385293,0.0006127265],"domain_scores_gemma":[0.99726117,0.000070870075,0.00065064366,0.0004981397,0.00040035148,0.0011188561],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007513237,0.0003353637,0.00078962365,0.0002231397,0.00007079288,0.00012456266,0.0002645041,0.000051003637,0.00044965488],"category_scores_gemma":[0.00024457774,0.00025311855,0.00043278962,0.00063634507,0.00051860546,0.00046975876,0.00006359863,0.00031056622,0.000042255873],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037049057,0.0013478852,0.9794833,0.000005957829,0.0052610356,0.0028620344,0.00023410053,0.00012286015,0.00016407821,0.0000045649062,0.0016531758,0.005156101],"study_design_scores_gemma":[0.004843014,0.0015790086,0.98565024,0.00028902644,0.0047779055,0.000069878915,0.00028430595,0.00009328821,0.00013595083,0.000057449906,0.0019129007,0.00030701587],"about_ca_topic_score_codex":0.000095855634,"about_ca_topic_score_gemma":0.00002907067,"teacher_disagreement_score":0.006166955,"about_ca_system_score_codex":0.00005650299,"about_ca_system_score_gemma":0.00042592778,"threshold_uncertainty_score":0.99999213},"labels":[],"label_agreement":null},{"id":"W2201368708","doi":"10.1016/j.jacc.2008.08.053","title":"The Pursuit of Clinically Relevant Measures of Platelet Function After Antiplatelet Drug Therapy⁎⁎Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.","year":2008,"lang":"en","type":"letter","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of British Columbia","funders":"","keywords":"Medicine; Antiplatelet drug; Cardiology; Internal medicine; Platelet; Drug; Intensive care medicine; Clopidogrel; Pharmacology; Myocardial infarction","score_opus":0.04099404926177815,"score_gpt":0.3105976674148184,"score_spread":0.2696036181530403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2201368708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8827121,0.015985342,0.00012703052,0.08955878,0.0051276144,0.003761082,0.0024037056,0.000008716652,0.00031558407],"genre_scores_gemma":[0.9366085,0.050022155,0.000072666655,0.0074704336,0.005486493,0.00007848019,0.000006693885,0.000121966,0.00013261806],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.96020657,0.027368132,0.007028708,0.000726004,0.00371113,0.0009594308],"domain_scores_gemma":[0.9563587,0.0125462515,0.023490278,0.0043324833,0.0031220932,0.00015024396],"candidate_categories":["metaepi_narrow","sts","open_science","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.024798498,0.001109352,0.010271585,0.00055298593,0.00049796316,0.000024213417,0.006094393,0.0006235911,0.00001407847],"category_scores_gemma":[0.0057884594,0.00036534359,0.006950426,0.0032747912,0.018481074,0.00016463448,0.0008366632,0.0043310225,3.2757205e-7],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08950708,0.00034911497,0.06040179,0.0005095137,0.03705396,0.0007546361,0.0019607958,0.0037212328,0.012831039,0.00008722167,0.7854043,0.0074192896],"study_design_scores_gemma":[0.008476444,0.01072157,0.22444302,0.0013395434,0.009332785,0.013003157,0.01607649,0.000018523968,0.00416097,0.00069064717,0.7109604,0.0007764528],"about_ca_topic_score_codex":0.00030161339,"about_ca_topic_score_gemma":0.00008173131,"teacher_disagreement_score":0.16404124,"about_ca_system_score_codex":0.0001860171,"about_ca_system_score_gemma":0.0025653255,"threshold_uncertainty_score":0.99987984},"labels":[],"label_agreement":null},{"id":"W2202602437","doi":"10.9778/cmajo.20150056","title":"Cost-effectiveness of clopidogrel, prasugrel and ticagrelor for dual antiplatelet therapy after acute coronary syndrome: a decision-analytic model","year":2015,"lang":"en","type":"article","venue":"CMAJ Open","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Women's College Hospital; University of Toronto; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre","funders":"","keywords":"Ticagrelor; Prasugrel; Clopidogrel; Medicine; Acute coronary syndrome; Internal medicine; Cost effectiveness; Quality-adjusted life year; Pharmacoeconomics; Cardiology; Intensive care medicine; Aspirin; Myocardial infarction","score_opus":0.07387191805944773,"score_gpt":0.35706582282684257,"score_spread":0.2831939047673948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2202602437","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97822005,0.005034509,0.0123123005,0.00007494916,0.00010036593,0.003937581,0.00014381274,0.000026997213,0.00014941879],"genre_scores_gemma":[0.9952452,0.00096037064,0.0026757824,0.00027319216,0.000028496672,0.00047016566,0.00008006194,0.00005303622,0.00021364923],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99844974,0.00012230064,0.00032210717,0.00045218482,0.00036646033,0.0002872079],"domain_scores_gemma":[0.9985384,0.00026812046,0.00009238947,0.0005244603,0.0002719214,0.00030474435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009976974,0.00025226988,0.0008991382,0.00009753501,0.00006193674,0.000053490825,0.00020774771,0.00014653172,0.000042783042],"category_scores_gemma":[0.00009259415,0.0001921549,0.00029888892,0.0001739873,0.0001738874,0.0002643971,0.00018039945,0.00011354058,0.000015166465],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.28555048,0.0035178717,0.25726813,0.0015092295,0.030046247,0.0063113957,0.0024442214,0.0018026135,0.0033262868,0.001612973,0.007312057,0.39929852],"study_design_scores_gemma":[0.12049227,0.010219046,0.79374653,0.0027355803,0.006472909,0.00952051,0.0007000733,0.022752455,0.006132416,0.013709667,0.01153774,0.0019807997],"about_ca_topic_score_codex":0.00002179309,"about_ca_topic_score_gemma":0.0000023731618,"teacher_disagreement_score":0.5364784,"about_ca_system_score_codex":0.000046820693,"about_ca_system_score_gemma":0.00031820012,"threshold_uncertainty_score":0.78358495},"labels":[],"label_agreement":null},{"id":"W2203137239","doi":"10.1016/j.thromres.2015.10.023","title":"An optimum prophylactic dose of prasugrel monotherapy may safely and effectively prevent the development of experimental thrombotic strokes","year":2015,"lang":"en","type":"letter","venue":"Thrombosis Research","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Prasugrel; Medicine; Clopidogrel; Myocardial infarction; Aspirin; Acute coronary syndrome; Internal medicine; Stroke (engine); Cardiology","score_opus":0.10813787848319253,"score_gpt":0.4065608542216056,"score_spread":0.29842297573841303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2203137239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97357696,0.012169129,0.00007588655,0.010203918,0.00009098054,0.0033299266,0.000038782156,0.00003612999,0.00047825894],"genre_scores_gemma":[0.99507827,0.00059673854,0.0010949282,0.0019180699,0.0005770067,0.0003016968,0.00009414779,0.000120743956,0.0002184025],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9942157,0.0015250746,0.0006098688,0.00065557176,0.00238285,0.0006109237],"domain_scores_gemma":[0.997577,0.00034729246,0.00023569084,0.0010492114,0.00060144294,0.00018934788],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00255903,0.00042991192,0.0012188134,0.00032673462,0.00021698864,0.000047285273,0.00048026486,0.0004581061,0.00014965559],"category_scores_gemma":[0.00007698719,0.00028030956,0.0003254906,0.00034414436,0.0010906057,0.00013498565,0.0001638441,0.0013537444,0.000013622178],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008910043,0.010923553,0.008026124,0.011767174,0.02516163,0.00036767422,0.03864109,0.000066845256,0.7340785,0.00010395907,0.1000433,0.061910104],"study_design_scores_gemma":[0.015291517,0.016312214,0.16990584,0.0032788613,0.0018158389,0.0001660428,0.00890803,0.00021507585,0.7319705,0.00035273356,0.04997426,0.0018091146],"about_ca_topic_score_codex":0.000084863525,"about_ca_topic_score_gemma":0.0000019940062,"teacher_disagreement_score":0.16187972,"about_ca_system_score_codex":0.00026506686,"about_ca_system_score_gemma":0.0011592364,"threshold_uncertainty_score":0.9999649},"labels":[],"label_agreement":null},{"id":"W2205509151","doi":"10.1055/s-0037-1613619","title":"Platelets give us many messages","year":2003,"lang":"en","type":"editorial","venue":"Thrombosis and Haemostasis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Platelet; Thrombosis; Medicine; Immunology; Internal medicine","score_opus":0.024406973430931157,"score_gpt":0.3051362947686696,"score_spread":0.2807293213377384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2205509151","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14000049,0.080489576,0.0001327692,0.0009287122,0.7577729,0.0019722516,0.0017606678,0.00045276387,0.016489863],"genre_scores_gemma":[0.019596726,0.27928877,0.0008044719,0.0013726248,0.69006455,0.00016089436,0.00249406,0.00044845074,0.0057694414],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971258,0.0001421355,0.00041852475,0.00079914153,0.0009935071,0.00052089087],"domain_scores_gemma":[0.998316,0.00021149631,0.00017781106,0.00071558385,0.00022935841,0.00034973465],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00035987122,0.00062032416,0.0016174236,0.00016343678,0.0002609819,0.000107662476,0.00015478705,0.0010508017,0.0008270785],"category_scores_gemma":[0.0001477963,0.00053013716,0.0007396104,0.00019200517,0.00026100923,0.00010414707,0.00007775962,0.0007371169,0.000088408924],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024361984,0.00015581718,0.00030025296,0.00046750478,0.0033368098,0.00018061043,0.00010696607,4.7879473e-7,0.000035540063,0.00005668307,0.9748644,0.020251285],"study_design_scores_gemma":[0.0033616936,0.00025957284,0.002213529,0.0004850489,0.0029690054,0.000043205036,0.00011613917,0.000001988246,0.00068779144,0.00008086913,0.989201,0.00058015896],"about_ca_topic_score_codex":0.00008404261,"about_ca_topic_score_gemma":0.0000070952237,"teacher_disagreement_score":0.1987992,"about_ca_system_score_codex":0.00008383133,"about_ca_system_score_gemma":0.00026696653,"threshold_uncertainty_score":0.99971503},"labels":[],"label_agreement":null},{"id":"W2209519262","doi":"10.1016/j.jacc.2008.01.051","title":"Clopidogrel Resistance","year":2008,"lang":"en","type":"letter","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of British Columbia","funders":"","keywords":"Medicine; Clopidogrel; Aspirin; Internal medicine; Incidence (geometry); Cardiology","score_opus":0.012229815542939119,"score_gpt":0.24511352678783002,"score_spread":0.2328837112448909,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2209519262","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13186912,0.037686884,0.0004764813,0.8152527,0.0031774854,0.0007969673,0.0005928821,0.000029474213,0.010118004],"genre_scores_gemma":[0.28073943,0.032450978,0.0016202483,0.6411194,0.02984917,0.000013515827,0.000024022567,0.00021074507,0.013972484],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.997361,0.0006476359,0.00075029355,0.00019881819,0.00074013206,0.00030213248],"domain_scores_gemma":[0.99671376,0.00022433799,0.0017105911,0.0007801325,0.00049275404,0.0000784424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033033447,0.00027501577,0.002574722,0.00021114932,0.00007385179,0.0000022106794,0.0005367333,0.00027796987,0.000011379324],"category_scores_gemma":[0.000191019,0.00017108186,0.003331586,0.00040480972,0.0013127227,0.000030008718,0.00006834313,0.0015356496,0.0000037617372],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010440693,0.000012886815,0.0029245473,0.00010301282,0.0038977384,0.00962963,0.000007621113,0.000025493355,0.000075380216,0.000007987561,0.9818949,0.0003767326],"study_design_scores_gemma":[0.0010899954,0.0004693577,0.008382138,0.00025884606,0.0012920251,0.018594451,0.000048717153,3.1379074e-7,0.0000995317,0.000080459016,0.96953326,0.00015092663],"about_ca_topic_score_codex":0.0000021485616,"about_ca_topic_score_gemma":3.8967835e-7,"teacher_disagreement_score":0.1741333,"about_ca_system_score_codex":0.00010620465,"about_ca_system_score_gemma":0.00074819196,"threshold_uncertainty_score":0.69765157},"labels":[],"label_agreement":null},{"id":"W2210409510","doi":"10.1161/jaha.115.002546","title":"Efficacy and Safety of Vorapaxar in Non–ST‐Segment Elevation Acute Coronary Syndrome Patients Undergoing Noncardiac Surgery","year":2015,"lang":"en","type":"article","venue":"Journal of the American Heart Association","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Alberta","funders":"National Institutes of Health; Regado Biosciences; Medicines Company; Stanford Bio-X; MyoKardia; Gilead Sciences; Daiichi Sankyo Europe; Sanofi; GlaxoSmithKline; Servier; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Internal medicine; Odds ratio; Myocardial infarction; Acute coronary syndrome; Perioperative; Cardiology; Placebo; Aspirin; Stroke (engine); Clinical endpoint; Platelet aggregation inhibitor; Anesthesia; Surgery; Randomized controlled trial","score_opus":0.010673738882365521,"score_gpt":0.2499205182077375,"score_spread":0.23924677932537197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2210409510","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99868673,0.00029936645,0.000060541417,0.0005268824,0.00019972275,0.00020430762,0.0000082438955,0.00000360894,0.00001061325],"genre_scores_gemma":[0.9989032,0.0006235425,0.00012178083,0.0002594565,0.00005398853,0.0000013952255,0.0000063064685,0.00001061532,0.000019724308],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99843574,0.0002956967,0.0004435068,0.00008040763,0.0006154564,0.00012921567],"domain_scores_gemma":[0.99851185,0.00032287522,0.0007120599,0.00011776993,0.0002494943,0.000085978296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012916336,0.00008398044,0.0006408752,0.000115452865,0.000035024274,0.000007800486,0.00004291525,0.0000361487,0.0000021251394],"category_scores_gemma":[0.0004843134,0.00006293667,0.00033918774,0.00029576488,0.000041102918,0.0001286262,0.000023046934,0.0001409184,0.0000011970338],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090936944,0.00015556328,0.99266666,0.000013832943,0.0006967311,0.000011417606,0.00015444765,0.00013550081,0.00019509014,5.242665e-7,0.0009262096,0.004134658],"study_design_scores_gemma":[0.0025869475,0.00044760632,0.9957673,0.00020547459,0.0003191402,0.00007428432,0.00016362203,0.000024614617,0.00009396101,0.000014700793,0.00024379304,0.000058546266],"about_ca_topic_score_codex":0.000017767796,"about_ca_topic_score_gemma":0.0000016015141,"teacher_disagreement_score":0.0040761116,"about_ca_system_score_codex":0.0004317469,"about_ca_system_score_gemma":0.00022257605,"threshold_uncertainty_score":0.25664827},"labels":[],"label_agreement":null},{"id":"W2210446786","doi":"","title":"Abstract 13208: Time-Dependent Interactions of Prasugrel vs Clopidogrel on the Long-Term Risks of Stroke after Acute Coronary Syndromes: Results from the TRILOGY ACS Trial","year":2014,"lang":"en","type":"article","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Prasugrel; Clopidogrel; Stroke (engine); Cardiology; Internal medicine; Atrial fibrillation; Population; Proportional hazards model; Myocardial infarction","score_opus":0.04385604198994142,"score_gpt":0.30755588014661706,"score_spread":0.26369983815667564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2210446786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996869,0.00031046063,0.0005053166,0.00044250765,0.00035673764,0.00084380206,0.00024685057,0.00002641361,0.0003988541],"genre_scores_gemma":[0.9989295,0.000140049,0.000009727496,0.00016554192,0.00033035048,0.000036719062,0.00028072018,0.000021983242,0.00008539219],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99839246,0.0002576854,0.0005123705,0.00025665143,0.0004403554,0.0001404464],"domain_scores_gemma":[0.9980078,0.0007862343,0.00034792925,0.00069343334,0.000112783586,0.000051845065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052223925,0.00015842733,0.00038349896,0.000061303566,0.000078578065,0.000013843061,0.00013922554,0.00011850997,0.00026786255],"category_scores_gemma":[0.00021688973,0.0000967223,0.00041215873,0.0000884159,0.00012354867,0.00008703019,0.000026038406,0.00023458216,0.000064636624],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.39719903,0.0028456794,0.43695635,0.00020601985,0.014150278,0.00021829028,0.0026050927,0.0023845322,0.031101555,0.000286073,0.0014216086,0.11062549],"study_design_scores_gemma":[0.015629595,0.00033837417,0.98106927,0.00020519695,0.00089905725,0.00003719983,0.000050165596,0.00017894169,0.001299711,0.000070995724,0.00012701719,0.00009445487],"about_ca_topic_score_codex":0.00005527313,"about_ca_topic_score_gemma":0.000008206586,"teacher_disagreement_score":0.544113,"about_ca_system_score_codex":0.000042524192,"about_ca_system_score_gemma":0.00006084527,"threshold_uncertainty_score":0.3944221},"labels":[],"label_agreement":null},{"id":"W2210519680","doi":"10.3978/j.issn.2072-1439.2015.12.44","title":"Prolonged dual antiplatelet therapy in renal failure: a challenging trade-off.","year":2015,"lang":"en","type":"article","venue":"PubMed","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Population Health Research Institute; Hamilton General Hospital","funders":"Harbin Medical University; Freiwillige Akademische Gesellschaft; Universität Basel","keywords":"Medicine; Dual (grammatical number); Intensive care medicine","score_opus":0.0378127120358033,"score_gpt":0.23592171651264887,"score_spread":0.19810900447684557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2210519680","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98216444,0.012198752,0.000036277102,0.0027963878,0.00011818654,0.001332578,0.0000044452695,0.00014297244,0.0012059791],"genre_scores_gemma":[0.99688333,0.0012773478,0.000054132775,0.00048151964,0.0003675683,0.0007546225,0.000027102951,0.00003829549,0.00011608542],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9982865,0.00012706502,0.0002564173,0.00033793275,0.00044637936,0.0005457176],"domain_scores_gemma":[0.9992224,0.000025461939,0.00004991686,0.0003207264,0.000035313773,0.0003462035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081020576,0.00020420924,0.00043885622,0.00017063161,0.000042496267,0.000026598806,0.000090009926,0.00013676276,0.000018664963],"category_scores_gemma":[0.00007645186,0.0001690981,0.0002446034,0.0003048788,0.00006782164,0.0001412936,0.000021535654,0.00026018635,0.0000135762675],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028695401,0.00051144115,0.022010071,0.000038224956,0.00073183264,0.0016513967,0.0010655742,0.00006270098,0.00024384225,0.000099850964,0.0019666413,0.96874887],"study_design_scores_gemma":[0.024801863,0.00034500816,0.84672034,0.00007349719,0.00012713435,0.00096379104,0.00066851627,0.00016046948,0.0033507121,0.00022421143,0.12202814,0.0005363006],"about_ca_topic_score_codex":0.000008270775,"about_ca_topic_score_gemma":0.00000886925,"teacher_disagreement_score":0.9682126,"about_ca_system_score_codex":0.00006526014,"about_ca_system_score_gemma":0.000074746196,"threshold_uncertainty_score":0.689562},"labels":[],"label_agreement":null},{"id":"W2211196883","doi":"10.1007/s11239-015-1264-9","title":"PON1 Q192R genetic variant and response to clopidogrel and prasugrel: pharmacokinetics, pharmacodynamics, and a meta-analysis of clinical outcomes","year":2015,"lang":"en","type":"review","venue":"Journal of Thrombosis and Thrombolysis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Prasugrel; Clopidogrel; Medicine; Internal medicine; Thienopyridine; Pharmacodynamics; Myocardial infarction; Aspirin; Cardiology; Pharmacology; Pharmacokinetics","score_opus":0.20499309320322961,"score_gpt":0.47567386966713976,"score_spread":0.27068077646391014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2211196883","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10392512,0.89439607,0.0001482843,0.0004910369,0.00014493272,0.0006030408,0.0002683711,0.000010640669,0.000012527496],"genre_scores_gemma":[0.016087841,0.9810601,0.002197333,0.00035628432,0.00014701231,0.000013006328,0.000014760048,0.00007313667,0.000050514773],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9940948,0.0013454637,0.0026809874,0.0006936091,0.0008568516,0.0003282816],"domain_scores_gemma":[0.99528843,0.0009269163,0.0017621565,0.0005336452,0.0005129423,0.0009758876],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004250423,0.0007298386,0.013621571,0.0011665412,0.00009421913,0.00009080811,0.00021178313,0.00037263916,0.00011839319],"category_scores_gemma":[0.0003946735,0.00046496018,0.005031528,0.00082637806,0.00043083838,0.00012861678,0.0002542927,0.0005980935,0.0000012427932],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061974296,0.0004655926,0.0035879842,0.0028687185,0.80491,0.00024615807,0.00030368604,0.00001015718,0.000022894634,0.000011814309,0.00036627727,0.18658695],"study_design_scores_gemma":[0.002081698,0.00075099507,0.04273084,0.00035730182,0.8639541,0.00046900223,0.00009990568,0.00007776371,0.0000017236548,0.000022073382,0.089038335,0.00041624534],"about_ca_topic_score_codex":0.000029814382,"about_ca_topic_score_gemma":0.000004898079,"teacher_disagreement_score":0.1861707,"about_ca_system_score_codex":0.000043980246,"about_ca_system_score_gemma":0.00034519605,"threshold_uncertainty_score":0.99978024},"labels":[],"label_agreement":null},{"id":"W2221602226","doi":"10.1016/j.cjca.2015.07.024","title":"SWITCHING AND PREMATURE DISCONTINUATION OF ADP RECEPTOR INHIBITOR THERAPY PRESCRIBED AT HOSPITAL DISCHARGE AMONG MYOCARDIAL INFARCTION PATIENTS TREATED WITH PERCUTANEOUS CORONARY INTERVENTION: INSIGHTS FROM THE CANADIAN OBSERVATIONAL ANTIPLATELET STUDY (COAPT)","year":2015,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Toronto Public Health","funders":"","keywords":"Medicine; Ticagrelor; Discontinuation; Clopidogrel; Percutaneous coronary intervention; Prasugrel; Internal medicine; Myocardial infarction; Cardiology; Conventional PCI; Aspirin; TIMI","score_opus":0.01756696714876863,"score_gpt":0.2174520942482799,"score_spread":0.19988512709951128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2221602226","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956126,0.0026059316,0.000022623382,0.00028267395,0.00047245758,0.0008112688,0.00011796526,0.000006444393,0.00006801419],"genre_scores_gemma":[0.9988441,0.0000940803,0.000019690713,0.0000702793,0.0006565504,0.000010300736,0.00026351865,0.00002568135,0.000015803402],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983494,0.00041654555,0.00043688325,0.0002181036,0.00034961945,0.00022940872],"domain_scores_gemma":[0.99819076,0.00006212149,0.00029257304,0.00021634405,0.0006332195,0.0006049814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027826245,0.00020972417,0.0006155411,0.00013383305,0.00022168069,0.00004136445,0.00012248191,0.00016495404,0.000016719798],"category_scores_gemma":[0.0001210738,0.00013513668,0.00026670875,0.00013810136,0.00018967885,0.00026037026,0.0000150687265,0.00032000715,0.0000012778263],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013162626,0.000036170582,0.98825186,0.000004296576,0.0021420966,0.00023828217,0.0025292865,0.00011090907,0.000100287725,0.000004728254,0.00071550265,0.0045503164],"study_design_scores_gemma":[0.005095784,0.0025273738,0.98577654,0.00014077095,0.00037363076,0.00034797227,0.001431793,0.000012528743,0.000046328383,0.000016811835,0.004080368,0.00015007747],"about_ca_topic_score_codex":0.042780858,"about_ca_topic_score_gemma":0.13306311,"teacher_disagreement_score":0.09028225,"about_ca_system_score_codex":0.000357011,"about_ca_system_score_gemma":0.0008187399,"threshold_uncertainty_score":0.96359336},"labels":[],"label_agreement":null},{"id":"W2228270545","doi":"10.1002/clc.22486","title":"Ticagrelor in Triple Antithrombotic Therapy: Predictors of Ischemic and Bleeding Complications","year":2016,"lang":"en","type":"article","venue":"Clinical Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Ticagrelor; Clopidogrel; Percutaneous coronary intervention; Internal medicine; Acute coronary syndrome; Antithrombotic; Myocardial infarction; Stroke (engine); Prasugrel; Clinical endpoint; Cardiology; Surgery; Randomized controlled trial","score_opus":0.05617316747149019,"score_gpt":0.3445980954815533,"score_spread":0.2884249280100631,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2228270545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99315464,0.0034177855,0.00062364567,0.0006823129,0.00018181365,0.0002570433,0.000010711755,0.000027127906,0.0016449048],"genre_scores_gemma":[0.9920677,0.007372947,0.00008835726,0.00019085998,0.00019994624,0.000012829282,0.000005903053,0.000011588349,0.000049844606],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988922,0.00015328357,0.0004366011,0.00026771976,0.00008650638,0.00016370474],"domain_scores_gemma":[0.9990151,0.00045948967,0.00006972637,0.00029383154,0.000058180445,0.00010367089],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053495076,0.00009363023,0.0006884787,0.00006082948,0.000020281754,0.0000016965033,0.00006783454,0.0001583584,0.000026867076],"category_scores_gemma":[0.00035178865,0.000058683312,0.00031257138,0.00010165035,0.0005180937,0.00003185143,0.000032963522,0.00011344752,0.000011127295],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026717814,0.00006995448,0.97132456,0.000018805878,0.00050819595,0.000017344028,0.000015064552,7.480453e-7,0.005677311,0.00018575886,0.0007082558,0.02120684],"study_design_scores_gemma":[0.004471515,0.00035259096,0.98238,0.00008347454,0.0001291261,0.000085010004,0.000031086674,0.000008354712,0.00032662682,0.00011966335,0.0119365975,0.000075984586],"about_ca_topic_score_codex":0.000002723751,"about_ca_topic_score_gemma":4.4889345e-7,"teacher_disagreement_score":0.021130856,"about_ca_system_score_codex":0.000011431079,"about_ca_system_score_gemma":0.000055115896,"threshold_uncertainty_score":0.23930359},"labels":[],"label_agreement":null},{"id":"W2232993138","doi":"10.1161/circinterventions.115.002816","title":"Clopidogrel Versus Aspirin as an Antiplatelet Monotherapy After 12-Month Dual-Antiplatelet Therapy in the Era of Drug-Eluting Stents","year":2016,"lang":"en","type":"article","venue":"Circulation Cardiovascular Interventions","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Clopidogrel; Aspirin; Hazard ratio; Internal medicine; Myocardial infarction; Antiplatelet drug; Ticlopidine; Confidence interval; Cardiology","score_opus":0.040892468392889965,"score_gpt":0.30235271395913854,"score_spread":0.2614602455662486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2232993138","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97724974,0.016005475,0.0037249296,0.00031803088,0.0004809579,0.0014206155,0.000050498573,0.00010502974,0.00064472423],"genre_scores_gemma":[0.99582446,0.003022952,0.00015014004,0.00019019358,0.00031160857,0.00021742939,0.00012459376,0.00008461018,0.00007399407],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9956239,0.00097249384,0.001009901,0.0007393757,0.0011330233,0.00052134343],"domain_scores_gemma":[0.9974663,0.00016350928,0.00024935135,0.0016780627,0.00027672196,0.00016604888],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019977666,0.00043241936,0.0009849627,0.00032745462,0.00017657368,0.00006995283,0.00031995086,0.00021961216,0.00046769896],"category_scores_gemma":[0.000105912,0.00029289018,0.0047951955,0.0005669607,0.0002366032,0.0005142604,0.00005062124,0.00035039827,0.000069129346],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007673482,0.0023626944,0.14332709,0.00044020388,0.018319083,0.0010170037,0.0025625776,0.0014000055,0.0023790137,0.0008479704,0.00013812202,0.81953275],"study_design_scores_gemma":[0.03816356,0.0012033271,0.939245,0.002089226,0.0016098395,0.0005649609,0.0012111932,0.0001962474,0.002868929,0.00052432163,0.011460813,0.0008625849],"about_ca_topic_score_codex":0.00015623997,"about_ca_topic_score_gemma":0.000050035927,"teacher_disagreement_score":0.81867015,"about_ca_system_score_codex":0.00011850331,"about_ca_system_score_gemma":0.00010487403,"threshold_uncertainty_score":0.9999523},"labels":[],"label_agreement":null},{"id":"W2236378300","doi":"10.1007/s40256-015-0155-y","title":"Prolonged Clopidogrel Use is Associated with Improved Clinical Outcomes Following Drug-Eluting But Not Bare Metal Stent Implantation","year":2016,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Providence Health Care; Victoria Heart Institute Foundation","funders":"","keywords":"Clopidogrel; Medicine; Hazard ratio; Drug-eluting stent; Stent; Myocardial infarction; Internal medicine; Confidence interval; Loading dose; Surgery; Cardiology; Percutaneous coronary intervention","score_opus":0.017007200535585007,"score_gpt":0.27220536490736424,"score_spread":0.2551981643717792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2236378300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99241394,0.0023601174,0.0037261082,0.00049213984,0.0003877788,0.00047921692,0.000037467245,0.00006443619,0.000038791266],"genre_scores_gemma":[0.997123,0.00078089634,0.0007681422,0.0007931711,0.00030477208,0.000013585114,0.000011903324,0.000088165776,0.000116365845],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.995174,0.00093864877,0.0011632484,0.00049114256,0.001669052,0.0005639162],"domain_scores_gemma":[0.9968901,0.00059764535,0.0006746164,0.00072524353,0.00065352774,0.00045886452],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0030993812,0.0004270595,0.0024818697,0.00022400108,0.0001585684,0.00006399706,0.00024221714,0.00010962445,0.000013654546],"category_scores_gemma":[0.00075268286,0.0002481851,0.0076058474,0.00039058478,0.0003383068,0.0005119069,0.000054314198,0.00043943946,0.000008283415],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026320086,0.00035322073,0.4181055,0.000036040718,0.13925906,0.0019567776,0.0008453445,0.000039749066,0.0011402214,0.000005297192,0.00010792937,0.43551883],"study_design_scores_gemma":[0.034421045,0.0029147228,0.9064684,0.0014554448,0.034506157,0.0020872902,0.0043157,0.000036639354,0.0066155433,0.000014701937,0.006002761,0.0011616024],"about_ca_topic_score_codex":0.00006508873,"about_ca_topic_score_gemma":0.000002529943,"teacher_disagreement_score":0.48836288,"about_ca_system_score_codex":0.00016836754,"about_ca_system_score_gemma":0.00039634737,"threshold_uncertainty_score":0.999997},"labels":[],"label_agreement":null},{"id":"W2241754167","doi":"10.1016/j.cjca.2015.07.066","title":"PLATELET REACTIVITY, P2Y12 RECEPTOR INHIBITOR SELECTION AND CLINICAL OUTCOMES IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION TREATED WITH PERCUTANEOUS CORONARY INTERVENTION: INSIGHTS FROM THE TRANSLATE-ACS STUDY","year":2015,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Toronto Public Health","funders":"","keywords":"Prasugrel; Medicine; Clopidogrel; Ticagrelor; Percutaneous coronary intervention; P2Y12; Internal medicine; Myocardial infarction; Mace; Cardiology; Conventional PCI; Loading dose","score_opus":0.014777238199962362,"score_gpt":0.2573263371571081,"score_spread":0.24254909895714577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2241754167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99839896,0.0004020644,0.00006973089,0.00019467929,0.00032834132,0.0005261106,0.00003228847,0.000008906193,0.000038938917],"genre_scores_gemma":[0.999308,0.0000802891,0.000026381907,0.00009035761,0.00041439803,0.0000051615507,0.00004625044,0.000022552054,0.000006597072],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99823445,0.00067221053,0.00042298052,0.00022075619,0.00025113788,0.00019844],"domain_scores_gemma":[0.9988668,0.000103429564,0.00016024365,0.0001631053,0.00028521032,0.0004212246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003471491,0.00018972503,0.00080313004,0.00012450154,0.000082130566,0.000024921015,0.00007721274,0.00016108216,0.0000060566304],"category_scores_gemma":[0.00005362629,0.000111173365,0.00024564812,0.00016317934,0.00018217895,0.00016412076,0.000007398866,0.0005087822,0.0000019121887],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068388316,0.000072605726,0.9731749,0.0000018757746,0.0051134797,0.0011410405,0.0005138228,0.00010835447,0.000009350757,5.9765784e-7,0.00014973238,0.012875371],"study_design_scores_gemma":[0.011639715,0.007456319,0.97426164,0.000057281744,0.0011165601,0.0018921249,0.000766568,0.0000024390142,0.000007241998,0.000009264408,0.0026596088,0.00013121622],"about_ca_topic_score_codex":0.0020148044,"about_ca_topic_score_gemma":0.0073433015,"teacher_disagreement_score":0.012744155,"about_ca_system_score_codex":0.00017538332,"about_ca_system_score_gemma":0.0005119314,"threshold_uncertainty_score":0.45335183},"labels":[],"label_agreement":null},{"id":"W2254242988","doi":"10.1161/str.43.suppl_1.a3546","title":"Abstract 3546: Genetic Variables Contributing To Aspirin Resistance: A Genome-Wide Association Study","year":2012,"lang":"en","type":"article","venue":"Stroke","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kimberly-Clark (Canada)","funders":"","keywords":"Medicine; Single-nucleotide polymorphism; Aspirin; Methylenetetrahydrofolate reductase; Genome-wide association study; Population; Internal medicine; Genetic association; Oncology; Allele; Genetics; Gene; Genotype; Biology","score_opus":0.010890310671490612,"score_gpt":0.25576796662356904,"score_spread":0.24487765595207844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2254242988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906065,0.0037288605,0.0007118821,0.00019973167,0.00017653136,0.0007333047,0.000048241258,0.00007687705,0.0037180763],"genre_scores_gemma":[0.996003,0.00005636683,0.0003798686,0.00055651134,0.00058555737,0.00004603282,0.000024885521,0.00002429056,0.0023235357],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99837655,0.00007916521,0.000258808,0.00020841364,0.00047336135,0.00060369313],"domain_scores_gemma":[0.99908346,0.00015103017,0.00009634777,0.00030217276,0.00011777308,0.00024920478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009668911,0.00014643978,0.00034019072,0.0000662078,0.00015100733,0.000030463865,0.000076047174,0.0000786262,0.0001902952],"category_scores_gemma":[0.0004420126,0.00013641038,0.00019832613,0.00014054473,0.000009948693,0.00007664865,0.00003744126,0.00014004341,0.00014495011],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022372947,0.0003375385,0.99442065,0.0000337608,0.0009375403,0.000035193083,0.00035467287,0.000018768813,0.0015873909,0.000012018909,0.00052331976,0.001515445],"study_design_scores_gemma":[0.001790568,0.00010447112,0.966721,0.00003766031,0.000413058,0.0000019869517,0.00061675295,6.02875e-7,0.00043327044,0.000011521794,0.02973,0.00013912741],"about_ca_topic_score_codex":0.000020368276,"about_ca_topic_score_gemma":0.0000129930995,"teacher_disagreement_score":0.02920668,"about_ca_system_score_codex":0.00021855028,"about_ca_system_score_gemma":0.000059628557,"threshold_uncertainty_score":0.55626535},"labels":[],"label_agreement":null},{"id":"W2254417216","doi":"10.1159/000415155","title":"Trends in Platelet Utilization in Canada 1981�19871","year":2015,"lang":"en","type":"article","venue":"Current studies in hematology and blood transfusion","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Red Cross Society","funders":"","keywords":"Platelet; Medicine; Internal medicine","score_opus":0.0988030108057858,"score_gpt":0.3439604570707969,"score_spread":0.24515744626501113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2254417216","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8904807,0.10855988,0.000013344783,0.00027473332,0.0003425253,0.00017954307,0.0000040494483,0.000010656775,0.00013456465],"genre_scores_gemma":[0.96913755,0.030699955,0.00001005852,0.000053711323,0.000021895094,0.000030810435,0.000031794105,0.0000074426657,0.000006792182],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989236,0.00010067844,0.0003172876,0.0002685834,0.00015808248,0.00023177102],"domain_scores_gemma":[0.99969685,0.000052005063,0.000027314745,0.00011542052,0.000033445758,0.00007493381],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020789243,0.00015018048,0.00055449654,0.00025176187,0.00003360022,0.0000017586191,0.0000386431,0.000073329174,0.000012817857],"category_scores_gemma":[0.00004055547,0.00012734723,0.00005283373,0.00040226936,0.00009636719,0.000047752885,0.000021881822,0.00020750854,6.5902066e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004952219,0.00042007127,0.91562223,0.0003247251,0.00013603947,0.0008016689,0.0018462625,0.00003723031,0.000010991702,0.0002682297,0.00022455021,0.07981277],"study_design_scores_gemma":[0.060400818,0.00072938064,0.898702,0.0040250462,0.00070404913,0.0020934078,0.015972741,0.00085154956,0.0039640344,0.0014807517,0.009987379,0.001088804],"about_ca_topic_score_codex":0.023597082,"about_ca_topic_score_gemma":0.49078593,"teacher_disagreement_score":0.46718884,"about_ca_system_score_codex":0.000086081265,"about_ca_system_score_gemma":0.00018059423,"threshold_uncertainty_score":0.98290485},"labels":[],"label_agreement":null},{"id":"W2255144061","doi":"10.1016/j.jamcollsurg.2016.01.053","title":"Continued Antiplatelet Therapy and Risk of Bleeding in Gastrointestinal Procedures: A Systematic Review","year":2016,"lang":"en","type":"review","venue":"Journal of the American College of Surgeons","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Clopidogrel; Aspirin; Perioperative; CINAHL; Gastrointestinal bleeding; MEDLINE; Platelet aggregation inhibitor; Surgery; Systematic review; Cochrane Library; Internal medicine; Randomized controlled trial","score_opus":0.01946889292897137,"score_gpt":0.28610639957844575,"score_spread":0.2666375066494744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2255144061","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013128795,0.9848753,0.000011543965,0.00009164515,0.000049225753,0.0016208822,0.00019228616,0.0000044510407,0.000025850579],"genre_scores_gemma":[0.004324947,0.99532616,0.0001336351,0.00004580664,0.00004945771,0.000018942721,0.0000010495477,0.00004166188,0.000058351718],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9960185,0.00091255456,0.0020478228,0.00018746061,0.0005891168,0.00024452416],"domain_scores_gemma":[0.99186176,0.0008870889,0.006285394,0.0004641386,0.0003682161,0.0001334194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021550434,0.00036295014,0.006949213,0.0003568517,0.000041437797,0.0000051552574,0.0003446907,0.0000519845,0.000015446607],"category_scores_gemma":[0.0017938945,0.00017364361,0.0024302776,0.0008233384,0.00044169874,0.000059047747,0.000056111865,0.0004223125,7.44956e-7],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064161536,0.0002963181,0.0069054235,0.93824756,0.005935618,0.00049385655,0.00003054421,2.9503627e-7,0.000020996882,0.000018030994,0.000765255,0.04664449],"study_design_scores_gemma":[0.0011814244,0.00046544056,0.0007167642,0.97172993,0.0062083667,0.011052614,0.00012235765,5.584345e-7,0.000005992381,0.000009706049,0.008346999,0.0001598644],"about_ca_topic_score_codex":0.00001861365,"about_ca_topic_score_gemma":0.0000034417635,"teacher_disagreement_score":0.046484627,"about_ca_system_score_codex":0.000062562875,"about_ca_system_score_gemma":0.00093393965,"threshold_uncertainty_score":0.70809805},"labels":[],"label_agreement":null},{"id":"W2255155055","doi":"10.1161/circoutcomes.7.suppl_1.385","title":"Abstract 385: The Impact of Aspirin Primary Prevention Treatment Guidelines: Temporal Trends in Aspirin Use for Primary vs Secondary Prevention, 2005-2013","year":2014,"lang":"en","type":"article","venue":"Circulation Cardiovascular Quality and Outcomes","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stuart Olson (Canada)","funders":"","keywords":"Medicine; Aspirin; Guideline; Stroke (engine); Contraindication; Population; Emergency department; Coronary artery disease; Emergency medicine; Internal medicine; Alternative medicine","score_opus":0.09527384327223512,"score_gpt":0.37826647947910086,"score_spread":0.28299263620686577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2255155055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9809361,0.008004517,0.008875561,0.00040502095,0.00010417595,0.0013116054,0.00007867025,0.000058434212,0.00022590515],"genre_scores_gemma":[0.99639106,0.0008302058,0.0005882838,0.00025632916,0.00019462158,0.0001308399,0.0012615989,0.00004191026,0.00030512834],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968502,0.00056674605,0.0011344843,0.000528888,0.000583331,0.00033638184],"domain_scores_gemma":[0.9980906,0.00023674975,0.00032062337,0.0009506558,0.0002537034,0.00014764075],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003176248,0.00037416036,0.0014083266,0.00026393635,0.00014224887,0.000055170807,0.00010690683,0.00021379949,0.000061542145],"category_scores_gemma":[0.00014757724,0.00025643126,0.0043966766,0.00024667574,0.00013095932,0.00038714093,0.000032914097,0.00014798409,0.0000030361778],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000618186,0.0004723926,0.51098806,0.0005846071,0.006913342,0.000006073468,0.0001615278,0.0047071823,0.00019305243,0.0001130293,0.00018724793,0.4750553],"study_design_scores_gemma":[0.007145362,0.00027805462,0.9804355,0.00015223633,0.0009654398,0.00002885953,0.000060195707,0.00017835418,0.000050113944,0.00042937603,0.01000107,0.00027541822],"about_ca_topic_score_codex":0.0007895068,"about_ca_topic_score_gemma":0.00007833186,"teacher_disagreement_score":0.47477987,"about_ca_system_score_codex":0.00028693702,"about_ca_system_score_gemma":0.0002643043,"threshold_uncertainty_score":0.9999888},"labels":[],"label_agreement":null},{"id":"W2260970468","doi":"","title":"Different perspective on ASA use.","year":2016,"lang":"en","type":"letter","venue":"PubMed","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Emmanuel Bible College","funders":"","keywords":"Perspective (graphical); Medicine; Computer science; Artificial intelligence","score_opus":0.030207517483209854,"score_gpt":0.23334884196540112,"score_spread":0.20314132448219127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2260970468","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018391553,0.0027857167,0.00006382813,0.9502814,0.0010149142,0.0023618634,0.0001787461,0.0002580984,0.02466392],"genre_scores_gemma":[0.07954419,0.00075762015,0.0000038699104,0.86948216,0.0109188305,0.0019083061,0.0001624423,0.00013471249,0.037087847],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99800414,0.00011108714,0.00016388425,0.0005290988,0.0006159776,0.0005758036],"domain_scores_gemma":[0.99885803,0.00012850662,0.00007524177,0.0006786524,0.00010535637,0.0001542017],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008546689,0.00036026744,0.0006439234,0.00015420883,0.000044366607,0.000041406674,0.00012741036,0.0004995344,0.00019870856],"category_scores_gemma":[0.000101636666,0.00022041965,0.0009358949,0.00005797479,0.0000962866,0.00005044666,0.000030965566,0.000812185,0.00014591655],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028775088,0.000056154542,0.0004644271,0.00006832338,0.0020610031,0.001847758,0.00001838468,5.0997013e-8,0.0000029606892,0.00019358541,0.90243053,0.09256906],"study_design_scores_gemma":[0.0014546664,0.000056723136,0.072597094,0.00011566893,0.00058321905,0.0000630668,0.000011719284,6.760384e-8,0.00020858135,0.0002865981,0.92433894,0.00028365894],"about_ca_topic_score_codex":0.000009482705,"about_ca_topic_score_gemma":3.8976074e-7,"teacher_disagreement_score":0.0922854,"about_ca_system_score_codex":0.00037811973,"about_ca_system_score_gemma":0.000035597244,"threshold_uncertainty_score":0.89884526},"labels":[],"label_agreement":null},{"id":"W2262097009","doi":"10.1161/str.44.suppl_1.a207","title":"Abstract 207: Vorapaxar in Patients with Prior Ischemic Stroke: Primary Results from the Stroke Cohort of the Multinational TRA 2°P-TIMI 50 Trial","year":2013,"lang":"en","type":"article","venue":"Stroke","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Stroke (engine); Clopidogrel; Aspirin; TIMI; Internal medicine; Dipyridamole; Placebo; Clinical endpoint; Cardiology; Myocardial infarction; Randomized controlled trial; Thrombolysis; Pathology","score_opus":0.006649663385767586,"score_gpt":0.2092179529450777,"score_spread":0.2025682895593101,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2262097009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923271,0.00038286368,0.000011991856,0.0003625133,0.00019142771,0.002238611,0.0014088671,0.000024712555,0.0030518984],"genre_scores_gemma":[0.9980659,0.000055097884,0.00022348422,0.00023264527,0.00025826713,0.00008024279,0.00035800287,0.000028554565,0.0006977996],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997682,0.0001103912,0.00053698424,0.00036452946,0.0010202443,0.00028584624],"domain_scores_gemma":[0.9984972,0.0002563901,0.00027229317,0.00068536197,0.00019596679,0.00009280736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003429466,0.00023543555,0.0004582102,0.000053817832,0.000098309356,0.000026544942,0.000296438,0.000131041,0.00023842386],"category_scores_gemma":[0.00016200711,0.00012774621,0.00039415402,0.000118853255,0.00021749189,0.00015462039,0.000044549583,0.0003916912,0.000020724938],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05168456,0.0013875925,0.9091518,0.000045206816,0.0021050123,0.000007756767,0.0003967189,0.00008592859,0.0074840467,0.000009340336,0.0049356665,0.022706386],"study_design_scores_gemma":[0.06060605,0.00022887597,0.93430716,0.000110674024,0.00026689586,0.0000010789895,0.00013980815,0.000015040173,0.0020843723,0.0000038753865,0.002101386,0.00013478672],"about_ca_topic_score_codex":0.00042127425,"about_ca_topic_score_gemma":0.000024894125,"teacher_disagreement_score":0.025155367,"about_ca_system_score_codex":0.00007218481,"about_ca_system_score_gemma":0.00024378677,"threshold_uncertainty_score":0.520934},"labels":[],"label_agreement":null},{"id":"W2262885968","doi":"10.1161/circ.128.suppl_22.a9819","title":"Abstract 9819: Elevated Plasma Serotonin and Endothelin-1 in Coronary Artery Disease Patients: A Potential for Novel Pharmacotherapeutic Targets?","year":2013,"lang":"en","type":"article","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Sacré-Cœur de Montréal","funders":"","keywords":"Medicine; Coronary artery disease; Serotonin; Endothelin receptor; Cardiology; Internal medicine; Disease; Endothelin 1; Receptor","score_opus":0.012980437265773463,"score_gpt":0.2434030279923097,"score_spread":0.23042259072653623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2262885968","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99492776,0.00077859557,0.001982139,0.00012865559,0.00009884697,0.0019602482,0.000056189856,0.000048748872,0.000018797937],"genre_scores_gemma":[0.9986547,0.000093551396,0.00012087373,0.00040898714,0.000094411174,0.00024280052,0.00033545733,0.00003161819,0.000017606688],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99908185,0.000022688362,0.00024071314,0.00026372992,0.0001832237,0.00020781202],"domain_scores_gemma":[0.99950045,0.000032289092,0.000065102664,0.00014476536,0.00010160484,0.0001557939],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008695775,0.00014944545,0.00020595486,0.00009531916,0.00006124986,0.00002664076,0.00003462851,0.00006493964,0.00023483046],"category_scores_gemma":[0.000021020896,0.00014236731,0.00015091187,0.000070742484,0.000039917995,0.0002303164,0.00000788768,0.000079150275,0.000020642126],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002328929,0.0012073914,0.7463238,0.00039885414,0.0006331947,0.000042207546,0.00020238673,0.001279801,0.16580136,0.00005102305,0.00006099399,0.08167005],"study_design_scores_gemma":[0.008999404,0.000041988988,0.96119857,0.000063419895,0.00016701006,0.000014748432,0.000031284453,0.028221577,0.0007174233,0.00016660562,0.0002214079,0.00015655183],"about_ca_topic_score_codex":0.000010404564,"about_ca_topic_score_gemma":6.520428e-7,"teacher_disagreement_score":0.21487479,"about_ca_system_score_codex":0.000045614088,"about_ca_system_score_gemma":0.000048714224,"threshold_uncertainty_score":0.580557},"labels":[],"label_agreement":null},{"id":"W2267992665","doi":"","title":"Quelle est la meilleure stratégie anti-plaquettaire à la phase aiguë des syndromes coronaires ?","year":2001,"lang":"fr","type":"article","venue":"Sang thrombose vaisseaux","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Gynecology; Medicine","score_opus":0.029629910920021662,"score_gpt":0.3302379334564958,"score_spread":0.3006080225364742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2267992665","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.68647236,0.28147218,0.0004373334,0.0010402116,0.0010905801,0.0006015039,0.00018347545,0.00038414245,0.028318193],"genre_scores_gemma":[0.9112058,0.07979169,0.00033529018,0.00035180285,0.0010766415,0.000040330124,0.00020111322,0.00020332207,0.006793971],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9951304,0.00096535805,0.00067714544,0.0009645677,0.00085826823,0.0014042419],"domain_scores_gemma":[0.99713266,0.00050190254,0.00019073066,0.0011242902,0.0001972332,0.00085315603],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0009299713,0.0008860973,0.001421496,0.00023833814,0.0006445217,0.0002311817,0.00047639076,0.00072578114,0.0049611707],"category_scores_gemma":[0.00023114281,0.00084754557,0.0011567519,0.0007684654,0.0019304301,0.0006313355,0.00013583618,0.0007927034,0.0011307884],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012606423,0.010978154,0.05829449,0.0037345113,0.01262593,0.05679242,0.003648468,0.00041477184,0.015631948,0.022563593,0.06465169,0.74940336],"study_design_scores_gemma":[0.018455489,0.0019092781,0.1645582,0.0060464074,0.0047566625,0.013342377,0.008013501,0.00043701066,0.0064976243,0.0035217123,0.77022904,0.002232684],"about_ca_topic_score_codex":0.00049947517,"about_ca_topic_score_gemma":0.00010771706,"teacher_disagreement_score":0.7471707,"about_ca_system_score_codex":0.00021259312,"about_ca_system_score_gemma":0.00090106,"threshold_uncertainty_score":0.99964696},"labels":[],"label_agreement":null},{"id":"W2268372242","doi":"10.1159/000395718","title":"Platelets, Drugs and Longevity in a Geriatric Population","year":2015,"lang":"en","type":"book-chapter","venue":"","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster University Medical Centre","funders":"","keywords":"Longevity; Platelet; Medicine; Gerontology; Internal medicine","score_opus":0.019513960197558043,"score_gpt":0.25075116040471573,"score_spread":0.23123720020715768,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2268372242","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12000676,0.060487274,0.000049697537,0.00018817783,0.0001891655,0.0011234133,0.000029299703,0.00015564352,0.81777054],"genre_scores_gemma":[0.5057594,0.00816031,0.00016224962,0.00030889735,0.0005084017,0.000010981518,0.00048303988,0.00010048735,0.48450622],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99894875,0.00001661311,0.00024383745,0.00031933284,0.0003274459,0.00014399295],"domain_scores_gemma":[0.9994295,0.000017641238,0.00006874026,0.00027437182,0.000052036645,0.00015771145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023974208,0.00023808335,0.00060370733,0.00020701326,0.000021496344,0.0000133589965,0.000036245776,0.00032679734,0.00052554917],"category_scores_gemma":[0.000012616229,0.00020259435,0.00021265184,0.000033600478,0.000037902726,0.000057060577,0.00003356968,0.00023024187,0.000059081674],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00260762,0.00020656496,0.016495643,0.0012863966,0.0021804897,0.0023981812,0.00041734992,0.000018830116,0.000017864857,0.06371744,0.011353213,0.8993004],"study_design_scores_gemma":[0.013787501,0.00055955496,0.0903625,0.0012288368,0.0022529818,0.0010898731,0.000100701334,0.00013226179,0.000019507477,0.034000833,0.8546734,0.001792064],"about_ca_topic_score_codex":0.00009380541,"about_ca_topic_score_gemma":0.000022057957,"teacher_disagreement_score":0.8975083,"about_ca_system_score_codex":0.0000841169,"about_ca_system_score_gemma":0.00006779377,"threshold_uncertainty_score":0.82615584},"labels":[],"label_agreement":null},{"id":"W2269771058","doi":"10.1159/000415157","title":"Platelet Utilization in Cardiopulmonary Bypass Surgery","year":2015,"lang":"en","type":"article","venue":"Current studies in hematology and blood transfusion","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Cardiopulmonary bypass; Medicine; Anesthesia","score_opus":0.14939102785978114,"score_gpt":0.3597238384086621,"score_spread":0.21033281054888098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2269771058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.78075314,0.21826589,0.000045002984,0.00016792731,0.0004445073,0.00019473108,0.0000026607797,0.000027681419,0.00009846535],"genre_scores_gemma":[0.91508025,0.0847293,0.000012126933,0.000039841423,0.000049946,0.00004236746,0.00003051719,0.000009806675,0.000005826416],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988451,0.00014620827,0.00032736294,0.00029554561,0.00016333362,0.00022245571],"domain_scores_gemma":[0.99956024,0.00012504858,0.000031355845,0.0001411687,0.00005778419,0.000084391264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004186693,0.00016146291,0.0007214234,0.00020533678,0.000053869528,0.0000026590876,0.00003096119,0.000113234026,0.0000048107026],"category_scores_gemma":[0.00009613218,0.00013537172,0.00013623723,0.00026208028,0.00018820797,0.000068107096,0.000027433589,0.0001894525,0.000002357704],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075066026,0.00063467614,0.94274604,0.0007714988,0.00035528946,0.0010946442,0.0012978999,0.000012743097,0.000025006537,0.00023105196,0.0002894523,0.05179104],"study_design_scores_gemma":[0.062049627,0.0013812374,0.822887,0.012295189,0.0033923716,0.016564319,0.018306004,0.00051386264,0.013727668,0.005490115,0.04081021,0.0025824092],"about_ca_topic_score_codex":0.000011283004,"about_ca_topic_score_gemma":0.000032060212,"teacher_disagreement_score":0.13432714,"about_ca_system_score_codex":0.000019807349,"about_ca_system_score_gemma":0.000053559837,"threshold_uncertainty_score":0.55202985},"labels":[],"label_agreement":null},{"id":"W2270148934","doi":"10.1007/s40119-016-0056-4","title":"Effect of Frailty and Age on Platelet Aggregation and Response to Aspirin in Older Patients with Atrial Fibrillation: A Pilot Study","year":2016,"lang":"en","type":"article","venue":"Cardiology and Therapy","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Aspirin; Atrial fibrillation; Internal medicine; Platelet; Stroke (engine); Platelet activation; Cardiology","score_opus":0.013529569918235559,"score_gpt":0.26932676952783835,"score_spread":0.2557971996096028,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2270148934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968277,0.0019124402,0.00003190331,0.0000616024,0.00003875025,0.0010850289,0.00000958372,0.000011701898,0.00002126164],"genre_scores_gemma":[0.9991533,0.0006486545,0.0000056405543,0.000060634127,0.00008871669,0.000010936474,0.0000063804027,0.000010584202,0.0000151525865],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988673,0.00055178296,0.0001257631,0.000243365,0.000104673454,0.00010716705],"domain_scores_gemma":[0.99935085,0.00036143558,0.00003527202,0.00015910437,0.000028397055,0.0000649348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053148885,0.00012710992,0.00045616797,0.00009472578,0.00003786911,0.0000043711657,0.000018458208,0.0000577361,0.000004250644],"category_scores_gemma":[0.000052222626,0.0000703375,0.00005212494,0.00007072175,0.00010757223,0.000035658923,0.000012033777,0.000048632333,8.407709e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08857237,0.000028301272,0.66086257,0.000013744549,0.00039199516,0.000057310775,0.00020411692,0.000007369127,0.0004740927,0.0000042366382,0.000003636281,0.24938028],"study_design_scores_gemma":[0.026346268,0.029858932,0.942178,0.00012465726,0.000057631387,0.000024161307,0.000019364803,5.7347336e-7,0.0007634694,0.000016852293,0.0005206669,0.00008939105],"about_ca_topic_score_codex":0.0000048060665,"about_ca_topic_score_gemma":0.0000016151786,"teacher_disagreement_score":0.28131548,"about_ca_system_score_codex":0.000010345393,"about_ca_system_score_gemma":0.000014333768,"threshold_uncertainty_score":0.286828},"labels":[],"label_agreement":null},{"id":"W22714619","doi":"10.1016/j.jacc.2009.05.074","title":"The Relative Efficacy and Safety of Clopidogrel in Women and Men","year":2009,"lang":"en","type":"review","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":140,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Clopidogrel; Medicine; Myocardial infarction; Internal medicine; Odds ratio; Stroke (engine); Cardiology; Aspirin; Confidence interval","score_opus":0.013172316692563324,"score_gpt":0.2921967813895563,"score_spread":0.279024464696993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W22714619","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0134513425,0.9849686,0.000015375274,0.00029105466,0.00007384523,0.00046922412,0.000040707793,0.000001626821,0.00068819744],"genre_scores_gemma":[0.016939702,0.9826941,0.000056193763,0.000047656966,0.00016298176,0.000004405632,6.065276e-7,0.000015830046,0.00007855765],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974308,0.0010924996,0.00089056825,0.00014219047,0.00024651963,0.0001974356],"domain_scores_gemma":[0.9970372,0.0009386554,0.0014773082,0.00033687896,0.00012007081,0.000089907575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012482083,0.00021244884,0.003636249,0.00015142772,0.00005734421,0.0000024051265,0.000229251,0.00010775939,0.0000012132674],"category_scores_gemma":[0.00032147576,0.0001024821,0.0009897737,0.00038359783,0.0010779481,0.000028271535,0.00008059155,0.00048005924,1.5013984e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026078653,0.00003294598,0.00055335416,0.0007579643,0.005607078,0.00019375487,0.00009859493,0.000008654577,0.0000026741202,0.00023549337,0.0006221299,0.9892795],"study_design_scores_gemma":[0.0024791255,0.0015462649,0.017141044,0.003911182,0.0023444057,0.0045953044,0.00043391078,6.9855554e-7,9.863612e-7,0.00037307074,0.9670395,0.00013449173],"about_ca_topic_score_codex":0.0000020034213,"about_ca_topic_score_gemma":3.1280263e-7,"teacher_disagreement_score":0.989145,"about_ca_system_score_codex":0.000097101525,"about_ca_system_score_gemma":0.00040477136,"threshold_uncertainty_score":0.4179099},"labels":[],"label_agreement":null},{"id":"W2272541304","doi":"10.1016/j.cjca.2016.01.038","title":"Timing of Coronary Bypass Surgery in Patients Receiving Clopidogrel: The Role of VerifyNow","year":2016,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Clopidogrel; Bypass grafting; Artery; Cardiology; Internal medicine; Coronary artery bypass surgery; Coronary care unit; Myocardial infarction","score_opus":0.01127260648495803,"score_gpt":0.20796623644391812,"score_spread":0.1966936299589601,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2272541304","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99389476,0.004536286,0.00007852861,0.00020970021,0.0002974735,0.00006181533,0.000014792894,0.000001422734,0.0009052277],"genre_scores_gemma":[0.9992477,0.00044823048,0.000014408731,0.000056445042,0.00020247335,0.0000010393649,0.000002154391,0.000011630344,0.000015888081],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998939,0.00022117316,0.00041394786,0.000077397824,0.00014014707,0.00020838129],"domain_scores_gemma":[0.99896955,0.00023930545,0.00021351938,0.00018786568,0.00020768853,0.00018205897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057738065,0.000080915466,0.0006077004,0.00021898383,0.000024820254,0.0000016166881,0.000109776774,0.000089953406,0.000028849505],"category_scores_gemma":[0.00030078748,0.000048154277,0.0004494979,0.000110614375,0.0002063725,0.000051343744,0.000008116174,0.00011674417,0.0000014283312],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022172053,0.0000037643606,0.86733145,0.00001302968,0.00041227043,0.00007735667,0.0000777816,0.00003386851,0.0003155426,0.000014552287,0.0007195625,0.13077909],"study_design_scores_gemma":[0.0010682187,0.00017245958,0.970673,0.00027988566,0.000121830846,0.00020331016,0.00014945542,7.732071e-7,0.00047250278,0.00007759589,0.026724963,0.000055975765],"about_ca_topic_score_codex":0.00019475,"about_ca_topic_score_gemma":0.0001654383,"teacher_disagreement_score":0.1307231,"about_ca_system_score_codex":0.00007479439,"about_ca_system_score_gemma":0.0007593081,"threshold_uncertainty_score":0.19636744},"labels":[],"label_agreement":null},{"id":"W2275266102","doi":"10.1097/aap.0000000000000360","title":"Periprocedural Management of Direct Oral Anticoagulants","year":2016,"lang":"en","type":"review","venue":"Regional Anesthesia & Pain Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Dabigatran; Rivaroxaban; Intensive care medicine; Warfarin; Internal medicine; Atrial fibrillation","score_opus":0.05535342325296007,"score_gpt":0.33447440934131795,"score_spread":0.2791209860883579,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2275266102","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012633008,0.99383116,0.00009431157,0.00446784,0.0000159217,0.0010215765,9.887387e-7,0.0000898406,0.00035206004],"genre_scores_gemma":[0.00008539083,0.99252975,0.00013346887,0.004186102,0.0005407381,0.00008963405,0.00017894273,0.00009788754,0.0021580853],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965321,0.0005412451,0.0008473392,0.0006053126,0.0010409076,0.00043308435],"domain_scores_gemma":[0.99822843,0.00024532367,0.00039691254,0.00071030605,0.00012737849,0.00029166552],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014482457,0.00064175087,0.004034089,0.00027857587,0.00006967926,0.0000051199204,0.00030464018,0.00027815666,0.0003458512],"category_scores_gemma":[0.00002649367,0.00035397257,0.0014858982,0.0004055168,0.00054655026,0.0000424037,0.000015825233,0.0001968668,0.000073530005],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018538558,0.00017873618,0.00006182549,0.043671828,0.0038647463,0.0026015213,0.000027163635,6.653343e-8,0.0000014101901,0.00056694273,0.018025873,0.9308145],"study_design_scores_gemma":[0.0012153585,0.0003385101,0.000292682,0.11408011,0.0042549837,0.002730371,0.00005698666,0.0000014346407,7.497909e-7,0.000035604688,0.8766742,0.00031903878],"about_ca_topic_score_codex":0.00000789394,"about_ca_topic_score_gemma":1.7948915e-7,"teacher_disagreement_score":0.93049544,"about_ca_system_score_codex":0.00008682292,"about_ca_system_score_gemma":0.00021141673,"threshold_uncertainty_score":0.9998912},"labels":[],"label_agreement":null},{"id":"W2275672421","doi":"10.1016/j.ahj.2016.01.004","title":"A randomized trial to compare the safety of rivaroxaban vs aspirin in addition to either clopidogrel or ticagrelor in acute coronary syndrome: The design of the GEMINI-ACS-1 phase II study","year":2016,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Janssen Research and Development; Bayer HealthCare","keywords":"Medicine; Ticagrelor; Clopidogrel; Acute coronary syndrome; TIMI; Rivaroxaban; Prasugrel; Aspirin; P2Y12; Internal medicine; Myocardial infarction; Cardiology; Atrial fibrillation; Percutaneous coronary intervention; Warfarin","score_opus":0.033878656307299776,"score_gpt":0.3326836934123949,"score_spread":0.2988050371050951,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2275672421","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99001676,0.00013704693,0.0009539915,0.004802277,0.00013807464,0.0038905866,0.00004064909,0.0000076036904,0.000013003643],"genre_scores_gemma":[0.9981963,0.00016761424,0.000189826,0.001083559,0.00010057918,0.00014984114,0.0000014064074,0.000022482607,0.000088364526],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99603784,0.002103169,0.0008013379,0.00019997398,0.00057914783,0.0002785603],"domain_scores_gemma":[0.9979459,0.0010465148,0.0002688014,0.00049693853,0.00009965738,0.00014215651],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025599748,0.00018991956,0.0011817509,0.00013576492,0.00015307225,0.000010482667,0.00030553262,0.000024360925,0.00030255833],"category_scores_gemma":[0.0004237459,0.000069645896,0.0004681268,0.00065640506,0.00046333988,0.0000576926,0.00009009669,0.00026444613,0.000008002152],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96002585,0.0014913038,0.0058804625,0.000006129418,0.001163373,0.00019251586,0.0020388698,0.00009239821,0.0008209231,0.0000052720607,0.0011021204,0.027180783],"study_design_scores_gemma":[0.83790314,0.014192411,0.13784364,0.0007947601,0.0008948204,0.0018865543,0.0036510986,0.00003776798,0.00038367242,0.00003090137,0.002165605,0.00021560714],"about_ca_topic_score_codex":0.000084894215,"about_ca_topic_score_gemma":0.000025090238,"teacher_disagreement_score":0.13196318,"about_ca_system_score_codex":0.000077281504,"about_ca_system_score_gemma":0.00027903004,"threshold_uncertainty_score":0.33128017},"labels":[],"label_agreement":null},{"id":"W2277314602","doi":"10.1161/strokeaha.115.012454","title":"Time-Varying Effects of Prasugrel Versus Clopidogrel on the Long-Term Risks of Stroke After Acute Coronary Syndromes","year":2016,"lang":"en","type":"article","venue":"Stroke","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Alberta","funders":"","keywords":"Prasugrel; Medicine; Clopidogrel; Stroke (engine); Acute coronary syndrome; Cardiology; Internal medicine; Aspirin; Hazard ratio; Proportional hazards model; Myocardial infarction; Confidence interval","score_opus":0.02165537792725322,"score_gpt":0.28376910163966007,"score_spread":0.2621137237124069,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2277314602","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949679,0.0030683167,0.00010494821,0.00016642702,0.00027563394,0.00051399827,0.00014131502,0.00003623701,0.00072525203],"genre_scores_gemma":[0.99712604,0.0010760358,0.000036038757,0.00008321204,0.00009540477,0.000040163337,0.000009431204,0.00003149032,0.0015021823],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986678,0.00011729755,0.00024249584,0.00024507762,0.0004685495,0.00025879705],"domain_scores_gemma":[0.99862844,0.0004785831,0.00012911207,0.0005959592,0.0000705873,0.00009730537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014999378,0.00020452353,0.00047362508,0.00008003054,0.000044098975,0.000004747573,0.0001530462,0.0001050373,0.00034107838],"category_scores_gemma":[0.00007328421,0.000110625595,0.0005576767,0.00007339144,0.00028569368,0.000065474,0.0000566523,0.00012652203,0.000085250475],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03961497,0.00121799,0.5517204,0.0012500192,0.02715823,0.0028183695,0.00046498817,0.000008407087,0.17726871,0.00025629482,0.0009569651,0.19726466],"study_design_scores_gemma":[0.011127752,0.0028807744,0.85811645,0.0014692459,0.0025270837,0.00010633365,0.00003345775,0.0000061330056,0.123270735,0.000013839098,0.00019729637,0.00025092656],"about_ca_topic_score_codex":0.0000041420294,"about_ca_topic_score_gemma":5.04953e-7,"teacher_disagreement_score":0.30639604,"about_ca_system_score_codex":0.00003274213,"about_ca_system_score_gemma":0.00006397651,"threshold_uncertainty_score":0.4511181},"labels":[],"label_agreement":null},{"id":"W2279508388","doi":"10.1056/jw201002230000002","title":"Clopidogrel and Proton-Pump Inhibitors: How Much of a Problem?","year":2010,"lang":"en","type":"article","venue":"Journal watch","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Clopidogrel; Medicine; CYP2C19; Proton-pump inhibitor; Clinical significance; Acute coronary syndrome; Internal medicine; Cardiology; Pharmacology; Intensive care medicine; Aspirin; Myocardial infarction","score_opus":0.006087216614481684,"score_gpt":0.23608438686557234,"score_spread":0.22999717025109065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2279508388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98958075,0.00081201486,0.00008278964,0.008528389,0.00017136551,0.00045635548,0.0000024495025,0.00001708363,0.0003487807],"genre_scores_gemma":[0.9959252,0.0014463933,0.0011377248,0.0001130504,0.00074154313,0.000015860034,0.0000020801647,0.000018643485,0.0005995137],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99914086,0.000036857335,0.0001998569,0.0001236743,0.00032467264,0.00017408184],"domain_scores_gemma":[0.99932104,0.000017095235,0.00011417222,0.00017152098,0.00016884829,0.00020733893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040049653,0.0001114884,0.00030162543,0.00005337106,0.00008608328,0.00003858019,0.000058813755,0.00009989223,0.000074439646],"category_scores_gemma":[0.00005072694,0.000076938704,0.00024915134,0.00009948678,0.00009353116,0.000118278476,0.000023087128,0.0004775923,0.0000038263497],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015904328,0.0011153775,0.3360479,0.0015803573,0.0022705044,0.000988063,0.0022659283,0.0000014562281,0.4588355,0.0004894443,0.020315366,0.17449966],"study_design_scores_gemma":[0.015440024,0.0020729336,0.039263733,0.001222221,0.0010894212,0.020583682,0.0013770739,0.00006358659,0.3732683,0.0075377566,0.5373854,0.0006958488],"about_ca_topic_score_codex":0.0000042266934,"about_ca_topic_score_gemma":0.0000016557624,"teacher_disagreement_score":0.51707006,"about_ca_system_score_codex":0.000011170554,"about_ca_system_score_gemma":0.00009581709,"threshold_uncertainty_score":0.31374693},"labels":[],"label_agreement":null},{"id":"W2283041027","doi":"10.1002/ccd.26428","title":"Influence of smoking on the antiplatelet effect of clopidogrel differs according to clopidogrel dose: Insights from the GRAVITAS trial","year":2016,"lang":"en","type":"article","venue":"Catheterization and Cardiovascular Interventions","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"","keywords":"Clopidogrel; Medicine; P2Y12; Percutaneous coronary intervention; Internal medicine; Conventional PCI; Confidence interval; Odds ratio; Aspirin; Platelet; Cardiology; Myocardial infarction","score_opus":0.019322127581151333,"score_gpt":0.2712261173057551,"score_spread":0.25190398972460376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2283041027","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905018,0.0029314253,0.004813543,0.00025476873,0.0001968498,0.0011535047,0.00006471516,0.000030841882,0.00005253855],"genre_scores_gemma":[0.9988213,0.00071123755,0.000012157503,0.00014477468,0.00013546612,0.000101950565,0.000029260982,0.0000264639,0.000017373131],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99800867,0.00055602175,0.00046969976,0.00032930356,0.00047332997,0.0001630016],"domain_scores_gemma":[0.9983909,0.00039954725,0.00014585037,0.0008478096,0.00012572878,0.00009014751],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005925362,0.00021711328,0.0006402228,0.00011076322,0.00016764499,0.000026529933,0.00021256122,0.00009478758,0.000022967408],"category_scores_gemma":[0.00039605005,0.0001018761,0.002371502,0.00030947424,0.00021916887,0.00008760268,0.00008682301,0.00011171043,0.000006202856],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05533312,0.0016223142,0.20304084,0.0018173186,0.07012874,0.00013549344,0.004117946,0.003547476,0.14529689,0.008605957,0.00059665774,0.5057573],"study_design_scores_gemma":[0.10634017,0.00845311,0.7108277,0.013994056,0.012434889,0.00010740394,0.0011267918,0.000059848564,0.1363338,0.00087831676,0.008277221,0.0011666784],"about_ca_topic_score_codex":0.000025460991,"about_ca_topic_score_gemma":0.0000011455522,"teacher_disagreement_score":0.50778687,"about_ca_system_score_codex":0.000022231563,"about_ca_system_score_gemma":0.000023164941,"threshold_uncertainty_score":0.41543868},"labels":[],"label_agreement":null},{"id":"W2286142535","doi":"10.1136/emermed-2015-205240.1","title":"BET 1: Which form of aspirin is the fastest to inhibit platelet aggregation in emergency department patients with non-ST segment elevation myocardial infarction?","year":2015,"lang":"en","type":"review","venue":"Emergency Medicine Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Aspirin; Medicine; Emergency department; Platelet; Myocardial infarction; Acute coronary syndrome; Platelet aggregation inhibitor; Internal medicine; Cardiology; Anesthesia; Nursing","score_opus":0.02934950091629383,"score_gpt":0.31969730848136646,"score_spread":0.2903478075650726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2286142535","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.028473472,0.9622667,0.0004662271,0.0008770973,0.0026211166,0.003997965,0.00013183538,0.000022529204,0.0011430741],"genre_scores_gemma":[0.0020592,0.99447054,0.0000372483,0.000058413345,0.0016808916,0.00019229026,0.0008285245,0.00008646875,0.00058644114],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9944565,0.0002663162,0.002300381,0.0004587582,0.002035471,0.00048252437],"domain_scores_gemma":[0.99629784,0.000031521133,0.0012681002,0.0005906424,0.001285177,0.0005267263],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001709485,0.00063069374,0.0020440803,0.00063718366,0.00016580342,0.000008296726,0.00028011572,0.00024812968,0.0041124676],"category_scores_gemma":[0.00023865083,0.00035660437,0.0006700616,0.0016775831,0.000056350236,0.00019838099,0.000067710025,0.00080913404,0.000032289085],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005431831,0.000640776,0.027955296,0.0040808422,0.00358839,0.0000125322085,0.0016708914,0.000046855854,0.0000016308796,0.000006797171,0.12525387,0.8361989],"study_design_scores_gemma":[0.0037727193,0.0021454133,0.014501739,0.011369008,0.0029454674,0.00013899487,0.00021072662,0.000007019792,0.000004007858,0.00006090631,0.9644472,0.00039681297],"about_ca_topic_score_codex":0.000044165197,"about_ca_topic_score_gemma":0.000052524996,"teacher_disagreement_score":0.83919334,"about_ca_system_score_codex":0.0004377532,"about_ca_system_score_gemma":0.00078866986,"threshold_uncertainty_score":0.9998886},"labels":[],"label_agreement":null},{"id":"W2287540005","doi":"10.1016/j.jacc.2015.12.036","title":"Impact of CYP2C19 Metabolizer Status on Patients With ACS Treated With Prasugrel Versus Clopidogrel","year":2016,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Alberta","funders":"","keywords":"Prasugrel; Medicine; Clopidogrel; CYP2C19; Internal medicine; Hazard ratio; Clinical endpoint; Myocardial infarction; Cardiology; P2Y12; Pharmacogenetics; Randomized controlled trial; Genotype; Confidence interval","score_opus":0.008761369443337353,"score_gpt":0.25893460591129464,"score_spread":0.2501732364679573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2287540005","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982735,0.0004912972,0.00011424818,0.00013401176,0.00010264837,0.00025639785,0.00022176873,0.000005422217,0.000400715],"genre_scores_gemma":[0.9988716,0.00072985166,0.00013921986,0.00004445212,0.0001295861,0.0000025398188,0.0000018139317,0.000027089702,0.000053797638],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99834645,0.00033014696,0.00038537197,0.00014400683,0.0005260092,0.0002680125],"domain_scores_gemma":[0.99759036,0.00021943162,0.0009668421,0.0004471721,0.0006247081,0.00015145345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018518303,0.00020355845,0.0013886614,0.00015894028,0.000033156695,0.0000015340867,0.00017505846,0.00004794209,0.000012978258],"category_scores_gemma":[0.00013410873,0.00007697426,0.0008627412,0.0003983643,0.00072806503,0.000059279395,0.000025017662,0.00014618904,0.0000011644311],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08404276,0.00019543807,0.89366364,0.000013370299,0.012040626,0.00013908424,0.00001668064,0.0003383857,0.0013383041,0.000028265586,0.00088665856,0.0072968034],"study_design_scores_gemma":[0.017354919,0.01860775,0.95847744,0.00019796327,0.0018031311,0.0002859125,0.00009677144,4.500787e-7,0.0012382462,0.0000065705303,0.001814752,0.00011610456],"about_ca_topic_score_codex":0.000016257196,"about_ca_topic_score_gemma":0.0000010970497,"teacher_disagreement_score":0.066687845,"about_ca_system_score_codex":0.00011289969,"about_ca_system_score_gemma":0.00046321403,"threshold_uncertainty_score":0.31389192},"labels":[],"label_agreement":null},{"id":"W2288267730","doi":"10.1111/hdi.12409","title":"Low‐dose aspirin for prevention of cardiovascular disease in patients on hemodialysis: A 5‐y prospective cohort study","year":2016,"lang":"en","type":"article","venue":"Hemodialysis International","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Aspirin; Prospective cohort study; Internal medicine; Hemodialysis; Stroke (engine); Myocardial infarction; Kidney disease; Cohort; Cohort study; Surgery","score_opus":0.011129299209555103,"score_gpt":0.2624198707140763,"score_spread":0.2512905715045212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2288267730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99350274,0.00015930136,0.0031305226,0.000059833783,0.00018420008,0.0025325043,0.00008985563,0.000029097702,0.00031192257],"genre_scores_gemma":[0.99843585,0.0000875737,0.00008595077,0.000040016792,0.00018709408,0.000710478,0.00015970608,0.000028495073,0.000264809],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99755126,0.00014455015,0.00047892402,0.0005679142,0.0010655978,0.00019172457],"domain_scores_gemma":[0.9986348,0.000076170916,0.00013883405,0.0005875737,0.00043919554,0.00012343035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058006495,0.00020442069,0.00065485376,0.0003583549,0.00003827724,0.000013026606,0.00016191648,0.00006061716,0.00011899196],"category_scores_gemma":[0.0003106972,0.00015201856,0.0015032061,0.00022524109,0.000058635127,0.00013612596,0.0000422631,0.000063827836,0.000019386092],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047435225,0.0044931653,0.933205,0.000037077785,0.010454505,0.000017053666,0.00008551426,0.0006777863,0.00006188207,0.00007782736,0.000033349388,0.04611329],"study_design_scores_gemma":[0.016656741,0.0005534973,0.9774766,0.0002251655,0.002251788,4.1762468e-7,0.00003406801,0.00021343317,0.0016693438,0.00031865638,0.00042123088,0.00017908691],"about_ca_topic_score_codex":0.0000226301,"about_ca_topic_score_gemma":0.0000054931734,"teacher_disagreement_score":0.0459342,"about_ca_system_score_codex":0.00025729125,"about_ca_system_score_gemma":0.00008539985,"threshold_uncertainty_score":0.6199137},"labels":[],"label_agreement":null},{"id":"W2288429160","doi":"10.1161/atvb.34.suppl_1.571","title":"Abstract 571: A Novel High-Throughput Whole Blood Immuno-Counting Assay is Useful in the Assessment of Platelet Responses to Antiplatelet Therapy","year":2014,"lang":"en","type":"article","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"","keywords":"Platelet; Whole blood; Ristocetin; Aspirin; Flow cytometry; Platelet-rich plasma; Chemistry; Medicine; Epinephrine; Platelet activation; Pharmacology; Internal medicine; Immunology; Platelet aggregation","score_opus":0.036583196056755564,"score_gpt":0.30794565290194226,"score_spread":0.2713624568451867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2288429160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960986,0.0003917325,0.0010535315,0.0014462277,0.00011320188,0.0006966567,0.000073024356,0.00003812259,0.00008894379],"genre_scores_gemma":[0.99061304,0.005023013,0.0009613695,0.0030909774,0.00012187578,0.00007768557,0.00006614666,0.00004336757,0.0000025321049],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99739456,0.00043606156,0.0006405881,0.00065774703,0.0003588682,0.0005121966],"domain_scores_gemma":[0.99835885,0.00033757664,0.00019188464,0.0008906654,0.00011007163,0.000110960034],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0023187078,0.00038497025,0.001050847,0.00020384789,0.00019882421,0.000071303875,0.0002991008,0.00025823733,0.00009424008],"category_scores_gemma":[0.00007808771,0.00026709388,0.0004909898,0.00036266947,0.00024638025,0.00012661755,0.00009357319,0.0002797369,0.000011290789],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007428102,0.00096861226,0.38768798,0.00008012233,0.0017302528,0.0000012079648,0.0010181172,0.000008246658,0.60450715,0.00037802535,0.000117256226,0.0034287402],"study_design_scores_gemma":[0.005221215,0.000955803,0.9787088,0.00022953135,0.0002129954,0.0000095470095,0.0003082268,0.000046852656,0.0036884244,0.000044452623,0.010270963,0.00030319093],"about_ca_topic_score_codex":0.00026413405,"about_ca_topic_score_gemma":0.000018272825,"teacher_disagreement_score":0.60081875,"about_ca_system_score_codex":0.000022547381,"about_ca_system_score_gemma":0.00006600201,"threshold_uncertainty_score":0.9999781},"labels":[],"label_agreement":null},{"id":"W2289181716","doi":"10.1161/str.43.suppl_1.a3645","title":"Abstract 3645: Omeprazole, A Potent Cyp 2c19 Inhibitor, Does Not Alter The Pharmacokinetics Or Platelet Aggregation Of Asa And Dipyridamole In Combination","year":2012,"lang":"en","type":"article","venue":"Stroke","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Celerion (Canada)","funders":"","keywords":"Medicine; Clopidogrel; Cmax; Pharmacology; Omeprazole; Pharmacokinetics; Crossover study; CYP2C19; Aspirin; Drug interaction; Active metabolite; Stroke (engine); Anesthesia; Internal medicine; Placebo","score_opus":0.013867894829483331,"score_gpt":0.2690745065593413,"score_spread":0.255206611729858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2289181716","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965878,0.0017788877,0.00006218549,0.0005338377,0.00024475093,0.00039449026,0.00004128142,0.000018233643,0.0003385079],"genre_scores_gemma":[0.9981064,0.0011110108,0.00005273016,0.00026640343,0.00022951321,0.000018262403,0.000030248673,0.000015143201,0.00017026612],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99906576,0.00004750129,0.00024505387,0.00013133882,0.00030850415,0.00020182123],"domain_scores_gemma":[0.99952507,0.00006372965,0.000095617186,0.00017909106,0.0000537947,0.00008271928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032280196,0.00012451253,0.00022583554,0.000081758735,0.000044951303,0.00001312689,0.000052108982,0.00006497928,0.00008272524],"category_scores_gemma":[0.000035607536,0.00007000545,0.00011180903,0.00009547795,0.0000878568,0.0001414674,0.000026720454,0.00014965219,0.0000062249555],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060206023,0.0022475782,0.17843933,0.00075389474,0.0015124454,0.00017222161,0.003943721,0.00010531198,0.27214545,0.0004561352,0.0012914052,0.5329119],"study_design_scores_gemma":[0.006664679,0.00020249796,0.40042615,0.00018295845,0.00024873667,0.00006292124,0.0005718794,0.00019731076,0.5850958,0.0000443751,0.0061217216,0.00018093844],"about_ca_topic_score_codex":0.000025598523,"about_ca_topic_score_gemma":0.000005913856,"teacher_disagreement_score":0.53273094,"about_ca_system_score_codex":0.000024980205,"about_ca_system_score_gemma":0.000027480934,"threshold_uncertainty_score":0.28547394},"labels":[],"label_agreement":null},{"id":"W2290413797","doi":"10.1093/bja/aev556","title":"Effectiveness of platelet inhibition on major adverse cardiac events in non-cardiac surgery after percutaneous coronary intervention: a prospective cohort study","year":2016,"lang":"en","type":"article","venue":"British Journal of Anaesthesia","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Work & Health; St. Michael's Hospital; University Health Network; University of Toronto; Hamilton Health Sciences; Toronto General Hospital; McMaster University","funders":"","keywords":"Mace; Medicine; Percutaneous coronary intervention; Myocardial infarction; Conventional PCI; Internal medicine; Perioperative; Cardiology; Clopidogrel; Cardiac surgery; Prospective cohort study; Surgery","score_opus":0.004561996371121865,"score_gpt":0.2240277581556347,"score_spread":0.21946576178451283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2290413797","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957607,0.0025804678,0.000034636603,0.000017451159,0.00020732227,0.0013144756,0.000034203353,0.000011023513,0.000039752875],"genre_scores_gemma":[0.9979298,0.001802224,0.000013283506,0.000016618034,0.00010799712,0.000059432183,0.000008245449,0.000036397287,0.000025976931],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973594,0.00084670726,0.00065101706,0.00027741957,0.0006399563,0.0002254802],"domain_scores_gemma":[0.9989356,0.00016266192,0.00027898196,0.00020621717,0.0002785182,0.00013803944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002037981,0.0001987798,0.0011557003,0.0002557247,0.000039084538,0.000008143291,0.00006745387,0.00010354176,0.000063401494],"category_scores_gemma":[0.00009801329,0.00017034047,0.0013261376,0.00020399806,0.00008711246,0.00022593769,0.000021023981,0.00021620505,0.000010672222],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009139531,0.0015228756,0.9090164,0.00016289233,0.0016047991,0.0222828,0.000072482566,0.0000036146978,0.00043444097,0.0000011519464,0.000052445037,0.05570657],"study_design_scores_gemma":[0.0035567589,0.0020945757,0.97989845,0.0070109614,0.00046772804,0.005273884,0.0002567934,2.2715219e-7,0.0011984567,0.000043253123,0.000023126568,0.00017575377],"about_ca_topic_score_codex":0.00007400881,"about_ca_topic_score_gemma":0.0000068469135,"teacher_disagreement_score":0.07088209,"about_ca_system_score_codex":0.00023831373,"about_ca_system_score_gemma":0.0001085701,"threshold_uncertainty_score":0.6946283},"labels":[],"label_agreement":null},{"id":"W2292685791","doi":"10.1161/str.44.suppl_1.awmp104","title":"Abstract WMP104: Effect Of Addition Of Clopidogrel To Aspirin On Stroke Incidence: Meta-analysis Of Randomized Trials","year":2013,"lang":"en","type":"article","venue":"Stroke","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Ottawa; McMaster University","funders":"","keywords":"Medicine; Aspirin; Clopidogrel; Stroke (engine); Randomized controlled trial; Internal medicine; Intracerebral hemorrhage; Incidence (geometry); Subarachnoid hemorrhage","score_opus":0.04831466874449361,"score_gpt":0.33807197943974954,"score_spread":0.2897573106952559,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2292685791","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99322575,0.00245117,0.00041188046,0.00009651888,0.00006274203,0.0019610869,0.000695504,0.000017825514,0.0010774928],"genre_scores_gemma":[0.9988208,0.00017863986,0.0002151148,0.0000810547,0.000063110994,0.00020966602,0.00012027585,0.000015494597,0.00029586372],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99646646,0.0009797851,0.0012831609,0.00026485088,0.0008278638,0.000177865],"domain_scores_gemma":[0.99585015,0.0024020001,0.0007233799,0.0005919097,0.00029625013,0.0001363196],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004280965,0.00023000553,0.006158664,0.0005586131,0.000020441026,0.000007435342,0.0001287561,0.00011823685,0.004353606],"category_scores_gemma":[0.0020091634,0.0001426984,0.009173429,0.00039001505,0.00013527072,0.00007159402,0.000021931603,0.00011630745,0.000031045165],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0953959,0.00041027338,0.0019960254,0.0005117352,0.7949354,0.000013613823,0.00014668563,0.0012061441,0.0877328,0.00015729785,0.0009439324,0.016550185],"study_design_scores_gemma":[0.0719225,0.0014849555,0.026226692,0.00010071578,0.57876563,0.0000017951131,0.00007842947,0.00006729462,0.32096803,0.000041780975,0.00015127033,0.00019092673],"about_ca_topic_score_codex":0.00024663055,"about_ca_topic_score_gemma":0.0000053865647,"teacher_disagreement_score":0.23323524,"about_ca_system_score_codex":0.00001803608,"about_ca_system_score_gemma":0.000048806,"threshold_uncertainty_score":0.9965565},"labels":[],"label_agreement":null},{"id":"W2294111544","doi":"10.1161/circinterventions.115.003499","title":"Letter by Pacheco et al Regarding Article, “Proton Pump Inhibitors, Platelet Reactivity, and Cardiovascular Outcomes After Drug-Eluting Stents in Clopidogrel-Treated Patients: The ADAPT-DES Study”","year":2016,"lang":"en","type":"letter","venue":"Circulation Cardiovascular Interventions","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal","funders":"","keywords":"Clopidogrel; Medicine; Medical prescription; Proton-pump inhibitor; Internal medicine; Drug-eluting stent; Psychological intervention; Aspirin; Cardiology; Stent; Pharmacology; Psychiatry","score_opus":0.02302007847462158,"score_gpt":0.2679302939993427,"score_spread":0.24491021552472111,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2294111544","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9202405,0.024993861,0.0013072283,0.04438801,0.0007365289,0.0074634915,0.00036243876,0.00027329978,0.00023463932],"genre_scores_gemma":[0.94741493,0.0009586738,0.000023016293,0.047790773,0.0009013935,0.0015983329,0.00080399594,0.00026501226,0.00024386538],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9908976,0.0026603923,0.0014651562,0.0017031782,0.002271856,0.0010018148],"domain_scores_gemma":[0.99625796,0.000249243,0.00037051216,0.002456849,0.00046208804,0.00020336892],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0031591868,0.0010415522,0.00241181,0.00059807353,0.00043344658,0.00029778818,0.00033322375,0.0006156545,0.00007591729],"category_scores_gemma":[0.00031946163,0.0007618331,0.009661557,0.00059939834,0.00039704167,0.0007049189,0.00033472077,0.0018662246,0.000044753673],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025133934,0.00087229285,0.7759311,0.0011127386,0.050300088,0.0015054834,0.00068657025,0.00017175214,0.00003160062,0.0000021727221,0.12863208,0.040502764],"study_design_scores_gemma":[0.0109777935,0.0001481008,0.30679747,0.002984073,0.006853643,0.00019038966,0.0002804018,0.000030125575,0.00014820069,0.000047726593,0.67041296,0.0011290878],"about_ca_topic_score_codex":0.00049277063,"about_ca_topic_score_gemma":0.000040639676,"teacher_disagreement_score":0.5417809,"about_ca_system_score_codex":0.00047189623,"about_ca_system_score_gemma":0.00007462172,"threshold_uncertainty_score":0.9994833},"labels":[],"label_agreement":null},{"id":"W2296363428","doi":"10.1160/th15-11-0882","title":"Vorapaxar and diplopia: Possible off-target PAR-receptor mismodulation","year":2016,"lang":"en","type":"review","venue":"Thrombosis and Haemostasis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Diplopia; Medicine; Aspirin; Clopidogrel; Placebo; Adverse effect; Cardiology; Internal medicine; Surgery; Pathology","score_opus":0.06389448242120994,"score_gpt":0.34500999138987554,"score_spread":0.2811155089686656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2296363428","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025690054,0.9951845,0.0000670194,0.00023564066,0.00014955825,0.0009049811,0.00030112054,0.000088297325,0.00049992214],"genre_scores_gemma":[0.0004326925,0.997823,0.00049967365,0.00013566852,0.00034796665,0.00006977731,0.00031827384,0.00009181135,0.0002811303],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99803525,0.00016112806,0.0004879631,0.0006419657,0.00032194855,0.00035176042],"domain_scores_gemma":[0.9988082,0.000100011566,0.00021554588,0.0005006374,0.000077010955,0.00029861752],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002759979,0.0005287649,0.0023506016,0.00016699852,0.00022454422,0.00006987571,0.00009081175,0.00039849893,0.00043663476],"category_scores_gemma":[0.00003221116,0.00034755853,0.0007825098,0.00019913513,0.00022682031,0.00013610855,0.00008072221,0.00019823297,0.00007643909],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003359581,0.00006939757,0.0003191651,0.00553335,0.00210612,0.000007317776,0.000051674808,1.7389505e-8,0.0000039118468,0.00012405183,0.0017929522,0.98995847],"study_design_scores_gemma":[0.0011933447,0.00013615924,0.001297466,0.010505363,0.0036349131,0.0000641437,0.000022320479,0.0000011183771,0.000026961028,0.00013960533,0.9825358,0.0004428502],"about_ca_topic_score_codex":0.000010418358,"about_ca_topic_score_gemma":8.1408956e-7,"teacher_disagreement_score":0.9895156,"about_ca_system_score_codex":0.00005031692,"about_ca_system_score_gemma":0.00013821192,"threshold_uncertainty_score":0.99989766},"labels":[],"label_agreement":null},{"id":"W2297274082","doi":"10.1016/j.amjcard.2016.03.001","title":"Relation Between Platelet Count and Platelet Reactivity to Thrombotic and Bleeding Risk: From the Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents Study","year":2016,"lang":"en","type":"article","venue":"The American Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital du Sacré-Cœur de Montréal","funders":"","keywords":"Platelet; Medicine; Antiplatelet drug; Drug; Internal medicine; Pharmacology; Clopidogrel; Aspirin","score_opus":0.0189233916327591,"score_gpt":0.28522304023871586,"score_spread":0.2662996486059568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2297274082","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99555886,0.0007402863,0.0021060882,0.000938731,0.00007778812,0.0005017808,0.000030292627,0.000010471852,0.000035726593],"genre_scores_gemma":[0.99675167,0.002478787,0.00021590923,0.000106281295,0.0004126806,0.0000044865687,0.0000020616937,0.000024876425,0.0000032270161],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975637,0.0010089932,0.00046128625,0.00024634064,0.00047087047,0.00024879407],"domain_scores_gemma":[0.997139,0.0014181808,0.00079563254,0.00034554262,0.0001739123,0.00012775237],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021972684,0.00021561082,0.00120992,0.00008362159,0.0001804268,0.000018678034,0.0001462815,0.000040252515,0.0000033085305],"category_scores_gemma":[0.00009109901,0.00009138654,0.00017927532,0.00019189777,0.0005655831,0.00012020809,0.00006792771,0.00034924602,5.7124964e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018813888,0.00004096757,0.8884374,0.0000034875222,0.004378753,0.00010046589,0.00092335086,0.00011366047,0.0033490753,0.0000062495137,0.000036938087,0.10072825],"study_design_scores_gemma":[0.0043670214,0.0033407372,0.9862325,0.00014644173,0.0007753154,0.000700742,0.0034434448,0.00000892433,0.00044746842,0.00006100064,0.0003521458,0.00012421353],"about_ca_topic_score_codex":0.00011512837,"about_ca_topic_score_gemma":0.0000029273451,"teacher_disagreement_score":0.10060404,"about_ca_system_score_codex":0.000047541565,"about_ca_system_score_gemma":0.00009524947,"threshold_uncertainty_score":0.37266347},"labels":[],"label_agreement":null},{"id":"W2301152330","doi":"10.1016/j.jjcc.2016.02.013","title":"Impact of preoperative dual antiplatelet therapy on bleeding complications in patients with acute coronary syndromes who undergo urgent coronary artery bypass grafting","year":2016,"lang":"en","type":"article","venue":"Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Thienopyridine; Clopidogrel; Interquartile range; Perioperative; Ticlopidine; Cardiology; Aspirin; Artery; Internal medicine; EuroSCORE; Blood transfusion; Acute coronary syndrome; Coronary artery bypass surgery; Canadian Cardiovascular Society; Anesthesia; Surgery; Myocardial infarction; Angina","score_opus":0.019490660963847727,"score_gpt":0.27823053559219624,"score_spread":0.2587398746283485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2301152330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997769,0.0008185283,0.00052529265,0.00021190774,0.00010718032,0.00035041623,0.000051890667,0.000009551113,0.00015621413],"genre_scores_gemma":[0.99782187,0.0018393061,0.000065845976,0.00010041349,0.00010780712,0.0000068065087,0.000017051665,0.000025425012,0.000015447962],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998401,0.00024851994,0.00053096603,0.00020070151,0.00035026154,0.00026857588],"domain_scores_gemma":[0.9986972,0.00020869622,0.00034613724,0.00024368646,0.00034027922,0.00016395494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002941169,0.00021665152,0.0009858799,0.00024643686,0.000056629906,0.0000064710475,0.000104681414,0.000109860826,0.000036663907],"category_scores_gemma":[0.000038233527,0.0001165581,0.00057914166,0.00014762134,0.00017728319,0.00017722309,0.000023303495,0.00021613904,0.0000029816774],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008065922,0.00023954625,0.9712893,0.000008543962,0.009675349,0.0009206343,0.00014145568,0.00050520163,0.0020199185,0.000028409671,0.00027091106,0.0068348083],"study_design_scores_gemma":[0.010831118,0.0063507506,0.97762465,0.00035658607,0.00028667474,0.0040073995,0.000058641115,0.0000048040115,0.0002224774,0.00004208307,0.000079664416,0.00013514892],"about_ca_topic_score_codex":0.0000020432492,"about_ca_topic_score_gemma":3.520199e-7,"teacher_disagreement_score":0.009388675,"about_ca_system_score_codex":0.00015382214,"about_ca_system_score_gemma":0.00027503987,"threshold_uncertainty_score":0.47531012},"labels":[],"label_agreement":null},{"id":"W230558582","doi":"10.1023/a:1021477316559","title":"Inhibition of Prostaglandin G/H Synthase Unveils a Potent Effect of Platelet Activating Factor on the Permeability of Bovine Aortic Endothelial Cells to Albumin","year":2002,"lang":"en","type":"article","venue":"Inflammation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Platelet-activating factor; Bradykinin; Albumin; Chemistry; Permeability (electromagnetism); Endothelial stem cell; Prostaglandin; Internal medicine; Endocrinology; Bovine serum albumin; Vascular permeability; In vitro; Pharmacology; Biochemistry; Biology; Receptor; Medicine","score_opus":0.014028783032263088,"score_gpt":0.23720196541425648,"score_spread":0.22317318238199338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W230558582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998074,0.0000324128,0.00024380552,0.00015586513,0.000037471716,0.0011852282,0.00008021873,0.000017808681,0.00017317006],"genre_scores_gemma":[0.99979585,0.000018739904,0.000023604167,0.000017343666,0.000066123815,0.000029677021,0.000018002156,0.000012260191,0.00001836994],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987532,0.00018429724,0.0004116137,0.00014706895,0.00038469542,0.000119146134],"domain_scores_gemma":[0.9990561,0.00027168653,0.00023544561,0.00028925168,0.000095399526,0.000052101903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003879564,0.00012633005,0.00035566243,0.00008972388,0.00003517128,0.000004859273,0.000044635897,0.0000630074,0.00021533034],"category_scores_gemma":[0.00040824778,0.0000819749,0.00023168871,0.00014708439,0.000064713844,0.00006542159,0.000014515771,0.000085515814,0.000009641324],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017608439,0.00013942178,0.0016095398,0.0005419625,0.00014295687,0.0000054373013,0.0010452138,0.000090842244,0.9338213,0.000023861468,0.000013988826,0.06080462],"study_design_scores_gemma":[0.0015748836,0.001268223,0.009606577,0.00040125352,0.00005146722,0.000004357231,0.00007969146,0.00049291184,0.9863915,0.000016766187,0.00004540633,0.00006694921],"about_ca_topic_score_codex":0.000017799355,"about_ca_topic_score_gemma":0.0000010034286,"teacher_disagreement_score":0.060737673,"about_ca_system_score_codex":0.000045056182,"about_ca_system_score_gemma":0.000015735981,"threshold_uncertainty_score":0.33428395},"labels":[],"label_agreement":null},{"id":"W2306151098","doi":"10.1016/j.ijcard.2016.03.153","title":"A pharmacodynamic analysis for the co-administration of inducers of CYP3A with ticagrelor: A cautionary tale in managing patients with acute coronary syndromes","year":2016,"lang":"en","type":"article","venue":"International Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Canadian Institutes of Health Research","keywords":"Ticagrelor; Medicine; Clopidogrel; Prasugrel; P2Y12; Acute coronary syndrome; Coronary artery disease; Internal medicine; Pharmacodynamics; Cardiology; Myocardial infarction; Pharmacology; Pharmacokinetics","score_opus":0.010534257779532933,"score_gpt":0.29022876840039313,"score_spread":0.2796945106208602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2306151098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9729561,0.00028345454,0.02576002,0.0005581582,0.00008649324,0.00017755812,0.00009603011,0.0000022613704,0.00007990434],"genre_scores_gemma":[0.99924904,0.00041077673,0.00017061854,0.00004543023,0.000056910416,0.000007921045,0.00003491992,0.000007423024,0.000016988035],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990552,0.000064170534,0.00033125846,0.00009362626,0.0003696057,0.00008610485],"domain_scores_gemma":[0.9988872,0.00018248601,0.00031319648,0.00009593832,0.00048760712,0.000033603377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000229199,0.00008244861,0.00041095898,0.00028139452,0.000014912588,0.000002583643,0.00013696979,0.000037345435,0.000017679673],"category_scores_gemma":[0.000020882482,0.000041127318,0.0003371505,0.00012840643,0.00018164236,0.00009469607,0.000011158268,0.000068277994,2.7135286e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018011315,0.00013589728,0.9192626,0.000022700284,0.044573467,0.0006317353,0.000081839054,0.0024184955,0.0015200169,0.00015071339,0.00004289722,0.013148358],"study_design_scores_gemma":[0.0067798337,0.0012222952,0.98559195,0.00014049765,0.0033986552,0.0015921568,0.00012786032,0.00012399732,0.0006325323,0.000079543024,0.00024186926,0.0000687869],"about_ca_topic_score_codex":0.0000028818104,"about_ca_topic_score_gemma":0.0000022120626,"teacher_disagreement_score":0.06632941,"about_ca_system_score_codex":0.00006721181,"about_ca_system_score_gemma":0.00016988214,"threshold_uncertainty_score":0.16771233},"labels":[],"label_agreement":null},{"id":"W2306267127","doi":"10.1016/j.jacc.2016.01.039","title":"A COGENT Argument for Gastrointestinal Protection With Low-Dose Aspirin ∗","year":2016,"lang":"en","type":"letter","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Heart and Stroke Foundation; Canadian Heart Research Centre; University of Toronto","funders":"","keywords":"Medicine; Aspirin; Conventional PCI; Clopidogrel; Percutaneous coronary intervention; Coronary artery disease; P2Y12; Cardiology; Internal medicine; Myocardial infarction","score_opus":0.01273910006024928,"score_gpt":0.24320653925751878,"score_spread":0.2304674391972695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2306267127","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2977107,0.0019184102,0.05430356,0.6382949,0.0013139913,0.0049348627,0.000982972,0.000035924542,0.0005047423],"genre_scores_gemma":[0.73303694,0.0009356644,0.006435145,0.21955293,0.03568499,0.00038616484,0.00004021756,0.00035557343,0.0035723706],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99794465,0.00036840708,0.00056997535,0.0002235397,0.00055064977,0.0003427705],"domain_scores_gemma":[0.9970854,0.00014496168,0.0015781672,0.00047190234,0.0006330588,0.00008649614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046880596,0.00028602875,0.0017250793,0.00018343444,0.00006381547,0.0000039559486,0.00028331118,0.00011166194,0.000009056494],"category_scores_gemma":[0.000111387795,0.00014328971,0.0018713626,0.00017526641,0.0006481751,0.000029978226,0.00004296155,0.00070117775,0.000001660207],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032835923,0.00013458141,0.007146841,0.0012430776,0.016217977,0.008774195,0.000017359816,0.00035243254,0.008615598,0.000020210231,0.90787315,0.016768623],"study_design_scores_gemma":[0.006011171,0.011030596,0.004140422,0.0024626877,0.00290904,0.07127195,0.00009473861,0.0000063287634,0.00096516305,0.00011313252,0.90072525,0.0002695248],"about_ca_topic_score_codex":0.0000027978238,"about_ca_topic_score_gemma":3.6768895e-7,"teacher_disagreement_score":0.43532628,"about_ca_system_score_codex":0.00018163452,"about_ca_system_score_gemma":0.00069016416,"threshold_uncertainty_score":0.5843185},"labels":[],"label_agreement":null},{"id":"W2313331966","doi":"10.1016/j.cjca.2013.07.502","title":"The First 100 Patients Started on Ticagrelor in Southern Saskatchewan: The Regina Prospective Ticagrelor Registry","year":2013,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of Regina","funders":"","keywords":"Ticagrelor; Medicine; Discontinuation; Acute coronary syndrome; Conventional PCI; Percutaneous coronary intervention; Internal medicine; Cardiology; Emergency medicine; Myocardial infarction","score_opus":0.006699529840839695,"score_gpt":0.19814271591586266,"score_spread":0.19144318607502298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313331966","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9796421,0.0019247952,0.00006215549,0.013130806,0.00046018747,0.000658439,0.000019811112,0.0000072846456,0.004094411],"genre_scores_gemma":[0.99784535,0.00009659887,0.000008571467,0.0008028715,0.0005821749,0.000020736328,0.000004232649,0.000022491367,0.0006169472],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998683,0.00019569155,0.0003009721,0.00016343768,0.00023221038,0.00042470364],"domain_scores_gemma":[0.99849546,0.0001869215,0.00015933695,0.00044364962,0.00035013983,0.00036446552],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042930074,0.00016392411,0.0004566486,0.00011140223,0.000252709,0.000040876428,0.00027400395,0.00013299896,0.000039161863],"category_scores_gemma":[0.00031108095,0.000087256325,0.0004046636,0.00017392598,0.00045221922,0.000050813946,0.000010717289,0.0005096317,0.00009814518],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015999696,0.000043714692,0.7890764,0.000047780515,0.0036373828,0.0011972496,0.005288548,0.00067792664,0.000021905558,0.00047548435,0.12780322,0.07013045],"study_design_scores_gemma":[0.0033123652,0.0008285869,0.62705517,0.00014465927,0.00024970053,0.00043202905,0.0069598905,0.000013288099,0.000022024647,0.0006682415,0.36013144,0.00018263521],"about_ca_topic_score_codex":0.0010422126,"about_ca_topic_score_gemma":0.0038228936,"teacher_disagreement_score":0.2323282,"about_ca_system_score_codex":0.00022994305,"about_ca_system_score_gemma":0.0009115237,"threshold_uncertainty_score":0.35582095},"labels":[],"label_agreement":null},{"id":"W2314821038","doi":"10.1177/155989770904009","title":"Results from CURRENT-OASIS 7","year":2009,"lang":"en","type":"article","venue":"MD Conference Express","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences","funders":"","keywords":"Clopidogrel; Medicine; Aspirin; Dosing; Myocardial infarction; Acute coronary syndrome; Randomized controlled trial; Stroke (engine); Cardiology; Ischemic stroke; Internal medicine; Ischemia","score_opus":0.03450951057448826,"score_gpt":0.2848699974713887,"score_spread":0.25036048689690044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2314821038","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96671283,0.010257366,0.0044963155,0.0008622162,0.00034575304,0.00032871956,0.00020616685,0.00024178813,0.01654882],"genre_scores_gemma":[0.99670136,0.0018199683,0.00029513598,0.00035419592,0.0003397345,0.000007687475,0.00020569573,0.000009344379,0.00026686516],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988694,0.000050295064,0.00021066233,0.00034291155,0.00030255844,0.00022416514],"domain_scores_gemma":[0.999095,0.000036554127,0.00005166712,0.0005411269,0.000101448604,0.00017419485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008406587,0.00015505402,0.00030505075,0.000042152064,0.00005874787,0.0000418946,0.00014614519,0.000069408736,0.00031230194],"category_scores_gemma":[0.00006135123,0.00013233584,0.00023053918,0.000084558575,0.00004913938,0.00009659993,0.000019724479,0.00015994615,0.00013307946],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015020174,0.00035140684,0.000971397,0.00001539933,0.00021851536,0.00014262763,0.0006521422,0.0000054546513,0.013780519,0.0008814755,0.0133253625,0.96815366],"study_design_scores_gemma":[0.01677687,0.00062552554,0.12534757,0.0011789388,0.0007850159,0.0000509369,0.0006825993,0.00043879604,0.07165869,0.006085262,0.77532357,0.0010462202],"about_ca_topic_score_codex":0.000033484645,"about_ca_topic_score_gemma":0.0000011077432,"teacher_disagreement_score":0.9671075,"about_ca_system_score_codex":0.000014332759,"about_ca_system_score_gemma":0.000078127705,"threshold_uncertainty_score":0.5396499},"labels":[],"label_agreement":null},{"id":"W2315416571","doi":"10.1177/171516350714000126","title":"Optimal Dosing of Acetylsalicylic Acid","year":2007,"lang":"fr","type":"article","venue":"Canadian Pharmacists Journal / Revue des Pharmaciens du Canada","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Dosing; Pharmacology; Medicine","score_opus":0.024828664147952595,"score_gpt":0.2792140422024733,"score_spread":0.2543853780545207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2315416571","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82623005,0.15781094,0.0016807154,0.00023208778,0.010059264,0.0004934975,0.0007869141,0.000026327249,0.0026802218],"genre_scores_gemma":[0.94390255,0.045493964,0.000557948,0.0022586263,0.0055659236,0.0000039987176,0.00004775563,0.00013135705,0.002037849],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99431086,0.00031738976,0.0012971341,0.00055728504,0.000997202,0.0025201084],"domain_scores_gemma":[0.99178517,0.00016119925,0.0004972592,0.00048312286,0.00094676827,0.0061264914],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002489489,0.00067924167,0.0010579798,0.0006898878,0.00086176355,0.00013505518,0.0006891336,0.00022464595,0.0034368034],"category_scores_gemma":[0.0002745909,0.0007738866,0.0009110796,0.0011936306,0.00082605786,0.0005020751,0.000055089393,0.0013203807,0.00003741774],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0009791291,0.00019352637,0.00279339,0.0014049059,0.0033658675,0.3683464,0.0018447934,0.0026532551,0.020264314,0.0001663551,0.019560128,0.578428],"study_design_scores_gemma":[0.005273028,0.00014013765,0.00011460663,0.0003167621,0.0016927817,0.69943935,0.00009524773,0.0009816977,0.053985383,0.000016785678,0.23715958,0.00078466925],"about_ca_topic_score_codex":0.033311706,"about_ca_topic_score_gemma":0.043236,"teacher_disagreement_score":0.5776433,"about_ca_system_score_codex":0.004484436,"about_ca_system_score_gemma":0.011008481,"threshold_uncertainty_score":0.9994712},"labels":[],"label_agreement":null},{"id":"W2315653449","doi":"10.1097/aap.0000000000000157","title":"Dose-Finding Methodology for Peripheral Nerve Blocks","year":2014,"lang":"en","type":"review","venue":"Regional Anesthesia & Pain Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal General Hospital; McGill University","funders":"","keywords":"Medicine; Peripheral nerve; Peripheral; Mood; Set (abstract data type); Anesthesia; Computer science; Internal medicine; Psychiatry","score_opus":0.15086396556083792,"score_gpt":0.3867792223306493,"score_spread":0.2359152567698114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2315653449","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000050917803,0.9737741,0.010041167,0.013874023,0.00004476612,0.0020021037,7.061409e-7,0.00015464681,0.000057610247],"genre_scores_gemma":[0.0000075618036,0.9645501,0.0025882379,0.024798602,0.0044416045,0.0005307046,0.00070372364,0.00018758832,0.0021919177],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9943008,0.0022459435,0.0010753393,0.00093440956,0.00073810504,0.00070542714],"domain_scores_gemma":[0.99498874,0.0029828188,0.0005321683,0.0008203248,0.00020545512,0.00047051886],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0062550707,0.0008947354,0.0054193055,0.0003850281,0.00021609906,0.0000146760085,0.00038763747,0.00077843835,0.0003151894],"category_scores_gemma":[0.00043816684,0.0005944955,0.0029730464,0.0004019472,0.0005482117,0.000038127942,0.000012849509,0.00056124805,0.000024738865],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004068425,0.000114727336,0.000023967741,0.024629163,0.0024692623,0.0008315179,0.000116620904,0.0000018554218,0.0000036072065,0.0018921286,0.06316526,0.90634507],"study_design_scores_gemma":[0.002332022,0.0010463379,0.000019824032,0.021391675,0.005947795,0.008143478,0.00008408659,0.000040866023,4.6301577e-7,0.0002993284,0.9601608,0.000533329],"about_ca_topic_score_codex":0.000022898144,"about_ca_topic_score_gemma":0.0000010872004,"teacher_disagreement_score":0.9058117,"about_ca_system_score_codex":0.00016934346,"about_ca_system_score_gemma":0.00048104496,"threshold_uncertainty_score":0.99965066},"labels":[],"label_agreement":null},{"id":"W2316358617","doi":"10.2174/138161212803251952","title":"Platelet Turnover in Atherothrombotic Disease","year":2012,"lang":"en","type":"review","venue":"Current Pharmaceutical Design","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; British Heart Foundation","keywords":"Platelet; Thrombus; Hemostasis; Medicine; Platelet activation; Thrombosis; Mean platelet volume; Acute coronary syndrome; Internal medicine; Cardiology; Myocardial infarction","score_opus":0.2850122247137125,"score_gpt":0.4436020832435641,"score_spread":0.15858985852985158,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2316358617","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000030409048,0.9941296,0.0019318353,0.000014423677,0.0008842241,0.0027491217,0.00004991554,0.000112399524,0.000098085664],"genre_scores_gemma":[0.00050178426,0.9977862,0.00006425499,0.00009272288,0.00083612546,0.00029617865,0.00021175662,0.00013418781,0.00007678906],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964762,0.00071847346,0.000733321,0.0006477766,0.0005887726,0.0008354567],"domain_scores_gemma":[0.99778235,0.00026492737,0.00013261859,0.0006099243,0.000039614555,0.0011705717],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000621522,0.00072961743,0.0023403054,0.0002655793,0.000052042335,0.000035922094,0.00025858506,0.00027224995,0.0010741246],"category_scores_gemma":[0.00005950216,0.00055304513,0.0017163167,0.0004781144,0.00017529048,0.00013050457,0.000059630427,0.0011796643,0.0011769448],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022216779,0.0009210934,0.000041074287,0.023322651,0.0006456358,0.0003587786,0.000020967094,0.000002278267,4.7043625e-7,0.00009439114,0.0004500539,0.97392046],"study_design_scores_gemma":[0.0017534926,0.000043653265,0.00006155741,0.013091958,0.007560465,0.00012177791,0.0000014192245,0.000063143976,0.0000033929932,0.000032612854,0.9767068,0.00055971043],"about_ca_topic_score_codex":2.993238e-7,"about_ca_topic_score_gemma":3.4614565e-8,"teacher_disagreement_score":0.9762568,"about_ca_system_score_codex":0.00024426944,"about_ca_system_score_gemma":0.00047342005,"threshold_uncertainty_score":0.999839},"labels":[],"label_agreement":null},{"id":"W2316396366","doi":"10.1016/j.cjca.2012.07.435","title":"474 Markedly Reduced Platelet Inhibition With Clopidogrel Given to Patients Undergoing Therapeutic Hypothermia Post Cardiac Arrest","year":2012,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Clopidogrel; Platelet; Loading dose; Platelet inhibition; Clinical endpoint; Cardiology; Internal medicine; Anesthesia; Clinical trial; Myocardial infarction","score_opus":0.010870671128203979,"score_gpt":0.21803484863752481,"score_spread":0.20716417750932084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2316396366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909062,0.0035487332,0.00055857335,0.00065852,0.0011997395,0.00034836188,0.00004675693,0.000011482264,0.0027216421],"genre_scores_gemma":[0.99667233,0.0001952916,0.00017709508,0.0009332005,0.0018832424,0.000007262385,0.000037177797,0.00004930886,0.00004506741],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99837416,0.0002756414,0.00033264808,0.00017125196,0.00024979972,0.00059650873],"domain_scores_gemma":[0.9979334,0.00008133948,0.00015012003,0.0002654618,0.00036619045,0.0012034861],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040433448,0.00022055817,0.00071865134,0.00031926844,0.00012911245,0.000016664035,0.000100489095,0.00016361808,0.000040004936],"category_scores_gemma":[0.00010025128,0.00017504077,0.0004783773,0.00020173509,0.00012824117,0.00016579639,0.000009155216,0.00028687346,0.000036315312],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003209701,0.000050545583,0.8896305,0.00012224395,0.0070981146,0.00071193406,0.0011278017,0.0009503137,0.0031119117,0.0002215617,0.012990995,0.08077436],"study_design_scores_gemma":[0.0035677361,0.0016043712,0.86000884,0.00027137809,0.00070442405,0.0008159837,0.00041710713,4.6246248e-7,0.000762625,0.00004678619,0.1314701,0.0003302085],"about_ca_topic_score_codex":0.00014753263,"about_ca_topic_score_gemma":0.00016934636,"teacher_disagreement_score":0.118479095,"about_ca_system_score_codex":0.0002606468,"about_ca_system_score_gemma":0.0010410452,"threshold_uncertainty_score":0.71379554},"labels":[],"label_agreement":null},{"id":"W2316897154","doi":"10.1177/171516350613900313","title":"CHARISMA Trial Results Released Early","year":2006,"lang":"en","type":"article","venue":"Canadian Pharmacists Journal / Revue des Pharmaciens du Canada","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"","keywords":"Charisma; Psychology; Political science; Law","score_opus":0.019807555693748046,"score_gpt":0.24004469580835702,"score_spread":0.220237140114609,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2316897154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98875046,0.0026043481,0.000062185994,0.00022309358,0.002108037,0.0006933837,0.00052605884,0.00005575838,0.0049766866],"genre_scores_gemma":[0.98881793,0.002436979,0.000084472646,0.0018829285,0.004101991,0.000020147452,0.00014240025,0.000074682546,0.0024384628],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99665505,0.00019451385,0.00081037526,0.0004828928,0.00074349414,0.0011137006],"domain_scores_gemma":[0.996217,0.00006688984,0.00025487572,0.00039298576,0.0005079249,0.0025602868],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000654145,0.00041367192,0.0005997868,0.00037843175,0.00080066733,0.00017984054,0.00036490243,0.00010851561,0.000620554],"category_scores_gemma":[0.00015293626,0.00041230026,0.00057342503,0.0005941226,0.00019488578,0.0002671472,0.00001906418,0.0007547457,0.000036340763],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.058166172,0.00039001633,0.0029848826,0.00027769562,0.0017986653,0.58991206,0.0005594404,0.0005701674,0.0038991822,0.00012240848,0.20302795,0.13829139],"study_design_scores_gemma":[0.121638246,0.0003475014,0.0005066999,0.00005655019,0.00092303206,0.5514413,0.000009324395,0.00054695504,0.0038080085,0.00010054894,0.31971353,0.00090826186],"about_ca_topic_score_codex":0.07563128,"about_ca_topic_score_gemma":0.03284832,"teacher_disagreement_score":0.13738313,"about_ca_system_score_codex":0.0016248465,"about_ca_system_score_gemma":0.005513205,"threshold_uncertainty_score":0.99983287},"labels":[],"label_agreement":null},{"id":"W2317043223","doi":"10.1016/j.cjca.2012.07.169","title":"167 Elevated Plasma Serotonin and Endothelin-1 in Coronary Artery Disease Patients: A Potential for Novel Pharmacotherapeutic Targets?","year":2012,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; CTL*; Coronary artery disease; Platelet; Diabetes mellitus; Aspirin; Internal medicine; Platelet activation; Clopidogrel; Platelet-poor plasma; Gastroenterology; Endocrinology; Platelet-rich plasma; Immunology; Immune system","score_opus":0.01374709879445233,"score_gpt":0.24068166295427948,"score_spread":0.22693456415982716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317043223","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876405,0.008465474,0.002337361,0.0002606242,0.0005733738,0.0004887887,0.00017754282,0.0000050992608,0.000051221134],"genre_scores_gemma":[0.9979153,0.00035143862,0.00013252125,0.00070200145,0.0007870114,0.000020300666,0.00003541566,0.000027536187,0.00002847417],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988818,0.00010268179,0.0003179498,0.0001282749,0.00011187812,0.0004574207],"domain_scores_gemma":[0.99860835,0.000048588125,0.00009912654,0.00011572336,0.00014942217,0.0009788178],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003180775,0.00015358662,0.00050041935,0.00025216665,0.00006224504,0.0000094374245,0.000073151714,0.00009263701,0.00003789319],"category_scores_gemma":[0.000062355844,0.00013557004,0.00034137932,0.00006715313,0.00012653765,0.00013280414,0.000005827424,0.00018233403,0.0000026440819],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041729845,0.00007273016,0.96375775,0.000106027815,0.00227294,0.0006260608,0.00023563759,0.0005743966,0.004052905,0.000078065816,0.0008326491,0.023217853],"study_design_scores_gemma":[0.020045532,0.00060100283,0.8739264,0.00010539225,0.001160044,0.0023785885,0.00017338962,0.00029255336,0.00042024982,0.000086863816,0.10050142,0.00030858425],"about_ca_topic_score_codex":0.000026454642,"about_ca_topic_score_gemma":0.000022523182,"teacher_disagreement_score":0.09966877,"about_ca_system_score_codex":0.00009854158,"about_ca_system_score_gemma":0.0005439452,"threshold_uncertainty_score":0.55283856},"labels":[],"label_agreement":null},{"id":"W2317139162","doi":"10.1056/nejm200006153422402","title":"Thrombotic Thrombocytopenic Purpura Associated with Clopidogrel","year":2000,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":646,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Services and Policy Research","funders":"National Heart, Lung, and Blood Institute","keywords":"Clopidogrel; Medicine; Ticlopidine; Thrombotic thrombocytopenic purpura; Thienopyridine; Antiplatelet drug; Internal medicine; Thrombocytopenic purpura; Platelet; Surgery; Aspirin","score_opus":0.015639249601655966,"score_gpt":0.25163260026933615,"score_spread":0.23599335066768018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317139162","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98142695,0.00798593,0.00024869823,0.0042692027,0.00020086399,0.00017885855,0.0000014569764,0.00002954382,0.0056584836],"genre_scores_gemma":[0.9910561,0.0032110587,0.0001587451,0.0011641001,0.0025397928,7.7156756e-7,0.000010574074,0.000029407225,0.0018294835],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99822193,0.00012530829,0.00046550963,0.0001463336,0.000787068,0.00025387274],"domain_scores_gemma":[0.99882627,0.00012744163,0.00020395214,0.0002335245,0.00019609644,0.00041272203],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006925872,0.00019848922,0.0009033172,0.000114873954,0.00006501683,0.000010991429,0.00013344221,0.0000819504,0.003983],"category_scores_gemma":[0.00016625026,0.000110038956,0.00022555093,0.00029045125,0.00018530995,0.00012678825,0.000006044648,0.0003886191,0.000023087627],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0070424504,0.00046165206,0.02726148,0.00006460802,0.0050576846,0.0045040697,0.0013455471,0.00020647759,0.0013848528,0.00012891355,0.017003931,0.93553835],"study_design_scores_gemma":[0.32564336,0.015175528,0.41849488,0.0045511266,0.005899552,0.023224927,0.00048146813,0.000062168605,0.00051683374,0.0010115136,0.2044018,0.0005368439],"about_ca_topic_score_codex":0.000022031378,"about_ca_topic_score_gemma":0.000009327066,"teacher_disagreement_score":0.9350015,"about_ca_system_score_codex":0.000055528984,"about_ca_system_score_gemma":0.00028038255,"threshold_uncertainty_score":0.9969275},"labels":[],"label_agreement":null},{"id":"W2317332416","doi":"10.3821/1913-701x-143.6.302","title":"Symptomatic Coronary Artery Disease: A Call to Action for Pharmacists","year":2010,"lang":"en","type":"article","venue":"Canadian Pharmacists Journal / Revue des Pharmaciens du Canada","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Angina; Coronary artery disease; Chest pain; Quality of life (healthcare); Physical therapy; Pharmacist; Disease; Internal medicine; Cardiology; Family medicine; Pharmacy; Myocardial infarction; Nursing","score_opus":0.03014822576452254,"score_gpt":0.2926941979177189,"score_spread":0.26254597215319636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317332416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914198,0.0010045302,0.0007006762,0.00038379178,0.0039438405,0.0013688668,0.0008474016,0.00007174358,0.00025935288],"genre_scores_gemma":[0.98690677,0.001585283,0.00038841247,0.007264403,0.002318561,0.00013741724,0.00014148685,0.00011088646,0.0011467661],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9969831,0.00010248309,0.00058870326,0.0005402732,0.0006124307,0.0011730198],"domain_scores_gemma":[0.9920755,0.000103398095,0.00016184765,0.00042649024,0.00063068455,0.0066020526],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00053985877,0.00047824322,0.0005778364,0.00044595887,0.00087962265,0.00016906856,0.00042253733,0.000084914536,0.0010617264],"category_scores_gemma":[0.00022837531,0.0004918839,0.0005786112,0.00046419297,0.0001557376,0.00034152376,0.000028378714,0.00077124586,0.000035598197],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040384843,0.00034632438,0.009964837,0.0015658982,0.0029814343,0.23369342,0.00079437136,0.0007450517,0.060450975,0.00005929527,0.15122299,0.53413695],"study_design_scores_gemma":[0.0074099437,0.0001351673,0.0009830834,0.00006806249,0.0014373525,0.75256795,0.000010185098,0.0036221554,0.0041511096,0.000083807456,0.22860228,0.00092893594],"about_ca_topic_score_codex":0.00088907836,"about_ca_topic_score_gemma":0.010834512,"teacher_disagreement_score":0.533208,"about_ca_system_score_codex":0.0012378363,"about_ca_system_score_gemma":0.0053896774,"threshold_uncertainty_score":0.99985147},"labels":[],"label_agreement":null},{"id":"W2317413142","doi":"10.7748/nop2004.11.16.8.35.c2344","title":"Antiplatelet therapy","year":2004,"lang":"en","type":"article","venue":"Nursing Older People","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Intensive care medicine; Antiplatelet drug; Drug; Pharmacology; Internal medicine; Aspirin; Clopidogrel","score_opus":0.01318895908555674,"score_gpt":0.2757923708762365,"score_spread":0.26260341179067975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317413142","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98577684,0.0057209865,0.0027041442,0.001340013,0.00028085554,0.0002912849,0.0000029879536,0.0002015957,0.0036812732],"genre_scores_gemma":[0.9972927,0.00082342717,0.00052178325,0.00082344416,0.00025149266,0.000008769419,0.0000334667,0.000036358586,0.00020854363],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99902433,0.000022298398,0.00013759057,0.00025115974,0.00028040571,0.00028420042],"domain_scores_gemma":[0.9994225,0.00001086669,0.000030017798,0.0003437523,0.000051697098,0.00014114853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008978835,0.00015349743,0.0002961888,0.00007249682,0.00012418789,0.000026118445,0.00006745974,0.00008851621,0.00023116246],"category_scores_gemma":[0.000008743338,0.00013032874,0.00030015063,0.00023585098,0.00007117488,0.00008534476,0.0000050762374,0.00012680974,0.00012205753],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00234433,0.004520352,0.0496294,0.00016475137,0.0016335066,0.00078103394,0.018555189,0.00042032945,0.028805546,0.003219135,0.0062840153,0.88364244],"study_design_scores_gemma":[0.033840604,0.0010022207,0.8448269,0.0015587572,0.00045418058,0.0027229576,0.0018451492,0.000043490247,0.08230878,0.0035103746,0.026948035,0.0009385632],"about_ca_topic_score_codex":0.000023108103,"about_ca_topic_score_gemma":0.0000023726918,"teacher_disagreement_score":0.88270384,"about_ca_system_score_codex":0.000068684945,"about_ca_system_score_gemma":0.000108917644,"threshold_uncertainty_score":0.5314652},"labels":[],"label_agreement":null},{"id":"W2318437853","doi":"10.1016/j.cjca.2012.07.476","title":"522 Characterization of Platelet Subpopulations Based on the Heterogeneity of NOS Signalling","year":2012,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Alberta Hospital Edmonton","funders":"","keywords":"Medicine; Signalling; Platelet; Internal medicine; Cell biology","score_opus":0.027464539451541696,"score_gpt":0.2417968264176021,"score_spread":0.2143322869660604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2318437853","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99193317,0.0004998531,0.006544949,0.00028430313,0.0002276313,0.00011874197,0.00004317584,0.0000018125199,0.00034637205],"genre_scores_gemma":[0.999196,0.000045952416,0.00003177757,0.00021635149,0.00046783604,0.0000015145542,0.000026276091,0.000010166373,0.000004111053],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99910945,0.00019967122,0.00031886392,0.000053684795,0.00013999826,0.00017833055],"domain_scores_gemma":[0.9990828,0.000081796636,0.00022580381,0.00016869933,0.00019679734,0.00024408057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005265993,0.00007940999,0.00041871637,0.00016717827,0.00005280687,0.0000027426636,0.00008310749,0.00008271258,0.000047074947],"category_scores_gemma":[0.00011067497,0.000055844637,0.00043350126,0.00010946172,0.00011309713,0.000048594666,0.0000026166654,0.00013134629,0.0000017204288],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006856601,0.0000369663,0.87718904,0.00010795247,0.0022953947,0.0001372089,0.0003127255,0.014306475,0.0941338,0.0009915308,0.0003691288,0.009434095],"study_design_scores_gemma":[0.0014603361,0.0004762619,0.9297115,0.00017409897,0.00055378827,0.0004969536,0.00008592134,0.00022260386,0.048340924,0.00003510707,0.018310029,0.00013248237],"about_ca_topic_score_codex":0.000056941757,"about_ca_topic_score_gemma":0.00002434626,"teacher_disagreement_score":0.052522436,"about_ca_system_score_codex":0.000037921058,"about_ca_system_score_gemma":0.0003932067,"threshold_uncertainty_score":0.22772782},"labels":[],"label_agreement":null},{"id":"W2318608459","doi":"10.1016/j.cjca.2013.07.500","title":"Economic Evaluation of Ticagrelor Versus Clopidogrel in Canadian Patients With Acute Coronary Syndromes Based on the Platelet Inhibition and Patient Outcomes (Plato) Trial","year":2013,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Toronto Public Health","funders":"","keywords":"Ticagrelor; Medicine; Clopidogrel; Myocardial infarction; Acute coronary syndrome; Internal medicine; Cardiology; Stroke (engine); Emergency medicine; Intensive care medicine","score_opus":0.01716266730969723,"score_gpt":0.23658302079388327,"score_spread":0.21942035348418604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2318608459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99703264,0.0002409833,0.000004541092,0.0010388722,0.0003782377,0.00078831596,0.000059156708,0.0000014606284,0.00045578327],"genre_scores_gemma":[0.99951893,0.000026076608,0.000012815954,0.0003214246,0.000054710858,0.000020599618,0.00003153011,0.0000123215,0.0000015787592],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99882096,0.0002549644,0.0003265752,0.0001232306,0.00021822315,0.00025601816],"domain_scores_gemma":[0.9988908,0.00013619602,0.00014997541,0.00017068273,0.00022054222,0.0004317867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043559071,0.00012825897,0.0004836488,0.0003460443,0.000059143655,0.000011554266,0.000055625842,0.00010571486,0.00011316194],"category_scores_gemma":[0.00011067071,0.00008336483,0.00017493834,0.00006603886,0.0001556705,0.00007745417,0.000003379052,0.00016961861,0.0000061461164],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020805528,0.000031178733,0.8986673,0.000019830713,0.0035978532,0.0006035878,0.00029120466,0.008713701,0.00000531653,0.00018348527,0.002640521,0.0644405],"study_design_scores_gemma":[0.049530752,0.0029574444,0.9443467,0.00008357541,0.00045874435,0.00015296292,0.00016198223,0.0002463561,0.000018288176,0.00006334794,0.0018576055,0.00012221883],"about_ca_topic_score_codex":0.018959105,"about_ca_topic_score_gemma":0.040932637,"teacher_disagreement_score":0.064318284,"about_ca_system_score_codex":0.00044260075,"about_ca_system_score_gemma":0.0026242954,"threshold_uncertainty_score":0.98757374},"labels":[],"label_agreement":null},{"id":"W2319011515","doi":"10.1093/eurheartj/eht309.2589","title":"Prolonged clopidogrel use improves clinical outcomes following drug eluting but not bare metal stent implantation","year":2013,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; Victoria Heart Institute Foundation","funders":"","keywords":"Medicine; Clopidogrel; Myocardial infarction; Hazard ratio; Internal medicine; Drug-eluting stent; Stent; Loading dose; Cardiology; Proportional hazards model; Surgery; Percutaneous coronary intervention; Confidence interval","score_opus":0.05800307145850087,"score_gpt":0.32715377878034463,"score_spread":0.26915070732184376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2319011515","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966081,0.00073428266,0.00015920319,0.0007609829,0.0009150253,0.00044984737,0.000005170509,0.0000946763,0.0002727077],"genre_scores_gemma":[0.9947267,0.00018292376,0.0012979899,0.0020468577,0.000897111,0.000004757847,0.000015958869,0.00006584203,0.00076187024],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99707854,0.00093853124,0.0007190251,0.00030235754,0.000541204,0.0004203149],"domain_scores_gemma":[0.99878454,0.0002025489,0.00013663642,0.0003033172,0.00014237034,0.00043056585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018198262,0.00023587061,0.0005846392,0.00010294273,0.00034422884,0.00024252775,0.00012512383,0.000049768576,0.00011144845],"category_scores_gemma":[0.00043673156,0.0001705921,0.0015590418,0.00008611226,0.000056579032,0.0005336995,0.00006558397,0.00066626334,0.00035769524],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021231698,0.00017735203,0.94998914,0.00003157221,0.0018971,0.0010760244,0.00027916033,0.0000072107496,0.006977051,0.000004973779,0.0023202833,0.03702784],"study_design_scores_gemma":[0.002935289,0.00021775931,0.9891073,0.000120319404,0.0004964679,0.0013453186,0.00039541334,0.00003943385,0.00046773057,0.00000459103,0.0046702926,0.00020008617],"about_ca_topic_score_codex":0.000017990149,"about_ca_topic_score_gemma":0.0000010718529,"teacher_disagreement_score":0.039118182,"about_ca_system_score_codex":0.000032457094,"about_ca_system_score_gemma":0.00008715532,"threshold_uncertainty_score":0.69565445},"labels":[],"label_agreement":null},{"id":"W2321024914","doi":"10.1136/heartjnl-2015-308840","title":"Effect of prior clopidogrel use on outcomes in medically managed acute coronary syndrome patients","year":2016,"lang":"en","type":"article","venue":"Heart","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Alberta","funders":"Daiichi Sankyo Company; Eli Lilly and Company","keywords":"Medicine; Clopidogrel; Acute coronary syndrome; Internal medicine; Cardiology; Platelet aggregation inhibitor; Aspirin; Interventional cardiology; Emergency medicine; Myocardial infarction; Intensive care medicine","score_opus":0.007582266953587237,"score_gpt":0.26056960124149436,"score_spread":0.25298733428790715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321024914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99875975,0.00010019861,0.000010697703,0.00038190754,0.00012013609,0.00052004214,0.00001871497,0.000034422825,0.00005410889],"genre_scores_gemma":[0.9986367,0.00015416449,0.00004092001,0.0005603518,0.0000113290125,0.000020437325,0.000011843153,0.000019146888,0.0005450584],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988126,0.0001750965,0.00021689342,0.0001972134,0.0004075034,0.00019065275],"domain_scores_gemma":[0.9992067,0.00029118816,0.00003472242,0.0003240277,0.000025848165,0.00011750749],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026607732,0.0001328349,0.0005125489,0.00009563296,0.000021036543,0.0000032261673,0.000055790315,0.00008068925,0.00012459142],"category_scores_gemma":[0.00016396708,0.000073512885,0.0002884955,0.00008152796,0.0000788459,0.00006947774,0.000025734322,0.00008500207,0.00009860825],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014594118,0.00025522962,0.97114307,0.000078032535,0.00041260707,0.00045756044,0.000016472388,2.0911793e-7,0.00021940614,0.000008249378,0.00038277503,0.025567003],"study_design_scores_gemma":[0.007124414,0.0021621154,0.9880253,0.00040395083,0.00016435549,0.000064478576,0.0000017635027,0.0000011688193,0.0006503371,0.000004747329,0.0013140673,0.00008329156],"about_ca_topic_score_codex":0.0000074435884,"about_ca_topic_score_gemma":0.0000011425975,"teacher_disagreement_score":0.025483713,"about_ca_system_score_codex":0.00003285048,"about_ca_system_score_gemma":0.000025897332,"threshold_uncertainty_score":0.29977685},"labels":[],"label_agreement":null},{"id":"W2321027227","doi":"10.1016/s0735-1097(15)61817-4","title":"LONG-TERM DUAL ANTIPLATELET THERAPY WITH TICAGRELOR AFTER DRUG-ELUTING STENTS: RESULTS OF A DECISION ANALYTIC MODEL","year":2015,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Ticagrelor; Medicine; Term (time); Drug; Dual (grammatical number); Intensive care medicine; Cardiology; Internal medicine; Clopidogrel; Aspirin; Pharmacology","score_opus":0.019689195360408956,"score_gpt":0.27351663078832916,"score_spread":0.2538274354279202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321027227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943066,0.0025007424,0.002101522,0.0003791846,0.00013901433,0.00025351916,0.000080742095,0.0000061013375,0.00023252626],"genre_scores_gemma":[0.9973626,0.0009653564,0.0011382799,0.0001917221,0.00022404133,0.0000024848089,0.0000018397046,0.00002689969,0.000086746084],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976501,0.00033854687,0.0008112036,0.00019752051,0.00074513804,0.00025748025],"domain_scores_gemma":[0.9972067,0.0001945089,0.001085109,0.00056091725,0.0007623366,0.00019044602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001064882,0.00020637561,0.0015459055,0.00021130717,0.000036283902,0.000004269248,0.00026231434,0.000059449678,0.0000028566733],"category_scores_gemma":[0.00022845519,0.000112737194,0.0009407035,0.0004896124,0.0006620308,0.000084967105,0.000073660645,0.0002554635,9.968095e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.31000254,0.0007274498,0.55593663,0.00015035903,0.019412622,0.009518935,0.00077695545,0.055800196,0.0047453465,0.000041121177,0.006455258,0.03643262],"study_design_scores_gemma":[0.07390676,0.015470829,0.8415157,0.0025474185,0.0060430756,0.0409318,0.0038230978,0.0031522615,0.0087608555,0.00051551114,0.0023726707,0.0009599824],"about_ca_topic_score_codex":0.0000050961494,"about_ca_topic_score_gemma":0.0000019294127,"teacher_disagreement_score":0.28557912,"about_ca_system_score_codex":0.00006566285,"about_ca_system_score_gemma":0.0005096989,"threshold_uncertainty_score":0.45972896},"labels":[],"label_agreement":null},{"id":"W2321137476","doi":"10.1016/s0735-1097(15)61638-2","title":"TICAGRELOR AND ASPIRIN FOR THE PREVENTION OF CARDIOVASCULAR EVENTS AFTER CORONARY ARTERY BYPASS SURGERY: THE TAP-CABG STUDY","year":2015,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"Medicine; Ticagrelor; Aspirin; Coronary artery bypass surgery; Cardiology; Internal medicine; Artery; Clopidogrel","score_opus":0.026562716818632818,"score_gpt":0.2731216132123064,"score_spread":0.24655889639367357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321137476","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98269564,0.014125005,0.001055125,0.0007490619,0.0004172783,0.0008771581,0.000042642645,0.0000034222621,0.000034661745],"genre_scores_gemma":[0.9984582,0.00081730046,0.000058644004,0.00013257243,0.0003757627,0.0000566745,9.68514e-7,0.000019519868,0.00008037064],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975748,0.00097988,0.00056088984,0.00014616293,0.0005538686,0.00018437307],"domain_scores_gemma":[0.9977427,0.00055426895,0.0005772514,0.0006194295,0.00041679866,0.000089521025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026095053,0.00015575593,0.0013111525,0.00008016168,0.000072683644,0.0000033636065,0.00025391785,0.00004410834,0.0000025906686],"category_scores_gemma":[0.00026777058,0.00007271835,0.0021021692,0.00024045065,0.00056897406,0.00005217888,0.00009055226,0.00018023135,4.5063692e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023735942,0.00075410097,0.7919623,0.00018395227,0.09100065,0.00091256166,0.00048142913,0.002408348,0.00037579966,0.000042086253,0.009141112,0.07900172],"study_design_scores_gemma":[0.005027988,0.0032147174,0.93966913,0.00012423463,0.010877454,0.005680081,0.0049428507,0.000032125194,0.00014507872,0.0002252889,0.029909994,0.00015107784],"about_ca_topic_score_codex":0.000008524192,"about_ca_topic_score_gemma":0.0000019288252,"teacher_disagreement_score":0.1477068,"about_ca_system_score_codex":0.000038455753,"about_ca_system_score_gemma":0.00030117744,"threshold_uncertainty_score":0.29653683},"labels":[],"label_agreement":null},{"id":"W2321361035","doi":"10.1016/s0735-1097(16)30455-7","title":"CLINICAL OUTCOMES FOLLOWING CORONARY ARTERY BYPASS GRAFTING IN RELATION TO TIMING OF SURGERY FOLLOWING TICAGRELOR DISCONTINUATION: INSIGHTS FROM THE UNIVERSITY OF OTTAWA HEART INSTITUTE REGISTRY","year":2016,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Discontinuation; Bypass grafting; Ticagrelor; Coronary artery bypass surgery; Artery; Internal medicine; Cardiology; Surgery; Myocardial infarction; Acute coronary syndrome","score_opus":0.027881350645305402,"score_gpt":0.2800801448297429,"score_spread":0.2521987941844375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321361035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99450284,0.0005683593,0.001713017,0.0023739135,0.00056834595,0.0001651456,0.000018653216,0.000003622426,0.00008608408],"genre_scores_gemma":[0.99902076,0.00011637809,0.00053679873,0.00014938743,0.0001346459,4.2244912e-7,0.0000013902774,0.0000091930215,0.000031031766],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99789286,0.00069730164,0.0008077842,0.00014214916,0.00033139603,0.00012853026],"domain_scores_gemma":[0.9969069,0.0017145451,0.00083017646,0.00036927784,0.000113947135,0.0000652031],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010880468,0.00011028336,0.001328999,0.00010886454,0.00006348789,0.000001440825,0.00021325376,0.00006585235,0.0000028367695],"category_scores_gemma":[0.00097410934,0.000060689676,0.0017742525,0.00030132828,0.00038783028,0.00013327709,0.000071139606,0.000174514,6.461522e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064070814,0.00003679952,0.99062365,0.0000057551347,0.0021494357,0.0003236741,0.00008449269,0.00013533844,0.001882527,0.000027679134,0.0005372244,0.0035527283],"study_design_scores_gemma":[0.001537523,0.00016814827,0.99433845,0.0005222125,0.00062677875,0.00010208331,0.00096146256,0.0000065473632,0.00012942353,0.00005986508,0.0014790013,0.00006849264],"about_ca_topic_score_codex":0.000034863235,"about_ca_topic_score_gemma":0.000017040393,"teacher_disagreement_score":0.0045178933,"about_ca_system_score_codex":0.000057805602,"about_ca_system_score_gemma":0.0002833037,"threshold_uncertainty_score":0.24748531},"labels":[],"label_agreement":null},{"id":"W2321605769","doi":"10.1093/eurheartj/eht310.p4815","title":"Delay in filling first prescription for clopidogrel after coronary stenting increases risk of death and myocardial infarction","year":2013,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; Victoria Heart Institute Foundation","funders":"","keywords":"Medicine; Clopidogrel; Myocardial infarction; Internal medicine; Hazard ratio; Medical prescription; Cardiology; Proportional hazards model; Propensity score matching; Revascularization; Confidence interval; Pharmacology","score_opus":0.018233592489132415,"score_gpt":0.24313410148746378,"score_spread":0.22490050899833136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321605769","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99418557,0.0043262243,0.00083885505,0.000068255475,0.000109137756,0.00033197668,0.000008931286,0.000013514096,0.00011753324],"genre_scores_gemma":[0.99607265,0.0021431237,0.0011195878,0.00014293402,0.0004491421,0.000010245898,0.000007713881,0.000025116216,0.000029513878],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990054,0.00025409198,0.00027659914,0.00013277926,0.00016154638,0.0001695829],"domain_scores_gemma":[0.99951595,0.00006598695,0.00009720033,0.00010242416,0.00009829596,0.00012012798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064803165,0.00010091592,0.00022481408,0.00010605391,0.00011810187,0.00003674681,0.00002928874,0.000030188456,0.00006485],"category_scores_gemma":[0.000113322116,0.000084700645,0.00024516167,0.000051615625,0.00003594808,0.00020886396,0.000024252258,0.0001886123,0.000008097913],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056211924,0.0000675127,0.9869359,0.000058111462,0.00023497791,0.000050425555,0.00014722956,0.00011711753,0.0003997573,0.0000020377597,0.00038031675,0.011044467],"study_design_scores_gemma":[0.0020723965,0.00027033454,0.99033034,0.00028854996,0.00018896555,0.0009974181,0.00011744497,0.0004461291,0.000040592557,0.000028348755,0.005135937,0.00008352513],"about_ca_topic_score_codex":0.000056496276,"about_ca_topic_score_gemma":0.000003321656,"teacher_disagreement_score":0.010960942,"about_ca_system_score_codex":0.000021604303,"about_ca_system_score_gemma":0.00002229826,"threshold_uncertainty_score":0.3453992},"labels":[],"label_agreement":null},{"id":"W2321824088","doi":"10.1016/j.cjca.2013.07.457","title":"Practice Patterns and Trends in the Use of Medical Therapy in Patients Undergoing Percutaneous Coronary Intervention in Ontario","year":2013,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Conventional PCI; Percutaneous coronary intervention; Medical therapy; Coronary artery disease; Clinical Practice; Intervention (counseling); Intensive care medicine; Internal medicine; Cardiology; Emergency medicine; Physical therapy; Myocardial infarction; Nursing","score_opus":0.02852401500956456,"score_gpt":0.25680218713531,"score_spread":0.22827817212574544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321824088","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976876,0.0010075155,0.000036546695,0.0009298427,0.000098505385,0.00011807845,0.0000021981427,5.964186e-7,0.000119109456],"genre_scores_gemma":[0.99872524,0.0006619927,0.000016567295,0.0005255085,0.000044035693,0.0000023164048,0.00000877647,0.0000061305986,0.000009417841],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99872094,0.00047499052,0.00035140963,0.00008416758,0.00020584006,0.00016265528],"domain_scores_gemma":[0.9993783,0.00019074834,0.00009766589,0.00010535001,0.000076096396,0.0001517909],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005598861,0.000075624084,0.00035302294,0.00035271843,0.000013329023,0.000011846881,0.00009199328,0.000113866154,0.000118518146],"category_scores_gemma":[0.00019989921,0.000053835352,0.00015857085,0.000095605326,0.000076427285,0.00015152259,0.000006507139,0.00038217273,5.0948967e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002403541,0.000022479035,0.89378107,0.000007181105,0.00015161383,0.0017350777,0.0008924167,0.000113409114,0.0000015839216,0.000008029074,0.0001737084,0.102873065],"study_design_scores_gemma":[0.0029710105,0.0007467291,0.9872595,0.00016871127,0.000035268553,0.0034786556,0.00082387,0.000009477893,5.4872095e-7,0.000021357919,0.004439108,0.0000457827],"about_ca_topic_score_codex":0.12960269,"about_ca_topic_score_gemma":0.48654747,"teacher_disagreement_score":0.35694477,"about_ca_system_score_codex":0.00016809032,"about_ca_system_score_gemma":0.00041048674,"threshold_uncertainty_score":0.87619334},"labels":[],"label_agreement":null},{"id":"W2321925246","doi":"10.1016/s0735-1097(16)30532-0","title":"UPTAKE OF GUIDELINE-RECOMMENDED ORAL ANTIPLATELET THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME","year":2016,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Acute coronary syndrome; Guideline; Internal medicine; Cardiology; Intensive care medicine; Myocardial infarction; Pathology","score_opus":0.009970576008167207,"score_gpt":0.2510498421448657,"score_spread":0.2410792661366985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321925246","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99770427,0.00047190872,0.0002156308,0.0009443747,0.0001765933,0.00028424917,0.00013616405,0.000004343163,0.0000624469],"genre_scores_gemma":[0.9977624,0.0011647916,0.0006390039,0.00031930904,0.000049537888,0.000002259235,0.0000025453214,0.000022543178,0.000037615893],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99806845,0.0003261488,0.00083704427,0.0001406027,0.00040670205,0.0002210548],"domain_scores_gemma":[0.9980949,0.000100048885,0.0009052016,0.0004001395,0.0004159328,0.00008379035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005364351,0.00017417483,0.001535119,0.0001811128,0.00002431618,0.0000010885568,0.0002835362,0.000057286914,0.000025319285],"category_scores_gemma":[0.00005450334,0.00008125741,0.00070865825,0.0003582525,0.00044947592,0.00007377419,0.00004674689,0.00015308305,7.984469e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01782242,0.00021106617,0.94358015,0.000011609336,0.0058399457,0.0012278865,0.00001564556,0.00007920936,0.0022431053,0.000018488678,0.0026987994,0.026251655],"study_design_scores_gemma":[0.012116329,0.0056399098,0.9724861,0.00016583731,0.00036821226,0.0038377352,0.000099843484,0.0000013144087,0.0007843917,0.000055396966,0.0043358565,0.000109068715],"about_ca_topic_score_codex":0.0000042759275,"about_ca_topic_score_gemma":9.126055e-7,"teacher_disagreement_score":0.028905936,"about_ca_system_score_codex":0.00005640289,"about_ca_system_score_gemma":0.0002736385,"threshold_uncertainty_score":0.3313581},"labels":[],"label_agreement":null},{"id":"W2323293892","doi":"10.1160/th15-09-0703","title":"Oral anticoagulants in coronary heart disease (Section IV) Position paper of the ESC Working Group on Thrombosis – Task Force on Anticoagulants in Heart Disease","year":2016,"lang":"en","type":"review","venue":"Thrombosis and Haemostasis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute; Hamilton General Hospital","funders":"Novo Nordisk Fonden","keywords":"Medicine; Thrombosis; Coronary heart disease; Cardiology; Section (typography); Coronary thrombosis; Internal medicine; Heart disease; Task force; Disease","score_opus":0.07263715310775717,"score_gpt":0.3404791114505433,"score_spread":0.2678419583427861,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2323293892","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2512249,0.74334776,0.000009591575,0.0014237172,0.0004529804,0.0028563356,0.0005242535,0.000065426975,0.000095007446],"genre_scores_gemma":[0.39860713,0.5997383,0.000013591456,0.0011263851,0.00014540732,0.00009278757,0.00017680334,0.000080177066,0.000019398834],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9958803,0.0007888272,0.0009073089,0.0009825653,0.00082329527,0.0006176793],"domain_scores_gemma":[0.9979718,0.000248725,0.00030274448,0.001036772,0.000050375285,0.0003895997],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005444241,0.00076328625,0.0029474956,0.00043053224,0.0002238602,0.000054011263,0.00022341868,0.0003373172,0.00010860141],"category_scores_gemma":[0.00007583567,0.000491607,0.0012351377,0.00063885096,0.0002939775,0.00019345476,0.00013036783,0.0005066379,0.000023024686],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049053864,0.004903589,0.14694215,0.018030023,0.0027593917,0.0002935898,0.00023636452,0.000018890974,0.00034231544,0.0007120824,0.0027643857,0.8180918],"study_design_scores_gemma":[0.003814527,0.00050911494,0.8442348,0.093139105,0.003956976,0.00004617073,0.000060374055,0.000015033108,0.000027432183,0.00028639182,0.053041387,0.0008686386],"about_ca_topic_score_codex":0.00011037079,"about_ca_topic_score_gemma":0.000031254753,"teacher_disagreement_score":0.8172232,"about_ca_system_score_codex":0.00025413663,"about_ca_system_score_gemma":0.00022504997,"threshold_uncertainty_score":0.99975353},"labels":[],"label_agreement":null},{"id":"W2323314749","doi":"10.1016/j.cjca.2011.07.176","title":"240 Clopidogrel discharge program: Streamlining the pre-authorization process","year":2011,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Kelowna General Hospital","funders":"","keywords":"Clopidogrel; Conventional PCI; Medicine; Prior authorization; Percutaneous coronary intervention; Pharmacist; Medical prescription; Authorization; Medical emergency; Emergency medicine; Family medicine; Pharmacy; Nursing; Internal medicine; Aspirin; Computer security","score_opus":0.029799299615861898,"score_gpt":0.27658837393987007,"score_spread":0.24678907432400818,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2323314749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9722929,0.005572525,0.007783401,0.0005537652,0.0009600922,0.0005576749,0.000017230817,0.000028235374,0.012234172],"genre_scores_gemma":[0.99834543,0.00016356175,0.00013764421,0.00015381486,0.0010902301,0.000012649835,0.000010799169,0.000018785111,0.000067098066],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990188,0.0001438401,0.00028602712,0.00011791348,0.0001443619,0.00028906978],"domain_scores_gemma":[0.99893063,0.000022309287,0.0001450959,0.0001963278,0.00027590254,0.00042975994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000426568,0.00011639219,0.00038942887,0.00012677161,0.00013536621,0.000014815202,0.00016685216,0.00011591572,0.000055820954],"category_scores_gemma":[0.0001328696,0.000073933734,0.0003909838,0.0001634309,0.0001980148,0.00008446014,0.000005240676,0.00027063035,0.000005182794],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006186662,0.000026451968,0.7419128,0.00009683082,0.0030228463,0.00095052854,0.0036882185,0.0003298577,0.00004697573,0.0020470996,0.0033199133,0.24393986],"study_design_scores_gemma":[0.0032117995,0.0020405704,0.7298851,0.00024818775,0.0019356579,0.0066890996,0.0023067712,0.000058962905,0.0004700832,0.0015290839,0.25126353,0.00036118808],"about_ca_topic_score_codex":0.00012147663,"about_ca_topic_score_gemma":0.000102946426,"teacher_disagreement_score":0.24794361,"about_ca_system_score_codex":0.000039895185,"about_ca_system_score_gemma":0.0009689954,"threshold_uncertainty_score":0.30149302},"labels":[],"label_agreement":null},{"id":"W2323732370","doi":"10.11909/j.issn.1671-5411.2016.03.007","title":"Impact of concomitant use of proton pump inhibitors and clopidogrel or ticagrelor on clinical outcomes in patients with acute coronary syndrome.","year":2016,"lang":"en","type":"article","venue":"PubMed","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta","funders":"","keywords":"Medicine; Ticagrelor; Clopidogrel; Acute coronary syndrome; Percutaneous coronary intervention; Concomitant; Internal medicine; Conventional PCI; Myocardial infarction; Cardiology; Clinical endpoint; Clinical trial","score_opus":0.03238331346222561,"score_gpt":0.28864749343434415,"score_spread":0.25626417997211853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2323732370","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972639,0.000039029208,0.0000044453495,0.00006485776,0.00004874762,0.002476319,0.00007749166,0.000013986026,0.000011203607],"genre_scores_gemma":[0.99935216,0.00020044394,0.000026067435,0.000050031602,0.000011160113,0.00024660229,0.0000073274105,0.000019765921,0.000086445005],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99870956,0.0000998449,0.00043998705,0.00022274561,0.00030156865,0.0002262707],"domain_scores_gemma":[0.99903446,0.00027635717,0.00015281311,0.00028540555,0.00007418453,0.00017678249],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024710127,0.00015303724,0.00068747177,0.00009687682,0.000011183841,0.000004068244,0.00004901097,0.000091563656,0.00001637732],"category_scores_gemma":[0.00023213951,0.00006819266,0.00026878508,0.00010500022,0.00023179836,0.00011154096,0.000028412227,0.00008405144,0.0000013510537],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012511061,0.0007864325,0.93274397,0.000042438463,0.0016970373,0.00014484346,0.000014053988,2.6533914e-7,0.0000036539977,0.0000035073815,0.00002162657,0.052031137],"study_design_scores_gemma":[0.011896589,0.0030402904,0.98431146,0.00017716672,0.00026264347,0.00003140257,0.000004698773,4.946573e-7,0.000128355,0.0000044505014,0.00004225397,0.000100222474],"about_ca_topic_score_codex":0.000015278156,"about_ca_topic_score_gemma":0.0000019298193,"teacher_disagreement_score":0.05193091,"about_ca_system_score_codex":0.000044968885,"about_ca_system_score_gemma":0.00007594398,"threshold_uncertainty_score":0.2780816},"labels":[],"label_agreement":null},{"id":"W2323753001","doi":"10.2174/1871529x1303140129154040","title":"Antiplatelet Therapies: Aspirin at the Heart of New Directions","year":2014,"lang":"en","type":"article","venue":"Cardiovascular & Haematological Disorders - Drug Targets","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Aspirin; Medicine; Analgesic; Cyclooxygenase; Drug; Intensive care medicine; Pharmacology; Bioinformatics; Internal medicine; Biology","score_opus":0.011712977329210129,"score_gpt":0.23810909731592828,"score_spread":0.22639611998671816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2323753001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7446135,0.23923409,0.006143747,0.0028427788,0.00041578032,0.0012143563,0.000016672468,0.0003109093,0.0052081607],"genre_scores_gemma":[0.98516285,0.012428211,0.00033149173,0.00088224816,0.00019336774,0.00006867792,0.0000708617,0.00006274174,0.00079956366],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966175,0.0006284985,0.0005441518,0.00070800463,0.0009043091,0.0005975369],"domain_scores_gemma":[0.9976794,0.00022802474,0.00011695736,0.0015278085,0.00012198379,0.0003258273],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010351207,0.00044791712,0.0016592293,0.000107136206,0.0004101332,0.000028705423,0.00031979784,0.00022827317,0.00048196773],"category_scores_gemma":[0.00028620622,0.00028311322,0.004415078,0.0004762325,0.00060615747,0.00009782894,0.00016391627,0.0003465877,0.00017377842],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029782937,0.0028272746,0.16446237,0.001583532,0.06034225,0.00052886084,0.0037175643,0.00306092,0.0022859264,0.0061300835,0.15646596,0.595617],"study_design_scores_gemma":[0.0038016043,0.00018263797,0.04256988,0.00012855862,0.0015072117,0.00068595144,0.00041187237,0.00009412501,0.003930857,0.0015505508,0.94464093,0.0004958259],"about_ca_topic_score_codex":0.00012245083,"about_ca_topic_score_gemma":0.000026911788,"teacher_disagreement_score":0.788175,"about_ca_system_score_codex":0.000044387187,"about_ca_system_score_gemma":0.00008317415,"threshold_uncertainty_score":0.9999621},"labels":[],"label_agreement":null},{"id":"W2325267069","doi":"10.1097/mca.0b013e32835f2fbd","title":"Quantification of the effect of clopidogrel on enzymatic infarct size related to a percutaneous coronary intervention in patients with acute coronary syndromes","year":2013,"lang":"en","type":"article","venue":"Coronary Artery Disease","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"Medicines Company","keywords":"Medicine; Clopidogrel; Percutaneous coronary intervention; Conventional PCI; Internal medicine; Cardiology; Myocardial infarction; Acute coronary syndrome; Confidence interval; Hazard ratio","score_opus":0.004756733862887824,"score_gpt":0.22219745011795405,"score_spread":0.21744071625506622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325267069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962567,0.000474946,0.000012797273,0.00016674759,0.00012876684,0.0028070083,0.00007611371,0.000039921586,0.000037009508],"genre_scores_gemma":[0.9992346,0.00003769587,0.000022592229,0.00016655319,0.0000074454556,0.00015025621,0.00016555487,0.000039686704,0.00017559137],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978772,0.0004049144,0.0005520586,0.00037331623,0.00055221544,0.00024030716],"domain_scores_gemma":[0.99843687,0.00022282534,0.0002004903,0.00079325907,0.00011360488,0.00023294258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017162439,0.000280787,0.00054842804,0.00013371525,0.00006070741,0.000009877009,0.00020411388,0.00007840898,0.00032747365],"category_scores_gemma":[0.00008981605,0.00018467385,0.00044307968,0.00031517024,0.00018189945,0.00018221236,0.00006463464,0.00016665144,0.0000660942],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013498283,0.0012278027,0.9593898,0.00053683546,0.00094788667,0.0004076111,0.00024129794,0.00027261756,0.0006196353,0.000015706251,0.00012487861,0.022717644],"study_design_scores_gemma":[0.0046071233,0.004290014,0.98814666,0.0012734642,0.0007357764,0.0002556713,0.00007518391,0.00015289494,0.00020733557,0.000057341018,0.0000102544245,0.00018827683],"about_ca_topic_score_codex":0.000012647705,"about_ca_topic_score_gemma":0.000001614251,"teacher_disagreement_score":0.028756863,"about_ca_system_score_codex":0.00008093732,"about_ca_system_score_gemma":0.000073128,"threshold_uncertainty_score":0.7530781},"labels":[],"label_agreement":null},{"id":"W2325918709","doi":"10.1177/2048872615598631","title":"Impact of chronic kidney disease on long-term ischemic and bleeding outcomes in medically managed patients with acute coronary syndromes: Insights from the TRILOGY ACS Trial","year":2015,"lang":"en","type":"article","venue":"European Heart Journal Acute Cardiovascular Care","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Alberta","funders":"","keywords":"Medicine; Acute coronary syndrome; Kidney disease; Internal medicine; Cardiology; Disease; Intensive care medicine; Myocardial infarction","score_opus":0.02181867731547216,"score_gpt":0.2711711235086184,"score_spread":0.24935244619314623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325918709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97193927,0.026204186,0.000071416864,0.00013573146,0.00033177465,0.0010113046,0.00014176274,0.000034659974,0.00012987018],"genre_scores_gemma":[0.9958578,0.0027758202,0.00003118536,0.00039892117,0.0005264399,0.000010638834,0.00028762355,0.000093912044,0.000017665447],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99604315,0.0010345629,0.0005717327,0.0005045912,0.0014302805,0.0004156852],"domain_scores_gemma":[0.9974531,0.000097244774,0.00016973683,0.0008554562,0.00032813678,0.0010963385],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006043868,0.00045333136,0.001331011,0.00019408682,0.00016363863,0.00007106864,0.00030571886,0.000079571095,0.000023270464],"category_scores_gemma":[0.00020984419,0.00025582899,0.0020515453,0.00025823052,0.00023758998,0.00022509202,0.00014377828,0.00073188456,0.000013732066],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.042808723,0.0005136642,0.8741227,0.00010605828,0.04853481,0.023168895,0.0011235431,0.00019085432,0.00005712171,0.0000014832306,0.0014858689,0.007886298],"study_design_scores_gemma":[0.08137538,0.0028834809,0.9061852,0.00078402826,0.0059656673,0.0011125345,0.00017682745,0.0000042760685,0.000015435653,0.0000032390415,0.0011934766,0.00030044123],"about_ca_topic_score_codex":0.000012223427,"about_ca_topic_score_gemma":0.0000011726304,"teacher_disagreement_score":0.042569146,"about_ca_system_score_codex":0.00034214748,"about_ca_system_score_gemma":0.00067241816,"threshold_uncertainty_score":0.9999894},"labels":[],"label_agreement":null},{"id":"W2328176302","doi":"10.1055/s-0035-1564834","title":"Platelet Function Tests","year":2016,"lang":"en","type":"review","venue":"Seminars in Thrombosis and Hemostasis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Platelet; Function (biology); Medicine; Internal medicine; Biology; Cell biology","score_opus":0.05562645291481003,"score_gpt":0.3535877046826176,"score_spread":0.2979612517678075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328176302","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00069640257,0.99694365,0.000013380998,0.00007645293,0.00018432557,0.00069528265,0.000090987516,0.000060418883,0.0012391069],"genre_scores_gemma":[0.0001939383,0.99877715,0.0000905177,0.00016058938,0.00020634597,0.000088321685,0.00013074919,0.00008005649,0.00027232812],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981233,0.00011220018,0.0005064131,0.00059597427,0.00029196014,0.0003701822],"domain_scores_gemma":[0.9989642,0.0001543996,0.00015895744,0.0005039614,0.00003841997,0.0001800458],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032525536,0.00047508196,0.0022371667,0.0002708229,0.00008764514,0.000031106163,0.00009763568,0.00047089715,0.0003932573],"category_scores_gemma":[0.000042465676,0.0003208352,0.00083207694,0.00033900252,0.00013562517,0.00008507131,0.000072015544,0.0003054084,0.000099013974],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029360745,0.000092606555,0.00021714969,0.00605844,0.00079441775,0.00005718764,0.000026368709,1.2693439e-8,0.0000016643396,0.000053142892,0.0029568311,0.98971283],"study_design_scores_gemma":[0.00076046924,0.00017550033,0.00045278986,0.045144513,0.0016966126,0.0001893176,0.00003922325,2.6447591e-7,0.0000075877165,0.00008555962,0.95108956,0.00035857272],"about_ca_topic_score_codex":0.0000064292262,"about_ca_topic_score_gemma":0.000002221431,"teacher_disagreement_score":0.98935425,"about_ca_system_score_codex":0.00011905335,"about_ca_system_score_gemma":0.00014785425,"threshold_uncertainty_score":0.99992436},"labels":[],"label_agreement":null},{"id":"W2330301568","doi":"10.1097/01.nurse.0000350767.47290.3f","title":"Aspirin-induced postoperative bleeding","year":2009,"lang":"en","type":"article","venue":"Nursing","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Aspirin; Medicine; Internal medicine","score_opus":0.023475668559672088,"score_gpt":0.3101772449384166,"score_spread":0.2867015763787445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2330301568","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9603368,0.0013083078,0.00041189458,0.0016997248,0.00014552668,0.00014948973,5.361275e-7,0.0000987088,0.03584902],"genre_scores_gemma":[0.9976572,0.000027162318,0.00033447178,0.0015400302,0.00022911339,0.0000011234665,0.0000073458414,0.0000098050805,0.00019374375],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99938256,0.000020172196,0.0000925422,0.00015459818,0.00017356355,0.00017656466],"domain_scores_gemma":[0.9996797,0.000007318584,0.000017586392,0.00014729022,0.000048758153,0.00009938375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000075200005,0.00009183911,0.00018261309,0.000050947754,0.00010022734,0.000019358155,0.00003339587,0.000052078853,0.00005943813],"category_scores_gemma":[0.00001376466,0.000079949146,0.00016451426,0.00011307055,0.000024229288,0.000080820115,0.0000019836496,0.00010837454,0.000035734596],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026198462,0.00020306912,0.0005384904,0.0000072925113,0.00011955286,0.00013976172,0.00092012575,0.000006374503,0.19435516,0.0010641009,0.000507985,0.80187607],"study_design_scores_gemma":[0.013276963,0.0047921357,0.37066025,0.0044034375,0.0015537427,0.0025064326,0.004901025,0.00089573744,0.5706091,0.0035681953,0.021519776,0.0013131886],"about_ca_topic_score_codex":0.0000014113072,"about_ca_topic_score_gemma":6.562819e-8,"teacher_disagreement_score":0.8005629,"about_ca_system_score_codex":0.00005936343,"about_ca_system_score_gemma":0.000038701048,"threshold_uncertainty_score":0.32602316},"labels":[],"label_agreement":null},{"id":"W2331278286","doi":"10.1016/j.amjcard.2016.03.034","title":"Impact of Anemia on Platelet Reactivity and Ischemic and Bleeding Risk: From the Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents Study","year":2016,"lang":"en","type":"article","venue":"The American Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Sacré-Cœur de Montréal; Université de Montréal","funders":"","keywords":"Medicine; Internal medicine; Clopidogrel; Anemia; Odds ratio; Confidence interval; Confounding; Adverse effect; Gastroenterology; Cardiology; Myocardial infarction","score_opus":0.013505087433208812,"score_gpt":0.29345340389077956,"score_spread":0.27994831645757073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2331278286","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982183,0.0010303679,0.00017232432,0.00018198555,0.000033995366,0.0002559111,0.00003364862,0.0000048467637,0.00006863978],"genre_scores_gemma":[0.99532235,0.0043606577,0.000058070746,0.000034092416,0.00020213795,0.000001954613,8.863925e-7,0.000017676573,0.0000021795204],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981858,0.0007471171,0.00035798873,0.00017609453,0.0003400789,0.00019291801],"domain_scores_gemma":[0.997484,0.0010319905,0.0009343458,0.00032542695,0.0001415167,0.000082719256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00136595,0.0001860691,0.0010951781,0.000065519795,0.000080885104,0.0000069921343,0.0001274697,0.00003015742,0.000004055502],"category_scores_gemma":[0.000067833935,0.00006980101,0.00030216863,0.0001279436,0.0007448183,0.00006671364,0.000042875574,0.00030192538,1.2770568e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005679734,0.00008551968,0.8643326,0.0000037821121,0.005120117,0.0000943991,0.00048768823,0.00006592484,0.034689337,0.0000015278035,0.000051933563,0.08938743],"study_design_scores_gemma":[0.0054142126,0.006401931,0.9817196,0.00014404308,0.0005986259,0.0010836622,0.0023623444,0.000006003856,0.0021148303,0.00001463785,0.00005220631,0.00008787035],"about_ca_topic_score_codex":0.00014435551,"about_ca_topic_score_gemma":8.7386303e-7,"teacher_disagreement_score":0.11738703,"about_ca_system_score_codex":0.000033527067,"about_ca_system_score_gemma":0.00011690469,"threshold_uncertainty_score":0.28464025},"labels":[],"label_agreement":null},{"id":"W2331964856","doi":"10.1136/annrheumdis-2014-eular.5589","title":"SAT0408 Long-Term Safety and Tolerability of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis: Pooled Safety Analysis of Three Phase 3, Randomized, Controlled Trials","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Medicine; Apremilast; Tolerability; Psoriatic arthritis; Placebo; Adverse effect; Randomized controlled trial; Internal medicine; Nausea; Gastroenterology; Surgery; Arthritis","score_opus":0.0190196144959197,"score_gpt":0.293338388482158,"score_spread":0.2743187739862383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2331964856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98743355,0.008097837,0.0009292228,0.00010504549,0.000063147156,0.002917685,0.000416684,0.000016198532,0.000020625526],"genre_scores_gemma":[0.99752915,0.0020558913,0.00005141045,0.000105717634,0.000015965627,0.000061985236,0.00015519404,0.000020699397,0.0000039784245],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99356174,0.0024147679,0.0026297602,0.000349467,0.00079070503,0.00025355784],"domain_scores_gemma":[0.99469084,0.0021867997,0.001534468,0.0009323429,0.0004303063,0.000225227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046234443,0.00034808877,0.0076619186,0.00027363215,0.000064521395,0.00001794826,0.0001936703,0.000081017635,0.00013404388],"category_scores_gemma":[0.004695624,0.00019191983,0.002314596,0.00050972245,0.0005950531,0.00018709575,0.00005928931,0.000091295326,2.8216513e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5185022,0.003908131,0.31167698,0.0006881509,0.020435454,0.0000022021593,0.00026646673,0.0005056757,0.0000074313602,0.000090300025,0.000007723454,0.14390928],"study_design_scores_gemma":[0.36662918,0.0006193463,0.61230445,0.0018862769,0.016120331,7.6479995e-7,0.00005862174,0.00168709,0.0002219552,0.0002987466,0.0000013369483,0.00017188444],"about_ca_topic_score_codex":0.00009807773,"about_ca_topic_score_gemma":0.00009245568,"teacher_disagreement_score":0.3006275,"about_ca_system_score_codex":0.00001579104,"about_ca_system_score_gemma":0.00013761861,"threshold_uncertainty_score":0.78262633},"labels":[],"label_agreement":null},{"id":"W2332029459","doi":"10.1097/hco.0b013e3283606957","title":"The role of clopidogrel in the management of ischemic heart disease","year":2013,"lang":"en","type":"review","venue":"Current Opinion in Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Daiichi-Sankyo; Daiichi Sankyo Europe; Medicure; Eli Lilly and Company","keywords":"Medicine; Clopidogrel; Cardiology; Internal medicine; Disease management; Disease; Intensive care medicine; Myocardial infarction","score_opus":0.059979906085952786,"score_gpt":0.3742278698130783,"score_spread":0.31424796372712555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2332029459","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016568984,0.99647886,0.000010239573,0.00005206584,0.0011182656,0.0016148067,0.000034926314,0.000006686849,0.0005184636],"genre_scores_gemma":[0.0014605824,0.99745274,0.0000083778095,0.00000808704,0.00032758317,0.0005312801,0.00018244387,0.000019365225,0.000009547645],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978407,0.0006301373,0.0007035841,0.00029725145,0.00027239026,0.00025591347],"domain_scores_gemma":[0.9986799,0.0002059447,0.00020515543,0.000808286,0.000043020376,0.000057706693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006668038,0.00025261237,0.0015822533,0.00012693419,0.000028114406,0.0000049891987,0.0003476805,0.00013741985,0.000009255456],"category_scores_gemma":[0.000023779286,0.00013392144,0.0012391345,0.00029623864,0.00023507858,0.000019531337,0.000102428916,0.00037926104,0.00001653541],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059110385,0.000085881096,0.0016478453,0.020200701,0.00065548014,0.0000057736465,0.00002630491,0.000004191231,1.4618861e-7,0.0008385797,0.0029239557,0.97355205],"study_design_scores_gemma":[0.00050177757,0.00003708003,0.0021158983,0.011189553,0.0006175797,0.000039831597,0.0001445927,0.0000020322786,2.1179052e-7,0.00013048558,0.9851103,0.00011066814],"about_ca_topic_score_codex":0.0000041280523,"about_ca_topic_score_gemma":7.2486806e-8,"teacher_disagreement_score":0.9821863,"about_ca_system_score_codex":0.000040888517,"about_ca_system_score_gemma":0.00013932172,"threshold_uncertainty_score":0.54611576},"labels":[],"label_agreement":null},{"id":"W2332512083","doi":"10.2741/1194","title":"Apoprotein (A) antagonises THE GPIIB/IIIA receptor on collagen and ADP-stimulated human platelets","year":2004,"lang":"en","type":"article","venue":"Frontiers in bioscience","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cape Breton University","funders":"","keywords":"Platelet; Fibrinogen; Chemistry; Receptor; Biochemistry; Internal medicine; Medicine","score_opus":0.009924547228842978,"score_gpt":0.2504474835380832,"score_spread":0.24052293630924024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2332512083","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939591,0.002707092,0.00073935324,0.0009766585,0.00041060607,0.000655427,0.000012650031,0.000060957937,0.00047813964],"genre_scores_gemma":[0.9969641,0.0006696559,0.0011899329,0.00084636285,0.00007582533,0.000021288728,0.000010342685,0.000015761854,0.00020673909],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99860394,0.000058266465,0.00019398188,0.00041596507,0.00039476706,0.00033307835],"domain_scores_gemma":[0.99939436,0.000016522474,0.000053878965,0.00036466197,0.0000335873,0.00013697158],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034815498,0.00017789313,0.00029197722,0.000113491136,0.00034075684,0.000049461447,0.00020969177,0.00009688074,0.000026956515],"category_scores_gemma":[0.00006981094,0.00012111763,0.00010516508,0.0005204121,0.00059921,0.00010217887,0.000042710206,0.00013615689,0.000013707801],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0065242182,0.0037907963,0.22914222,0.0005325691,0.0013133433,0.0023679864,0.0064535392,0.0040861736,0.4633914,0.0051719723,0.032906253,0.24431954],"study_design_scores_gemma":[0.030618556,0.004931934,0.4968532,0.0020905486,0.00046104562,0.0005050495,0.004256687,0.001452016,0.35564834,0.005940643,0.094991975,0.002249998],"about_ca_topic_score_codex":0.000047931284,"about_ca_topic_score_gemma":0.0000044557655,"teacher_disagreement_score":0.26771098,"about_ca_system_score_codex":0.00009440046,"about_ca_system_score_gemma":0.00009803917,"threshold_uncertainty_score":0.49390334},"labels":[],"label_agreement":null},{"id":"W2332641076","doi":"10.1016/s0735-1097(16)30028-6","title":"DUAL ANTI-PLATELET THERAPY IS NOT SUPERIOR TO ASPIRIN ALONE AFTER CORONARY ARTERY BYPASS IN DIABETIC PATIENTS WITH MULTI-VESSEL DISEASE: INSIGHTS FROM THE FREEDOM TRIAL","year":2016,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Aspirin; Coronary artery disease; Cardiology; Internal medicine; Disease; Dual (grammatical number); Artery; Platelet; Randomized controlled trial","score_opus":0.009941486604348414,"score_gpt":0.22807375512204323,"score_spread":0.21813226851769482,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2332641076","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942301,0.0012269226,0.00010300639,0.0023446553,0.000432181,0.0012084893,0.00044212278,0.0000067923947,0.000005736298],"genre_scores_gemma":[0.997311,0.00037813553,0.00008347832,0.001563871,0.00055419636,0.000043429704,0.0000033942279,0.00003374081,0.000028745962],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99731696,0.0008307268,0.00064321863,0.00028964478,0.00062559743,0.00029384132],"domain_scores_gemma":[0.9980585,0.00035900783,0.00041638923,0.0006993745,0.00025144964,0.00021528546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027205475,0.00027560614,0.0014408517,0.00013923428,0.0000657352,0.00000806015,0.00035760208,0.00006121506,0.000029080702],"category_scores_gemma":[0.000102942075,0.000116608564,0.0007123649,0.00034849538,0.0006325517,0.000103667895,0.00008566505,0.00023659863,0.0000049139594],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.175082,0.0006244925,0.81161535,0.000006033637,0.0032300772,0.0017084444,0.00020266668,0.00007045662,0.0018271508,0.0000017173071,0.00081253663,0.0048190868],"study_design_scores_gemma":[0.06138859,0.0034403466,0.93046963,0.00016782536,0.00040920902,0.00011847294,0.00026292008,0.0000025528582,0.00035640888,0.000010881833,0.0032037557,0.00016937625],"about_ca_topic_score_codex":0.000021080423,"about_ca_topic_score_gemma":0.000009699972,"teacher_disagreement_score":0.118854314,"about_ca_system_score_codex":0.00007206181,"about_ca_system_score_gemma":0.0002828346,"threshold_uncertainty_score":0.47551593},"labels":[],"label_agreement":null},{"id":"W2335209503","doi":"10.1177/1715163515569572","title":"A pharmacist’s guide to the 2012 update of the Canadian Cardiovascular Society Guidelines for the Use of Antiplatelet Therapy","year":2015,"lang":"en","type":"article","venue":"Canadian Pharmacists Journal / Revue des Pharmaciens du Canada","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Université de Montréal; Queen Elizabeth II Health Sciences Centre; Saskatchewan Health Authority; Sunnybrook Health Science Centre; Hôpital du Sacré-Cœur de Montréal; St. Michael's Hospital; Alberta Health Services","funders":"","keywords":"Medicine; Pharmacist; Canadian Cardiovascular Society; Intensive care medicine; Family medicine; Pharmacy; Internal medicine; Myocardial infarction","score_opus":0.20852486210659008,"score_gpt":0.3406373990271622,"score_spread":0.13211253692057215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2335209503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8230671,0.1275375,0.0037798057,0.018898888,0.01088733,0.00864877,0.00670855,0.00006090118,0.0004110969],"genre_scores_gemma":[0.94953793,0.022899484,0.00073556794,0.02426174,0.0016161569,0.000076751516,0.00003927307,0.00010270396,0.000730406],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99607277,0.0003259171,0.00097604305,0.0003969821,0.001159077,0.0010692041],"domain_scores_gemma":[0.9923606,0.00018263153,0.00033140922,0.0010161868,0.003612922,0.0024962751],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.002649056,0.0004603798,0.00079280173,0.00018728913,0.0013002197,0.00014912128,0.0012004112,0.00009926476,0.00013955611],"category_scores_gemma":[0.0006234786,0.0002674977,0.0019123626,0.0009711878,0.00046205384,0.0002863462,0.00006566653,0.00056673575,0.0000045991246],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056184863,0.000037609476,0.0012747964,0.000120523466,0.0065145884,0.002293316,0.0010553126,0.025812421,0.00050586386,0.000023979976,0.8493373,0.11246246],"study_design_scores_gemma":[0.0041041737,0.000047859132,0.00006153598,0.000040265244,0.0011433872,0.06268141,0.000045132776,0.0034113266,0.0037105,0.000010395266,0.9244358,0.00030819775],"about_ca_topic_score_codex":0.33413887,"about_ca_topic_score_gemma":0.5017335,"teacher_disagreement_score":0.16759461,"about_ca_system_score_codex":0.0014161406,"about_ca_system_score_gemma":0.0142420465,"threshold_uncertainty_score":0.99999994},"labels":[],"label_agreement":null},{"id":"W2336744020","doi":"10.1136/heartjnl-2015-308691","title":"Ticagrelor and aspirin for the prevention of cardiovascular events after coronary artery bypass graft surgery","year":2016,"lang":"en","type":"article","venue":"Heart","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; St. Paul's Hospital; University of British Columbia","funders":"University of British Columbia; AstraZeneca","keywords":"Medicine; Ticagrelor; Aspirin; Myocardial infarction; Stroke (engine); Placebo; Coronary artery bypass surgery; Cardiopulmonary bypass; Surgery; Artery; Cardiology; Anesthesia; Internal medicine; Clopidogrel","score_opus":0.02066293808168101,"score_gpt":0.25095092731737356,"score_spread":0.23028798923569255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2336744020","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9721726,0.022164593,0.0041908342,0.0006742678,0.00013291513,0.0006082277,0.000018721052,0.000020774194,0.000017039085],"genre_scores_gemma":[0.99758625,0.0014923787,0.00008595304,0.00017376032,0.00013398015,0.0001254413,0.000006683981,0.000018322404,0.00037720567],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9991993,0.00007506517,0.00017858895,0.00018104346,0.00020547587,0.00016055041],"domain_scores_gemma":[0.9992679,0.00021492894,0.000026967688,0.00036237662,0.00005928952,0.000068531815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047370116,0.000098517354,0.0003449215,0.00003756037,0.000043700573,0.0000037080604,0.000028272138,0.00005521362,0.00005261008],"category_scores_gemma":[0.00004124308,0.000053703625,0.0009019316,0.000048299713,0.00008575726,0.000062124454,0.000018528972,0.000033866738,0.0000125387605],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005170768,0.00053897075,0.33191234,0.00097116764,0.017311372,0.00015393062,0.00013239321,0.000007830972,0.0041159713,0.00010120624,0.0066066845,0.63297737],"study_design_scores_gemma":[0.0030443151,0.00025409865,0.8482479,0.0005667776,0.002006151,0.00045621928,0.000042846095,0.000014133374,0.0032270532,0.00042880815,0.14153646,0.00017523312],"about_ca_topic_score_codex":0.0000033295476,"about_ca_topic_score_gemma":8.5697764e-7,"teacher_disagreement_score":0.6328021,"about_ca_system_score_codex":0.000010958662,"about_ca_system_score_gemma":0.00004717319,"threshold_uncertainty_score":0.21899703},"labels":[],"label_agreement":null},{"id":"W2338580196","doi":"10.1161/circoutcomes.9.suppl_2.138","title":"Abstract 138: Contemporary Patterns of Use of Antiplatelet Agents in Patients With Acute Myocardial Infarction: Insight From the National Cardiovascular Data Registry (NCDR)","year":2016,"lang":"en","type":"article","venue":"Circulation Cardiovascular Quality and Outcomes","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Christie (Canada)","funders":"","keywords":"Ticagrelor; Prasugrel; Medicine; Clopidogrel; Myocardial infarction; P2Y12; Medical prescription; Internal medicine; Acute coronary syndrome; Cardiology; Emergency medicine; Pharmacology","score_opus":0.11816192263094784,"score_gpt":0.3101184130278013,"score_spread":0.19195649039685347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2338580196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909841,0.0037855208,0.0023816007,0.0002330874,0.00014292765,0.0008110381,0.0015663502,0.000030422507,0.000064952925],"genre_scores_gemma":[0.9975554,0.0008837603,0.000079641555,0.00027959124,0.00012385477,0.000015003265,0.0010213477,0.00003384272,0.000007601203],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99579465,0.0005286844,0.0008828174,0.0006794423,0.0018890518,0.00022534323],"domain_scores_gemma":[0.9968422,0.00042934288,0.000322872,0.0018331656,0.00045566945,0.000116764604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015571987,0.00031868272,0.0014143253,0.000133412,0.00009498621,0.00003491637,0.00026668547,0.00020699871,0.000028965474],"category_scores_gemma":[0.00038897354,0.00019304061,0.0014838462,0.00024738334,0.000258925,0.00072072755,0.0001434592,0.00017996696,0.0000027496521],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005987341,0.00015193537,0.962289,0.00010718792,0.027006472,0.000036342044,0.000118323514,0.0002815169,0.000043268392,0.000047422298,0.00006453574,0.009255257],"study_design_scores_gemma":[0.008844272,0.00003409877,0.9830526,0.0002771587,0.0013728397,0.00001597119,0.000050267507,0.000012392632,0.00007354854,0.000040967265,0.005965498,0.0002603721],"about_ca_topic_score_codex":0.0008167131,"about_ca_topic_score_gemma":0.0000094949755,"teacher_disagreement_score":0.025633631,"about_ca_system_score_codex":0.00006829732,"about_ca_system_score_gemma":0.00020264518,"threshold_uncertainty_score":0.78719676},"labels":[],"label_agreement":null},{"id":"W2339352537","doi":"10.1177/2048872616644910","title":"Vorapaxar in patients with coronary artery bypass grafting: Findings from the TRA 2°P-TIMI 50 trial","year":2016,"lang":"en","type":"article","venue":"European Heart Journal Acute Cardiovascular Care","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"TIMI; Bypass grafting; Cardiology; Internal medicine; Artery; Medicine; Myocardial infarction; Percutaneous coronary intervention","score_opus":0.014622756238538606,"score_gpt":0.2206008544456109,"score_spread":0.2059780982070723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2339352537","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98276335,0.014131279,0.0005872941,0.00044157053,0.0005634426,0.0009959725,0.00010649242,0.00007517149,0.00033540517],"genre_scores_gemma":[0.995997,0.0012227213,0.00021373485,0.0009340609,0.0013463869,0.000013642842,0.00008215913,0.00013734498,0.00005296132],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99548775,0.00132086,0.00058141426,0.0005920521,0.0014203172,0.0005975931],"domain_scores_gemma":[0.9980017,0.00012728985,0.00010687038,0.0010591035,0.00033432993,0.00037072884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011015178,0.00044505444,0.0009863633,0.00014113115,0.00034600493,0.00012402379,0.00035783421,0.00009941209,0.0001091886],"category_scores_gemma":[0.00009306334,0.00023129351,0.002819778,0.0002738218,0.00018793541,0.00030637,0.000093630726,0.0006330202,0.00013201508],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07546731,0.00060971023,0.72760564,0.000053847263,0.04568441,0.013340824,0.0030270752,0.000119508935,0.00045277883,0.000005390315,0.008009541,0.12562396],"study_design_scores_gemma":[0.10110619,0.0012020097,0.7866365,0.00060217414,0.0028510394,0.0013023396,0.00055763917,5.987825e-7,0.00010669518,0.000006185627,0.10519198,0.00043664596],"about_ca_topic_score_codex":0.0000063099,"about_ca_topic_score_gemma":0.0000012124669,"teacher_disagreement_score":0.12518731,"about_ca_system_score_codex":0.00018230894,"about_ca_system_score_gemma":0.0001482813,"threshold_uncertainty_score":0.94318753},"labels":[],"label_agreement":null},{"id":"W2342529502","doi":"10.1016/j.amjmed.2015.10.046","title":"Updated Meta-Analysis of Aspirin in Primary Prevention of Cardiovascular Disease","year":2016,"lang":"en","type":"letter","venue":"The American Journal of Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Aspirin; Stroke (engine); Randomized controlled trial; Primary prevention; Myocardial infarction; Internal medicine; Guideline; Diabetes mellitus; Disease; Pathology; Endocrinology","score_opus":0.03793146895003479,"score_gpt":0.2879267569929576,"score_spread":0.24999528804292281,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2342529502","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2389989,0.24611588,0.0035935498,0.5091926,0.00029205251,0.0011295,0.00020523345,0.000020747837,0.00045155315],"genre_scores_gemma":[0.7411141,0.03045572,0.00031345338,0.22033735,0.0056932103,0.000037384867,0.0005370464,0.0002004857,0.0013112955],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99452305,0.0012575376,0.0015681478,0.00027911013,0.0020932206,0.00027895786],"domain_scores_gemma":[0.9953512,0.00027018736,0.002383777,0.0013085548,0.0005264437,0.00015982662],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030163794,0.0003602882,0.0066007385,0.0012076786,0.000020465766,0.0000026345667,0.00047246306,0.00010914752,0.0004876021],"category_scores_gemma":[0.00014197938,0.00016956605,0.009182827,0.001459722,0.0013229683,0.00006333934,0.000046265413,0.0008286024,0.0000016652061],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023769774,0.0001304865,0.000528377,0.00034428792,0.9205671,0.0017079815,0.00011471092,0.00050890626,0.00018138626,0.0000031396296,0.030789355,0.04274727],"study_design_scores_gemma":[0.0029899674,0.0012214136,0.010035248,0.00053406885,0.8488532,0.000151326,0.000099681674,0.000006853343,0.000047476926,0.00009291774,0.13579589,0.00017197723],"about_ca_topic_score_codex":0.00009405787,"about_ca_topic_score_gemma":6.5546925e-7,"teacher_disagreement_score":0.50211513,"about_ca_system_score_codex":0.000087121545,"about_ca_system_score_gemma":0.00037592926,"threshold_uncertainty_score":0.9261127},"labels":[],"label_agreement":null},{"id":"W2343474005","doi":"10.1016/j.jcin.2015.12.024","title":"Effect of Pre-Hospital Ticagrelor During the First 24 h After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction","year":2016,"lang":"en","type":"article","venue":"JACC: Cardiovascular Interventions","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Canadian Heart Research Centre; University of Toronto; Southlake Regional Health Center","funders":"AstraZeneca France","keywords":"Ticagrelor; Percutaneous coronary intervention; Medicine; Myocardial infarction; Internal medicine; Cardiology; Elevation (ballistics); Acute ST segment elevation myocardial infarction; ST segment; ST elevation; Intervention (counseling)","score_opus":0.0030502894674210974,"score_gpt":0.20424038335526778,"score_spread":0.2011900938878467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343474005","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99082005,0.0038852438,0.0024942541,0.000104773404,0.00039650663,0.002109561,0.000073001,0.000063607,0.000052977208],"genre_scores_gemma":[0.9988261,0.0002688121,0.000040155515,0.000025034149,0.00013147888,0.00040708898,0.000107665925,0.000050831066,0.00014285036],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973251,0.00040786937,0.00061798317,0.00046765635,0.0008666127,0.000314785],"domain_scores_gemma":[0.9986187,0.00008743549,0.00015842631,0.00083816546,0.00020995854,0.00008731138],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082348083,0.00030907404,0.0007061734,0.00022017884,0.00011871268,0.000027671997,0.00015284833,0.00013033835,0.00022287182],"category_scores_gemma":[0.00009173171,0.0001801686,0.0038042762,0.0002718424,0.00016883324,0.0002927904,0.00011045936,0.00020489267,0.00002191644],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011700918,0.0014458784,0.78933835,0.0019843236,0.0146944625,0.00021002982,0.00025025828,0.00028826192,0.00016497372,0.000008282235,0.000106370935,0.17980792],"study_design_scores_gemma":[0.009687696,0.0025191065,0.98116964,0.0022036077,0.002332607,0.00015005114,0.000037019752,0.0000057534207,0.0004421432,0.0000057747034,0.0012113993,0.000235224],"about_ca_topic_score_codex":0.00003480407,"about_ca_topic_score_gemma":0.000016072689,"teacher_disagreement_score":0.19183129,"about_ca_system_score_codex":0.0003947142,"about_ca_system_score_gemma":0.000031570486,"threshold_uncertainty_score":0.7347062},"labels":[],"label_agreement":null},{"id":"W2345567484","doi":"10.5539/gjhs.v9n1p89","title":"Dual Antiplatelet Therapy after Coronary Artery Bypass Graft Surgery: A Review","year":2016,"lang":"en","type":"review","venue":"Global Journal of Health Science","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Aspirin; Clopidogrel; Myocardial infarction; Angina; Acute coronary syndrome; Cardiology; Internal medicine; Unstable angina; Thrombosis; Surgery; Coronary artery disease; Artery; Complication; Platelet aggregation inhibitor","score_opus":0.04836212247325979,"score_gpt":0.3713743229087178,"score_spread":0.32301220043545803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2345567484","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005769669,0.996115,0.000052643685,0.0009265291,0.0011665715,0.00097388704,0.00009550211,0.000025065581,0.00006782466],"genre_scores_gemma":[0.0007202105,0.9951022,0.000085341664,0.0034817546,0.0005294367,0.000018457711,0.000011258425,0.000030066676,0.00002126868],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99398136,0.00045767872,0.0021670058,0.0005438318,0.001931771,0.0009183226],"domain_scores_gemma":[0.99595875,0.00012103,0.001837948,0.00069434807,0.00051554124,0.0008723777],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0056518354,0.0005450277,0.004651775,0.0003153869,0.000218403,0.000058022237,0.0005211307,0.00016932364,0.00020170264],"category_scores_gemma":[0.0001307932,0.00030615405,0.002727189,0.0013229284,0.0006636271,0.00040267713,0.00008362152,0.00046129955,0.00010486594],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016587958,0.00011378709,0.0005723271,0.0132124815,0.00053001905,0.0025503605,0.0000028072309,1.5429093e-8,1.4692617e-7,0.000007223795,0.0075588133,0.9752861],"study_design_scores_gemma":[0.00060716696,0.00030726328,0.0021025382,0.15103574,0.0004519716,0.062662855,0.0000033490253,4.8731877e-8,2.3409385e-7,0.00002122693,0.78256315,0.00024446007],"about_ca_topic_score_codex":0.0000030906385,"about_ca_topic_score_gemma":2.5801137e-7,"teacher_disagreement_score":0.9750417,"about_ca_system_score_codex":0.0005611781,"about_ca_system_score_gemma":0.010450337,"threshold_uncertainty_score":0.9999391},"labels":[],"label_agreement":null},{"id":"W2356178583","doi":"","title":"Interventional therapy and bypass surgery in octogenarians with angina pectoris","year":2003,"lang":"en","type":"article","venue":"Chinese Journal of Multiple Organ Diseases in the Elderly","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Conventional PCI; Angina; Myocardial infarction; Cardiology; Percutaneous coronary intervention; Internal medicine; Unstable angina; Revascularization; Coronary artery disease; Artery; Diabetes mellitus; Coronary artery bypass surgery; Clinical endpoint; Bypass surgery; Surgery; Canadian Cardiovascular Society; Randomized controlled trial","score_opus":0.014278415868710887,"score_gpt":0.24743224867219932,"score_spread":0.23315383280348842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2356178583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9686845,0.030464968,0.00014063851,0.00035055785,0.00012645249,0.00017289724,0.000011073721,0.00000851693,0.00004041333],"genre_scores_gemma":[0.99817,0.0013746254,0.00008204427,0.00014426092,0.00016651471,0.0000076362385,0.000008120369,0.000026286472,0.000020511383],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984765,0.00032881438,0.0004082847,0.00015869565,0.000418709,0.00020900839],"domain_scores_gemma":[0.99893963,0.00041941405,0.00016740029,0.00022983499,0.000104202605,0.0001395427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059490517,0.00020865956,0.00051278877,0.0002733851,0.00005745672,0.00003856054,0.00013044561,0.00005312736,0.00009062903],"category_scores_gemma":[0.00044446613,0.00010919958,0.0004133533,0.00045124252,0.00010801789,0.00018081634,0.000009028213,0.00025575122,0.0000012199281],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017601417,0.00102613,0.9860295,0.00006006855,0.00037801772,0.001187446,0.0005007253,0.00003232349,0.00020135018,0.000032706357,0.00016936028,0.008622201],"study_design_scores_gemma":[0.0067308675,0.00070049905,0.987979,0.00033578783,0.00012787891,0.0017974201,0.00073568634,0.000011408575,0.00009734161,0.00030529476,0.0010163322,0.00016246733],"about_ca_topic_score_codex":0.000011904807,"about_ca_topic_score_gemma":0.000030186291,"teacher_disagreement_score":0.029485518,"about_ca_system_score_codex":0.00004166051,"about_ca_system_score_gemma":0.00019336832,"threshold_uncertainty_score":0.44530296},"labels":[],"label_agreement":null},{"id":"W2378256387","doi":"","title":"Should patients prescribed long-term low-dose aspirin receive proton pump inhibitors? Systematic review and meta-analysis","year":2014,"lang":"en","type":"article","venue":"Medical Decision Making","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Aspirin; Internal medicine; Clopidogrel; Observational study; Randomized controlled trial; Cohort study; Proton-pump inhibitor; Relative risk; Adverse effect; Cohort; Meta-analysis; Medical prescription; Intensive care medicine; Confidence interval; Pharmacology","score_opus":0.0390957876871832,"score_gpt":0.3338881069804447,"score_spread":0.2947923192932615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2378256387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.70917994,0.21916306,0.052453723,0.0017141913,0.00035110587,0.01611826,0.00003449366,0.0003252706,0.00065992726],"genre_scores_gemma":[0.99059314,0.002832098,0.00025324314,0.005537197,0.00009424174,0.0004778997,0.000051091163,0.00004061445,0.00012048974],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99507844,0.00062378525,0.0010697953,0.00061353826,0.0022965982,0.00031783085],"domain_scores_gemma":[0.99766403,0.00045723064,0.0002971547,0.00087759004,0.00024748445,0.00045649474],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0025526604,0.00033346209,0.0029481591,0.00022648319,0.00011616049,0.00005905512,0.00024137218,0.00021671766,0.001361004],"category_scores_gemma":[0.0039726514,0.00020254502,0.0018606463,0.0005901102,0.00010642579,0.0001192614,0.00015578358,0.00032539698,0.000059880735],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010545314,0.0018614703,0.03865859,0.5244265,0.31493154,0.0008791815,0.00028204155,0.000018447692,0.000020474754,0.00009259453,0.0012803327,0.11649427],"study_design_scores_gemma":[0.003343911,0.00043302402,0.026966942,0.047418315,0.9197211,0.00010418248,0.000014993451,0.0007442518,0.0001128712,0.00018960454,0.00035472907,0.0005960791],"about_ca_topic_score_codex":0.000002305878,"about_ca_topic_score_gemma":0.0000032424034,"teacher_disagreement_score":0.60478956,"about_ca_system_score_codex":0.000039339033,"about_ca_system_score_gemma":0.000045873305,"threshold_uncertainty_score":0.9995519},"labels":[],"label_agreement":null},{"id":"W2383273465","doi":"10.1016/j.cjca.2015.07.197","title":"LESS BLEEDING AND COMPARABLE ANTITHROMBOTIC EFFICACY WITH SHORTENED DURATION OF DUAL ANTIPLATELET THERAPY AFTER PERCUTANEOUS CORONARY INTERVENTION WITH 2ND GENERATION DRUG ELUTING STENTS","year":2015,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Toronto Public Health","funders":"","keywords":"Medicine; Percutaneous coronary intervention; Conventional PCI; Prasugrel; Acute coronary syndrome; Internal medicine; Clopidogrel; Ticagrelor; Stent; Cardiology; Myocardial infarction; Zotarolimus; Odds ratio; Drug-eluting stent; Surgery","score_opus":0.034742021823035964,"score_gpt":0.24461837991614552,"score_spread":0.20987635809310956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2383273465","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916595,0.005655488,0.002093127,0.000089736895,0.0001643222,0.00022032911,0.0000075958874,0.0000053869985,0.000104504354],"genre_scores_gemma":[0.9990061,0.00030046474,0.00024080562,0.000048427868,0.00034016452,0.0000017997171,0.000025815092,0.000020892001,0.000015508416],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99887335,0.00017584319,0.00036033642,0.00015761786,0.00021467295,0.00021817508],"domain_scores_gemma":[0.99888706,0.000024379871,0.0002062797,0.00012736848,0.00040608217,0.0003488014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044864064,0.00015022453,0.0006141613,0.00019386626,0.000072864386,0.000026135789,0.000049506816,0.00007493716,0.000007902939],"category_scores_gemma":[0.000021290562,0.00010917763,0.00014855551,0.00010651798,0.000201405,0.00016430177,0.0000054989987,0.00016109369,4.635645e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010509344,0.00006514297,0.8921896,0.00013352591,0.0060151876,0.010473344,0.0022208623,0.02744051,0.010330781,0.000034386227,0.00048419784,0.040103074],"study_design_scores_gemma":[0.026289858,0.008739627,0.8078662,0.0012146628,0.002478542,0.13609797,0.008917535,0.0018383468,0.004042889,0.000028870203,0.0017731063,0.0007123702],"about_ca_topic_score_codex":0.00024494273,"about_ca_topic_score_gemma":0.0005354802,"teacher_disagreement_score":0.12562463,"about_ca_system_score_codex":0.00007718991,"about_ca_system_score_gemma":0.00042850507,"threshold_uncertainty_score":0.44521347},"labels":[],"label_agreement":null},{"id":"W2394645284","doi":"10.1024/0040-5930/a000339","title":"Neue Antiaggregantien - klinische Aspekte","year":2012,"lang":"de","type":"review","venue":"Therapeutische Umschau","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"","keywords":"Prasugrel; Ticagrelor; Medicine; Clopidogrel; Intensive care medicine; Aspirin; Acute coronary syndrome; Disease; Myocardial infarction; Internal medicine","score_opus":0.08303898831714443,"score_gpt":0.33075927829890517,"score_spread":0.24772028998176074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2394645284","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007217392,0.9832487,0.0004609362,0.000321738,0.0045892755,0.0032414477,0.000304884,0.00047222854,0.00663902],"genre_scores_gemma":[0.00662991,0.9735912,0.00026860225,0.0016737409,0.009885885,0.00021307275,0.0014406365,0.00072554307,0.0055713938],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98953414,0.0019232784,0.0021456785,0.0018500118,0.0018520032,0.0026948713],"domain_scores_gemma":[0.99307746,0.00040475544,0.0012540112,0.0035266096,0.00029989585,0.0014372681],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.0025729942,0.002555661,0.0063470155,0.0005930321,0.0006419008,0.0002457875,0.0014184668,0.0021632137,0.0075487834],"category_scores_gemma":[0.000062621104,0.0020598,0.0061831917,0.0012814759,0.0007692894,0.0005364496,0.00040713957,0.0029095423,0.02649593],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041621897,0.00088945276,0.00047054386,0.009067136,0.028937211,0.00048131245,0.00041568486,0.0000015905671,0.000042568594,0.00085996144,0.0010038504,0.95741445],"study_design_scores_gemma":[0.0030160185,0.0004512981,0.0002395178,0.009647885,0.049776185,0.00058054895,0.000086826454,0.00001552477,0.00015908615,0.000031358624,0.93395233,0.0020434214],"about_ca_topic_score_codex":0.000043759657,"about_ca_topic_score_gemma":0.0000026147636,"teacher_disagreement_score":0.955371,"about_ca_system_score_codex":0.00018005972,"about_ca_system_score_gemma":0.0012669917,"threshold_uncertainty_score":0.9993908},"labels":[],"label_agreement":null},{"id":"W2397867274","doi":"10.1056/nejmoa0805002","title":"Aspirin and Extended-Release Dipyridamole versus Clopidogrel for Recurrent Stroke","year":2008,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":966,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Population Health Research Institute; Boehringer Ingelheim (Canada)","funders":"National Institute of Neurological Disorders and Stroke","keywords":"Dipyridamole; Clopidogrel; Aspirin; Medicine; Stroke (engine); Ticlopidine; Cardiology; Internal medicine; Anesthesia; Physics","score_opus":0.034480340047675515,"score_gpt":0.2930483216181666,"score_spread":0.25856798157049105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2397867274","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95264226,0.04001318,0.0026790071,0.002805103,0.0010408352,0.00024633008,0.000008293574,0.000016353799,0.000548613],"genre_scores_gemma":[0.98243177,0.010357845,0.00073124876,0.0003633347,0.0056056217,0.0000026163398,0.000010523708,0.000021368598,0.0004756992],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987444,0.000052953797,0.00039847748,0.00014470225,0.00045851246,0.00020091396],"domain_scores_gemma":[0.9987643,0.00019465026,0.00017920321,0.00016137546,0.00019244126,0.0005080621],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046226167,0.00016084117,0.00057789683,0.00014130135,0.00008456199,0.0000043694463,0.00007215272,0.0000618831,0.00008499712],"category_scores_gemma":[0.00033707297,0.00010554587,0.00024878312,0.000082373146,0.00016595781,0.00007207364,0.0000125893075,0.00023763596,0.0000019392003],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028636321,0.00020677823,0.0034938997,0.00012574586,0.0010468703,0.0010628644,0.00054883544,0.0000111813815,0.0010517588,0.00016038027,0.013440595,0.95021474],"study_design_scores_gemma":[0.367224,0.022032382,0.03909697,0.0009197998,0.0020081063,0.010279115,0.00040814688,0.00010796273,0.00081658526,0.00035924304,0.5564639,0.0002837669],"about_ca_topic_score_codex":0.0000102416625,"about_ca_topic_score_gemma":0.0000037896243,"teacher_disagreement_score":0.949931,"about_ca_system_score_codex":0.000028910374,"about_ca_system_score_gemma":0.00019368215,"threshold_uncertainty_score":0.43040356},"labels":[],"label_agreement":null},{"id":"W2398172984","doi":"10.1177/0310057x1404200508","title":"Evaluation of Differences in Patient and Physician Perception of Benefit and Risks of Aspirin and Antifibrinolytic Therapy in Cardiac Surgery","year":2014,"lang":"en","type":"article","venue":"Anaesthesia and Intensive Care","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Aspirin; Antifibrinolytic; Myocardial infarction; Perioperative; Stroke (engine); Intensive care medicine; Surgery; Anesthesia; Internal medicine; Tranexamic acid","score_opus":0.046110562319240884,"score_gpt":0.2846024811725847,"score_spread":0.2384919188533438,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2398172984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9790706,0.020598222,0.0000015063838,0.00003400286,0.000012246233,0.0002488204,0.000006311915,0.0000019910433,0.000026287707],"genre_scores_gemma":[0.9847563,0.015115052,0.0000048514953,0.000092124355,0.000008527575,0.0000061116352,0.000010736603,0.0000059508234,3.6760136e-7],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992261,0.0001427249,0.00019769536,0.0001606041,0.00019820286,0.000074681775],"domain_scores_gemma":[0.9990683,0.000058753347,0.00008480236,0.00009953755,0.0006574419,0.00003116749],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026744924,0.00009297078,0.0005237401,0.00012580783,0.000012940276,0.000003581121,0.000011777564,0.000051429237,0.0000012597991],"category_scores_gemma":[0.00007905474,0.000074740514,0.00007443779,0.000071909395,0.0001643389,0.00004683289,0.000010539567,0.0000401425,3.450228e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000091258975,0.000012200499,0.5497236,0.00011022752,0.000049001217,0.0000011514791,0.0021518723,0.0000010852606,0.00159261,0.000011712053,0.0000013201843,0.4462539],"study_design_scores_gemma":[0.00071932666,0.000574779,0.97846025,0.00052714546,0.00015354095,0.0000038610133,0.016269919,0.00020353543,0.0029268963,0.00008366254,0.000008368425,0.000068691996],"about_ca_topic_score_codex":0.0002961587,"about_ca_topic_score_gemma":0.00002042864,"teacher_disagreement_score":0.44618523,"about_ca_system_score_codex":0.00000944356,"about_ca_system_score_gemma":0.000025271545,"threshold_uncertainty_score":0.30478296},"labels":[],"label_agreement":null},{"id":"W2398769057","doi":"10.7326/acpjc-2002-136-1-005","title":"Abciximab was more effective than tirofiban in preventing ischemic events in patients having coronary stenting","year":2002,"lang":"en","type":"article","venue":"ACP Journal Club","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Tirofiban; Abciximab; Medicine; Cardiology; Internal medicine; Revascularization; Coronary stenting; Percutaneous coronary intervention; Stent; Myocardial infarction; Restenosis","score_opus":0.009560753313377798,"score_gpt":0.24225297171169016,"score_spread":0.23269221839831236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2398769057","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949159,0.0037715172,0.000023434382,0.00007312548,0.00016954266,0.00048209212,0.0000019951729,0.000020938178,0.00054145016],"genre_scores_gemma":[0.9989785,0.00035509473,0.00008345527,0.00013735528,0.00015732896,0.000013961628,0.000011827701,0.000036850422,0.00022563685],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99817324,0.00019427012,0.000444646,0.0002584497,0.00049061055,0.0004387938],"domain_scores_gemma":[0.99934494,0.00006260154,0.00017959866,0.00019617616,0.000070477436,0.00014620919],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052813714,0.00020526246,0.00042838333,0.00021148844,0.00012488975,0.00001814865,0.0001348813,0.00010470673,0.000114941206],"category_scores_gemma":[0.0001309045,0.00018454419,0.00036555267,0.0002536033,0.0000312022,0.00030978187,0.00006983838,0.0006271028,0.000023630773],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026007873,0.0004668741,0.94685745,0.00006718638,0.000211935,0.00035062697,0.00077728956,0.000031861193,0.0004451445,5.4723876e-7,0.0001340105,0.050397],"study_design_scores_gemma":[0.0076117804,0.00019765635,0.9888223,0.0012461267,0.00011861389,0.00032948094,0.00047394156,0.0003102756,0.00049467915,0.000023463963,0.00018575204,0.00018595402],"about_ca_topic_score_codex":0.00001449052,"about_ca_topic_score_gemma":0.0000032860833,"teacher_disagreement_score":0.050211046,"about_ca_system_score_codex":0.00021649999,"about_ca_system_score_gemma":0.000023992654,"threshold_uncertainty_score":0.75254935},"labels":[],"label_agreement":null},{"id":"W2403012624","doi":"10.1055/s-0028-1087133","title":"Acetylsalicylic Acid, Hemostasis and Human Thromboembolism","year":2008,"lang":"en","type":"review","venue":"Seminars in Thrombosis and Hemostasis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Saint-Sacrement","funders":"","keywords":"Hemostasis; Medicine; Thrombosis; Internal medicine","score_opus":0.0689182180570729,"score_gpt":0.3704430769552784,"score_spread":0.30152485889820546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2403012624","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012371463,0.98469144,0.0000028731822,0.00014196038,0.00010709745,0.0012119156,0.0001649641,0.00010186417,0.001206422],"genre_scores_gemma":[0.0014041604,0.99689656,0.00036582924,0.00036496748,0.00021372868,0.0001385032,0.00031826316,0.00017833854,0.000119627555],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963854,0.00024446976,0.00093870057,0.001180777,0.0005305713,0.00072008633],"domain_scores_gemma":[0.9981553,0.00013239711,0.00029140853,0.0009211317,0.00006556129,0.00043418468],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003402255,0.0010037682,0.00495169,0.00048975536,0.00039267473,0.0000818512,0.00022469251,0.0008321358,0.00016886304],"category_scores_gemma":[0.000048838338,0.00084800745,0.0011812925,0.0006947869,0.0006141297,0.00015908567,0.0002665421,0.00076757954,0.000023199505],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015120066,0.00024991488,0.00068215054,0.008517083,0.0015474302,0.00018424056,0.00038701828,3.051053e-8,0.000011181729,0.00019449473,0.0045763077,0.983635],"study_design_scores_gemma":[0.0013968884,0.0002423703,0.0016557886,0.02088688,0.0033908403,0.0014872951,0.0003157249,7.604241e-7,0.00006428757,0.00009403832,0.9695299,0.000935177],"about_ca_topic_score_codex":0.00007845581,"about_ca_topic_score_gemma":0.000011652757,"teacher_disagreement_score":0.9826999,"about_ca_system_score_codex":0.000157402,"about_ca_system_score_gemma":0.00020984218,"threshold_uncertainty_score":0.9993971},"labels":[],"label_agreement":null},{"id":"W2407442640","doi":"10.1088/1752-7155/10/1/017104","title":"Changes in CYP2C19 enzyme activity evaluated by the [ <sup>13</sup> C]-pantoprazole breath test after co-administration of clopidogrel and proton pump inhibitors following percutaneous coronary intervention and correlation to platelet reactivity","year":2016,"lang":"en","type":"article","venue":"Journal of Breath Research","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut Universitaire de Cardiologie et de Pneumologie de Québec","funders":"","keywords":"Clopidogrel; CYP2C19; Pantoprazole; Percutaneous coronary intervention; Aspirin; Medicine; Proton-pump inhibitor; Pharmacology; Conventional PCI; Omeprazole; Internal medicine; Cardiology; Cytochrome P450; Myocardial infarction; Metabolism","score_opus":0.02713219117101998,"score_gpt":0.3431516886513321,"score_spread":0.3160194974803121,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2407442640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961569,0.001240259,0.00013819503,0.0011957432,0.00002976731,0.0011610258,0.00003403306,0.0000075976914,0.000036512498],"genre_scores_gemma":[0.9987202,0.0009377359,0.000013499505,0.000022223781,0.00010556507,0.000044533874,0.0000070672895,0.000019636194,0.00012950928],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9976281,0.0005556448,0.00036893593,0.00023946975,0.0009370708,0.0002708052],"domain_scores_gemma":[0.9985976,0.0005826971,0.00017185551,0.00020001843,0.00027267914,0.00017513067],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003068401,0.00015616821,0.00041206108,0.0002976514,0.000101310376,0.000042020318,0.000080821184,0.00014126254,0.000030978874],"category_scores_gemma":[0.00047185205,0.0000952177,0.00016502525,0.0002447945,0.00015853638,0.00031844826,0.000052727853,0.00040356698,0.0000021032245],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018834293,0.0011424988,0.36976707,0.0003076363,0.0004714738,0.0016985057,0.0019077681,0.000021114129,0.19560303,0.0000015160916,0.00019982015,0.4100453],"study_design_scores_gemma":[0.008721079,0.009394442,0.8300703,0.0032531125,0.00031025874,0.012678512,0.0015549209,0.0013652673,0.13130383,0.00006640904,0.0009788844,0.00030296648],"about_ca_topic_score_codex":0.00010591752,"about_ca_topic_score_gemma":0.00005749806,"teacher_disagreement_score":0.46030325,"about_ca_system_score_codex":0.00016580704,"about_ca_system_score_gemma":0.00015665045,"threshold_uncertainty_score":0.38828653},"labels":[],"label_agreement":null},{"id":"W2407458675","doi":"10.1093/eurheartj/ehw203","title":"Biolimus-A9 polymer-free coated stent in high bleeding risk patients with acute coronary syndrome: a<i>Leaders Free ACS</i>sub-study","year":2016,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canada Excellence Research Chairs, Government of Canada","keywords":"Medicine; Percutaneous coronary intervention; Conventional PCI; Acute coronary syndrome; Myocardial infarction; Stent; Internal medicine; Cardiology; Revascularization; Surgery; Interventional cardiology","score_opus":0.015867415951142678,"score_gpt":0.23190243878596184,"score_spread":0.21603502283481915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2407458675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969562,0.0011661431,0.00007959716,0.0006115307,0.000348046,0.0005371322,0.00008110434,0.000086634354,0.00013359117],"genre_scores_gemma":[0.9982413,0.0007541345,0.00006776972,0.00042385093,0.00020858501,0.000004463296,0.00001340771,0.000108588145,0.00017786727],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99694043,0.0007601122,0.0004897697,0.0004156664,0.0008137953,0.00058020244],"domain_scores_gemma":[0.9983985,0.00006684917,0.00019609189,0.0007510833,0.00013945423,0.0004480618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007821435,0.0003407903,0.0005779058,0.0002776862,0.0002649882,0.00005660983,0.00037084363,0.00005196258,0.00015046385],"category_scores_gemma":[0.00007801125,0.0002072907,0.00027981965,0.00030932008,0.00017788968,0.00028665227,0.00016946644,0.0005269201,0.00012628218],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020212065,0.00088955404,0.9783815,0.000011288403,0.0018202823,0.0074785873,0.00029709816,0.000004543336,0.001316969,0.0000017660086,0.002885264,0.004891939],"study_design_scores_gemma":[0.024427952,0.0031652076,0.9659438,0.0005542658,0.00064526044,0.0032331387,0.0004782692,0.0000010125825,0.0006184964,0.0000073733545,0.0006197531,0.00030547942],"about_ca_topic_score_codex":0.000017599754,"about_ca_topic_score_gemma":0.000004863534,"teacher_disagreement_score":0.022406746,"about_ca_system_score_codex":0.00011272554,"about_ca_system_score_gemma":0.00010002349,"threshold_uncertainty_score":0.84530693},"labels":[],"label_agreement":null},{"id":"W2409947585","doi":"10.1136/heartjnl-2016-309890.109","title":"109 Marked Differences in the Pharmacodynamics of Modern P2Y12 Inhibitors in Patients Undergoing Treatment for ST Segment Elevation MI (STEMI) and Non ST Segment Elevation MI (NSTEMI)","year":2016,"lang":"en","type":"article","venue":"Heart View","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Ottawa Mental Health Centre","funders":"","keywords":"Prasugrel; Ticagrelor; Medicine; P2Y12; Internal medicine; Cardiology; Myocardial infarction; Acute coronary syndrome; Clopidogrel; Pharmacodynamics; Aspirin; ST segment; Unstable angina; Pharmacokinetics","score_opus":0.020082395480545995,"score_gpt":0.2655131181217669,"score_spread":0.24543072264122093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2409947585","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99302125,0.002844342,0.0020204047,0.00035964674,0.000075716205,0.0016018924,0.000043778564,0.000009912504,0.000023062981],"genre_scores_gemma":[0.99468213,0.0046804682,0.00009968718,0.00016599483,0.000046397538,0.00018658926,0.00008061449,0.0000151788,0.000042959236],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99869996,0.00015376325,0.0004024784,0.00023890565,0.0003106375,0.00019425967],"domain_scores_gemma":[0.99943155,0.00017202062,0.00011290759,0.00017882769,0.0000532529,0.00005145812],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041126492,0.0001644983,0.0003585928,0.00009224097,0.000050389437,0.0000106205325,0.00004290024,0.00005986864,0.000017927552],"category_scores_gemma":[0.00002300905,0.00009836491,0.00013314784,0.00012321828,0.000035503796,0.00010237255,0.00001441687,0.00004748011,0.000001055653],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010752269,0.00081283256,0.6246512,0.001066434,0.00030045677,0.0000045536362,0.00096840295,0.000023684264,0.0061336937,0.00003563305,0.00018118919,0.3647467],"study_design_scores_gemma":[0.039176874,0.00337946,0.9290985,0.008246974,0.00079088326,0.000015618061,0.001109764,0.0041749305,0.009075537,0.00049144286,0.0038242878,0.00061571406],"about_ca_topic_score_codex":0.000018648016,"about_ca_topic_score_gemma":0.000050250146,"teacher_disagreement_score":0.36413097,"about_ca_system_score_codex":0.00017815288,"about_ca_system_score_gemma":0.00007664471,"threshold_uncertainty_score":0.40112045},"labels":[],"label_agreement":null},{"id":"W2409965891","doi":"","title":"Comparison of abciximab and eptifibatide on angiographic and clinical outcomes in rescue percutaneous coronary intervention for failed fibrinolytic therapy.","year":2010,"lang":"en","type":"article","venue":"PubMed","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Abciximab; Medicine; TIMI; Eptifibatide; Conventional PCI; Percutaneous coronary intervention; Cardiology; Myocardial infarction; Internal medicine; Mace; Thrombolysis; Reteplase","score_opus":0.03864895774826428,"score_gpt":0.3322113818711186,"score_spread":0.2935624241228543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2409965891","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963894,0.0019828063,0.000023278768,0.00013933597,0.00012561228,0.0012539279,0.000013232809,0.000022756372,0.00004963434],"genre_scores_gemma":[0.9987821,0.00072382326,0.0001258294,0.00007483313,0.000041091193,0.00015737192,0.00001771343,0.00001630576,0.00006092983],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989867,0.000067501904,0.00037832125,0.00024559916,0.00013850248,0.00018338075],"domain_scores_gemma":[0.9993272,0.0002482769,0.00006899554,0.00021576852,0.000036060603,0.00010371149],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004394585,0.00012149936,0.0005161491,0.00013694353,0.00003015074,0.0000117911095,0.00004678442,0.00011196657,0.000009008649],"category_scores_gemma":[0.00013275615,0.00009574073,0.00042478726,0.000069691196,0.00016788027,0.000042865544,0.000018649664,0.0001678391,4.0206882e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015404504,0.000363131,0.69029886,0.00006078391,0.00034323276,0.000015956835,0.000049314585,8.446681e-7,0.00008407517,0.00003063695,0.0000131279085,0.3071996],"study_design_scores_gemma":[0.0049229283,0.0004905803,0.99349564,0.00003946632,0.00014205831,0.00006142329,0.00011388677,0.0001372371,0.00019706022,0.00010165115,0.00020411382,0.000093941744],"about_ca_topic_score_codex":0.000028881153,"about_ca_topic_score_gemma":0.00008297103,"teacher_disagreement_score":0.30710566,"about_ca_system_score_codex":0.000007097226,"about_ca_system_score_gemma":0.000010344817,"threshold_uncertainty_score":0.39041936},"labels":[],"label_agreement":null},{"id":"W2409973356","doi":"10.20452/pamw.911","title":"Antiplatelet therapy in patients with atherosclerotic coronary artery disease undergoing elective endoscopic gastrointestinal procedures. Key messages for clinical practice","year":2010,"lang":"en","type":"article","venue":"Polskie Archiwum Medycyny Wewnętrznej","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Clopidogrel; Discontinuation; Coronary artery disease; Aspirin; Stent; Surgery; Internal medicine","score_opus":0.01875553938143512,"score_gpt":0.30402118533350647,"score_spread":0.2852656459520714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2409973356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99206895,0.00070623803,0.0022764003,0.0009006286,0.00024293433,0.0031267211,0.000056836438,0.00015784118,0.00046347463],"genre_scores_gemma":[0.9860852,0.0008064526,0.01060372,0.0014175188,0.00039039235,0.00029207824,0.00017648237,0.00013360553,0.000094589166],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99641824,0.00031467938,0.00070423854,0.0009187135,0.0007569422,0.0008871698],"domain_scores_gemma":[0.9965317,0.0014412587,0.0002870023,0.0007487373,0.0003395923,0.0006516972],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007850394,0.0005245783,0.0008130771,0.00021850535,0.00022428353,0.00006709863,0.00028257,0.000121724544,0.000061324354],"category_scores_gemma":[0.0025862197,0.00041454448,0.00045676093,0.00029381222,0.00041543244,0.00042663424,0.000064464955,0.0009276966,0.000022181013],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021476336,0.0032242874,0.9470271,0.00023082833,0.00083122455,0.00042732066,0.00025048514,0.000011241014,0.00061427243,0.00054893707,0.0002307156,0.025127245],"study_design_scores_gemma":[0.021427024,0.0034201483,0.97030234,0.0007245631,0.0003403543,0.0002518707,0.00011842941,0.000050616203,0.00015822946,0.00059144176,0.0021934544,0.00042150498],"about_ca_topic_score_codex":0.000012560972,"about_ca_topic_score_gemma":0.000060201957,"teacher_disagreement_score":0.02470574,"about_ca_system_score_codex":0.00006206106,"about_ca_system_score_gemma":0.0010904085,"threshold_uncertainty_score":0.99983066},"labels":[],"label_agreement":null},{"id":"W2410426826","doi":"10.3810/pgm.2005.01.1566","title":"Stroke prevention","year":2005,"lang":"en","type":"review","venue":"Postgraduate Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre","funders":"","keywords":"Medicine; Stroke (engine); Clopidogrel; Ischemic stroke; Intensive care medicine; Randomized controlled trial; Clinical trial; Minor stroke; Cardiology; Aspirin; Internal medicine; Ischemia","score_opus":0.10554034697612029,"score_gpt":0.40677337627046767,"score_spread":0.30123302929434737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2410426826","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000014062541,0.99165195,0.00012455744,0.0005127299,0.00039427276,0.0014140314,0.000035739402,0.00018856408,0.0056640664],"genre_scores_gemma":[0.000022569193,0.9822745,0.00013165432,0.00027484781,0.0029031902,0.00009709143,0.0008551043,0.00012269687,0.01331838],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972134,0.00021375349,0.00083453755,0.0005796931,0.0007339724,0.00042459503],"domain_scores_gemma":[0.998319,0.00008369989,0.00030790674,0.00082011084,0.0001150166,0.00035431117],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00046976385,0.00062609225,0.0033405249,0.0003858825,0.000081529826,0.000011494753,0.0001946004,0.00033059568,0.0008691881],"category_scores_gemma":[0.00012639118,0.0004089949,0.0018662267,0.0003699527,0.00020255579,0.00006209101,0.00004694483,0.0005639682,0.00056623324],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004134082,0.00011175485,0.0000035321732,0.006274647,0.0017213308,0.00020961429,0.000023032628,5.809305e-8,6.855859e-7,0.00005898362,0.003662326,0.9878927],"study_design_scores_gemma":[0.0017553142,0.0004885102,0.000018116294,0.028015072,0.012416516,0.0013553991,0.000018394008,0.0000018254972,9.879598e-7,0.000026053198,0.95558465,0.0003191433],"about_ca_topic_score_codex":0.000011860169,"about_ca_topic_score_gemma":0.0000017711708,"teacher_disagreement_score":0.98757356,"about_ca_system_score_codex":0.00014018564,"about_ca_system_score_gemma":0.00033652651,"threshold_uncertainty_score":0.9998362},"labels":[],"label_agreement":null},{"id":"W2412372380","doi":"10.1161/circulationaha.111.046243","title":"Aspirin","year":2012,"lang":"en","type":"article","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton General Hospital","funders":"","keywords":"Medicine; Aspirin; Stroke (engine); Blood flow; Blood pressure; Cardiology; Internal medicine; Surgery","score_opus":0.022988717751216227,"score_gpt":0.26846754506302123,"score_spread":0.245478827311805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2412372380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872659,0.0022764679,0.0033140564,0.000049081227,0.00010076957,0.000091699134,4.0514504e-7,0.000051657567,0.0068499898],"genre_scores_gemma":[0.9992662,0.000017824455,0.00008485558,0.00021353099,0.00032701495,0.0000038160924,0.000028411165,0.0000067917777,0.000051521492],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996916,0.000012800942,0.000051829335,0.000048428174,0.000101119804,0.00009423816],"domain_scores_gemma":[0.999785,0.000004448118,0.000011660913,0.000111859204,0.000017494292,0.00006952595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008429509,0.00003551235,0.00006662249,0.000022700333,0.000025773297,0.0000032375856,0.000009929533,0.000029033114,0.00016572815],"category_scores_gemma":[0.000009489383,0.000031871175,0.000099227764,0.000055914123,0.000010502883,0.00008314474,0.0000030151177,0.000027026246,0.00018684064],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022710268,0.000060226143,0.94162416,0.000021389202,0.00008033228,0.0000026488447,0.00007839443,0.000018158567,0.0033834206,0.0011370963,0.00011575988,0.05345567],"study_design_scores_gemma":[0.0003929762,0.00000522165,0.9805332,0.000011033286,0.00006997935,0.000048999853,0.000017745131,0.00006204652,0.00082837784,0.00005906388,0.017930489,0.000040898984],"about_ca_topic_score_codex":0.000001220085,"about_ca_topic_score_gemma":3.6335184e-8,"teacher_disagreement_score":0.05341477,"about_ca_system_score_codex":0.00001610106,"about_ca_system_score_gemma":0.000009196101,"threshold_uncertainty_score":0.24015208},"labels":[],"label_agreement":null},{"id":"W2413284498","doi":"10.1016/j.jacc.2016.04.019","title":"Dual Antiplatelet Therapy in the Prevention of Recurrent Ischemic Events ∗","year":2016,"lang":"en","type":"letter","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Internal medicine; Cardiology; Coronary artery disease; Myocardial infarction; CAD","score_opus":0.017679292115177332,"score_gpt":0.2797162612032589,"score_spread":0.26203696908808155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2413284498","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8797281,0.0065756207,0.000084976455,0.11146953,0.00079578836,0.00067339354,0.00019813397,0.0000039824854,0.00047047177],"genre_scores_gemma":[0.9546954,0.013680048,0.00006204238,0.027064536,0.0041495906,0.00001283423,0.0000139287995,0.000045966834,0.00027562788],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961569,0.001572105,0.0009729824,0.0001995662,0.0007997858,0.0002986924],"domain_scores_gemma":[0.9965421,0.0003324242,0.0020992188,0.00068494934,0.00030425732,0.00003707051],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012897743,0.0002779535,0.0020411087,0.0002580311,0.00003496292,0.0000020539835,0.00059807644,0.00024785218,0.000018286188],"category_scores_gemma":[0.00012349179,0.00013102511,0.00243563,0.00039645252,0.0005911791,0.000046944046,0.00006193004,0.0010889798,0.0000014971524],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005837452,0.00014448106,0.012572659,0.00021131108,0.007322781,0.002136282,0.0000878195,0.000023134062,0.004929623,0.000010803893,0.93818974,0.028533928],"study_design_scores_gemma":[0.0059562554,0.0038840803,0.024281004,0.0013963392,0.0012258916,0.010637316,0.00029402983,0.000001038317,0.0020401212,0.00039132228,0.94963044,0.000262158],"about_ca_topic_score_codex":0.000003693984,"about_ca_topic_score_gemma":4.0835246e-7,"teacher_disagreement_score":0.08440499,"about_ca_system_score_codex":0.00007310566,"about_ca_system_score_gemma":0.000443365,"threshold_uncertainty_score":0.5343049},"labels":[],"label_agreement":null},{"id":"W2414622235","doi":"","title":"Thrombotic thrombocytopenic purpura associated with clopidogrel: further evaluation.","year":2002,"lang":"en","type":"article","venue":"PubMed","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Clopidogrel; Medicine; Thrombotic thrombocytopenic purpura; Internal medicine; Odds ratio; Concomitant; Epidemiology; Gastroenterology; Platelet; Surgery; Myocardial infarction","score_opus":0.05329822229294618,"score_gpt":0.2342240550137542,"score_spread":0.18092583272080803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2414622235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96848214,0.008129284,0.00007301909,0.0012726919,0.00016049967,0.0024116673,0.000007086561,0.00023309846,0.019230507],"genre_scores_gemma":[0.99619275,0.000319202,0.000029328465,0.00067474757,0.00015308168,0.0010544717,0.000037920137,0.000047995873,0.0014905189],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9980908,0.0001561259,0.00019842827,0.0003179568,0.0008009751,0.00043572724],"domain_scores_gemma":[0.99905044,0.000048435533,0.00008056225,0.0004335726,0.00018886037,0.00019810913],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005588246,0.00019063652,0.00042088202,0.000071128445,0.000091624395,0.00003808182,0.00010243403,0.00010083135,0.0015386017],"category_scores_gemma":[0.0001780903,0.00013967628,0.0002528986,0.00035590306,0.00011437363,0.00013958207,0.000018367573,0.0001536249,0.0001360823],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036520886,0.0014370128,0.09710528,0.00007131249,0.007600789,0.00026681714,0.0007173112,0.00015447765,0.00004473167,0.00018279714,0.008717608,0.88333666],"study_design_scores_gemma":[0.005772351,0.00011492459,0.9875611,0.000048930975,0.0015155271,0.00010140639,0.00010550646,0.0004483113,0.00013908041,0.00010320921,0.0038321503,0.00025749076],"about_ca_topic_score_codex":0.000004533039,"about_ca_topic_score_gemma":0.0000064580013,"teacher_disagreement_score":0.89045584,"about_ca_system_score_codex":0.00013945877,"about_ca_system_score_gemma":0.000037284815,"threshold_uncertainty_score":0.99937415},"labels":[],"label_agreement":null},{"id":"W2415180841","doi":"","title":"Aspirin and clopidogrel in patients with ACS undergoing PCI: CURE and PCI-CURE.","year":2003,"lang":"en","type":"article","venue":"PubMed","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences","funders":"","keywords":"Medicine; Conventional PCI; Clopidogrel; Aspirin; Cardiology; Internal medicine; Percutaneous coronary intervention; Myocardial infarction","score_opus":0.007380608950692273,"score_gpt":0.17843051211484523,"score_spread":0.17104990316415294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2415180841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99307287,0.0047460976,0.000035845816,0.00015494303,0.00004590094,0.0006329619,0.0000033375813,0.000025771711,0.0012822712],"genre_scores_gemma":[0.99842834,0.0008804893,0.00006888954,0.0003171417,0.000032901302,0.00008695131,0.000011917482,0.000019881476,0.00015349995],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991077,0.00005688128,0.00012104282,0.00023641049,0.00020481355,0.0002731188],"domain_scores_gemma":[0.9995721,0.000034196877,0.000033268978,0.00016496838,0.00003077986,0.00016466728],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017878872,0.0001309168,0.00024233248,0.00006987631,0.000042755313,0.000022041435,0.000026835976,0.00006814285,0.000007179922],"category_scores_gemma":[0.00005820272,0.00010103283,0.000043542164,0.00013796655,0.00007239057,0.00009496457,0.000015081267,0.00011532047,0.0000017879969],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027627955,0.00011973207,0.9210105,0.00009882047,0.00018450063,0.00006306128,0.000073577605,0.0000026895118,0.000001171504,0.00021709982,0.00011511467,0.07783744],"study_design_scores_gemma":[0.0069512776,0.00009110583,0.983085,0.00006423203,0.000111181296,0.000031824722,0.00007436248,0.0000012755077,0.00004421679,0.000100771234,0.00931026,0.00013450815],"about_ca_topic_score_codex":0.0000053297167,"about_ca_topic_score_gemma":0.000020126181,"teacher_disagreement_score":0.07770293,"about_ca_system_score_codex":0.000024696843,"about_ca_system_score_gemma":0.000034943896,"threshold_uncertainty_score":0.4119999},"labels":[],"label_agreement":null},{"id":"W2417061285","doi":"","title":"Aspirin resistance: does it exist and is it an important clinical problem?","year":2006,"lang":"en","type":"article","venue":"PubMed","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton General Hospital","funders":"","keywords":"Medicine; Aspirin; Intensive care medicine; Resistance (ecology); MEDLINE; Internal medicine; Law","score_opus":0.03191055143997365,"score_gpt":0.2954713553342433,"score_spread":0.2635608038942696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2417061285","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9688336,0.0051997155,0.000026171769,0.0041999784,0.00013744514,0.0009973579,0.000032169737,0.0000891276,0.020484392],"genre_scores_gemma":[0.9838168,0.0013915851,0.0002661032,0.0026380753,0.0006510474,0.00034798132,0.000047684985,0.000028348544,0.010812366],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99839735,0.000079952544,0.00047814715,0.00040330857,0.00029791213,0.00034330704],"domain_scores_gemma":[0.9991435,0.00003496681,0.00009240649,0.00040357187,0.000058255773,0.000267303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008483363,0.00015316626,0.00038597974,0.000042021158,0.00008090943,0.000042046726,0.000073813615,0.00011547033,0.000071597984],"category_scores_gemma":[0.00003713319,0.000105945845,0.00025386966,0.00009830137,0.00017414856,0.00010479444,0.00002373929,0.00014360218,0.000007370209],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021588453,0.0011798637,0.7143126,0.0004827511,0.0010592275,0.00092458306,0.00023007185,7.131737e-7,0.000060760933,0.0019154868,0.068683855,0.2089912],"study_design_scores_gemma":[0.0021743812,0.000051775372,0.6785043,0.00003653449,0.00025385615,0.00003406621,0.00013340982,0.0000022136294,0.00026393463,0.0018215191,0.31654802,0.0001760233],"about_ca_topic_score_codex":0.000036539946,"about_ca_topic_score_gemma":0.0001554712,"teacher_disagreement_score":0.24786416,"about_ca_system_score_codex":0.000020523932,"about_ca_system_score_gemma":0.000044127777,"threshold_uncertainty_score":0.4320346},"labels":[],"label_agreement":null},{"id":"W2417077379","doi":"10.1051/ject/201547113","title":"Performance Evaluation of the Plateletworks<sup>®</sup> in the Measurement of Blood Cell Counts as compared to the Beckman Coulter Unicel DXH 800","year":2015,"lang":"en","type":"article","venue":"Journal of ExtraCorporeal Technology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal University Hospital; University of Saskatchewan","funders":"","keywords":"Hematology analyzer; Medicine; Spectrum analyzer; Coefficient of variation; Accuracy and precision; Linearity; Biomedical engineering; Point-of-care testing; Reproducibility; Nuclear medicine; Statistics; Mathematics; Internal medicine; Pathology; Computer science","score_opus":0.050198061796073716,"score_gpt":0.2852009916151942,"score_spread":0.23500292981912047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2417077379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925348,0.003041458,0.000029904766,0.0012371808,0.000098222525,0.00041735324,0.00000302308,0.00000581878,0.0026322089],"genre_scores_gemma":[0.9993753,0.00026745492,0.00006803022,0.00015869804,0.00009038859,0.00000863111,0.0000014465412,0.000009029735,0.000021030482],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9979536,0.00015349525,0.00046621062,0.000089927766,0.0011963481,0.00014045351],"domain_scores_gemma":[0.99834895,0.00003102431,0.00038395627,0.0004099935,0.00078317575,0.00004289574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032120058,0.000103410384,0.0003160827,0.0001386093,0.000033437795,0.000004803201,0.00042110452,0.00011551051,0.000027820428],"category_scores_gemma":[0.00011972074,0.000050118284,0.00017482607,0.0004007924,0.00014729594,0.000040756906,0.000033151104,0.0003540762,0.000005729314],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01071458,0.007780824,0.29361814,0.0005556591,0.0065983343,0.0005397589,0.017124107,0.16485542,0.024039976,0.0028353296,0.047003426,0.42433444],"study_design_scores_gemma":[0.073471665,0.014186665,0.4555585,0.0053565335,0.020125348,0.01196118,0.038878687,0.057383128,0.1345,0.013856795,0.17313457,0.0015869248],"about_ca_topic_score_codex":0.000010884997,"about_ca_topic_score_gemma":0.000010149373,"teacher_disagreement_score":0.4227475,"about_ca_system_score_codex":0.0000599237,"about_ca_system_score_gemma":0.000338071,"threshold_uncertainty_score":0.20437643},"labels":[],"label_agreement":null},{"id":"W2418482154","doi":"10.1191/1358863x04vm526xx","title":"Vascular viewpoint","year":2004,"lang":"en","type":"letter","venue":"Vascular Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Medicine; Clopidogrel; Aspirin; Internal medicine; Myocardial infarction; Stroke (engine); Vascular disease; Population; Cardiology; Disease; Surgery","score_opus":0.016211958462759687,"score_gpt":0.24809993339048636,"score_spread":0.23188797492772667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2418482154","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00075953046,0.1894589,0.0033770143,0.7939919,0.0016193494,0.0022327134,0.00003091359,0.0006545698,0.007875071],"genre_scores_gemma":[0.0004795414,0.02454384,0.00043911237,0.94766784,0.021221135,0.00015461259,0.0020251884,0.0003777982,0.003090922],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99360293,0.00031133456,0.00093582534,0.0013204037,0.0027873425,0.001042175],"domain_scores_gemma":[0.99615335,0.00009166326,0.00025934706,0.0026937935,0.00035252346,0.00044930447],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.00096748583,0.0011008335,0.0029718108,0.00059433916,0.00018396352,0.000027898472,0.0004753481,0.0016650804,0.0034397354],"category_scores_gemma":[0.00028196545,0.0008184645,0.003502858,0.0006427173,0.00062015135,0.000093118186,0.0001050884,0.0031495236,0.0009033984],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006529529,0.0001310744,0.000046468518,0.0024180515,0.0092808,0.011207165,0.00015721291,0.000015764434,0.0001318604,0.0001159215,0.9640416,0.012388771],"study_design_scores_gemma":[0.008647373,0.0005576271,0.00076662085,0.0034284594,0.007532604,0.00097045104,0.000046578283,0.0000070826836,0.0000791788,0.0005697441,0.97660446,0.0007897981],"about_ca_topic_score_codex":0.00017109555,"about_ca_topic_score_gemma":0.000001733861,"teacher_disagreement_score":0.16491507,"about_ca_system_score_codex":0.00036528744,"about_ca_system_score_gemma":0.00060678186,"threshold_uncertainty_score":0.99987453},"labels":[],"label_agreement":null},{"id":"W2419375683","doi":"","title":"Results of the BRAT study--a pilot study investigating the possible significance of ASA nonresponsiveness on the benefits and risks of ASA on thrombosis in patients undergoing coronary artery bypass surgery.","year":2000,"lang":"en","type":"article","venue":"PubMed","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; McMaster University Medical Centre","funders":"","keywords":"Medicine; Internal medicine; Thrombosis; Bypass grafting; Artery; Cardiology; Coronary artery bypass surgery; Prospective cohort study; Surgery","score_opus":0.09760982604436161,"score_gpt":0.2725718175827292,"score_spread":0.17496199153836758,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2419375683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964847,0.00032644224,1.7351236e-7,0.00028514361,0.00008943508,0.0025671038,0.00004905096,0.000009188046,0.00018879236],"genre_scores_gemma":[0.99927986,0.000137976,0.0000010820136,0.00020586736,0.000030022024,0.00029437803,0.0000043277146,0.00001966365,0.000026803214],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970695,0.0011618192,0.00055777014,0.00029718576,0.0006726282,0.00024113926],"domain_scores_gemma":[0.99665546,0.002218448,0.00028989985,0.0006727522,0.00010316486,0.00006028505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018879918,0.00018431089,0.0005177924,0.00007922536,0.00013481373,0.000012982803,0.00020355043,0.000036018562,0.0000075143253],"category_scores_gemma":[0.000671214,0.00009676915,0.00014247037,0.00044797937,0.00024880774,0.000061216364,0.000051903695,0.00019197527,5.3724006e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004910081,0.0028982249,0.9425263,0.00004857694,0.000654579,0.0000052527957,0.0011976367,0.00067737675,0.00006458685,0.000008376859,0.000051724317,0.046957288],"study_design_scores_gemma":[0.0038174165,0.0014648514,0.9903721,0.00028506093,0.00020533186,0.0000013582026,0.0017733009,0.0000074297786,0.0019561711,0.000020326786,0.000005001556,0.00009162917],"about_ca_topic_score_codex":0.00021525397,"about_ca_topic_score_gemma":0.00014770679,"teacher_disagreement_score":0.047845826,"about_ca_system_score_codex":0.00003405971,"about_ca_system_score_gemma":0.0000962014,"threshold_uncertainty_score":0.39461315},"labels":[],"label_agreement":null},{"id":"W2419529379","doi":"10.1016/j.cjca.2015.07.245","title":"DUAL ANTIPLATELET THERAPY AND SURGICAL REVASCULARIZATION: A SURVEY OF CANADIAN CARDIAC SURGEONS","year":2015,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Toronto Public Health","funders":"","keywords":"Medicine; Prasugrel; Clopidogrel; Ticagrelor; Acute coronary syndrome; Aspirin; Myocardial infarction; Revascularization; Internal medicine; Cardiac surgery; Cardiology; Coronary artery disease; Population","score_opus":0.05460302429953851,"score_gpt":0.25303441940695415,"score_spread":0.19843139510741564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2419529379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9665408,0.02895491,0.000072617426,0.000492149,0.00062363414,0.00019612428,0.0001701956,0.0000048103516,0.002944749],"genre_scores_gemma":[0.99432796,0.0049408865,0.0000421834,0.0001050803,0.00043518102,0.000001623707,0.00007718474,0.000023540491,0.00004634009],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99804837,0.00068218034,0.00044747072,0.00017372976,0.00024517495,0.0004030775],"domain_scores_gemma":[0.996466,0.000105619,0.00013688434,0.0002762975,0.00094064674,0.0020745578],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021014628,0.00017139337,0.0011100237,0.00088044006,0.000076322474,0.000017923256,0.00009872313,0.00023189111,0.000027464059],"category_scores_gemma":[0.0003590004,0.0001473516,0.0004811683,0.00057585025,0.00032443152,0.00007763772,0.000007742632,0.00024639178,0.0000034961618],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004987585,0.0000046934047,0.9679288,0.00001903032,0.0027011535,0.003588052,0.00020065566,0.00025975247,0.00003262078,0.00023484344,0.012505183,0.012026416],"study_design_scores_gemma":[0.0027260417,0.00035085226,0.59349257,0.000038946277,0.00019568384,0.004793818,0.00011704874,0.000004057913,0.00006371094,0.00003298552,0.39803925,0.00014505413],"about_ca_topic_score_codex":0.17297758,"about_ca_topic_score_gemma":0.069037415,"teacher_disagreement_score":0.38553408,"about_ca_system_score_codex":0.00009916949,"about_ca_system_score_gemma":0.0056318347,"threshold_uncertainty_score":0.9990633},"labels":[],"label_agreement":null},{"id":"W2420699618","doi":"","title":"Antithrombotic treatment in acute coronary syndromes.","year":2010,"lang":"en","type":"article","venue":"PubMed","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Antithrombotic; Medicine; Acute coronary syndrome; Holy Grail; Coagulation cascade; Fibrin; Platelet; Cardiology; Thrombin; Platelet activation; Intensive care medicine; Pathophysiology; Internal medicine; Myocardial infarction; Immunology","score_opus":0.017825455073700282,"score_gpt":0.24080517502630683,"score_spread":0.22297971995260654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2420699618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960196,0.00080079515,0.0000071004633,0.00027367068,0.0002529939,0.00079771434,0.00000605139,0.000059715294,0.001782344],"genre_scores_gemma":[0.9974909,0.00052527373,0.00006317461,0.00017606217,0.00006614973,0.0005443904,0.000022352411,0.000017330642,0.001094411],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99925023,0.000019671534,0.00011869154,0.00019161231,0.00014406892,0.0002757321],"domain_scores_gemma":[0.9995071,0.000014960975,0.000018625604,0.00029125292,0.000014377406,0.00015362896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010310648,0.00011350492,0.0002824317,0.000075592194,0.000026259248,0.000009815691,0.000049435355,0.0000692739,0.000117279225],"category_scores_gemma":[0.00001277399,0.00008789445,0.00019889056,0.00012202448,0.00006129959,0.00005748007,0.000011939349,0.0001113986,0.00004462215],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028906975,0.00067293074,0.47929686,0.000025983496,0.0012470164,0.0029805508,0.000069942886,0.0000024332755,0.0005746689,0.00013397221,0.00016940002,0.51453716],"study_design_scores_gemma":[0.0025539366,0.00006699103,0.98922133,0.0000061721985,0.0002636456,0.00078313384,0.000015810188,0.000007757262,0.0007268064,0.000044252953,0.006216947,0.00009319602],"about_ca_topic_score_codex":0.00002600732,"about_ca_topic_score_gemma":0.000022392831,"teacher_disagreement_score":0.514444,"about_ca_system_score_codex":0.000044746062,"about_ca_system_score_gemma":0.000041644285,"threshold_uncertainty_score":0.35842314},"labels":[],"label_agreement":null},{"id":"W24262587","doi":"10.1016/j.jcin.2012.12.001","title":"Switching From Prasugrel to Clopidogrel","year":2013,"lang":"en","type":"letter","venue":"JACC: Cardiovascular Interventions","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bristol-Myers Squibb Canada; Medicines Company; Sanofi; Eisai; Otsuka America; GlaxoSmithKline","keywords":"Prasugrel; Clopidogrel; Conventional PCI; Medicine; Acute coronary syndrome; Aspirin; Percutaneous coronary intervention; Cardiology; Internal medicine; P2Y12; Thienopyridine; Myocardial infarction","score_opus":0.04475426753600642,"score_gpt":0.290458753643045,"score_spread":0.2457044861070386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W24262587","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.041624125,0.28890935,0.16086884,0.46683368,0.010050032,0.012697466,0.001683661,0.002532949,0.01479991],"genre_scores_gemma":[0.038114946,0.004624412,0.009310901,0.8671586,0.041907426,0.0032140552,0.009488019,0.0013355945,0.024846071],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99401593,0.00056878466,0.0011143705,0.0015412278,0.0018177587,0.00094192196],"domain_scores_gemma":[0.995267,0.00012299725,0.0002293123,0.0034451745,0.00047247502,0.00046308042],"candidate_categories":["metaepi_narrow","metaepi_broad","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.00064514566,0.00094355084,0.0025569506,0.0006386043,0.00027275854,0.0002818442,0.0006621749,0.0013161631,0.0028173034],"category_scores_gemma":[0.00025462778,0.0008873268,0.023350786,0.0005215317,0.00008472166,0.00023855039,0.0003454412,0.002641784,0.005535676],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045081157,0.00015372528,0.00020725459,0.0008503969,0.04060773,0.002192536,0.0000987597,0.00005636753,0.000042828753,0.000012056164,0.8967363,0.058996964],"study_design_scores_gemma":[0.0020032125,0.00020006401,0.003400386,0.0032727926,0.011487312,0.0004016935,0.0000835606,0.00001769897,0.00010308143,0.00018996984,0.9779189,0.0009212968],"about_ca_topic_score_codex":0.00096282345,"about_ca_topic_score_gemma":0.000012845834,"teacher_disagreement_score":0.4003249,"about_ca_system_score_codex":0.0003027038,"about_ca_system_score_gemma":0.0001976663,"threshold_uncertainty_score":0.99998033},"labels":[],"label_agreement":null},{"id":"W2460231123","doi":"10.1053/j.gastro.2016.06.033","title":"Concurrent Lower Gastrointestinal Bleeding Risk and Myocardial Ischemic Risk: Resume Aspirin or Not?","year":2016,"lang":"en","type":"letter","venue":"Gastroenterology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Aspirin; Clopidogrel; Cardiology; Internal medicine; Gastrointestinal bleeding","score_opus":0.014653242268332175,"score_gpt":0.24483608477826224,"score_spread":0.23018284250993007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2460231123","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8894575,0.0016630928,0.0070409533,0.096220195,0.0022740297,0.0011985417,0.0014831204,0.00030717786,0.00035535742],"genre_scores_gemma":[0.41832748,0.0070378813,0.0012933823,0.53189516,0.03642204,0.00027589974,0.0011215551,0.0004907603,0.0031358434],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961156,0.0004915997,0.0006053007,0.0010609783,0.00051459635,0.0012119075],"domain_scores_gemma":[0.9981836,0.00020035083,0.00047999778,0.0006995078,0.00014398368,0.0002925326],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00048831396,0.0007024684,0.0014101858,0.00023902315,0.00015117538,0.000039501934,0.00024700965,0.00052012247,0.00043013305],"category_scores_gemma":[0.0002129395,0.00049673463,0.0009125474,0.00006499439,0.00059867435,0.00008371647,0.00021077762,0.0024336723,0.00013351365],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009559651,0.00007482478,0.19637616,0.00029422657,0.002578242,0.006049282,0.00003111231,0.0000012602109,0.00047737345,8.0757496e-7,0.76046187,0.024095181],"study_design_scores_gemma":[0.011695639,0.004893583,0.032201044,0.001295322,0.0036148266,0.017775547,0.000021884389,0.000022624188,0.00008220308,0.000009318341,0.9279174,0.0004705645],"about_ca_topic_score_codex":0.000027684842,"about_ca_topic_score_gemma":0.0000061790715,"teacher_disagreement_score":0.47113004,"about_ca_system_score_codex":0.00010397322,"about_ca_system_score_gemma":0.0001202351,"threshold_uncertainty_score":0.99986774},"labels":[],"label_agreement":null},{"id":"W2461216475","doi":"10.1038/nrneurol.2016.97","title":"How good is aspirin for patients with acute brain ischaemia?","year":2016,"lang":"en","type":"review","venue":"Nature Reviews Neurology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute; Hamilton General Hospital","funders":"","keywords":"Medicine; Aspirin; Cerebral ischaemia; Cardiology; Intensive care medicine; Internal medicine; Ischemia","score_opus":0.016315321270198743,"score_gpt":0.3134274007987904,"score_spread":0.29711207952859164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2461216475","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000011002831,0.98921937,0.00017117072,0.0027981221,0.00047918168,0.006568482,0.00043988027,0.0000670722,0.00024569864],"genre_scores_gemma":[0.0000028664515,0.98403716,0.00016104853,0.011669246,0.0008092956,0.00078471605,0.0006912205,0.00017638408,0.0016680429],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99679315,0.0005424657,0.0006155702,0.0010850858,0.00036883564,0.0005949081],"domain_scores_gemma":[0.99737686,0.0003153398,0.00064232515,0.0012303219,0.00018603858,0.00024910737],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00036596518,0.0008717654,0.0050080847,0.00020310855,0.00008690898,0.000028495084,0.00038400383,0.0017494834,0.00007342147],"category_scores_gemma":[0.0002521491,0.00044567126,0.0031119853,0.00030560084,0.0001286033,0.00009126171,0.00007619708,0.0014741387,0.00010558341],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027229026,0.00010220215,0.000026591919,0.017306183,0.001955074,0.00013530046,0.0000031070138,1.0490159e-9,1.4981066e-7,0.00012541217,0.023443725,0.95663],"study_design_scores_gemma":[0.0023226845,0.0015500045,0.000018454988,0.009347716,0.0068001724,0.0005805875,1.368129e-7,5.483045e-8,6.033891e-7,0.000021152746,0.9789311,0.00042732724],"about_ca_topic_score_codex":1.716434e-7,"about_ca_topic_score_gemma":5.224453e-7,"teacher_disagreement_score":0.9562026,"about_ca_system_score_codex":0.000036643676,"about_ca_system_score_gemma":0.0002624532,"threshold_uncertainty_score":0.9997995},"labels":[],"label_agreement":null},{"id":"W2467394834","doi":"10.1016/j.ijcard.2016.06.063","title":"Safety and effectiveness of the new P2Y12r inhibitor agents vs clopidogrel in ACS patients according to the geographic area: East Asia vs Europe","year":2016,"lang":"en","type":"article","venue":"International Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta","funders":"","keywords":"Medicine; Prasugrel; Ticagrelor; Internal medicine; Clopidogrel; Myocardial infarction; Acute coronary syndrome; Mace; Clinical endpoint; Unstable angina; Stroke (engine); Conventional PCI; Incidence (geometry); Percutaneous coronary intervention; Cardiology; Randomized controlled trial","score_opus":0.009363441696010768,"score_gpt":0.24889973983207986,"score_spread":0.23953629813606908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2467394834","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941715,0.0005785125,0.0015648596,0.0020777567,0.0011440844,0.00021582583,0.000018210616,0.0000031486663,0.00022610645],"genre_scores_gemma":[0.99832577,0.0008214478,0.000012134514,0.00025876323,0.0005492532,0.0000022435684,0.000002258529,0.000010964064,0.000017150882],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985421,0.00043412735,0.00035865826,0.0001294629,0.0004077147,0.0001279652],"domain_scores_gemma":[0.9989231,0.00020207065,0.00018993644,0.00015749793,0.00044378216,0.0000835838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006855391,0.00011017886,0.0004126835,0.00016061046,0.000031237905,0.0000091216,0.00028252538,0.0000596044,0.000004291307],"category_scores_gemma":[0.00044075877,0.000051767132,0.0003409513,0.0001456365,0.000103427126,0.00008017799,0.00012344276,0.0001487349,0.0000021181029],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005214857,0.000032325817,0.9687592,0.00001129358,0.0011433936,0.00007098394,0.000049355218,0.00014127104,0.001116236,0.00012880875,0.0002645341,0.023067763],"study_design_scores_gemma":[0.004111595,0.00028734395,0.97733235,0.0005748075,0.00011545703,0.0003796273,0.00004706122,0.0000013651708,0.0005238535,0.00008276292,0.016486274,0.000057492525],"about_ca_topic_score_codex":0.000008643695,"about_ca_topic_score_gemma":0.0000028550696,"teacher_disagreement_score":0.023010269,"about_ca_system_score_codex":0.000069563124,"about_ca_system_score_gemma":0.0000953848,"threshold_uncertainty_score":0.21110025},"labels":[],"label_agreement":null},{"id":"W2468077222","doi":"10.2217/bmm-2016-0070","title":"Platelet Function Testing As a Biomarker for Efficacy of Antiplatelet Drugs","year":2016,"lang":"en","type":"review","venue":"Biomarkers in Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; University of Ottawa; Montreal Heart Institute","funders":"","keywords":"Medicine; Clopidogrel; Aspirin; Antiplatelet drug; Platelet; Ticagrelor; Prasugrel; Intensive care medicine; Biomarker; Internal medicine; Drug; Cardiology; Pharmacology","score_opus":0.06912722511856849,"score_gpt":0.36351654685060425,"score_spread":0.29438932173203575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2468077222","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00079586013,0.9914918,0.00039261984,0.00010268417,0.0010400905,0.0034373177,0.000085246225,0.00010889315,0.0025455132],"genre_scores_gemma":[0.00091515615,0.99674046,0.00039181055,0.00013538628,0.00070617435,0.000229161,0.00041164982,0.00016633146,0.00030384804],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957987,0.00028247136,0.0016620613,0.0009084639,0.0007145115,0.0006337683],"domain_scores_gemma":[0.9957291,0.0020700986,0.00077741087,0.00090427103,0.00023647938,0.00028267514],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019105802,0.0007909267,0.0043049604,0.0010821434,0.00008247308,0.000008927147,0.00029258552,0.000697116,0.0003522855],"category_scores_gemma":[0.0019202232,0.00050038716,0.0014442763,0.0012844794,0.0005486872,0.00007870714,0.00006684084,0.00028094102,0.000046705947],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021708983,0.0001768579,0.000047959904,0.01976603,0.004895816,0.00022832968,0.000038619695,4.0792067e-8,0.00007629097,0.000029628158,0.004799182,0.96777034],"study_design_scores_gemma":[0.012056541,0.0009421957,0.00030396186,0.09917795,0.0039256467,0.0006291794,0.000069466936,0.000009407431,0.00001321956,0.000083482664,0.88231206,0.0004769076],"about_ca_topic_score_codex":0.00003909713,"about_ca_topic_score_gemma":7.2615404e-7,"teacher_disagreement_score":0.96729344,"about_ca_system_score_codex":0.00018216546,"about_ca_system_score_gemma":0.0005650997,"threshold_uncertainty_score":0.9997448},"labels":[],"label_agreement":null},{"id":"W2472412017","doi":"10.1016/j.ahj.2016.03.017","title":"Health-related quality of life outcomes with prasugrel among medically managed non–ST-segment elevation acute coronary syndrome patients: Insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes (TRILOGY ACS) trial","year":2016,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Alberta","funders":"Daiichi-Sankyo; Eli Lilly and Company","keywords":"Prasugrel; Medicine; Clopidogrel; Internal medicine; Acute coronary syndrome; Randomized controlled trial; Aspirin; Quality of life (healthcare); Cardiology; Myocardial infarction","score_opus":0.017650663835960666,"score_gpt":0.2815937832672029,"score_spread":0.26394311943124227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2472412017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96922106,0.00034243343,0.0052259807,0.022080908,0.0002962876,0.0025196704,0.00023987558,0.00006493742,0.00000886935],"genre_scores_gemma":[0.9884844,0.000630091,0.0008141933,0.009460932,0.00013687076,0.000104306375,0.0002458022,0.000064635184,0.000058813523],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9934511,0.0015396073,0.0017280757,0.0005938161,0.002024346,0.00066306436],"domain_scores_gemma":[0.99619806,0.0007345767,0.0009913368,0.00071487366,0.0003493247,0.0010118091],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014676847,0.0004764798,0.0017308256,0.00023067757,0.00048250167,0.000052989366,0.00040519633,0.000239904,0.0002622504],"category_scores_gemma":[0.00035383925,0.00023065449,0.000511332,0.0006851512,0.00081996433,0.00031263332,0.00014671875,0.0010413501,0.00003539987],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20439011,0.0038808705,0.5534059,0.00013516737,0.0467354,0.005514282,0.0042216354,0.0006637216,0.0025082408,0.00015297486,0.024937239,0.1534545],"study_design_scores_gemma":[0.026121942,0.011271464,0.95918673,0.0004489426,0.0006575303,0.0007566587,0.00072678464,0.00002024411,0.000036685185,0.000054568765,0.0003916207,0.00032679722],"about_ca_topic_score_codex":0.0005359095,"about_ca_topic_score_gemma":0.00006846338,"teacher_disagreement_score":0.40578088,"about_ca_system_score_codex":0.00025701863,"about_ca_system_score_gemma":0.0007075691,"threshold_uncertainty_score":0.94058174},"labels":[],"label_agreement":null},{"id":"W2487010569","doi":"10.1016/j.amjcard.2016.07.025","title":"Temporal Trends, Predictors, and Outcomes of In-Hospital Gastrointestinal Bleeding Associated With Percutaneous Coronary Intervention","year":2016,"lang":"en","type":"article","venue":"The American Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Percutaneous coronary intervention; Medicine; Gastrointestinal bleeding; Intervention (counseling); Emergency medicine; Internal medicine; Cardiology; Intensive care medicine; Myocardial infarction; Nursing","score_opus":0.006651797463389808,"score_gpt":0.23696103479161126,"score_spread":0.23030923732822145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2487010569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981269,0.00046439286,0.0006240516,0.00061660976,0.000048317208,0.00005472834,0.000008695596,0.0000070471815,0.000049257847],"genre_scores_gemma":[0.999513,0.0002133441,0.00011567061,0.000027900434,0.000081025224,9.562663e-7,0.0000019801862,0.000011369763,0.000034812456],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990066,0.0002395082,0.00031892883,0.000093272225,0.00018795751,0.00015367813],"domain_scores_gemma":[0.99908346,0.00019628259,0.00042830847,0.00011050368,0.00011303936,0.00006840479],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004516943,0.0001080634,0.00075576484,0.00012257847,0.00002006195,0.0000027391968,0.00008194035,0.000018357432,0.000009561657],"category_scores_gemma":[0.00010827894,0.000049907274,0.00032154814,0.0001162831,0.00063367165,0.000051328156,0.000017063914,0.00013164975,2.3475872e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018004279,0.00005084514,0.9601793,0.0000044509748,0.001210245,0.00085716497,0.000101961785,0.000014872411,0.00073918083,0.0000051422,0.000041832733,0.034994535],"study_design_scores_gemma":[0.0020162652,0.00763996,0.9682583,0.0003487802,0.0003869756,0.020481938,0.00071770395,0.0000028183663,0.000021091279,0.000025886697,0.000041804164,0.000058458296],"about_ca_topic_score_codex":0.000009409853,"about_ca_topic_score_gemma":0.0000021170029,"teacher_disagreement_score":0.034936078,"about_ca_system_score_codex":0.00004277798,"about_ca_system_score_gemma":0.0000396342,"threshold_uncertainty_score":0.23347896},"labels":[],"label_agreement":null},{"id":"W2493314352","doi":"10.1016/j.ahj.2016.07.014","title":"Baseline characteristics, adenosine diphosphate receptor inhibitor treatment patterns, and in-hospital outcomes of myocardial infarction patients undergoing percutaneous coronary intervention in the prospective Canadian Observational AntiPlatelet sTudy (COAPT)","year":2016,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Hôtel-Dieu de Montréal; St. Michael's Hospital; Royal Jubilee Hospital; Thunder Bay Regional Health Sciences Centre; University of Toronto; Université de Sherbrooke; Western University; Health Sciences North; Institut Universitaire de Cardiologie et de Pneumologie de Québec; London Health Sciences Centre; University of Alberta Hospital; Saint John Regional Hospital; Centre de Santé et de Services Sociaux de Chicoutimi; Hamilton General Hospital; Centre hospitalier universitaire de Québec; Canadian Heart Research Centre; Eli Lilly (Canada); Université Laval; Population Health Research Institute; Regina Qu'Appelle Health Region; Canadian VIGOUR Centre","funders":"University of Toronto; Heart and Stroke Foundation of Canada","keywords":"Medicine; Percutaneous coronary intervention; Observational study; Myocardial infarction; Internal medicine; Cardiology; Prospective cohort study; Adenosine","score_opus":0.012657669315749815,"score_gpt":0.26068263352239146,"score_spread":0.24802496420664163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2493314352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99746686,0.0002061433,0.000015820528,0.0012597938,0.00021761909,0.00073730526,0.000087476416,0.0000066371117,0.0000023478426],"genre_scores_gemma":[0.9984008,0.0011325176,0.00003688443,0.00019221196,0.00015224707,0.000021393435,0.000036534057,0.000018115594,0.000009304274],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984599,0.0002946685,0.00046743764,0.00021340844,0.00032974101,0.0002348443],"domain_scores_gemma":[0.99925405,0.00015871314,0.00017100092,0.00013706372,0.00014200366,0.00013715052],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036666272,0.0001765531,0.00049898826,0.00014582444,0.00009141906,0.000026567477,0.00005321814,0.000033842123,0.000051378105],"category_scores_gemma":[0.00015268485,0.00010675062,0.00019223936,0.00015083847,0.000106119136,0.0001704209,0.000015325528,0.00015593068,0.000003085569],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006465594,0.0010450805,0.93575865,0.0000075163457,0.00036059084,0.00021774585,0.000728193,0.0000014860027,0.000059428516,0.0000010254008,0.000021412541,0.061152294],"study_design_scores_gemma":[0.0041315397,0.004178636,0.988942,0.0002266652,0.0001019516,0.00029679356,0.0017285172,0.0000063391367,0.000028739014,0.000004626917,0.0002344701,0.00011970005],"about_ca_topic_score_codex":0.0069764364,"about_ca_topic_score_gemma":0.0048179,"teacher_disagreement_score":0.061032593,"about_ca_system_score_codex":0.00043981755,"about_ca_system_score_gemma":0.00017003088,"threshold_uncertainty_score":0.9996362},"labels":[],"label_agreement":null},{"id":"W2494512335","doi":"10.1056/nejmc1603852","title":"Aspirin before Coronary Artery Surgery.","year":2016,"lang":"en","type":"article","venue":"PubMed","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Aspirin; Artery; Cardiology; Coronary artery disease; Surgery; Internal medicine","score_opus":0.020180189815350025,"score_gpt":0.20661678168746378,"score_spread":0.18643659187211375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2494512335","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99356747,0.0014002824,0.00017090826,0.0013560642,0.00023348602,0.0004311644,0.000011062191,0.0001298349,0.0026997118],"genre_scores_gemma":[0.995078,0.00016534822,0.000009846166,0.0007171979,0.0003090705,0.00041001145,0.000013499191,0.00002126828,0.0032757167],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9990992,0.00003481189,0.00014398166,0.00019023173,0.00021585393,0.00031592353],"domain_scores_gemma":[0.99937195,0.000055729917,0.000028589231,0.00030519947,0.000032863016,0.00020565302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024357668,0.000103563,0.00025245614,0.0000614148,0.00003379957,0.0000071186655,0.00004703411,0.00005716342,0.00017963088],"category_scores_gemma":[0.00005369697,0.00006209411,0.00037390404,0.00007745578,0.00007151003,0.00008572389,0.000012864038,0.000041599305,0.00012085422],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018550835,0.000055195265,0.17550108,0.000019233754,0.00030180928,0.0003236339,0.000008672536,3.410976e-8,0.000034710032,0.00004034273,0.0026115493,0.82091826],"study_design_scores_gemma":[0.0009326813,0.000019781668,0.93533933,0.000032887343,0.00009530259,0.00036872245,0.000009871237,2.447341e-7,0.0005223696,0.00012929215,0.062462397,0.00008710192],"about_ca_topic_score_codex":0.0000013953661,"about_ca_topic_score_gemma":0.0000014117368,"teacher_disagreement_score":0.8208311,"about_ca_system_score_codex":0.00003456947,"about_ca_system_score_gemma":0.000035132314,"threshold_uncertainty_score":0.2532124},"labels":[],"label_agreement":null},{"id":"W2494820302","doi":"10.1016/b978-012406061-6/50021-7","title":"Aspirin for Heart Disease","year":2006,"lang":"en","type":"book-chapter","venue":"Elsevier eBooks","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Aspirin; Medicine; Cardiology; Disease; Internal medicine","score_opus":0.014669957042087386,"score_gpt":0.24973270036419762,"score_spread":0.23506274332211025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2494820302","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013967884,0.017611336,0.000052287458,0.00021987216,0.00022880634,0.0017230439,0.00022268777,0.00014035244,0.97966194],"genre_scores_gemma":[0.0016501845,0.00011288322,0.00020413818,0.0021935008,0.0013350655,0.00013803692,0.0004903295,0.0001704905,0.9937054],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984456,0.000014291829,0.00034008804,0.000499066,0.00039285803,0.00030811588],"domain_scores_gemma":[0.9986827,0.000037008485,0.0000946706,0.0007220858,0.00012198275,0.00034155734],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014407413,0.00042635994,0.0008060814,0.000111557434,0.00010160044,0.000024612586,0.000102381,0.00024931107,0.00021118202],"category_scores_gemma":[0.00001194943,0.0003832419,0.0016494915,0.0000071255527,0.00013537283,0.000020057192,0.00003500252,0.00023706589,0.00017438548],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000600384,0.000035738147,0.00005164804,0.0007002945,0.0007051345,0.00022594623,0.0000081678145,0.0000016063368,0.000017410877,0.0024193919,0.009024335,0.9862099],"study_design_scores_gemma":[0.0014943337,0.00013161244,0.00027897154,0.0007602448,0.0016525335,0.00004128871,0.0000011011491,0.0000032783673,0.000026638016,0.0066970303,0.9885167,0.00039629923],"about_ca_topic_score_codex":2.3858502e-7,"about_ca_topic_score_gemma":9.672019e-7,"teacher_disagreement_score":0.9858136,"about_ca_system_score_codex":0.000061035906,"about_ca_system_score_gemma":0.00025805752,"threshold_uncertainty_score":0.99986196},"labels":[],"label_agreement":null},{"id":"W2495375730","doi":"10.1002/cpt.438","title":"The Effects of Different Aspirin Dosing Frequencies and the Timing of Aspirin Intake in Primary and Secondary Prevention of Cardiovascular Disease: A Systematic Review","year":2016,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"Universidade de Vigo; Leids Universitair Medisch Centrum; Karolinska Institutet; Universiteit Leiden","keywords":"Aspirin; Dosing; Medicine; Chronotherapy (sleep phase); Primary prevention; Intensive care medicine; Disease; Low dose aspirin; Internal medicine; Blood pressure","score_opus":0.05694217177846646,"score_gpt":0.3829627969252457,"score_spread":0.32602062514677926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2495375730","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0035286825,0.9907988,0.000062986786,0.00013113683,0.0002942643,0.00513826,0.000018583956,0.0000101664455,0.000017173661],"genre_scores_gemma":[0.0022150802,0.9965143,0.000010489785,0.00080516894,0.00009272309,0.00028350335,0.000016005155,0.000039377486,0.000023352293],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9927455,0.0041625975,0.002109106,0.00037884587,0.00037623788,0.00022766675],"domain_scores_gemma":[0.9927634,0.0052027693,0.0010957586,0.00071524485,0.00011609568,0.00010670785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034531192,0.00038817243,0.00538645,0.00008463273,0.000064771026,0.0000067465453,0.00027753253,0.00024191411,0.000007765526],"category_scores_gemma":[0.00020126643,0.00017614657,0.0026719915,0.00015985999,0.0016789192,0.000037314334,0.00016232794,0.00055107847,6.4938484e-7],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024135067,0.00015193615,0.000037809776,0.6119231,0.01607245,0.000018372004,0.00002410747,9.342269e-8,0.000010452003,0.00001657947,0.00001150152,0.37149227],"study_design_scores_gemma":[0.007354218,0.00050852785,0.00067206164,0.8014529,0.15196517,0.000073060066,0.000018695593,0.000010669529,0.000037210764,0.00015353602,0.03746821,0.0002857578],"about_ca_topic_score_codex":0.0000014541018,"about_ca_topic_score_gemma":3.1281934e-7,"teacher_disagreement_score":0.3712065,"about_ca_system_score_codex":0.00004938826,"about_ca_system_score_gemma":0.00034511555,"threshold_uncertainty_score":0.7183048},"labels":[],"label_agreement":null},{"id":"W2511440114","doi":"10.1111/ijlh.12553","title":"Variability in platelet dense granule adenosine triphosphate release findings amongst patients tested multiple times as part of an assessment for a bleeding disorder","year":2016,"lang":"en","type":"article","venue":"International Journal of Laboratory Hematology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Regional Laboratory Medicine Program; McMaster University","funders":"Canadian Hemophilia Society; McMaster University","keywords":"Cohort; Platelet; Adenosine diphosphate; Medicine; Adenosine triphosphate; Internal medicine; Granule (geology); Cohort study; Blood Platelet Disorders; Platelet aggregation; Gastroenterology; Biology","score_opus":0.007401059131309467,"score_gpt":0.2921417355506834,"score_spread":0.28474067641937395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2511440114","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996685,0.00039445638,0.0014850813,0.000507165,0.00043035732,0.00032161816,0.00014495112,0.000011523377,0.000019837993],"genre_scores_gemma":[0.9985896,0.00013668888,0.00092696294,0.00016750649,0.00009033155,0.00001998025,0.00003135855,0.000020538815,0.000017058775],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99819446,0.00018190319,0.0007888984,0.00020391513,0.0004420266,0.0001887959],"domain_scores_gemma":[0.9972878,0.0005153628,0.00044137985,0.00015864387,0.0014495663,0.00014721684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080765603,0.00015311982,0.0005708133,0.0002360577,0.000029942654,0.000011281593,0.00019627754,0.00012146303,0.00016112046],"category_scores_gemma":[0.001410069,0.00010955582,0.00021968009,0.00014809753,0.00011729506,0.00030986872,0.00002803049,0.0001324516,0.000002681588],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048807547,0.001833276,0.979435,0.00007970367,0.00091068214,0.00039478697,0.0001244253,0.000019171512,0.0039227344,0.0006785472,0.0003166109,0.007404255],"study_design_scores_gemma":[0.08056534,0.003877271,0.7516182,0.0023195373,0.0006810341,0.0010931927,0.00050404615,0.0007205611,0.14029697,0.0036923147,0.013945789,0.0006857686],"about_ca_topic_score_codex":0.000009598906,"about_ca_topic_score_gemma":0.000007788852,"teacher_disagreement_score":0.22781688,"about_ca_system_score_codex":0.00012432576,"about_ca_system_score_gemma":0.00033415624,"threshold_uncertainty_score":0.44675568},"labels":[],"label_agreement":null},{"id":"W2511888356","doi":"10.1182/blood.v110.11.934.934","title":"Normal Response to Aspirin in Healthy Individuals: Cross-Comparison of Light Transmission Aggregometry, VerifyNow™ System, Platelet Count Drop, Thrombelastography (TEG®) and Urinary 11-dehydrothromboxane B2.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute; Hôpital du Sacré-Cœur de Montréal","funders":"","keywords":"Aspirin; Medicine; Platelet; Urinary system; Prospective cohort study; Population; Internal medicine; Cohort; Anesthesia; Surgery","score_opus":0.011885200222793836,"score_gpt":0.301701241609422,"score_spread":0.2898160413866282,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2511888356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98020273,0.017581876,0.0005517381,0.0001612126,0.000114873896,0.0009718875,0.000037837137,0.000102831254,0.0002749979],"genre_scores_gemma":[0.9987049,0.00034439118,0.0005650051,0.00015176467,0.00010122393,0.00002547482,0.000028186187,0.000054448195,0.00002461407],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968912,0.00022116309,0.0009098291,0.00056440424,0.0007954397,0.0006179417],"domain_scores_gemma":[0.99850726,0.00016871888,0.0001989295,0.00052228104,0.00010039758,0.0005023879],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0020369103,0.00035661756,0.0010900251,0.0008407016,0.0001429181,0.00003328358,0.00018147327,0.00031201798,0.00005589549],"category_scores_gemma":[0.000045387176,0.00032514168,0.0003383839,0.0010315123,0.00016169391,0.00014668159,0.000058367285,0.0003344991,0.000011665575],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02755967,0.006011774,0.88979715,0.0025790955,0.0013660557,0.001475885,0.004367745,0.00004174867,0.05311952,0.000054579836,0.00008828022,0.013538489],"study_design_scores_gemma":[0.0194357,0.0072087063,0.86448723,0.002001957,0.00048464834,0.0011276976,0.0012146056,0.000023225712,0.07904745,0.000008555974,0.02442856,0.0005316616],"about_ca_topic_score_codex":0.00010461264,"about_ca_topic_score_gemma":0.000018626277,"teacher_disagreement_score":0.02592793,"about_ca_system_score_codex":0.000060399776,"about_ca_system_score_gemma":0.0001470973,"threshold_uncertainty_score":0.99992007},"labels":[],"label_agreement":null},{"id":"W2512102811","doi":"10.1016/j.cjca.2015.07.591","title":"DURATION OF DUAL ANTIPLATELET THERAPY AND ASSOCIATED OUTCOMES FOLLOWING PERCUTANEOUS CORONARY INTERVENTION FOR ACUTE MYOCARDIAL INFARCTION: CONTEMPORARY PRACTICE INSIGHTS FROM THE CANADIAN OBSERVATIONAL ANTIPLATELET STUDY (COAPT)","year":2015,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Toronto Public Health","funders":"","keywords":"Medicine; Percutaneous coronary intervention; Ticagrelor; Conventional PCI; Clopidogrel; Prasugrel; Myocardial infarction; Internal medicine; Discontinuation; Cardiology; Observational study; Acute coronary syndrome","score_opus":0.07303264115583788,"score_gpt":0.3091309847230649,"score_spread":0.236098343567227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2512102811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988284,0.0073760403,0.00016765128,0.0018336232,0.0011075266,0.00080733345,0.00018876084,0.000008187899,0.00022687751],"genre_scores_gemma":[0.99822116,0.00019331802,0.00008749811,0.0007281621,0.0004627363,0.000010748325,0.00025135663,0.000026571872,0.000018453618],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978166,0.000673141,0.00068824354,0.00021101741,0.00035759696,0.00025338048],"domain_scores_gemma":[0.9974467,0.0004518712,0.00042604055,0.00021566563,0.0009102282,0.0005494606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011307622,0.00021289375,0.0009224958,0.00022578471,0.00028015178,0.00005573246,0.00013169424,0.00022121579,0.0000054271204],"category_scores_gemma":[0.0009060046,0.00015982336,0.0006502632,0.00016154758,0.000156586,0.00036357448,0.00001200573,0.00030115945,0.0000011030886],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022107349,0.00004504041,0.95640904,0.0000048190736,0.02551522,0.0046248236,0.0021032642,0.00023280467,0.00020570538,0.000075960306,0.0028373646,0.00573522],"study_design_scores_gemma":[0.009672955,0.0020555297,0.9450402,0.000060705857,0.0016025119,0.003328661,0.0039489972,0.000034597942,0.0000195198,0.00022754923,0.033814024,0.00019471321],"about_ca_topic_score_codex":0.041832056,"about_ca_topic_score_gemma":0.04448277,"teacher_disagreement_score":0.030976659,"about_ca_system_score_codex":0.00029172367,"about_ca_system_score_gemma":0.003259103,"threshold_uncertainty_score":0.9729529},"labels":[],"label_agreement":null},{"id":"W2513182923","doi":"10.1016/j.jjcc.2016.07.021","title":"Short- versus standard-term dual antiplatelet therapy after percutaneous coronary intervention with drug-eluting stent implantation: A meta-analysis","year":2016,"lang":"en","type":"review","venue":"Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Native Mental Health Association of Canada; University of British Columbia; Alberta Health Services","funders":"","keywords":"Medicine; Percutaneous coronary intervention; Conventional PCI; Internal medicine; Odds ratio; Myocardial infarction; Cardiology; Discontinuation; Confidence interval; Drug-eluting stent; Stent; Randomized controlled trial; Meta-analysis; Surgery","score_opus":0.07083621146056247,"score_gpt":0.35000207827940516,"score_spread":0.2791658668188427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2513182923","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011982952,0.9852967,0.0012199831,0.000037784936,0.00047135263,0.0005930778,0.00026099893,0.000023428998,0.00011370869],"genre_scores_gemma":[0.096376486,0.90223265,0.00010647736,0.000033537523,0.0009201009,0.00003546856,0.00012430496,0.000071008886,0.00009994392],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99553293,0.0012446766,0.0014899576,0.00047971963,0.0008273382,0.00042535446],"domain_scores_gemma":[0.9973193,0.00036879032,0.0009815029,0.0005695182,0.000523418,0.00023746172],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0012492676,0.0006564067,0.008485816,0.0006646847,0.00008492472,0.000043226057,0.00021208054,0.00035769658,0.0003372343],"category_scores_gemma":[0.00002848059,0.00033907674,0.016780345,0.000353923,0.0001848592,0.00013798333,0.000051865693,0.00061822194,0.0000131189145],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01099858,0.0000308791,0.00015366818,0.00070643006,0.49581963,0.020171078,0.000031543816,0.000019632327,9.4675727e-7,0.0000016811151,0.000075068136,0.47199085],"study_design_scores_gemma":[0.003290044,0.0022036957,0.00032908263,0.0012453563,0.5679776,0.10461965,0.000080069054,2.7631873e-7,0.0000020586572,0.000003186962,0.31986997,0.00037901188],"about_ca_topic_score_codex":0.0000010164464,"about_ca_topic_score_gemma":0.000001948932,"teacher_disagreement_score":0.47161186,"about_ca_system_score_codex":0.00021110234,"about_ca_system_score_gemma":0.00034874456,"threshold_uncertainty_score":0.9999061},"labels":[],"label_agreement":null},{"id":"W2516569607","doi":"10.1016/j.ahj.2016.08.008","title":"A critical reappraisal of aspirin for secondary prevention in patients with ischemic heart disease","year":2016,"lang":"en","type":"review","venue":"American Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Aspirin; Antithrombotic; Intensive care medicine; Disease; Coronary artery disease; Vascular disease; Cardiology; Internal medicine","score_opus":0.022189191268336166,"score_gpt":0.3623177656967814,"score_spread":0.34012857442844524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2516569607","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0075564687,0.99061376,0.0003115382,0.00015958436,0.00010675612,0.0010067344,0.00015170212,0.000014537262,0.00007893773],"genre_scores_gemma":[0.008225069,0.9893036,0.0012648844,0.00027194002,0.00050631544,0.00011869092,0.00012764407,0.00010483998,0.00007702589],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99801546,0.00025925392,0.0006448042,0.0003055221,0.000427626,0.00034733894],"domain_scores_gemma":[0.9985602,0.00025758563,0.00025677396,0.00031732093,0.00020511338,0.00040299463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035383474,0.00029228828,0.0019649253,0.00022438279,0.000054700435,0.00001685008,0.00009145716,0.00007867294,0.00012417979],"category_scores_gemma":[0.00023907225,0.00018714421,0.0013292645,0.00021108797,0.0003448795,0.00012582245,0.000021939562,0.00041758118,0.00001044459],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014353791,0.0005451526,0.008132414,0.006197027,0.0006139182,0.00004081548,0.00000920924,9.2558196e-8,0.0000013986848,0.000013288253,0.0021164673,0.98089486],"study_design_scores_gemma":[0.0024449464,0.001707308,0.011169171,0.027778216,0.0015240208,0.00031842035,0.000015632922,2.8121858e-7,0.0000015501104,0.00001915361,0.95476735,0.0002539327],"about_ca_topic_score_codex":0.0000032718417,"about_ca_topic_score_gemma":3.3736978e-7,"teacher_disagreement_score":0.9806409,"about_ca_system_score_codex":0.00005760415,"about_ca_system_score_gemma":0.0012500132,"threshold_uncertainty_score":0.7631519},"labels":[],"label_agreement":null},{"id":"W2520966309","doi":"10.2459/jcm.0000000000000434","title":"Optimal duration of dual anti-platelet therapy after percutaneous coronary intervention","year":2016,"lang":"en","type":"article","venue":"Journal of Cardiovascular Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"Società Italiana di Cardiologia","keywords":"Medicine; Percutaneous coronary intervention; Conventional PCI; Myocardial infarction; TIMI; Internal medicine; Cardiology; Thrombosis; Stent; Acute coronary syndrome; Intensive care medicine","score_opus":0.011201872786660193,"score_gpt":0.24580525156274707,"score_spread":0.2346033787760869,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2520966309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88542426,0.10310926,0.010012952,0.0005597449,0.00047566567,0.00027116135,0.0000072244916,0.000018294455,0.00012143699],"genre_scores_gemma":[0.97481143,0.02347111,0.0003536212,0.00012215726,0.0011011912,0.0000045944903,0.00000665302,0.000039340623,0.000089868576],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.996838,0.00028248868,0.0010363742,0.00022630928,0.0013755483,0.00024128829],"domain_scores_gemma":[0.99809325,0.00008029574,0.00040582736,0.00051445316,0.00068867067,0.00021750313],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001626405,0.00025468305,0.0013680793,0.0002943123,0.000038191272,0.0000066796456,0.000121532896,0.00014971494,0.00060440286],"category_scores_gemma":[0.00018802825,0.00014100848,0.002775148,0.00019600957,0.00029940478,0.00024099372,0.000023993109,0.00020417964,0.0000095691485],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012774828,0.00065309764,0.008475142,0.0003440002,0.035090394,0.019054418,0.0006905753,0.00036390114,0.08792724,0.000028955425,0.0010747522,0.8335227],"study_design_scores_gemma":[0.08032342,0.016165411,0.38069037,0.00869796,0.012391445,0.24765962,0.0016726679,0.000059969043,0.06294583,0.00018381697,0.18816446,0.0010450316],"about_ca_topic_score_codex":0.0000078993735,"about_ca_topic_score_gemma":2.2934923e-7,"teacher_disagreement_score":0.8324777,"about_ca_system_score_codex":0.00007880964,"about_ca_system_score_gemma":0.000108455155,"threshold_uncertainty_score":0.66177875},"labels":[],"label_agreement":null},{"id":"W2521854455","doi":"10.1161/circoutcomes.5.suppl_1.a63","title":"Abstract 63: Hospital Length of Stay after Percutaneous Coronary Intervention among Acute Coronary Syndrome Patients Treated with Clopidogrel or Prasugrel in a United States Hospital Database","year":2012,"lang":"en","type":"article","venue":"Circulation Cardiovascular Quality and Outcomes","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Douglas College","funders":"","keywords":"Prasugrel; Medicine; Clopidogrel; Acute coronary syndrome; Percutaneous coronary intervention; Internal medicine; Conventional PCI; Myocardial infarction; Cardiology; Unstable angina; Ticagrelor; Population; Emergency medicine; Database","score_opus":0.016467364060348585,"score_gpt":0.2685645658519441,"score_spread":0.2520972017915955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2521854455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936381,0.0041078334,0.00036226606,0.000032149208,0.00013235354,0.0012973803,0.0003424425,0.00007722501,0.0000102510985],"genre_scores_gemma":[0.9962894,0.00083766895,0.00014220386,0.00007619359,0.000028300767,0.00006494862,0.0024830645,0.000055706652,0.000022512306],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99706346,0.00038262625,0.0007581533,0.0004929645,0.00086866424,0.00043412048],"domain_scores_gemma":[0.99843657,0.00012909029,0.00024026187,0.000692025,0.00023746317,0.00026457873],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00082998903,0.00041162482,0.0011472604,0.00029072782,0.00008602082,0.000029019287,0.00009207473,0.00019890904,0.00008768694],"category_scores_gemma":[0.000094143434,0.00031219554,0.0010504648,0.0003889281,0.00027443268,0.00068355986,0.000063814136,0.0002518967,0.0000060106827],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014997793,0.0012892614,0.98120046,0.00055339566,0.008970373,0.0010643261,0.0008419767,0.00019988428,0.0000057130915,0.000008935868,0.000004398773,0.004361519],"study_design_scores_gemma":[0.006852096,0.00055125274,0.9881178,0.0004144832,0.0020489425,0.00042019674,0.0009862327,0.000066485474,0.000017624632,0.0000051563143,0.000069457485,0.00045026405],"about_ca_topic_score_codex":0.00040981604,"about_ca_topic_score_gemma":0.000017927037,"teacher_disagreement_score":0.006921431,"about_ca_system_score_codex":0.00013448333,"about_ca_system_score_gemma":0.000045606008,"threshold_uncertainty_score":0.999933},"labels":[],"label_agreement":null},{"id":"W2525245748","doi":"10.1016/j.cjca.2016.07.407","title":"ISCHEMIC AND BLEEDING OUTCOMES AFTER CORONARY ARTERY BYPASS GRAFTING AMONG PATIENTS INITIALLY TREATED WITH A P2Y12 RECEPTOR ANTAGONIST FOR ACUTE CORONARY SYNDROMES - INSIGHTS ON TIMING OF DISCONTINUATION OF TICAGRELOR AND CLOPIDOGREL PRIOR TO SURGERY","year":2016,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Ticagrelor; Discontinuation; P2Y12; Clopidogrel; Bypass grafting; Internal medicine; Cardiology; Artery; Acute coronary syndrome; Myocardial infarction","score_opus":0.01417700453266502,"score_gpt":0.23269818076936688,"score_spread":0.21852117623670186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2525245748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984142,0.0005166736,0.0002848061,0.00017607331,0.00012593252,0.0003342117,0.000099876146,0.000003661291,0.00004453336],"genre_scores_gemma":[0.9993857,0.00019921058,0.0001583797,0.00007766698,0.00010551652,0.000013000247,0.000017543774,0.000022800605,0.000020138368],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99896026,0.00007532968,0.0004334507,0.00017266146,0.00013608599,0.000222239],"domain_scores_gemma":[0.9987809,0.0002863103,0.0002508235,0.00010283549,0.00024993994,0.00032919282],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019792325,0.00016290294,0.0008613589,0.00030517424,0.00005839407,0.0000080953505,0.000046054778,0.000097668184,0.00000551563],"category_scores_gemma":[0.00012337226,0.00010296223,0.0002218844,0.000072388684,0.00025837912,0.00013908783,0.000010181134,0.00007496894,2.783419e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002388586,0.000010365628,0.9724067,0.00004499448,0.0025700082,0.0003168159,0.0002533713,0.0000023172088,0.0015236869,0.0000042139814,0.00019667327,0.020282295],"study_design_scores_gemma":[0.0030613756,0.001240233,0.99169743,0.0008220491,0.00088972785,0.00062055414,0.0001431104,0.0000015408327,0.00097397924,0.000005031778,0.00040856955,0.00013642585],"about_ca_topic_score_codex":0.000028926648,"about_ca_topic_score_gemma":0.000043276505,"teacher_disagreement_score":0.020145869,"about_ca_system_score_codex":0.000057376274,"about_ca_system_score_gemma":0.00024618147,"threshold_uncertainty_score":0.41986778},"labels":[],"label_agreement":null},{"id":"W2526069136","doi":"10.1016/j.cjca.2016.07.087","title":"DUAL ANTIPLATELET THERAPY IN TYPE 1 AND TYPE 2 MYOCARDIAL INFARCTIONS: A SYSTEMATIC REVIEW OF RANDOMIZED CONTROLLED TRIALS AND OBSERVATIONAL STUDIES","year":2016,"lang":"en","type":"review","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Ticagrelor; Clopidogrel; Prasugrel; Observational study; Myocardial infarction; Randomized controlled trial; Aspirin; Cardiology; Internal medicine; Acute coronary syndrome; Intensive care medicine; Platelet aggregation inhibitor","score_opus":0.12559859640966625,"score_gpt":0.3776558910185989,"score_spread":0.25205729460893267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2526069136","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023745775,0.9949916,0.000010581966,0.00020730113,0.00067236135,0.0037482607,0.000046482033,0.0000026650346,0.00008326515],"genre_scores_gemma":[0.0006563294,0.9982326,0.000017846973,0.00023518936,0.00068552425,0.000091195165,0.000021972239,0.000024987445,0.000034381756],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9902449,0.0059206774,0.0031857144,0.00019077407,0.00024049498,0.0002174161],"domain_scores_gemma":[0.9917876,0.0046157804,0.0019166522,0.00023300425,0.0011843799,0.0002625498],"candidate_categories":["metaresearch","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.013183805,0.0003485842,0.029666001,0.00063600985,0.000043250686,0.000012306569,0.000086924505,0.0002791866,0.000020488715],"category_scores_gemma":[0.0252832,0.000175369,0.0029888137,0.00029882608,0.00043075858,0.000058080535,0.000012056891,0.0002811384,0.0000022117551],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029091042,0.000008944838,0.00015547547,0.7246952,0.14233904,0.00083284744,0.00010832594,0.0000020944217,0.0000011648706,0.0004776828,0.0023900988,0.099898055],"study_design_scores_gemma":[0.1072923,0.00039919786,0.000037251775,0.6459735,0.029474845,0.0046930206,0.000044962504,2.1323203e-7,1.1908451e-7,0.00013628895,0.21172084,0.00022744428],"about_ca_topic_score_codex":0.00001871093,"about_ca_topic_score_gemma":0.000008189009,"teacher_disagreement_score":0.20933074,"about_ca_system_score_codex":0.0000946359,"about_ca_system_score_gemma":0.0030499108,"threshold_uncertainty_score":0.9847396},"labels":[],"label_agreement":null},{"id":"W2526201295","doi":"10.1016/j.cjca.2016.07.171","title":"UPTAKE OF NOVEL ORAL ANTIPLATELET ADP ANTAGONISTS AFTER ACUTE CORONARY SYNDROME IN QUÉBEC: A 2010-2014 POPULATION-BASED COHORT ANALYSIS","year":2016,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Prasugrel; Ticagrelor; Clopidogrel; Acute coronary syndrome; Randomized controlled trial; Cohort; Population; Platelet aggregation inhibitor; Internal medicine; P2Y12; Cardiology; Aspirin; Myocardial infarction","score_opus":0.00944608944868006,"score_gpt":0.2342411195399036,"score_spread":0.22479503009122354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2526201295","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927018,0.0018858064,0.0039815954,0.00064060185,0.00030095107,0.0001764371,0.00022578724,0.00000463946,0.00008237701],"genre_scores_gemma":[0.9990961,0.00019339663,0.00020302861,0.00020274747,0.00010956643,0.0000064582587,0.000046763686,0.000023413337,0.00011851945],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99833417,0.00013838224,0.0006904072,0.00022602039,0.00023080323,0.00038024326],"domain_scores_gemma":[0.9985653,0.00007255974,0.00024628371,0.00036588038,0.00023144209,0.00051851786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005138766,0.00019730737,0.0013808671,0.00091225473,0.000039528935,0.0000076220463,0.00015796727,0.00020171763,0.00031293088],"category_scores_gemma":[0.000065602835,0.00014312235,0.0010989228,0.00037346425,0.0002061717,0.000101300335,0.000007757048,0.000173836,0.000012077819],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077659404,0.00001516048,0.98390085,0.000016298958,0.0069147195,0.0038662364,0.000015515448,0.0011202692,0.0004358363,0.000006751262,0.00068998797,0.002241779],"study_design_scores_gemma":[0.0034082213,0.0003402706,0.9853772,0.00010600831,0.0026586442,0.003167543,0.000012694125,0.000022959273,0.000060370792,0.0000071731524,0.004685343,0.00015356981],"about_ca_topic_score_codex":0.009579693,"about_ca_topic_score_gemma":0.015507779,"teacher_disagreement_score":0.0063943015,"about_ca_system_score_codex":0.00025841212,"about_ca_system_score_gemma":0.0018779334,"threshold_uncertainty_score":0.9970156},"labels":[],"label_agreement":null},{"id":"W2526267487","doi":"10.1016/j.ahj.2016.09.006","title":"Ticagrelor with aspirin or alone in high-risk patients after coronary intervention: Rationale and design of the TWILIGHT study","year":2016,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":119,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"Icahn School of Medicine at Mount Sinai; AstraZeneca","keywords":"Medicine; Ticagrelor; Aspirin; Twilight; Internal medicine; Intervention (counseling); Cardiology; Intensive care medicine; Clopidogrel","score_opus":0.012330302207728329,"score_gpt":0.24972520533630949,"score_spread":0.23739490312858116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2526267487","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99791294,0.00031668547,0.0009319847,0.00034012244,0.000038155074,0.00044664412,0.000006646516,0.0000040587884,0.0000027366357],"genre_scores_gemma":[0.9990804,0.00016806815,0.00040025005,0.00017187989,0.000047220772,0.000020312957,5.6457014e-7,0.000010642159,0.000100669364],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989142,0.0003331384,0.00022538856,0.000118820106,0.0002955946,0.00011287506],"domain_scores_gemma":[0.9994839,0.00008856278,0.00011277716,0.00015052246,0.00008623625,0.00007799861],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027185745,0.00008628047,0.00026916308,0.000053142,0.000051325816,0.000007808137,0.000044528693,0.000013035363,0.0001676712],"category_scores_gemma":[0.000042893415,0.00003661468,0.0000991384,0.0001400999,0.00021565452,0.00008012529,0.000022674603,0.00010395669,0.0000036733873],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004178348,0.00056919747,0.9608304,0.000006299353,0.00028691752,0.00007153007,0.00016773594,0.000005441757,0.000041884472,5.668967e-7,0.00009600357,0.033745658],"study_design_scores_gemma":[0.005780813,0.0034453974,0.9893001,0.00023921017,0.00016007986,0.00023596143,0.00035973362,0.0000031441816,0.00013763041,0.000014213018,0.00026350445,0.000060259954],"about_ca_topic_score_codex":0.000029098415,"about_ca_topic_score_gemma":0.000022513776,"teacher_disagreement_score":0.033685397,"about_ca_system_score_codex":0.00002820952,"about_ca_system_score_gemma":0.00007182729,"threshold_uncertainty_score":0.1835882},"labels":[],"label_agreement":null},{"id":"W2527129721","doi":"10.1016/j.cjca.2016.07.572","title":"Développement et validation d’un instrument de mesure du risque de non-adhésion à la double thérapie antiplaquettaire suite à une angioplastie coronarienne: Protocole de recherche","year":2016,"lang":"fr","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Université du Québec à Trois-Rivières","funders":"","keywords":"Humanities; Medicine; Gynecology; Philosophy","score_opus":0.0450735667635789,"score_gpt":0.32593553213657905,"score_spread":0.2808619653730002,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2527129721","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83471906,0.009918683,0.1173957,0.02932265,0.0014396457,0.0025927208,0.00012389146,0.000023546236,0.0044640745],"genre_scores_gemma":[0.98938394,0.0060056453,0.0016391808,0.00055964396,0.0018099386,0.00017700675,0.000023315883,0.000063191765,0.00033811937],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9944031,0.0032157693,0.0006552514,0.00031345777,0.00028946053,0.0011229491],"domain_scores_gemma":[0.99693584,0.0004559864,0.00035952625,0.00035928423,0.00039768455,0.0014916899],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.008170317,0.00036171835,0.000881247,0.0003077772,0.00022476351,0.000056590405,0.00031502388,0.0008907859,0.00017082982],"category_scores_gemma":[0.0005164015,0.00029199925,0.00076882134,0.0003002205,0.00041365932,0.0002525867,0.00003227376,0.0007859964,0.000022797198],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035065105,0.00010416507,0.6028008,0.00040334533,0.006787591,0.010421905,0.0034923556,0.009540064,0.010457027,0.0034569798,0.024807906,0.32422137],"study_design_scores_gemma":[0.02362666,0.002020792,0.3285769,0.0032062246,0.002253942,0.019500464,0.0010296883,0.00015424343,0.027517665,0.0053569824,0.5859604,0.000796059],"about_ca_topic_score_codex":0.0017316015,"about_ca_topic_score_gemma":0.0006764182,"teacher_disagreement_score":0.56115246,"about_ca_system_score_codex":0.0033743186,"about_ca_system_score_gemma":0.011148332,"threshold_uncertainty_score":0.9999532},"labels":[],"label_agreement":null},{"id":"W2527608741","doi":"10.1016/j.cjca.2016.07.172","title":"CLOPIDOGREL VERSUS NOVEL P2Y12 INHIBITOR USE IN FIBRINOLYSIS TREATED ST SEGMENT ELEVATION MYOCARDIAL INFARCTION: INSIGHTS FROM THE CANADIAN OBSERVATIONAL ANTIPLATELET STUDY (COAPT)","year":2016,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Toronto Public Health","funders":"","keywords":"Medicine; Clopidogrel; Ticagrelor; Prasugrel; Percutaneous coronary intervention; P2Y12; Cardiology; Internal medicine; Fibrinolysis; Myocardial infarction; Aspirin; Conventional PCI; Observational study","score_opus":0.060106821332868036,"score_gpt":0.2542534543108845,"score_spread":0.19414663297801643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2527608741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951338,0.0008859875,0.0002965184,0.0017328556,0.0011044861,0.00043656293,0.00022769408,0.0000083701525,0.00017369779],"genre_scores_gemma":[0.9971113,0.0001792826,0.000041102565,0.00037338457,0.0021340833,0.000013652288,0.0000877389,0.000025614736,0.000033819426],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980188,0.0003362847,0.00058062834,0.00027957457,0.00036488994,0.00041981222],"domain_scores_gemma":[0.99797964,0.00032318447,0.00018403931,0.00037240284,0.00045619698,0.0006845559],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036910936,0.00023630791,0.0007119429,0.00047559102,0.00024550068,0.000057857433,0.00018529655,0.00022293469,0.000052342435],"category_scores_gemma":[0.00033740923,0.00015301941,0.00046232392,0.00040576828,0.00018308991,0.00028709372,0.000013614973,0.00030017755,0.000013112175],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094760227,0.000017214992,0.9827439,0.0000021148949,0.003137099,0.00082174805,0.00023232904,0.0005617999,0.0006612661,0.000090643145,0.0016235518,0.0091607105],"study_design_scores_gemma":[0.007963529,0.00043864796,0.88240236,0.00007178745,0.00045915597,0.0001831112,0.00029940662,0.0000070873148,0.00005570489,0.000022779064,0.107931055,0.00016539267],"about_ca_topic_score_codex":0.14333375,"about_ca_topic_score_gemma":0.5006026,"teacher_disagreement_score":0.35726887,"about_ca_system_score_codex":0.0010708392,"about_ca_system_score_gemma":0.003100279,"threshold_uncertainty_score":0.86237085},"labels":[],"label_agreement":null},{"id":"W2528445625","doi":"10.69645/qmbo4787","title":"Advances in fibrinolysis","year":2016,"lang":"en","type":"article","venue":"˜The œbiomedical & life sciences collection.","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Fibrinolysis; Medicine; Internal medicine","score_opus":0.012096494020997155,"score_gpt":0.2711984066166146,"score_spread":0.25910191259561743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2528445625","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82135564,0.055439085,0.031737644,0.040363893,0.0027865653,0.001659536,0.000026514768,0.000485967,0.04614514],"genre_scores_gemma":[0.99221975,0.004426986,0.00012547184,0.0008978641,0.00032051123,0.000040820192,0.0000014743649,0.0000070837914,0.0019600284],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99823755,0.00010587291,0.0002465702,0.00033350172,0.0007528292,0.00032365878],"domain_scores_gemma":[0.9992559,0.00020499736,0.00004882417,0.00021724812,0.00004202539,0.00023101339],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065174466,0.00011369844,0.00024640124,0.00022006978,0.00035413384,0.000019081657,0.0002125323,0.00006799525,0.0005638079],"category_scores_gemma":[0.00018079349,0.000053186515,0.00021308301,0.0019944552,0.0012379086,0.00019616426,0.00004328701,0.00009156179,0.000095354975],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008607701,0.00075361645,0.09813019,0.000083820916,0.00032422252,0.00015144411,0.0004098737,0.00003791208,0.0040063243,0.0010603104,0.027896767,0.8662847],"study_design_scores_gemma":[0.0046185707,0.00089453394,0.07440821,0.0002986919,0.00014117538,0.00026965947,0.00072310294,0.00060451485,0.00054687203,0.0020770645,0.91507614,0.00034147876],"about_ca_topic_score_codex":0.000030220104,"about_ca_topic_score_gemma":0.00003582253,"teacher_disagreement_score":0.8871794,"about_ca_system_score_codex":0.000062891864,"about_ca_system_score_gemma":0.00037547658,"threshold_uncertainty_score":0.61733013},"labels":[],"label_agreement":null},{"id":"W2530088942","doi":"10.1161/circulationaha.116.024526","title":"Response by Bagai et al to Letter Regarding Article, “Individualizing Duration of Dual Antiplatelet Therapy After Acute Coronary Syndrome or Percutaneous Coronary Intervention”","year":2016,"lang":"en","type":"letter","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Population Health Research Institute; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Percutaneous coronary intervention; Acute coronary syndrome; Cardiology; Internal medicine; Myocardial infarction","score_opus":0.018072905643786958,"score_gpt":0.27626652689958214,"score_spread":0.2581936212557952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2530088942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79366475,0.000996159,0.0016795059,0.20177518,0.0003346469,0.0010645184,0.0003556361,0.00011223098,0.000017374316],"genre_scores_gemma":[0.6560603,0.0002586087,0.0001319551,0.3415357,0.00021991435,0.00007234448,0.0011059259,0.00011245671,0.00050280325],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959965,0.00083540595,0.00088188186,0.0007772287,0.0010083772,0.0005006509],"domain_scores_gemma":[0.99829656,0.00025897927,0.00035379108,0.0007320073,0.00021900542,0.00013964763],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00090355595,0.00051542337,0.00086905377,0.00036619333,0.000115728224,0.000073753064,0.00015116803,0.0005716582,0.00085284916],"category_scores_gemma":[0.000082128645,0.00041034102,0.00079977076,0.00024386785,0.00011911961,0.00039801677,0.00007068333,0.00060084753,0.00011001498],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029090118,0.00019658043,0.016347665,0.00019691087,0.004511531,0.03072635,0.000656971,0.000027679649,0.09471825,0.0000021495891,0.8117996,0.011726239],"study_design_scores_gemma":[0.0073048635,0.0013788358,0.21913344,0.002473204,0.0010718969,0.038334284,0.00006236838,0.00006056105,0.0025606342,0.000045060846,0.72646105,0.0011137902],"about_ca_topic_score_codex":0.000008590928,"about_ca_topic_score_gemma":9.4581657e-7,"teacher_disagreement_score":0.20278578,"about_ca_system_score_codex":0.000215012,"about_ca_system_score_gemma":0.00012881403,"threshold_uncertainty_score":0.99983484},"labels":[],"label_agreement":null},{"id":"W2530948693","doi":"10.1093/ehjqcco/qcw051","title":"Duration of dual antiplatelet therapy and associated outcomes following percutaneous coronary intervention for acute myocardial infarction: contemporary practice insights from the Canadian Observational Antiplatelet Study","year":2016,"lang":"en","type":"article","venue":"European Heart Journal - Quality of Care and Clinical Outcomes","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hamilton Health Sciences; Population Health Research Institute; Saint John Regional Hospital; Centre Hospitalier de l’Université de Montréal; Thunder Bay Regional Health Sciences Centre; Royal Jubilee Hospital; Canadian VIGOUR Centre; University of Alberta; University of Ottawa; London Health Sciences Centre; Health Sciences North; Institut Universitaire de Cardiologie et de Pneumologie de Québec; McMaster University; Eli Lilly (Canada); Canadian Heart Research Centre; Western University; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Percutaneous coronary intervention; Conventional PCI; Internal medicine; Myocardial infarction; Cardiology; Discontinuation; Cardiogenic shock; Ticagrelor; Observational study","score_opus":0.14768907392871208,"score_gpt":0.4206815998060233,"score_spread":0.27299252587731127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2530948693","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915649,0.0032844248,0.000043036463,0.003701887,0.00045739338,0.0006862168,0.0001663176,0.000017329628,0.00007845816],"genre_scores_gemma":[0.996375,0.0012779122,0.00016629498,0.001853769,0.00017599044,0.0000025461118,0.0000879147,0.000025834255,0.000034686615],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953493,0.0022168434,0.0014253925,0.00027919924,0.00056198635,0.00016728426],"domain_scores_gemma":[0.9944792,0.0039179884,0.0006048362,0.00024471155,0.00053494,0.00021834079],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002742646,0.0002105609,0.0009802092,0.00006716187,0.00036288615,0.000064079846,0.00009540858,0.000109800676,0.000014342226],"category_scores_gemma":[0.002358481,0.000120050645,0.0012633469,0.00007588082,0.00018769492,0.00036673734,0.000041118034,0.0002731434,0.0000015574597],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021117611,0.00029233968,0.9737775,0.000011988206,0.009067736,0.00022609171,0.0010648315,3.3123038e-7,0.00016053108,0.000030616022,0.00020442916,0.013051895],"study_design_scores_gemma":[0.009439056,0.0021164294,0.9815291,0.00015486,0.00081394165,0.00016236605,0.002862797,0.0000013874677,0.000012475038,0.00007017252,0.0026871844,0.00015023309],"about_ca_topic_score_codex":0.0017592822,"about_ca_topic_score_gemma":0.001314899,"teacher_disagreement_score":0.012901662,"about_ca_system_score_codex":0.000045493074,"about_ca_system_score_gemma":0.00024483463,"threshold_uncertainty_score":0.48955232},"labels":[],"label_agreement":null},{"id":"W2531723129","doi":"10.1016/j.cjca.2015.07.658","title":"IDENTIFYING VASCULAR COMPLICATIONS AND IMPROVING OUTCOMES FOR TAVI PATIENTS","year":2015,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Incidence (geometry); Aortic valve replacement; Retrospective cohort study; Cohort; Academic institution; Population; Emergency medicine; Surgery; Intensive care medicine; Internal medicine; Stenosis","score_opus":0.037351525087779294,"score_gpt":0.2748545156861732,"score_spread":0.23750299059839391,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2531723129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94783556,0.00576581,0.04387646,0.0005956767,0.00059621024,0.0003536681,0.000039047605,0.0000074589534,0.0009301191],"genre_scores_gemma":[0.99865395,0.000046775753,0.0006832639,0.0003449452,0.00021984307,0.0000055291043,0.000015732272,0.000012323846,0.00001761878],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99936867,0.000050856986,0.00020814309,0.000093979,0.0000963714,0.00018198167],"domain_scores_gemma":[0.998693,0.000034720364,0.0000853844,0.00014139031,0.0004262242,0.0006193154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032522948,0.00007830734,0.00038871486,0.00014698452,0.000079842765,0.000016817921,0.00006689338,0.0000644236,0.0000014065374],"category_scores_gemma":[0.00027261837,0.00006552973,0.00034591634,0.000044292305,0.00008791167,0.00006661502,0.0000065327526,0.00008902337,0.0000018779407],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053816002,0.0000047571107,0.95393026,0.000043217395,0.0014037486,0.000051998402,0.00020959029,0.00012236048,0.000052485433,0.000302306,0.0035406433,0.040284846],"study_design_scores_gemma":[0.004045922,0.0002627089,0.85081804,0.000031285083,0.000571541,0.0003251085,0.0003119686,0.000014102414,0.000018862447,0.0005844801,0.14291087,0.00010511046],"about_ca_topic_score_codex":0.00013010221,"about_ca_topic_score_gemma":0.00006676883,"teacher_disagreement_score":0.13937023,"about_ca_system_score_codex":0.000072440664,"about_ca_system_score_gemma":0.0005468051,"threshold_uncertainty_score":0.2672225},"labels":[],"label_agreement":null},{"id":"W2537558475","doi":"10.1160/th16-04-0340","title":"A randomised study for optimising crossover from ticagrelor to clopidogrel in patients with acute coronary syndrome","year":2016,"lang":"en","type":"article","venue":"Thrombosis and Haemostasis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Ticagrelor; Clopidogrel; Acute coronary syndrome; Medicine; Internal medicine; Cardiology; Crossover study; Aspirin; Myocardial infarction; Pathology","score_opus":0.024351263218633474,"score_gpt":0.28772940723271595,"score_spread":0.2633781440140825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2537558475","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957439,0.00018459336,0.0007732885,0.00036945537,0.000046301673,0.002597102,0.0002287306,0.000034691708,0.000021966516],"genre_scores_gemma":[0.99771863,0.00016557035,0.001416299,0.0004156778,0.000022466182,0.00014210194,0.000037254205,0.000038324953,0.00004370207],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99873227,0.000047994567,0.00024763297,0.00041966213,0.00027341937,0.0002790087],"domain_scores_gemma":[0.9992262,0.00013483713,0.000049973638,0.00031557406,0.00008186803,0.00019155178],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015210448,0.00021124881,0.00067383813,0.000082046456,0.0001038731,0.00003231765,0.0000681428,0.00006209105,0.00012478152],"category_scores_gemma":[0.000026860993,0.00012526751,0.00015738308,0.00013148338,0.00007374437,0.00012021514,0.000042356078,0.000049091108,0.000010210998],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.058798674,0.0014892301,0.86499375,0.00003246486,0.0045282315,0.00011050866,0.00091803283,0.0000031133943,0.0001882663,0.000009731644,0.0003310675,0.06859691],"study_design_scores_gemma":[0.108489186,0.0016684023,0.88772714,0.00024339133,0.0010855864,0.0000073489205,0.00017321203,0.0000035295777,0.00016738473,0.000026048196,0.00020026782,0.00020847273],"about_ca_topic_score_codex":0.000039313574,"about_ca_topic_score_gemma":0.00000989031,"teacher_disagreement_score":0.06838843,"about_ca_system_score_codex":0.000048723683,"about_ca_system_score_gemma":0.000039670875,"threshold_uncertainty_score":0.5108261},"labels":[],"label_agreement":null},{"id":"W2537933383","doi":"10.1016/j.jacc.2016.08.021","title":"Selecting the Duration of Antiplatelet Therapy Following Percutaneous Coronary Intervention","year":2016,"lang":"en","type":"letter","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Percutaneous coronary intervention; Duration (music); Cardiology; Internal medicine; Myocardial infarction","score_opus":0.012236129589979546,"score_gpt":0.26063122744454686,"score_spread":0.24839509785456731,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2537933383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91394025,0.006686509,0.00048967026,0.07686784,0.0011860448,0.0004971631,0.00009106916,0.000010050526,0.00023138913],"genre_scores_gemma":[0.9746565,0.002908235,0.0000833159,0.018927997,0.0030842004,0.0000037828397,0.0000079558895,0.000050509425,0.00027747604],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965628,0.0012617544,0.001039432,0.00019414163,0.00066301454,0.00027890052],"domain_scores_gemma":[0.9960164,0.00052203,0.0024474638,0.0005505686,0.00042435573,0.00003917088],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010716347,0.00027572396,0.0018691985,0.00018811907,0.00011093343,0.0000052571822,0.0004891365,0.00023372936,0.000018328665],"category_scores_gemma":[0.00020989303,0.0001339269,0.0039160433,0.00031362966,0.0005704292,0.00006251315,0.00006678721,0.00095268566,0.000001158155],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015066138,0.00016019164,0.038185187,0.00056952843,0.060297094,0.02915292,0.00029691524,0.0003041713,0.06966372,0.000026198186,0.6722945,0.11398343],"study_design_scores_gemma":[0.007918027,0.0075247656,0.02409374,0.0027511215,0.0060642133,0.21822554,0.0013733619,0.000022261242,0.006599697,0.0004541911,0.72430784,0.0006652355],"about_ca_topic_score_codex":0.000009758619,"about_ca_topic_score_gemma":5.327952e-7,"teacher_disagreement_score":0.18907261,"about_ca_system_score_codex":0.000100020006,"about_ca_system_score_gemma":0.00030130162,"threshold_uncertainty_score":0.54613805},"labels":[],"label_agreement":null},{"id":"W2538536654","doi":"10.1177/1747493016672085","title":"Platelet glycoprotein gene Ia C807T, HPA-3, and Ibα VNTR polymorphisms are associated with increased ischemic stroke risk: Evidence from a comprehensive meta-analysis","year":2016,"lang":"en","type":"review","venue":"International Journal of Stroke","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Odds ratio; Meta-analysis; Medicine; Genotype; Publication bias; Allele; Confidence interval; Glycoprotein Ib; Internal medicine; Genetics; Funnel plot; Bioinformatics; Stroke (engine); Oncology; Platelet membrane glycoprotein; Gene; Biology; Platelet","score_opus":0.055347480291566636,"score_gpt":0.3195389112880464,"score_spread":0.2641914309964798,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2538536654","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.082395,0.9109467,0.0010628509,0.00014804685,0.00014626418,0.00047276946,0.0047807153,0.00002374283,0.000023902445],"genre_scores_gemma":[0.03459352,0.9633955,0.0005476812,0.00011422137,0.00066279445,0.000031998155,0.00027917873,0.00007240218,0.00030271948],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9951653,0.00059570686,0.0013456934,0.0005757524,0.00199095,0.00032659515],"domain_scores_gemma":[0.99317086,0.0010331089,0.0035078716,0.00048606665,0.0013992984,0.00040277842],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004965466,0.0007124472,0.005245971,0.0008256201,0.000087407105,0.00012621244,0.0006405607,0.00036019398,0.0008643782],"category_scores_gemma":[0.00045324332,0.00042232874,0.006004962,0.00029685654,0.00021414345,0.0003111726,0.00012054226,0.00086591044,0.000019816567],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013537961,0.00018450634,0.0024256082,0.000197983,0.90457225,0.0036144648,0.00003344482,0.000011346489,0.0004130497,0.0000013727656,0.00028109716,0.08691109],"study_design_scores_gemma":[0.005950094,0.0004898663,0.00531075,0.013334549,0.8279333,0.0022415747,0.00006678874,0.000016386246,0.0008147926,0.0000118247435,0.14301333,0.0008167462],"about_ca_topic_score_codex":0.0002700385,"about_ca_topic_score_gemma":0.000030046944,"teacher_disagreement_score":0.14273223,"about_ca_system_score_codex":0.00031867056,"about_ca_system_score_gemma":0.0005366275,"threshold_uncertainty_score":0.99982285},"labels":[],"label_agreement":null},{"id":"W2540898917","doi":"10.1016/j.jval.2016.09.1692","title":"Proton Pump Inhibitors and Major Adverse Cardiovascular Outcomes: A Systematic Review","year":2016,"lang":"en","type":"review","venue":"Value in Health","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Clopidogrel; Observational study; Mace; Meta-analysis; Internal medicine; MEDLINE; Adverse effect; Stroke (engine); Population; Concomitant; Intensive care medicine; Systematic review; Myocardial infarction; Percutaneous coronary intervention","score_opus":0.04688973419482255,"score_gpt":0.32791915394278925,"score_spread":0.2810294197479667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2540898917","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000013087264,0.9760866,0.000020782909,0.00017400914,0.0002010502,0.0233139,0.00004614065,0.00008423161,0.000060171926],"genre_scores_gemma":[0.0000074049753,0.9961426,0.00003846665,0.000599863,0.00016335242,0.0027149469,0.00004528485,0.00011466158,0.00017339295],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9936368,0.002137267,0.0020108612,0.00077649613,0.0008724364,0.00056616095],"domain_scores_gemma":[0.99708813,0.00023850545,0.00060489326,0.0015691743,0.00006456184,0.00043474103],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0041392604,0.0006832364,0.009988227,0.0003437995,0.00008309612,0.00001300652,0.00018573864,0.00030812382,0.000028170734],"category_scores_gemma":[0.0005510151,0.00039849916,0.0039852676,0.0004555623,0.00008301247,0.00007740268,0.000074268704,0.0004510352,0.0001370053],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000064009982,0.000052238713,0.000039127313,0.8966878,0.002757747,0.00020118583,0.000021772486,2.7236507e-7,2.45268e-9,0.000021595284,0.000048636848,0.10016319],"study_design_scores_gemma":[0.00071936107,0.00007506723,0.000005756977,0.6295025,0.004696847,0.0004889498,0.000010452757,5.832421e-7,5.272153e-8,0.0000064557985,0.36425677,0.00023722353],"about_ca_topic_score_codex":0.00019317605,"about_ca_topic_score_gemma":7.763528e-7,"teacher_disagreement_score":0.36420813,"about_ca_system_score_codex":0.00047164076,"about_ca_system_score_gemma":0.0011257294,"threshold_uncertainty_score":0.9998467},"labels":[],"label_agreement":null},{"id":"W2544153823","doi":"10.1016/j.jacc.2016.09.201","title":"TCT-55 Risk–Benefit Analysis of Upstream Antithrombotic Therapy in Patients with Non–ST-Segment Elevation Acute Coronary Syndromes Prior to Coronary Angiography","year":2016,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Sacré-Cœur de Montréal","funders":"","keywords":"Medicine; Antithrombotic; Cardiology; Internal medicine; Coronary angiography; Acute coronary syndrome; Elevation (ballistics); ST segment; ST elevation; Electrocardiography; Myocardial infarction","score_opus":0.005864122771174664,"score_gpt":0.23198732651094173,"score_spread":0.22612320373976708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2544153823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971797,0.0006035729,0.0010282075,0.00025970844,0.00009520707,0.00047729138,0.00033449306,0.0000045532047,0.000017296747],"genre_scores_gemma":[0.9973021,0.0019964487,0.00047517367,0.00013495455,0.00003859144,0.00000704493,0.000006416893,0.000020478305,0.000018800703],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99811196,0.0002786791,0.00064300135,0.00020709337,0.00053087174,0.00022841178],"domain_scores_gemma":[0.99780095,0.0001548536,0.0010345863,0.00048723284,0.00041159758,0.00011078939],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039387005,0.00020127103,0.001704899,0.00077223085,0.000043804623,0.000002020797,0.0002667634,0.000053876458,0.000021442045],"category_scores_gemma":[0.000035130914,0.00010338867,0.0016312315,0.0016547461,0.00039635977,0.00007731026,0.000044396187,0.0001178189,8.0004656e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0071041393,0.00022192109,0.94816047,0.000008918124,0.027517248,0.000141639,0.00003656163,0.0014110017,0.0009924072,0.0000051311126,0.00013740735,0.014263157],"study_design_scores_gemma":[0.0045825825,0.0049104993,0.98421156,0.00015275447,0.005112167,0.00023921013,0.00016969845,0.0000048313364,0.00035473876,0.00002130427,0.00011842405,0.00012222903],"about_ca_topic_score_codex":0.000014266936,"about_ca_topic_score_gemma":0.0000068039353,"teacher_disagreement_score":0.03605109,"about_ca_system_score_codex":0.00008475987,"about_ca_system_score_gemma":0.00014724846,"threshold_uncertainty_score":0.42160678},"labels":[],"label_agreement":null},{"id":"W2547486604","doi":"10.1161/jaha.116.003977","title":"Relationship of Platelet Reactivity With Bleeding Outcomes During Long‐Term Treatment With Dual Antiplatelet Therapy for Medically Managed Patients With Non‐ST‐Segment Elevation Acute Coronary Syndromes","year":2016,"lang":"en","type":"article","venue":"Journal of the American Heart Association","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Alberta","funders":"St. Jude Medical; National Institutes of Health; Regado Biosciences; Duke Clinical Research Institute; Medicines Company; Amarin Corporation; Janssen Pharmaceuticals; Belvoir Media Group; Gilead Sciences; Eisai; Boston VA Research Institute; GlaxoSmithKline; Eli Lilly and Company; Bristol-Myers Squibb; AstraZeneca; Amylin Pharmaceuticals; Pfizer; Daiichi Sankyo Europe; Sanofi; American Heart Association","keywords":"Medicine; Internal medicine; Cardiology; Acute coronary syndrome; ST elevation; Platelet; ST segment; Major bleeding; Myocardial infarction","score_opus":0.01198056498101895,"score_gpt":0.25533433732740013,"score_spread":0.24335377234638117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2547486604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99671847,0.00004529242,0.0010184309,0.0013278698,0.00005656855,0.00077523745,0.000038624195,0.000014830212,0.0000046928863],"genre_scores_gemma":[0.998748,0.00025591144,0.0006265602,0.00010801714,0.000067549125,0.000021616628,0.000013366551,0.000033102686,0.00012589821],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99809474,0.00015533857,0.00040274658,0.00017649087,0.00093173864,0.0002389374],"domain_scores_gemma":[0.9976816,0.0003998726,0.001209608,0.00022211588,0.00038782202,0.00009896363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004973893,0.00020802241,0.0008111929,0.0001277841,0.0001661728,0.000016606906,0.00007662699,0.000053411422,0.000007522562],"category_scores_gemma":[0.000074388285,0.000091191025,0.00033438212,0.00023848577,0.000109239874,0.00028940878,0.000011922372,0.00012973147,5.685378e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008456621,0.00044625567,0.9759755,0.000022496237,0.0045016427,0.000035045112,0.00015164299,0.000019337267,0.0021601177,0.0000012562765,0.00003401585,0.008196063],"study_design_scores_gemma":[0.013999296,0.005330336,0.975825,0.00035444458,0.0009134537,0.00019184483,0.00006735324,0.000003246285,0.0031378225,0.000006364155,0.000039792234,0.00013105756],"about_ca_topic_score_codex":0.000011213922,"about_ca_topic_score_gemma":0.0000063581133,"teacher_disagreement_score":0.008065006,"about_ca_system_score_codex":0.0005849874,"about_ca_system_score_gemma":0.00018076507,"threshold_uncertainty_score":0.3718662},"labels":[],"label_agreement":null},{"id":"W2550509512","doi":"","title":"Duration of dual antiplatelet therapy after coronary stent insertion: Does the benefit of extended therapy outweigh the risk?","year":2016,"lang":"en","type":"article","venue":"PubMed","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Health Authority","funders":"","keywords":"Medicine; Platelet aggregation inhibitor; Coronary stent; Duration (music); Stent; Cardiology; Internal medicine; Surgery; Aspirin","score_opus":0.014417697562989704,"score_gpt":0.21064838578067654,"score_spread":0.19623068821768685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550509512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9858868,0.0099751735,0.00008416664,0.0021318388,0.00022190872,0.0014767762,0.000060491937,0.000034277225,0.00012857655],"genre_scores_gemma":[0.9764921,0.021786802,0.000010541844,0.00039114914,0.00021798689,0.0007366563,0.000009013424,0.000025761365,0.00032995758],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99831855,0.00021491395,0.00043627678,0.00023979756,0.00051967835,0.00027077043],"domain_scores_gemma":[0.99863183,0.00017612548,0.00025962607,0.0006815029,0.00017626204,0.000074653864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007100927,0.00019441676,0.000365732,0.00005300262,0.00010280052,0.000012692551,0.00016293935,0.00009032968,0.00017171656],"category_scores_gemma":[0.000044437707,0.00006681172,0.0004966513,0.00015641811,0.0003166558,0.00012706715,0.00003002976,0.00010636179,0.000004415718],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0072504138,0.00032035337,0.13447931,0.000018046017,0.0015474856,0.000021439626,0.00037052293,0.0000025605825,0.002452052,0.00015591849,0.00008801942,0.8532939],"study_design_scores_gemma":[0.00416092,0.00017329914,0.9602678,0.000034036373,0.00013538485,0.000048610324,0.00015019179,0.0000033001102,0.030079449,0.00051815127,0.0043205377,0.00010831008],"about_ca_topic_score_codex":0.000025016572,"about_ca_topic_score_gemma":0.000006880455,"teacher_disagreement_score":0.85318553,"about_ca_system_score_codex":0.00002279894,"about_ca_system_score_gemma":0.000037863374,"threshold_uncertainty_score":0.2724503},"labels":[],"label_agreement":null},{"id":"W2550639229","doi":"10.1016/j.ijcard.2016.11.240","title":"Longitudinal treatment patterns with ADP receptor inhibitors after myocardial infarction: Insights from the Canadian Observational AntiPlatelet sTudy","year":2016,"lang":"en","type":"article","venue":"International Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Population Health Research Institute; Queen Elizabeth II Health Sciences Centre; Hamilton Health Sciences; Dalhousie University; Université de Montréal; Hôpital du Sacré-Cœur de Montréal; Vancouver General Hospital; University of British Columbia; Royal Alexandra Hospital; St. Michael's Hospital; St. Boniface Hospital; University of Manitoba; Institut universitaire de cardiologie et de pneumologie de Québec; Regina Qu'Appelle Health Region; University of Alberta; Canadian VIGOUR Centre; McMaster University; St Mary's Hospital; Canadian Heart Research Centre; Eli Lilly (Canada); University of Toronto","funders":"Daiichi-Sankyo; Heart and Stroke Foundation of Canada; University of Toronto; Eli Lilly and Company","keywords":"Medicine; Observational study; Myocardial infarction; Internal medicine; Cardiology; Intensive care medicine","score_opus":0.025095277544900405,"score_gpt":0.264451710582473,"score_spread":0.23935643303757262,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550639229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99232537,0.00065808825,0.00046176385,0.0044224896,0.0015719504,0.00025647716,0.00013806167,0.000009937877,0.00015585922],"genre_scores_gemma":[0.9938281,0.00042961948,0.000045614863,0.00053395104,0.005028291,0.000026514319,0.000043684413,0.000019089957,0.000045101453],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99827254,0.00022560036,0.00040649893,0.0002206961,0.0006898566,0.00018483879],"domain_scores_gemma":[0.9984647,0.00017850964,0.00018437392,0.0002245613,0.0007458032,0.000202021],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000183601,0.00019712506,0.00047152306,0.0001637627,0.000094897994,0.000040897157,0.00020680722,0.00009987812,0.00020115328],"category_scores_gemma":[0.00005511385,0.00009253952,0.00048408937,0.000077717574,0.00013297432,0.00018950905,0.000025324547,0.00015764537,0.000027399097],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028184457,0.00007569218,0.9755247,7.8695876e-7,0.008784053,0.0018193524,0.00020956084,0.000056428093,0.00014248748,0.000030429499,0.0006987951,0.009839256],"study_design_scores_gemma":[0.0050326805,0.0010852476,0.9283991,0.00009947339,0.0004270623,0.0012193061,0.00019947626,7.7490336e-7,0.00014225817,0.000053527372,0.06322452,0.00011660902],"about_ca_topic_score_codex":0.0032714095,"about_ca_topic_score_gemma":0.007105691,"teacher_disagreement_score":0.06252572,"about_ca_system_score_codex":0.0004695136,"about_ca_system_score_gemma":0.00062030705,"threshold_uncertainty_score":0.49454144},"labels":[],"label_agreement":null},{"id":"W2551517087","doi":"10.1182/blood.v112.11.1980.1980","title":"Aspirin Resistance in Children after Interventional Cardiac Catheterisation.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Aspirin; Medicine; Platelet; Internal medicine; Platelet activation; Epinephrine; Cardiology; Anesthesia","score_opus":0.007987917336856288,"score_gpt":0.2186450616404423,"score_spread":0.21065714430358604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551517087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856829,0.013087336,0.000031912805,0.00004538833,0.000035220262,0.00018553114,0.000020201263,0.000029626332,0.0008818875],"genre_scores_gemma":[0.99851453,0.00029373568,0.00022818135,0.00009543106,0.00014595324,0.000050906663,0.000053433876,0.00001266819,0.0006051348],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993399,0.000043511896,0.00014565817,0.00016509465,0.00018366652,0.00012217592],"domain_scores_gemma":[0.99969065,0.0000063057532,0.000022009026,0.00020264905,0.000024904095,0.000053468415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000084403124,0.0000816096,0.0001839722,0.00005689763,0.000030363404,0.0000044039302,0.000039399263,0.000042963988,0.00012613292],"category_scores_gemma":[0.000010481738,0.000075961434,0.00035017743,0.00009118811,0.000049645652,0.00004860737,0.000013950074,0.000074155796,0.000045512028],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015788712,0.0005271764,0.99797744,0.000020777861,0.000407041,0.00013559325,0.000121708625,5.8726965e-7,0.00010194653,0.000032915606,0.00013303863,0.00038386448],"study_design_scores_gemma":[0.0022804826,0.000050637464,0.9947629,0.00008383523,0.000120315526,0.00013076479,0.000008087514,2.2028935e-7,0.0006593867,0.00005415851,0.0017640638,0.00008513371],"about_ca_topic_score_codex":0.0000113706665,"about_ca_topic_score_gemma":0.0000051492266,"teacher_disagreement_score":0.012831659,"about_ca_system_score_codex":0.000014652969,"about_ca_system_score_gemma":0.000038345446,"threshold_uncertainty_score":0.30976176},"labels":[],"label_agreement":null},{"id":"W2551938621","doi":"10.1080/09537104.2016.1256726","title":"ISTH Advanced Training Course on platelet bleeding disorders: How should they be investigated?","year":2016,"lang":"en","type":"article","venue":"Platelets","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Platelet; Course (navigation); Medicine; Internal medicine; Engineering","score_opus":0.050004033088879817,"score_gpt":0.28127078301809777,"score_spread":0.23126674992921795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551938621","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9813588,0.0012984623,0.00026575438,0.012311084,0.00033550174,0.0005412324,0.00005511889,0.00039077873,0.0034432535],"genre_scores_gemma":[0.9944443,0.0017366353,0.00024610703,0.0020857635,0.00033074844,0.000047945705,0.000051420942,0.00009936024,0.0009577265],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976343,0.000081779166,0.00027759708,0.00063063443,0.00066546205,0.00071022933],"domain_scores_gemma":[0.99857026,0.00021591914,0.00012282461,0.00056330056,0.00007387567,0.00045382706],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00034547094,0.00043564086,0.0006763512,0.00014051385,0.00020206741,0.000052833406,0.0002012725,0.00023682615,0.00022497158],"category_scores_gemma":[0.00017900563,0.0002885735,0.00044410018,0.0001876681,0.00020487141,0.00030695694,0.000039528233,0.000314078,0.00009603158],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022332538,0.0005204035,0.004237279,0.00016419195,0.0022007278,0.001433979,0.002163626,0.00011126389,0.05375513,0.0021017066,0.0045169317,0.92656153],"study_design_scores_gemma":[0.058137484,0.0052305995,0.031125525,0.0064278916,0.001966218,0.0023088397,0.0065224445,0.0005943187,0.1526081,0.009171549,0.7213482,0.004558825],"about_ca_topic_score_codex":0.000007728015,"about_ca_topic_score_gemma":0.000013948718,"teacher_disagreement_score":0.9220027,"about_ca_system_score_codex":0.00007913519,"about_ca_system_score_gemma":0.00014635304,"threshold_uncertainty_score":0.99995667},"labels":[],"label_agreement":null},{"id":"W2552082553","doi":"10.1016/j.thromres.2016.11.018","title":"Platelet function one and three months after coronary bypass surgery in relation to once or twice daily dosing of acetylsalicylic acid","year":2016,"lang":"en","type":"article","venue":"Thrombosis Research","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute; Université de Montréal","funders":"Stockholms Läns Landsting; Hjärt-Lungfonden","keywords":"Dosing; Platelet; Medicine; Bypass surgery; Anesthesia; Internal medicine; Cardiology; Surgery; Artery","score_opus":0.10335839474555623,"score_gpt":0.3519046036192704,"score_spread":0.24854620887371415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552082553","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953313,0.0020666758,0.0006963128,0.0010689627,0.000047182875,0.0005056443,0.000014672418,0.00003307793,0.00023618301],"genre_scores_gemma":[0.99795043,0.0014156289,0.00015730702,0.00010271725,0.00009944567,0.00009401399,0.000010082488,0.000033510874,0.00013685814],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977006,0.00030336995,0.0003524045,0.00039377165,0.0008268425,0.0004230244],"domain_scores_gemma":[0.9985473,0.0005893757,0.000047931633,0.0004332992,0.00019505667,0.00018703789],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017141739,0.00014375588,0.0004920323,0.0004195063,0.00008282612,0.00001912786,0.00008041894,0.000145338,0.00032660746],"category_scores_gemma":[0.00034611812,0.000100500074,0.00012729684,0.0006711869,0.000201287,0.00028225375,0.00010471185,0.00021683119,0.00005104594],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018170703,0.00040241214,0.40896758,0.00032597964,0.00062262657,0.0000880166,0.0005963355,0.000005143394,0.3342961,0.000068568,0.0004798715,0.23597665],"study_design_scores_gemma":[0.0017849675,0.00050465023,0.9829448,0.0009972034,0.000058690508,0.000014904314,0.0001484869,0.000017591075,0.012654337,0.00011758474,0.0006221759,0.00013464682],"about_ca_topic_score_codex":0.00015152032,"about_ca_topic_score_gemma":0.000188926,"teacher_disagreement_score":0.5739772,"about_ca_system_score_codex":0.00014090484,"about_ca_system_score_gemma":0.00016367792,"threshold_uncertainty_score":0.4098274},"labels":[],"label_agreement":null},{"id":"W2558898014","doi":"10.2174/1381612823666161123145148","title":"Traditional and Alternative Therapies for Refractory Angina","year":2017,"lang":"en","type":"review","venue":"Current Pharmaceutical Design","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Refractory (planetary science); Medicine; Angina; Intensive care medicine; Internal medicine; Myocardial infarction; Materials science; Metallurgy","score_opus":0.52364480881021,"score_gpt":0.489979091184749,"score_spread":0.033665717625461,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558898014","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000022952493,0.98345596,0.0133531615,0.000041033603,0.00066200027,0.0020624367,0.00025139644,0.000048628317,0.00012311716],"genre_scores_gemma":[0.00007218199,0.9974302,0.0002893414,0.000058158177,0.001255887,0.00043462275,0.0002937437,0.00005960438,0.00010626081],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99839616,0.00023884593,0.00031054666,0.0004638451,0.0002900772,0.0003005083],"domain_scores_gemma":[0.99865544,0.00049062195,0.00016473283,0.0003119271,0.000077703684,0.000299576],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042712776,0.00040648688,0.0014069768,0.00011259715,0.00019450534,0.00006456907,0.00017540982,0.00016408213,0.0001088673],"category_scores_gemma":[0.00009971653,0.00029825207,0.0011056531,0.000042490647,0.00029007785,0.000104088766,0.000020335423,0.00043888876,0.000025785213],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017232021,0.0002530878,9.329277e-7,0.010434094,0.0017469579,0.000032658107,0.000020799293,7.58812e-8,0.0000010013432,0.0007574729,0.0019199189,0.9846607],"study_design_scores_gemma":[0.0015263861,0.00023182014,0.000007733766,0.0062521067,0.0050226287,0.00014665446,0.000002839992,0.00006330275,0.000007396873,0.0005219648,0.9859095,0.00030761978],"about_ca_topic_score_codex":1.1587452e-7,"about_ca_topic_score_gemma":5.5163754e-9,"teacher_disagreement_score":0.98435307,"about_ca_system_score_codex":0.00006684188,"about_ca_system_score_gemma":0.0002818738,"threshold_uncertainty_score":0.99994695},"labels":[],"label_agreement":null},{"id":"W2561536322","doi":"10.71781/27772","title":"Rôle de la PKC delta dans la fonction plaquettaire en réponse à la thrombine via le récepteur GPIb alpha","year":2015,"lang":"fr","type":"dissertation","venue":"Papyrus : Institutional Repository (Université de Montréal)","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Heart and Stroke Foundation of Canada","keywords":"Medicine; Molecular biology; Chemistry; Biology","score_opus":0.0036591378631154626,"score_gpt":0.19372453859380184,"score_spread":0.19006540073068637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561536322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88204676,0.055624034,0.0043705967,0.00030137203,0.0012808564,0.00063851755,0.0001470464,0.00025512555,0.055335715],"genre_scores_gemma":[0.9684051,0.0032001499,0.0003617175,0.00011436131,0.00064569525,0.00005228911,0.0016976909,0.00010271318,0.025420245],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952155,0.0017036111,0.000510978,0.00083291676,0.0010589785,0.00067802565],"domain_scores_gemma":[0.9973603,0.00047861453,0.00036278562,0.00062889286,0.00038526594,0.0007841482],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0011236232,0.0007254048,0.00084457337,0.00033141254,0.0038559125,0.00009207564,0.00043948393,0.0012934976,0.00008319325],"category_scores_gemma":[0.00019697665,0.0008398841,0.0010117319,0.00040651983,0.0008569652,0.00052966224,0.00013734307,0.00094401377,0.000103996565],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.028167512,0.0065812496,0.072028495,0.0025288088,0.019343657,0.1054293,0.20407936,0.025549226,0.3060951,0.11950289,0.014245969,0.096448444],"study_design_scores_gemma":[0.018118618,0.00089115044,0.26500973,0.0024447213,0.007987415,0.0335939,0.22190598,0.0067623314,0.03144282,0.0022398944,0.4071061,0.0024973503],"about_ca_topic_score_codex":0.029731955,"about_ca_topic_score_gemma":0.0022951055,"teacher_disagreement_score":0.3928601,"about_ca_system_score_codex":0.0059084413,"about_ca_system_score_gemma":0.006915331,"threshold_uncertainty_score":0.9994052},"labels":[],"label_agreement":null},{"id":"W2561539584","doi":"10.1093/bja/aew357","title":"Prospective observational study of the effect of dual antiplatelet therapy with tranexamic acid treatment on platelet function and bleeding after cardiac surgery","year":2016,"lang":"en","type":"article","venue":"British Journal of Anaesthesia","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Assistance publique-Hôpitaux de Paris; Fondation Leducq","keywords":"Medicine; Clopidogrel; Aspirin; Tranexamic acid; Platelet; Anesthesia; Cardiac surgery; Antifibrinolytic; Internal medicine; Prospective cohort study; Cardiology; Surgery; Blood loss","score_opus":0.017076875237671776,"score_gpt":0.22742505920966086,"score_spread":0.21034818397198907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561539584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99421626,0.004962557,0.000011135398,0.000075441545,0.000069069494,0.0006315597,0.000016974365,0.0000062673143,0.000010736821],"genre_scores_gemma":[0.9963701,0.0034370287,0.000007468231,0.000024026236,0.00010898179,0.00001689132,0.0000016421415,0.000021809918,0.000012075846],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985696,0.00026905126,0.00036254138,0.0001608188,0.00050231663,0.00013566561],"domain_scores_gemma":[0.99920857,0.00014417131,0.00028659945,0.00014195118,0.00015085765,0.0000678234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053116295,0.00016507224,0.0007457005,0.000090982336,0.000061668004,0.000014199462,0.000043004224,0.000056656987,0.000016145055],"category_scores_gemma":[0.00002556298,0.00008523377,0.0004151178,0.0001495497,0.0001186872,0.00013680808,0.0000050549306,0.00009646988,2.8159184e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014133658,0.0004623247,0.78507245,0.000029236362,0.0022124238,0.00055959425,0.00014582204,0.0000048818674,0.0025522474,0.000002876275,0.000029465149,0.19479501],"study_design_scores_gemma":[0.0077788234,0.015255108,0.95242524,0.0009015919,0.00050782575,0.0013926146,0.00013886412,4.964388e-7,0.021414995,0.0000100597745,0.00008145758,0.00009293102],"about_ca_topic_score_codex":0.000026729793,"about_ca_topic_score_gemma":0.0000052562877,"teacher_disagreement_score":0.19470207,"about_ca_system_score_codex":0.0000522125,"about_ca_system_score_gemma":0.00008581692,"threshold_uncertainty_score":0.34757325},"labels":[],"label_agreement":null},{"id":"W2565381353","doi":"10.1016/j.ijcard.2016.12.173","title":"P2Y12 receptor inhibition with prasugrel and ticagrelor in STEMI patients after fibrinolytic therapy: Analysis from the SAMPA randomized trial","year":2016,"lang":"en","type":"article","venue":"International Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital du Sacré-Cœur de Montréal","funders":"","keywords":"Medicine; Prasugrel; Ticagrelor; P2Y12; Internal medicine; Randomized controlled trial; Cardiology; Pharmacology; Clopidogrel; Aspirin","score_opus":0.008394316960224314,"score_gpt":0.24081490551719176,"score_spread":0.23242058855696746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565381353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927742,0.0020024923,0.0030037016,0.0014574894,0.00030551234,0.00034698285,0.00003549657,0.000004276572,0.000069839814],"genre_scores_gemma":[0.9957179,0.0030196873,0.000089280176,0.00033150794,0.00077216374,0.000021384327,0.00001767793,0.0000090869635,0.000021327374],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9984481,0.00044845106,0.0004338931,0.00014210503,0.00042072972,0.000106727864],"domain_scores_gemma":[0.9985935,0.0006426312,0.00023547794,0.00012422317,0.0003455234,0.00005862373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005897935,0.00011399873,0.0007392182,0.00018071901,0.000014947594,0.00001662409,0.00008670553,0.00007342685,0.00009134956],"category_scores_gemma":[0.00023322836,0.000049270417,0.00057643827,0.00009686113,0.00019086043,0.000103283004,0.00002124354,0.00011487798,0.0000040499185],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7914822,0.00005446181,0.17035192,0.000001325366,0.012214061,0.00012444665,0.00013705083,0.000021354403,0.00017466747,0.000020582327,0.00008412633,0.025333814],"study_design_scores_gemma":[0.7375652,0.00055099063,0.25710434,0.00019287232,0.0014029497,0.00009147007,0.000050542483,0.000006168563,0.00019329663,0.00021798462,0.0025243412,0.00009983904],"about_ca_topic_score_codex":0.000012885357,"about_ca_topic_score_gemma":0.0000034456932,"teacher_disagreement_score":0.086752415,"about_ca_system_score_codex":0.000059506314,"about_ca_system_score_gemma":0.00006618996,"threshold_uncertainty_score":0.20091893},"labels":[],"label_agreement":null},{"id":"W2565657509","doi":"10.32396/usurj.v2i2.151","title":"Aspirin for Primary Prevention of Myocardial Infarction: An Evidence Based Clinical Inquiry","year":2016,"lang":"en","type":"article","venue":"USURJ University of Saskatchewan Undergraduate Research Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Aspirin; Myocardial infarction; Medicine; Primary prevention; Secondary prevention; Incidence (geometry); Disease; Intensive care medicine; Internal medicine; Cardiology","score_opus":0.12570585221296637,"score_gpt":0.3804123048398844,"score_spread":0.25470645262691805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565657509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93021995,0.00071153196,0.06418025,0.004017819,0.00017102437,0.0005383773,0.000018415156,0.000022618471,0.00012003991],"genre_scores_gemma":[0.9925295,0.0036513438,0.0027098244,0.000050225663,0.00037346565,6.615074e-7,0.00001158414,0.000017108714,0.00065625185],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9966989,0.0011581435,0.0004145508,0.00029498327,0.0010826432,0.00035075107],"domain_scores_gemma":[0.9968975,0.00074728107,0.00024997068,0.0003974162,0.0012965618,0.0004112381],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0050036674,0.00012652227,0.0005205999,0.00034211227,0.00025532462,0.000015537882,0.00027945082,0.00015864603,0.00007244857],"category_scores_gemma":[0.00031295608,0.0001038544,0.0009394353,0.00028706537,0.000925844,0.0005771854,0.00006920103,0.00037117963,0.0000059921003],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030992221,0.0022666645,0.13323855,0.00096053275,0.0038119485,0.0003020479,0.0013182014,0.00008727944,0.040468182,0.00024935417,0.0027837313,0.7835213],"study_design_scores_gemma":[0.060038574,0.027822278,0.7967256,0.012360408,0.002513038,0.0007374106,0.027366849,0.0002498224,0.013685691,0.017436916,0.03997906,0.0010843693],"about_ca_topic_score_codex":0.000049544375,"about_ca_topic_score_gemma":0.00002948229,"teacher_disagreement_score":0.7824369,"about_ca_system_score_codex":0.0001903774,"about_ca_system_score_gemma":0.0023114546,"threshold_uncertainty_score":0.42350593},"labels":[],"label_agreement":null},{"id":"W2569641608","doi":"10.1016/j.jacc.2016.10.043","title":"Dual Antiplatelet Therapy Versus Aspirin Monotherapy in Diabetics With Multivessel Disease Undergoing CABG","year":2017,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Heart and Stroke Foundation; Canadian VIGOUR Centre; St. Michael's Hospital; University of Alberta","funders":"","keywords":"Medicine; Aspirin; Internal medicine; Hazard ratio; Myocardial infarction; Coronary artery disease; Cardiology; Diabetes mellitus; Clopidogrel; Revascularization; Confidence interval; Stroke (engine); Surgery","score_opus":0.02220135363531753,"score_gpt":0.28712936481672324,"score_spread":0.2649280111814057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2569641608","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953104,0.002236471,0.00027552916,0.0012939837,0.00031584912,0.00027893588,0.000040962776,0.0000062112867,0.00024161005],"genre_scores_gemma":[0.993954,0.005131577,0.00029340648,0.00019998135,0.00034670808,0.0000045097486,0.0000011776998,0.000032429925,0.000036223744],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983935,0.00033535305,0.00041631993,0.00018558663,0.00039377323,0.00027546188],"domain_scores_gemma":[0.9976704,0.00024435215,0.0009570823,0.00075319206,0.00021285693,0.00016212414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043402007,0.00020938594,0.0011831397,0.00014291873,0.00015485828,0.000012631394,0.0003892612,0.00005238448,0.0000056232907],"category_scores_gemma":[0.00018750025,0.00012667393,0.00064293394,0.00015762218,0.0010483922,0.0001134307,0.000057613004,0.0003052089,8.905271e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.072984286,0.00026497786,0.89213836,0.00006355508,0.0056932974,0.0044599725,0.000118418124,0.004187179,0.003425481,0.00012480178,0.00040783206,0.016131815],"study_design_scores_gemma":[0.026373802,0.00286109,0.9610296,0.00028794256,0.00037057442,0.00072509336,0.00076380075,0.000044052358,0.0018668389,0.00008473139,0.005365131,0.00022738123],"about_ca_topic_score_codex":0.000014104691,"about_ca_topic_score_gemma":0.000009972146,"teacher_disagreement_score":0.068891175,"about_ca_system_score_codex":0.00007076744,"about_ca_system_score_gemma":0.0005822744,"threshold_uncertainty_score":0.51656127},"labels":[],"label_agreement":null},{"id":"W2571192847","doi":"","title":"Biochemical Aspirin Resistance Affect on Stroke Severity in Acute Stroke Patients Who Had Taken Aspirin","year":2011,"lang":"en","type":"article","venue":"Journal of the Korean Neurological Association","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Aspirin; Medicine; Stroke (engine); Internal medicine; Modified Rankin Scale; Odds ratio; Confidence interval; Clopidogrel; Cardiology; Gastroenterology; Ischemic stroke; Ischemia","score_opus":0.014328683397694036,"score_gpt":0.22749567473728172,"score_spread":0.2131669913395877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2571192847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970478,0.00011033644,0.000013002243,0.0009453454,0.00022761546,0.0002492755,0.0000369933,0.000015372052,0.0013542984],"genre_scores_gemma":[0.997622,0.00012637684,0.00007052262,0.0014686697,0.00014807016,0.0000032310024,0.0000057435113,0.000013366144,0.0005419786],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99783164,0.00047663777,0.00044477612,0.00019863695,0.00078270555,0.0002655955],"domain_scores_gemma":[0.99878836,0.00013647221,0.00056762405,0.00023087126,0.00015754868,0.000119105556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073870964,0.00016840427,0.00047975662,0.000080247955,0.00006437237,0.00001634846,0.0002417448,0.00021529954,0.000029273275],"category_scores_gemma":[0.00058141,0.000102930564,0.00066101796,0.00016462686,0.00005056717,0.0000968933,0.000053007014,0.000715587,0.000007600491],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039239563,0.0008983922,0.9890715,0.000015829228,0.00045382022,0.00015917535,0.00007872268,0.000007459966,0.0010562987,0.000038080052,0.0020248184,0.0022719647],"study_design_scores_gemma":[0.0026767163,0.0011666303,0.9900933,0.000079724225,0.00025295155,0.000016435644,0.0000060885163,0.0000152151115,0.004372781,0.00022296123,0.0010007251,0.000096501615],"about_ca_topic_score_codex":0.0000032485987,"about_ca_topic_score_gemma":0.0000050299063,"teacher_disagreement_score":0.0033164823,"about_ca_system_score_codex":0.00018847022,"about_ca_system_score_gemma":0.00004025444,"threshold_uncertainty_score":0.41973865},"labels":[],"label_agreement":null},{"id":"W2586768887","doi":"10.71781/4611","title":"Dépistage de la résistance à l'aspirine chez les patients coronariens stables, suivis à la clinique externe de cardiologie de l'Hôpital du Sacré-Coeur de Montréal","year":2006,"lang":"fr","type":"dissertation","venue":"Papyrus : Institutional Repository (Université de Montréal)","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.003909127313717487,"score_gpt":0.18445963229566828,"score_spread":0.1805505049819508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586768887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8959462,0.08458492,0.006524316,0.00009648483,0.00057963363,0.00065881334,0.00055753434,0.00021997359,0.0108321],"genre_scores_gemma":[0.96874666,0.013010336,0.0012693027,0.00018154313,0.00072241836,0.00008341031,0.0019300393,0.000119531855,0.013936756],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9942861,0.0015562599,0.0007656231,0.0010294425,0.0009220595,0.0014405055],"domain_scores_gemma":[0.9968256,0.00059529603,0.0005620009,0.0006775184,0.00045418472,0.0008854302],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.001347917,0.00093031133,0.0011758258,0.0002796917,0.0038500128,0.00012788286,0.0005780923,0.0012271918,0.00006090876],"category_scores_gemma":[0.00037926188,0.0010832758,0.0014127418,0.00031904588,0.0010601055,0.0003428691,0.00017509282,0.0011261482,0.000023307079],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.005311744,0.0013971729,0.9066599,0.000769578,0.00271053,0.032286942,0.011042483,0.011789284,0.007770234,0.0059951334,0.0015696507,0.012697319],"study_design_scores_gemma":[0.0056101587,0.00038504158,0.8934406,0.0009574457,0.0023035698,0.0030290908,0.010968857,0.0012109376,0.005920078,0.0003301565,0.07475188,0.001092167],"about_ca_topic_score_codex":0.08987906,"about_ca_topic_score_gemma":0.008787224,"teacher_disagreement_score":0.08109183,"about_ca_system_score_codex":0.012798076,"about_ca_system_score_gemma":0.006024558,"threshold_uncertainty_score":0.99961036},"labels":[],"label_agreement":null},{"id":"W2586967649","doi":"10.1016/j.ahj.2017.02.003","title":"Association of measured platelet reactivity with changes in P2Y12 receptor inhibitor therapy and outcomes after myocardial infarction: Insights into routine clinical practice from the TReatment with ADP receptor iNhibitorS: Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome (TRANSLATE-ACS) study","year":2017,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"AstraZeneca","keywords":"Medicine; Myocardial infarction; Platelet; Internal medicine; Cardiology; Receptor; Pharmacology","score_opus":0.024678323482172623,"score_gpt":0.3335766680560403,"score_spread":0.30889834457386767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586967649","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951918,0.0009648489,0.000010737661,0.002522664,0.00016372127,0.0010757006,0.00005915316,0.000009703443,0.0000016467092],"genre_scores_gemma":[0.9876594,0.011309316,0.00045604157,0.0001396571,0.00023581134,0.00014573018,0.00001455058,0.00003170909,0.00000780432],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997314,0.0008465297,0.0005218896,0.00039875865,0.00068708486,0.00023177319],"domain_scores_gemma":[0.9980603,0.00036741982,0.0007547151,0.00043341852,0.00020277772,0.00018140068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067364605,0.00033719264,0.0011986885,0.00007058673,0.00019561082,0.0000567474,0.000069126036,0.0000878699,0.000026226231],"category_scores_gemma":[0.000036904476,0.00018267076,0.00022447815,0.00009347868,0.00026681216,0.00036977592,0.000026306343,0.00033111632,5.7700277e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012433223,0.0021280511,0.9392857,0.000006716079,0.008628378,0.00025412065,0.0028194985,0.0000010460225,0.00017842458,4.806473e-8,0.0000067968695,0.034257997],"study_design_scores_gemma":[0.01114803,0.021698121,0.9625186,0.0002553463,0.0012665316,0.0002714945,0.001470619,0.0000019912873,0.00023777444,0.0000012811774,0.000945994,0.00018422415],"about_ca_topic_score_codex":0.0022824197,"about_ca_topic_score_gemma":0.0013101156,"teacher_disagreement_score":0.03407377,"about_ca_system_score_codex":0.00033843686,"about_ca_system_score_gemma":0.00021178386,"threshold_uncertainty_score":0.7449097},"labels":[],"label_agreement":null},{"id":"W2588134752","doi":"10.1056/jc200505130000004","title":"Bleeding Risk with Combination Therapies in Elderly MI Patients","year":2005,"lang":"en","type":"article","venue":"Journal watch","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Observational study; Intensive care medicine; Internal medicine; Medical diagnosis; Anticoagulant therapy; Emergency medicine; Pathology","score_opus":0.006199485150351848,"score_gpt":0.22630395835275485,"score_spread":0.220104473202403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588134752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99557954,0.001223317,0.00019706467,0.0024209952,0.000058021753,0.00010979349,0.0000010735885,0.000014296821,0.0003959045],"genre_scores_gemma":[0.99629825,0.0027448526,0.00035267125,0.00017593426,0.00019769958,0.0000028510233,0.0000044899466,0.000014048536,0.0002091749],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99921715,0.000054722328,0.0001655944,0.00008813103,0.0003221394,0.00015228339],"domain_scores_gemma":[0.99962646,0.00001778827,0.00008375329,0.00008383008,0.00010625283,0.00008190997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002543408,0.000085068226,0.00017124317,0.00006709976,0.00010202613,0.00003993584,0.000044662087,0.000043243544,0.000120741446],"category_scores_gemma":[0.000015378706,0.000057679557,0.00011664237,0.000102875594,0.000021504027,0.00018308224,0.00000514889,0.00026110248,0.00001796926],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061201333,0.0004854217,0.72436494,0.000013675001,0.00037536083,0.00006395561,0.0012164647,0.00008984748,0.00011009355,0.000016980555,0.0011413734,0.2715099],"study_design_scores_gemma":[0.016240979,0.0015557213,0.9451078,0.00030922977,0.000287302,0.0003490168,0.00085734343,0.00013046438,0.0010642628,0.0004908891,0.033377804,0.00022916382],"about_ca_topic_score_codex":0.000007882808,"about_ca_topic_score_gemma":0.0000094159095,"teacher_disagreement_score":0.27128074,"about_ca_system_score_codex":0.00007856266,"about_ca_system_score_gemma":0.00003153211,"threshold_uncertainty_score":0.2352104},"labels":[],"label_agreement":null},{"id":"W2589348902","doi":"10.1016/j.ijcard.2017.02.062","title":"Longer-term oral antiplatelet use in stable post-myocardial infarction patients: Insights from the long Term rIsk, clinical manaGement and healthcare Resource utilization of stable coronary artery dISease (TIGRIS) observational study","year":2017,"lang":"en","type":"article","venue":"International Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Clopidogrel; Internal medicine; Coronary artery disease; Percutaneous coronary intervention; Myocardial infarction; Cardiology; Aspirin; Conventional PCI; Guideline; Ticagrelor; Antithrombotic","score_opus":0.0854583913880576,"score_gpt":0.350522359025875,"score_spread":0.26506396763781737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589348902","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960915,0.0014917123,0.00038920395,0.00034855254,0.00089658174,0.0005593156,0.00018831194,0.0000071698164,0.000027694643],"genre_scores_gemma":[0.9958247,0.0028167502,0.000057057907,0.00034872352,0.0006026935,0.000009436763,0.00030473567,0.000017572254,0.000018345658],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971281,0.00079957704,0.0009116518,0.00028671426,0.0007074728,0.00016646666],"domain_scores_gemma":[0.997469,0.00031315317,0.00079795625,0.0004296717,0.0008414524,0.0001487595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007419714,0.00017851766,0.0006392552,0.0001689518,0.0001615917,0.00008046074,0.00034275476,0.000105842795,0.000012071357],"category_scores_gemma":[0.000438448,0.00013241582,0.00037550795,0.000054366017,0.00022753276,0.0005736656,0.00017757765,0.0003705975,0.00000133914],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0070155053,0.00036960604,0.966765,0.000016913591,0.0034640508,0.0009440215,0.00020450575,0.00021614776,0.000009241023,0.00003105653,0.0001954313,0.02076851],"study_design_scores_gemma":[0.007199988,0.00054911897,0.9900468,0.00019970031,0.0005434565,0.00008849889,0.0003333475,0.000040943192,0.000004854906,0.0001226466,0.00076052785,0.00011009718],"about_ca_topic_score_codex":0.000113292444,"about_ca_topic_score_gemma":0.00005879157,"teacher_disagreement_score":0.02328181,"about_ca_system_score_codex":0.00008936471,"about_ca_system_score_gemma":0.00014804555,"threshold_uncertainty_score":0.53997606},"labels":[],"label_agreement":null},{"id":"W2590631479","doi":"10.1182/blood.v106.11.1882.1882","title":"Incidence of Aspirin ’Resistance’ as Determined Using the PFA-100 in Pediatric Patients with Arterial Ischemic Stroke.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Aspirin; Internal medicine; Population; Stroke (engine); Hemostasis; Platelet; Pediatric stroke; Regimen; Anesthesia; Surgery; Cardiology; Ischemia; Ischemic stroke","score_opus":0.007012577329677734,"score_gpt":0.22545020193739526,"score_spread":0.21843762460771754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590631479","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979764,0.0012070627,0.000035129167,0.000022968492,0.000029607892,0.0002864857,0.000008599725,0.000013430923,0.0004203037],"genre_scores_gemma":[0.99910015,0.00007131008,0.00038823453,0.00008419236,0.00027124208,0.00000845803,0.000007751286,0.0000146374605,0.00005404005],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991065,0.00003903811,0.00020523615,0.00016324209,0.00031853336,0.00016744171],"domain_scores_gemma":[0.99950594,0.000021386384,0.00008997852,0.00027058486,0.00006030168,0.000051789317],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010357555,0.00011302197,0.00023335742,0.00006255622,0.000034053166,0.000008064954,0.00009360275,0.000048169626,0.000039209408],"category_scores_gemma":[0.00002569287,0.000075499855,0.00010970103,0.00017342443,0.000053312197,0.00008227602,0.000021435662,0.00008768642,0.0000049725168],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001747666,0.0011760116,0.9833778,0.00014358765,0.00026159204,0.00008103617,0.0003040545,0.0000531536,0.009745201,0.000006976317,0.000045970046,0.0030569548],"study_design_scores_gemma":[0.026184427,0.00048545402,0.9270841,0.00030589828,0.0017771279,0.00005298378,0.00012067698,0.000044814176,0.042138755,0.000009730398,0.0014540764,0.00034194154],"about_ca_topic_score_codex":0.000012270131,"about_ca_topic_score_gemma":0.000032632273,"teacher_disagreement_score":0.05629368,"about_ca_system_score_codex":0.000017452165,"about_ca_system_score_gemma":0.00011337595,"threshold_uncertainty_score":0.30787948},"labels":[],"label_agreement":null},{"id":"W2590877119","doi":"10.1016/j.ahj.2017.01.004","title":"Corrigendum to “A critical reappraisal of aspirin for secondary prevention in patients with ischemic heart disease” [Am Heart J 181 (2016) 92–100]","year":2017,"lang":"en","type":"erratum","venue":"American Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Aspirin; Cardiology; Internal medicine; Secondary prevention; Heart disease; Disease","score_opus":0.021045976306262065,"score_gpt":0.32869880931441164,"score_spread":0.3076528330081496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590877119","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90768856,0.021250838,0.0029630403,0.013517582,0.03508625,0.00913643,0.002348504,0.00023130748,0.0077775065],"genre_scores_gemma":[0.93533057,0.0008696097,0.0072513716,0.007324897,0.008546177,0.00040049886,0.0019723906,0.0005886287,0.03771587],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965077,0.0002485126,0.0007880019,0.00064293295,0.0010445949,0.00076827005],"domain_scores_gemma":[0.99704516,0.000097010445,0.00037589855,0.0008822275,0.0005835684,0.0010161329],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00060317863,0.00050587254,0.0018116012,0.0003957964,0.00026527874,0.0000823201,0.00026405972,0.00021613023,0.00025124787],"category_scores_gemma":[0.0005524018,0.00043267538,0.0011023509,0.0002137823,0.00058636063,0.00024176342,0.00007251538,0.0013430521,0.000030611092],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005093671,0.0008431797,0.07530889,0.0005016769,0.0005217429,0.00007041017,0.0000532692,0.000002356831,0.00008686431,0.00000530742,0.90932375,0.00818886],"study_design_scores_gemma":[0.0027199946,0.0036465942,0.34988973,0.0025386119,0.0005706902,0.00021741187,0.00008363974,0.000005990386,0.000044945926,0.00002362395,0.6398538,0.00040497616],"about_ca_topic_score_codex":0.00008615903,"about_ca_topic_score_gemma":0.00001200784,"teacher_disagreement_score":0.27458084,"about_ca_system_score_codex":0.00011265198,"about_ca_system_score_gemma":0.0024933394,"threshold_uncertainty_score":0.9998125},"labels":[],"label_agreement":null},{"id":"W2591400841","doi":"10.1182/blood.v106.11.4156.4156","title":"Clopidogrel Use in Children.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Clopidogrel; Medicine; Aspirin; Percutaneous coronary intervention; Population; Warfarin; Thienopyridine; Surgery; Internal medicine; Regimen; Pediatrics; Myocardial infarction; Atrial fibrillation","score_opus":0.009187213803840385,"score_gpt":0.22429996460621582,"score_spread":0.21511275080237544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591400841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99528563,0.003632138,0.000018866807,0.00011923428,0.000014147955,0.00015374598,0.0000034104921,0.00004734137,0.00072550215],"genre_scores_gemma":[0.9979501,0.0004900652,0.0004447289,0.00053584814,0.00026517324,0.0000065280483,0.000016957918,0.000012022235,0.00027861338],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99949807,0.000018758681,0.00009768664,0.00012925395,0.000120499986,0.00013573712],"domain_scores_gemma":[0.999699,0.000008622763,0.000012293103,0.00020123964,0.000012606336,0.00006622817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000060392784,0.00006950103,0.00014614259,0.000051063253,0.000016831134,0.000009050261,0.000034372682,0.000045747838,0.00009558353],"category_scores_gemma":[0.000018794819,0.000060256472,0.00014675992,0.00009396872,0.00002101823,0.00007211264,0.000010192734,0.00007836496,0.00009483596],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048242502,0.0007737272,0.9793887,0.000005605059,0.00028148424,0.000053009288,0.000028623796,0.000008083335,0.00025630125,0.00008981459,0.00018283924,0.018883564],"study_design_scores_gemma":[0.0064807218,0.00005136453,0.97875446,0.00003249302,0.00019047926,0.0002900185,0.000007703404,0.000006364285,0.0027404588,0.000010027513,0.011349002,0.00008692541],"about_ca_topic_score_codex":0.000017101058,"about_ca_topic_score_gemma":0.0000073084534,"teacher_disagreement_score":0.018796638,"about_ca_system_score_codex":0.0000072461594,"about_ca_system_score_gemma":0.000023300046,"threshold_uncertainty_score":0.24571876},"labels":[],"label_agreement":null},{"id":"W2591456311","doi":"10.1016/s1474-4422(17)30038-8","title":"Efficacy and safety of ticagrelor versus aspirin in acute stroke or transient ischaemic attack of atherosclerotic origin: a subgroup analysis of SOCRATES, a randomised, double-blind, controlled trial","year":2017,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":196,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotchkiss Brain Institute; University of Calgary","funders":"National Institutes of Health; AstraZeneca","keywords":"Medicine; Ticagrelor; Aspirin; Stroke (engine); Internal medicine; Myocardial infarction; Cardiology; Randomized controlled trial; Clinical endpoint; Subgroup analysis; Clopidogrel; Confidence interval","score_opus":0.08448508380058245,"score_gpt":0.3518250801862449,"score_spread":0.26733999638566247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591456311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954859,0.0006022584,0.000054193733,0.0009683381,0.00015965223,0.0024857835,0.000047570724,0.0000100973,0.00018622821],"genre_scores_gemma":[0.9977999,0.0018435393,0.000013799272,0.00010783854,0.0000962813,0.00006798699,0.000013350349,0.00001495584,0.00004237101],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9982805,0.00033232756,0.0006220139,0.00026613695,0.0002379096,0.0002610841],"domain_scores_gemma":[0.9979876,0.00062534,0.00044442172,0.00081213744,0.000067162495,0.00006329429],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008157975,0.00018057063,0.0023413429,0.0001612167,0.00006173709,0.000006908458,0.00028577234,0.00012610879,0.00006170814],"category_scores_gemma":[0.00012844904,0.00010715159,0.000626872,0.00019038653,0.0005210955,0.00003299582,0.00004393292,0.0002213314,9.843961e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98360753,0.00027558042,0.0027221018,0.00006280786,0.009381679,0.00004775558,0.00020577988,0.00027435072,0.0024188855,0.0001234513,0.000009785989,0.0008703059],"study_design_scores_gemma":[0.9544945,0.0027432614,0.03215182,0.00003129551,0.0092282975,0.000012044075,0.000016565133,0.0006598188,0.0004349266,0.000005864985,0.00013700595,0.000084603686],"about_ca_topic_score_codex":0.000042716725,"about_ca_topic_score_gemma":0.00007743699,"teacher_disagreement_score":0.029429717,"about_ca_system_score_codex":0.0000072847365,"about_ca_system_score_gemma":0.000087771725,"threshold_uncertainty_score":0.4369515},"labels":[],"label_agreement":null},{"id":"W2594375289","doi":"10.1007/s10557-017-6720-7","title":"Personalizing Antiplatelet Therapies for Acute Coronary Syndrome (ACS) in Patients Undergoing Percutaneous Coronary Intervention (PCI): Are They Cost-effective?","year":2017,"lang":"en","type":"letter","venue":"Cardiovascular Drugs and Therapy","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Heart and Stroke Foundation","funders":"","keywords":"Medicine; Percutaneous coronary intervention; Conventional PCI; Acute coronary syndrome; Cardiology; Internal medicine; Interventional cardiology; Myocardial infarction","score_opus":0.014604659998805131,"score_gpt":0.25725052707838986,"score_spread":0.24264586707958472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594375289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.832083,0.15411888,0.00016006682,0.0043532467,0.0007314673,0.0079249,0.00039979353,0.00014793273,0.0000806995],"genre_scores_gemma":[0.91761625,0.060347095,0.00007982029,0.017185036,0.0009068203,0.0011393282,0.0019191301,0.00036638204,0.00044013694],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952543,0.00062414515,0.000632948,0.0014792914,0.0010684408,0.00094091956],"domain_scores_gemma":[0.99722403,0.0002972742,0.0004216589,0.001568644,0.00030725088,0.00018111792],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00095772464,0.0011043705,0.0028233978,0.00039379694,0.0006008509,0.00024763434,0.00044798176,0.0011177486,0.00004071923],"category_scores_gemma":[0.000048521193,0.00096718257,0.004767147,0.0001107013,0.0003236438,0.00034549544,0.00012364707,0.0013438391,0.00001268535],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067090737,0.00071541016,0.05974864,0.002587153,0.11514524,0.030284684,0.0021077646,0.000045575787,0.000055256674,0.000011534546,0.011557946,0.77103174],"study_design_scores_gemma":[0.053902157,0.0038214838,0.2560865,0.0065148505,0.009106688,0.022364348,0.0012640636,0.000066915505,0.000076394645,0.00050230016,0.6431901,0.0031042127],"about_ca_topic_score_codex":0.00006544574,"about_ca_topic_score_gemma":0.000005444733,"teacher_disagreement_score":0.7679275,"about_ca_system_score_codex":0.00029296026,"about_ca_system_score_gemma":0.00012985761,"threshold_uncertainty_score":0.9992779},"labels":[],"label_agreement":null},{"id":"W2594716256","doi":"10.1016/j.cjca.2017.02.014","title":"Dyspnea Attributed to Ticagrelor: Variable Tolerability in Different Clinical Settings","year":2017,"lang":"en","type":"letter","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Ticagrelor; Medicine; Tolerability; Discontinuation; TIMI; Acute coronary syndrome; Prasugrel; Myocardial infarction; Internal medicine; Clopidogrel; Aspirin; Context (archaeology); Cardiology; Adverse effect; Thrombolysis","score_opus":0.03600589764437561,"score_gpt":0.301665239262978,"score_spread":0.2656593416186024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594716256","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17840567,0.0046590106,0.0034534582,0.79917514,0.0065980577,0.0012460079,0.0005217691,0.000024555477,0.00591633],"genre_scores_gemma":[0.512112,0.00040644594,0.0003928125,0.44945014,0.0361013,0.000024569088,0.0003688792,0.00013984051,0.0010040033],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964337,0.0008379309,0.0011576617,0.0004533119,0.00032106324,0.0007963791],"domain_scores_gemma":[0.99671316,0.00030479993,0.0004168323,0.0009911989,0.0004602056,0.0011138018],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0018791805,0.0003830991,0.0030519392,0.00047664822,0.00011938375,0.00004990896,0.0005500936,0.00116316,0.000118435586],"category_scores_gemma":[0.0017941776,0.0003055977,0.0015076232,0.000114435425,0.00033903925,0.00005614349,0.000037641206,0.0030972944,0.00003634216],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018564666,0.000006039199,0.07396857,0.000103374456,0.0018266378,0.014790352,0.00002104422,0.0000860804,0.0000044965195,0.0000053910803,0.90413684,0.004865538],"study_design_scores_gemma":[0.0017054306,0.00045785686,0.07379408,0.00036903392,0.0007816009,0.0028562986,0.000011771244,0.0000027586993,0.000004332176,0.00015206404,0.91961026,0.00025449396],"about_ca_topic_score_codex":0.00044908802,"about_ca_topic_score_gemma":0.00020494737,"teacher_disagreement_score":0.349725,"about_ca_system_score_codex":0.00045584128,"about_ca_system_score_gemma":0.002995635,"threshold_uncertainty_score":0.9999396},"labels":[],"label_agreement":null},{"id":"W2594918639","doi":"10.1111/jth.13667","title":"Once versus twice daily aspirin after coronary bypass surgery: a randomized trial","year":2017,"lang":"en","type":"article","venue":"Journal of Thrombosis and Haemostasis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; Population Health Research Institute; McMaster University; Hamilton General Hospital","funders":"Hamilton Health Sciences","keywords":"Medicine; Aspirin; Randomized controlled trial; Dosing; Coronary artery bypass surgery; Anesthesia; Myocardial infarction; Surgery; Artery; Internal medicine","score_opus":0.07762880843527774,"score_gpt":0.3478077116382417,"score_spread":0.27017890320296395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594918639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98881286,0.007379019,0.00008889456,0.0020200284,0.00096172525,0.0002934963,0.000014739532,0.000010444861,0.00041881253],"genre_scores_gemma":[0.9871978,0.011357802,0.00034471668,0.0003710677,0.00062514574,0.000014179061,0.000004053879,0.00002381123,0.0000613845],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9982743,0.00020949436,0.0005945551,0.00018727718,0.0005094694,0.00022487903],"domain_scores_gemma":[0.99826115,0.00037520958,0.00046991548,0.00044402,0.000194692,0.00025501012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014971092,0.00020228866,0.0015633268,0.00010845836,0.00026621946,0.00015044355,0.00015397102,0.00011053411,0.00021764515],"category_scores_gemma":[0.0004830428,0.00014327733,0.0014389659,0.000045671648,0.00032657982,0.00035247643,0.00006427713,0.00022591987,0.000007323553],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.93238705,0.00022086898,0.0030788255,0.00005704094,0.0043032,0.00033882476,0.0001105925,0.0000012559483,0.00007634023,0.00001723918,0.0013577107,0.058051053],"study_design_scores_gemma":[0.92543703,0.000889934,0.058302168,0.00047411467,0.004102818,0.00024973234,0.00015484358,0.000015051716,0.00043678575,0.000046962956,0.009657889,0.00023267313],"about_ca_topic_score_codex":0.000054143304,"about_ca_topic_score_gemma":0.000008706307,"teacher_disagreement_score":0.05781838,"about_ca_system_score_codex":0.000039903996,"about_ca_system_score_gemma":0.00016404685,"threshold_uncertainty_score":0.584268},"labels":[],"label_agreement":null},{"id":"W2594939932","doi":"10.1016/s0735-1097(17)33649-5","title":"COMPARISON OF TRIPLE ANTITHROMBOTIC THERAPY TO TICAGRELOR-BASED DUAL ANTIPLATELET THERAPY FOR LEFT VENTRICLE DYSFUNCTION FOLLOWING STEMI USING NATURAL RANDOMIZATION: A RETROSPECTIVE PILOT STUDY","year":2017,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Ticagrelor; Antithrombotic; Cardiology; Randomization; Ventricle; Internal medicine; Fibrinolytic agent; Clopidogrel; Randomized controlled trial; Myocardial infarction","score_opus":0.04325590741831405,"score_gpt":0.3456952415373094,"score_spread":0.3024393341189954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594939932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98937756,0.0014507292,0.006077461,0.00029445553,0.0011865898,0.0015561603,0.000031280615,0.000007505581,0.000018234161],"genre_scores_gemma":[0.99881595,0.00012678395,0.0005486896,0.0000987478,0.00035612134,0.000006108396,0.0000016372776,0.00002868041,0.000017300314],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978391,0.0004932834,0.000726532,0.00020808399,0.0005077401,0.00022529656],"domain_scores_gemma":[0.9970742,0.00020237564,0.0015069538,0.00055941346,0.00057407375,0.00008301193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011158065,0.00019958349,0.0021266963,0.00018956746,0.00031106843,0.00001508232,0.0003039789,0.000039486375,0.0000045947404],"category_scores_gemma":[0.00043642597,0.00013109122,0.0011805805,0.0002623001,0.00029470184,0.00010326634,0.000039413662,0.0001977326,2.3285315e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08219823,0.00093708956,0.84561384,0.000030861178,0.0080573885,0.00013274021,0.00020773473,0.0059245485,0.054336865,0.000012489918,0.00047497996,0.0020732202],"study_design_scores_gemma":[0.07010848,0.02733488,0.8773099,0.00021462626,0.0016092404,0.0004691257,0.0018060846,0.0013670012,0.019055007,0.0000403064,0.0004279139,0.00025740836],"about_ca_topic_score_codex":0.000015825162,"about_ca_topic_score_gemma":0.0000021339872,"teacher_disagreement_score":0.03528186,"about_ca_system_score_codex":0.00010325031,"about_ca_system_score_gemma":0.00028226848,"threshold_uncertainty_score":0.53457445},"labels":[],"label_agreement":null},{"id":"W2596358769","doi":"10.1016/s0140-6736(17)30751-1","title":"Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial","year":2017,"lang":"en","type":"article","venue":"The Lancet","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":219,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Janssen Research and Development","keywords":"Rivaroxaban; Medicine; P2Y12; Aspirin; Clopidogrel; Internal medicine; Acute coronary syndrome; Double blind; Randomized controlled trial; Cardiology; Myocardial infarction; Atrial fibrillation; Warfarin; Alternative medicine; Placebo","score_opus":0.06708174095132563,"score_gpt":0.34190544288480607,"score_spread":0.27482370193348044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2596358769","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99390566,0.000112014655,0.000037027425,0.0017571093,0.00031783493,0.0029525142,0.000052852054,0.000058703223,0.0008063014],"genre_scores_gemma":[0.99749005,0.00048313427,0.00014887215,0.0004893479,0.00078396226,0.00035207707,0.00013927298,0.00003312191,0.00008015884],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9980305,0.00015910901,0.00053165725,0.0004137826,0.0004202451,0.0004447412],"domain_scores_gemma":[0.9982963,0.0002745301,0.00023199657,0.00094922865,0.00007626129,0.00017167124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011324541,0.0002456743,0.0009607371,0.000111619396,0.00018568337,0.0000962047,0.0002779965,0.00012315929,0.00010689688],"category_scores_gemma":[0.00023662216,0.00016558198,0.00022905103,0.00016681729,0.00018503779,0.00020388934,0.000082751045,0.0003651367,0.000054795433],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9855842,0.00042821906,0.0067336173,0.000058543414,0.0006630419,0.0013503244,0.0004050076,0.00008049173,0.00062218437,0.000038859856,0.0005925859,0.003442928],"study_design_scores_gemma":[0.9259595,0.001385855,0.069208965,0.00090764486,0.0005027229,0.000060761413,0.00030971182,0.000066639484,0.00077659916,0.000037218244,0.0005067803,0.0002775967],"about_ca_topic_score_codex":0.000059510843,"about_ca_topic_score_gemma":0.00006029164,"teacher_disagreement_score":0.062475346,"about_ca_system_score_codex":0.0000823785,"about_ca_system_score_gemma":0.00014497917,"threshold_uncertainty_score":0.6752237},"labels":[],"label_agreement":null},{"id":"W2597299390","doi":"10.1016/s0735-1097(17)34405-4","title":"EFFECTS OF TICAGRELOR VERSUS CLOPIDOGREL IN FIBRINOLYTIC-TREATED STEMI PATIENTS UNDERGOING EARLY PCI","year":2017,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Regina Qu'Appelle Health Region","funders":"","keywords":"Medicine; Ticagrelor; Conventional PCI; Clopidogrel; Cardiology; Internal medicine; Fibrinolytic therapy; Aspirin; Myocardial infarction","score_opus":0.0103258809105667,"score_gpt":0.2557071110816521,"score_spread":0.24538123017108543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2597299390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99762917,0.00076147425,0.000031587482,0.00016725369,0.00042954297,0.0002559568,0.00001584687,0.0000032487624,0.00070594106],"genre_scores_gemma":[0.99899006,0.0006713065,0.00008446887,0.000032652468,0.0001585663,0.0000018738976,4.9839406e-7,0.000015859627,0.000044714645],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99858105,0.0002878178,0.00047788653,0.000120412755,0.00033177013,0.00020107528],"domain_scores_gemma":[0.9976345,0.0004369781,0.0011128293,0.0004864962,0.00024579538,0.000083459556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024785532,0.0001373118,0.001207566,0.00013282691,0.00006874339,0.000004140685,0.00034736766,0.000062242936,0.0000018508039],"category_scores_gemma":[0.000616348,0.00009150881,0.0008211033,0.00015016312,0.00058241695,0.000068796784,0.00009679971,0.00019741165,0.0000011892283],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008747464,0.00011127386,0.9798083,0.00016555382,0.0029528374,0.00048770237,0.000041227904,0.00012453995,0.0018734827,0.000063998654,0.00031451072,0.005309137],"study_design_scores_gemma":[0.010648327,0.0027180729,0.98070884,0.00039814264,0.0007919223,0.00018737097,0.00011666636,0.000006125085,0.003868365,0.000029853652,0.0004385262,0.00008779606],"about_ca_topic_score_codex":0.000026510172,"about_ca_topic_score_gemma":0.0000032482983,"teacher_disagreement_score":0.005221341,"about_ca_system_score_codex":0.00007208605,"about_ca_system_score_gemma":0.00019961825,"threshold_uncertainty_score":0.3731621},"labels":[],"label_agreement":null},{"id":"W2598641184","doi":"10.2147/tcrm.s127292","title":"Comparison of prophylactic effect of UGIB and effects on platelet function between PPIs and H&lt;sub&gt;2&lt;/sub&gt;RAs combined with DAPT: systematic review and meta-analysis","year":2017,"lang":"en","type":"article","venue":"Therapeutics and Clinical Risk Management","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Peking University Third Hospital; Peking University; Chinese Medical Association; Western New England University","keywords":"Medicine; Meta-analysis; Internal medicine; Platelet; Gastroenterology; Pharmacology","score_opus":0.05040481546045149,"score_gpt":0.3591482649975808,"score_spread":0.3087434495371293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2598641184","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89882827,0.09763615,0.00036601975,0.00017781089,0.000022427976,0.0028273538,0.000016854114,0.000018200784,0.00010693498],"genre_scores_gemma":[0.9417247,0.05785026,0.00004754386,0.00022787275,0.000019244804,0.000062511535,0.000013270852,0.00002314382,0.000031423227],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9973226,0.00073158054,0.0008274031,0.00047640598,0.0004561057,0.0001859036],"domain_scores_gemma":[0.9971655,0.0008518549,0.000883567,0.0008589926,0.00007823183,0.00016184633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022492935,0.00033896463,0.0037511007,0.00010813563,0.00019435682,0.000055628465,0.00011315465,0.00011345731,0.0000058430805],"category_scores_gemma":[0.00007810878,0.00019806228,0.0006214441,0.00013217723,0.0003372774,0.00006163,0.000102188926,0.00020642107,0.0000013385086],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050524315,0.0006873618,0.12374673,0.22386827,0.5790361,0.000045926106,0.00011315965,0.0000074645673,0.00006138121,0.00042082107,0.000016640508,0.06694369],"study_design_scores_gemma":[0.0048185317,0.0082768565,0.16371426,0.0018810901,0.82012606,0.0000035923508,0.000023951045,0.00020227332,0.00050813647,0.000120976656,0.000088663975,0.00023563697],"about_ca_topic_score_codex":0.0000075706457,"about_ca_topic_score_gemma":0.0000066073317,"teacher_disagreement_score":0.24108991,"about_ca_system_score_codex":0.000009072969,"about_ca_system_score_gemma":0.000008005083,"threshold_uncertainty_score":0.8076745},"labels":[],"label_agreement":null},{"id":"W2602040050","doi":"10.1007/s40256-017-0227-2","title":"The 100 Most Influential Papers in the Field of Thrombolytic Therapy: A Bibliometric Analysis","year":2017,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Scopus; Medicine; Citation; Bibliometrics; MEDLINE; Library science; Family medicine; Political science; Computer science; Law","score_opus":0.027913649623673105,"score_gpt":0.3564253405306674,"score_spread":0.3285116909069943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2602040050","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002644264,0.99535084,0.00008893936,0.00010018187,0.00019400092,0.00065415225,0.000011530855,0.000007214004,0.0009489077],"genre_scores_gemma":[0.03305528,0.9661543,0.000029080142,0.00020637151,0.00044089364,0.000027652515,0.000010787914,0.000054684824,0.000021000204],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9937,0.00165101,0.0014974625,0.00036093267,0.002337491,0.00045306404],"domain_scores_gemma":[0.9936426,0.0013813648,0.0019764318,0.0024457118,0.00038177136,0.00017208465],"candidate_categories":["metaepi_narrow","metaepi_broad","bibliometrics"],"consensus_categories":["bibliometrics"],"category_scores_codex":[0.0052270945,0.00053194625,0.006193895,0.016637484,0.00024334289,0.00015554373,0.0014934636,0.00018167649,0.00002852378],"category_scores_gemma":[0.00067749363,0.0002601116,0.020288438,0.04886294,0.0007419586,0.000111797184,0.00008041804,0.0009970005,0.0000042528914],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001353956,0.00008840972,0.00012482374,0.00046710548,0.102050334,0.00024002691,0.00018125838,0.00005467488,1.5890299e-7,0.0000041048525,0.00009598829,0.8965577],"study_design_scores_gemma":[0.0012261822,0.00055361254,0.00190128,0.0017717179,0.056222465,0.0005627109,0.0005331707,0.000002005913,0.0000020958173,0.000004932864,0.9369663,0.0002535213],"about_ca_topic_score_codex":0.0002174063,"about_ca_topic_score_gemma":0.00000304368,"teacher_disagreement_score":0.93687034,"about_ca_system_score_codex":0.000083544306,"about_ca_system_score_gemma":0.00081568235,"threshold_uncertainty_score":0.9999851},"labels":[],"label_agreement":null},{"id":"W2603558844","doi":"10.1016/j.ahj.2017.03.018","title":"When academic research organizations and clinical research organizations disagree: Processes to minimize discrepancies prior to unblinding of randomized trials","year":2017,"lang":"en","type":"editorial","venue":"American Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Prasugrel; Ticagrelor; Medicine; Clopidogrel; P2Y12; Randomized controlled trial; Crossover study; Acute coronary syndrome; Internal medicine; Cardiology; Anesthesia; Myocardial infarction","score_opus":0.16031882180335763,"score_gpt":0.5227465480733223,"score_spread":0.36242772626996467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2603558844","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.34621584,0.049736746,0.019595874,0.08997528,0.4621868,0.028792873,0.0021466722,0.000431456,0.0009184108],"genre_scores_gemma":[0.064102344,0.07821174,0.012007804,0.0004051552,0.8394537,0.00027029534,0.00029739592,0.00043078215,0.0048207697],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98465866,0.007451723,0.0024653373,0.0008099491,0.003728702,0.00088561187],"domain_scores_gemma":[0.944659,0.03544316,0.0012260939,0.0012475089,0.015658237,0.0017659982],"candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.042477906,0.000400677,0.0050484887,0.0013823976,0.0015847526,0.0003984276,0.00075535337,0.00057326234,0.00022524474],"category_scores_gemma":[0.49113807,0.00029848053,0.000738852,0.002859324,0.002581351,0.00022608832,0.00049067754,0.0038553188,0.000055797525],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028817097,0.00024999387,0.0061342167,0.00029873042,0.0025960328,0.00005418102,0.0022258887,0.000004403679,0.00022317818,0.000018321056,0.9543518,0.0050261975],"study_design_scores_gemma":[0.052107703,0.0018656669,0.0029639832,0.004388309,0.0032026516,0.0002559978,0.0048897825,0.0000061984388,0.00033947986,0.0003639035,0.92895114,0.00066516607],"about_ca_topic_score_codex":0.00028079562,"about_ca_topic_score_gemma":0.00003780026,"teacher_disagreement_score":0.44866017,"about_ca_system_score_codex":0.00019261068,"about_ca_system_score_gemma":0.009005975,"threshold_uncertainty_score":0.9999467},"labels":[],"label_agreement":null},{"id":"W2603790147","doi":"10.1016/j.ahj.2017.03.015","title":"Dual antiplatelet therapy in patients with diabetes and acute coronary syndromes managed without revascularization","year":2017,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Alberta","funders":"Daiichi Sankyo Europe; Daiichi-Sankyo","keywords":"Medicine; Prasugrel; Clopidogrel; Internal medicine; Acute coronary syndrome; Percutaneous coronary intervention; Cardiology; Aspirin; Clinical endpoint; Myocardial infarction; Revascularization; Diabetes mellitus; Randomized controlled trial; Endocrinology","score_opus":0.010454342570921968,"score_gpt":0.25691020549718097,"score_spread":0.24645586292625898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2603790147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984388,0.0007118353,0.00003535484,0.00037492177,0.000054998058,0.00031341973,0.0000049374175,0.000019791658,0.000045991936],"genre_scores_gemma":[0.99678344,0.0020344602,0.0004915518,0.0005268482,0.00007302377,0.000005995207,0.00001581966,0.000031786545,0.00003707562],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99880195,0.00012023009,0.00019438479,0.0002237357,0.00037850672,0.00028121143],"domain_scores_gemma":[0.99917805,0.000019252679,0.00016959755,0.00036712384,0.00008653556,0.00017945361],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026978058,0.00017395212,0.00053849514,0.000116555544,0.0003813102,0.00012084516,0.00008162458,0.000037471757,0.000031268668],"category_scores_gemma":[0.00002698638,0.00012533624,0.00014456088,0.00008904456,0.00038431006,0.00030870002,0.00003056723,0.00025900424,0.000004330999],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008020003,0.00012504472,0.9549609,0.000009888653,0.00097268954,0.0002607769,0.00007126405,0.000003198902,0.00014480823,0.0000020154296,0.000059178252,0.042588275],"study_design_scores_gemma":[0.0057523097,0.0014376077,0.99114853,0.00015554515,0.00017172174,0.0005200918,0.00006936062,0.000023695637,0.000103022205,0.000014869386,0.00043756256,0.00016567794],"about_ca_topic_score_codex":0.000013966248,"about_ca_topic_score_gemma":0.0000017092304,"teacher_disagreement_score":0.042422596,"about_ca_system_score_codex":0.00002539949,"about_ca_system_score_gemma":0.00005372931,"threshold_uncertainty_score":0.5111064},"labels":[],"label_agreement":null},{"id":"W2604910616","doi":"10.1136/heartjnl-2016-310090","title":"Predicting the risk of bleeding during dual antiplatelet therapy after acute coronary syndromes","year":2017,"lang":"en","type":"article","venue":"Heart","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Alberta; St. Michael's Hospital","funders":"Daiichi Sankyo Company; Eli Lilly and Company","keywords":"Medicine; TIMI; Cardiology; Internal medicine; Myocardial infarction; Acute coronary syndrome; Aspirin; Unstable angina; Clopidogrel; Framingham Risk Score; Coronary artery disease; Creatinine; Thrombolysis; Surgery; Disease","score_opus":0.0158657131590182,"score_gpt":0.2656148605492964,"score_spread":0.2497491473902782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604910616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944566,0.004272235,0.000006981118,0.0003443622,0.00019295287,0.0003244101,0.00003153024,0.000055239627,0.0003156956],"genre_scores_gemma":[0.9947128,0.004558472,0.00006494353,0.00012156319,0.0002444895,0.00002246123,0.0000047110457,0.000029666442,0.00024083587],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989055,0.00006908172,0.00021092588,0.00022164633,0.00033251182,0.00026034864],"domain_scores_gemma":[0.99893796,0.000049945007,0.0001309917,0.00073752896,0.000057478217,0.00008607329],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035669643,0.00015493885,0.00036960948,0.000040571864,0.00053956505,0.000046793335,0.0001254251,0.00007802692,0.0001564911],"category_scores_gemma":[0.000046179972,0.000099624245,0.0004215162,0.000043036925,0.00021841798,0.00016921948,0.00007669175,0.00021777341,0.000020329187],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011990691,0.00006300946,0.98690295,0.000050673196,0.0018228483,0.00047167827,0.00032565143,0.0000052798937,0.0065017445,0.0000049822693,0.0001033831,0.0025487535],"study_design_scores_gemma":[0.0021506108,0.00015825604,0.9835754,0.000187576,0.00036724933,0.0015251903,0.00015072346,0.000052155618,0.010720441,0.000021050326,0.00098464,0.00010673332],"about_ca_topic_score_codex":0.000041966003,"about_ca_topic_score_gemma":0.000001498689,"teacher_disagreement_score":0.004218696,"about_ca_system_score_codex":0.000012165341,"about_ca_system_score_gemma":0.0000402307,"threshold_uncertainty_score":0.41499528},"labels":[],"label_agreement":null},{"id":"W2605266757","doi":"10.1136/bmjopen-2016-015421","title":"Optimal duration of dual antiplatelet therapy following percutaneous coronary intervention: protocol for an umbrella review","year":2017,"lang":"en","type":"article","venue":"BMJ Open","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Agency for Drugs and Technologies in Health; University of Ottawa","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Percutaneous coronary intervention; Protocol (science); Duration (music); Cardiology; Internal medicine; Intensive care medicine; Alternative medicine; Myocardial infarction; Pathology","score_opus":0.16328065592217408,"score_gpt":0.4781829789269679,"score_spread":0.3149023230047938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2605266757","genre_codex":"protocol","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"protocol","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.27064407,0.0017506725,0.00054895884,0.0006684253,0.00017671841,0.7230257,0.00003636354,0.000051030227,0.003098061],"genre_scores_gemma":[0.52870136,0.0010467514,0.005410421,0.001083282,0.000528351,0.46085677,0.0003159118,0.000109190965,0.0019479577],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99869466,0.00012103909,0.00046324084,0.00028349026,0.00027505122,0.00016254463],"domain_scores_gemma":[0.99852276,0.000021926124,0.00033678228,0.00090047246,0.00012807468,0.00008998942],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011393857,0.00015944496,0.00059163314,0.000024597748,0.00026605625,0.00010908642,0.00036584443,0.000073440366,0.00024481793],"category_scores_gemma":[0.00010870755,0.00012797205,0.0006614773,0.00003095447,0.00005893835,0.00041993486,0.00011488968,0.000068721325,0.000009206739],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.052490886,0.0030541017,0.013286232,0.017981464,0.0053610643,0.003195971,0.0005175111,0.000039135735,0.0136408815,0.00033836917,0.014320451,0.8757739],"study_design_scores_gemma":[0.16054259,0.038134705,0.120933026,0.119410485,0.0036722475,0.028413929,0.0012156111,0.002653077,0.03633101,0.0006080602,0.4845158,0.0035694805],"about_ca_topic_score_codex":0.00003326617,"about_ca_topic_score_gemma":0.0000038683293,"teacher_disagreement_score":0.8722044,"about_ca_system_score_codex":0.000015964193,"about_ca_system_score_gemma":0.00012429942,"threshold_uncertainty_score":0.5218549},"labels":[],"label_agreement":null},{"id":"W2608182940","doi":"10.2215/cjn.00100117","title":"Post Hoc Analyses of Randomized Clinical Trial for the Effect of Clopidogrel Added to Aspirin on Kidney Function","year":2017,"lang":"en","type":"article","venue":"Clinical Journal of the American Society of Nephrology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute on Minority Health and Health Disparities; National Institute on Aging; National Institutes of Health; Northern California Institute for Research and Education","keywords":"Medicine; Aspirin; Clopidogrel; Post-hoc analysis; Randomized controlled trial; Post hoc; Renal function; Clinical trial; Internal medicine; Cardiology","score_opus":0.08000098792498138,"score_gpt":0.45389775219688094,"score_spread":0.37389676427189955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2608182940","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98348975,0.00063824124,0.0018318545,0.011884921,0.0009115471,0.00119486,0.000024682844,0.0000042076695,0.000019957577],"genre_scores_gemma":[0.96896017,0.0021597382,0.00062284875,0.026667936,0.0015196899,0.000014861364,0.0000026890036,0.000019241514,0.00003285637],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99468845,0.0023464428,0.0021071467,0.00021147216,0.00045072482,0.00019576671],"domain_scores_gemma":[0.9826405,0.011165616,0.004538712,0.00092870125,0.0005088054,0.0002176807],"candidate_categories":["metaepi_broad","sts"],"consensus_categories":[],"category_scores_codex":[0.010567316,0.00018215354,0.0033405824,0.000040759405,0.00014469984,0.000007923349,0.0006596638,0.0001714299,0.000021357817],"category_scores_gemma":[0.007900882,0.000085652355,0.010887398,0.00011594534,0.0037868437,0.00003748555,0.000109702676,0.00050482416,0.000001361563],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8908431,0.00041905226,0.0052126544,0.000055135504,0.011673874,0.0000018927929,0.000036316662,0.000029642466,0.0016913703,0.000011051275,0.023845067,0.06618083],"study_design_scores_gemma":[0.79839134,0.080043234,0.07703921,0.0003009684,0.014528432,0.000038214836,0.00022016553,0.00019153015,0.001583033,0.00014193673,0.02736839,0.00015354661],"about_ca_topic_score_codex":0.000029478364,"about_ca_topic_score_gemma":8.764642e-7,"teacher_disagreement_score":0.09245177,"about_ca_system_score_codex":0.000013820549,"about_ca_system_score_gemma":0.00028884798,"threshold_uncertainty_score":0.9990183},"labels":[],"label_agreement":null},{"id":"W2609173746","doi":"10.1016/j.ijcard.2017.04.077","title":"The underutilisation of dual antiplatelet therapy in acute coronary syndrome","year":2017,"lang":"en","type":"article","venue":"International Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"National Health and Medical Research Council; National Heart Foundation of Australia; Medical Research Council; Sanofi; Eli Lilly and Company","keywords":"Medicine; Clopidogrel; Acute coronary syndrome; Ticagrelor; Internal medicine; Medical prescription; Cardiology; Myocardial infarction; Unstable angina; Warfarin; Guideline; Aspirin; Antiplatelet drug; Logistic regression; Atrial fibrillation; Emergency medicine","score_opus":0.024068309238000074,"score_gpt":0.3125765471133934,"score_spread":0.2885082378753933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2609173746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942996,0.0021337187,0.00031902362,0.0015113753,0.0010271639,0.00009100574,0.000008699095,0.000003097535,0.0006063505],"genre_scores_gemma":[0.98988444,0.009675463,0.000038129358,0.0000948932,0.0002451272,0.0000017209021,0.0000059778777,0.000008158673,0.000046123445],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99892527,0.00011195886,0.00038721686,0.00008403092,0.00037996174,0.000111570385],"domain_scores_gemma":[0.9988474,0.00011160718,0.0003955604,0.00024361827,0.00036059436,0.000041171326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006191131,0.00008308433,0.0003881958,0.0001050932,0.00007295999,0.0000241248,0.00033728709,0.00007697589,0.000014716088],"category_scores_gemma":[0.000117270225,0.000053655847,0.0004197874,0.000022923574,0.0002579749,0.00014183894,0.000042496733,0.00017527015,0.0000025627858],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009437246,0.00010892082,0.8225944,0.000008784671,0.013053392,0.013086126,0.00016133176,0.0004309246,0.0064318236,0.001446135,0.0005888571,0.13265206],"study_design_scores_gemma":[0.0039788815,0.0004639033,0.9710177,0.000059389502,0.00008859238,0.01773306,0.000085747735,0.00001881151,0.0008676136,0.0010022044,0.0046320423,0.000052032454],"about_ca_topic_score_codex":0.000006053088,"about_ca_topic_score_gemma":0.000001443492,"teacher_disagreement_score":0.14842331,"about_ca_system_score_codex":0.000043334447,"about_ca_system_score_gemma":0.00012835818,"threshold_uncertainty_score":0.2188022},"labels":[],"label_agreement":null},{"id":"W2610939032","doi":"10.1161/jaha.117.005894","title":"Randomized Trial Comparing the Effects of Ticagrelor Versus Clopidogrel on Myocardial Perfusion in Patients With Coronary Artery Disease","year":2017,"lang":"en","type":"article","venue":"Journal of the American Heart Association","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Heart Institute; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Ticagrelor; Medicine; Clopidogrel; P2Y12; Adenosine; Coronary artery disease; Cardiology; Internal medicine; Crossover study; Loading dose; Aspirin; Anesthesia; Placebo","score_opus":0.009603766736307801,"score_gpt":0.2574500433044192,"score_spread":0.24784627656811137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2610939032","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974735,0.000114984774,0.000005398109,0.0008111748,0.00077169226,0.0007753394,0.000001803995,0.0000031271088,0.000043020744],"genre_scores_gemma":[0.9993194,0.00010937872,0.000012190057,0.00020526616,0.0003190302,0.0000069642824,0.0000013997852,0.000009999663,0.00001640258],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.998069,0.0006878027,0.00030931656,0.000081109974,0.00072725053,0.0001255305],"domain_scores_gemma":[0.9977103,0.0008693005,0.0009135408,0.00030723188,0.00012995636,0.00006970984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009808159,0.000097880446,0.0008441593,0.000049536615,0.00016418875,0.000023145883,0.0001372562,0.000024610685,0.000002172142],"category_scores_gemma":[0.0019977468,0.000048019156,0.00073449494,0.00006902919,0.00016821963,0.00008045059,0.000029534423,0.00022046226,0.0000014934593],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.53405625,0.00018552764,0.4636549,0.0000076813085,0.00050862925,0.0000058419027,0.000062779254,0.000026571603,0.000012685182,0.0000022977977,0.00010227527,0.0013745566],"study_design_scores_gemma":[0.37567994,0.0009565004,0.62245667,0.00015515219,0.00060105236,0.0000012879641,0.000021069383,0.00003215119,0.000019948648,0.00000758931,0.000033701766,0.000034897417],"about_ca_topic_score_codex":0.000017076669,"about_ca_topic_score_gemma":0.0000015520106,"teacher_disagreement_score":0.1588018,"about_ca_system_score_codex":0.00016239731,"about_ca_system_score_gemma":0.00011051624,"threshold_uncertainty_score":0.23916338},"labels":[],"label_agreement":null},{"id":"W2611440549","doi":"10.21037/jtd.2017.04.46","title":"Tailored antiplatelet therapy in high-risk ACS patients treated with PCI stenting: lessons from the ANTARCTIC trial","year":2017,"lang":"en","type":"letter","venue":"Journal of Thoracic Disease","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"Fonds de Recherche du Québec - Santé","keywords":"Medicine; Conventional PCI; Clopidogrel; Internal medicine; Cardiology; Aspirin; Myocardial infarction","score_opus":0.026714977138750023,"score_gpt":0.3016314185116486,"score_spread":0.27491644137289856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2611440549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9371438,0.0052624377,0.0000144655705,0.05504989,0.0006279981,0.0013306161,0.00052046665,0.000027445963,0.000022859746],"genre_scores_gemma":[0.95812273,0.006345118,0.000043117594,0.028433679,0.0056550005,0.00003264138,0.0009597025,0.00015595942,0.000252071],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952177,0.0009938906,0.000977881,0.0005480687,0.001682394,0.0005800743],"domain_scores_gemma":[0.99521,0.00033954825,0.002143574,0.0014085129,0.0005097761,0.00038857272],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0007164661,0.0006812001,0.0016916415,0.00030051195,0.0003334599,0.00027966397,0.0008348089,0.00046432856,0.00012314884],"category_scores_gemma":[0.00042367182,0.0003762577,0.0013969075,0.00022849182,0.000302793,0.00036231097,0.000069274625,0.0025349497,0.000016805967],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.35808522,0.0018817064,0.42767927,0.00029598436,0.009241893,0.029811379,0.00018251591,0.00003299887,0.000009821489,6.466564e-7,0.120391965,0.052386608],"study_design_scores_gemma":[0.19022024,0.004727272,0.68493104,0.007034994,0.0148594035,0.00025536312,0.00014909115,0.000017500397,0.00012116927,0.000255375,0.09610106,0.0013275113],"about_ca_topic_score_codex":0.00025350528,"about_ca_topic_score_gemma":0.000008046026,"teacher_disagreement_score":0.25725174,"about_ca_system_score_codex":0.00014208193,"about_ca_system_score_gemma":0.0007256691,"threshold_uncertainty_score":0.9998689},"labels":[],"label_agreement":null},{"id":"W2611927417","doi":"10.1016/j.cjca.2017.05.001","title":"Incidence and Prognostic Implications of Late Bleeding After Myocardial Infarction or Unstable Angina According to Treatment Strategy","year":2017,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta; University of Calgary","funders":"Government of Alberta; Alberta Health Services","keywords":"Medicine; Unstable angina; Incidence (geometry); Myocardial infarction; Cardiology; Internal medicine; Stable angina; Angina","score_opus":0.026435793280625897,"score_gpt":0.2841175819148685,"score_spread":0.2576817886342426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2611927417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99555784,0.001483588,0.00093700644,0.00064103864,0.00018305227,0.0002159529,0.00002410742,0.0000031697327,0.0009542171],"genre_scores_gemma":[0.9987701,0.0005246587,0.00009970591,0.00007636486,0.0004573737,0.000013127576,0.000002315264,0.000010652318,0.000045663066],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99929285,0.00004667176,0.00022119637,0.000120987934,0.000073177216,0.0002451246],"domain_scores_gemma":[0.9989203,0.000038946644,0.0001404021,0.00024077209,0.00021028661,0.00044928474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024074377,0.00010246167,0.00047042567,0.00019539011,0.00018899904,0.000037898917,0.00008984666,0.0000751637,0.000011368919],"category_scores_gemma":[0.00017472098,0.00007850469,0.00021553894,0.00006288133,0.00013377644,0.00014525467,0.000013149832,0.00008486751,0.0000017465304],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000406956,0.000003095618,0.9441232,0.00002291539,0.0010225994,0.00031717075,0.00014068016,0.0006841181,0.0011746499,0.000069697664,0.00010209941,0.051932804],"study_design_scores_gemma":[0.0009330213,0.0008553245,0.98689485,0.000118215234,0.0005954104,0.0014482498,0.00024305057,0.00000504243,0.00016787188,0.00011077478,0.008542847,0.00008533827],"about_ca_topic_score_codex":0.00068166805,"about_ca_topic_score_gemma":0.0005186531,"teacher_disagreement_score":0.051847465,"about_ca_system_score_codex":0.00011909616,"about_ca_system_score_gemma":0.0008964247,"threshold_uncertainty_score":0.32013282},"labels":[],"label_agreement":null},{"id":"W2615996435","doi":"10.1111/voxs.12357","title":"Survey for bacterial testing of platelet components in Latin America","year":2017,"lang":"en","type":"article","venue":"ISBT Science Series","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services","funders":"Health Canada; Canadian Blood Services","keywords":"Apheresis; Buffy coat; Latin Americans; Contamination; Quarantine; Medicine; Platelet; Biology; Surgery; Immunology; Political science; Pathology","score_opus":0.08753445869361928,"score_gpt":0.3136421872867846,"score_spread":0.22610772859316533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2615996435","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988316,0.00006235706,0.000070828864,0.000095931384,0.00018588344,0.00023095858,0.000045320565,0.000013810973,0.00046329075],"genre_scores_gemma":[0.99840796,0.00002359264,0.001389762,0.000028680204,0.000054266922,0.000008535136,0.00001729383,0.0000069484436,0.000062977684],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99916416,0.000025608628,0.00017208824,0.00020284366,0.000216873,0.00021845],"domain_scores_gemma":[0.9992128,0.000079809164,0.00012857257,0.00036672526,0.00014406584,0.000068000314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006363543,0.00008080191,0.00028000973,0.00006949877,0.00028662372,0.000058217785,0.000248861,0.000026451171,0.000018042309],"category_scores_gemma":[0.001240766,0.00006867435,0.00006970314,0.00016571843,0.0010939591,0.00035307722,0.000060557948,0.00004309058,0.0000028398467],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001614129,0.00014525939,0.7083088,0.00010606358,0.00005615041,0.000025609066,0.00047897984,0.000029511326,0.2223183,0.00008540129,0.00006066507,0.06677108],"study_design_scores_gemma":[0.0011053166,0.00019233245,0.97132146,0.00008369676,0.000010362978,0.000009665336,0.000082987266,0.00016287,0.025487954,0.000059522263,0.0014033009,0.00008051226],"about_ca_topic_score_codex":0.0004139054,"about_ca_topic_score_gemma":0.000056939287,"teacher_disagreement_score":0.26301265,"about_ca_system_score_codex":0.000016176125,"about_ca_system_score_gemma":0.00015965378,"threshold_uncertainty_score":0.40307376},"labels":[],"label_agreement":null},{"id":"W2621785677","doi":"10.1016/j.cjca.2017.06.001","title":"Rationale, Design and Baseline Characteristics of Participants in the C ardiovascular O utco m es for P eople Using A nticoagulation S trategie s (COMPASS) Trial","year":2017,"lang":"en","type":"review","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":161,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Institut universitaire de cardiologie et de pneumologie de Québec; Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"LEO Pharma; Servier; University of Cape Town; Eisai; Amarin Corporation; Wellcome Trust; Regeneron Pharmaceuticals; Pfizer; Heart and Stroke Foundation of Canada; Daiichi Sankyo Europe; Sanofi; GlaxoSmithKline; Amgen; Bayer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Compass; Baseline (sea); Internal medicine; Cartography","score_opus":0.318366813479228,"score_gpt":0.39548677216601125,"score_spread":0.07711995868678323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2621785677","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004384125,0.9543034,0.038800854,0.000047515623,0.00040380817,0.0019639938,0.00007908954,0.0000014439653,0.000015813392],"genre_scores_gemma":[0.09118575,0.9059582,0.00049932394,0.00003703328,0.0021349464,0.000058611393,0.00008661511,0.000034210483,0.000005323011],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972843,0.0011282084,0.0009295166,0.00017396365,0.00019172182,0.00029227976],"domain_scores_gemma":[0.99790394,0.00050972076,0.0007123302,0.00036479736,0.00027772132,0.00023149767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003424094,0.00022858252,0.0029238642,0.00032768314,0.00011765529,0.000040820178,0.00019937535,0.00026372488,0.0000046021673],"category_scores_gemma":[0.0009936076,0.00015599588,0.001563394,0.00008959895,0.00019146652,0.00007725928,0.000005870236,0.00025928026,3.9552563e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036341376,0.000021382728,0.0003629585,0.004179246,0.007121507,0.0007007939,0.00015504206,0.0011511585,0.000002635089,0.00019443952,0.00040875978,0.98206794],"study_design_scores_gemma":[0.014745012,0.00054573605,0.0014176618,0.0034095778,0.01295631,0.0017620609,0.0000714065,0.0003214988,0.0000011736288,0.00012999865,0.96439385,0.00024573354],"about_ca_topic_score_codex":0.00005573173,"about_ca_topic_score_gemma":0.00005212966,"teacher_disagreement_score":0.9818222,"about_ca_system_score_codex":0.000082787505,"about_ca_system_score_gemma":0.0035439648,"threshold_uncertainty_score":0.6361328},"labels":[],"label_agreement":null},{"id":"W2622671544","doi":"10.1080/09537104.2017.1316485","title":"Platelet reactivity in stable cardiovascular patients with chronic kidney disease","year":2017,"lang":"en","type":"article","venue":"Platelets","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung","keywords":"Medicine; Clopidogrel; Aspirin; Kidney disease; Internal medicine; Antiplatelet drug; Platelet; Platelet activation; Fibrinogen; Von Willebrand factor; Population; Drug; Gastroenterology; Cardiology; Pharmacology","score_opus":0.009968066668461797,"score_gpt":0.2254497640230666,"score_spread":0.21548169735460482,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2622671544","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99393153,0.002812459,0.00008120059,0.00019968869,0.00016353148,0.0008784263,0.0000864208,0.00008789685,0.0017588281],"genre_scores_gemma":[0.9984672,0.0005714853,0.000056379213,0.00018119536,0.00018790585,0.00006202569,0.00021169377,0.00006281026,0.0001992726],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99772567,0.000075013275,0.00023807271,0.0006166062,0.00076023967,0.00058443163],"domain_scores_gemma":[0.9972254,0.000025696721,0.00012354254,0.0018502151,0.000110294124,0.0006648299],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032632722,0.00033248376,0.0007635236,0.00012120398,0.00034496762,0.00010495054,0.00026518677,0.00012223744,0.00015599122],"category_scores_gemma":[0.00021359399,0.00026924658,0.00053063117,0.000106364234,0.0001809303,0.00051114324,0.000090215275,0.00032493,0.00008887994],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045796623,0.0010248058,0.88042825,0.00047906858,0.0029027243,0.0052211643,0.00007843278,0.00030821058,0.00016238575,0.00005390478,0.0007464296,0.10401498],"study_design_scores_gemma":[0.012702145,0.00019106406,0.9040703,0.00040488542,0.0004069718,0.000036230733,0.0000060903803,0.00010570959,0.0010458489,0.000043766984,0.080591224,0.00039575188],"about_ca_topic_score_codex":0.00026741327,"about_ca_topic_score_gemma":0.000030443342,"teacher_disagreement_score":0.103619225,"about_ca_system_score_codex":0.00020953256,"about_ca_system_score_gemma":0.0004428796,"threshold_uncertainty_score":0.999976},"labels":[],"label_agreement":null},{"id":"W2624188282","doi":"10.1002/clc.22733","title":"Relative efficacy and safety of ticagelor vs clopidogrel as a function of time to invasive management in non–ST‐segment elevation acute coronary syndrome in the PLATO trial","year":2017,"lang":"en","type":"article","venue":"Clinical Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Servier; Duke Clinical Research Institute; Daiichi-Sankyo; Medicines Company; Abbott Vascular; Regeneron Pharmaceuticals; Amarin Corporation; Boston Scientific Corporation; Alnylam Pharmaceuticals; Kowa Company; Sanofi; GlaxoSmithKline; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Ticagrelor; Medicine; Clopidogrel; Hazard ratio; Acute coronary syndrome; Internal medicine; Cardiology; Stroke (engine); Myocardial infarction; Randomization; Randomized controlled trial; Angiography; Aspirin; Confidence interval","score_opus":0.03203893549778407,"score_gpt":0.338094751129285,"score_spread":0.3060558156315009,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2624188282","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954954,0.00020020838,0.00040904025,0.00060757465,0.00016511626,0.0018960584,0.000016027227,0.000005707101,0.0012048753],"genre_scores_gemma":[0.9982567,0.0009457992,0.00008502247,0.00041502906,0.000080467675,0.00006670459,0.000041931748,0.000009337997,0.00009902758],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9981851,0.0004590529,0.0006808217,0.00031788004,0.00019840238,0.00015874906],"domain_scores_gemma":[0.9983777,0.0007302654,0.00022269519,0.00055017066,0.00005224666,0.00006692576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016460159,0.00012599477,0.0008763277,0.00009415278,0.00005234629,0.00000472512,0.00015299219,0.0001858984,0.00003288586],"category_scores_gemma":[0.0005924697,0.00009176652,0.000314636,0.00009030703,0.00029019543,0.00005964981,0.00011561014,0.00022659023,0.00003445768],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5821782,0.001368174,0.2628562,0.0002821771,0.011253158,0.0035325126,0.0006848688,0.0002692144,0.00026375844,0.0017964845,0.0010904454,0.13442482],"study_design_scores_gemma":[0.03859558,0.0047846544,0.9543946,0.00014013359,0.000769294,0.00009501148,0.00009654312,0.000010575487,0.000005872417,0.0003360749,0.00068915955,0.00008254001],"about_ca_topic_score_codex":0.0000074870704,"about_ca_topic_score_gemma":0.000002037526,"teacher_disagreement_score":0.69153833,"about_ca_system_score_codex":0.000030186256,"about_ca_system_score_gemma":0.000056338904,"threshold_uncertainty_score":0.374213},"labels":[],"label_agreement":null},{"id":"W2628945097","doi":"10.1016/j.jtcvs.2017.06.039","title":"Eight-year follow-up of the Clopidogrel After Surgery for Coronary Artery Disease (CASCADE) trial","year":2017,"lang":"en","type":"article","venue":"Journal of Thoracic and Cardiovascular Surgery","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Sanofi; Bristol-Myers Squibb","keywords":"Medicine; Clopidogrel; Aspirin; Coronary artery disease; Cardiology; Internal medicine; Placebo; Angina; Coronary artery bypass surgery; Revascularization; Artery; Surgery; Myocardial infarction","score_opus":0.028293779794678987,"score_gpt":0.28152107153498346,"score_spread":0.25322729174030445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2628945097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9374197,0.05803202,0.00078869733,0.0003347158,0.0027112276,0.0006107029,0.00005135485,0.000010161205,0.000041435054],"genre_scores_gemma":[0.99025625,0.007667663,0.000073115814,0.00015148048,0.0015668169,0.000038045288,0.0000083133245,0.0000510874,0.00018722245],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970709,0.0003659828,0.00086714386,0.00030729896,0.0010406134,0.00034806255],"domain_scores_gemma":[0.99673754,0.0004470416,0.00065737666,0.0013747202,0.00040298075,0.00038032274],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0033617464,0.0002962955,0.0017791317,0.00019100611,0.0003310996,0.000082455736,0.00024547993,0.00017152034,0.000035361223],"category_scores_gemma":[0.0009424022,0.00019338852,0.011188928,0.00010193668,0.00035081076,0.00034622656,0.00009720513,0.00027298805,0.0000020681337],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.25047028,0.00050224713,0.3823132,0.0016467327,0.027947657,0.0025014693,0.00014502628,0.00001898938,0.00006307378,0.000022646629,0.007840578,0.3265281],"study_design_scores_gemma":[0.025226858,0.00028697206,0.9089464,0.0022257504,0.015152977,0.002287213,0.00021778242,0.00001951682,0.0010474626,0.00043682355,0.04351652,0.0006357406],"about_ca_topic_score_codex":0.0000048114275,"about_ca_topic_score_gemma":7.086953e-7,"teacher_disagreement_score":0.5266332,"about_ca_system_score_codex":0.000029405943,"about_ca_system_score_gemma":0.0005435718,"threshold_uncertainty_score":0.9987138},"labels":[],"label_agreement":null},{"id":"W2655541289","doi":"","title":"Oral antiplatelet therapy [1] (multiple letters)","year":2005,"lang":"en","type":"article","venue":"JAMA","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine","score_opus":0.017125936307835023,"score_gpt":0.25499677323200104,"score_spread":0.23787083692416602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2655541289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869063,0.0039318413,0.000452344,0.0063306773,0.000100967416,0.00026175205,0.000008838901,0.00016875261,0.0018385287],"genre_scores_gemma":[0.9860832,0.0011965772,0.0009014459,0.010093458,0.0010377597,0.000013296491,0.00004360184,0.000033473578,0.000597203],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989575,0.000052146133,0.00017061408,0.00024408981,0.0002934179,0.00028219126],"domain_scores_gemma":[0.99936205,0.000033954624,0.000035843503,0.00037372197,0.000050987346,0.00014343017],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018350878,0.000162496,0.00030801934,0.00006607648,0.000080139536,0.000040429462,0.000095398595,0.00009241227,0.0006446815],"category_scores_gemma":[0.000035882305,0.00012930765,0.00037351498,0.000130966,0.00006313952,0.00018435119,0.000018756591,0.00016545375,0.0004391883],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015556554,0.00032326631,0.032716308,0.000020799054,0.0006713379,0.00028100246,0.00020524014,0.00005343439,0.03856442,0.00008166672,0.029001687,0.8965252],"study_design_scores_gemma":[0.012788582,0.00013514094,0.08928427,0.000040681338,0.00007223002,0.00027975623,0.000048332127,0.00032441606,0.032804497,0.000014794226,0.86396706,0.0002402512],"about_ca_topic_score_codex":0.000012846265,"about_ca_topic_score_gemma":0.0000033156964,"teacher_disagreement_score":0.89628494,"about_ca_system_score_codex":0.000028647324,"about_ca_system_score_gemma":0.000030503592,"threshold_uncertainty_score":0.705881},"labels":[],"label_agreement":null},{"id":"W2673874234","doi":"10.1080/09537104.2017.1320372","title":"Personalizing antiplatelet therapies: What have we learned from recent trials?","year":2017,"lang":"en","type":"review","venue":"Platelets","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute; Université de Montréal","funders":"Fonds de Recherche du Québec - Santé","keywords":"Medicine; P2Y12; Percutaneous coronary intervention; Acute coronary syndrome; Aspirin; Ticagrelor; Intensive care medicine; Clopidogrel; Prasugrel; Internal medicine; Cardiology; Platelet; Thrombosis; Platelet aggregation inhibitor; Myocardial infarction","score_opus":0.4183813471130396,"score_gpt":0.4426010490014832,"score_spread":0.024219701888443634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2673874234","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024636663,0.9936202,0.00002965615,0.00079017266,0.0015842946,0.0023036343,0.0002637841,0.00025236155,0.00090951705],"genre_scores_gemma":[0.000044657885,0.9933088,0.00015410567,0.0003062128,0.0022264507,0.00016939179,0.002078947,0.0003007167,0.0014107327],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9936098,0.0012472408,0.001679201,0.0014843479,0.0010830855,0.00089632435],"domain_scores_gemma":[0.9945273,0.0010274594,0.0015133979,0.0022220472,0.00018537576,0.00052441447],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.0021183288,0.0013534462,0.009224408,0.00036099105,0.00052150746,0.00088053575,0.0007612263,0.0012574423,0.0027856755],"category_scores_gemma":[0.0007593017,0.0009890989,0.0054277484,0.00018446268,0.00025498116,0.0006169116,0.00016526805,0.0013077252,0.00094819255],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042196424,0.0001555558,0.000004218867,0.0047047213,0.010868865,0.002422992,0.00040589468,2.5369653e-7,0.0000040680015,0.000010648654,0.0016235566,0.97937727],"study_design_scores_gemma":[0.003006102,0.00012834287,0.0000047550075,0.046522576,0.0077183605,0.00071213755,0.00043371512,0.000005162413,0.000019851877,0.00017471085,0.94033307,0.0009412128],"about_ca_topic_score_codex":0.000052551837,"about_ca_topic_score_gemma":0.0000056696226,"teacher_disagreement_score":0.97843605,"about_ca_system_score_codex":0.00022690016,"about_ca_system_score_gemma":0.00075176096,"threshold_uncertainty_score":0.9999216},"labels":[],"label_agreement":null},{"id":"W2724746343","doi":"10.1097/hco.0000000000000440","title":"P2Y12 receptor inhibitor resistance and coronary artery disease","year":2017,"lang":"en","type":"review","venue":"Current Opinion in Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Population Health Research Institute; McMaster University; Hamilton Health Sciences; University of Toronto; St. Michael's Hospital; University of Ottawa","funders":"Bhabha Atomic Research Centre","keywords":"Medicine; P2Y12; Clopidogrel; Prasugrel; Ticagrelor; Coronary artery disease; CYP2C19; Intensive care medicine; Internal medicine; Myocardial infarction; Cardiology","score_opus":0.13502762079376987,"score_gpt":0.4028479127627689,"score_spread":0.26782029196899904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2724746343","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006317489,0.9904905,0.000026491638,0.00006178414,0.0076953187,0.0011613006,0.00028977045,0.000049368966,0.00016228174],"genre_scores_gemma":[0.00013754064,0.99465847,0.000014886364,0.000013196934,0.003343332,0.0003165798,0.0013312646,0.000057924433,0.00012678874],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997482,0.0005098948,0.00059562636,0.0007973049,0.00023054727,0.00038460063],"domain_scores_gemma":[0.9982048,0.00012981982,0.00025981155,0.001010329,0.000054467004,0.0003407391],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003769331,0.0004872984,0.0028382952,0.000162531,0.00011891375,0.00002735089,0.00020746654,0.0003543831,0.00003072902],"category_scores_gemma":[0.00016580746,0.00040520236,0.0012633547,0.00009264387,0.0003657204,0.00007782985,0.00013980924,0.0006758847,0.000075184485],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021919506,0.000052315572,0.0014842869,0.025259145,0.00057095394,0.0001345944,0.000012517347,1.6125068e-7,4.422449e-8,0.00007363916,0.011644788,0.96054834],"study_design_scores_gemma":[0.0010786646,0.00004875113,0.003168949,0.030788671,0.0007210265,0.00028208087,0.0000063283205,2.8701882e-7,1.9674461e-8,0.000041187137,0.9635049,0.0003591066],"about_ca_topic_score_codex":4.505487e-7,"about_ca_topic_score_gemma":2.2254376e-7,"teacher_disagreement_score":0.9601893,"about_ca_system_score_codex":0.000118961645,"about_ca_system_score_gemma":0.000445037,"threshold_uncertainty_score":0.99983996},"labels":[],"label_agreement":null},{"id":"W2727750907","doi":"10.14740/cr556w","title":"Ticagrelor-Associated Conduction Disorder: A Case Report and Review of the Literature","year":2017,"lang":"en","type":"article","venue":"Cardiology Research","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Ticagrelor; Medicine; Cardiology; Internal medicine; Myocardial infarction; Percutaneous coronary intervention; Atrioventricular block; Heart block; Anesthesia; Electrocardiography","score_opus":0.05794523645630424,"score_gpt":0.39423998923721204,"score_spread":0.3362947527809078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2727750907","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81271166,0.18182729,0.0000070039478,0.0023650173,0.00012985706,0.0005146088,0.000012384004,0.0000109385055,0.0024212715],"genre_scores_gemma":[0.9435912,0.055254906,0.000005478588,0.00010152849,0.00012380253,0.000026468435,0.000021598622,0.000009277422,0.00086575036],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9985683,0.0005448229,0.00017595633,0.00023093859,0.00027896784,0.00020099044],"domain_scores_gemma":[0.99816835,0.00008797703,0.00008962444,0.0010373323,0.00054010417,0.000076622375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021570046,0.00007860974,0.0004994332,0.000041374024,0.00047676553,0.000019248344,0.00012272982,0.00014175329,0.000016652317],"category_scores_gemma":[0.0033366901,0.000047527734,0.00030540678,0.0001284125,0.0008390583,0.000050697116,0.0001420984,0.0004176219,0.0000028824938],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061548164,0.00022013763,0.6015747,0.011045715,0.006453666,0.29431146,0.0005417261,9.3141466e-7,0.0026692855,0.0008331844,0.023965774,0.05776791],"study_design_scores_gemma":[0.002962014,0.0004037792,0.36863875,0.011047519,0.0009844422,0.55685484,0.00042635784,0.000009166934,0.00051856326,0.0005924714,0.057329018,0.00023305748],"about_ca_topic_score_codex":0.000025243302,"about_ca_topic_score_gemma":0.0000031153725,"teacher_disagreement_score":0.2625434,"about_ca_system_score_codex":0.000023105216,"about_ca_system_score_gemma":0.00012519993,"threshold_uncertainty_score":0.39945707},"labels":[],"label_agreement":null},{"id":"W2729362012","doi":"10.14740/jmc.v8i7.2853","title":"Acute Ischemic Stroke Associated With OrthoVisc (Hyaluronic Acid) Injection","year":2017,"lang":"en","type":"article","venue":"Journal of Medical Cases","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Viscosupplementation; Hyaluronic acid; Osteoarthritis; Synovial fluid; Stroke (engine); Analgesic; Anesthesia; Migraine; Surgery; Internal medicine; Intra articular; Pathology","score_opus":0.01767421618883814,"score_gpt":0.2931270120067915,"score_spread":0.27545279581795334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2729362012","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99367887,0.003190898,0.00033766736,0.0016371665,0.00024251008,0.00008022907,0.000009781753,0.000019866024,0.00080301776],"genre_scores_gemma":[0.9969716,0.0015215916,0.00005124254,0.00039079515,0.00061789714,0.0000017742855,0.000007036634,0.000019598096,0.0004184327],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99770564,0.000070207825,0.00032330668,0.00012337444,0.001565969,0.0002115124],"domain_scores_gemma":[0.99849516,0.00008318474,0.00046932173,0.00030202404,0.00022826764,0.00042204096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075030373,0.00013758415,0.0004879057,0.000078459954,0.0002095201,0.00005561818,0.00023444818,0.00017804587,0.0004805312],"category_scores_gemma":[0.0017113107,0.00008665355,0.00042026685,0.000051871455,0.00021018022,0.00021385026,0.00003886677,0.00055213104,0.000008173972],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014792195,0.0025749987,0.25532907,0.00026451715,0.027631603,0.15504274,0.00038403287,0.000017668604,0.007316147,0.00009104657,0.05381038,0.48274562],"study_design_scores_gemma":[0.07512017,0.025361495,0.43434215,0.008445842,0.019255713,0.26926348,0.0018972725,0.00039539812,0.044063717,0.00008368413,0.1203388,0.0014322872],"about_ca_topic_score_codex":0.0000110303445,"about_ca_topic_score_gemma":0.000016834376,"teacher_disagreement_score":0.48131332,"about_ca_system_score_codex":0.00006754373,"about_ca_system_score_gemma":0.00058910047,"threshold_uncertainty_score":0.52614796},"labels":[],"label_agreement":null},{"id":"W2732163131","doi":"10.1016/j.amjcard.2017.06.019","title":"Quantifying Ischemic Risk After Percutaneous Coronary Intervention Attributable to High Platelet Reactivity on Clopidogrel (From the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents Study)","year":2017,"lang":"en","type":"article","venue":"The American Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Sacré-Cœur de Montréal","funders":"Abbott Vascular; Boston Scientific Corporation; Cardiovascular Research Foundation; Medtronic; Cordis; Eli Lilly and Company","keywords":"Medicine; Mace; Clopidogrel; Percutaneous coronary intervention; Internal medicine; Myocardial infarction; Conventional PCI; Cardiology; Residual risk; P2Y12","score_opus":0.026282049302500346,"score_gpt":0.31500596875138454,"score_spread":0.2887239194488842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2732163131","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972111,0.0006857955,0.00066348474,0.00050472294,0.00024894503,0.0005506367,0.0000713392,0.000012091679,0.000051859355],"genre_scores_gemma":[0.9980092,0.0010292882,0.0002147298,0.00021347604,0.0004666594,0.0000121634575,0.00000779427,0.00003553598,0.000011160181],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970968,0.001176221,0.0005284516,0.0002919358,0.00058084144,0.00032575632],"domain_scores_gemma":[0.9967839,0.0005029498,0.0013703903,0.0009805238,0.00024806804,0.000114171184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018205099,0.00027038608,0.0013396052,0.000077933946,0.00035966584,0.000044136512,0.0004496047,0.00004563418,0.0000140964885],"category_scores_gemma":[0.00011693373,0.000138007,0.00064216234,0.00011712131,0.0005189771,0.00011401446,0.00012203568,0.0006663606,0.0000033074753],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020470016,0.00030706782,0.85319275,0.000009164811,0.006861039,0.0020970847,0.0005518041,0.0009895216,0.0042720763,0.0000030446527,0.00014527845,0.11110118],"study_design_scores_gemma":[0.0037055975,0.006428746,0.979483,0.00025748787,0.0008090674,0.0044691423,0.0028354356,0.000020368701,0.00097309024,0.000010718754,0.0008406025,0.00016675399],"about_ca_topic_score_codex":0.00040504098,"about_ca_topic_score_gemma":0.000011593018,"teacher_disagreement_score":0.12629026,"about_ca_system_score_codex":0.00007990305,"about_ca_system_score_gemma":0.00010918938,"threshold_uncertainty_score":0.5627762},"labels":[],"label_agreement":null},{"id":"W2733384621","doi":"10.14740/cr560w","title":"Comparison of Clopidogrel With Prasugrel and Ticagrelor in Patients With Acute Coronary Syndrome: Clinical Outcomes From the National Cardiovascular Database ACTION Registry","year":2017,"lang":"en","type":"article","venue":"Cardiology Research","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Prasugrel; Ticagrelor; Acute coronary syndrome; Clopidogrel; Internal medicine; Cardiology; Percutaneous coronary intervention; Myocardial infarction; Cardiogenic shock; Atrial fibrillation; Database","score_opus":0.17177630190623913,"score_gpt":0.45137612954958967,"score_spread":0.27959982764335056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2733384621","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961135,0.00222543,0.00012005508,0.0003318195,0.00008182602,0.0007226636,0.00014329187,0.000012204186,0.00024922943],"genre_scores_gemma":[0.99844706,0.00088737835,0.00018251034,0.00005255839,0.0000976644,0.000045738878,0.00022230274,0.00002133356,0.00004347388],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970221,0.0007561667,0.00032403957,0.00049581606,0.0010972571,0.00030460407],"domain_scores_gemma":[0.9974492,0.00062706927,0.00012654377,0.0011656022,0.0005005622,0.0001310324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020408873,0.00016403836,0.0011216332,0.0000816676,0.00031742235,0.00002793598,0.0003099407,0.00019140313,0.000011118723],"category_scores_gemma":[0.0006254583,0.000093862385,0.00031084396,0.00010475292,0.001827112,0.00013850298,0.00019277389,0.00076698273,0.0000072263156],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003190684,0.00015364184,0.98315287,0.000031044015,0.0076656044,0.000379751,0.00003439492,0.000017539613,0.0000055043647,0.000020284944,0.0005174549,0.0048312475],"study_design_scores_gemma":[0.006276444,0.00076041464,0.9906724,0.00013571359,0.00063052063,0.00017913252,0.00018486193,0.000020660495,0.000011375889,0.00002057793,0.000999485,0.000108412016],"about_ca_topic_score_codex":0.000101823854,"about_ca_topic_score_gemma":0.000014732297,"teacher_disagreement_score":0.0075195525,"about_ca_system_score_codex":0.000049938593,"about_ca_system_score_gemma":0.00028386168,"threshold_uncertainty_score":0.67320704},"labels":[],"label_agreement":null},{"id":"W2735969606","doi":"10.1139/cjpp-2017-0314","title":"Inhibition of platelet aggregation ex vivo is repressed in apolipoprotein E deficient mice","year":2017,"lang":"en","type":"article","venue":"Canadian Journal of Physiology and Pharmacology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Ex vivo; Apolipoprotein E; Endocrinology; Platelet; Internal medicine; Prostacyclin; Endogeny; In vivo; Bradykinin; Chemistry; Apolipoprotein B; Basal (medicine); Agonist; In vitro; Biology; Medicine; Biochemistry; Cholesterol; Receptor","score_opus":0.015751981452447963,"score_gpt":0.2765784669393494,"score_spread":0.26082648548690146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2735969606","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99612826,0.0025738052,0.000012263904,0.00065825606,0.00025004862,0.00014069346,0.000018389992,0.000001375318,0.00021689764],"genre_scores_gemma":[0.9985081,0.00056876824,0.00002750688,0.000685503,0.00016978063,0.0000024383078,0.000004072389,0.000006127075,0.000027703361],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993045,0.00009621999,0.00025361762,0.00011718489,0.000056550063,0.00017197078],"domain_scores_gemma":[0.99924827,0.000026941783,0.00028901585,0.00012320757,0.00011080855,0.00020176705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023140093,0.00008229153,0.00033868616,0.00017739215,0.00011063016,0.000005253925,0.0000771937,0.00011703407,0.0006236521],"category_scores_gemma":[0.000036459885,0.00007441195,0.00011699727,0.00003943902,0.00029790975,0.00008708864,0.000009542249,0.00019262411,0.0000020943392],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072400575,0.00005347399,0.0057019596,0.00014463882,0.0002645095,0.0003982939,0.00051738194,0.00004674813,0.9850896,0.000062961306,0.0011623385,0.0058341115],"study_design_scores_gemma":[0.0037604156,0.00031649513,0.06987042,0.000121340534,0.00014920841,0.00033675943,0.000070626804,0.00005206636,0.92240673,0.0008487975,0.0019852116,0.000081900536],"about_ca_topic_score_codex":0.0013529916,"about_ca_topic_score_gemma":0.00037027782,"teacher_disagreement_score":0.06416846,"about_ca_system_score_codex":0.000031867716,"about_ca_system_score_gemma":0.00033240457,"threshold_uncertainty_score":0.68285525},"labels":[],"label_agreement":null},{"id":"W2737697654","doi":"","title":"Informing informed consent: outcomes of laser photocoagulation for ROP in a Canadian tertiary care center.","year":2017,"lang":"en","type":"article","venue":"Investigative Ophthalmology & Visual Science","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children; University of Toronto; McMaster University","funders":"","keywords":"Tertiary care; Center (category theory); Medicine; Informed consent; Family medicine; Optometry; Alternative medicine","score_opus":0.04538820319822554,"score_gpt":0.3750048679643354,"score_spread":0.32961666476610985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2737697654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99681336,0.00005983452,0.000001567316,0.0002283413,0.00011757295,0.0011006199,0.00003701899,0.000008736504,0.0016329364],"genre_scores_gemma":[0.99922085,0.000004546707,0.00027415404,0.00029555208,0.00001930698,0.00010298185,0.000028480805,0.000008319487,0.000045837824],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99873203,0.0000307939,0.00028661537,0.00025789445,0.0002489023,0.00044377963],"domain_scores_gemma":[0.99877137,0.00011355201,0.00018752075,0.00032363765,0.00023689894,0.00036704095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003575317,0.00014608027,0.00034374383,0.00027385534,0.00040737676,0.000033796605,0.00027641645,0.00009175193,0.000024379271],"category_scores_gemma":[0.0017499062,0.00012339659,0.00014040887,0.0001545628,0.0025320197,0.00045087977,0.00006570468,0.000093183415,0.00000407499],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006467897,0.000032430486,0.98996484,0.000091205344,0.000049604343,0.00009706472,0.0013322654,0.000014765647,0.0072527924,0.000032827054,0.0000047547564,0.0010627893],"study_design_scores_gemma":[0.001680497,0.00022625412,0.9250483,0.00017961148,0.00002844302,0.0001060761,0.0006606079,0.00015532968,0.07149044,0.00019011169,0.00011641276,0.0001178997],"about_ca_topic_score_codex":0.024405282,"about_ca_topic_score_gemma":0.012095166,"teacher_disagreement_score":0.06491651,"about_ca_system_score_codex":0.0001983382,"about_ca_system_score_gemma":0.0027894464,"threshold_uncertainty_score":0.9820913},"labels":[],"label_agreement":null},{"id":"W2737845351","doi":"10.1016/j.ahj.2017.07.013","title":"Effects of ticagrelor versus clopidogrel on platelet function in fibrinolytic-treated STEMI patients undergoing early PCI","year":2017,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hamilton Health Sciences; University of Saskatchewan; Southlake Regional Health Center; McMaster University; London Health Sciences Centre; St. Michael's Hospital; Regina Qu'Appelle Health Region","funders":"","keywords":"Medicine; Ticagrelor; Clopidogrel; Conventional PCI; Aspirin; Internal medicine; Loading dose; Tenecteplase; Cardiology; Fibrinolysis; P2Y12; Population; Myocardial infarction; Anesthesia; Thrombolysis","score_opus":0.014749214590455972,"score_gpt":0.271508875781297,"score_spread":0.25675966119084104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2737845351","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985367,0.00027924098,0.000031954358,0.000111798465,0.00034570572,0.00024597015,0.000002316834,0.00001839316,0.0004279195],"genre_scores_gemma":[0.99909955,0.00042752686,0.00006509989,0.00013746315,0.0001917702,0.0000041408844,0.000003654498,0.000025499787,0.000045293764],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99870956,0.00011572794,0.00028364107,0.00019151745,0.0004092591,0.00029027386],"domain_scores_gemma":[0.9988972,0.00023373867,0.00025662498,0.00032917457,0.00009360999,0.00018963004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001467556,0.00016187591,0.0005121576,0.0001507117,0.0002059428,0.000045302742,0.000097831726,0.000053905474,0.000022322742],"category_scores_gemma":[0.00024040129,0.0001355031,0.00031803554,0.00010801366,0.00019165427,0.00014166247,0.000026718099,0.0002983011,0.00003720175],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008510929,0.00038416157,0.89256877,0.00009163036,0.00080404256,0.0002651523,0.0001084905,0.000027049471,0.00084300665,0.000020325115,0.00026903537,0.09610741],"study_design_scores_gemma":[0.009807479,0.0049922587,0.9805047,0.000527095,0.00020404195,0.000070424234,0.00008143139,0.000018053643,0.0029725032,0.0000115892035,0.00067533425,0.0001351262],"about_ca_topic_score_codex":0.00012288165,"about_ca_topic_score_gemma":0.0000060025122,"teacher_disagreement_score":0.09597228,"about_ca_system_score_codex":0.00008945269,"about_ca_system_score_gemma":0.00009463158,"threshold_uncertainty_score":0.5525656},"labels":[],"label_agreement":null},{"id":"W2739077924","doi":"10.1161/circoutcomes.5.suppl_1.a211","title":"Abstract 211: A Comparison of Bleeding in Patients Treated with Clopidogrel or Prasugrel in a US Hospital Database","year":2012,"lang":"en","type":"article","venue":"Circulation Cardiovascular Quality and Outcomes","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Douglas College","funders":"","keywords":"Prasugrel; Clopidogrel; Medicine; Percutaneous coronary intervention; Internal medicine; Incidence (geometry); Conventional PCI; Acute coronary syndrome; P2Y12; Cardiology; Aspirin; Myocardial infarction","score_opus":0.049778381546268034,"score_gpt":0.3264026278252309,"score_spread":0.27662424627896287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739077924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938786,0.0048038713,0.00028811602,0.000035423935,0.00006769474,0.0007602801,0.000025104659,0.000031892367,0.00010900624],"genre_scores_gemma":[0.9993462,0.00016598732,0.00016175337,0.00006272647,0.000047048456,0.000025488922,0.00016182783,0.000024438383,0.0000045034562],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997808,0.00020653584,0.00065177534,0.0003248788,0.00068025576,0.00032854712],"domain_scores_gemma":[0.99897903,0.00011131039,0.00016158554,0.00048182547,0.000107366606,0.00015890393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001150321,0.0002410327,0.0011825535,0.00022647539,0.00004955803,0.000015629656,0.000058602487,0.00013849136,0.000024079342],"category_scores_gemma":[0.00019142307,0.00018000262,0.0005477731,0.00039980424,0.00009965938,0.0003697155,0.000029206523,0.00019354037,0.0000030264632],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054787105,0.0008211531,0.98714495,0.00040818957,0.0015718275,0.000018588486,0.0006468778,0.000245862,0.000022635664,0.000048083642,0.000003706277,0.0085202865],"study_design_scores_gemma":[0.008358455,0.00010083612,0.9896243,0.00024693905,0.00048335025,0.0000076212086,0.0005891525,0.00004970997,0.000113185306,0.000002842344,0.00017475587,0.00024882104],"about_ca_topic_score_codex":0.00036879114,"about_ca_topic_score_gemma":0.00002486383,"teacher_disagreement_score":0.008271466,"about_ca_system_score_codex":0.00008520553,"about_ca_system_score_gemma":0.00005376255,"threshold_uncertainty_score":0.7340294},"labels":[],"label_agreement":null},{"id":"W2740440155","doi":"10.1016/j.jcin.2017.05.059","title":"Impact of Aspirin and Clopidogrel Hyporesponsiveness in Patients Treated With Drug-Eluting Stents","year":2017,"lang":"en","type":"article","venue":"JACC: Cardiovascular Interventions","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Sacré-Cœur de Montréal","funders":"","keywords":"Medicine; Clopidogrel; Percutaneous coronary intervention; Aspirin; Hazard ratio; Internal medicine; Discontinuation; Myocardial infarction; Clinical endpoint; Drug-eluting stent; Cardiology; Confidence interval; Surgery; Randomized controlled trial","score_opus":0.022882822455111137,"score_gpt":0.3019433308848259,"score_spread":0.27906050842971475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740440155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939129,0.00465389,0.00018732979,0.000013803053,0.00005710367,0.0006819062,0.00004821081,0.000029831757,0.00041506172],"genre_scores_gemma":[0.9992905,0.00025787426,0.00009587327,0.000006550096,0.000041032585,0.000040737967,0.00006812244,0.000038446673,0.00016083276],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982153,0.00021587934,0.00042106622,0.0003966716,0.00046088223,0.00029017095],"domain_scores_gemma":[0.99813765,0.000027226028,0.00021113381,0.0011878973,0.0002848708,0.00015121809],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005624829,0.00024836845,0.00089765433,0.00025238036,0.00019681007,0.000057686568,0.00018118019,0.00008886325,0.000032267544],"category_scores_gemma":[0.0001500909,0.00019249422,0.00341981,0.00015081467,0.00021101016,0.00023266733,0.000116193,0.00017200896,0.0000062693275],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008360371,0.00049817073,0.9507794,0.00028657416,0.008173342,0.00013437329,0.00006268836,0.00012233327,0.000021208378,0.000011226969,0.000021763584,0.039052933],"study_design_scores_gemma":[0.009155421,0.00052945304,0.98646057,0.0016116078,0.0015156601,0.000060209342,0.000068644724,0.00002141714,0.00019754717,0.000009966133,0.00017545356,0.00019403323],"about_ca_topic_score_codex":0.0006185762,"about_ca_topic_score_gemma":0.000029936507,"teacher_disagreement_score":0.038858898,"about_ca_system_score_codex":0.00009193281,"about_ca_system_score_gemma":0.00007225943,"threshold_uncertainty_score":0.7849686},"labels":[],"label_agreement":null},{"id":"W2740504638","doi":"10.1093/cvr/cvx141","title":"Context-dependent signalling in platelets in vascular diseases: ROCK2 around thrombosis","year":2017,"lang":"en","type":"letter","venue":"Cardiovascular Research","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"Canadian Institutes of Health Research","keywords":"Context (archaeology); Thrombosis; Platelet; Medicine; ROCK2; Cardiology; Biology; Internal medicine; Kinase; Cell biology; Rho-associated protein kinase","score_opus":0.08821677922454091,"score_gpt":0.35061672535893035,"score_spread":0.26239994613438944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740504638","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21482423,0.73202693,0.0006339374,0.034928087,0.0012687227,0.010497904,0.0003315503,0.00036699962,0.0051216204],"genre_scores_gemma":[0.9142187,0.04682473,0.000047929527,0.024910836,0.008847511,0.0015661772,0.0015437196,0.0007354566,0.0013049188],"study_design_codex":"case_report","study_design_gemma":"not_applicable","domain_scores_codex":[0.9833896,0.0029154073,0.0011696708,0.0027147655,0.0071544396,0.00265608],"domain_scores_gemma":[0.99228865,0.00050436234,0.00017443139,0.0057364493,0.000746342,0.000549752],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0071966383,0.0011504646,0.004612841,0.0021456648,0.0005736631,0.0005385945,0.0017083471,0.0022276472,0.00027003867],"category_scores_gemma":[0.0009915787,0.0011147119,0.008609178,0.0009167926,0.0008019523,0.0004307213,0.0006349124,0.008378419,0.00047662403],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018123328,0.002167232,0.02461412,0.014227449,0.1244636,0.38322303,0.0012894958,0.0054614833,0.00035467965,0.00006376616,0.27722028,0.16510253],"study_design_scores_gemma":[0.0112620555,0.00028278475,0.011575138,0.0041096574,0.003065255,0.00033711674,0.0006055421,0.00016906021,0.00020412587,0.00041403514,0.96639735,0.0015778717],"about_ca_topic_score_codex":0.0016768663,"about_ca_topic_score_gemma":0.00006495983,"teacher_disagreement_score":0.69939446,"about_ca_system_score_codex":0.001383881,"about_ca_system_score_gemma":0.0013532552,"threshold_uncertainty_score":0.9991303},"labels":[],"label_agreement":null},{"id":"W2741390388","doi":"10.1161/circinterventions.117.005579","title":"Platelet Transfusion for Ticagrelor Reversal","year":2017,"lang":"en","type":"letter","venue":"Circulation Cardiovascular Interventions","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; Kruger (Canada); Population Health Research Institute","funders":"","keywords":"Medicine; Ticagrelor; Population; Aspirin; Thrombosis; Coronary artery disease; Internal medicine; Surgery; Clopidogrel","score_opus":0.06446482404800673,"score_gpt":0.3151843967133341,"score_spread":0.25071957266532735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741390388","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0107475845,0.15073884,0.5014232,0.2998991,0.008337324,0.01770916,0.0026251876,0.0014715195,0.00704809],"genre_scores_gemma":[0.4212352,0.024591208,0.008749896,0.32766405,0.08720204,0.008219992,0.08742994,0.0030305823,0.031877093],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964956,0.00023441591,0.00077958667,0.0010402562,0.0008779309,0.0005721848],"domain_scores_gemma":[0.99641025,0.00009194746,0.00029191654,0.0024855784,0.0005519026,0.00016838073],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.00085413357,0.0005819347,0.0016472454,0.0003864799,0.0006534674,0.00017989532,0.00037369973,0.0012745343,0.00037587696],"category_scores_gemma":[0.00026587068,0.00059133436,0.02225415,0.00013850105,0.00020645464,0.00022617127,0.000052368858,0.0011248672,0.00015429758],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002784982,0.0002529543,0.00019578527,0.007900779,0.051201724,0.0022267925,0.00011380521,0.00037853603,0.00006757685,0.00016237257,0.8287946,0.108426556],"study_design_scores_gemma":[0.004519075,0.00013638177,0.0015371671,0.0018898868,0.011179605,0.0009884159,0.000021317315,0.0001541904,0.000070287,0.0002892043,0.97860456,0.00060994196],"about_ca_topic_score_codex":0.00003565724,"about_ca_topic_score_gemma":0.0000026468383,"teacher_disagreement_score":0.49267328,"about_ca_system_score_codex":0.00021489809,"about_ca_system_score_gemma":0.00021202395,"threshold_uncertainty_score":0.9996538},"labels":[],"label_agreement":null},{"id":"W2742594813","doi":"10.1136/gutjnl-2017-314472.369","title":"PWE-124 Daily aspirin 300mg: how much do patients take? drug accountability for the first 5 years of the aspect study","year":2017,"lang":"en","type":"article","venue":"","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Aspirin; Medicine; Drug; Accountability; Computer science; Internal medicine; Pharmacology; Political science","score_opus":0.020094216966856274,"score_gpt":0.2748824249692214,"score_spread":0.2547882080023651,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2742594813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948541,0.00043263493,0.00004302872,0.0011580512,0.00034073892,0.0022498327,0.00003876892,0.00002554682,0.00085729157],"genre_scores_gemma":[0.99851626,0.000043848286,0.000017666427,0.0002468496,0.00014243905,0.00008486067,0.0000049600535,0.00002200263,0.00092111673],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99870974,0.00006154734,0.0001939183,0.00029559288,0.00053087843,0.00020829638],"domain_scores_gemma":[0.9975689,0.00016076771,0.00015766313,0.0018657834,0.00018997838,0.00005691914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006214027,0.00015388217,0.00034066674,0.000019396883,0.0004968071,0.00012591614,0.0005751821,0.000049154103,0.00008995805],"category_scores_gemma":[0.00029294883,0.000079970254,0.0005124742,0.00006198025,0.00023847182,0.00017139188,0.00015464248,0.00012719324,0.0000071705385],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005103046,0.0012270563,0.958395,0.000085966865,0.0011670325,0.000003809351,0.0012096585,0.0000030673602,0.000021655875,0.00009917819,0.004414511,0.032862738],"study_design_scores_gemma":[0.004049945,0.00023766914,0.97222006,0.00003605645,0.00047647968,0.0000015939763,0.0023931721,0.000016067037,0.00036175354,0.0000787352,0.020025121,0.000103369646],"about_ca_topic_score_codex":0.00022881872,"about_ca_topic_score_gemma":0.0003226827,"teacher_disagreement_score":0.03275937,"about_ca_system_score_codex":0.00003527918,"about_ca_system_score_gemma":0.00006356167,"threshold_uncertainty_score":0.38210887},"labels":[],"label_agreement":null},{"id":"W2747051583","doi":"10.7326/acpjc-2017-167-4-017","title":"In high-risk patients with arthritis and previous upper GI bleeding, celecoxib vs naproxen reduced recurrent bleeding","year":2017,"lang":"en","type":"letter","venue":"Annals of Internal Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Medicine; Naproxen; Celecoxib; Upper gastrointestinal bleeding; Internal medicine; Arthritis; Gastrointestinal bleeding; Osteoarthritis; Gastroenterology; GI bleeding; Surgery; Endoscopy; Alternative medicine; Pathology","score_opus":0.01859015023350375,"score_gpt":0.28198412360167124,"score_spread":0.2633939733681675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2747051583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8706105,0.027584242,0.000012836915,0.099127404,0.0008929403,0.00094500475,0.0001394645,0.000033192122,0.00065444736],"genre_scores_gemma":[0.8048116,0.06144857,0.00010424034,0.1239163,0.0073812366,0.000095546944,0.00034545135,0.00018575364,0.0017113285],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.996588,0.0001352528,0.0008616013,0.0007334691,0.0010929663,0.0005887434],"domain_scores_gemma":[0.9974655,0.00011930446,0.00090280594,0.0006956529,0.0005784587,0.00023829474],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005907675,0.000595574,0.0019065859,0.00050233497,0.000092744616,0.00002838457,0.0003609873,0.00047446258,0.0002746548],"category_scores_gemma":[0.00043675772,0.00041987613,0.00032943278,0.00012064287,0.0005141709,0.00022240088,0.000105937695,0.001713933,0.0000085633665],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040397304,0.00026879355,0.08165964,0.0013327867,0.0031984707,0.0025502713,0.00067198445,5.22371e-7,0.000049364346,0.000008167071,0.7822972,0.123923086],"study_design_scores_gemma":[0.035049856,0.016962636,0.19507296,0.095253,0.0025841428,0.000823935,0.00018957198,0.000014222991,0.0021966924,0.00046575008,0.64990866,0.0014785667],"about_ca_topic_score_codex":0.00083795015,"about_ca_topic_score_gemma":0.000014965175,"teacher_disagreement_score":0.13238852,"about_ca_system_score_codex":0.000042526466,"about_ca_system_score_gemma":0.00009175085,"threshold_uncertainty_score":0.9998253},"labels":[],"label_agreement":null},{"id":"W2748683758","doi":"10.1161/circ.132.suppl_3.19642","title":"Abstract 19642: Consistent Benefit of Ticagrelor Both Early and Late in Patients With Prior MI in PEGASUS-TIMI 54","year":2015,"lang":"en","type":"article","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Ticagrelor; Medicine; TIMI; Stroke (engine); Myocardial infarction; Placebo; Internal medicine; Cardiology; Clinical endpoint; Acute coronary syndrome; Randomized controlled trial; Thrombolysis","score_opus":0.014587183070813059,"score_gpt":0.21961946156608178,"score_spread":0.20503227849526873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2748683758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988025,0.0005293341,0.000018839133,0.00003003361,0.000021458798,0.00032345252,0.0000031342395,0.000009163264,0.0002621254],"genre_scores_gemma":[0.99983096,0.000016251863,0.000056055193,0.00003032246,0.000012105172,0.0000050194785,0.000030393898,0.000010779671,0.000008137612],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993228,0.000016841434,0.00018691306,0.00014192826,0.00022831981,0.00010320482],"domain_scores_gemma":[0.9996348,0.000015124733,0.00006150276,0.00013595773,0.000075953954,0.00007664104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013275865,0.00007740429,0.00020656576,0.000091438014,0.00001123641,0.0000071518807,0.0000194537,0.00005366033,0.000011051148],"category_scores_gemma":[0.000025466123,0.00006645895,0.00004600359,0.000111434834,0.0000426977,0.000083278006,0.0000069398916,0.000060476912,0.0000032336966],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052598066,0.00014452843,0.99019814,0.000051725852,0.00006230486,0.00001490967,0.0004108854,0.00043815663,0.0001325481,0.000030061767,0.0000018682883,0.007988896],"study_design_scores_gemma":[0.005534858,0.00010114667,0.99371976,0.0001695445,0.000061787614,0.0000028895977,0.000037865844,0.00014731573,0.00005261605,0.00006892154,0.00002943621,0.00007388247],"about_ca_topic_score_codex":0.00008996571,"about_ca_topic_score_gemma":0.000022596112,"teacher_disagreement_score":0.0079150135,"about_ca_system_score_codex":0.000041992193,"about_ca_system_score_gemma":0.000050186056,"threshold_uncertainty_score":0.27101177},"labels":[],"label_agreement":null},{"id":"W2749472472","doi":"10.1016/j.jcin.2017.06.042","title":"Percutaneous Coronary Interventions in Patients Requiring Long-Term Oral Anticoagulation","year":2017,"lang":"en","type":"letter","venue":"JACC: Cardiovascular Interventions","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"","keywords":"Medicine; Percutaneous; Psychological intervention; Term (time); Percutaneous coronary intervention; Cardiology; Intensive care medicine; Internal medicine; Myocardial infarction; Nursing","score_opus":0.05876490425209119,"score_gpt":0.3214905542161767,"score_spread":0.26272564996408554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2749472472","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8355563,0.10600701,0.009913528,0.025981383,0.007203123,0.0096238665,0.0009686811,0.0010015699,0.003744507],"genre_scores_gemma":[0.9695681,0.0018874018,0.0003295832,0.009725242,0.0026270289,0.00026447113,0.009467069,0.00040312775,0.005727974],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99391603,0.0007283062,0.001520032,0.0013567214,0.0015529542,0.0009259491],"domain_scores_gemma":[0.99543405,0.00006176066,0.00051784806,0.003269366,0.00049994333,0.00021705196],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.00097286364,0.00088189385,0.0024721334,0.00095759693,0.0004734706,0.00030887395,0.0007351347,0.0012101213,0.0008129006],"category_scores_gemma":[0.00029168263,0.00091975206,0.021932181,0.0002810419,0.00032800337,0.0005238627,0.00037667743,0.0022960028,0.00035413456],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077850354,0.0033829305,0.47987965,0.02020106,0.07088935,0.060351297,0.00023765187,0.00040630822,0.000018538989,0.000025811665,0.19609942,0.1677295],"study_design_scores_gemma":[0.00656483,0.0006150804,0.8978358,0.016377764,0.012859535,0.0036493528,0.000026708623,0.000027670058,0.000014402307,0.00006469416,0.06071918,0.0012449607],"about_ca_topic_score_codex":0.00011879904,"about_ca_topic_score_gemma":0.000053556065,"teacher_disagreement_score":0.41795617,"about_ca_system_score_codex":0.00059529283,"about_ca_system_score_gemma":0.00016686277,"threshold_uncertainty_score":0.99932534},"labels":[],"label_agreement":null},{"id":"W2750459267","doi":"10.1007/s11239-017-1541-x","title":"Effects of statin therapy on platelet reactivity after percutaneous coronary revascularization in patients with acute coronary syndrome","year":2017,"lang":"en","type":"article","venue":"Journal of Thrombosis and Thrombolysis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Sacré-Cœur de Montréal","funders":"","keywords":"Medicine; Clopidogrel; Percutaneous coronary intervention; Internal medicine; Acute coronary syndrome; Conventional PCI; Cardiology; Statin; Coronary artery disease; Myocardial infarction; P2Y12; Revascularization; Loading dose; Platelet activation; Platelet","score_opus":0.008446738776890677,"score_gpt":0.24527707109975988,"score_spread":0.2368303323228692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2750459267","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982399,0.0010528144,0.000047619124,0.00009954717,0.000083484665,0.00042907815,0.000019241897,0.000006428707,0.000021886577],"genre_scores_gemma":[0.99215263,0.007420386,0.0002340089,0.0001108753,0.000024279128,0.000005960573,0.000011705845,0.00003266498,0.000007493718],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99837404,0.00013993132,0.00041105138,0.00023733864,0.00064298126,0.0001946382],"domain_scores_gemma":[0.99857295,0.000098330056,0.00057431473,0.0004383621,0.00018787054,0.00012817315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002761835,0.0002424525,0.0010850234,0.00018053089,0.00012887674,0.00003951114,0.00014013267,0.000119383156,0.000049378214],"category_scores_gemma":[0.00004224526,0.00016515426,0.00038756398,0.0000958891,0.00018573581,0.000352966,0.00003582685,0.00025332047,0.0000013811608],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007956928,0.0022999074,0.95044714,0.00022584928,0.0076558255,0.002635714,0.00048169182,0.000023464594,0.0070486944,0.000008968921,0.000019435292,0.021196354],"study_design_scores_gemma":[0.007032572,0.0039237943,0.9839014,0.00073506735,0.0011510961,0.00066199637,0.00003248791,0.0000085060665,0.0023115445,0.000047841735,0.000020847048,0.00017287061],"about_ca_topic_score_codex":0.00002644962,"about_ca_topic_score_gemma":0.0000031720424,"teacher_disagreement_score":0.03345421,"about_ca_system_score_codex":0.000060114082,"about_ca_system_score_gemma":0.00006839176,"threshold_uncertainty_score":0.6734795},"labels":[],"label_agreement":null},{"id":"W2751164087","doi":"10.1056/jg200808060000001","title":"Gastrointestinal Bleeding Is Associated with Poor Outcomes in Ischemic Stroke Patients","year":2008,"lang":"en","type":"article","venue":"Journal watch","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Stroke (engine); Ischemic stroke; Gastrointestinal bleeding; Internal medicine; Acute stroke; Major bleeding; Cardiology; Emergency medicine; Ischemia; Myocardial infarction","score_opus":0.013709760667879494,"score_gpt":0.23388875214209603,"score_spread":0.22017899147421655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2751164087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99762964,0.00013331395,0.00006410911,0.00129673,0.00004928658,0.000116916766,0.000009201238,0.000022964705,0.00067785336],"genre_scores_gemma":[0.99727577,0.00022702538,0.00033974985,0.00052343437,0.000088790046,0.0000025450229,0.000010039075,0.000022724515,0.0015099361],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987048,0.00003683246,0.00026391182,0.00014257873,0.00054313324,0.0003087492],"domain_scores_gemma":[0.999389,0.000036551384,0.00012073995,0.000102406775,0.00016779799,0.0001835354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018012291,0.00015279966,0.0004012792,0.00007846974,0.0001288471,0.000017047549,0.00007406298,0.000037389105,0.00013472553],"category_scores_gemma":[0.00009774753,0.00010409341,0.0002645969,0.00014448653,0.000047163372,0.0001322466,0.00001505462,0.00042431505,0.000014981183],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033082216,0.00034179748,0.9911374,0.0000071348613,0.00033572278,0.0014409103,0.00015400494,0.0000065299637,0.00056887645,1.9078566e-7,0.004951381,0.00072523876],"study_design_scores_gemma":[0.008817584,0.00063533033,0.98165095,0.0004881898,0.00018119266,0.0056232847,0.00018462767,0.000035320205,0.0011037037,0.000005720669,0.0011032231,0.0001708976],"about_ca_topic_score_codex":0.000008139807,"about_ca_topic_score_gemma":0.0000027138815,"teacher_disagreement_score":0.009486465,"about_ca_system_score_codex":0.00015448032,"about_ca_system_score_gemma":0.000101383,"threshold_uncertainty_score":0.42448062},"labels":[],"label_agreement":null},{"id":"W2751347423","doi":"10.1016/j.ijcard.2017.05.091","title":"Sex differences in the effect of diabetes mellitus on platelet reactivity and coronary thrombosis: From the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents (ADAPT-DES) study","year":2017,"lang":"en","type":"article","venue":"International Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Sacré-Cœur de Montréal","funders":"","keywords":"Medicine; Internal medicine; Hazard ratio; Diabetes mellitus; Antiplatelet drug; Myocardial infarction; Population; Clopidogrel; Cardiology; Proportional hazards model; Logistic regression; Drug-eluting stent; Percutaneous coronary intervention; Confidence interval; Endocrinology","score_opus":0.02844503236862718,"score_gpt":0.3172608092284102,"score_spread":0.28881577685978305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2751347423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975501,0.00137468,0.00003192869,0.00031355204,0.000195994,0.0003413617,0.000027873859,0.000002536483,0.00016197775],"genre_scores_gemma":[0.99813753,0.0015303835,0.000017178261,0.000052209176,0.00023948797,0.00000755033,0.000004807368,0.000009186899,0.0000016539659],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977691,0.0009064982,0.0003659538,0.00015713643,0.000668704,0.00013259411],"domain_scores_gemma":[0.99776125,0.0011846252,0.0005600839,0.00030559106,0.00015521224,0.000033211658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016617095,0.00015903935,0.00081806816,0.00007020204,0.000098006014,0.000030794243,0.00040545978,0.000052710322,0.000004463803],"category_scores_gemma":[0.00010309944,0.00007236474,0.0002476748,0.000030815747,0.00039416135,0.0001177411,0.00005769497,0.00030908443,1.3880336e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016429166,0.00017421698,0.96370053,0.000008745329,0.005302621,0.00026320928,0.0006065215,0.000062445964,0.001351845,0.0000113072565,0.000015467456,0.026860163],"study_design_scores_gemma":[0.0063879294,0.0033597813,0.9861735,0.0002540291,0.0002466318,0.00018389695,0.0011207671,0.000027747252,0.0020695722,0.00006894836,0.00004200267,0.00006518159],"about_ca_topic_score_codex":0.000072177754,"about_ca_topic_score_gemma":0.0000074345767,"teacher_disagreement_score":0.026794981,"about_ca_system_score_codex":0.000028075881,"about_ca_system_score_gemma":0.000056106855,"threshold_uncertainty_score":0.29509485},"labels":[],"label_agreement":null},{"id":"W2751817513","doi":"10.1161/strokeaha.117.018919","title":"Letter by Spence Regarding Article, “Antiplatelet Regimen for Patients With Breakthrough Strokes While on Aspirin: A Systematic Review and Meta-Analysis”","year":2017,"lang":"en","type":"review","venue":"Stroke","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Aspirin; Medicine; Clopidogrel; Regimen; Stroke (engine); Ticagrelor; Systematic review; Meta-analysis; Platelet aggregation inhibitor; Antiplatelet drug; MEDLINE; Internal medicine; Intensive care medicine","score_opus":0.06675381172225271,"score_gpt":0.32773825307090465,"score_spread":0.26098444134865195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2751817513","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000029012306,0.9914779,0.00016491438,0.00016963884,0.000030815827,0.006567133,0.0010552991,0.000044773577,0.00046051192],"genre_scores_gemma":[0.0002101226,0.99338,0.00018079861,0.0011563849,0.000082491,0.0010293165,0.00059167447,0.00009112016,0.003278081],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9968215,0.00029120836,0.00088100886,0.0008797854,0.0006805102,0.00044596297],"domain_scores_gemma":[0.99664426,0.00019595688,0.0009961426,0.001775297,0.00018297887,0.00020538927],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006176619,0.0007388282,0.009953628,0.00016519833,0.00022340039,0.00013679366,0.0003192843,0.00020004908,0.000084746454],"category_scores_gemma":[0.000121261524,0.00041953308,0.0046372055,0.00019845419,0.00012919786,0.00017378932,0.000058106143,0.00030615943,0.000031475494],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008286877,0.00012602359,0.000022909257,0.59489036,0.39526936,0.000052691466,0.000007297853,2.4541427e-7,6.359854e-8,0.000020323745,0.003971226,0.0055566155],"study_design_scores_gemma":[0.00073924,0.00024177536,0.0000039477854,0.04107162,0.6644791,0.000036260193,0.000002736357,5.1410876e-7,0.0000013518637,0.0000013313922,0.29310074,0.00032141933],"about_ca_topic_score_codex":0.0000061014803,"about_ca_topic_score_gemma":0.0000015720111,"teacher_disagreement_score":0.55381876,"about_ca_system_score_codex":0.000056774446,"about_ca_system_score_gemma":0.00007683582,"threshold_uncertainty_score":0.99982566},"labels":[],"label_agreement":null},{"id":"W2753042161","doi":"10.1016/j.jacc.2017.07.768","title":"Efficacy and Safety of Ticagrelor Over Time in Patients With Prior MI in PEGASUS-TIMI 54","year":2017,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Ticagrelor; Medicine; TIMI; Myocardial infarction; Hazard ratio; Aspirin; Stroke (engine); Internal medicine; Cardiology; Population; Placebo; Thrombolysis; Acute coronary syndrome; Confidence interval","score_opus":0.005093548123033934,"score_gpt":0.23459910706855958,"score_spread":0.22950555894552563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2753042161","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99855274,0.0003592033,0.000015366453,0.00037669763,0.000052698164,0.00023277823,0.000020245972,0.0000011461044,0.00038910672],"genre_scores_gemma":[0.99942577,0.00025704704,0.00014195753,0.00006558274,0.00005873026,9.137219e-7,5.5790906e-7,0.000010865817,0.00003857922],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989154,0.00019616493,0.00038887825,0.000103288854,0.00025495086,0.00014135583],"domain_scores_gemma":[0.99861145,0.000114042705,0.0006941244,0.000387829,0.00013085634,0.00006170838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036664703,0.00010274262,0.0010292392,0.00011715093,0.000040553838,0.0000024466185,0.00020545504,0.00004083609,0.000009395116],"category_scores_gemma":[0.00023774989,0.00006188449,0.0002709104,0.000118122975,0.00069278496,0.000054625754,0.00006449077,0.00017424443,4.290082e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01658834,0.00012614302,0.9762183,0.00003000961,0.00090496993,0.00017220553,0.00004630486,0.0002129926,0.00033187657,0.0000137601055,0.0002613939,0.005093694],"study_design_scores_gemma":[0.009890786,0.0012119983,0.9872625,0.00020680919,0.0002510695,0.00018317091,0.000044051227,0.000009572062,0.00012189412,0.000015311289,0.0007410037,0.00006184146],"about_ca_topic_score_codex":0.00001269144,"about_ca_topic_score_gemma":0.000002905717,"teacher_disagreement_score":0.011044182,"about_ca_system_score_codex":0.000037277,"about_ca_system_score_gemma":0.0001495829,"threshold_uncertainty_score":0.2552595},"labels":[],"label_agreement":null},{"id":"W2754609628","doi":"10.1016/j.cjca.2017.09.002","title":"Antiplatelet Effect of Different Loading Doses of Ticagrelor in Patients With Non–ST-Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: The APELOT Trial","year":2017,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Ticagrelor; Percutaneous coronary intervention; Acute coronary syndrome; Internal medicine; Cardiology; ST elevation; Myocardial infarction","score_opus":0.008349754545694485,"score_gpt":0.23592483863029526,"score_spread":0.22757508408460078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754609628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980584,0.00052127946,0.00015294693,0.00009609542,0.0004754272,0.00053624035,0.00003162404,0.0000022799682,0.00012572718],"genre_scores_gemma":[0.99967015,0.00011870551,0.000010545689,0.00001937032,0.00012265806,0.0000036214637,0.000024292962,0.000018921659,0.000011737079],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985714,0.00028724194,0.00050887046,0.00014322775,0.00024477733,0.0002444729],"domain_scores_gemma":[0.9985409,0.00021882346,0.00051921635,0.0003587097,0.00017454593,0.0001878268],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045906613,0.00017457084,0.0009979481,0.00021034142,0.00013595387,0.000016015,0.00025418657,0.00011773911,0.000025132234],"category_scores_gemma":[0.0001838178,0.000107627995,0.00052435475,0.00006147443,0.0003581651,0.00011052659,0.000022216478,0.0002595307,9.60733e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033474416,0.000028978962,0.94884354,0.000158655,0.0035429127,0.0034777718,0.00010119409,0.00016458053,0.00018141816,0.000017561706,0.000072699804,0.009936292],"study_design_scores_gemma":[0.03255065,0.008440052,0.95088047,0.00068205904,0.0010736812,0.0059451414,0.0000735651,0.00000955938,0.00013951879,0.00003192006,0.00006765324,0.00010573804],"about_ca_topic_score_codex":0.000097016105,"about_ca_topic_score_gemma":0.00019797726,"teacher_disagreement_score":0.009830553,"about_ca_system_score_codex":0.00012276506,"about_ca_system_score_gemma":0.00034735986,"threshold_uncertainty_score":0.4388942},"labels":[],"label_agreement":null},{"id":"W2757327926","doi":"10.5114/aic.2017.70184","title":"Genetic testing in antiplatelet therapy – not effective for perioperative bleeding","year":2017,"lang":"en","type":"editorial","venue":"Advances in Interventional Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Perioperative; Interventional cardiology; Internal medicine; Genetic testing; Cardiology; Surgery","score_opus":0.023674508618850176,"score_gpt":0.3525729512861511,"score_spread":0.32889844266730095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2757327926","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12451818,0.17598884,0.0035113913,0.000073790376,0.6861787,0.005026691,0.00091854966,0.000099259494,0.0036846306],"genre_scores_gemma":[0.5024782,0.016432196,0.0015090712,0.00006900682,0.47547528,0.0024805008,0.00097576267,0.00014202025,0.00043796064],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99728066,0.00033016977,0.0006416139,0.0008543,0.00040331433,0.000489918],"domain_scores_gemma":[0.9970211,0.0017313742,0.00031439637,0.00041610334,0.0004466311,0.00007038907],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009198786,0.0004514296,0.0016615624,0.0003255847,0.00014793577,0.00003986096,0.00031168913,0.0006891504,0.000026326825],"category_scores_gemma":[0.0025117067,0.0004134555,0.0012225604,0.000119703735,0.0003109263,0.0002242208,0.0000866825,0.00082475913,0.0000072153043],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02838472,0.0009092419,0.1343583,0.004068273,0.008024446,0.0051846732,0.00046208865,0.0070779603,0.0012288701,0.00042598328,0.056778785,0.75309664],"study_design_scores_gemma":[0.015503265,0.003066545,0.058006197,0.0033814888,0.0002738638,0.00024908737,0.00009560986,0.00015673607,0.00022670667,0.0009207789,0.91737777,0.0007419489],"about_ca_topic_score_codex":0.00003081124,"about_ca_topic_score_gemma":0.000051056053,"teacher_disagreement_score":0.860599,"about_ca_system_score_codex":0.00025103678,"about_ca_system_score_gemma":0.00025768412,"threshold_uncertainty_score":0.99983174},"labels":[],"label_agreement":null},{"id":"W2757485237","doi":"10.1155/2017/3132063","title":"Platelet Carbonic Anhydrase II, a Forgotten Enzyme, May Be Responsible for Aspirin Resistance","year":2017,"lang":"en","type":"article","venue":"Oxidative Medicine and Cellular Longevity","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"Ministerstwo Edukacji i Nauki","keywords":"Carbonic anhydrase; Enzyme; Aspirin; Biochemistry; Platelet; Chemistry; Medicine; Internal medicine","score_opus":0.042147196322431836,"score_gpt":0.3079840793168856,"score_spread":0.26583688299445374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2757485237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96279484,0.017314464,0.0020660425,0.009865739,0.00018204517,0.0012060074,0.00007850154,0.000070137394,0.006422213],"genre_scores_gemma":[0.9870373,0.0012769748,0.00052934664,0.0013313628,0.0005491634,0.00010074145,0.00017921756,0.00004720848,0.008948708],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979206,0.00013881168,0.00035603644,0.00065746385,0.00045258427,0.00047450428],"domain_scores_gemma":[0.9977753,0.00017771758,0.00025547028,0.0011987912,0.00019702553,0.00039566413],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012010767,0.00036435254,0.0008947243,0.0001305149,0.0010094873,0.00004193998,0.00024723148,0.00017734781,0.00016076799],"category_scores_gemma":[0.0008675856,0.00028214764,0.00031744805,0.00010784424,0.0008192909,0.00022041168,0.00013565378,0.00027851012,0.000004831945],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0435557,0.0024592902,0.06259201,0.006276158,0.008337085,0.007992653,0.007982127,0.000008547503,0.5462483,0.026993835,0.1390236,0.14853066],"study_design_scores_gemma":[0.020154487,0.0024403515,0.021849759,0.001431364,0.0017569873,0.00012942408,0.0009937256,0.00011634163,0.26303527,0.0024439213,0.6847675,0.0008808673],"about_ca_topic_score_codex":0.000089708315,"about_ca_topic_score_gemma":0.00010836596,"teacher_disagreement_score":0.5457439,"about_ca_system_score_codex":0.000051423132,"about_ca_system_score_gemma":0.00021176142,"threshold_uncertainty_score":0.99996305},"labels":[],"label_agreement":null},{"id":"W2760466433","doi":"10.1016/j.cjca.2017.07.216","title":"MANAGEMENT OF STEMI WITH ANTERIOR WALL MOTION ABNORMALITIES USING TRIPLE VERSUS DOUBLE ANTI-THROMBOTIC THERAPY: THE MAGIC MULTICENTER RETROSPECTIVE REGISTRY","year":2017,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Lachine Hospital","funders":"","keywords":"Medicine; Percutaneous coronary intervention; Clinical endpoint; Internal medicine; Myocardial infarction; Retrospective cohort study; TIMI; Acute coronary syndrome; Cardiology; Clinical trial; Surgery","score_opus":0.03434945189263154,"score_gpt":0.2723478497069612,"score_spread":0.23799839781432963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2760466433","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99160755,0.0039401846,0.0007774254,0.00030232934,0.0006001598,0.0002842892,0.000013240388,0.000003491752,0.0024713606],"genre_scores_gemma":[0.99823236,0.0011759285,0.00009586905,0.000045417906,0.00032387013,0.0000017616036,0.0000029581315,0.000017670238,0.000104173545],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99902445,0.000105209394,0.00028236402,0.00013550038,0.00019138676,0.0002611084],"domain_scores_gemma":[0.99861807,0.00001356123,0.00039225642,0.00053645694,0.0002531593,0.00018650947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004231645,0.00013920113,0.00061035354,0.000097650576,0.00023987627,0.000043087748,0.00025348223,0.00007523306,0.000023908666],"category_scores_gemma":[0.000014757946,0.00008875182,0.00038353982,0.00004714283,0.0004922679,0.00013788756,0.000013874414,0.0001903414,0.000001338753],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012987964,0.000035765,0.9451903,0.00036934984,0.01971105,0.0060648564,0.0011114301,0.002528346,0.0010186852,0.0005935694,0.0006843508,0.009704302],"study_design_scores_gemma":[0.017528083,0.00081269676,0.9694967,0.0005235631,0.0013002486,0.0016781895,0.0022566828,0.000052804564,0.00062362227,0.000034719083,0.0055137016,0.0001789558],"about_ca_topic_score_codex":0.0007615872,"about_ca_topic_score_gemma":0.00017195567,"teacher_disagreement_score":0.024306402,"about_ca_system_score_codex":0.00015858425,"about_ca_system_score_gemma":0.00028625084,"threshold_uncertainty_score":0.3619194},"labels":[],"label_agreement":null},{"id":"W2760740884","doi":"10.1182/blood.v114.22.174.174","title":"A Meta-Analysis of Randomized Controlled Trials of Aspirin in Primary Prevention of Cardiovascular Disease.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Aspirin; Relative risk; Stroke (engine); Myocardial infarction; Internal medicine; Meta-analysis; Cochrane Library; Number needed to harm; Randomized controlled trial; Confidence interval; Surgery; Number needed to treat","score_opus":0.0524765519359269,"score_gpt":0.2951564967381479,"score_spread":0.24267994480222102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2760740884","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7492388,0.24652055,0.0012602868,0.00004227461,0.0000127463845,0.002429411,0.000048141817,0.000011240753,0.00043657023],"genre_scores_gemma":[0.99646914,0.0029637048,0.00023764765,0.0000321687,0.00002346095,0.00011019494,0.00008025295,0.000008511995,0.000074937496],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99442834,0.002283934,0.0021480105,0.00023297107,0.0007819802,0.00012473931],"domain_scores_gemma":[0.9976801,0.00057195756,0.0008138279,0.0006617562,0.00019235372,0.0000799759],"candidate_categories":["metaepi_broad"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.010388179,0.00017869603,0.016687855,0.00055399875,0.000008733077,0.000002938755,0.000086137356,0.00007325329,0.00015791373],"category_scores_gemma":[0.001181162,0.000112406626,0.042428877,0.0006179277,0.00008595531,0.00004317602,0.000010751097,0.00005868158,3.5539856e-7],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10344405,0.0018994197,0.0004439923,0.00017942164,0.8895823,0.000026798973,0.00004162443,0.0014063923,0.0012177108,0.00009688868,0.0000014356667,0.0016600107],"study_design_scores_gemma":[0.30469027,0.00010211798,0.0062763146,0.0000410894,0.6858882,0.0000011488023,0.000010161461,0.000043413107,0.0026976054,0.00017480881,0.000013824725,0.000061111765],"about_ca_topic_score_codex":0.000024542353,"about_ca_topic_score_gemma":6.3455695e-7,"teacher_disagreement_score":0.24723034,"about_ca_system_score_codex":0.000008064635,"about_ca_system_score_gemma":0.00013783164,"threshold_uncertainty_score":0.99791044},"labels":[],"label_agreement":null},{"id":"W2761745965","doi":"10.1093/eurheartj/ehx504.3132","title":"3132Casein Kinase 2 is a critical regulator of platelet Ca2+ signaling and activation in arterial thrombosis","year":2017,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Thrombosis; Regulator; Platelet; Platelet activation; Internal medicine; Cardiology; Biochemistry; Gene","score_opus":0.05130053738206339,"score_gpt":0.3285275357164957,"score_spread":0.2772269983344323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2761745965","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99752045,0.00029930996,0.00018763795,0.0012149672,0.000108045795,0.000089488785,0.0000049383475,0.000009041816,0.00056613813],"genre_scores_gemma":[0.99851185,0.000118791984,0.0004346707,0.00032833597,0.0005604737,5.666548e-7,0.0000018936042,0.000022878901,0.00002051818],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99897933,0.00019871276,0.00025355758,0.00015371488,0.0002397525,0.00017495803],"domain_scores_gemma":[0.9993572,0.000045618355,0.000095641735,0.0002627486,0.00006920992,0.00016953729],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063262286,0.00010693023,0.00030480573,0.00008339227,0.00024558438,0.00009778932,0.00007085899,0.00003747708,0.0001845916],"category_scores_gemma":[0.00026179443,0.00009304403,0.00017065318,0.00003239111,0.00015366728,0.00021963542,0.00003496384,0.00022476006,0.000008855264],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033235564,0.00071139616,0.11952771,0.0003912111,0.0007790616,0.002787045,0.002045755,0.000020723506,0.8266254,0.00032941083,0.005550841,0.037907857],"study_design_scores_gemma":[0.0046647685,0.00037060716,0.9213629,0.0009828702,0.00012003439,0.0012264048,0.00024474514,0.000083373474,0.06528661,0.00012342141,0.0053465017,0.0001877992],"about_ca_topic_score_codex":0.000007894488,"about_ca_topic_score_gemma":3.7873386e-7,"teacher_disagreement_score":0.8018352,"about_ca_system_score_codex":0.000018786857,"about_ca_system_score_gemma":0.000050536488,"threshold_uncertainty_score":0.37942255},"labels":[],"label_agreement":null},{"id":"W2762667584","doi":"10.1093/eurheartj/ehx504.3111","title":"3111Genetic variability in PAR4 platelet response in relation to bleeding and ischemic outcomes: a genetic substudy of the TRACER trial","year":2017,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Ministerio de Economía y Competitividad","keywords":"Medicine; Platelet; Internal medicine; Cardiology","score_opus":0.0395750621810101,"score_gpt":0.3120965391548713,"score_spread":0.2725214769738612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2762667584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99776006,0.00043261613,0.000043701508,0.0007869589,0.00017062262,0.00051463983,0.0000014951249,0.0000049181476,0.00028499434],"genre_scores_gemma":[0.99942446,0.00009300852,0.00017130005,0.00012161509,0.00011423505,0.0000028641246,2.1262011e-7,0.000018372093,0.0000539352],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977776,0.0011997279,0.00040281992,0.00018183555,0.00026216698,0.00017589562],"domain_scores_gemma":[0.99912906,0.00015944871,0.00012882506,0.00042980688,0.00003515723,0.00011770417],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004385553,0.000110551475,0.00031923136,0.00009946841,0.00015615691,0.000046031077,0.00013933796,0.00003674388,0.000028870081],"category_scores_gemma":[0.0013327993,0.00007662958,0.0001778355,0.00008750447,0.00007247531,0.000072339244,0.000064892614,0.00033617805,0.0000055125965],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02553671,0.00016361044,0.9614002,0.000017654627,0.000078753495,0.0001935716,0.0010476109,0.00013843854,0.007965751,0.0000013077344,0.00006793562,0.0033884214],"study_design_scores_gemma":[0.017602056,0.00029819572,0.9802988,0.0001441674,0.000053112588,0.00029505292,0.00009189584,0.000043433552,0.0003414961,0.000014216992,0.0007422466,0.000075315555],"about_ca_topic_score_codex":0.000006947821,"about_ca_topic_score_gemma":0.000003648501,"teacher_disagreement_score":0.018898576,"about_ca_system_score_codex":0.000043149863,"about_ca_system_score_gemma":0.000077758275,"threshold_uncertainty_score":0.31248635},"labels":[],"label_agreement":null},{"id":"W2762777438","doi":"10.1093/eurheartj/ehx504.p3968","title":"P3968Does dual-antiplatelet therapy decrease the risk of stroke following coronary artery bypass grafting?","year":2017,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; St Mary's Hospital Centre","funders":"","keywords":"Medicine; Bypass grafting; Cardiology; Artery; Stroke (engine); Internal medicine","score_opus":0.02836797028060281,"score_gpt":0.28293919260478523,"score_spread":0.2545712223241824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2762777438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884513,0.0068670516,0.00010753137,0.000811438,0.0005571786,0.00024195078,0.000021264237,0.00004049641,0.0029017648],"genre_scores_gemma":[0.99373764,0.003876495,0.000245106,0.0006561063,0.0010014513,0.0000017187004,0.0000054771085,0.00006691349,0.00040906563],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974704,0.00087246334,0.00042962685,0.00024121939,0.0006090405,0.00037725206],"domain_scores_gemma":[0.99802625,0.000119408076,0.00040430692,0.00096862315,0.00010730276,0.00037411295],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0023466258,0.00024665525,0.0004997576,0.000080434955,0.0013949979,0.00020722566,0.00033931452,0.000046674657,0.0002144372],"category_scores_gemma":[0.00040323974,0.00014855413,0.00139488,0.00004901796,0.00023525949,0.00024942993,0.00009255076,0.0006385739,0.00006614787],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019031019,0.00035004993,0.90909094,0.000020508262,0.0063002026,0.008769592,0.0007133387,0.000028494707,0.010992943,0.000017309118,0.0056199497,0.0561936],"study_design_scores_gemma":[0.00569288,0.0004234222,0.9440611,0.00020607034,0.0005593657,0.0072270045,0.00035547197,0.00002844914,0.0019847793,0.00004196306,0.039215807,0.00020368773],"about_ca_topic_score_codex":0.000008977739,"about_ca_topic_score_gemma":0.0000011163943,"teacher_disagreement_score":0.055989914,"about_ca_system_score_codex":0.000017216713,"about_ca_system_score_gemma":0.00012722953,"threshold_uncertainty_score":0.99990505},"labels":[],"label_agreement":null},{"id":"W2766048514","doi":"10.1016/j.ahj.2017.10.021","title":"Duration of ischemia and treatment effects of pre- versus in-hospital ticagrelor in patients with ST-segment elevation myocardial infarction: Insights from the ATLANTIC study","year":2017,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Southlake Regional Health Center; Canadian Heart Research Centre; University of Toronto","funders":"","keywords":"Medicine; Ticagrelor; Cardiology; Myocardial infarction; Internal medicine; Ischemia; ST segment; Acute coronary syndrome","score_opus":0.006261336937676879,"score_gpt":0.24655347447061776,"score_spread":0.24029213753294087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766048514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989999,0.00017891519,0.000015614622,0.00012463306,0.000090399844,0.00058032107,0.0000018748673,0.0000021479052,0.000006197154],"genre_scores_gemma":[0.99962485,0.00019288191,0.000054745593,0.000015299916,0.00008547374,0.000012092797,0.0000071905283,0.000006549912,9.4133077e-7],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992143,0.000101049736,0.00021371925,0.000110484296,0.00027850238,0.00008192636],"domain_scores_gemma":[0.9993805,0.00009516131,0.00020550717,0.00020705878,0.000064817636,0.000046935795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000753779,0.000089837726,0.0003177658,0.000045346,0.00008323536,0.000017379303,0.000039464998,0.000017467088,0.0000034168088],"category_scores_gemma":[0.0000618961,0.000053249925,0.00007304009,0.000063417756,0.00013664583,0.00010796506,0.00001340793,0.0000899993,3.2751362e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030395682,0.00072093785,0.98249,0.0000063791167,0.00057519245,0.000013963857,0.001336598,0.000009843386,0.00021032621,0.0000012461973,0.000007664241,0.011588256],"study_design_scores_gemma":[0.009804183,0.0069765123,0.9816899,0.00010961243,0.00025478384,0.0000032698129,0.0006145236,0.000012488354,0.00043175998,0.000003106804,0.000046721103,0.000053187818],"about_ca_topic_score_codex":0.00079998234,"about_ca_topic_score_gemma":0.00006745813,"teacher_disagreement_score":0.011535068,"about_ca_system_score_codex":0.000061850646,"about_ca_system_score_gemma":0.000062296036,"threshold_uncertainty_score":0.2171469},"labels":[],"label_agreement":null},{"id":"W2766257307","doi":"10.1161/circulationaha.117.031164","title":"International Expert Consensus on Switching Platelet P2Y <sub>12</sub> Receptor–Inhibiting Therapies","year":2017,"lang":"en","type":"review","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":385,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Prasugrel; Medicine; Ticagrelor; Cangrelor; Intensive care medicine; Clopidogrel; Modalities; P2Y12; Aspirin; Internal medicine","score_opus":0.08489093925865474,"score_gpt":0.34530321875742254,"score_spread":0.2604122794987678,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766257307","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0080689285,0.9863233,0.000230813,0.00015584036,0.00112509,0.0009847677,0.000040161416,0.00017546365,0.0028956595],"genre_scores_gemma":[0.0423496,0.9543176,0.000068414345,0.00014964938,0.0019565374,0.00008003831,0.00091334584,0.00011598474,0.000048799993],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997595,0.00020615105,0.0006397082,0.00062566,0.00063014677,0.00030334247],"domain_scores_gemma":[0.9982375,0.0001850049,0.00061977876,0.0006937765,0.00012668675,0.00013724636],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004621037,0.00050742785,0.0014174713,0.00028022425,0.0003459176,0.00014765139,0.00021705178,0.00043896836,0.000113596485],"category_scores_gemma":[0.00024802508,0.00043639264,0.001424859,0.000079098936,0.00007664581,0.000109382396,0.000044703356,0.0004892176,0.00022104754],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006922122,0.000063984284,0.000043606917,0.0012236581,0.0015787788,0.00010075707,0.00017654178,0.0000090539115,0.00039209073,0.00008634812,0.0004611935,0.9957948],"study_design_scores_gemma":[0.001059391,0.000035281777,0.00016638522,0.015853131,0.00052945403,0.00034498476,0.00005228957,0.000054028373,0.0002295253,0.000038069105,0.9811741,0.0004633612],"about_ca_topic_score_codex":0.000007886693,"about_ca_topic_score_gemma":8.538812e-7,"teacher_disagreement_score":0.9953314,"about_ca_system_score_codex":0.00025402778,"about_ca_system_score_gemma":0.00021528118,"threshold_uncertainty_score":0.9998088},"labels":[],"label_agreement":null},{"id":"W2766346676","doi":"10.71781/11711","title":"Développement d’une plateforme de criblage par SPR pour la caractérisation d’inhibiteurs de la DHFR R67","year":2017,"lang":"fr","type":"dissertation","venue":"Open MIND","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Natural Sciences and Engineering Research Council of Canada; Université de Montréal","keywords":"Molecular biology; Biology","score_opus":0.026760773690321506,"score_gpt":0.34337337497613996,"score_spread":0.3166126012858185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766346676","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9075001,0.0047357087,0.00044008228,0.0006490047,0.00058649655,0.0012887799,0.00012519937,0.000008249367,0.084666416],"genre_scores_gemma":[0.96100736,0.0058273585,0.0021308614,0.0001265438,0.0008482119,0.00012450265,0.0025251221,0.000129045,0.027281016],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9964724,0.0006933464,0.0006249941,0.0007629605,0.00061554794,0.00083072035],"domain_scores_gemma":[0.99759936,0.00028143683,0.0005755242,0.00087023096,0.00018496175,0.00048848847],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0023980096,0.0006428591,0.000980865,0.00017145785,0.0006496771,0.00066550774,0.0007309018,0.0009115017,0.003606041],"category_scores_gemma":[0.00034253206,0.00063903787,0.000685129,0.00014817566,0.00023511292,0.00045108338,0.000091955444,0.0007128976,0.0011361187],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025358575,0.0010086724,0.04476751,0.00068826025,0.0033549613,0.004264952,0.020517485,0.00020874916,0.030167522,0.00018786817,0.0023638294,0.8899343],"study_design_scores_gemma":[0.010146597,0.0003505468,0.4538091,0.0055596065,0.0049514393,0.00095516135,0.017758971,0.0004503109,0.18036045,0.0005391926,0.32358706,0.0015315447],"about_ca_topic_score_codex":0.0013308622,"about_ca_topic_score_gemma":0.0003673534,"teacher_disagreement_score":0.88840276,"about_ca_system_score_codex":0.00045791673,"about_ca_system_score_gemma":0.0021394822,"threshold_uncertainty_score":0.9996416},"labels":[],"label_agreement":null},{"id":"W2766703403","doi":"10.1161/jaha.117.006577","title":"Double‐Dose Versus Standard‐Dose Clopidogrel According to Smoking Status Among Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention","year":2017,"lang":"en","type":"article","venue":"Journal of the American Heart Association","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute; Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Clopidogrel; Percutaneous coronary intervention; Aspirin; Myocardial infarction; Acute coronary syndrome; Internal medicine; Hazard ratio; Regimen; Cardiology; Ticlopidine; Confidence interval; Anesthesia","score_opus":0.014213269250467661,"score_gpt":0.28975519510329906,"score_spread":0.2755419258528314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766703403","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979714,0.00016344473,0.00008832582,0.0005406208,0.00075146253,0.0003749236,0.00002264787,0.000021431859,0.000065717984],"genre_scores_gemma":[0.99887276,0.0002605725,0.0003313749,0.00020278712,0.0001626423,0.000003682194,0.000007945733,0.000036600097,0.00012163124],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99782354,0.000194629,0.00040770537,0.00018491347,0.0010421856,0.0003470056],"domain_scores_gemma":[0.99761164,0.0001709256,0.0011999503,0.00039347218,0.00041960544,0.00020438185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005901104,0.00018751516,0.000690281,0.00011561054,0.00054504874,0.00014837077,0.00021876667,0.000056455207,0.000016658998],"category_scores_gemma":[0.00034108313,0.00013386528,0.0006562329,0.00015088334,0.00010601956,0.00046684837,0.00010686779,0.00033915194,0.0000037981076],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017738657,0.00012843727,0.96539336,0.000017764247,0.0029686668,0.00020629635,0.00020911141,0.00013708627,0.0000978116,0.0000017818528,0.00029915408,0.012801852],"study_design_scores_gemma":[0.00842602,0.0032211076,0.984723,0.0005082439,0.0012441567,0.00037897425,0.0008895563,0.000014139147,0.000056073517,0.000010768664,0.00036994647,0.00015806138],"about_ca_topic_score_codex":0.000125901,"about_ca_topic_score_gemma":0.00004860589,"teacher_disagreement_score":0.019329572,"about_ca_system_score_codex":0.0012551553,"about_ca_system_score_gemma":0.00024186772,"threshold_uncertainty_score":0.54588675},"labels":[],"label_agreement":null},{"id":"W2766996225","doi":"10.1016/j.jacc.2017.09.128","title":"TCT-76 Impact of Post-Discharge Dual Antiplatelet Therapy vs. Aspirin Alone After CABG in Patients with Left Main Disease: Results from the EXCEL Trial","year":2017,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"","keywords":"Medicine; Aspirin; Internal medicine; Cardiology; Disease; Physical therapy","score_opus":0.009658834362884325,"score_gpt":0.26048518211098814,"score_spread":0.2508263477481038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766996225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99412453,0.0010688634,0.0000119557135,0.0013586505,0.00029213523,0.00075929024,0.0023097626,0.000003825491,0.00007101347],"genre_scores_gemma":[0.99838144,0.0006622402,0.000040028455,0.0002505327,0.0005638785,0.000005686865,0.00002346896,0.000032198994,0.000040531442],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971613,0.0007867841,0.0008136662,0.00024710275,0.0006650771,0.0003260385],"domain_scores_gemma":[0.9959996,0.0002903052,0.0019448631,0.0012243189,0.00036596123,0.00017497008],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008772848,0.0002777509,0.001707678,0.00011886335,0.00012518106,0.000013750315,0.00057141774,0.000077606324,0.000026533831],"category_scores_gemma":[0.0004945408,0.00013161308,0.0015271358,0.00014847858,0.0010673378,0.00013245923,0.000112723515,0.0003849062,0.0000011901701],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.42597258,0.00022357688,0.5675811,0.000007495018,0.002913431,0.00065363274,0.00008338083,0.00015361188,0.00031011258,0.0000019725212,0.0009825815,0.0011164964],"study_design_scores_gemma":[0.07053305,0.004656276,0.9228787,0.00018244598,0.00045485658,0.00022985667,0.00010861408,0.0000036969661,0.00013087875,0.000032764845,0.00064955855,0.00013931295],"about_ca_topic_score_codex":0.00018054432,"about_ca_topic_score_gemma":0.00002222614,"teacher_disagreement_score":0.3554395,"about_ca_system_score_codex":0.00007882727,"about_ca_system_score_gemma":0.0006054908,"threshold_uncertainty_score":0.5367026},"labels":[],"label_agreement":null},{"id":"W2767635514","doi":"","title":"Abstract 13794: An Orally-Active Small-Molecule Antagonist of the Platelet Protease-Activated Receptor-4, BMS-986141, Prevents Aeterial Thrombosis With Low Bleeding Liability in Cynomolgus Monkeys","year":2017,"lang":"en","type":"article","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer","funders":"","keywords":"Medicine; Antagonist; Pharmacology; Platelet; Thrombosis; Orally active; Receptor antagonist; Receptor; Platelet aggregation; Anesthesia; Oral administration; Internal medicine","score_opus":0.026286075560324154,"score_gpt":0.274544260766592,"score_spread":0.24825818520626786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767635514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99753976,0.000025696365,0.00009757946,0.000077004675,0.00016079476,0.0016278209,0.00003502921,0.000039709048,0.00039659278],"genre_scores_gemma":[0.9995086,0.000018197601,0.000108601176,0.000024216004,0.00012304705,0.00006626174,0.00010652659,0.00003719565,0.0000073560277],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99844724,0.00013646999,0.00034800972,0.0004342494,0.00037960554,0.0002544545],"domain_scores_gemma":[0.9984021,0.000021708425,0.00041561245,0.00090493815,0.00014469851,0.00011091255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002812285,0.00023229225,0.00045374795,0.000059997736,0.00031481983,0.000076171484,0.00023983573,0.00016611083,0.000096225456],"category_scores_gemma":[0.000115528564,0.00017505574,0.00022309984,0.00013668292,0.00023293415,0.0004329102,0.00004793575,0.00022089168,0.0000036570013],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00241781,0.0007503629,0.38405234,0.00027517893,0.00047151247,0.000025601288,0.0005658035,0.0003733349,0.6020088,0.000017706281,0.000003804838,0.009037714],"study_design_scores_gemma":[0.0023744775,0.00011807522,0.74033576,0.0003369298,0.00007974942,0.00000889179,0.00009588474,0.00018710313,0.2562452,0.000041178217,0.000017539647,0.00015924075],"about_ca_topic_score_codex":0.00048826108,"about_ca_topic_score_gemma":0.000032153333,"teacher_disagreement_score":0.35628343,"about_ca_system_score_codex":0.0001625885,"about_ca_system_score_gemma":0.00018299006,"threshold_uncertainty_score":0.7138566},"labels":[],"label_agreement":null},{"id":"W2770523298","doi":"10.1007/s11239-017-1581-2","title":"Long-term pharmacodynamic effects of Ticagrelor versus Clopidogrel in fibrinolytic-treated STEMI patients undergoing early PCI","year":2017,"lang":"en","type":"article","venue":"Journal of Thrombosis and Thrombolysis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hamilton Health Sciences; Regina General Hospital; Southlake Regional Health Center; McMaster University; London Health Sciences Centre; St. Michael's Hospital; Regina Qu'Appelle Health Region","funders":"AstraZeneca Canada","keywords":"Medicine; Ticagrelor; Clopidogrel; Conventional PCI; Percutaneous coronary intervention; Internal medicine; Pharmacodynamics; Aspirin; Loading dose; Cardiology; Myocardial infarction; Anesthesia; Pharmacokinetics","score_opus":0.021230844730024376,"score_gpt":0.3053977695932749,"score_spread":0.2841669248632505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2770523298","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967908,0.0022718783,0.000040350245,0.00008543468,0.00037919835,0.0002452095,0.000005880368,0.000008790441,0.00017245454],"genre_scores_gemma":[0.9906784,0.009058101,0.000074318275,0.000023525781,0.000113998525,0.0000023608125,0.000004813421,0.000028321803,0.000016144875],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99833906,0.00009381748,0.00059682253,0.00021733569,0.00048833754,0.00026464576],"domain_scores_gemma":[0.9982831,0.00020673542,0.0007020208,0.00041237677,0.00020424336,0.00019153062],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022785782,0.00023386697,0.0010896332,0.00023462933,0.00015548413,0.00006481277,0.0002149795,0.00011898237,0.000034855413],"category_scores_gemma":[0.00014830078,0.00018453048,0.0006221944,0.00012594678,0.0001901531,0.00035941822,0.00008633042,0.00022860851,0.0000036990948],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007874744,0.00055615936,0.97296697,0.0005285828,0.0040275273,0.00010078466,0.00019373394,0.000005970346,0.0058131884,0.000017260054,0.000017539809,0.014984787],"study_design_scores_gemma":[0.015068169,0.0012014947,0.9733547,0.0013449702,0.0026915437,0.000020278572,0.0000412907,0.00003408929,0.006051537,0.000017623139,0.000007478934,0.00016685619],"about_ca_topic_score_codex":0.000043575823,"about_ca_topic_score_gemma":0.000013861161,"teacher_disagreement_score":0.014817932,"about_ca_system_score_codex":0.00007968601,"about_ca_system_score_gemma":0.00007934128,"threshold_uncertainty_score":0.75249344},"labels":[],"label_agreement":null},{"id":"W2770819426","doi":"10.1161/atvb.36.suppl_1.505","title":"Abstract 505: Circulating Monocyte-Platelet Aggregates are Different Across Phenotypes of Vascular Disease","year":2016,"lang":"en","type":"article","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Berger (Canada)","funders":"","keywords":"Medicine; Interquartile range; Platelet; Internal medicine; Cardiology; Platelet activation; Vascular disease; Coronary artery disease; Abdominal aortic aneurysm; Aspirin; Gastroenterology; Surgery; Aneurysm","score_opus":0.033791556611150006,"score_gpt":0.2873040182700103,"score_spread":0.25351246165886027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2770819426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99487686,0.0033650189,0.0005932688,0.0003691837,0.00013540832,0.00041943986,0.00012353802,0.000091217225,0.000026067964],"genre_scores_gemma":[0.9810418,0.018338911,0.00009149707,0.00022438755,0.00014272075,0.000051690717,0.000051559568,0.000053828197,0.0000035948444],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99773896,0.00014911895,0.00055179605,0.000708662,0.00027342167,0.0005780622],"domain_scores_gemma":[0.9983365,0.000118344375,0.00026943418,0.00077112025,0.00012910695,0.00037550426],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032057724,0.00042878717,0.0011447401,0.000086215245,0.0002176471,0.000033676217,0.00016437391,0.00021964477,0.00024106471],"category_scores_gemma":[0.00008849093,0.00027199858,0.0010019758,0.0001309105,0.00048712848,0.00014282897,0.0001290498,0.00012041924,0.00002352211],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046268364,0.00038144912,0.72511166,0.0002900169,0.0027643593,0.0000021398089,0.000186961,0.0000030735282,0.25138125,0.00018207863,0.00002583643,0.019624913],"study_design_scores_gemma":[0.0032648246,0.00017032263,0.9897596,0.0007829814,0.0004948657,0.0000015355461,0.00017152831,0.000018063873,0.0036074193,0.00018140208,0.0011827361,0.00036470813],"about_ca_topic_score_codex":0.000048580172,"about_ca_topic_score_gemma":0.000010648768,"teacher_disagreement_score":0.26464796,"about_ca_system_score_codex":0.00004060253,"about_ca_system_score_gemma":0.000033301465,"threshold_uncertainty_score":0.99997324},"labels":[],"label_agreement":null},{"id":"W2774600364","doi":"10.1161/circ.132.suppl_3.17348","title":"Abstract 17348: Clinical Outcomes in Acute Coronary Syndrome Patients Following Coronary Artery Bypass Grafting in Relation to Timing of Ticagrelor Discontinuation: Insights From the CAPITAL Registry","year":2015,"lang":"en","type":"article","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Ticagrelor; Discontinuation; Acute coronary syndrome; Intensive care unit; Artery; Anesthesia; Surgery; Myocardial infarction; Internal medicine","score_opus":0.037153477011252746,"score_gpt":0.2955731032315272,"score_spread":0.2584196262202744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2774600364","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981521,0.00036622616,0.00022397263,0.00016780823,0.00033591274,0.00064153946,0.000010989844,0.000024309555,0.000077153294],"genre_scores_gemma":[0.9992241,0.0000110570545,0.00013702482,0.00012779585,0.000050618786,0.000018699006,0.0004024571,0.00001998355,0.000008259744],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99822736,0.00014476341,0.00071991485,0.00029707185,0.00045761833,0.00015327129],"domain_scores_gemma":[0.99903995,0.0002610123,0.0001883335,0.00033314843,0.00007373088,0.000103823295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004106248,0.00014726222,0.0004304612,0.000097187265,0.0000457139,0.000016284548,0.000089918016,0.00014271506,0.000009740296],"category_scores_gemma":[0.0003199502,0.00011803755,0.00027521446,0.00020261838,0.000041543324,0.00032220574,0.000034115943,0.00020743464,0.000017453935],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024008048,0.00023555839,0.9917194,0.000006562477,0.0003562329,0.00023819093,0.0012774924,0.0005479492,0.00009496537,0.000011410956,0.0000140798875,0.005258027],"study_design_scores_gemma":[0.0035363813,0.0000822407,0.9942785,0.00026241032,0.00019674492,0.000017554798,0.0005853766,0.0006957031,0.0000076791275,0.00019998677,0.000008259138,0.00012918744],"about_ca_topic_score_codex":0.00006491569,"about_ca_topic_score_gemma":0.00003404945,"teacher_disagreement_score":0.0051288395,"about_ca_system_score_codex":0.00012533685,"about_ca_system_score_gemma":0.00008802291,"threshold_uncertainty_score":0.48134315},"labels":[],"label_agreement":null},{"id":"W2775297947","doi":"10.1111/jvim.14886","title":"Comparison of Multiplate, Platelet Function Analyzer-200, and Plateletworks in Healthy Dogs Treated with Aspirin and Clopidogrel","year":2017,"lang":"en","type":"article","venue":"Journal of Veterinary Internal Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"College of Veterinary Medicine, North Carolina State University; University of Guelph","keywords":"Clopidogrel; Medicine; Aspirin; Platelet; Crossover study; Adenosine diphosphate; Thromboelastography; Internal medicine; Pharmacology; Epinephrine; Anesthesia; Placebo; Platelet aggregation; Pathology","score_opus":0.04342841940884276,"score_gpt":0.35781684320767965,"score_spread":0.3143884237988369,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2775297947","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902276,0.008203484,0.00046183492,0.00051884435,0.00018061064,0.00019229563,0.0000031558113,0.000008048051,0.00020413178],"genre_scores_gemma":[0.9965896,0.0026730478,0.00020461933,0.0001464337,0.00032212047,0.0000021146318,0.0000045154,0.000021596354,0.00003594668],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982958,0.00008831247,0.000802475,0.00020642074,0.00039205348,0.0002149531],"domain_scores_gemma":[0.9983424,0.000095065734,0.0008590551,0.0002655629,0.00017541707,0.0002625272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053471763,0.00022948257,0.0011547739,0.0003253039,0.00009402146,0.000020165846,0.00013393423,0.0001227503,0.000042878943],"category_scores_gemma":[0.00005930583,0.00014955622,0.00012180923,0.0000877278,0.0004166875,0.00023536057,0.000048819158,0.00048668747,5.223403e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05316102,0.00030581164,0.84295505,0.0003440079,0.0010570167,0.0033468234,0.00046852053,0.000041573483,0.0034887062,0.000007399017,0.000131594,0.09469247],"study_design_scores_gemma":[0.02190034,0.037898704,0.9197997,0.004552239,0.0004605416,0.011061805,0.0005895903,0.0009493351,0.0003159151,0.000021312913,0.0022772795,0.00017327406],"about_ca_topic_score_codex":0.00024114965,"about_ca_topic_score_gemma":0.000022160852,"teacher_disagreement_score":0.09451919,"about_ca_system_score_codex":0.000044210392,"about_ca_system_score_gemma":0.000044156786,"threshold_uncertainty_score":0.6098726},"labels":[],"label_agreement":null},{"id":"W2776894078","doi":"10.1016/j.cjca.2017.12.012","title":"2018 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology Focused Update of the Guidelines for the Use of Antiplatelet Therapy","year":2017,"lang":"en","type":"review","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":212,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital; Women's College Hospital; St. Joseph’s Healthcare Hamilton; University of Ottawa; Vancouver General Hospital; Royal Jubilee Hospital; University of British Columbia; Montreal Heart Institute; Southlake Regional Health Center; Université de Montréal; University of Alberta; Hamilton Health Sciences; University of Toronto; Toronto General Hospital; McMaster University; McMaster University Medical Centre","funders":"Canadian Cardiovascular Society","keywords":"Medicine; Interventional cardiology; Internal medicine; Canadian Cardiovascular Society; Intensive care medicine; Family medicine; Cardiology; Myocardial infarction","score_opus":0.22750251831466115,"score_gpt":0.3559914366473711,"score_spread":0.12848891833270995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2776894078","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00041080636,0.9914529,0.0006691579,0.0009998428,0.0024063124,0.0013938325,0.0025269177,0.0000030376796,0.00013722094],"genre_scores_gemma":[0.012396872,0.98483646,0.00019415675,0.00026646553,0.0018736132,0.000036247857,0.0001525891,0.0000855576,0.00015801909],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99543595,0.001035749,0.0019077007,0.0003483115,0.00050359155,0.00076869107],"domain_scores_gemma":[0.9921145,0.00050752284,0.0022375744,0.0014466565,0.0029392634,0.00075448136],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0036073094,0.000498401,0.005230734,0.000625478,0.00037440704,0.00003442364,0.0011252762,0.0010114617,0.000030925858],"category_scores_gemma":[0.0018524388,0.000310281,0.016091486,0.00029640226,0.00072351244,0.00011433832,0.00003355335,0.00068565726,0.0000022824377],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011721125,0.0000070008723,0.005378088,0.0021272865,0.09189429,0.00016850137,0.00007180144,0.0014231107,0.0000020884545,0.00012027936,0.15110998,0.74758035],"study_design_scores_gemma":[0.0015853931,0.0002264078,0.0019676182,0.002339374,0.008444857,0.0010063715,0.000033608492,0.000008176606,0.0000051930533,0.00004183345,0.98410326,0.00023790958],"about_ca_topic_score_codex":0.1776722,"about_ca_topic_score_gemma":0.22330694,"teacher_disagreement_score":0.83299327,"about_ca_system_score_codex":0.0009181651,"about_ca_system_score_gemma":0.017868074,"threshold_uncertainty_score":0.9999349},"labels":[],"label_agreement":null},{"id":"W2778371664","doi":"10.1016/j.cjca.2017.12.023","title":"Associations Between Complex PCI and Prasugrel or Clopidogrel Use in Patients With Acute Coronary Syndrome Who Undergo PCI: From the PROMETHEUS Study","year":2017,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Daiichi-Sankyo; Eli Lilly and Company","keywords":"Prasugrel; Medicine; Conventional PCI; Clopidogrel; Acute coronary syndrome; Cardiology; Internal medicine; Myocardial infarction","score_opus":0.046321705510865105,"score_gpt":0.2748668087993715,"score_spread":0.22854510328850636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2778371664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99770975,0.00035181217,0.00008388871,0.00068817014,0.00012473739,0.0005429112,0.00042622417,0.000003543401,0.00006897429],"genre_scores_gemma":[0.99934036,0.00009136907,0.00006943312,0.0001739596,0.0001919697,0.000004660428,0.00005987711,0.000020697931,0.0000476953],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986375,0.00035809487,0.000322419,0.00017783012,0.00022663584,0.00027751992],"domain_scores_gemma":[0.9984206,0.00026282083,0.00030794527,0.00043355871,0.00020535091,0.00036970974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040590492,0.00015485987,0.00085842476,0.00012525232,0.00035268167,0.00007531179,0.00025171903,0.000110768124,0.000015136917],"category_scores_gemma":[0.0003127331,0.00009334747,0.00016262625,0.00007542514,0.000285419,0.0001874389,0.00002772448,0.00034012523,0.000001967415],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035100922,0.000014540949,0.98987037,0.0000023355365,0.0046645515,0.0017235862,0.00023741511,0.000015736085,6.1907576e-7,0.0000059716986,0.00069848425,0.0024153986],"study_design_scores_gemma":[0.005983164,0.001398019,0.9884421,0.000069525326,0.0012311859,0.00048311148,0.00022761738,8.601057e-7,2.3370754e-7,0.00006120036,0.001990676,0.00011228386],"about_ca_topic_score_codex":0.0026426087,"about_ca_topic_score_gemma":0.007741888,"teacher_disagreement_score":0.005632155,"about_ca_system_score_codex":0.00013791237,"about_ca_system_score_gemma":0.0008676231,"threshold_uncertainty_score":0.4320155},"labels":[],"label_agreement":null},{"id":"W2780097767","doi":"10.11909/j.issn.1671-5411.2017.11.003","title":"Impact of triple antithrombotic therapy in patients with acute coronary syndrome undergoing percutaneous coronary intervention in real-world practice.","year":2017,"lang":"en","type":"article","venue":"PubMed","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta","funders":"National Institute on Alcohol Abuse and Alcoholism","keywords":"Medicine; Percutaneous coronary intervention; Clopidogrel; Acute coronary syndrome; Conventional PCI; Internal medicine; Hazard ratio; Aspirin; Antithrombotic; Myocardial infarction; Regimen; Cardiology; Confidence interval; Surgery","score_opus":0.01967902538743004,"score_gpt":0.2862200400557723,"score_spread":0.26654101466834224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2780097767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971093,0.0005522041,0.000008658162,0.000062501196,0.000110719804,0.0015871986,0.000017093931,0.00002545804,0.00052685005],"genre_scores_gemma":[0.99794686,0.0015685153,0.000052497293,0.000034154535,0.000013452813,0.00011098691,0.00006099033,0.00003550644,0.00017705887],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99851483,0.00014348114,0.0003404488,0.0002928779,0.00035698875,0.00035134266],"domain_scores_gemma":[0.9988659,0.00006911922,0.0002892797,0.00057537074,0.000085793654,0.000114547984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036359503,0.00019485908,0.00055463816,0.00023276621,0.00007269547,0.00003377315,0.00016511761,0.00007037447,0.000048616334],"category_scores_gemma":[0.00010592943,0.00015042146,0.00031423155,0.00016118001,0.00012381669,0.0004894686,0.000041836298,0.00018702296,0.0000030378494],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008562926,0.0014087273,0.9242397,0.00005238739,0.0014897198,0.0029218863,0.00008061109,0.000028468314,0.000010478095,0.000006278393,0.000014733303,0.061184105],"study_design_scores_gemma":[0.011192755,0.0014051932,0.98584557,0.00022966845,0.0002235253,0.0008231444,0.00005822628,0.000014329186,0.000011761916,0.000025557645,0.0000112625185,0.00015898944],"about_ca_topic_score_codex":0.00078401953,"about_ca_topic_score_gemma":0.00031006974,"teacher_disagreement_score":0.061605908,"about_ca_system_score_codex":0.00025956603,"about_ca_system_score_gemma":0.000110598274,"threshold_uncertainty_score":0.6134009},"labels":[],"label_agreement":null},{"id":"W2782047366","doi":"10.1016/j.accpm.2017.12.012","title":"Management of antiplatelet therapy in patients undergoing elective invasive procedures. Proposals from the French Working Group on perioperative haemostasis (GIHP) and the French Study Group on thrombosis and haemostasis (GFHT). In collaboration with the French Society for Anaesthesia and Intensive Care Medicine (SFAR)","year":2018,"lang":"en","type":"review","venue":"Anaesthesia Critical Care & Pain Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Hemophilia Society; HEC Montréal; Bell Canada Enterprises (Canada)","funders":"","keywords":"Medicine; Discontinuation; Prasugrel; Perioperative; Clopidogrel; Aspirin; Ticagrelor; Thrombosis; Anesthesia; Platelet aggregation inhibitor; Stroke (engine); Coronary artery disease; Surgery; Intensive care medicine; Internal medicine","score_opus":0.03578417650398619,"score_gpt":0.32438435641511204,"score_spread":0.28860017991112585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2782047366","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.32381454,0.66125214,0.000056350822,0.004584264,0.000041724914,0.010157503,0.00004083051,0.000024393463,0.000028229022],"genre_scores_gemma":[0.5094621,0.48651546,0.00008736326,0.0027263393,0.00013229647,0.00079252204,0.00021455,0.00006769598,0.0000016166151],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.99359494,0.0023211255,0.0010282083,0.0013263971,0.001143035,0.000586294],"domain_scores_gemma":[0.993263,0.004146909,0.00039359467,0.0007924771,0.0012285915,0.00017539549],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0023226165,0.0010203101,0.0029977493,0.00023522455,0.0006187935,0.00008766998,0.00036738682,0.00035259663,0.0000092847395],"category_scores_gemma":[0.0013452594,0.00046148838,0.00033876474,0.0011803315,0.0029820672,0.000119658616,0.00009057728,0.0007824226,3.2308972e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023884424,0.0005267487,0.040784396,0.009386613,0.004509867,0.00020614812,0.1082769,0.0000012855022,5.1531674e-7,0.00072694215,0.0014526605,0.8317395],"study_design_scores_gemma":[0.04380907,0.046329726,0.1841718,0.11190128,0.011562608,0.000037693564,0.589577,0.000027477921,0.000007565101,0.00036229574,0.010840124,0.0013733363],"about_ca_topic_score_codex":0.0012355114,"about_ca_topic_score_gemma":0.005350581,"teacher_disagreement_score":0.83036613,"about_ca_system_score_codex":0.00030433986,"about_ca_system_score_gemma":0.0003522611,"threshold_uncertainty_score":0.9997837},"labels":[],"label_agreement":null},{"id":"W2782086424","doi":"","title":"Abstract 19004: The Impact of Dual Antiplatelet Therapy on Mortality: A Patient-Level Meta-Analysis","year":2016,"lang":"en","type":"article","venue":"","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences; University of British Columbia","funders":"","keywords":"Medicine; Clopidogrel; Stroke (engine); Aspirin; Internal medicine; Myocardial infarction; Percutaneous coronary intervention; Randomized controlled trial; Surgery; Cardiology","score_opus":0.1384385603470403,"score_gpt":0.3471274140237105,"score_spread":0.2086888536766702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2782086424","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942603,0.002350534,0.00023869365,0.00041177365,0.000023685685,0.00039753882,0.00024389989,0.00004460699,0.00202896],"genre_scores_gemma":[0.99831104,0.0007704739,0.000025487698,0.0004386506,0.00005079732,0.000021666336,0.000025119702,0.000022644956,0.00033414297],"study_design_codex":"meta_analysis","study_design_gemma":"observational","domain_scores_codex":[0.9982088,0.00012254958,0.00041606367,0.0003228002,0.0006556878,0.0002740512],"domain_scores_gemma":[0.99837583,0.00019935316,0.00016834625,0.0009795292,0.00014074208,0.00013621485],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00043628534,0.00027379693,0.0011726426,0.00015954919,0.00006647013,0.000015987987,0.000121936,0.00008758744,0.006327713],"category_scores_gemma":[0.00003875999,0.00009468486,0.0066716466,0.00042514692,0.00014731714,0.00008506124,0.000020309464,0.000095911346,0.000056010227],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013704763,0.0008148872,0.021797055,0.000010518141,0.92297673,0.00013832666,0.00018754088,0.00014699416,0.0071171965,0.00018907346,0.0013157171,0.043935455],"study_design_scores_gemma":[0.0031803898,0.0010228574,0.8588207,0.0000120659015,0.10939484,0.000037452566,0.00008786339,0.000015905685,0.026123349,0.00018252738,0.00083538593,0.00028667023],"about_ca_topic_score_codex":0.00050186604,"about_ca_topic_score_gemma":0.000014498416,"teacher_disagreement_score":0.8370236,"about_ca_system_score_codex":0.000026570347,"about_ca_system_score_gemma":0.00008752031,"threshold_uncertainty_score":0.9945806},"labels":[],"label_agreement":null},{"id":"W2782320791","doi":"","title":"Clinical Research Use of Clopidogrel Post-Coronary Artery Bypass Surgery in Canadian Patients With Acute Coronary Syndromes","year":2011,"lang":"en","type":"article","venue":"","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Clopidogrel; Medicine; Coronary artery bypass surgery; Cardiology; Internal medicine; Acute coronary syndrome; Randomized controlled trial; Bypass surgery; Artery; Clinical trial; Myocardial infarction","score_opus":0.10591496852005043,"score_gpt":0.3238865792964873,"score_spread":0.21797161077643684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2782320791","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99818724,0.00033182817,0.0000044788826,0.00009575447,0.00012259049,0.00042697514,0.00007010059,0.000026380607,0.0007346223],"genre_scores_gemma":[0.99799997,0.00050454447,0.0002716101,0.00050329376,0.00002867002,0.0000200964,0.0001845264,0.00003639848,0.00045092232],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99755055,0.00036741394,0.00052054744,0.000378272,0.00057304045,0.00061017874],"domain_scores_gemma":[0.9980105,0.00035804784,0.000057924677,0.0005800988,0.00040401093,0.00058941526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000928411,0.00017467831,0.0006393325,0.00048343054,0.00006067533,0.000009283657,0.00012026604,0.00017947005,0.0005899019],"category_scores_gemma":[0.000120727345,0.00013037764,0.00033267416,0.00036384087,0.0003598708,0.00023758062,0.00004327833,0.00034762188,0.000046452606],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028679878,0.000657374,0.97218907,0.000034509227,0.001257028,0.004087319,0.00009261362,2.3748717e-7,0.0000037911232,0.000032741587,0.0012218076,0.01755553],"study_design_scores_gemma":[0.0018256442,0.0009003743,0.99501324,0.00016333237,0.00015501589,0.0002692879,0.00011001717,0.000004068742,0.000022615248,0.000011963418,0.001365249,0.00015921552],"about_ca_topic_score_codex":0.057411544,"about_ca_topic_score_gemma":0.035479624,"teacher_disagreement_score":0.022824155,"about_ca_system_score_codex":0.00008421084,"about_ca_system_score_gemma":0.001219448,"threshold_uncertainty_score":0.98212034},"labels":[],"label_agreement":null},{"id":"W2782843702","doi":"10.1177/2048872617740832","title":"Ischemic and bleeding outcomes after coronary artery bypass grafting among patients initially treated with a P2Y<sub>12</sub> receptor antagonist for acute coronary syndromes: Insights on timing of discontinuation of ticagrelor and clopidogrel prior to surgery","year":2018,"lang":"en","type":"article","venue":"European Heart Journal Acute Cardiovascular Care","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute; University of Ottawa","funders":"Canadian Institutes of Health Research","keywords":"Ticagrelor; Discontinuation; Medicine; Bypass grafting; Cardiology; Internal medicine; Artery; Antagonist; Acute coronary syndrome; Myocardial infarction; Receptor","score_opus":0.01906668889324422,"score_gpt":0.24661226008997789,"score_spread":0.22754557119673366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2782843702","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995192,0.003033535,0.00034135836,0.000035393015,0.00018916055,0.0009755411,0.00011698079,0.00003652101,0.00007954834],"genre_scores_gemma":[0.9975406,0.0011206175,0.00059574464,0.0001821628,0.00029454043,0.00002495512,0.00011818779,0.00011251326,0.0000106690295],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974249,0.00031740256,0.00068232423,0.0005143412,0.00068471796,0.00037630886],"domain_scores_gemma":[0.99821645,0.00013995594,0.000247849,0.00036267,0.0006931351,0.0003399293],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00054218015,0.00040944343,0.0012985244,0.00031091875,0.00027166193,0.000065454195,0.00009162384,0.00009043946,0.0000051519673],"category_scores_gemma":[0.00009044879,0.00031028825,0.0011343719,0.00019936943,0.00029333145,0.00030535916,0.000089423884,0.00023872504,0.0000034292261],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00925086,0.0002729415,0.86579055,0.0005283937,0.036983024,0.0027057691,0.004470286,0.000013628269,0.014552655,0.000001006384,0.00052465126,0.064906225],"study_design_scores_gemma":[0.005899522,0.0024254331,0.9634355,0.0023495299,0.006267797,0.002492196,0.0009142465,0.000012596564,0.014832119,6.200262e-7,0.00089724467,0.0004732505],"about_ca_topic_score_codex":0.0000021160522,"about_ca_topic_score_gemma":9.390655e-7,"teacher_disagreement_score":0.09764489,"about_ca_system_score_codex":0.00007115105,"about_ca_system_score_gemma":0.000078904355,"threshold_uncertainty_score":0.9999349},"labels":[],"label_agreement":null},{"id":"W2783032459","doi":"10.1161/circinterventions.117.005795","title":"Impact of Clopidogrel Therapy on Mortality and Cancer in Patients With Cardiovascular and Cerebrovascular Disease","year":2018,"lang":"en","type":"review","venue":"Circulation Cardiovascular Interventions","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute; University of British Columbia","funders":"","keywords":"Medicine; Clopidogrel; Aspirin; Myocardial infarction; Stroke (engine); Internal medicine; Cancer; Randomized controlled trial; Clinical trial; Surgery; Cardiology","score_opus":0.07837455463407918,"score_gpt":0.3687968541261507,"score_spread":0.29042229949207155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2783032459","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18014489,0.8163354,0.00029849017,0.000002134114,0.000113109716,0.0026897497,0.00034316402,0.00004580667,0.000027285907],"genre_scores_gemma":[0.16873544,0.8301466,0.00002196023,0.0000072852185,0.00017772752,0.0003204911,0.0004576212,0.00012389108,0.000008970396],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9953411,0.0007527601,0.001035886,0.0012099068,0.0012389333,0.0004213847],"domain_scores_gemma":[0.9967304,0.000059925453,0.00033330673,0.0020559428,0.00042011036,0.00040035488],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0009673278,0.0008188829,0.003970735,0.00069751876,0.0001293018,0.00005666451,0.00016795068,0.00035783483,0.00009335433],"category_scores_gemma":[0.00008996833,0.00061029097,0.016597487,0.0007301617,0.00041092566,0.00018596993,0.00008456227,0.00041500668,0.000006631301],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018686533,0.0006863405,0.25180456,0.013980268,0.094948985,0.000032777156,0.000042770145,0.0006340541,2.8056723e-8,0.000022818995,0.000014367279,0.6376462],"study_design_scores_gemma":[0.0057595423,0.00046186193,0.8996356,0.023306238,0.023791721,0.000031887153,0.0000055697583,0.000019135567,2.2485716e-7,0.000015529857,0.04634952,0.00062317745],"about_ca_topic_score_codex":0.0002969971,"about_ca_topic_score_gemma":0.000008304313,"teacher_disagreement_score":0.647831,"about_ca_system_score_codex":0.00032154168,"about_ca_system_score_gemma":0.00039165243,"threshold_uncertainty_score":0.99963486},"labels":[],"label_agreement":null},{"id":"W2784120816","doi":"10.1016/s0140-6736(17)32450-9","title":"Questions regarding the CONCERN trial","year":2018,"lang":"en","type":"letter","venue":"The Lancet","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Aspirin; Celecoxib; Esomeprazole; Internal medicine; Concomitant; Naproxen; Bleed; Randomized controlled trial; Gastroenterology; Upper gastrointestinal bleeding; Surgery; Alternative medicine; Endoscopy","score_opus":0.0636545430381405,"score_gpt":0.3126209688870328,"score_spread":0.24896642584889228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2784120816","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0041908296,0.0061266134,0.00010606225,0.9709116,0.0014030429,0.0009973777,0.00007379221,0.00016078087,0.016029853],"genre_scores_gemma":[0.007538147,0.0013904166,0.000026363954,0.8347375,0.14632623,0.000098751625,0.00017688653,0.000057157475,0.009648567],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985366,0.0003191365,0.00017766905,0.00022854908,0.00041639042,0.0003216897],"domain_scores_gemma":[0.99821275,0.00018571709,0.00009919532,0.0013978075,0.00007410141,0.000030402862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057457254,0.00019927487,0.00066920824,0.000023639597,0.00026781354,0.00006295211,0.00044239537,0.00028179304,0.0003378271],"category_scores_gemma":[0.00012800285,0.000090265115,0.0005808077,0.00009553231,0.00037460178,0.000024267594,0.000052624964,0.0011719113,0.00029492626],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035845789,0.0000075716944,0.000021658763,0.00004137555,0.0008413967,0.00012977076,0.00007118239,4.4286708e-7,0.0000032481369,0.00007232672,0.99382997,0.0013964555],"study_design_scores_gemma":[0.016042924,0.0001238298,0.00009896826,0.00018638221,0.0009156401,0.00014363842,0.000022352784,0.0000048022803,0.000016183696,0.00039325334,0.9819292,0.0001228317],"about_ca_topic_score_codex":0.000023489623,"about_ca_topic_score_gemma":0.0000018873005,"teacher_disagreement_score":0.1449232,"about_ca_system_score_codex":0.00003411163,"about_ca_system_score_gemma":0.0001110332,"threshold_uncertainty_score":0.50914365},"labels":[],"label_agreement":null},{"id":"W2785490330","doi":"10.1160/th17-07-0492","title":"Atherothrombosis and Thromboembolism: Position Paper from the Second Maastricht Consensus Conference on Thrombosis","year":2018,"lang":"en","type":"article","venue":"Thrombosis and Haemostasis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Heart, Lung, and Blood Institute; CARIM School for Cardiovascular Diseases, Universiteit Maastricht; British Heart Foundation","keywords":"Medicine; Thrombus; Thrombosis; Platelet activation; Platelet; Proteases; Disease; Coagulation; Immunology; Bioinformatics; Cardiology; Pathology; Internal medicine; Biology","score_opus":0.05731777908344704,"score_gpt":0.30408484910174866,"score_spread":0.24676707001830162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2785490330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9826009,0.0022708154,0.00006520103,0.008807862,0.00018084317,0.00069583347,0.00043898186,0.00012206479,0.0048174574],"genre_scores_gemma":[0.98484695,0.0050865384,0.00052911596,0.008745356,0.0005057034,0.000038620696,0.00007678403,0.000062704654,0.00010825191],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99767387,0.00022244008,0.00039037465,0.0007636239,0.00048247192,0.0004671975],"domain_scores_gemma":[0.9983084,0.0002855798,0.00014082203,0.0007614005,0.00021013911,0.00029363358],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00031231967,0.00046583553,0.0009210497,0.000076622266,0.00071057526,0.00017977771,0.00016044467,0.00023951799,0.0037432273],"category_scores_gemma":[0.00003827015,0.00032125373,0.00027905783,0.00026346304,0.0012082868,0.00015242898,0.00011453056,0.00029457966,0.00010783848],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047563394,0.0034318564,0.17908254,0.00071301777,0.029949652,0.0001326817,0.020632332,0.0000021238523,0.19501986,0.04259437,0.16679941,0.35688582],"study_design_scores_gemma":[0.004626803,0.0011717582,0.9484856,0.00044737174,0.0021170648,0.000078791854,0.0021341864,0.000079577294,0.016274069,0.003075315,0.020838354,0.0006710887],"about_ca_topic_score_codex":0.00028298007,"about_ca_topic_score_gemma":0.00012676526,"teacher_disagreement_score":0.7694031,"about_ca_system_score_codex":0.00004460109,"about_ca_system_score_gemma":0.00007936801,"threshold_uncertainty_score":0.99992394},"labels":[],"label_agreement":null},{"id":"W2786978571","doi":"10.1016/j.ijcard.2017.10.103","title":"Development and external validation of a post-discharge bleeding risk score in patients with acute coronary syndrome: The BleeMACS score","year":2018,"lang":"en","type":"article","venue":"International Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta","funders":"","keywords":"Medicine; Conventional PCI; Acute coronary syndrome; Percutaneous coronary intervention; Internal medicine; Framingham Risk Score; Cohort; Population; Antithrombotic; Surgery; Myocardial infarction; Disease","score_opus":0.011368107282917346,"score_gpt":0.25105344787459355,"score_spread":0.2396853405916762,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2786978571","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99760646,0.00041773025,0.0013230663,0.00010239961,0.00030910978,0.00015198166,0.000016438129,0.000003268329,0.00006956292],"genre_scores_gemma":[0.9988225,0.0002519825,0.0005992379,0.00009178882,0.00019560364,0.0000029760574,0.000015894886,0.000010025876,0.0000099756235],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988327,0.00008885286,0.00037480125,0.000113130525,0.0004760367,0.00011448089],"domain_scores_gemma":[0.9987235,0.00004642934,0.0003191724,0.000091015885,0.00076440553,0.000055496028],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042545868,0.000103587496,0.00034225066,0.00017346871,0.000041363757,0.000011061276,0.0001544834,0.000053436655,0.000024401972],"category_scores_gemma":[0.000048387705,0.0000627285,0.00013358382,0.00006766929,0.00017704797,0.00012961755,0.000048137994,0.00017303256,0.0000022356564],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003137692,0.00004871887,0.9811976,0.000009077111,0.002962793,0.00046474265,0.00028262453,0.000045574463,0.00046611723,0.000044209035,0.000016317126,0.011324542],"study_design_scores_gemma":[0.0036069255,0.0009048665,0.9880648,0.0002901169,0.00029936235,0.0049195425,0.00010539153,0.0000068341847,0.0013927507,0.000061250226,0.00028166838,0.00006646847],"about_ca_topic_score_codex":0.0000041042535,"about_ca_topic_score_gemma":0.0000013068311,"teacher_disagreement_score":0.011258073,"about_ca_system_score_codex":0.000056788005,"about_ca_system_score_gemma":0.00014624587,"threshold_uncertainty_score":0.25579938},"labels":[],"label_agreement":null},{"id":"W2787972950","doi":"10.1016/j.jvs.2018.01.019","title":"Rivaroxaban in peripheral artery disease: The new kid on the block?","year":2018,"lang":"en","type":"editorial","venue":"Journal of Vascular Surgery","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Arterial disease; Peripheral; Rivaroxaban; Block (permutation group theory); Internal medicine; Vascular disease; Warfarin; Combinatorics","score_opus":0.011546223664015236,"score_gpt":0.24379676106906084,"score_spread":0.23225053740504562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2787972950","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11124197,0.056582827,0.00009532763,0.0070955525,0.823795,0.0007954617,0.000049489063,0.000041887117,0.00030248682],"genre_scores_gemma":[0.039651837,0.015303498,0.000014385727,0.0013514602,0.94263744,0.000014592907,0.00005533845,0.00013203188,0.0008394087],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9948381,0.0007502728,0.000987484,0.00034841994,0.0026017013,0.0004740187],"domain_scores_gemma":[0.9952058,0.0019568345,0.000637026,0.0012002388,0.0005386832,0.0004614004],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003422695,0.0004900583,0.0013993913,0.00031957918,0.00017158478,0.00012259046,0.00049835513,0.00043275236,0.00038284616],"category_scores_gemma":[0.0029910307,0.0002484008,0.004506659,0.00036286423,0.0002415488,0.000117101314,0.000058750207,0.0017761182,0.000042512078],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013458462,0.00023380967,0.0008390599,0.00009297793,0.0031148465,0.0018121419,0.00010374924,0.000025344762,0.0000068413383,0.000007136017,0.9882918,0.0041264477],"study_design_scores_gemma":[0.0013300525,0.00015896604,0.0058266986,0.0017906767,0.0013987728,0.00015847129,0.00007819763,0.000009584446,0.000018397084,0.00013174009,0.9888169,0.00028153014],"about_ca_topic_score_codex":0.000024379933,"about_ca_topic_score_gemma":0.0000075393746,"teacher_disagreement_score":0.11884244,"about_ca_system_score_codex":0.00019096579,"about_ca_system_score_gemma":0.0027287886,"threshold_uncertainty_score":0.99999684},"labels":[],"label_agreement":null},{"id":"W2789265301","doi":"10.1097/mca.0000000000000605","title":"Rivaroxaban with or without aspirin for prevention of cardiovascular disease","year":2018,"lang":"en","type":"editorial","venue":"Coronary Artery Disease","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hamilton General Hospital; Hamilton Health Sciences; Population Health Research Institute; McMaster University","funders":"Haematology Society of Australia and New Zealand; Hamilton Health Sciences; Heart and Stroke Foundation of Canada; Bayer; AstraZeneca","keywords":"Medicine; Rivaroxaban; Stroke (engine); Aspirin; Family medicine; Population; General surgery; Internal medicine; Warfarin; Environmental health","score_opus":0.017533041118710343,"score_gpt":0.2731916629350487,"score_spread":0.25565862181633836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789265301","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24365251,0.09855806,0.02279672,0.00023178192,0.60007286,0.020883732,0.012274936,0.0010160769,0.0005133323],"genre_scores_gemma":[0.25465414,0.0038247416,0.000822871,0.00019531079,0.71294695,0.0019321963,0.016312398,0.0005703481,0.008741057],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957278,0.0002231088,0.00061518984,0.0011773895,0.0017102287,0.0005462792],"domain_scores_gemma":[0.9952713,0.00017646086,0.00029340165,0.0021714785,0.00092673476,0.0011606154],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00038409652,0.0007362816,0.0016791088,0.00019875045,0.00017538451,0.000038819784,0.0003366904,0.00035747897,0.00024621273],"category_scores_gemma":[0.00035849513,0.0005540524,0.0028997066,0.00019564586,0.00047683122,0.00024134883,0.000086976106,0.00030996016,0.000034217494],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14511128,0.0025193843,0.0058198418,0.010710795,0.030579463,0.0031447196,0.00008980072,0.00014205978,0.000011266071,0.000011585519,0.76849693,0.033362858],"study_design_scores_gemma":[0.011376031,0.0027930716,0.00650923,0.0031897288,0.029405091,0.000040574927,0.000049864815,0.00016697182,0.000026857646,0.00015357074,0.945426,0.0008630405],"about_ca_topic_score_codex":0.000005869877,"about_ca_topic_score_gemma":0.0000028084826,"teacher_disagreement_score":0.17692901,"about_ca_system_score_codex":0.00011126672,"about_ca_system_score_gemma":0.0023051526,"threshold_uncertainty_score":0.99969107},"labels":[],"label_agreement":null},{"id":"W2790418998","doi":"10.1007/s11883-018-0717-y","title":"Weighing the Anti-Ischemic Benefits and Bleeding Risks from Aspirin Therapy: a Rational Approach","year":2018,"lang":"en","type":"review","venue":"Current Atherosclerosis Reports","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Aspirin; Medicine; Intensive care medicine; Myocardial infarction; Clinical trial; Stroke (engine); Randomized controlled trial; Primary prevention; Disease; Physical therapy; Internal medicine","score_opus":0.17621862302115987,"score_gpt":0.3498015454083408,"score_spread":0.17358292238718093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790418998","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.035373926,0.96155894,0.00012936004,0.000015062001,0.0009760445,0.001577236,0.0000723639,0.00012467819,0.0001723781],"genre_scores_gemma":[0.005578569,0.99077487,0.000111444,0.000047998987,0.002078243,0.00031846238,0.00091989205,0.00014256769,0.000027968663],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963635,0.00020353205,0.0010395343,0.0011650294,0.0007847016,0.00044367104],"domain_scores_gemma":[0.9975247,0.00014605596,0.0008662121,0.0010887957,0.00014142666,0.00023285583],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008231414,0.0007663231,0.0020330236,0.0000974816,0.00040934718,0.00019982054,0.00022602546,0.00038215445,0.00009446442],"category_scores_gemma":[0.00007188184,0.00047228913,0.0015560723,0.00032330287,0.00029434584,0.00014484093,0.00016678912,0.0007023191,0.000020749707],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016018297,0.00023327532,0.0021876502,0.0018860723,0.001835563,0.000014221845,0.00017725333,0.0000012358338,0.000023738603,0.000010999519,0.0012733985,0.99234056],"study_design_scores_gemma":[0.00058984343,0.000049138293,0.0023332364,0.0160951,0.0026701414,0.0003503989,0.000026011508,0.00001870609,0.00003406039,0.000012653277,0.9772904,0.0005303258],"about_ca_topic_score_codex":0.000022919738,"about_ca_topic_score_gemma":3.6106064e-7,"teacher_disagreement_score":0.99181026,"about_ca_system_score_codex":0.000086139386,"about_ca_system_score_gemma":0.0002976295,"threshold_uncertainty_score":0.9997729},"labels":[],"label_agreement":null},{"id":"W2790425144","doi":"10.1016/s0735-1097(18)31738-8","title":"OUTCOMES OF SWITCHING P2Y12 INHIBITORS IN PATIENTS WHO UNDERWENT PERCUTANEOUS CORONARY INTERVENTION: A RETROSPECTIVE COHORT STUDY","year":2018,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Prasugrel; Ticagrelor; P2Y12; Clopidogrel; Percutaneous coronary intervention; Internal medicine; Incidence (geometry); Cohort; Retrospective cohort study; Acute coronary syndrome; Cardiology; Aspirin; Myocardial infarction","score_opus":0.006760907565190616,"score_gpt":0.26073126221613613,"score_spread":0.25397035465094553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790425144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983032,0.00024889945,0.00008189416,0.000120288816,0.00044511916,0.00052859774,0.000020269359,0.0000035918179,0.0002481748],"genre_scores_gemma":[0.99956673,0.00007417225,0.000045313107,0.00008051478,0.00017695069,0.0000026881526,5.965701e-7,0.00001545275,0.000037565547],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99786097,0.00054055196,0.00075217354,0.0001558894,0.0005300492,0.00016039444],"domain_scores_gemma":[0.99813277,0.000082816325,0.0009009007,0.000337809,0.00048268648,0.0000630461],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071154116,0.00014666484,0.0015803324,0.00019059997,0.00004573348,0.0000019637152,0.00021380311,0.000042167227,0.000014195541],"category_scores_gemma":[0.00020503796,0.000094883966,0.0010137977,0.0003380248,0.00043810034,0.000049904116,0.00009877458,0.00024237184,6.306755e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023958737,0.00039335576,0.99174297,0.000014535936,0.0032135656,0.0002959696,0.00017272361,0.000042565152,0.00012481182,0.000009110276,0.00026816488,0.0013263437],"study_design_scores_gemma":[0.00288728,0.006394179,0.9861215,0.00013412518,0.00061401486,0.0010411371,0.0024797965,0.000004737811,0.000095835785,0.000066448716,0.00008374036,0.00007720314],"about_ca_topic_score_codex":0.00003578426,"about_ca_topic_score_gemma":0.0000145206495,"teacher_disagreement_score":0.0060008233,"about_ca_system_score_codex":0.00020347124,"about_ca_system_score_gemma":0.00011163284,"threshold_uncertainty_score":0.38692558},"labels":[],"label_agreement":null},{"id":"W2790583333","doi":"10.1016/j.ahj.2018.02.011","title":"Caffeine and incidence of dyspnea in patients treated with ticagrelor","year":2018,"lang":"en","type":"letter","venue":"American Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bristol-Myers Squibb Canada; Medtronic; GlaxoSmithKline; AstraZeneca; Stiftelsen Erik and Lily Philipsons Minnesfond; Medicines Company; Pfizer","keywords":"Medicine; Ejection fraction; Conventional PCI; Cardiology; Internal medicine; Percutaneous coronary intervention; Placebo; Myocardial infarction; Ticagrelor; Clinical endpoint; Randomized controlled trial; Heart failure","score_opus":0.007850150070981488,"score_gpt":0.24314134775137766,"score_spread":0.23529119768039616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790583333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98004234,0.000617426,0.000012053729,0.01898024,0.000034856013,0.00020914346,0.000012899595,0.000009849782,0.000081201084],"genre_scores_gemma":[0.8896855,0.0006578926,0.00045058117,0.107806176,0.0011336643,0.0000053946674,0.000047302678,0.000057630503,0.00015581984],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985381,0.0001437627,0.0003092944,0.0002218277,0.0005099693,0.00027709393],"domain_scores_gemma":[0.9991427,0.00005742792,0.00021627556,0.00023870957,0.00021379,0.00013110031],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000150041,0.00021488777,0.00086733315,0.00021817989,0.00004536883,0.000015288428,0.00006951908,0.000114038674,0.000092665534],"category_scores_gemma":[0.000042937787,0.00014860193,0.00017187514,0.00025734995,0.0006138527,0.000057280813,0.000020244726,0.0007820961,0.00000758074],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008381767,0.00009947378,0.8727255,0.0000873988,0.0006320811,0.001168095,0.00007698889,4.942521e-7,0.00003022329,1.263804e-7,0.11566545,0.008675977],"study_design_scores_gemma":[0.003168979,0.005357287,0.87019396,0.001066066,0.0006200228,0.0023717447,0.00005842337,0.0000071048685,0.00014359439,0.0000043174355,0.116709135,0.00029937274],"about_ca_topic_score_codex":0.0001553866,"about_ca_topic_score_gemma":0.0000040803625,"teacher_disagreement_score":0.09035679,"about_ca_system_score_codex":0.00005235862,"about_ca_system_score_gemma":0.00014416219,"threshold_uncertainty_score":0.6059811},"labels":[],"label_agreement":null},{"id":"W2790704012","doi":"10.1016/j.cct.2018.03.008","title":"Impact of ticagrelor versus aspirin on graft patency after CABG: Rationale and design of the TARGET (ticagrelor antiplatelet therapy to reduce graft events and thrombosis) randomized controlled trial (NCT02053909)","year":2018,"lang":"en","type":"article","venue":"Contemporary Clinical Trials","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"University of Ottawa","keywords":"Medicine; Ticagrelor; Aspirin; Thrombosis; Surgery; Randomized controlled trial; Coronary artery bypass surgery; Cardiology; Stenosis; Coronary artery disease; Artery; Clopidogrel; Internal medicine; Anesthesia","score_opus":0.2418584243529774,"score_gpt":0.45253890158526194,"score_spread":0.21068047723228453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790704012","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97797126,0.004249989,0.00044854856,0.00080787373,0.0010937563,0.015136419,0.00009663905,0.00002715657,0.00016838145],"genre_scores_gemma":[0.99577916,0.0021672756,0.00032662752,0.00040307382,0.00077846803,0.00038635984,0.000020121633,0.000039461196,0.00009944286],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9885788,0.0070105856,0.0029219838,0.00058490096,0.0006285982,0.0002751437],"domain_scores_gemma":[0.9855578,0.0119733205,0.001037821,0.00068957085,0.00039295855,0.00034854136],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.014547545,0.00041545392,0.0051355483,0.00013513539,0.0000979962,0.000024861023,0.00019815072,0.00030268278,0.00024000769],"category_scores_gemma":[0.014776531,0.00021361241,0.0029026533,0.00023258412,0.0008747336,0.00011950501,0.00007286789,0.0002510357,0.00001022346],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98279744,0.0009206513,0.0033904498,0.000026681504,0.007288146,0.000010930275,0.00013238982,0.0000032735372,0.0010845109,0.000048029757,0.0008118922,0.0034855767],"study_design_scores_gemma":[0.96294236,0.009832742,0.023193756,0.00032291087,0.0010780947,0.0000046120576,0.00002740579,0.000070656366,0.0014185217,0.0006000319,0.00027248007,0.00023642473],"about_ca_topic_score_codex":0.000021491844,"about_ca_topic_score_gemma":4.14704e-7,"teacher_disagreement_score":0.019855104,"about_ca_system_score_codex":0.000020093396,"about_ca_system_score_gemma":0.00055096333,"threshold_uncertainty_score":0.9935224},"labels":[],"label_agreement":null},{"id":"W2792635961","doi":"10.1161/circ.132.suppl_3.17121","title":"Abstract 17121: Reduction in Total Cardiovascular Events With Long-term Use of Ticagrelor in Patients With Prior Myocardial Infarction in the PEGASUS-TIMI 54 Trial","year":2015,"lang":"en","type":"article","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"","keywords":"Ticagrelor; Medicine; TIMI; Myocardial infarction; Aspirin; Internal medicine; Hazard ratio; Placebo; Cardiology; Stroke (engine); Clinical endpoint; Discontinuation; Acute coronary syndrome; Adverse effect; Randomized controlled trial; Percutaneous coronary intervention; Confidence interval","score_opus":0.027729747940440787,"score_gpt":0.24179266924508722,"score_spread":0.21406292130464644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792635961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99755204,0.00024963028,0.00016559992,0.000028521532,0.00014780466,0.0018053127,0.0000034664886,0.000014380757,0.000033244592],"genre_scores_gemma":[0.99955297,0.000022632923,0.000036408896,0.0000131613915,0.00014270633,0.00005686524,0.00015195958,0.000021187694,0.0000020923442],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99814135,0.00021342178,0.00035904354,0.0002800393,0.0008185016,0.00018766228],"domain_scores_gemma":[0.99926484,0.000026163016,0.00011344625,0.0003881654,0.00014550243,0.000061872495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006142689,0.00015890782,0.00040650857,0.00023874885,0.000026005946,0.000017718647,0.000050999068,0.00011532377,0.0000061418154],"category_scores_gemma":[0.00007823445,0.000112992464,0.0002615872,0.00046502842,0.000056595924,0.00039404852,0.00000900726,0.00019353817,0.0000029785017],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025207683,0.00058615755,0.94229245,0.000050922365,0.0004779555,0.000032730986,0.00078494544,0.017208563,0.000032634984,0.000004041881,0.0000032163398,0.013318689],"study_design_scores_gemma":[0.048169877,0.00034196378,0.9505837,0.00021513269,0.0002966214,0.00003453113,0.00011104856,0.000075382624,0.000021257752,0.000008428189,0.000015082864,0.00012696945],"about_ca_topic_score_codex":0.00019300824,"about_ca_topic_score_gemma":0.000026754133,"teacher_disagreement_score":0.022962194,"about_ca_system_score_codex":0.000200901,"about_ca_system_score_gemma":0.00015105685,"threshold_uncertainty_score":0.4607699},"labels":[],"label_agreement":null},{"id":"W2794178834","doi":"10.1161/circoutcomes.117.004194","title":"Clinical Outcomes of Plavix and Generic Clopidogrel for Patients Hospitalized With an Acute Coronary Syndrome","year":2018,"lang":"en","type":"article","venue":"Circulation Cardiovascular Quality and Outcomes","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre","funders":"Institute for Clinical Evaluative Sciences","keywords":"Clopidogrel; Medicine; Acute coronary syndrome; Hazard ratio; Myocardial infarction; Internal medicine; Confidence interval; Propensity score matching; Stroke (engine); Population; Proportional hazards model; Cardiology; Emergency medicine","score_opus":0.044785945541038735,"score_gpt":0.3428603959327899,"score_spread":0.2980744503917512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2794178834","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905187,0.0012675177,0.0067019146,0.00007564709,0.00018426638,0.001082481,0.00008293649,0.000065286105,0.00002127575],"genre_scores_gemma":[0.99648815,0.0004981621,0.0021809237,0.00044187825,0.000072394374,0.000042470438,0.00021421704,0.00003925364,0.000022561104],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975879,0.0003232828,0.0006798191,0.0005754735,0.0005831852,0.00025033258],"domain_scores_gemma":[0.9983132,0.00014078694,0.00018913753,0.00073334255,0.0003749581,0.00024857925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011364091,0.0002858292,0.0015544613,0.00009457411,0.00017996233,0.000026548052,0.000081605474,0.0001973751,0.000011517552],"category_scores_gemma":[0.00013739953,0.0002139905,0.0013465444,0.00013842655,0.000508648,0.00023241248,0.000041315183,0.000096059855,0.0000018763445],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006211175,0.00023797489,0.9671337,0.00016602254,0.01212387,0.000017853152,0.00012340867,0.0000073890074,0.0000045388642,0.00019623942,0.000005536428,0.01936234],"study_design_scores_gemma":[0.010116232,0.0012662661,0.9841539,0.000038489692,0.0032500143,0.000101541926,0.00006593718,0.000063418694,0.000010414366,0.00017607278,0.00045989148,0.00029778792],"about_ca_topic_score_codex":0.00003330899,"about_ca_topic_score_gemma":0.0000019466816,"teacher_disagreement_score":0.019064553,"about_ca_system_score_codex":0.000021992428,"about_ca_system_score_gemma":0.00006318757,"threshold_uncertainty_score":0.8726279},"labels":[],"label_agreement":null},{"id":"W2794542610","doi":"10.1093/eurheartj/ehx493.5769","title":"5769Changes in thromboembolic risk profile and antithrombotic therapy use over a decade: a comparison of Euro Heart Survey on AF and EURObservational research programme AF pilot registry","year":2017,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact","funders":"Det Obelske Familiefond; European Society of Cardiology","keywords":"Medicine; Antithrombotic; Fibrinolytic agent; Cardiology; Internal medicine; Intensive care medicine","score_opus":0.34397833751086754,"score_gpt":0.4301195195721723,"score_spread":0.08614118206130478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2794542610","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99464816,0.0039748433,0.000009866938,0.00049506844,0.000092057184,0.0005067032,0.000037525966,0.000018567618,0.00021718183],"genre_scores_gemma":[0.9944198,0.0045495173,0.00039524294,0.00020003089,0.0002685045,0.000003683465,0.000015653957,0.000057254936,0.0000903114],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995972,0.0020993722,0.00039149728,0.0003730369,0.00072756776,0.00043651884],"domain_scores_gemma":[0.9982805,0.00035746998,0.000240091,0.0005687689,0.00026160912,0.0002915179],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043057394,0.00020813137,0.00061940996,0.0002108004,0.0006406259,0.0003256017,0.00017712673,0.00005110375,0.00005297921],"category_scores_gemma":[0.0010888273,0.0001683903,0.00012871981,0.00016874913,0.0005133849,0.00026894783,0.000108643064,0.0009369341,0.000013765899],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010373525,0.00060614274,0.98748374,0.000047699814,0.000179597,0.00013011495,0.0003212766,0.0000050617214,0.0018964651,0.000024657305,0.004090225,0.0041776453],"study_design_scores_gemma":[0.0036663003,0.0019587195,0.9870011,0.00043111516,0.000033676548,0.00030912063,0.00007419842,0.000084285486,0.00035177384,0.00002530211,0.005923151,0.00014123828],"about_ca_topic_score_codex":0.00032670077,"about_ca_topic_score_gemma":0.00007462026,"teacher_disagreement_score":0.004036407,"about_ca_system_score_codex":0.00002846952,"about_ca_system_score_gemma":0.000121124474,"threshold_uncertainty_score":0.6866757},"labels":[],"label_agreement":null},{"id":"W2794549158","doi":"10.1093/eurheartj/ehx504.p3698","title":"P3698Impact of triple antithrombotic therapy in patients with acute coronary syndrome undergoing percutaneous coronary intervention in real-world practice","year":2017,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta","funders":"","keywords":"Medicine; Percutaneous coronary intervention; Antithrombotic; Acute coronary syndrome; Cardiology; Internal medicine; Intervention (counseling); Myocardial infarction; Nursing","score_opus":0.028502695561365577,"score_gpt":0.31256511782929935,"score_spread":0.28406242226793377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2794549158","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99709576,0.000762207,0.000026811551,0.00019925048,0.00018900857,0.00036995843,0.0000058741584,0.000016196722,0.0013349262],"genre_scores_gemma":[0.9966855,0.0025232132,0.00034093356,0.00014639461,0.000048097223,7.843805e-7,0.00001344718,0.00005232054,0.00018932737],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99800485,0.00063015404,0.00042990048,0.00021728015,0.0004399227,0.00027789216],"domain_scores_gemma":[0.9988774,0.00007141026,0.00035575152,0.00043568516,0.00011040149,0.00014936195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009370425,0.00018380933,0.00048638755,0.00024533016,0.00018357125,0.00007555998,0.0001772486,0.000031693144,0.00013680392],"category_scores_gemma":[0.000118224794,0.00014439102,0.0002672508,0.000121680176,0.00011455203,0.0005720793,0.000045917044,0.00045176345,0.000018708928],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059070573,0.0009701147,0.96477824,0.000039319802,0.00070044235,0.019641196,0.00021167487,0.00004786631,0.00017170774,0.000004323907,0.00010873039,0.0074193054],"study_design_scores_gemma":[0.009339247,0.003268593,0.96712077,0.0011353095,0.00014809679,0.018386828,0.00015771718,0.000014005404,0.00001870944,0.000008972652,0.00025534944,0.00014639054],"about_ca_topic_score_codex":0.000063808686,"about_ca_topic_score_gemma":0.00004584329,"teacher_disagreement_score":0.007272915,"about_ca_system_score_codex":0.00012274302,"about_ca_system_score_gemma":0.00013433676,"threshold_uncertainty_score":0.5888095},"labels":[],"label_agreement":null},{"id":"W2795179713","doi":"10.1097/meg.0000000000001125","title":"Reduction in postpercutaneous coronary intervention angina in addition to gastrointestinal events in patients on combined proton pump inhibitors and dual antiplatelet therapy: a systematic review and meta-analysis","year":2018,"lang":"en","type":"review","venue":"European Journal of Gastroenterology & Hepatology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Capital District Health Authority","funders":"","keywords":"Medicine; Internal medicine; Percutaneous coronary intervention; Conventional PCI; Odds ratio; Myocardial infarction; Randomized controlled trial; Acute coronary syndrome; Clopidogrel; Coronary artery disease; Cardiology; Unstable angina; Angina; Meta-analysis; Stroke (engine)","score_opus":0.027058914564583595,"score_gpt":0.28148016756544886,"score_spread":0.25442125300086527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2795179713","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.49613497,0.5008716,0.000013113532,0.00012987028,0.00006341516,0.0027490088,0.000027727809,0.0000068800678,0.0000034225623],"genre_scores_gemma":[0.31541216,0.6838147,0.000070260045,0.00037492765,0.000036562546,0.00008964236,0.00014267677,0.000052591462,0.0000064734168],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99055076,0.00608414,0.0021915014,0.0005201425,0.00027366052,0.00037981773],"domain_scores_gemma":[0.9980537,0.000069867376,0.0012329804,0.00031078563,0.00016257336,0.00017005482],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0022802535,0.0005061896,0.0059424792,0.0017090025,0.000029798446,0.00000994456,0.00015185225,0.00009995251,0.000045584708],"category_scores_gemma":[0.00015256499,0.00037341716,0.0014394365,0.000471383,0.00012709809,0.00009850753,0.000080068814,0.0006739955,0.000008145144],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.036914025,0.007150198,0.29134768,0.45589918,0.1574095,0.030379383,0.0004790421,0.000014214925,0.000006713743,0.0000041121534,0.00024892093,0.020147035],"study_design_scores_gemma":[0.017772282,0.077302516,0.08632139,0.25858974,0.43429878,0.123495676,0.00009752129,0.0000091926895,0.0000019946592,0.000009885029,0.0013177751,0.00078325707],"about_ca_topic_score_codex":0.00000715918,"about_ca_topic_score_gemma":0.000020450216,"teacher_disagreement_score":0.27688926,"about_ca_system_score_codex":0.0001560384,"about_ca_system_score_gemma":0.00004175465,"threshold_uncertainty_score":0.9998718},"labels":[],"label_agreement":null},{"id":"W2796149177","doi":"10.1055/s-0038-1635259","title":"Prediction of Post-Discharge Bleeding in Elderly Patients with Acute Coronary Syndromes: Insights from the BleeMACS Registry","year":2018,"lang":"en","type":"article","venue":"Thrombosis and Haemostasis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta","funders":"","keywords":"Medicine; Acute coronary syndrome; Incidence (geometry); Internal medicine; Clopidogrel; Hazard ratio; Receiver operating characteristic; Confidence interval; Framingham Risk Score; Surgery; Myocardial infarction","score_opus":0.031237004131916886,"score_gpt":0.25971192302838325,"score_spread":0.22847491889646637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2796149177","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997351,0.0012423024,0.000040527146,0.00027345383,0.00007287236,0.0004127137,0.0003141229,0.000029344616,0.00026368257],"genre_scores_gemma":[0.9976927,0.0015433416,0.00014099812,0.00026441386,0.000077641256,0.000013672379,0.00022816073,0.000022177617,0.000016919228],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99892205,0.00005306594,0.00024368783,0.00027985635,0.00032932142,0.00017204462],"domain_scores_gemma":[0.9992431,0.000051716383,0.000103597806,0.0003553076,0.00016214323,0.00008413077],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008263861,0.00017033007,0.0004100213,0.000057042005,0.00014649479,0.000019485098,0.00009059293,0.000092959286,0.00011848523],"category_scores_gemma":[0.000013134929,0.00010314912,0.00010711943,0.00020766287,0.00029935435,0.00016581248,0.00004012471,0.00012372434,0.0000047966387],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017013886,0.0005070845,0.9651333,0.00008532273,0.003380164,0.000031487212,0.0027515208,6.7523376e-7,0.002028342,0.00012404379,0.0007186514,0.023538033],"study_design_scores_gemma":[0.0037117165,0.0014725905,0.99011177,0.0004797562,0.00095267704,0.000020860849,0.00095971,0.000018054527,0.0016329995,0.00007094949,0.0004520145,0.00011693194],"about_ca_topic_score_codex":0.00025362367,"about_ca_topic_score_gemma":0.000045853893,"teacher_disagreement_score":0.024978451,"about_ca_system_score_codex":0.00002492403,"about_ca_system_score_gemma":0.000054185202,"threshold_uncertainty_score":0.42062992},"labels":[],"label_agreement":null},{"id":"W2797432399","doi":"10.1097/mca.0000000000000623","title":"Early discontinuation of prasugrel or clopidogrel in acute coronary syndromes","year":2018,"lang":"en","type":"article","venue":"Coronary Artery Disease","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Alberta; St. Michael's Hospital","funders":"Daiichi-Sankyo; Daiichi Sankyo Europe; Eli Lilly and Company","keywords":"Prasugrel; Medicine; Clopidogrel; Acute coronary syndrome; Myocardial infarction; Internal medicine; Discontinuation; Post-hoc analysis; Cardiology","score_opus":0.01847761317695457,"score_gpt":0.27074352016358977,"score_spread":0.2522659069866352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2797432399","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99636024,0.0018771067,0.00017645267,0.00025496527,0.00021054546,0.0006637764,0.00008936975,0.00007226468,0.0002952715],"genre_scores_gemma":[0.9974242,0.00045807922,0.000119401564,0.00036076683,0.000159226,0.000056655077,0.00015009879,0.0000372008,0.0012343875],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998395,0.00011638592,0.00040476097,0.00039195656,0.00038227797,0.00030957072],"domain_scores_gemma":[0.99884206,0.000050303985,0.0001048297,0.00056217663,0.0001067757,0.00033384596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014835763,0.00023064323,0.0004579019,0.00015876179,0.00006836806,0.000013535452,0.00014052953,0.00007735436,0.00059238845],"category_scores_gemma":[0.000045144854,0.00018642517,0.00031861372,0.00025861952,0.0003490209,0.00033344227,0.000057756533,0.00011413979,0.000117620926],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016621912,0.001447264,0.9127982,0.0001664956,0.0010053689,0.005713028,0.00051507266,0.0000039596607,0.00074705173,0.00012182438,0.00086261093,0.059997167],"study_design_scores_gemma":[0.0035830557,0.001267377,0.9923752,0.00033949234,0.000602164,0.00034564405,0.00012534548,0.00012818055,0.00014599554,0.00016898313,0.00069795933,0.00022060363],"about_ca_topic_score_codex":0.0000065980876,"about_ca_topic_score_gemma":0.000006247395,"teacher_disagreement_score":0.079576954,"about_ca_system_score_codex":0.000043703112,"about_ca_system_score_gemma":0.00027383323,"threshold_uncertainty_score":0.76021975},"labels":[],"label_agreement":null},{"id":"W2800355218","doi":"10.1016/s0016-5085(18)32702-1","title":"Mo1651 - Non-Vitamin K Antagonist Oral Anticoagulants and Gastrointestinal Bleeding: A Network Meta-Analysis","year":2018,"lang":"en","type":"article","venue":"Gastroenterology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal General Hospital; McGill University; University of Ottawa","funders":"","keywords":"Vitamin K antagonist; Gastrointestinal bleeding; Meta-analysis; Medicine; Antagonist; Vitamin k; Gastroenterology; Internal medicine; Warfarin; Atrial fibrillation; Receptor","score_opus":0.042956665557508406,"score_gpt":0.29106187999606764,"score_spread":0.24810521443855924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800355218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97776246,0.0005658252,0.020376988,0.00065128994,0.00011329818,0.00023343075,0.000026671383,0.00006424882,0.00020577828],"genre_scores_gemma":[0.992498,0.00007011025,0.005033289,0.0016932841,0.00041779032,0.000017786499,0.000059884867,0.00002482989,0.00018503684],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99811304,0.00014666225,0.00033059012,0.0005088113,0.00023065883,0.0006702498],"domain_scores_gemma":[0.9990488,0.000029198001,0.00011307038,0.00041200357,0.00012190143,0.00027501467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004066329,0.00027953836,0.0015244733,0.00017213133,0.00016449518,0.00003537319,0.000117837546,0.000064323474,0.0004595495],"category_scores_gemma":[0.000022430291,0.00022148571,0.0011364464,0.00028052856,0.00051731267,0.000065758664,0.000095554795,0.00017093318,0.000035643545],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020250042,0.00017174403,0.8676013,0.000023887422,0.12633644,0.00043853215,0.000047669884,0.000040895196,0.00088122115,0.000026035028,0.0021490364,0.00025824088],"study_design_scores_gemma":[0.0040323567,0.004622621,0.70500565,0.000020528718,0.2762595,0.005828913,0.000106938176,0.0023068483,0.0001914669,0.00007315865,0.0013141036,0.00023789467],"about_ca_topic_score_codex":0.00003706093,"about_ca_topic_score_gemma":0.00007141142,"teacher_disagreement_score":0.16259563,"about_ca_system_score_codex":0.000015669293,"about_ca_system_score_gemma":0.000024343208,"threshold_uncertainty_score":0.9031925},"labels":[],"label_agreement":null},{"id":"W2800892555","doi":"10.3233/ch-170331","title":"Comparative evaluation of Plateletworks, Multiplate analyzer and Platelet function analyzer-200 in cardiology patients","year":2018,"lang":"en","type":"article","venue":"Clinical Hemorheology and Microcirculation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Korea University","keywords":"Platelet; Kappa; Adenosine diphosphate; Coefficient of variation; Medicine; Spectrum analyzer; Whole blood; Cohen's kappa; Hematology analyzer; Internal medicine; Nuclear medicine; Chemistry; Platelet aggregation; Chromatography; Mathematics; Physics; Statistics","score_opus":0.05902920681871009,"score_gpt":0.3753316333440221,"score_spread":0.316302426525312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800892555","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995483,0.0020703452,0.0013980493,0.000036897516,0.00021390709,0.0005156751,0.0000073727965,0.00001747896,0.00025726654],"genre_scores_gemma":[0.99884725,0.00039898654,0.0001332684,0.00017228018,0.00020787198,0.0000111971885,0.00020581779,0.000009686419,0.000013663868],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979927,0.0005566439,0.0006443278,0.00043119202,0.00017697844,0.00019816925],"domain_scores_gemma":[0.9988542,0.00022279886,0.00020419293,0.00018564053,0.00043833393,0.00009483055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014084892,0.00016204947,0.00079079863,0.00015541728,0.00008508245,0.000004855452,0.00003402286,0.00038113122,0.000068369176],"category_scores_gemma":[0.000119351644,0.00014701404,0.00016451963,0.00020030583,0.0006864324,0.00009910024,0.000033159045,0.0002406196,0.00000882285],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017522831,0.00014657725,0.928348,0.000029990166,0.00060084526,0.0000063807624,0.00018391835,0.00015030235,0.0003806212,0.000056138077,0.00007174603,0.068273164],"study_design_scores_gemma":[0.008246441,0.0005587255,0.9779089,0.000051537012,0.0006751416,0.000045241948,0.00010315801,0.0111594,0.0002985359,0.00053643883,0.00028298344,0.00013349875],"about_ca_topic_score_codex":0.000014224113,"about_ca_topic_score_gemma":0.000029863588,"teacher_disagreement_score":0.068139665,"about_ca_system_score_codex":0.000031375184,"about_ca_system_score_gemma":0.000073127114,"threshold_uncertainty_score":0.59950584},"labels":[],"label_agreement":null},{"id":"W2802447724","doi":"10.18433/jpps29854","title":"Clinical Outcomes of Aspirin Interaction with Other Non-Steroidal Anti-Inflammatory Drugs: A Systematic Review","year":2018,"lang":"en","type":"review","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"University of Alberta","keywords":"Rofecoxib; Celecoxib; Aspirin; Naproxen; Meloxicam; Medicine; Ibuprofen; Diclofenac; Pharmacology; Acetaminophen; Cyclooxygenase; Internal medicine; Chemistry","score_opus":0.11600169318304944,"score_gpt":0.4874939756943182,"score_spread":0.37149228251126876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2802447724","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0023086923,0.99467623,0.00009142545,0.00012907002,0.0007156813,0.0017415986,0.000011922129,0.00001833805,0.00030706904],"genre_scores_gemma":[0.0021053778,0.9957097,0.00020190584,0.0011914195,0.00066327234,0.000025804897,0.0000023668538,0.00004527775,0.000054867636],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99299157,0.0011521389,0.003327497,0.00044007294,0.001674116,0.0004146367],"domain_scores_gemma":[0.99507177,0.0006873701,0.002854067,0.00037133598,0.0004702423,0.0005452119],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0061966046,0.00055118103,0.005757868,0.00033943704,0.000105611085,0.000054733926,0.00074148976,0.00012420845,0.0003619225],"category_scores_gemma":[0.00027689838,0.0002809823,0.003546345,0.00063214154,0.00102217,0.0004119828,0.00008857993,0.00095015496,0.00007008798],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023653796,0.0005846241,0.0025023744,0.7872718,0.007677838,0.00024044946,0.00004711946,7.2877515e-7,0.00000585418,0.0000060320813,0.0004337397,0.2009929],"study_design_scores_gemma":[0.0018104229,0.00046359826,0.00002911414,0.43307185,0.028296052,0.001662922,0.0000435331,0.000022299586,0.000035562316,0.0000013268813,0.5342905,0.00027283374],"about_ca_topic_score_codex":0.0000026611974,"about_ca_topic_score_gemma":2.752384e-7,"teacher_disagreement_score":0.53385675,"about_ca_system_score_codex":0.00009408577,"about_ca_system_score_gemma":0.0010313507,"threshold_uncertainty_score":0.99996424},"labels":[],"label_agreement":null},{"id":"W2802531586","doi":"10.1016/j.ahj.2018.04.020","title":"Safety of ticagrelor in patients with baseline conduction abnormalities: A PLATO (Study of Platelet Inhibition and Patient Outcomes) analysis","year":2018,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Alberta","funders":"AstraZeneca","keywords":"Medicine; Ticagrelor; Clopidogrel; Cardiology; Internal medicine; Acute coronary syndrome; Hazard ratio; Myocardial infarction; Anesthesia; Confidence interval","score_opus":0.008335680668072212,"score_gpt":0.25347256342873914,"score_spread":0.24513688276066692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2802531586","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99934465,0.00006535323,0.0001823533,0.00007223064,0.000024422638,0.00026814264,0.000017768345,0.0000056253607,0.000019441406],"genre_scores_gemma":[0.99946034,0.00004206285,0.0002522551,0.0001927536,0.00002542218,0.0000027973877,0.000011855116,0.000009660497,0.0000028431139],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99864686,0.00017142035,0.0004838379,0.00014441836,0.00041048817,0.00014295531],"domain_scores_gemma":[0.999153,0.000052207168,0.00024248644,0.00016333985,0.00027644544,0.000112486756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028919603,0.000113692644,0.00067226304,0.00033175165,0.000058288962,0.0000058721384,0.000020640693,0.000022953956,0.000091338006],"category_scores_gemma":[0.000043135256,0.000080517886,0.0001576204,0.0005987454,0.00027018672,0.00010064002,0.000013902891,0.00012859568,8.557216e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00281488,0.0008508066,0.9833375,0.000011614375,0.0016629817,0.000017282122,0.0015732668,0.000060606795,0.00004291493,0.0000017837567,0.00002628705,0.009600047],"study_design_scores_gemma":[0.0048646713,0.005891559,0.9816464,0.00006729534,0.0006957607,0.00006485601,0.0060783415,0.00005614642,0.00038023412,0.0000026691157,0.0001625927,0.00008947372],"about_ca_topic_score_codex":0.00025789265,"about_ca_topic_score_gemma":0.000041192885,"teacher_disagreement_score":0.009510573,"about_ca_system_score_codex":0.00003209392,"about_ca_system_score_gemma":0.00004828593,"threshold_uncertainty_score":0.3283424},"labels":[],"label_agreement":null},{"id":"W2805464159","doi":"10.2196/10516","title":"The Use of Aspirin to Reduce the Risk of Thrombotic Events in Patients With End-Stage Renal Disease: Protocol for a Randomized Controlled Trial","year":2018,"lang":"en","type":"article","venue":"JMIR Research Protocols","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Institut National d'assurance Maladie-Invalidité; Harvard T.H. Chan School of Public Health","keywords":"Medicine; Aspirin; TIMI; Internal medicine; Myocardial infarction; End stage renal disease; Population; Diabetes mellitus; Kidney disease; Hemodialysis; Thrombolysis; Endocrinology","score_opus":0.12649568223444096,"score_gpt":0.4777283247759658,"score_spread":0.3512326425415248,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2805464159","genre_codex":"protocol","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"protocol","genre_consensus":"protocol","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10666107,0.0000024682197,0.00012906024,0.00014481145,0.000005615452,0.8929718,0.000042787775,0.000011454364,0.00003094738],"genre_scores_gemma":[0.03651459,7.1782046e-7,0.00011794135,0.000023100423,0.0001380327,0.9626891,0.0000070460437,0.000033424036,0.0004760745],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9934317,0.0032332249,0.0008259401,0.00034450507,0.0016549687,0.00050967763],"domain_scores_gemma":[0.995094,0.0022206157,0.00036433936,0.00097062695,0.001135427,0.00021498401],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0064636813,0.00020631372,0.0012056067,0.00016318407,0.0002616211,0.00003769423,0.0003737678,0.00006892649,0.000084823354],"category_scores_gemma":[0.00347501,0.00008638765,0.0007091734,0.00047558246,0.0008961257,0.00010349802,0.00010524573,0.00030599235,0.00000442033],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9883557,0.0018579073,0.0055730166,0.00036544818,0.0008194497,0.0000024961096,0.00013358223,0.00002041353,0.000065201115,0.000119155615,0.0005217987,0.0021658498],"study_design_scores_gemma":[0.9481577,0.0075862305,0.019188821,0.0022765696,0.00008065666,2.4177916e-7,0.00002519156,0.00010596888,0.00065911823,0.00014943002,0.021668745,0.000101308375],"about_ca_topic_score_codex":0.000027284517,"about_ca_topic_score_gemma":0.0000141096625,"teacher_disagreement_score":0.07014648,"about_ca_system_score_codex":0.00005697336,"about_ca_system_score_gemma":0.0006855951,"threshold_uncertainty_score":0.41601625},"labels":[],"label_agreement":null},{"id":"W2808245286","doi":"10.1016/j.jcin.2018.01.263","title":"Platelet Reactivity and Risk of Ischemic Stroke After Coronary Drug-Eluting Stent Implantation","year":2018,"lang":"en","type":"article","venue":"JACC: Cardiovascular Interventions","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital du Sacré-Cœur de Montréal","funders":"OrbusNeich; Bayer Fund; Medicines Company; Boston Scientific Corporation; Cardiovascular Systems; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; CSL Behring; Medtronic; Abbott Vascular; Abbott Laboratories; Sanofi; Novartis Pharmaceuticals Corporation; Edwards Lifesciences","keywords":"Clopidogrel; Medicine; Aspirin; P2Y12; Internal medicine; Hazard ratio; Drug-eluting stent; Cardiology; Stroke (engine); Confidence interval; Antiplatelet drug; Prospective cohort study; Percutaneous coronary intervention; Myocardial infarction","score_opus":0.014781656660503663,"score_gpt":0.26228217106772167,"score_spread":0.24750051440721801,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808245286","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9674075,0.026033955,0.0043269447,0.000021271167,0.00021179058,0.000511342,0.0001985907,0.000072086026,0.0012164668],"genre_scores_gemma":[0.995193,0.0035198266,0.0005261486,0.000025415015,0.00026143252,0.00006546432,0.000073591145,0.00003675533,0.00029836476],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99805725,0.00028650614,0.00046245506,0.00043435488,0.00048160218,0.00027786446],"domain_scores_gemma":[0.9986808,0.000059881502,0.00016837522,0.0007034725,0.00024099376,0.00014647793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009299471,0.00023023595,0.00069545436,0.00016567155,0.00015042168,0.000024898634,0.000088647794,0.00011319934,0.00017565802],"category_scores_gemma":[0.000096603,0.00021281026,0.0034535,0.00016663624,0.00024447704,0.00020078348,0.000103581115,0.00024520236,0.000035212423],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025389956,0.0008999357,0.26362163,0.0017521685,0.052691042,0.0005123104,0.0010177438,0.00005838136,0.0064369207,0.000038578328,0.0017452071,0.6686871],"study_design_scores_gemma":[0.006517334,0.00051483314,0.91372716,0.0013120068,0.010132494,0.0019190384,0.0009536971,0.00012545608,0.033179436,0.00003867423,0.031097343,0.0004825208],"about_ca_topic_score_codex":0.00018315922,"about_ca_topic_score_gemma":0.000035824174,"teacher_disagreement_score":0.66820455,"about_ca_system_score_codex":0.000049536637,"about_ca_system_score_gemma":0.00004677933,"threshold_uncertainty_score":0.8678151},"labels":[],"label_agreement":null},{"id":"W2808505738","doi":"10.18433/jpps29624","title":"Comparison of Ticagrelor with Clopidogrel in Reducing Interleukin-17 and Myeloperoxidase Expression in Thrombus and Improving Postprocedural Coronary Flow in ST-segment Elevation Myocardial Infarction Patients","year":2018,"lang":"en","type":"article","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Ticagrelor; Medicine; Clopidogrel; Internal medicine; Cardiology; Percutaneous coronary intervention; Myocardial infarction; Acute coronary syndrome; Conventional PCI; Thrombus","score_opus":0.03503703306176987,"score_gpt":0.3661850674401865,"score_spread":0.3311480343784166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808505738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973278,0.0018401637,0.00010854107,0.00027454624,0.00012609054,0.00028950698,0.0000022359848,0.000004055928,0.000027067927],"genre_scores_gemma":[0.9981173,0.00064754783,0.0009460749,0.00017425929,0.0001021382,0.0000028369611,0.0000019841982,0.0000066672173,0.000001168792],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983191,0.00013568501,0.0005757783,0.00022138601,0.0005136019,0.00023445685],"domain_scores_gemma":[0.9993815,0.00007248124,0.00020402075,0.000051431678,0.0001352381,0.00015535484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008453306,0.00013562274,0.00038945628,0.00029650217,0.0000659235,0.000026194892,0.000084671236,0.000035111865,0.00003246796],"category_scores_gemma":[0.00007897222,0.00009446145,0.000055153938,0.00037388052,0.00043759667,0.00051073614,0.000053898242,0.0002954987,2.7573793e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029266735,0.00035463975,0.77489233,0.000074570526,0.000034464985,0.000024557841,0.0011403797,0.000121572724,0.057881203,0.0000014685131,0.000012728188,0.1625354],"study_design_scores_gemma":[0.011031713,0.001627558,0.9211978,0.0008858593,0.00011733843,0.00013556574,0.001012648,0.01922118,0.044341035,0.000012517437,0.0002648992,0.00015189515],"about_ca_topic_score_codex":0.000029836423,"about_ca_topic_score_gemma":0.000009714704,"teacher_disagreement_score":0.16238351,"about_ca_system_score_codex":0.00009575866,"about_ca_system_score_gemma":0.00014632319,"threshold_uncertainty_score":0.38520262},"labels":[],"label_agreement":null},{"id":"W2810052516","doi":"10.5339/qfarc.2018.hbpd660","title":"CYP2C19 Genetic Polymorphism Prevalence in Qataris","year":2018,"lang":"en","type":"article","venue":"","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"CYP2C19; Genotyping; Genotype; DNA extraction; TaqMan; Saliva; Clopidogrel; genomic DNA; Population; Biology; Polymerase chain reaction; Medicine; Genetics; Molecular biology; DNA; Gene; Internal medicine; Myocardial infarction","score_opus":0.008835369771463231,"score_gpt":0.2505519446120724,"score_spread":0.24171657484060918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810052516","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9793516,0.0059093335,0.0009228767,0.00023586233,0.0000829655,0.00019890859,0.000001882369,0.000058380094,0.013238189],"genre_scores_gemma":[0.9938696,0.00088599604,0.00081240106,0.0009076948,0.00023970759,0.000008364227,0.0000027807102,0.000011655174,0.0032617978],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99930155,0.000027938357,0.00012589524,0.00019276026,0.00017445513,0.00017739252],"domain_scores_gemma":[0.99953955,0.000010488633,0.0000142144645,0.00031321048,0.000034490484,0.000088071596],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00008714352,0.00008349626,0.00015829747,0.00006260138,0.000028384575,0.0000067829906,0.00006582579,0.000050073588,0.0021937431],"category_scores_gemma":[0.00001885462,0.00006701265,0.00011939484,0.00013993193,0.00010515798,0.00003977727,0.00002092699,0.00005984878,0.00037525131],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007167671,0.00044022623,0.77859074,0.00021245627,0.00040383733,0.0006469283,0.00051236915,0.0000031777954,0.006051316,0.0007092084,0.0045615905,0.20715135],"study_design_scores_gemma":[0.002036855,0.00030990646,0.9756736,0.00010684771,0.00012540222,0.00021513522,0.00006135354,0.00015672648,0.006318521,0.00025113943,0.014581952,0.00016253546],"about_ca_topic_score_codex":0.00007544011,"about_ca_topic_score_gemma":0.0000123634045,"teacher_disagreement_score":0.20698883,"about_ca_system_score_codex":0.000018484552,"about_ca_system_score_gemma":0.000050568837,"threshold_uncertainty_score":0.9987184},"labels":[],"label_agreement":null},{"id":"W2811018004","doi":"10.1016/j.thromres.2018.06.022","title":"Gender-related differences in post-discharge bleeding among patients with acute coronary syndrome on dual antiplatelet therapy: A BleeMACS sub-study","year":2018,"lang":"en","type":"article","venue":"Thrombosis Research","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta","funders":"","keywords":"Acute coronary syndrome; Medicine; Internal medicine; Cardiology; Myocardial infarction","score_opus":0.06284568611833038,"score_gpt":0.33104841414090536,"score_spread":0.26820272802257494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2811018004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960376,0.0002814819,0.0000019746024,0.0001010167,0.00010972424,0.0025260414,0.000044562094,0.000114196344,0.00078339636],"genre_scores_gemma":[0.9986005,0.0008080658,0.000011210566,0.00008861371,0.000067736015,0.00012938009,0.00010655225,0.00008706979,0.00010086819],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99486655,0.0006609534,0.0004488223,0.0008496651,0.002144743,0.0010292624],"domain_scores_gemma":[0.99806213,0.00018289244,0.000085745596,0.0007378173,0.00060978637,0.00032161956],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012537371,0.00040336992,0.000883014,0.0006944321,0.00047688826,0.000096378695,0.00032193513,0.00021074127,0.0007702281],"category_scores_gemma":[0.000057217872,0.0002820804,0.00020962574,0.0012820853,0.00076553284,0.00028853334,0.00015900437,0.0008632301,0.00021686504],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035555004,0.00364173,0.98125625,0.000037865226,0.003822113,0.0009745647,0.00263605,7.7730715e-7,0.002191451,0.000027400965,0.000114944065,0.0017413531],"study_design_scores_gemma":[0.009836786,0.012885376,0.9737746,0.00029788434,0.00017435093,0.00007775319,0.0014657434,0.000041294115,0.0010665829,0.00003833109,0.000010238321,0.00033107662],"about_ca_topic_score_codex":0.00020858519,"about_ca_topic_score_gemma":0.000040459614,"teacher_disagreement_score":0.009243646,"about_ca_system_score_codex":0.00013939489,"about_ca_system_score_gemma":0.00021483458,"threshold_uncertainty_score":0.99996316},"labels":[],"label_agreement":null},{"id":"W2811131397","doi":"10.1159/000489165","title":"H2 Receptor Antagonists versus Proton Pump Inhibitors in Patients on Dual Antiplatelet Therapy for Coronary Artery Disease: A Systematic Review","year":2018,"lang":"en","type":"review","venue":"Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of Ottawa","funders":"","keywords":"Coronary artery disease; Medicine; Cardiology; Pharmacology; Clopidogrel; Disease; Internal medicine; Myocardial infarction","score_opus":0.037834147069218595,"score_gpt":0.32006111684651745,"score_spread":0.28222696977729883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2811131397","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020516082,0.96763843,0.0000053157582,0.0000338694,0.0017416816,0.027834537,0.0005354905,0.0000919083,0.00006713191],"genre_scores_gemma":[0.00052701385,0.9859855,0.00000999393,0.00040006806,0.0011208863,0.0077736317,0.0039541665,0.00016254505,0.0000661745],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9949456,0.0013647907,0.0014423056,0.0010951662,0.0004822504,0.0006699259],"domain_scores_gemma":[0.9970888,0.0004104948,0.0005680347,0.0013861039,0.00022649251,0.00032010395],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00097183435,0.0009046451,0.0071659163,0.00029140362,0.000109713605,0.000022022754,0.0002870424,0.00060450105,0.00003897436],"category_scores_gemma":[0.0005273172,0.0006440546,0.0035463076,0.00032953112,0.00024602097,0.00006733848,0.00006596151,0.0004490794,0.00021167588],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037215129,0.00028650323,0.00043311872,0.919852,0.0054477835,0.00052310165,0.000012612177,2.0296636e-7,1.67875e-7,0.000009314644,0.005221213,0.06449243],"study_design_scores_gemma":[0.005741557,0.0021322786,0.00014417025,0.42350847,0.005007553,0.00016404068,0.0000066853445,2.8210962e-7,0.0000013568612,0.0000026352209,0.56274295,0.0005480173],"about_ca_topic_score_codex":6.6498876e-7,"about_ca_topic_score_gemma":1.5313462e-7,"teacher_disagreement_score":0.55752176,"about_ca_system_score_codex":0.0003136962,"about_ca_system_score_gemma":0.0005111579,"threshold_uncertainty_score":0.99960107},"labels":[],"label_agreement":null},{"id":"W2847030778","doi":"10.1097/hco.0000000000000550","title":"Diabetes and multivessel disease","year":2018,"lang":"en","type":"review","venue":"Current Opinion in Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; Heart and Stroke Foundation","funders":"","keywords":"Medicine; Diabetes mellitus; Disease; Internal medicine; Endocrinology","score_opus":0.09861446264164452,"score_gpt":0.4008945159523479,"score_spread":0.30228005331070334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2847030778","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012689199,0.99502254,0.0000389965,0.000013183147,0.0036848346,0.0008784396,0.00011205597,0.00004517733,0.00007787213],"genre_scores_gemma":[0.00011310599,0.99642336,0.000011601121,0.00001203986,0.0024137849,0.0002463578,0.0007210983,0.0000442794,0.000014398097],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979837,0.00044849323,0.00042923525,0.00064072106,0.00014946678,0.000348384],"domain_scores_gemma":[0.99892956,0.00014833477,0.00011726797,0.00048397167,0.000052932664,0.00026791223],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00028866009,0.00039379118,0.0023428272,0.0002523402,0.00004539773,0.000011758643,0.000113017326,0.00025445348,0.000020680724],"category_scores_gemma":[0.0001374707,0.00030469813,0.0010862341,0.00018493088,0.00033607183,0.000037622587,0.00011025765,0.0003766645,0.000063156476],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033051812,0.000051122435,0.004311756,0.035063755,0.0006570931,0.000016780265,0.000013393056,2.5416568e-7,2.1910878e-8,0.000058753074,0.002572427,0.95722157],"study_design_scores_gemma":[0.00075079076,0.00006473787,0.0028106067,0.019159405,0.0009501325,0.000053547647,0.0000065911136,0.000004773063,2.8677533e-8,0.000043598713,0.9758775,0.00027823765],"about_ca_topic_score_codex":3.390892e-7,"about_ca_topic_score_gemma":2.3541034e-8,"teacher_disagreement_score":0.9733051,"about_ca_system_score_codex":0.000058485653,"about_ca_system_score_gemma":0.00024303632,"threshold_uncertainty_score":0.9999405},"labels":[],"label_agreement":null},{"id":"W2883553853","doi":"10.1016/j.transci.2018.07.004","title":"Bleeding by the numbers: The utility and the limitations of bleeding scores, bleeding prediction tools, and bleeding case definitions","year":2018,"lang":"en","type":"review","venue":"Transfusion and Apheresis Science","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Antithrombotic; Major bleeding; Bleeding time; Von Willebrand disease; Stroke (engine); Intensive care medicine; Von Willebrand factor; Internal medicine","score_opus":0.13912986835219995,"score_gpt":0.3088326079992385,"score_spread":0.16970273964703855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883553853","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.029948935,0.9641058,0.00032876185,0.0005142109,0.0001976754,0.0014738196,0.00023810328,0.000051462044,0.0031412197],"genre_scores_gemma":[0.13799772,0.86154723,0.00008297272,0.00008254039,0.00014201437,0.00007159841,0.00001609118,0.000021462785,0.000038374677],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975276,0.00022492599,0.0005936844,0.0006320225,0.0006517145,0.00037003652],"domain_scores_gemma":[0.9975808,0.0013903703,0.00022462338,0.0004183042,0.00018842613,0.00019745446],"candidate_categories":["sts"],"consensus_categories":["sts"],"category_scores_codex":[0.002960015,0.00035780948,0.0008469076,0.00012965982,0.0026768853,0.0003267373,0.00028034163,0.00016047971,0.000049004924],"category_scores_gemma":[0.00038878567,0.0001718232,0.0003958064,0.0010223071,0.004168872,0.00039694863,0.00011612663,0.00044304304,0.0000013594936],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015703533,0.0000835903,0.00021980934,0.0026486558,0.00055106415,0.000029194847,0.0027019933,5.615539e-7,0.00019094645,0.0030427799,0.00079739146,0.989577],"study_design_scores_gemma":[0.0117200855,0.00091710966,0.0018826169,0.04643072,0.03718673,0.026166264,0.055016782,0.0039077527,0.00042343303,0.0018966283,0.8124496,0.0020023065],"about_ca_topic_score_codex":0.00016781798,"about_ca_topic_score_gemma":0.000050738607,"teacher_disagreement_score":0.9875747,"about_ca_system_score_codex":0.000031981283,"about_ca_system_score_gemma":0.00020475997,"threshold_uncertainty_score":0.9986215},"labels":[],"label_agreement":null},{"id":"W2884256087","doi":"10.1016/j.ijcard.2018.03.103","title":"Impact of percutaneous coronary intervention extent, complexity and platelet reactivity on outcomes after drug-eluting stent implantation","year":2018,"lang":"en","type":"article","venue":"International Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Sacré-Cœur de Montréal","funders":"","keywords":"Conventional PCI; Medicine; Percutaneous coronary intervention; Mace; Cardiology; Internal medicine; Myocardial infarction; Clopidogrel; Coronary artery disease; Stent; Drug-eluting stent","score_opus":0.02341607827895913,"score_gpt":0.33264813192596737,"score_spread":0.30923205364700823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884256087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975891,0.0004928877,0.00082670595,0.00012873772,0.0005280495,0.00009934859,0.00005146364,0.000007243712,0.00027646168],"genre_scores_gemma":[0.99895436,0.00032823533,0.00011595906,0.000083855324,0.00046891876,0.000001359365,0.00001894022,0.000009988793,0.00001838424],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988437,0.00017014316,0.00040010497,0.00012944153,0.00033910526,0.00011747996],"domain_scores_gemma":[0.9988905,0.000114699564,0.00031184926,0.00010798188,0.00049973855,0.00007523471],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003692159,0.00012262126,0.00048876874,0.00017499157,0.000026242857,0.000010134796,0.00009131888,0.000060356473,0.00006284852],"category_scores_gemma":[0.00008866621,0.00008903639,0.00074413733,0.000030692485,0.00020497052,0.00010335293,0.0000371953,0.0001596229,0.0000040733817],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01632675,0.00022240797,0.8175637,0.000029294382,0.0069897,0.0027370588,0.00029150446,0.00011224179,0.006060803,0.000072249226,0.00015558075,0.14943871],"study_design_scores_gemma":[0.002200929,0.0012088213,0.9694627,0.00013955652,0.00018634586,0.025589442,0.00010028265,0.00003572424,0.0005040091,0.0002502652,0.00024869482,0.000073249066],"about_ca_topic_score_codex":0.00003653666,"about_ca_topic_score_gemma":0.0000040097175,"teacher_disagreement_score":0.15189898,"about_ca_system_score_codex":0.00010809921,"about_ca_system_score_gemma":0.000049976723,"threshold_uncertainty_score":0.36307985},"labels":[],"label_agreement":null},{"id":"W2884951008","doi":"10.4244/eij-d-18-00293","title":"Biolimus A9 polymer-free coated stents in high bleeding risk patients undergoing complex PCI: evidence from the LEADERS FREE randomised clinical trial","year":2018,"lang":"en","type":"article","venue":"EuroIntervention","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canada Excellence Research Chairs, Government of Canada","keywords":"Medicine; Conventional PCI; Stent; Surgery; Target lesion; Bare metal; Internal medicine; Percutaneous coronary intervention; Myocardial infarction; Restenosis","score_opus":0.1190032612652064,"score_gpt":0.35027336353483596,"score_spread":0.23127010226962957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884951008","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938113,0.001524819,0.0013673642,0.00047233974,0.00144319,0.0011654984,0.00006149819,0.00008367734,0.0000703304],"genre_scores_gemma":[0.9979678,0.0005320922,0.000075406126,0.00026976565,0.00088229007,0.000008941787,0.00014405526,0.000035754834,0.00008389617],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996445,0.0012990026,0.00095103896,0.0004891518,0.00050588883,0.00030994441],"domain_scores_gemma":[0.997688,0.0008272579,0.00037864613,0.00085161097,0.0001302715,0.00012421847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014495895,0.0002241514,0.00054919446,0.0000912394,0.00018007094,0.0000581019,0.00043078783,0.0001112839,0.00035696113],"category_scores_gemma":[0.002665118,0.00016657526,0.0010385505,0.00024162866,0.00031764052,0.00019606041,0.00017643813,0.0003194021,0.00008329171],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.25515375,0.0013198097,0.71467906,0.000074872485,0.001721496,0.000054967542,0.0005219464,0.0000045448896,0.00071820285,0.000018064286,0.0069108396,0.018822482],"study_design_scores_gemma":[0.38634574,0.0025381197,0.60707027,0.0016801889,0.00066134124,0.0000043437526,0.0003255745,0.00028781226,0.0005774158,0.00017310244,0.00014843814,0.00018768976],"about_ca_topic_score_codex":0.00063153624,"about_ca_topic_score_gemma":0.0002668843,"teacher_disagreement_score":0.131192,"about_ca_system_score_codex":0.00006199682,"about_ca_system_score_gemma":0.000053861342,"threshold_uncertainty_score":0.6792742},"labels":[],"label_agreement":null},{"id":"W2885841032","doi":"10.1161/circinterventions.114.001555","title":"In-Hospital Switching Between Clopidogrel and Prasugrel Among Patients With Acute Myocardial Infarction Treated With Percutaneous Coronary Intervention","year":2014,"lang":"en","type":"article","venue":"Circulation Cardiovascular Interventions","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Prasugrel; Clopidogrel; Medicine; Percutaneous coronary intervention; Myocardial infarction; Cardiology; Internal medicine; Bivalirudin; Loading dose; Emergency medicine","score_opus":0.00653856728509415,"score_gpt":0.22651039557066907,"score_spread":0.21997182828557493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885841032","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9587741,0.0008996432,0.0386025,0.00007021059,0.00012665136,0.001211599,0.00002241385,0.00012356938,0.00016929428],"genre_scores_gemma":[0.9986811,0.000092688555,0.00028182138,0.00002943497,0.00018441521,0.00008777295,0.00053839537,0.00007078254,0.00003357827],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975213,0.00033028304,0.00052546005,0.0006300433,0.00067231955,0.00032063783],"domain_scores_gemma":[0.99873734,0.00004221443,0.00017071328,0.00057517213,0.00028139024,0.00019319593],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00047637674,0.00034561197,0.00077946903,0.00035476979,0.00019992565,0.00008101083,0.000084698426,0.00018001905,0.00003764212],"category_scores_gemma":[0.00004536402,0.00029572542,0.0016266081,0.00039687287,0.00015044525,0.0005584496,0.00004672031,0.00031744712,0.000011880413],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032950248,0.00037635557,0.9525739,0.00017912428,0.010953443,0.0001405962,0.00015742036,0.0009021555,0.000017001788,0.00004223437,0.000015174399,0.034313075],"study_design_scores_gemma":[0.0070320456,0.0011033312,0.9843051,0.0008434429,0.0048225,0.00045569407,0.00010205077,0.00034749668,0.00001425247,0.0000530692,0.0005499646,0.0003710401],"about_ca_topic_score_codex":0.00015331456,"about_ca_topic_score_gemma":0.000023233686,"teacher_disagreement_score":0.039906994,"about_ca_system_score_codex":0.0001666917,"about_ca_system_score_gemma":0.000030439744,"threshold_uncertainty_score":0.9999495},"labels":[],"label_agreement":null},{"id":"W2886309612","doi":"10.1161/circ.132.suppl_3.18632","title":"Abstract 18632: Variation in Patient Profiles and Outcomes in US and non-US Subgroups of the Cangrelor versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition (CHAMPION) PHOENIX Trial","year":2015,"lang":"en","type":"article","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Gibson Energy (Canada)","funders":"","keywords":"Cangrelor; Medicine; Clopidogrel; Conventional PCI; Percutaneous coronary intervention; Bivalirudin; Cardiology; Internal medicine; Clinical endpoint; Aspirin; Clinical trial; P2Y12; Anesthesia; Myocardial infarction","score_opus":0.019182456003277656,"score_gpt":0.25961886739105755,"score_spread":0.24043641138777988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886309612","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977143,0.00023658287,0.00020241435,0.000082524704,0.00014262277,0.0015347622,0.00001987956,0.0000066789175,0.000060224193],"genre_scores_gemma":[0.99963355,0.000107994165,0.00013026237,0.000022191944,0.000022193075,0.000044174656,0.00002894564,0.000009589502,0.0000010804281],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99904007,0.000066200584,0.0003059506,0.00016812791,0.00032087,0.00009879219],"domain_scores_gemma":[0.99958813,0.000027856993,0.000121524456,0.0001474351,0.000064935804,0.000050144517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003638838,0.000101888436,0.00026710235,0.00011284758,0.00002124797,0.000008666008,0.000023712595,0.00006415753,0.0000051149586],"category_scores_gemma":[0.000026090918,0.0000780231,0.00006833695,0.00016978358,0.00003416045,0.000097162636,0.000020354737,0.000062768784,3.4169716e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2057698,0.0008966987,0.6195308,0.00040987818,0.0008224761,0.000075588025,0.009402257,0.015774984,0.011078471,0.00030002452,0.000015029743,0.13592397],"study_design_scores_gemma":[0.04142074,0.0005545943,0.9545897,0.00013553478,0.00004050653,0.0000027769236,0.00032468955,0.00019361643,0.0025887522,0.000057670193,0.000015779737,0.000075604454],"about_ca_topic_score_codex":0.00015543423,"about_ca_topic_score_gemma":0.000026769972,"teacher_disagreement_score":0.33505893,"about_ca_system_score_codex":0.00009099655,"about_ca_system_score_gemma":0.00004836422,"threshold_uncertainty_score":0.31816894},"labels":[],"label_agreement":null},{"id":"W2887167855","doi":"10.1016/j.hrcr.2018.07.017","title":"Cyclical sinus bradycardia and atrioventricular block induced by ticagrelor","year":2018,"lang":"en","type":"article","venue":"HeartRhythm Case Reports","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Medicine; Ticagrelor; Cardiology; Atrioventricular block; Bradycardia; Internal medicine; Sinus bradycardia; Sinus (botany); Coronary sinus; Heart block; Atrioventricular node; Anesthesia; Electrocardiography; Heart rate; Tachycardia; Myocardial infarction; Percutaneous coronary intervention","score_opus":0.01013294984841277,"score_gpt":0.25721150458666164,"score_spread":0.24707855473824888,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887167855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909611,0.0066883992,0.0000762998,0.00036566192,0.00022788797,0.0004527285,0.000007920001,0.00012417529,0.0010958447],"genre_scores_gemma":[0.99805313,0.00019868686,0.000113033486,0.0005757346,0.00074008974,0.000015443735,0.000021757107,0.000037326023,0.0002448205],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.998263,0.00007220046,0.00038231356,0.0005127517,0.00040256232,0.00036717177],"domain_scores_gemma":[0.9986864,0.000038871196,0.000088480185,0.0005924041,0.00012630927,0.00046758997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031695273,0.00022009185,0.00050778687,0.00005377974,0.00018368258,0.000035671124,0.0000033874076,0.00018095324,0.00012073965],"category_scores_gemma":[0.00012056146,0.00018769629,0.00035857668,0.00021356065,0.00016778066,0.00007310042,0.00004400668,0.00018305927,0.00004568846],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009927318,0.00010388984,0.0006925531,0.00004159818,0.0004115197,0.9859961,0.00005259177,2.504287e-7,0.0017619177,0.000012401923,0.005001998,0.0058259005],"study_design_scores_gemma":[0.00082400127,0.00025340464,0.0028987085,0.000045728084,0.00037818798,0.8795122,0.000025614,0.000043710785,0.004096618,0.000028350276,0.11169678,0.00019669617],"about_ca_topic_score_codex":0.000057393856,"about_ca_topic_score_gemma":0.0000022928966,"teacher_disagreement_score":0.10669478,"about_ca_system_score_codex":0.00003574545,"about_ca_system_score_gemma":0.00009388493,"threshold_uncertainty_score":0.7654033},"labels":[],"label_agreement":null},{"id":"W2887423791","doi":"10.1161/strokeaha.118.022696","title":"Dual Antiplatelet Therapy for Minor Stroke and High-Risk Transient Ischemic Attack","year":2018,"lang":"en","type":"article","venue":"Stroke","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Stroke (engine); Minor stroke; Clopidogrel; Neurology; Discontinuation; Emergency medicine; Internal medicine; Aspirin; Psychiatry","score_opus":0.015895580329445092,"score_gpt":0.2644674321638691,"score_spread":0.24857185183442398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887423791","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907374,0.004343201,0.0014591978,0.00023434756,0.00025248976,0.00073692156,0.0005067111,0.00008703518,0.0016426987],"genre_scores_gemma":[0.9921803,0.0019893323,0.0009949475,0.00038559613,0.0009632339,0.000043244592,0.00007745402,0.00004436255,0.0033215529],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99867904,0.000042045584,0.00022137763,0.00040812243,0.0002684525,0.00038098896],"domain_scores_gemma":[0.9992092,0.000055588065,0.0000661716,0.0003551694,0.00012068951,0.0001931362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021141487,0.00023571552,0.0004317854,0.00007472625,0.00017755659,0.000028756554,0.00006991361,0.00013345065,0.00024830748],"category_scores_gemma":[0.000022744629,0.00019092317,0.00036993448,0.000070803915,0.00025112004,0.00007973835,0.00001590274,0.00013926336,0.000037894028],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017392287,0.0008636903,0.06618346,0.0002948851,0.008110068,0.00019002007,0.0015999109,0.000007615883,0.20909348,0.00015358976,0.11249879,0.5836122],"study_design_scores_gemma":[0.024179867,0.0037395195,0.07230772,0.00008777887,0.000988922,0.00023167949,0.00042670194,0.00020064008,0.16144532,0.000019361387,0.73582923,0.0005432642],"about_ca_topic_score_codex":0.000025991678,"about_ca_topic_score_gemma":0.0000073974843,"teacher_disagreement_score":0.6233304,"about_ca_system_score_codex":0.000016321192,"about_ca_system_score_gemma":0.00005897127,"threshold_uncertainty_score":0.77856207},"labels":[],"label_agreement":null},{"id":"W2888341484","doi":"10.1016/j.cjca.2018.08.024","title":"Effect of Clopidogrel vs Ticagrelor on Platelet Aggregation and Inflammation Markers After Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction","year":2018,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Natural Science Foundation of China","keywords":"Medicine; Ticagrelor; Clopidogrel; Percutaneous coronary intervention; Internal medicine; Cardiology; Myocardial infarction","score_opus":0.0056954321960692835,"score_gpt":0.2373712797654954,"score_spread":0.23167584756942614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888341484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949471,0.0006514291,0.0028675972,0.00022222858,0.0006491691,0.00046719768,0.000033333825,0.000005535139,0.0001564471],"genre_scores_gemma":[0.9981936,0.00018711404,0.00006305523,0.00007394091,0.0013818525,0.000012743902,0.000055185174,0.000016221276,0.00001625729],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9989106,0.00027535862,0.00036951355,0.000130983,0.00014296395,0.00017058162],"domain_scores_gemma":[0.99896985,0.00015006903,0.00020603003,0.00012186025,0.00035398122,0.0001981775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007945216,0.0001257389,0.00045138344,0.00030729917,0.00006805959,0.000009893005,0.00004266395,0.00016952546,0.000024349447],"category_scores_gemma":[0.00032456324,0.00010806922,0.00039512737,0.000079277794,0.0002105627,0.000106230254,0.0000045139323,0.00013820273,0.0000029709552],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027619248,0.0000046769633,0.07252004,0.00029484238,0.0020099794,0.00022452224,0.00024487067,0.00027436973,0.001056701,0.000090285415,0.0011524729,0.894508],"study_design_scores_gemma":[0.016221793,0.04541782,0.82624143,0.0013229235,0.0029215752,0.014065498,0.00025913795,0.0006136871,0.0074879774,0.00057455164,0.08438228,0.00049131626],"about_ca_topic_score_codex":0.00004236874,"about_ca_topic_score_gemma":0.000060115144,"teacher_disagreement_score":0.8940167,"about_ca_system_score_codex":0.00012584146,"about_ca_system_score_gemma":0.00018138069,"threshold_uncertainty_score":0.44069347},"labels":[],"label_agreement":null},{"id":"W2888458270","doi":"10.1016/s0140-6736(18)31858-0","title":"Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial","year":2018,"lang":"en","type":"article","venue":"The Lancet","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":785,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Servier; Abbott Vascular; Regeneron Pharmaceuticals; Daiichi Sankyo Europe; Sanofi; University of Bern; Amarin Corporation; Boston Scientific Corporation; Amgen; Pfizer; Biosensors International Group; Canada Research Chairs; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Ticagrelor; Medicine; Aspirin; Clopidogrel; Percutaneous coronary intervention; Acute coronary syndrome; Coronary artery disease; Myocardial infarction; Internal medicine; Clinical endpoint; Cardiology; Randomized controlled trial","score_opus":0.042590679705046854,"score_gpt":0.324734246856156,"score_spread":0.2821435671511091,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888458270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85286534,0.009723438,0.058330208,0.0035606464,0.0016674745,0.065842345,0.00745522,0.00037003536,0.00018530048],"genre_scores_gemma":[0.91861737,0.0028575442,0.025532648,0.0047139097,0.0054598185,0.032976046,0.003375071,0.0007977978,0.005669781],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99330854,0.000435055,0.0020127401,0.0015193628,0.0008365277,0.0018877467],"domain_scores_gemma":[0.99361205,0.0026008685,0.0009130524,0.0016953399,0.00067835517,0.0005003189],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002708172,0.0011723022,0.003843743,0.0001978409,0.0007539653,0.00028435205,0.0012924292,0.0005620158,0.000082751096],"category_scores_gemma":[0.00078445155,0.00084721646,0.0017827336,0.00032944736,0.00046140284,0.00048276878,0.00014227723,0.00034128744,0.0000133365975],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9149109,0.0014202754,0.0003614333,0.0010759387,0.0048105745,0.000012587578,0.0025383378,0.00003928668,0.0067769857,0.0001126785,0.036439918,0.031501103],"study_design_scores_gemma":[0.81270945,0.009559518,0.00023116215,0.00072033016,0.0037327926,0.000018632616,0.00084320904,0.029169356,0.014096793,0.0003164091,0.12725537,0.0013469766],"about_ca_topic_score_codex":0.0002883304,"about_ca_topic_score_gemma":0.00046500395,"teacher_disagreement_score":0.10220143,"about_ca_system_score_codex":0.00036026843,"about_ca_system_score_gemma":0.00061889476,"threshold_uncertainty_score":0.9993979},"labels":[],"label_agreement":null},{"id":"W2888578238","doi":"10.1177/1074248418795889","title":"The Role of Direct Oral Anticoagulants in Patients With Coronary Artery Disease","year":2018,"lang":"en","type":"review","venue":"Journal of Cardiovascular Pharmacology and Therapeutics","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; University of Alberta","funders":"","keywords":"Medicine; Coronary artery disease; Cardiology; Internal medicine; Rivaroxaban; Dabigatran; Atrial fibrillation; Warfarin","score_opus":0.01891203307842382,"score_gpt":0.2953590808218932,"score_spread":0.2764470477434694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888578238","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.026314707,0.9725323,0.0000145756785,0.000009735236,0.00033742943,0.00070333725,0.00002645421,0.0000063200105,0.000055164383],"genre_scores_gemma":[0.05110682,0.94842285,0.000021296542,0.00007020821,0.00029303503,0.000010974516,0.000015284233,0.000049343133,0.000010167146],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972003,0.0008662979,0.0007650312,0.00024151517,0.00062471203,0.00030212983],"domain_scores_gemma":[0.99840283,0.00018670743,0.0004878161,0.00039569804,0.00033030528,0.00019664227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011210665,0.0003752402,0.002829421,0.0002078823,0.00010155825,0.000016373991,0.0002283932,0.000205687,0.000010877347],"category_scores_gemma":[0.000013305601,0.00020474511,0.0023063906,0.00022755637,0.0004834812,0.000082762,0.000049656737,0.0005142564,0.000001905458],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028213381,0.0004364526,0.010062297,0.0015673729,0.06695306,0.000567873,0.0000342331,0.000009105174,6.544187e-7,0.0000048410557,0.000028804507,0.91751397],"study_design_scores_gemma":[0.004787374,0.0007277016,0.011661874,0.0023633458,0.0482307,0.0005666314,0.000022281749,0.0000054876427,0.000010389723,0.000034345536,0.9313603,0.00022954564],"about_ca_topic_score_codex":7.9848235e-7,"about_ca_topic_score_gemma":2.6398368e-7,"teacher_disagreement_score":0.9313315,"about_ca_system_score_codex":0.000051602983,"about_ca_system_score_gemma":0.0004687833,"threshold_uncertainty_score":0.83492637},"labels":[],"label_agreement":null},{"id":"W2888949983","doi":"10.1093/eurheartj/ehy563.p3625","title":"P3625Barriers to the use and titration of betablockers in patients with stable coronary artery disease. Insights from the CLARIFY registry","year":2018,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"Novo Nordisk Fonden; Vetenskapsrådet; Hjärt-Lungfonden","keywords":"Medicine; Coronary artery disease; Disease; Cardiology; Internal medicine","score_opus":0.02203881924574166,"score_gpt":0.2243179868182957,"score_spread":0.20227916757255404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888949983","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977418,0.0008396461,0.00014232505,0.00084829703,0.00008073086,0.00022946578,0.000019386349,0.0000065799222,0.00009177518],"genre_scores_gemma":[0.99745226,0.00008037051,0.00013863672,0.0019407215,0.00030847377,9.46673e-7,0.00001575476,0.000017610982,0.00004521711],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989607,0.00033093593,0.00016365122,0.00012971925,0.0002920581,0.00012298039],"domain_scores_gemma":[0.9993233,0.000047249625,0.00005952005,0.0002876972,0.000100862526,0.0001813596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002154736,0.00009139852,0.00014115602,0.000032303848,0.00018793585,0.000057116253,0.000078007135,0.000022635897,0.000037681624],"category_scores_gemma":[0.00006210641,0.00004653467,0.00006795124,0.00010428595,0.0001506223,0.00015667897,0.000025342688,0.00028827405,0.000010915239],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016267092,0.00006241072,0.9891419,0.000004722233,0.00018506736,0.00009008576,0.00060381705,0.000029695953,0.00008119398,0.0000061485507,0.006969747,0.0011985328],"study_design_scores_gemma":[0.001366217,0.0002793449,0.9604815,0.00016513067,0.000104515326,0.00003748797,0.0001723384,0.000015753158,0.000033814926,0.000008751543,0.037275378,0.000059748636],"about_ca_topic_score_codex":0.00001163549,"about_ca_topic_score_gemma":0.000014092137,"teacher_disagreement_score":0.03030563,"about_ca_system_score_codex":0.000016145616,"about_ca_system_score_gemma":0.00007498986,"threshold_uncertainty_score":0.18976288},"labels":[],"label_agreement":null},{"id":"W2889324007","doi":"10.1093/eurheartj/ehy563.p3680","title":"P3680The high-risk ECG pattern of ST-elevation myocardial infarction: a substudy of the randomized trial of primary PCI with or without routine manual thrombectomy (TOTAL trial)","year":2018,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Population Health Research Institute","funders":"","keywords":"Medicine; Conventional PCI; Myocardial infarction; Randomized controlled trial; Cardiology; Internal medicine; Stroke (engine); Emergency medicine","score_opus":0.021672685352032914,"score_gpt":0.2735189248732807,"score_spread":0.2518462395212478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889324007","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953902,0.0002192651,0.0012306904,0.00015584308,0.00066117715,0.001930158,0.000024953626,0.000018790955,0.00036895214],"genre_scores_gemma":[0.99707466,0.0002184354,0.00021920352,0.00012331178,0.0021761216,0.000008613961,0.000009493387,0.000047012658,0.00012314091],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9950131,0.0026946738,0.00092090754,0.00021063657,0.00095265097,0.00020799389],"domain_scores_gemma":[0.99790955,0.00020963397,0.0008721564,0.00047077955,0.00042845195,0.00010945058],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036027792,0.00022206752,0.0013562245,0.0001171336,0.00016687263,0.000020419051,0.00015393362,0.000050914317,0.00022734934],"category_scores_gemma":[0.00027769955,0.00011419686,0.00091461465,0.00026917973,0.00054991833,0.00011778907,0.000058582307,0.00037136933,0.000006052187],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9562624,0.00052870665,0.034343645,0.000044019907,0.0025770967,0.000017238468,0.00077090424,0.000014791857,0.00055250904,0.0000031178506,0.00027682344,0.004608738],"study_design_scores_gemma":[0.84494257,0.005876053,0.14488716,0.00026527603,0.001748079,0.00062219944,0.00022113469,0.000028527531,0.00090170687,0.000009165582,0.0003731977,0.00012492911],"about_ca_topic_score_codex":0.00005354715,"about_ca_topic_score_gemma":0.000006035965,"teacher_disagreement_score":0.11131983,"about_ca_system_score_codex":0.000034952103,"about_ca_system_score_gemma":0.00029862177,"threshold_uncertainty_score":0.46568128},"labels":[],"label_agreement":null},{"id":"W2889529794","doi":"10.2174/1389200219666180820114435","title":"Managing Clopidogrel Hypersensitivity without Interrupting Therapy: The Toronto Approach","year":2018,"lang":"en","type":"review","venue":"Current Vascular Pharmacology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Clopidogrel; Medicine; Discontinuation; Adverse effect; Hypersensitivity reaction; Platelet aggregation inhibitor; Angioedema; Dermatology; Intensive care medicine; Internal medicine; Aspirin","score_opus":0.09169889645200735,"score_gpt":0.3971455935236131,"score_spread":0.30544669707160577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889529794","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014205238,0.9906807,0.0010787562,0.000036662197,0.0030320114,0.0026824486,0.000015514606,0.00020216455,0.0021296905],"genre_scores_gemma":[0.00027502797,0.9933739,0.00008497393,0.00041578797,0.0049512982,0.0004044619,0.000260708,0.00015981031,0.000074050324],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99585444,0.0012042022,0.0006636488,0.0010244745,0.0005212413,0.0007319904],"domain_scores_gemma":[0.9981557,0.0001184694,0.0003695246,0.00097651215,0.00016474158,0.0002150368],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012898453,0.00085297186,0.0026689381,0.00012869181,0.00033460642,0.00005899644,0.00051691994,0.00034591256,0.0002749698],"category_scores_gemma":[0.000028560013,0.0005296372,0.0039104447,0.00027544072,0.0004793983,0.00013894959,0.0002752541,0.0009836701,0.00018298802],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007429786,0.00035765898,0.000012726993,0.0075905984,0.0069332514,0.000041720203,0.00013782349,8.6475416e-7,0.0000027233875,0.000020899663,0.0025085746,0.9823189],"study_design_scores_gemma":[0.0018213467,0.00009417133,0.000019513847,0.0027385063,0.009963834,0.0005814822,0.00008408156,0.00016595233,0.000004269756,0.000006826307,0.98399425,0.0005257552],"about_ca_topic_score_codex":0.00003199795,"about_ca_topic_score_gemma":0.0000025190554,"teacher_disagreement_score":0.9817931,"about_ca_system_score_codex":0.00032204858,"about_ca_system_score_gemma":0.00033984435,"threshold_uncertainty_score":0.9997155},"labels":[],"label_agreement":null},{"id":"W2890383764","doi":"10.1161/circ.132.suppl_3.12118","title":"Abstract 12118: Risk of Thrombotic Events After Discontinuation of Aspirin in Perioperative Period in Patients With Established or at Risk of Coronary Artery Disease: A Systematic Review and Meta-analysis","year":2015,"lang":"en","type":"review","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Aspirin; Discontinuation; Perioperative; Meta-analysis; Coronary artery disease; Internal medicine; Disease; Cardiology; Surgery","score_opus":0.03404713505908504,"score_gpt":0.29339926315987613,"score_spread":0.2593521281007911,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890383764","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23855145,0.7572589,0.000025991449,0.0000017803508,0.0000070854803,0.0037416255,0.0004060685,0.0000035698197,0.0000035083287],"genre_scores_gemma":[0.5181292,0.48097515,0.000015028723,0.0000034722136,0.0000030390981,0.00023537697,0.0006113653,0.000019764993,0.000007532652],"study_design_codex":"systematic_review","study_design_gemma":"observational","domain_scores_codex":[0.99627405,0.0010054059,0.0015362998,0.00040697012,0.00064572314,0.00013157069],"domain_scores_gemma":[0.9971826,0.000105006446,0.001676449,0.00062910747,0.0003114308,0.000095402705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010201042,0.00036526736,0.006446677,0.00039608605,0.000019099445,0.0000074301483,0.000077055316,0.00012164258,0.000156246],"category_scores_gemma":[0.00026763743,0.00021459706,0.0014800349,0.0007590247,0.00008742068,0.00021063116,0.000029944104,0.00015458565,0.0000014923378],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004467622,0.0005306351,0.35813537,0.548814,0.088797286,0.000023271563,0.00032172646,0.00016413444,9.2092314e-8,7.141124e-7,5.0142944e-7,0.002765495],"study_design_scores_gemma":[0.0008012447,0.000065767206,0.5357373,0.035521455,0.42769203,0.0000028518398,0.000025826726,0.000019507785,5.1815597e-8,0.0000014947015,0.0000074396603,0.00012505667],"about_ca_topic_score_codex":0.00002723545,"about_ca_topic_score_gemma":0.000064992186,"teacher_disagreement_score":0.51329255,"about_ca_system_score_codex":0.00015014937,"about_ca_system_score_gemma":0.00021721834,"threshold_uncertainty_score":0.8751014},"labels":[],"label_agreement":null},{"id":"W2891516600","doi":"10.1016/j.jacc.2018.08.2087","title":"TCT-842 Patterns of Proton Pump Inhibitor Use in Patients Post Coronary Revascularization: Impact of Bleeding Risk on Prescription Patterns","year":2018,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Heart Institute; University of Ottawa","funders":"","keywords":"Medicine; Medical prescription; Cardiology; Proton-pump inhibitor; Internal medicine; Revascularization; Pharmacology; Myocardial infarction","score_opus":0.010804607197985067,"score_gpt":0.2564621839980612,"score_spread":0.24565757680007613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891516600","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982682,0.000097386546,0.00024190763,0.000050215804,0.00023751803,0.00070827734,0.00036809992,0.0000033614235,0.00002501908],"genre_scores_gemma":[0.9990606,0.0004545184,0.000040223233,0.000071098475,0.00032794307,0.0000058911232,0.000008805257,0.00002138847,0.000009572619],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977716,0.000628322,0.000757175,0.00015712842,0.0005033769,0.00018239637],"domain_scores_gemma":[0.99703985,0.000096959884,0.0014085106,0.00040940693,0.00096679706,0.00007845637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005399947,0.00016709858,0.0011270466,0.00026373653,0.00003722309,0.0000028625195,0.00019463299,0.00007709695,0.000017097667],"category_scores_gemma":[0.00037984512,0.00010866792,0.001168969,0.00030063727,0.0003099576,0.0001247101,0.00006234559,0.00024056359,5.007644e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064297915,0.0002062822,0.98607004,0.00009146061,0.0017512239,0.000049431947,0.00009506087,0.00063252106,0.0034981272,0.0000028504173,0.00009623758,0.0010769608],"study_design_scores_gemma":[0.0034048692,0.008110857,0.9810812,0.0005789015,0.00052582705,0.00025135942,0.00025929755,0.000022079903,0.005598487,0.000009581494,0.00007030748,0.000087216795],"about_ca_topic_score_codex":0.00010552673,"about_ca_topic_score_gemma":0.0000045783972,"teacher_disagreement_score":0.007904575,"about_ca_system_score_codex":0.00012380576,"about_ca_system_score_gemma":0.00017949437,"threshold_uncertainty_score":0.4431349},"labels":[],"label_agreement":null},{"id":"W2892105291","doi":"10.1093/eurheartj/ehy562","title":"Impact of lesion complexity on peri-procedural adverse events and the benefit of potent intravenous platelet adenosine diphosphate receptor inhibition after percutaneous coronary intervention: core laboratory analysis from 10 854 patients from the CHAMPION PHOENIX trial","year":2018,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Sacré-Cœur de Montréal","funders":"Medicines Company","keywords":"Medicine; Percutaneous coronary intervention; Adverse effect; Peri; Adenosine diphosphate; Platelet; Adenosine; Lesion; Cardiology; Pharmacology; Internal medicine; Platelet aggregation; Myocardial infarction; Surgery","score_opus":0.026925740234768895,"score_gpt":0.2782891159527139,"score_spread":0.251363375717945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892105291","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972262,0.0013536273,0.000036294467,0.0001333455,0.00021336607,0.00045854473,0.0005484681,0.000011834078,0.000018356832],"genre_scores_gemma":[0.99832535,0.00043986118,0.000060075392,0.00021839736,0.0006155834,0.0000024004103,0.00029254172,0.000028254433,0.000017543098],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99787456,0.0006163833,0.00055342715,0.0002419056,0.00053308316,0.00018066404],"domain_scores_gemma":[0.99873596,0.00008973007,0.0003730075,0.00030400953,0.0003509844,0.00014628838],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005694802,0.00021630562,0.0005514581,0.00008366584,0.00022786269,0.000018113144,0.0001055224,0.000052716532,0.0015510521],"category_scores_gemma":[0.00006771928,0.00012074699,0.0008989006,0.00021001959,0.00037768047,0.00009808462,0.000067927926,0.00029087972,0.000024467758],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.66573864,0.00272472,0.27558878,0.000057249705,0.010989592,0.0004839178,0.0065390966,0.00013322367,0.0033629728,0.0000065076515,0.0017387441,0.032636557],"study_design_scores_gemma":[0.0287385,0.004012776,0.96419185,0.00046119036,0.0011561366,0.00013326407,0.00028604883,0.00009146778,0.0005716944,0.000034737343,0.00019430205,0.00012800038],"about_ca_topic_score_codex":0.00009839413,"about_ca_topic_score_gemma":0.000009728989,"teacher_disagreement_score":0.6886031,"about_ca_system_score_codex":0.00008006144,"about_ca_system_score_gemma":0.000048580514,"threshold_uncertainty_score":0.9993617},"labels":[],"label_agreement":null},{"id":"W2892566498","doi":"10.1016/j.jtcvs.2018.08.114","title":"Aspirin in coronary artery surgery: 1-year results of the Aspirin and Tranexamic Acid for Coronary Artery Surgery trial","year":2018,"lang":"en","type":"article","venue":"Journal of Thoracic and Cardiovascular Surgery","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut universitaire de cardiologie et de pneumologie de Québec","funders":"National Health and Medical Research Council; Australian and New Zealand College of Anaesthetists; Medical Research Council; National Institute for Health and Care Research","keywords":"Aspirin; Tranexamic acid; Medicine; Artery; Surgery; Cardiology; Internal medicine; Blood loss","score_opus":0.03210586919958794,"score_gpt":0.2755406765682239,"score_spread":0.24343480736863596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892566498","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9577329,0.039364174,0.00039870193,0.00024092633,0.00137151,0.0007569109,0.000057843095,0.000019084484,0.000057920133],"genre_scores_gemma":[0.99046355,0.007912307,0.0000830709,0.00020906815,0.001171364,0.000023939643,0.000027861099,0.000062425606,0.000046416513],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99537146,0.0009366414,0.0016673973,0.00048658546,0.0010208129,0.00051711284],"domain_scores_gemma":[0.9963637,0.0015699207,0.00059255766,0.00080866343,0.00038093905,0.0002842125],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.008724428,0.00040670013,0.0026052438,0.00057019986,0.00015558382,0.000043033488,0.00015572083,0.00029506386,0.000017791654],"category_scores_gemma":[0.00066241773,0.00029768414,0.005043374,0.00046498526,0.000564378,0.0003265206,0.000066389424,0.00040953915,0.000002101895],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17212117,0.00072012073,0.15792218,0.0014512625,0.013802261,0.0026725936,0.00039810652,0.000026263904,0.0010003609,0.0000075352477,0.004954551,0.6449236],"study_design_scores_gemma":[0.036143363,0.001492219,0.89121705,0.0051122634,0.0067654615,0.022950951,0.0011935133,0.0000606744,0.009021869,0.00033640256,0.02449766,0.0012085801],"about_ca_topic_score_codex":0.000012395802,"about_ca_topic_score_gemma":0.0000064606174,"teacher_disagreement_score":0.73329484,"about_ca_system_score_codex":0.00005406851,"about_ca_system_score_gemma":0.0006404727,"threshold_uncertainty_score":0.99994755},"labels":[],"label_agreement":null},{"id":"W2893389879","doi":"10.1016/j.cjca.2018.07.193","title":"PROLONGED DUAL ANTIPLATELET THERAPY AFTER ACS: 1 YEAR EXPERIENCE OF A DEDICATED DAPT CLINIC","year":2018,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Alberta Hospital Edmonton","funders":"","keywords":"Medicine; Acute coronary syndrome; Internal medicine; Clinical trial; Emergency medicine; Cardiology; Myocardial infarction","score_opus":0.02224438964108241,"score_gpt":0.2744609005295713,"score_spread":0.2522165108884889,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2893389879","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923413,0.005207219,0.00027486484,0.00021460772,0.0004841322,0.00017158398,0.000020271282,0.00000720515,0.0012788104],"genre_scores_gemma":[0.9971276,0.0008044708,0.000098893535,0.0004239443,0.0014442259,0.0000062318045,0.0000054855714,0.000021715843,0.00006746864],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99861,0.00020391014,0.00046875197,0.00017098042,0.00020138145,0.00034495277],"domain_scores_gemma":[0.99847156,0.00003982856,0.00019544411,0.00031501075,0.0004536795,0.0005244715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005046368,0.00014544596,0.00074312754,0.00024686928,0.00005718128,0.000008543151,0.00015817177,0.0001956942,0.0003982124],"category_scores_gemma":[0.00014882704,0.000114465525,0.00048522302,0.00019356252,0.0008099032,0.00007707696,0.0000097875,0.00024287561,0.000036957063],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012621735,0.000050001086,0.89060503,0.00007335553,0.007339735,0.0075378013,0.0055339397,0.000020654532,0.00988267,0.000057693953,0.018436758,0.04784061],"study_design_scores_gemma":[0.009038343,0.004421197,0.6116995,0.0002405548,0.00048402656,0.0063688247,0.0012949613,0.0000036270492,0.009608945,0.00012422362,0.3563567,0.0003590716],"about_ca_topic_score_codex":0.00008839524,"about_ca_topic_score_gemma":0.00007464008,"teacher_disagreement_score":0.33791995,"about_ca_system_score_codex":0.00003906041,"about_ca_system_score_gemma":0.0011527645,"threshold_uncertainty_score":0.46677685},"labels":[],"label_agreement":null},{"id":"W2893465077","doi":"10.1016/j.cjca.2018.07.285","title":"SAME DAY DISCHARGE AFTER ELECTIVE PERCUTANEOUS CORONARY INTERVENTION IN ONTARIO: HOSPITAL VARIATION IN UTILIZATION AND CLINICAL OUTCOMES","year":2018,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Toronto Public Health","funders":"","keywords":"Conventional PCI; Medicine; Percutaneous coronary intervention; Propensity score matching; Observational study; Incidence (geometry); Population; Emergency medicine; Surgery; Internal medicine; Myocardial infarction","score_opus":0.01644661828423652,"score_gpt":0.2776327851168718,"score_spread":0.2611861668326353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2893465077","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99678475,0.0011111525,0.0010055663,0.00018803103,0.00055080786,0.0001609378,0.0000057008124,0.000002095884,0.00019095105],"genre_scores_gemma":[0.99933493,0.00014771809,0.000041178828,0.00015837596,0.0002475112,0.0000024605292,0.000008959967,0.000008954838,0.00004988195],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99892503,0.00028472726,0.000394656,0.00013892935,0.00007839955,0.0001782704],"domain_scores_gemma":[0.9994407,0.00005253572,0.00008987371,0.00009192741,0.00012404866,0.00020087672],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005900181,0.00009018607,0.00045790226,0.00023649693,0.000024277037,0.000009390811,0.00004313028,0.00014025663,0.00007295253],"category_scores_gemma":[0.00020056836,0.0000782094,0.00027056175,0.00007442184,0.00014801328,0.000101659345,0.000006756269,0.0002707596,0.000003179632],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034856284,0.000013022513,0.9882225,0.0000043482273,0.00032538408,0.00085559086,0.00067037006,0.000006940882,0.0000068641048,0.000023158858,0.00004789157,0.009475399],"study_design_scores_gemma":[0.0015990374,0.0009587599,0.9930424,0.00006800635,0.00013336173,0.0013218893,0.00016459027,0.000014952846,0.0000014258121,0.00022343204,0.0023979626,0.000074149895],"about_ca_topic_score_codex":0.0133270295,"about_ca_topic_score_gemma":0.33119133,"teacher_disagreement_score":0.3178643,"about_ca_system_score_codex":0.00029696527,"about_ca_system_score_gemma":0.000539362,"threshold_uncertainty_score":0.99324334},"labels":[],"label_agreement":null},{"id":"W2893533072","doi":"10.1016/j.cjca.2018.07.391","title":"CONTEMPORARY ANTIPLATELET THERAPY IN MODERATE TO HIGH-RISK PATIENTS WITH NON-ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION: INSIGHTS FROM THE CANADIAN ACS REFLECTIVE II STUDY","year":2018,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Toronto Public Health","funders":"","keywords":"Medicine; Interquartile range; Internal medicine; Framingham Risk Score; Cardiology; Logistic regression; Myocardial infarction; Hazard ratio; Atrial fibrillation; Confidence interval; Disease","score_opus":0.01448319985431413,"score_gpt":0.23398994732296685,"score_spread":0.21950674746865273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2893533072","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959224,0.0005370755,0.00030988382,0.00078289834,0.0006663872,0.001061103,0.0001280858,0.000005654165,0.00058651186],"genre_scores_gemma":[0.9962768,0.000084560976,0.000042046995,0.0019181556,0.0015435993,0.000022785867,0.000072205636,0.00003106149,0.000008770207],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99801946,0.00053330517,0.00043507776,0.00029447486,0.00033295454,0.00038470127],"domain_scores_gemma":[0.9977928,0.000060266048,0.000197478,0.00037850623,0.0008237377,0.0007472152],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045611916,0.00024285751,0.00074266864,0.00045954413,0.0005559208,0.000045679568,0.00020202815,0.00016489752,0.000016184042],"category_scores_gemma":[0.00008039467,0.00016126562,0.00019143515,0.0004198249,0.000195812,0.00016069965,0.000014125113,0.0004535525,0.000008378806],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033808865,0.00002893553,0.97515506,0.0000013313029,0.003176091,0.00041507118,0.00361094,0.0010211341,0.000035727917,0.000009759304,0.005007474,0.008157563],"study_design_scores_gemma":[0.008409851,0.005556057,0.95872724,0.000050026512,0.00017946622,0.000041646967,0.00082362426,0.0000060100947,0.000080641665,0.00009728948,0.02583823,0.00018992992],"about_ca_topic_score_codex":0.21886216,"about_ca_topic_score_gemma":0.40573105,"teacher_disagreement_score":0.18686888,"about_ca_system_score_codex":0.000557632,"about_ca_system_score_gemma":0.003621758,"threshold_uncertainty_score":0.7863395},"labels":[],"label_agreement":null},{"id":"W2894284536","doi":"10.1016/j.cjca.2018.07.332","title":"REAL-WORLD USE OF TICAGRELOR DOES NOT REDUCE MAJOR ADVERSE CARDIOVASCULAR EVENTS, BUT INCREASES MAJOR BLEEDING AND HEALTHCARE VISITS FOR DYSPNEA COMPARED TO CLOPIDOGREL: A CANADIAN REGISTRY STUDY","year":2018,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Alberta Hospital Edmonton","funders":"","keywords":"Medicine; Ticagrelor; Clopidogrel; Percutaneous coronary intervention; Mace; Prasugrel; Conventional PCI; Acute coronary syndrome; Internal medicine; Hazard ratio; Coronary artery disease; Cardiology; Aspirin; Myocardial infarction; Emergency medicine; Confidence interval","score_opus":0.03455002705598098,"score_gpt":0.2891351343750999,"score_spread":0.25458510731911893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2894284536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934955,0.0021253242,0.00029505143,0.0012616131,0.00070831995,0.0013399422,0.00061595545,0.000013909702,0.00014435759],"genre_scores_gemma":[0.996458,0.00024752537,0.00055865647,0.00052122865,0.0019268356,0.000029197236,0.000030107902,0.000059760216,0.00016868192],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972195,0.0004057913,0.00078530377,0.00045587998,0.000364641,0.0007689021],"domain_scores_gemma":[0.9950504,0.00017368146,0.00025791593,0.0006905229,0.0011577472,0.002669765],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010960199,0.00032749074,0.001721631,0.00095031323,0.00032413699,0.00002750779,0.00026556282,0.00019111132,0.000018867711],"category_scores_gemma":[0.0006274001,0.00027581328,0.0009624658,0.00037365255,0.00028936713,0.0001471956,0.000030963016,0.00028479486,0.0000037954435],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006103871,0.00007000084,0.9271041,0.00066876,0.028456317,0.0042496747,0.0017340265,0.0005085134,0.0010667864,0.0003304532,0.011268186,0.018439276],"study_design_scores_gemma":[0.0096420925,0.0031676784,0.7730318,0.0007224031,0.006917031,0.0028063178,0.0048696054,0.000024089735,0.0008934169,0.0000735984,0.19711174,0.000740247],"about_ca_topic_score_codex":0.31529915,"about_ca_topic_score_gemma":0.3936165,"teacher_disagreement_score":0.18584356,"about_ca_system_score_codex":0.00046387612,"about_ca_system_score_gemma":0.003162826,"threshold_uncertainty_score":0.9999694},"labels":[],"label_agreement":null},{"id":"W2894345503","doi":"10.1161/atvbaha.118.311404","title":"Effect of Different Doses of Acetylsalicylic Acid on the Antithrombotic Activity of Clopidogrel in a Mouse Arterial Thrombosis Model","year":2018,"lang":"en","type":"article","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Antithrombotic; Clopidogrel; Medicine; Thrombosis; Aspirin; Cardiology; Pharmacology; Internal medicine; Anesthesia","score_opus":0.03220252564266975,"score_gpt":0.29998228551793366,"score_spread":0.2677797598752639,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2894345503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986236,0.0001037128,0.00025509394,0.0001428002,0.00009735953,0.0006562013,0.00005731236,0.000019013858,0.00004491738],"genre_scores_gemma":[0.99656796,0.0031231462,0.000052728294,0.00010280353,0.00006632332,0.000043892367,0.000012144748,0.000030108968,8.977969e-7],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99792033,0.0005891955,0.00049253576,0.000432013,0.00024546185,0.00032047502],"domain_scores_gemma":[0.998634,0.00020257435,0.00025228862,0.0007382955,0.00008994153,0.000082909966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005949695,0.00033613623,0.0014840679,0.00016102863,0.00007853868,0.000008603555,0.00018550587,0.00022381659,0.00006037929],"category_scores_gemma":[0.00008067014,0.00020393309,0.000664373,0.00022690368,0.0010723013,0.00006251964,0.000105088795,0.00012258899,0.0000026431157],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023601773,0.00058429374,0.09538916,0.00024508586,0.0011226919,4.147697e-8,0.00036325445,0.0000043198625,0.90080875,0.00040988196,0.000012381861,0.0008240944],"study_design_scores_gemma":[0.0026569308,0.0035591375,0.61227095,0.00026641242,0.00040559814,4.108526e-7,0.000041286956,0.00044630773,0.38016945,0.00003867951,0.000005883331,0.00013894736],"about_ca_topic_score_codex":0.00007696956,"about_ca_topic_score_gemma":0.000026390871,"teacher_disagreement_score":0.52063936,"about_ca_system_score_codex":0.00002268711,"about_ca_system_score_gemma":0.0000358867,"threshold_uncertainty_score":0.83161503},"labels":[],"label_agreement":null},{"id":"W2895129572","doi":"10.1016/j.jcjd.2018.08.013","title":"Trends and Determinants of Self-Reported Aspirin Use Among Patients with Diabetes Stratified by the Presence of Cardiovascular Diseases—A Repeated Pan-Canadian Cross-Sectional Study","year":2018,"lang":"en","type":"article","venue":"Canadian Journal of Diabetes","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Aspirin; Diabetes mellitus; Cross-sectional study; Primary prevention; Secondary prevention; Disease; Environmental health; Internal medicine; Gerontology; Endocrinology; Pathology","score_opus":0.011425916067648569,"score_gpt":0.22980534646785597,"score_spread":0.2183794304002074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2895129572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99662334,0.0025388189,0.000001057339,0.000009730626,0.00012379145,0.00038447717,0.00028272634,0.0000068497607,0.000029233015],"genre_scores_gemma":[0.9997566,0.000011193292,0.000014242807,0.000031031053,0.00008377219,0.000008591277,0.00003227769,0.000029068415,0.000033240023],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99783343,0.0001996696,0.00067589566,0.00026432762,0.0006005974,0.0004260802],"domain_scores_gemma":[0.99708253,0.00009906924,0.00041884903,0.0005193786,0.0009739703,0.0009062134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005400515,0.00022627192,0.0007075284,0.00038788724,0.00021970563,0.00008617872,0.00020358569,0.00009480359,0.000056501463],"category_scores_gemma":[0.0002518131,0.0001544157,0.00041169513,0.00041813712,0.00070793624,0.00031878744,0.000012858407,0.0001759128,4.3040532e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041761952,0.00013780316,0.9889183,0.000048194514,0.005544272,0.00004877722,0.00019061005,0.000015425354,0.000026765365,5.022419e-7,0.000103982406,0.0049236054],"study_design_scores_gemma":[0.002475684,0.0014191035,0.992947,0.00016271477,0.0018187674,0.0000058490664,0.000092931026,0.000040132487,0.0006561445,0.0000044976987,0.0002173436,0.00015987318],"about_ca_topic_score_codex":0.012523864,"about_ca_topic_score_gemma":0.036739934,"teacher_disagreement_score":0.024216069,"about_ca_system_score_codex":0.00007866861,"about_ca_system_score_gemma":0.00095816806,"threshold_uncertainty_score":0.9940518},"labels":[],"label_agreement":null},{"id":"W2896051458","doi":"10.1016/j.jtcvs.2018.09.087","title":"A perspective on the one-year results of the Aspirin and Tranexemic Acid for Coronary Artery Surgery trial","year":2018,"lang":"en","type":"letter","venue":"Journal of Thoracic and Cardiovascular Surgery","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Jubilee Hospital; University of British Columbia","funders":"","keywords":"Medicine; Aspirin; Perspective (graphical); Artery; Surgery; Coronary artery bypass surgery; Clinical trial; Randomized controlled trial; Cardiology; Internal medicine","score_opus":0.041407329367689455,"score_gpt":0.28030026702797317,"score_spread":0.23889293766028372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896051458","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79528797,0.111052446,0.0002795525,0.08762517,0.0026993873,0.002409976,0.000307803,0.000027791995,0.0003098976],"genre_scores_gemma":[0.90300435,0.027349707,0.00008078355,0.049841672,0.01887629,0.00009351855,0.00007897173,0.00022584421,0.0004488477],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99525446,0.0012102011,0.0011179919,0.00050078373,0.001506511,0.0004100402],"domain_scores_gemma":[0.9949829,0.0022996538,0.0008187172,0.001083958,0.0006778997,0.00013688623],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0063180216,0.00047532376,0.002656041,0.00033623868,0.00021891386,0.000056727404,0.00023110544,0.00061741483,0.000017563534],"category_scores_gemma":[0.0010594453,0.0002695087,0.009166805,0.00024739586,0.0006178236,0.00011278424,0.000057173173,0.0013201495,0.000001766419],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15438114,0.0003353778,0.00064546795,0.0018515276,0.060011465,0.0018178459,0.00067114405,0.00000640464,0.00009658882,0.00001575235,0.716666,0.06350127],"study_design_scores_gemma":[0.036593605,0.0029781573,0.012060559,0.012444486,0.04212324,0.014330087,0.0026335553,0.000009994013,0.004034986,0.0011965871,0.86984575,0.0017490161],"about_ca_topic_score_codex":0.000008791013,"about_ca_topic_score_gemma":5.9310645e-7,"teacher_disagreement_score":0.15317972,"about_ca_system_score_codex":0.00009180062,"about_ca_system_score_gemma":0.0006343342,"threshold_uncertainty_score":0.9999757},"labels":[],"label_agreement":null},{"id":"W2896414613","doi":"10.1007/s00228-018-2564-8","title":"Trends in concomitant clopidogrel and proton pump inhibitor treatment among ACS inpatients, 2000–2016","year":2018,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Clopidogrel; Lansoprazole; Medicine; Esomeprazole; Concomitant; Acute coronary syndrome; Omeprazole; Rabeprazole; Proton-pump inhibitor; Pantoprazole; CYP2C19; Internal medicine; Drug; Pharmacology; Aspirin; Myocardial infarction","score_opus":0.049308081505132925,"score_gpt":0.38468215333036476,"score_spread":0.3353740718252318,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896414613","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937799,0.0016469676,0.000022006949,0.00059449684,0.0012888475,0.00030249672,0.000004707497,0.000013097922,0.002347468],"genre_scores_gemma":[0.99131465,0.0034251742,0.00008827343,0.0011651897,0.0035855754,0.0000040561927,0.0000034457642,0.000029342576,0.00038427362],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9967094,0.0013865043,0.0012307633,0.00023006488,0.00020017094,0.00024306965],"domain_scores_gemma":[0.99869734,0.00016831656,0.00046342466,0.00013559543,0.00016029012,0.0003750107],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016994847,0.00017721912,0.0007693,0.00020617158,0.00004743066,0.000011026166,0.000108596905,0.000068676265,0.00036072874],"category_scores_gemma":[0.00011478027,0.00012069052,0.00041073773,0.00015175898,0.00054249814,0.00010476045,0.000045957513,0.0003801596,0.000037638572],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010205005,0.001782465,0.42559487,0.00003092335,0.0014058503,0.0041519515,0.0004226628,0.0000033408494,0.0011462463,0.000002885842,0.00732311,0.54793066],"study_design_scores_gemma":[0.03210294,0.013887617,0.7857264,0.00022047713,0.00065673765,0.00032491796,0.000052720607,0.000034123794,0.0030224533,0.000008470183,0.16379145,0.00017165147],"about_ca_topic_score_codex":0.0000030935917,"about_ca_topic_score_gemma":0.0000013982783,"teacher_disagreement_score":0.54775906,"about_ca_system_score_codex":0.000057956036,"about_ca_system_score_gemma":0.00016144256,"threshold_uncertainty_score":0.49216166},"labels":[],"label_agreement":null},{"id":"W2896637531","doi":"10.1177/1715163518802866","title":"Dual antiplatelet therapy: A new whiteboard video for patient education","year":2018,"lang":"en","type":"article","venue":"Canadian Pharmacists Journal / Revue des Pharmaciens du Canada","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Regina General Hospital; Sunnybrook Health Science Centre; University of Alberta; St. Michael's Hospital","funders":"University of Alberta","keywords":"Dual (grammatical number); Whiteboard; Interactive whiteboard; Medicine; Computer science; Multimedia; Art","score_opus":0.026555427962283547,"score_gpt":0.27648764494153727,"score_spread":0.24993221697925372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896637531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986789,0.006411611,0.00043557154,0.0004003673,0.0035082167,0.0010205467,0.0002604162,0.000042271735,0.0011319988],"genre_scores_gemma":[0.9772038,0.0059032897,0.0005212758,0.010044637,0.00500203,0.00003567837,0.00009390557,0.00008594369,0.0011094331],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99753654,0.000108486805,0.0005184145,0.00043748933,0.00046990346,0.00092915166],"domain_scores_gemma":[0.9953776,0.000049714894,0.00020157675,0.0003224102,0.0009632817,0.0030854417],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00035444504,0.000384514,0.00048624413,0.00034646728,0.00083605945,0.00015833192,0.00024694833,0.0000855409,0.0012034635],"category_scores_gemma":[0.000120548524,0.00037240898,0.00044376377,0.00046830787,0.00019826523,0.00027555163,0.000018529769,0.00035654265,0.000021803553],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012378772,0.00010344884,0.00089591235,0.00009301794,0.0008826362,0.008480415,0.0010312413,0.00002597921,0.0039366237,0.000020430633,0.18710779,0.7961846],"study_design_scores_gemma":[0.0042897593,0.000353224,0.000054836048,0.0000514919,0.00030764833,0.30616045,0.00003064777,0.0002370895,0.016612006,0.000098504344,0.6713331,0.00047130103],"about_ca_topic_score_codex":0.0100953635,"about_ca_topic_score_gemma":0.014664905,"teacher_disagreement_score":0.7957133,"about_ca_system_score_codex":0.0012404069,"about_ca_system_score_gemma":0.014956151,"threshold_uncertainty_score":0.9998728},"labels":[],"label_agreement":null},{"id":"W2896677774","doi":"10.1007/s40256-018-0305-0","title":"Morphine and Ticagrelor Interaction in Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction: ATLANTIC-Morphine","year":2018,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Canada Research Chairs; Canadian Heart Research Centre; Southlake Regional Health Center; University of Toronto","funders":"AstraZeneca","keywords":"Medicine; Ticagrelor; Morphine; Percutaneous coronary intervention; Myocardial infarction; Cardiology; Internal medicine; Anesthesia","score_opus":0.006196942118179152,"score_gpt":0.23536688538845008,"score_spread":0.22916994327027093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896677774","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903541,0.006079037,0.0023127075,0.00036663754,0.0003481914,0.00034390093,0.0000037277387,0.000018443116,0.0001732597],"genre_scores_gemma":[0.9935942,0.004681882,0.00063481514,0.00030571013,0.0006933249,0.000008117384,0.0000326793,0.000033930857,0.00001528634],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99751073,0.00036630066,0.0007568619,0.00030609893,0.0007897743,0.00027020494],"domain_scores_gemma":[0.99884754,0.00006235169,0.00029591742,0.00034031566,0.00029070082,0.00016318708],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013474394,0.00024075207,0.0010355149,0.00052375696,0.000052165906,0.000031942403,0.0001004936,0.00007123515,0.000059547718],"category_scores_gemma":[0.000078769364,0.00021697891,0.0011246748,0.00051344396,0.0003250688,0.00033155558,0.000052793155,0.00040656087,0.000008831592],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053955363,0.00045152826,0.08548024,0.00012577885,0.0063678883,0.0018720289,0.0011561913,0.0009165386,0.0016187056,0.000012722667,0.00013447135,0.89646834],"study_design_scores_gemma":[0.01270308,0.00450344,0.9153645,0.0012394754,0.0026720732,0.034409158,0.0038043193,0.00067695393,0.00032388052,0.000099671706,0.023621809,0.0005816622],"about_ca_topic_score_codex":0.00027014108,"about_ca_topic_score_gemma":0.0000101743735,"teacher_disagreement_score":0.8958867,"about_ca_system_score_codex":0.0003624035,"about_ca_system_score_gemma":0.00011081121,"threshold_uncertainty_score":0.8848143},"labels":[],"label_agreement":null},{"id":"W2896884606","doi":"10.1002/ccd.27921","title":"Pre‐hospital administration of ticagrelor in diabetic patients with ST‐elevation myocardial infarction undergoing primary angioplasty: A sub‐analysis of the ATLANTIC trial","year":2018,"lang":"en","type":"article","venue":"Catheterization and Cardiovascular Interventions","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Southlake Regional Health Center; Canadian Heart Research Centre; University of Toronto; St. Michael's Hospital","funders":"AstraZeneca","keywords":"Medicine; Ticagrelor; Primary angioplasty; Myocardial infarction; Cardiology; Internal medicine; Angioplasty; Percutaneous coronary intervention","score_opus":0.007959952470651073,"score_gpt":0.22644192053249634,"score_spread":0.21848196806184528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896884606","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874588,0.0003108692,0.0110990945,0.000024824758,0.00014677818,0.000862518,0.00003464368,0.0000148191175,0.00004760328],"genre_scores_gemma":[0.99934673,0.00011049704,0.00003660942,0.000017640457,0.00005654503,0.000044821027,0.00036412652,0.0000130723265,0.000009959287],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985907,0.0001956873,0.0004385211,0.00023839776,0.0004209297,0.000115754345],"domain_scores_gemma":[0.9990958,0.000029599201,0.00018073544,0.000387208,0.00026264106,0.00004400871],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029467812,0.00012779042,0.00049393665,0.00027239427,0.000071602575,0.00001800778,0.00005924142,0.00007607737,0.000020209318],"category_scores_gemma":[0.00008988588,0.00009688764,0.0016218831,0.00082924083,0.00019405135,0.00012442583,0.000030918447,0.00006659193,5.819715e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060714073,0.0014067226,0.9572851,0.00055503554,0.02509348,0.0000025866907,0.00061740045,0.00043915413,0.0006287477,0.00023015444,0.0000088227325,0.0076613612],"study_design_scores_gemma":[0.011787015,0.0014389887,0.9767748,0.00035453128,0.008682169,0.0000033358442,0.00007642774,0.00019289287,0.0005166636,0.000012921468,0.000049337643,0.00011089377],"about_ca_topic_score_codex":0.00001448511,"about_ca_topic_score_gemma":0.000035663947,"teacher_disagreement_score":0.019489694,"about_ca_system_score_codex":0.00003876286,"about_ca_system_score_gemma":0.000086223736,"threshold_uncertainty_score":0.39509633},"labels":[],"label_agreement":null},{"id":"W2897299959","doi":"10.1016/j.jtcvs.2018.10.025","title":"Hacked by the Russians","year":2018,"lang":"en","type":"letter","venue":"Journal of Thoracic and Cardiovascular Surgery","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Tranexamic acid; Medicine; Mace; Aspirin; Placebo; Myocardial infarction; Clinical trial; Randomized controlled trial; Surgery; Internal medicine; Alternative medicine; Percutaneous coronary intervention; Blood loss; Pathology","score_opus":0.018354843215331797,"score_gpt":0.26171176906147303,"score_spread":0.24335692584614124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897299959","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.034769263,0.7386196,0.0030451359,0.21861272,0.002704044,0.000640275,0.00007482353,0.000069955546,0.0014641352],"genre_scores_gemma":[0.09236917,0.1414037,0.00031614595,0.70124364,0.058227807,0.000045092267,0.0003605163,0.00053868594,0.005495232],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957753,0.00079242844,0.0008221995,0.00038707964,0.0017450175,0.00047799837],"domain_scores_gemma":[0.9974621,0.00034310285,0.00047782238,0.001093674,0.00041451922,0.00020879881],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0033838109,0.0004865183,0.0023475522,0.0002617267,0.00021878797,0.000117066185,0.00026706528,0.00075081695,0.00012705254],"category_scores_gemma":[0.00018780825,0.00028923727,0.008572415,0.00026495606,0.00047920196,0.0001482267,0.00006273864,0.0018649033,0.000026155969],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023183042,0.000028711378,0.00034347814,0.0003800061,0.018750964,0.0043280744,0.00004792366,0.0000010202056,0.0000083988125,4.98877e-7,0.8706378,0.10524134],"study_design_scores_gemma":[0.0003524272,0.000094906565,0.0004401383,0.0006688345,0.00860035,0.015579806,0.00008026602,0.0000020463506,0.00018024197,0.000059147165,0.9736178,0.00032405063],"about_ca_topic_score_codex":0.000011011966,"about_ca_topic_score_gemma":1.3521026e-7,"teacher_disagreement_score":0.59721595,"about_ca_system_score_codex":0.00005165014,"about_ca_system_score_gemma":0.000383366,"threshold_uncertainty_score":0.99995595},"labels":[],"label_agreement":null},{"id":"W2897591802","doi":"10.1055/s-0038-1673381","title":"In Vitro Reversal of the Anti-Aggregant Effect of Ticagrelor Using Untreated Platelets","year":2018,"lang":"en","type":"article","venue":"Thrombosis and Haemostasis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; McMaster University; Population Health Research Institute","funders":"Hamilton Health Sciences","keywords":"Ticagrelor; Platelet; Medicine; Platelet transfusion; Pharmacology; Anesthesia; Acute coronary syndrome; Cardiology; Internal medicine; Myocardial infarction","score_opus":0.02670027590252475,"score_gpt":0.30719578558613747,"score_spread":0.2804955096836127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897591802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99816614,0.0010871111,0.000014487969,0.00017431143,0.00007379704,0.00032240266,0.000029801537,0.000009483857,0.0001224784],"genre_scores_gemma":[0.9991094,0.0005913132,0.00012371785,0.000095863485,0.000047957827,0.0000018334609,0.0000042444644,0.00001563607,0.000010027823],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990645,0.0001229157,0.00024444945,0.00018080226,0.00021462078,0.00017271226],"domain_scores_gemma":[0.99940604,0.00006452892,0.00010313852,0.00030660865,0.000064656546,0.000054999917],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002622643,0.00014043871,0.00062662543,0.000073680094,0.00006209955,0.000005058559,0.00007090784,0.00008235862,0.0000837791],"category_scores_gemma":[0.00004398083,0.000085666106,0.00022965268,0.000310122,0.00039885187,0.000054901753,0.00004787932,0.00007839544,0.0000021348117],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003623634,0.0003550716,0.12648371,0.0007844207,0.0022539466,0.000050152845,0.0011286982,0.000007324019,0.8148991,0.00007602725,0.00031967388,0.05001824],"study_design_scores_gemma":[0.0032563426,0.00032146488,0.08595777,0.00038042694,0.00075044023,0.000045056473,0.000061850034,0.0001973299,0.9087121,0.000014024787,0.00020782676,0.00009535543],"about_ca_topic_score_codex":0.00020892778,"about_ca_topic_score_gemma":0.000003807841,"teacher_disagreement_score":0.09381301,"about_ca_system_score_codex":0.00001996307,"about_ca_system_score_gemma":0.000040105228,"threshold_uncertainty_score":0.34933624},"labels":[],"label_agreement":null},{"id":"W2897713884","doi":"10.1002/ccd.27909","title":"Are all P2Y12 equally effective in vein graft angioplasty? A report from the UK database","year":2018,"lang":"en","type":"letter","venue":"Catheterization and Cardiovascular Interventions","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact","funders":"","keywords":"Prasugrel; Medicine; Ticagrelor; Clopidogrel; P2Y12; Angioplasty; Internal medicine; Cardiology; Regimen; Aspirin","score_opus":0.03621649786460921,"score_gpt":0.28913252424969244,"score_spread":0.2529160263850832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897713884","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.40447718,0.2955954,0.15543224,0.114334665,0.0055845263,0.014664059,0.0069798348,0.00091288873,0.0020192014],"genre_scores_gemma":[0.6224241,0.007503101,0.00051711645,0.29348576,0.014003883,0.0027833418,0.054832768,0.0006338872,0.0038160295],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963401,0.0008225997,0.000701413,0.000995537,0.0007367562,0.00040360694],"domain_scores_gemma":[0.9972975,0.00013114567,0.00034793303,0.0018566205,0.0002427782,0.00012398427],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00093631225,0.0005063495,0.0011455574,0.00023634233,0.00017280337,0.00014501374,0.00026224597,0.0005423494,0.00029940112],"category_scores_gemma":[0.00034564573,0.00039675162,0.0049657617,0.00032631098,0.00029634166,0.00013481152,0.00018763819,0.00089646346,0.000057499667],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004856846,0.0007135829,0.026420189,0.0023838764,0.06408568,0.0316135,0.0012244898,0.00005350801,0.00032141173,0.000030315416,0.8467002,0.025967574],"study_design_scores_gemma":[0.0033003234,0.00019065624,0.0557779,0.004091811,0.008207472,0.0016365963,0.00028417166,0.00004582988,0.00012451164,0.000106624,0.9255103,0.0007238282],"about_ca_topic_score_codex":0.00018765048,"about_ca_topic_score_gemma":0.000055335495,"teacher_disagreement_score":0.28809232,"about_ca_system_score_codex":0.000090133384,"about_ca_system_score_gemma":0.000070471644,"threshold_uncertainty_score":0.9998484},"labels":[],"label_agreement":null},{"id":"W2899366185","doi":"10.18433/jpps29913","title":"Appropriateness of Ticagrelor Use at Initiation: A Population-Based Cohort Study","year":2018,"lang":"en","type":"article","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"The Quebec Population Health Research Network; Université Laval","funders":"AstraZeneca Canada; AstraZeneca","keywords":"Ticagrelor; Medicine; Concomitant; Medical prescription; Acute coronary syndrome; Context (archaeology); Population; Cohort; Retrospective cohort study; Logistic regression; Emergency medicine; Internal medicine; Myocardial infarction; Pharmacology; Environmental health","score_opus":0.09238000853712654,"score_gpt":0.40631249300378336,"score_spread":0.31393248446665684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899366185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974648,0.00066710386,0.00036452833,0.00040309603,0.00037869895,0.00047215313,0.000005015982,0.000016040043,0.00022859058],"genre_scores_gemma":[0.99821526,0.00013998848,0.00047526174,0.0006441713,0.00048339684,0.000004838058,0.0000024950057,0.000010548847,0.000024065308],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973534,0.0002429932,0.0006516528,0.00022036239,0.0012826134,0.0002490042],"domain_scores_gemma":[0.9984801,0.00017476676,0.0003259773,0.00014155642,0.00055925845,0.00031833927],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016782172,0.00015006003,0.0004643615,0.00018864927,0.00022178693,0.000040732295,0.00022396543,0.000030141566,0.0010590558],"category_scores_gemma":[0.00022196698,0.00010293641,0.00033524196,0.000584861,0.00048153184,0.00038552706,0.000043881366,0.00017129954,0.00001563662],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013123509,0.00086158904,0.98326504,0.00004036198,0.00038931164,0.00008970428,0.0001046198,0.000111645604,0.004956996,0.000029370356,0.00008756806,0.008751448],"study_design_scores_gemma":[0.008070705,0.0011270485,0.9367943,0.000091191614,0.0016145385,0.00024416723,0.00014003957,0.00535918,0.037886683,0.000030286923,0.008451947,0.00018993899],"about_ca_topic_score_codex":0.000030784915,"about_ca_topic_score_gemma":0.0000022485,"teacher_disagreement_score":0.04647076,"about_ca_system_score_codex":0.00008086696,"about_ca_system_score_gemma":0.0002823489,"threshold_uncertainty_score":0.9998541},"labels":[],"label_agreement":null},{"id":"W2900564308","doi":"10.1016/j.ahj.2018.10.009","title":"Design and rationale of the Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Standard DAPT Regimen (MASTER DAPT) Study","year":2018,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"ReCor Medical; Abbott Vascular; Boston Scientific Corporation; Terumo; AstraZeneca","keywords":"Medicine; Regimen; Randomized controlled trial; Stent; Surgery; Adverse effect; Drug-eluting stent; Clinical endpoint; Coronary artery disease; Coronary stent; Internal medicine; Concomitant; Restenosis","score_opus":0.021230586850841088,"score_gpt":0.2639476795569573,"score_spread":0.24271709270611622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900564308","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982113,0.00020624361,0.00076483644,0.00006528708,0.00006720399,0.0006346977,0.00002319759,0.0000076351225,0.000019559757],"genre_scores_gemma":[0.9985909,0.00018314969,0.0010585822,0.00007376032,0.000044832603,0.0000055161545,0.000010635791,0.000015444224,0.000017207518],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986466,0.0002799911,0.000264575,0.00015212296,0.00051050173,0.00014621906],"domain_scores_gemma":[0.9989431,0.00003730571,0.0002936279,0.00019724874,0.00043088975,0.00009784756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035711922,0.00011530515,0.0003185537,0.000072655654,0.00017741977,0.000019927336,0.00006424536,0.00001535803,0.00004131425],"category_scores_gemma":[0.000007788497,0.00007067534,0.00007044592,0.00023122808,0.0002452436,0.00011595014,0.000024593457,0.000093661656,9.0045916e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07907734,0.001543179,0.86307955,0.00009441654,0.009463281,0.00006001358,0.0036111628,0.00026169393,0.003965297,0.000025344374,0.00036319977,0.038455512],"study_design_scores_gemma":[0.016402695,0.027081802,0.9303205,0.0003257652,0.0021452338,0.00013419658,0.011206432,0.000100432124,0.011986797,0.000009146463,0.00010160923,0.00018539524],"about_ca_topic_score_codex":0.00016250061,"about_ca_topic_score_gemma":0.000006245806,"teacher_disagreement_score":0.06724094,"about_ca_system_score_codex":0.000034036544,"about_ca_system_score_gemma":0.00006907396,"threshold_uncertainty_score":0.28820568},"labels":[],"label_agreement":null},{"id":"W2900800197","doi":"10.1111/ijn.12707","title":"Meta‐analysis of risk and protective factors for gastrointestinal bleeding after percutaneous coronary intervention","year":2018,"lang":"en","type":"review","venue":"International Journal of Nursing Practice","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Gastrointestinal bleeding; Percutaneous coronary intervention; Myocardial infarction; Internal medicine; Cochrane Library; Surgery; Meta-analysis","score_opus":0.09740550812263456,"score_gpt":0.41199676011259484,"score_spread":0.3145912519899603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900800197","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012704132,0.97501075,0.022627879,0.00006302924,0.00036353842,0.000429837,0.00019662533,0.0000072305174,0.00003069068],"genre_scores_gemma":[0.024756461,0.9680799,0.00653537,0.000022292303,0.00046294395,0.00001655361,0.0000616809,0.000042342104,0.00002241913],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9977765,0.0003637956,0.0008715976,0.00023019918,0.00062899047,0.00012891169],"domain_scores_gemma":[0.9942902,0.0015555045,0.002239156,0.00013435497,0.0016771307,0.00010371059],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010014436,0.0002638611,0.0019375723,0.0007592716,0.0000447499,0.000052931657,0.00017107745,0.00010095679,0.000087543056],"category_scores_gemma":[0.0015769008,0.0001906533,0.004775647,0.00020116889,0.00014977538,0.0003306117,0.000024343519,0.00041512787,8.246922e-7],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004524689,0.0006882645,0.000068725865,0.0011400223,0.56834567,0.0006307669,0.0006011345,0.0000106827865,0.0000029759103,0.000015432794,0.000027502574,0.42394418],"study_design_scores_gemma":[0.00063750235,0.0010962089,0.00027262347,0.012301108,0.9054578,0.040827997,0.00081871706,0.00003546665,0.0000037678942,0.00009618374,0.038286168,0.00016643849],"about_ca_topic_score_codex":0.000011974646,"about_ca_topic_score_gemma":0.0000010247095,"teacher_disagreement_score":0.42377773,"about_ca_system_score_codex":0.00021878767,"about_ca_system_score_gemma":0.00015336515,"threshold_uncertainty_score":0.7774616},"labels":[],"label_agreement":null},{"id":"W2901518893","doi":"10.1016/j.amjcard.2018.11.026","title":"Impact of Point-of-Care Platelet Function Testing Among Patients With and Without Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents (from the ADAPT-DES Study)","year":2018,"lang":"en","type":"article","venue":"The American Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Sacré-Cœur de Montréal","funders":"Abbott Vascular; Boston Scientific Corporation; Cardiovascular Research Foundation; Medtronic; Cordis; Eli Lilly and Company","keywords":"Medicine; Percutaneous coronary intervention; Clopidogrel; Internal medicine; Acute coronary syndrome; Hazard ratio; P2Y12; Myocardial infarction; Conventional PCI; Confidence interval; Stent; Cardiology","score_opus":0.01258805669846056,"score_gpt":0.25739062333314205,"score_spread":0.2448025666346815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901518893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977151,0.0010903951,0.00069187256,0.0000125020315,0.00005781981,0.00036981155,0.000018368875,0.000010967231,0.000033131844],"genre_scores_gemma":[0.9994852,0.000114177936,0.00021647124,0.000021975566,0.00011829496,0.0000022560307,0.000008632398,0.00002967885,0.0000033118831],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982716,0.000582387,0.0004113239,0.0001770853,0.0003485768,0.00020907131],"domain_scores_gemma":[0.9978121,0.0003536988,0.0008966262,0.00027775418,0.0005795684,0.000080281425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039583392,0.00020354637,0.0009044066,0.00007681374,0.00016817368,0.000010866627,0.00015357832,0.000027065153,0.0000057515363],"category_scores_gemma":[0.00007041534,0.00009590327,0.00032484587,0.0002087585,0.0014638716,0.00012850988,0.000060971503,0.00023317945,3.245781e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0138396025,0.00007163956,0.9263846,0.000020541007,0.009424469,0.00018874124,0.0016352647,0.00035570087,0.00017223763,2.7742308e-7,0.000006142301,0.04790076],"study_design_scores_gemma":[0.0030449717,0.031245992,0.93809974,0.00061256724,0.002535899,0.006540733,0.017765727,0.000021826114,0.00001571646,0.000015112687,0.0000014436865,0.000100282174],"about_ca_topic_score_codex":0.00017136753,"about_ca_topic_score_gemma":0.000016629217,"teacher_disagreement_score":0.047800478,"about_ca_system_score_codex":0.00006752113,"about_ca_system_score_gemma":0.0001187037,"threshold_uncertainty_score":0.5393696},"labels":[],"label_agreement":null},{"id":"W2902127546","doi":"10.1161/circinterventions.118.007368","title":"Dual Antiplatelet Therapy After Percutaneous Coronary Intervention","year":2018,"lang":"en","type":"letter","venue":"Circulation Cardiovascular Interventions","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute; London Health Sciences Centre; Western University","funders":"","keywords":"Percutaneous coronary intervention; Medicine; Cardiology; Dual (grammatical number); Internal medicine; Myocardial infarction; Philosophy","score_opus":0.034033963689881166,"score_gpt":0.2790848303161687,"score_spread":0.24505086662628756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902127546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.50393534,0.36819878,0.032975048,0.065935716,0.009501089,0.010553589,0.0015872485,0.002600553,0.004712663],"genre_scores_gemma":[0.8911521,0.0047517954,0.0004395253,0.07589101,0.013357804,0.000637792,0.009591254,0.0005539134,0.0036248155],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9936103,0.00088098756,0.0013455952,0.001511612,0.0018167807,0.0008347118],"domain_scores_gemma":[0.9960123,0.00006993153,0.0003570416,0.0024890895,0.0008363146,0.00023537774],"candidate_categories":["metaepi_narrow","metaepi_broad","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00096319336,0.0009792398,0.0019482949,0.00074426003,0.0003358235,0.0002219882,0.00031641682,0.0016095088,0.0044977083],"category_scores_gemma":[0.000095177005,0.0009784977,0.021847647,0.00052974076,0.0004511631,0.00032859418,0.00015290357,0.0017770043,0.0011434337],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016841835,0.0012884437,0.004570927,0.0045638247,0.10143226,0.05145524,0.00034259973,0.00026692243,0.000156959,0.000020927724,0.7045869,0.12963076],"study_design_scores_gemma":[0.004813535,0.00056684756,0.02753285,0.0027819183,0.0071091997,0.025023874,0.000066905726,0.0001032496,0.00007491282,0.00019012351,0.9305358,0.0012007921],"about_ca_topic_score_codex":0.00004388392,"about_ca_topic_score_gemma":0.0000039931024,"teacher_disagreement_score":0.38721678,"about_ca_system_score_codex":0.00037476572,"about_ca_system_score_gemma":0.00016674337,"threshold_uncertainty_score":0.9996866},"labels":[],"label_agreement":null},{"id":"W2902590072","doi":"10.1161/jaha.118.010394","title":"Temporal Trends in Utilization of Cardiac Therapies and Outcomes for Myocardial Infarction by Degree of Chronic Kidney Disease: A Report From the NCDR Chest Pain–MI Registry","year":2018,"lang":"en","type":"article","venue":"Journal of the American Heart Association","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"American College of Cardiology Foundation","keywords":"Medicine; Myocardial infarction; Chest pain; Kidney disease; Cardiology; Internal medicine; Disease; Intensive care medicine","score_opus":0.019248124932058245,"score_gpt":0.29009172821171114,"score_spread":0.2708436032796529,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902590072","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913038,0.0024759853,0.00023964912,0.0054646987,0.00021572679,0.0001825538,0.000098120676,0.0000048417046,0.000014631862],"genre_scores_gemma":[0.9983567,0.00054458587,0.00009159392,0.00044335955,0.0004356951,0.0000063642888,0.00003436042,0.0000122081265,0.0000751131],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985161,0.00040106673,0.00044192004,0.00010051361,0.00043010945,0.00011029748],"domain_scores_gemma":[0.9981777,0.00026757925,0.0010050451,0.00022875343,0.00025437406,0.0000665184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015332362,0.00009332591,0.00055832,0.00006101512,0.000065558095,0.000010988019,0.00007141012,0.00004405517,0.000007491528],"category_scores_gemma":[0.0011870245,0.00005754704,0.000591191,0.0002575194,0.00017804549,0.00008522519,0.000014997423,0.00010421342,9.4763834e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004423807,0.000069850495,0.95838356,0.000015483294,0.00095946743,7.718033e-7,0.00022003044,0.000002697048,0.0017128993,0.0000014467345,0.012558364,0.025633052],"study_design_scores_gemma":[0.00085332134,0.00030013168,0.9732696,0.00009640442,0.00046024786,0.000006162882,0.00028233763,0.00005577466,0.00045015514,0.00005560238,0.024116762,0.000053499687],"about_ca_topic_score_codex":0.0003058785,"about_ca_topic_score_gemma":0.000017157841,"teacher_disagreement_score":0.025579551,"about_ca_system_score_codex":0.00017417847,"about_ca_system_score_gemma":0.0002314788,"threshold_uncertainty_score":0.23467003},"labels":[],"label_agreement":null},{"id":"W2904019681","doi":"10.1136/bmj.k5130","title":"Dual antiplatelet therapy with aspirin and clopidogrel for acute high risk transient ischaemic attack and minor ischaemic stroke: a clinical practice guideline","year":2018,"lang":"en","type":"article","venue":"BMJ","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":103,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact; McMaster University; University of Toronto","funders":"","keywords":"Clopidogrel; Medicine; Aspirin; Ischaemic stroke; Guideline; Minor stroke; Cardiology; Stroke (engine); Internal medicine; Ischemia","score_opus":0.030945429929473776,"score_gpt":0.37958383291651143,"score_spread":0.34863840298703763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2904019681","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98051673,0.0058029783,0.006233954,0.0048984936,0.00023782498,0.00180635,0.0002040628,0.0000799597,0.00021965432],"genre_scores_gemma":[0.9367141,0.018255407,0.03598232,0.005459399,0.0027150933,0.000114041686,0.00014612809,0.000095996664,0.00051749725],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977154,0.00019222083,0.00068569503,0.000634889,0.0003828336,0.00038892403],"domain_scores_gemma":[0.9983152,0.00026863546,0.00026794698,0.00048740132,0.00037052948,0.00029024857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013568196,0.0003180226,0.0007348657,0.00007839734,0.00018850819,0.000040393872,0.00007839171,0.00021511606,0.000042555683],"category_scores_gemma":[0.00016985163,0.00022642505,0.00026578517,0.00011965742,0.0004888938,0.00020914804,0.00003518149,0.00027865608,0.000013455204],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09257582,0.0015379925,0.059658024,0.00025399376,0.0224822,0.0015628834,0.001510754,0.00001348983,0.0031624697,0.00020927127,0.14063892,0.67639416],"study_design_scores_gemma":[0.039608795,0.011682452,0.042651653,0.00024385902,0.004497063,0.00481978,0.0005941051,0.00074251974,0.0018039853,0.000042435695,0.892607,0.00070639065],"about_ca_topic_score_codex":0.000053518772,"about_ca_topic_score_gemma":0.000016996568,"teacher_disagreement_score":0.751968,"about_ca_system_score_codex":0.0000140614175,"about_ca_system_score_gemma":0.00015841698,"threshold_uncertainty_score":0.9233346},"labels":[],"label_agreement":null},{"id":"W2904274506","doi":"10.1093/eurheartj/ehy566.p5732","title":"P5732Prasugrel or clopidogrel in non-ST-elevation acute coronary syndrome with CYP2C19 genetic variants undergoing percutaneous coronary intervention","year":2018,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Bhabha Atomic Research Centre","keywords":"Medicine; Clopidogrel; Percutaneous coronary intervention; Acute coronary syndrome; CYP2C19; Internal medicine; Cardiology; Ticlopidine; Aspirin; Myocardial infarction","score_opus":0.020821924453436582,"score_gpt":0.2751342201009686,"score_spread":0.25431229564753205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2904274506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99404126,0.0008129064,0.003656212,0.00021438953,0.00034050844,0.00034874334,0.000008103265,0.00005385539,0.00052400405],"genre_scores_gemma":[0.99490833,0.00091420655,0.0022265923,0.0006151556,0.0004486898,0.00000242568,0.000025504369,0.00008883108,0.0007702805],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978749,0.0004587455,0.0004577558,0.00033910488,0.00047117728,0.0003982755],"domain_scores_gemma":[0.9990788,0.00005521892,0.00015450554,0.0003118165,0.00014504704,0.00025460968],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006174834,0.00025040112,0.00039103025,0.00022168893,0.00024936424,0.00007800508,0.00014192975,0.00006204703,0.00078964984],"category_scores_gemma":[0.000043118034,0.00018943375,0.00026136328,0.00027111263,0.00014303044,0.00023576635,0.000055904675,0.00045460218,0.0002847632],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0128058875,0.0011468111,0.63352096,0.00027610487,0.0031805295,0.2817557,0.0011851536,0.00023059256,0.0059703686,0.000012245225,0.0035744256,0.05634127],"study_design_scores_gemma":[0.0030344375,0.003417843,0.68946385,0.00090667163,0.00024159072,0.30156073,0.00018668518,0.00020111221,0.000019860427,0.000010849512,0.0007781528,0.00017819715],"about_ca_topic_score_codex":0.000005576386,"about_ca_topic_score_gemma":0.000016660844,"teacher_disagreement_score":0.056163076,"about_ca_system_score_codex":0.00013559073,"about_ca_system_score_gemma":0.00019698437,"threshold_uncertainty_score":0.8646112},"labels":[],"label_agreement":null},{"id":"W2904821510","doi":"10.1136/bmj.k5108","title":"Clopidogrel plus aspirin versus aspirin alone for acute minor ischaemic stroke or high risk transient ischaemic attack: systematic review and meta-analysis","year":2018,"lang":"en","type":"review","venue":"BMJ","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":154,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact","funders":"Dell Medical School, University of Texas at Austin; McMaster University","keywords":"Aspirin; Ischaemic stroke; Medicine; Clopidogrel; Cardiology; Internal medicine; Minor stroke; Stroke (engine); Anesthesia; Ischemia","score_opus":0.12745254621538477,"score_gpt":0.40644696736137903,"score_spread":0.27899442114599426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2904821510","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000049217986,0.9786276,0.0011569116,0.00029786964,0.00027548947,0.016442688,0.0029762844,0.00011120264,0.000062718675],"genre_scores_gemma":[0.00001982288,0.98621714,0.0011301794,0.0005194986,0.00045741434,0.004581164,0.0013411699,0.00017476534,0.005558844],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9934869,0.0010065158,0.0025080405,0.0013837152,0.0009079767,0.0007068896],"domain_scores_gemma":[0.9947524,0.00057438156,0.0016019528,0.002283262,0.00031797486,0.0004700289],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_narrow","metaepi_broad"],"category_scores_codex":[0.0022325239,0.0012972351,0.01991249,0.0004986256,0.0002011327,0.00006255807,0.0004976258,0.0005825293,0.00048811792],"category_scores_gemma":[0.00030331188,0.0007719608,0.015179529,0.0009142492,0.00022016618,0.00011684109,0.00010666437,0.0005047955,0.0001800284],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003610312,0.00005405414,3.1109457e-7,0.49352044,0.49759686,0.00013341145,0.000020756228,0.0000010489988,5.2877997e-8,0.000006716659,0.003470517,0.004834811],"study_design_scores_gemma":[0.002299019,0.00053304824,8.334384e-7,0.033301644,0.7124137,0.00037947114,0.000016478976,0.000009798643,8.455244e-7,0.000001154475,0.25045004,0.0005938981],"about_ca_topic_score_codex":0.0000466651,"about_ca_topic_score_gemma":0.000059666712,"teacher_disagreement_score":0.4602188,"about_ca_system_score_codex":0.00020133387,"about_ca_system_score_gemma":0.00067972357,"threshold_uncertainty_score":0.99997795},"labels":[],"label_agreement":null},{"id":"W2905058249","doi":"10.5603/mrj.a2018.0037","title":"Rationale and design of PREvalence of DyspneA in patients treated with TicagrelOR (PREDATOR) program","year":2018,"lang":"en","type":"article","venue":"Medical Research Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Ticagrelor; Medicine; Acute coronary syndrome; Clopidogrel; Coronary artery disease; Placebo; Percutaneous coronary intervention; Internal medicine; Cardiology; Aspirin; Myocardial infarction","score_opus":0.04277248400681125,"score_gpt":0.3567703035332275,"score_spread":0.3139978195264162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905058249","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973408,0.0009431223,0.00080233114,0.00015082983,0.000010065738,0.0006109537,0.0000038155104,0.000004836757,0.00013323959],"genre_scores_gemma":[0.9979105,0.0011731811,0.00072669034,0.000017386144,0.00007661304,0.00001580213,0.0000031430186,0.000007556753,0.00006911412],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971314,0.00039438065,0.0002570149,0.000121708545,0.0018724096,0.00022308297],"domain_scores_gemma":[0.9985653,0.0001963748,0.000051813484,0.00012253068,0.0007320019,0.00033194828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021788762,0.00006189801,0.0002225299,0.00016340842,0.00005413671,0.000008883801,0.00010331295,0.000067245994,0.0005901446],"category_scores_gemma":[0.0014384796,0.000038055357,0.00004390342,0.00029429642,0.0008832372,0.00006453047,0.000029386867,0.000331146,0.000002769871],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005747673,0.001445887,0.7429297,0.00035269003,0.00031225276,0.00017623695,0.00023408975,0.0000012744503,0.00024783448,0.00003273436,0.00054142356,0.2479782],"study_design_scores_gemma":[0.009943601,0.011017243,0.9722888,0.0016434097,0.000085008265,0.0002103135,0.00010827311,0.00087376044,0.0028473756,0.000096354925,0.00080478564,0.000081106184],"about_ca_topic_score_codex":0.000006223137,"about_ca_topic_score_gemma":0.000001393867,"teacher_disagreement_score":0.24789709,"about_ca_system_score_codex":0.000026979396,"about_ca_system_score_gemma":0.0004916502,"threshold_uncertainty_score":0.646167},"labels":[],"label_agreement":null},{"id":"W2905071154","doi":"10.1016/j.ijcha.2018.11.008","title":"Short term outcome following acute phase switch among P2Y12 inhibitors in patients presenting with acute coronary syndrome treated with PCI: A systematic review and meta-analysis including 22,500 patients from 14 studies","year":2018,"lang":"en","type":"review","venue":"IJC Heart & Vasculature","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"AstraZeneca","keywords":"Medicine; Prasugrel; Mace; Acute coronary syndrome; Internal medicine; Interquartile range; Odds ratio; Clopidogrel; Myocardial infarction; Conventional PCI; Meta-analysis; Percutaneous coronary intervention; Confidence interval; Cardiology","score_opus":0.056557111089473845,"score_gpt":0.35739929637024215,"score_spread":0.3008421852807683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905071154","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.36486238,0.6287227,0.0000035349506,0.000008285469,0.000048709862,0.0060610063,0.00021157655,0.00007812671,0.000003617587],"genre_scores_gemma":[0.21674156,0.7791193,0.00015065812,0.00018807022,0.00005331841,0.001153489,0.0022430643,0.00023542986,0.0001150829],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9924381,0.001066543,0.0022270053,0.0017100826,0.0017620923,0.0007961747],"domain_scores_gemma":[0.99634737,0.00025441824,0.00080282823,0.0017136907,0.00046110136,0.00042059776],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00096495316,0.0016554125,0.01851596,0.0006938132,0.00032330432,0.000121436926,0.00031956256,0.0005896416,0.00003744871],"category_scores_gemma":[0.00014144968,0.0009232301,0.0072988602,0.0020284383,0.00020395956,0.00049271865,0.0002933107,0.0009586459,0.000009204902],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000086424065,0.00040845605,0.18212157,0.1625181,0.65291154,0.0014068417,0.00013665501,5.317196e-7,6.5452824e-8,7.121036e-8,0.000055117136,0.0003546428],"study_design_scores_gemma":[0.0031483504,0.00046497656,0.033373673,0.083617255,0.87762326,0.00022244878,0.000029567469,0.0000016909217,4.2717548e-7,5.703074e-7,0.0006131568,0.00090459903],"about_ca_topic_score_codex":0.000033316068,"about_ca_topic_score_gemma":0.000022982378,"teacher_disagreement_score":0.22471176,"about_ca_system_score_codex":0.00030249957,"about_ca_system_score_gemma":0.00012162717,"threshold_uncertainty_score":0.9996193},"labels":[],"label_agreement":null},{"id":"W2905374907","doi":"10.1093/eurheartj/ehy566.p5798","title":"P5798Prevalence of interatrial block and its association with specific coronary arteries in patients with ST- segment elevated myocardial infarction","year":2018,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Cardiology; Internal medicine; Myocardial infarction; Coronary arteries; Artery","score_opus":0.012114391433114146,"score_gpt":0.22602377450115205,"score_spread":0.2139093830680379,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905374907","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998975,0.0003583759,0.000038324004,0.00008081553,0.00016367639,0.00022548676,0.000009211564,0.000011581048,0.00013752158],"genre_scores_gemma":[0.998949,0.0002858244,0.000111347435,0.000085919055,0.0004984215,8.030555e-7,0.000008096812,0.000018596682,0.000041988627],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99875754,0.00030952718,0.00022246139,0.00013967113,0.00040672458,0.00016405647],"domain_scores_gemma":[0.99940556,0.000019006313,0.00013621653,0.000093648894,0.00025485022,0.000090688845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005255483,0.00010754789,0.00023308887,0.00008638165,0.00008605654,0.000029797557,0.000032389067,0.000024444402,0.00007276699],"category_scores_gemma":[0.000025111118,0.000077452605,0.000066211156,0.00011663773,0.00005541402,0.0001498298,0.000018497474,0.00018754556,0.0000100154175],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006312659,0.00013870985,0.988223,0.000019085162,0.00035040974,0.00006443861,0.00038057295,0.000012458657,0.0010169299,0.0000013831585,0.00053568016,0.0029446539],"study_design_scores_gemma":[0.006433372,0.0028612115,0.9848822,0.00030083657,0.00009557347,0.00027816268,0.00007192429,0.0000068073696,0.00054392737,9.560828e-7,0.0044348026,0.00009025916],"about_ca_topic_score_codex":6.1241263e-7,"about_ca_topic_score_gemma":6.8248175e-7,"teacher_disagreement_score":0.0038991221,"about_ca_system_score_codex":0.00006853722,"about_ca_system_score_gemma":0.000043327494,"threshold_uncertainty_score":0.31584254},"labels":[],"label_agreement":null},{"id":"W2905638888","doi":"10.1016/j.acvdsp.2018.10.019","title":"Impact and predictive factors of bleeding complications in elderly patients admitted for an acute coronary syndrome: Insights from the ANTARCTIC trial","year":2018,"lang":"en","type":"article","venue":"Archives of Cardiovascular Diseases Supplements","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Saint-François d'Assise","funders":"Biotronik; Daiichi-Sankyo; Novartis; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Mace; Internal medicine; Myocardial infarction; Acute coronary syndrome; Prasugrel; Stroke (engine); Randomized controlled trial; Cardiology; Clopidogrel; Adverse effect; Percutaneous coronary intervention","score_opus":0.01564512044830049,"score_gpt":0.27927222554677616,"score_spread":0.2636271050984757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905638888","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870168,0.004155254,0.0012341035,0.000011449737,0.00008701099,0.0026779072,0.004780189,0.000018181963,0.00001912157],"genre_scores_gemma":[0.99526733,0.0007259211,0.00019984733,0.000021920932,0.00007379358,0.00014562359,0.0035304592,0.00003366223,0.000001420798],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980397,0.0002495055,0.0004651117,0.00044064064,0.00053644844,0.00026857987],"domain_scores_gemma":[0.9984126,0.00032057567,0.00014923974,0.00074759976,0.0001389406,0.0002310633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000894882,0.00025679625,0.0008085278,0.00015782446,0.00014802864,0.000015212559,0.0002283543,0.000049931135,0.000024380379],"category_scores_gemma":[0.00007920207,0.00018229196,0.0013384516,0.00018075322,0.00045675802,0.00021007768,0.00009041583,0.00008735492,4.2146232e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025334995,0.0013217819,0.9383362,0.0000920389,0.023738172,0.000011436525,0.0013479586,0.00003956567,0.00026610025,0.000013218678,0.000032668653,0.0094658835],"study_design_scores_gemma":[0.03946672,0.0056757685,0.9479561,0.00017460212,0.005008686,0.000007508853,0.00043727882,0.00021101093,0.00021482736,0.00047169853,0.00021395118,0.00016188913],"about_ca_topic_score_codex":0.00023100685,"about_ca_topic_score_gemma":0.000010451084,"teacher_disagreement_score":0.018729487,"about_ca_system_score_codex":0.000027730852,"about_ca_system_score_gemma":0.00012510389,"threshold_uncertainty_score":0.74336505},"labels":[],"label_agreement":null},{"id":"W2906553061","doi":"10.4317/medoral.22708","title":"Antiplatelet therapy in patients undergoing oral surgery: A systematic review and meta-analysis","year":2018,"lang":"en","type":"review","venue":"Medicina oral, patología oral y cirugía bucal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact","funders":"","keywords":"Medicine; Randomized controlled trial; MEDLINE; Meta-analysis; Cochrane Library; Systematic review; Intensive care medicine; Complication; Surgery; Internal medicine","score_opus":0.10169756590692366,"score_gpt":0.3469349349270975,"score_spread":0.24523736902017382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906553061","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012456315,0.9918733,0.000035512443,0.0002868192,0.0002143424,0.006004567,0.00013046824,0.00015524264,0.00005411235],"genre_scores_gemma":[0.003771265,0.99144244,0.000084688014,0.002445065,0.00008536699,0.00062127644,0.0011620038,0.00018850021,0.00019940463],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.989019,0.003394626,0.003259996,0.0017299332,0.0014372712,0.0011592155],"domain_scores_gemma":[0.9947725,0.0009471887,0.0013661971,0.0019139969,0.00034573526,0.00065437227],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.003901033,0.0017155736,0.029839808,0.0014645323,0.00019126468,0.00008467509,0.00052726676,0.0009515825,0.00086031255],"category_scores_gemma":[0.0010555686,0.001061343,0.0089693675,0.003117417,0.0006010625,0.000223873,0.000185791,0.0010202222,0.00014904584],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013905711,0.0006386206,0.003798977,0.6672698,0.29809663,0.0009930518,0.000046212295,1.0183864e-7,1.2216099e-8,0.000015468122,0.0040832786,0.02491878],"study_design_scores_gemma":[0.002084693,0.0006224801,0.00024733218,0.067800425,0.8539724,0.00040956328,0.000030232486,0.0000043268888,4.2925737e-7,0.000019243704,0.073739395,0.0010694986],"about_ca_topic_score_codex":0.00011071017,"about_ca_topic_score_gemma":0.00008035353,"teacher_disagreement_score":0.59946936,"about_ca_system_score_codex":0.0002173112,"about_ca_system_score_gemma":0.0007099738,"threshold_uncertainty_score":0.99955904},"labels":[],"label_agreement":null},{"id":"W2906907797","doi":"10.4212/cjhp.v71i6.2849","title":"Ticagrelor and Acetylsalicylic Acid after Placement of Pipeline Embolization Device for Cerebral Aneurysm: A Case Series","year":2019,"lang":"en","type":"article","venue":"The Canadian Journal of Hospital Pharmacy","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Ticagrelor; Series (stratigraphy); Embolization; Pipeline (software); Medicine; Aneurysm; Aspirin; Internal medicine; Cardiology; Surgery; Computer science; Clopidogrel; Geology; Operating system","score_opus":0.011647975253947663,"score_gpt":0.26132919811761574,"score_spread":0.24968122286366806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906907797","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99083984,0.0058417176,0.000081629834,0.0023622632,0.00024038498,0.00049785676,0.000055096065,0.0000034491072,0.00007775062],"genre_scores_gemma":[0.9986949,0.0001365647,0.00009994542,0.0006472216,0.00021729719,0.000006508983,0.0000068374666,0.00001957757,0.00017115257],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99926615,0.00004043964,0.0002639228,0.00009103582,0.00015073473,0.000187729],"domain_scores_gemma":[0.99915,0.000023271507,0.00013277358,0.00013558535,0.00024124769,0.00031714543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024693078,0.00011383302,0.0002698627,0.00008845827,0.000076634664,0.000025992915,0.000072808136,0.00002561509,0.000194299],"category_scores_gemma":[0.000041106494,0.00007862331,0.00018602794,0.00009136453,0.00009833791,0.00017597472,0.000009606331,0.00011031566,0.0000038231706],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034904275,0.0012144858,0.7282788,0.005555985,0.012559526,0.045729104,0.03301297,0.0010285664,0.017134711,0.0024026795,0.029449493,0.08872941],"study_design_scores_gemma":[0.11473786,0.019666355,0.08250718,0.0024053336,0.016746774,0.32262808,0.01857042,0.0044270265,0.16216214,0.00176664,0.2512761,0.0031060835],"about_ca_topic_score_codex":0.0003511961,"about_ca_topic_score_gemma":0.0007614423,"teacher_disagreement_score":0.6457716,"about_ca_system_score_codex":0.000043623528,"about_ca_system_score_gemma":0.0004200714,"threshold_uncertainty_score":0.32061654},"labels":[],"label_agreement":null},{"id":"W2909749835","doi":"10.1016/j.actbio.2019.01.008","title":"Biomimetic modification of poly(vinyl alcohol): Encouraging endothelialization and preventing thrombosis with antiplatelet monotherapy","year":2019,"lang":"en","type":"article","venue":"Acta Biomaterialia","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"National Institute of Dental and Craniofacial Research; Oregon National Primate Research Center; National Institutes of Health; National Heart, Lung, and Blood Institute; Paralyzed Veterans of America","keywords":"Vinyl alcohol; Materials science; Surface modification; Thrombosis; Biomedical engineering; Composite material; Medicine; Polymer; Chemical engineering; Surgery","score_opus":0.016245224906635842,"score_gpt":0.2643927852687134,"score_spread":0.24814756036207755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909749835","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99733853,0.0009695007,0.00066017354,0.000119051285,0.0001973681,0.0005304568,0.000024195864,0.00006783808,0.00009286276],"genre_scores_gemma":[0.99839616,0.0005822418,0.0006569251,0.000049269263,0.00006837007,0.000011861354,0.000087164815,0.000038366714,0.00010966605],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989534,0.00006898414,0.00027498772,0.00029105393,0.00022497322,0.00018658057],"domain_scores_gemma":[0.99932677,0.000015729114,0.00018512302,0.00034390253,0.00006645868,0.00006203748],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020207069,0.00017511359,0.00039617158,0.000130054,0.000052523552,0.000044528068,0.00007139345,0.00008398378,0.00016667414],"category_scores_gemma":[0.00000781068,0.00013699692,0.000097923,0.00018382295,0.000079112586,0.00022119487,0.000019283814,0.000026796259,0.000010078205],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049875205,0.000083771854,0.037760515,0.000219687,0.00047529963,0.0000035499443,0.0002780733,0.0000011543302,0.956383,0.0001145246,0.000013299802,0.004168381],"study_design_scores_gemma":[0.0048927716,0.00036549495,0.101846136,0.00040577663,0.00036924175,0.000091393,0.00018954404,0.00031062606,0.8901139,0.000066032975,0.0010878952,0.0002611684],"about_ca_topic_score_codex":0.000079066165,"about_ca_topic_score_gemma":6.2766736e-7,"teacher_disagreement_score":0.06626907,"about_ca_system_score_codex":0.000017443532,"about_ca_system_score_gemma":0.000035947432,"threshold_uncertainty_score":0.5586572},"labels":[],"label_agreement":null},{"id":"W2910540289","doi":"10.1371/journal.pone.0210821","title":"Competing risks of major bleeding and thrombotic events with prasugrel-based dual antiplatelet therapy after stent implantation - An observational analysis from BASKET-PROVE II","year":2019,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"Daiichi Sankyo Company; Eli Lilly and Company","keywords":"Prasugrel; Medicine; Discontinuation; Internal medicine; Hazard ratio; Myocardial infarction; Cardiology; Thrombosis; Stent; Percutaneous coronary intervention; Confidence interval","score_opus":0.09295259943747,"score_gpt":0.28454783053978133,"score_spread":0.19159523110231133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910540289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976886,0.0011201763,0.00030722513,0.000085580126,0.000018269071,0.0005969631,0.00012580746,0.000036087386,0.000021309534],"genre_scores_gemma":[0.99627334,0.00020490399,0.0024844771,0.00020757955,0.0000751533,0.000023775823,0.0006875647,0.000027748893,0.000015462325],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984329,0.00009808431,0.0002865754,0.00035463562,0.0006410986,0.00018672479],"domain_scores_gemma":[0.9991397,0.00010199901,0.0001779589,0.00029177498,0.00018266225,0.000105857674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022721906,0.0001870778,0.00062880316,0.00014750224,0.000078767036,0.00001790322,0.000054097603,0.00007739047,0.0002571113],"category_scores_gemma":[0.000013016512,0.00014879786,0.00016337709,0.00029166392,0.000051198553,0.00018903079,0.000020560432,0.00011895678,0.000004953543],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029849056,0.0012504251,0.92453015,0.000117664975,0.010508276,0.000023840348,0.00042289402,0.00026699892,0.059361823,0.000006774295,6.462045e-7,0.0005256156],"study_design_scores_gemma":[0.006117493,0.00096711144,0.95928377,0.00034451424,0.00466233,0.0000047098156,0.00033672573,0.00620741,0.021854687,0.000020974054,0.000002548652,0.00019771354],"about_ca_topic_score_codex":0.00011086378,"about_ca_topic_score_gemma":0.000014064235,"teacher_disagreement_score":0.037507135,"about_ca_system_score_codex":0.00002404102,"about_ca_system_score_gemma":0.00006509865,"threshold_uncertainty_score":0.6067801},"labels":[],"label_agreement":null},{"id":"W2911008930","doi":"10.1001/jama.2018.20396","title":"Medication Co-payment Vouchers, Adherence With Antiplatelet Therapy, and Adverse Cardiovascular Events After Myocardial Infarction","year":2019,"lang":"en","type":"letter","venue":"JAMA","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; University of Toronto; Health Sciences Centre; University Health Network","funders":"","keywords":"Medicine; Otorhinolaryngology; Family medicine; Neurology; Psychiatry","score_opus":0.014144926895631668,"score_gpt":0.2358754649744013,"score_spread":0.22173053807876963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911008930","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8462338,0.049914964,0.00054055115,0.093804896,0.001364416,0.0051294104,0.0002977159,0.00033176213,0.002382514],"genre_scores_gemma":[0.61148673,0.030581845,0.00022404217,0.3442088,0.008181002,0.0005580124,0.0029684778,0.00027936455,0.0015117428],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963748,0.00031873118,0.00037309047,0.0008881133,0.0015567093,0.00048859644],"domain_scores_gemma":[0.9982925,0.00006270911,0.00019018368,0.001154331,0.0001521395,0.0001481216],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042668742,0.0005838283,0.0011456326,0.00020250646,0.00009189333,0.000046513604,0.00016176717,0.0010134471,0.0002632647],"category_scores_gemma":[0.000026576134,0.00044700387,0.0010477714,0.000172986,0.00018909051,0.00024571113,0.000044733235,0.0012765643,0.00013931941],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009369032,0.0002914385,0.07934067,0.0017745646,0.050323788,0.005050328,0.0008566576,0.00005282949,0.00024630842,0.000003193518,0.481638,0.3710532],"study_design_scores_gemma":[0.009821115,0.00060405314,0.10578481,0.00059876096,0.0017734687,0.0006093726,0.00005994304,0.000012447959,0.00018585629,0.000007770173,0.87999046,0.00055194966],"about_ca_topic_score_codex":0.00008832686,"about_ca_topic_score_gemma":7.8644547e-7,"teacher_disagreement_score":0.39835244,"about_ca_system_score_codex":0.00010541263,"about_ca_system_score_gemma":0.00025982223,"threshold_uncertainty_score":0.9997982},"labels":[],"label_agreement":null},{"id":"W2911330885","doi":"10.1093/ehjcvp/pvz004","title":"Platelet inhibition with standard vs. lower maintenance dose of ticagrelor early after myocardial infarction (ELECTRA): a randomized, open-label, active-controlled pharmacodynamic and pharmacokinetic study","year":2019,"lang":"en","type":"article","venue":"European Heart Journal - Cardiovascular Pharmacotherapy","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Ticagrelor; Pharmacodynamics; Open label; Myocardial infarction; Medicine; Pharmacology; Pharmacokinetics; Randomized controlled trial; Platelet; Anesthesia; Cardiology; Internal medicine; Clopidogrel","score_opus":0.01236013469327582,"score_gpt":0.2793098667455458,"score_spread":0.26694973205227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911330885","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9771037,0.013005172,0.0010898897,0.00019757569,0.0005438681,0.007225774,0.000035675253,0.00007984391,0.0007184797],"genre_scores_gemma":[0.9864913,0.010890497,0.00031108054,0.0010741488,0.0006510836,0.0001615289,0.000010917298,0.00021479624,0.00019460123],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99243206,0.0035316504,0.0010386229,0.0008115246,0.001506663,0.00067949336],"domain_scores_gemma":[0.9977751,0.0001612506,0.00037557664,0.0006318587,0.00056218135,0.0004940762],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0047981096,0.0006931291,0.0031439897,0.0003926789,0.00022215875,0.00024271995,0.00025717498,0.00008034554,0.0005606796],"category_scores_gemma":[0.000037467,0.0005010275,0.0019936827,0.00047019988,0.0003100431,0.0007123427,0.00009578413,0.0009844138,0.00005627128],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.86245614,0.0014039978,0.0027094935,0.00013062799,0.047943708,0.0026157338,0.0011533786,0.00045468152,0.036399834,0.000003675854,0.00022628487,0.04450243],"study_design_scores_gemma":[0.9395758,0.005501529,0.017069163,0.00051227474,0.0075072017,0.004678435,0.00017222374,0.000383512,0.005494266,0.00001412621,0.018289028,0.00080244185],"about_ca_topic_score_codex":0.000024494098,"about_ca_topic_score_gemma":4.6849783e-7,"teacher_disagreement_score":0.07711964,"about_ca_system_score_codex":0.00017055082,"about_ca_system_score_gemma":0.0002111169,"threshold_uncertainty_score":0.9997441},"labels":[],"label_agreement":null},{"id":"W2913124357","doi":"10.14309/00000434-200709002-00141","title":"Aspirin Use in the Setting of Acute Myocardial Infarction and Peptic Ulcer Bleeding Does Not Increase the Rebleeding Rate","year":2007,"lang":"en","type":"article","venue":"The American Journal of Gastroenterology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Aspirin; Clopidogrel; Myocardial infarction; Internal medicine; Percutaneous coronary intervention; Peptic ulcer; Mortality rate; Peptic; Gastroenterology; Surgery","score_opus":0.009236025690662583,"score_gpt":0.25622085151200386,"score_spread":0.24698482582134126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913124357","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953271,0.00008640598,0.0006666335,0.0036351809,0.000110758476,0.0001481336,0.0000034137818,0.00000438838,0.000017995046],"genre_scores_gemma":[0.9953716,0.00045678762,0.00013801917,0.0036757232,0.00033790045,0.000001979614,0.0000010169109,0.000012338696,0.0000046605414],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99825567,0.00062352384,0.00045850282,0.0001081867,0.00026342444,0.00029067066],"domain_scores_gemma":[0.9986228,0.00044013828,0.00055735075,0.00020590921,0.00010351685,0.000070304886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039451155,0.00012780413,0.0004998514,0.00014674944,0.00010166909,0.000022884495,0.00019134238,0.000023238312,0.0000049912546],"category_scores_gemma":[0.00011030914,0.000054818047,0.00026834322,0.00018728312,0.0005469043,0.00012091839,0.000050476552,0.00042921634,4.2676905e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03171737,0.000083648825,0.93058664,0.000017731967,0.0024752787,0.0002367084,0.0023811143,0.00010059866,0.024083665,0.000030405787,0.000062021274,0.008224799],"study_design_scores_gemma":[0.0019232499,0.0029428147,0.9842761,0.00009059163,0.0010747182,0.0040060245,0.0050463094,0.0000567213,0.00039940036,0.00004255216,0.000095220836,0.000046287216],"about_ca_topic_score_codex":0.00013137162,"about_ca_topic_score_gemma":0.00002727513,"teacher_disagreement_score":0.05368945,"about_ca_system_score_codex":0.000027702996,"about_ca_system_score_gemma":0.000026060708,"threshold_uncertainty_score":0.22354151},"labels":[],"label_agreement":null},{"id":"W2913270590","doi":"10.1097/fpc.0000000000000368","title":"International survey of patients undergoing percutaneous coronary intervention and their attitudes toward pharmacogenetic testing","year":2019,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital; University of Toronto; Sunnybrook Health Science Centre; Health Sciences Centre; University of Ottawa","funders":"National Heart, Lung, and Blood Institute","keywords":"Pharmacogenetics; Medicine; Percutaneous coronary intervention; Conventional PCI; Confidence interval; Odds ratio; Genotyping; Population; Clopidogrel; Internal medicine; Genotype; Myocardial infarction; Environmental health; Genetics","score_opus":0.03036995556552156,"score_gpt":0.28224366050951033,"score_spread":0.25187370494398875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913270590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99100304,0.008076984,0.00014813035,0.00001851064,0.00020948466,0.00029634906,0.00011334891,0.000012461331,0.000121687626],"genre_scores_gemma":[0.9884235,0.010857721,0.00039381546,0.000120914,0.0000428208,0.0000023467223,0.000111882786,0.000023395773,0.000023578503],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99922824,0.00005790074,0.00023358107,0.00022694157,0.00012273212,0.00013057643],"domain_scores_gemma":[0.99944746,0.00010620747,0.000086441854,0.00009638758,0.00016783015,0.00009567565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018094807,0.00014209827,0.00023160018,0.000054564942,0.00003525224,0.000019136452,0.000069949136,0.000037297417,0.000089506124],"category_scores_gemma":[0.000025725383,0.00012936244,0.000087714994,0.000051608073,0.000059111415,0.00003067636,0.00009849901,0.00007323107,0.000003790259],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039793353,0.00015685568,0.83919466,0.00021408289,0.0006185479,0.000008428288,0.00013170978,0.00014229698,0.03692389,0.000001205796,0.000012556712,0.12219785],"study_design_scores_gemma":[0.0036191938,0.00036203134,0.98184973,0.00008315564,0.0002112955,0.0001918138,0.00007779418,0.0045780037,0.007756048,0.000016461167,0.001067102,0.00018737293],"about_ca_topic_score_codex":0.000015816815,"about_ca_topic_score_gemma":0.0000021044184,"teacher_disagreement_score":0.14265509,"about_ca_system_score_codex":0.000024094777,"about_ca_system_score_gemma":0.000041106567,"threshold_uncertainty_score":0.5275247},"labels":[],"label_agreement":null},{"id":"W2914521218","doi":"10.1161/str.50.suppl_1.37","title":"Abstract 37: Secondary Stroke Prevention With Aspirin and Clopidogrel in <i>CYP2C19</i> *17 Carriers Increases Risk of Major Non-CNS Bleeding","year":2019,"lang":"en","type":"article","venue":"Stroke","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Clopidogrel; Aspirin; Odds ratio; Stroke (engine); CYP2C19; Internal medicine; Cardiology","score_opus":0.00514687746895042,"score_gpt":0.22541663961709563,"score_spread":0.2202697621481452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914521218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901922,0.0028877265,0.00006302945,0.000021458267,0.00006301387,0.0005819572,0.0002133963,0.000028888124,0.0059483484],"genre_scores_gemma":[0.9976626,0.0009057628,0.00026953325,0.00005377644,0.00008814264,0.000016991868,0.000052970183,0.000029838116,0.0009203885],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99872214,0.000047763635,0.0002969748,0.00032798783,0.0003328341,0.00027230426],"domain_scores_gemma":[0.99923646,0.00006669049,0.00016485588,0.00031764022,0.000059535767,0.00015482618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033130805,0.00020515601,0.0005183317,0.00013692967,0.000047063826,0.000016768783,0.00007488149,0.000112683076,0.00023367525],"category_scores_gemma":[0.000025278052,0.00017143246,0.00024537722,0.00012175851,0.00011142805,0.00017882494,0.000033767414,0.00030125535,0.000008864641],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001555146,0.00019641637,0.9638349,0.00047813912,0.0013373529,0.00008030207,0.0001767115,0.000059867307,0.01270318,0.00002860307,0.000098937184,0.019450478],"study_design_scores_gemma":[0.010452907,0.0010154147,0.97351867,0.0008117499,0.00082327105,0.000074968106,0.0017204605,0.000051857813,0.009937753,0.00004553665,0.0012583557,0.00028907906],"about_ca_topic_score_codex":0.00041296706,"about_ca_topic_score_gemma":0.00011742911,"teacher_disagreement_score":0.0191614,"about_ca_system_score_codex":0.000035191053,"about_ca_system_score_gemma":0.0001794099,"threshold_uncertainty_score":0.6990813},"labels":[],"label_agreement":null},{"id":"W2914521613","doi":"10.1161/circ.132.suppl_3.13611","title":"Abstract 13611: Adherence to Non-VKA Oral Anticoagulant Medications Based on the Pharmacy Quality Alliance Measure","year":2015,"lang":"en","type":"article","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Pharmacy; Measure (data warehouse); Oral anticoagulant; Anticoagulant; Intensive care medicine; Quality (philosophy); Warfarin; Atrial fibrillation; Family medicine; Internal medicine","score_opus":0.14704387323400175,"score_gpt":0.37770948680429706,"score_spread":0.2306656135702953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914521613","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9755802,0.0003952488,0.017257648,0.0036402084,0.00018551011,0.0007859354,0.000013867433,0.00008153663,0.0020598425],"genre_scores_gemma":[0.9973414,0.000018316823,0.00011968434,0.0021780198,0.00017720593,0.00005306829,0.00007231646,0.000015805766,0.000024206505],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99851656,0.00011587846,0.00023825909,0.00025308508,0.0007031387,0.00017309676],"domain_scores_gemma":[0.9988481,0.00008312789,0.00008222999,0.0005015136,0.0002341593,0.00025088704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00097061397,0.0001304105,0.00021847978,0.00003833244,0.00010731716,0.000026011041,0.000121192934,0.000048821694,0.00015433869],"category_scores_gemma":[0.0002754194,0.000093614246,0.00017314318,0.00024808798,0.000053807038,0.00007933819,0.000009174262,0.00013970493,0.0002422184],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022325716,0.001516415,0.7439483,0.00030588993,0.0011457327,0.00011867598,0.0019228295,0.02164828,0.041178036,0.0014417307,0.014887774,0.16965377],"study_design_scores_gemma":[0.0021037287,0.00005644242,0.98471445,0.00017159861,0.00016592174,0.0000074697077,0.00012465952,0.0069342405,0.0016869338,0.0001180285,0.0037491529,0.00016736185],"about_ca_topic_score_codex":0.000080865226,"about_ca_topic_score_gemma":0.000006214348,"teacher_disagreement_score":0.24076617,"about_ca_system_score_codex":0.000074104944,"about_ca_system_score_gemma":0.00028062062,"threshold_uncertainty_score":0.38174784},"labels":[],"label_agreement":null},{"id":"W2915284549","doi":"10.1016/j.jacc.2018.11.055","title":"Interval From Initiation of Prasugrel to Coronary Angiography in Patients With Non–ST-Segment Elevation Myocardial Infarction","year":2019,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"Institut de Cardiométabolisme et Nutrition; Fédération Française de Cardiologie; Servier; Institut National de la Santé et de la Recherche Médicale; Daiichi Sankyo Europe; Sanofi; GlaxoSmithKline; Abbott Vascular; Société Française de Cardiologie; Daiichi-Sankyo; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Prasugrel; Cardiology; Internal medicine; Myocardial infarction; TIMI; Population; Stroke (engine); Percutaneous coronary intervention; Revascularization","score_opus":0.004593472175434185,"score_gpt":0.21629769377834276,"score_spread":0.21170422160290858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2915284549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979217,0.00014292377,0.0008475468,0.00020318117,0.0002679202,0.00043887866,0.000093232906,0.0000022502725,0.00008238972],"genre_scores_gemma":[0.999184,0.00006463117,0.0003459041,0.0002523658,0.000121343226,0.000003929625,0.000012878197,0.000011224978,0.0000037125671],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987301,0.00023195377,0.00043166545,0.000110694025,0.00038544473,0.00011011171],"domain_scores_gemma":[0.9986739,0.00006773479,0.0006425144,0.00022752555,0.00033712765,0.000051190265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002678622,0.00010252637,0.00076917117,0.00027617218,0.000013630983,0.000001389563,0.00011373558,0.000041135754,0.000008645621],"category_scores_gemma":[0.000043190375,0.00006846896,0.0006471151,0.000475302,0.000118497985,0.000074538904,0.00003348895,0.00013166342,9.889243e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007354888,0.00008172879,0.9840931,0.000013641274,0.0018017767,0.000011783249,0.000059289105,0.0019044741,0.0015739276,0.0000050577696,0.00025753636,0.002842755],"study_design_scores_gemma":[0.0036527645,0.0033219657,0.9912835,0.00014911345,0.00040331078,0.000042237145,0.00034239012,0.000009676013,0.0002687902,0.000025393885,0.00043527273,0.00006557928],"about_ca_topic_score_codex":0.000022426726,"about_ca_topic_score_gemma":0.0000017568045,"teacher_disagreement_score":0.0071903644,"about_ca_system_score_codex":0.00007096868,"about_ca_system_score_gemma":0.00012668179,"threshold_uncertainty_score":0.2792083},"labels":[],"label_agreement":null},{"id":"W2917064815","doi":"10.3390/jcm8020264","title":"Aspirin Use among Adults with Cardiovascular Disease in the United States: Implications for an Intervention Approach","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Population and Public Health; Augusta University","keywords":"Medicine; Aspirin; Stroke (engine); Angina; Myocardial infarction; Diabetes mellitus; Population; Behavioral Risk Factor Surveillance System; Socioeconomic status; Disease; Internal medicine; Physical therapy; Environmental health","score_opus":0.08104838484014734,"score_gpt":0.3783511403474265,"score_spread":0.29730275550727914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2917064815","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98324245,0.0017045415,0.012650849,0.0011216152,0.00013188695,0.0010685113,0.000009816648,0.00001062016,0.00005971018],"genre_scores_gemma":[0.9966197,0.0012113053,0.00036778665,0.00093899976,0.0005983235,0.00003090942,0.00018027356,0.000022605855,0.000030084026],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974981,0.00048173292,0.0010576403,0.00023411421,0.0005517385,0.00017669605],"domain_scores_gemma":[0.9975751,0.00056292163,0.0003774725,0.0006877178,0.00046631735,0.0003304503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038913568,0.0001475794,0.0008435217,0.00018814218,0.000035665173,0.000016796786,0.00021201622,0.00007983451,0.000014813347],"category_scores_gemma":[0.0007809417,0.00007354616,0.001017575,0.00034781912,0.00020688224,0.00023312436,0.000011308386,0.000409561,0.0000012870843],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012829442,0.001903276,0.9305727,0.0004926004,0.0030120283,0.00009413564,0.000590983,0.0037603278,0.0000034307327,0.0001534337,0.0004991067,0.04608857],"study_design_scores_gemma":[0.018971043,0.004678789,0.9571428,0.0014221359,0.0020143306,0.00010978917,0.0015867761,0.002075822,8.499316e-7,0.00015056772,0.011744879,0.00010226096],"about_ca_topic_score_codex":0.00009884685,"about_ca_topic_score_gemma":0.000006557266,"teacher_disagreement_score":0.04598631,"about_ca_system_score_codex":0.000021217797,"about_ca_system_score_gemma":0.00008760088,"threshold_uncertainty_score":0.2999125},"labels":[],"label_agreement":null},{"id":"W2917620857","doi":"10.1002/clc.23164","title":"Rationale, design and baseline characteristics of the effect of ticagrelor on health outcomes in diabetes mellitus patients Intervention study","year":2019,"lang":"en","type":"article","venue":"Clinical Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute; University of Toronto; St. Michael's Hospital","funders":"Esperion Therapeutics; Daiichi Sankyo Europe; Servier; Duke Clinical Research Institute; Eisai; Kowa Company; St. Jude Medical; TauRx Pharmaceuticals; Belvoir Media Group; Novo Nordisk; Daiichi-Sankyo; Medicines Company; Abbott Vascular; Regeneron Pharmaceuticals; AstraZeneca; Amarin Corporation; Boston Scientific Corporation; Idorsia Pharmaceuticals; Bristol-Myers Squibb; Cleveland Clinic; Sanofi; Amgen; Pfizer; Eli Lilly and Company; Ironwood Pharmaceuticals, Incorporated","keywords":"Medicine; Ticagrelor; Myocardial infarction; Internal medicine; Percutaneous coronary intervention; Aspirin; Clinical endpoint; Diabetes mellitus; Stroke (engine); Coronary artery disease; Cardiology; Placebo; Randomized controlled trial","score_opus":0.02255336970657593,"score_gpt":0.33561343354273926,"score_spread":0.3130600638361633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2917620857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99734473,0.00044944446,0.00014038286,0.000111916444,0.00028133532,0.0016410948,0.000014809492,0.0000044797644,0.000011813697],"genre_scores_gemma":[0.9995515,0.00016451596,0.000016196573,0.00016810818,0.000035427624,0.00001941582,0.000022311553,0.00000700153,0.000015532178],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99668765,0.0022662266,0.0006159876,0.00018419151,0.00014405532,0.000101897705],"domain_scores_gemma":[0.9976463,0.0017930584,0.00018563114,0.0002719089,0.000060047907,0.00004307429],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024867216,0.0000909743,0.0010137283,0.000039794035,0.000012468613,0.0000013128852,0.00005701138,0.0000728518,0.000013192966],"category_scores_gemma":[0.0012322124,0.000052441836,0.0004065204,0.000059345137,0.000106788975,0.0000132931145,0.000035491466,0.0001384999,0.0000038402977],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009467229,0.00033833404,0.95440435,0.00011732764,0.0004175514,0.0000015381482,0.000016983447,0.000018447394,0.0000045468446,0.000007076314,0.000018184464,0.04370894],"study_design_scores_gemma":[0.005874753,0.008026521,0.98560387,0.00009690962,0.00015382514,6.3940644e-7,0.000016442587,0.00006533046,0.000036892856,0.000012711691,0.000073597774,0.00003851546],"about_ca_topic_score_codex":0.0000028624172,"about_ca_topic_score_gemma":4.7993916e-7,"teacher_disagreement_score":0.043670423,"about_ca_system_score_codex":0.000012450029,"about_ca_system_score_gemma":0.00002591206,"threshold_uncertainty_score":0.2138516},"labels":[],"label_agreement":null},{"id":"W2917818298","doi":"10.1111/trf.15219","title":"Reversal of the antiplatelet effect of ticagrelor by simulated platelet transfusion","year":2019,"lang":"en","type":"article","venue":"Transfusion","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Jiangsu Province's Key Provincial Talents Program","keywords":"Ticagrelor; Platelet; Clopidogrel; Medicine; Aspirin; Antiplatelet drug; Platelet transfusion; Cohort; Pharmacology; P2Y12; Adenosine diphosphate; Anesthesia; Internal medicine; Platelet aggregation","score_opus":0.003464973104736056,"score_gpt":0.21627423772060347,"score_spread":0.2128092646158674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2917818298","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995938,0.0014122719,0.00013478709,0.00012795873,0.00021342775,0.0013374914,0.000047786252,0.000045015913,0.00074327504],"genre_scores_gemma":[0.9971908,0.0024412156,0.000013767034,0.0000619972,0.000024391038,0.0000025348115,0.000042403466,0.000033592587,0.00018930271],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99836135,0.00019018496,0.00038559758,0.0002873606,0.00055270875,0.00022277664],"domain_scores_gemma":[0.9990911,0.00013940869,0.000084599764,0.0005309811,0.00006988257,0.000084047075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035709856,0.00022205435,0.0007018731,0.00006704335,0.000055593566,0.0000035985404,0.00015882638,0.00020278408,0.0006019495],"category_scores_gemma":[0.000020462032,0.00013573434,0.0007532175,0.0003604439,0.00012222464,0.000066477376,0.000016111066,0.00022577545,0.000023750445],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064779716,0.00023187035,0.030802077,0.00083802996,0.0004921753,0.000016730315,0.00035053724,0.00021118062,0.93587226,0.000019696727,0.00022435756,0.024463095],"study_design_scores_gemma":[0.012628585,0.0016696082,0.014206256,0.0006533395,0.0006138803,0.000062009094,0.000049986596,0.00037656928,0.9651626,0.000007650091,0.004370373,0.00019918059],"about_ca_topic_score_codex":0.0000935521,"about_ca_topic_score_gemma":0.0000019442246,"teacher_disagreement_score":0.029290283,"about_ca_system_score_codex":0.000017391381,"about_ca_system_score_gemma":0.00004334368,"threshold_uncertainty_score":0.6590925},"labels":[],"label_agreement":null},{"id":"W2918862291","doi":"10.1016/s0735-1097(19)30851-4","title":"APPLICATION OF TICAGRELOR OR CLOPIDOGREL BASED DUAL ANTIPLATELET THERAPY FOLLOWING A PHARMACOINVASIVE STRATEGY IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION: INSIGHTS FROM THE VITAL HEART RESPONSE REGISTRY","year":2019,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre","funders":"","keywords":"Medicine; Ticagrelor; Clopidogrel; Cardiology; Internal medicine; Myocardial infarction; Fibrinolysis; Prasugrel; Aspirin; ST segment; Acute ST segment elevation myocardial infarction; Acute coronary syndrome; Percutaneous coronary intervention","score_opus":0.012974036321989051,"score_gpt":0.273809386524015,"score_spread":0.2608353502020259,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2918862291","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951803,0.0012245583,0.0008135921,0.0016311619,0.0003196011,0.0006941055,0.00009198045,0.00000613138,0.000038590042],"genre_scores_gemma":[0.99826175,0.00044824256,0.00015587526,0.00069431047,0.0003789934,0.0000134419515,0.000009838645,0.000019634752,0.000017892939],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9972334,0.0011564674,0.00069493277,0.00019989505,0.00053980085,0.00017552062],"domain_scores_gemma":[0.9975579,0.0008126281,0.0008342471,0.00048994506,0.00023959724,0.000065714565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083215587,0.00018057165,0.0010792756,0.00014231341,0.000055560024,0.000005521005,0.00022936416,0.0000854448,0.00001273926],"category_scores_gemma":[0.00016412452,0.00010154984,0.001019182,0.000572089,0.00030813002,0.00008817431,0.000035703673,0.00032111662,0.0000017654373],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11846476,0.00032439662,0.34864378,0.000048949314,0.007218741,0.0004981206,0.00024535233,0.013598273,0.5010112,0.000064399355,0.002400171,0.00748187],"study_design_scores_gemma":[0.0163068,0.0039859577,0.93528295,0.00026552845,0.00082116196,0.0011314766,0.0028071965,0.0004903201,0.019978048,0.00012737747,0.018536469,0.00026670963],"about_ca_topic_score_codex":0.000035135123,"about_ca_topic_score_gemma":0.000002425774,"teacher_disagreement_score":0.58663917,"about_ca_system_score_codex":0.000099565565,"about_ca_system_score_gemma":0.00073275476,"threshold_uncertainty_score":0.41410822},"labels":[],"label_agreement":null},{"id":"W2919041175","doi":"10.1161/circresaha.118.313141","title":"Synergy of Dual Pathway Inhibition in Chronic Cardiovascular Disease","year":2019,"lang":"en","type":"article","venue":"Circulation Research","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Population Health Research Institute; McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"Daiichi Sankyo Europe; Servier; Pfizer","keywords":"Medicine; Rivaroxaban; Antithrombotic; Aspirin; Adverse effect; Warfarin; Coronary artery disease; Internal medicine; Clopidogrel; Pharmacology; Cardiology; Atrial fibrillation","score_opus":0.04162049004168899,"score_gpt":0.31189370318644416,"score_spread":0.27027321314475516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2919041175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880549,0.009369158,0.0002066938,0.000076301185,0.000049296694,0.0007181713,0.0000093102135,0.000024865834,0.0014913148],"genre_scores_gemma":[0.9991564,0.00033857813,0.000006911852,0.000016157166,0.00013165879,0.000041733652,0.00013245034,0.000022102424,0.00015399093],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976107,0.000325963,0.00025120337,0.00033170954,0.0011846715,0.00029578773],"domain_scores_gemma":[0.9988346,0.00006271087,0.000028164386,0.0006505132,0.00026610887,0.0001578831],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012686985,0.0000969239,0.00032936427,0.00037591587,0.000043718188,0.000013760633,0.000039646806,0.000086527485,0.0003473266],"category_scores_gemma":[0.000102235645,0.000093740186,0.0004828843,0.0006390932,0.00010521211,0.00012803162,0.000038391827,0.00022718479,0.00013531625],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023664213,0.0011067159,0.46407974,0.0039378353,0.0034317449,0.0022479256,0.0006328091,0.27633584,0.12492579,0.009793812,0.0002287397,0.110912636],"study_design_scores_gemma":[0.005316407,0.00019712468,0.97229433,0.00057877635,0.00011086389,0.00004108167,0.0001920298,0.00928002,0.005873138,0.00063186453,0.005272697,0.00021164166],"about_ca_topic_score_codex":0.00010834375,"about_ca_topic_score_gemma":0.0000044033104,"teacher_disagreement_score":0.50821465,"about_ca_system_score_codex":0.00025978519,"about_ca_system_score_gemma":0.0005509971,"threshold_uncertainty_score":0.38226137},"labels":[],"label_agreement":null},{"id":"W2919131998","doi":"10.1016/s0735-1097(19)31695-x","title":"DIFFERENCES IN THE EFFECT OF CLOPIDOGREL BETWEEN MEN AND WOMEN: A GENETIC APPROACH","year":2019,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Clopidogrel; Acute coronary syndrome; Internal medicine; Drug; Adverse effect; Cardiology; Pharmacology; Aspirin; Myocardial infarction","score_opus":0.007061382580225762,"score_gpt":0.23132387630306753,"score_spread":0.22426249372284177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2919131998","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968591,0.0018772794,0.00005820785,0.00018719591,0.000048780035,0.00031031598,0.000013794822,0.0000012390726,0.00064412423],"genre_scores_gemma":[0.9991543,0.00052894704,0.00007352659,0.0000601996,0.00014773497,0.00000540905,2.8960275e-7,0.0000068314043,0.000022726783],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982332,0.0009160898,0.00033550675,0.00009344226,0.00027591427,0.0001458219],"domain_scores_gemma":[0.9988352,0.000400268,0.00040588088,0.00026779776,0.00004697851,0.00004385691],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008101162,0.000104580286,0.001276007,0.000093523246,0.000018388166,0.0000017858952,0.00024429636,0.000038329974,0.000002740336],"category_scores_gemma":[0.000066731634,0.000047661426,0.00043066923,0.00025490188,0.00044533334,0.000017802819,0.000041577714,0.00018600385,2.824667e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010023743,0.000014445747,0.9939976,0.00008541497,0.0011569557,0.000030813557,0.00017464496,0.000043735654,0.00045981546,0.000007964777,0.00013022093,0.002896031],"study_design_scores_gemma":[0.0021064656,0.003361498,0.9907987,0.00005191615,0.00038560096,0.0009421538,0.0016277047,0.000011645311,0.00022865707,0.000043234446,0.00039076403,0.000051653642],"about_ca_topic_score_codex":0.00000464491,"about_ca_topic_score_gemma":6.786133e-8,"teacher_disagreement_score":0.0033470523,"about_ca_system_score_codex":0.000021643935,"about_ca_system_score_gemma":0.00006530925,"threshold_uncertainty_score":0.19435765},"labels":[],"label_agreement":null},{"id":"W2920082292","doi":"10.1038/s41598-019-40628-0","title":"Determinants of high platelet reactivity in patients with acute coronary syndromes treated with ticagrelor","year":2019,"lang":"en","type":"article","venue":"Scientific Reports","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Uniwersytet Mikolaja Kopernika w Toruniu","keywords":"Ticagrelor; Medicine; Acute coronary syndrome; Percutaneous coronary intervention; Myocardial infarction; Internal medicine; Cardiology; Pharmacodynamics; Odds ratio; Platelet aggregation inhibitor; Logistic regression; Platelet; Pharmacokinetics","score_opus":0.006105034282838153,"score_gpt":0.21693102058916924,"score_spread":0.2108259863063311,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2920082292","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99855584,0.000063031875,0.0000037214804,0.0000062220765,0.00031105895,0.00082087156,0.00001028874,0.000033647786,0.00019531553],"genre_scores_gemma":[0.9987381,0.000006676942,0.00009652592,0.000009816532,0.0000056251024,0.000011835858,0.00013108349,0.000023845509,0.0009764904],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980443,0.000039507304,0.00033699072,0.0006036185,0.0007051098,0.0002704657],"domain_scores_gemma":[0.9985815,0.000019994488,0.00024187715,0.00087449374,0.000168971,0.00011312667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033341313,0.00018000176,0.00057541684,0.00014099674,0.00005063386,0.000023774051,0.0000616009,0.00007016773,0.0001229399],"category_scores_gemma":[0.000013821843,0.00011570028,0.000110378125,0.00045197344,0.00023209782,0.00020100313,0.000026865171,0.00010014378,0.00001576467],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016970964,0.0004535742,0.98478365,0.000064883076,0.00029536674,0.005901888,0.000049063856,0.000012050133,0.00061821454,0.0000014214919,0.000048021466,0.0060747513],"study_design_scores_gemma":[0.002805043,0.00074119045,0.97951746,0.00031033886,0.00021130632,0.0014933288,0.000025796153,0.000010538953,0.014442107,0.000030137617,0.0002501436,0.00016263922],"about_ca_topic_score_codex":0.00006050387,"about_ca_topic_score_gemma":0.000014078093,"teacher_disagreement_score":0.013823892,"about_ca_system_score_codex":0.000044480912,"about_ca_system_score_gemma":0.00018243866,"threshold_uncertainty_score":0.47181204},"labels":[],"label_agreement":null},{"id":"W2921476261","doi":"10.1016/j.jacc.2019.03.011","title":"Ticagrelor Versus Clopidogrel in Patients With STEMI Treated With Fibrinolysis","year":2019,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Heart Research Centre; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Ticagrelor; Clopidogrel; Internal medicine; Hazard ratio; Myocardial infarction; Cardiology; Stroke (engine); Confidence interval","score_opus":0.005473962978377258,"score_gpt":0.2134880101656841,"score_spread":0.20801404718730684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921476261","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983834,0.00025634878,0.000023789704,0.000173302,0.00009623329,0.00027347135,0.000021844739,0.0000041136377,0.00076749525],"genre_scores_gemma":[0.9994973,0.000098837336,0.00014544012,0.00006998239,0.000076289376,0.000001768124,0.0000017713727,0.000017029717,0.000091609276],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988089,0.0002039368,0.0003090435,0.00012665935,0.00037185376,0.00017958783],"domain_scores_gemma":[0.9987546,0.00010771369,0.00046068782,0.00035286995,0.000252416,0.000071708586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015684059,0.00013467805,0.0010958273,0.0001415767,0.000019346766,0.0000018486678,0.00015673827,0.00003793586,0.000011259031],"category_scores_gemma":[0.000029661993,0.000068288056,0.000429716,0.00050814566,0.0002950191,0.000044583132,0.000026654045,0.00017943759,0.000002734315],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02725742,0.00006050042,0.9671955,0.000020211086,0.0027659745,0.00015294441,0.000011981225,0.0007519873,0.000083385494,0.0000137601955,0.00015750703,0.0015288169],"study_design_scores_gemma":[0.01331821,0.0063290875,0.9764782,0.00015323088,0.0008604243,0.00034156104,0.0003526863,0.000005729288,0.0002364008,0.0000023634382,0.0018213058,0.00010079858],"about_ca_topic_score_codex":0.0000075902035,"about_ca_topic_score_gemma":0.0000017001629,"teacher_disagreement_score":0.013939211,"about_ca_system_score_codex":0.00007059242,"about_ca_system_score_gemma":0.00017253905,"threshold_uncertainty_score":0.2784706},"labels":[],"label_agreement":null},{"id":"W2921678403","doi":"10.1136/bmjopen-2018-026053","title":"Rationale and design of a prospective substudy of clinical endpoint adjudication processes within an investigator-reported randomised controlled trial in patients with coronary artery disease: the GLOBAL LEADERS Adjudication Sub-StudY (GLASSY)","year":2019,"lang":"en","type":"article","venue":"BMJ Open","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"Medicines Company; University of Bern; AstraZeneca","keywords":"Medicine; Adjudication; Coronary artery disease; Clinical endpoint; Clinical trial; Randomized controlled trial; Internal medicine; Cardiology; Intensive care medicine; Family medicine; Law","score_opus":0.07548922689362798,"score_gpt":0.36237212055050766,"score_spread":0.2868828936568797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921678403","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92101276,0.0001566147,0.000109821754,0.00010183411,0.000046461842,0.07851804,0.000015683912,0.00001148366,0.000027319269],"genre_scores_gemma":[0.9954107,0.00001700059,0.0000898673,0.00009825236,0.000031707837,0.004221442,0.00010677821,0.000013758848,0.000010530297],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996818,0.000987256,0.001044156,0.00039781566,0.0006402425,0.00011250914],"domain_scores_gemma":[0.9977589,0.0003076567,0.0008365707,0.00049415795,0.0004419003,0.00016080462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026271027,0.0001645301,0.00094988156,0.0000467883,0.00004820225,0.00002123199,0.0001653959,0.000056108838,0.000014843769],"category_scores_gemma":[0.0017259931,0.000102038015,0.000106250016,0.00029083196,0.00027787115,0.00027983254,0.000042724787,0.00009768673,0.0000011414832],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.46566534,0.002095338,0.5307102,0.000049304297,0.0007343975,0.0000062150025,0.0005015546,0.00007608787,0.000008598852,0.000010237792,0.0000075598787,0.0001351463],"study_design_scores_gemma":[0.40724108,0.00231015,0.5886296,0.000103171595,0.0005144323,0.0000022567046,0.00083593494,0.0001777992,0.000026109752,0.00008332575,4.0081406e-7,0.00007572692],"about_ca_topic_score_codex":0.000029269846,"about_ca_topic_score_gemma":0.00004578076,"teacher_disagreement_score":0.07439792,"about_ca_system_score_codex":0.00003520151,"about_ca_system_score_gemma":0.0017398786,"threshold_uncertainty_score":0.41609892},"labels":[],"label_agreement":null},{"id":"W2924598001","doi":"10.1093/ehjcvp/pvz013","title":"External applicability of the COMPASS trial: the Western Denmark Heart Registry","year":2019,"lang":"en","type":"article","venue":"European Heart Journal - Cardiovascular Pharmacotherapy","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"Aarhus Universitetshospital","keywords":"Compass; Medicine; Geography; Cartography","score_opus":0.030462027017349503,"score_gpt":0.30369431096325766,"score_spread":0.27323228394590815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2924598001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9563813,0.035658654,0.0010186997,0.0015205664,0.0012939067,0.0020228238,0.000011321551,0.000053366504,0.0020393163],"genre_scores_gemma":[0.99037564,0.0025402736,0.00013667336,0.0038441906,0.0020677107,0.000017187233,0.0000019163117,0.00012324878,0.0008931477],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99346495,0.0031526757,0.00078611873,0.00048425698,0.0016247103,0.0004873041],"domain_scores_gemma":[0.99695146,0.00014187378,0.00025974962,0.0020975487,0.00025014154,0.00029919695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0049301055,0.0003894041,0.0011199886,0.00007133519,0.000354085,0.00011358114,0.0007344535,0.00007296118,0.00044751167],"category_scores_gemma":[0.000040742587,0.00022002695,0.0064434973,0.00035555515,0.00033046448,0.00014550313,0.000110944165,0.0010641397,0.0002476814],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08616958,0.0031423306,0.45495984,0.0010450631,0.054676194,0.0009809398,0.0018915465,0.0060628364,0.2203677,0.000064449545,0.05867478,0.11196475],"study_design_scores_gemma":[0.044954192,0.00033452443,0.14137743,0.0002622946,0.001113875,0.0053643542,0.00010434764,0.000028939601,0.009029827,0.000019865658,0.7970962,0.00031415187],"about_ca_topic_score_codex":0.0000121764515,"about_ca_topic_score_gemma":2.2188179e-7,"teacher_disagreement_score":0.73842144,"about_ca_system_score_codex":0.000080585356,"about_ca_system_score_gemma":0.00019232392,"threshold_uncertainty_score":0.89724386},"labels":[],"label_agreement":null},{"id":"W2928378917","doi":"10.1016/j.bja.2019.03.009","title":"Anti-platelet therapy and the anaesthesiologist: controversies and unresolved clinical dilemmas continue","year":2019,"lang":"en","type":"letter","venue":"British Journal of Anaesthesia","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"March of Dimes Canada","funders":"","keywords":"Medicine; Aspirin; Perioperative; Mace; Clopidogrel; Percutaneous coronary intervention; P2Y12; Adverse effect; Internal medicine; Incidence (geometry); Intensive care medicine; Cardiology; Anesthesia; Myocardial infarction","score_opus":0.024201601046091484,"score_gpt":0.25825518302149614,"score_spread":0.23405358197540466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2928378917","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.66003054,0.18479703,0.000025324014,0.15391321,0.00028923206,0.00074942457,0.000030031535,0.00002424572,0.00014092235],"genre_scores_gemma":[0.17876388,0.41762885,0.00016343746,0.3998438,0.00307539,0.000006356346,0.00004390437,0.00009562288,0.00037873533],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963275,0.0010900301,0.0010971614,0.00043228976,0.0006196192,0.00043340467],"domain_scores_gemma":[0.9972096,0.00096358714,0.0009318789,0.00041895921,0.00031624216,0.00015975205],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0022305448,0.00042617944,0.0025902195,0.00013360995,0.00018673495,0.0002521689,0.00032660767,0.0008367561,0.00004286517],"category_scores_gemma":[0.0004894089,0.00029838787,0.0013322935,0.00010198516,0.0016733003,0.00015700764,0.000050944698,0.0023914375,0.0000061042165],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00301602,0.00009405307,0.018178081,0.00013213737,0.0031377142,0.028893428,0.00006489887,9.093353e-7,0.000003967397,0.00004021609,0.62205064,0.32438797],"study_design_scores_gemma":[0.018943254,0.0014611649,0.0862722,0.00091030204,0.0008783047,0.025099624,0.000096862525,0.000008842828,0.000008418982,0.00015312487,0.86582464,0.00034325966],"about_ca_topic_score_codex":0.000097412034,"about_ca_topic_score_gemma":0.0000033171002,"teacher_disagreement_score":0.48126668,"about_ca_system_score_codex":0.00002389642,"about_ca_system_score_gemma":0.00024319878,"threshold_uncertainty_score":0.99994683},"labels":[],"label_agreement":null},{"id":"W2935057163","doi":"10.1016/j.cjca.2019.03.025","title":"Factors Affecting Delay in Filling Prescriptions for Dual Antiplatelet Therapy After Coronary Stenting","year":2019,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes; University of British Columbia; St. Paul's Hospital; Providence Health Care","funders":"","keywords":"Medicine; Conventional PCI; Percutaneous coronary intervention; Medical prescription; Odds ratio; Internal medicine; Cardiology; Clopidogrel; Confidence interval; Stent; Logistic regression; Myocardial infarction; Pharmacology","score_opus":0.02583014498847267,"score_gpt":0.24787348543819687,"score_spread":0.2220433404497242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2935057163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913284,0.0062053096,0.0008794156,0.0000699226,0.0007713137,0.0004071637,0.000030088768,0.000006350538,0.00030203818],"genre_scores_gemma":[0.99891025,0.00021845376,0.00009942741,0.00014972688,0.00051430747,0.000005595307,0.000018426721,0.000027699907,0.000056086392],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988555,0.0001333197,0.00034171343,0.00016239178,0.00010882984,0.00039826616],"domain_scores_gemma":[0.9991421,0.00013731117,0.00011425785,0.00016037031,0.00015049626,0.00029544393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005011439,0.00015101639,0.00063727086,0.00032233755,0.00006799634,0.00001812622,0.00007653751,0.0001490761,0.00005915055],"category_scores_gemma":[0.00008342324,0.00012287748,0.00065650983,0.00011077064,0.000059677044,0.000120449906,0.000006004306,0.00027147974,0.0000037468976],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005640194,0.0000049767555,0.9872836,0.000038078866,0.0009254984,0.00074062176,0.00043351375,0.0027009905,0.0009570755,0.000012437059,0.00030063116,0.0060385684],"study_design_scores_gemma":[0.0044511417,0.0006320278,0.9544626,0.00019891036,0.00016440806,0.0017729676,0.0013137199,0.000050116058,0.00033818683,0.000044324508,0.036373932,0.00019765699],"about_ca_topic_score_codex":0.000103958046,"about_ca_topic_score_gemma":0.00019404141,"teacher_disagreement_score":0.0360733,"about_ca_system_score_codex":0.00009678758,"about_ca_system_score_gemma":0.00049099815,"threshold_uncertainty_score":0.50107986},"labels":[],"label_agreement":null},{"id":"W2936489929","doi":"10.1161/circinterventions.119.007811","title":"Clopidogrel Pharmacogenetics","year":2019,"lang":"en","type":"review","venue":"Circulation Cardiovascular Interventions","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":221,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ted Rogers Centre for Heart Research; St. Michael's Hospital; University of Ottawa","funders":"National Heart, Lung, and Blood Institute; University of California, San Francisco; Sharp HealthCare; University of Minnesota; Aurora Research Institute; Minneapolis Heart Institute Foundation; Konyang University; Chung-Ang University; York University; Ajou University; Henry Ford Health System; Greenville Health System; NorthShore University HealthSystem; Minneapolis Heart Institute; Chonnam National University; NYU Langone Medical Center; University of California","keywords":"Clopidogrel; Medicine; Percutaneous coronary intervention; CYP2C19; Conventional PCI; Internal medicine; Pharmacogenetics; Cardiology; Prasugrel; Acute coronary syndrome; Genotyping; Intensive care medicine; Aspirin; Genotype; Myocardial infarction; Genetics","score_opus":0.21878450863371585,"score_gpt":0.42038841800896215,"score_spread":0.2016039093752463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2936489929","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000013464391,0.98319185,0.011056082,0.0000074530094,0.0011060282,0.0025637918,0.00012105148,0.00022019299,0.0017200673],"genre_scores_gemma":[0.0002946195,0.99574316,0.00018360173,0.00004103313,0.0007530439,0.00027360808,0.0016262735,0.00019081996,0.0008938732],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99625033,0.00049305335,0.0011227592,0.00086726446,0.0008565907,0.00041001974],"domain_scores_gemma":[0.9972849,0.000058091915,0.00029517477,0.0018549488,0.0002538884,0.00025302332],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00063510466,0.0006405142,0.0036687688,0.0005311746,0.0001429879,0.000079109406,0.00026230302,0.00052455615,0.0006262181],"category_scores_gemma":[0.000066365326,0.00059337553,0.040040404,0.0006819782,0.00009511411,0.000106342246,0.00010459477,0.00055182585,0.0017094326],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000065643135,0.00015097974,0.00003641742,0.048404805,0.031998754,0.00009832473,0.000007862739,0.00016102805,1.5809454e-7,0.00008772313,0.0004186703,0.9186287],"study_design_scores_gemma":[0.0010873877,0.000042934993,0.00013319853,0.020556731,0.062027756,0.0011130978,0.000009142666,0.000029306071,5.7871466e-7,0.000012495185,0.9144857,0.00050169305],"about_ca_topic_score_codex":0.0000039217193,"about_ca_topic_score_gemma":2.2144461e-7,"teacher_disagreement_score":0.918127,"about_ca_system_score_codex":0.00025489536,"about_ca_system_score_gemma":0.0003856681,"threshold_uncertainty_score":0.9996518},"labels":[],"label_agreement":null},{"id":"W2938138790","doi":"10.1177/1060028019845334","title":"Switching to Clopidogrel in Patients With Acute Coronary Syndrome Managed With Percutaneous Coronary Intervention Initially Treated With Prasugrel or Ticagrelor: Systematic Review and Meta-analysis","year":2019,"lang":"en","type":"review","venue":"Annals of Pharmacotherapy","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of Alberta; Surrey Memorial Hospital","funders":"","keywords":"Prasugrel; Medicine; Ticagrelor; Clopidogrel; Mace; Acute coronary syndrome; Percutaneous coronary intervention; Internal medicine; Randomized controlled trial; Meta-analysis; Hazard ratio; Adverse effect; Cardiology; Myocardial infarction; Confidence interval","score_opus":0.08105371926491761,"score_gpt":0.3783654172461942,"score_spread":0.2973116979812766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2938138790","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013602524,0.97607696,0.00010165085,0.00007280477,0.000010429127,0.009821887,0.00023735595,0.000053812968,0.000022570228],"genre_scores_gemma":[0.019305024,0.97736007,0.00018541366,0.00170519,0.000007938955,0.00046785086,0.00035490107,0.00016612215,0.00044745993],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9956565,0.0008777302,0.001326011,0.00085984217,0.00085394375,0.000425957],"domain_scores_gemma":[0.9974937,0.00016783967,0.0009744665,0.00075421226,0.0003380815,0.00027173845],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006466242,0.0009525396,0.010129713,0.0007301949,0.000056811085,0.00003686364,0.0003016061,0.0001651004,0.0004314687],"category_scores_gemma":[0.000012340366,0.00047806298,0.0021567459,0.0013943163,0.00008274567,0.00019886845,0.00004051724,0.00040109095,0.000016936729],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00427625,0.00064133777,0.00029734924,0.4209709,0.5558165,0.0045853136,0.000065692046,0.000008433425,0.0000010079724,0.0000014059509,0.000024545374,0.013311334],"study_design_scores_gemma":[0.003088129,0.0050645373,0.00051630964,0.111879244,0.8731839,0.0045898044,0.000023478253,0.0000041126295,0.0000023852049,5.267078e-7,0.00096677366,0.0006807869],"about_ca_topic_score_codex":0.000029032575,"about_ca_topic_score_gemma":0.000011521517,"teacher_disagreement_score":0.31736746,"about_ca_system_score_codex":0.00005591227,"about_ca_system_score_gemma":0.00016710206,"threshold_uncertainty_score":0.9997671},"labels":[],"label_agreement":null},{"id":"W2938613025","doi":"10.22374/1710-6222.26.1.5","title":"TREATMENT COMPLETION AND IMPLEMENTATION BY PATIENTS INITIATING TICAGRELOR","year":2019,"lang":"en","type":"article","venue":"Journal of Population Therapeutics and Clinical Pharmacology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Université du Québec; Université Laval; The Quebec Population Health Research Network","funders":"AstraZeneca Canada; AstraZeneca","keywords":"Ticagrelor; Completion (oil and gas wells); Medicine; Internal medicine; Aspirin; Clopidogrel; Engineering","score_opus":0.030162023097523683,"score_gpt":0.41062680646734134,"score_spread":0.38046478336981765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2938613025","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99759144,0.0010514398,0.00008452455,0.00065914483,0.00034790966,0.00023051223,0.0000071413338,0.0000044030094,0.000023481998],"genre_scores_gemma":[0.9945353,0.0036332607,0.0001054659,0.0014684643,0.0001856338,0.0000010550292,0.000048866896,0.000007905031,0.000013998353],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99908453,0.00013276032,0.0004790991,0.00009462412,0.00012572132,0.00008328012],"domain_scores_gemma":[0.9993761,0.000116006006,0.00027769734,0.00003899454,0.000104511906,0.0000866801],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022367244,0.00007646246,0.00029775844,0.000039537543,0.000040548563,0.000009937645,0.000017595034,0.000059358506,0.00012898698],"category_scores_gemma":[0.0000056186373,0.00005659116,0.0001284391,0.000032130087,0.00003123301,0.000068760855,0.0000079607225,0.00009597901,0.000002286781],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005477019,0.00028098107,0.8430047,0.000014832678,0.0007250586,0.0000029297114,0.000049895898,0.0000019273627,0.0009961907,0.000035974197,0.00009497269,0.15424483],"study_design_scores_gemma":[0.011745004,0.0029373465,0.97273564,0.000012207072,0.0009350908,0.000037976275,0.000096282376,0.00044232165,0.00015614614,0.00010343867,0.010729997,0.00006853499],"about_ca_topic_score_codex":0.000008645055,"about_ca_topic_score_gemma":6.1642754e-7,"teacher_disagreement_score":0.15417628,"about_ca_system_score_codex":0.000030902313,"about_ca_system_score_gemma":0.000017589962,"threshold_uncertainty_score":0.23077206},"labels":[],"label_agreement":null},{"id":"W2940147581","doi":"10.14740/cr842","title":"Optimal Duration for Clopidogrel Suspension Prior to Coronary Artery Bypass Grafting","year":2019,"lang":"en","type":"article","venue":"Cardiology Research","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Clopidogrel; Angioplasty; Cardiology; Bypass grafting; Internal medicine; Loading dose; Artery; TIMI; Surgery; Anesthesia; Percutaneous coronary intervention; Myocardial infarction","score_opus":0.05255778545584969,"score_gpt":0.36287605936783063,"score_spread":0.31031827391198097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2940147581","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922811,0.0013110247,0.0020049966,0.0008951054,0.0002974308,0.0020201437,0.000011497848,0.000058091096,0.0011206411],"genre_scores_gemma":[0.99651057,0.00016092195,0.00080116815,0.00027130096,0.00064311275,0.00017424457,0.00012333544,0.00003356829,0.0012817904],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99801266,0.0003243636,0.00022975779,0.00047270226,0.0003933074,0.00056722586],"domain_scores_gemma":[0.99848187,0.00032649894,0.00002463614,0.00049775065,0.00046239208,0.00020683445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001673989,0.00013269247,0.000554948,0.00020280803,0.00019518372,0.000019901654,0.00012488662,0.00019287388,0.000068185596],"category_scores_gemma":[0.0003004241,0.00011456935,0.00038711674,0.00022609344,0.0001182437,0.00006926141,0.00009882853,0.00030877235,0.00042391065],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02358218,0.0002501321,0.45500365,0.0006594101,0.005372404,0.0020649491,0.0010186514,0.0017511983,0.3690491,0.0011742039,0.03400267,0.10607146],"study_design_scores_gemma":[0.01616788,0.0074313497,0.77843326,0.0003630527,0.0005189736,0.0044813403,0.0032752387,0.0016096758,0.017554304,0.00030981097,0.16898462,0.0008704853],"about_ca_topic_score_codex":0.0000023048697,"about_ca_topic_score_gemma":6.8041237e-7,"teacher_disagreement_score":0.3514948,"about_ca_system_score_codex":0.000083719024,"about_ca_system_score_gemma":0.00017510736,"threshold_uncertainty_score":0.54486555},"labels":[],"label_agreement":null},{"id":"W2940510093","doi":"10.1161/strokeaha.119.024786","title":"Dual Versus Mono Antiplatelet Therapy in Large Atherosclerotic Stroke","year":2019,"lang":"en","type":"article","venue":"Stroke","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Population Health Research Institute","funders":"","keywords":"Medicine; Aspirin; Clopidogrel; Stroke (engine); Hazard ratio; Internal medicine; Cardiology; Myocardial infarction; Clinical endpoint; Randomized controlled trial; Confidence interval","score_opus":0.017267455727567545,"score_gpt":0.2594017896852419,"score_spread":0.24213433395767436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2940510093","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99009806,0.0023705522,0.000037732927,0.00010764042,0.0005313729,0.0006708262,0.000084227446,0.00009668289,0.006002915],"genre_scores_gemma":[0.99517274,0.001466234,0.00007332499,0.00027135588,0.00020702141,0.000020089807,0.000049581544,0.000047246103,0.0026924042],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99835265,0.00007920644,0.00025023395,0.0003867233,0.00041634188,0.0005148752],"domain_scores_gemma":[0.9991629,0.00005484087,0.000053771266,0.000542453,0.00004421352,0.00014178465],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00026979778,0.00023777851,0.0005050921,0.00013884614,0.000048635666,0.000025633179,0.00011068982,0.00014946205,0.0011206293],"category_scores_gemma":[0.000019347548,0.00020635604,0.00043084944,0.00016456575,0.00004506194,0.00012035962,0.000036836016,0.00028578012,0.000554549],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013937438,0.0012855123,0.8727497,0.00011508015,0.0026455657,0.0006697591,0.0007069838,0.000106639156,0.055828292,0.0009369386,0.00059501495,0.050423082],"study_design_scores_gemma":[0.09464832,0.003495271,0.81364125,0.00024141786,0.00027088562,0.00010002295,0.0015651452,0.0004780261,0.020801986,0.000048866223,0.06379364,0.0009151814],"about_ca_topic_score_codex":0.000022026212,"about_ca_topic_score_gemma":0.000009711437,"teacher_disagreement_score":0.08071088,"about_ca_system_score_codex":0.00005448242,"about_ca_system_score_gemma":0.0000842871,"threshold_uncertainty_score":0.99979246},"labels":[],"label_agreement":null},{"id":"W2942638642","doi":"10.1053/j.gastro.2019.04.041","title":"Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled Trial","year":2019,"lang":"en","type":"article","venue":"Gastroenterology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":154,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut universitaire de cardiologie et de pneumologie de Québec; Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"Janssen Pharmaceuticals; Merck Sharp and Dohme; Daiichi-Sankyo; Fresenius Medical Care North America; AstraZeneca; Biotronik; Amarin Corporation; Portola Pharmaceuticals; Boehringer Ingelheim; Bristol-Myers Squibb; Cleveland Clinic; Duke University; Medtronic; Roche; Bayer HealthCare; Sanofi; Merck; GlaxoSmithKline; Icahn School of Medicine at Mount Sinai; Pfizer; Daiichi Sankyo Europe; Servier; LEO Pharma Research Foundation; Bayer; Eli Lilly and Company; Novartis; Astellas Pharma Canada; U.S. Department of Veterans Affairs","keywords":"Medicine; Aspirin; Double blind; Pantoprazole; Placebo; Randomized controlled trial; Rivaroxaban; Internal medicine; Gastroenterology; Warfarin; Omeprazole","score_opus":0.011900392354253386,"score_gpt":0.26461918358608183,"score_spread":0.25271879123182844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2942638642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896381,0.00008573636,0.000105925654,0.0003470602,0.00038834146,0.00932318,0.000003949578,0.00002523574,0.00008245989],"genre_scores_gemma":[0.99786574,0.0000635241,0.00017096456,0.0005829499,0.00012877885,0.0008732414,0.00003517277,0.000029365678,0.00025028578],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99700034,0.0006936429,0.00078928383,0.0005545739,0.0003335094,0.0006286576],"domain_scores_gemma":[0.99910647,0.000118631426,0.00015847142,0.00035766955,0.0000460695,0.00021267912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014181942,0.00028948497,0.0018433266,0.0004155535,0.000025126734,0.000010252455,0.00013870196,0.00012515104,0.00014883443],"category_scores_gemma":[0.00013838308,0.00022092274,0.00044012576,0.00014322683,0.000051736377,0.00009745793,0.00010964896,0.0002917545,0.000044998695],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.69410735,0.00086274557,0.30376524,0.000030703522,0.00034794453,0.000027838794,0.00012997854,0.00010610818,0.0000436636,0.0000022257009,0.00001048428,0.0005656979],"study_design_scores_gemma":[0.89402944,0.0030798377,0.10217811,0.00019395299,0.00016966919,0.000037909085,0.000038892675,0.000101235724,0.000020664565,0.000011191244,0.000035405687,0.0001036844],"about_ca_topic_score_codex":0.000045356574,"about_ca_topic_score_gemma":0.00022685315,"teacher_disagreement_score":0.20158713,"about_ca_system_score_codex":0.00007572147,"about_ca_system_score_gemma":0.000059947368,"threshold_uncertainty_score":0.9008968},"labels":[],"label_agreement":null},{"id":"W2943109321","doi":"10.1161/circulationaha.118.033580","title":"Combination Antiplatelet and Oral Anticoagulant Therapy in Patients With Coronary and Peripheral Artery Disease","year":2019,"lang":"en","type":"review","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute","funders":"British Heart Foundation; Maastricht Universitair Medisch Centrum; Universiteit Maastricht; McMaster University","keywords":"Medicine; Clopidogrel; Acute coronary syndrome; Antithrombotic; Coronary artery disease; Percutaneous coronary intervention; Internal medicine; Cardiology; Aspirin; Myocardial infarction","score_opus":0.027627845741973245,"score_gpt":0.27241181542660153,"score_spread":0.2447839696846283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2943109321","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.42971233,0.5689613,0.00002710111,0.0000062966465,0.000044400807,0.0012036394,0.000015972013,0.000019207515,0.000009709323],"genre_scores_gemma":[0.42468765,0.57434815,0.00000891629,0.000035027362,0.000022656555,0.000019101555,0.0008391478,0.000032466476,0.000006875644],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99866086,0.00014461727,0.0002952751,0.0004284399,0.00028878474,0.00018202943],"domain_scores_gemma":[0.99936813,0.00003184955,0.00013573325,0.00027663418,0.00005973733,0.00012793996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012541114,0.00031507874,0.001071482,0.00016756778,0.000052898515,0.00004238036,0.000037090373,0.00015930834,0.000021630156],"category_scores_gemma":[0.000009457893,0.00023594197,0.0001779189,0.00014153979,0.000079555095,0.00017664577,0.000017355458,0.00016726578,0.000004395443],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003049677,0.00016489369,0.39955848,0.002707775,0.00027161834,0.000051606003,0.000024924077,0.0000034511856,1.6388448e-7,0.000021095972,0.0000037568727,0.5968873],"study_design_scores_gemma":[0.0056805946,0.00021153771,0.9739409,0.0040913466,0.00080669165,0.000062600935,0.0000060657635,0.0001460297,5.0797183e-8,0.000021077118,0.014731642,0.00030145352],"about_ca_topic_score_codex":0.0000033329034,"about_ca_topic_score_gemma":4.2559788e-7,"teacher_disagreement_score":0.5965858,"about_ca_system_score_codex":0.000064657535,"about_ca_system_score_gemma":0.00011628389,"threshold_uncertainty_score":0.9621435},"labels":[],"label_agreement":null},{"id":"W2943966317","doi":"10.1016/j.cjca.2019.04.026","title":"Outcomes Among Clopidogrel, Prasugrel, and Ticagrelor in ST-Elevation Myocardial Infarction Patients Who Underwent Primary Percutaneous Coronary Intervention From the TOTAL Trial","year":2019,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University Health Network; Hamilton Health Sciences; Southlake Regional Health Center; McMaster University; London Health Sciences Centre; University of British Columbia; Population Health Research Institute; Canadian VIGOUR Centre; University of Alberta","funders":"Canadian Institutes of Health Research; Medtronic","keywords":"Medicine; Prasugrel; Clopidogrel; Ticagrelor; Percutaneous coronary intervention; Internal medicine; Cardiology; Myocardial infarction; Hazard ratio; Conventional PCI; Stroke (engine); Confidence interval","score_opus":0.00766408689834819,"score_gpt":0.21565413828230948,"score_spread":0.2079900513839613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2943966317","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960442,0.0011683311,0.00012551842,0.00038364696,0.0013541934,0.0006095495,0.00003805468,0.000004413222,0.00027204485],"genre_scores_gemma":[0.9987214,0.00023679527,0.000013206045,0.00028069736,0.0005862966,0.0000047873195,0.000090819034,0.000016047512,0.00004991915],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99857575,0.00035940378,0.00044321077,0.00017304865,0.00022704317,0.00022152044],"domain_scores_gemma":[0.99912614,0.00015006443,0.00018233238,0.00018317057,0.00014140416,0.00021688182],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004027694,0.00014423794,0.00060866115,0.0001623044,0.0000600841,0.000024596175,0.000082390514,0.00016775336,0.00004433107],"category_scores_gemma":[0.00014285698,0.000105145824,0.00044322066,0.00008459571,0.00014733312,0.00014093303,0.000016483546,0.00033023595,0.000006017489],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003993665,0.00001121448,0.97344244,0.000012789125,0.00097507,0.00013928307,0.00017557612,0.0002711984,0.000014995223,0.000015493466,0.00051650224,0.020431783],"study_design_scores_gemma":[0.01830664,0.0010334712,0.97587925,0.00009462915,0.00031371272,0.000470372,0.00025138384,0.000017158478,8.3464755e-7,0.0000884277,0.0034424572,0.00010166251],"about_ca_topic_score_codex":0.0009123886,"about_ca_topic_score_gemma":0.0004565335,"teacher_disagreement_score":0.02033012,"about_ca_system_score_codex":0.00026335375,"about_ca_system_score_gemma":0.00035759556,"threshold_uncertainty_score":0.42877224},"labels":[],"label_agreement":null},{"id":"W2944595736","doi":"10.1016/j.ahj.2019.05.004","title":"Clinical consequences of bleeding among individuals with a recent acute coronary syndrome: Insights from the APPRAISE-2 trial","year":2019,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Pfizer; Bristol-Myers Squibb","keywords":"Medicine; Aspirin; Apixaban; Acute coronary syndrome; TIMI; Thienopyridine; Internal medicine; Prasugrel; Myocardial infarction; Hazard ratio; Clopidogrel; Cardiology; Surgery; Percutaneous coronary intervention; Warfarin; Confidence interval; Atrial fibrillation; Rivaroxaban","score_opus":0.028739349356186106,"score_gpt":0.31989667133335214,"score_spread":0.29115732197716604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944595736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959956,0.0019310324,0.000039947834,0.00093023776,0.000360298,0.00056082674,0.000015881866,0.000020204436,0.00014601248],"genre_scores_gemma":[0.9946397,0.0032381942,0.00067887676,0.0010598503,0.00031329418,0.000008320589,0.000010897133,0.0000218246,0.000029070054],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99777734,0.00047206203,0.0005704988,0.00024838228,0.0006955396,0.00023620354],"domain_scores_gemma":[0.99832267,0.00055522803,0.0004026386,0.00033513462,0.00013617294,0.0002481691],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006253321,0.00017103895,0.00089082035,0.00005910789,0.00013172138,0.00003788517,0.00017844107,0.000060200466,0.000334563],"category_scores_gemma":[0.00007873889,0.0000936943,0.0004770816,0.0002949066,0.0012220484,0.00013836277,0.000035941433,0.00055463554,0.000024068038],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0113802105,0.0001920084,0.9736209,0.000005350714,0.0039292993,0.0004147196,0.0002903178,0.0000068132613,0.00039776386,0.000010378247,0.0007408601,0.009011411],"study_design_scores_gemma":[0.019716585,0.0051732156,0.95808154,0.0003505588,0.0011132077,0.00401295,0.002125122,0.000006896314,0.00021006436,0.000059767324,0.008977106,0.0001729606],"about_ca_topic_score_codex":0.00008208474,"about_ca_topic_score_gemma":0.0000022850063,"teacher_disagreement_score":0.015539302,"about_ca_system_score_codex":0.000023288409,"about_ca_system_score_gemma":0.00044968884,"threshold_uncertainty_score":0.45026883},"labels":[],"label_agreement":null},{"id":"W2944900921","doi":"10.1055/s-0037-1682170","title":"Kosten-Effektivität der Schlaganfall-Thrombektomie im erweiterten Zeitfenster","year":2019,"lang":"de","type":"article","venue":"RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Gynecology; Medicine; Philosophy","score_opus":0.010245072590755145,"score_gpt":0.2577008537867529,"score_spread":0.24745578119599776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944900921","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6049956,0.36893925,0.0011454392,0.0015897967,0.0068955645,0.005575866,0.0005973132,0.0008894961,0.009371661],"genre_scores_gemma":[0.967515,0.012177043,0.0010127005,0.006898571,0.004624474,0.00018258313,0.0015757226,0.0009789178,0.0050349697],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9832853,0.00084902934,0.003078375,0.0043556322,0.0038247043,0.004606933],"domain_scores_gemma":[0.98992646,0.00059204875,0.0010952385,0.005001636,0.00096467446,0.0024199546],"candidate_categories":["metaepi_narrow","scholarly_communication","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.0018917827,0.0033023646,0.004528877,0.0010743696,0.0009937617,0.0011305324,0.0018863591,0.0025451872,0.0061522387],"category_scores_gemma":[0.00015429838,0.0031220955,0.004316429,0.0015232877,0.0010853016,0.0023554375,0.0010804228,0.002802162,0.020515189],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013102164,0.010302417,0.2560803,0.009375258,0.2702667,0.0209748,0.005138122,0.0012588436,0.018043503,0.003745655,0.10497902,0.2867332],"study_design_scores_gemma":[0.049060177,0.0045782784,0.0749039,0.005694168,0.074144445,0.0034111775,0.0021220765,0.0031863654,0.022055624,0.0027479918,0.74675,0.011345797],"about_ca_topic_score_codex":0.00035024039,"about_ca_topic_score_gemma":0.000048569527,"teacher_disagreement_score":0.64177096,"about_ca_system_score_codex":0.00051526044,"about_ca_system_score_gemma":0.0018953426,"threshold_uncertainty_score":0.99990636},"labels":[],"label_agreement":null},{"id":"W2945508931","doi":"10.1007/s11910-019-0950-y","title":"Early Secondary Prevention in Transient Ischemic Attack (TIA) and Minor Stroke","year":2019,"lang":"en","type":"review","venue":"Current Neurology and Neuroscience Reports","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of Calgary","funders":"National Institute of Neurological Disorders and Stroke; Canadian Institutes of Health Research","keywords":"Clopidogrel; Medicine; Minor stroke; Aspirin; Stroke (engine); Dipyridamole; Neurology; Internal medicine; Secondary prevention; Cardiology; Ischemic stroke; Anesthesia; Ischemia; Stenosis","score_opus":0.07182625699833747,"score_gpt":0.35509594678656875,"score_spread":0.2832696897882313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945508931","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.27637297,0.7217371,0.000009841628,0.000021515441,0.00091011944,0.0008077286,0.000012496946,0.000021589356,0.00010663065],"genre_scores_gemma":[0.021211373,0.9782613,0.0000016924041,0.00013202419,0.00006836971,0.00004898474,0.000031293912,0.000026829637,0.00021815364],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974467,0.00021589175,0.0006087903,0.0010967428,0.0002631007,0.000368776],"domain_scores_gemma":[0.99899614,0.00005689528,0.00029562952,0.00043963833,0.00002236865,0.00018931455],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00034657374,0.00036090642,0.0013180948,0.00020439991,0.000069850794,0.000028899125,0.00008415435,0.00024680124,0.000014416322],"category_scores_gemma":[0.000058351427,0.00029976168,0.00045098734,0.00021705836,0.0003348096,0.00013938804,0.00007675688,0.0008267705,0.0000044113503],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006541999,0.00017327121,0.0035284006,0.0073652193,0.000032503878,0.0017336818,0.000034265075,5.441363e-7,0.00008068924,0.0000013131674,0.00019744165,0.98678726],"study_design_scores_gemma":[0.0005055259,0.0004901688,0.0145409135,0.0016004184,0.0007372555,0.010816474,0.000001495228,0.000006422939,0.000007346693,0.0000032458393,0.9710554,0.00023534943],"about_ca_topic_score_codex":0.0000015917942,"about_ca_topic_score_gemma":7.513774e-7,"teacher_disagreement_score":0.9865519,"about_ca_system_score_codex":0.000009949349,"about_ca_system_score_gemma":0.00036362585,"threshold_uncertainty_score":0.99994546},"labels":[],"label_agreement":null},{"id":"W2946008018","doi":"10.1016/s1474-4422(19)30165-6","title":"The uncertain role for phosphodiesterase inhibitors in stroke prevention","year":2019,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia; University of Calgary; Foothills Medical Centre","funders":"National Institute of Neurological Disorders and Stroke; Canadian Institutes of Health Research; Covidien; Boehringer Ingelheim; Medtronic; Heart and Stroke Foundation of Canada; F. Hoffmann-La Roche; Alberta Innovates - Health Solutions","keywords":"Cilostazol; Medicine; Clopidogrel; Pharmacology; Aspirin; Phosphodiesterase; Phosphodiesterase 3; Dipyridamole; Stroke (engine); Internal medicine; Cardiology; Chemistry; Biochemistry; Enzyme","score_opus":0.02473123652386836,"score_gpt":0.28052678669928044,"score_spread":0.25579555017541206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946008018","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.085711,0.011008143,0.000048849288,0.89846516,0.0013246986,0.0023184216,0.00009233161,0.00006638843,0.0009649974],"genre_scores_gemma":[0.036964756,0.002787137,0.000015996227,0.943048,0.009633714,0.00048392842,0.0003301201,0.000093932234,0.0066424403],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981587,0.00044556562,0.0002769875,0.00035967198,0.00022667613,0.00053241395],"domain_scores_gemma":[0.9982252,0.0007231339,0.00014307401,0.0008452716,0.00004236159,0.00002092711],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005687705,0.00024470742,0.00068699854,0.000053163694,0.00011991234,0.000027761313,0.00032790322,0.0004305278,0.000019592468],"category_scores_gemma":[0.000092223556,0.00013611872,0.0005033915,0.00007624996,0.00015511212,0.000026857266,0.000058873917,0.0013313942,0.000036758425],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003286041,0.000039054958,0.002552323,0.00018919446,0.00047781915,0.0002958259,0.000091892725,0.000056552828,0.00007941828,0.000064599546,0.97446734,0.01839996],"study_design_scores_gemma":[0.0026736564,0.00050130894,0.0014396573,0.00004672716,0.00022492658,0.00011523008,0.000017766593,0.000093405266,0.000091776805,0.0008536031,0.99381286,0.00012905427],"about_ca_topic_score_codex":0.000023829096,"about_ca_topic_score_gemma":0.000025415078,"teacher_disagreement_score":0.048746247,"about_ca_system_score_codex":0.000022764645,"about_ca_system_score_gemma":0.00010461191,"threshold_uncertainty_score":0.57843196},"labels":[],"label_agreement":null},{"id":"W2946390076","doi":"10.1136/gutjnl-2019-318352","title":"Incidences, temporal trends and risks of hospitalisation for gastrointestinal bleeding in new or chronic low-dose aspirin users after treatment for <i>Helicobacter pylori</i>: a territory-wide cohort study","year":2019,"lang":"en","type":"article","venue":"Gut","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Population and Public Health","funders":"","keywords":"Aspirin; Helicobacter pylori; Medicine; Cohort; Gastrointestinal bleeding; Cohort study; Internal medicine; Low dose aspirin; Gastroenterology","score_opus":0.03502044845814245,"score_gpt":0.31361979282437846,"score_spread":0.278599344366236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946390076","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996766,0.00057058706,0.0002617123,0.000091399495,0.00009853131,0.0021384538,0.000032343803,0.00002095143,0.000020026953],"genre_scores_gemma":[0.99806184,0.000045607187,0.0006360167,0.000046585337,0.00023220958,0.00032809295,0.00007064822,0.000025470037,0.000553518],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989237,0.0000297573,0.0003015055,0.00032374501,0.00018991438,0.0002313879],"domain_scores_gemma":[0.9994488,0.00008022737,0.000099247525,0.00021738824,0.000047651854,0.00010669301],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023714514,0.0001865717,0.00045260944,0.00013845696,0.000025712738,0.000019016534,0.00004636599,0.000044332402,0.000052449177],"category_scores_gemma":[0.000030712497,0.00013975472,0.0002129209,0.00009635654,0.000037456255,0.00014032426,0.000016354657,0.000051010185,0.0000020609648],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033255802,0.00029459305,0.9758534,0.00014240351,0.00030142508,0.000027959573,0.00031243145,0.000011348362,0.00039537295,0.0000019358006,0.00006386093,0.019269686],"study_design_scores_gemma":[0.011836375,0.00666927,0.97862154,0.0004157132,0.0004452891,0.000032603115,0.00043325845,0.0002474848,0.00027641567,0.00000959953,0.00086671166,0.00014573612],"about_ca_topic_score_codex":0.0007106807,"about_ca_topic_score_gemma":0.0006476313,"teacher_disagreement_score":0.01912395,"about_ca_system_score_codex":0.00017650978,"about_ca_system_score_gemma":0.0002545769,"threshold_uncertainty_score":0.5699032},"labels":[],"label_agreement":null},{"id":"W2946796958","doi":"10.1093/eurheartj/ehz372","title":"Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk","year":2019,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":572,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Janssen Pharmaceuticals; National Center for Advancing Translational Sciences; Janssen Biotech; Abbott Vascular; National Institutes of Health; Idorsia Pharmaceuticals; Daiichi Sankyo Europe; Servier; Terumo; AstraZeneca; Amarin Corporation; Biotronik; Biosense Webster; Novo Nordisk; Cordis; Daiichi-Sankyo; Sanofi; Abiomed; GlaxoSmithKline; Chiesi USA; Cook Medical; Biosensors International Group; Medicure; Boston Scientific Corporation; University of Florida; Medtronic; CSL Behring; Bristol-Myers Squibb; Eli Lilly and Company; Chiesi Farmaceutici; B. Braun Melsungen; Chiesi España; Edwards Lifesciences; Amgen; Pfizer","keywords":"Medicine; Percutaneous coronary intervention; Major bleeding; MEDLINE; Severe bleeding; Surgery; Internal medicine; Myocardial infarction","score_opus":0.033214670432440994,"score_gpt":0.31604861662349487,"score_spread":0.2828339461910539,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946796958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916425,0.0057077776,0.00009454007,0.00056330056,0.00082196534,0.00075580203,0.000058667036,0.000041070292,0.00031439902],"genre_scores_gemma":[0.9955635,0.0024896953,0.0006676582,0.00026344895,0.0007189989,0.000005633683,0.000036884943,0.00007822327,0.00017596304],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99551135,0.0019223033,0.0007025254,0.00042517335,0.00081489515,0.0006237718],"domain_scores_gemma":[0.9970434,0.0018385426,0.00029700578,0.0003304385,0.0002534856,0.00023716001],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0051444313,0.00023420501,0.0004597496,0.00019056768,0.00067978754,0.00014430078,0.00024593543,0.00009145432,0.00036350562],"category_scores_gemma":[0.00087245036,0.00017796695,0.0004595819,0.00021106945,0.00014104349,0.00013472622,0.00016018355,0.002086465,0.0002234375],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002406281,0.0001132362,0.9801818,0.000051647854,0.00079519453,0.000464992,0.00073386065,0.00034730832,0.00025801695,0.00014899128,0.0026659975,0.011832649],"study_design_scores_gemma":[0.011217212,0.0016599871,0.9742188,0.002232972,0.0004474155,0.0016511596,0.0033115575,0.00015529954,0.000116355346,0.00086702226,0.0038341077,0.00028813226],"about_ca_topic_score_codex":0.00012464337,"about_ca_topic_score_gemma":0.000007797897,"teacher_disagreement_score":0.011544517,"about_ca_system_score_codex":0.0002475981,"about_ca_system_score_gemma":0.00014279816,"threshold_uncertainty_score":0.90647686},"labels":[],"label_agreement":null},{"id":"W2947389973","doi":"10.1016/j.cjca.2019.05.027","title":"“Ticagrelor or Prasugrel, Doctor?” The Basis for Decision in Clinical Practice","year":2019,"lang":"en","type":"letter","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"Canadian Institutes of Health Research; Fondation Institut de Cardiologie de Montréal","keywords":"Prasugrel; Ticagrelor; Medicine; Percutaneous coronary intervention; Clopidogrel; Conventional PCI; Myocardial infarction; Internal medicine; Cardiology; P2Y12; Stent; Antithrombotic","score_opus":0.04746702677982832,"score_gpt":0.3483463460127451,"score_spread":0.3008793192329168,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947389973","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007118277,0.023439014,0.008080907,0.9427004,0.010622816,0.0023192195,0.00026833898,0.000011824288,0.005439226],"genre_scores_gemma":[0.035266947,0.0055347756,0.0019494175,0.90960616,0.045488734,0.000038595448,0.00008013132,0.00015463552,0.0018805877],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99665856,0.0008957816,0.001159828,0.00032979043,0.0003735124,0.0005825329],"domain_scores_gemma":[0.99066335,0.007098837,0.0005312027,0.0006679291,0.00070278253,0.00033590538],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0031040492,0.0002899559,0.0017657263,0.00040492628,0.000082852224,0.000037944028,0.00044459137,0.0012221616,0.0000961097],"category_scores_gemma":[0.012837519,0.00016851892,0.001937939,0.00018967921,0.00030071186,0.000100347344,0.000017083901,0.0025627613,0.00004717135],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016847752,0.000003898017,0.0025197824,0.00007337348,0.0024219498,0.008980236,0.000036094454,0.000069934074,5.3089957e-7,0.0000150347405,0.9501012,0.034093216],"study_design_scores_gemma":[0.0022431912,0.0010224787,0.006282792,0.00044975622,0.0019455781,0.009346354,0.00010538563,0.0000037612544,8.80419e-7,0.00006576252,0.97834647,0.00018756698],"about_ca_topic_score_codex":0.00015692282,"about_ca_topic_score_gemma":0.00028672794,"teacher_disagreement_score":0.034865916,"about_ca_system_score_codex":0.00026529268,"about_ca_system_score_gemma":0.0065546334,"threshold_uncertainty_score":0.9997384},"labels":[],"label_agreement":null},{"id":"W2947496689","doi":"10.1111/bcp.13997","title":"Adjusted indirect comparisons to assess bioequivalence between generic clopidogrel products in Serbia","year":2019,"lang":"en","type":"article","venue":"British Journal of Clinical Pharmacology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Bioequivalence; Clopidogrel; Medicine; Statistics; Econometrics; Pharmacology; Mathematics; Internal medicine; Pharmacokinetics; Aspirin","score_opus":0.17948918823694818,"score_gpt":0.4284412158986257,"score_spread":0.24895202766167754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947496689","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98944664,0.005946487,0.00015305601,0.0014864035,0.0021457456,0.0005362162,0.000015067565,0.000021180791,0.00024921424],"genre_scores_gemma":[0.98885936,0.0041559082,0.0015505948,0.0029861745,0.0022504614,0.000005474042,0.0000092681075,0.000026885175,0.00015589401],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99661165,0.00082078174,0.0014420775,0.00034198404,0.00040900885,0.00037448632],"domain_scores_gemma":[0.9981448,0.00046403674,0.0004190502,0.00016896529,0.00035872584,0.00044440647],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002342984,0.00015565599,0.0014751,0.00018548135,0.00003499176,0.00002137629,0.00029493502,0.00019910069,0.0003836068],"category_scores_gemma":[0.0005053979,0.00016246276,0.00051065034,0.0005204264,0.00012244032,0.00012918854,0.00007730138,0.0009865214,0.00009134423],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013083741,0.00077478617,0.8374575,0.00014987624,0.0010300629,0.0026365726,0.000026068334,0.00015858476,0.0027736921,0.0000012653124,0.03709587,0.11658735],"study_design_scores_gemma":[0.0076625445,0.0010735017,0.94611907,0.00036160572,0.0005954499,0.0016829462,0.00003638914,0.000028658595,0.0015809893,0.000008361686,0.04067343,0.00017706054],"about_ca_topic_score_codex":0.000024383804,"about_ca_topic_score_gemma":0.000006141544,"teacher_disagreement_score":0.11641029,"about_ca_system_score_codex":0.000044282548,"about_ca_system_score_gemma":0.00050219346,"threshold_uncertainty_score":0.66250396},"labels":[],"label_agreement":null},{"id":"W2949738989","doi":"10.1136/bmjopen-2018-022271","title":"Dual antiplatelet therapy following percutaneous coronary intervention: protocol for a systematic review","year":2019,"lang":"en","type":"review","venue":"BMJ Open","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Agency for Drugs and Technologies in Health; University of Ottawa","funders":"","keywords":"Medicine; Percutaneous coronary intervention; Conventional PCI; Myocardial infarction; Acute coronary syndrome; Internal medicine; Ticagrelor; Randomized controlled trial; Meta-analysis; Number needed to harm; Intensive care medicine; Cardiology; Relative risk; Number needed to treat; Confidence interval","score_opus":0.19058079457770818,"score_gpt":0.49996357036965855,"score_spread":0.3093827757919504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949738989","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[2.412301e-7,0.5177254,0.000020642314,0.000018529789,0.00009277501,0.48170656,0.000037390935,0.000040098257,0.00035835447],"genre_scores_gemma":[1.6246769e-7,0.5117419,0.00009813547,0.000335153,0.00012853467,0.48493376,0.0002926116,0.00010097297,0.0023687657],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9955791,0.0008550147,0.0017772345,0.000762375,0.00061646046,0.000409809],"domain_scores_gemma":[0.9968617,0.00024151783,0.0009132174,0.0016843348,0.00013276876,0.00016646681],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0025223598,0.0007437391,0.007876928,0.00010981928,0.00012901842,0.00017236754,0.00075678865,0.00033356762,0.00045070442],"category_scores_gemma":[0.00022912644,0.00048317312,0.007067522,0.00025054568,0.00003301674,0.00018100126,0.00028224348,0.00029952583,0.0003786741],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004316703,0.00018561337,8.579315e-7,0.78508055,0.005488419,0.0013356379,0.000010683911,3.713854e-8,8.489145e-8,0.000011515824,0.0026011427,0.20485376],"study_design_scores_gemma":[0.0024263158,0.00047099125,2.3894202e-7,0.5336819,0.0055813342,0.009061548,0.000012227605,0.0000012703355,1.4856471e-7,0.000003916455,0.44842452,0.0003355651],"about_ca_topic_score_codex":0.000005209818,"about_ca_topic_score_gemma":4.6714135e-7,"teacher_disagreement_score":0.44582337,"about_ca_system_score_codex":0.000122046295,"about_ca_system_score_gemma":0.0007278461,"threshold_uncertainty_score":0.999762},"labels":[],"label_agreement":null},{"id":"W2949894892","doi":"10.1016/j.cjca.2019.06.003","title":"Antiplatelet Therapy and Coronary Artery Bypass Grafting: Analysis of Current Evidence With a Focus on Acute Coronary Syndrome","year":2019,"lang":"en","type":"review","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Population Health Research Institute; McMaster University; Thrombosis and Atherosclerosis Research Institute; Impact","funders":"Hamilton Health Sciences; Heart and Stroke Foundation of Canada","keywords":"Medicine; Acute coronary syndrome; Aspirin; Randomized controlled trial; Population; Clopidogrel; Cardiology; Bypass grafting; Internal medicine; Intensive care medicine; Regimen; Artery; Myocardial infarction","score_opus":0.07033018873527797,"score_gpt":0.3151357928222229,"score_spread":0.24480560408694496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949894892","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05626763,0.9423139,0.00013146226,0.000047265192,0.00035505556,0.0006088655,0.00020077522,0.0000060920584,0.000068945265],"genre_scores_gemma":[0.24573414,0.7539167,0.000014523836,0.000047800248,0.00015501815,0.000008865677,0.00006230694,0.00004446802,0.00001618458],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99717873,0.0006044548,0.0009120931,0.0004448392,0.00038668988,0.00047320244],"domain_scores_gemma":[0.9971686,0.0003660143,0.00082621526,0.00063539523,0.00028686263,0.0007169098],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006312279,0.000531259,0.005909731,0.0015432944,0.00007274369,0.000020949052,0.0003127535,0.00036092714,0.000034509514],"category_scores_gemma":[0.000047021415,0.00035934208,0.002649815,0.0007115038,0.0003910457,0.000103592254,0.000019669782,0.0007955155,0.0000064206197],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008607404,0.000014447517,0.016100965,0.0016188672,0.10383712,0.01593007,0.00004835005,0.00009117007,0.0000011960991,0.000025607435,0.00038163178,0.8610898],"study_design_scores_gemma":[0.0032354782,0.005919646,0.07508142,0.022846423,0.106797785,0.112293005,0.00004849446,0.0000047645344,0.0000013530279,0.000019659632,0.6730036,0.0007483728],"about_ca_topic_score_codex":0.000040974137,"about_ca_topic_score_gemma":0.000039854473,"teacher_disagreement_score":0.8603415,"about_ca_system_score_codex":0.00017976477,"about_ca_system_score_gemma":0.0030631255,"threshold_uncertainty_score":0.99988586},"labels":[],"label_agreement":null},{"id":"W2950216718","doi":"10.1016/s0140-6736(19)30685-3","title":"Dyspnoea in the GLOBAL LEADERS trial – Authors' reply","year":2019,"lang":"en","type":"letter","venue":"The Lancet","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Political science","score_opus":0.06001828288645753,"score_gpt":0.31660759876187367,"score_spread":0.2565893158754161,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950216718","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012324247,0.0041289334,0.000018310007,0.96533084,0.0012071219,0.0015303615,0.00008567714,0.00007545294,0.015299064],"genre_scores_gemma":[0.0155453775,0.0004646136,0.000013692855,0.9521517,0.02907812,0.00006801549,0.00027685048,0.0000351323,0.002366495],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975827,0.0006220364,0.00026635503,0.00035404682,0.0006891267,0.00048578237],"domain_scores_gemma":[0.99787873,0.00018594519,0.00010323488,0.0017870785,0.000020260688,0.000024724197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011045894,0.00027485457,0.00096259546,0.00003376298,0.00006692864,0.000054877186,0.00072237063,0.00040401862,0.00010612268],"category_scores_gemma":[0.00012662313,0.00013548518,0.0006354745,0.0002252791,0.0001992653,0.000032078133,0.000038945946,0.001680932,0.00029408102],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007781663,0.000027832535,0.0005036092,0.00010816655,0.00046474562,0.00067525986,0.00022652393,0.0000021676676,5.9391454e-7,0.000066040404,0.9888156,0.0013277787],"study_design_scores_gemma":[0.026232136,0.00018069579,0.0013614162,0.00014574891,0.000447061,0.00019711108,0.00018627441,0.0000041992976,0.000001655139,0.0004501041,0.9706225,0.00017111353],"about_ca_topic_score_codex":0.00006865871,"about_ca_topic_score_gemma":0.0000041872736,"teacher_disagreement_score":0.027870998,"about_ca_system_score_codex":0.00007574667,"about_ca_system_score_gemma":0.0001521029,"threshold_uncertainty_score":0.73029065},"labels":[],"label_agreement":null},{"id":"W2951424940","doi":"10.1016/j.jcin.2019.03.034","title":"Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y12 Receptor Inhibitor Treatment in Percutaneous Coronary Intervention","year":2019,"lang":"en","type":"review","venue":"JACC: Cardiovascular Interventions","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":531,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Wilfrid Laurier University; Sinai Health System; University of Ottawa","funders":"Duke Clinical Research Institute; Scott R. MacKenzie Foundation; National Center for Advancing Translational Sciences; ZonMw; Janssen Research and Development; Centros de Investigación y Desarrollo, Universidad de Valparaíso; National Human Genome Research Institute; National Heart, Lung, and Blood Institute; TherOx; Daiichi Sankyo Europe; St. Jude Medical; National Institutes of Health; Eli Lilly Canada; Amarin Corporation; OrbusNeich; Terumo; MedImmune; Janssen Pharmaceuticals; Medtronic; Novo Nordisk; Eisai; Cleveland Clinic; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Boston Scientific Corporation; Osprey Medical; Regado Biosciences; Medicines Company; Biotronik; AstraZeneca; Abbott Vascular; Boston VA Research Institute; Sanofi-Aventis Deutschland; Novartis; Belvoir Media Group; Merck KGaA; Abbott Laboratories; Bayer; Gilead Sciences; Boehringer Ingelheim; American College of Cardiology Foundation; University of Florida; Mayo Clinic; CSL Behring; Chiesi Farmaceutici; Pfizer; Icahn School of Medicine at Mount Sinai; Bristol-Myers Squibb; Eli Lilly and Company; Takeda Pharmaceutical Company; Amgen","keywords":"Prasugrel; Ticagrelor; Medicine; Percutaneous coronary intervention; Clopidogrel; P2Y12; Coronary artery disease; Intensive care medicine; Acute coronary syndrome; Conventional PCI; Guideline; Internal medicine; Aspirin; Cardiology; Myocardial infarction; Pathology","score_opus":0.12259984203682167,"score_gpt":0.35083594145603614,"score_spread":0.22823609941921447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2951424940","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014512934,0.97609484,0.00091144233,0.000026876547,0.001096681,0.006754547,0.00038340694,0.00015541077,0.000063833824],"genre_scores_gemma":[0.006861692,0.9864258,0.0012684696,0.000041796982,0.0005212492,0.0016498046,0.0025347802,0.00023277827,0.000463636],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99508965,0.0007605531,0.0017468968,0.0012679545,0.0005479378,0.0005869919],"domain_scores_gemma":[0.9977499,0.0002882044,0.00042873176,0.0010812646,0.00022634918,0.00022555159],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.00078646786,0.00089906034,0.003327574,0.0005224795,0.00019865244,0.00010426431,0.00015106832,0.00048125445,0.00017660852],"category_scores_gemma":[0.00019124101,0.0007797522,0.010312448,0.00040051763,0.0000943717,0.000080728794,0.00010050897,0.00033399076,0.00010992163],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043136318,0.00076347945,0.000048470672,0.011779988,0.015956027,0.000569001,0.000058525653,0.00013216953,0.000018068455,0.000010412942,0.0007994296,0.96943307],"study_design_scores_gemma":[0.0066929697,0.0039891256,0.00021463587,0.04823261,0.013839467,0.003635311,0.0002920806,0.00008056344,0.000019486642,0.000016173,0.9221419,0.0008456778],"about_ca_topic_score_codex":0.00010240049,"about_ca_topic_score_gemma":0.000015720203,"teacher_disagreement_score":0.9685874,"about_ca_system_score_codex":0.001165961,"about_ca_system_score_gemma":0.00022617276,"threshold_uncertainty_score":0.99959904},"labels":[],"label_agreement":null},{"id":"W2952829358","doi":"10.1161/circ.126.suppl_21.a18805","title":"Abstract 18805: Vorapaxar, A Platelet Thrombin-Receptor Antagonist, in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Results from the TRACER Trial","year":2012,"lang":"en","type":"article","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Percutaneous coronary intervention; Cardiology; Internal medicine; Acute coronary syndrome; Platelet; ST elevation; Platelet activation; Antagonist; Thrombin; Receptor; Myocardial infarction","score_opus":0.013678779235678494,"score_gpt":0.24060971288844743,"score_spread":0.22693093365276892,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952829358","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99584794,0.0005697666,0.0008494013,0.00014070395,0.00048884866,0.0017682012,0.00021501238,0.0000631348,0.00005698816],"genre_scores_gemma":[0.9949863,0.00010302462,0.00013083965,0.00013088889,0.00022292077,0.000043980926,0.0043160114,0.00004685485,0.000019177438],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978999,0.00013590962,0.0005862712,0.00039317086,0.0006375846,0.00034716702],"domain_scores_gemma":[0.9988976,0.00017152863,0.00027705438,0.00043467284,0.00009269306,0.00012645635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041900342,0.00027168676,0.00040039737,0.00007951235,0.00018884506,0.000049321647,0.00010582222,0.00017045873,0.00034190426],"category_scores_gemma":[0.000040726827,0.00020663829,0.0002907097,0.00020570373,0.00008187073,0.00047202007,0.000025777377,0.0002592633,0.000053394822],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12189001,0.0034148663,0.8401021,0.00011402396,0.0029770243,0.0004220121,0.0021055858,0.0040320796,0.001298593,0.000019786254,0.00038061893,0.023243329],"study_design_scores_gemma":[0.051377714,0.00055170996,0.9460439,0.00037047738,0.00037602126,0.00026179806,0.00029779982,0.00029567216,0.000051136478,0.000016541511,0.00010852716,0.00024870585],"about_ca_topic_score_codex":0.000084477426,"about_ca_topic_score_gemma":0.000015369586,"teacher_disagreement_score":0.105941825,"about_ca_system_score_codex":0.0003046314,"about_ca_system_score_gemma":0.000099264944,"threshold_uncertainty_score":0.8426465},"labels":[],"label_agreement":null},{"id":"W2953921097","doi":"10.5435/jaaos-d-17-00827","title":"Preoperative Management of Antithrombotics in Arthroplasty","year":2019,"lang":"en","type":"review","venue":"Journal of the American Academy of Orthopaedic Surgeons","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Object Research Systems (Canada)","funders":"","keywords":"Medicine; Antithrombotic; Perioperative; Guideline; Arthroplasty; Intensive care medicine; Surgery; Internal medicine","score_opus":0.04101417989425293,"score_gpt":0.3424603654290058,"score_spread":0.3014461855347529,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953921097","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.027732808,0.9708842,0.000032631768,0.00013667342,0.00026148764,0.0006992469,0.00003791989,0.00000429278,0.0002107204],"genre_scores_gemma":[0.01747576,0.98187107,0.00023572808,0.00008987644,0.00008326265,0.0000043737978,0.0000027967185,0.000042990414,0.00019415333],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964745,0.000520443,0.0016319023,0.00021401714,0.0008937427,0.00026539023],"domain_scores_gemma":[0.9959013,0.00025094484,0.0032899496,0.00033514388,0.0000973148,0.0001253791],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001036559,0.0003449111,0.0041029695,0.00041644258,0.000027391128,0.0000046950813,0.0003739771,0.00014002604,0.000055138156],"category_scores_gemma":[0.00007827356,0.00020284556,0.0035394477,0.0010708178,0.0006538198,0.00006853329,0.00013149415,0.000972002,0.000005311059],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028504521,0.00043351363,0.023120284,0.015116026,0.008739725,0.00015114936,0.00006164876,0.00006866771,0.0000021754636,0.00009501015,0.0007404359,0.9511863],"study_design_scores_gemma":[0.0021698612,0.0005704359,0.081068166,0.07272427,0.014798367,0.0011648613,0.00048420607,0.0000047916024,0.000020098363,0.000017647084,0.8265843,0.00039303204],"about_ca_topic_score_codex":0.00000842528,"about_ca_topic_score_gemma":5.311803e-7,"teacher_disagreement_score":0.95079327,"about_ca_system_score_codex":0.00008238129,"about_ca_system_score_gemma":0.00047785562,"threshold_uncertainty_score":0.82718015},"labels":[],"label_agreement":null},{"id":"W2953971561","doi":"10.1016/j.jacc.2019.02.079","title":"Rivaroxaban Plus Aspirin Versus Aspirin in Relation to Vascular Risk in the COMPASS Trial","year":2019,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":124,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute; Hamilton Health Sciences","funders":"","keywords":"Medicine; Rivaroxaban; Aspirin; Hazard ratio; Internal medicine; Myocardial infarction; Confidence interval; Stroke (engine); Warfarin; Cardiology; Relative risk; Diabetes mellitus; Surgery; Atrial fibrillation","score_opus":0.015802702165103946,"score_gpt":0.2755209817123894,"score_spread":0.2597182795472855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953971561","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956465,0.00061120413,0.00019587958,0.001160068,0.0006885857,0.0008133594,0.000014194914,0.0000035529583,0.0008666982],"genre_scores_gemma":[0.99881953,0.00026249533,0.00012958312,0.00035946065,0.0003800681,0.000008784464,0.0000014653351,0.000014114116,0.000024526496],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970719,0.0014196183,0.00061542715,0.00015933956,0.00051254506,0.00022116695],"domain_scores_gemma":[0.9982929,0.0003999223,0.00055342546,0.0005488439,0.00013666153,0.000068203706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019414962,0.00014454784,0.0011890413,0.00025126382,0.000034073797,0.0000041888484,0.0003923125,0.00006836741,0.000008998461],"category_scores_gemma":[0.00034846296,0.0000850397,0.001036399,0.00073111354,0.00018250325,0.000052568284,0.000057574518,0.00049689214,0.000008803191],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.32875896,0.00037618712,0.54561836,0.000085078886,0.0051321494,0.0011245168,0.00077141274,0.10275515,0.0014039843,0.0006429705,0.0033291988,0.010002057],"study_design_scores_gemma":[0.080820054,0.005184764,0.8814513,0.00016903912,0.00068236364,0.0005050948,0.0023739992,0.00013956758,0.0000907287,0.00015416449,0.028254265,0.00017463649],"about_ca_topic_score_codex":0.00006445662,"about_ca_topic_score_gemma":0.0000176895,"teacher_disagreement_score":0.33583298,"about_ca_system_score_codex":0.00016698173,"about_ca_system_score_gemma":0.00026598613,"threshold_uncertainty_score":0.34678182},"labels":[],"label_agreement":null},{"id":"W2954349287","doi":"10.1016/j.tcm.2019.06.007","title":"Editorial commentary: Marital status and cardiovascular disease: Can a soulmate prevent a “broken heart”?","year":2019,"lang":"en","type":"review","venue":"Trends in Cardiovascular Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Acute coronary syndrome; Prasugrel; Ticagrelor; Clopidogrel; Aspirin; Percutaneous coronary intervention; Internal medicine; Cardiology; Myocardial infarction","score_opus":0.03245549859392519,"score_gpt":0.31503033694002225,"score_spread":0.28257483834609703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954349287","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006927754,0.97975814,0.000018424806,0.0003253839,0.016050376,0.0026355279,0.00041558346,0.00019070964,0.0005365819],"genre_scores_gemma":[0.00036583707,0.94959766,0.00005290768,0.00031759747,0.045991085,0.0005139167,0.002503376,0.0003349675,0.00032265572],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98965305,0.0015113662,0.0015623128,0.0022880158,0.0034778244,0.001507446],"domain_scores_gemma":[0.9938085,0.00021300575,0.00023711922,0.004186442,0.00016716724,0.0013877838],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0028132044,0.0017167527,0.011447678,0.0014758862,0.00016929113,0.00006419136,0.00043917343,0.00085247966,0.00027071775],"category_scores_gemma":[0.00018706029,0.0013504206,0.012308426,0.0014473982,0.0006129705,0.00015605151,0.00040014237,0.0016286388,0.0000410326],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025730612,0.00024232645,0.00043435534,0.017620793,0.04912523,0.00096189865,0.00013589548,0.00004370789,1.3871032e-7,0.0000123896225,0.05149155,0.8796744],"study_design_scores_gemma":[0.008163291,0.00037388963,0.0008083042,0.016285738,0.064539514,0.00047107038,0.00010795883,0.000008175119,1.8975592e-7,0.00001733119,0.9081351,0.0010894131],"about_ca_topic_score_codex":0.0010608042,"about_ca_topic_score_gemma":0.000016249609,"teacher_disagreement_score":0.878585,"about_ca_system_score_codex":0.00063332106,"about_ca_system_score_gemma":0.00061869365,"threshold_uncertainty_score":0.99955785},"labels":[],"label_agreement":null},{"id":"W2955008328","doi":"10.20996/1819-6446-2019-15-3-343-348","title":"Study of the Association of V640L (rs6133) Polymorphism in the Platelet P-selectin Gene with Acetylsalicylic Acid Resistance in Patients after Coronary Bypass Surgery","year":2019,"lang":"en","type":"article","venue":"Rational Pharmacotherapy in Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine; Arachidonic acid; Genotype; Aspirin; Gastroenterology; Allele; Clopidogrel; Cardiology; Angina; Gene polymorphism; Platelet; Gene; Myocardial infarction; Biology","score_opus":0.008973843627974477,"score_gpt":0.24523586911726158,"score_spread":0.2362620254892871,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955008328","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967986,0.0015264248,0.000004274494,0.00030676567,0.00014334006,0.001050895,0.000031577132,0.000005631459,0.00013250478],"genre_scores_gemma":[0.99871135,0.00024939276,0.000009724391,0.0006830103,0.00007556055,0.00015011434,0.000035109595,0.0000193896,0.00006632541],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973978,0.0010893984,0.00048070855,0.0002602605,0.00054813514,0.00022373997],"domain_scores_gemma":[0.9989967,0.0003534507,0.00023046936,0.00028852664,0.00011005504,0.000020842075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010143961,0.00016125664,0.0006235474,0.00017087864,0.000023791083,0.0000038051814,0.00014675295,0.0001056889,0.00004481471],"category_scores_gemma":[0.000031818883,0.00010344499,0.00017955349,0.00054342137,0.000056472134,0.00007665744,0.00001514697,0.00026489754,0.0000020789255],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057209833,0.00055171846,0.9854124,0.00002421512,0.0005474616,0.000041715553,0.0008733227,0.00059868343,0.0057155443,0.000012748042,0.00018165156,0.00031955473],"study_design_scores_gemma":[0.00948662,0.0002579795,0.98658085,0.00004533023,0.000048599013,0.0000125983415,0.00017250291,0.000005703287,0.0028371827,0.000022025837,0.0004271073,0.00010348638],"about_ca_topic_score_codex":0.000040249095,"about_ca_topic_score_gemma":0.0001581269,"teacher_disagreement_score":0.0037656375,"about_ca_system_score_codex":0.00016007324,"about_ca_system_score_gemma":0.00017249267,"threshold_uncertainty_score":0.4218364},"labels":[],"label_agreement":null},{"id":"W2957404589","doi":"10.1002/clc.23232","title":"Invasive and antiplatelet treatment of patients with non‐ST‐segment elevation myocardial infarction: Understanding and addressing the global risk‐treatment paradox","year":2019,"lang":"en","type":"review","venue":"Clinical Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"AstraZeneca","keywords":"Medicine; Myocardial infarction; Revascularization; Intensive care medicine; Risk assessment; Cardiac catheterization; Internal medicine; Cardiology","score_opus":0.18905565435587635,"score_gpt":0.3944958574087059,"score_spread":0.20544020305282956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2957404589","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0654362,0.9305205,0.00047956526,0.000033493503,0.00041845182,0.0025392093,0.0004193217,0.000021011963,0.00013224586],"genre_scores_gemma":[0.07143058,0.9273916,0.000041836072,0.00004223892,0.00044719182,0.000079906466,0.0005272045,0.000031020816,0.0000084260455],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970685,0.0008764178,0.00081873883,0.0006829759,0.00026054546,0.00029281568],"domain_scores_gemma":[0.9975773,0.00095503754,0.00062525633,0.00058073323,0.00009515512,0.00016653624],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003992228,0.00050240185,0.0035386835,0.0000651184,0.00016319484,0.000024250623,0.0000701554,0.00049723824,0.0000073974124],"category_scores_gemma":[0.00010335004,0.000263113,0.0012330426,0.00016076192,0.0006035834,0.000046977442,0.00005619434,0.00021430239,0.000005143168],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006900964,0.00014489141,0.3790906,0.0009486151,0.010934279,0.000052313157,0.000031032196,0.000008280441,1.5411862e-8,0.000032914177,0.00003676776,0.6080302],"study_design_scores_gemma":[0.01885648,0.0135809705,0.33268672,0.0043381294,0.04671388,0.00060200354,0.00027499566,0.000010985822,3.7297025e-7,0.00015355897,0.5820457,0.0007362137],"about_ca_topic_score_codex":0.000018768089,"about_ca_topic_score_gemma":0.0000039021293,"teacher_disagreement_score":0.60729396,"about_ca_system_score_codex":0.00045872634,"about_ca_system_score_gemma":0.00042154102,"threshold_uncertainty_score":0.9999821},"labels":[],"label_agreement":null},{"id":"W2958122699","doi":"10.3324/haematol.2018.213348","title":"Atherogenic lipid stress induces platelet hyperactivity through CD36-mediated hyposensitivity to prostacyclin: the role of phosphodiesterase 3A","year":2019,"lang":"en","type":"article","venue":"Haematologica","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Biotechnology and Biological Sciences Research Council; RWTH Aachen University; British Heart Foundation","keywords":"Prostacyclin; Platelet activation; Endocrinology; Internal medicine; CD36; Platelet; Cyclic adenosine monophosphate; Phosphodiesterase; Signal transduction; Chemistry; Medicine; Biochemistry; Receptor; Enzyme","score_opus":0.012808694681206238,"score_gpt":0.24818343581369018,"score_spread":0.23537474113248394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2958122699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936539,0.0025623138,0.0000186873,0.0005294183,0.00014790082,0.0014073447,0.00009266637,0.000113000315,0.0014747513],"genre_scores_gemma":[0.9983777,0.00036712203,0.0001767169,0.00078787346,0.00007581731,0.000056408917,0.000047944006,0.000030388208,0.00008005313],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99809045,0.0002303752,0.00036022183,0.00046997727,0.0004518392,0.00039713795],"domain_scores_gemma":[0.99829406,0.00044560357,0.00018525518,0.00079888676,0.00013293594,0.00014328244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032701332,0.0002980142,0.00093028694,0.000045021075,0.00012391918,0.000024980209,0.00020116637,0.00019163519,0.00022397794],"category_scores_gemma":[0.00022287719,0.00018177893,0.00046094277,0.00030197887,0.00016103886,0.00015553935,0.00012582459,0.00030025604,0.00030615876],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01254748,0.0048820395,0.50760096,0.00096682634,0.005253698,0.0018070766,0.007734955,0.00020090907,0.36685917,0.0018142919,0.00063262467,0.08969997],"study_design_scores_gemma":[0.002673342,0.00097211625,0.07597053,0.0003664021,0.00037751306,0.0010833147,0.0036535426,0.00007250095,0.8961079,0.00033929522,0.017813737,0.0005697872],"about_ca_topic_score_codex":0.000079371384,"about_ca_topic_score_gemma":0.0000123751515,"teacher_disagreement_score":0.5292488,"about_ca_system_score_codex":0.00002708091,"about_ca_system_score_gemma":0.00009383,"threshold_uncertainty_score":0.741273},"labels":[],"label_agreement":null},{"id":"W2963446855","doi":"10.3389/fcvm.2019.00109","title":"Platelet Function in Aging","year":2019,"lang":"en","type":"review","venue":"Frontiers in Cardiovascular Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":127,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research; Université de Montréal; Institut de Cardiologie de Montréal; Canada Foundation for Innovation; Heart and Stroke Foundation of Canada","keywords":"Platelet; Hemostasis; Thrombus; Thrombosis; Medicine; Platelet activation; Disease; Cardiology; Internal medicine","score_opus":0.031405855608307116,"score_gpt":0.2894445331951667,"score_spread":0.2580386775868596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2963446855","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000020355157,0.98775136,0.0036001964,0.000039942497,0.003713502,0.0026313523,0.0000121734265,0.00010235348,0.0021287424],"genre_scores_gemma":[0.000105336854,0.99679214,0.00026689243,0.00018530323,0.0013275456,0.00021023198,0.00045475032,0.00019899456,0.0004588112],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99459416,0.0006984031,0.0013061926,0.0012840223,0.0013191099,0.00079812156],"domain_scores_gemma":[0.9974126,0.000088414934,0.00022048358,0.0019504416,0.00007534149,0.00025268874],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0024266762,0.0009218566,0.0091154855,0.0019233681,0.00004649741,0.00001659043,0.0003337441,0.0008446889,0.000111462294],"category_scores_gemma":[0.00016976112,0.00072974485,0.0051164012,0.0017361629,0.00021983043,0.00013567464,0.00008627136,0.0014580245,0.000098112745],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010838608,0.000067782,0.0008501953,0.022393525,0.008739905,0.0018634859,0.000069192654,0.000055258297,7.381634e-8,0.000009611478,0.0037071265,0.96213543],"study_design_scores_gemma":[0.0059644687,0.00017344039,0.00066611427,0.04198236,0.010781461,0.0006732161,0.00021546766,0.000025109668,2.7356157e-7,0.000037574468,0.93888533,0.00059516745],"about_ca_topic_score_codex":0.000079042016,"about_ca_topic_score_gemma":0.0000030057888,"teacher_disagreement_score":0.9615403,"about_ca_system_score_codex":0.0007207476,"about_ca_system_score_gemma":0.0004759728,"threshold_uncertainty_score":0.99951535},"labels":[],"label_agreement":null},{"id":"W2964900000","doi":"10.1016/s1474-4422(19)30280-7","title":"Antithrombotics and bleeding risk: paradoxical findings","year":2019,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Calgary","funders":"","keywords":"Medicine","score_opus":0.025362596319350814,"score_gpt":0.2588904235513212,"score_spread":0.23352782723197038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2964900000","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.39196053,0.0027305682,0.000040438354,0.6032389,0.0005739559,0.0003458344,0.000036874924,0.000082733226,0.000990176],"genre_scores_gemma":[0.11612158,0.0078029535,0.000029482346,0.8676915,0.00779332,0.000008513122,0.00007018415,0.00006601939,0.00041644406],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983953,0.0002615711,0.00018527932,0.00041945322,0.00025515936,0.00048322696],"domain_scores_gemma":[0.9987951,0.00037987204,0.000092059454,0.00066580914,0.000026769489,0.00004041143],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00029715573,0.0002649139,0.001005068,0.0000619859,0.000111871734,0.000028015518,0.00021931432,0.00063177693,0.0000817577],"category_scores_gemma":[0.00008129433,0.00017079069,0.00027463122,0.0000787551,0.00030779626,0.000025302465,0.0000988553,0.0026548766,0.00012638718],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004177797,0.000016341228,0.040459,0.00022251466,0.00078404235,0.00140212,0.000053463547,0.000005661835,0.000058424765,0.00009797049,0.9555218,0.00096086663],"study_design_scores_gemma":[0.0016161054,0.00039591364,0.04716691,0.000040806673,0.000978156,0.0016146884,0.0000033355782,0.00010436791,0.000024224915,0.00028352093,0.9475801,0.00019185043],"about_ca_topic_score_codex":0.0000090640615,"about_ca_topic_score_gemma":4.6405827e-7,"teacher_disagreement_score":0.27583894,"about_ca_system_score_codex":0.000006383403,"about_ca_system_score_gemma":0.000043542208,"threshold_uncertainty_score":0.99964607},"labels":[],"label_agreement":null},{"id":"W2967615168","doi":"10.1093/eurheartj/ehz453","title":"Impact of long-term ticagrelor monotherapy following 1-month dual antiplatelet therapy in patients who underwent complex percutaneous coronary intervention: insights from the Global Leaders trial","year":2019,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":127,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Medicines Company; Biosensors International Group; AstraZeneca","keywords":"Medicine; Conventional PCI; Percutaneous coronary intervention; Ticagrelor; Internal medicine; Hazard ratio; Cardiology; Myocardial infarction; Clinical endpoint; Stent; Surgery; Confidence interval; Randomized controlled trial","score_opus":0.043145733483155015,"score_gpt":0.31760835767110557,"score_spread":0.27446262418795053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2967615168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994773,0.003274492,0.000052305706,0.00013597739,0.0005502622,0.0008736518,0.000025158408,0.00002414427,0.00029104203],"genre_scores_gemma":[0.9983531,0.00065457274,0.000033436503,0.00037697732,0.00041912438,0.0000011230057,0.000073042116,0.000050862058,0.00003771233],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99714077,0.00095881894,0.00062170485,0.00030263074,0.0006426703,0.00033343365],"domain_scores_gemma":[0.9990217,0.000093678456,0.00019976903,0.00041117845,0.00008303666,0.00019061436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039586925,0.00029379787,0.0006744321,0.00007704441,0.0001315083,0.00007850824,0.00021852921,0.0000662489,0.00063988596],"category_scores_gemma":[0.000022114136,0.00018750037,0.0016203914,0.00018335944,0.000115510586,0.00017719994,0.000046079836,0.00041026095,0.00006561291],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.041665986,0.0009038188,0.9330788,0.000009141401,0.002080009,0.0014710225,0.0006612037,0.00008749168,0.00029591226,0.0000023065306,0.0003643117,0.019379959],"study_design_scores_gemma":[0.06619017,0.0048385607,0.9270002,0.00037247228,0.00009766269,0.00078870705,0.00019961597,0.000029736293,0.00001771478,0.000014852175,0.00026530284,0.00018497978],"about_ca_topic_score_codex":0.00003575161,"about_ca_topic_score_gemma":0.000006331399,"teacher_disagreement_score":0.024524184,"about_ca_system_score_codex":0.00019778505,"about_ca_system_score_gemma":0.00010741858,"threshold_uncertainty_score":0.76460433},"labels":[],"label_agreement":null},{"id":"W2968978780","doi":"10.1002/ccd.28428","title":"Clinical relevance of ticagrelor monotherapy following 1‐month dual antiplatelet therapy after bifurcation percutaneous coronary intervention: Insight from GLOBAL LEADERS trial","year":2019,"lang":"en","type":"article","venue":"Catheterization and Cardiovascular Interventions","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Biosensors International Group; AstraZeneca","keywords":"Medicine; Ticagrelor; Percutaneous coronary intervention; Conventional PCI; Hazard ratio; Clinical endpoint; Internal medicine; Aspirin; Myocardial infarction; Cardiology; Stroke (engine); Stent; Randomized controlled trial; Confidence interval; Surgery","score_opus":0.03223534324488532,"score_gpt":0.3135992630906763,"score_spread":0.281363919845791,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2968978780","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9477769,0.037523013,0.011873784,0.0000685487,0.0010183884,0.0013513902,0.00009190474,0.000090331145,0.00020573883],"genre_scores_gemma":[0.9911865,0.0073010256,0.00039717054,0.00017538077,0.00022463825,0.00007410724,0.0003937855,0.000047587924,0.00019980368],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99715775,0.00047666332,0.00094679475,0.00065510336,0.00052524416,0.00023841878],"domain_scores_gemma":[0.9986028,0.0000662192,0.00019035232,0.00082582515,0.00015871784,0.00015608629],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005791701,0.00030619107,0.0009939891,0.00010769864,0.00008504097,0.00005181526,0.00012327592,0.00024747758,0.00048599427],"category_scores_gemma":[0.00006516035,0.0002804966,0.005887471,0.00027059848,0.00020708561,0.00025071573,0.000053082018,0.00018915113,0.00004251841],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06984981,0.003919079,0.20730887,0.00067017734,0.044466425,0.00077791954,0.0016654282,0.00023155315,0.0027156118,0.0002621619,0.00012495472,0.668008],"study_design_scores_gemma":[0.3022974,0.011880548,0.6112591,0.0053452193,0.009772712,0.0017038792,0.0036112468,0.0011603936,0.0020732651,0.00070748676,0.047845025,0.0023437196],"about_ca_topic_score_codex":0.000027977976,"about_ca_topic_score_gemma":0.0000038745125,"teacher_disagreement_score":0.6656643,"about_ca_system_score_codex":0.00005224798,"about_ca_system_score_gemma":0.00006050497,"threshold_uncertainty_score":0.9999647},"labels":[],"label_agreement":null},{"id":"W2969233303","doi":"10.1097/md.0000000000016880","title":"Antiplatelet therapy and coronary artery bypass grafting","year":2019,"lang":"en","type":"article","venue":"Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute; Impact","funders":"Hamilton Health Sciences; Heart and Stroke Foundation of Canada","keywords":"Medicine; Mace; Internal medicine; Odds ratio; Aspirin; Randomized controlled trial; Cardiology; Confidence interval; Myocardial infarction; MEDLINE; Adverse effect; Hazard ratio; Surgery; Percutaneous coronary intervention","score_opus":0.01650873114842045,"score_gpt":0.24379573666057386,"score_spread":0.22728700551215342,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2969233303","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97470546,0.018690389,0.0000597503,0.001966164,0.0002579919,0.0004352831,0.0000022465538,0.00009886963,0.0037838717],"genre_scores_gemma":[0.99098426,0.0048261033,0.00007295391,0.002764133,0.00038298385,0.000007751986,0.000033450615,0.00003059692,0.00089775387],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99884766,0.000049282928,0.0002137808,0.000306214,0.0003328144,0.00025026198],"domain_scores_gemma":[0.9993164,0.00006599156,0.000047787507,0.00035226837,0.000049051716,0.00016853145],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00030887936,0.00018439429,0.00049598946,0.000096303374,0.00005907753,0.0000074700124,0.000060166098,0.00008055927,0.00092949765],"category_scores_gemma":[0.000024397383,0.0001270959,0.00011490983,0.00014488268,0.00015249502,0.0000741848,0.000023520073,0.00016676147,0.00009546824],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022904521,0.00019328886,0.5562744,0.00019979978,0.0018651959,0.0014530608,0.00091270136,0.0000030365745,0.043634232,0.00035352985,0.0044934377,0.38832688],"study_design_scores_gemma":[0.022058835,0.0017885822,0.84737015,0.00050357083,0.00026473828,0.0033607509,0.00076376484,0.00019805838,0.0013931674,0.00019790654,0.12175488,0.00034559114],"about_ca_topic_score_codex":0.000010650612,"about_ca_topic_score_gemma":4.1644734e-7,"teacher_disagreement_score":0.3879813,"about_ca_system_score_codex":0.000013334414,"about_ca_system_score_gemma":0.000028710421,"threshold_uncertainty_score":0.9999838},"labels":[],"label_agreement":null},{"id":"W2970201384","doi":"10.1093/eurheartj/ehz404","title":"Estimating individual lifetime benefit and bleeding risk of adding rivaroxaban to aspirin for patients with stable cardiovascular disease: results from the COMPASS trial","year":2019,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"Bayer","keywords":"Medicine; Rivaroxaban; Aspirin; Cohort; Myocardial infarction; Stroke (engine); Internal medicine; Hazard ratio; Warfarin; Surgery; Confidence interval; Atrial fibrillation","score_opus":0.023047868233657943,"score_gpt":0.24793066057825836,"score_spread":0.2248827923446004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2970201384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951738,0.0016049516,0.0008991945,0.0001358334,0.00026153127,0.0011110606,0.0006429752,0.000022462316,0.00014815807],"genre_scores_gemma":[0.9926637,0.000052656258,0.0058985935,0.00014943047,0.0010586045,0.000004895683,0.00008805089,0.00005444268,0.000029666093],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99791956,0.0003109319,0.00041425435,0.00031828822,0.0007478962,0.00028909906],"domain_scores_gemma":[0.9984441,0.00033563832,0.00025022877,0.00043825028,0.00017970322,0.00035207605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020006741,0.00019124191,0.000523749,0.000069677735,0.00030862397,0.00011301167,0.00015301103,0.00002466706,0.000027221007],"category_scores_gemma":[0.00044789063,0.00012381012,0.0004991922,0.00012501424,0.000047104084,0.00013356587,0.000086134125,0.00028096084,0.000012234192],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.098585166,0.00043263996,0.811354,0.00013727554,0.012689945,0.00008437686,0.0016985278,0.02308345,0.00008218853,0.000019817151,0.0024942197,0.04933839],"study_design_scores_gemma":[0.06503425,0.0014215956,0.91055346,0.0010502678,0.0022905853,0.000030953608,0.00017146685,0.0006628934,0.000031977463,0.000015754436,0.018501572,0.00023524504],"about_ca_topic_score_codex":0.000019590003,"about_ca_topic_score_gemma":4.3000895e-7,"teacher_disagreement_score":0.09919943,"about_ca_system_score_codex":0.000023222337,"about_ca_system_score_gemma":0.00006287846,"threshold_uncertainty_score":0.50488305},"labels":[],"label_agreement":null},{"id":"W2970625842","doi":"10.1161/circresaha.119.315235","title":"Response by Chan and Weitz to Letter Regarding Article, “Antithrombotic Agents: New Directions in Antithrombotic Therapy”","year":2019,"lang":"en","type":"letter","venue":"Circulation Research","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Antithrombotic; Medicine; Fibrinolytic agent; Internal medicine","score_opus":0.07826360882543366,"score_gpt":0.36018542116612484,"score_spread":0.2819218123406912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2970625842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6150315,0.0041932133,0.00030459114,0.3779815,0.00025867147,0.0017977293,0.000016152118,0.00007286642,0.00034375393],"genre_scores_gemma":[0.6362869,0.0023308182,0.00009959196,0.34841913,0.002056806,0.00012178681,0.00028236938,0.00021953342,0.010183028],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99546516,0.0011672905,0.0004065524,0.00086740457,0.0013161614,0.00077740446],"domain_scores_gemma":[0.99814385,0.0004677436,0.00006557115,0.00086535775,0.00023099962,0.0002264516],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017715598,0.00032051848,0.0007129858,0.0010635026,0.00021117268,0.00019493194,0.00018186193,0.0005421893,0.00047592257],"category_scores_gemma":[0.0004100689,0.00030667058,0.00027325453,0.0011385926,0.00015434186,0.00019992967,0.00008485394,0.0016048556,0.00042193657],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006487252,0.0000900584,0.022444678,0.00015704925,0.0004526026,0.0004028891,0.00033178215,0.00011263086,0.007603413,0.0000043466616,0.96331394,0.004437893],"study_design_scores_gemma":[0.002995171,0.000227244,0.21729682,0.0006486385,0.00007878588,0.00008552557,0.00006780243,0.00033689113,0.00033029314,0.00005579702,0.777496,0.00038102226],"about_ca_topic_score_codex":0.00028422067,"about_ca_topic_score_gemma":0.000010748783,"teacher_disagreement_score":0.19485214,"about_ca_system_score_codex":0.00027479103,"about_ca_system_score_gemma":0.00031188928,"threshold_uncertainty_score":0.99993855},"labels":[],"label_agreement":null},{"id":"W2970797239","doi":"10.1056/nejmoa1908077","title":"Ticagrelor in Patients with Stable Coronary Disease and Diabetes","year":2019,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":362,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Hamilton Health Sciences; University of Toronto; McMaster University; Population Health Research Institute","funders":"Agence Nationale de la Recherche; AstraZeneca","keywords":"Ticagrelor; Medicine; Internal medicine; Cardiology; Diabetes mellitus; Disease; Coronary disease; Coronary heart disease; Myocardial infarction; Acute coronary syndrome; Endocrinology","score_opus":0.004135683001723299,"score_gpt":0.1963194579564556,"score_spread":0.19218377495473232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2970797239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99270755,0.0057672,0.000016253889,0.001006734,0.00011287056,0.0001862896,0.0000018305909,0.000004601046,0.0001966525],"genre_scores_gemma":[0.99839747,0.00045754362,0.00006496924,0.00044697092,0.00041310533,4.7512128e-7,0.0000074437676,0.00001231218,0.00019973339],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990887,0.000044162414,0.0002226681,0.00009843396,0.0004013992,0.00014464602],"domain_scores_gemma":[0.9992617,0.00007050631,0.000088996734,0.0001240664,0.00009274381,0.00036201396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002832326,0.00010327815,0.00041284141,0.00011208761,0.000013592963,0.000004041306,0.00004182884,0.000024595502,0.0002524277],"category_scores_gemma":[0.000069761176,0.000057395373,0.000048608414,0.000093800685,0.00006432217,0.0000965519,0.000009541905,0.0001593319,0.00000331469],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004445993,0.000097619675,0.9404319,0.00006864399,0.00023410571,0.00017825284,0.00009415794,0.000012598906,0.00005588648,0.000015145848,0.00034665607,0.05401906],"study_design_scores_gemma":[0.08083874,0.0019339537,0.91025126,0.00072205515,0.00032834522,0.00004569058,0.00005120978,0.000013937643,0.0000115457115,0.00008695036,0.0056512016,0.00006509885],"about_ca_topic_score_codex":0.0000051422535,"about_ca_topic_score_gemma":0.0000010988277,"teacher_disagreement_score":0.07639275,"about_ca_system_score_codex":0.000018678109,"about_ca_system_score_gemma":0.000106004525,"threshold_uncertainty_score":0.27639064},"labels":[],"label_agreement":null},{"id":"W2971019453","doi":"10.1016/s0140-6736(19)31887-2","title":"Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial","year":2019,"lang":"en","type":"article","venue":"The Lancet","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":210,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Hamilton Health Sciences; University of Toronto; McMaster University; Population Health Research Institute","funders":"AstraZeneca","keywords":"Conventional PCI; Percutaneous coronary intervention; Medicine; Coronary artery disease; Ticagrelor; Internal medicine; Placebo; Diabetes mellitus; Cardiology; Randomized controlled trial; Left main coronary artery disease; Myocardial infarction; Endocrinology","score_opus":0.008155374353100117,"score_gpt":0.21662912041542998,"score_spread":0.20847374606232985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2971019453","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99005294,0.0056773946,0.000010322366,0.00005829616,0.000064720174,0.0037690094,0.000031932734,0.000028000448,0.00030740476],"genre_scores_gemma":[0.99876934,0.00014171308,0.00002186957,0.00015237773,0.000083627725,0.00013706725,0.000072695286,0.000022865668,0.0005984311],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99876237,0.00020719087,0.0002692468,0.00023609586,0.0002975375,0.00022757656],"domain_scores_gemma":[0.99909925,0.00016485843,0.0001408232,0.0004421789,0.000052214607,0.0001006737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034445873,0.00018256444,0.0009559667,0.000049392696,0.000022019261,0.000008112903,0.00009536977,0.00003822448,0.00019328397],"category_scores_gemma":[0.00004191949,0.00010140166,0.00018976441,0.00005167599,0.00015183266,0.00007945754,0.000020940812,0.00013289899,0.000004923947],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.91429234,0.0011321431,0.078007065,0.00031642782,0.0010449511,0.00012803482,0.00028255762,0.000024546021,0.00012003315,0.0000038426538,0.00024226069,0.0044058096],"study_design_scores_gemma":[0.9635267,0.0036463498,0.029865699,0.0005536525,0.0012146314,0.000045913355,0.00007797196,0.00047592903,0.000010525243,0.000017271555,0.00039400713,0.00017134567],"about_ca_topic_score_codex":0.0000036470651,"about_ca_topic_score_gemma":0.0000017435505,"teacher_disagreement_score":0.049234375,"about_ca_system_score_codex":0.000090076705,"about_ca_system_score_gemma":0.00011885978,"threshold_uncertainty_score":0.41350397},"labels":[],"label_agreement":null},{"id":"W2971090230","doi":"10.1002/clc.23262","title":"How do cardiologists select patients for dual antiplatelet therapy continuation beyond 1 year after a myocardial infarction? Insights from the EYESHOT Post‐MI Study","year":2019,"lang":"en","type":"article","venue":"Clinical Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Care Foundation","funders":"Heart Care Foundation of India","keywords":"Medicine; Conventional PCI; Myocardial infarction; Internal medicine; Percutaneous coronary intervention; Cardiology; Observational study; Coronary artery disease; Atrial fibrillation","score_opus":0.020233431840682624,"score_gpt":0.2991677193132189,"score_spread":0.2789342874725363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2971090230","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99088556,0.0026188488,0.0001377191,0.00040758066,0.002032683,0.003259479,0.0002072035,0.000081960854,0.00036896055],"genre_scores_gemma":[0.99360573,0.00072347047,0.00004032894,0.001990705,0.0025757165,0.00030351814,0.00062824023,0.00005416249,0.00007811201],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996294,0.0013864345,0.00062185404,0.00086612086,0.00041316563,0.00041841343],"domain_scores_gemma":[0.99686223,0.0012642011,0.00019348819,0.0009406169,0.00057964807,0.00015982351],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092488556,0.00035144232,0.0014525303,0.000067257504,0.00014042707,0.00007180551,0.00020246327,0.00048655865,0.000046379802],"category_scores_gemma":[0.0006376316,0.00022877319,0.0017197992,0.0001703826,0.00030123082,0.00012739541,0.000091783426,0.00048930594,0.00008543833],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008473774,0.00027140364,0.97090966,0.0000063834505,0.0063660587,0.000035992005,0.00024638357,0.000013780406,0.000114319526,0.000026475132,0.0025906526,0.010945151],"study_design_scores_gemma":[0.015331436,0.004321692,0.9364887,0.000014715765,0.0008318183,0.000017616425,0.00058355805,0.0000062906365,0.000027115693,0.0002380704,0.041859407,0.0002795944],"about_ca_topic_score_codex":0.000020491332,"about_ca_topic_score_gemma":0.0000058481114,"teacher_disagreement_score":0.039268754,"about_ca_system_score_codex":0.000040430423,"about_ca_system_score_gemma":0.00014167975,"threshold_uncertainty_score":0.93290997},"labels":[],"label_agreement":null},{"id":"W2971407847","doi":"10.1007/s10557-019-06905-w","title":"Chewed or Crushed Administration of Adenosine Diphosphate Receptor Inhibitors in Acute Coronary Syndromes: a Systematic Review and Meta-analysis of Randomized Controlled Trials","year":2019,"lang":"en","type":"review","venue":"Cardiovascular Drugs and Therapy","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; University of Toronto; London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Randomized controlled trial; Pharmacology; Adenosine; Meta-analysis; Internal medicine; Intensive care medicine","score_opus":0.07912530663309206,"score_gpt":0.34945362360990045,"score_spread":0.27032831697680837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2971407847","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003350844,0.97336376,0.000035530997,0.00003649639,0.000077431534,0.025835292,0.00027565108,0.00002304735,0.000017723656],"genre_scores_gemma":[0.0015424667,0.994554,0.000046801342,0.0001040721,0.000029337842,0.002942689,0.00042584786,0.00008357754,0.00027120835],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98437476,0.0079704095,0.005471426,0.0008317709,0.0010604655,0.00029114637],"domain_scores_gemma":[0.9925505,0.0025291743,0.002946698,0.0014502691,0.00034529495,0.00017808561],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.018831557,0.0010121668,0.10728165,0.00081610365,0.00004109662,0.000038664846,0.00020204452,0.0004649705,0.00026170237],"category_scores_gemma":[0.0011958769,0.00049351656,0.059264757,0.001248689,0.00027306657,0.00010526408,0.00004478659,0.00028345542,0.0000023693663],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01629294,0.00010589566,4.409336e-7,0.30277652,0.6669568,0.000056570876,0.00006226543,9.614106e-7,5.786908e-7,0.000009962498,0.000007344117,0.013729755],"study_design_scores_gemma":[0.09754695,0.0002131711,0.0000018093526,0.045224916,0.85168374,0.00018271456,0.000046204565,0.0000048290626,0.000008387726,0.0000029658054,0.004710068,0.00037425134],"about_ca_topic_score_codex":0.00001686192,"about_ca_topic_score_gemma":4.6911174e-7,"teacher_disagreement_score":0.25755158,"about_ca_system_score_codex":0.00004450523,"about_ca_system_score_gemma":0.00044105694,"threshold_uncertainty_score":0.9997516},"labels":[],"label_agreement":null},{"id":"W2972695727","doi":"","title":"Knowledge, attitudes and current practices of Palestinian internists toward aspirin prescription","year":2019,"lang":"en","type":"article","venue":"University of Toronto Medical Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Aspirin; Medicine; Medical prescription; Myocardial infarction; Disease; Stroke (engine); Angina; Coronary artery disease; Intensive care medicine; Family medicine; Internal medicine; Nursing","score_opus":0.023700240900442544,"score_gpt":0.30572486490740197,"score_spread":0.28202462400695943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972695727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9691865,0.026261257,0.000664975,0.00015618649,0.00024318718,0.00010101383,0.0000027041094,0.000008924858,0.0033752597],"genre_scores_gemma":[0.98639184,0.013055383,0.00020880971,0.000012308901,0.000100045705,2.8843703e-8,0.0000032401142,0.0000037838752,0.00022455932],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99917495,0.0000876007,0.00013500055,0.00010632785,0.00039398303,0.000102156606],"domain_scores_gemma":[0.9992594,0.000038970935,0.00023557818,0.000095925585,0.00013520749,0.00023487718],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003844512,0.000067881,0.00025332463,0.000026479045,0.000031116153,0.0000052573478,0.0001127461,0.0000663967,0.0012456084],"category_scores_gemma":[0.0001228938,0.00006013407,0.00016130212,0.000016035263,0.00014165642,0.00019675889,0.00005771445,0.0001891487,0.0000064733154],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013720018,0.00073189224,0.29784504,0.0010395718,0.00082562334,0.00012680487,0.0024891219,7.2209536e-7,0.00072074024,0.00015980138,0.0005359896,0.6941527],"study_design_scores_gemma":[0.004931994,0.00087013614,0.8933377,0.0021721958,0.000489197,0.00063286844,0.00303251,0.00014769501,0.00012359,0.00002130394,0.094106056,0.00013475557],"about_ca_topic_score_codex":0.00026558747,"about_ca_topic_score_gemma":0.00019037783,"teacher_disagreement_score":0.69401795,"about_ca_system_score_codex":0.000059815626,"about_ca_system_score_gemma":0.00021521395,"threshold_uncertainty_score":0.9996674},"labels":[],"label_agreement":null},{"id":"W2973068166","doi":"10.1161/circulationaha.119.040167","title":"Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention","year":2019,"lang":"en","type":"review","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":796,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; 123 Certification (Canada)","funders":"Janssen Pharmaceuticals; National Center for Advancing Translational Sciences; Abbott Vascular; St. Jude Medical; National Institutes of Health; Idorsia Pharmaceuticals; Daiichi Sankyo Europe; Gilead Sciences; Servier; Eisai; Sanofi; Abiomed; Osprey Medical; Chiesi USA; Claret Medical; Biosense Webster; Novo Nordisk; Daiichi-Sankyo; Medicines Company; Cook Medical; Boston Scientific Corporation; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; Abbott Laboratories; CSL Behring; University of Florida; B. Braun Melsungen; Amgen; Pfizer; Medicure","keywords":"Medicine; Percutaneous coronary intervention; Clinical trial; Population; Guideline; Regulatory affairs; Intensive care medicine; Medical emergency; Myocardial infarction; Internal medicine; Environmental health; Pathology; Public administration","score_opus":0.022787057699700592,"score_gpt":0.2842924585683699,"score_spread":0.2615054008686693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2973068166","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.058787167,0.939403,0.00019103728,0.0000013365652,0.00038832778,0.0009494648,0.000021434485,0.000058310874,0.0001998996],"genre_scores_gemma":[0.3030477,0.69548875,0.000041596704,0.00000865328,0.0000703352,0.000013969466,0.001259517,0.000051339277,0.000018165276],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99824226,0.00022337078,0.0005709715,0.00042121738,0.0003250543,0.00021715538],"domain_scores_gemma":[0.9990732,0.00013231269,0.00035390916,0.00032063792,0.000058546317,0.00006138026],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00027572733,0.00028768482,0.0011484348,0.00029634702,0.00006624123,0.000028367593,0.00007243595,0.0003092851,0.00008875618],"category_scores_gemma":[0.000115245624,0.00027367007,0.0009791533,0.00024550152,0.00001935301,0.00012176771,0.000034655084,0.0003592618,0.00019174838],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044396234,0.00009931953,0.06109117,0.009754096,0.00051614735,0.000054632823,0.000032583594,0.00012087736,9.593644e-8,0.00006863977,0.000007091668,0.928211],"study_design_scores_gemma":[0.011650188,0.00074723054,0.62826777,0.18566568,0.022102512,0.0016101744,0.0002077628,0.0007210931,5.502293e-7,0.0003655346,0.14662719,0.002034292],"about_ca_topic_score_codex":0.000023612774,"about_ca_topic_score_gemma":0.0000031971276,"teacher_disagreement_score":0.92617667,"about_ca_system_score_codex":0.00043108079,"about_ca_system_score_gemma":0.00013164213,"threshold_uncertainty_score":0.99997157},"labels":[],"label_agreement":null},{"id":"W2973841278","doi":"10.1016/j.jacc.2019.07.065","title":"Major Bleeding in Patients With Coronary or Peripheral Artery Disease Treated With Rivaroxaban Plus Aspirin","year":2019,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Institut universitaire de cardiologie et de pneumologie de Québec; Hamilton Health Sciences; Population Health Research Institute; McMaster University","funders":"","keywords":"Medicine; Rivaroxaban; Aspirin; Coronary artery disease; Internal medicine; Hemostasis; Thrombosis; Hazard ratio; Adverse effect; Gastroenterology; Surgery; Anesthesia; Warfarin; Atrial fibrillation; Confidence interval","score_opus":0.006480789575476556,"score_gpt":0.21879359493606185,"score_spread":0.21231280536058528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2973841278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99868757,0.000207053,0.000034462053,0.00020437504,0.000094261006,0.0004888501,0.000055778382,0.000006806486,0.00022083239],"genre_scores_gemma":[0.99920034,0.00005312464,0.00011587357,0.00025457065,0.00012288842,0.0000047230014,0.0000060771663,0.00002929089,0.00021311139],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998548,0.00023386971,0.0003666654,0.0001749202,0.00043202832,0.0002445341],"domain_scores_gemma":[0.9986978,0.0000669106,0.00046771113,0.0003479965,0.00025798375,0.00016156891],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017504516,0.00019372067,0.0011697364,0.00014603107,0.000037508697,0.000003967036,0.00019620273,0.000036771362,0.000030603667],"category_scores_gemma":[0.000029727207,0.0000959488,0.0004247168,0.00039363766,0.00037427104,0.00009440116,0.00003817082,0.00023162007,0.00000154148],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04770212,0.00012026076,0.9477332,0.000041361513,0.0016619457,0.0007959128,0.000019155857,0.0010860862,0.000058175578,0.0000060381367,0.00019160513,0.0005841049],"study_design_scores_gemma":[0.012907313,0.0047593093,0.9797093,0.00026662962,0.0006899824,0.00057946995,0.00029163627,0.00001943455,0.000023110275,0.0000047870635,0.00061568496,0.0001333209],"about_ca_topic_score_codex":0.0000066117136,"about_ca_topic_score_gemma":0.0000026731755,"teacher_disagreement_score":0.034794807,"about_ca_system_score_codex":0.00015554784,"about_ca_system_score_gemma":0.00042387226,"threshold_uncertainty_score":0.39126787},"labels":[],"label_agreement":null},{"id":"W2975329953","doi":"10.1161/circulationaha.119.040580","title":"Evolution of Medicare Formulary Coverage Changes for Antithrombotic Therapies After Guideline Updates","year":2019,"lang":"en","type":"letter","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences","funders":"","keywords":"Formulary; Medicine; Veterans Affairs; Haven; Center of excellence; Family medicine; Guideline; Health care; Antithrombotic; Medicaid; Gerontology; Law; Internal medicine; Political science","score_opus":0.013662961641934758,"score_gpt":0.254375996041005,"score_spread":0.24071303439907027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2975329953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.34764865,0.1323151,0.17748904,0.32714286,0.003020432,0.009694079,0.0016512561,0.0004179764,0.0006205678],"genre_scores_gemma":[0.8988386,0.0007060205,0.00030057173,0.09027267,0.0031059755,0.00011216394,0.0064307223,0.00009133096,0.00014195051],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99833614,0.00006916231,0.00041714386,0.00037590973,0.0005434003,0.00025827446],"domain_scores_gemma":[0.9986909,0.0000856156,0.00025929845,0.0005441517,0.00038619482,0.000033816726],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025423872,0.00028320044,0.00073981786,0.00021605566,0.00004621656,0.00001453072,0.000093840135,0.00063118205,0.00026556334],"category_scores_gemma":[0.000056928733,0.0002464014,0.000614366,0.000109756395,0.00007664622,0.00010531869,0.000019850806,0.0002796335,0.0000220163],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014445614,0.0002428657,0.09257581,0.012625355,0.0075050746,0.00025863553,0.00091126596,0.0005010714,0.0043481314,0.00013850833,0.83551514,0.043933555],"study_design_scores_gemma":[0.003605824,0.0002614378,0.06423255,0.0010803427,0.0024118652,0.00007694327,0.000072139446,0.0015277388,0.00032991747,0.001034648,0.92482555,0.0005410275],"about_ca_topic_score_codex":0.000015458994,"about_ca_topic_score_gemma":0.000002369896,"teacher_disagreement_score":0.55118996,"about_ca_system_score_codex":0.00013028862,"about_ca_system_score_gemma":0.00016098042,"threshold_uncertainty_score":0.9999988},"labels":[],"label_agreement":null},{"id":"W2975423547","doi":"10.1001/jamacardio.2019.3355","title":"Benefit and Risks of Aspirin in Addition to Ticagrelor in Acute Coronary Syndromes","year":2019,"lang":"en","type":"article","venue":"JAMA Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":134,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Abbott Vascular; Regeneron Pharmaceuticals; National Institutes of Health; Idorsia Pharmaceuticals; Daiichi Sankyo Europe; Gilead Sciences; Servier; Eisai; Osprey Medical; Daiichi-Sankyo; Medicines Company; AstraZeneca; Amarin Corporation; Ironwood Pharmaceuticals, Incorporated; Boston Scientific Corporation; Bristol-Myers Squibb; Eli Lilly and Company; Abbott Laboratories; CSL Behring; Pfizer; Amgen; Edwards Lifesciences; Sanofi; Medicure; American Heart Association","keywords":"Ticagrelor; Medicine; Aspirin; Percutaneous coronary intervention; Acute coronary syndrome; Conventional PCI; Clopidogrel; Internal medicine; Myocardial infarction; Coronary artery disease; Context (archaeology); Cardiology; Stroke (engine)","score_opus":0.02400867189315251,"score_gpt":0.29330016851356233,"score_spread":0.2692914966204098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2975423547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965175,0.0015718172,0.000025666639,0.000246878,0.000083850784,0.00039270383,0.00004621215,0.00001204193,0.0011033465],"genre_scores_gemma":[0.99867773,0.0006939785,0.0000841125,0.00031598186,0.000041074378,0.000025385243,0.00006224768,0.0000110705,0.000088423665],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992251,0.000075257456,0.0001943931,0.00022820594,0.00010209589,0.00017497993],"domain_scores_gemma":[0.9995851,0.00006711897,0.000028437022,0.00022295877,0.000030251394,0.0000661292],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020682342,0.00009656585,0.0005864641,0.00016955512,0.0000072007592,0.0000025984157,0.000046538356,0.00014918177,0.000085118205],"category_scores_gemma":[0.00002766403,0.00008711296,0.0001411144,0.0001413863,0.000049701215,0.000048579193,0.000042087082,0.00013123832,0.000044928416],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013024027,0.000045602217,0.8867364,0.00009607163,0.0006443321,0.00094383524,0.0001262419,0.0003225433,0.002233958,0.00032334254,0.00018430215,0.107040964],"study_design_scores_gemma":[0.002734193,0.00048661165,0.9913358,0.00012307173,0.00010340162,0.0007505786,0.00011982928,0.0000271025,0.00022086738,0.00016580395,0.0038423485,0.00009039458],"about_ca_topic_score_codex":0.00004709167,"about_ca_topic_score_gemma":0.000009382053,"teacher_disagreement_score":0.10695057,"about_ca_system_score_codex":0.000031743995,"about_ca_system_score_gemma":0.000028228958,"threshold_uncertainty_score":0.35523635},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"split"},{"id":"W2975451791","doi":"10.1016/j.jacc.2019.08.503","title":"TCT-413 Different Safety Pattern of Ticagrelor Monotherapy Following Percutaneous Coronary Interventions Related to Pulse Pressure Levels: A Subanalysis of the GLOBAL LEADERS Randomized Multicenter Trial","year":2019,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Ticagrelor; Randomized controlled trial; Psychological intervention; Pulse pressure; Cardiology; Internal medicine; Percutaneous; Percutaneous coronary intervention; Blood pressure; Myocardial infarction; Nursing","score_opus":0.014718302965636032,"score_gpt":0.2876479659280911,"score_spread":0.2729296629624551,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2975451791","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99319786,0.0021708135,0.0011322628,0.0012601884,0.00065536797,0.0012996191,0.00018689848,0.000004585501,0.00009242082],"genre_scores_gemma":[0.99914145,0.00031657596,0.00007249183,0.00018089874,0.00007242067,0.000006393151,0.0000017948146,0.000019256164,0.00018869572],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9960563,0.0017029,0.0012994872,0.0001858161,0.00054622494,0.00020926584],"domain_scores_gemma":[0.99740136,0.00043013875,0.0012190893,0.0005960643,0.00025802723,0.000095322146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008516071,0.00021270363,0.002854022,0.000115862145,0.000047489724,0.000002819898,0.0004541626,0.00008642968,0.0000740552],"category_scores_gemma":[0.0003048765,0.00011218293,0.007301202,0.00038881824,0.0005604838,0.000036920457,0.00009666134,0.0002510222,0.0000010459746],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7720637,0.0004891089,0.14213297,0.000216197,0.0643119,0.0002613375,0.00059767335,0.00749711,0.0055946726,0.00003536685,0.00020530602,0.0065947142],"study_design_scores_gemma":[0.6921043,0.006158463,0.2481525,0.0020843772,0.034945697,0.005459339,0.006946579,0.0009129988,0.001536532,0.0001682486,0.0010223101,0.000508665],"about_ca_topic_score_codex":0.000026070193,"about_ca_topic_score_gemma":0.000005387592,"teacher_disagreement_score":0.10601953,"about_ca_system_score_codex":0.00008981344,"about_ca_system_score_gemma":0.0001445625,"threshold_uncertainty_score":0.73634577},"labels":[],"label_agreement":null},{"id":"W2976166882","doi":"10.1056/nejmoa1908419","title":"Ticagrelor with or without Aspirin in High-Risk Patients after PCI","year":2019,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1000,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; University Health Network","funders":"Janssen Pharmaceuticals; Abbott Vascular; St. Jude Medical; MicroPort; Idorsia Pharmaceuticals; PharmaMar; Daiichi Sankyo Europe; Gilead Sciences; Servier; Eisai; British Heart Foundation; Sanofi; Abiomed; Osprey Medical; Amarin Pharma; Novo Nordisk; Medicines Company; AstraZeneca; Amarin Corporation; Boston Scientific Corporation; Massachusetts Medical Society; Regeneron Pharmaceuticals; Medicure; US WorldMeds; Bristol-Myers Squibb; Eli Lilly and Company; Pfizer; Icahn School of Medicine at Mount Sinai; CSL Behring; Cardinal Health; Amgen","keywords":"Ticagrelor; Conventional PCI; Percutaneous coronary intervention; Aspirin; P2Y12; Medicine; Cardiology; Internal medicine; Clopidogrel; Myocardial infarction","score_opus":0.006067489123158599,"score_gpt":0.22754679371736009,"score_spread":0.22147930459420148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2976166882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966003,0.0015682655,0.00018720624,0.0007067614,0.00029810425,0.000267442,0.0000021141539,0.000008453575,0.0003614005],"genre_scores_gemma":[0.9962502,0.00071099226,0.0003364293,0.00063771295,0.0012873636,0.0000017276485,0.0000052509695,0.000024423423,0.00074588833],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984727,0.00010099112,0.00041591094,0.00014558097,0.00066371454,0.00020111524],"domain_scores_gemma":[0.9990196,0.000087865235,0.00021216461,0.00021777398,0.00016735488,0.00029524817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050983723,0.00016704446,0.0007312066,0.00019515335,0.000014692702,0.0000056777308,0.00008324459,0.00006287867,0.00089093513],"category_scores_gemma":[0.00011662305,0.000080428574,0.00010477456,0.00019196916,0.00006869481,0.00009949106,0.000011435811,0.00037055917,0.000025987312],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018943977,0.00012720161,0.83736485,0.000054962253,0.00034351004,0.00061911135,0.0003855874,0.0000184622,0.000029959301,0.0000049703376,0.00032551243,0.14178188],"study_design_scores_gemma":[0.20938987,0.008262461,0.7499459,0.0017029166,0.00070816505,0.0008133718,0.00017565447,0.000018555982,0.00006572129,0.0000613301,0.028710084,0.0001460135],"about_ca_topic_score_codex":0.00009005374,"about_ca_topic_score_gemma":0.0000512087,"teacher_disagreement_score":0.19044589,"about_ca_system_score_codex":0.00003892741,"about_ca_system_score_gemma":0.0001784594,"threshold_uncertainty_score":0.9755115},"labels":[],"label_agreement":null},{"id":"W2976614863","doi":"10.1016/j.amjcard.2019.09.006","title":"Interruption of Dual Antiplatelet Therapy Within Six Months After Coronary Stents (from the Dual Antiplatelet Therapy Study)","year":2019,"lang":"en","type":"article","venue":"The American Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"U.S. Department of Health and Human Services","keywords":"Thienopyridine; Medicine; Conventional PCI; Odds ratio; Internal medicine; Cardiology; Percutaneous coronary intervention; Confidence interval; Clopidogrel; Incidence (geometry); Randomization; Myocardial infarction; Aspirin; Randomized controlled trial","score_opus":0.021050339344680036,"score_gpt":0.2788093480696358,"score_spread":0.2577590087249558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2976614863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903174,0.007344851,0.0001028273,0.00049709,0.00072741514,0.0008549216,0.00003945957,0.00002039934,0.000095612],"genre_scores_gemma":[0.9920657,0.005819367,0.00004374002,0.0011089445,0.00084592396,0.00001366592,0.000013538134,0.000054509812,0.000034565273],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99603564,0.0016504045,0.0008918237,0.00032266823,0.0007256468,0.0003738469],"domain_scores_gemma":[0.99723136,0.00044373833,0.0010015041,0.00087689987,0.00032100177,0.00012552082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015829956,0.00036637697,0.001731077,0.00012855661,0.000091165304,0.000023599947,0.00042518697,0.00009337497,0.00011478087],"category_scores_gemma":[0.000041292853,0.00018551905,0.0011090247,0.00031326464,0.0008161165,0.00014688844,0.00009149164,0.000641626,0.000025862968],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05971544,0.0004155296,0.8135234,0.000009026735,0.014910722,0.0015176091,0.004056671,0.00088556105,0.014003665,0.000009316986,0.00041739835,0.09053565],"study_design_scores_gemma":[0.0097871935,0.010193255,0.9624869,0.000108005544,0.0005538194,0.0037153186,0.008979856,0.000025331516,0.0011845756,0.00006791365,0.0026454553,0.00025236027],"about_ca_topic_score_codex":0.00007778917,"about_ca_topic_score_gemma":0.0000025429192,"teacher_disagreement_score":0.14896351,"about_ca_system_score_codex":0.00004160438,"about_ca_system_score_gemma":0.00016198706,"threshold_uncertainty_score":0.7565247},"labels":[],"label_agreement":null},{"id":"W2977710227","doi":"10.1007/s40256-019-00373-1","title":"Efficacy and Safety of Clopidogrel, Prasugrel and Ticagrelor in ACS Patients Treated with PCI: A Propensity Score Analysis of the RENAMI and BleeMACS Registries","year":2019,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta","funders":"","keywords":"Prasugrel; Medicine; Ticagrelor; Clopidogrel; Mace; Percutaneous coronary intervention; Internal medicine; Conventional PCI; Myocardial infarction; Acute coronary syndrome; Cardiology; Clinical endpoint; Randomized controlled trial","score_opus":0.006303911963001988,"score_gpt":0.19919777267439476,"score_spread":0.19289386071139278,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2977710227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897043,0.009591508,0.000048972914,0.00006537901,0.000015758105,0.0004907462,0.00001215706,0.0000038928283,0.0000672932],"genre_scores_gemma":[0.9944289,0.005397351,0.00008812074,0.000032993394,0.000015688334,0.0000015983029,0.000005057016,0.000017400333,0.00001294579],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980584,0.0003177558,0.00050259684,0.0002473734,0.0007055082,0.00016841674],"domain_scores_gemma":[0.9983846,0.000102271406,0.0005053226,0.00051501713,0.00036801537,0.00012476342],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007044666,0.00019580174,0.0017115789,0.0002573498,0.000040114188,0.000012385664,0.00009997719,0.00004957013,0.0000026257937],"category_scores_gemma":[0.00009865728,0.00011451064,0.0006656222,0.0010313969,0.0008329991,0.00010001772,0.000062542065,0.00020236101,1.12604674e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038870745,0.00012102234,0.9004813,0.00013066565,0.023531662,0.000030886036,0.0006504423,0.00031337608,0.00007123364,0.000008403274,0.0000037161535,0.070770256],"study_design_scores_gemma":[0.008203124,0.0011057848,0.97547495,0.00056337484,0.012857464,0.00019104838,0.00051885523,0.000025718053,0.0004182959,0.0000022184595,0.000501769,0.00013736766],"about_ca_topic_score_codex":0.00013501025,"about_ca_topic_score_gemma":0.000005017202,"teacher_disagreement_score":0.07499372,"about_ca_system_score_codex":0.000030070594,"about_ca_system_score_gemma":0.00012073345,"threshold_uncertainty_score":0.46696085},"labels":[],"label_agreement":null},{"id":"W2978236603","doi":"10.14309/00000434-200509001-00092","title":"Reappraisal of Upper Gastrointestinal Bleeding Prevalence in Acute Myocardial Infarct Patients Undergoing Urgent Coronary Angiography","year":2005,"lang":"en","type":"article","venue":"The American Journal of Gastroenterology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôpital Fleurimont","funders":"","keywords":"Medicine; Gastrointestinal bleeding; Myocardial infarction; Internal medicine; Angiography; Upper gastrointestinal bleeding; Anticoagulant; Population; Cohort; Surgery; Endoscopy","score_opus":0.006509143719364321,"score_gpt":0.24571603842147566,"score_spread":0.23920689470211134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2978236603","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997725,0.0004971025,0.00067782676,0.0008218277,0.00008772127,0.00013771604,0.000008682251,0.0000071616723,0.000036935882],"genre_scores_gemma":[0.9963394,0.0007364006,0.0018611958,0.0008496602,0.00018619254,0.0000028104332,0.0000031375985,0.000017738443,0.0000034983764],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982331,0.00030443334,0.0005830906,0.0001485367,0.00036849274,0.00036235258],"domain_scores_gemma":[0.9987082,0.00011556844,0.00063058606,0.0002108935,0.00016239684,0.00017238312],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048053535,0.00016600452,0.0007039748,0.00029927294,0.000036548074,0.0000054420693,0.00022312377,0.000017699023,0.000038724447],"category_scores_gemma":[0.000074839925,0.00011766087,0.00083637855,0.00022211492,0.0005217785,0.00011214913,0.000057555266,0.0002986191,0.0000017519387],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019039031,0.00028943538,0.9719677,0.000018966346,0.0012102855,0.0000933324,0.00015677587,0.0003208426,0.000521998,0.0000056204713,0.00008200207,0.006294018],"study_design_scores_gemma":[0.003523934,0.01384912,0.9767733,0.00028493238,0.00063982664,0.0044128946,0.00027690874,0.000031047166,0.0000490125,0.000008471508,0.000094431634,0.000056070792],"about_ca_topic_score_codex":0.000006664933,"about_ca_topic_score_gemma":0.0000026564046,"teacher_disagreement_score":0.0155150965,"about_ca_system_score_codex":0.00003455852,"about_ca_system_score_gemma":0.000092447444,"threshold_uncertainty_score":0.4798071},"labels":[],"label_agreement":null},{"id":"W2979707677","doi":"10.1016/j.cjca.2019.07.428","title":"COST-EFFECTIVENESS OF SHORTER DURATIONS OF TICAGRELOR-BASED DUAL ANTIPLATELET THERAPY FOLLOWING MYOCARDIAL INFARCTION","year":2019,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Ticagrelor; Medicine; Discontinuation; Acute coronary syndrome; Clopidogrel; Myocardial infarction; Aspirin; Internal medicine; Quality-adjusted life year; Cardiology; Cost effectiveness; Intensive care medicine","score_opus":0.027005771718169008,"score_gpt":0.2750973962823612,"score_spread":0.24809162456419218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979707677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99237347,0.0016683146,0.0035026753,0.000096384276,0.0008667457,0.00045666943,0.000031326508,0.0000044043727,0.0010000274],"genre_scores_gemma":[0.9993468,0.00014120508,0.000057666624,0.00008998224,0.00030386087,0.0000050373833,0.00002841103,0.00001941156,0.000007653484],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985623,0.00041206524,0.00043527357,0.00013322706,0.00022221998,0.00023491208],"domain_scores_gemma":[0.99876004,0.0001787753,0.00018474256,0.00025053282,0.0003578944,0.0002680342],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008232413,0.00013863988,0.0009564074,0.00035595722,0.00004234961,0.0000064568453,0.00008685878,0.00016772894,0.000050322906],"category_scores_gemma":[0.0000873086,0.000118028714,0.0011587965,0.0001941054,0.00014891358,0.000092904855,0.000004450716,0.00020364791,0.0000053985013],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034217837,0.000030057081,0.89465684,0.00016919573,0.009690488,0.000633398,0.00021361608,0.016838565,0.054329887,0.0002603653,0.0005271024,0.019228693],"study_design_scores_gemma":[0.010721066,0.0016758034,0.9430141,0.00036540016,0.0009148863,0.0011413126,0.00023980529,0.000058593356,0.014610374,0.000102660844,0.026910065,0.0002459473],"about_ca_topic_score_codex":0.00014128887,"about_ca_topic_score_gemma":0.000021267831,"teacher_disagreement_score":0.048357237,"about_ca_system_score_codex":0.00008080595,"about_ca_system_score_gemma":0.0013587403,"threshold_uncertainty_score":0.48130712},"labels":[],"label_agreement":null},{"id":"W2979778936","doi":"10.1093/ehjcvp/pvz048","title":"P2Y12 inhibitors in acute coronary syndrome patients with renal dysfunction: an analysis from the RENAMI and BleeMACS projects","year":2019,"lang":"en","type":"article","venue":"European Heart Journal - Cardiovascular Pharmacotherapy","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta","funders":"","keywords":"Medicine; Acute coronary syndrome; Internal medicine; Myocardial infarction; Hazard ratio; Prasugrel; Renal function; Kidney disease; Ticagrelor; Clinical endpoint; Cardiology; Confidence interval; Clinical trial","score_opus":0.012632708451280393,"score_gpt":0.24462247632410378,"score_spread":0.23198976787282338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979778936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.981233,0.016878685,0.00027189188,0.00014815918,0.0002780303,0.0009577129,0.000030531977,0.00006436764,0.00013762942],"genre_scores_gemma":[0.9937805,0.0039435476,0.00021144775,0.0013094052,0.00043664157,0.000010638999,0.00010357348,0.00011385359,0.00009038104],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99546564,0.001724328,0.00049355073,0.0006604326,0.0012027822,0.00045324877],"domain_scores_gemma":[0.9983725,0.00006541937,0.00013649915,0.00085974194,0.00018890788,0.00037692892],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016570204,0.00041775298,0.0010263288,0.00031083077,0.00026244868,0.00015553864,0.00021739122,0.000069292415,0.00036883645],"category_scores_gemma":[0.000008405894,0.0002669005,0.001620052,0.0008552561,0.00012973869,0.00047487035,0.000047101516,0.0007410478,0.000050331837],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026245841,0.00034160045,0.92596775,0.000021102209,0.044559497,0.0027261216,0.0005701541,0.0026104024,0.0009171209,8.7656684e-7,0.00035960908,0.01930119],"study_design_scores_gemma":[0.014010198,0.00089751085,0.9535021,0.00017731667,0.0064113946,0.0024917093,0.00017979398,0.00018883697,0.00020191433,0.0000029684056,0.021552488,0.0003837526],"about_ca_topic_score_codex":0.000043836986,"about_ca_topic_score_gemma":0.000004457061,"teacher_disagreement_score":0.038148105,"about_ca_system_score_codex":0.000100935096,"about_ca_system_score_gemma":0.0001071553,"threshold_uncertainty_score":0.9999783},"labels":[],"label_agreement":null},{"id":"W2979957865","doi":"10.1093/ehjcvp/pvz056","title":"Impact of reduced-dose prasugrel vs. standard-dose clopidogrel on in-hospital outcomes of percutaneous coronary intervention in 62 737 patients with acute coronary syndromes: a nationwide registry study in Japan","year":2019,"lang":"en","type":"article","venue":"European Heart Journal - Cardiovascular Pharmacotherapy","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"Japanese Association of Cardiovascular Intervention and Therapeutics","keywords":"Prasugrel; Medicine; Clopidogrel; Percutaneous coronary intervention; Acute coronary syndrome; Internal medicine; Cardiology; Emergency medicine; Aspirin; Myocardial infarction","score_opus":0.014256960035437664,"score_gpt":0.30828563454790875,"score_spread":0.2940286745124711,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979957865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99270487,0.004371512,0.000011653389,0.00004820063,0.0003077206,0.0023560105,0.00006192089,0.00002839116,0.0001097251],"genre_scores_gemma":[0.99722326,0.0023096346,0.000078772384,0.00008014935,0.0000655549,0.0000138880905,0.000035788737,0.00014118972,0.000051789855],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99448043,0.001679813,0.0012053633,0.00059647695,0.0015563014,0.00048162133],"domain_scores_gemma":[0.9981793,0.00008945774,0.00039404127,0.0008052926,0.000304415,0.00022748506],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002030621,0.00051316724,0.0017839975,0.00077366,0.000054018485,0.000033753742,0.00030241846,0.00008571754,0.00016703765],"category_scores_gemma":[0.00005084861,0.00040110026,0.0024411767,0.0005990689,0.00012034323,0.00033193725,0.000053176194,0.00086425396,0.000016684697],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0154197,0.0050721485,0.9434968,0.00012024071,0.011807798,0.006276321,0.0013803369,0.002783901,0.0007893259,6.807149e-7,0.000047006575,0.012805691],"study_design_scores_gemma":[0.03898065,0.011984235,0.94345003,0.0010752643,0.0005663247,0.0027452814,0.00054580026,0.000024450608,0.00009907055,0.0000030789843,0.00015599316,0.00036984353],"about_ca_topic_score_codex":0.0000880214,"about_ca_topic_score_gemma":0.0000051492484,"teacher_disagreement_score":0.023560952,"about_ca_system_score_codex":0.0004427893,"about_ca_system_score_gemma":0.0002744644,"threshold_uncertainty_score":0.9998441},"labels":[],"label_agreement":null},{"id":"W2980115092","doi":"10.1182/blood.v106.11.2175.2175","title":"A Novel Inherited Platelet Function Disorder Involving the Thromboxane A2 Pathway of Platelet Activation.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hospital for Sick Children","funders":"","keywords":"Platelet; Thromboxane A2; Platelet activation; Thromboxane receptor; Internal medicine; Thromboxane; Endocrinology; Platelet disorder; Chemistry; GPVI; Medicine","score_opus":0.014263375915548049,"score_gpt":0.2228538831262656,"score_spread":0.20859050721071756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980115092","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926384,0.003615495,0.0021172164,0.00046532834,0.0000624175,0.00041617983,0.000017352973,0.0000886102,0.0005789639],"genre_scores_gemma":[0.9980756,0.0003694394,0.00032877433,0.0006068506,0.00033792996,0.000028260167,0.000075311975,0.000033366825,0.00014448831],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988612,0.000045555284,0.00028639197,0.00022948504,0.000360173,0.00021720922],"domain_scores_gemma":[0.9992259,0.000071187314,0.000116913834,0.00040610763,0.000108674896,0.000071179944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021558293,0.00017531912,0.00032884363,0.00007118057,0.00012911158,0.000017277407,0.0001008346,0.000118563876,0.00023293808],"category_scores_gemma":[0.00006768546,0.000121719335,0.00027099677,0.00029847957,0.00009338077,0.00016031973,0.000032623957,0.0001962476,0.000021115758],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016719572,0.0063903914,0.014816512,0.0003695464,0.0062166043,0.00004465182,0.002021795,0.0007185248,0.7827278,0.0017139394,0.0009447615,0.18236354],"study_design_scores_gemma":[0.03553633,0.0011700602,0.28281233,0.0006237652,0.0015799986,0.000633598,0.0021782003,0.0007304551,0.51341456,0.0002643275,0.16021357,0.0008427676],"about_ca_topic_score_codex":0.000041096795,"about_ca_topic_score_gemma":0.000012956148,"teacher_disagreement_score":0.26931322,"about_ca_system_score_codex":0.00001696772,"about_ca_system_score_gemma":0.00008044685,"threshold_uncertainty_score":0.49635702},"labels":[],"label_agreement":null},{"id":"W2980254259","doi":"","title":"The Appropriate Use of Dual Antiplatelet Therapy After Coronary Artery Bypass Grafting Surgery","year":2019,"lang":"en","type":"article","venue":"MacSphere (McMaster University)","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Bypass grafting; Artery; Cardiology; Surgery; Coronary artery bypass surgery; Internal medicine","score_opus":0.016612486370567687,"score_gpt":0.1914810788590309,"score_spread":0.1748685924884632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980254259","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99083096,0.0012637501,0.000113254595,0.0001064355,0.00023658886,0.00046110456,0.000018845009,0.00006713714,0.006901911],"genre_scores_gemma":[0.948105,0.0012909268,0.000081014216,0.00022744191,0.000073361916,0.000001521265,0.000019574403,0.000036853064,0.05016435],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99849766,0.0001959713,0.00024603185,0.00034108714,0.00035267987,0.00036653568],"domain_scores_gemma":[0.9989064,0.00024491074,0.00011327027,0.00050838577,0.00010555312,0.00012148486],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021157136,0.00023693273,0.0004734269,0.00009953384,0.00012018049,0.00004459848,0.00013179462,0.00012585273,0.009046503],"category_scores_gemma":[0.000012104985,0.00017877902,0.0005957845,0.00034354263,0.00017093807,0.0003120767,0.00009241753,0.00019628838,0.000079144],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009393005,0.00020944331,0.38843554,0.0000972537,0.0024986477,0.0017795592,0.00024627798,0.00006316633,0.0020944073,0.00012302487,0.0003520242,0.59470767],"study_design_scores_gemma":[0.0066944663,0.00035869682,0.281565,0.00029829677,0.0004174838,0.0004169733,0.0015230577,0.00023092005,0.002631488,0.000032277192,0.7052536,0.00057773944],"about_ca_topic_score_codex":0.000024577643,"about_ca_topic_score_gemma":0.000008996183,"teacher_disagreement_score":0.7049016,"about_ca_system_score_codex":0.000038681177,"about_ca_system_score_gemma":0.000094887415,"threshold_uncertainty_score":0.9918594},"labels":[],"label_agreement":null},{"id":"W2980545229","doi":"10.1177/2047487319882154","title":"Risk factors and clinical outcomes in chronic coronary and peripheral artery disease: An analysis of the randomized, double-blind COMPASS trial","year":2019,"lang":"en","type":"article","venue":"European Journal of Preventive Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Rivaroxaban; Hazard ratio; Internal medicine; Risk factor; Aspirin; Coronary artery disease; Myocardial infarction; Stroke (engine); Population; Cardiology; Body mass index; Surgery; Physical therapy; Warfarin; Confidence interval; Atrial fibrillation","score_opus":0.02839599568714979,"score_gpt":0.31717153648372626,"score_spread":0.28877554079657647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980545229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99338305,0.0049926788,0.00034976442,0.000037404032,0.00037576593,0.000741096,0.00002364938,0.0000035719531,0.00009299983],"genre_scores_gemma":[0.99705017,0.0026210833,0.000015126985,0.000032682954,0.00020110639,0.0000017183715,0.000011135344,0.000015284706,0.00005170365],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9926668,0.0058929464,0.00085059716,0.00022987016,0.0002113006,0.00014847639],"domain_scores_gemma":[0.9984303,0.00043372816,0.00055609044,0.0003034906,0.00010369144,0.00017267771],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003268661,0.0001723935,0.0020200054,0.00017108697,0.00003714192,0.000011163629,0.00013943156,0.000046056855,0.00005099939],"category_scores_gemma":[0.00017219484,0.00009582773,0.002102839,0.0001288544,0.0004694076,0.00009399519,0.00007355055,0.00036081814,7.6343235e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3139372,0.000080411046,0.6721363,0.000011268769,0.0120055955,0.00013539392,0.000092868824,0.00041100173,0.000008751012,0.000009351777,0.000004464485,0.0011673892],"study_design_scores_gemma":[0.3386495,0.0006246766,0.65379274,0.00003493199,0.0064896117,0.000041082778,0.000121723424,0.0001046412,0.00000130373,0.000010461664,0.00006721332,0.00006208148],"about_ca_topic_score_codex":0.0000051660113,"about_ca_topic_score_gemma":0.000003603011,"teacher_disagreement_score":0.024712343,"about_ca_system_score_codex":0.00003670921,"about_ca_system_score_gemma":0.000114649796,"threshold_uncertainty_score":0.39077413},"labels":[],"label_agreement":null},{"id":"W2980690141","doi":"10.1016/j.cjco.2019.09.001","title":"Comparison of Preventive Cardiovascular Pharmacotherapy in Surgical vs Percutaneous Coronary Revascularization","year":2019,"lang":"en","type":"article","venue":"CJC Open","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; St. Paul's Hospital; Native Mental Health Association of Canada; University of British Columbia","funders":"","keywords":"Medicine; Conventional PCI; Percutaneous coronary intervention; Pharmacotherapy; Internal medicine; Clopidogrel; Contraindication; Cardiology; Revascularization; Surgery; Myocardial infarction","score_opus":0.019373605081645838,"score_gpt":0.33139496091459386,"score_spread":0.31202135583294804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980690141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97654516,0.014868683,0.00014121945,0.00004094843,0.000121836005,0.0019801832,0.000009338615,0.00002374564,0.006268899],"genre_scores_gemma":[0.99704343,0.0017124595,0.0001751378,0.000090563546,0.000054768425,0.000026935832,0.0000911985,0.00003304701,0.0007724675],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983208,0.00028776878,0.00036505045,0.0003680975,0.00045220388,0.00020604502],"domain_scores_gemma":[0.99914,0.00004308933,0.00007620479,0.00056077,0.0000887632,0.00009117292],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005391375,0.00016760526,0.0011638337,0.00008545473,0.000031317042,0.000021339643,0.00026096634,0.00010744855,0.0010416902],"category_scores_gemma":[0.0000122172905,0.00015096128,0.0007329159,0.0002550164,0.00005804421,0.0001511557,0.00009151592,0.00016843808,0.00007789424],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012028481,0.0024153597,0.75626457,0.0007729809,0.010991737,0.002989443,0.0019069355,0.0047068703,0.015834393,0.00039287412,0.00043158425,0.19126475],"study_design_scores_gemma":[0.06975486,0.0035121492,0.42662764,0.002382865,0.004196444,0.007143513,0.0024897836,0.0055983756,0.048818078,0.0003133624,0.42728302,0.0018799265],"about_ca_topic_score_codex":0.00007251378,"about_ca_topic_score_gemma":0.0000020360726,"teacher_disagreement_score":0.42685145,"about_ca_system_score_codex":0.000060124865,"about_ca_system_score_gemma":0.000112550675,"threshold_uncertainty_score":0.9998715},"labels":[],"label_agreement":null},{"id":"W2981362354","doi":"10.1093/eurheartj/ehz748.0137","title":"2350Evaluation of the pharmacodynamics of a ticagrelor reversal agent PB2452","year":2019,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Ticagrelor; Medicine; P2Y12; Aspirin; Pharmacodynamics; Pharmacology; Acute coronary syndrome; Anesthesia; Internal medicine; Clopidogrel; Pharmacokinetics; Myocardial infarction","score_opus":0.02802088883114533,"score_gpt":0.29816522265080353,"score_spread":0.2701443338196582,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981362354","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935157,0.0009315739,0.00019087031,0.00033966903,0.00035834737,0.00018772358,0.0000037378245,0.0000065331233,0.0044658994],"genre_scores_gemma":[0.99847573,0.0002764906,0.00018404929,0.00030688327,0.00018016754,1.8760097e-7,0.0000017413892,0.000017091825,0.0005576308],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987929,0.00036509233,0.00024008454,0.00007801117,0.00042229408,0.00010165461],"domain_scores_gemma":[0.9994328,0.000023307432,0.00013206758,0.0002173247,0.00012196837,0.00007254435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008946902,0.00006816556,0.00019482036,0.00004070595,0.000041134306,0.000006129879,0.000090644615,0.0000147106175,0.0005609111],"category_scores_gemma":[0.000048246784,0.000043545082,0.00042585394,0.00010174705,0.00004957454,0.000044123128,0.000030878015,0.00018758327,0.00007297154],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024814804,0.0009030482,0.43088517,0.0006190754,0.0031343936,0.00022851684,0.0019255232,0.0020717683,0.46435353,0.0003405621,0.015800485,0.07725647],"study_design_scores_gemma":[0.004754268,0.00044349968,0.94146544,0.0005141168,0.00065917906,0.0015310161,0.0002120934,0.0011695244,0.01001992,0.000030237792,0.03907445,0.00012623063],"about_ca_topic_score_codex":7.913494e-7,"about_ca_topic_score_gemma":5.7417072e-8,"teacher_disagreement_score":0.5105803,"about_ca_system_score_codex":0.000020970936,"about_ca_system_score_gemma":0.0000876722,"threshold_uncertainty_score":0.61415833},"labels":[],"label_agreement":null},{"id":"W2981445333","doi":"10.1093/eurheartj/ehz745.0116","title":"4112Risk factors and clinical outcomes in chronic CAD and PAD: an analysis of the randomized, double-blind COMPASS trial","year":2019,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Population Health Research Institute","funders":"","keywords":"Medicine; Aspirin; Rivaroxaban; Internal medicine; Risk factor; Coronary artery disease; Antithrombotic; Hazard ratio; Body mass index; Stroke (engine); Cardiology; Surgery; Warfarin; Confidence interval; Atrial fibrillation","score_opus":0.06807670208019517,"score_gpt":0.3657650004787879,"score_spread":0.29768829839859273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981445333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971551,0.0016172067,0.000023529494,0.00016180854,0.00024491022,0.0006140913,0.0000046806126,0.000007341127,0.0001713608],"genre_scores_gemma":[0.99844265,0.0011070058,0.000017805278,0.0001201073,0.00020851698,8.268615e-7,0.0000044455974,0.000016993428,0.00008166854],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970754,0.0016242488,0.00061903935,0.00020226507,0.0003125262,0.00016655645],"domain_scores_gemma":[0.99895936,0.00031123572,0.00018847112,0.00030355132,0.000045252647,0.00019214665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030530482,0.00014593863,0.0012746034,0.00018731807,0.000075328615,0.000045317647,0.00009472979,0.000047359423,0.000110830784],"category_scores_gemma":[0.00009593702,0.00007738262,0.001103101,0.00020510827,0.00020504599,0.00009344543,0.00004915224,0.000428801,0.000003897007],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.179445,0.000108337015,0.8168859,0.000009191962,0.0027255237,0.000021022106,0.00013386374,0.000052779837,0.000022212607,0.000013474281,0.0000150983215,0.00056764076],"study_design_scores_gemma":[0.39466652,0.00024737517,0.6027002,0.000027138432,0.0016459243,0.000038312977,0.00009382911,0.00018822095,0.0000063924854,0.0000030667372,0.0003256397,0.000057368037],"about_ca_topic_score_codex":0.0000359088,"about_ca_topic_score_gemma":0.000028901713,"teacher_disagreement_score":0.21522154,"about_ca_system_score_codex":0.000026621383,"about_ca_system_score_gemma":0.00009240121,"threshold_uncertainty_score":0.31555715},"labels":[],"label_agreement":null},{"id":"W2981454988","doi":"10.1093/eurheartj/ehz745.0127","title":"4181Prognosis of patients with mid-range left ventricular ejection fraction treated with PCI: insight from the global leaders study","year":2019,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Ejection fraction; Medicine; Conventional PCI; Cardiology; Percutaneous coronary intervention; Internal medicine; Heart failure; Clinical endpoint; Randomized controlled trial; Myocardial infarction","score_opus":0.018434079337463764,"score_gpt":0.24004546056992107,"score_spread":0.2216113812324573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981454988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99762964,0.0009189028,0.00012729836,0.000100950354,0.00010052723,0.0005860298,0.000011499161,0.000027667085,0.00049747183],"genre_scores_gemma":[0.9994627,0.000055315457,0.000041255003,0.00017535166,0.00018332522,0.0000012166274,0.000023689365,0.0000281979,0.000028927669],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983598,0.00048684463,0.0001987236,0.00019433018,0.00059761206,0.00016266144],"domain_scores_gemma":[0.9992896,0.000028770142,0.00013726158,0.000256872,0.00018105107,0.00010648929],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024195631,0.00015428552,0.00028833788,0.00004371655,0.00014054212,0.00003765634,0.00007387968,0.00002487807,0.00018735568],"category_scores_gemma":[0.000014160216,0.0000821057,0.00018930662,0.00021162983,0.000058387974,0.00015346696,0.000012815928,0.00024221021,0.000054260207],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018944337,0.0006599091,0.99446267,0.000008246721,0.0011117001,0.0001975219,0.00022795281,0.000054066746,0.0000316679,2.3592268e-7,0.00021382072,0.0011377459],"study_design_scores_gemma":[0.006366427,0.002197954,0.9820596,0.00015924014,0.00065445545,0.00021432793,0.0013730127,0.000004830701,0.00013242036,6.189498e-7,0.006734311,0.000102791724],"about_ca_topic_score_codex":0.000034942135,"about_ca_topic_score_gemma":0.000004558335,"teacher_disagreement_score":0.012403089,"about_ca_system_score_codex":0.000066802444,"about_ca_system_score_gemma":0.000039773833,"threshold_uncertainty_score":0.3348173},"labels":[],"label_agreement":null},{"id":"W2981583992","doi":"10.1093/eurheartj/ehz748.0145","title":"2387Recurrent cardiovascular events and mortality in relation to antiplatelet therapy in patients with myocardial infarction without obstructive coronary artery disease (MINOCA)","year":2019,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Montreal Heart Institute; University of Toronto; Population Health Research Institute","funders":"","keywords":"Medicine; Clopidogrel; Myocardial infarction; Internal medicine; Coronary artery disease; Regimen; Cardiology; Hazard ratio; Stroke (engine); Surgery; Confidence interval","score_opus":0.016078732556613767,"score_gpt":0.24748772774350702,"score_spread":0.23140899518689326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981583992","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969584,0.0014923832,0.00005875998,0.000051913765,0.0003137028,0.0009584821,0.000009977669,0.000019963521,0.00013643462],"genre_scores_gemma":[0.9989261,0.0005043753,0.000070562026,0.00022047934,0.00017976461,0.0000058770547,0.00003604262,0.000043709908,0.000013095176],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976986,0.0006568443,0.0003235065,0.00037736227,0.00065556815,0.00028808622],"domain_scores_gemma":[0.99913365,0.000016945183,0.00007206709,0.00034145336,0.000094868476,0.00034104363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007710425,0.0002242552,0.00048666197,0.00023953404,0.00007500621,0.000033673918,0.000060107213,0.000040125393,0.000031348613],"category_scores_gemma":[0.000025857236,0.00018293808,0.0002958067,0.0002201382,0.000039310304,0.00030717358,0.000034322376,0.00040776882,0.00003716532],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036449628,0.00018884332,0.97646624,0.000019398967,0.00072252215,0.00025960375,0.0002541351,0.00073592213,0.000028602753,0.000001524033,0.000016389647,0.017661877],"study_design_scores_gemma":[0.009709204,0.00060581084,0.9873772,0.00031543,0.00012267557,0.00022633311,0.00005640231,0.000023732473,0.0000060111156,0.000014407621,0.0013282446,0.00021449733],"about_ca_topic_score_codex":0.000006145068,"about_ca_topic_score_gemma":0.0000011308219,"teacher_disagreement_score":0.01744738,"about_ca_system_score_codex":0.00010804503,"about_ca_system_score_gemma":0.000076117176,"threshold_uncertainty_score":0.7459998},"labels":[],"label_agreement":null},{"id":"W2981588251","doi":"10.1093/eurheartj/ehz746.0053","title":"5194Impact of established cardiovascular disease on outcomes in the Global Leaders trial","year":2019,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Medicine; Ticagrelor; Percutaneous coronary intervention; Internal medicine; Myocardial infarction; Aspirin; Conventional PCI; Clinical endpoint; Stroke (engine); Cardiology; Coronary artery disease; Revascularization; Clopidogrel; Stent; Cohort; Randomized controlled trial; Surgery","score_opus":0.04662266977817129,"score_gpt":0.3077661256492653,"score_spread":0.261143455871094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981588251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895966,0.0029135137,0.000027306629,0.00089481234,0.00041639913,0.00055248494,0.000011181296,0.000016980313,0.0055707097],"genre_scores_gemma":[0.9981099,0.00020182761,0.00002389402,0.0011233452,0.00041485627,0.0000015085893,0.0000049916866,0.00002379973,0.00009592792],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971979,0.0010741303,0.00032496895,0.00020211675,0.000918556,0.00028227878],"domain_scores_gemma":[0.9989098,0.000075567565,0.00006881403,0.00066246314,0.000049007867,0.00023439783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019955873,0.00017368214,0.000553696,0.000088987945,0.00006426037,0.000052287414,0.00020151548,0.000023012659,0.00015262963],"category_scores_gemma":[0.00022096891,0.000103105165,0.0017415877,0.00021875302,0.00008161735,0.00011388031,0.000020568767,0.0003609859,0.00014438007],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.043454196,0.0011826352,0.93244934,0.00010540989,0.0037025115,0.0037051116,0.0005211694,0.0023354446,0.000041248662,0.0001442833,0.0038888934,0.008469761],"study_design_scores_gemma":[0.04184741,0.0009326206,0.9213021,0.00017729394,0.0004621611,0.0005712076,0.00062160747,0.000012306234,0.000011929653,0.000033004857,0.033878602,0.00014976396],"about_ca_topic_score_codex":0.000007312947,"about_ca_topic_score_gemma":2.69819e-7,"teacher_disagreement_score":0.02998971,"about_ca_system_score_codex":0.00005631419,"about_ca_system_score_gemma":0.00013691302,"threshold_uncertainty_score":0.42045066},"labels":[],"label_agreement":null},{"id":"W2981659316","doi":"10.1093/eurheartj/ehz748.0699","title":"P1952Value of GRACE risk score in risk stratification in acute coronary syndrome patients undergoing PCI in the Global Leaders study","year":2019,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre","funders":"","keywords":"Medicine; Acute coronary syndrome; Internal medicine; Conventional PCI; Percutaneous coronary intervention; Framingham Risk Score; Ticagrelor; Clinical endpoint; Aspirin; Randomized controlled trial; Cardiology; Myocardial infarction","score_opus":0.029919421733045518,"score_gpt":0.2863837408741201,"score_spread":0.2564643191410746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981659316","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99806494,0.00074112666,0.0000150683845,0.00007649233,0.000115213355,0.0006855155,0.000010856541,0.000007507518,0.0002832705],"genre_scores_gemma":[0.99925035,0.00056618126,0.000041056093,0.00007472369,0.000024464658,0.0000018453867,0.000008977721,0.000017897613,0.00001452259],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969982,0.0016511692,0.0004525107,0.00020714426,0.00047310052,0.00021786967],"domain_scores_gemma":[0.99933445,0.00007200575,0.00018237873,0.000300552,0.00004390275,0.00006670642],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018159604,0.0001348592,0.0003142247,0.00012909544,0.0000619126,0.000025894384,0.000159933,0.000029477394,0.000030958698],"category_scores_gemma":[0.00007726674,0.00009999127,0.00016910145,0.00036547438,0.00005257304,0.00015805499,0.00002577606,0.0005615058,0.000045205386],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004018721,0.000752939,0.9936473,0.00001892461,0.00015851182,0.0007066725,0.001400511,0.0009596551,0.00001118865,0.0000053715867,0.00003975126,0.0018973219],"study_design_scores_gemma":[0.005863666,0.0011440668,0.9852124,0.00026692625,0.00011439009,0.00067886256,0.006499933,0.0000566517,0.0000028582842,0.000038429345,0.000030645064,0.00009116685],"about_ca_topic_score_codex":0.000039720173,"about_ca_topic_score_gemma":0.000072150186,"teacher_disagreement_score":0.008434877,"about_ca_system_score_codex":0.00010284517,"about_ca_system_score_gemma":0.00009685102,"threshold_uncertainty_score":0.40775257},"labels":[],"label_agreement":null},{"id":"W2981659669","doi":"10.1016/j.thromres.2019.09.033","title":"Rivaroxaban plus aspirin for cardiovascular protection: Rationale for the vascular dose and dual pathway inhibition","year":2019,"lang":"en","type":"review","venue":"Thrombosis Research","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"Boehringer Ingelheim; Bayer; Pfizer","keywords":"Rivaroxaban; Aspirin; Medicine; Pharmacology; Thrombin generation; ATHEROSCLEROTIC VASCULAR DISEASE; Coronary artery disease; Thrombin; Vascular disease; Cardiology; Platelet; Internal medicine; Warfarin; Atrial fibrillation","score_opus":0.34536453010458873,"score_gpt":0.4302358989388002,"score_spread":0.08487136883421148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981659669","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014425465,0.97272384,0.0051663704,0.00020826269,0.00019488091,0.021158367,0.00024782968,0.00006223304,0.00009398467],"genre_scores_gemma":[0.00023494023,0.986503,0.00022845627,0.00004870647,0.0013936975,0.010229399,0.0007181733,0.00014620683,0.0004973996],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99565125,0.00073823304,0.00053962664,0.0009244066,0.0014934443,0.0006530659],"domain_scores_gemma":[0.99656403,0.00090103864,0.000113861155,0.0013256149,0.00090719655,0.0001882421],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004813473,0.0004620814,0.002253866,0.00032703378,0.000782273,0.00015770085,0.0001967143,0.0004899238,0.000061889994],"category_scores_gemma":[0.00046336147,0.0003045131,0.0050031575,0.0005513477,0.00036080886,0.00013186155,0.00015690252,0.00073392625,0.000066767214],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019046557,0.00013127546,9.153674e-7,0.04338391,0.014913489,0.000010374478,0.00012239287,0.000020968782,0.000019697884,0.00076898845,0.0012426068,0.9391949],"study_design_scores_gemma":[0.0031201888,0.0005399355,0.000038439808,0.0047093285,0.005523472,0.000105600375,0.000151691,0.000119289834,0.00003093467,0.000191393,0.98513305,0.00033667337],"about_ca_topic_score_codex":0.000041257143,"about_ca_topic_score_gemma":0.000003452896,"teacher_disagreement_score":0.9838905,"about_ca_system_score_codex":0.0003075511,"about_ca_system_score_gemma":0.0011939231,"threshold_uncertainty_score":0.9999407},"labels":[],"label_agreement":null},{"id":"W2981660530","doi":"10.1093/eurheartj/ehz748.0680","title":"P1933Comparing treatment recommendations for the DAPT and PRECISE-DAPT scores after percutaneous coronary intervention","year":2019,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Conventional PCI; Percutaneous coronary intervention; Internal medicine; Aspirin; Concordance; Cardiology; Cohort; Myocardial infarction","score_opus":0.04282006523216948,"score_gpt":0.3068656563659643,"score_spread":0.26404559113379483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981660530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986617,0.009593344,0.0009218787,0.0014575453,0.00034450533,0.0005062453,0.000009978461,0.000026000345,0.00052344543],"genre_scores_gemma":[0.9956858,0.0016050548,0.0005672512,0.00028731333,0.0003685566,0.000008089486,0.000011734717,0.000029704193,0.0014364866],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9992176,0.0001767394,0.00019096739,0.00014528017,0.00011791714,0.00015147969],"domain_scores_gemma":[0.9995142,0.00009886317,0.000049418257,0.00018653345,0.000044034903,0.0001069416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037058545,0.00011156896,0.00018281417,0.00004455635,0.00019621535,0.0000782882,0.000049250575,0.000015465275,0.00046138317],"category_scores_gemma":[0.000015605576,0.00006979314,0.000363868,0.00003031263,0.000034111872,0.000086873006,0.000026237609,0.00012690412,0.000069936614],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005297562,0.00065893336,0.2704178,0.00013558895,0.0028456836,0.00086828804,0.0020657335,0.00018595128,0.0019006636,0.00005416687,0.010305752,0.70526385],"study_design_scores_gemma":[0.004185979,0.0018419945,0.5802411,0.0005192406,0.0006259953,0.023369575,0.00078015146,0.00061665877,0.00012728042,0.00003568856,0.38747245,0.00018393641],"about_ca_topic_score_codex":0.0000027856274,"about_ca_topic_score_gemma":0.0000018540068,"teacher_disagreement_score":0.7050799,"about_ca_system_score_codex":0.000042943764,"about_ca_system_score_gemma":0.000020642428,"threshold_uncertainty_score":0.5051822},"labels":[],"label_agreement":null},{"id":"W2981766629","doi":"10.1016/j.ahj.2019.09.006","title":"Applying contemporary antithrombotic therapy in the secondary prevention of chronic atherosclerotic cardiovascular disease","year":2019,"lang":"en","type":"review","venue":"American Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Population Health Research Institute; McMaster University; Hamilton Health Sciences; University of Alberta","funders":"University of Alberta","keywords":"Medicine; Antithrombotic; Aspirin; Intensive care medicine; Fibrinolytic agent; Myocardial infarction; Internal medicine; Stroke (engine); Cardiology","score_opus":0.09526659649130413,"score_gpt":0.3486183494204148,"score_spread":0.25335175292911066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981766629","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0038687438,0.9924848,0.00012305513,0.000032831136,0.0002011583,0.0031417457,0.000017394797,0.000017509501,0.0001127339],"genre_scores_gemma":[0.031802837,0.96707666,0.000040334366,0.0001904828,0.000532051,0.00019057712,0.000047143378,0.00008719037,0.00003270561],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99587524,0.0015486294,0.0008954392,0.00041381037,0.0008898184,0.0003770847],"domain_scores_gemma":[0.99798834,0.0001656794,0.00051452697,0.0010513433,0.00008003196,0.00020007676],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015467958,0.00044909873,0.0035077592,0.0002912201,0.00010964308,0.000050179635,0.0003311519,0.00010600343,0.00010341155],"category_scores_gemma":[0.00003800998,0.0002827238,0.005765505,0.0006215164,0.0003405063,0.00013493304,0.000034263692,0.0010732657,0.00003837421],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000079233396,0.00028385688,0.00061874837,0.00517199,0.004623925,0.0002200157,0.000052615316,0.000020931715,0.0000026087428,0.0000036627464,0.00023345713,0.98868895],"study_design_scores_gemma":[0.0015591938,0.0010189052,0.003384168,0.015105324,0.0033122161,0.001522869,0.00020328512,0.000008921881,8.621281e-7,0.000014614443,0.97355115,0.00031846337],"about_ca_topic_score_codex":0.00004050066,"about_ca_topic_score_gemma":4.8736615e-7,"teacher_disagreement_score":0.9883705,"about_ca_system_score_codex":0.00016403412,"about_ca_system_score_gemma":0.00278088,"threshold_uncertainty_score":0.9999625},"labels":[],"label_agreement":null},{"id":"W2982016389","doi":"10.1093/eurheartj/ehz748.0679","title":"P1932Predictors of DAPT use in patients beyond 1 year post myocardial infarction: Insights from the TIGRIS observational study","year":2019,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Heart Research Centre; University of Toronto; St. Michael's Hospital; University of Ottawa","funders":"","keywords":"Medicine; Internal medicine; Clopidogrel; Prasugrel; Cardiology; Aspirin; Coronary artery disease; Myocardial infarction; Observational study; Discontinuation; Ticagrelor; Conventional PCI","score_opus":0.04150320670496606,"score_gpt":0.2563110690413376,"score_spread":0.21480786233637156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982016389","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980045,0.00030613865,0.0000037172965,0.00015635688,0.0005018749,0.00035875838,0.00002776731,0.000011582312,0.00062931894],"genre_scores_gemma":[0.9983796,0.000048158232,0.000044784985,0.00075681624,0.00058577774,8.740625e-7,0.000052607415,0.000024956533,0.00010641816],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99817044,0.0005992265,0.0003365116,0.00016138094,0.0006027932,0.00012965764],"domain_scores_gemma":[0.99919856,0.00010891853,0.00009645923,0.0002973633,0.00019526375,0.00010341996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037668768,0.000116670446,0.00026734077,0.00007952036,0.000085369014,0.000041844633,0.00011172799,0.000027504515,0.00024446574],"category_scores_gemma":[0.00010322557,0.00007833349,0.00025918172,0.00016353202,0.000042846234,0.00022509736,0.000049065235,0.0003463435,0.00011620333],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000542563,0.00032309827,0.99455905,0.0000026552966,0.00040591962,0.000035418976,0.00077410083,0.000047688194,0.00014297194,0.000008238961,0.002862258,0.00029606448],"study_design_scores_gemma":[0.0041871266,0.000627011,0.9769345,0.00006605038,0.00009649273,0.000018167051,0.00056501094,0.000005054852,0.0000109111525,0.000008488048,0.017404841,0.00007634084],"about_ca_topic_score_codex":0.00003874485,"about_ca_topic_score_gemma":0.0000038310295,"teacher_disagreement_score":0.017624516,"about_ca_system_score_codex":0.000030457326,"about_ca_system_score_gemma":0.00009469673,"threshold_uncertainty_score":0.3194347},"labels":[],"label_agreement":null},{"id":"W2982040731","doi":"10.1093/eurheartj/ehz748.0136","title":"2349Selatogrel, a novel P2Y12 inhibitor for emergency use, achieves rapid, consistent and sustained platelet inhibition following single-dose subcutaneous administration in stable CAD patients","year":2019,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Medicine; P2Y12; Aspirin; Ticagrelor; Clopidogrel; Prasugrel; Pharmacokinetics; Pharmacology; Pharmacodynamics; Placebo; Platelet; Anesthesia; Adverse effect; Oral administration; Platelet aggregation inhibitor; Internal medicine","score_opus":0.029463148634232966,"score_gpt":0.2587978032743382,"score_spread":0.22933465464010525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982040731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966783,0.0012024078,0.00025580384,0.0001828361,0.0004954315,0.0008896512,0.000032011474,0.000034813245,0.00022874007],"genre_scores_gemma":[0.9983057,0.00022080277,0.00054032344,0.00018383129,0.00026001493,0.000005066657,0.00009905043,0.000061830964,0.00032340668],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99816245,0.00020849521,0.0005956635,0.00030469915,0.00035409158,0.00037461353],"domain_scores_gemma":[0.99918526,0.00007274621,0.00016688148,0.00017877386,0.00015829735,0.00023802911],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069667626,0.0002241561,0.00039488688,0.00018066379,0.00018390515,0.00010837536,0.00003990692,0.00006832305,0.00006280937],"category_scores_gemma":[0.0001872706,0.00020559448,0.00037905807,0.00015246216,0.000031557047,0.00038967206,0.00003000916,0.00029087788,0.000017704884],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014562888,0.0036642877,0.834639,0.00069927284,0.001487067,0.0038644946,0.0019786307,0.00013317204,0.113973506,0.00012270748,0.0045826198,0.020292344],"study_design_scores_gemma":[0.07412131,0.018630283,0.764563,0.0027148637,0.0010605394,0.01315323,0.0039692437,0.0006483658,0.0098989345,0.00009161919,0.10916774,0.001980846],"about_ca_topic_score_codex":0.0000027492297,"about_ca_topic_score_gemma":0.0000043438326,"teacher_disagreement_score":0.10458512,"about_ca_system_score_codex":0.00008884439,"about_ca_system_score_gemma":0.0001133849,"threshold_uncertainty_score":0.83838993},"labels":[],"label_agreement":null},{"id":"W2982138431","doi":"10.1093/eurheartj/ehz745.0059","title":"3294Frequency, management and outcomes of patients with stable coronary artery disease eligible for COMPASS. An analysis of the CLARIFY registry","year":2019,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"","keywords":"Medicine; Coronary artery disease; Rivaroxaban; Internal medicine; Revascularization; Population; Stroke (engine); Compass; Aspirin; Diabetes mellitus; Cardiology; Observational study; Hazard ratio; Ejection fraction; Warfarin; Heart failure; Surgery; Myocardial infarction; Confidence interval; Atrial fibrillation","score_opus":0.014907415238734619,"score_gpt":0.25304201867331433,"score_spread":0.2381346034345797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982138431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99817103,0.0006128901,0.00022171841,0.000117000905,0.00005590806,0.0003677642,0.000060368213,0.0000068569834,0.00038645644],"genre_scores_gemma":[0.9988439,0.00009369662,0.00036875324,0.00028682416,0.000023505652,0.0000014321045,0.00003311954,0.000018859322,0.00032988354],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99896884,0.00015710434,0.00024087602,0.00014963189,0.0003445003,0.0001390503],"domain_scores_gemma":[0.99913335,0.000023709632,0.0001516802,0.000420645,0.000113290575,0.0001573166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032354193,0.000106076615,0.00038380813,0.00010435688,0.0000778684,0.00001709221,0.000101936115,0.000019289824,0.00006231124],"category_scores_gemma":[0.000008390445,0.00006244992,0.00035541193,0.00015423924,0.00007536577,0.00009498268,0.000031400985,0.00014323102,0.0000015323709],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007360285,0.00023401536,0.9946513,0.00010374576,0.0030209245,0.000030440651,0.000045036304,0.00025640236,0.00003452733,0.000043896533,0.000302874,0.00054081966],"study_design_scores_gemma":[0.0024162128,0.00025504734,0.9921063,0.000090857946,0.0025777405,0.000017111584,0.00012268584,0.00007961001,0.000024060426,0.000015211075,0.002221247,0.000073900876],"about_ca_topic_score_codex":0.0000018088697,"about_ca_topic_score_gemma":6.954408e-7,"teacher_disagreement_score":0.0025449742,"about_ca_system_score_codex":0.000014945858,"about_ca_system_score_gemma":0.000036521567,"threshold_uncertainty_score":0.2546634},"labels":[],"label_agreement":null},{"id":"W2982169819","doi":"10.1503/cmaj.191037","title":"The cardiovascular benefits of low-dosage acetylsalicylic acid","year":2019,"lang":"en","type":"article","venue":"Canadian Medical Association Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Canadian Pacific Railway (Canada); University of Calgary","funders":"","keywords":"Odds ratio; Confidence interval; Medicine; Stroke (engine); Odds; Coronary artery disease; Internal medicine; Ischemic stroke; Cardiology; Logistic regression; Ischemia","score_opus":0.004437665192800261,"score_gpt":0.2002767614328673,"score_spread":0.19583909624006704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982169819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96162874,0.026377201,0.000039625535,0.006918046,0.00086120935,0.00025897592,0.000020967544,0.000016066633,0.0038791993],"genre_scores_gemma":[0.99173105,0.0040617986,0.00001486177,0.0025885869,0.0009845399,0.000004248671,0.000008345377,0.000020508613,0.00058605324],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99690086,0.00019728797,0.0003631411,0.0001385631,0.00197629,0.00042386504],"domain_scores_gemma":[0.9980052,0.000104066035,0.00014084952,0.00030600186,0.00039258215,0.0010512664],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0023994807,0.00011609985,0.00041019986,0.00009030099,0.00021797254,0.000041168812,0.00021237845,0.0002732437,0.0012911088],"category_scores_gemma":[0.0007619443,0.00008101483,0.00090633385,0.00023113424,0.000051619038,0.00007176448,0.000013881213,0.0005930666,0.00020460843],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018799242,0.000117336596,0.21608703,0.0001741647,0.014907522,0.0007531054,0.0005276688,0.00019382077,0.0002543432,0.0017414619,0.041829076,0.7232265],"study_design_scores_gemma":[0.003912889,0.00013224012,0.13405727,0.00029791766,0.00039673655,0.0011711709,0.0005571013,0.000081356084,0.0006478034,0.00006391088,0.8584824,0.00019916685],"about_ca_topic_score_codex":0.00031673262,"about_ca_topic_score_gemma":0.00066860666,"teacher_disagreement_score":0.8166534,"about_ca_system_score_codex":0.00033735324,"about_ca_system_score_gemma":0.0019373788,"threshold_uncertainty_score":0.99962187},"labels":[],"label_agreement":null},{"id":"W2982183151","doi":"10.1093/eurheartj/ehz746.1005","title":"P6411Dyspnea in ticagrelor treated patients in the all-comer randomized GLOBAL LEADERS study and its association with clinical outcomes","year":2019,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Southlake Regional Health Center","funders":"","keywords":"Medicine; Ticagrelor; Percutaneous coronary intervention; Conventional PCI; Internal medicine; Context (archaeology); Aspirin; Stroke (engine); Acute coronary syndrome; Myocardial infarction; Clinical endpoint; Randomized controlled trial; Adverse effect; Incidence (geometry)","score_opus":0.04324222455491191,"score_gpt":0.3404264346168804,"score_spread":0.2971842100619685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982183151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968919,0.00032321538,0.0000022173292,0.0008122351,0.000106503714,0.0010041245,0.0000019536883,0.000011118319,0.00084672554],"genre_scores_gemma":[0.99829406,0.00019897905,0.000012115148,0.0012653334,0.00007275966,0.0000029620553,0.000004461957,0.00001536044,0.00013395937],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99578726,0.0028655597,0.0004522054,0.00018060596,0.000495734,0.00021860625],"domain_scores_gemma":[0.9992621,0.0003093988,0.00012338301,0.00013911261,0.00006709215,0.00009890329],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040679583,0.00013761288,0.0006516617,0.00006143613,0.000044520966,0.000046956637,0.0000758652,0.000036461493,0.000040396215],"category_scores_gemma":[0.00035017045,0.00007254179,0.00025352224,0.00015531344,0.00003825793,0.00009590705,0.000017088862,0.00040220295,0.00007744266],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011159368,0.0006122559,0.9857171,0.0000049346695,0.00067850814,0.00022373351,0.0005705251,0.000005580723,8.2244145e-7,0.00000210618,0.00018646075,0.00083856983],"study_design_scores_gemma":[0.14994743,0.00048099284,0.847941,0.000047975787,0.00024890216,0.00007215106,0.0006872343,0.00002317795,4.731595e-7,0.0000018085028,0.000473922,0.00007492458],"about_ca_topic_score_codex":0.0000103811435,"about_ca_topic_score_gemma":0.000009817729,"teacher_disagreement_score":0.13878807,"about_ca_system_score_codex":0.00006682379,"about_ca_system_score_gemma":0.00003131001,"threshold_uncertainty_score":0.29581684},"labels":[],"label_agreement":null},{"id":"W2982244572","doi":"10.1093/eurheartj/ehz745.0466","title":"P3607Temporal trends in the characteristics, management, and clinical outcomes of patients with prior myocardial infarction who are admitted with an acute coronary syndrome","year":2019,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Mace; Acute coronary syndrome; Internal medicine; Myocardial infarction; Aspirin; Conventional PCI; Cardiology; Unstable angina; Ticagrelor; Percutaneous coronary intervention; Revascularization; Stroke (engine); Canadian Cardiovascular Society; Clopidogrel; Angina","score_opus":0.0189414813699794,"score_gpt":0.2822883810712945,"score_spread":0.2633468997013151,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982244572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99916,0.00007000128,0.000011335215,0.00014671244,0.000100444784,0.00025914572,0.00001846264,0.000011915733,0.00022199722],"genre_scores_gemma":[0.99881566,0.00016998134,0.00012453944,0.00056454475,0.000070933995,0.0000010131695,0.000050136907,0.000028629041,0.00017455609],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984293,0.0005061568,0.00032122323,0.00018776245,0.0003932451,0.00016233412],"domain_scores_gemma":[0.99932754,0.000024232284,0.00018233217,0.00027132605,0.00006499699,0.00012959413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062540534,0.00014437661,0.00047244158,0.00013187458,0.000067442474,0.000035500845,0.000086443324,0.000027275752,0.000055039873],"category_scores_gemma":[0.000006328968,0.00008008861,0.0001681681,0.00013164981,0.000089419234,0.00017272533,0.000026890137,0.0003165576,0.000007995354],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022559972,0.00028142967,0.9851031,0.00001752928,0.0012019131,0.00094290765,0.000093506525,8.623446e-7,6.861189e-7,0.0000020954174,0.00009636533,0.010003625],"study_design_scores_gemma":[0.0062814965,0.002874327,0.98741007,0.00017090472,0.00046424585,0.0011876923,0.00016879445,0.0000045542756,1.9386944e-7,8.246951e-7,0.0013311454,0.00010575919],"about_ca_topic_score_codex":0.0000013370212,"about_ca_topic_score_gemma":9.03074e-7,"teacher_disagreement_score":0.009897866,"about_ca_system_score_codex":0.000012502969,"about_ca_system_score_gemma":0.000019240282,"threshold_uncertainty_score":0.32659188},"labels":[],"label_agreement":null},{"id":"W2982456693","doi":"10.1016/j.jacc.2019.08.1038","title":"Ticagrelor Alone Versus Dual Antiplatelet Therapy From 1 Month After Drug-Eluting Coronary Stenting","year":2019,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":148,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Ticagrelor; Percutaneous coronary intervention; Clinical endpoint; Internal medicine; Myocardial infarction; Aspirin; Confidence interval; Revascularization; Randomized controlled trial; Cardiology","score_opus":0.010731861664318738,"score_gpt":0.2410117563086056,"score_spread":0.23027989464428686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982456693","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913198,0.0060365284,0.00004399724,0.00058335246,0.0010705632,0.00029716495,0.00008951712,0.00001149443,0.00054761715],"genre_scores_gemma":[0.99694234,0.0014217703,0.0003714234,0.00035883693,0.0007173405,0.0000029563448,0.000003786392,0.00003454135,0.00014699214],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99791133,0.00045011533,0.0006014377,0.0002164176,0.0005063571,0.0003143164],"domain_scores_gemma":[0.99796414,0.00037571776,0.00078370934,0.0005108908,0.00024703634,0.00011848119],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005376315,0.00021641854,0.0014808775,0.000112622925,0.000061178514,0.000005737913,0.0002568714,0.000068586094,0.000074700256],"category_scores_gemma":[0.00009020475,0.00013984206,0.0013800195,0.000285036,0.00040014036,0.00008621185,0.000102547325,0.00036662648,0.000012418676],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0719914,0.00018954328,0.8572407,0.00004938454,0.015746703,0.0039709527,0.00022752835,0.00093781244,0.023572296,0.000031300762,0.0031319805,0.022910442],"study_design_scores_gemma":[0.017739046,0.0023933183,0.9501765,0.00027036827,0.0012860721,0.0034597034,0.0027965684,0.00006951751,0.0039290064,0.000066926994,0.017488312,0.00032465652],"about_ca_topic_score_codex":0.000018738503,"about_ca_topic_score_gemma":0.0000011504291,"teacher_disagreement_score":0.09293585,"about_ca_system_score_codex":0.000059368493,"about_ca_system_score_gemma":0.00020919563,"threshold_uncertainty_score":0.57025933},"labels":[],"label_agreement":null},{"id":"W2982536055","doi":"10.1097/mca.0000000000000808","title":"Interaction of CYP2C19 G681A polymorphism and omeprazole on clopidogrel responsiveness and impact in patients with acute coronary syndrome","year":2019,"lang":"en","type":"article","venue":"Coronary Artery Disease","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Associated Medical Services","funders":"","keywords":"Clopidogrel; CYP2C19; Omeprazole; Medicine; Acute coronary syndrome; Percutaneous coronary intervention; Internal medicine; Mann–Whitney U test; Gastroenterology; Receiver operating characteristic; Logistic regression; Cardiology; Pharmacology; Aspirin; Myocardial infarction","score_opus":0.005555789960539086,"score_gpt":0.23305666089910537,"score_spread":0.22750087093856627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982536055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977156,0.0012259858,0.0000044747635,0.00007860383,0.00008595749,0.0007023186,0.00012422875,0.000023816763,0.000039037666],"genre_scores_gemma":[0.9991679,0.0002471382,0.00000901732,0.00023809438,0.000012472562,0.000018084284,0.00018079851,0.000029298924,0.00009719118],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99884605,0.00010265354,0.00020859044,0.00036120895,0.00027630615,0.00020516016],"domain_scores_gemma":[0.99913,0.000067552035,0.000080842656,0.00037530606,0.00005080746,0.0002954902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000081975835,0.00022055798,0.00041276135,0.0001975564,0.00003780625,0.000011430923,0.000051461095,0.000055237586,0.00011769238],"category_scores_gemma":[0.000009790008,0.00017306037,0.00013062416,0.00012354905,0.00011615786,0.0002940796,0.000043372507,0.00013121947,0.00001696256],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.041391023,0.0005925985,0.94784915,0.00012212868,0.00052346196,0.0014861347,0.000078122976,0.000030182548,0.00016453034,0.000011367698,0.000021290272,0.0077299955],"study_design_scores_gemma":[0.007115007,0.0025156643,0.98871374,0.00046710885,0.0003199691,0.00044280736,0.00007630971,0.000057412984,0.00002548622,0.000028703962,0.000046549198,0.00019124417],"about_ca_topic_score_codex":0.000005768996,"about_ca_topic_score_gemma":5.2191876e-7,"teacher_disagreement_score":0.040864576,"about_ca_system_score_codex":0.00005364743,"about_ca_system_score_gemma":0.00011171391,"threshold_uncertainty_score":0.7057197},"labels":[],"label_agreement":null},{"id":"W2983296520","doi":"10.1177/1715163519882464","title":"Review of the top 5 cardiology studies of 2017-18","year":2019,"lang":"en","type":"review","venue":"Canadian Pharmacists Journal / Revue des Pharmaciens du Canada","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Native Mental Health Association of Canada; University of British Columbia; Alberta Health Services","funders":"","keywords":"Cardiology; Internal medicine; Medicine; Medical physics","score_opus":0.1836614107938805,"score_gpt":0.396594444857836,"score_spread":0.21293303406395553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983296520","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003005236,0.99386525,0.0000026609189,0.00003204939,0.0028362693,0.0013247975,0.0009254538,0.0000066442144,0.0007063535],"genre_scores_gemma":[0.0012827584,0.99555117,0.0000132580835,0.0016204814,0.00085128436,0.000025078923,0.00006241767,0.000076370074,0.000517205],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960932,0.0007217599,0.0014426832,0.00042268907,0.0006047013,0.0007149306],"domain_scores_gemma":[0.9956812,0.00020916872,0.0011360748,0.00084796787,0.0011411869,0.0009843908],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010901464,0.0006204025,0.0043845447,0.00032198272,0.00026188183,0.000014026077,0.0008913079,0.00015576999,0.0005022239],"category_scores_gemma":[0.0004757491,0.00042048938,0.0028231472,0.00081994606,0.00051697966,0.000086695174,0.00009274992,0.000999919,0.000008251346],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002990416,0.000017408871,0.00006893615,0.24450375,0.007387364,0.011107417,0.000047346763,0.000011142084,0.000003551518,0.000007614422,0.08921824,0.6475973],"study_design_scores_gemma":[0.0006234226,0.000026296348,0.0000011393522,0.02586935,0.008222617,0.2565044,0.0000030350259,0.0000011770619,0.000012133482,0.0000030365502,0.7084647,0.00026869192],"about_ca_topic_score_codex":0.0013819376,"about_ca_topic_score_gemma":0.0009707328,"teacher_disagreement_score":0.6473287,"about_ca_system_score_codex":0.0015378211,"about_ca_system_score_gemma":0.01486084,"threshold_uncertainty_score":0.9998247},"labels":[],"label_agreement":null},{"id":"W2984201945","doi":"10.1093/eurheartj/ehz807","title":"Pharmacodynamics, pharmacokinetics, and safety of single-dose subcutaneous administration of selatogrel, a novel P2Y12 receptor antagonist, in patients with chronic coronary syndromes","year":2019,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"National Institutes of Health; Eisai; Idorsia Pharmaceuticals; British Heart Foundation; Osprey Medical; Daiichi-Sankyo; Medicines Company; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; CSL Behring; US WorldMeds; Ionis Pharmaceuticals; Abbott Vascular; Medicure; Gilead Sciences; Daiichi Sankyo Europe; Sanofi; ZonMw; Amgen; Pfizer","keywords":"Medicine; P2Y12; Pharmacodynamics; Pharmacokinetics; Placebo; Pharmacology; Antagonist; Platelet aggregation inhibitor; Platelet; Internal medicine; Anesthesia; Receptor; Platelet aggregation","score_opus":0.01332700713066531,"score_gpt":0.24809951303008348,"score_spread":0.23477250589941817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984201945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972169,0.0018259104,0.00006961403,0.000059801634,0.00013470408,0.00036836913,0.00005053285,0.0000114844,0.00026272424],"genre_scores_gemma":[0.99848676,0.0009397979,0.00028889402,0.000055185774,0.00008049923,3.931099e-7,0.000045518103,0.000039543123,0.000063394145],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99871576,0.0001565801,0.00041445295,0.00018100484,0.00034459724,0.00018760722],"domain_scores_gemma":[0.99935234,0.000031871296,0.00020054738,0.00015162362,0.000121993544,0.0001416411],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003141707,0.00015668907,0.0003869038,0.0001102085,0.000040026396,0.000012704432,0.00006552256,0.000029697547,0.00020805633],"category_scores_gemma":[0.0000099968975,0.00013090498,0.00012932639,0.00011815488,0.000115065566,0.00010473628,0.00002568288,0.0002518053,0.0000075951016],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015640942,0.00146609,0.91011536,0.0003673068,0.00082173274,0.00055008085,0.00022548622,0.000313063,0.057806272,0.000008319644,0.00012941562,0.012555948],"study_design_scores_gemma":[0.016201453,0.005459245,0.96642363,0.000710465,0.00024687863,0.004803862,0.000052061976,0.00020134571,0.002236076,8.6473943e-7,0.0034621763,0.00020191271],"about_ca_topic_score_codex":0.0000014533516,"about_ca_topic_score_gemma":6.432945e-7,"teacher_disagreement_score":0.056308318,"about_ca_system_score_codex":0.00006550343,"about_ca_system_score_gemma":0.00014203366,"threshold_uncertainty_score":0.533815},"labels":[],"label_agreement":null},{"id":"W2986994361","doi":"10.1016/j.ejim.2019.10.023","title":"Fifty years of research on antithrombotic therapy: Achievements and disappointments","year":2019,"lang":"en","type":"review","venue":"European Journal of Internal Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; Population Health Research Institute; McMaster University","funders":"","keywords":"Antithrombotic; Medicine; Intensive care medicine; Fibrinolytic agent; Internal medicine","score_opus":0.17780549620518774,"score_gpt":0.43525434021615356,"score_spread":0.2574488440109658,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986994361","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016753078,0.979382,0.000032601707,0.00006199899,0.00060542754,0.00045559052,0.000009366105,0.0000061794826,0.002693795],"genre_scores_gemma":[0.010615765,0.9876449,0.000040402065,0.00016799911,0.00092346966,9.125098e-7,0.0000075956336,0.000083794155,0.0005151663],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956611,0.0013768143,0.0011626922,0.00026898866,0.0012794249,0.00025100898],"domain_scores_gemma":[0.9978689,0.00032347065,0.00082427304,0.00044104728,0.00028040077,0.0002618889],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003449987,0.0003050061,0.0023086942,0.00068971515,0.00003030742,0.000013523606,0.0003958591,0.000063251064,0.00021089696],"category_scores_gemma":[0.00029370878,0.0001852824,0.0007580931,0.00026206562,0.0004006597,0.000055145905,0.00009760943,0.0010502508,0.00007573221],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006765514,0.0002399827,0.00015585909,0.0044758124,0.0033873466,0.0028476415,0.00015823211,2.964371e-7,0.00001960006,0.000017717162,0.0018268313,0.98619413],"study_design_scores_gemma":[0.004996159,0.0093790535,0.0034109908,0.13113898,0.0014418595,0.0021667273,0.00013863614,4.4975704e-7,0.000008749263,0.000008496917,0.84715855,0.0001513728],"about_ca_topic_score_codex":0.0000045377446,"about_ca_topic_score_gemma":5.29084e-8,"teacher_disagreement_score":0.98604274,"about_ca_system_score_codex":0.00006863378,"about_ca_system_score_gemma":0.000143092,"threshold_uncertainty_score":0.75555974},"labels":[],"label_agreement":null},{"id":"W2988101840","doi":"10.7326/acpj201911190-054","title":"Review: After PCI with DESs, long- and standard-term DAPT increase some adverse outcomes vs short-term DAPT","year":2019,"lang":"en","type":"letter","venue":"Annals of Internal Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Conventional PCI; Term (time); Internal medicine; Cardiology; Adverse effect; Myocardial infarction","score_opus":0.02536138645695432,"score_gpt":0.311679794570916,"score_spread":0.2863184081139617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988101840","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22502132,0.4430645,0.00019104673,0.3277622,0.00067480066,0.0020974348,0.00043113067,0.000100185236,0.00065738446],"genre_scores_gemma":[0.070040114,0.1350669,0.000040793668,0.789071,0.002852205,0.00008207791,0.00046500863,0.00016337712,0.002218475],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99563533,0.00022363145,0.0010954259,0.0008565255,0.0015438636,0.00064522505],"domain_scores_gemma":[0.99699,0.0002397607,0.000471809,0.0013316146,0.00060118665,0.00036562895],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00070634804,0.00091041793,0.0033228737,0.00037539736,0.000045566285,0.000016865897,0.000410069,0.00047264594,0.00092262594],"category_scores_gemma":[0.00025302984,0.00056430796,0.0008761154,0.00015169235,0.0007777993,0.00025895567,0.00016137144,0.0014159103,0.000034567252],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0084613515,0.00013060823,0.15920913,0.013718129,0.008060592,0.01682986,0.00013430933,3.103021e-7,0.000034304285,0.0000058274777,0.78219545,0.011220107],"study_design_scores_gemma":[0.009655619,0.005785103,0.109775744,0.12955658,0.009256136,0.0035369317,0.00006160005,0.0000032056823,0.00028508098,0.000055704448,0.73074764,0.0012806698],"about_ca_topic_score_codex":0.00015132752,"about_ca_topic_score_gemma":0.000011447096,"teacher_disagreement_score":0.46130887,"about_ca_system_score_codex":0.00004436504,"about_ca_system_score_gemma":0.00020675728,"threshold_uncertainty_score":0.99999064},"labels":[],"label_agreement":null},{"id":"W2988588188","doi":"10.1016/j.ahj.2019.10.001","title":"Average daily ischemic versus bleeding risk in patients with ACS undergoing PCI: Insights from the BleeMACS and RENAMI registries","year":2019,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta","funders":"","keywords":"Medicine; Conventional PCI; Prasugrel; Percutaneous coronary intervention; Myocardial infarction; Clopidogrel; Ticagrelor; Internal medicine; Cardiology; Acute coronary syndrome; Revascularization","score_opus":0.0075266352108390175,"score_gpt":0.22143794532209488,"score_spread":0.21391131011125586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988588188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99672896,0.002283009,0.000061289895,0.00026514102,0.00011889938,0.00017924016,0.000006584514,0.000016046351,0.00034085562],"genre_scores_gemma":[0.99716043,0.0020196552,0.00021007215,0.00037025978,0.00016950424,0.0000018883413,0.00001085594,0.000022805947,0.00003451135],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99883777,0.00012889634,0.00020405732,0.00021468595,0.0003880359,0.00022652981],"domain_scores_gemma":[0.9990433,0.00033289182,0.00016143445,0.000261428,0.00006475987,0.00013618641],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015151265,0.00015603472,0.00038300242,0.000058992122,0.00018174673,0.00006661481,0.00007983059,0.000034869303,0.00003217584],"category_scores_gemma":[0.00008864699,0.0000961328,0.00010905935,0.00022599942,0.00021193341,0.00017729083,0.000033558732,0.00047255904,0.000012099682],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025579575,0.000049104656,0.9905094,0.000008874305,0.00052446953,0.00003912656,0.0005545702,0.0000729484,0.00023656357,0.0000063563184,0.00051110063,0.0049295668],"study_design_scores_gemma":[0.010834109,0.0012104571,0.97518253,0.00045418928,0.00028549615,0.00011735567,0.0029342957,0.00004651216,0.0002684673,0.00003413131,0.008404006,0.00022845714],"about_ca_topic_score_codex":0.00022492892,"about_ca_topic_score_gemma":0.00003351261,"teacher_disagreement_score":0.015326838,"about_ca_system_score_codex":0.000065624234,"about_ca_system_score_gemma":0.00014357398,"threshold_uncertainty_score":0.39201817},"labels":[],"label_agreement":null},{"id":"W2989031263","doi":"10.15829/1560-4071-2019-10-22-28","title":"Association of T715P (RS6136), M62I (RS2228315), S290N (RS6131), V640L (RS6133) polymorphisms in the P-selectin gene and its ligand with acetylsalicylic acid resistance in patients with coronary artery disease after coronary artery bypass grafting","year":2019,"lang":"en","type":"article","venue":"Russian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Russian Foundation for Basic Research","keywords":"Medicine; Internal medicine; Coronary artery disease; Genotype; Artery; Arachidonic acid; Allele; Cardiology; Gastroenterology; Angina; Myocardial infarction; Gene; Biology; Genetics; Biochemistry","score_opus":0.00437649477436996,"score_gpt":0.19522424150149584,"score_spread":0.19084774672712587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989031263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869469,0.011135729,0.00007299896,0.0008275148,0.00012262864,0.0006717186,0.000037136688,0.000009655719,0.00017571378],"genre_scores_gemma":[0.9983607,0.0007305752,0.000108599095,0.00040556965,0.00021804628,0.000024236717,0.000029472767,0.000044368102,0.00007846224],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970964,0.0006667615,0.00070663134,0.00036091235,0.00069087243,0.00047838798],"domain_scores_gemma":[0.99853754,0.0001655092,0.0005824448,0.0003674085,0.00014467567,0.00020244217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009856519,0.00032657658,0.0011245232,0.00030216062,0.000055676144,0.00002008142,0.00018434146,0.00018507265,0.000014587997],"category_scores_gemma":[0.00006712593,0.00021265596,0.00030007958,0.00036690646,0.00011782173,0.0002741552,0.000032054097,0.0005483102,0.0000037741224],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016706,0.00015351055,0.97777975,0.000079375975,0.0014025914,0.0019524462,0.00045563345,0.000063846346,0.00073551876,0.000022845741,0.00005576132,0.0005927418],"study_design_scores_gemma":[0.010183452,0.0013344431,0.98538095,0.0005261588,0.00060802884,0.0009880014,0.00015646365,0.0000075063117,0.00027628345,0.0000724003,0.00022263211,0.00024366779],"about_ca_topic_score_codex":0.0000016617846,"about_ca_topic_score_gemma":0.000017691482,"teacher_disagreement_score":0.011413766,"about_ca_system_score_codex":0.00016430211,"about_ca_system_score_gemma":0.0002676355,"threshold_uncertainty_score":0.86718583},"labels":[],"label_agreement":null},{"id":"W2990805028","doi":"10.1055/s-0039-1700546","title":"Efficacy and Safety of Glycoprotein IIb/IIIa Inhibitors on Top of Ticagrelor in STEMI: A Subanalysis of the ATLANTIC Trial","year":2019,"lang":"en","type":"article","venue":"Thrombosis and Haemostasis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Southlake Regional Health Center; University of Toronto","funders":"","keywords":"Ticagrelor; Medicine; Internal medicine; Pharmacology; Cardiology; Acute coronary syndrome; Myocardial infarction","score_opus":0.021575855559217254,"score_gpt":0.27502797792594663,"score_spread":0.25345212236672937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2990805028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99759406,0.0010255041,0.0000045913434,0.00023438035,0.00004240883,0.000904331,0.000020253485,0.0000050015274,0.00016948048],"genre_scores_gemma":[0.99839026,0.0014668168,0.00003633157,0.00003712659,0.000025198617,0.000005683462,0.000006064008,0.0000115658,0.000020926054],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99877733,0.00011700965,0.00045064697,0.00021000906,0.00031631393,0.00012871274],"domain_scores_gemma":[0.99919605,0.00013120596,0.00017978324,0.00038780383,0.00005229067,0.00005283688],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036095647,0.00013320871,0.00083462,0.000107192616,0.000028449007,0.000004275874,0.0000700566,0.00008677979,0.000090717745],"category_scores_gemma":[0.00005990672,0.00008564059,0.000306415,0.00032577888,0.00017793756,0.00003079599,0.000049125832,0.00009471,0.0000011840083],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.117782295,0.0023611,0.66242063,0.0023538545,0.005862902,0.000009573395,0.0032108964,0.00007390319,0.04312291,0.0013660426,0.00014943047,0.16128649],"study_design_scores_gemma":[0.08894784,0.0019318472,0.80775696,0.0018622003,0.0022066084,0.000008936364,0.0009215963,0.00006391636,0.09566296,0.000067288165,0.0003230967,0.0002467766],"about_ca_topic_score_codex":0.0003669436,"about_ca_topic_score_gemma":0.000020911766,"teacher_disagreement_score":0.16103971,"about_ca_system_score_codex":0.000014670176,"about_ca_system_score_gemma":0.000046576,"threshold_uncertainty_score":0.3492322},"labels":[],"label_agreement":null},{"id":"W2991077341","doi":"10.1016/j.ijcard.2019.11.132","title":"Comparative external validation of the PRECISE-DAPT and PARIS risk scores in 4424 acute coronary syndrome patients treated with prasugrel or ticagrelor","year":2019,"lang":"en","type":"article","venue":"International Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Terumo; Medicure; AstraZeneca; Abbott Laboratories","keywords":"Prasugrel; Medicine; Ticagrelor; Acute coronary syndrome; Conventional PCI; Percutaneous coronary intervention; Interquartile range; Internal medicine; Aspirin; Cardiology; Clopidogrel; Coronary stent; Stent; Myocardial infarction","score_opus":0.011476173065007202,"score_gpt":0.2687748169513812,"score_spread":0.257298643886374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2991077341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983222,0.00057307165,0.00037687973,0.00006282953,0.00024227412,0.00027956063,0.000038612066,0.0000032224252,0.00010134405],"genre_scores_gemma":[0.9988499,0.000844116,0.00012822694,0.0000358158,0.000058182377,0.0000036438853,0.000010791922,0.000008685484,0.000060611106],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987405,0.00023295863,0.0003705237,0.00012532754,0.00043439277,0.0000963274],"domain_scores_gemma":[0.99887127,0.00013556737,0.00038965518,0.00012323931,0.0004306563,0.000049597948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021459251,0.00011184809,0.0005360922,0.000127822,0.00001667011,0.00000867241,0.00014960425,0.00006521688,0.000041749397],"category_scores_gemma":[0.000042183114,0.000059964557,0.00020031925,0.000079752426,0.00013385055,0.000119478325,0.00003965624,0.00019726908,0.0000038082158],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007081634,0.00007700043,0.9860458,0.000009293515,0.0031610976,0.0003073808,0.0001484005,0.001060334,0.0003517223,0.00000873302,0.00004159048,0.0017070634],"study_design_scores_gemma":[0.0055963006,0.0013297887,0.98663455,0.0003303858,0.00048226578,0.0038204133,0.00006522892,0.00006754,0.0014388391,0.000047608577,0.0001206189,0.000066480956],"about_ca_topic_score_codex":0.000009707205,"about_ca_topic_score_gemma":0.0000014436204,"teacher_disagreement_score":0.0035130326,"about_ca_system_score_codex":0.000054723667,"about_ca_system_score_gemma":0.00010251854,"threshold_uncertainty_score":0.24452837},"labels":[],"label_agreement":null},{"id":"W2992535809","doi":"10.1111/jocs.14371","title":"When is the optimal time to discontinue clopidogrel before in‐hospital coronary bypass surgery? A closer look at the current literature","year":2019,"lang":"en","type":"review","venue":"Journal of Cardiac Surgery","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Clopidogrel; Discontinuation; Bypass grafting; Coronary artery bypass surgery; Artery; Cardiology; Intensive care medicine; Internal medicine; Myocardial infarction","score_opus":0.01672315814840444,"score_gpt":0.28039334950160916,"score_spread":0.26367019135320474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2992535809","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01156874,0.98149276,0.0000019447418,0.0016334099,0.0035642069,0.0012222232,0.00039472518,0.000015212327,0.00010679572],"genre_scores_gemma":[0.0002483882,0.993404,0.000008295017,0.00042493021,0.0032711914,0.000075499076,0.00024973653,0.00013615297,0.0021818443],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9946242,0.0011459327,0.0017344145,0.0004945549,0.0013452264,0.0006556935],"domain_scores_gemma":[0.9950651,0.0019376981,0.0011438257,0.0011396663,0.00036277864,0.00035095887],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0031970362,0.0007833866,0.005565718,0.0004889788,0.00013397996,0.00012898813,0.00042919684,0.00038179776,0.00038924647],"category_scores_gemma":[0.000301525,0.00038094266,0.01402348,0.00063641806,0.00016348016,0.00025172718,0.00023248536,0.0017022162,0.0004061213],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022132558,0.00010848308,0.0021188667,0.002238689,0.0034046972,0.0004701966,0.00032924823,0.0000010367588,1.1571115e-7,5.4486054e-7,0.3069696,0.68413717],"study_design_scores_gemma":[0.00019358314,0.000107065964,0.0025139353,0.027322894,0.0045608487,0.0013375262,0.000029302473,4.7215173e-7,0.0000011116708,0.000007321452,0.9635263,0.0003996288],"about_ca_topic_score_codex":0.0000020204636,"about_ca_topic_score_gemma":4.7405362e-7,"teacher_disagreement_score":0.6837375,"about_ca_system_score_codex":0.00033814562,"about_ca_system_score_gemma":0.001431292,"threshold_uncertainty_score":0.9998642},"labels":[],"label_agreement":null},{"id":"W2992535931","doi":"10.1177/0003319719889524","title":"Outcome of Patients With Prior Stroke/Transient Ischemic Attack and Acute Coronary Syndromes","year":2019,"lang":"en","type":"article","venue":"Angiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta","funders":"Capital Health Research and Development of Special Fund","keywords":"Medicine; Stroke (engine); Internal medicine; Acute coronary syndrome; Antithrombotic; Odds ratio; Percutaneous coronary intervention; Cardiology; Confidence interval; Myocardial infarction","score_opus":0.01005147118098528,"score_gpt":0.24662342287517697,"score_spread":0.23657195169419168,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2992535931","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99797285,0.0011107792,0.000025664955,0.000048488226,0.00005256372,0.0003090374,0.000035061268,0.000016482718,0.00042904692],"genre_scores_gemma":[0.99898505,0.00014647536,0.00011359039,0.00021693639,0.000009732485,0.0000048416923,0.00006382893,0.0000120482555,0.00044747832],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99942094,0.000024126512,0.0001358915,0.0001743544,0.000102371436,0.00014229903],"domain_scores_gemma":[0.9996352,0.000024608622,0.00003898956,0.00020041737,0.000043615626,0.000057168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004354343,0.00009782499,0.00037030253,0.000038549413,0.0000146167185,0.0000012883468,0.000039641764,0.00007009437,0.00013252306],"category_scores_gemma":[0.0000035698872,0.00006777089,0.00013468463,0.0000383936,0.00009939642,0.000033785953,0.000017940223,0.00006203894,0.000022378203],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009214923,0.00007974839,0.9946784,0.000061355764,0.0011170394,0.000036015066,0.0000524772,0.0000016760889,0.0006677273,0.000008838875,0.00021263007,0.0021625983],"study_design_scores_gemma":[0.0036882674,0.0009128136,0.9905304,0.000025114818,0.0003949225,0.00010633916,0.00003733933,0.0000028229344,0.00026111698,9.606583e-7,0.0039612027,0.00007871162],"about_ca_topic_score_codex":0.0000028122383,"about_ca_topic_score_gemma":5.512281e-7,"teacher_disagreement_score":0.004148013,"about_ca_system_score_codex":0.000007073103,"about_ca_system_score_gemma":0.000018899402,"threshold_uncertainty_score":0.27636167},"labels":[],"label_agreement":null},{"id":"W2992943043","doi":"","title":"Aspirin resistance and its implications in clinical practice.","year":2005,"lang":"en","type":"article","venue":"PubMed","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Aspirin; Medicine; Clinical Practice; Intensive care medicine; Resistance (ecology); Internal medicine; Family medicine","score_opus":0.04195375588700834,"score_gpt":0.32836002544332266,"score_spread":0.2864062695563143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2992943043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9363475,0.022329388,0.000054315376,0.018552825,0.00004714078,0.00084424095,0.0000054820634,0.000051018167,0.021768132],"genre_scores_gemma":[0.993143,0.0025321594,0.00032713282,0.0019802281,0.00022655271,0.0003818082,0.0000052413925,0.000008578869,0.0013952818],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.999278,0.0000646221,0.0002156829,0.00017769955,0.000102328275,0.00016164915],"domain_scores_gemma":[0.9994903,0.00010385808,0.00003951943,0.00018831983,0.000043949585,0.00013404645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006077569,0.00005583503,0.00015928358,0.00003556016,0.000025965846,0.000009503811,0.000035777826,0.000052370935,0.000009570681],"category_scores_gemma":[0.00046527255,0.00005045445,0.00008576191,0.00010727444,0.000031312855,0.000120842284,0.000014202467,0.00011335807,0.000016134687],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041914257,0.00032061784,0.040111963,0.00003195276,0.00016654712,0.00003778,0.000033173106,0.0000017084367,0.000009575658,0.0028239614,0.0014595586,0.954584],"study_design_scores_gemma":[0.00093879376,0.000006076999,0.67275196,0.000007342973,0.00005482708,0.000027063083,0.000012521715,0.0000030912383,0.00003381647,0.000045829394,0.32607913,0.00003951517],"about_ca_topic_score_codex":0.0000011396082,"about_ca_topic_score_gemma":0.000014885746,"teacher_disagreement_score":0.9545445,"about_ca_system_score_codex":0.000022475713,"about_ca_system_score_gemma":0.000025904445,"threshold_uncertainty_score":0.20574728},"labels":[],"label_agreement":null},{"id":"W2994251220","doi":"10.1161/circinterventions.118.007019","title":"Impact of Platelet Endothelial Aggregation Receptor-1 Genotypes on Platelet Reactivity and Early Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary Intervention and Treated With Aspirin and Clopidogrel","year":2019,"lang":"en","type":"article","venue":"Circulation Cardiovascular Interventions","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute","funders":"Government of Jiangsu Province","keywords":"Medicine; Clopidogrel; Percutaneous coronary intervention; Aspirin; Internal medicine; Myocardial infarction; Cardiology; Acute coronary syndrome; Hazard ratio; Prospective cohort study; Coronary artery disease; Platelet; Gastroenterology; Confidence interval","score_opus":0.012782030938839107,"score_gpt":0.2485580620206637,"score_spread":0.23577603108182457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994251220","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914462,0.006319491,0.00049189874,0.000008729751,0.00007487246,0.0014543531,0.000071416325,0.000056290497,0.00007674859],"genre_scores_gemma":[0.99877036,0.0007978684,0.00009619005,0.000007085877,0.000029724592,0.00003152977,0.00018307084,0.000054837685,0.000029320627],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99757266,0.00035997614,0.00054539694,0.0006493411,0.0006062077,0.0002664374],"domain_scores_gemma":[0.99878055,0.00010509465,0.00018172713,0.00060844346,0.000184363,0.00013980594],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00057045574,0.00036121666,0.0011604456,0.00041962657,0.00009689965,0.000052192576,0.000059781112,0.00019709335,0.00003419381],"category_scores_gemma":[0.00007869582,0.00031024555,0.002281031,0.00024430864,0.0001425583,0.00032918528,0.00005242936,0.00024585082,0.000007256743],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009817809,0.00038727588,0.8903885,0.00049443624,0.010783913,0.000058500853,0.00016100986,0.0020429033,0.00021134323,0.000033369164,0.0000011045181,0.094455875],"study_design_scores_gemma":[0.009798018,0.0018316755,0.9848084,0.0012702096,0.0010911567,0.0003661689,0.000085842956,0.00014392918,0.00020612573,0.000031159976,0.0000646822,0.00030263123],"about_ca_topic_score_codex":0.0004310367,"about_ca_topic_score_gemma":0.000022229528,"teacher_disagreement_score":0.09441992,"about_ca_system_score_codex":0.0001935705,"about_ca_system_score_gemma":0.0000449987,"threshold_uncertainty_score":0.999935},"labels":[],"label_agreement":null},{"id":"W2994677882","doi":"10.1002/ccd.28649","title":"Impact of established cardiovascular disease on outcomes in the randomized global leaders trial","year":2019,"lang":"en","type":"article","venue":"Catheterization and Cardiovascular Interventions","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Medicine; Randomized controlled trial; Disease; Intensive care medicine; MEDLINE; Physical therapy; Internal medicine","score_opus":0.031192734950124968,"score_gpt":0.31854898141825705,"score_spread":0.28735624646813207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994677882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9815557,0.010513062,0.003933093,0.000083452964,0.00023512007,0.0028604364,0.000068022,0.00003779659,0.00071329414],"genre_scores_gemma":[0.9985009,0.0009009979,0.000019519928,0.00008734468,0.00005653094,0.00019852372,0.00013801495,0.000022403117,0.000075786644],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9971043,0.00093436555,0.00054981705,0.0004301421,0.0007485061,0.00023289952],"domain_scores_gemma":[0.99837095,0.000089256,0.000088360226,0.0012108807,0.00010835537,0.00013220272],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0016237365,0.0002684178,0.0014542313,0.00016684823,0.00006179839,0.000053930766,0.0001658375,0.000079927864,0.00011412567],"category_scores_gemma":[0.00028020845,0.00016897518,0.015725601,0.00039066156,0.00023891711,0.00013388749,0.000034319164,0.0001436516,0.000016656157],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.51513386,0.00619317,0.2317654,0.0020269332,0.16796981,0.00039457763,0.0017269726,0.026873777,0.0000631983,0.005826719,0.00018948573,0.041836116],"study_design_scores_gemma":[0.70252633,0.0012120915,0.28251114,0.0006924255,0.010044981,0.000088511035,0.0008436872,0.0004583564,0.000015127064,0.00029934483,0.00084821554,0.00045977178],"about_ca_topic_score_codex":0.00007064904,"about_ca_topic_score_gemma":9.827639e-7,"teacher_disagreement_score":0.1873925,"about_ca_system_score_codex":0.00006168038,"about_ca_system_score_gemma":0.00008881235,"threshold_uncertainty_score":0.9941317},"labels":[],"label_agreement":null},{"id":"W2994867355","doi":"10.4212/cjhp.v72i6.2947","title":"For Patients Needing Oral Anticoagulation for Atrial Fibrillation and Dual Antiplatelet Therapy after Percutaneous Coronary Intervention, Is Double Therapy Preferred over Triple Therapy?","year":2019,"lang":"en","type":"article","venue":"The Canadian Journal of Hospital Pharmacy","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Percutaneous coronary intervention; Atrial fibrillation; Intervention (counseling); Cardiology; Internal medicine; Surgery; Myocardial infarction","score_opus":0.024890294808176158,"score_gpt":0.2907226912438612,"score_spread":0.265832396435685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994867355","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9833822,0.012136927,0.000046234338,0.0007015721,0.0012091858,0.0023998418,0.00009957515,0.00001067167,0.00001379087],"genre_scores_gemma":[0.9960142,0.002393662,0.00006379141,0.00045574445,0.0008274451,0.000008256301,0.0000715137,0.00005042837,0.00011497041],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986972,0.00006058316,0.0004411768,0.00020316233,0.00028403223,0.0003138096],"domain_scores_gemma":[0.99883413,0.00007340453,0.00026392148,0.00016254545,0.00041272398,0.00025329352],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004126959,0.00022459067,0.00041743796,0.0001558055,0.00022003482,0.00012499577,0.000104412466,0.00007579474,0.00026343405],"category_scores_gemma":[0.000019985819,0.00015727527,0.0007869958,0.000106687505,0.000079322155,0.00040572634,0.000007919703,0.00013976518,0.000002666981],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.060816366,0.00016491141,0.7255913,0.00008283076,0.003482048,0.00006486111,0.0030528503,0.00011810803,0.0009770212,0.000032592725,0.0026618447,0.20295523],"study_design_scores_gemma":[0.18891019,0.016039213,0.6312484,0.00038287148,0.00084081874,0.00096895586,0.0005176957,0.0023328278,0.00391362,0.0011098663,0.15270795,0.0010276075],"about_ca_topic_score_codex":0.00046320408,"about_ca_topic_score_gemma":0.000064673375,"teacher_disagreement_score":0.20192763,"about_ca_system_score_codex":0.0000916186,"about_ca_system_score_gemma":0.00026743943,"threshold_uncertainty_score":0.6413499},"labels":[],"label_agreement":null},{"id":"W2995308085","doi":"10.1093/ehjcvp/pvz052","title":"Impact of chronic obstructive pulmonary disease and dyspnoea on clinical outcomes in ticagrelor treated patients undergoing percutaneous coronary intervention in the randomized GLOBAL LEADERS trial","year":2019,"lang":"en","type":"article","venue":"European Heart Journal - Cardiovascular Pharmacotherapy","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Southlake Regional Health Center","funders":"Daiichi Sankyo Europe; Medicure; Medicines Company; Amgen; Biosensors International Group; AstraZeneca","keywords":"Medicine; Internal medicine; Ticagrelor; Percutaneous coronary intervention; COPD; Hazard ratio; Conventional PCI; Myocardial infarction; Clinical endpoint; Cardiology; Randomized controlled trial; Confidence interval","score_opus":0.03449033274264302,"score_gpt":0.3542081879002301,"score_spread":0.3197178551575871,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995308085","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9822627,0.014489489,0.000032620857,0.00008233403,0.0003831978,0.0024277566,0.000021811138,0.00002051374,0.00027961135],"genre_scores_gemma":[0.9920215,0.0073166643,0.000014433516,0.0002380059,0.00030002242,0.000011443293,0.000022420312,0.00005279381,0.000022696197],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99149513,0.005920844,0.0009955398,0.0004373546,0.00078328437,0.00036786398],"domain_scores_gemma":[0.99852335,0.0004822496,0.0001970888,0.00045515038,0.00009286366,0.00024927923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034068453,0.00036207237,0.0015457482,0.00018620757,0.000073511575,0.000043917546,0.00018606053,0.00006796143,0.00011090358],"category_scores_gemma":[0.00017894866,0.00022787291,0.005523641,0.00025104254,0.00026764057,0.00016639082,0.000028840203,0.0006106452,0.00002205403],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.36311337,0.0015855863,0.58442146,0.00006516862,0.008809666,0.00220671,0.0001757137,0.0010337383,0.00004582931,0.0000038054063,0.000024652669,0.038514297],"study_design_scores_gemma":[0.34389305,0.0017724553,0.65163255,0.0002386931,0.0008986848,0.0009603142,0.000115345276,0.00015978747,0.000003105681,0.000021665926,0.0001308389,0.00017351874],"about_ca_topic_score_codex":0.000031120646,"about_ca_topic_score_gemma":0.0000010941441,"teacher_disagreement_score":0.0672111,"about_ca_system_score_codex":0.00031257546,"about_ca_system_score_gemma":0.00016362924,"threshold_uncertainty_score":0.92923874},"labels":[],"label_agreement":null},{"id":"W2995986946","doi":"10.1016/j.cjca.2019.12.013","title":"A Critical Comparison of Canadian and International Guidelines Recommendations for Antiplatelet Therapy in Coronary Artery Disease","year":2019,"lang":"en","type":"review","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Royal Jubilee Hospital; University of British Columbia; McMaster University; Population Health Research Institute; Université de Montréal; University of Toronto; Hamilton Health Sciences; Hamilton General Hospital; Southlake Regional Health Center; Montreal Heart Institute","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Coronary artery disease; Cardiology; Internal medicine; Disease; Intensive care medicine","score_opus":0.18503583587536232,"score_gpt":0.41665139169893545,"score_spread":0.23161555582357313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995986946","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00063066115,0.9938878,0.00015247823,0.002607692,0.0011474872,0.00056196377,0.0008000044,0.00000204345,0.0002098671],"genre_scores_gemma":[0.020692397,0.977583,0.00024276403,0.00027239646,0.00078230014,0.000018194434,0.00033441756,0.000033896886,0.00004061642],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99816,0.00020880841,0.0009978511,0.00020993849,0.00010705056,0.000316325],"domain_scores_gemma":[0.99779105,0.0002788815,0.0002453106,0.00022193043,0.0005575419,0.00090527005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004912472,0.00023431356,0.0022179957,0.0017140809,0.000049394657,0.000018502918,0.0001966779,0.00025936132,0.000047719877],"category_scores_gemma":[0.00053032854,0.00019881678,0.0009832833,0.00019504734,0.00018797793,0.00007611935,0.000008581157,0.00033200646,0.0000023232824],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001930944,0.000009306091,0.009931443,0.0013103381,0.0021259778,0.0005152409,0.000043082713,0.00002833391,2.8363968e-7,0.00018716186,0.024516344,0.9611394],"study_design_scores_gemma":[0.0012145863,0.0002473422,0.0021439106,0.0034011614,0.00096958794,0.0016187795,0.00007658358,0.000012765161,1.2669301e-7,0.00008438295,0.9900717,0.00015906342],"about_ca_topic_score_codex":0.0020494119,"about_ca_topic_score_gemma":0.007830518,"teacher_disagreement_score":0.96555537,"about_ca_system_score_codex":0.0001778527,"about_ca_system_score_gemma":0.005687561,"threshold_uncertainty_score":0.9999493},"labels":[],"label_agreement":null},{"id":"W2996052135","doi":"10.15420/ecr.2019.14.3.ge1","title":"Personalised Approaches to Improving the Effect of Anti-platelet Agents: Where Do We Stand?","year":2019,"lang":"en","type":"review","venue":"European Cardiology Review","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Heart and Stroke Foundation; University of Toronto","funders":"","keywords":"Clopidogrel; CYP2C19; P2Y12; Pharmacology; Platelet; Drug; Cytochrome P450; Medicine; Internal medicine; Myocardial infarction; Metabolism","score_opus":0.10869964994137195,"score_gpt":0.31121510340031255,"score_spread":0.20251545345894062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996052135","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000044228585,0.9895166,0.000056844587,0.00016257909,0.00034863866,0.0056439186,0.0001319629,0.00006624079,0.00402897],"genre_scores_gemma":[0.00007796068,0.99818313,0.00002032913,0.00019454285,0.00066018256,0.0001257255,0.000108504,0.00019466066,0.00043494924],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9905868,0.0065148086,0.001050527,0.0009208964,0.00042941413,0.0004975468],"domain_scores_gemma":[0.99686,0.00038097907,0.0005594033,0.0019170303,0.00006860139,0.0002139557],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0039808666,0.0008573326,0.007676278,0.00012458499,0.0000988192,0.000024984773,0.00069606263,0.00021749422,0.0001339232],"category_scores_gemma":[0.0002595613,0.00045175935,0.0055275587,0.00047805763,0.00020006247,0.000042901876,0.00027441714,0.00073854416,0.0008064616],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003423639,0.000008245348,0.00002864074,0.25855285,0.0034874643,0.00033996013,0.000018894738,0.0000016860595,4.6220842e-7,0.0000072153134,0.006890401,0.7306299],"study_design_scores_gemma":[0.0006342582,0.00043541682,0.000026151469,0.13808335,0.014091141,0.00135393,0.000011230189,2.9931175e-7,7.485864e-7,1.4544732e-7,0.8450162,0.0003471361],"about_ca_topic_score_codex":9.733974e-7,"about_ca_topic_score_gemma":3.5340307e-8,"teacher_disagreement_score":0.83812577,"about_ca_system_score_codex":0.00007468153,"about_ca_system_score_gemma":0.00020844176,"threshold_uncertainty_score":0.9999715},"labels":[],"label_agreement":null},{"id":"W2996361566","doi":"10.4244/eij-d-19-00699","title":"Ticagrelor monotherapy beyond one month after PCI in ACS or stable CAD in elderly patients: a pre-specified analysis of the GLOBAL LEADERS trial","year":2020,"lang":"en","type":"article","venue":"EuroIntervention","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Biosensors International Group; Université Paris Diderot; Prince of Songkla University; Warszawski Uniwersytet Medyczny; Medicines Company; Assistance publique-Hôpitaux de Paris; National University of Ireland; Uniwersytet Warszawski; University of Toronto; Inselspital, Universitätsspital Bern; Erasmus Medisch Centrum; University of Bern; Universidade Estadual de Campinas; University of Galway; Amsterdam University Medical Centers; AstraZeneca","keywords":"Ticagrelor; Medicine; Hazard ratio; Conventional PCI; Percutaneous coronary intervention; Internal medicine; Aspirin; Clinical endpoint; Myocardial infarction; Confidence interval; Subgroup analysis; Randomized controlled trial; Cardiology","score_opus":0.03743980579532649,"score_gpt":0.2839659076828398,"score_spread":0.2465261018875133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996361566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99679965,0.00087041705,0.0006319559,0.0005723991,0.00008196538,0.00083482644,0.000056122357,0.000017521239,0.00013514416],"genre_scores_gemma":[0.9992993,0.00010367008,0.000035468896,0.0003107641,0.00004771447,0.00001579419,0.000042406817,0.000014065617,0.00013084618],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984385,0.0002408988,0.00050975557,0.00027689637,0.000355431,0.00017852717],"domain_scores_gemma":[0.9994617,0.000019962883,0.00012802813,0.0002711728,0.000052671883,0.000066433146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019173094,0.00013498809,0.00048490326,0.00011215196,0.000016654367,0.000014924654,0.000113972565,0.0000623491,0.00033581987],"category_scores_gemma":[0.00008879039,0.000098134304,0.00079789996,0.001087908,0.00005974919,0.0001032257,0.00002870151,0.00012994689,0.0000049833284],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.37065247,0.003516923,0.5911987,0.00030218673,0.0045154765,0.00009719696,0.0029821785,0.00056945736,0.00021589176,0.00006811757,0.00028956996,0.025591826],"study_design_scores_gemma":[0.04816972,0.0019627323,0.9466808,0.00023693303,0.001096012,0.0000010373841,0.00037693005,0.0004172859,0.00035535154,0.000036846937,0.0005360555,0.000130316],"about_ca_topic_score_codex":0.00012525388,"about_ca_topic_score_gemma":0.0005708471,"teacher_disagreement_score":0.35548207,"about_ca_system_score_codex":0.00008612126,"about_ca_system_score_gemma":0.00004049769,"threshold_uncertainty_score":0.40018007},"labels":[],"label_agreement":null},{"id":"W2996641914","doi":"10.1016/j.amjcard.2019.11.033","title":"Comparison of Age (&lt;75 Years Vs ≥75 Years) and Platelet Reactivity to the Risk of Thrombotic and Bleeding Events After Successful Percutaneous Coronary Intervention With Drug-Eluting Stents (from the ADAPT-DES Study)","year":2019,"lang":"en","type":"article","venue":"The American Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Sacré-Cœur de Montréal","funders":"OrbusNeich; Bristol-Myers Squibb; AstraZeneca; CSL Behring; Cardiovascular Systems; Bayer Fund; Medicines Company; Boston Scientific Corporation; Novartis Pharmaceuticals Corporation; Center for Social Inclusion; Medtronic; Abbott Laboratories","keywords":"Medicine; Percutaneous coronary intervention; Internal medicine; Clopidogrel; Cardiology; Myocardial infarction; Proportional hazards model; Coronary artery disease","score_opus":0.012402047781545935,"score_gpt":0.2723612107590719,"score_spread":0.25995916297752597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996641914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99703497,0.0022681162,0.00012891949,0.000079548765,0.00007860203,0.0003731539,0.000016763357,0.000003955097,0.00001599958],"genre_scores_gemma":[0.9992091,0.0005594114,0.000053236265,0.000049583337,0.00010218056,0.0000024874641,0.0000013116655,0.000016347201,0.000006322583],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981652,0.00086685404,0.0003440489,0.00015153822,0.00031211923,0.00016027095],"domain_scores_gemma":[0.9986149,0.0004087707,0.00054368,0.00028759512,0.00008373627,0.00006133017],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010198402,0.00013049228,0.00091870315,0.000050517763,0.000058186168,0.000009621799,0.00018223877,0.000024112625,0.0000066547764],"category_scores_gemma":[0.00004771561,0.00006550659,0.00025338182,0.0001258157,0.00048722333,0.000057693644,0.00009909687,0.00029357232,0.000001028791],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044686664,0.0000732657,0.9499214,0.000016746491,0.0030313379,0.0001900561,0.0043535116,0.0005926759,0.0011499752,6.8337323e-7,0.000016375912,0.036185246],"study_design_scores_gemma":[0.0011932341,0.0029293858,0.97360957,0.00022826668,0.0012103417,0.0013391762,0.01924323,0.000029788138,0.000057755555,0.000022438102,0.00006738665,0.000069439404],"about_ca_topic_score_codex":0.0002603848,"about_ca_topic_score_gemma":0.000017226059,"teacher_disagreement_score":0.036115807,"about_ca_system_score_codex":0.000024701556,"about_ca_system_score_gemma":0.00002300657,"threshold_uncertainty_score":0.2671281},"labels":[],"label_agreement":null},{"id":"W2998969873","doi":"10.1016/j.acvdsp.2019.09.025","title":"Frequency, management and outcomes of patients with stable coronary artery disease eligible for COMPASS. An analysis of the CLARIFY Registry","year":2020,"lang":"en","type":"article","venue":"Archives of Cardiovascular Diseases Supplements","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Medicine; Compass; Coronary artery disease; Internal medicine; Cardiology; Disease; Cartography","score_opus":0.009179862163962913,"score_gpt":0.22887200701809343,"score_spread":0.21969214485413052,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2998969873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9828651,0.0062909354,0.0041920855,0.000095987445,0.000026033213,0.001648412,0.004800179,0.000019519866,0.000061726525],"genre_scores_gemma":[0.9961797,0.0006388644,0.001241054,0.00015015203,0.00001816011,0.00008569343,0.001641735,0.000032469983,0.0000121869625],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99769276,0.00016646195,0.0004942821,0.00047406423,0.00090653927,0.0002658968],"domain_scores_gemma":[0.99807405,0.00007224673,0.00022311772,0.001138227,0.00011694493,0.00037543004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009929401,0.0002673418,0.0012313057,0.00016445335,0.00008584131,0.000010449417,0.0002913502,0.00004111546,0.000036666235],"category_scores_gemma":[0.000030791034,0.00018653812,0.0023790225,0.0003522217,0.00036000216,0.0001268787,0.00014240165,0.00008823069,1.5957274e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019253129,0.0006750385,0.9243389,0.0011271412,0.06686398,0.000020079713,0.0001460965,0.0016264721,0.00002051348,0.0001702765,0.00004714743,0.003039042],"study_design_scores_gemma":[0.006067493,0.0002684756,0.94812083,0.000092417904,0.043402925,6.6490117e-7,0.00024730442,0.00036388432,0.00017075076,0.00015636644,0.0009281305,0.0001807304],"about_ca_topic_score_codex":0.000032807446,"about_ca_topic_score_gemma":0.0000030377496,"teacher_disagreement_score":0.023781953,"about_ca_system_score_codex":0.000012115231,"about_ca_system_score_gemma":0.00008042143,"threshold_uncertainty_score":0.7606804},"labels":[],"label_agreement":null},{"id":"W2999002463","doi":"10.1038/s41569-019-0314-y","title":"Dual-pathway inhibition for secondary and tertiary antithrombotic prevention in cardiovascular disease","year":2020,"lang":"en","type":"review","venue":"Nature Reviews Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":121,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Thrombosis and Atherosclerosis Research Institute; McMaster University; Population Health Research Institute; Hamilton General Hospital","funders":"","keywords":"Medicine; Antithrombotic; Disease; Coronary artery disease; Antiplatelet drug; Vitamin K antagonist; Cilostazol; Intensive care medicine; Internal medicine; Cardiology; Myocardial infarction; Aspirin; Clopidogrel; Warfarin; Atrial fibrillation","score_opus":0.030286052164723225,"score_gpt":0.3210851552692832,"score_spread":0.29079910310456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2999002463","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000032514276,0.9913168,0.0005515835,0.00008724472,0.00042751836,0.0071414285,0.00020618463,0.00006829003,0.00016842467],"genre_scores_gemma":[0.0001763066,0.99450666,0.00028638076,0.00032988845,0.0013359693,0.0011718955,0.0020342092,0.000115234725,0.00004346268],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955082,0.0014288152,0.0010710399,0.0012500463,0.0002920092,0.00044987758],"domain_scores_gemma":[0.99820745,0.0001403545,0.00028855714,0.0009362542,0.000077042096,0.00035032068],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013372652,0.0007607293,0.007692983,0.00029875245,0.00007980451,0.000023575732,0.000108838496,0.0012723159,0.000018413324],"category_scores_gemma":[0.00044404832,0.0005868553,0.0072594443,0.00041138878,0.00014461923,0.00011484565,0.00010288991,0.0015253797,0.000032192347],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006556693,0.000035128265,0.000037873622,0.059362542,0.0035959005,0.0011115808,0.000008003201,9.71295e-7,0.0000010484688,0.00009959808,0.000679824,0.93500197],"study_design_scores_gemma":[0.001579924,0.00014588806,0.00043501903,0.019485755,0.013975441,0.001474154,0.000004890553,0.0000023777736,7.8415553e-7,0.00015073913,0.96225303,0.0004920183],"about_ca_topic_score_codex":0.0000011294389,"about_ca_topic_score_gemma":7.8047736e-7,"teacher_disagreement_score":0.9615732,"about_ca_system_score_codex":0.00014861769,"about_ca_system_score_gemma":0.0007676224,"threshold_uncertainty_score":0.9996583},"labels":[],"label_agreement":null},{"id":"W2999271152","doi":"10.1016/j.atherosclerosis.2020.01.002","title":"Association of diabetes with outcomes in patients undergoing contemporary percutaneous coronary intervention: Pre-specified subgroup analysis from the randomized GLOBAL LEADERS study","year":2020,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Servier; Biosensors International Group; Medicines Company; Abbott Laboratories; Medicure; AstraZeneca; CSL Behring; Novartis; Terumo; Biotronik; Bayer; Amgen; Pfizer; Philips","keywords":"Medicine; Percutaneous coronary intervention; Conventional PCI; Clinical endpoint; Hazard ratio; Myocardial infarction; Internal medicine; Type 2 diabetes; Diabetes mellitus; Stent; Cardiology; Confidence interval; Drug-eluting stent; Randomized controlled trial; Endocrinology","score_opus":0.021593017905133852,"score_gpt":0.24121991158163253,"score_spread":0.21962689367649868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2999271152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99709654,0.0006180724,0.00016766188,0.00067467446,0.000038865608,0.0012422419,0.00007634473,0.000040468807,0.00004510497],"genre_scores_gemma":[0.99919534,0.00006385272,0.000032877655,0.0004939242,0.000025347657,0.000039870552,0.00010695925,0.000018084473,0.000023741019],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978363,0.0006195656,0.0004979822,0.0003141477,0.00056248007,0.00016953977],"domain_scores_gemma":[0.9987261,0.00055841473,0.00027919913,0.00027400878,0.00008850732,0.0000737283],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039563281,0.00019809762,0.0011346863,0.00003515389,0.000057624307,0.000025736186,0.00013943756,0.00007277082,0.00008301957],"category_scores_gemma":[0.00020373634,0.00012533029,0.0008622532,0.0005037819,0.00010386655,0.00009492893,0.00003907321,0.00012002932,0.0000036793897],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01914307,0.0008283544,0.96226424,0.000019706298,0.015053298,0.0000049686078,0.0021896372,0.00008132934,0.000018871917,0.0000023617733,0.000041019826,0.00035314637],"study_design_scores_gemma":[0.086917326,0.00067371747,0.9047546,0.00008250296,0.0034416548,1.1758263e-7,0.0038677196,0.000114845454,0.000020500893,0.00000839362,0.0000038285957,0.00011481703],"about_ca_topic_score_codex":0.00032165906,"about_ca_topic_score_gemma":0.00025853614,"teacher_disagreement_score":0.06777425,"about_ca_system_score_codex":0.00013156858,"about_ca_system_score_gemma":0.000039841907,"threshold_uncertainty_score":0.51108205},"labels":[],"label_agreement":null},{"id":"W3000497502","doi":"10.7326/acpj202001210-005","title":"In ACS with planned invasive evaluation, prasugrel vs ticagrelor reduced a composite of death, MI, or stroke at 1 y","year":2020,"lang":"en","type":"letter","venue":"Annals of Internal Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"William Osler Health System","funders":"","keywords":"Ticagrelor; Prasugrel; Medicine; Clopidogrel; Acute coronary syndrome; Myocardial infarction; Internal medicine; Aspirin; Cardiology; Stroke (engine)","score_opus":0.06792427774839507,"score_gpt":0.33750247806621786,"score_spread":0.26957820031782276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3000497502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.52614737,0.005743199,0.000036613044,0.4651484,0.00024658247,0.0011472036,0.00016191005,0.000018669829,0.0013500757],"genre_scores_gemma":[0.50200707,0.0025160569,0.00012756184,0.48974404,0.0024682912,0.00006798561,0.0005815391,0.000103071594,0.0023843828],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9960766,0.0002882667,0.0010021928,0.00051307055,0.0017584807,0.00036139612],"domain_scores_gemma":[0.9971793,0.00044062923,0.0007069871,0.0005392277,0.0009405097,0.00019334661],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00047508295,0.00045277813,0.0018341679,0.0004055938,0.00002796591,0.0000050885264,0.00032697993,0.00033761765,0.0012632657],"category_scores_gemma":[0.0008221836,0.00028975494,0.00036121035,0.0002829637,0.0003922065,0.000078735364,0.00008174581,0.00087825354,0.000022605613],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.041233175,0.00021366846,0.0057753543,0.0021168888,0.006377706,0.0094637135,0.0012618575,0.000012321105,0.010917026,0.000003544976,0.92108756,0.0015372044],"study_design_scores_gemma":[0.061959844,0.055763658,0.032152135,0.081122465,0.013406947,0.0065161805,0.0013527895,0.00021173117,0.37296945,0.00039015093,0.37208858,0.0020660807],"about_ca_topic_score_codex":0.00015595793,"about_ca_topic_score_gemma":0.000032588465,"teacher_disagreement_score":0.54899895,"about_ca_system_score_codex":0.00006847046,"about_ca_system_score_gemma":0.00046229424,"threshold_uncertainty_score":0.9999555},"labels":[],"label_agreement":null},{"id":"W3000965386","doi":"10.3390/jcm9020332","title":"Head-to-Head Comparison of Consensus-Recommended Platelet Function Tests to Assess P2Y12 Inhibition—Insights for Multi-Center Trials","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National de la Recherche Scientifique; Université de Montréal; University of Ottawa; Montreal Heart Institute","funders":"Fonds de Recherche du Québec - Santé; Fondation Institut de Cardiologie de Montréal","keywords":"Medicine; P2Y12; Head (geology); Center (category theory); Platelet; Internal medicine; Platelet aggregation","score_opus":0.5003894497103819,"score_gpt":0.5403855361611961,"score_spread":0.039996086450814206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3000965386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9213791,0.0013543015,0.041118752,0.033216156,0.001560553,0.001211055,0.000033770095,0.000025611625,0.00010068703],"genre_scores_gemma":[0.97667474,0.00020526185,0.0049063656,0.014542836,0.0035719005,0.000011058724,0.000027564109,0.000032761134,0.000027545935],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9941144,0.000655917,0.0039414484,0.0003010999,0.00074278406,0.0002443451],"domain_scores_gemma":[0.99350625,0.0028298444,0.0013398824,0.00024319497,0.0009619337,0.0011189092],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0037459512,0.00024767203,0.0033915567,0.00020426347,0.000057710462,0.000009125751,0.00012247279,0.00021070478,0.0001602015],"category_scores_gemma":[0.015047916,0.00016081164,0.0012096909,0.00031341787,0.00011464976,0.000060955022,0.000031256488,0.00052507437,0.000017108247],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16773513,0.010703135,0.0964934,0.0014778852,0.009754362,0.00064779806,0.0021365548,0.0003390302,0.03683009,0.00016034883,0.22710866,0.4466136],"study_design_scores_gemma":[0.2325144,0.071528785,0.18702449,0.0068666516,0.0061595957,0.00045749746,0.0024370442,0.0018769737,0.01459966,0.00031106645,0.47548732,0.00073650817],"about_ca_topic_score_codex":0.000003449019,"about_ca_topic_score_gemma":0.000007655817,"teacher_disagreement_score":0.4458771,"about_ca_system_score_codex":0.00003122408,"about_ca_system_score_gemma":0.00021456178,"threshold_uncertainty_score":0.99324876},"labels":[],"label_agreement":null},{"id":"W3003176613","doi":"10.9778/cmajo.20190105","title":"Impact of updated recommendations on acetylsalicylic acid use for primary prevention of cardiovascular disease in Canada: a population-based survey","year":2020,"lang":"en","type":"article","venue":"CMAJ Open","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal; Université Laval; Centre hospitalier de l'Université Laval; Hôpital du Sacré-Cœur de Montréal; Centre hospitalier universitaire de Québec","funders":"","keywords":"Primary prevention; Medicine; Disease; Environmental health; Internal medicine","score_opus":0.06568615337985473,"score_gpt":0.32119157534022763,"score_spread":0.2555054219603729,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3003176613","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99542487,0.00041313676,0.0009950493,0.00025118032,0.000028180826,0.001782787,0.0010773948,0.000008813187,0.000018605098],"genre_scores_gemma":[0.9936929,0.00006612306,0.00022098715,0.0002415099,0.000019396532,0.00007149986,0.005652795,0.000023606355,0.000011224028],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99872047,0.00027487718,0.00035181566,0.00024933476,0.00026201326,0.00014149638],"domain_scores_gemma":[0.9990287,0.00009046345,0.00012035047,0.00043225146,0.00014094761,0.00018728312],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003725762,0.00013000691,0.00059947715,0.0000634447,0.00003068196,0.000012803636,0.00015143878,0.000036512356,0.000095979434],"category_scores_gemma":[0.00030222806,0.000116513474,0.0006037279,0.000328827,0.000014877739,0.00013984722,0.00003512399,0.0000652369,8.045025e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004812666,0.0002837916,0.96197397,0.00019003851,0.002445763,0.000011134714,0.000033199176,0.015231001,0.00016654973,0.00001063868,0.0010033341,0.013837909],"study_design_scores_gemma":[0.0038546592,0.0002391396,0.9933975,0.0001414616,0.00043067065,3.8813926e-7,0.000012134234,0.000769889,0.00032640828,0.0000074668974,0.00070964335,0.0001106422],"about_ca_topic_score_codex":0.65438676,"about_ca_topic_score_gemma":0.074889965,"teacher_disagreement_score":0.57949674,"about_ca_system_score_codex":0.00028745714,"about_ca_system_score_gemma":0.0021993231,"threshold_uncertainty_score":0.94199085},"labels":[],"label_agreement":null},{"id":"W3003568155","doi":"10.1016/j.ahj.2020.01.015","title":"Xarelto plus Acetylsalicylic acid: Treatment patterns and Outcomes in patients with Atherosclerosis (XATOA): Rationale and design of a prospective registry study to assess rivaroxaban 2.5 mg twice daily plus aspirin for prevention of atherothrombotic events in coronary artery disease, peripheral artery disease, or both","year":2020,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Population Health Research Institute; McMaster University","funders":"ResMed; National Institute for Health and Care Excellence; Boston Scientific Corporation; Medtronic; Bayer; AstraZeneca; Novartis; St. Jude Medical; Servier; Pfizer","keywords":"Medicine; Aspirin; Rivaroxaban; Coronary artery disease; Regimen; Internal medicine; Population; Warfarin; Adverse effect; Clinical trial; Surgery; Atrial fibrillation","score_opus":0.04578995346314531,"score_gpt":0.3026893288148248,"score_spread":0.2568993753516795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3003568155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923327,0.00016708604,0.0034979163,0.00024406725,0.000019228979,0.003609025,0.00011871138,0.0000108061995,4.5104207e-7],"genre_scores_gemma":[0.9985371,0.000095559706,0.00074187596,0.0002445462,0.00003719711,0.00026250302,0.000024396451,0.00003930439,0.00001751095],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981643,0.0003100944,0.00046768106,0.00038742714,0.0004256056,0.00024487794],"domain_scores_gemma":[0.99895245,0.000093690694,0.00023929118,0.00021511647,0.000090822075,0.00040860617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017028279,0.00026291574,0.000884064,0.00011129794,0.00006942367,0.000020276233,0.00007205876,0.000023714087,0.000013767765],"category_scores_gemma":[0.0000585513,0.0001935928,0.0001692487,0.00022313288,0.00012172561,0.00018840794,0.00003199887,0.00011305303,2.5821154e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016628366,0.0020601135,0.976148,0.00012217397,0.0007611576,0.000039802093,0.0025051185,0.00040259436,0.00015875272,9.091837e-7,0.000005452043,0.0011675607],"study_design_scores_gemma":[0.014342424,0.010913475,0.97075504,0.00042820442,0.0003999417,0.000018659946,0.0026594908,0.0002603034,0.000024512412,0.000009799575,0.0000037032744,0.00018441495],"about_ca_topic_score_codex":0.00005900012,"about_ca_topic_score_gemma":0.000052337906,"teacher_disagreement_score":0.008853362,"about_ca_system_score_codex":0.00022729344,"about_ca_system_score_gemma":0.00035240562,"threshold_uncertainty_score":0.78944856},"labels":[],"label_agreement":null},{"id":"W3003782634","doi":"10.1007/s00392-020-01604-1","title":"The association of body mass index with long-term clinical outcomes after ticagrelor monotherapy following abbreviated dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a prespecified sub-analysis of the GLOBAL LEADERS Trial","year":2020,"lang":"en","type":"article","venue":"Clinical Research in Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Ticagrelor; Percutaneous coronary intervention; Internal medicine; Acute coronary syndrome; Clinical endpoint; Conventional PCI; Body mass index; Aspirin; Cardiology; Myocardial infarction; Clopidogrel; Population; Randomized controlled trial","score_opus":0.1113483862215064,"score_gpt":0.4317558195938669,"score_spread":0.3204074333723605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3003782634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957333,0.0010146076,0.00008779735,0.0011577772,0.00030575893,0.0016104867,0.000028228204,0.000014026365,0.00004802041],"genre_scores_gemma":[0.9959784,0.0034834456,0.000008398943,0.00025324876,0.00015633403,0.000049923066,0.0000316906,0.000022672795,0.000015850153],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9898474,0.006054094,0.0018120357,0.0005930662,0.0011641858,0.0005292185],"domain_scores_gemma":[0.9924048,0.0060824538,0.00038472228,0.000630321,0.0003275623,0.00017011868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0066803354,0.00022471316,0.0018989472,0.00014463416,0.000079504425,0.000022768,0.00038595995,0.00046110636,0.000020764433],"category_scores_gemma":[0.003358673,0.00012890315,0.002834025,0.0013096104,0.0007849312,0.00006407488,0.0001278124,0.0010391074,0.0000033187168],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12269659,0.00044757058,0.85427064,0.000027150172,0.013496618,0.00040174086,0.00005480487,0.00010521872,0.0000048700017,0.000007654846,0.000019569785,0.008467579],"study_design_scores_gemma":[0.051475752,0.0035279535,0.9436963,0.00011661099,0.00069207145,0.000005913637,0.0001654326,0.00010254398,0.0000055637033,0.000043263582,0.00005505027,0.00011355141],"about_ca_topic_score_codex":0.000020150044,"about_ca_topic_score_gemma":0.00011887578,"teacher_disagreement_score":0.08942567,"about_ca_system_score_codex":0.00021990084,"about_ca_system_score_gemma":0.000371367,"threshold_uncertainty_score":0.5256518},"labels":[],"label_agreement":null},{"id":"W3004445727","doi":"10.1016/j.cjca.2020.02.001","title":"Drug-Induced Acute Coronary Syndrome: A New Cardiovascular Concern With Immune Checkpoint Inhibitors and the Need for a Prospective Registry","year":2020,"lang":"en","type":"letter","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Acute coronary syndrome; Internal medicine; Prospective cohort study; Drug; Cardiology; Intensive care medicine; Pharmacology; Myocardial infarction","score_opus":0.012316242976780927,"score_gpt":0.21256023988733388,"score_spread":0.20024399691055295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3004445727","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.090230234,0.13669425,0.0030505548,0.7605152,0.0023415452,0.0058032437,0.00043916312,0.000051694697,0.00087409595],"genre_scores_gemma":[0.8972784,0.001703305,0.00018686292,0.08761021,0.011987441,0.0001155727,0.00020317711,0.00021077415,0.00070424937],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973793,0.00040189485,0.00068402133,0.0004806683,0.00044172688,0.0006123889],"domain_scores_gemma":[0.9974733,0.0001652665,0.00048388093,0.000680999,0.0004452262,0.000751315],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006008927,0.00052037975,0.0030844524,0.00022645766,0.00021916801,0.000059205475,0.00034548814,0.00057414407,0.000010536251],"category_scores_gemma":[0.00017493081,0.00033630207,0.0033188842,0.00020900005,0.00095018605,0.0000790792,0.000030070089,0.002105116,0.0000029672437],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059475414,0.0000033698323,0.0033077507,0.00050257944,0.119214475,0.100238204,0.00093643344,0.00011351464,0.000060977636,0.00003773866,0.76429147,0.005345981],"study_design_scores_gemma":[0.01830953,0.0012280168,0.0038342192,0.0005552073,0.015020772,0.102226645,0.0004904069,0.0000031672937,0.00009156028,0.0002956997,0.8574613,0.00048348706],"about_ca_topic_score_codex":0.0012789969,"about_ca_topic_score_gemma":0.00008775982,"teacher_disagreement_score":0.8070482,"about_ca_system_score_codex":0.0003079242,"about_ca_system_score_gemma":0.0054450324,"threshold_uncertainty_score":0.9999089},"labels":[],"label_agreement":null},{"id":"W3004848796","doi":"10.1161/jaha.119.013396","title":"Aspirin Reduces the Potentiating Effect of CD40L on Platelet Aggregation via Inhibition of Myosin Light Chain","year":2020,"lang":"en","type":"article","venue":"Journal of the American Heart Association","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal; Montreal Heart Institute","funders":"Institut de Cardiologie de Montréal; Heart and Stroke Foundation of Canada","keywords":"Myosin light-chain kinase; Platelet; Medicine; Thrombin; Thromboxane A2; Thromboxane; Pharmacology; Platelet activation; Ex vivo; Aspirin; Internal medicine; Endocrinology; Myosin; Biochemistry; Chemistry; In vitro","score_opus":0.006932972735062004,"score_gpt":0.24187970455998212,"score_spread":0.23494673182492012,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3004848796","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902469,0.00034590173,0.00010858605,0.008901265,0.00011325862,0.00023096934,0.0000053111607,0.0000072128346,0.000040600193],"genre_scores_gemma":[0.9986242,0.00010118219,0.000045946854,0.0008479288,0.00035138513,0.0000018951915,0.000002518978,0.000012304792,0.00001265204],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99798596,0.00067375455,0.00045120527,0.000083638326,0.00069455046,0.000110902256],"domain_scores_gemma":[0.9979782,0.00027534628,0.001377797,0.00012263685,0.00019346944,0.00005251995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012951258,0.00009858251,0.0005659616,0.00005898506,0.00008439122,0.000009780945,0.00007778068,0.000040657455,0.00000735482],"category_scores_gemma":[0.0007269974,0.00005559251,0.0006758646,0.00039247956,0.000053175652,0.000079916135,0.000017049746,0.00023537439,0.0000020747173],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003045492,0.00020696307,0.15601856,0.00016351882,0.0019244152,0.000013199332,0.0017228696,0.0013139371,0.75090104,0.000013161282,0.0028235398,0.08185331],"study_design_scores_gemma":[0.0015168597,0.002264546,0.10652497,0.00043424245,0.00047593712,0.000037736947,0.00024390251,0.00032116304,0.8875271,0.000029820425,0.0005525655,0.00007114072],"about_ca_topic_score_codex":0.000018216426,"about_ca_topic_score_gemma":4.7809885e-7,"teacher_disagreement_score":0.13662608,"about_ca_system_score_codex":0.000115548,"about_ca_system_score_gemma":0.000057197645,"threshold_uncertainty_score":0.22669968},"labels":[],"label_agreement":null},{"id":"W3005738087","doi":"10.1161/str.51.suppl_1.159","title":"Abstract 159: Trends in Dual Antiplatelet Therapy Prescription Patterns for Secondary Prevention in Patients With Noncardioembolic Ischemic Stroke","year":2020,"lang":"en","type":"article","venue":"Stroke","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Guideline; Clopidogrel; Aspirin; Stroke (engine); Internal medicine; Clinical endpoint; Medical prescription; Randomized controlled trial; Ischemic stroke; Pharmacology","score_opus":0.01566600225373705,"score_gpt":0.25040458391732456,"score_spread":0.23473858166358752,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005738087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967716,0.0006750987,0.00019954957,0.00012164412,0.00007495386,0.0008060623,0.00041455982,0.000051634353,0.00088493363],"genre_scores_gemma":[0.9980786,0.00021018552,0.000082584724,0.00025188297,0.00021002555,0.0000838567,0.0008392067,0.000044564174,0.0001990869],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99852747,0.00004801548,0.00033058046,0.00041366834,0.0003436704,0.00033661156],"domain_scores_gemma":[0.9994709,0.000016993543,0.000093890936,0.0002319567,0.000054882676,0.00013138707],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014374139,0.00023652232,0.00050664356,0.00019045656,0.000034923847,0.000024429808,0.00006708098,0.00012957948,0.00020209605],"category_scores_gemma":[0.00001030077,0.00020466924,0.00035316308,0.00018061759,0.00003247084,0.00023525817,0.000017058139,0.00027867133,0.000006063503],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068681063,0.00049141963,0.729836,0.00014026694,0.0006521538,0.00007261266,0.00039355046,0.00006289815,0.005189739,0.00000289707,0.00043133862,0.25585905],"study_design_scores_gemma":[0.02205932,0.0010433241,0.96791965,0.00012283846,0.00009091094,0.0000060977395,0.00014157563,0.000050286642,0.0038179497,0.000002644716,0.0045276186,0.00021779745],"about_ca_topic_score_codex":0.000022883594,"about_ca_topic_score_gemma":0.000021098685,"teacher_disagreement_score":0.25564125,"about_ca_system_score_codex":0.00004879901,"about_ca_system_score_gemma":0.000068515736,"threshold_uncertainty_score":0.83461696},"labels":[],"label_agreement":null},{"id":"W3006186234","doi":"10.1161/strokeaha.119.027465","title":"Disability After Minor Stroke and Transient Ischemic Attack in the POINT Trial","year":2020,"lang":"en","type":"article","venue":"Stroke","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Institute of Neurological Disorders and Stroke","keywords":"Medicine; Aspirin; Stroke (engine); Clopidogrel; Internal medicine; Modified Rankin Scale; Minor stroke; Odds ratio; Post-hoc analysis; Clinical endpoint; Cardiology; Randomized controlled trial; Myocardial infarction; Physical therapy; Ischemic stroke; Ischemia","score_opus":0.02190115500793382,"score_gpt":0.26402028659817267,"score_spread":0.24211913159023885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006186234","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911483,0.0018626163,0.000042001077,0.004003584,0.00005058721,0.00066027243,0.00006587857,0.000020364216,0.0021463784],"genre_scores_gemma":[0.9978597,0.000081998485,0.00003637724,0.0015077665,0.00029666588,0.000054761043,0.000011188506,0.000009520644,0.00014198935],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990675,0.00009185537,0.00017762337,0.00024375971,0.00024685025,0.00017240278],"domain_scores_gemma":[0.9995819,0.000042385727,0.000018358476,0.00023197793,0.000012118278,0.00011327706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019065411,0.000118971686,0.0002592862,0.000011209995,0.000025630148,0.000016276445,0.00006676643,0.000053469994,0.00021336196],"category_scores_gemma":[0.000037789832,0.00007694929,0.00028426753,0.000064286105,0.00013886708,0.00004647762,0.000015564194,0.00017439641,0.000014601481],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3865452,0.0030947211,0.44139197,0.0011269817,0.0023826417,0.0012168082,0.019580133,0.000023477702,0.01712073,0.000047480302,0.03658897,0.090880856],"study_design_scores_gemma":[0.13775201,0.002607263,0.54858834,0.00010163018,0.0012174742,0.00010025983,0.005161061,0.00017339086,0.0032762422,0.0000072208873,0.30048802,0.0005270987],"about_ca_topic_score_codex":0.000009646693,"about_ca_topic_score_gemma":0.000008793342,"teacher_disagreement_score":0.26389906,"about_ca_system_score_codex":0.00001499412,"about_ca_system_score_gemma":0.000025225127,"threshold_uncertainty_score":0.31379008},"labels":[],"label_agreement":null},{"id":"W3006707881","doi":"10.1016/j.cjco.2020.02.005","title":"Meta-analysis Comparing Outcomes of Type 2 Myocardial Infarction and Type 1 Myocardial Infarction With a Focus on Dual Antiplatelet Therapy","year":2020,"lang":"en","type":"article","venue":"CJC Open","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Montreal Heart Institute; Université de Montréal; University of Ottawa; St. Michael's Hospital; McGill University; Sunnybrook Hospital; Hamilton Health Sciences; University of Toronto","funders":"Abbott Vascular; Boston Scientific Corporation; Medtronic; Bayer; AstraZeneca; Eli Lilly and Company; Servier; Amgen; Sanofi; Merck; Abbott Laboratories","keywords":"Myocardial infarction; Medicine; Cardiology; Internal medicine; Dual (grammatical number)","score_opus":0.087098064591738,"score_gpt":0.30862161845221703,"score_spread":0.22152355386047903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006707881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938176,0.002021845,0.00011532524,0.0012841155,0.000088328874,0.0007859672,0.000018590994,0.000046896577,0.0018213257],"genre_scores_gemma":[0.9975245,0.0007644654,0.00014405856,0.0012519296,0.0001286817,0.000019048044,0.0000800678,0.000029173852,0.000058075373],"study_design_codex":"meta_analysis","study_design_gemma":"observational","domain_scores_codex":[0.9985257,0.0001649872,0.0002984244,0.00039761682,0.0004295019,0.0001838049],"domain_scores_gemma":[0.999076,0.00006727297,0.0001353745,0.00038002117,0.00017442947,0.00016689833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000294731,0.00024214502,0.00181681,0.00013303428,0.0000955512,0.00007456202,0.00012936405,0.00009316082,0.00022895545],"category_scores_gemma":[0.000048500482,0.00016515689,0.0007585163,0.0007340979,0.00009099488,0.000183595,0.00008625788,0.00017758187,0.00002068109],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01737804,0.00024629288,0.3485446,0.000039661736,0.62144065,0.000093913266,0.00092774414,0.0016669482,0.0014058157,0.00026868065,0.00060374686,0.007383921],"study_design_scores_gemma":[0.011284963,0.0037055467,0.7917273,0.000024011279,0.17966016,0.00008011677,0.00037125754,0.00053050305,0.0024337391,0.00007927088,0.009516467,0.00058669335],"about_ca_topic_score_codex":0.00021055294,"about_ca_topic_score_gemma":0.000009223252,"teacher_disagreement_score":0.44318268,"about_ca_system_score_codex":0.000017684892,"about_ca_system_score_gemma":0.00008081666,"threshold_uncertainty_score":0.6734903},"labels":[],"label_agreement":null},{"id":"W3007436575","doi":"10.4212/cjhp.v73i1.2959","title":"For Primary Prevention, Should All Moderate- to High-Risk Patients Be Considered Candidates for Acetylsalicylic Acid?","year":2020,"lang":"en","type":"article","venue":"The Canadian Journal of Hospital Pharmacy","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"University of British Columbia","keywords":"Primary prevention; Primary (astronomy); Medicine; Internal medicine; Physics; Disease","score_opus":0.04258510932575454,"score_gpt":0.2999158820163828,"score_spread":0.25733077269062826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007436575","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9601315,0.0021049546,0.0014527394,0.033721194,0.00036588384,0.0016154482,0.0005527711,0.000012571588,0.000042898457],"genre_scores_gemma":[0.98200816,0.00014632061,0.00056445925,0.016461236,0.0005518754,0.00004385857,0.00010622162,0.000044073702,0.00007378304],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99877936,0.00006668381,0.00037889567,0.00017196522,0.00024948062,0.00035363613],"domain_scores_gemma":[0.99799764,0.00006566793,0.00020369088,0.00015290143,0.00048594188,0.0010941548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028765335,0.00018209689,0.00042298957,0.00007848276,0.00025689707,0.00007083501,0.00021666128,0.000041626325,0.00007838696],"category_scores_gemma":[0.00028872216,0.0001329811,0.00051520014,0.00011107694,0.00007008053,0.0001643023,0.000013927367,0.00019864056,0.000005253186],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021734739,0.0007976611,0.09759765,0.00084842223,0.01777725,0.00039609024,0.012022765,0.001772777,0.002510843,0.00066564593,0.7508808,0.09299537],"study_design_scores_gemma":[0.07420824,0.014739717,0.03772579,0.00041157074,0.009494849,0.00016556184,0.0009662722,0.0007872785,0.051482245,0.005341799,0.80316055,0.0015161234],"about_ca_topic_score_codex":0.0010194615,"about_ca_topic_score_gemma":0.00089681346,"teacher_disagreement_score":0.09147925,"about_ca_system_score_codex":0.0001302837,"about_ca_system_score_gemma":0.0012093468,"threshold_uncertainty_score":0.5422812},"labels":[],"label_agreement":null},{"id":"W3008887920","doi":"10.1007/s12265-020-09969-4","title":"Facilitation Through Aggrastat or Cangrelor Bolus and Infusion Over PrasugreL: a MUlticenter Randomized Open-label Trial in PatientS with ST-elevation Myocardial InFarction Referred for PrimAry PercutaneouS InTERvention (FABOLUS FASTER) Trial: Design and Rationale","year":2020,"lang":"en","type":"article","venue":"Journal of Cardiovascular Translational Research","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Bern; Inselspital, Universitätsspital Bern; Medicure","keywords":"Prasugrel; Cangrelor; Medicine; Percutaneous coronary intervention; Tirofiban; Ticagrelor; Conventional PCI; Internal medicine; Myocardial infarction; Cardiology; Thienopyridine; Randomized controlled trial; Clopidogrel; Clinical trial; Platelet aggregation inhibitor; Anesthesia; Platelet","score_opus":0.10348586347563285,"score_gpt":0.3609718110992749,"score_spread":0.2574859476236421,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3008887920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89124835,0.0042609554,0.09229317,0.0008484864,0.00014048952,0.011126154,0.000053408665,0.000010895392,0.000018115785],"genre_scores_gemma":[0.98764473,0.002050241,0.008992614,0.00018330992,0.00038484563,0.0003301517,0.00034001976,0.00005072241,0.00002334303],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99464005,0.0017853102,0.00092664047,0.0003935977,0.0019903095,0.00026410082],"domain_scores_gemma":[0.99705106,0.00106139,0.00024689254,0.00016485115,0.0012910317,0.00018479471],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0049482156,0.00022525499,0.0011184188,0.00029820754,0.00017232803,0.00015280966,0.00011391255,0.00015516176,0.000025032134],"category_scores_gemma":[0.0013687245,0.00016489878,0.00058529194,0.00036752556,0.00017651558,0.00088978,0.00003834728,0.00040214122,7.081127e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.93073326,0.00052169745,0.00035700903,0.00024727485,0.0035502147,0.000038215836,0.0010514604,0.0013826019,0.000113772476,0.00002356861,0.00006815589,0.06191275],"study_design_scores_gemma":[0.9732844,0.0064170333,0.0121291885,0.00033714963,0.00121584,0.00007376586,0.00023486836,0.0028296472,0.000017085966,0.00028179272,0.0029855021,0.00019368494],"about_ca_topic_score_codex":0.000045878704,"about_ca_topic_score_gemma":0.0000074653326,"teacher_disagreement_score":0.09639643,"about_ca_system_score_codex":0.00014604793,"about_ca_system_score_gemma":0.0005328325,"threshold_uncertainty_score":0.6724377},"labels":[],"label_agreement":null},{"id":"W3009142126","doi":"10.1016/j.athoracsur.2020.01.061","title":"No Excuse for Inadequate Adherence to Guideline-Driven Medical Therapy","year":2020,"lang":"en","type":"letter","venue":"The Annals of Thoracic Surgery","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Contraindication; Guideline; Medical therapy; Population; Appropriate Use Criteria; Atrial fibrillation; Family medicine; Intensive care medicine; Cardiology; Internal medicine; Alternative medicine","score_opus":0.18122777860487005,"score_gpt":0.40936991836916353,"score_spread":0.22814213976429348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3009142126","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011340815,0.009939262,0.0015207902,0.97408164,0.0008585297,0.0015588928,0.00022690136,0.00014712237,0.0003260519],"genre_scores_gemma":[0.0052404786,0.0112383645,0.00033385554,0.9725797,0.008136164,0.00024552576,0.0006842327,0.0001534598,0.0013882051],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99576515,0.00049023045,0.0010463395,0.00058267394,0.0014896386,0.0006259535],"domain_scores_gemma":[0.9956595,0.0015965481,0.00039705436,0.0011578631,0.00082585734,0.0003632193],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018780677,0.0004938033,0.0017154269,0.00020291025,0.00011147617,0.00003082558,0.000662775,0.00057245255,0.00091490796],"category_scores_gemma":[0.002164977,0.00032236605,0.0023924925,0.00038380537,0.00022788279,0.00006571113,0.000118032076,0.00093085255,0.0002557565],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022654275,0.00005137639,0.000051984323,0.0004454958,0.0013083904,0.0005986663,0.00006145809,0.00000238839,0.00004582616,0.000001863949,0.7819847,0.21318242],"study_design_scores_gemma":[0.00023528252,0.00038526094,0.000023995948,0.0009698046,0.0002559588,0.000063475265,0.000022886208,0.000093093295,0.0026014124,0.00018619017,0.9948032,0.00035943286],"about_ca_topic_score_codex":0.00004685411,"about_ca_topic_score_gemma":0.0000012026985,"teacher_disagreement_score":0.21282299,"about_ca_system_score_codex":0.000013829184,"about_ca_system_score_gemma":0.00076732633,"threshold_uncertainty_score":0.9999984},"labels":[],"label_agreement":null},{"id":"W3009673715","doi":"10.1016/j.jcin.2020.01.219","title":"Routine CYP2C19 Genotyping to Adjust Thienopyridine Treatment After Primary PCI for STEMI","year":2020,"lang":"en","type":"article","venue":"JACC: Cardiovascular Interventions","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Merck Sharp and Dohme; Servier; Canada Excellence Research Chairs, Government of Canada; Fondation Leducq; Novo Nordisk; Medicines Company; Actelion Pharmaceuticals; Boston Scientific Corporation; Amgen; Boehringer Ingelheim; Fondation Simone et Cino Del Duca; Medtronic; Fédération Française de Cardiologie; Bayer; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; Biotronik; American College of Cardiology Foundation; Pfizer; Sanofi; Abbott Vascular; Abbott Laboratories","keywords":"Percutaneous coronary intervention; Thienopyridine; Myocardial infarction; Clopidogrel; Medicine; Prasugrel; Internal medicine; Clinical endpoint; Cardiology; Conventional PCI; Genotype; Randomized controlled trial; Biology","score_opus":0.07921475331830882,"score_gpt":0.3028655398799813,"score_spread":0.2236507865616725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3009673715","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5623682,0.14528437,0.27565756,0.0049908496,0.0008088377,0.0071748537,0.0006473803,0.00071481435,0.0023531257],"genre_scores_gemma":[0.9892295,0.0010023094,0.0033058268,0.0022833787,0.0013476197,0.0014030567,0.00041832047,0.0001278493,0.0008821117],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99735284,0.00016140568,0.0006202198,0.0007993663,0.0005441653,0.00052199775],"domain_scores_gemma":[0.99804133,0.000047097277,0.0000771244,0.0009868339,0.0002632787,0.00058433943],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.00046332736,0.0004228333,0.0012450742,0.00017629036,0.00018915326,0.00007030845,0.00019407582,0.00014773068,0.0003510171],"category_scores_gemma":[0.00013656465,0.00037212332,0.010236827,0.00045196584,0.00005489599,0.00014927807,0.00012135216,0.0001631336,0.00026749365],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012387901,0.0034830961,0.010692765,0.0093955165,0.1382469,0.0020621698,0.004242038,0.0063487184,0.005551697,0.00069779943,0.01928441,0.787607],"study_design_scores_gemma":[0.023463555,0.0046443064,0.048130132,0.0020235549,0.022945402,0.0006510042,0.0010246267,0.00035162634,0.0070488458,0.00004672161,0.88816226,0.0015079791],"about_ca_topic_score_codex":0.000029762403,"about_ca_topic_score_gemma":0.000006629987,"teacher_disagreement_score":0.8688778,"about_ca_system_score_codex":0.00027825427,"about_ca_system_score_gemma":0.00012018675,"threshold_uncertainty_score":0.99987304},"labels":[],"label_agreement":null},{"id":"W3009918962","doi":"10.1016/j.jcin.2019.12.018","title":"DAPT Score and the Impact of Ticagrelor Monotherapy During the Second Year After PCI","year":2020,"lang":"en","type":"article","venue":"JACC: Cardiovascular Interventions","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"Canadian Institutes of Health Research; Terumo; Biotronik; Daiichi-Sankyo; Medicines Company; Boston Scientific Corporation; Eli Lilly and Company; Bristol-Myers Squibb; AstraZeneca; CSL Behring; Biosensors International Group; Medtronic; Bayer; Edwards Lifesciences; Amgen; Sanofi; Merck; St. Jude Medical; Abbott Laboratories","keywords":"Medicine; Ticagrelor; Conventional PCI; Percutaneous coronary intervention; Internal medicine; Cardiology; Aspirin; Myocardial infarction; Clinical endpoint; Major bleeding; Stent; Clopidogrel; Population; Randomized controlled trial","score_opus":0.021346317985264894,"score_gpt":0.26809327734705457,"score_spread":0.24674695936178967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3009918962","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94158643,0.05499087,0.0013904241,0.00054320437,0.00005635424,0.0007972541,0.000062035855,0.00004361256,0.00052978867],"genre_scores_gemma":[0.9977465,0.0013178191,0.000047452504,0.00017756391,0.0002525945,0.00009784137,0.000009534166,0.000038417442,0.00031225898],"study_design_codex":"meta_analysis","study_design_gemma":"observational","domain_scores_codex":[0.9984867,0.00028748243,0.00035608961,0.00029431938,0.00036176833,0.0002136534],"domain_scores_gemma":[0.9988597,0.000054430344,0.000075631215,0.0007675677,0.000103177845,0.00013950086],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000496434,0.00020697017,0.00066726486,0.000052136304,0.00013383398,0.000047984355,0.00017790563,0.00007326257,0.001098978],"category_scores_gemma":[0.00007082367,0.00010966658,0.0077576553,0.00023460817,0.00035720205,0.000093284216,0.000092585906,0.00024968965,0.000032964388],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03826164,0.0018078535,0.23865163,0.008068832,0.5489128,0.0015172538,0.017216798,0.0033382343,0.003939659,0.0031112623,0.00867484,0.12649918],"study_design_scores_gemma":[0.033319004,0.00074628484,0.929734,0.00092010846,0.008813586,0.001029816,0.0016024061,0.0004057085,0.0022102122,0.0003606761,0.020230003,0.00062821707],"about_ca_topic_score_codex":0.000043620246,"about_ca_topic_score_gemma":0.000004724695,"teacher_disagreement_score":0.69108236,"about_ca_system_score_codex":0.000029613162,"about_ca_system_score_gemma":0.000044173907,"threshold_uncertainty_score":0.99981415},"labels":[],"label_agreement":null},{"id":"W3010522600","doi":"10.1038/s41573-020-0061-0","title":"Therapeutic strategies for thrombosis: new targets and approaches","year":2020,"lang":"en","type":"review","venue":"Nature Reviews Drug Discovery","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":387,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Antithrombotic; Medicine; Thrombosis; Intensive care medicine; Anticoagulant; Fibrinolytic agent; Surgery; Internal medicine","score_opus":0.09240540115367263,"score_gpt":0.3529825232773089,"score_spread":0.26057712212363626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010522600","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000010946151,0.99247515,0.001119774,0.00028418706,0.00027661267,0.0051809503,0.00011409922,0.00007873236,0.000469406],"genre_scores_gemma":[0.000029741517,0.9955356,0.000488827,0.00087559124,0.0013843565,0.00045371638,0.0005707431,0.00014152021,0.00051991385],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99724424,0.00031386354,0.0007755244,0.00093028427,0.00034152306,0.00039453837],"domain_scores_gemma":[0.9984179,0.00017122559,0.00040504892,0.00068107067,0.00003188693,0.0002928676],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00045705013,0.0008960755,0.0052365833,0.000107226755,0.00010841563,0.00023570507,0.0002821702,0.0007350232,0.000020855145],"category_scores_gemma":[0.000091707996,0.00055810425,0.0036208893,0.00033493366,0.000109008266,0.00039679094,0.000076291275,0.001167064,0.00002899235],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003777638,0.000058109097,0.0000017738574,0.06880619,0.0022569434,0.00001387872,0.00007349288,9.6971206e-8,2.8155662e-7,0.002039575,0.0071875304,0.9195244],"study_design_scores_gemma":[0.0006158944,0.000073897274,0.0000053447257,0.020441903,0.011590803,0.000102467806,0.00013421566,0.0000017530872,8.9622523e-7,0.0004819584,0.96601975,0.000531133],"about_ca_topic_score_codex":0.0000026210841,"about_ca_topic_score_gemma":0.0000019927886,"teacher_disagreement_score":0.9588322,"about_ca_system_score_codex":0.00006961766,"about_ca_system_score_gemma":0.0011395417,"threshold_uncertainty_score":0.999687},"labels":[],"label_agreement":null},{"id":"W3011575338","doi":"10.1177/1715163520909137","title":"Use of low-dose acetylsalicylic acid for cardiovascular disease prevention: A practical, stepwise approach for pharmacists","year":2020,"lang":"en","type":"article","venue":"Canadian Pharmacists Journal / Revue des Pharmaciens du Canada","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Regina General Hospital; Vancouver General Hospital; Saskatchewan Health; Native Mental Health Association of Canada; University of Saskatchewan; University of Alberta; University of British Columbia; Saskatchewan Health Authority; University of British Columbia Hospital","funders":"","keywords":"Medicine; Disease; Placebo; Diabetes mellitus; Randomized controlled trial; Intensive care medicine; Clinical trial; Gastrointestinal bleeding; Primary prevention; Internal medicine; Dementia; Physical therapy; Alternative medicine","score_opus":0.1414287112090138,"score_gpt":0.32228421003476826,"score_spread":0.18085549882575447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011575338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7926572,0.04177732,0.13745895,0.001574723,0.0025873578,0.013173822,0.010327784,0.0002122027,0.00023061517],"genre_scores_gemma":[0.97925246,0.0075253616,0.006239763,0.003975844,0.0018833096,0.00030684206,0.0004268522,0.00016007124,0.00022950488],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960602,0.00027649428,0.000901092,0.0007805632,0.00086125557,0.0011204096],"domain_scores_gemma":[0.99237615,0.00015728743,0.00035172157,0.0005443926,0.0011187496,0.005451699],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00076775864,0.0005728588,0.0011473049,0.00025200637,0.00061516976,0.00017103898,0.000401544,0.0001024411,0.00020920443],"category_scores_gemma":[0.00086601503,0.00058939675,0.0026883287,0.0006366635,0.0002741732,0.000641623,0.000044114033,0.0005133739,0.0000027677982],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.043277778,0.0024051087,0.0021247717,0.028940983,0.0670401,0.13811396,0.0036131043,0.040510774,0.027474934,0.00038254732,0.21321721,0.43289873],"study_design_scores_gemma":[0.04332406,0.0008424268,0.00003486734,0.00024341175,0.020916967,0.27545023,0.00008832001,0.08428721,0.022015035,0.00011104099,0.5501538,0.0025326582],"about_ca_topic_score_codex":0.0004667856,"about_ca_topic_score_gemma":0.00015676816,"teacher_disagreement_score":0.43036607,"about_ca_system_score_codex":0.00082467153,"about_ca_system_score_gemma":0.007846318,"threshold_uncertainty_score":0.9996557},"labels":[],"label_agreement":null},{"id":"W3012374151","doi":"10.1161/circulationaha.119.044598","title":"Rivaroxaban Plus Aspirin Versus Aspirin Alone in Patients With Prior Percutaneous Coronary Intervention (COMPASS-PCI)","year":2020,"lang":"en","type":"article","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Population Health Research Institute; University of Alberta","funders":"","keywords":"Medicine; Conventional PCI; Percutaneous coronary intervention; Mace; Aspirin; Myocardial infarction; Rivaroxaban; Internal medicine; Cardiology; Hazard ratio; Acute coronary syndrome; Stroke (engine); Warfarin; Confidence interval; Atrial fibrillation","score_opus":0.021521942163514243,"score_gpt":0.24546241998285154,"score_spread":0.2239404778193373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3012374151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968967,0.00037714356,0.0013858813,0.00019587207,0.00011389657,0.0006908888,0.000008385924,0.00009742421,0.00023384593],"genre_scores_gemma":[0.99895185,0.0000108941895,0.000118298194,0.00025172904,0.00010611096,0.000013143901,0.00050541235,0.000033060034,0.000009499487],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99872607,0.000077829085,0.0002701222,0.00033835205,0.00039388138,0.00019372287],"domain_scores_gemma":[0.9994098,0.000021759197,0.00008463851,0.00022745805,0.00010870807,0.00014766518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008246336,0.00017040642,0.00032580984,0.00007860489,0.000055104116,0.000019853056,0.00006752928,0.00008783099,0.00014204229],"category_scores_gemma":[0.000040338557,0.00015992906,0.0002051239,0.0002307873,0.000045258745,0.00015804126,0.000024648973,0.0001600453,0.00006923722],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0111104045,0.0004187215,0.9153732,0.00022895163,0.00044627467,0.0003551614,0.00054308795,0.003062133,0.00036697372,0.000041661275,0.00003564617,0.0680178],"study_design_scores_gemma":[0.016128154,0.0006697255,0.97939026,0.00017872144,0.00021149444,0.000051542953,0.00010820745,0.0025607604,0.00005547675,0.00001141904,0.00044093275,0.00019332374],"about_ca_topic_score_codex":0.000025758902,"about_ca_topic_score_gemma":0.000011597221,"teacher_disagreement_score":0.06782448,"about_ca_system_score_codex":0.00018884047,"about_ca_system_score_gemma":0.000055908004,"threshold_uncertainty_score":0.65217173},"labels":[],"label_agreement":null},{"id":"W3012643609","doi":"10.1503/cmaj.191599","title":"Canadian Stroke Best Practice Recommendations, seventh edition: acetylsalicylic acid for prevention of vascular events","year":2020,"lang":"en","type":"article","venue":"Canadian Medical Association Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Home and Community Care Support Services; University of Saskatchewan; University Health Network; Health Sciences Centre; Women's College Hospital; University of Calgary; University of British Columbia; McMaster University; Ontario Stroke Network; Toronto General Hospital; University of Toronto; Dalhousie University; Hôpital Notre-Dame; Heart and Stroke Foundation; Sunnybrook Health Science Centre; McGill University; University of Ottawa","funders":"","keywords":"Stroke (engine); Cognitive impairment; Medicine; Family medicine; Emergency medicine; Cognition; Psychiatry; Engineering","score_opus":0.013899887174142938,"score_gpt":0.27855725250139185,"score_spread":0.26465736532724893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3012643609","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10840279,0.0076258164,0.016877726,0.8550018,0.0031150875,0.0024837567,0.0015628097,0.00007500731,0.0048552277],"genre_scores_gemma":[0.94212556,0.0042122165,0.0025696505,0.04264912,0.006674957,0.00007114754,0.0007869193,0.00007076923,0.00083968736],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975109,0.00027985126,0.00050087145,0.00018667278,0.0011091111,0.00041260474],"domain_scores_gemma":[0.99584764,0.00010639065,0.00030360397,0.00012232031,0.0008109143,0.0028091073],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014071784,0.00013391206,0.0003503948,0.00017471453,0.00028274563,0.000032194286,0.0001481567,0.00031866456,0.0024524583],"category_scores_gemma":[0.0035176193,0.00013788666,0.00051260967,0.00025680134,0.000019909854,0.0002650132,0.00000772193,0.00050601404,0.000060573228],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040078096,0.0005590083,0.025606275,0.0002898901,0.008973485,0.0005073564,0.0012987885,0.000035940884,0.00018827719,0.00071087386,0.5807861,0.38064322],"study_design_scores_gemma":[0.0032732987,0.00040308197,0.0022186683,0.00019914824,0.0006450197,0.00025860383,0.0013383284,0.00013618887,0.0001509627,0.00008248859,0.9911414,0.0001528418],"about_ca_topic_score_codex":0.008709775,"about_ca_topic_score_gemma":0.0459476,"teacher_disagreement_score":0.8337228,"about_ca_system_score_codex":0.0010434036,"about_ca_system_score_gemma":0.0059836833,"threshold_uncertainty_score":0.9996515},"labels":[],"label_agreement":null},{"id":"W3012752992","doi":"10.5603/cj.a2020.0040","title":"Oral NAloxone to overcome the moRphine effect in acute COronary syndrome patients treated with TICagrelor — NARCOTIC trial","year":2020,"lang":"en","type":"article","venue":"Cardiology Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Ticagrelor; Medicine; Pharmacodynamics; (+)-Naloxone; Acute coronary syndrome; Morphine; P2Y12; Pharmacokinetics; Pharmacology; Anesthesia; Opioid; Myocardial infarction; Internal medicine; Clopidogrel; Receptor","score_opus":0.01265364570249358,"score_gpt":0.24337897253156598,"score_spread":0.2307253268290724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3012752992","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960827,0.0008081269,0.00020649537,0.0015622075,0.0002055061,0.0010189784,0.000016044189,0.00003309847,0.00006682883],"genre_scores_gemma":[0.9974993,0.00014165748,0.000042408323,0.0018772578,0.00029516558,0.000032082353,0.00003536037,0.000032281787,0.000044475826],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99809176,0.00056455604,0.0003248609,0.0002798559,0.0003561723,0.0003828162],"domain_scores_gemma":[0.99908125,0.00011521121,0.00007586182,0.00024614928,0.00009155111,0.00038998722],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043521659,0.0002468083,0.0009896863,0.00009598182,0.00012504972,0.000020665828,0.00017885063,0.00012027745,0.00007674605],"category_scores_gemma":[0.00012804529,0.00013405307,0.00048720403,0.00033916841,0.00014208675,0.000074647935,0.000048847312,0.00059188943,0.00006762312],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16587299,0.00013316101,0.7960733,0.000028955554,0.006130127,0.024879592,0.00019137414,0.0004692861,0.00027942768,0.0000032972082,0.0015546205,0.004383821],"study_design_scores_gemma":[0.08143767,0.014092742,0.88860875,0.000084523155,0.0015403607,0.013218168,0.000035582707,0.000036385733,0.00004326866,0.00001110231,0.0006909519,0.00020047893],"about_ca_topic_score_codex":0.000002843184,"about_ca_topic_score_gemma":4.3160853e-7,"teacher_disagreement_score":0.09253542,"about_ca_system_score_codex":0.00008251115,"about_ca_system_score_gemma":0.00009324072,"threshold_uncertainty_score":0.54665256},"labels":[],"label_agreement":null},{"id":"W3013308201","doi":"10.1017/cem.2020.17","title":"Outcome of applying the European Society of Cardiology (ESC) 0/1-hour algorithm in patients with suspected myocardial infarction","year":2020,"lang":"en","type":"letter","venue":"Canadian Journal of Emergency Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Myocardial infarction; Cardiology; Internal medicine; Algorithm; Computer science","score_opus":0.041135158900714786,"score_gpt":0.26720504467876915,"score_spread":0.22606988577805437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013308201","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.29646337,0.042263784,0.0065281177,0.6027389,0.030616086,0.008508478,0.0009958028,0.00007688114,0.011808594],"genre_scores_gemma":[0.8978739,0.0037774288,0.00030003447,0.06803575,0.028919747,0.000026844928,0.00055601244,0.00027777202,0.00023254496],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968455,0.0004938096,0.0013376491,0.00022813345,0.00073063845,0.000364313],"domain_scores_gemma":[0.99770814,0.000052136038,0.0008130915,0.00036961833,0.0007292419,0.00032778698],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075212424,0.00031784573,0.001523966,0.00032086013,0.000067716996,0.0000019866388,0.00030768718,0.00022060164,0.00026366394],"category_scores_gemma":[0.00018363376,0.0001970765,0.0008798207,0.00056704896,0.0003496049,0.00005189017,0.00001650493,0.001584637,0.0000018255981],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015557345,0.000014146332,0.45144674,0.0003549841,0.0038010157,0.0007467782,0.0006134215,0.000053406286,0.00002143935,0.0000011060616,0.5342757,0.008515667],"study_design_scores_gemma":[0.005351633,0.0013818848,0.45804057,0.0007960526,0.0021572176,0.00008008533,0.00051369576,0.000011044403,0.0000042819092,0.000020925994,0.5313866,0.00025598585],"about_ca_topic_score_codex":0.001590796,"about_ca_topic_score_gemma":0.0001671433,"teacher_disagreement_score":0.6014105,"about_ca_system_score_codex":0.00014022463,"about_ca_system_score_gemma":0.0006652998,"threshold_uncertainty_score":0.8036547},"labels":[],"label_agreement":null},{"id":"W3013321278","doi":"10.1016/j.jacc.2020.03.011","title":"Ticagrelor With or Without Aspirin After Complex PCI","year":2020,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":172,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"British Heart Foundation","keywords":"Medicine; Ticagrelor; Aspirin; Conventional PCI; Percutaneous coronary intervention; Myocardial infarction; Hazard ratio; Internal medicine; Cardiology; Placebo; Stroke (engine); Stent; Surgery; Confidence interval","score_opus":0.024018351571015107,"score_gpt":0.26753159518919156,"score_spread":0.24351324361817644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013321278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916644,0.00063159247,0.0014086501,0.005114012,0.000080062106,0.00022445279,0.0000403947,0.000009157211,0.0008272552],"genre_scores_gemma":[0.99486583,0.00018494263,0.0012079116,0.0030996713,0.0005235546,0.0000033582717,6.650272e-7,0.00002172362,0.0000923292],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987305,0.0002473252,0.00036095633,0.00012764709,0.0003574606,0.00017610058],"domain_scores_gemma":[0.9988075,0.000074983895,0.000431889,0.00027297938,0.00023160741,0.00018103814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018088987,0.00014341007,0.0012790349,0.000053091622,0.000033838696,0.0000027859833,0.00021628002,0.00003360886,0.00005652369],"category_scores_gemma":[0.00007936298,0.00006940339,0.00071103405,0.00035069534,0.00066615077,0.00003596296,0.000051866427,0.00022453349,0.000004369972],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13944426,0.00019123002,0.7820928,0.00033096786,0.017051866,0.009566937,0.0003253006,0.0011548437,0.011147419,0.0001242307,0.024261193,0.014308943],"study_design_scores_gemma":[0.0138409715,0.01731246,0.56174034,0.0004016041,0.0049652313,0.039208613,0.0028582304,0.00019852158,0.0020639019,0.000050625342,0.35686886,0.0004906215],"about_ca_topic_score_codex":0.0000018950467,"about_ca_topic_score_gemma":0.0000010665491,"teacher_disagreement_score":0.3326077,"about_ca_system_score_codex":0.000026013222,"about_ca_system_score_gemma":0.00030355458,"threshold_uncertainty_score":0.2830188},"labels":[],"label_agreement":null},{"id":"W3013912639","doi":"10.1016/j.jacc.2020.03.008","title":"Ticagrelor With or Without Aspirin in High-Risk Patients With Diabetes Mellitus Undergoing Percutaneous Coronary Intervention","year":2020,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"British Heart Foundation","keywords":"Medicine; Percutaneous coronary intervention; Ticagrelor; Aspirin; Diabetes mellitus; Internal medicine; Cardiology; Conventional PCI; Intervention (counseling); Clopidogrel; Myocardial infarction; Endocrinology; Nursing","score_opus":0.007252439192800467,"score_gpt":0.22181615552219805,"score_spread":0.21456371632939758,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013912639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99785554,0.00069658,0.00046767134,0.0005221451,0.00007020978,0.00029939262,0.000037645354,0.0000075689736,0.000043252607],"genre_scores_gemma":[0.9984501,0.00036503337,0.0006802726,0.00033254735,0.00012504963,0.0000026061923,0.0000027629771,0.00002541675,0.000016230917],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99842227,0.00043484365,0.00041913852,0.00016066138,0.00036559484,0.00019751338],"domain_scores_gemma":[0.99863327,0.00017287675,0.0006558049,0.00021282845,0.00020369732,0.000121530975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021258563,0.0001622035,0.0011381019,0.00008713896,0.000040585266,0.0000035873422,0.00017807403,0.00003884547,0.0000118429125],"category_scores_gemma":[0.00013629952,0.00008199193,0.00040766515,0.00036613405,0.00041867435,0.000060259197,0.0000441839,0.00029134922,0.0000011334333],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01658447,0.000095925345,0.97116095,0.00008432498,0.0023197485,0.00092771644,0.000057409732,0.0016482134,0.000112188536,0.0000072013277,0.0000869482,0.006914914],"study_design_scores_gemma":[0.010018132,0.019104157,0.9632724,0.0006625165,0.0018033731,0.0023848466,0.0014339335,0.000101245765,0.00023958934,0.00003341059,0.00074453914,0.0002018614],"about_ca_topic_score_codex":0.000009238813,"about_ca_topic_score_gemma":0.000015571897,"teacher_disagreement_score":0.01900823,"about_ca_system_score_codex":0.000069945665,"about_ca_system_score_gemma":0.00021973865,"threshold_uncertainty_score":0.3343534},"labels":[],"label_agreement":null},{"id":"W3016068993","doi":"10.1093/cvr/cvaa100","title":"Efficacy and safety of rivaroxaban plus aspirin in women and men with chronic coronary or peripheral artery disease","year":2020,"lang":"en","type":"article","venue":"Cardiovascular Research","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton General Hospital; Heart and Stroke Foundation; Population Health Research Institute; Université Laval; Hamilton Health Sciences; McMaster University","funders":"Bayer","keywords":"Aspirin; Rivaroxaban; Medicine; Arterial disease; Cardiology; Coronary artery disease; Internal medicine; Peripheral; Vascular disease; Atrial fibrillation; Warfarin","score_opus":0.036887973555695654,"score_gpt":0.2954034315763324,"score_spread":0.25851545802063675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016068993","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9445251,0.05318786,0.00018058326,0.00038148835,0.000008800079,0.0012835029,0.000016339689,0.000033417797,0.00038289547],"genre_scores_gemma":[0.99213624,0.007268176,0.000047463105,0.000096949094,0.0001690315,0.00010580765,0.000021700369,0.000047872934,0.00010677513],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9970248,0.00049415155,0.00026078578,0.0006073326,0.0010575358,0.00055542495],"domain_scores_gemma":[0.9983763,0.00009925562,0.000023893368,0.0006216273,0.00012601881,0.00075292384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011646945,0.00021874391,0.00086639344,0.0001420155,0.00010924548,0.000031628195,0.0001343681,0.000083046805,0.000095533745],"category_scores_gemma":[0.00013168307,0.00016183793,0.0003150286,0.000507488,0.0006064982,0.00011931029,0.00017828704,0.00041637418,0.000004980267],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.21169873,0.0007543933,0.123220235,0.008474713,0.027051382,0.026858784,0.010084539,0.003276925,0.0020038132,0.00020654884,0.0005920255,0.58577794],"study_design_scores_gemma":[0.040780805,0.0030165217,0.92496705,0.00079664285,0.0005443763,0.0005646655,0.0017056699,0.0014718231,0.00020658667,0.00003538502,0.0254274,0.00048306937],"about_ca_topic_score_codex":0.000028926022,"about_ca_topic_score_gemma":0.0000032265496,"teacher_disagreement_score":0.80174685,"about_ca_system_score_codex":0.00024005224,"about_ca_system_score_gemma":0.0006593239,"threshold_uncertainty_score":0.6599559},"labels":[],"label_agreement":null},{"id":"W3016977922","doi":"10.22088/cjim.11.2.124","title":"Prevalence rate of laboratory defined aspirin resistance in cardiovascular disease patients: A systematic review and meta-analysis.","year":2020,"lang":"en","type":"review","venue":"PubMed","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Aspirin; Cochrane Library; Meta-analysis; Odds ratio; MEDLINE; Internal medicine; Disease; Drug resistance; Intensive care medicine","score_opus":0.041826059059627455,"score_gpt":0.2612580711805011,"score_spread":0.21943201212087365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016977922","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000005322911,0.98836666,0.000013426387,0.000057161174,0.000017305747,0.010823528,0.00064666604,0.00003355584,0.000036395562],"genre_scores_gemma":[0.0001982998,0.9875575,0.00002165215,0.00039038374,0.000017236755,0.011451222,0.0001494848,0.000056670142,0.00015755618],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99449176,0.0021277396,0.0015324727,0.00085726357,0.0006484991,0.00034226687],"domain_scores_gemma":[0.99683493,0.00017824523,0.0006685941,0.0016305998,0.00024250029,0.00044513392],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0021672659,0.00059179077,0.014931215,0.00029984856,0.000027635377,0.000019920195,0.0002656032,0.00013779821,0.000023291517],"category_scores_gemma":[0.0013055,0.0004053688,0.0097516375,0.0018866424,0.0001035653,0.00009178907,0.000081885846,0.00026499474,0.0000064107617],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021897979,0.00006271572,0.00003952759,0.68666434,0.30972862,0.00010919259,0.0000041453914,4.4755222e-7,4.1934012e-10,0.000012676268,0.000024782852,0.0033316244],"study_design_scores_gemma":[0.00040020997,0.0000088836105,0.0010283767,0.037744336,0.88460994,0.0000018302983,0.0000012677518,1.6920924e-7,4.5831907e-8,0.000004441075,0.0759124,0.00028812865],"about_ca_topic_score_codex":0.000003855585,"about_ca_topic_score_gemma":0.0000019013316,"teacher_disagreement_score":0.64892006,"about_ca_system_score_codex":0.0000956697,"about_ca_system_score_gemma":0.00021775748,"threshold_uncertainty_score":0.99983984},"labels":[],"label_agreement":null},{"id":"W3017778342","doi":"10.1016/j.jtcvs.2020.04.051","title":"Commentary: Rushing to revascularize may be risky, but one size does not fit all","year":2020,"lang":"en","type":"letter","venue":"Journal of Thoracic and Cardiovascular Surgery","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; University of Toronto","funders":"University of Toronto","keywords":"Medicine; Perioperative; Clopidogrel; Acute coronary syndrome; Context (archaeology); Bypass grafting; Artery; Internal medicine; Cardiology; Guideline; Scopus; Adverse effect; Myocardial infarction; Coronary artery bypass surgery; MEDLINE; Surgery","score_opus":0.04385442785959906,"score_gpt":0.28711238819372803,"score_spread":0.24325796033412897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3017778342","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07189943,0.09517931,0.0017036425,0.8272817,0.0022493938,0.0011386208,0.0002955864,0.00012958114,0.00012269917],"genre_scores_gemma":[0.042230427,0.036658198,0.001679159,0.9028176,0.015642127,0.000034375724,0.00017075514,0.00029919262,0.00046815322],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99175704,0.0014375636,0.0016217254,0.00094197714,0.003355544,0.0008861248],"domain_scores_gemma":[0.9953301,0.0010687974,0.00069048145,0.0014961846,0.00050952734,0.0009049436],"candidate_categories":["metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0035629936,0.0009874933,0.0053227525,0.0005135161,0.00024113894,0.00025063043,0.0004674815,0.00089239125,0.00024871872],"category_scores_gemma":[0.00095475785,0.0007389822,0.013234085,0.00042444613,0.00021983196,0.00033465945,0.000273143,0.0033106084,0.000022251985],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015881697,0.00012750951,0.0012218606,0.0021781481,0.064427674,0.029702516,0.00019140173,0.000029592204,0.00019741541,6.348134e-7,0.8402416,0.06009348],"study_design_scores_gemma":[0.0010551767,0.00021114871,0.00086718926,0.0020040458,0.020925898,0.0037405863,0.0002513065,0.000004109235,0.0014292371,0.00004106241,0.9685622,0.0009080552],"about_ca_topic_score_codex":0.000120522156,"about_ca_topic_score_gemma":0.0000017016682,"teacher_disagreement_score":0.12832059,"about_ca_system_score_codex":0.00018214552,"about_ca_system_score_gemma":0.00036740617,"threshold_uncertainty_score":0.9995061},"labels":[],"label_agreement":null},{"id":"W3021319484","doi":"10.1016/j.ahj.2020.04.017","title":"Blunting periprocedural myocardial necrosis: Rationale and design of the randomized ALPHEUS study","year":2020,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institut de Cardiométabolisme et Nutrition; Commission for Environmental Cooperation; AstraZeneca","keywords":"Medicine; Ticagrelor; Clopidogrel; Conventional PCI; Aspirin; Percutaneous coronary intervention; Myocardial infarction; Cardiology; Internal medicine; P2Y12; Loading dose; Randomized controlled trial; Stent; Coronary artery disease","score_opus":0.024663646294443828,"score_gpt":0.26852368966123236,"score_spread":0.24386004336678851,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3021319484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99227524,0.0017311218,0.0018825801,0.0031987177,0.000064509215,0.0007915076,0.0000017509697,0.000013621268,0.000040945448],"genre_scores_gemma":[0.9961539,0.00023701998,0.00074119424,0.0025051583,0.00031689683,0.00001498608,4.607348e-7,0.0000131370425,0.000017260638],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985803,0.0005076793,0.00028625605,0.00012883852,0.00036130805,0.00013566249],"domain_scores_gemma":[0.9993529,0.00014884249,0.00014038678,0.00010453157,0.000100349476,0.0001530074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060419703,0.00010356644,0.0006593909,0.000024145207,0.00017786682,0.000032469732,0.00006191756,0.000014586411,0.000051599687],"category_scores_gemma":[0.0004076136,0.00006328006,0.00045364373,0.00018573122,0.00034235526,0.00006333089,0.000028986451,0.00019076257,0.0000030732588],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22732732,0.00122557,0.62403554,0.00018092545,0.014397982,0.0002542052,0.031191029,0.004068614,0.04667777,0.000057776084,0.010626244,0.03995703],"study_design_scores_gemma":[0.40778542,0.005667133,0.5125901,0.00039804826,0.0067556817,0.006045284,0.039950836,0.009106967,0.004165824,0.0001700631,0.0064693047,0.00089529966],"about_ca_topic_score_codex":0.000015231854,"about_ca_topic_score_gemma":1.1955568e-7,"teacher_disagreement_score":0.1804581,"about_ca_system_score_codex":0.000009896575,"about_ca_system_score_gemma":0.00016938783,"threshold_uncertainty_score":0.2580486},"labels":[],"label_agreement":null},{"id":"W3022090417","doi":"10.1016/b978-0-12-387837-3.00028-6","title":"Platelet Aggregation","year":2012,"lang":"en","type":"book-chapter","venue":"Platelets","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Regional Laboratory Medicine Program","funders":"","keywords":"Platelet aggregation; Medicine; Business; Platelet; Internal medicine","score_opus":0.01993176667237999,"score_gpt":0.23581670588303505,"score_spread":0.21588493921065505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3022090417","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014444961,0.06479414,0.00010477593,0.00019871078,0.0006866637,0.0009905689,0.000097344535,0.0004094671,0.9182734],"genre_scores_gemma":[0.18432839,0.019635448,0.00030347068,0.0011991977,0.0030242773,0.000032669363,0.0016966851,0.00038025252,0.7893996],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99815655,0.000015663994,0.00037769324,0.0004314032,0.00060521957,0.00041350172],"domain_scores_gemma":[0.9986673,0.000044983237,0.00018445242,0.0006448863,0.000110890236,0.0003474981],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0001815589,0.00049612083,0.0008521342,0.00019052491,0.00009712053,0.000025623916,0.00011531986,0.0006835761,0.004795764],"category_scores_gemma":[0.000018962899,0.00045504305,0.00082491885,0.000032829364,0.000108786524,0.000116149364,0.0000459906,0.00054244016,0.0032363546],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006432607,0.00010444588,0.00012544412,0.00041971292,0.0032242003,0.002149559,0.000114547955,0.00000374961,0.00017878618,0.020769374,0.011541957,0.96072495],"study_design_scores_gemma":[0.0015911626,0.00011023716,0.00022205444,0.0005150039,0.000798615,0.0015386121,0.0000042157176,0.000006821356,0.0015989954,0.0019204967,0.99117273,0.0005210426],"about_ca_topic_score_codex":0.000003258465,"about_ca_topic_score_gemma":9.3976735e-7,"teacher_disagreement_score":0.97963077,"about_ca_system_score_codex":0.000101246296,"about_ca_system_score_gemma":0.00011321382,"threshold_uncertainty_score":0.99979013},"labels":[],"label_agreement":null},{"id":"W3022207339","doi":"10.1016/j.jtcvs.2020.04.053","title":"Commentary: Enough is enough, but when is enough enough?","year":2020,"lang":"en","type":"letter","venue":"Journal of Thoracic and Cardiovascular Surgery","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Computer science","score_opus":0.027020415236870887,"score_gpt":0.26126982651914676,"score_spread":0.2342494112822759,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3022207339","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015095505,0.35265365,0.0009757783,0.627238,0.0021317073,0.00087456213,0.00041299532,0.00011948043,0.00049836363],"genre_scores_gemma":[0.0267564,0.10100317,0.0008641261,0.8470217,0.0223802,0.000035891266,0.00046466786,0.00042439115,0.0010494413],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99070376,0.0012966461,0.001978095,0.0011993701,0.0036435467,0.0011786065],"domain_scores_gemma":[0.9949902,0.00053420546,0.0010675935,0.0018704734,0.00073198066,0.00080550043],"candidate_categories":["metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0024564923,0.0013674155,0.0060832384,0.00068268145,0.00041771907,0.00026864934,0.0006098275,0.0013534116,0.00083425007],"category_scores_gemma":[0.00020229431,0.0011724521,0.01566612,0.00051091367,0.00043334765,0.0005423853,0.00026270552,0.0039980784,0.00009847077],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007916178,0.00013687584,0.0004518439,0.0018162511,0.04272141,0.027069911,0.0010745378,0.000003622586,0.00002758297,0.000001017783,0.81321377,0.11269156],"study_design_scores_gemma":[0.0013232597,0.00032851472,0.00019491455,0.0015219612,0.016424976,0.009790652,0.00044105426,0.0000069382486,0.0014740537,0.00020046644,0.9671722,0.0011209967],"about_ca_topic_score_codex":0.00012366501,"about_ca_topic_score_gemma":3.7050668e-7,"teacher_disagreement_score":0.25165048,"about_ca_system_score_codex":0.00022257477,"about_ca_system_score_gemma":0.00074948993,"threshold_uncertainty_score":0.999943},"labels":[],"label_agreement":null},{"id":"W3025260826","doi":"10.1111/j.1538-7836.2006.02234.x","title":"Evidence that pre‐existent variability in platelet response to ADP accounts for ‘clopidogrel resistance’","year":2006,"lang":"en","type":"article","venue":"Journal of Thrombosis and Haemostasis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"Clopidogrel; Platelet; P2Y12; Medicine; Aspirin; Adenosine diphosphate; Ticlopidine; Internal medicine; Pharmacology; Ticagrelor; Cardiology; Platelet aggregation","score_opus":0.07613211955272191,"score_gpt":0.34041604421250876,"score_spread":0.26428392465978684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3025260826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98665243,0.006045804,0.0018439523,0.0045754607,0.00014346061,0.00059041305,0.00005503612,0.000010040603,0.00008338899],"genre_scores_gemma":[0.99343,0.0027267959,0.0029838374,0.0005199494,0.00018272686,0.000019802155,0.0000036360004,0.000020917261,0.00011230155],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981817,0.00024851432,0.0005674287,0.0002584858,0.00047458604,0.0002692732],"domain_scores_gemma":[0.99837357,0.00060179713,0.0002901061,0.00029920993,0.0002584304,0.00017691453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030493878,0.0001839393,0.0007180392,0.00018920189,0.000095402385,0.000057067617,0.00012976072,0.00010800954,0.000047431513],"category_scores_gemma":[0.00068281,0.00014430964,0.00043973228,0.00022026115,0.00007383685,0.00024850294,0.000035688096,0.00016106083,0.0000017284286],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20943083,0.0033049912,0.4925156,0.0023493543,0.0038281821,0.0006407642,0.002944503,0.0004296018,0.020531392,0.00061144197,0.0692595,0.19415385],"study_design_scores_gemma":[0.0049593546,0.00076303136,0.9443418,0.0019403514,0.00052295614,0.00012367437,0.00027926275,0.000016823265,0.0066633113,0.00089261646,0.039246168,0.00025065645],"about_ca_topic_score_codex":0.000037322865,"about_ca_topic_score_gemma":0.00004512876,"teacher_disagreement_score":0.45182618,"about_ca_system_score_codex":0.00016036411,"about_ca_system_score_gemma":0.00015673961,"threshold_uncertainty_score":0.5884777},"labels":[],"label_agreement":null},{"id":"W3025638984","doi":"10.1161/hcq.13.suppl_1.283","title":"Abstract 283: Variation In Ticagrelor Utilization And Outcomes In Patients With Acute Coronary Syndrome","year":2020,"lang":"en","type":"article","venue":"Circulation Cardiovascular Quality and Outcomes","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences","funders":"","keywords":"Ticagrelor; Medicine; Acute coronary syndrome; Clopidogrel; Hazard ratio; Internal medicine; Quartile; Myocardial infarction; Proportional hazards model; Population; Cohort; Unstable angina; Emergency medicine; Cardiology; Confidence interval","score_opus":0.03854600091673943,"score_gpt":0.28067215209259233,"score_spread":0.2421261511758529,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3025638984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946883,0.001690575,0.00205295,0.0005589996,0.000043831267,0.00085061707,0.000024183286,0.000056407258,0.000034154342],"genre_scores_gemma":[0.9986441,0.00030108937,0.0001371042,0.0006973762,0.000014281879,0.000021117377,0.00015501796,0.000025740976,0.000004145851],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979914,0.00020459344,0.00048701282,0.00048963417,0.00061253854,0.00021480821],"domain_scores_gemma":[0.9992482,0.00008912444,0.00009195065,0.00032056015,0.000083220155,0.00016693248],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005620862,0.00024484587,0.0009553152,0.00013822634,0.000070081354,0.000037836333,0.000048709702,0.00014986843,0.000023204651],"category_scores_gemma":[0.00013946164,0.00020394253,0.00038583775,0.00029087724,0.00007576083,0.00039253282,0.000031318712,0.0001731174,0.000005463145],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029742482,0.00012462147,0.98719174,0.0001934168,0.0021783193,0.0001227115,0.00042968546,0.00041265044,0.000011479896,0.00018232694,7.309009e-7,0.00885487],"study_design_scores_gemma":[0.007853479,0.000076191434,0.99071515,0.00005663714,0.00056708744,0.000027864313,0.00009656899,0.0002009682,0.0000042374954,0.0000896004,0.000060661492,0.0002515305],"about_ca_topic_score_codex":0.00006693843,"about_ca_topic_score_gemma":0.000007130625,"teacher_disagreement_score":0.00860334,"about_ca_system_score_codex":0.000060437167,"about_ca_system_score_gemma":0.000050457875,"threshold_uncertainty_score":0.83165354},"labels":[],"label_agreement":null},{"id":"W3029263531","doi":"10.3760/cma.j.issn.1672-7088.2006.01.004","title":"Study the position in bed for the patients who have used heparin sodium after percutaneous coronary intervention therapy","year":2006,"lang":"en","type":"article","venue":"˜The œJournal of practical nursing","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Percutaneous coronary intervention; Heparin; Heparin sodium; Internal medicine; Cardiology; Surgery; Myocardial infarction","score_opus":0.022287797074631164,"score_gpt":0.3231154113846538,"score_spread":0.3008276143100226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3029263531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907493,0.0019027997,0.0030061016,0.0030075863,0.00021826457,0.00103995,0.0000026876082,0.0000057061293,0.0000676286],"genre_scores_gemma":[0.9990972,0.00009847982,0.0000614673,0.00035357807,0.00030286243,0.000014672516,0.0000048446213,0.000020062198,0.00004680169],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9983143,0.00050948677,0.00041432722,0.00010743491,0.00046839076,0.00018604977],"domain_scores_gemma":[0.99876213,0.0006014723,0.00020707215,0.00021235316,0.00017504519,0.000041939806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010808025,0.00012725609,0.00024266388,0.000049833103,0.0001950524,0.000056727396,0.00011090936,0.000054238593,0.000024576239],"category_scores_gemma":[0.000051391464,0.000060078426,0.00038673662,0.00008051301,0.00013904001,0.00016989626,0.000011191644,0.0003617621,0.0000019540882],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1432514,0.026304144,0.36069205,0.00006262415,0.0039239633,0.0025388983,0.0147417905,0.00039562356,0.0019188969,0.00013063673,0.0037406336,0.44229934],"study_design_scores_gemma":[0.010356695,0.0040149065,0.96627367,0.00039347712,0.0015707121,0.004620297,0.009201485,0.00096907833,0.0002532895,0.0009368988,0.0012480161,0.00016148764],"about_ca_topic_score_codex":0.000036210877,"about_ca_topic_score_gemma":0.000037955793,"teacher_disagreement_score":0.6055816,"about_ca_system_score_codex":0.00012173496,"about_ca_system_score_gemma":0.00004477442,"threshold_uncertainty_score":0.2449927},"labels":[],"label_agreement":null},{"id":"W3030109053","doi":"10.3760/cma.j.issn.1001-4497.2016.01.007","title":"Benefit and safety of dual anti-platelet therapy after coronary artery bypass grafting: a Meta-analysis of 15 studies","year":2016,"lang":"en","type":"article","venue":"Chinese Journal of Thoracic and Cardiovaescular Surgery","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Aspirin; Cochrane Library; Randomized controlled trial; Observational study; Meta-analysis; Placebo; Surgery; Internal medicine; Clopidogrel","score_opus":0.03787707827634942,"score_gpt":0.3063370733509178,"score_spread":0.2684599950745684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3030109053","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.68535465,0.31383395,0.00033904382,0.00017835102,0.000094369905,0.00012494375,0.00005621128,0.0000073136466,0.000011172606],"genre_scores_gemma":[0.9190829,0.08051456,0.000097664095,0.00009803768,0.00012931794,0.000007061597,0.000006472468,0.000029561574,0.00003443466],"study_design_codex":"meta_analysis","study_design_gemma":"observational","domain_scores_codex":[0.9970917,0.00035921947,0.0011742893,0.00031163075,0.00080862374,0.00025450677],"domain_scores_gemma":[0.99742806,0.0005936024,0.00063005456,0.00049554865,0.00063905306,0.0002136949],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025929317,0.00039111575,0.004685063,0.0006451188,0.0000672877,0.000013858462,0.00008075788,0.00013547548,0.000068173686],"category_scores_gemma":[0.00018229989,0.00019406769,0.0069595627,0.00060814194,0.0003843143,0.00026077902,0.00006596395,0.00015842791,4.957669e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004712902,0.00017128637,0.25805435,0.00026363306,0.6589152,0.0016322384,0.00030957625,0.000048112324,0.0018514446,0.000004402076,0.000052064766,0.073984794],"study_design_scores_gemma":[0.0021114985,0.00028096378,0.7580756,0.00029914608,0.23062344,0.003958468,0.00041330358,0.000009174253,0.0027433606,0.00019841724,0.00087450165,0.0004121398],"about_ca_topic_score_codex":0.0000032386868,"about_ca_topic_score_gemma":0.0000013070987,"teacher_disagreement_score":0.5000213,"about_ca_system_score_codex":0.000020152298,"about_ca_system_score_gemma":0.00008460588,"threshold_uncertainty_score":0.79138505},"labels":[],"label_agreement":null},{"id":"W3030148622","doi":"10.1111/bcp.14310","title":"Effect of low‐dose aspirin on health outcomes: An umbrella review of systematic reviews and meta‐analyses","year":2020,"lang":"en","type":"review","venue":"British Journal of Clinical Pharmacology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Global Health Research","funders":"Instituto de Salud Carlos III; National Institute for Health and Care Research; Department of Health and Social Care; Cancer Research UK; European Regional Development Fund; King's College London; King's College Hospital NHS Foundation Trust","keywords":"Medicine; Aspirin; Observational study; Randomized controlled trial; Relative risk; Internal medicine; Meta-analysis; Placebo; Population; Confidence interval; Alternative medicine; Pathology; Environmental health","score_opus":0.39619558479226374,"score_gpt":0.6020476870058424,"score_spread":0.2058521022135787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3030148622","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009533563,0.9948549,0.000013870548,0.00024014366,0.0005478463,0.0041438676,0.0000664943,0.000008726603,0.000028817241],"genre_scores_gemma":[0.00005392788,0.99412256,0.00007503817,0.0050841556,0.0004990798,0.00006536571,0.000025038222,0.00005565939,0.000019150455],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9713714,0.018827537,0.008468421,0.0004265226,0.00064785953,0.0002582625],"domain_scores_gemma":[0.9854742,0.0050260164,0.0080707595,0.00038537878,0.00030211473,0.00074151595],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.016933361,0.00053683034,0.03180102,0.00016872298,0.000037461683,0.0000107551605,0.00042029624,0.00031190057,0.00026949463],"category_scores_gemma":[0.00488844,0.00033884612,0.01108471,0.00031600613,0.00026603366,0.00006981265,0.00006752559,0.0013623649,0.000012523665],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017450597,0.00030689887,0.0000030087526,0.54454076,0.022283278,0.000754351,0.0000016524373,1.7932946e-7,2.466683e-7,4.8336045e-7,0.0023426313,0.429592],"study_design_scores_gemma":[0.002784651,0.0057356628,0.000018336705,0.54578125,0.21132031,0.0042631463,0.0000015139672,8.6742665e-7,0.0000027749907,0.0000016781031,0.22992192,0.00016789592],"about_ca_topic_score_codex":0.000009032757,"about_ca_topic_score_gemma":6.491102e-7,"teacher_disagreement_score":0.42942414,"about_ca_system_score_codex":0.000038246897,"about_ca_system_score_gemma":0.0007475414,"threshold_uncertainty_score":0.99990636},"labels":[],"label_agreement":null},{"id":"W3031115393","doi":"10.1161/circulationaha.120.046786","title":"Comparative Efficacy and Safety of Oral P2Y <sub>12</sub> Inhibitors in Acute Coronary Syndrome","year":2020,"lang":"en","type":"article","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":141,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Institute of General Medical Sciences","keywords":"Medicine; Acute coronary syndrome; Internal medicine; Intensive care medicine; Cardiology; Myocardial infarction","score_opus":0.02450122144162067,"score_gpt":0.2602579650722887,"score_spread":0.23575674363066804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3031115393","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99765444,0.0012146997,0.00039047803,0.00016885856,0.000032798616,0.0004198857,0.00001034838,0.000024934923,0.000083540406],"genre_scores_gemma":[0.99952424,0.00016589428,0.00003213175,0.00013265066,0.00002223958,0.0000045654697,0.00010711847,0.00000999285,0.000001144208],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99925804,0.00006343058,0.00022071364,0.00018497667,0.00017467162,0.000098146455],"domain_scores_gemma":[0.99968565,0.000027932378,0.000058519276,0.0001021,0.000033037613,0.00009277279],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008391309,0.000098597804,0.00036640943,0.000050313014,0.000029280907,0.0000046540285,0.00002550653,0.000062573,0.000015109129],"category_scores_gemma":[0.000015431024,0.000095768824,0.00010118638,0.00017103029,0.00007182232,0.000094431736,0.000016716636,0.0000897099,0.000008369139],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031839935,0.00028764983,0.8041389,0.000244255,0.0012757668,0.0004923385,0.0031874075,0.0021417183,0.1530642,0.00013925409,0.00011860632,0.031725887],"study_design_scores_gemma":[0.0034482302,0.00013868156,0.98817617,0.00009711121,0.00020349561,0.00011516379,0.00011489087,0.0010936939,0.006420528,0.000026466387,0.000073040006,0.00009255744],"about_ca_topic_score_codex":0.0000037041375,"about_ca_topic_score_gemma":0.0000012257432,"teacher_disagreement_score":0.18403722,"about_ca_system_score_codex":0.000026666037,"about_ca_system_score_gemma":0.0000376769,"threshold_uncertainty_score":0.39053392},"labels":[],"label_agreement":null},{"id":"W3033326294","doi":"10.1007/s00415-020-09932-y","title":"Platelet function/reactivity testing and prediction of risk of recurrent vascular events and outcomes after TIA or ischaemic stroke: systematic review and meta-analysis","year":2020,"lang":"en","type":"review","venue":"Journal of Neurology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Meath Foundation; Irish Institute of Clinical Neuroscience; Trinity College Dublin; Irish Heart Foundation; Sanofi; Bayer HealthCare; British Heart Foundation; Biogen; Amgen; State Government of Victoria; Heart and Stroke Foundation of Canada; Pfizer; U.S. Department of Veterans Affairs; Alnylam Pharmaceuticals; National Institute for Health and Care Research","keywords":"Medicine; Clopidogrel; Internal medicine; Aspirin; Stroke (engine); Modified Rankin Scale; Myocardial infarction; Neurology; Meta-analysis; Platelet aggregation inhibitor; Cardiology; Cochrane Library; Ischemia; Ischemic stroke","score_opus":0.05892811836044125,"score_gpt":0.3070638768093184,"score_spread":0.24813575844887714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033326294","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008953072,0.9897439,0.000118672935,0.000058426347,0.000056710054,0.00085611746,0.0002063635,0.000005178911,0.0000015697033],"genre_scores_gemma":[0.010087559,0.98963547,0.000055551896,0.00012628081,0.000035802244,0.000025006426,0.000006608833,0.000021892187,0.00000584009],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9964955,0.0012618762,0.0014725863,0.0002844266,0.00036577892,0.00011985471],"domain_scores_gemma":[0.9962709,0.0007898463,0.0023083605,0.00028737797,0.00019815876,0.0001453657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011330284,0.0003282072,0.008983914,0.00031448645,0.000028396675,0.000005555966,0.00007097948,0.00017833045,0.00003168369],"category_scores_gemma":[0.0011834658,0.00017979993,0.00271685,0.00031884393,0.0000803614,0.0000845673,0.00005750899,0.000559032,3.4649898e-7],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000445055,0.000116363335,0.0043063117,0.5414491,0.42996824,0.00024360298,0.000024543544,0.0000016705893,0.0000010981877,5.745854e-7,0.000011974935,0.023431424],"study_design_scores_gemma":[0.00065552315,0.0009564995,0.0071021635,0.007943615,0.97704214,0.002457514,0.0000045010474,0.000008660628,2.3766952e-7,0.000006397004,0.003726379,0.00009637005],"about_ca_topic_score_codex":0.0000043557925,"about_ca_topic_score_gemma":0.0000016861792,"teacher_disagreement_score":0.5470739,"about_ca_system_score_codex":0.000010399251,"about_ca_system_score_gemma":0.000092563314,"threshold_uncertainty_score":0.7332028},"labels":[],"label_agreement":null},{"id":"W3034279729","doi":"10.2337/db20-403-p","title":"403-P: Impact of Diabetes-Related Factors and Background Antihyperglycemic Therapy on the Efficacy and Safety of Ticagrelor Added to Aspirin: Insights from the THEMIS Trial","year":2020,"lang":"en","type":"article","venue":"Diabetes","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ticagrelor; Medicine; Mace; Internal medicine; Aspirin; Diabetes mellitus; Stroke (engine); TIMI; Placebo; Type 2 diabetes; Conventional PCI; Myocardial infarction; Clopidogrel; Endocrinology","score_opus":0.028327581846401707,"score_gpt":0.2575246463528806,"score_spread":0.22919706450647886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034279729","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99143827,0.006617325,0.0000013606036,0.00067176786,0.000052193594,0.0009982145,0.000099839664,0.000028050019,0.00009297025],"genre_scores_gemma":[0.9983813,0.0006929012,0.000005646724,0.00070454966,0.00012230831,0.000010527279,0.000049331346,0.000029316388,0.0000040771397],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986699,0.00019178228,0.0003374595,0.00029902326,0.00028651324,0.00021527284],"domain_scores_gemma":[0.99785906,0.0013831346,0.000119978955,0.00039956218,0.000057713332,0.00018053922],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015317665,0.00025999526,0.00067480525,0.000034966313,0.000094814146,0.000022167018,0.00016295053,0.00010497091,0.00014054886],"category_scores_gemma":[0.00022072229,0.000116829906,0.00039126727,0.00026001624,0.00025386192,0.000048233596,0.00005178317,0.00018677114,0.000004991652],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0665284,0.0009960673,0.45972538,0.0001575735,0.017454686,0.000009382685,0.01173894,0.00006179565,0.39416268,0.00033377507,0.0011146934,0.047716603],"study_design_scores_gemma":[0.048225798,0.0060473,0.8462605,0.00038010583,0.0006925847,4.5147928e-7,0.0005884764,0.00015216372,0.09628496,0.00016795729,0.0008607348,0.0003389566],"about_ca_topic_score_codex":0.000025455563,"about_ca_topic_score_gemma":4.2453752e-7,"teacher_disagreement_score":0.3865351,"about_ca_system_score_codex":0.000013204742,"about_ca_system_score_gemma":0.000052186468,"threshold_uncertainty_score":0.47641855},"labels":[],"label_agreement":null},{"id":"W3037187678","doi":"10.1055/s-0040-1713376","title":"Dual Pathway Inhibition for Vascular Protection in Patients with Atherosclerotic Disease: Rationale and Review of the Evidence","year":2020,"lang":"en","type":"review","venue":"Thrombosis and Haemostasis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"Heart and Stroke Foundation of Canada; Bayer","keywords":"Medicine; Aspirin; Coronary artery disease; Clopidogrel; Rivaroxaban; Acute coronary syndrome; Internal medicine; Cardiology; Vascular disease; Regimen; Revascularization; Warfarin; Surgery; Myocardial infarction; Atrial fibrillation","score_opus":0.08847145436685977,"score_gpt":0.30744440454713684,"score_spread":0.21897295018027707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3037187678","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0037666503,0.98949516,0.00006725814,0.000287539,0.000020508396,0.0061574928,0.00019290308,0.00001047959,0.0000020031048],"genre_scores_gemma":[0.001126773,0.9978722,0.0000553516,0.00018927618,0.00004003207,0.0005432032,0.00013890352,0.00003053359,0.0000037662019],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99866027,0.0001828807,0.00036348225,0.00034279184,0.00033742876,0.00011313269],"domain_scores_gemma":[0.9992492,0.000058994636,0.00022046223,0.000268126,0.00011241388,0.00009079441],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026574565,0.00023487302,0.0011883572,0.000043991113,0.000083901476,0.000014189915,0.000038302234,0.000077837525,0.000016556838],"category_scores_gemma":[0.000140572,0.00013653582,0.00045280604,0.0002632516,0.00011009599,0.00009022414,0.00003836363,0.000126182,6.8341603e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011703819,0.00013165532,0.0007049632,0.17541616,0.00058838894,0.0000012005927,0.00003947767,1.7460623e-7,7.996161e-7,0.00003803819,0.000062151834,0.82289994],"study_design_scores_gemma":[0.002750087,0.0005087257,0.04565005,0.5905003,0.008736578,0.000006680914,0.000016934413,0.0000048642282,0.000011365441,0.00003193798,0.35140568,0.00037676384],"about_ca_topic_score_codex":0.0000047459384,"about_ca_topic_score_gemma":0.0000013713386,"teacher_disagreement_score":0.8225232,"about_ca_system_score_codex":0.00004618288,"about_ca_system_score_gemma":0.00021331536,"threshold_uncertainty_score":0.5567769},"labels":[],"label_agreement":null},{"id":"W3037628525","doi":"10.1007/s12928-020-00684-0","title":"Very late stent thrombosis in Ostia of the bifurcation lesion: correlation of computed tomographic imaging with histology","year":2020,"lang":"en","type":"article","venue":"Cardiovascular Intervention and Therapeutics","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nova Scotia Hospital","funders":"","keywords":"Medicine; Radiology; Computed tomographic; Interventional radiology; Lesion; Computed tomographic angiography; Thrombosis; Neuroradiology; Stent; Computed tomography; Angiography; Surgery; Neurology","score_opus":0.027146429081802974,"score_gpt":0.2508388727521618,"score_spread":0.22369244367035884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3037628525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9521986,0.026410602,0.02044136,0.00039241443,0.00010089691,0.0003697302,0.000004455516,0.000020223744,0.0000616983],"genre_scores_gemma":[0.9986756,0.000957057,0.000085584084,0.00021827687,0.000020317633,0.000005884741,0.000018165569,0.000014336391,0.0000047919743],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989198,0.00021945674,0.0003102992,0.0001899202,0.00026569833,0.00009486223],"domain_scores_gemma":[0.99939984,0.000019814084,0.00012889913,0.00027691497,0.00013394924,0.000040587303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002558246,0.00011635595,0.00043377443,0.000087172615,0.000033960463,0.000005871151,0.0000698376,0.000059422637,0.000010661344],"category_scores_gemma":[0.000009609923,0.00008277328,0.0009131705,0.00035425444,0.00017560244,0.000054884582,0.000032081316,0.00012431046,5.716811e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011624024,0.00047506587,0.7887444,0.0012161303,0.010237978,0.000030603027,0.0017666166,0.0047467626,0.004596467,0.0006827773,0.000017402104,0.1863234],"study_design_scores_gemma":[0.0060449513,0.00036821427,0.97447515,0.0008064447,0.0026494213,0.00007875352,0.00059398805,0.008880242,0.0038120875,0.00009532253,0.0020221572,0.00017327642],"about_ca_topic_score_codex":0.00002041083,"about_ca_topic_score_gemma":0.0000029827816,"teacher_disagreement_score":0.18615013,"about_ca_system_score_codex":0.000019424795,"about_ca_system_score_gemma":0.00002653934,"threshold_uncertainty_score":0.33753964},"labels":[],"label_agreement":null},{"id":"W3038441428","doi":"10.1007/s40801-020-00204-9","title":"Risk of Adverse Cardiovascular Events Following a Myocardial Infarction in Patients Receiving Combined Clopidogrel and Proton Pump Inhibitor Treatment: A Nested Case–Control Study","year":2020,"lang":"en","type":"article","venue":"Drugs - Real World Outcomes","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Institute of Population and Public Health; University of Ottawa","funders":"Canadian Institutes of Health Research; University of Ottawa","keywords":"Clopidogrel; Myocardial infarction; Medicine; Nested case-control study; Internal medicine; Cardiology; Adverse effect; Proton-pump inhibitor; Case-control study","score_opus":0.008979068727267801,"score_gpt":0.2440145057981307,"score_spread":0.23503543707086288,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3038441428","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940658,0.0004401401,0.000008549904,0.000091049165,0.0001904288,0.004946531,0.000047850197,0.00008096941,0.0001286802],"genre_scores_gemma":[0.99915355,0.00023891243,0.000023455175,0.000100247606,0.0001056438,0.0002674084,0.000032157575,0.000046241683,0.000032403022],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973598,0.00060930365,0.0005975155,0.0005154204,0.0006033991,0.0003145274],"domain_scores_gemma":[0.998957,0.00013524693,0.00017810818,0.00041692273,0.000073989795,0.00023875834],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004790876,0.00035957506,0.0014176862,0.00024992687,0.00012390451,0.000010615844,0.00006468536,0.00008293797,0.000008148691],"category_scores_gemma":[0.00016301358,0.00029402925,0.0016614285,0.0005583893,0.0000393639,0.00017576427,0.0000490279,0.00019232523,0.000003945603],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001935353,0.00072711514,0.96234715,0.000098129865,0.010808109,0.0005959693,0.002823972,0.00010470039,0.0000051908214,0.0000013463147,0.0000018648523,0.020551097],"study_design_scores_gemma":[0.041136064,0.0012132379,0.9512947,0.00012036462,0.0045082704,0.000010952799,0.0011956268,0.00010219469,0.000032751617,0.0000054614143,0.00014485947,0.00023550658],"about_ca_topic_score_codex":0.001163213,"about_ca_topic_score_gemma":0.0001103643,"teacher_disagreement_score":0.039200712,"about_ca_system_score_codex":0.00015042993,"about_ca_system_score_gemma":0.00006667653,"threshold_uncertainty_score":0.9999512},"labels":[],"label_agreement":null},{"id":"W3039424678","doi":"10.1007/s10557-020-06988-w","title":"Next-Generation Sequencing of CYP2C19 in Stent Thrombosis: Implications for Clopidogrel Pharmacogenomics","year":2020,"lang":"en","type":"article","venue":"Cardiovascular Drugs and Therapy","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Toronto; University of Alberta; St. Michael's Hospital","funders":"National Heart, Lung, and Blood Institute","keywords":"CYP2C19; Pharmacogenomics; Medicine; Clopidogrel; Allele; Genetics; Compound heterozygosity; Genetic variation; DNA sequencing; Bioinformatics; Gene; Internal medicine; Genotype; Pharmacology; Aspirin; Biology","score_opus":0.12637154550655566,"score_gpt":0.29688151932353674,"score_spread":0.17050997381698108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3039424678","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8845866,0.10660975,0.006736587,0.00077792216,0.00006530397,0.0010610297,0.000037214737,0.000034560093,0.000091039576],"genre_scores_gemma":[0.9480245,0.049830824,0.00057787774,0.00097210845,0.00036126972,0.00012093933,0.000074245574,0.00003474849,0.0000034674924],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99888754,0.00007761146,0.00030466873,0.0003598279,0.00017604814,0.0001943076],"domain_scores_gemma":[0.99933016,0.000026400647,0.000059384078,0.0003220876,0.0001191813,0.00014277834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036697477,0.00017457509,0.0006291444,0.0000630938,0.000074579075,0.000022140788,0.00007697861,0.000081208666,0.000008139457],"category_scores_gemma":[0.000015891765,0.00015707783,0.0010900759,0.00020155596,0.000064705215,0.000101440106,0.000017429158,0.00009097333,0.0000011434946],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059743307,0.00016965161,0.008594502,0.00039274697,0.010114495,0.000009484451,0.0032029974,0.0020027335,0.2996654,0.00097461586,0.00019162698,0.6740843],"study_design_scores_gemma":[0.108166106,0.0031350465,0.11319714,0.00070465414,0.0094807595,0.00034386094,0.009050964,0.030279731,0.3479058,0.0016848497,0.3726858,0.0033652864],"about_ca_topic_score_codex":0.000018787674,"about_ca_topic_score_gemma":4.452394e-7,"teacher_disagreement_score":0.670719,"about_ca_system_score_codex":0.00004151216,"about_ca_system_score_gemma":0.00011254199,"threshold_uncertainty_score":0.6405448},"labels":[],"label_agreement":null},{"id":"W3039622010","doi":"10.1016/j.jacc.2020.05.031","title":"Post-Discharge Bleeding and Mortality Following Acute Coronary Syndromes With or Without PCI","year":2020,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Alberta; St. Michael's Hospital","funders":"Duke Clinical Research Institute; National Heart, Lung, and Blood Institute","keywords":"Medicine; Conventional PCI; Hazard ratio; Percutaneous coronary intervention; Acute coronary syndrome; Internal medicine; Cardiology; Myocardial infarction; Confidence interval; Population","score_opus":0.019394080484892665,"score_gpt":0.2783887845625521,"score_spread":0.25899470407765945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3039622010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958475,0.001303478,0.00033012134,0.0019382295,0.00012371152,0.00021338553,0.000058427566,0.0000100020725,0.0001751401],"genre_scores_gemma":[0.99765545,0.0006113376,0.0003917724,0.0010475909,0.00021712082,0.000002139899,0.0000010735199,0.000021203443,0.00005232496],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987614,0.00019841662,0.000345766,0.0001549801,0.0003551526,0.00018428778],"domain_scores_gemma":[0.998933,0.00008402348,0.00044018685,0.00020482184,0.0001511735,0.00018680353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028369843,0.00015851205,0.0013746277,0.000055687593,0.00007482907,0.0000044140215,0.00017297454,0.000038327325,0.0000088215775],"category_scores_gemma":[0.000084453284,0.0000826188,0.00071091164,0.00026555033,0.00041692518,0.00008965132,0.00007065514,0.00023085537,5.003324e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008805469,0.000031584193,0.95648277,0.00007548067,0.016662328,0.0047397413,0.00014216124,0.0000829707,0.011225353,0.000028396149,0.00052526273,0.0011984855],"study_design_scores_gemma":[0.009117336,0.0139796855,0.8747261,0.00033525462,0.01284154,0.076875925,0.006102487,0.0001232656,0.001468993,0.000036713707,0.0039893645,0.00040334405],"about_ca_topic_score_codex":0.0000048730385,"about_ca_topic_score_gemma":9.381567e-7,"teacher_disagreement_score":0.081756674,"about_ca_system_score_codex":0.000023319626,"about_ca_system_score_gemma":0.00026854879,"threshold_uncertainty_score":0.33690968},"labels":[],"label_agreement":null},{"id":"W3040330927","doi":"10.1016/j.medj.2020.05.003","title":"Life and limb protection with dual anti-thrombotic pathway inhibition: COMPASS ushers in a new day in atherothrombotic risk reduction","year":2020,"lang":"en","type":"review","venue":"Med","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oakville-Trafalgar Memorial Hospital; St Joseph's Health Centre; Thrombosis and Atherosclerosis Research Institute; McMaster University; Population Health Research Institute; University of Toronto; St. Michael's Hospital","funders":"Janssen Pharmaceuticals; Duke Clinical Research Institute; St. Jude Medical; Cardiological Society of India; Defence Science Institute; Ferring Pharmaceuticals; Belvoir Media Group; Novo Nordisk; Daiichi-Sankyo; Medicines Company; Boston Scientific Corporation; Merck; Mayo Clinic; Bayer; Abbott Laboratories; CSL Behring; Cleveland Clinic; Bristol-Myers Squibb; Eli Lilly and Company; Biotronik; AstraZeneca; Pfizer; Icahn School of Medicine at Mount Sinai; Takeda Pharmaceutical Company; American College of Cardiology Foundation; Boehringer Ingelheim; Amgen","keywords":"Dual (grammatical number); Reduction (mathematics); Medicine; Compass; Pharmacology; Internal medicine; Art","score_opus":0.03687716629519933,"score_gpt":0.26595359014027453,"score_spread":0.2290764238450752,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3040330927","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.024148706,0.9717186,0.0003024459,0.0002708889,0.00014768205,0.0032533165,0.000012818765,0.00009058491,0.00005495083],"genre_scores_gemma":[0.025782695,0.97323877,0.00008838314,0.000048357408,0.00042652446,0.00017091555,0.00010751828,0.00008495323,0.00005189227],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975609,0.0006126503,0.0005501365,0.0006206924,0.0003739949,0.00028160273],"domain_scores_gemma":[0.99902004,0.000040167357,0.00025463148,0.00031128922,0.000031343072,0.00034255008],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00040443233,0.0004367839,0.0021671036,0.00028611414,0.000059903996,0.000038199778,0.000048019618,0.00029680307,0.00005351668],"category_scores_gemma":[0.00014102127,0.00033760536,0.00035390284,0.0007941185,0.00012516034,0.00011912164,0.000027701184,0.0007624935,0.000027065647],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003366521,0.0003289057,0.0003924659,0.010519932,0.0012354846,0.0008433482,0.0007079632,0.00004620316,0.00003227299,0.000016905115,0.00017748642,0.98536235],"study_design_scores_gemma":[0.014275319,0.002930994,0.008667038,0.06282162,0.005522364,0.0029849259,0.00088964147,0.00015876851,0.000062760904,0.000067744135,0.89998055,0.0016382982],"about_ca_topic_score_codex":0.00015644978,"about_ca_topic_score_gemma":0.000048250397,"teacher_disagreement_score":0.98372406,"about_ca_system_score_codex":0.00018777595,"about_ca_system_score_gemma":0.0010613794,"threshold_uncertainty_score":0.9999076},"labels":[],"label_agreement":null},{"id":"W3040911709","doi":"10.1111/apt.15790","title":"Fewer gastrointestinal bleeds with ticagrelor and prasugrel compared with clopidogrel in patients with acute coronary syndrome following percutaneous coronary intervention","year":2020,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Tellabs (Canada)","funders":"Agency for Healthcare Research and Quality","keywords":"Medicine; Prasugrel; Clopidogrel; Ticagrelor; Acute coronary syndrome; Percutaneous coronary intervention; Internal medicine; Cardiology; Hazard ratio; Myocardial infarction; Conventional PCI; Confidence interval","score_opus":0.012965283200558769,"score_gpt":0.25493470716851485,"score_spread":0.2419694239679561,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3040911709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99616784,0.0011659027,0.00021039449,0.0010595935,0.0000770353,0.00117499,0.00003332572,0.00009000477,0.000020906406],"genre_scores_gemma":[0.98938626,0.00015803953,0.0017009611,0.008312137,0.000033937486,0.00003499799,0.00027509552,0.00007221075,0.00002634985],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981777,0.00016645002,0.00030508288,0.00051008054,0.00040342798,0.00043725077],"domain_scores_gemma":[0.9993153,0.00005848812,0.000114160095,0.00017360334,0.00007522329,0.0002632313],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00008658184,0.0003935378,0.00059551885,0.00008778638,0.00011611861,0.000018515513,0.00012726092,0.00006300683,0.00017386537],"category_scores_gemma":[1.3227097e-7,0.00028926154,0.00013658367,0.00022638879,0.0002973304,0.00018010118,0.00006078428,0.0003875079,0.000010097428],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03321542,0.0011004361,0.92083895,0.00007749175,0.026389755,0.014924092,0.00041386345,0.000096127085,0.0019833893,0.0000015469258,0.000023601899,0.00093531545],"study_design_scores_gemma":[0.033116214,0.023659566,0.88972986,0.00045411068,0.031775024,0.018886203,0.000743258,0.0005819418,0.00035632943,0.000003833271,0.00015388365,0.00053976924],"about_ca_topic_score_codex":0.000015721018,"about_ca_topic_score_gemma":0.000005665707,"teacher_disagreement_score":0.031109093,"about_ca_system_score_codex":0.0000946187,"about_ca_system_score_gemma":0.00009506043,"threshold_uncertainty_score":0.99995595},"labels":[],"label_agreement":null},{"id":"W3044790822","doi":"10.1016/j.clinbiochem.2020.07.003","title":"Aspirin: Bitter pill or miracle drug?","year":2020,"lang":"en","type":"review","venue":"Clinical Biochemistry","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Aspirin; Pill; Intensive care medicine; Disease; Medical prescription; Drug; Clinical trial; Brand names; Alternative medicine; Pharmacology; Internal medicine; Advertising","score_opus":0.12610481640781018,"score_gpt":0.44783010057521794,"score_spread":0.32172528416740775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3044790822","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017245232,0.9966517,0.000006520149,0.0002578302,0.0004188881,0.00036460522,0.000096468604,0.0001537894,0.0018777419],"genre_scores_gemma":[0.000032329284,0.98570967,0.00012045666,0.0017766475,0.0030022257,0.000053624917,0.0005800413,0.00009987546,0.008625126],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969571,0.00015395989,0.0012116611,0.0009817529,0.00035864385,0.00033688158],"domain_scores_gemma":[0.9975122,0.00036512228,0.00030202494,0.0010983356,0.00006885076,0.0006534654],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0003770199,0.00053842395,0.00324764,0.00002937065,0.000052003325,0.000029949293,0.00034887975,0.0008153744,0.0010794891],"category_scores_gemma":[0.00057726126,0.00035700522,0.00436487,0.00027414566,0.00028407012,0.000021421009,0.00016863554,0.0010860512,0.0013072275],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016034975,0.00025878154,0.000037825463,0.020998023,0.0017349538,0.0012483511,0.0000019167687,3.4045935e-9,0.0000019209788,5.1589126e-7,0.038744148,0.93681324],"study_design_scores_gemma":[0.0010140857,0.000114916955,0.00000622259,0.010109838,0.004092418,0.00037702406,0.000010843355,3.680384e-7,0.000058058384,0.0000020091377,0.9837985,0.0004157122],"about_ca_topic_score_codex":8.149374e-7,"about_ca_topic_score_gemma":5.965954e-8,"teacher_disagreement_score":0.94505435,"about_ca_system_score_codex":0.000053144133,"about_ca_system_score_gemma":0.0009536764,"threshold_uncertainty_score":0.9998882},"labels":[],"label_agreement":null},{"id":"W3046880024","doi":"10.1161/circoutcomes.120.006660","title":"Comparative Methodological Assessment of the Randomized GLOBAL LEADERS Trial Using Total Ischemic and Bleeding Events","year":2020,"lang":"en","type":"article","venue":"Circulation Cardiovascular Quality and Outcomes","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Medicine; Ticagrelor; Percutaneous coronary intervention; Hazard ratio; Myocardial infarction; Internal medicine; Aspirin; Randomized controlled trial; Revascularization; Clinical endpoint; Stroke (engine); Cardiology; Confidence interval","score_opus":0.30901295107908533,"score_gpt":0.4464865313168852,"score_spread":0.13747358023779988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3046880024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9519089,0.0052804337,0.040622547,0.0006481283,0.00013367068,0.0012215258,0.0000122308675,0.000028258479,0.00014433893],"genre_scores_gemma":[0.9979174,0.00013974172,0.0014189004,0.00038174866,0.000108328124,0.000014250778,0.000009764846,0.0000074532,0.0000023735236],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99650973,0.0018079227,0.0005353695,0.0003488277,0.00064405275,0.00015411117],"domain_scores_gemma":[0.99896747,0.0003684018,0.0001721349,0.0002669677,0.000088964014,0.00013604313],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025278896,0.00019669753,0.001882164,0.00002150952,0.00013913568,0.000017699265,0.000060301805,0.00012342093,0.000011242873],"category_scores_gemma":[0.00057637476,0.00012869592,0.002205957,0.00018992538,0.00038126644,0.00009648337,0.000072505565,0.0001553493,3.1782037e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.115475774,0.00035330106,0.794773,0.0014449364,0.056074835,0.00002317352,0.003571249,0.012557666,0.003243756,0.005324692,0.00002059248,0.0071370676],"study_design_scores_gemma":[0.30986947,0.000048828442,0.67884964,0.00007161473,0.0040885275,0.00006575491,0.0013556035,0.004890573,0.00021853184,0.00022342095,0.000088131266,0.0002298862],"about_ca_topic_score_codex":0.000031378113,"about_ca_topic_score_gemma":1.9322746e-7,"teacher_disagreement_score":0.1943937,"about_ca_system_score_codex":0.000046442125,"about_ca_system_score_gemma":0.000083042425,"threshold_uncertainty_score":0.5248067},"labels":[],"label_agreement":null},{"id":"W3048061055","doi":"10.1136/neurintsurg-2020-snis.159","title":"E-127 Clopidogrel hyper-responsiveness is associated with hemorrhagic complications post cerebrovascular stenting procedures","year":2020,"lang":"en","type":"article","venue":"","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Clopidogrel; Aspirin; Regimen; Thromboelastography; Incidence (geometry); Platelet; Prospective cohort study; Clinical endpoint; Anesthesia; Internal medicine; Surgery; Randomized controlled trial","score_opus":0.01925509349141064,"score_gpt":0.23982226724220693,"score_spread":0.2205671737507963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048061055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856286,0.0013144612,0.0019249662,0.007867887,0.000025210351,0.0006909923,0.00003264807,0.00033091067,0.0021843424],"genre_scores_gemma":[0.9847148,0.00007347779,0.0004736255,0.013896546,0.000098249664,0.000039039503,0.00017123141,0.000050234634,0.00048281904],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99846035,0.00008463783,0.0002373733,0.00044471765,0.00047100688,0.00030193565],"domain_scores_gemma":[0.99873966,0.00006503468,0.000082935614,0.00036675946,0.00045645205,0.000289168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012287915,0.00023108392,0.00046623117,0.00005947289,0.0002023966,0.000042969987,0.0001395719,0.000092341405,0.0003783353],"category_scores_gemma":[0.00019972857,0.00017445248,0.0004270878,0.0004685984,0.00009821507,0.00010243468,0.000043190325,0.00016958678,0.00011808501],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007560157,0.0040552677,0.8134325,0.0030359456,0.0349057,0.0012388877,0.006492016,0.00064616976,0.06871472,0.0024317428,0.013954878,0.043531995],"study_design_scores_gemma":[0.017573386,0.0017166373,0.91960543,0.00096709526,0.0048942054,0.0011484618,0.004888279,0.002672069,0.018617772,0.00006299527,0.026370522,0.0014831455],"about_ca_topic_score_codex":0.000019901227,"about_ca_topic_score_gemma":0.0000067264327,"teacher_disagreement_score":0.10617291,"about_ca_system_score_codex":0.00003456321,"about_ca_system_score_gemma":0.00026676996,"threshold_uncertainty_score":0.7113966},"labels":[],"label_agreement":null},{"id":"W3048239589","doi":"10.1093/icvts/ivaa115","title":"Antiplatelet therapy and coronary artery bypass grafting: a systematic review and network meta-analysis","year":2020,"lang":"en","type":"review","venue":"Interactive Cardiovascular and Thoracic Surgery","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Population Health Research Institute; McMaster University; Impact","funders":"","keywords":"Medicine; Ticagrelor; Randomized controlled trial; Internal medicine; Odds ratio; Clopidogrel; Cochrane Library; Adverse effect; Cardiology; Acute coronary syndrome; Aspirin; Surgery; Myocardial infarction","score_opus":0.10600358522838019,"score_gpt":0.34151430127252924,"score_spread":0.23551071604414905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048239589","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009617159,0.99540687,0.0002902962,0.00008143822,0.00013401723,0.0036811016,0.00012355187,0.00011568235,0.00007087044],"genre_scores_gemma":[0.0018510562,0.9955939,0.00005329413,0.00095629826,0.00024357249,0.0007537396,0.00034314697,0.00015276503,0.00005223235],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9922253,0.0033250973,0.001553821,0.0015532951,0.0007735287,0.00056894514],"domain_scores_gemma":[0.99523795,0.0019542896,0.00068280566,0.0013425361,0.00024146124,0.0005409432],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_narrow","metaepi_broad"],"category_scores_codex":[0.0031787022,0.0013080478,0.025605135,0.00047336082,0.00021748316,0.0001777391,0.0001559258,0.00040490585,0.00008477341],"category_scores_gemma":[0.00038236045,0.0008851163,0.024601879,0.0012425911,0.00025063066,0.00026585837,0.00019790155,0.0008223885,0.000016714135],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007923278,0.00003060885,0.000021769747,0.24072313,0.5744412,0.0014964298,0.000027844113,5.2966976e-7,2.6955087e-8,0.0000020857783,0.00010288342,0.18307424],"study_design_scores_gemma":[0.00019116509,0.00004719752,0.000031701366,0.047345508,0.7628424,0.00639498,0.000034685607,0.0000050870776,5.6033554e-7,0.0000080545515,0.18243375,0.0006648688],"about_ca_topic_score_codex":0.000010098049,"about_ca_topic_score_gemma":5.7646355e-7,"teacher_disagreement_score":0.19337763,"about_ca_system_score_codex":0.000054888827,"about_ca_system_score_gemma":0.00017714738,"threshold_uncertainty_score":0.9999671},"labels":[],"label_agreement":null},{"id":"W3049538636","doi":"10.14740/gr1285","title":"Does Extended Use of Clopidogrel-Based Dual Anti-Platelet Therapy Increase the Risk of Gastrointestinal Bleeding?","year":2020,"lang":"en","type":"article","venue":"Gastroenterology Research","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Clopidogrel; Gastrointestinal bleeding; Platelet; Dual (grammatical number); Internal medicine; Cardiology; Aspirin","score_opus":0.05774433931711824,"score_gpt":0.314591431238858,"score_spread":0.25684709192173977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3049538636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995493,0.0003050045,0.00084966334,0.0024826573,0.0000466654,0.00064330484,0.000115384624,0.000039406346,0.000024908375],"genre_scores_gemma":[0.99751896,0.0006206805,0.00082207413,0.00071247737,0.00020764707,0.000029206847,0.000036443234,0.00003301362,0.00001948362],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963156,0.0013311766,0.000476461,0.0004214994,0.0008075671,0.00064766925],"domain_scores_gemma":[0.99787,0.00050685526,0.00018831786,0.000574142,0.00055481266,0.00030586895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014004878,0.00021850264,0.0006769446,0.0001849901,0.00014567269,0.000019352856,0.00029111546,0.00008176433,0.00023272599],"category_scores_gemma":[0.00075856136,0.0001148815,0.0005186666,0.00036347084,0.0013607666,0.00008092333,0.00012669899,0.00078103004,0.00001033737],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017709767,0.00048681875,0.95874,0.00011825056,0.0007966063,0.00029947635,0.00014163708,0.00011566073,0.01847707,0.000020240113,0.000970094,0.002124389],"study_design_scores_gemma":[0.009028164,0.0063470937,0.9650773,0.00018622883,0.00021882003,0.00039354397,0.0003896237,0.0014164926,0.01553344,0.000047598747,0.0012556904,0.00010604163],"about_ca_topic_score_codex":0.00014525515,"about_ca_topic_score_gemma":0.000008192695,"teacher_disagreement_score":0.008681603,"about_ca_system_score_codex":0.000018505354,"about_ca_system_score_gemma":0.00019025695,"threshold_uncertainty_score":0.5013801},"labels":[],"label_agreement":null},{"id":"W3080963011","doi":"10.1001/jama.2020.12443","title":"Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary Intervention","year":2020,"lang":"en","type":"article","venue":"JAMA","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":404,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Montreal Heart Institute; St. Michael's Hospital; Université de Montréal; University of Alberta; Canadian VIGOUR Centre; University of Ottawa; Heart and Stroke Foundation; University of Toronto","funders":"Duke Clinical Research Institute; National Heart, Lung, and Blood Institute; Arts and Humanities Research Council; American Regent; Esperion Therapeutics; Servier; Novo Nordisk; Chung-Ang University; University of Toronto; Daiichi-Sankyo; Greenville Health System; NorthShore University HealthSystem; National Institutes of Health; Regeneron Pharmaceuticals; Ajou University; Amgen; Heart and Stroke Foundation of Canada; Henry Ford Health System; University of Minnesota; Aurora Research Institute; York University; Sunnybrook Research Institute; Pfizer; Sharp HealthCare; Sanofi; HLS Therapeutics; GlaxoSmithKline; NYU Langone Medical Center; CSL Behring; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Percutaneous coronary intervention; Clopidogrel; Conventional PCI; Internal medicine; Randomized controlled trial; Cardiology; Ticagrelor; Myocardial infarction; Hazard ratio; Coronary artery disease; Clinical endpoint; Confidence interval","score_opus":0.013106275461057535,"score_gpt":0.2754705644234851,"score_spread":0.2623642889624276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3080963011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968831,0.0014074016,0.000110385445,0.0006738953,0.00017940914,0.00048605254,0.000018427805,0.00008226979,0.00015907268],"genre_scores_gemma":[0.997628,0.00016615237,0.00005550767,0.0014269077,0.00033245917,0.000032968084,0.00009903071,0.000031047453,0.00022793231],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987433,0.00018928653,0.00028648358,0.00026287645,0.00036149932,0.00015658549],"domain_scores_gemma":[0.99949396,0.000065583,0.00008692564,0.00014415236,0.00009759797,0.000111808586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020853468,0.0001929984,0.00044124713,0.000056876157,0.0000376197,0.000011597011,0.00006057354,0.00013541598,0.0008025358],"category_scores_gemma":[0.000077634875,0.00014792047,0.0007778489,0.00012495814,0.000058495545,0.00008038096,0.000019942872,0.0001985909,0.00009804374],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07162385,0.00073925965,0.64120173,0.0008493284,0.0029648456,0.00058061624,0.000416617,0.000034160228,0.063561216,0.000037927835,0.007009459,0.21098101],"study_design_scores_gemma":[0.029722897,0.013403791,0.765393,0.0004862358,0.0008316556,0.0010567544,0.000059744652,0.00044983812,0.16302383,0.000018540908,0.025052316,0.00050139433],"about_ca_topic_score_codex":0.000012342462,"about_ca_topic_score_gemma":7.5207873e-7,"teacher_disagreement_score":0.21047962,"about_ca_system_score_codex":0.000047700883,"about_ca_system_score_gemma":0.00003416124,"threshold_uncertainty_score":0.87872046},"labels":[],"label_agreement":null},{"id":"W3081423218","doi":"10.1161/circinterventions.120.009177","title":"Impact of Bleeding and Myocardial Infarction on Mortality in All-Comer Patients Undergoing Percutaneous Coronary Intervention","year":2020,"lang":"en","type":"article","venue":"Circulation Cardiovascular Interventions","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Southlake Regional Health Center","funders":"","keywords":"Medicine; Percutaneous coronary intervention; Myocardial infarction; Internal medicine; Hazard ratio; Cardiology; Adverse effect; Mortality rate; Stent; Surgery; Confidence interval","score_opus":0.056999919428698635,"score_gpt":0.32346572663038925,"score_spread":0.2664658072016906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081423218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928674,0.0028037652,0.003154573,0.000046268244,0.00013546433,0.00067073654,0.000033148634,0.000058529196,0.00023010613],"genre_scores_gemma":[0.9991193,0.00037570522,0.000032325403,0.00006674315,0.000096528944,0.000021481083,0.00025224348,0.00003237193,0.0000033297388],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99798864,0.00025631703,0.00060134695,0.00042344842,0.0005260444,0.00020419562],"domain_scores_gemma":[0.99914396,0.00004525632,0.00013658445,0.00033700964,0.00016735702,0.00016983],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039130458,0.00021851168,0.00063286565,0.00023358333,0.000066574605,0.000027391068,0.00006431454,0.00012461316,0.0001009928],"category_scores_gemma":[0.00018843274,0.0002198162,0.0042886185,0.0003192462,0.00007552675,0.00021721813,0.0000490007,0.00021444561,0.000010963873],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037737426,0.00050459284,0.944277,0.00052905356,0.011726102,0.000065179614,0.00033521553,0.019360913,0.00047121762,0.0000755478,0.000024085026,0.022253735],"study_design_scores_gemma":[0.003744131,0.0006920727,0.99133945,0.00044726633,0.001726387,0.00011829091,0.00013383277,0.001459818,0.00002794365,0.000058893263,0.000068687325,0.00018320649],"about_ca_topic_score_codex":0.000098892444,"about_ca_topic_score_gemma":0.0000071408595,"teacher_disagreement_score":0.047062486,"about_ca_system_score_codex":0.00020791945,"about_ca_system_score_gemma":0.000044216755,"threshold_uncertainty_score":0.8963844},"labels":[],"label_agreement":null},{"id":"W3081478694","doi":"10.1007/s11606-020-06131-3","title":"Risk of Pneumonia with Ticagrelor Versus Clopidogrel: a Population-Based Cohort Study","year":2020,"lang":"en","type":"article","venue":"Journal of General Internal Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of British Columbia","funders":"","keywords":"Medicine; Ticagrelor; Clopidogrel; Cohort study; Pneumonia; Population; Cohort; Internal medicine; Emergency medicine; Intensive care medicine; Aspirin; Environmental health","score_opus":0.017311772480900187,"score_gpt":0.2846254116449009,"score_spread":0.2673136391640007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081478694","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99428266,0.0011850086,0.0019102262,0.0016287115,0.0003585037,0.00032913164,0.0000050428234,0.000014250918,0.00028646257],"genre_scores_gemma":[0.9971393,0.0001994267,0.0005545293,0.0005648475,0.0014341193,0.0000028057646,0.000005528431,0.000026954405,0.00007252463],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978411,0.00015217929,0.0007185105,0.00017077288,0.00096826424,0.00014918191],"domain_scores_gemma":[0.9983173,0.000110373614,0.00061743223,0.00019540841,0.0004081818,0.00035131286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004553052,0.00018628952,0.00088595407,0.00013778289,0.000033531167,0.000006218668,0.00015596412,0.000047565245,0.00020625185],"category_scores_gemma":[0.00033901352,0.00010925508,0.0003197658,0.00023011344,0.00009604015,0.00006338771,0.000015772184,0.00035721262,0.0000034417446],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016077287,0.00029347386,0.972703,0.00005399536,0.003658038,0.00078418973,0.00026387314,0.0005521873,0.0011449168,0.000008222203,0.0006236215,0.0038372227],"study_design_scores_gemma":[0.018504042,0.018185722,0.9562569,0.00042007733,0.0035401373,0.00022581217,0.00037014266,0.00095099414,0.0005106107,0.000007025331,0.0009099239,0.000118586446],"about_ca_topic_score_codex":0.0003236246,"about_ca_topic_score_gemma":0.000012393309,"teacher_disagreement_score":0.017892247,"about_ca_system_score_codex":0.00005202844,"about_ca_system_score_gemma":0.000114525705,"threshold_uncertainty_score":0.4455293},"labels":[],"label_agreement":null},{"id":"W3081745622","doi":"10.14740/jmc3549","title":"Severe Bleeding Tendency due to Excessive Fibrinolysis in Two Patients With Aortic Disease: Role of Tranexamic Acid in Non-Surgical Candidate","year":2020,"lang":"en","type":"article","venue":"Journal of Medical Cases","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Tranexamic acid; Bleeding diathesis; Fibrinolysis; Surgery; Aortic dissection; Aortic aneurysm; Disseminated intravascular coagulation; Coagulation; Thrombosis; Coagulation Disorder; Cardiology; Aneurysm; Anesthesia; Internal medicine; Aorta; Blood loss; Platelet","score_opus":0.007487598812365988,"score_gpt":0.2609137682011374,"score_spread":0.2534261693887714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081745622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99528587,0.0029887995,0.00006724354,0.0013466409,0.000037140493,0.00021131002,0.000017949798,0.0000054299862,0.000039601895],"genre_scores_gemma":[0.99895364,0.00041584639,0.000039192582,0.00034691487,0.00021169832,0.0000047978415,0.0000088127335,0.000016211716,0.0000028745787],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99730974,0.00009834216,0.00061852584,0.00018717871,0.0015405425,0.00024566904],"domain_scores_gemma":[0.9985495,0.00011233067,0.00018116792,0.00011675507,0.00012666272,0.00091358036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000288797,0.0001592795,0.00077837904,0.00019237692,0.000020494288,0.0000095362275,0.00016800826,0.00006279904,0.0003189202],"category_scores_gemma":[0.00043333112,0.00010806237,0.00026541675,0.00046580067,0.000075541735,0.00012797819,0.00003617305,0.00037280878,0.0000028008492],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010931194,0.0008606178,0.8708154,0.0004098648,0.00056449417,0.053051297,0.0011406679,0.00030955856,0.00029129777,0.0000067430633,0.00008534349,0.061533518],"study_design_scores_gemma":[0.024233624,0.0021454727,0.9623876,0.0039394926,0.0008604189,0.0022574498,0.001682262,0.0005639368,0.0012751878,0.000028573686,0.00029166444,0.0003342845],"about_ca_topic_score_codex":0.00006969549,"about_ca_topic_score_gemma":0.000026792728,"teacher_disagreement_score":0.091572225,"about_ca_system_score_codex":0.00005531807,"about_ca_system_score_gemma":0.00036224182,"threshold_uncertainty_score":0.44066557},"labels":[],"label_agreement":null},{"id":"W3082553983","doi":"10.1161/circoutcomes.120.006582","title":"Long-Term Bleeding Risk Prediction with Dual Antiplatelet Therapy After Acute Coronary Syndromes Treated Without Revascularization","year":2020,"lang":"en","type":"article","venue":"Circulation Cardiovascular Quality and Outcomes","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre","funders":"","keywords":"Medicine; Revascularization; Cardiology; Internal medicine; Term (time); Myocardial infarction","score_opus":0.037355763916886976,"score_gpt":0.2800130350031941,"score_spread":0.2426572710863071,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082553983","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9651822,0.012344722,0.020159632,0.00034727395,0.00009660642,0.0013372361,0.0001068168,0.0003791807,0.000046322908],"genre_scores_gemma":[0.9908801,0.007182764,0.00020655,0.0007540897,0.00021751093,0.00008459358,0.0005650774,0.000084811596,0.000024535553],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963299,0.0005912236,0.00065105304,0.0009077552,0.0011326537,0.00038740414],"domain_scores_gemma":[0.99837244,0.000067855,0.00020955312,0.00071517105,0.00024932297,0.00038568734],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00087954535,0.0005092602,0.0014160057,0.00014248118,0.00032652335,0.00012841153,0.00008354344,0.00028467807,0.000078593825],"category_scores_gemma":[0.00008231137,0.00040154706,0.0015900222,0.00045986567,0.00020569674,0.000558688,0.000045619898,0.00033332853,0.000017451195],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017266924,0.00009313727,0.9553509,0.00024154625,0.022147454,0.00047282752,0.00045959518,0.0006099095,0.0002870819,0.00002131267,0.000005378418,0.018584201],"study_design_scores_gemma":[0.009791846,0.0002698086,0.98254883,0.0001302511,0.004866252,0.0007902537,0.000094927585,0.00040503792,0.00034313716,0.000015767277,0.00026683434,0.00047706638],"about_ca_topic_score_codex":0.000034425793,"about_ca_topic_score_gemma":0.0000017685596,"teacher_disagreement_score":0.027197953,"about_ca_system_score_codex":0.00006882283,"about_ca_system_score_gemma":0.00007690429,"threshold_uncertainty_score":0.99984366},"labels":[],"label_agreement":null},{"id":"W3085268750","doi":"10.1016/j.jacc.2020.06.085","title":"Trial Design Principles for Patients at High Bleeding Risk Undergoing PCI","year":2020,"lang":"en","type":"review","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Canada Excellence Research Chairs, Government of Canada; British Heart Foundation","keywords":"Medicine; Conventional PCI; Percutaneous coronary intervention; Clinical endpoint; Clinical trial; Research design; Population; Randomized controlled trial; Major bleeding; Intervention (counseling); Clinical study design; Intensive care medicine; Emergency medicine; Internal medicine; Nursing; Myocardial infarction","score_opus":0.04974499385021138,"score_gpt":0.3062412764728468,"score_spread":0.25649628262263546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3085268750","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0053265183,0.9875635,0.0027312143,0.0001139469,0.0013314411,0.0024186901,0.0004181632,0.000011205574,0.000085339874],"genre_scores_gemma":[0.00614283,0.9901341,0.0014980279,0.000060395218,0.0019728488,0.00003557368,0.000010403118,0.00007028515,0.00007550256],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99628055,0.0013494445,0.0013204451,0.00027085302,0.00048696902,0.0002917393],"domain_scores_gemma":[0.9933977,0.0016831688,0.0039960146,0.00042028836,0.00033000275,0.00017281612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009996056,0.00037270875,0.005637379,0.000186447,0.00014722114,0.0000055681394,0.00047488985,0.00016822788,0.0000054231823],"category_scores_gemma":[0.0014765585,0.00022063543,0.005696498,0.0003988221,0.00035630778,0.000036667392,0.00016366168,0.00046045854,0.0000021082938],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13734373,0.0002694905,0.0014109582,0.008974426,0.057575464,0.0006481939,0.000036665795,0.00085734454,0.0000066209777,0.00017964028,0.015482971,0.77721447],"study_design_scores_gemma":[0.019609705,0.0060843765,0.00009510338,0.0028739567,0.016370155,0.0012163116,0.000050647162,0.000004478622,0.0000058281653,0.00004966399,0.9534256,0.00021416775],"about_ca_topic_score_codex":0.0000014469286,"about_ca_topic_score_gemma":2.8776856e-7,"teacher_disagreement_score":0.9379426,"about_ca_system_score_codex":0.00032866866,"about_ca_system_score_gemma":0.001276356,"threshold_uncertainty_score":0.8997252},"labels":[],"label_agreement":null},{"id":"W3087038991","doi":"10.1093/ehjcvp/pvaa106","title":"PRECISE-DAPT score for bleeding risk prediction in patients on dual or single antiplatelet regimens: insights from the GLOBAL LEADERS and GLASSY","year":2020,"lang":"en","type":"article","venue":"European Heart Journal - Cardiovascular Pharmacotherapy","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Agence Nationale de la Recherche; Medicines Company; Biosensors International Group; AstraZeneca","keywords":"Dual (grammatical number); Internal medicine; Medicine; Philosophy","score_opus":0.07440001213608693,"score_gpt":0.2866779878047502,"score_spread":0.21227797566866324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3087038991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9659633,0.029634375,0.001311721,0.0007574075,0.0005322135,0.0013256315,0.00016382217,0.0001005454,0.00021098068],"genre_scores_gemma":[0.9827936,0.010579707,0.00029777753,0.0033711034,0.002759652,0.000014055897,0.00004815139,0.00011848295,0.000017443244],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962471,0.0011844416,0.00059869484,0.0006281176,0.000909142,0.0004324925],"domain_scores_gemma":[0.9986695,0.0001698324,0.00016771289,0.00039639618,0.00016425943,0.00043227422],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009408435,0.00040882648,0.00079619524,0.00008134672,0.00041455036,0.00015117724,0.00018519195,0.00008731617,0.000053291744],"category_scores_gemma":[0.00018405746,0.00027445675,0.0014446398,0.00036802609,0.00015690243,0.00028044946,0.000040441333,0.0006412545,0.000028083361],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.060194604,0.0018542719,0.5309076,0.000381478,0.04200417,0.002983598,0.008007542,0.008633144,0.008793591,0.000018653753,0.04128718,0.29493418],"study_design_scores_gemma":[0.07219477,0.005478413,0.39647517,0.0012592816,0.0037094525,0.0009763367,0.0011963287,0.0013731869,0.0053249523,0.00007571863,0.5109427,0.000993695],"about_ca_topic_score_codex":0.00001631656,"about_ca_topic_score_gemma":0.0000011699547,"teacher_disagreement_score":0.4696555,"about_ca_system_score_codex":0.00013939846,"about_ca_system_score_gemma":0.000076281016,"threshold_uncertainty_score":0.99997073},"labels":[],"label_agreement":null},{"id":"W3087604547","doi":"10.1016/j.jcin.2020.07.005","title":"Duration of Dual Antiplatelet Therapy After PCI","year":2020,"lang":"en","type":"letter","venue":"JACC: Cardiovascular Interventions","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"St. Jude Medical; Bristol-Myers Squibb Canada; Eisai; Daiichi-Sankyo; Medicines Company; Boston Scientific Corporation; Eli Lilly and Company; AstraZeneca; CSL Behring; Bayer Corporation; Chiesi Farmaceutici; Merck; Boehringer Ingelheim; Amgen; Gilead Sciences","keywords":"Conventional PCI; Duration (music); Medicine; Dual (grammatical number); Cardiology; Internal medicine; Physics; Myocardial infarction; Philosophy","score_opus":0.0415388024336637,"score_gpt":0.2759779505833124,"score_spread":0.23443914814964872,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3087604547","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09275782,0.5365695,0.020843565,0.32667157,0.004776567,0.009116862,0.0024798696,0.0013648318,0.0054194364],"genre_scores_gemma":[0.62099236,0.03000506,0.0013941427,0.3157644,0.016948655,0.00130332,0.008924929,0.00084673514,0.0038203942],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99496657,0.0006146745,0.0013061947,0.0009858893,0.0015798392,0.0005468335],"domain_scores_gemma":[0.9970465,0.000065501634,0.00037083565,0.0018533574,0.00047456348,0.00018927919],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005163909,0.0007258106,0.0023907772,0.00042504288,0.00012585767,0.00008149787,0.00029379403,0.00089171116,0.0014968357],"category_scores_gemma":[0.00012154076,0.0006659566,0.021699198,0.00053244014,0.00026380716,0.00020630301,0.00013515809,0.0016439796,0.00029955452],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011107592,0.00049234304,0.0007489248,0.004684623,0.08487728,0.014679094,0.00024080845,0.00003908948,0.00024167943,0.000020774656,0.85000116,0.0428635],"study_design_scores_gemma":[0.0046011684,0.0005249431,0.0025177267,0.0016577069,0.006825231,0.0013856045,0.000053777894,0.000015605781,0.0013607548,0.00008894296,0.9802852,0.00068328885],"about_ca_topic_score_codex":0.000041332667,"about_ca_topic_score_gemma":0.000001913419,"teacher_disagreement_score":0.52823454,"about_ca_system_score_codex":0.000098381664,"about_ca_system_score_gemma":0.00020625808,"threshold_uncertainty_score":0.9995792},"labels":[],"label_agreement":null},{"id":"W3090004135","doi":"10.1016/j.cjca.2020.07.025","title":"ASSOCIATION OF TICAGRELOR WITH RISK OF PNEUMONIA: A POPULATION-BASED COHORT STUDY","year":2020,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Ticagrelor; Clopidogrel; Percutaneous coronary intervention; Conventional PCI; Pneumonia; Internal medicine; Community-acquired pneumonia; Streptococcus pneumoniae; Cohort; Acute coronary syndrome; Aspirin; Intensive care medicine; Cardiology; Myocardial infarction; Antibiotics","score_opus":0.007410497658661195,"score_gpt":0.21217401865018756,"score_spread":0.20476352099152637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3090004135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973217,0.0004335521,0.0010869872,0.00053541834,0.00006787296,0.00024686314,0.000034851313,0.0000027839803,0.00026996963],"genre_scores_gemma":[0.9995457,0.00003441157,0.000062017556,0.00010478235,0.00022439062,0.0000017932928,0.000008124806,0.000010669794,0.000008145484],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989367,0.00025587136,0.0003452724,0.00009057307,0.0002395836,0.00013198427],"domain_scores_gemma":[0.99867237,0.00008459178,0.0003970315,0.00012468547,0.00039878624,0.00032253074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047809666,0.0000803508,0.0007387184,0.000116858035,0.000030186091,0.0000027730605,0.00006768737,0.00007408356,0.000021469481],"category_scores_gemma":[0.00038727387,0.00006239037,0.0003304127,0.00016168153,0.000043775846,0.000026750962,0.0000022462332,0.00016824796,0.0000010756804],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003062044,0.00000767987,0.99019295,0.00002245999,0.003513876,0.00014679845,0.00010580727,0.004678786,0.00005285427,0.000004476134,0.00025559636,0.0007124823],"study_design_scores_gemma":[0.0021415162,0.0013305381,0.9925449,0.000029180897,0.0022003516,0.000052588486,0.0002054297,0.00003365416,0.000060862578,0.000008104274,0.0013394492,0.000053419604],"about_ca_topic_score_codex":0.00088668993,"about_ca_topic_score_gemma":0.0005000442,"teacher_disagreement_score":0.0046451315,"about_ca_system_score_codex":0.00009520866,"about_ca_system_score_gemma":0.00084332604,"threshold_uncertainty_score":0.25442055},"labels":[],"label_agreement":null},{"id":"W3091097216","doi":"10.3390/medicina56100519","title":"Ticagrelor as an Alternative Antiplatelet Therapy in Cardiac Patients Non-Sensitive to Aspirin","year":2020,"lang":"en","type":"article","venue":"Medicina","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; The Scarborough Hospital; McMaster University; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Ticagrelor; Medicine; Aspirin; P2Y12; Coronary artery disease; Platelet; Myocardial infarction; Pharmacology; Internal medicine; Agonist; Arachidonic acid; Cardiology; Clopidogrel; Receptor; Chemistry","score_opus":0.01687402458362723,"score_gpt":0.27315352806314985,"score_spread":0.2562795034795226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3091097216","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937632,0.00039406025,0.00026889957,0.0017850869,0.00024806813,0.0011510676,0.000022868495,0.00006377046,0.0023029924],"genre_scores_gemma":[0.98708177,0.00065832137,0.00012119701,0.011357101,0.00055583805,0.000020628744,0.000111902766,0.000044732955,0.000048488695],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99803644,0.00016079436,0.00030014577,0.0005146344,0.0006251091,0.00036289057],"domain_scores_gemma":[0.9988078,0.000051851206,0.000054321525,0.00031754444,0.00014625989,0.0006222564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027682947,0.00025535526,0.00073878316,0.00012851301,0.000049492508,0.000013689335,0.00013105084,0.000094693874,0.00010637597],"category_scores_gemma":[0.00014374712,0.00020643872,0.00030150742,0.00037184407,0.000084308405,0.00011121241,0.000042370066,0.00025233076,0.00031129172],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015985701,0.0019197953,0.24285996,0.0003712076,0.0028708796,0.005421992,0.05502895,0.00019058933,0.0073277927,0.00016678196,0.0043691956,0.66348714],"study_design_scores_gemma":[0.027268196,0.01603401,0.8753533,0.0011499863,0.00043682422,0.0000443124,0.0061966632,0.0007580774,0.042606786,0.0000926316,0.02900576,0.0010534606],"about_ca_topic_score_codex":0.000115373325,"about_ca_topic_score_gemma":0.0000029894863,"teacher_disagreement_score":0.6624337,"about_ca_system_score_codex":0.00005780414,"about_ca_system_score_gemma":0.000090216316,"threshold_uncertainty_score":0.8418327},"labels":[],"label_agreement":null},{"id":"W3091786344","doi":"10.1016/j.ahj.2020.09.019","title":"Design and rationale of the XIENCE short DAPT clinical program: An assessment of the safety of 3-month and 1-month DAPT in patients at high bleeding risk undergoing PCI with an everolimus-eluting stent","year":2020,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Duke Clinical Research Institute; Data Science Institute, Columbia University; Abbott Vascular; St. Jude Medical; Idorsia Pharmaceuticals; Ferring Pharmaceuticals; Novo Nordisk; Daiichi-Sankyo; Belvoir Media Group; OrbusNeich; Siemens Medical Solutions USA; Bayer Fund; Canada Excellence Research Chairs, Government of Canada; Medicines Company; Boston Scientific Corporation; Bristol-Myers Squibb; Cleveland Clinic; American College of Cardiology Foundation; Gilead Sciences; Center for Social Inclusion; Medtronic; Sanofi; Janssen Scientific Affairs; Roche; Novartis; Abbott Laboratories; CSL Behring; Chiesi Farmaceutici; Pfizer; Icahn School of Medicine at Mount Sinai; Eli Lilly and Company; Biotronik; AstraZeneca; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation; Merck; Mayo Clinic; Scott R. MacKenzie Foundation; Edwards Lifesciences; Roivant Sciences; Boehringer Ingelheim; Amgen","keywords":"Medicine; Conventional PCI; Percutaneous coronary intervention; Internal medicine; Myocardial infarction; Stent; Cardiology; Surgery","score_opus":0.03780935993126013,"score_gpt":0.3300168008840337,"score_spread":0.29220744095277357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3091786344","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99784607,0.00022513953,0.0010682009,0.00024416292,0.00002696827,0.00056912686,0.0000050898534,0.000005010241,0.000010246547],"genre_scores_gemma":[0.99237144,0.00051467033,0.006896778,0.00015212539,0.000046271547,0.0000039781207,0.0000018473223,0.000012022096,8.5783535e-7],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99797446,0.0006315093,0.0005072704,0.0001980535,0.0005320698,0.0001566381],"domain_scores_gemma":[0.99894935,0.0001949082,0.0003677577,0.00019209956,0.00012608463,0.00016981279],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092600135,0.00011203235,0.00046575078,0.000028419176,0.00016668938,0.000012822764,0.000102591875,0.000026967416,0.0000045096112],"category_scores_gemma":[0.00010179684,0.000063265434,0.0001267418,0.00022103572,0.0004890088,0.00013095258,0.00007024718,0.000273767,2.1913564e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011091111,0.00027218496,0.9641226,0.000024208533,0.00020258462,0.0000027448189,0.0004326723,0.0015465581,0.00022959537,0.0000073640367,0.0000035200337,0.03204685],"study_design_scores_gemma":[0.001988811,0.0042613414,0.9865529,0.00022632985,0.00022565344,0.00004842298,0.0012450278,0.005151465,0.00020025196,0.00001179553,0.000018373898,0.00006964872],"about_ca_topic_score_codex":0.000058493275,"about_ca_topic_score_gemma":0.000023239101,"teacher_disagreement_score":0.0319772,"about_ca_system_score_codex":0.000037145815,"about_ca_system_score_gemma":0.00025467767,"threshold_uncertainty_score":0.25798893},"labels":[],"label_agreement":null},{"id":"W3092245181","doi":"10.1093/eurheartj/ehaa699","title":"Towards a better standard for defining high bleeding risk patients: can we now translate this into a better practice?","year":2020,"lang":"en","type":"letter","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Medicine; Intensive care medicine; MEDLINE","score_opus":0.020976697674713177,"score_gpt":0.2773063299825202,"score_spread":0.25632963230780703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092245181","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012195031,0.0051699686,0.0037365963,0.9744318,0.0014010174,0.00090642757,0.0006211684,0.00015985493,0.0013781495],"genre_scores_gemma":[0.007324582,0.005092699,0.021600056,0.94536114,0.01915016,0.000023613666,0.00058604137,0.00054877263,0.0003129599],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9949587,0.0012410942,0.0008693588,0.0007206136,0.0013776822,0.0008325771],"domain_scores_gemma":[0.9976779,0.00027140204,0.00058289745,0.00046435135,0.0005363427,0.00046707093],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0012411142,0.0006962602,0.0012739507,0.000286688,0.00066812,0.00038012292,0.0003153628,0.00029148668,0.00051171356],"category_scores_gemma":[0.00037476319,0.0005817871,0.0018086167,0.00020880613,0.00012343266,0.00031807498,0.00007567105,0.004690797,0.0002178964],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012380879,0.000052631352,0.0023947146,0.0003962409,0.0030521054,0.0051278677,0.0014248466,0.000002864004,0.00002427039,0.0000010038941,0.9165792,0.069706194],"study_design_scores_gemma":[0.0060815588,0.0014397994,0.00094583514,0.001217733,0.0033922007,0.0012551845,0.000075252865,0.0000094815005,0.000061090184,0.00015045717,0.98474896,0.0006224427],"about_ca_topic_score_codex":0.000016824972,"about_ca_topic_score_gemma":0.0000013802252,"teacher_disagreement_score":0.06908375,"about_ca_system_score_codex":0.0002141931,"about_ca_system_score_gemma":0.00036370353,"threshold_uncertainty_score":0.99966335},"labels":[],"label_agreement":null},{"id":"W3092868987","doi":"10.1016/j.amjcard.2020.09.057","title":"Safety and Efficacy of 1-Month Dual Antiplatelet Therapy (Ticagrelor + Aspirin) Followed by 23-Month Ticagrelor Monotherapy in Patients Undergoing Staged Percutaneous Coronary Intervention (A Sub-Study from GLOBAL LEADERS)","year":2020,"lang":"en","type":"article","venue":"The American Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"AstraZeneca","keywords":"Ticagrelor; Medicine; Aspirin; Percutaneous coronary intervention; Internal medicine; Cardiology; P2Y12; Clopidogrel; Myocardial infarction","score_opus":0.013445303896729297,"score_gpt":0.25763018439408863,"score_spread":0.24418488049735934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092868987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99236304,0.005325159,0.00075161346,0.0007009152,0.00011975815,0.0006212701,0.00007038481,0.000018451237,0.00002941376],"genre_scores_gemma":[0.9950773,0.004043439,0.000065316875,0.0005822889,0.00015513116,0.000002302599,0.00003765527,0.00003394367,0.0000026339044],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99688464,0.0011717974,0.0008563479,0.00032692368,0.00044502263,0.00031525147],"domain_scores_gemma":[0.9983514,0.00041204505,0.0005985328,0.00029830987,0.00014014448,0.00019959644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005369773,0.0002974214,0.0016091774,0.00007145871,0.0000736218,0.000014214503,0.00022739219,0.00007609334,0.000016194801],"category_scores_gemma":[0.00013629468,0.0002079139,0.0006772253,0.00028694008,0.0006181518,0.0000927594,0.000055809636,0.00039180004,0.0000029366004],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10580604,0.0007447599,0.7284104,0.00002096692,0.007120188,0.0012038024,0.002160576,0.0005647391,0.0029738613,0.0000046574623,0.00022103415,0.15076898],"study_design_scores_gemma":[0.034237713,0.023666574,0.9318944,0.00013446654,0.00078173034,0.000699023,0.0075183962,0.00005245497,0.00026316097,0.000026595832,0.0004394885,0.0002859546],"about_ca_topic_score_codex":0.000056403052,"about_ca_topic_score_gemma":0.000007057116,"teacher_disagreement_score":0.20348404,"about_ca_system_score_codex":0.000097675824,"about_ca_system_score_gemma":0.000101686404,"threshold_uncertainty_score":0.84784824},"labels":[],"label_agreement":null},{"id":"W3094217864","doi":"10.1093/eurheartj/ehaa670","title":"Ticagrelor alone vs. ticagrelor plus aspirin following percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: TWILIGHT-ACS","year":2020,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":176,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; University Health Network","funders":"British Heart Foundation; AstraZeneca","keywords":"Medicine; Ticagrelor; Percutaneous coronary intervention; Aspirin; Internal medicine; Acute coronary syndrome; Myocardial infarction; Cardiology; Hazard ratio; Conventional PCI; Stroke (engine); Confidence interval","score_opus":0.018776893917309002,"score_gpt":0.2515241245591724,"score_spread":0.2327472306418634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094217864","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995992,0.0007665485,0.0012394227,0.00087790855,0.00024037891,0.0006100482,0.000014810143,0.000067964706,0.00019090959],"genre_scores_gemma":[0.9968716,0.00016885358,0.00076048385,0.0015998897,0.00022124073,0.000004009361,0.00015161642,0.00009194582,0.00013035201],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974907,0.0003600128,0.0005667378,0.0003979369,0.000773817,0.0004108183],"domain_scores_gemma":[0.99901485,0.000032626045,0.0001499007,0.00025354087,0.00010932787,0.00043975184],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004536622,0.0003066109,0.0005880311,0.0001353846,0.00017771067,0.00007382862,0.00015576601,0.000057452584,0.0002522182],"category_scores_gemma":[0.00004301419,0.00024831708,0.000507063,0.00024746518,0.00005778058,0.00028486605,0.00008120514,0.00056520145,0.00024279548],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01674887,0.0014811932,0.8571445,0.00032858274,0.004641873,0.06054078,0.0019436349,0.0004930197,0.0024906306,0.000005552988,0.0033753437,0.050806027],"study_design_scores_gemma":[0.011135924,0.0048122127,0.97003704,0.00097077736,0.0006943081,0.0073619685,0.00024916852,0.00024107556,0.00008243034,0.0000025582663,0.004064635,0.00034788784],"about_ca_topic_score_codex":0.000002310008,"about_ca_topic_score_gemma":6.7056067e-7,"teacher_disagreement_score":0.11289256,"about_ca_system_score_codex":0.00021210234,"about_ca_system_score_gemma":0.000111338464,"threshold_uncertainty_score":0.9999969},"labels":[],"label_agreement":null},{"id":"W3095153061","doi":"10.1161/circulationaha.120.050244","title":"Ticagrelor or Prasugrel in Patients With ST-Segment–Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention","year":2020,"lang":"en","type":"article","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Services and Policy Research","funders":"","keywords":"Medicine; Prasugrel; Ticagrelor; Myocardial infarction; Percutaneous coronary intervention; Internal medicine; Cardiology; Clinical endpoint; Hazard ratio; TIMI; Randomized controlled trial; Confidence interval","score_opus":0.012888005009082514,"score_gpt":0.2215756912863804,"score_spread":0.2086876862772979,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095153061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98894405,0.00015246753,0.009500002,0.0002672095,0.00008552461,0.000804069,0.000007834689,0.000086448614,0.00015240606],"genre_scores_gemma":[0.9981032,0.000048923295,0.00024853903,0.0005755183,0.0001307981,0.000015902351,0.0008367341,0.000028690794,0.000011708217],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987708,0.00009055391,0.0002748608,0.00029056857,0.00041943282,0.00015378476],"domain_scores_gemma":[0.9995184,0.00003539057,0.00009975628,0.00014521701,0.00010720078,0.00009401141],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000106523956,0.00014288678,0.00023796193,0.00008960936,0.00006325241,0.000022816379,0.00003571665,0.00009029084,0.00012111883],"category_scores_gemma":[0.000077989025,0.00012185187,0.00013826607,0.00027097535,0.00003189739,0.0002739935,0.000016419732,0.00013108042,0.000023740487],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004611707,0.00025814114,0.92936575,0.00023306414,0.0003302474,0.00006208251,0.0003307707,0.0017991548,0.0006394592,0.000025225334,0.000046407735,0.062298],"study_design_scores_gemma":[0.005332966,0.0005576821,0.99173725,0.00018589015,0.00022816076,0.0000614131,0.00013209316,0.0013268002,0.000015622676,0.000020986985,0.00024854534,0.00015258543],"about_ca_topic_score_codex":0.000007083435,"about_ca_topic_score_gemma":0.000004282072,"teacher_disagreement_score":0.062371515,"about_ca_system_score_codex":0.00023917285,"about_ca_system_score_gemma":0.000102417565,"threshold_uncertainty_score":0.4968975},"labels":[],"label_agreement":null},{"id":"W3095853160","doi":"10.3390/diagnostics10110871","title":"Personalization of Aspirin Therapy Ex Vivo in Patients with Atherosclerosis Using Light Transmission Aggregometry","year":2020,"lang":"en","type":"article","venue":"Diagnostics","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto; McMaster University; St. Michael's Hospital","funders":"Genome Canada","keywords":"Aspirin; Ex vivo; Medicine; Personalization; Transmission (telecommunications); In vivo; Cardiology; Internal medicine; Computer science; World Wide Web; Biology","score_opus":0.020727737695984565,"score_gpt":0.22513302987687156,"score_spread":0.204405292180887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095853160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925471,0.0028549938,0.0040308987,0.00013369625,0.000020353884,0.00033369646,0.000017822818,0.000019165704,0.00004229709],"genre_scores_gemma":[0.99632853,0.0026087563,0.00043435753,0.0005012898,0.00004519148,0.0000030438416,0.000046355086,0.000028151311,0.0000043076066],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991728,0.000041699142,0.0001719925,0.0001689766,0.00032183045,0.00012266861],"domain_scores_gemma":[0.9995768,0.00004742452,0.000063983156,0.00011805023,0.000087756234,0.00010595704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000049175196,0.000119667726,0.00027216785,0.0000620382,0.00002395826,0.0000063590824,0.00004816348,0.00006709027,0.00011554376],"category_scores_gemma":[0.000048170394,0.00009208462,0.00011708366,0.00036851806,0.000033428445,0.000053229196,0.000006739085,0.00007127897,0.0000020999944],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069068314,0.00047548005,0.9819197,0.00014764945,0.00014876992,0.000011768239,0.001122888,0.0001696448,0.0024725567,0.000009155643,0.00005713736,0.012774566],"study_design_scores_gemma":[0.010818989,0.0013871723,0.9515993,0.0011823024,0.00024388358,0.0000018481537,0.0002004617,0.0010096726,0.02868326,0.000008127562,0.004596439,0.00026855708],"about_ca_topic_score_codex":0.000009521189,"about_ca_topic_score_gemma":3.758901e-7,"teacher_disagreement_score":0.030320413,"about_ca_system_score_codex":0.000019892965,"about_ca_system_score_gemma":0.00004300485,"threshold_uncertainty_score":0.3755102},"labels":[],"label_agreement":null},{"id":"W3097673503","doi":"10.1097/mjt.0000000000001286","title":"Verifying Death Reports in the Platelet Inhibition and Patient Outcomes (PLATO) Trial","year":2020,"lang":"en","type":"article","venue":"American Journal of Therapeutics","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Université de Montréal; The Scarborough Hospital; Montreal Heart Institute","funders":"","keywords":"Ticagrelor; Medicine; Clopidogrel; Clinical endpoint; Cause of death; Clinical trial; Emergency medicine; Internal medicine; Aspirin","score_opus":0.03240628321502531,"score_gpt":0.2844714848723852,"score_spread":0.2520652016573599,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097673503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927464,0.0020276543,0.00018855234,0.0046738302,0.000087557404,0.00021471578,0.0000013420035,0.0000072729513,0.000052633524],"genre_scores_gemma":[0.9869306,0.00081240066,0.00024504928,0.011884417,0.000110161076,0.000002260983,0.0000014821273,0.000012779316,8.6130126e-7],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99882764,0.00014200616,0.0004345233,0.0001041378,0.000364966,0.00012671974],"domain_scores_gemma":[0.99929065,0.00008248582,0.00035252314,0.00012980767,0.000052837895,0.00009169567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028203937,0.00011239201,0.00042698745,0.00005349367,0.000042238593,0.00002363525,0.000046004385,0.000028187316,0.000008065549],"category_scores_gemma":[0.0000407965,0.000067675806,0.00024814752,0.00016828395,0.00009475778,0.00006928258,0.000012266888,0.00025563664,6.276277e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.042667776,0.00057594693,0.097082175,0.000042302592,0.0021847666,0.007094839,0.0135494,0.000116580064,0.0013683107,0.00007372866,0.00018040268,0.83506376],"study_design_scores_gemma":[0.19901943,0.060687825,0.3567512,0.00093966495,0.00391857,0.036553174,0.062314294,0.00047681335,0.009718476,0.0017568134,0.26612929,0.0017344294],"about_ca_topic_score_codex":0.0000060322463,"about_ca_topic_score_gemma":3.5562473e-7,"teacher_disagreement_score":0.8333293,"about_ca_system_score_codex":0.000019619963,"about_ca_system_score_gemma":0.0000639725,"threshold_uncertainty_score":0.27597392},"labels":[],"label_agreement":null},{"id":"W3099865510","doi":"10.1016/j.hlc.2020.09.491","title":"484 Effect of Longer-Term Administration of Evolocumab in Patients With Angiographic Coronary Artery Disease: Results of the GLAGOV Open Label Extension Study","year":2020,"lang":"en","type":"article","venue":"Heart Lung and Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta; University of Calgary","funders":"","keywords":"Evolocumab; Discontinuation; Medicine; Placebo; Adverse effect; Interquartile range; Internal medicine; Clinical endpoint; Statin; Cardiology; Incidence (geometry); Clinical trial; Cholesterol; Apolipoprotein B","score_opus":0.014416791339787908,"score_gpt":0.26691909663900554,"score_spread":0.25250230529921763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3099865510","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977265,0.00075601373,0.000011179466,0.00006600377,0.000017103293,0.0013873243,0.000021596657,0.0000060651564,0.000008221363],"genre_scores_gemma":[0.9998497,0.00001312657,0.000005982606,0.000027825277,0.000010979475,0.000011628938,0.00007122519,0.000008021752,0.0000015454185],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99898684,0.00019018659,0.00025521958,0.00018494247,0.00031763903,0.000065188906],"domain_scores_gemma":[0.9994327,0.000037748963,0.00013954443,0.00025299593,0.000079140766,0.000057873516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022044269,0.00008626617,0.00029420838,0.000045055265,0.000031261334,0.0000054153033,0.00004366085,0.000032870495,0.0000027555445],"category_scores_gemma":[0.00004801342,0.00005726418,0.00008101742,0.00024107569,0.000056054712,0.0000878585,0.000024305436,0.000049139395,1.2966913e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013384757,0.00053083844,0.9828685,0.00024548543,0.00015414415,0.000008809224,0.00033680757,0.00004662743,0.0006977268,0.0000016267823,0.00001245152,0.0017122516],"study_design_scores_gemma":[0.010565662,0.0021155253,0.98595506,0.00030986418,0.00036248376,0.0000038445396,0.000060531976,0.0003356283,0.00023282638,0.000003356718,0.0000015512268,0.00005363791],"about_ca_topic_score_codex":0.000011040274,"about_ca_topic_score_gemma":0.0000039530473,"teacher_disagreement_score":0.0030866135,"about_ca_system_score_codex":0.0000075594494,"about_ca_system_score_gemma":0.000045040884,"threshold_uncertainty_score":0.23351656},"labels":[],"label_agreement":null},{"id":"W3106618360","doi":"10.1093/ehjci/ehaa946.3382","title":"Comparing clinical outcomes following 1 year of dual antiplatelet therapy in patients risk stratified by the PRECISE-DAPT and DAPT scores","year":2020,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Conventional PCI; Mace; Internal medicine; TIMI; Cardiology; Dyslipidemia; Percutaneous coronary intervention; Myocardial infarction; Disease","score_opus":0.0723395800606644,"score_gpt":0.31702405878887624,"score_spread":0.24468447872821183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3106618360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99708927,0.0018274353,0.00004594847,0.0003113431,0.00014557998,0.00024272507,0.000008992216,0.00001794891,0.0003107715],"genre_scores_gemma":[0.9981069,0.0010552724,0.00011799602,0.00049669604,0.00016989326,5.086729e-7,0.000006771083,0.00003123611,0.000014734662],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99777126,0.0008831695,0.0005595376,0.00020421951,0.000384925,0.00019688657],"domain_scores_gemma":[0.99925095,0.00015500581,0.00016242522,0.00018175949,0.0000415283,0.00020831724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012945341,0.00015105362,0.0005342339,0.0000385296,0.00012757257,0.00005559946,0.00010938583,0.000035081925,0.00003119991],"category_scores_gemma":[0.00021869231,0.00009600295,0.0004486154,0.000103777274,0.00009768774,0.00010324303,0.000050055918,0.0005604108,0.000011692314],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006598184,0.00014380147,0.98733383,0.0000075663247,0.0005123001,0.00008267368,0.00038255783,0.000015928137,0.00011137497,0.0000022716617,0.0017467487,0.009001153],"study_design_scores_gemma":[0.0073385425,0.0006532924,0.98933417,0.00008281769,0.000090010566,0.00002703639,0.00018337322,0.00004854755,0.000109591325,0.0000051302336,0.0020285626,0.00009890014],"about_ca_topic_score_codex":0.000006140235,"about_ca_topic_score_gemma":8.1962196e-7,"teacher_disagreement_score":0.008902253,"about_ca_system_score_codex":0.000006813138,"about_ca_system_score_gemma":0.00003593677,"threshold_uncertainty_score":0.39148867},"labels":[],"label_agreement":null},{"id":"W3107319594","doi":"10.1093/ehjci/ehaa946.3395","title":"Genetic polymorphisms and cardiovascular outcomes in Chinese patients undergoing PCI and treated with clopidogrel and aspirin","year":2020,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Mace; Clopidogrel; Internal medicine; Percutaneous coronary intervention; Aspirin; Conventional PCI; Cardiology; Myocardial infarction; CYP2C19; Single-nucleotide polymorphism; Prospective cohort study; Genotype","score_opus":0.01569878267091318,"score_gpt":0.2278064906176908,"score_spread":0.2121077079467776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3107319594","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9841142,0.014978809,0.00007971531,0.00040623828,0.000020715606,0.00017703105,0.0000026119383,0.000022383269,0.00019825326],"genre_scores_gemma":[0.9962997,0.002353343,0.0003589508,0.0007883845,0.00013826012,8.16135e-7,0.000002587443,0.000039379658,0.00001860237],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988528,0.0002508535,0.00019307263,0.0002503677,0.00026230922,0.00019060378],"domain_scores_gemma":[0.999412,0.000029895766,0.000036418205,0.00013468656,0.00003107835,0.00035594957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021094168,0.00018215641,0.00045965082,0.000078022225,0.0001069285,0.000061583785,0.000033011274,0.000025190886,0.000011955166],"category_scores_gemma":[0.00004974745,0.00012322716,0.0001536872,0.00011750834,0.00008352699,0.00008874254,0.000044170138,0.0002183601,0.000004275721],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021178533,0.000036931717,0.9843865,0.000042025666,0.00060058257,0.00093494094,0.00023297188,0.000021477708,0.00005230919,7.4819127e-7,0.000027114302,0.013452595],"study_design_scores_gemma":[0.007168305,0.00065852405,0.9886268,0.00012750507,0.00021667047,0.001782119,0.00006758069,0.000037411453,0.00000929931,0.0000032113808,0.0011596956,0.0001428838],"about_ca_topic_score_codex":0.0000066678904,"about_ca_topic_score_gemma":0.0000019465522,"teacher_disagreement_score":0.013309712,"about_ca_system_score_codex":0.000009733656,"about_ca_system_score_gemma":0.00002717065,"threshold_uncertainty_score":0.5025058},"labels":[],"label_agreement":null},{"id":"W3107329362","doi":"10.1093/ehjci/ehaa946.3396","title":"PEAR1 rs12041331 polymorphisms and the risk of adverse cardiovascular outcomes in patients with acute coronary syndrome and/or percutaneous coronary intervention: a systematic review and meta-analysis","year":2020,"lang":"en","type":"review","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Percutaneous coronary intervention; Internal medicine; Acute coronary syndrome; Conventional PCI; Meta-analysis; Subgroup analysis; Cardiology; Population; Adverse effect; Myocardial infarction","score_opus":0.03213835648556763,"score_gpt":0.27958242575920683,"score_spread":0.2474440692736392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3107329362","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003662102,0.99346477,0.000026554291,0.000093361254,0.000023595065,0.0025618675,0.0001413699,0.000013824375,0.000012536817],"genre_scores_gemma":[0.014540984,0.9848088,0.00009067193,0.00023974208,0.000015731408,0.000026312258,0.00003352292,0.00007353479,0.00017069033],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9914943,0.00580272,0.0012816959,0.000461243,0.00073451904,0.00022550415],"domain_scores_gemma":[0.9979232,0.00026669906,0.0007341693,0.00069258694,0.000104173414,0.0002791809],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0028786338,0.0005644481,0.010807377,0.00024580723,0.00014281014,0.000034584515,0.00018247409,0.00006804905,0.00014060253],"category_scores_gemma":[0.00017113534,0.00025035787,0.007390801,0.00041572074,0.00028877243,0.00010254588,0.00016091966,0.00070874294,0.000009483622],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041108645,0.000114317816,0.004162179,0.17510514,0.8004105,0.014643933,0.00010176333,0.0000016470742,3.08859e-9,0.0000012328642,0.000017947534,0.0050302153],"study_design_scores_gemma":[0.0021122603,0.0005437157,0.01866143,0.026490932,0.8635905,0.08529217,0.000045004537,0.0000014340028,2.237007e-9,6.15712e-7,0.0030214866,0.00024044474],"about_ca_topic_score_codex":0.000008272823,"about_ca_topic_score_gemma":0.0000012363112,"teacher_disagreement_score":0.14861421,"about_ca_system_score_codex":0.00003922693,"about_ca_system_score_gemma":0.00008107294,"threshold_uncertainty_score":0.9999949},"labels":[],"label_agreement":null},{"id":"W3107736646","doi":"10.1093/ehjci/ehaa946.2578","title":"Adenosine diphosphate receptor inhibitor monotherapy with ticagrelor or clopidogrel following percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials","year":2020,"lang":"en","type":"review","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; London Health Sciences Centre","funders":"","keywords":"Medicine; Percutaneous coronary intervention; Ticagrelor; Internal medicine; Clopidogrel; Randomized controlled trial; Aspirin; Conventional PCI; Number needed to harm; Mace; Acute coronary syndrome; Meta-analysis; Relative risk; Cardiology; Confidence interval; Number needed to treat; Myocardial infarction","score_opus":0.09630434579513364,"score_gpt":0.3668332470069295,"score_spread":0.27052890121179585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3107736646","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00001897828,0.9887735,0.00030995533,0.00046251848,0.00012796796,0.010165182,0.00006904173,0.000043092976,0.000029749515],"genre_scores_gemma":[0.00012574,0.9971244,0.00055699487,0.00073953974,0.00026329138,0.00021025212,0.000066605,0.00015272119,0.00076050137],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9732514,0.019551905,0.005459236,0.00052791135,0.00092381093,0.00028572953],"domain_scores_gemma":[0.9921915,0.0028336796,0.0036998189,0.0005692346,0.00026182117,0.00044397556],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.016553206,0.00087648607,0.06696705,0.00035809109,0.00014028384,0.00013674528,0.00022967494,0.000115836294,0.0018509285],"category_scores_gemma":[0.0034403463,0.0003709535,0.04831656,0.00076852576,0.00014127234,0.00009849299,0.000051658866,0.0007132424,0.00003406219],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032730088,0.00011063256,5.248023e-7,0.21617939,0.74200606,0.002666106,0.00005666733,5.439181e-7,4.2096468e-7,0.0000017929519,0.00025917764,0.005988573],"study_design_scores_gemma":[0.060198013,0.00054111955,3.3902134e-7,0.11893968,0.77445126,0.008699527,0.000026576363,0.0000037713223,2.0756828e-7,3.2315586e-7,0.036856797,0.00028238952],"about_ca_topic_score_codex":0.0000010527536,"about_ca_topic_score_gemma":2.2999869e-7,"teacher_disagreement_score":0.097239695,"about_ca_system_score_codex":0.000061257386,"about_ca_system_score_gemma":0.00023746699,"threshold_uncertainty_score":0.99987423},"labels":[],"label_agreement":null},{"id":"W3108018155","doi":"10.1093/ehjci/ehaa946.1431","title":"Prognosis in patients with prior myocardial infarction and PEGASUS-TIMI 54 criteria in the CLARIFY registry","year":2020,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"","keywords":"Medicine; TIMI; Ticagrelor; Myocardial infarction; Internal medicine; Population; Stroke (engine); Acute coronary syndrome; Coronary artery disease; Inclusion and exclusion criteria; Cardiology; Surgery; Thrombolysis","score_opus":0.022825582558786903,"score_gpt":0.2559414238497509,"score_spread":0.23311584129096397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3108018155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943014,0.00047494614,0.000025699725,0.0042906897,0.000052070576,0.0002733018,0.0000023842863,0.000013244275,0.0005662754],"genre_scores_gemma":[0.9960367,0.00015537057,0.00016696639,0.0031695054,0.00043401064,0.0000019970032,0.0000065464824,0.00002147714,0.0000074059512],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986598,0.00051764835,0.00019065698,0.00015828814,0.00030634901,0.00016725928],"domain_scores_gemma":[0.9996437,0.000017914257,0.000049196788,0.0001119908,0.000044165237,0.00013305664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005283746,0.0001074738,0.00020208684,0.000054094275,0.00009008023,0.000079472244,0.00006623389,0.000040924355,0.000035192716],"category_scores_gemma":[0.00007090505,0.00006889098,0.00010255831,0.00016382744,0.000054758963,0.000120695935,0.000021372263,0.0006930372,0.00001040772],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009770939,0.00010919469,0.9893152,0.00002655519,0.00008479153,0.00042554064,0.0010745238,0.000007263259,0.000060702838,0.0000024649341,0.0020814897,0.005835194],"study_design_scores_gemma":[0.0036469502,0.00060931453,0.97425145,0.0001230351,0.000062902036,0.00046638763,0.00019013385,0.00001407393,0.000010691737,0.0000018427676,0.020543074,0.000080171776],"about_ca_topic_score_codex":0.0000025131806,"about_ca_topic_score_gemma":8.329194e-7,"teacher_disagreement_score":0.018461583,"about_ca_system_score_codex":0.000017852111,"about_ca_system_score_gemma":0.00005458455,"threshold_uncertainty_score":0.30109403},"labels":[],"label_agreement":null},{"id":"W3108298016","doi":"10.1002/clc.23505","title":"Use of risk scores to identify lower and higher risk subsets among <scp>COMPASS‐eligible</scp> patients with chronic coronary syndromes. Insights from the <scp>CLARIFY</scp> registry","year":2020,"lang":"en","type":"article","venue":"Clinical Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"Servier","keywords":"Medicine; Aspirin; Internal medicine; Stroke (engine); Myocardial infarction; Rivaroxaban; Population; Cardiology; Warfarin; Atrial fibrillation","score_opus":0.03874280775650923,"score_gpt":0.2931678323105486,"score_spread":0.25442502455403937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3108298016","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863124,0.011023717,0.00033556795,0.000111681285,0.0006635823,0.00090198545,0.00043085736,0.000095113275,0.00012510011],"genre_scores_gemma":[0.99221593,0.004952643,0.00010791665,0.0013499015,0.0009369329,0.00003839798,0.00027255077,0.000072563314,0.000053170494],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99564576,0.0013209131,0.0009301576,0.0010438036,0.00055804505,0.000501338],"domain_scores_gemma":[0.99297374,0.0044075316,0.0004975885,0.0011757769,0.0002736597,0.0006717196],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004493028,0.00045114942,0.0017945165,0.00006331665,0.00018655944,0.000046699908,0.0003892524,0.0007743456,0.000020887703],"category_scores_gemma":[0.00283548,0.0002935597,0.0009160765,0.00032737333,0.0013489848,0.00016999169,0.00030886132,0.0014316095,0.000071544404],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002988926,0.00013919795,0.97552216,0.000046770696,0.0035731904,0.00050633936,0.00019560453,0.00018421358,0.000022707505,0.000018119446,0.017477214,0.0020156163],"study_design_scores_gemma":[0.0042475243,0.0015103208,0.9582846,0.00015100959,0.0021288265,0.000028551322,0.00009737717,0.000023127926,0.00003149165,0.00013432163,0.03327678,0.000086035645],"about_ca_topic_score_codex":0.00022602502,"about_ca_topic_score_gemma":0.000040142677,"teacher_disagreement_score":0.0172375,"about_ca_system_score_codex":0.000044732293,"about_ca_system_score_gemma":0.00018001643,"threshold_uncertainty_score":0.99995166},"labels":[],"label_agreement":null},{"id":"W3108441977","doi":"10.1016/j.ejim.2020.11.014","title":"Gastroprotection in patients on antiplatelet and/or anticoagulant therapy: a position paper of National Association of Hospital Cardiologists (ANMCO) and the Italian Association of Hospital Gastroenterologists and Endoscopists (AIGO)","year":2020,"lang":"en","type":"review","venue":"European Journal of Internal Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Care Foundation","funders":"","keywords":"Medicine; Anticoagulant therapy; Association (psychology); Anticoagulant; Internal medicine; Emergency medicine; Intensive care medicine; General surgery","score_opus":0.012276783147971615,"score_gpt":0.25884634704306975,"score_spread":0.24656956389509813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3108441977","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.63630646,0.3608249,0.000099184486,0.00094105426,0.0005573007,0.0010312332,0.00011204565,0.0000073435094,0.00012048364],"genre_scores_gemma":[0.52927387,0.47033554,0.000026251475,0.00008049685,0.00023391191,0.0000023209952,0.000019561268,0.000019413887,0.000008599865],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99614054,0.001242614,0.0013402761,0.0002288877,0.0008808681,0.0001668248],"domain_scores_gemma":[0.996103,0.00030760764,0.002848558,0.00011512748,0.00052901293,0.000096723874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022117018,0.00029490193,0.0020269733,0.0002565466,0.000027930531,0.000011439353,0.00012895183,0.000104317376,0.0000105548925],"category_scores_gemma":[0.0014573138,0.00016434379,0.00041759378,0.00014784551,0.00025900424,0.00010046767,0.000050206618,0.0005184587,4.2664388e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02335077,0.0014715551,0.40748218,0.0074324207,0.013309714,0.00090037304,0.002495707,0.0000073445544,0.00019582736,0.000045633526,0.0009027317,0.5424058],"study_design_scores_gemma":[0.046259195,0.047884077,0.8353655,0.05199499,0.0026868216,0.0006407784,0.00028398036,0.000014183619,0.00007223423,0.00003456858,0.014411698,0.00035201295],"about_ca_topic_score_codex":0.0000142807385,"about_ca_topic_score_gemma":0.0000018135365,"teacher_disagreement_score":0.54205376,"about_ca_system_score_codex":0.00016579025,"about_ca_system_score_gemma":0.00006897511,"threshold_uncertainty_score":0.6701745},"labels":[],"label_agreement":null},{"id":"W3108789529","doi":"10.1093/ehjci/ehaa946.1434","title":"Comparison of prasugrel and ticagrelor for patient with acute coronary syndrome: a systematic review and meta-analysis","year":2020,"lang":"en","type":"review","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Prasugrel; Ticagrelor; Medicine; Acute coronary syndrome; Myocardial infarction; Internal medicine; Randomized controlled trial; Clinical endpoint; Stroke (engine); Platelet aggregation inhibitor; Cardiology; Aspirin","score_opus":0.11011527668173114,"score_gpt":0.37266745816801267,"score_spread":0.2625521814862815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3108789529","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004136098,0.9966702,0.00029317985,0.00016824201,0.000013196728,0.0026700352,0.00009900618,0.0000130167855,0.00003176535],"genre_scores_gemma":[0.0005668474,0.9980051,0.00078955136,0.00037652353,0.000020543996,0.000043250755,0.000040675524,0.00006749308,0.00009003166],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99686277,0.0011125349,0.0011153434,0.00032370083,0.00040844324,0.00017721516],"domain_scores_gemma":[0.99816585,0.00016395845,0.00083876704,0.00035413084,0.0001401426,0.00033717084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082420214,0.0003929377,0.010109737,0.00015502618,0.000097306125,0.00003984046,0.000096759184,0.00004763217,0.000064523316],"category_scores_gemma":[0.00008033178,0.0002094418,0.003364901,0.00031616676,0.00008427934,0.000048230515,0.000054100823,0.00036885517,0.000009962778],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000040564875,0.000060782288,0.000018163266,0.54316133,0.44979218,0.0014140342,0.000045642733,2.3072434e-7,4.5507612e-8,0.000002227945,0.00054547144,0.00491933],"study_design_scores_gemma":[0.0002902201,0.0009894485,0.000040664654,0.044228263,0.8145409,0.040339664,0.000020949836,0.0000026935743,7.673247e-8,3.275987e-7,0.09937841,0.00016838513],"about_ca_topic_score_codex":1.5827061e-7,"about_ca_topic_score_gemma":7.180109e-8,"teacher_disagreement_score":0.49893308,"about_ca_system_score_codex":0.00001948344,"about_ca_system_score_gemma":0.000119224394,"threshold_uncertainty_score":0.8540789},"labels":[],"label_agreement":null},{"id":"W3108956418","doi":"10.1093/ehjci/ehaa946.3538","title":"Cost-effectiveness of ticagrelor in patients with type 2 diabetes and coronary artery disease with a history of PCI: an economic evaluation of THEMIS-PCI using a Swedish healthcare perpective","year":2020,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; St. Michael's Hospital","funders":"AstraZeneca","keywords":"Medicine; Ticagrelor; Conventional PCI; Percutaneous coronary intervention; Stroke (engine); Population; Coronary artery disease; Myocardial infarction; Internal medicine; Aspirin; Cardiology","score_opus":0.08104575058781555,"score_gpt":0.298287445077775,"score_spread":0.21724169448995945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3108956418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961241,0.003234477,0.000015824198,0.000024794359,0.000035673067,0.00049257686,0.000015843703,0.0000044159856,0.000052290197],"genre_scores_gemma":[0.99972963,0.000051368752,0.00006847453,0.000060224873,0.00005163785,0.000001840277,0.000014025693,0.000021931926,8.7898593e-7],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99844456,0.0008062177,0.00020385152,0.00015699906,0.00028355565,0.00010484661],"domain_scores_gemma":[0.99920386,0.000040938965,0.00014609542,0.00012164313,0.00027938647,0.00020806596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006530258,0.00010070391,0.00033891408,0.00006357111,0.000022234344,0.0000034599634,0.000036778754,0.000013038185,0.000030182586],"category_scores_gemma":[0.000046449033,0.000076835684,0.00006696472,0.000058619382,0.00012746277,0.00012393379,0.0000134963175,0.00012434993,4.85879e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0074653276,0.0002128057,0.98553556,0.00033049917,0.00029140225,0.0000366436,0.00093014014,0.0006356738,0.00072869466,0.0000017334195,0.000012180854,0.0038193266],"study_design_scores_gemma":[0.0054960237,0.0020410998,0.9896721,0.00063957484,0.0004137121,0.000045571884,0.00025021535,0.0012259788,0.00010491883,0.00000443564,0.00002591185,0.00008044185],"about_ca_topic_score_codex":0.0000035139217,"about_ca_topic_score_gemma":8.5217863e-7,"teacher_disagreement_score":0.004136543,"about_ca_system_score_codex":0.00018244471,"about_ca_system_score_gemma":0.00054189627,"threshold_uncertainty_score":0.31332684},"labels":[],"label_agreement":null},{"id":"W3109483050","doi":"10.1093/ehjci/ehaa946.1471","title":"Transfusion requirements in cardiac Surgery III (TRICS III), Ticagrelor Substudy","year":2020,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University Health Network; Mount Sinai Hospital; McMaster University","funders":"","keywords":"Medicine; Ticagrelor; Aspirin; Clopidogrel; Blood product; Acute coronary syndrome; Anesthesia; Cardiac surgery; Surgery; Myocardial infarction; Internal medicine","score_opus":0.07225373413632084,"score_gpt":0.2890440071514393,"score_spread":0.21679027301511844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3109483050","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891353,0.0056967246,0.00039612656,0.0017693231,0.0003881942,0.00027431146,0.0000037126829,0.000053955933,0.0022823217],"genre_scores_gemma":[0.9916044,0.0052716937,0.000070862276,0.0019285504,0.00095796114,0.0000013034585,0.000010592212,0.00004937325,0.00010524649],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99771756,0.00067542144,0.00045613182,0.00025133387,0.0005669604,0.00033262125],"domain_scores_gemma":[0.999133,0.00007113645,0.00006405001,0.000190999,0.00006845559,0.0004723824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015179021,0.0001733103,0.0005910813,0.00013133272,0.00014836299,0.000047030255,0.00008930106,0.000036187877,0.000296827],"category_scores_gemma":[0.00010371402,0.00014785568,0.0007459168,0.00038001247,0.000040879004,0.00013019689,0.000029645957,0.00047301725,0.00017070901],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003432016,0.0006560668,0.8442306,0.0001461005,0.0012506039,0.010347231,0.0033699716,0.000048935755,0.010130682,0.000011555796,0.055572156,0.07080406],"study_design_scores_gemma":[0.0055418797,0.00046862307,0.81406254,0.00036973733,0.00041619423,0.00084541534,0.0007868472,0.000058241825,0.0012553016,0.000005556915,0.17579609,0.00039357258],"about_ca_topic_score_codex":0.0000041990465,"about_ca_topic_score_gemma":3.8739114e-7,"teacher_disagreement_score":0.120223925,"about_ca_system_score_codex":0.00004304428,"about_ca_system_score_gemma":0.000106125895,"threshold_uncertainty_score":0.60293794},"labels":[],"label_agreement":null},{"id":"W3109524120","doi":"10.1093/ehjci/ehaa946.2577","title":"Ticagrelor monotherapy beyond 1 month versus standard dual antiplatelet therapy after drug-eluting coronary stenting: a pre-specified per-protocol analysis of the GLOBAL LEADERS trial","year":2020,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Ticagrelor; Medicine; Aspirin; Population; Clopidogrel; Myocardial infarction; Coronary artery disease; Internal medicine; Acute coronary syndrome; Antiplatelet drug; Platelet aggregation inhibitor; Randomized controlled trial; Cardiology","score_opus":0.06281567363810334,"score_gpt":0.3218881897069422,"score_spread":0.25907251606883885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3109524120","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9857138,0.0010713271,0.0002218035,0.0018229975,0.00033890878,0.009618715,0.00006268421,0.000061252875,0.0010885416],"genre_scores_gemma":[0.99653566,0.0001998001,0.00027391154,0.001443892,0.0011699111,0.00022956885,0.000008962508,0.00006703652,0.00007125628],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9961832,0.0010633152,0.00075819454,0.0004327601,0.0010923069,0.000470186],"domain_scores_gemma":[0.99851924,0.00008733025,0.00033225742,0.00048279227,0.0001885449,0.0003898067],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010133722,0.0003468343,0.0008923211,0.00010830196,0.00032177294,0.00011034976,0.0002750874,0.00006755001,0.0008114535],"category_scores_gemma":[0.000087808265,0.00023471504,0.0020000543,0.00075923087,0.0002790761,0.00015108175,0.000086219625,0.00057026895,0.000019718536],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.868237,0.00041818383,0.08651676,0.000056030512,0.014353607,0.0009941995,0.0036339285,0.00061964826,0.00089292513,0.00001852555,0.0028561812,0.021402985],"study_design_scores_gemma":[0.23284748,0.005918196,0.62661624,0.00021640692,0.0035201376,0.00046003168,0.002749605,0.00048339486,0.00142037,0.000012736713,0.12506486,0.00069055177],"about_ca_topic_score_codex":0.0000035128194,"about_ca_topic_score_gemma":0.0000022463714,"teacher_disagreement_score":0.63538957,"about_ca_system_score_codex":0.00009202014,"about_ca_system_score_gemma":0.00021718243,"threshold_uncertainty_score":0.95714015},"labels":[],"label_agreement":null},{"id":"W3109646113","doi":"10.1093/ehjci/ehaa946.3380","title":"Favorable therapeutic index of an orally-active small-molecule antagonist of the platelet protease-activated receptor-4, BMS-986141, compared with the P2Y12 antagonist ticagrelor in cynomolgus monkeys","year":2020,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Medicine; Pharmacology; P2Y12; Platelet; Ticagrelor; Antagonist; Platelet activation; Thrombin; In vivo; Ex vivo; Receptor antagonist; Receptor; In vitro; Internal medicine; Aspirin; Chemistry; Biochemistry; Clopidogrel; Platelet aggregation; Biology","score_opus":0.035414991046781856,"score_gpt":0.25795512135049004,"score_spread":0.22254013030370817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3109646113","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947376,0.0005385041,0.0002516976,0.0024395532,0.00006781924,0.0009073878,0.00002833221,0.000032459397,0.0009966174],"genre_scores_gemma":[0.998305,0.00009572378,0.00017114902,0.0010963248,0.00018172195,0.0000063676234,0.000017250639,0.00007790223,0.000048547445],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969307,0.0012979553,0.00050576555,0.0003160378,0.0005779256,0.0003716268],"domain_scores_gemma":[0.9985853,0.000056155404,0.0003664486,0.0004977088,0.00020824134,0.00028617636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005491491,0.000297544,0.00066004257,0.00007325451,0.00029359935,0.00006943342,0.00041815222,0.000056139197,0.00014513123],"category_scores_gemma":[0.00004898621,0.00016638658,0.00034776382,0.0005752132,0.00043727382,0.00015335393,0.000078240446,0.00084443344,0.000013212587],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037800506,0.0027443618,0.10676196,0.00050866976,0.0046180165,0.0025695504,0.009795244,0.0026972897,0.80865824,0.00008603911,0.0016074753,0.022152627],"study_design_scores_gemma":[0.014952138,0.0040582097,0.37738538,0.0009295695,0.0004558749,0.0027521353,0.0053194207,0.0010677258,0.56990594,0.000020285765,0.022433653,0.00071966473],"about_ca_topic_score_codex":0.000049097802,"about_ca_topic_score_gemma":0.00000771148,"teacher_disagreement_score":0.27062342,"about_ca_system_score_codex":0.000056298144,"about_ca_system_score_gemma":0.0003433609,"threshold_uncertainty_score":0.6785048},"labels":[],"label_agreement":null},{"id":"W3110571006","doi":"10.1093/ehjci/ehaa946.1412","title":"Antiplatelet therapy prescription patterns for acute coronary syndrome: a decade analysed","year":2020,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Population Health Research Institute; McMaster University","funders":"","keywords":"Medicine; Ticagrelor; Clopidogrel; Acute coronary syndrome; Percutaneous coronary intervention; Conventional PCI; Medical prescription; P2Y12; Internal medicine; Cardiology; Guideline; Aspirin; Emergency medicine; Myocardial infarction; Pharmacology","score_opus":0.05331212601390209,"score_gpt":0.3096371289603238,"score_spread":0.2563250029464217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110571006","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853359,0.003144531,0.0082175145,0.0023779876,0.00018562895,0.00044817588,0.000041035517,0.000096818825,0.00015240844],"genre_scores_gemma":[0.9897271,0.002922041,0.00070417434,0.005681808,0.0006879738,0.0000045240317,0.000060162973,0.000077144614,0.00013507296],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99842244,0.0002981315,0.0003199294,0.0002808796,0.0003550283,0.0003236058],"domain_scores_gemma":[0.9990882,0.00002762551,0.00009907479,0.00021220102,0.000102574806,0.00047032113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041318403,0.00020544557,0.0004417583,0.000080629026,0.00022424934,0.00008861911,0.00014077839,0.00004563912,0.0003498379],"category_scores_gemma":[0.0000319713,0.00016533978,0.0007800501,0.00014313668,0.00003794826,0.00017722706,0.000028167833,0.00035132898,0.000095995536],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020679185,0.0009121219,0.5933316,0.00027948085,0.019262224,0.033850793,0.0021955795,0.00024039042,0.13607764,0.000029052628,0.09172132,0.10142063],"study_design_scores_gemma":[0.0101797385,0.0024315096,0.85880995,0.00016105053,0.0007563653,0.022532515,0.0001427949,0.0003532814,0.002270439,0.000013107917,0.10203647,0.00031278632],"about_ca_topic_score_codex":6.359397e-7,"about_ca_topic_score_gemma":7.100953e-8,"teacher_disagreement_score":0.26547837,"about_ca_system_score_codex":0.000023412433,"about_ca_system_score_gemma":0.000064933985,"threshold_uncertainty_score":0.67423606},"labels":[],"label_agreement":null},{"id":"W3112696609","doi":"10.1016/j.cjco.2020.11.021","title":"Implications of the Antiplatelet Therapy Gap Left With Discontinuation of Prasugrel in Canada","year":2020,"lang":"en","type":"article","venue":"CJC Open","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Université de Montréal; University of Ottawa; Hamilton Health Sciences; Montreal Heart Institute","funders":"LEO Pharma Research Foundation; Université de Montréal; Heart and Stroke Foundation of Canada; Roche","keywords":"Prasugrel; Medicine; Clopidogrel; Discontinuation; Ticagrelor; P2Y12; Gynecology; Internal medicine; Aspirin","score_opus":0.028137106767815334,"score_gpt":0.26257485321674295,"score_spread":0.23443774644892762,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112696609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992038,0.0005398231,0.000076501776,0.0036473472,0.000012686661,0.0007701897,0.000025068686,0.0000031888665,0.0028871624],"genre_scores_gemma":[0.99897826,0.00018315672,0.000052193616,0.0006901309,0.000015109144,0.0000110863,0.000015268031,0.00000950259,0.000045266668],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994159,0.00004780151,0.00017282495,0.00012177058,0.00016035452,0.00008136263],"domain_scores_gemma":[0.9995036,0.000021428188,0.00009512754,0.00027500573,0.00005949501,0.000045324996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000843035,0.000066202076,0.00028582895,0.000012052591,0.00002317797,0.0000061926685,0.00022045626,0.00001823998,0.00008543999],"category_scores_gemma":[0.000020780315,0.000039258262,0.00005979908,0.00018314274,0.000044683493,0.00006360384,0.0000427408,0.00006188353,6.6759895e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011652993,0.00015046826,0.9555368,0.000057012698,0.0004668067,0.000013869524,0.00089903566,0.00019115003,0.010671592,0.00049764465,0.0014309228,0.028919397],"study_design_scores_gemma":[0.003206883,0.00014341706,0.97122955,0.00011166519,0.00005527479,0.000015713193,0.0004973934,0.00005492271,0.021233592,0.000046649304,0.003329499,0.00007543964],"about_ca_topic_score_codex":0.09338875,"about_ca_topic_score_gemma":0.10479506,"teacher_disagreement_score":0.028843956,"about_ca_system_score_codex":0.00002784802,"about_ca_system_score_gemma":0.00081794907,"threshold_uncertainty_score":0.91264844},"labels":[],"label_agreement":null},{"id":"W3118525042","doi":"10.3390/jcm10020255","title":"Correlation between PlateletWorks® and PFA-100® for Measuring Platelet Function before Urgent Surgery in Patients with Chronic Antiplatelet Therapy","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Instituto de Salud Carlos III","keywords":"Medicine; Clopidogrel; Concordance; Platelet; Hemostasis; Aspirin; Epinephrine; Point-of-care testing; Internal medicine; Surgery; Antiplatelet drug; Anesthesia","score_opus":0.056619779368398813,"score_gpt":0.3215570012026791,"score_spread":0.2649372218342803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3118525042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854905,0.008794983,0.0033521152,0.0009967714,0.00085150293,0.00046251933,0.0000055956316,0.000014992434,0.000031047442],"genre_scores_gemma":[0.9920004,0.0045688585,0.00013174485,0.000491754,0.002644425,0.000005532638,0.00009169322,0.00003965125,0.00002591691],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99671686,0.00022954232,0.0017068743,0.00030737894,0.00073238905,0.00030695467],"domain_scores_gemma":[0.99680823,0.0011615705,0.0007522195,0.00023417732,0.00063446775,0.0004093562],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027174733,0.00023988997,0.0016556374,0.00022285314,0.00007633308,0.000013838284,0.00005367233,0.000256598,0.00010299322],"category_scores_gemma":[0.0011687333,0.0001567634,0.0004682165,0.00033434498,0.00016568141,0.0001982484,0.000017810156,0.00061018753,0.0000012151569],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0065656137,0.00022889928,0.7017517,0.00010079825,0.0010341554,0.00023504245,0.000044994944,0.00008786454,0.000010621586,0.0000069781786,0.00038099958,0.28955236],"study_design_scores_gemma":[0.026055928,0.0043599573,0.95745546,0.0017563847,0.0005078666,0.00015390325,0.000046275225,0.00012193887,0.00007077105,0.00013034309,0.009188113,0.00015304897],"about_ca_topic_score_codex":0.000003751968,"about_ca_topic_score_gemma":0.000006931019,"teacher_disagreement_score":0.2893993,"about_ca_system_score_codex":0.00007168969,"about_ca_system_score_gemma":0.00048243644,"threshold_uncertainty_score":0.6392626},"labels":[],"label_agreement":null},{"id":"W3120043760","doi":"10.1002/prp2.707","title":"Tyrosine kinase inhibitors targeting vascular endothelial growth factor and the risk of aortic dissection—A pharmacovigilance analysis","year":2021,"lang":"en","type":"article","venue":"Pharmacology Research & Perspectives","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Aortic dissection; Blood pressure; Internal medicine; Cardiology; Pharmacovigilance; Odds ratio; Risk factor; Adverse effect; Aorta","score_opus":0.019202630278666047,"score_gpt":0.352676969428183,"score_spread":0.33347433914951696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3120043760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9380742,0.059596613,0.00024999233,0.0011001662,0.00012572481,0.00051027833,0.000070895396,0.00004008879,0.00023203863],"genre_scores_gemma":[0.95918,0.039878603,0.00006481782,0.00008231844,0.0005244119,0.00008520117,0.000016260106,0.000023498562,0.00014491101],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99597573,0.002037737,0.00030854632,0.00055314763,0.0006695572,0.0004552641],"domain_scores_gemma":[0.9974552,0.0009856585,0.00010440937,0.0002566773,0.0009868578,0.00021121415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001573901,0.00019530903,0.00067850633,0.00032941048,0.0005186692,0.000033343953,0.00013695992,0.000075846525,0.00081963214],"category_scores_gemma":[0.0011479728,0.00013569793,0.000807632,0.0014686238,0.0014046048,0.00012193939,0.00013238698,0.0007207405,0.0000061584137],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007439401,0.0015758948,0.33776432,0.00036843194,0.050525077,0.00059106696,0.011692558,0.00013970435,0.5838627,0.00077083224,0.0012859786,0.0039840224],"study_design_scores_gemma":[0.023540474,0.00038842336,0.19629394,0.00006708668,0.0150083555,0.00010488405,0.019139947,0.0031518347,0.73850775,0.00062790094,0.002682383,0.0004870488],"about_ca_topic_score_codex":0.00013852392,"about_ca_topic_score_gemma":0.00000633828,"teacher_disagreement_score":0.15464503,"about_ca_system_score_codex":0.00009083931,"about_ca_system_score_gemma":0.0002201265,"threshold_uncertainty_score":0.8974397},"labels":[],"label_agreement":null},{"id":"W3120971269","doi":"10.14740/jocmr4389","title":"Survival Benefit of Aspirin in Patients With Congestive Heart Failure: A Meta-Analysis","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Medicine Research","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health","keywords":"Medicine; Heart failure; Aspirin; Meta-analysis; Etiology; Placebo; Internal medicine; Population; Mortality rate; Cardiology; Alternative medicine; Pathology","score_opus":0.2553294463670365,"score_gpt":0.49507624622581925,"score_spread":0.23974679985878272,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3120971269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98370945,0.006403046,0.0001128284,0.009113111,0.000078775265,0.00022778237,0.0000086140535,0.000002979348,0.00034342686],"genre_scores_gemma":[0.99823487,0.0004898566,0.0005026652,0.0002403239,0.0003233453,0.0000034363106,0.000013432803,0.00001582286,0.00017623615],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9934198,0.0013846023,0.0017281764,0.00028350702,0.0028751085,0.00030875098],"domain_scores_gemma":[0.9919401,0.0027257362,0.00039461203,0.00048710467,0.003994049,0.0004584412],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.010766963,0.0001480494,0.0034636057,0.0005830807,0.000032496177,0.00000777059,0.00017086761,0.00014190706,0.0010329661],"category_scores_gemma":[0.0048095076,0.00008224977,0.0020587882,0.0020051438,0.0005822554,0.0000847736,0.000056995956,0.0012160526,0.000004266098],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00404823,0.0012771696,0.873464,0.00008308107,0.11677832,0.0005790448,0.00005720587,0.000071936454,0.000020422141,0.000094648894,0.00056047534,0.002965497],"study_design_scores_gemma":[0.011197286,0.0047884076,0.92133987,0.0002069661,0.058172166,0.000037172034,0.00049601763,0.0000133171,0.00020115354,0.00016890983,0.0032926402,0.0000861066],"about_ca_topic_score_codex":0.000040051094,"about_ca_topic_score_gemma":0.00006894036,"teacher_disagreement_score":0.058606155,"about_ca_system_score_codex":0.000033996643,"about_ca_system_score_gemma":0.00063811673,"threshold_uncertainty_score":0.99988025},"labels":[],"label_agreement":null},{"id":"W3121592627","doi":"10.1136/heartjnl-2020-318045","title":"Antiplatelet therapy in patients with myocardial infarction without obstructive coronary artery disease","year":2021,"lang":"en","type":"article","venue":"Heart","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton General Hospital; Sunnybrook Health Science Centre; Montreal Heart Institute; McMaster University; University of Toronto; Population Health Research Institute","funders":"Sanofi; Bristol-Myers Squibb","keywords":"Medicine; Clopidogrel; Myocardial infarction; Internal medicine; Cardiology; Coronary artery disease; Aspirin; Stroke (engine)","score_opus":0.008125350118143691,"score_gpt":0.22461388104837948,"score_spread":0.2164885309302358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3121592627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977682,0.0010908289,0.000027133154,0.00022576314,0.00015737276,0.00043176394,0.000020642008,0.0000522182,0.0002260303],"genre_scores_gemma":[0.9978658,0.0003064039,0.0001251129,0.001233619,0.00013262354,0.000026485477,0.00020294763,0.00003061981,0.00007637395],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987935,0.000113344475,0.0001588302,0.00032573674,0.00037405742,0.00023454842],"domain_scores_gemma":[0.999287,0.000017932805,0.000027516913,0.00033850683,0.00013739099,0.0001916411],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000071138566,0.00016512418,0.00034447646,0.00006887095,0.00006251545,0.000018901108,0.000028458991,0.000061658226,0.0001526786],"category_scores_gemma":[0.000018060771,0.00013526667,0.0001970222,0.0002114549,0.000077874975,0.00014990523,0.000016160082,0.00015990266,0.00003108017],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005148657,0.00035620853,0.98363554,0.00001718938,0.00039935234,0.00039679412,0.0000743568,0.000021392563,0.00015322662,0.000010523463,0.00014870062,0.009638032],"study_design_scores_gemma":[0.008321448,0.00028421544,0.9853482,0.000092046685,0.00008097328,0.00011134528,0.00006484265,0.000009154066,0.00023255737,0.000042417654,0.005247032,0.0001657453],"about_ca_topic_score_codex":0.0000056513545,"about_ca_topic_score_gemma":0.0000020991824,"teacher_disagreement_score":0.009472286,"about_ca_system_score_codex":0.000044886303,"about_ca_system_score_gemma":0.00018879186,"threshold_uncertainty_score":0.55160147},"labels":[],"label_agreement":null},{"id":"W3123850694","doi":"10.1016/j.jcin.2020.12.005","title":"Stent Thrombosis Risk Over Time on the Basis of Clinical Presentation and Platelet Reactivity","year":2021,"lang":"en","type":"article","venue":"JACC: Cardiovascular Interventions","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Data Science Institute, Columbia University; Canada Excellence Research Chairs, Government of Canada; Janssen Scientific Affairs; Bayer Fund; Daiichi-Sankyo; Medicines Company; Cordis; Boston Scientific Corporation; OrbusNeich; American Medical Association; Chiesi Farmaceutici; Eli Lilly and Company; Bristol-Myers Squibb; AstraZeneca; CSL Behring; National Heart, Lung, and Blood Institute; Cardiovascular Research Foundation; Novartis Pharmaceuticals Corporation; Biosensors International Group; Medtronic; Abbott Vascular; Abbott Laboratories","keywords":"Medicine; Conventional PCI; Percutaneous coronary intervention; Clopidogrel; Internal medicine; Cardiology; Myocardial infarction; Aspirin; Hazard ratio; Unstable angina; Acute coronary syndrome; Stent; Confidence interval","score_opus":0.06993271253366812,"score_gpt":0.3570684548885802,"score_spread":0.28713574235491207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3123850694","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860626,0.009809952,0.0015028953,0.00030878012,0.00020448155,0.00050954433,0.000105412844,0.000043322492,0.0014530027],"genre_scores_gemma":[0.9932645,0.0057579563,0.00015741237,0.00012006877,0.0001924962,0.00004832398,0.0000719048,0.000029270795,0.0003580795],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9969238,0.0011900575,0.0006061953,0.00044858438,0.00064665155,0.00018471463],"domain_scores_gemma":[0.9979989,0.0003888443,0.00018394682,0.0010781715,0.00022774625,0.0001224005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018933626,0.00018639953,0.0008786649,0.00007345643,0.00015206148,0.000036193578,0.00009487609,0.00013788755,0.0007254348],"category_scores_gemma":[0.000751686,0.00013632131,0.0068768244,0.000252816,0.00017416428,0.00011135501,0.00009911334,0.00034670904,0.000052886637],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011274416,0.0049070846,0.15561454,0.0011690117,0.120312035,0.00051228446,0.00043234392,0.0005808026,0.001960848,0.0013380082,0.0113694435,0.70067614],"study_design_scores_gemma":[0.003863264,0.0003317403,0.9596757,0.00078369305,0.006583204,0.00014251533,0.00030929735,0.00023441146,0.011755892,0.00019566392,0.015896188,0.00022841891],"about_ca_topic_score_codex":0.00008012363,"about_ca_topic_score_gemma":0.0000079995825,"teacher_disagreement_score":0.8040612,"about_ca_system_score_codex":0.00002871081,"about_ca_system_score_gemma":0.00007288676,"threshold_uncertainty_score":0.7943002},"labels":[],"label_agreement":null},{"id":"W3129578382","doi":"10.1161/jaha.120.016602","title":"Platelet Quiescence in Patients With Acute Coronary Syndrome Undergoing Coronary Artery Bypass Graft Surgery","year":2021,"lang":"en","type":"review","venue":"Journal of the American Heart Association","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke; Montreal Heart Institute; University of Ottawa","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Acute coronary syndrome; Perioperative; Coronary artery bypass surgery; Internal medicine; Cardiology; Artery; Regimen; Myocardial infarction; Bypass surgery; Platelet aggregation inhibitor; Odds ratio; Platelet; Surgery","score_opus":0.014169117874443424,"score_gpt":0.26622213448660237,"score_spread":0.25205301661215895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3129578382","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.43112257,0.56797266,0.0000066108537,0.00014622614,0.000334399,0.00037611887,0.000027045187,0.000010367619,0.000003999751],"genre_scores_gemma":[0.08230264,0.91687614,0.00007172791,0.00040492625,0.00012298406,0.000009491904,0.000059966613,0.000060641654,0.000091461225],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99632037,0.0010031178,0.00093942136,0.00024633983,0.0011373844,0.00035337935],"domain_scores_gemma":[0.9964764,0.00089923077,0.0018611801,0.00035851635,0.00027315278,0.00013151408],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090437004,0.0003391476,0.0035999175,0.0002561172,0.000096166485,0.00003863192,0.00017471393,0.00014594327,0.000019422983],"category_scores_gemma":[0.00026345393,0.00021967503,0.0020571793,0.00081442995,0.00008729111,0.00019838012,0.00005748928,0.00078581076,0.000008147133],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037782907,0.00040894301,0.8511322,0.00088963663,0.0097003495,0.0022427395,0.000037741404,0.000008748723,4.8573077e-7,5.634824e-7,0.0025214956,0.13267928],"study_design_scores_gemma":[0.0014609843,0.00061208336,0.9111162,0.020708982,0.004799517,0.0076137898,0.000073956966,8.752559e-7,7.23688e-7,0.00000418243,0.053253103,0.00035561973],"about_ca_topic_score_codex":0.0000088062,"about_ca_topic_score_gemma":0.000004784072,"teacher_disagreement_score":0.3489035,"about_ca_system_score_codex":0.0012031706,"about_ca_system_score_gemma":0.0015724351,"threshold_uncertainty_score":0.89580876},"labels":[],"label_agreement":null},{"id":"W3130386910","doi":"10.1016/j.jcin.2020.11.046","title":"Ticagrelor Monotherapy Versus Dual-Antiplatelet Therapy After PCI","year":2021,"lang":"en","type":"review","venue":"JACC: Cardiovascular Interventions","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences; St. Michael's Hospital","funders":"Janssen Pharmaceuticals; National Human Genome Research Institute; Amarin Pharma; Abbott Vascular; GE Healthcare; St. Jude Medical; National Center for Advancing Translational Sciences; Johnson and Johnson; National Institutes of Health; Defence Science Institute; Duke Clinical Research Institute; Eisai; Janssen Scientific Affairs; British Heart Foundation; OrbusNeich; Siemens Medical Solutions USA; Medicines Company; Boston Scientific Corporation; Novartis Pharmaceuticals Corporation; Eli Lilly and Company; Foundation for Cardiovascular Research; Bayer; Gilead Sciences; University of Florida; Medtronic; Abbott Laboratories; CSL Behring; Chiesi Farmaceutici; AstraZeneca; Bristol-Myers Squibb; Scott R. MacKenzie Foundation; Portola Pharmaceuticals; Boehringer Ingelheim; Amgen; Merck","keywords":"Ticagrelor; Conventional PCI; Medicine; Dual (grammatical number); Cardiology; Internal medicine; Percutaneous coronary intervention; Myocardial infarction","score_opus":0.14032586870038571,"score_gpt":0.3872493015605913,"score_spread":0.24692343286020557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3130386910","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021433296,0.99178237,0.0013574157,0.0000457629,0.0020614897,0.002665384,0.00026644111,0.00034998156,0.0012568111],"genre_scores_gemma":[0.00027140763,0.9925045,0.00043019146,0.00012498129,0.0015260531,0.0015225699,0.0014543212,0.0004264808,0.0017395236],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9929519,0.0013038467,0.001696335,0.0016844663,0.0014199946,0.00094341545],"domain_scores_gemma":[0.994844,0.00021462273,0.0003566685,0.0036446787,0.00043084729,0.00050913496],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.0011733654,0.001398573,0.006952883,0.00064521603,0.00025882793,0.00025951784,0.00044596827,0.0010201703,0.003814564],"category_scores_gemma":[0.00015347813,0.0011729801,0.060884193,0.0011303419,0.00024974736,0.00022605968,0.0002284272,0.0012063786,0.001087777],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041432198,0.0005791414,0.0000077006,0.0076987687,0.10221409,0.0031953845,0.000038446065,0.000005225402,2.7042606e-7,0.00007143579,0.0019775508,0.88379765],"study_design_scores_gemma":[0.007161055,0.00035282123,0.00003357923,0.023375096,0.02681116,0.002416277,0.00005714736,0.0000014898075,0.000009874431,0.000009415049,0.9387163,0.0010557923],"about_ca_topic_score_codex":0.00002590002,"about_ca_topic_score_gemma":0.0000048473335,"teacher_disagreement_score":0.9367387,"about_ca_system_score_codex":0.00032033466,"about_ca_system_score_gemma":0.00062392786,"threshold_uncertainty_score":0.99987644},"labels":[],"label_agreement":null},{"id":"W3133078938","doi":"10.1016/j.atherosclerosis.2021.02.010","title":"DAPT risk stratification using coronary artery angioscopy at 2 weeks: Personalized medicine at its finest?","year":2021,"lang":"en","type":"letter","venue":"Atherosclerosis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre","funders":"","keywords":"Medicine; Cardiology; Thrombus; Internal medicine; Myocardial infarction; Angioscopy; Acute coronary syndrome; Unstable angina; Stent; Mace; Percutaneous coronary intervention","score_opus":0.0552984829563499,"score_gpt":0.2721253612657069,"score_spread":0.216826878309357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3133078938","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.878418,0.037679512,0.00038949106,0.07954469,0.0010815186,0.0014427266,0.0005640859,0.00028397926,0.00059594814],"genre_scores_gemma":[0.30113947,0.05432177,0.0014351612,0.5563575,0.018812986,0.00045507305,0.020383222,0.0011663003,0.04592849],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99571836,0.0005111122,0.0007091223,0.0012060569,0.0011916362,0.0006637316],"domain_scores_gemma":[0.997419,0.0002130014,0.0005054778,0.0013411695,0.00028590034,0.00023544072],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003544832,0.0007971153,0.0014865722,0.00016831358,0.0004995429,0.000045822337,0.0002629345,0.0010754784,0.0051175007],"category_scores_gemma":[0.000100415535,0.00069472345,0.0012383806,0.0003720517,0.00039763987,0.00013466088,0.00013154991,0.0010091665,0.00024656436],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074711704,0.00025620745,0.015095277,0.00091291015,0.005989828,0.0017800016,0.00096957455,0.000019625322,0.09048628,0.000011727354,0.8807898,0.0029416387],"study_design_scores_gemma":[0.013507807,0.0010068754,0.07619828,0.00581009,0.014779755,0.0026952138,0.00047750282,0.0005588506,0.008696642,0.000071719056,0.873746,0.0024513032],"about_ca_topic_score_codex":0.0000781103,"about_ca_topic_score_gemma":0.000011113603,"teacher_disagreement_score":0.57727855,"about_ca_system_score_codex":0.00059161073,"about_ca_system_score_gemma":0.00021206653,"threshold_uncertainty_score":0.9995504},"labels":[],"label_agreement":null},{"id":"W3134517982","doi":"10.1016/j.jacc.2021.01.015","title":"Platelet Reactivity in Patients With Acute Coronary Syndromes Awaiting Surgical Revascularization","year":2021,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Heart and Stroke Foundation; University of Toronto","funders":"Roche Diagnostics","keywords":"Medicine; Revascularization; Cardiology; Internal medicine; Platelet; Acute coronary syndrome; Myocardial infarction","score_opus":0.0073107150948584654,"score_gpt":0.234549396815109,"score_spread":0.22723868172025052,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134517982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998409,0.0005772239,0.00015153378,0.0003485005,0.00010830461,0.00015100998,0.00003419405,0.0000039732936,0.00021630163],"genre_scores_gemma":[0.9989917,0.0005259403,0.00024130833,0.000092828865,0.000090859576,0.0000015786657,0.00000778219,0.000014545136,0.00003345865],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984064,0.0005204804,0.0003723858,0.00013767292,0.00040040317,0.00016263788],"domain_scores_gemma":[0.9987142,0.00012377741,0.00047189294,0.00028077347,0.00034276024,0.00006657432],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003627031,0.000116353775,0.0010515744,0.00009082681,0.000039612092,0.0000025303682,0.00011036894,0.00005035994,0.0000076224987],"category_scores_gemma":[0.000104249564,0.000073260315,0.0005928562,0.00047510926,0.00026092088,0.00007275258,0.000049546656,0.00025969656,4.1050643e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004483406,0.00015136601,0.9751755,0.000028627515,0.0035493977,0.010422976,0.000015244585,0.00063215493,0.0004883751,0.00004073167,0.00014827895,0.0048639434],"study_design_scores_gemma":[0.0050194385,0.00081020186,0.9729306,0.00015460524,0.00060734403,0.017316366,0.00016845322,0.000008501513,0.0007806608,0.000031286712,0.0020830578,0.000089491004],"about_ca_topic_score_codex":0.0000028084758,"about_ca_topic_score_gemma":9.437755e-7,"teacher_disagreement_score":0.0068933903,"about_ca_system_score_codex":0.00007217525,"about_ca_system_score_gemma":0.00034448222,"threshold_uncertainty_score":0.2987469},"labels":[],"label_agreement":null},{"id":"W3135826736","doi":"10.1111/ijcp.14105","title":"The FDA and PLATO Investigators death lists: Call for a match","year":2021,"lang":"en","type":"article","venue":"International Journal of Clinical Practice","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Medicine; Ticagrelor; Stroke (engine); Sudden death; Clopidogrel; Sepsis; Sudden cardiac death; Clinical trial; Emergency medicine; Myocardial infarction; Internal medicine","score_opus":0.06734298504748298,"score_gpt":0.4637316589599007,"score_spread":0.3963886739124177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135826736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8909851,0.015917992,0.0056120153,0.081567615,0.00293367,0.000204777,0.00001718439,0.000013748834,0.002747918],"genre_scores_gemma":[0.9620997,0.013026663,0.009594042,0.011998488,0.0025464557,0.000004132119,0.0000070811407,0.000018761395,0.0007046827],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99834377,0.00019518459,0.0007210811,0.000115281626,0.00053449755,0.00009018999],"domain_scores_gemma":[0.9930925,0.0046181274,0.00045762552,0.00012539186,0.0015033996,0.00020295799],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0020401638,0.000071352195,0.00027162692,0.000023364812,0.00006472108,0.00008702287,0.00013554355,0.0000719395,0.00001840333],"category_scores_gemma":[0.021868179,0.000045958506,0.00043342775,0.000039118557,0.000098848024,0.000245751,0.00003968218,0.0003414751,0.000004220294],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037807193,0.0027877192,0.1494046,0.00013994443,0.032166235,0.015888307,0.0006496599,0.00005519736,0.0005260662,0.045005515,0.074360214,0.64120936],"study_design_scores_gemma":[0.0037773426,0.00027717103,0.0230658,0.00012877847,0.00060003705,0.0065585794,0.00042626372,0.000077921635,0.0002069429,0.0026685693,0.96214443,0.00006818042],"about_ca_topic_score_codex":0.000004606252,"about_ca_topic_score_gemma":0.00000222217,"teacher_disagreement_score":0.8877842,"about_ca_system_score_codex":0.000022057024,"about_ca_system_score_gemma":0.00048823783,"threshold_uncertainty_score":0.98637104},"labels":[],"label_agreement":null},{"id":"W3136631970","doi":"10.1016/j.jcin.2021.01.024","title":"Effect of CYP2C19 Genotype on Ischemic Outcomes During Oral P2Y12 Inhibitor Therapy","year":2021,"lang":"en","type":"review","venue":"JACC: Cardiovascular Interventions","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":163,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Alberta; St. Michael's Hospital; University of Ottawa; Heart and Stroke Foundation; University of Toronto","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"P2Y12; CYP2C19; Medicine; Genotype; Internal medicine; Clopidogrel; Biology; Aspirin; Genetics; Gene","score_opus":0.04870494635805145,"score_gpt":0.367007035469202,"score_spread":0.31830208911115054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3136631970","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022046573,0.97412264,0.00008515914,0.000009424257,0.00078017754,0.0021609343,0.00012964099,0.00015788055,0.0005075729],"genre_scores_gemma":[0.00489391,0.9923257,0.00005173838,0.000018080651,0.0004460229,0.0004707027,0.0006397031,0.00022417077,0.0009299315],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9944932,0.0014869916,0.001335078,0.0010024183,0.0011508643,0.0005314328],"domain_scores_gemma":[0.99647254,0.00019738334,0.00038949802,0.002453485,0.00023713172,0.000249935],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0014380852,0.0010005789,0.0071973386,0.00041904274,0.00016129931,0.000049626844,0.00038684925,0.0006174913,0.00052845164],"category_scores_gemma":[0.0001873912,0.0007371034,0.05385417,0.0006954944,0.00014036064,0.00010336712,0.00018696462,0.0008812881,0.00022486674],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001690574,0.00045370686,0.00019142476,0.049072336,0.08830184,0.0007079051,0.000017350678,0.000010322696,0.000011756227,0.000014878479,0.00031626777,0.86073315],"study_design_scores_gemma":[0.0050609736,0.0008583673,0.0004887835,0.06663388,0.032511003,0.0006743933,0.000021336798,3.6070597e-7,0.0012559092,8.672597e-7,0.89178324,0.0007108721],"about_ca_topic_score_codex":0.000020921103,"about_ca_topic_score_gemma":8.1148465e-7,"teacher_disagreement_score":0.891467,"about_ca_system_score_codex":0.00022863831,"about_ca_system_score_gemma":0.00023917669,"threshold_uncertainty_score":0.999508},"labels":[],"label_agreement":null},{"id":"W3137208668","doi":"10.1161/str.52.suppl_1.p252","title":"Abstract P252: Discharge Antithrombotic Therapy for Ischemic Stroke Patients With Prior Aspirin Failure","year":2021,"lang":"en","type":"article","venue":"Stroke","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Aspirin; Clopidogrel; Antithrombotic; Stroke (engine); Warfarin; Dipyridamole; Internal medicine; Atrial fibrillation; Vitamin K antagonist; Antiplatelet drug; Cardiology; Fibrinolytic agent; Ticlopidine; Platelet aggregation inhibitor","score_opus":0.009653717276116866,"score_gpt":0.24054695516432098,"score_spread":0.23089323788820412,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3137208668","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942467,0.002285745,0.00056437484,0.00029791595,0.00012494434,0.0008141325,0.00037293762,0.00008127648,0.0012119629],"genre_scores_gemma":[0.99546915,0.00028556885,0.00129293,0.00035135724,0.00022736099,0.00005864178,0.00048223766,0.000062083,0.0017706442],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984962,0.000022917315,0.0002224424,0.0004329356,0.00043496102,0.00039057084],"domain_scores_gemma":[0.99896294,0.00003971021,0.00008330206,0.0004919835,0.000245294,0.00017677041],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009103512,0.00025636487,0.00047427329,0.000052094678,0.00012833854,0.00004420254,0.000099685705,0.000109468696,0.00044339662],"category_scores_gemma":[0.000028930117,0.00019087439,0.00048100387,0.00010908831,0.000075318436,0.00014104697,0.000021516666,0.00018769408,0.000035219513],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004186894,0.0028590253,0.7697135,0.0007262358,0.0072087166,0.00023580053,0.0002982201,0.000022853916,0.10588634,0.00020105034,0.0077135265,0.100947835],"study_design_scores_gemma":[0.02148495,0.00090330525,0.7617316,0.00030923722,0.00061045645,0.00003581433,0.00037433582,0.0000111306645,0.08002737,0.000011961452,0.1339722,0.00052762876],"about_ca_topic_score_codex":0.0000040916098,"about_ca_topic_score_gemma":0.000009204124,"teacher_disagreement_score":0.12625867,"about_ca_system_score_codex":0.00003164707,"about_ca_system_score_gemma":0.00020190525,"threshold_uncertainty_score":0.77836317},"labels":[],"label_agreement":null},{"id":"W3142088941","doi":"10.1016/j.cjca.2021.03.017","title":"Successful Therapy With Ticagrelor in Three-Vessel Stent Thrombosis Related to Clopidogrel Resistance","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Wonkwang University","keywords":"Ticagrelor; Medicine; Clopidogrel; Percutaneous coronary intervention; Aspirin; Cardiology; Thrombosis; Internal medicine; Stent; P2Y12; Platelet; Conventional PCI; Coronary stent; Myocardial infarction","score_opus":0.015784227358113277,"score_gpt":0.24672596001768435,"score_spread":0.23094173265957108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3142088941","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.973009,0.016470144,0.00089314417,0.0045719296,0.00030992166,0.00020380146,0.000012515293,0.000007381248,0.004522177],"genre_scores_gemma":[0.99682707,0.0015264632,0.000326679,0.0008598473,0.00024025007,0.000005864052,0.0000075590283,0.000027907437,0.00017837873],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985599,0.00019644274,0.00039908732,0.00022841731,0.00021928639,0.00039687433],"domain_scores_gemma":[0.99839956,0.00005630845,0.000096087824,0.00033918468,0.00042247467,0.00068636815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003686564,0.00016574647,0.0008246642,0.00027014225,0.000065792105,0.00002057963,0.00014629013,0.00014838103,0.00008718146],"category_scores_gemma":[0.00009459995,0.0001283355,0.00037187268,0.0005160367,0.00014439056,0.000070201255,0.0000078106605,0.00034011746,0.000011762291],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016131685,0.00003050076,0.94798404,0.00006436577,0.0045027384,0.016338816,0.0005882824,0.0024164906,0.0008669259,0.0012279121,0.0066210856,0.017745648],"study_design_scores_gemma":[0.00478095,0.000613202,0.768358,0.00039649333,0.0002697442,0.0024807325,0.00061882695,0.0000024923836,0.0004656995,0.00049590884,0.22126746,0.0002505091],"about_ca_topic_score_codex":0.00016451516,"about_ca_topic_score_gemma":0.0045096627,"teacher_disagreement_score":0.21464638,"about_ca_system_score_codex":0.00016533748,"about_ca_system_score_gemma":0.002076663,"threshold_uncertainty_score":0.52333695},"labels":[],"label_agreement":null},{"id":"W3142626752","doi":"10.1201/9781482268294","title":"Drug Therapy for Stroke Prevention","year":2001,"lang":"en","type":"book","venue":"","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Stroke (engine); Medicine; Physical medicine and rehabilitation; Engineering","score_opus":0.0198670616713411,"score_gpt":0.2786176376675438,"score_spread":0.2587505759962027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3142626752","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010893528,0.02588057,0.00690229,0.00021798498,0.00029093187,0.002709554,0.00007418274,0.00022322137,0.9626119],"genre_scores_gemma":[0.00028548943,0.012744562,0.00035933734,0.000601358,0.0010685162,0.00010186002,0.00082205166,0.00007342814,0.9839434],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990042,0.000020732175,0.00020173927,0.000300873,0.00028236877,0.000190103],"domain_scores_gemma":[0.9993103,0.00003424093,0.000073132076,0.0003816166,0.00010077483,0.00009991345],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00016189908,0.00023838034,0.00051956833,0.00008474284,0.00005389425,0.000015376103,0.00007424397,0.00021720216,0.0016621919],"category_scores_gemma":[0.000006392895,0.00018642121,0.0014501848,0.000024362596,0.000037582864,0.000035695248,0.000009251957,0.00013945889,0.000072101786],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014612806,0.0002428466,0.00007702443,0.00024499846,0.0036165281,0.00005161593,0.000030296766,0.0000012650379,0.000046068522,0.0016540512,0.56095076,0.43162325],"study_design_scores_gemma":[0.0039441264,0.00030819367,0.00008274262,0.00017335027,0.00050160615,0.00004454869,0.000016819127,0.0000052156647,0.00024355596,0.002886241,0.99159116,0.00020245917],"about_ca_topic_score_codex":0.0000019157605,"about_ca_topic_score_gemma":0.00000273055,"teacher_disagreement_score":0.4314208,"about_ca_system_score_codex":0.00006706893,"about_ca_system_score_gemma":0.00037492497,"threshold_uncertainty_score":0.9992504},"labels":[],"label_agreement":null},{"id":"W3147869686","doi":"","title":"Aspirin and clopidogrel in patients with ACS undergoing PCI: CURE and PCI-CURE.","year":2003,"lang":"en","type":"article","venue":"PubMed","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton General Hospital","funders":"","keywords":"Medicine; Conventional PCI; Clopidogrel; Aspirin; Cardiology; Internal medicine; Percutaneous coronary intervention; Myocardial infarction","score_opus":0.007380608950692273,"score_gpt":0.17843051211484523,"score_spread":0.17104990316415294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3147869686","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99307287,0.0047460976,0.000035845816,0.00015494303,0.00004590094,0.0006329619,0.0000033375813,0.000025771711,0.0012822712],"genre_scores_gemma":[0.99842834,0.0008804893,0.00006888954,0.0003171417,0.000032901302,0.00008695131,0.000011917482,0.000019881476,0.00015349995],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991077,0.00005688128,0.00012104282,0.00023641049,0.00020481355,0.0002731188],"domain_scores_gemma":[0.9995721,0.000034196877,0.000033268978,0.00016496838,0.00003077986,0.00016466728],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017878872,0.0001309168,0.00024233248,0.00006987631,0.000042755313,0.000022041435,0.000026835976,0.00006814285,0.000007179922],"category_scores_gemma":[0.00005820272,0.00010103283,0.000043542164,0.00013796655,0.00007239057,0.00009496457,0.000015081267,0.00011532047,0.0000017879969],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027627955,0.00011973207,0.9210105,0.00009882047,0.00018450063,0.00006306128,0.000073577605,0.0000026895118,0.000001171504,0.00021709982,0.00011511467,0.07783744],"study_design_scores_gemma":[0.0069512776,0.00009110583,0.983085,0.00006423203,0.000111181296,0.000031824722,0.00007436248,0.0000012755077,0.00004421679,0.000100771234,0.00931026,0.00013450815],"about_ca_topic_score_codex":0.0000053297167,"about_ca_topic_score_gemma":0.000020126181,"teacher_disagreement_score":0.07770293,"about_ca_system_score_codex":0.000024696843,"about_ca_system_score_gemma":0.000034943896,"threshold_uncertainty_score":0.4119999},"labels":[],"label_agreement":null},{"id":"W3148255055","doi":"10.2215/cjn.12120720","title":"Prasugrel and Ticagrelor in Patients with Drug-Eluting Stents and Kidney Failure","year":2021,"lang":"en","type":"article","venue":"Clinical Journal of the American Society of Nephrology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Université de Genève; McGill University","keywords":"Ticagrelor; Prasugrel; Medicine; Clopidogrel; Hazard ratio; Internal medicine; Myocardial infarction; Stroke (engine); Cardiology; Confidence interval","score_opus":0.01158830117163903,"score_gpt":0.2805874575368505,"score_spread":0.2689991563652115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3148255055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99046385,0.00082896085,0.000050128736,0.008515068,0.000040945,0.000086409826,0.0000035474013,0.0000022567024,0.000008806463],"genre_scores_gemma":[0.9749458,0.0014458289,0.002776923,0.02070664,0.00009135668,4.1122286e-7,0.000001232319,0.000010172014,0.000021666787],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987385,0.00028030464,0.00046639977,0.00014465548,0.00022370537,0.00014641733],"domain_scores_gemma":[0.9986993,0.00024203098,0.0005144646,0.00017133019,0.00020203926,0.0001708237],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004741302,0.00009239276,0.0006684356,0.00001641941,0.00003793251,0.0000049407254,0.00008265391,0.00005523178,0.000007292115],"category_scores_gemma":[0.00019051398,0.000055642107,0.00039548174,0.00016578133,0.0010897196,0.000039685267,0.00008470606,0.00038561376,2.1871115e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009915052,0.0002791539,0.9753869,0.000036536167,0.0010614644,0.00002400348,0.00017248363,0.0000020522295,0.00020802072,0.0000036085053,0.005063028,0.016771218],"study_design_scores_gemma":[0.0056683645,0.00080549176,0.9830809,0.00014991149,0.0003907811,0.0001733158,0.0008343023,0.000020093918,0.0000277913,0.000032345535,0.008757058,0.000059632115],"about_ca_topic_score_codex":0.000005066069,"about_ca_topic_score_gemma":0.0000011080912,"teacher_disagreement_score":0.016711585,"about_ca_system_score_codex":0.000011799001,"about_ca_system_score_gemma":0.00018709227,"threshold_uncertainty_score":0.40151173},"labels":[],"label_agreement":null},{"id":"W3151570147","doi":"10.1111/j.1538-7836.2007.02511.x","title":"Evidence that pre‐existent variability in platelet response to ADP accounts for ‘clopidogrel resistance’: reply to a rebuttal","year":2007,"lang":"en","type":"article","venue":"Journal of Thrombosis and Haemostasis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"Clopidogrel; Platelet; Rebuttal; Medicine; Adenosine diphosphate; P2Y12; Internal medicine; Platelet activation; Pharmacology; Cardiology; Platelet aggregation; Aspirin","score_opus":0.08920013852451782,"score_gpt":0.367058945227012,"score_spread":0.2778588067024942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3151570147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9819812,0.0032375308,0.005071444,0.008469852,0.00020124874,0.0009120256,0.000050120678,0.000012758558,0.00006381829],"genre_scores_gemma":[0.98763734,0.002128552,0.006826047,0.003096511,0.00019081443,0.000017500688,0.000002200278,0.000026785343,0.000074273485],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99767035,0.00021506415,0.00074392644,0.00035947398,0.00061869697,0.00039251006],"domain_scores_gemma":[0.99753153,0.0009054665,0.00029997804,0.00043400316,0.00036639208,0.00046264727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007963741,0.00021571374,0.00081076386,0.00031366793,0.00011039506,0.000057547295,0.00017304554,0.00011097354,0.000038632337],"category_scores_gemma":[0.002427716,0.00017411217,0.0004676517,0.00037705858,0.00006242863,0.0002497282,0.00006179673,0.00020952818,0.00000288197],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.39087448,0.001956658,0.16944575,0.0013909765,0.0036367245,0.0010374901,0.010773612,0.00009727721,0.01916132,0.00019178442,0.037658527,0.3637754],"study_design_scores_gemma":[0.0048250016,0.0019016962,0.867726,0.0029651818,0.0005022659,0.00024297471,0.0011853757,0.0000049777773,0.010477197,0.00021909684,0.109610066,0.00034013548],"about_ca_topic_score_codex":0.000028168337,"about_ca_topic_score_gemma":0.000051385865,"teacher_disagreement_score":0.6982803,"about_ca_system_score_codex":0.00025375627,"about_ca_system_score_gemma":0.00018357146,"threshold_uncertainty_score":0.7100088},"labels":[],"label_agreement":null},{"id":"W3152487419","doi":"10.2139/ssrn.3204732","title":"Ticagrelor with Aspirin on Platelet Reactivity in Minor Stroke or Transient Ischemic Attack: A Randomised, Open-Label, Blinded-Endpoint Trial","year":2018,"lang":"en","type":"article","venue":"SSRN Electronic Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Stroke Network","funders":"","keywords":"Aspirin; Ticagrelor; Medicine; Minor stroke; Stroke (engine); Clinical endpoint; Cardiology; Internal medicine; Open label; Platelet inhibition; Platelet; Randomized controlled trial; Double blinded; Clopidogrel; Anesthesia; Placebo","score_opus":0.041288509481341065,"score_gpt":0.319134897137714,"score_spread":0.27784638765637293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3152487419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920651,0.0011034323,0.0011125124,0.000633884,0.00016931933,0.0019402128,0.000011106456,0.00003619656,0.0029282733],"genre_scores_gemma":[0.9945059,0.0019928545,0.000120223,0.00037164113,0.00084850093,0.00006899426,0.000013650038,0.00006400115,0.0020142398],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99600166,0.00027339498,0.0005465248,0.0005129716,0.00069492456,0.001970494],"domain_scores_gemma":[0.9988051,0.00012407663,0.00021253797,0.000450554,0.0001300684,0.00027763884],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0025147875,0.00038056378,0.0009067157,0.00023408828,0.0001983152,0.0000899591,0.00035435287,0.00018007412,0.00021768177],"category_scores_gemma":[0.00010956489,0.0002468316,0.00029632938,0.0003294675,0.00018154312,0.00026365014,0.00003708446,0.0020986015,0.00005929128],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.90848047,0.0020292501,0.00011200139,0.000023406392,0.0017981905,0.0004385428,0.00016431282,0.000007005267,0.002488268,0.0002365977,0.00040175425,0.08382019],"study_design_scores_gemma":[0.9256539,0.02638435,0.0004165758,0.0003977713,0.00072214374,0.004199866,0.0008830597,0.00009325648,0.0085684,0.00021638304,0.031882748,0.00058159203],"about_ca_topic_score_codex":0.00003872266,"about_ca_topic_score_gemma":0.0007379737,"teacher_disagreement_score":0.083238594,"about_ca_system_score_codex":0.0007432162,"about_ca_system_score_gemma":0.0038205446,"threshold_uncertainty_score":0.9999984},"labels":[],"label_agreement":null},{"id":"W3153761360","doi":"10.1097/fjc.0000000000001006","title":"In-hospital Bleeding Outcomes of Oral Anticoagulant and Dual Antiplatelet Therapy During Percutaneous Coronary Intervention: An Analysis From the Japanese Nationwide Registry","year":2021,"lang":"en","type":"article","venue":"Journal of Cardiovascular Pharmacology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"Medicine; Percutaneous coronary intervention; Oral anticoagulant; Anticoagulant; Internal medicine; Warfarin; Atrial fibrillation; Myocardial infarction","score_opus":0.012956296601117794,"score_gpt":0.2894616257607079,"score_spread":0.2765053291595901,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3153761360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9449677,0.053635817,0.00009056535,0.0005738652,0.0005145677,0.00017577203,0.000018983175,0.000009405694,0.000013337693],"genre_scores_gemma":[0.9840174,0.015216091,0.00015340294,0.000203145,0.000339947,0.0000029819453,0.00002311577,0.0000226388,0.000021282942],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99747527,0.0006246453,0.00071987393,0.00029367072,0.0006555558,0.00023101503],"domain_scores_gemma":[0.9986322,0.00014934968,0.00030350397,0.00036482725,0.0004090716,0.00014103664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00097088784,0.00021894692,0.0014241675,0.00022675295,0.00008737972,0.00003078924,0.000162377,0.00013207657,0.00021383075],"category_scores_gemma":[0.00007262013,0.00015792892,0.0025214097,0.0004353157,0.0001811758,0.0002713549,0.000069340356,0.0003858886,6.8884015e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031403492,0.0018179511,0.6503075,0.00014776558,0.21793558,0.061137028,0.0027786577,0.0063995793,0.04607173,0.000010521458,0.00012854744,0.0101248445],"study_design_scores_gemma":[0.012034388,0.0004803824,0.9366595,0.00008656423,0.0157478,0.017926492,0.002931222,0.00026866124,0.012623439,0.000026965596,0.00097505,0.00023954526],"about_ca_topic_score_codex":0.00013394254,"about_ca_topic_score_gemma":0.000008922863,"teacher_disagreement_score":0.28635204,"about_ca_system_score_codex":0.000053660202,"about_ca_system_score_gemma":0.000107767824,"threshold_uncertainty_score":0.64401543},"labels":[],"label_agreement":null},{"id":"W3155904894","doi":"10.1080/09537104.2021.1904134","title":"Dual antiplatelet therapy (PEGASUS) vs. dual pathway (COMPASS): a head-to-head in vitro comparison","year":2021,"lang":"en","type":"article","venue":"Platelets","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute; University of Ottawa","funders":"Heart and Stroke Foundation of Canada","keywords":"Medicine; Antithrombotic; Thrombogenicity; Rivaroxaban; Aspirin; Thrombus; Platelet activation; Clopidogrel; Thrombosis; Anticoagulant; Cardiology; Internal medicine; Pharmacology; Platelet; Warfarin; Atrial fibrillation","score_opus":0.03500310484127666,"score_gpt":0.3012709863737498,"score_spread":0.26626788153247316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3155904894","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873313,0.007869371,0.00017129707,0.0016775214,0.00048188464,0.00076632446,0.00008195642,0.00023330249,0.0013870735],"genre_scores_gemma":[0.9943068,0.0008873833,0.0006075112,0.002789333,0.0004617048,0.00006846301,0.0003811188,0.00010273295,0.0003949692],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9960617,0.000308071,0.00080382446,0.00095784216,0.0008840079,0.0009845948],"domain_scores_gemma":[0.9980632,0.0001581295,0.00012109227,0.000889164,0.00020504755,0.0005633557],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004886396,0.00055930164,0.0015473426,0.00032322537,0.00016743608,0.00010112884,0.0001712961,0.00031408897,0.00046560928],"category_scores_gemma":[0.00010214549,0.0005196322,0.0006605183,0.0009278781,0.00010598441,0.00018234331,0.00011181599,0.0006758701,0.0005186678],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025387032,0.0053307847,0.038854368,0.0003352846,0.002804769,0.051188294,0.003036594,0.0007035154,0.53166157,0.000258162,0.0068330118,0.33360663],"study_design_scores_gemma":[0.02304696,0.0010105968,0.118863314,0.00046376468,0.0001680814,0.0040735686,0.0005255709,0.00091968477,0.57138634,0.000121851255,0.2781485,0.0012717961],"about_ca_topic_score_codex":0.00009665344,"about_ca_topic_score_gemma":0.000083785664,"teacher_disagreement_score":0.33233485,"about_ca_system_score_codex":0.00013561592,"about_ca_system_score_gemma":0.00037924646,"threshold_uncertainty_score":0.9997255},"labels":[],"label_agreement":null},{"id":"W3156012846","doi":"10.1042/cs20201445","title":"The pleiotropic effects of antithrombotic drugs in the metabolic–cardiovascular–neurodegenerative disease continuum: impact beyond reduced clotting","year":2021,"lang":"en","type":"review","venue":"Clinical Science","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Antithrombotic; Medicine; Endothelial dysfunction; Disease; Pharmacology; Bioinformatics; Internal medicine; Biology","score_opus":0.04468118423945389,"score_gpt":0.4131018798354265,"score_spread":0.3684206955959726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3156012846","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.051269818,0.9459997,0.000023081797,0.00007340138,0.00075396255,0.0017246694,0.000013082888,0.000019658713,0.00012264795],"genre_scores_gemma":[0.04401025,0.9550896,0.00003878231,0.00013675413,0.00054079347,0.00008839059,0.000020217496,0.000034569504,0.000040608662],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9925466,0.0029298214,0.0013183767,0.0010457652,0.0015062536,0.00065318844],"domain_scores_gemma":[0.9934805,0.0032957813,0.0004620612,0.0020901805,0.00026791412,0.00040353756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0069483942,0.00047570578,0.003567392,0.00012806494,0.0004087987,0.00015555104,0.0011620997,0.00016971986,0.000010080377],"category_scores_gemma":[0.0066123665,0.00022009002,0.006439307,0.002109245,0.002311995,0.0001303004,0.000253105,0.00091004645,0.000012992497],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036955455,0.0003198088,0.00057114515,0.002034947,0.0020479336,0.00032833914,0.0001103091,0.000008157069,0.000007392445,0.00035471527,0.00013418541,0.9940461],"study_design_scores_gemma":[0.00445568,0.00073102425,0.11761608,0.025620954,0.030749347,0.000296209,0.00030837566,0.00007721883,0.000119394455,0.00017956617,0.81861866,0.0012275071],"about_ca_topic_score_codex":0.000017613835,"about_ca_topic_score_gemma":0.0000016679761,"teacher_disagreement_score":0.9928186,"about_ca_system_score_codex":0.00006226811,"about_ca_system_score_gemma":0.002495988,"threshold_uncertainty_score":0.89750105},"labels":[],"label_agreement":null},{"id":"W3156191605","doi":"10.1111/jocs.15636","title":"Ticagrelor use and practice patterns among Canadian cardiac surgeons","year":2021,"lang":"en","type":"article","venue":"Journal of Cardiac Surgery","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; University of Alberta; Université Laval; University of British Columbia; University of Manitoba; University Health Network; Dalhousie University; University of Toronto; McGill University; University of Calgary; St. Michael's Hospital","funders":"","keywords":"Ticagrelor; Medicine; Perioperative; P2Y12; Platelet inhibition; Acute coronary syndrome; Internal medicine; Clopidogrel; Surgery; Myocardial infarction","score_opus":0.02202641065653499,"score_gpt":0.2506175102201619,"score_spread":0.2285910995636269,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3156191605","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97608304,0.020522427,0.000027079559,0.00100217,0.0015106446,0.00009764846,0.00008234653,0.00001186215,0.0006627886],"genre_scores_gemma":[0.9757469,0.022697978,0.000104766856,0.0006280846,0.0005688904,0.0000025326747,0.000028662664,0.000034793622,0.00018734772],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99779147,0.0006558021,0.00046618207,0.00018750067,0.00054826326,0.00035075517],"domain_scores_gemma":[0.9957138,0.0020316697,0.00021259194,0.00032323875,0.0008642228,0.00085452717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018066318,0.00017592867,0.0010259883,0.00025907782,0.00009717177,0.00011459723,0.000036990205,0.00012723767,0.00008572183],"category_scores_gemma":[0.0028678407,0.00015633703,0.0016854312,0.00024378116,0.00007738851,0.00057195005,0.000021915335,0.00031464308,0.0000067998753],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019932994,0.000050501636,0.95372534,0.000053381576,0.0035711874,0.0053749587,0.0000914342,0.0000027182916,0.00020057926,0.000013458063,0.0138079375,0.022909204],"study_design_scores_gemma":[0.00018164252,0.000021959555,0.7602726,0.00019866475,0.0014710219,0.0022472832,0.00060096127,9.1587145e-7,0.00062980066,0.0000040597815,0.2342213,0.00014979154],"about_ca_topic_score_codex":0.0033713386,"about_ca_topic_score_gemma":0.0003314556,"teacher_disagreement_score":0.22041336,"about_ca_system_score_codex":0.00009721071,"about_ca_system_score_gemma":0.001395284,"threshold_uncertainty_score":0.6375239},"labels":[],"label_agreement":null},{"id":"W3156680192","doi":"10.1186/s13012-021-01117-z","title":"Impact of provincial and national implementation strategies on P2Y12 inhibitor utilization for acute coronary syndrome in the elderly: an interrupted time series analysis from 2008 to 2018","year":2021,"lang":"en","type":"article","venue":"Implementation Science","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Population Health Research Institute; McMaster University; Impact","funders":"Ontario Ministry of Health and Long-Term Care; CorHealth Ontario; Hamilton Health Sciences","keywords":"Ticagrelor; Medicine; Conventional PCI; Acute coronary syndrome; Percutaneous coronary intervention; Clopidogrel; Medical prescription; Emergency medicine; P2Y12; Polypharmacy; Internal medicine; Aspirin; Myocardial infarction; Pharmacology","score_opus":0.05275996470239852,"score_gpt":0.4337488792038147,"score_spread":0.3809889145014162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3156680192","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99571556,0.00003861201,0.0025697972,0.00025548087,0.000030105113,0.0006674675,0.0006943142,0.000010229425,0.000018454079],"genre_scores_gemma":[0.9975936,0.000025084046,0.00067265506,0.00015611974,0.000027703436,0.00006432806,0.0014473284,0.000005486877,0.000007740568],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985959,0.000081713675,0.00028693964,0.0002921992,0.00058787834,0.00015540175],"domain_scores_gemma":[0.9992981,0.000055199493,0.00009711508,0.00014920134,0.0003343654,0.0000659995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048239194,0.0000988228,0.0001942709,0.00028600392,0.00013426984,0.000100045574,0.00008954131,0.000021546575,0.00029175126],"category_scores_gemma":[0.000034218334,0.00007626248,0.000114718,0.0010761407,0.00010296192,0.0007402148,0.000022238943,0.000031992342,0.0000016904592],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004321236,0.001023691,0.47638044,0.00006776765,0.0047142315,0.00011632602,0.017158234,0.0013542683,0.28557318,0.0022405223,0.0015836066,0.2054665],"study_design_scores_gemma":[0.0015622118,0.001750333,0.9800375,0.000011779832,0.0003826691,0.00003510517,0.0078212395,0.00028618475,0.0076673785,0.00032031295,0.000037368358,0.000087885935],"about_ca_topic_score_codex":0.00022157855,"about_ca_topic_score_gemma":0.00056240935,"teacher_disagreement_score":0.5036571,"about_ca_system_score_codex":0.000109319815,"about_ca_system_score_gemma":0.00069410383,"threshold_uncertainty_score":0.31944716},"labels":[],"label_agreement":null},{"id":"W3157146533","doi":"10.1016/s0735-1097(21)01540-0","title":"ROLE OF GENETICS IN SEX-SPECIFIC EFFECTS OF CLOPIDOGREL ON ATHEROTHROMBOTIC EVENTS","year":2021,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Clopidogrel; Internal medicine; Cardiology; Genetics; Aspirin","score_opus":0.00750291966196134,"score_gpt":0.24363202648279855,"score_spread":0.2361291068208372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3157146533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988218,0.010894116,0.00008606162,0.00014342881,0.00020196082,0.00017059725,0.000017815779,0.0000015328127,0.00026646935],"genre_scores_gemma":[0.99470675,0.004723635,0.0002708195,0.0000916904,0.00015111039,0.00000159266,5.971088e-7,0.000015595144,0.000038238224],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99827296,0.0005685861,0.00053896324,0.00011526346,0.00035764236,0.00014656059],"domain_scores_gemma":[0.9984416,0.00024728535,0.0006247876,0.00040709582,0.00022237746,0.00005686787],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030902436,0.00011689977,0.0013766483,0.0001227515,0.000014595945,5.660919e-7,0.00018681004,0.000055454984,0.0000066333964],"category_scores_gemma":[0.00011505875,0.000081642196,0.0009555139,0.00039493054,0.0003224955,0.000013909743,0.000047573354,0.00019175193,5.7710804e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041858526,0.0008253577,0.5613346,0.00048668642,0.0068092165,0.001287653,0.0002888619,0.0068506603,0.3871192,0.00037554998,0.0008362254,0.029600134],"study_design_scores_gemma":[0.004457159,0.002874094,0.8184152,0.0006499217,0.00062723906,0.0015567151,0.0011789696,0.000017395223,0.16508837,0.000543755,0.004465345,0.00012580569],"about_ca_topic_score_codex":0.0000023773669,"about_ca_topic_score_gemma":6.8753275e-7,"teacher_disagreement_score":0.25708064,"about_ca_system_score_codex":0.000043560805,"about_ca_system_score_gemma":0.00022894092,"threshold_uncertainty_score":0.33292723},"labels":[],"label_agreement":null},{"id":"W3157210380","doi":"10.1371/journal.pone.0250553","title":"Ticagrelor vs Clopidogrel in addition to Aspirin in minor ischemic stroke/ transient ischemic attack—Protocol for a systematic review and network meta-analysis","year":2021,"lang":"en","type":"review","venue":"PLoS ONE","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"University of Ottawa","keywords":"Medicine; Clopidogrel; Ticagrelor; Aspirin; Stroke (engine); Population; Randomized controlled trial; Odds ratio; Hazard ratio; Internal medicine; Platelet aggregation inhibitor; MEDLINE; Intensive care medicine; Emergency medicine; Physical therapy; Confidence interval","score_opus":0.19811198163850424,"score_gpt":0.36778115400350625,"score_spread":0.169669172365002,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3157210380","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000013997264,0.80037266,0.000083549916,0.00011659402,0.0000049176642,0.19906159,0.00024155981,0.000023728673,0.00008138666],"genre_scores_gemma":[0.0000025203058,0.60855716,0.00079132954,0.00044648562,0.0000801684,0.38908356,0.0005758113,0.000054680404,0.00040829962],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9956847,0.0005648471,0.0017857343,0.000885907,0.00060129917,0.00047752468],"domain_scores_gemma":[0.9978829,0.00034220703,0.00042352325,0.00093699835,0.00016254548,0.00025181277],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001158504,0.0006541886,0.013837349,0.00039892603,0.000036165286,0.000032692224,0.00019397444,0.000315375,0.00043239768],"category_scores_gemma":[0.0002799784,0.00048671226,0.004995253,0.0015391472,0.000035565416,0.00006097228,0.000050261715,0.0004055302,0.000027747492],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000062192856,0.0006388656,0.0000040092013,0.8225044,0.1719866,0.00005590407,0.000016958018,0.000002567718,0.0000017038737,0.0000015610108,0.0022750285,0.0024502187],"study_design_scores_gemma":[0.000762921,0.00010420865,0.0000013563262,0.32556546,0.5289346,0.000019763895,0.000006477773,0.0000104631035,0.0000053864633,1.9593067e-7,0.14428513,0.00030405805],"about_ca_topic_score_codex":0.0000051225747,"about_ca_topic_score_gemma":0.000023373399,"teacher_disagreement_score":0.49693894,"about_ca_system_score_codex":0.00015202729,"about_ca_system_score_gemma":0.00020682176,"threshold_uncertainty_score":0.9997585},"labels":[],"label_agreement":null},{"id":"W3157860815","doi":"10.1182/blood.v130.suppl_1.3612.3612","title":"Brain-Derived Neurotrophic Factor Induces Platelet Aggregation","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Platelet; Chemistry; Thrombin; Neurotrophic factors; Brain-derived neurotrophic factor; Stimulation; Internal medicine; Thromboxane A2; Confocal microscopy; Endocrinology; Blot; Adenosine diphosphate; Platelet activation; Receptor; Platelet factor 4; Biochemistry; Cell biology; Biology; Medicine; Platelet aggregation","score_opus":0.024678365355506642,"score_gpt":0.26648240062222184,"score_spread":0.2418040352667152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3157860815","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962772,0.00093703484,0.000033921075,0.0008521287,0.00013609686,0.00025340967,0.000011071207,0.00008447781,0.0014146612],"genre_scores_gemma":[0.998347,0.0002884321,0.0000606538,0.0007008922,0.00036238434,0.0000124257995,0.000017870758,0.000023854534,0.00018647936],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99920315,0.00003532138,0.00012313499,0.0002234948,0.00023406735,0.00018082882],"domain_scores_gemma":[0.99908036,0.000022145476,0.00009847727,0.00062654685,0.000049872215,0.00012260779],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000060876602,0.00013038103,0.00024036814,0.000041970674,0.00029220662,0.0000778439,0.00014848595,0.000087718894,0.00013539942],"category_scores_gemma":[0.00018516956,0.00011054946,0.00023206275,0.000029138591,0.00008808825,0.00014781831,0.000035940742,0.00012865143,0.000077474375],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090997503,0.0018669803,0.09681666,0.0003204546,0.0037740266,0.0034053382,0.00068133365,0.00000564465,0.60612804,0.00035409498,0.0008304533,0.284907],"study_design_scores_gemma":[0.008940794,0.00029914716,0.69127077,0.00012598913,0.00032343573,0.00033198614,0.000027205258,0.0000092267155,0.29176167,0.00013250535,0.0065331236,0.0002441597],"about_ca_topic_score_codex":0.000014926434,"about_ca_topic_score_gemma":0.0000014336961,"teacher_disagreement_score":0.5944541,"about_ca_system_score_codex":0.0000061068476,"about_ca_system_score_gemma":0.00005484361,"threshold_uncertainty_score":0.45080763},"labels":[],"label_agreement":null},{"id":"W3158832301","doi":"10.1016/j.cjco.2021.04.010","title":"De-escalation of P2Y12 Inhibitor Use After Percutaneous Coronary Intervention and Acute Coronary Syndromes","year":2021,"lang":"en","type":"article","venue":"CJC Open","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada","keywords":"Medicine; Clopidogrel; Percutaneous coronary intervention; Prasugrel; Ticagrelor; Myocardial infarction; Internal medicine; P2Y12; Thienopyridine; De-escalation; Cardiology; Retrospective cohort study; Adverse effect","score_opus":0.015864085579879842,"score_gpt":0.2782946032763582,"score_spread":0.26243051769647835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3158832301","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951607,0.0039054377,0.0001691679,0.00012043214,0.00007495337,0.0003157216,0.000035304573,0.000016630189,0.00020164381],"genre_scores_gemma":[0.99654704,0.0007841503,0.0005296506,0.00026099713,0.000033062566,0.00001704651,0.0001234047,0.000017858953,0.0016868124],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992765,0.000089384754,0.00017902858,0.00020104993,0.0001397312,0.00011429913],"domain_scores_gemma":[0.99952734,0.00003126003,0.00004237686,0.0002266468,0.00008254954,0.00008980715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001147528,0.000096911346,0.00031315797,0.000031136744,0.000035918718,0.0000536626,0.000058331403,0.00007213651,0.00057573646],"category_scores_gemma":[0.00002713555,0.00008997328,0.00017983917,0.00006985846,0.00006308624,0.00026197426,0.00014535265,0.00007326465,0.000010360847],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008342087,0.0010942037,0.6696334,0.0006114696,0.0045656143,0.031757347,0.0010834055,0.000013231447,0.030445645,0.00016757913,0.0014385629,0.25084746],"study_design_scores_gemma":[0.002239975,0.00039780373,0.9693711,0.0004996498,0.0007897133,0.020438876,0.00037054106,0.00007732896,0.0029255787,0.000117907955,0.002620943,0.00015062928],"about_ca_topic_score_codex":0.000024487801,"about_ca_topic_score_gemma":0.0000039757356,"teacher_disagreement_score":0.29973763,"about_ca_system_score_codex":0.000032370208,"about_ca_system_score_gemma":0.00006911081,"threshold_uncertainty_score":0.63039106},"labels":[],"label_agreement":null},{"id":"W3159150173","doi":"10.1016/s0735-1097(21)02427-x","title":"ISCHEMIC AND BLEEDING OUTCOMES OF CARRIERS OF CYP2C19*17 TREATED WITH CLOPIDOGREL: INSIGHTS FROM THE TAILOR-PCI STUDY","year":2021,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Clopidogrel; Conventional PCI; CYP2C19; Cardiology; Internal medicine; Aspirin; Myocardial infarction","score_opus":0.00984592371232438,"score_gpt":0.24522785247936518,"score_spread":0.2353819287670408,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3159150173","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938519,0.0048998585,0.000043168602,0.00049567135,0.00010286657,0.00021335526,0.000065011416,0.0000034378747,0.000324725],"genre_scores_gemma":[0.99875873,0.00077158253,0.00012520005,0.00012477313,0.00014947378,0.0000022048355,0.0000016252309,0.000016153084,0.000050273185],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99838996,0.00043305298,0.00051787146,0.00014452667,0.0003850991,0.00012947223],"domain_scores_gemma":[0.9978711,0.0003715545,0.00082237547,0.0004225882,0.00043652605,0.00007585578],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025641397,0.00015664259,0.0016253303,0.00007171243,0.000055075798,0.000002526693,0.00020491231,0.00004385818,0.0000070032006],"category_scores_gemma":[0.00016511217,0.000075450655,0.0006328862,0.00041080717,0.00080981,0.000039570154,0.00007326664,0.0002121331,7.6729435e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002080608,0.00008721497,0.970395,0.000020253949,0.011179538,0.00045650455,0.0003437862,0.00014873166,0.013791327,0.00001747126,0.00092913583,0.0005504241],"study_design_scores_gemma":[0.006670072,0.0026066813,0.9316132,0.00021042606,0.005110658,0.0022076953,0.03363756,0.000006746583,0.015087264,0.000037144888,0.0026634005,0.00014916764],"about_ca_topic_score_codex":0.0000608997,"about_ca_topic_score_gemma":0.000009086127,"teacher_disagreement_score":0.03878182,"about_ca_system_score_codex":0.00002214012,"about_ca_system_score_gemma":0.0002764803,"threshold_uncertainty_score":0.30767882},"labels":[],"label_agreement":null},{"id":"W3159741711","doi":"10.1016/s0735-1097(21)02549-3","title":"PERIOPERATIVE MANAGEMENT OF ORAL ANTICOAGULANTS IN CARDIAC SURGERY, WHEN IS THE OPTIMAL STOP TIME","year":2021,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Southlake Regional Health Center","funders":"","keywords":"Medicine; Perioperative; Anesthesia; Surgery","score_opus":0.014625264531518332,"score_gpt":0.26342746453301497,"score_spread":0.24880220000149664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3159741711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925478,0.0038346278,0.00010686926,0.002324463,0.0002091074,0.0002098291,0.000090145346,0.0000022691074,0.0006749029],"genre_scores_gemma":[0.996072,0.0025965378,0.00048759574,0.0003303391,0.00011052729,0.0000034072673,0.0000019384238,0.000013740951,0.00038391355],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978546,0.0008976271,0.0005238153,0.00013662946,0.0003951001,0.00019222267],"domain_scores_gemma":[0.99859416,0.0001840036,0.00044126916,0.00042399403,0.00030046437,0.000056116238],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092028826,0.00013522034,0.0017354236,0.00009304005,0.000044717824,0.0000035945932,0.00021429302,0.000039210303,0.00004111915],"category_scores_gemma":[0.0000641163,0.00007691133,0.0014912208,0.0003954827,0.0005391995,0.000038904916,0.000105641724,0.00019442022,0.0000018669914],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013876283,0.0008146131,0.7071389,0.0006244291,0.07804973,0.016273437,0.0028587782,0.005590706,0.033053175,0.00068943406,0.07880883,0.06222168],"study_design_scores_gemma":[0.004446962,0.001262144,0.87391186,0.0008862991,0.005158645,0.0067568207,0.016852975,0.00014980198,0.02705187,0.00020774206,0.06287338,0.00044148584],"about_ca_topic_score_codex":0.000010689057,"about_ca_topic_score_gemma":4.92863e-7,"teacher_disagreement_score":0.16677296,"about_ca_system_score_codex":0.000047270896,"about_ca_system_score_gemma":0.00031024517,"threshold_uncertainty_score":0.31363532},"labels":[],"label_agreement":null},{"id":"W3159986375","doi":"10.1002/ccd.29772","title":"External validation of the <scp>GRACE</scp> risk score 2.0 in the contemporary <scp>all‐comers GLOBAL LEADERS</scp> trial","year":2021,"lang":"en","type":"article","venue":"Catheterization and Cardiovascular Interventions","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Framingham Risk Score; Ticagrelor; Acute coronary syndrome; Percutaneous coronary intervention; Internal medicine; Cohort; Conventional PCI; Randomized controlled trial; Cardiology; Myocardial infarction; Disease","score_opus":0.05738855697806062,"score_gpt":0.296554991073637,"score_spread":0.23916643409557636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3159986375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9488311,0.03220269,0.016373929,0.00008954519,0.0004467281,0.00095777016,0.00010114287,0.000035493613,0.00096159935],"genre_scores_gemma":[0.99687976,0.0021253484,0.00005436399,0.00022525113,0.00015775833,0.00009169483,0.00020688436,0.00002391065,0.0002350606],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968988,0.0012002274,0.00057791226,0.0004063856,0.00068285124,0.00023386028],"domain_scores_gemma":[0.9985202,0.000116372525,0.00021261894,0.0008588969,0.000196049,0.00009588134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011099046,0.00023054525,0.0005612618,0.00008361437,0.0001874,0.00009080173,0.00022782061,0.00014531818,0.000016117834],"category_scores_gemma":[0.0006600413,0.00016374675,0.0037488933,0.00059854024,0.00027799833,0.00017247417,0.0000870862,0.00025359853,0.0000068256268],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015572562,0.00809424,0.79482615,0.0041815513,0.0537251,0.0011099195,0.021759285,0.005577238,0.008022979,0.0058107837,0.0078253215,0.0875102],"study_design_scores_gemma":[0.10035451,0.0013491096,0.74541456,0.003771343,0.013522243,0.0018519134,0.040177293,0.0004259017,0.018283881,0.0021541042,0.07234064,0.00035449455],"about_ca_topic_score_codex":0.000032697662,"about_ca_topic_score_gemma":0.000007087962,"teacher_disagreement_score":0.098797254,"about_ca_system_score_codex":0.00004035047,"about_ca_system_score_gemma":0.0001467083,"threshold_uncertainty_score":0.66773987},"labels":[],"label_agreement":null},{"id":"W3160621470","doi":"","title":"Étude TWILIGHT: réduction de la durée de double thérapie antiplaquettaire chez les patients à haut risque ischémique ou hémorragique post-ICP","year":2021,"lang":"fr","type":"article","venue":"","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Gynecology","score_opus":0.008315746088655854,"score_gpt":0.25142773759324444,"score_spread":0.2431119915045886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3160621470","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91811186,0.051664945,0.0053746644,0.007031635,0.0013631921,0.0007193686,0.00008569972,0.00029890364,0.015349725],"genre_scores_gemma":[0.96466696,0.019713432,0.00129939,0.0019129717,0.0015084709,0.0000809091,0.00039100245,0.00014859097,0.010278292],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99532217,0.0012786792,0.0006748159,0.0009066812,0.00061527063,0.0012023926],"domain_scores_gemma":[0.99733263,0.00024370494,0.00017993202,0.0008889119,0.00064285233,0.0007119525],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001238687,0.00066487666,0.00089272566,0.00017848778,0.00042139538,0.00017873943,0.00027088993,0.0010305239,0.0025688405],"category_scores_gemma":[0.00036351566,0.0006538504,0.0011688294,0.0005209013,0.00048547745,0.0004939056,0.00014119648,0.00098601,0.00022027147],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049999068,0.012015669,0.61126,0.0041672946,0.013050079,0.011004178,0.007199939,0.003832551,0.042479135,0.047502123,0.022102853,0.22038625],"study_design_scores_gemma":[0.02117096,0.000893528,0.38668668,0.002516596,0.003632384,0.0032709038,0.006041889,0.0012322952,0.36806497,0.0013059301,0.20308991,0.0020939726],"about_ca_topic_score_codex":0.0021348896,"about_ca_topic_score_gemma":0.0004933506,"teacher_disagreement_score":0.3255858,"about_ca_system_score_codex":0.00059077167,"about_ca_system_score_gemma":0.0014812364,"threshold_uncertainty_score":0.9995913},"labels":[],"label_agreement":null},{"id":"W3161736931","doi":"10.1002/clc.23618","title":"Contemporary use of <scp>guideline‐based</scp> higher potency <scp>P2Y12</scp> receptor inhibitor therapy in patients with <scp>moderate‐to‐high</scp> risk <scp>non‐ST‐segment</scp> elevation myocardial infarction: Results from the Canadian <scp>ACS</scp> reflective <scp>II cross‐sectional</scp> study","year":2021,"lang":"en","type":"article","venue":"Clinical Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"HalTech; Oakville-Trafalgar Memorial Hospital; Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec; St. Mary's University; University of British Columbia; Health Sciences Centre; Royal Columbian Hospital; Lawson Health Research Institute; Regina General Hospital; Saint John Regional Hospital; London Health Sciences Centre; Sunnybrook Health Science Centre; St. Michael's Hospital; University of Toronto; Western University; McGill University Health Centre; Canadian Heart Research Centre; St Joseph's Health Care","funders":"AstraZeneca Canada; AstraZeneca","keywords":"Prasugrel; P2Y12; Potency; Medicine; Ticagrelor; Clopidogrel; Myocardial infarction; Internal medicine; Pharmacology; Chemistry; Biochemistry","score_opus":0.04782406356210015,"score_gpt":0.31269821636018136,"score_spread":0.2648741527980812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3161736931","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9745894,0.0039617224,0.0009414434,0.00030350927,0.005862157,0.006259473,0.0054695657,0.00042028056,0.0021924302],"genre_scores_gemma":[0.9719965,0.0017705498,0.0012564147,0.0062352903,0.00660314,0.00095505716,0.007914026,0.0005167723,0.002752246],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9759962,0.007464833,0.0058393604,0.004615505,0.003193678,0.0028904302],"domain_scores_gemma":[0.96419287,0.021681806,0.0026613548,0.003865185,0.0053627896,0.0022359684],"candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0069058235,0.0023394064,0.0051787663,0.0010047035,0.0018522926,0.0005111094,0.0013925778,0.0029468627,0.000027411606],"category_scores_gemma":[0.03893616,0.0019660718,0.0030089712,0.0031382346,0.0017300493,0.001081261,0.00066754216,0.0044372254,0.0002301201],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005595609,0.0021617762,0.81359047,0.000056895547,0.008729535,0.00051925273,0.0024206936,0.0043460582,0.0004173616,0.00003244043,0.16554113,0.0016248553],"study_design_scores_gemma":[0.025755398,0.006019396,0.7635568,0.000265571,0.0011759338,0.00005031579,0.0034553723,0.00008152818,0.0012451581,0.00027707248,0.19795129,0.00016621676],"about_ca_topic_score_codex":0.01585899,"about_ca_topic_score_gemma":0.004654955,"teacher_disagreement_score":0.050033696,"about_ca_system_score_codex":0.0012802875,"about_ca_system_score_gemma":0.005372091,"threshold_uncertainty_score":0.99944717},"labels":[],"label_agreement":null},{"id":"W3162702235","doi":"10.1161/circ.142.suppl_3.17306","title":"Abstract 17306: Primary Prevention Aspirin Use Trends and Associations With Health Beliefs Among African Americans, 2015-2019","year":2020,"lang":"en","type":"article","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Milton District Hospital","funders":"","keywords":"Aspirin; Medicine; Poisson regression; Primary prevention; Population; Demography; Disease; Gerontology; Environmental health; Internal medicine","score_opus":0.028715870676957415,"score_gpt":0.2773345318430313,"score_spread":0.2486186611660739,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3162702235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905495,0.0012781636,0.0044899955,0.0026173329,0.000024276933,0.00035094813,0.000040477582,0.00011414887,0.00053514197],"genre_scores_gemma":[0.9977068,0.00015532422,0.00029054223,0.00075620844,0.00013463433,0.0000124862045,0.00084696576,0.0000235318,0.00007353052],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998996,0.00006595271,0.00021494234,0.0002603219,0.00029926826,0.00016351118],"domain_scores_gemma":[0.99935913,0.000026437621,0.00018712896,0.00015849546,0.00005846103,0.00021034738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001385859,0.00012292534,0.0002961415,0.00007719769,0.000114009476,0.000037113747,0.00002842174,0.000054742995,0.0000347532],"category_scores_gemma":[0.000024349472,0.00011280808,0.00012776551,0.0003224898,0.000059652324,0.00027079752,0.000009599031,0.00011681634,0.000006992819],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014845782,0.00015843082,0.84383243,0.000119667915,0.0005103278,0.000014852662,0.00083793385,0.00048074077,0.0004951404,0.000048156147,0.0011249046,0.15222894],"study_design_scores_gemma":[0.0011822662,0.00017419901,0.9965388,0.000069410395,0.00014855612,0.00000768588,0.00009403616,0.00015841638,0.000015231469,0.000011928092,0.0014805638,0.000118877986],"about_ca_topic_score_codex":0.00013475899,"about_ca_topic_score_gemma":0.00001689362,"teacher_disagreement_score":0.15270637,"about_ca_system_score_codex":0.000105177896,"about_ca_system_score_gemma":0.00012681463,"threshold_uncertainty_score":0.460018},"labels":[],"label_agreement":null},{"id":"W3162733632","doi":"10.1161/circ.142.suppl_3.17411","title":"Abstract 17411: De Novo Protein Synthesis of Alpha-Toxin Activated Platelets","year":2020,"lang":"en","type":"article","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Discovery Air (Canada)","funders":"","keywords":"Phosphorylation; Platelet; Platelet activation; Protein phosphorylation; Cell biology; Biology; Protein kinase A; Immunology","score_opus":0.021796530310680646,"score_gpt":0.24529856616603718,"score_spread":0.22350203585535652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3162733632","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967645,0.00033165282,0.0011333835,0.0004164538,0.000016061202,0.00040526857,0.000008482307,0.0000834065,0.00084081583],"genre_scores_gemma":[0.99943787,0.000023112305,0.0001651333,0.0001786812,0.00011690256,0.000021443851,0.000028311604,0.000023029726,0.0000055409214],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99917424,0.00003920513,0.00021573485,0.00018495378,0.00023988892,0.00014596984],"domain_scores_gemma":[0.9995019,0.000034726494,0.00009369769,0.00017228864,0.000065041204,0.00013235748],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001247843,0.00010785035,0.00026907644,0.00004501168,0.000036489357,0.0000080165755,0.0000510031,0.000102169055,0.00024869663],"category_scores_gemma":[0.00019143222,0.00010388241,0.00023239305,0.00017796454,0.00003539556,0.0000925311,0.000008468875,0.00009627386,0.000032581866],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047547265,0.00009855978,0.012455047,0.00029579448,0.00037596308,0.00009158818,0.00020503452,0.00030077907,0.95093703,0.00006631376,0.000030475774,0.034667913],"study_design_scores_gemma":[0.0009786672,0.00003237699,0.40661803,0.00016848238,0.00014715863,0.00003484195,0.00006901985,0.00042979012,0.5908687,0.00005594068,0.00048273557,0.000114228016],"about_ca_topic_score_codex":0.000009810351,"about_ca_topic_score_gemma":2.491968e-7,"teacher_disagreement_score":0.39416298,"about_ca_system_score_codex":0.00003900202,"about_ca_system_score_gemma":0.00008909675,"threshold_uncertainty_score":0.42362016},"labels":[],"label_agreement":null},{"id":"W3162810209","doi":"10.1016/j.ijcard.2021.05.012","title":"Results of an international crowdsourcing survey on the treatment of non-ST segment elevation ACS patients at high-bleeding risk undergoing percutaneous intervention","year":2021,"lang":"en","type":"article","venue":"International Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"St. Jude Medical; Esperion Therapeutics; HLS Therapeutics; Idorsia Pharmaceuticals; Medicines Company; Regado Biosciences; Osprey Medical; Daiichi-Sankyo; AstraZeneca; Amarin Corporation; Ironwood Pharmaceuticals, Incorporated; Regeneron Pharmaceuticals; Duke Clinical Research Institute; Eisai; Boston VA Research Institute; Boston Scientific Corporation; Eli Lilly and Company; Cleveland Clinic; Bristol-Myers Squibb; CSL Behring; Belvoir Media Group; Novo Nordisk; MyoKardia; Daiichi Sankyo Europe; Servier; Gilead Sciences; Amgen; Pfizer; PTC Therapeutics; Sanofi; American Heart Association","keywords":"Medicine; Percutaneous coronary intervention; Conventional PCI; Aspirin; Acute coronary syndrome; Internal medicine; Guideline; Clopidogrel; ST segment; Crowdsourcing; Cardiology; Emergency medicine; Intensive care medicine; Myocardial infarction","score_opus":0.017831938173305053,"score_gpt":0.2830030433831565,"score_spread":0.2651711052098515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3162810209","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99581045,0.0002132317,0.00183198,0.00020249924,0.0013101983,0.00011918169,0.00030240318,0.0000044347116,0.00020560922],"genre_scores_gemma":[0.99638736,0.0023103878,0.00018062338,0.000047198035,0.00051901705,0.0000020518817,0.0004802407,0.000014058467,0.000059065704],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99784696,0.00043166184,0.00074810337,0.00018076564,0.00068014394,0.000112389156],"domain_scores_gemma":[0.9969118,0.00049534166,0.0008054989,0.00020144592,0.0015286028,0.000057269535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075258536,0.00013592523,0.00045270973,0.00017590616,0.000048948616,0.000016238107,0.00019259503,0.00008172037,0.00004237328],"category_scores_gemma":[0.00061594695,0.000096926604,0.00057270145,0.0000789683,0.000067869274,0.00010584645,0.000041101426,0.00012267778,0.000002078133],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022622522,0.002006608,0.797692,0.000043116615,0.019262146,0.0011771049,0.0011700441,0.029191062,0.021441953,0.00016112556,0.0005138402,0.10471848],"study_design_scores_gemma":[0.008268578,0.0032071115,0.9598734,0.00037758079,0.00046054574,0.0010708409,0.00038740726,0.00027450768,0.02448589,0.00008966244,0.0013867386,0.00011775441],"about_ca_topic_score_codex":0.00008603102,"about_ca_topic_score_gemma":0.00003557145,"teacher_disagreement_score":0.16218138,"about_ca_system_score_codex":0.00041379107,"about_ca_system_score_gemma":0.00010125878,"threshold_uncertainty_score":0.3952552},"labels":[],"label_agreement":null},{"id":"W3162843285","doi":"10.1016/j.jacc.2021.03.298","title":"Diabetes-Related Factors and the Effects of Ticagrelor Plus Aspirin in the THEMIS and THEMIS-PCI Trials","year":2021,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Ticagrelor; Aspirin; Conventional PCI; Diabetes mellitus; Cardiology; Internal medicine; Clopidogrel; Myocardial infarction; Endocrinology","score_opus":0.010979384197370715,"score_gpt":0.25648591905869245,"score_spread":0.24550653486132173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3162843285","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9793576,0.017985016,0.000016872917,0.0018030884,0.00015291397,0.00035172104,0.000018799203,0.000002194532,0.00031178942],"genre_scores_gemma":[0.99530345,0.0041925125,0.00002063089,0.0003172448,0.00011106188,0.0000047398726,8.033047e-7,0.000011197362,0.000038366674],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963949,0.002367627,0.00063908054,0.00012423245,0.000307277,0.00016689581],"domain_scores_gemma":[0.9946048,0.0040853806,0.00074003683,0.00037034124,0.0001437251,0.000055671644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024020195,0.00015316086,0.001951295,0.00006396599,0.000054350592,0.0000050490253,0.00022009041,0.00006509351,0.0000050403482],"category_scores_gemma":[0.0025368258,0.000060103135,0.0009775921,0.00035711864,0.0012465663,0.000025939245,0.000074589545,0.00030916982,1.15147245e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020161051,0.0004937255,0.7245949,0.0016257515,0.047661915,0.0028554706,0.005288596,0.0006058147,0.14572899,0.002487186,0.005564266,0.042932354],"study_design_scores_gemma":[0.059317566,0.003775005,0.79730004,0.0017037737,0.013714902,0.010499014,0.018141521,0.00012520468,0.081114575,0.0042379284,0.00951471,0.00055575196],"about_ca_topic_score_codex":0.000006750141,"about_ca_topic_score_gemma":8.857736e-7,"teacher_disagreement_score":0.072705165,"about_ca_system_score_codex":0.00002279914,"about_ca_system_score_gemma":0.0002036454,"threshold_uncertainty_score":0.45930254},"labels":[],"label_agreement":null},{"id":"W3163994391","doi":"10.22541/au.161746912.20636917/v1","title":"Ticagrelor Use and Practice Pattern among Canadian Cardiac Surgeons","year":2021,"lang":"en","type":"preprint","venue":"","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; University of British Columbia; University of Alberta; Université Laval; Toronto General Hospital; University of Toronto; Dalhousie University; University of Ottawa","funders":"","keywords":"Ticagrelor; Medicine; Perioperative; P2Y12; Acute coronary syndrome; Internal medicine; Clopidogrel; Surgery; Myocardial infarction","score_opus":0.024929711148822416,"score_gpt":0.25887283552052603,"score_spread":0.23394312437170361,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3163994391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98185676,0.0080549065,0.00047551206,0.0017211465,0.00064029894,0.0006470635,0.00012504208,0.00008638014,0.006392867],"genre_scores_gemma":[0.98862445,0.0070968834,0.00028673577,0.0019402511,0.00017341178,0.00003450328,0.0004923248,0.000049132606,0.0013022843],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99829215,0.00027665013,0.0002180813,0.0005477777,0.00031891666,0.0003464216],"domain_scores_gemma":[0.9978251,0.00028457335,0.00006237042,0.00077027804,0.00029072285,0.00076698005],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00039619923,0.00027700813,0.0006732878,0.00012918461,0.00008835987,0.00023689742,0.00006572489,0.00034582597,0.00043444402],"category_scores_gemma":[0.0006024502,0.0002527387,0.0005836591,0.00008545975,0.000106366286,0.00017554179,0.00016767954,0.0005215955,0.000018674664],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001489382,0.00015411354,0.896875,0.0005988947,0.011001182,0.007617127,0.00068818923,0.00002313488,0.00003750036,0.000060091214,0.008801463,0.073994316],"study_design_scores_gemma":[0.00065212115,0.000032317967,0.8817099,0.00046098104,0.0033866896,0.00035563676,0.0015533352,0.00007098708,0.00009986819,0.0000071896757,0.11114468,0.0005263398],"about_ca_topic_score_codex":0.38733757,"about_ca_topic_score_gemma":0.067977965,"teacher_disagreement_score":0.31935963,"about_ca_system_score_codex":0.00009516169,"about_ca_system_score_gemma":0.00094305305,"threshold_uncertainty_score":0.9999925},"labels":[],"label_agreement":null},{"id":"W3169785013","doi":"10.1136/bmj.n1332","title":"P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trials","year":2021,"lang":"en","type":"review","venue":"BMJ","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":255,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto; McMaster University; Hamilton Health Sciences","funders":"","keywords":"Medicine; Hazard ratio; Internal medicine; P2Y12; Population; Meta-analysis; Confidence interval; Myocardial infarction; Clinical endpoint; Randomized controlled trial; Clopidogrel; Platelet aggregation inhibitor; Aspirin","score_opus":0.2857867087896908,"score_gpt":0.4082237731116951,"score_spread":0.1224370643220043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3169785013","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012689914,0.98349565,0.00022690305,0.00012419284,0.00031115476,0.012847249,0.0016063397,0.00005985505,0.00005968721],"genre_scores_gemma":[0.00085234054,0.98901385,0.00049093354,0.0006570873,0.0006966052,0.0047332267,0.0028239458,0.00015333029,0.0005786651],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9840875,0.007160394,0.0052031763,0.0010765718,0.0019952538,0.00047707267],"domain_scores_gemma":[0.99143505,0.0030155382,0.0029703712,0.0017405758,0.0005586907,0.00027977227],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.008231719,0.0012353163,0.03609382,0.000991358,0.00010429578,0.00009584038,0.00025825415,0.00086341595,0.008794423],"category_scores_gemma":[0.0012614422,0.0006662405,0.055010825,0.0015329982,0.00017095215,0.00012142612,0.00008087994,0.0004892666,0.000019535286],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027756164,0.00048241563,0.000007813681,0.001004191,0.6179953,0.000800542,0.00015298979,0.000009495412,0.0000016729977,0.000003842428,0.0013266397,0.35045895],"study_design_scores_gemma":[0.066615224,0.0003360443,0.00005233359,0.000797004,0.59293723,0.00018728348,0.00005577016,0.0000038227513,0.000023181683,0.0000019849801,0.33849272,0.00049739756],"about_ca_topic_score_codex":0.000014352711,"about_ca_topic_score_gemma":0.0000039931606,"teacher_disagreement_score":0.34996155,"about_ca_system_score_codex":0.000081597835,"about_ca_system_score_gemma":0.0014260826,"threshold_uncertainty_score":0.9995789},"labels":[],"label_agreement":null},{"id":"W3171522046","doi":"10.1002/rth2.12502","title":"Considerations for use of direct oral anticoagulants in arterial disease","year":2021,"lang":"en","type":"article","venue":"Research and Practice in Thrombosis and Haemostasis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute; Impact; Ottawa Hospital; Hamilton Health Sciences; University of Ottawa","funders":"Servier; LEO Pharma; Pfizer","keywords":"Medicine; Stroke (engine); Arterial disease; Cardiology; Intensive care medicine; Disease; Randomized controlled trial; Internal medicine; Peripheral; Clinical trial; Coronary heart disease; Vascular disease; Narrative review; Acute coronary syndrome; Myocardial infarction","score_opus":0.35546175230942845,"score_gpt":0.46786901950717996,"score_spread":0.11240726719775151,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3171522046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895855,0.0053967056,0.00002454458,0.0041440823,0.000028101706,0.00046574065,0.00014088025,0.0000054888887,0.00020895584],"genre_scores_gemma":[0.9706003,0.027267434,0.0017923728,0.00020339445,0.000033786928,0.00003644266,0.00003643674,0.000010152761,0.000019687748],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99855876,0.0004801863,0.00020848402,0.00025847033,0.00026145842,0.00023261979],"domain_scores_gemma":[0.9959653,0.0033581178,0.000032299115,0.00019085866,0.00028536978,0.00016806938],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010197329,0.00008191243,0.00038519935,0.00013664202,0.000099802266,0.00009239845,0.000017577735,0.000052910895,0.00006190437],"category_scores_gemma":[0.004996292,0.000074150055,0.000066834546,0.00023366383,0.00018689124,0.00031653332,0.00004085284,0.00013537263,6.5073385e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.046379413,0.01309732,0.5864721,0.0037743072,0.004995128,0.0048014605,0.0057702204,0.000054746764,0.035580967,0.010988366,0.012251121,0.27583483],"study_design_scores_gemma":[0.015627863,0.0010310896,0.9247017,0.0010922418,0.0008169639,0.00027764312,0.004861369,0.0006807943,0.011460966,0.0051597506,0.03384325,0.00044639537],"about_ca_topic_score_codex":0.00020861797,"about_ca_topic_score_gemma":0.00015466563,"teacher_disagreement_score":0.33822957,"about_ca_system_score_codex":0.0000152398725,"about_ca_system_score_gemma":0.00025986557,"threshold_uncertainty_score":0.59813887},"labels":[],"label_agreement":null},{"id":"W3173777542","doi":"10.1111/jth.15325","title":"International Society on Thrombosis and Haemostasis: Present and future","year":2021,"lang":"en","type":"editorial","venue":"Journal of Thrombosis and Haemostasis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Thrombosis; Medicine; Intensive care medicine; Internal medicine","score_opus":0.03340982260916653,"score_gpt":0.3272332834608368,"score_spread":0.29382346085167027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3173777542","genre_codex":"editorial","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20844375,0.15940331,0.00008455928,0.049940716,0.57739276,0.0011581071,0.0015328245,0.00007758056,0.0019664052],"genre_scores_gemma":[0.0034863348,0.5348908,0.00087181595,0.00059394113,0.45978808,0.000008267709,0.00017493092,0.00007227185,0.00011356622],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968475,0.000121767975,0.000702617,0.0005425582,0.0014777649,0.0003077789],"domain_scores_gemma":[0.9976526,0.00030129767,0.00057571346,0.00035418282,0.0007032573,0.00041294645],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006186124,0.0005173051,0.0015913099,0.00016755018,0.00024403055,0.00027886892,0.00018365697,0.00076935097,0.00019256835],"category_scores_gemma":[0.0000987109,0.0004010028,0.0010404618,0.00014910386,0.00026271533,0.00023921595,0.00018810853,0.0011179835,0.0000014685005],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005419361,0.00028695,0.00047498982,0.00041914385,0.010202441,0.00007871021,0.00051405735,9.575266e-7,0.00005838498,0.000016677322,0.92372054,0.06368519],"study_design_scores_gemma":[0.0053905854,0.0006265551,0.0048288614,0.0012354294,0.0037533157,0.00016106805,0.0017930499,0.000010797586,0.0002806051,0.000043745713,0.98150134,0.0003746386],"about_ca_topic_score_codex":0.000019622028,"about_ca_topic_score_gemma":0.00000191561,"teacher_disagreement_score":0.37548748,"about_ca_system_score_codex":0.0001258008,"about_ca_system_score_gemma":0.000345255,"threshold_uncertainty_score":0.9998442},"labels":[],"label_agreement":null},{"id":"W3173954863","doi":"10.1093/ehjacc/zuab033","title":"‘Ticagrelor alone vs. dual antiplatelet therapy from 1 month after drug-eluting coronary stenting among patients with STEMI’: a <i>post hoc</i> analysis of the randomized GLOBAL LEADERS trial","year":2021,"lang":"en","type":"article","venue":"European Heart Journal Acute Cardiovascular Care","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"Medicines Company","keywords":"Ticagrelor; Medicine; Percutaneous coronary intervention; Conventional PCI; Internal medicine; Aspirin; Clinical endpoint; Myocardial infarction; Post-hoc analysis; Hazard ratio; Cardiology; Randomized controlled trial; Confidence interval","score_opus":0.010593698922597811,"score_gpt":0.2225185242518372,"score_spread":0.2119248253292394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3173954863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94059545,0.05649442,0.00024288024,0.00011778595,0.00056615064,0.001322118,0.0003903112,0.00005499003,0.0002159036],"genre_scores_gemma":[0.99533546,0.0024603733,0.00031922938,0.00072811905,0.00061075826,0.000018121704,0.00038416722,0.00010724445,0.000036548714],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99143493,0.0039027128,0.0010978252,0.000768406,0.0021686293,0.0006274948],"domain_scores_gemma":[0.9962663,0.0001645065,0.00041993635,0.0013287757,0.0014447909,0.00037570402],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0016372002,0.00058198266,0.0030430283,0.00016590563,0.00043069033,0.00017165099,0.00029253095,0.00011735423,0.00009798529],"category_scores_gemma":[0.00017117054,0.00036967013,0.011152508,0.0012184306,0.0005255516,0.00026842905,0.00020703819,0.0006815672,0.000008668391],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.45451486,0.00036184635,0.29551217,0.00007529859,0.22655961,0.0071025207,0.0028208669,0.0015852465,0.00007191038,7.6584314e-7,0.00019047699,0.011204418],"study_design_scores_gemma":[0.4313127,0.00040102482,0.51515377,0.00056325074,0.0456125,0.0005882813,0.0034964776,0.000033473174,0.00026546174,9.500623e-7,0.0020864175,0.0004856642],"about_ca_topic_score_codex":0.000043000084,"about_ca_topic_score_gemma":0.000009637325,"teacher_disagreement_score":0.21964161,"about_ca_system_score_codex":0.00015025157,"about_ca_system_score_gemma":0.00028744614,"threshold_uncertainty_score":0.99987555},"labels":[],"label_agreement":null},{"id":"W3176740384","doi":"10.15420/ecr.2020.45","title":"2020 Asian Pacific Society of Cardiology Consensus Recommendations on Antithrombotic Management for High-risk Chronic Coronary Syndrome","year":2021,"lang":"en","type":"review","venue":"European Cardiology Review","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Biosense Webster; Abbott Vascular; Regeneron Pharmaceuticals; Orient Europharma; Boston Scientific Corporation; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; CSL Behring; Daiichi Sankyo Europe; Sanofi; Servier; American College of Cardiology Foundation; Amgen; Pfizer","keywords":"Medicine; Antithrombotic; Asia pacific; Acute coronary syndrome; Intensive care medicine; Consensus conference; Cardiology; Internal medicine; Myocardial infarction","score_opus":0.04115686427521839,"score_gpt":0.3160812144214424,"score_spread":0.27492435014622396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3176740384","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000008685023,0.9885686,0.0004468486,0.00039758504,0.00081569236,0.004279222,0.00092542625,0.00009251198,0.0044654184],"genre_scores_gemma":[0.00017230901,0.9927341,0.0007666782,0.00033436858,0.0006546626,0.00028081614,0.004369258,0.00019929883,0.00048852],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9920962,0.0043970193,0.0014816911,0.0012050131,0.00025235242,0.0005677526],"domain_scores_gemma":[0.99665475,0.00038233274,0.0007956465,0.0017840283,0.000186571,0.0001967015],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017767736,0.00081737357,0.008401359,0.00010908199,0.00019054898,0.00001058135,0.000372646,0.00030655443,0.00013124716],"category_scores_gemma":[0.00010950965,0.0006647229,0.0075166766,0.00045399784,0.00040088606,0.000019874133,0.00020552338,0.0007352757,0.00024727738],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001588928,0.000037899175,0.000032352797,0.10875745,0.02153631,0.0021552378,0.000003695182,0.000008124745,8.968334e-8,0.00014348704,0.10877708,0.7585324],"study_design_scores_gemma":[0.0010369649,0.0006804001,0.00047154538,0.08274233,0.029243851,0.007817715,0.000031896565,3.595471e-7,6.3755984e-8,0.0000061794253,0.87751365,0.00045505105],"about_ca_topic_score_codex":7.1624146e-7,"about_ca_topic_score_gemma":9.815149e-8,"teacher_disagreement_score":0.76873654,"about_ca_system_score_codex":0.00022915367,"about_ca_system_score_gemma":0.00035946598,"threshold_uncertainty_score":0.9995804},"labels":[],"label_agreement":null},{"id":"W3181291734","doi":"10.1016/j.jcin.2021.04.043","title":"Impact of Age on the Safety and Efficacy of Ticagrelor Monotherapy in Patients Undergoing PCI","year":2021,"lang":"en","type":"article","venue":"JACC: Cardiovascular Interventions","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences","funders":"Abbott Vascular; St. Jude Medical; Eisai; Janssen Scientific Affairs; Idorsia Pharmaceuticals; OrbusNeich; Siemens Medical Solutions USA; Daiichi-Sankyo; Medicines Company; Boston Scientific Corporation; Novartis Pharmaceuticals Corporation; Gilead Sciences; Bayer; Abbott Laboratories; CSL Behring; Chiesi Farmaceutici; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; Edwards Lifesciences; Scott R. MacKenzie Foundation; Boehringer Ingelheim; Amgen; Regeneron Pharmaceuticals; Medtronic","keywords":"Ticagrelor; Medicine; Conventional PCI; Percutaneous coronary intervention; Aspirin; Hazard ratio; Internal medicine; Myocardial infarction; Clinical endpoint; Stroke (engine); Confidence interval; Cardiology; Randomized controlled trial","score_opus":0.02433357033887436,"score_gpt":0.29348849388650333,"score_spread":0.269154923547629,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3181291734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98664075,0.010920252,0.0010415933,0.000065106564,0.000062860025,0.0004598837,0.000033426648,0.000014357108,0.00076176703],"genre_scores_gemma":[0.99760437,0.0020917116,0.000077404526,0.000034042547,0.000031589487,0.000011600587,0.000047958547,0.000024786852,0.00007651133],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983431,0.00034242275,0.00047723026,0.00026393676,0.00039924463,0.00017405956],"domain_scores_gemma":[0.9987242,0.00019887346,0.00009225326,0.00075853866,0.00015633732,0.00006977464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005054595,0.0001635049,0.000707303,0.00012752817,0.000054214852,0.000013312427,0.00009037955,0.00007665014,0.00018528865],"category_scores_gemma":[0.00030266424,0.00011558646,0.0050300914,0.00033600387,0.0001141072,0.000050801562,0.00005093428,0.00016472311,0.0000050584217],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005778919,0.007884426,0.5652024,0.0017747515,0.09196041,0.00053935644,0.0013693433,0.005576867,0.0007009038,0.0035468312,0.0004826197,0.31518313],"study_design_scores_gemma":[0.009901316,0.00059825316,0.98552126,0.00121906,0.0009981492,0.000029943614,0.000143342,0.000019522187,0.00077488256,0.00008235334,0.0005851779,0.0001267326],"about_ca_topic_score_codex":0.000044018652,"about_ca_topic_score_gemma":0.000011567836,"teacher_disagreement_score":0.42031884,"about_ca_system_score_codex":0.000069974616,"about_ca_system_score_gemma":0.00009237339,"threshold_uncertainty_score":0.5072982},"labels":[],"label_agreement":null},{"id":"W3182880598","doi":"10.1007/s10557-021-07213-y","title":"Ticagrelor or Clopidogrel After an Acute Coronary Syndrome in the Elderly: A Propensity Score Matching Analysis from 16,653 Patients Treated with PCI Included in Two Large Multinational Registries","year":2021,"lang":"en","type":"article","venue":"Cardiovascular Drugs and Therapy","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta","funders":"AstraZeneca","keywords":"Medicine; Ticagrelor; Clopidogrel; Percutaneous coronary intervention; Acute coronary syndrome; Hazard ratio; Internal medicine; Conventional PCI; Propensity score matching; Cardiology; Population; Proportional hazards model; Incidence (geometry); Confidence interval; Myocardial infarction","score_opus":0.01622971902274478,"score_gpt":0.2506818035223317,"score_spread":0.23445208449958693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3182880598","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9831834,0.015339194,0.00031806165,0.00010942986,0.000026729185,0.0008169377,0.00012823974,0.000036201796,0.000041842275],"genre_scores_gemma":[0.99425405,0.0037373551,0.00014493756,0.00047294152,0.00004869141,0.00013678177,0.0011204479,0.00003890805,0.000045909317],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971439,0.00065832806,0.00034780573,0.00069813494,0.000793753,0.0003580368],"domain_scores_gemma":[0.99863946,0.000081253784,0.00007349535,0.0008680035,0.00020893001,0.00012887883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006660248,0.00034300407,0.0010951393,0.00019594256,0.00016221053,0.00009788918,0.00014908165,0.00010827074,0.000076487944],"category_scores_gemma":[0.000018637866,0.00020649895,0.0008449599,0.0010285763,0.00013159697,0.00024436606,0.000058997484,0.00029306687,0.0000025111262],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004501983,0.0009242201,0.9145992,0.000034322507,0.020560648,0.00646139,0.0021508809,0.000077969904,0.000018222014,0.000023060573,0.000005051008,0.050643053],"study_design_scores_gemma":[0.017069962,0.00040554817,0.9767807,0.00015580386,0.002763525,0.00037519963,0.00089349336,0.00006794066,0.00008834262,0.00008729285,0.0009861477,0.00032605408],"about_ca_topic_score_codex":0.000499085,"about_ca_topic_score_gemma":0.00039860228,"teacher_disagreement_score":0.06218149,"about_ca_system_score_codex":0.000073409334,"about_ca_system_score_gemma":0.0001498556,"threshold_uncertainty_score":0.84207827},"labels":[],"label_agreement":null},{"id":"W3183258858","doi":"10.3390/jcm10143140","title":"Misreported Cancer Deaths in PLATO Trial","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"Institut de Cardiologie de Montréal; Johns Hopkins University","keywords":"Ticagrelor; Clopidogrel; Medicine; Prasugrel; Aspirin; Internal medicine","score_opus":0.12844017612292088,"score_gpt":0.49051464142773166,"score_spread":0.3620744653048108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3183258858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9678583,0.020519024,0.0001331842,0.007109381,0.0020498557,0.00015917336,0.0000012158437,0.000007790099,0.002162048],"genre_scores_gemma":[0.97764856,0.013122053,0.00020703813,0.003013925,0.00549725,0.0000032687715,0.000003600108,0.0000164815,0.00048781006],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9966746,0.0002420631,0.002044696,0.00017415624,0.0006860684,0.00017840484],"domain_scores_gemma":[0.99785984,0.00051297277,0.0005560515,0.00024786207,0.00044223687,0.0003810401],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0024575018,0.00011932351,0.0014077398,0.00010470444,0.000018160836,0.00000424827,0.0000782391,0.0001613381,0.0012161996],"category_scores_gemma":[0.0048898356,0.00007714918,0.0007314796,0.00028535063,0.00013491222,0.000058229394,0.000015932648,0.00063840934,0.0000046119817],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1601714,0.0026118632,0.34076318,0.00019319846,0.0037893092,0.050757527,0.0002515134,0.0000328179,0.0010173857,0.00010469281,0.016926633,0.4233805],"study_design_scores_gemma":[0.3891753,0.004358927,0.44216326,0.0028244494,0.0020735315,0.0039311126,0.00053796486,0.000047049463,0.00056769815,0.0005674787,0.15354732,0.00020591517],"about_ca_topic_score_codex":0.00001569051,"about_ca_topic_score_gemma":0.000012916238,"teacher_disagreement_score":0.42317456,"about_ca_system_score_codex":0.00003212006,"about_ca_system_score_gemma":0.0009078757,"threshold_uncertainty_score":0.99969685},"labels":[],"label_agreement":null},{"id":"W3184998821","doi":"10.1016/j.cjco.2021.07.013","title":"Provision of a DAPT Score to Cardiologists and Extension of Dual Antiplatelet Therapy Beyond 1 Year After ACS: Randomized Substudy of the Prospective Canadian ACS Reflective II Study","year":2021,"lang":"en","type":"article","venue":"CJC Open","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institut universitaire de cardiologie et de pneumologie de Québec; Health Sciences Centre; HalTech; University of British Columbia; University Hospital; York Central Hospital; McGill University Health Centre; Royal Columbian Hospital; University of Saskatchewan; Saskatchewan Health Authority; London Health Sciences Centre; Sunnybrook Health Science Centre; St. Michael's Hospital; University of Toronto; Western University; Canadian Heart Research Centre; Saskatchewan Health; St Joseph's Health Care","funders":"Servier; Novo Nordisk; Bristol-Myers Squibb; AstraZeneca; CSL Behring; Medtronic; AstraZeneca Canada; Novartis; HDL Therapeutics; Sanofi; Merck; Bayer; Boehringer Ingelheim; Amgen; Pfizer","keywords":"Medicine; Internal medicine; Acute coronary syndrome; Myocardial infarction; Cardiology; Randomized controlled trial","score_opus":0.01900230711283445,"score_gpt":0.29337515144002213,"score_spread":0.27437284432718767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3184998821","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99121827,0.0025331276,0.0000041026155,0.00013223152,0.00007284475,0.005403533,0.00006295355,0.000005826056,0.0005671221],"genre_scores_gemma":[0.99908596,0.00036554292,0.00007485673,0.0001483229,0.000029764147,0.00013746509,0.0000106703,0.000021188973,0.00012622395],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982175,0.0004976954,0.00035921126,0.00040594238,0.00033685326,0.00018276741],"domain_scores_gemma":[0.9984931,0.00007839689,0.00013583264,0.0006467306,0.0005233699,0.00012261358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009094713,0.00017553764,0.0013294653,0.000087031236,0.00010241244,0.00001628202,0.00017207838,0.0000818023,0.000029377543],"category_scores_gemma":[0.0002853242,0.00010782397,0.00025888078,0.0003748022,0.00022450485,0.00008186762,0.000294743,0.00012661578,8.481946e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2974603,0.0019863872,0.5982176,0.0001438017,0.009396089,0.000688129,0.03392623,0.0000281625,0.046871137,0.00017627187,0.0003251487,0.01078074],"study_design_scores_gemma":[0.098040596,0.0018771394,0.82628596,0.00029674126,0.0006724318,0.00006150318,0.0062932125,0.0000021201915,0.06602016,0.0001696499,0.00010176301,0.00017873316],"about_ca_topic_score_codex":0.0043248744,"about_ca_topic_score_gemma":0.0026553238,"teacher_disagreement_score":0.22806834,"about_ca_system_score_codex":0.000044640754,"about_ca_system_score_gemma":0.0004771881,"threshold_uncertainty_score":0.6537945},"labels":[],"label_agreement":null},{"id":"W3185760221","doi":"10.1007/s00228-021-03177-y","title":"Pharmacodynamic effects of indobufen compared with aspirin in patients with coronary atherosclerosis","year":2021,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton General Hospital","funders":"","keywords":"Aspirin; Medicine; Pharmacodynamics; Internal medicine; Thromboxane B2; Pharmacology; Gastroenterology; Pharmacokinetics; Platelet","score_opus":0.022003987445535115,"score_gpt":0.3196779995525838,"score_spread":0.2976740121070487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3185760221","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99759156,0.00081546564,0.00019852168,0.00012890116,0.0006641085,0.0002474652,0.0000047201734,0.000009303329,0.00033997156],"genre_scores_gemma":[0.99720776,0.00057997415,0.00040040127,0.0013044172,0.0004231103,0.0000012325811,0.000010596255,0.00004022522,0.000032281587],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99647325,0.0017508758,0.0009936416,0.00020772878,0.00036883695,0.00020568176],"domain_scores_gemma":[0.99824584,0.00038134324,0.0005792672,0.00015441462,0.00039039034,0.00024874372],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009032693,0.00016745157,0.00097287894,0.00009289421,0.000023193266,0.0000047885337,0.0001574459,0.000038399885,0.00016084098],"category_scores_gemma":[0.00007455967,0.00011522381,0.0003504332,0.00021816032,0.00024347602,0.000082829894,0.000047962752,0.0005842801,0.0000093203425],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018049499,0.0032653697,0.94730985,0.00018869364,0.0025643883,0.00555579,0.00007149984,0.00030431777,0.0029233133,0.0000011245771,0.00060724857,0.01915891],"study_design_scores_gemma":[0.052121148,0.0043963664,0.9382417,0.00045238956,0.00095643336,0.00015457436,0.000021031407,0.000024786284,0.00211255,0.0000012488903,0.0014014365,0.00011628841],"about_ca_topic_score_codex":6.389493e-7,"about_ca_topic_score_gemma":5.095949e-7,"teacher_disagreement_score":0.03407165,"about_ca_system_score_codex":0.000023835424,"about_ca_system_score_gemma":0.00023466542,"threshold_uncertainty_score":0.46986908},"labels":[],"label_agreement":null},{"id":"W3185803355","doi":"10.1136/bmjopen-2021-048719","title":"Impact of aspirin use on clinical outcomes in patients with vasospastic angina: a systematic review and meta-analysis","year":2021,"lang":"en","type":"review","venue":"BMJ Open","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Sanming Project of Medicine in Shenzhen","keywords":"Medicine; Aspirin; Internal medicine; Meta-analysis; Funnel plot; Myocardial infarction; Incidence (geometry); Subgroup analysis; Coronary artery disease; Publication bias; Observational study; Angina; Placebo; Unstable angina; Cohort study; Surgery; Pathology; Alternative medicine","score_opus":0.2712013403139539,"score_gpt":0.5101161389361415,"score_spread":0.23891479862218762,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3185803355","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00026976498,0.9782917,0.0000068551294,0.000011643413,0.000009002411,0.021207118,0.00017317392,0.000005705088,0.000025062456],"genre_scores_gemma":[0.0002040037,0.9973587,0.000067627494,0.0002295571,0.00000688062,0.0014474335,0.00033027513,0.000042749823,0.00031278213],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99557793,0.0015714231,0.0016344036,0.00051502994,0.0005197119,0.00018151224],"domain_scores_gemma":[0.996711,0.00060510455,0.00090045325,0.0014636721,0.0001658647,0.0001539046],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0019079328,0.0004614886,0.02101818,0.00022611862,0.000017563176,0.000055903318,0.00026574617,0.00014920787,0.00020110409],"category_scores_gemma":[0.0008858864,0.0002171553,0.0089242505,0.0008243578,0.000048344507,0.000093555995,0.000165242,0.00023568125,0.000011581657],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051841078,0.0004031038,0.02636697,0.44655177,0.5247191,0.00009989382,0.0000032417515,0.0000011840459,4.1344008e-11,0.0000035116186,0.000037691556,0.0017616795],"study_design_scores_gemma":[0.00087536627,0.00053168455,0.022486025,0.14591974,0.829385,0.000014459918,0.0000020380887,2.1910247e-7,9.0532165e-10,2.1649188e-7,0.00057588535,0.00020936695],"about_ca_topic_score_codex":0.00006483522,"about_ca_topic_score_gemma":0.000011037506,"teacher_disagreement_score":0.3046659,"about_ca_system_score_codex":0.000055733286,"about_ca_system_score_gemma":0.000393204,"threshold_uncertainty_score":0.99351585},"labels":[],"label_agreement":null},{"id":"W3186240465","doi":"10.5114/kitp.2021.107476","title":"Severe complication of early cessation of therapywith ticagrelor after drug-eluting stent implantation","year":2021,"lang":"en","type":"article","venue":"Polish Journal of Cardio-Thoracic Surgery","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Ticagrelor; Stent; Complication; Drug-eluting stent; Surgery; Cardiothoracic surgery; General surgery; Internal medicine; Acute coronary syndrome; Myocardial infarction","score_opus":0.02265464553053602,"score_gpt":0.28625020368992765,"score_spread":0.2635955581593916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3186240465","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98392737,0.013736795,0.0013941361,0.00016082826,0.00025175777,0.0001207376,0.000035819397,0.000010138957,0.00036242447],"genre_scores_gemma":[0.99656594,0.0025964372,0.00029579492,0.000094193005,0.00034881118,0.000004276646,0.000037468413,0.000024269275,0.000032832664],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997646,0.00041872478,0.0008467843,0.00014901388,0.0007401264,0.00019940396],"domain_scores_gemma":[0.99730915,0.0002900998,0.0007386879,0.00027949925,0.0012466301,0.00013594373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013802598,0.00014536388,0.000846595,0.00023217182,0.00003758255,0.000019761259,0.000064081185,0.00007774926,0.000055124732],"category_scores_gemma":[0.00015618067,0.00012427206,0.0010485228,0.0003458549,0.00007230624,0.0002509667,0.000016583293,0.00016386353,0.0000020021068],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004920492,0.00035441562,0.5852339,0.00097293686,0.0042744637,0.0005329431,0.0015959943,0.00029825573,0.010690503,0.00004512796,0.0005506162,0.3905303],"study_design_scores_gemma":[0.0011664433,0.00011680975,0.9088778,0.0014549128,0.0016431406,0.0035981317,0.0012245621,0.000019681034,0.08019856,0.0001491095,0.0012998406,0.0002510377],"about_ca_topic_score_codex":0.000016822445,"about_ca_topic_score_gemma":9.509539e-7,"teacher_disagreement_score":0.39027926,"about_ca_system_score_codex":0.00005090102,"about_ca_system_score_gemma":0.0004046093,"threshold_uncertainty_score":0.5067668},"labels":[],"label_agreement":null},{"id":"W3193614870","doi":"10.1056/nejmoa2108749","title":"Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk","year":2021,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":544,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Terumo","keywords":"Medicine; Conventional PCI; Cardiology; Drug-eluting stent; Antiplatelet drug; Internal medicine; Coronary stent; Percutaneous coronary intervention; P2Y12; Aspirin; Stent; Clopidogrel; Myocardial infarction; Restenosis","score_opus":0.008914497911162245,"score_gpt":0.23058048709616713,"score_spread":0.22166598918500488,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3193614870","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9797612,0.017673964,0.000058798694,0.0014341671,0.00069149217,0.00011512332,0.0000055773767,0.000009805863,0.0002498761],"genre_scores_gemma":[0.9811578,0.01441757,0.0001514689,0.00080887915,0.0031274082,0.0000010959253,0.000019302928,0.000025501562,0.00029098216],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998046,0.00018662648,0.0005763487,0.00018571595,0.0007487554,0.00025655382],"domain_scores_gemma":[0.99882025,0.00012144024,0.0002414776,0.00021177281,0.0002802261,0.00032481097],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00074930454,0.00019228538,0.0007452248,0.00019456008,0.000047532307,0.000009208802,0.00006592076,0.00009580671,0.0011682762],"category_scores_gemma":[0.00025589872,0.0001259357,0.0002410369,0.00026725786,0.0000748245,0.00010774103,0.000027839855,0.000420217,0.000009091137],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010181016,0.00026093927,0.7235785,0.000029950928,0.00078638596,0.005115837,0.0008061946,0.000026296655,0.001121601,0.000008734288,0.002565156,0.2555194],"study_design_scores_gemma":[0.1790403,0.001748469,0.7658005,0.00069182436,0.0003781635,0.0022007364,0.00013481015,0.0000059130175,0.0017823188,0.00018375643,0.047875714,0.00015751646],"about_ca_topic_score_codex":0.000041022427,"about_ca_topic_score_gemma":0.000014829603,"teacher_disagreement_score":0.25536186,"about_ca_system_score_codex":0.000074871285,"about_ca_system_score_gemma":0.00015294302,"threshold_uncertainty_score":0.9997448},"labels":[],"label_agreement":null},{"id":"W3193621036","doi":"10.1093/eurheartj/ehab533","title":"Ticagrelor monotherapy in patients with chronic kidney disease undergoing percutaneous coronary intervention: TWILIGHT-CKD","year":2021,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences","funders":"AstraZeneca","keywords":"Medicine; Ticagrelor; Aspirin; Percutaneous coronary intervention; Kidney disease; Internal medicine; Hazard ratio; Myocardial infarction; Placebo; Renal function; Stroke (engine); Clinical endpoint; Conventional PCI; Randomized controlled trial; Cardiology; Confidence interval","score_opus":0.01174160567273132,"score_gpt":0.24396633958087935,"score_spread":0.23222473390814802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3193621036","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99117523,0.006676307,0.0002531683,0.00082521484,0.00019826248,0.00018360438,0.000008005548,0.00003843822,0.00064177817],"genre_scores_gemma":[0.9962246,0.00086318003,0.00021144157,0.0015142644,0.0004129983,0.0000012561238,0.00004951772,0.000064560554,0.0006581852],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99827373,0.0004632843,0.00029193264,0.0002697546,0.00040903414,0.00029223989],"domain_scores_gemma":[0.99890244,0.000030175455,0.00006421679,0.0003005619,0.00012241819,0.00058018777],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00024812203,0.00018286437,0.00028621982,0.0000899781,0.00014562653,0.00007290662,0.00008091971,0.000024312454,0.0012587638],"category_scores_gemma":[0.000067715584,0.00014583529,0.00038788354,0.00016079594,0.000058458474,0.00013876182,0.000033853397,0.00036112132,0.000118930926],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003540146,0.0009618657,0.9492258,0.00014448162,0.0007005505,0.025501769,0.00015973125,0.00012583534,0.00024827177,0.000017886518,0.0021353564,0.017238295],"study_design_scores_gemma":[0.009022033,0.0008156573,0.95538384,0.0012874474,0.00016503179,0.005195008,0.00006576581,0.000028158798,0.00005519212,0.000016818713,0.027755488,0.00020954439],"about_ca_topic_score_codex":9.713192e-7,"about_ca_topic_score_gemma":0.000003335049,"teacher_disagreement_score":0.025620133,"about_ca_system_score_codex":0.00016541497,"about_ca_system_score_gemma":0.00046866864,"threshold_uncertainty_score":0.99965423},"labels":[],"label_agreement":null},{"id":"W3193891400","doi":"10.1016/j.cjco.2021.08.006","title":"Impact of Clopidogrel Stop Interval on Major Adverse Bleeding Events in Cardiac Surgery","year":2021,"lang":"en","type":"article","venue":"CJC Open","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Faculty of Medicine, Prince of Songkla University; Dalhousie University; Dalhousie Medical Research Foundation","keywords":"Clopidogrel; Medicine; Adverse effect; Cardiac surgery; Cardiology; Major bleeding; Internal medicine; Myocardial infarction","score_opus":0.02717940537801176,"score_gpt":0.32245986481700384,"score_spread":0.29528045943899206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3193891400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951676,0.0009460336,0.000005960013,0.00005867248,0.00020128158,0.0002992263,0.00008589257,0.000010635613,0.0032246567],"genre_scores_gemma":[0.9986236,0.00031545697,0.000035633642,0.000106456064,0.00009975058,0.00001913328,0.00014355303,0.000019714262,0.00063668244],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99899894,0.00014173996,0.00023479619,0.00022344387,0.00021066518,0.00019039758],"domain_scores_gemma":[0.9993157,0.00011399244,0.00005853872,0.000337829,0.00006795602,0.00010601719],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00040834415,0.0001205866,0.00075055734,0.00009038446,0.000023589835,0.000007844131,0.000115012626,0.00006253079,0.0011243488],"category_scores_gemma":[0.00014651907,0.00010192088,0.00086993806,0.00024399668,0.000024466834,0.00011448236,0.000113587135,0.00011852608,0.000045831774],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018773655,0.0005557092,0.9518414,0.00013280644,0.002458215,0.0007545246,0.00029563333,0.000032002772,0.0014513513,0.000036482095,0.0073576462,0.033206843],"study_design_scores_gemma":[0.0019394624,0.00017237595,0.98967105,0.000997954,0.00020500626,0.000041359734,0.00044309476,0.000009839645,0.0031690006,0.00003354104,0.0031552904,0.00016202367],"about_ca_topic_score_codex":0.00014309454,"about_ca_topic_score_gemma":0.0000038629396,"teacher_disagreement_score":0.03782963,"about_ca_system_score_codex":0.000089498426,"about_ca_system_score_gemma":0.00030671788,"threshold_uncertainty_score":0.99978876},"labels":[],"label_agreement":null},{"id":"W3194353953","doi":"10.1002/clc.23716","title":"Ticagrelor or clopidogrel dual antiplatelet therapy following a pharmacoinvasive strategy in <scp>ST</scp>‐segment elevation myocardial infarction","year":2021,"lang":"en","type":"article","venue":"Clinical Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Heart Research Centre; Canadian VIGOUR Centre; University of Saskatchewan; Vanguard College; University of Alberta","funders":"Alberta Health Services; Pfizer","keywords":"Medicine; Ticagrelor; Clopidogrel; Cardiology; Myocardial infarction; Internal medicine; ST segment; Aspirin; P2Y12; Prasugrel; Platelet aggregation inhibitor","score_opus":0.07413262247522462,"score_gpt":0.3733440142081129,"score_spread":0.2992113917328883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3194353953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892227,0.005885277,0.00074108253,0.00043427967,0.0016620462,0.00068213284,0.00002989185,0.00011280951,0.0012297729],"genre_scores_gemma":[0.9783686,0.016154157,0.00013013168,0.0024940434,0.0020940767,0.0000829303,0.00037374755,0.000051219846,0.00025112112],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958268,0.0012411729,0.0010424193,0.00084809185,0.0004292655,0.0006122747],"domain_scores_gemma":[0.99745315,0.0013445292,0.00016399997,0.00052652124,0.00022173034,0.00029009246],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014127698,0.0003502201,0.0015126575,0.00014342609,0.000109568486,0.00003335907,0.00011195672,0.0005486453,0.00009833537],"category_scores_gemma":[0.0014279105,0.00028996472,0.0017554753,0.00050892815,0.00020493369,0.00014032831,0.00008120043,0.00073401246,0.00008445143],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038961642,0.0010665683,0.74828404,0.000121109806,0.013950088,0.023140721,0.00028706886,0.0011896883,0.009242617,0.00027325528,0.011507338,0.18704131],"study_design_scores_gemma":[0.030488037,0.002282389,0.8406133,0.00016598334,0.0012815953,0.002564506,0.0015664658,0.0002899629,0.0020973152,0.00040456114,0.11785715,0.0003887083],"about_ca_topic_score_codex":0.000008792726,"about_ca_topic_score_gemma":0.0000050207977,"teacher_disagreement_score":0.18665262,"about_ca_system_score_codex":0.000090831534,"about_ca_system_score_gemma":0.00069230737,"threshold_uncertainty_score":0.99995524},"labels":[],"label_agreement":null},{"id":"W3194570774","doi":"10.1038/s41569-021-00598-1","title":"Bleeding avoidance strategies in percutaneous coronary intervention","year":2021,"lang":"en","type":"review","venue":"Nature Reviews Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":156,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"St. Jude Medical; HLS Therapeutics; Idorsia Pharmaceuticals; Duke Clinical Research Institute; Eisai; Daiichi-Sankyo; Belvoir Media Group; Janssen Scientific Affairs; Canada Excellence Research Chairs, Government of Canada; Medicines Company; Regado Biosciences; Osprey Medical; AstraZeneca; Amarin Corporation; Agence Nationale de la Recherche; Ironwood Pharmaceuticals, Incorporated; Abbott Vascular; Boston VA Research Institute; Boston Scientific Corporation; Bristol-Myers Squibb; Cleveland Clinic; Novo Nordisk; MyoKardia; Daiichi Sankyo Europe; Servier; Gilead Sciences; Abbott Laboratories; CSL Behring; Eli Lilly and Company; Pfizer; Cardinal Health; Amgen; Edwards Lifesciences; Abiomed; Sanofi; Regeneron Pharmaceuticals; American Heart Association","keywords":"Medicine; Conventional PCI; Percutaneous coronary intervention; Antithrombotic; Revascularization; Cardiology; Complication; Internal medicine; Intensive care medicine; Myocardial infarction","score_opus":0.03285098105186077,"score_gpt":0.3662658522997298,"score_spread":0.33341487124786906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3194570774","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000034431756,0.9951905,0.00009687209,0.000019536801,0.0008396206,0.0017010076,0.000024940693,0.00005815314,0.002034923],"genre_scores_gemma":[0.00024051958,0.9973143,0.00019789537,0.00014268309,0.0008935446,0.00020276557,0.0007124277,0.00007638196,0.00021951793],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955899,0.0017059982,0.0011363346,0.000866855,0.00024845236,0.00045246727],"domain_scores_gemma":[0.9984623,0.00016587706,0.00034996,0.000799748,0.00009850634,0.00012359448],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0010875763,0.00066286867,0.007525095,0.00026481305,0.000052483898,0.000032589265,0.00025418223,0.001815468,0.00013198447],"category_scores_gemma":[0.0002611049,0.00049722544,0.005622535,0.00053903065,0.00011362659,0.00008971805,0.000104614155,0.0026649304,0.000095829004],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022946875,0.00003688574,0.000036069905,0.03124723,0.0012906189,0.0073050805,0.00001183269,0.0000018119066,0.0000013198796,0.00033944676,0.0008556132,0.95885116],"study_design_scores_gemma":[0.0003408362,0.00009330579,0.000043192842,0.05528521,0.003338642,0.03775777,0.00006765945,4.7019597e-7,1.1633494e-7,0.000028437604,0.9026889,0.0003554368],"about_ca_topic_score_codex":0.0000036055558,"about_ca_topic_score_gemma":0.0000057407633,"teacher_disagreement_score":0.95849574,"about_ca_system_score_codex":0.0002679336,"about_ca_system_score_gemma":0.0005179166,"threshold_uncertainty_score":0.99974793},"labels":[],"label_agreement":null},{"id":"W3195918964","doi":"10.3390/jpm11080813","title":"Plateletworks® as a Point-of-Care Test for ASA Non-Sensitivity","year":2021,"lang":"en","type":"article","venue":"Journal of Personalized Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; McMaster University; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Aspirin; Adverse effect; Sensitivity (control systems); Point-of-care testing; Point of care; Intensive care medicine; Pharmacology; Internal medicine; Anesthesia; Pathology","score_opus":0.013288884374027993,"score_gpt":0.2964584242474629,"score_spread":0.2831695398734349,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3195918964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9100989,0.068644255,0.0102635175,0.0070730546,0.0007886793,0.0005361024,0.000034434805,0.000021904107,0.002539128],"genre_scores_gemma":[0.9893997,0.0038193658,0.0021644256,0.0017536458,0.002065078,0.0000048806114,0.000039308274,0.00003968926,0.0007139259],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981117,0.00009337685,0.0006169867,0.00019669448,0.00072650507,0.0002546898],"domain_scores_gemma":[0.99688727,0.00063484884,0.00040229218,0.0002494219,0.0015070625,0.00031908537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088732137,0.00020565407,0.0012411142,0.00014419405,0.00006906456,0.0000071061313,0.000071722934,0.00013102432,0.00057993917],"category_scores_gemma":[0.0016730357,0.00014865404,0.0010166876,0.00027612172,0.00023362212,0.0000923206,0.000019144285,0.00029717883,0.000004343559],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.039750174,0.0031633258,0.034709647,0.007793847,0.015983302,0.044088572,0.021498417,0.00012278378,0.47366467,0.0012819115,0.08002838,0.27791497],"study_design_scores_gemma":[0.17397295,0.023515197,0.058368564,0.022912087,0.017437395,0.076717466,0.06559006,0.00071740587,0.11233853,0.0013287335,0.44570166,0.0013999615],"about_ca_topic_score_codex":0.0000065062004,"about_ca_topic_score_gemma":0.0000025987433,"teacher_disagreement_score":0.36567327,"about_ca_system_score_codex":0.00007121473,"about_ca_system_score_gemma":0.00059532805,"threshold_uncertainty_score":0.6349927},"labels":[],"label_agreement":null},{"id":"W3195985033","doi":"10.1016/j.jvs.2021.06.420","title":"Platelet Works as a Point-of-Care Test for ASA Non-Sensitivity","year":2021,"lang":"en","type":"article","venue":"Journal of Vascular Surgery","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Platelet; Internal medicine; Aspirin; Adverse effect; Confidence interval; Platelet activation; Cardiology; Surgery","score_opus":0.011537998903850467,"score_gpt":0.2518174578261522,"score_spread":0.24027945892230176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3195985033","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95733404,0.03506778,0.0063479003,0.00030360976,0.0004897846,0.00021097298,0.000014777317,0.000013415761,0.00021771187],"genre_scores_gemma":[0.9927326,0.0051916125,0.0009576642,0.000386799,0.00060257287,0.0000043096543,0.00003335888,0.000041062038,0.000050063703],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99814755,0.00014617029,0.000631435,0.00019547268,0.0006098955,0.00026945403],"domain_scores_gemma":[0.9969331,0.0010763764,0.0003469754,0.00039243844,0.0010176167,0.00023350934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013334461,0.00019069796,0.0011782118,0.00024388566,0.0000675628,0.000030089845,0.000056883604,0.00016147223,0.00011014464],"category_scores_gemma":[0.0015015295,0.00016212655,0.0036448275,0.00036994813,0.000054295426,0.00018340009,0.00002732032,0.00027057086,0.0000062799613],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053438516,0.0028578169,0.1264403,0.003620972,0.01915581,0.034533743,0.0012132854,0.00051600306,0.037239723,0.000060780167,0.015012835,0.7540049],"study_design_scores_gemma":[0.023208313,0.002167453,0.2826232,0.013875093,0.008216207,0.0287801,0.0075475657,0.0002657017,0.4731593,0.00042764953,0.15810792,0.0016214941],"about_ca_topic_score_codex":0.0000034382413,"about_ca_topic_score_gemma":0.0000018246486,"teacher_disagreement_score":0.7523834,"about_ca_system_score_codex":0.00004983076,"about_ca_system_score_gemma":0.0007493196,"threshold_uncertainty_score":0.66113293},"labels":[],"label_agreement":null},{"id":"W3197102732","doi":"10.1161/circulationaha.121.056680","title":"Abbreviated Antiplatelet Therapy in Patients at High Bleeding Risk With or Without Oral Anticoagulant Therapy After Coronary Stenting: An Open-Label, Randomized, Controlled Trial","year":2021,"lang":"en","type":"article","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Medicine; Regimen; Adverse effect; Stroke (engine); Hazard ratio; Internal medicine; Randomized controlled trial; Myocardial infarction; Population; Randomization; Surgery; Confidence interval","score_opus":0.032170321062461225,"score_gpt":0.2877963678226889,"score_spread":0.2556260467602277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3197102732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98836887,0.0024077229,0.0002043267,0.00003815574,0.00028254683,0.0085445875,0.000015226294,0.000082285434,0.0000562698],"genre_scores_gemma":[0.9948425,0.0031943445,0.00024729193,0.00031873913,0.00015456977,0.00048601627,0.0005815224,0.00008067602,0.00009433604],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99617505,0.0012748472,0.0008177116,0.00067262136,0.00066563085,0.00039414354],"domain_scores_gemma":[0.99833155,0.00017910507,0.00041739608,0.00053597195,0.00037019697,0.00016577468],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013368699,0.00040966566,0.0024081245,0.00015565468,0.0001954049,0.00015162452,0.00014576309,0.00019144188,0.00045692732],"category_scores_gemma":[0.00012942232,0.0002576037,0.00030356075,0.00040845454,0.00011657283,0.0004740222,0.000053819338,0.00021866188,0.000011083869],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.61245,0.0013990294,0.37590256,0.000014856416,0.0015038742,0.00020118376,0.00016506591,0.0000615623,0.0004946434,0.0000062716967,0.0000037618347,0.007797206],"study_design_scores_gemma":[0.7011616,0.0010675269,0.29486898,0.00019376336,0.00048009717,0.00004821749,0.0000421712,0.0015704125,0.00023259265,0.00002322074,0.000039187235,0.0002721923],"about_ca_topic_score_codex":0.000084953426,"about_ca_topic_score_gemma":0.000027845645,"teacher_disagreement_score":0.08871164,"about_ca_system_score_codex":0.000108589906,"about_ca_system_score_gemma":0.00020990484,"threshold_uncertainty_score":0.9999876},"labels":[],"label_agreement":null},{"id":"W3198366962","doi":"10.1161/jaha.120.021115","title":"Factor V Leiden and the Risk of Bleeding in Patients With Acute Coronary Syndromes Treated With Antiplatelet Therapy: Pooled Analysis of 3 Randomized Clinical Trials","year":2021,"lang":"en","type":"review","venue":"Journal of the American Heart Association","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Population Health Research Institute; McMaster University","funders":"National Institute for Health and Care Research","keywords":"Medicine; Internal medicine; Hazard ratio; Myocardial infarction; Risk factor; Stroke (engine); Factor V Leiden; Proportional hazards model; Randomized controlled trial; Gastroenterology; Surgery; Confidence interval; Thrombosis; Venous thrombosis","score_opus":0.03516520047664657,"score_gpt":0.35830789965763843,"score_spread":0.32314269918099187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3198366962","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6060694,0.3928914,0.000010783077,0.000049605347,0.00003387557,0.00087094115,0.0000699882,0.000002329094,0.0000016956452],"genre_scores_gemma":[0.2737803,0.7260291,0.000044824657,0.000036740326,0.0000437908,0.000008274797,0.000021283378,0.000020563826,0.000015148427],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9832462,0.013094843,0.002370039,0.00019232093,0.00093748246,0.00015912311],"domain_scores_gemma":[0.98282754,0.0075874883,0.008638106,0.0003065177,0.00056964275,0.000070706184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01295247,0.00028373708,0.014072235,0.00037633037,0.00005461213,0.000023140072,0.00015165813,0.00013540698,0.000015982796],"category_scores_gemma":[0.0030572196,0.00010981586,0.005669695,0.0014428574,0.00035594797,0.000077988625,0.00002955359,0.00054412906,1.3892578e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04823713,0.00020975387,0.6590213,0.00011940444,0.19933107,0.00001598662,0.000078193065,0.00001364896,6.316515e-7,5.160952e-7,0.000017037053,0.092955306],"study_design_scores_gemma":[0.12457653,0.0009139611,0.64224344,0.0045148986,0.22653402,0.00006525403,0.00010618661,0.00002672767,0.0000039798124,0.000002577058,0.000842826,0.00016960145],"about_ca_topic_score_codex":0.000097592834,"about_ca_topic_score_gemma":0.0000043793248,"teacher_disagreement_score":0.33313766,"about_ca_system_score_codex":0.00013662368,"about_ca_system_score_gemma":0.00038814943,"threshold_uncertainty_score":0.9619498},"labels":[],"label_agreement":null},{"id":"W3199203187","doi":"10.1161/strokeaha.121.035002","title":"Cilostazol for Secondary Stroke Prevention","year":2021,"lang":"en","type":"review","venue":"Stroke","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Population Health Research Institute","funders":"National Center for Advancing Translational Sciences; National Institute of Neurological Disorders and Stroke; British Heart Foundation; Alzheimer's Society; National Institute of Nursing Research; National Heart, Lung, and Blood Institute","keywords":"Cilostazol; Medicine; Stroke (engine); Discontinuation; Clopidogrel; Clinical trial; Adverse effect; Aspirin; Randomized controlled trial; Internal medicine; Platelet aggregation inhibitor; Population; Placebo; Antiplatelet drug; Cardiology; Alternative medicine","score_opus":0.04892344570305177,"score_gpt":0.35373458616715925,"score_spread":0.30481114046410746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3199203187","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00001877062,0.9917621,0.0009288313,0.000016347685,0.00039473167,0.0018502827,0.0012430834,0.000074667405,0.0037112029],"genre_scores_gemma":[0.0000063129137,0.9699596,0.00048725546,0.00006641566,0.00087411096,0.00035605274,0.0025466084,0.00008916414,0.025614465],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99828184,0.00012434614,0.00046078063,0.0004989517,0.00031408574,0.00032001725],"domain_scores_gemma":[0.99885345,0.00008259789,0.00017736273,0.00060675095,0.000117218464,0.00016261934],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023496967,0.0003812546,0.0021510427,0.00013250395,0.00008552128,0.00003559227,0.00012243466,0.00035056824,0.0006852571],"category_scores_gemma":[0.00005870251,0.00032211325,0.004391216,0.00011059264,0.000043798926,0.000053887485,0.000044642456,0.0003651442,0.000058553782],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033716347,0.00008956691,0.000002321459,0.015513627,0.003928239,0.00007558181,0.000006012922,5.5386444e-8,0.00000185264,0.0001269451,0.0027893702,0.9774327],"study_design_scores_gemma":[0.0012936615,0.00021501565,0.0000035225758,0.00884915,0.008681077,0.00020455196,0.000038556536,5.270601e-7,0.000018852726,0.000017842276,0.9804106,0.00026666728],"about_ca_topic_score_codex":0.0000011352645,"about_ca_topic_score_gemma":0.0000010933469,"teacher_disagreement_score":0.9776212,"about_ca_system_score_codex":0.00008673926,"about_ca_system_score_gemma":0.0010576735,"threshold_uncertainty_score":0.9999231},"labels":[],"label_agreement":null},{"id":"W3199731838","doi":"10.1177/17151635211045973","title":"Extended antithrombotic therapy for secondary prevention of cardiovascular events: A tool for pharmacists","year":2021,"lang":"en","type":"article","venue":"Canadian Pharmacists Journal / Revue des Pharmaciens du Canada","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Saskatchewan Health; Saskatchewan Health Authority","funders":"","keywords":"Antithrombotic; Secondary prevention; Medicine; Intensive care medicine; Cardiology; Internal medicine","score_opus":0.03479339332757555,"score_gpt":0.29165700410968803,"score_spread":0.2568636107821125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3199731838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93940175,0.04565683,0.0085958075,0.00008683433,0.0022112243,0.0022682352,0.0015485443,0.000035563116,0.00019519193],"genre_scores_gemma":[0.9609556,0.034237657,0.0013065826,0.0012206163,0.001064465,0.0001418668,0.00031042332,0.00010809783,0.0006546891],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99687535,0.00023147755,0.0007974248,0.00057073863,0.0006108973,0.00091412454],"domain_scores_gemma":[0.99630684,0.000115612485,0.0002703512,0.00047239254,0.0016141107,0.0012206888],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009930586,0.0004297708,0.0010512611,0.00027227434,0.00056865654,0.000068008674,0.0003145407,0.000099979006,0.00071342307],"category_scores_gemma":[0.00021344126,0.00045115085,0.0021107597,0.0004920782,0.0001365611,0.00031592336,0.000021974225,0.00037626535,0.000001922324],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002567894,0.0005490633,0.00093559286,0.0026449014,0.01902075,0.030778313,0.00045396257,0.0013056722,0.020084627,0.00006692137,0.014322139,0.90727013],"study_design_scores_gemma":[0.04237326,0.00054808473,0.00032495966,0.0002234412,0.005124751,0.52095765,0.00004014795,0.0018788866,0.11528911,0.0006619948,0.31131083,0.0012668645],"about_ca_topic_score_codex":0.0005170622,"about_ca_topic_score_gemma":0.0007267655,"teacher_disagreement_score":0.9060033,"about_ca_system_score_codex":0.0009307681,"about_ca_system_score_gemma":0.009522485,"threshold_uncertainty_score":0.999794},"labels":[],"label_agreement":null},{"id":"W3200223380","doi":"10.1161/jaha.119.015560","title":"Efficacy and Safety of Ticagrelor Monotherapy by Clinical Presentation: Pre‐Specified Analysis of the GLOBAL LEADERS Trial","year":2021,"lang":"en","type":"article","venue":"Journal of the American Heart Association","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Ticagrelor; Acute coronary syndrome; Aspirin; Clopidogrel; Internal medicine; Myocardial infarction; Coronary artery disease; Clinical endpoint; Scad; Cardiology; Randomized controlled trial","score_opus":0.026308792499912234,"score_gpt":0.3562423899885236,"score_spread":0.32993359748861134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3200223380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99447477,0.00096478703,0.00017809142,0.003910852,0.00019528168,0.00020662705,0.000022670625,0.0000026528746,0.00004426771],"genre_scores_gemma":[0.9978209,0.001219447,0.00011306557,0.00052189187,0.00019865282,8.2111757e-7,0.0000027696028,0.000005418427,0.00011703978],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977086,0.0008215138,0.00066051015,0.00009789345,0.00061856804,0.00009290504],"domain_scores_gemma":[0.9979803,0.00045841702,0.0009826275,0.00022526109,0.00029591576,0.00005745311],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009298346,0.00007232416,0.00081053615,0.00003208807,0.0000522723,0.000009377285,0.00009137078,0.00004885395,0.000023295803],"category_scores_gemma":[0.00080076145,0.00004351749,0.0012957946,0.0007963977,0.0001873035,0.00004495167,0.000021020336,0.00015364774,2.2811317e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02959441,0.00047707307,0.94441545,0.000009575535,0.012964745,0.000001682452,0.00026532524,0.00020946072,0.0009743588,0.000014302329,0.00308581,0.007987778],"study_design_scores_gemma":[0.014301802,0.0003586725,0.97759634,0.000033019212,0.0037650873,0.000010087418,0.00039816007,0.00006229624,0.0010656915,0.000020750504,0.0023464004,0.00004167511],"about_ca_topic_score_codex":0.000022018237,"about_ca_topic_score_gemma":0.000004685205,"teacher_disagreement_score":0.033180878,"about_ca_system_score_codex":0.00011414215,"about_ca_system_score_gemma":0.00019175188,"threshold_uncertainty_score":0.17745918},"labels":[],"label_agreement":null},{"id":"W3200574352","doi":"10.1016/j.jacc.2021.07.048","title":"Intracranial Hemorrhage During Dual Antiplatelet Therapy","year":2021,"lang":"en","type":"review","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; St. Michael's Hospital; Toronto General Hospital; University Health Network; University of Toronto","funders":"National Institutes of Health; AstraZeneca","keywords":"Medicine; Ticagrelor; Stroke (engine); Disease; Complication; Internal medicine; Intracerebral hemorrhage; Ambulatory; Cardiology; Intensive care medicine; Clopidogrel; Aspirin; Subarachnoid hemorrhage","score_opus":0.02138599839038306,"score_gpt":0.298286827075407,"score_spread":0.2769008286850239,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3200574352","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07967494,0.9185962,0.000041887895,0.00010966248,0.0008110749,0.0004222454,0.00016609988,0.00000960455,0.00016828002],"genre_scores_gemma":[0.013526927,0.9836794,0.00027197515,0.000088508044,0.002211309,0.0000065429845,0.000008266455,0.00007434941,0.000132692],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961876,0.0012927118,0.0012821867,0.00028724584,0.0005922003,0.0003580404],"domain_scores_gemma":[0.99632317,0.00024705444,0.0021165449,0.00077784597,0.00037052133,0.00016485967],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006776427,0.0004564973,0.0071549295,0.0002738736,0.00009707641,0.000008167166,0.00046246187,0.00022529012,0.000040159484],"category_scores_gemma":[0.00018914329,0.00026913072,0.0069684596,0.0007889216,0.0006435663,0.00005018324,0.0001398905,0.00091760646,0.0000035789078],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015864499,0.00014146641,0.00043891696,0.003513773,0.018976321,0.032684118,0.000014593329,0.000034710236,0.0001672016,0.000021360376,0.0013021708,0.9411189],"study_design_scores_gemma":[0.0023551572,0.0007158872,0.0007871215,0.0038190244,0.0049201236,0.20221029,0.00013642774,8.9029226e-7,0.000074830816,0.000008611268,0.7846802,0.0002914382],"about_ca_topic_score_codex":0.0000017318315,"about_ca_topic_score_gemma":2.7079162e-7,"teacher_disagreement_score":0.9408275,"about_ca_system_score_codex":0.00012024375,"about_ca_system_score_gemma":0.0012064393,"threshold_uncertainty_score":0.9999761},"labels":[],"label_agreement":null},{"id":"W3203015600","doi":"10.1111/bjh.17847","title":"Intensified antiplatelet therapy in patients after percutaneous coronary intervention with high on‐treatment platelet reactivity: the OPTImal Management of Antithrombotic Agents (OPTIMA)‐2 Trial","year":2021,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton General Hospital","funders":"","keywords":"Medicine; Clopidogrel; Percutaneous coronary intervention; Mace; Ticagrelor; Cilostazol; Conventional PCI; Internal medicine; Aspirin; Randomized controlled trial; Antithrombotic; Clinical trial; Cardiology; Myocardial infarction","score_opus":0.015220089550454327,"score_gpt":0.2512518552541826,"score_spread":0.23603176570372825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3203015600","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99606615,0.0026391484,0.00007567297,0.00018086111,0.00030986711,0.0006488908,0.000017315495,0.000008399061,0.000053670545],"genre_scores_gemma":[0.99287677,0.0062544984,0.00053413265,0.00016818762,0.000042746677,0.000014073246,0.000036336514,0.000029434499,0.00004379754],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.9980691,0.00033383636,0.0006493763,0.00025692486,0.00043383404,0.0002569325],"domain_scores_gemma":[0.9989639,0.00007186951,0.00033972185,0.00027020267,0.00027503222,0.000079299716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025346794,0.00021296329,0.0010296418,0.0001165775,0.000050954135,0.000026882186,0.00011246443,0.000107246415,0.00019497449],"category_scores_gemma":[0.000023468474,0.00015188099,0.00048721788,0.00016441835,0.00016831329,0.000100343306,0.00003717122,0.00026770437,0.0000043625496],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19947056,0.0075541786,0.0149310175,0.00018138644,0.006726511,0.60967946,0.00024675883,0.0002937029,0.00007277612,0.00005666115,0.00015723675,0.16062972],"study_design_scores_gemma":[0.17930722,0.01817214,0.46308333,0.003596192,0.001024745,0.32923105,0.0010793802,0.000031473468,0.0035711895,0.000093776645,0.00045742778,0.00035209188],"about_ca_topic_score_codex":0.000039494196,"about_ca_topic_score_gemma":0.000018928009,"teacher_disagreement_score":0.4481523,"about_ca_system_score_codex":0.0000926277,"about_ca_system_score_gemma":0.000090321475,"threshold_uncertainty_score":0.6193527},"labels":[],"label_agreement":null},{"id":"W3203918587","doi":"10.1136/bmjopen-2020-046741","title":"Continuation versus discontinuation of aspirin-based antiplatelet therapy for perioperative bleeding and ischaemic events in adults undergoing neurosurgery: protocol for a systematic review and meta-analysis","year":2021,"lang":"en","type":"review","venue":"BMJ Open","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Beijing Municipal Administration of Hospitals; Ministry of Science and Technology of the People's Republic of China","keywords":"Medicine; Meta-analysis; Observational study; Perioperative; Systematic review; Randomized controlled trial; Neurosurgery; MEDLINE; Stroke (engine); Publication bias; Aspirin; Subgroup analysis; Platelet aggregation inhibitor; Intensive care medicine; Internal medicine; Surgery","score_opus":0.22322099748833982,"score_gpt":0.47993818033366425,"score_spread":0.2567171828453244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3203918587","genre_codex":"review","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000029323895,0.58685714,0.00037452337,0.00006374933,0.000010915432,0.41256428,0.00008624041,0.0000059177805,0.000007909978],"genre_scores_gemma":[0.000115384886,0.44321007,0.00020613751,0.00010863351,0.000017463235,0.5558197,0.00042098452,0.000042250726,0.000059396516],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99661213,0.00080839545,0.0014382827,0.0006346133,0.0003036583,0.00020290128],"domain_scores_gemma":[0.9969055,0.0010258869,0.0012122224,0.00047858153,0.00030490413,0.00007290514],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0027763548,0.0004454746,0.0083768,0.000264639,0.00008080735,0.000071501716,0.00015748138,0.0001498228,0.00002621021],"category_scores_gemma":[0.00083364855,0.00029951287,0.002424038,0.0005416452,0.000038556023,0.00019375322,0.00006777869,0.000109865076,2.8952545e-7],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014291202,0.0001404417,0.000027894699,0.90691763,0.08201471,0.000008040429,0.00007822193,0.0000048586776,7.675342e-7,0.000034472516,0.000014172665,0.009329657],"study_design_scores_gemma":[0.013943382,0.0007907029,0.000018215916,0.39141726,0.588168,0.000024738265,0.00013402886,0.00027416582,0.000011765064,0.0000036233848,0.0046974192,0.0005166837],"about_ca_topic_score_codex":0.000013804161,"about_ca_topic_score_gemma":0.00003418391,"teacher_disagreement_score":0.51550037,"about_ca_system_score_codex":0.00004553448,"about_ca_system_score_gemma":0.00050828943,"threshold_uncertainty_score":0.9999457},"labels":[],"label_agreement":null},{"id":"W3205586638","doi":"10.1016/j.cjca.2021.07.041","title":"USE AND OUTCOME OF DUAL ANTIPLATELET THERAPY FOR ACUTE CORONARY SYNDROME IN PATIENTS WITH CHRONIC KIDNEY DISEASE: INSIGHTS FROM THE CANADIAN OBSERVATIONAL ANTIPLATELET STUDY (COAPT), A MULTICENTRE PROSPECTIVE COHORT STUDY","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Toronto Public Health","funders":"","keywords":"Medicine; Internal medicine; Acute coronary syndrome; Kidney disease; Percutaneous coronary intervention; Ticagrelor; Clopidogrel; Cardiology; Conventional PCI; Prasugrel; Prospective cohort study; Aspirin; Myocardial infarction","score_opus":0.023881394012622164,"score_gpt":0.25511176402184693,"score_spread":0.23123037000922478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3205586638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932078,0.0027117631,0.000014894493,0.00030147692,0.00023729024,0.0027364278,0.0007793253,0.000004013413,0.0000069914677],"genre_scores_gemma":[0.99899024,0.00017283819,0.000030412406,0.0003083652,0.0001411802,0.000042301854,0.00026446735,0.000035258472,0.000014935466],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979131,0.000390767,0.0005682176,0.00037013565,0.000368941,0.00038884592],"domain_scores_gemma":[0.9974391,0.00019563803,0.00021584456,0.0003882441,0.00079945824,0.00096174557],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003034709,0.00026746118,0.0011329167,0.00022723395,0.00021757107,0.000047593458,0.00014919505,0.00011080513,0.000021170157],"category_scores_gemma":[0.00023071574,0.00018526068,0.0002593585,0.00026888945,0.00021960858,0.0002110372,0.000017782582,0.00032605734,6.552399e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022058897,0.00013050801,0.97876567,0.000010504962,0.008856469,0.008835472,0.00048283688,0.0001992198,0.000005881335,0.000012811827,0.00011375739,0.0003809679],"study_design_scores_gemma":[0.016652897,0.0019002231,0.97780126,0.00008949,0.0013484077,0.00037306166,0.00047236917,0.000011706324,0.0000048027327,0.000022577713,0.001132463,0.00019071337],"about_ca_topic_score_codex":0.023151722,"about_ca_topic_score_gemma":0.2313819,"teacher_disagreement_score":0.20823018,"about_ca_system_score_codex":0.00041472202,"about_ca_system_score_gemma":0.005222195,"threshold_uncertainty_score":0.9833532},"labels":[],"label_agreement":null},{"id":"W3205738917","doi":"10.1016/j.cjca.2021.07.039","title":"PHARMACODYNAMIC EVALUATION OF THE PLATELET ANTIAGGREGANT EFFECT OF SWALLOWED TICAGRELOR AGAINST CHEWED TICAGRELOR IN PATIENTS WITH ACUTE CORONARY SYNDROME. TICA-MASTICA-SICA TRIAL","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Ticagrelor; Medicine; P2Y12; Acute coronary syndrome; Pharmacodynamics; Internal medicine; Platelet; Platelet aggregation inhibitor; Anesthesia; Platelet aggregation; Cardiology; Pharmacology; Myocardial infarction; Pharmacokinetics","score_opus":0.008041697170076809,"score_gpt":0.23960458965958809,"score_spread":0.23156289248951129,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3205738917","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968157,0.0012118913,0.000068888956,0.00016020302,0.0005914271,0.0007923981,0.0000641805,0.0000028146135,0.00029251492],"genre_scores_gemma":[0.9995603,0.00014620193,0.000027953613,0.00007089512,0.00010615689,0.000008098666,0.000045645298,0.00002454758,0.000010212116],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972419,0.000982272,0.0006212272,0.00020373832,0.0006261434,0.00032472392],"domain_scores_gemma":[0.99807113,0.00019710748,0.00033378022,0.00035785814,0.0007229422,0.00031716918],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011412251,0.0002002584,0.0011929126,0.0002227572,0.00004894312,0.0000060461493,0.00019106666,0.00015266128,0.00006188354],"category_scores_gemma":[0.0005062487,0.00012961474,0.00061680214,0.00035958507,0.0003394651,0.00006210671,0.000020007205,0.00035047485,0.0000023732803],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13158128,0.0003389145,0.6669936,0.0005846636,0.037338328,0.012709568,0.0004965202,0.0119958725,0.0063279634,0.00008929106,0.0008727755,0.13067117],"study_design_scores_gemma":[0.11059981,0.0034569993,0.8748143,0.0005656729,0.0052459044,0.0016537806,0.000052216124,0.00032420104,0.0023952224,0.00002158269,0.0006634292,0.00020691584],"about_ca_topic_score_codex":0.000022597498,"about_ca_topic_score_gemma":0.000049448015,"teacher_disagreement_score":0.20782062,"about_ca_system_score_codex":0.00019486634,"about_ca_system_score_gemma":0.0027889858,"threshold_uncertainty_score":0.52855355},"labels":[],"label_agreement":null},{"id":"W3205940763","doi":"10.1016/j.cjca.2021.07.021","title":"EICOSAPENTAENOIC ACID REDUCES EXPRESSION OF PLATELET ACTIVATION AND AGGREGATION PROTEINS IN PULMONARY AND VASCULAR ENDOTHELIUM DURING INFLAMMATION","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Platelet activation; Endothelial activation; Eicosapentaenoic acid; Platelet; Thrombin; Umbilical vein; Inflammation; Pharmacology; Statin; Internal medicine; Endocrinology; Biochemistry; Chemistry; Polyunsaturated fatty acid; Fatty acid; In vitro","score_opus":0.007856073897485726,"score_gpt":0.2086884896622669,"score_spread":0.2008324157647812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3205940763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99280703,0.006308858,0.00035103792,0.00019342368,0.000057366007,0.00015190404,0.0000037496377,0.0000022140898,0.00012439594],"genre_scores_gemma":[0.9980422,0.0015447749,0.00012611244,0.000014609356,0.0002396974,0.0000041300104,0.000013257938,0.0000088023635,0.0000063838706],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99921465,0.00016240425,0.0002710081,0.000114691386,0.00011113875,0.00012609646],"domain_scores_gemma":[0.9994479,0.000020564072,0.00013584652,0.00009838477,0.00013378078,0.00016351789],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023870895,0.00008095306,0.0003602482,0.00023770441,0.00004095401,0.000009143993,0.00002961589,0.000098827855,0.000009026106],"category_scores_gemma":[0.00011320316,0.00007457648,0.00011526663,0.000102258884,0.00007730879,0.00015951975,0.0000084169915,0.00013914345,2.159595e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021383243,0.0000042874667,0.047156498,0.00014734856,0.00022611248,0.0005566418,0.0003496261,0.00033521125,0.91251636,0.000021364443,0.0000062957683,0.038466416],"study_design_scores_gemma":[0.0014630371,0.00007892301,0.3166065,0.00042870807,0.000069711474,0.0016730165,0.00037923962,0.000009760804,0.6779213,0.00011143402,0.0011895917,0.00006878573],"about_ca_topic_score_codex":0.00004934558,"about_ca_topic_score_gemma":0.000043328342,"teacher_disagreement_score":0.26945,"about_ca_system_score_codex":0.000055425782,"about_ca_system_score_gemma":0.0003649249,"threshold_uncertainty_score":0.30411404},"labels":[],"label_agreement":null},{"id":"W3206842346","doi":"10.1016/j.cjca.2021.07.042","title":"REAL-WORLD EFFICACY AND SAFETY OF DUAL ANTIPLATELET THERAPY WITH TICAGRELOR AS COMPARED TO CLOPIDOGREL","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Research Manitoba","funders":"","keywords":"Ticagrelor; Medicine; Clopidogrel; Mace; Internal medicine; Acute coronary syndrome; Propensity score matching; P2Y12; Conventional PCI; Stroke (engine); Prasugrel; Retrospective cohort study; Aspirin; Cardiology; Myocardial infarction","score_opus":0.016852181296123467,"score_gpt":0.26089944496335377,"score_spread":0.24404726366723029,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3206842346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882388,0.004383198,0.0002979965,0.0012156364,0.00018909486,0.00018584893,0.00002637792,0.0000054831967,0.005457532],"genre_scores_gemma":[0.9961276,0.002373449,0.00035272076,0.0005007219,0.00046458782,0.0000012609544,0.000014789805,0.000021766544,0.00014308332],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987849,0.00018491078,0.000373782,0.0001798753,0.0001837758,0.0002927363],"domain_scores_gemma":[0.9982815,0.000103232065,0.00011552494,0.0002621171,0.00042314496,0.000814521],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029500452,0.000153557,0.0009639447,0.00025466472,0.00007058743,0.000012368198,0.00007733134,0.000084991705,0.000073955096],"category_scores_gemma":[0.00008529113,0.000118419244,0.00026921424,0.00029849476,0.0002340018,0.000039521005,0.000010404087,0.00020883426,0.00000531056],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032939415,0.00011078179,0.6606777,0.0002499338,0.026053917,0.050771955,0.0023862575,0.0053723766,0.012100667,0.003931246,0.020720627,0.18468517],"study_design_scores_gemma":[0.010400139,0.0015125584,0.6441472,0.00028716202,0.00051094097,0.012336608,0.0003826072,0.0000024015294,0.0024500205,0.00006418785,0.32767388,0.0002322702],"about_ca_topic_score_codex":0.000361735,"about_ca_topic_score_gemma":0.0006953221,"teacher_disagreement_score":0.30695325,"about_ca_system_score_codex":0.00005430682,"about_ca_system_score_gemma":0.0017078993,"threshold_uncertainty_score":0.48289967},"labels":[],"label_agreement":null},{"id":"W3207379738","doi":"10.1093/eurheartj/ehab702","title":"Ticagrelor monotherapy in patients at high bleeding risk undergoing percutaneous coronary intervention: TWILIGHT-HBR","year":2021,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":103,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences","funders":"Univerzita Karlova v Praze; AstraZeneca","keywords":"Medicine; Ticagrelor; Percutaneous coronary intervention; Aspirin; Hazard ratio; Internal medicine; Discontinuation; Population; Conventional PCI; Absolute risk reduction; Cardiology; Clopidogrel; Confidence interval; Myocardial infarction","score_opus":0.014671183439153902,"score_gpt":0.25051662701114497,"score_spread":0.23584544357199105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3207379738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99267757,0.0048461445,0.00016042558,0.0003365091,0.000458342,0.00012289832,0.000005537582,0.000039883576,0.0013527151],"genre_scores_gemma":[0.994314,0.002970646,0.0005351454,0.0005881371,0.00047885763,6.743981e-7,0.000022337412,0.000060985338,0.0010292095],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979553,0.00066317286,0.00039991134,0.00027396172,0.00040285024,0.00030476856],"domain_scores_gemma":[0.9992182,0.00007288807,0.000107154665,0.00024357479,0.00012245587,0.00023567281],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00053707993,0.00017890078,0.00033918978,0.00010691951,0.0002577007,0.000067712266,0.00008304779,0.000042326683,0.0014147237],"category_scores_gemma":[0.00009624918,0.00015983658,0.0005263731,0.00015774854,0.00004316359,0.00012432584,0.000071498696,0.0004603887,0.00024084156],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015475001,0.000609057,0.94365567,0.00005780808,0.0007797982,0.0130796945,0.00045368235,0.00013673017,0.0010869954,0.000017007405,0.0023496435,0.036226414],"study_design_scores_gemma":[0.0072045997,0.00065490475,0.95717615,0.000651809,0.00018373804,0.014539302,0.0002657006,0.000034799436,0.00050722726,0.000047270707,0.01850689,0.00022759553],"about_ca_topic_score_codex":0.000003232892,"about_ca_topic_score_gemma":0.0000050254193,"teacher_disagreement_score":0.03599882,"about_ca_system_score_codex":0.00018856811,"about_ca_system_score_gemma":0.00007196042,"threshold_uncertainty_score":0.9994981},"labels":[],"label_agreement":null},{"id":"W3208902254","doi":"10.1093/eurheartj/ehab724.2117","title":"Ticagrelor monotherapy after percutaneous coronary intervention in patients with concomitant diabetes mellitus and chronic kidney disease: a TWILIGHT substudy","year":2021,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Ticagrelor; Percutaneous coronary intervention; Internal medicine; Aspirin; Kidney disease; Conventional PCI; Myocardial infarction; Stroke (engine); Clinical endpoint; Cardiology; Diabetes mellitus; Randomized controlled trial; Endocrinology","score_opus":0.007540336718370686,"score_gpt":0.22694499401091453,"score_spread":0.21940465729254385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3208902254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95828444,0.040876813,0.000026752223,0.00034510047,0.00010278204,0.00024197568,0.000015170914,0.000020854517,0.000086086744],"genre_scores_gemma":[0.9968079,0.0018479273,0.000087451524,0.0008803213,0.0001693752,0.0000038766,0.000030647316,0.00004942942,0.00012311304],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99838924,0.00048275507,0.00026965758,0.00026691216,0.00031687596,0.0002745639],"domain_scores_gemma":[0.99911296,0.000027031567,0.00005332175,0.00022543869,0.00010359643,0.00047767643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027013375,0.00018182024,0.0003217956,0.000074262076,0.00008748491,0.00007011285,0.00004842412,0.000023351013,0.0006301749],"category_scores_gemma":[0.00003722434,0.00013702888,0.00023211808,0.00010603311,0.000084941654,0.000116534175,0.000031495398,0.00027742053,0.000027592807],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024819945,0.0005692103,0.97062695,0.00008177735,0.00047458473,0.00776758,0.00022801914,0.0000047747003,0.00016867471,0.0000017386272,0.00022844477,0.017366255],"study_design_scores_gemma":[0.0070033,0.00086945953,0.98193836,0.00065961655,0.00021103413,0.0010352737,0.00007287662,0.000026076268,0.000080306025,0.000007314488,0.007924218,0.00017216583],"about_ca_topic_score_codex":4.924367e-7,"about_ca_topic_score_gemma":0.0000014102296,"teacher_disagreement_score":0.039028887,"about_ca_system_score_codex":0.00009286658,"about_ca_system_score_gemma":0.00013773497,"threshold_uncertainty_score":0.6899973},"labels":[],"label_agreement":null},{"id":"W3209545679","doi":"10.1161/strokeaha.121.034622","title":"Antithrombotic Therapy for Stroke Prevention in Patients With Ischemic Stroke With Aspirin Treatment Failure","year":2021,"lang":"en","type":"article","venue":"Stroke","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotchkiss Brain Institute; University of Calgary","funders":"National Institute of Neurological Disorders and Stroke; National Institute on Aging","keywords":"Aspirin; Antithrombotic; Clopidogrel; Ischemic stroke; Stroke (engine); Fibrinolytic agent; Platelet aggregation inhibitor; Vascular disease","score_opus":0.010580377639376531,"score_gpt":0.24456989540075508,"score_spread":0.23398951776137855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3209545679","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955258,0.0012345503,0.0010096835,0.00012960822,0.000046253666,0.0012511635,0.00018214856,0.000048766884,0.0005720335],"genre_scores_gemma":[0.9930121,0.00030077755,0.002063218,0.00009104355,0.000091826965,0.00014677725,0.0004729039,0.000050269675,0.0037710965],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99858415,0.000052615505,0.00020688669,0.000439149,0.00037330211,0.00034389898],"domain_scores_gemma":[0.999196,0.000024714638,0.00007808744,0.00042079276,0.00016514717,0.00011525932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000069371905,0.00026889224,0.0005081269,0.00008813716,0.00006831631,0.000029849685,0.000060047263,0.00009296246,0.00011149544],"category_scores_gemma":[0.000007538194,0.00018519134,0.00031159216,0.00014275243,0.000060110095,0.00012242034,0.000010955718,0.0001116779,0.0000067893848],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005251021,0.0023346965,0.93326384,0.0001106082,0.003314257,0.00012150017,0.00017726762,0.00009256845,0.0057893475,0.000037690446,0.00019238728,0.04931483],"study_design_scores_gemma":[0.07769565,0.012336974,0.81043386,0.0005857437,0.0012273748,0.000051150222,0.0008816716,0.00003461609,0.067337126,0.000011917414,0.028782671,0.0006212482],"about_ca_topic_score_codex":0.000012129685,"about_ca_topic_score_gemma":0.00013126666,"teacher_disagreement_score":0.122829966,"about_ca_system_score_codex":0.00010864466,"about_ca_system_score_gemma":0.00028503512,"threshold_uncertainty_score":0.75518835},"labels":[],"label_agreement":null},{"id":"W3209601391","doi":"10.1016/j.jacc.2021.09.1070","title":"TCT-217 Predictors of Dyspnea in Patients Receiving Ticagrelor After PCI: Insights From the Twilight Trial","year":2021,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences","funders":"","keywords":"Medicine; Ticagrelor; Conventional PCI; Twilight; Internal medicine; Cardiology; Percutaneous coronary intervention; Myocardial infarction","score_opus":0.006583065872207186,"score_gpt":0.22315837554503073,"score_spread":0.21657530967282354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3209601391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946124,0.0031306068,0.000035264293,0.00059852964,0.0008923413,0.0002764695,0.000073716044,0.000002802183,0.000377885],"genre_scores_gemma":[0.9982246,0.0006374397,0.00008085342,0.0003124583,0.0006787282,0.000005142814,0.0000034046798,0.00001592735,0.000041452764],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974869,0.00095171214,0.00073598174,0.0001575721,0.0004988855,0.00016897701],"domain_scores_gemma":[0.9979248,0.00045629602,0.00066710875,0.0005049631,0.00036881753,0.00007798557],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033438765,0.00014640596,0.0012728133,0.0000871526,0.00003656143,0.0000031844966,0.00027363584,0.000073037074,0.00002031098],"category_scores_gemma":[0.00059240154,0.00007864269,0.0010689701,0.00045329082,0.00048328005,0.00005146682,0.000098847435,0.00030795226,9.961667e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07224099,0.00035465026,0.91149074,0.00003355777,0.00578054,0.0009649023,0.00039706661,0.00020638487,0.0015233158,0.000031075433,0.0031925866,0.0037842127],"study_design_scores_gemma":[0.023586487,0.0014668138,0.95901287,0.00025260044,0.0010674703,0.00029358358,0.0007385529,0.0000047873214,0.001886403,0.00013673553,0.011445355,0.00010834692],"about_ca_topic_score_codex":0.000007465348,"about_ca_topic_score_gemma":0.000008077297,"teacher_disagreement_score":0.04865451,"about_ca_system_score_codex":0.00006207348,"about_ca_system_score_gemma":0.0003714912,"threshold_uncertainty_score":0.32069558},"labels":[],"label_agreement":null},{"id":"W3210709233","doi":"10.1016/j.jacc.2021.09.1092","title":"TCT-239 Efficacy and Safety of Short-Infusion Tirofiban in Patients Undergoing Percutaneous Coronary Intervention: The SAVI-PCI Trial","year":2021,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Medicure (Canada)","funders":"","keywords":"Medicine; Tirofiban; Conventional PCI; Percutaneous coronary intervention; Cardiology; Internal medicine; Myocardial infarction","score_opus":0.010450205306632852,"score_gpt":0.25840854896890286,"score_spread":0.24795834366227001,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3210709233","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99557066,0.0029262307,0.000072437564,0.0005036004,0.00034218427,0.0003076642,0.000026080548,0.0000023949692,0.00024874738],"genre_scores_gemma":[0.9972153,0.002352687,0.00007218697,0.00011457221,0.00018484051,0.00000113158,0.0000033251442,0.000011769789,0.000044237415],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99796116,0.0007734804,0.0006597938,0.000128535,0.00033735717,0.00013968037],"domain_scores_gemma":[0.9985867,0.00038644206,0.00043263682,0.00030863716,0.0002270824,0.00005847474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053331704,0.00011904508,0.00096848013,0.000077664634,0.00006125306,0.0000027318868,0.00016222459,0.000052924403,0.000015860176],"category_scores_gemma":[0.00027945393,0.00007057826,0.0008247394,0.00026979388,0.00044771575,0.00003281376,0.000118356875,0.0002437469,2.3628972e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.28778565,0.001041186,0.5491182,0.00024458772,0.007060414,0.004371138,0.00040072948,0.0015703758,0.0052113384,0.00017611278,0.001496554,0.14152373],"study_design_scores_gemma":[0.050128493,0.0075146854,0.91462636,0.00066905265,0.0013385158,0.0186959,0.0028039839,0.00002033511,0.0004635456,0.0001050193,0.0034666536,0.00016745648],"about_ca_topic_score_codex":0.0000033206143,"about_ca_topic_score_gemma":0.0000058474848,"teacher_disagreement_score":0.36550817,"about_ca_system_score_codex":0.00006890247,"about_ca_system_score_gemma":0.000246955,"threshold_uncertainty_score":0.2878098},"labels":[],"label_agreement":null},{"id":"W3210931544","doi":"10.1016/j.jacc.2021.09.888","title":"TCT-38 Ticagrelor With and Without Aspirin in Patients With Previous Coronary Artery Bypass Graft Undergoing Percutaneous Coronary Intervention: The TWILIGHT-CABG Subanalysis","year":2021,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences","funders":"","keywords":"Medicine; Ticagrelor; Percutaneous coronary intervention; Cardiology; Internal medicine; Aspirin; Conventional PCI; Artery; Myocardial infarction","score_opus":0.0058192698029149,"score_gpt":0.22295507579074786,"score_spread":0.21713580598783297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3210931544","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949079,0.0033095167,0.0002681682,0.0009951586,0.00007758121,0.00027666424,0.000020567879,0.0000053085078,0.00013911999],"genre_scores_gemma":[0.9985513,0.0006578941,0.00023616145,0.00030589974,0.00008792623,0.000004354363,0.000004670084,0.000024077966,0.00012771919],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979277,0.00068709505,0.00049650454,0.00021919502,0.00045299676,0.00021650219],"domain_scores_gemma":[0.9983917,0.00019293866,0.0005229739,0.00044340407,0.00035252396,0.00009647142],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034329898,0.00019937778,0.0011669826,0.00010953204,0.00008634305,0.000008802403,0.00019269284,0.000046743193,0.000015166286],"category_scores_gemma":[0.000067366105,0.00010071936,0.0005790732,0.0004414241,0.00070326263,0.00006860284,0.00008151545,0.00031804794,5.9773845e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006902443,0.00016110922,0.9772925,0.000061403305,0.006871427,0.0042276205,0.00007329439,0.00063289184,0.00010249435,0.00001290601,0.0001356026,0.003526351],"study_design_scores_gemma":[0.005060546,0.0033920135,0.9244561,0.00044204938,0.0027051668,0.061135676,0.0018480017,0.000027713171,0.00007111177,0.000041678446,0.0006629356,0.00015701435],"about_ca_topic_score_codex":0.0000034727605,"about_ca_topic_score_gemma":0.000037142247,"teacher_disagreement_score":0.056908056,"about_ca_system_score_codex":0.000085000436,"about_ca_system_score_gemma":0.00030988423,"threshold_uncertainty_score":0.41072163},"labels":[],"label_agreement":null},{"id":"W3211970263","doi":"10.1016/j.amjcard.2021.08.055","title":"Outcomes in Patients Stratified by PRECISE-DAPT Versus DAPT Scores After Percutaneous Coronary Interventions","year":2021,"lang":"en","type":"article","venue":"The American Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Conventional PCI; Percutaneous coronary intervention; Internal medicine; Cardiology; Confidence interval; Stent; Myocardial infarction","score_opus":0.01601240379480116,"score_gpt":0.28299641338303183,"score_spread":0.26698400958823065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211970263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940346,0.0045048795,0.00027458434,0.0004400721,0.00035371908,0.0001221766,0.000030272844,0.000007756836,0.00023197755],"genre_scores_gemma":[0.99851406,0.00086312176,0.000094077186,0.0002787419,0.000121959034,0.000005696834,0.000016880262,0.000017139595,0.000088352375],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983635,0.0005579908,0.00044956416,0.00014982825,0.00026793132,0.0002111795],"domain_scores_gemma":[0.99895173,0.00021250914,0.00022999622,0.0003121816,0.00019100866,0.00010257958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000260928,0.0001437471,0.0008830234,0.000074902455,0.0000385189,0.000011321464,0.00014813883,0.000039078473,0.00007465917],"category_scores_gemma":[0.00014213372,0.00009448037,0.0010047881,0.00014964135,0.00035199293,0.00005369853,0.000044052205,0.00029363966,0.0000075958906],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021673646,0.00038006296,0.8742846,0.0000348826,0.00632456,0.005005443,0.00034029316,0.00037360858,0.00068523077,0.000018628021,0.0015653961,0.08931363],"study_design_scores_gemma":[0.004095057,0.0029533748,0.9859229,0.00011402735,0.00082145736,0.0032238273,0.0012139789,0.0000030807641,0.000084362364,0.00005740623,0.0013714725,0.00013909381],"about_ca_topic_score_codex":0.00000687279,"about_ca_topic_score_gemma":0.000004303628,"teacher_disagreement_score":0.11163823,"about_ca_system_score_codex":0.000059035385,"about_ca_system_score_gemma":0.00012227814,"threshold_uncertainty_score":0.38527974},"labels":[],"label_agreement":null},{"id":"W3212545163","doi":"10.1055/s-0041-1736638","title":"Infections Deaths in the PLATO Trial","year":2021,"lang":"en","type":"article","venue":"TH Open","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Clopidogrel; Ticagrelor; Medicine; Pneumonia; Prasugrel; Internal medicine; Intensive care medicine; Emergency medicine; Myocardial infarction","score_opus":0.04464117320512804,"score_gpt":0.3488450723093924,"score_spread":0.3042038991042643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212545163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9380859,0.0010388073,0.000060064707,0.0009775511,0.00011385684,0.00066609884,0.0000033478902,0.000013764677,0.059040595],"genre_scores_gemma":[0.9971126,0.00020842944,0.00003530831,0.001402857,0.00016750795,0.00006242084,0.000023606808,0.0000062819563,0.000981029],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994882,0.000113112575,0.0000868842,0.00010461176,0.00011819449,0.00008904272],"domain_scores_gemma":[0.9996118,0.00004514876,0.000011593972,0.00027987652,0.000020949958,0.000030626434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028254936,0.00004804561,0.00015068264,0.00001717101,0.000060072245,0.000046622794,0.000109335226,0.000029662186,0.00048203446],"category_scores_gemma":[0.00005883865,0.000031224772,0.00012347296,0.00017742699,0.000016818882,0.00005904539,0.000049246606,0.00009325339,0.00006848684],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13634111,0.016608192,0.18549536,0.00034488007,0.0072865533,0.016453663,0.014436984,0.00030273586,0.0028004022,0.08069733,0.104000986,0.4352318],"study_design_scores_gemma":[0.1569032,0.0008051607,0.12982297,0.00016841198,0.0005955795,0.0010243716,0.0027286923,0.000030874995,0.0018455979,0.0024361971,0.70333344,0.00030551516],"about_ca_topic_score_codex":0.00007776265,"about_ca_topic_score_gemma":0.00005834712,"teacher_disagreement_score":0.59933245,"about_ca_system_score_codex":0.000011347261,"about_ca_system_score_gemma":0.00014145255,"threshold_uncertainty_score":0.52779394},"labels":[],"label_agreement":null},{"id":"W3212767676","doi":"10.1159/000520673","title":"Comparison of Prasugrel and Ticagrelor for Patients with Acute Coronary Syndrome: A Systematic Review and Meta-Analysis","year":2021,"lang":"en","type":"review","venue":"Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Prasugrel; Ticagrelor; Medicine; Acute coronary syndrome; Internal medicine; Myocardial infarction; Stroke (engine); Clinical endpoint; Cardiology; Randomized controlled trial","score_opus":0.0641854856607135,"score_gpt":0.36431213650934013,"score_spread":0.30012665084862666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212767676","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000119041615,0.99445415,0.00036658518,0.000016066137,0.000018829975,0.004583799,0.0004185986,0.000012381217,0.0000105645595],"genre_scores_gemma":[0.0012625251,0.9965054,0.00019516393,0.00009838332,0.000008455476,0.0008021216,0.0010057435,0.000037294627,0.000084949825],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9976197,0.000624137,0.00084637786,0.0005155675,0.00020244614,0.00019177528],"domain_scores_gemma":[0.99805063,0.0003672783,0.0005209626,0.0006762266,0.00026079014,0.00012409147],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.00037969745,0.00040957626,0.02181474,0.00014391508,0.00004043079,0.0000067708775,0.0000877547,0.00024215505,0.000023274726],"category_scores_gemma":[0.00012267353,0.00023063023,0.0043869694,0.00032302228,0.00017829511,0.000022556093,0.000058937574,0.00015685408,0.0000014533226],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011427213,0.000027860911,0.00024734918,0.4769984,0.52130055,0.00009976996,0.000004461232,1.449547e-7,2.8944291e-9,0.000010571557,0.00005745424,0.0012419776],"study_design_scores_gemma":[0.00046041212,0.00045934896,0.00017446232,0.02088985,0.96426815,0.0017774065,0.000014413201,6.243398e-7,2.0937449e-8,9.848505e-7,0.011752427,0.00020187226],"about_ca_topic_score_codex":6.2570837e-7,"about_ca_topic_score_gemma":1.8188948e-7,"teacher_disagreement_score":0.45610854,"about_ca_system_score_codex":0.000020771477,"about_ca_system_score_gemma":0.00011784221,"threshold_uncertainty_score":0.99270743},"labels":[],"label_agreement":null},{"id":"W3214144683","doi":"10.5772/intechopen.96328","title":"Dual Antiplatelet Therapy after PCI: When Could We Go Shorter?","year":2021,"lang":"en","type":"book-chapter","venue":"IntechOpen eBooks","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Conventional PCI; Medicine; Percutaneous coronary intervention; Duration (music); Internal medicine; Cardiology; Stent; Intensive care medicine; Expert opinion; Myocardial infarction","score_opus":0.029094248603402227,"score_gpt":0.2560403919421354,"score_spread":0.22694614333873317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214144683","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0066689397,0.045184515,0.00026551884,0.00057928206,0.00079231674,0.0019152426,0.000245822,0.0003664762,0.9439819],"genre_scores_gemma":[0.0649808,0.010961645,0.00026518558,0.0039990805,0.001338395,0.00016229923,0.0003625582,0.0004010287,0.917529],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99660754,0.00006565153,0.00073211535,0.001073586,0.0009560888,0.00056503346],"domain_scores_gemma":[0.9973673,0.00006358282,0.00020738345,0.0015769304,0.00041556708,0.00036920325],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0002914605,0.00094587693,0.0016637507,0.00026010018,0.00011401744,0.00016175209,0.0003393843,0.0010505994,0.009299138],"category_scores_gemma":[0.000017528297,0.0008161485,0.001654964,0.000030641673,0.0003641453,0.000086336135,0.00023457366,0.0013009526,0.0007992308],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005729025,0.00019394053,0.00014651651,0.00037410072,0.0121527705,0.025700195,0.0008379839,5.056366e-7,0.0021217593,0.006121591,0.034428682,0.91219294],"study_design_scores_gemma":[0.0030630564,0.00038103544,0.000043567205,0.0020672362,0.0007502014,0.0018511015,0.00006799431,0.0000021786811,0.0039364994,0.0025770587,0.9843514,0.000908659],"about_ca_topic_score_codex":0.000015150951,"about_ca_topic_score_gemma":0.00001795649,"teacher_disagreement_score":0.94992274,"about_ca_system_score_codex":0.00012606556,"about_ca_system_score_gemma":0.00048103154,"threshold_uncertainty_score":0.9999788},"labels":[],"label_agreement":null},{"id":"W3215579504","doi":"10.1161/circ.144.suppl_1.13669","title":"Abstract 13669: Secondary Prevention Aspirin Trends in the Upper Midwest, 2015-2019","year":2021,"lang":"en","type":"article","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Milton District Hospital","funders":"","keywords":"Medicine; Aspirin; Secondary prevention; Gerontology; Intensive care medicine; Internal medicine","score_opus":0.020156826344883055,"score_gpt":0.29282778061678194,"score_spread":0.2726709542718989,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215579504","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863402,0.0049805692,0.00024195941,0.00074730127,0.000114531045,0.00014027621,0.0000066178386,0.000028755894,0.0073997932],"genre_scores_gemma":[0.9980554,0.00010271216,0.00003588832,0.00039097448,0.00018834876,0.000012375064,0.00075585436,0.00001230818,0.0004461129],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9991318,0.00009770964,0.00018803272,0.00020059662,0.00025076992,0.00013109433],"domain_scores_gemma":[0.9995264,0.000023577664,0.000044730652,0.0003176658,0.000049899678,0.00003774261],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00030307737,0.000091800386,0.00015806152,0.000089753084,0.000052649808,0.000025910093,0.00004581713,0.00008529825,0.0010339108],"category_scores_gemma":[0.00001699733,0.00007415356,0.00028906748,0.00028164656,0.000022305749,0.00014100314,0.000008109068,0.00015576935,0.00006647866],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017437132,0.00068038376,0.22249588,0.00016865318,0.0004141676,0.00044146442,0.00079226424,0.0005967114,0.011421972,0.0006919716,0.0046470324,0.75747514],"study_design_scores_gemma":[0.0012211083,0.000017381097,0.98701847,0.00007358753,0.000098082564,0.00013107732,0.00016287633,0.00008276377,0.00058777106,0.00035700272,0.010164607,0.00008529159],"about_ca_topic_score_codex":0.000010048226,"about_ca_topic_score_gemma":0.000012547855,"teacher_disagreement_score":0.76452255,"about_ca_system_score_codex":0.000037077396,"about_ca_system_score_gemma":0.00008850708,"threshold_uncertainty_score":0.9998793},"labels":[],"label_agreement":null},{"id":"W3215734459","doi":"10.1002/rth2.12618","title":"Aspirin nonsensitivity in patients with vascular disease: Assessment by light transmission aggregometry (aspirin nonsensitivity in vascular patients)","year":2021,"lang":"en","type":"article","venue":"Research and Practice in Thrombosis and Haemostasis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto General Hospital; St. Michael's Hospital","funders":"","keywords":"Aspirin; Medicine; Internal medicine; Antithrombotic; Adverse effect; Cardiology; Population; Clopidogrel","score_opus":0.036793027688553075,"score_gpt":0.36001701496588034,"score_spread":0.32322398727732726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215734459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98501694,0.010362805,0.00011719015,0.0029434997,0.000023539757,0.0010369394,0.00008417977,0.00001667393,0.0003982379],"genre_scores_gemma":[0.9711654,0.027559651,0.0005171319,0.00031466462,0.000022629478,0.000047989317,0.00031283795,0.000041823114,0.00001782697],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9940334,0.0023753308,0.00042252944,0.0009216731,0.0015361017,0.0007109797],"domain_scores_gemma":[0.9970771,0.0012104155,0.00008855029,0.0005588006,0.00050976005,0.0005553632],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0031681883,0.00032723538,0.0008023349,0.0004603985,0.00021470344,0.00013882254,0.00007593874,0.00018762585,0.00006648011],"category_scores_gemma":[0.0007655205,0.00028047786,0.00017323963,0.0013597194,0.000246873,0.00058778195,0.00013343358,0.0009173689,0.0000040758905],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029783002,0.0066907685,0.8409873,0.00054171676,0.0005935407,0.000852548,0.00039993812,0.000009806382,0.00035844077,0.000023139371,0.00024064098,0.14632386],"study_design_scores_gemma":[0.010517443,0.0006702392,0.9742378,0.0011952446,0.00022261233,0.000009338323,0.0006399459,0.00007584355,0.00056280947,0.000047734127,0.011477884,0.0003431321],"about_ca_topic_score_codex":0.00054047856,"about_ca_topic_score_gemma":0.00018480244,"teacher_disagreement_score":0.14598073,"about_ca_system_score_codex":0.00020044313,"about_ca_system_score_gemma":0.0004163542,"threshold_uncertainty_score":0.9999647},"labels":[],"label_agreement":null},{"id":"W3215982691","doi":"10.1016/j.jjcc.2021.10.024","title":"Determinants of long-term dual antiplatelet therapy use in post myocardial infarction patients: Insights from the TIGRIS registry","year":2021,"lang":"en","type":"article","venue":"Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital; University of Ottawa","funders":"European Society of Cardiology; National Institute for Health and Care Research; London School of Hygiene and Tropical Medicine; AstraZeneca","keywords":"Medicine; Internal medicine; Myocardial infarction; Cardiology; Percutaneous coronary intervention; Coronary artery disease; Discontinuation; Unstable angina; Diabetes mellitus","score_opus":0.017012793399564848,"score_gpt":0.257761246966729,"score_spread":0.24074845356716412,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215982691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99201,0.006868311,0.000054579945,0.00010988644,0.000695966,0.0001452757,0.000035374167,0.00000509425,0.000075525626],"genre_scores_gemma":[0.99028444,0.008304165,0.000030078581,0.00044980046,0.00084315613,0.0000020565742,0.000054889955,0.000017644472,0.000013738362],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99805653,0.0005751993,0.00063943,0.00018222877,0.00036518555,0.00018141566],"domain_scores_gemma":[0.9982748,0.0002592004,0.0003758943,0.0003916743,0.00061363756,0.00008477109],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002537347,0.00016303526,0.00091973465,0.00010382975,0.00004623943,0.000017846554,0.00011596202,0.00020848293,0.000023724591],"category_scores_gemma":[0.000299291,0.000105766296,0.0008069392,0.00017956026,0.00015974144,0.00018931556,0.00004004647,0.00036811456,0.0000029208138],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024574935,0.00010455748,0.971658,0.000011389573,0.0015696911,0.0027364586,0.00017840393,0.000048076265,0.00381832,0.000002478484,0.00037624265,0.017038906],"study_design_scores_gemma":[0.005609473,0.0004941231,0.9856373,0.00014875513,0.00027678083,0.0017118136,0.00013753018,0.0000017331339,0.003205926,0.000027404643,0.0026483622,0.00010079612],"about_ca_topic_score_codex":0.00003316657,"about_ca_topic_score_gemma":0.000017775264,"teacher_disagreement_score":0.016938109,"about_ca_system_score_codex":0.00004294934,"about_ca_system_score_gemma":0.000309175,"threshold_uncertainty_score":0.43130246},"labels":[],"label_agreement":null},{"id":"W3216253384","doi":"10.1093/eurheartj/ehab724.1238","title":"Mortality after bleeding versus myocardial infarction in coronary artery disease: a systematic review and meta-analysis","year":2021,"lang":"en","type":"review","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Myocardial infarction; Internal medicine; Hazard ratio; Percutaneous coronary intervention; Coronary artery disease; Cardiology; Revascularization; Meta-analysis; Acute coronary syndrome; Population; Antithrombotic; Confidence interval","score_opus":0.13284409874658343,"score_gpt":0.3695275483725144,"score_spread":0.23668344962593096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216253384","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000054327833,0.9981204,0.000014285025,0.00008008761,0.00015616528,0.001361281,0.000051800875,0.000021591184,0.00014001165],"genre_scores_gemma":[0.0005888763,0.9981051,0.000022961534,0.00053654675,0.00031198253,0.0001235901,0.000101930644,0.00006722451,0.00014178448],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9937332,0.0036675977,0.0011995723,0.00047573948,0.00063444924,0.00028942688],"domain_scores_gemma":[0.99826396,0.00013034591,0.00037181095,0.0006566093,0.000107644875,0.00046960943],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0026475415,0.00048113888,0.007590912,0.00036624196,0.00009658516,0.0001270992,0.000107078195,0.00007292659,0.00066014205],"category_scores_gemma":[0.00020750257,0.00033075176,0.011110275,0.0006696183,0.000057545865,0.00014730933,0.00008536857,0.0007600244,0.00005622814],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059288457,0.00006733804,0.00023739434,0.46499664,0.5246371,0.007753041,0.000015095521,0.0000014355679,1.5675203e-8,0.0000013100085,0.00028400842,0.0019473599],"study_design_scores_gemma":[0.0003818629,0.00003944962,0.002766657,0.0654419,0.8478498,0.0032422577,0.000013430185,6.549911e-7,2.6376683e-9,3.3597374e-7,0.0800151,0.0002485842],"about_ca_topic_score_codex":6.745028e-7,"about_ca_topic_score_gemma":7.6933014e-7,"teacher_disagreement_score":0.39955473,"about_ca_system_score_codex":0.0001060722,"about_ca_system_score_gemma":0.0002122059,"threshold_uncertainty_score":0.99991447},"labels":[],"label_agreement":null},{"id":"W3216403068","doi":"10.1161/circ.144.suppl_1.10602","title":"Abstract 10602: Baseline Clinical and Genetic Data Based Machine Learning Predictions of 1-Year Ischemic Outcomes Following Percutaneous Coronary Intervention","year":2021,"lang":"en","type":"article","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; St. Michael's Hospital","funders":"","keywords":"Medicine; Percutaneous coronary intervention; Library science; Gerontology; Internal medicine; Myocardial infarction","score_opus":0.038148640041241404,"score_gpt":0.3186206170530827,"score_spread":0.2804719770118413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216403068","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98113096,0.0042721443,0.014033568,0.000106323125,0.00013156713,0.00015423512,0.000044850494,0.000050685456,0.00007566882],"genre_scores_gemma":[0.9966618,0.0002451673,0.0012018733,0.00005922343,0.00006573602,0.0000022430524,0.0017160266,0.000019158251,0.000028773311],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988303,0.00013544445,0.00040611107,0.00030562872,0.00022719425,0.000095283096],"domain_scores_gemma":[0.9992049,0.00013396027,0.00009255527,0.00041432455,0.00007716491,0.000077127275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039445734,0.0001001977,0.0002961822,0.000048943417,0.00006849201,0.00001208382,0.000052803935,0.00008939321,0.00021033971],"category_scores_gemma":[0.0004350136,0.000099015,0.00033460627,0.00009151564,0.0000479559,0.00009600989,0.000043953118,0.00017020754,0.0000049344967],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008402364,0.00018383861,0.96547693,0.00012178453,0.0004675604,0.00025152872,0.000015786647,0.0010982038,0.0050097336,0.0000019951426,0.000023297725,0.027265314],"study_design_scores_gemma":[0.0018917382,0.000039980867,0.9447431,0.00016441794,0.0006648277,0.00023967231,0.00007975614,0.05158583,0.000120829434,0.000007836883,0.00037864884,0.0000833534],"about_ca_topic_score_codex":0.00001474149,"about_ca_topic_score_gemma":0.000004922597,"teacher_disagreement_score":0.050487626,"about_ca_system_score_codex":0.000014503612,"about_ca_system_score_gemma":0.000073411,"threshold_uncertainty_score":0.40377146},"labels":[],"label_agreement":null},{"id":"W3217126963","doi":"10.1161/circinterventions.120.011035","title":"Incidence of Myocardial Infarction Types in Patients Treated With Ticagrelor in the THEMIS Trial","year":2021,"lang":"en","type":"article","venue":"Circulation Cardiovascular Interventions","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Population Health Research Institute","funders":"AstraZeneca","keywords":"Ticagrelor; Myocardial infarction; Incidence (geometry); Clinical trial; Coronary heart disease; Coronary angiography","score_opus":0.02200236046223168,"score_gpt":0.2665579496614944,"score_spread":0.2445555891992627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217126963","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940964,0.0031056926,0.0011341043,0.000059817332,0.00008415236,0.00080724637,0.000009309757,0.000018420207,0.0006848438],"genre_scores_gemma":[0.9994077,0.0001366614,0.000044826036,0.000041896576,0.000072301955,0.00008827068,0.00017504634,0.000015302317,0.00001796018],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981079,0.0004407523,0.00043791797,0.00027316023,0.0005888601,0.00015137755],"domain_scores_gemma":[0.9989693,0.000051713567,0.00007975997,0.0005790167,0.0002820053,0.000038204813],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065155287,0.00013118013,0.00047356833,0.00017028338,0.00004694728,0.000020309717,0.00008230224,0.00008985551,0.00006722561],"category_scores_gemma":[0.00019225734,0.00009880721,0.0017504621,0.0007811042,0.00007350364,0.0001224367,0.000020242087,0.0001641599,0.0000072192292],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005878518,0.0018475846,0.9529368,0.00032402662,0.0060480554,0.0001788821,0.0005641119,0.0066336677,0.00011389969,0.00030779126,0.000040385374,0.025126273],"study_design_scores_gemma":[0.029081838,0.00020607043,0.96797913,0.0004413138,0.0010986852,0.000057223133,0.00022525252,0.00008109911,0.00018398614,0.00005162465,0.00047668355,0.00011710137],"about_ca_topic_score_codex":0.00006995169,"about_ca_topic_score_gemma":0.000030411644,"teacher_disagreement_score":0.02500917,"about_ca_system_score_codex":0.00007979705,"about_ca_system_score_gemma":0.00009427369,"threshold_uncertainty_score":0.40292412},"labels":[],"label_agreement":null},{"id":"W3217625748","doi":"10.1093/ehjcvp/pvab080","title":"The association of PRECISE-DAPT score with ischaemic outcomes in patients taking dual antiplatelet therapy following percutaneous coronary intervention: a meta-analysis","year":2021,"lang":"en","type":"review","venue":"European Heart Journal - Cardiovascular Pharmacotherapy","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Percutaneous coronary intervention; Internal medicine; Odds ratio; Conventional PCI; Confidence interval; Myocardial infarction; Cardiology; Stent; Stroke (engine)","score_opus":0.09026410061716333,"score_gpt":0.3530020672107679,"score_spread":0.26273796659360454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217625748","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.028642805,0.9687953,0.00014435689,0.000046364352,0.00045721402,0.0016970242,0.000062223975,0.000051597643,0.00010311105],"genre_scores_gemma":[0.02589466,0.97265625,0.0001333669,0.00017072381,0.00034714612,0.000046190093,0.00014741135,0.00028341217,0.00032082593],"study_design_codex":"meta_analysis","study_design_gemma":"not_applicable","domain_scores_codex":[0.98611504,0.007585416,0.0020873807,0.00086952787,0.002609224,0.00073342817],"domain_scores_gemma":[0.9959269,0.00050076714,0.0015100823,0.001246303,0.00053130975,0.0002846371],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0067245294,0.0010296823,0.008798189,0.00069234037,0.00043598385,0.0002605279,0.0004879668,0.00022540189,0.00030279733],"category_scores_gemma":[0.00012154739,0.0006067278,0.048664603,0.00150622,0.000098454475,0.0002571416,0.00009210708,0.0015763859,0.000017645163],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034542455,0.00039936256,0.008120564,0.00041486602,0.6671853,0.003878451,0.00013019305,0.00021982993,0.0000035713058,5.514774e-7,0.000109023924,0.3191929],"study_design_scores_gemma":[0.0067078453,0.00044007343,0.003925194,0.0017889525,0.3871422,0.003874856,0.00006343608,0.0000038943176,0.00001197645,8.565265e-7,0.5953927,0.00064797176],"about_ca_topic_score_codex":0.000014166264,"about_ca_topic_score_gemma":0.0000030527765,"teacher_disagreement_score":0.5952837,"about_ca_system_score_codex":0.0003872287,"about_ca_system_score_gemma":0.00032108117,"threshold_uncertainty_score":0.99963844},"labels":[],"label_agreement":null},{"id":"W39804353","doi":"10.1055/s-0037-1613403","title":"Platelet P-selectin expression: requirement for protein kinase C, but not protein tyrosine kinase or phosphoinositide 3-kinase","year":2003,"lang":"en","type":"article","venue":"Thrombosis and Haemostasis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"","keywords":"Rottlerin; Protein kinase C; P-selectin; Thrombin; Platelet activation; Platelet; Tyrosine kinase; Protein kinase A; Kinase; Molecular biology; Phosphoinositide 3-kinase; Cell biology; Chemistry; Signal transduction; Biology; Protein kinase B; Immunology","score_opus":0.060919330803900135,"score_gpt":0.3091719866189358,"score_spread":0.24825265581503567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W39804353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889427,0.0037520549,0.0012212065,0.0009425548,0.00009308396,0.0043144114,0.00020717885,0.00017066149,0.00035616578],"genre_scores_gemma":[0.9873102,0.00091695396,0.0078867795,0.000990371,0.00017980704,0.0011957373,0.000118549055,0.00011102192,0.0012905822],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99706644,0.00018104355,0.0005849329,0.0008496143,0.0005806339,0.00073734595],"domain_scores_gemma":[0.9983192,0.00006427515,0.00019302804,0.00072245364,0.00022713,0.0004739032],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00063151814,0.00054364966,0.0009935763,0.00013123444,0.00055411184,0.00010812257,0.00013613596,0.00022755019,0.00084310677],"category_scores_gemma":[0.00025555363,0.00042043143,0.00048764294,0.00033921233,0.0002006751,0.00021845257,0.000059777834,0.00023678361,0.000022005363],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009966045,0.0018162292,0.0006479575,0.0015187332,0.0013794629,0.00049964385,0.00043826268,0.000005893763,0.89658046,0.0021583356,0.0066769854,0.07831199],"study_design_scores_gemma":[0.009081647,0.0012705053,0.0011506146,0.00093786133,0.00046433383,0.00008122943,0.0003998979,0.00002061477,0.94376856,0.00017339957,0.042082194,0.00056915585],"about_ca_topic_score_codex":0.000093513365,"about_ca_topic_score_gemma":0.000014308503,"teacher_disagreement_score":0.07774283,"about_ca_system_score_codex":0.000116357405,"about_ca_system_score_gemma":0.0002487712,"threshold_uncertainty_score":0.99982476},"labels":[],"label_agreement":null},{"id":"W40949538","doi":"10.1136/bmj.327.7405.43","title":"Interventional pharmacotherapy","year":2003,"lang":"en","type":"review","venue":"BMJ","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Boniface Hospital; Health Sciences Centre","funders":"","keywords":"Medicine; Antithrombotic; Thrombosis; Thrombus; Percutaneous coronary intervention; Cardiology; Pharmacotherapy; Internal medicine; Percutaneous; Myocardial infarction","score_opus":0.08457721311656226,"score_gpt":0.43367727838309444,"score_spread":0.3491000652665322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W40949538","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000012390955,0.99212533,0.00013879259,0.0000333464,0.00036584557,0.0009103864,0.000026266482,0.00004999433,0.0063487682],"genre_scores_gemma":[7.632377e-7,0.9908112,0.0001304979,0.00031004797,0.00070148456,0.00014949663,0.00018156735,0.000055280583,0.0076596052],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998791,0.00016621582,0.00038565465,0.00024216546,0.00025657666,0.00015843319],"domain_scores_gemma":[0.9993885,0.000022906965,0.00012895973,0.00031654353,0.00003414878,0.000108902605],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00026252065,0.0002433793,0.0011956376,0.00009335668,0.000031251577,0.000012711674,0.00008237665,0.0001522857,0.0032856106],"category_scores_gemma":[0.000011399464,0.00018025147,0.002956132,0.00013506593,0.00003596905,0.000022912802,0.000010849947,0.00020484262,0.0005214853],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018904339,0.00012272492,0.0000017156729,0.007221193,0.0023941875,0.00015951613,0.0000018353719,3.452408e-8,1.3097007e-7,0.00013119531,0.035293926,0.95465463],"study_design_scores_gemma":[0.00072655524,0.000053457872,0.0000016394179,0.008312429,0.0023065936,0.0010154195,0.0000014980322,2.3748736e-7,9.85118e-7,0.000014910078,0.9873863,0.00017999508],"about_ca_topic_score_codex":5.42419e-7,"about_ca_topic_score_gemma":4.9800352e-8,"teacher_disagreement_score":0.9544746,"about_ca_system_score_codex":0.000044627624,"about_ca_system_score_gemma":0.00024699778,"threshold_uncertainty_score":0.9976255},"labels":[],"label_agreement":null},{"id":"W4200079602","doi":"10.1093/eurheartj/ehab785","title":"Dual antithrombotic treatment in chronic coronary syndrome: European Society of Cardiology criteria vs. CHADS-P2A2RC score","year":2021,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"Novo Nordisk Fonden","keywords":"Medicine; Antithrombotic; Internal medicine; Cardiology; Acute coronary syndrome; CHA2DS2–VASc score; Myocardial infarction; Ischemic stroke","score_opus":0.047764425149919736,"score_gpt":0.30073099164835526,"score_spread":0.2529665664984355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200079602","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9836922,0.012980508,0.00016873369,0.00038154775,0.00033061847,0.00017475738,0.000015422955,0.000034160483,0.0022220244],"genre_scores_gemma":[0.9905532,0.007226713,0.00042778684,0.00037972053,0.00082355295,0.0000011993285,0.000042196036,0.000073843075,0.000471814],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971373,0.0013682116,0.0004613569,0.00032855093,0.00029649728,0.00040809534],"domain_scores_gemma":[0.9990978,0.000045572135,0.00010152197,0.00040034193,0.000115288545,0.00023947818],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081234006,0.00024238112,0.0007880905,0.00008187502,0.00013063331,0.00003225794,0.0000917477,0.000046631496,0.00028404646],"category_scores_gemma":[0.000034135126,0.00020626782,0.00096116244,0.00020676987,0.00017472991,0.000095489035,0.00008106163,0.0003604679,0.000116868956],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005570617,0.00094382564,0.70371705,0.0006163961,0.005903373,0.16627121,0.0015822886,0.001249988,0.075214855,0.000039273673,0.02524634,0.018658359],"study_design_scores_gemma":[0.0040077795,0.001391443,0.89990485,0.0004400713,0.00025862423,0.06360921,0.00024734673,0.000040325896,0.0006963723,0.0000059778617,0.029258473,0.00013951158],"about_ca_topic_score_codex":0.0000030223887,"about_ca_topic_score_gemma":0.0000010686315,"teacher_disagreement_score":0.19618784,"about_ca_system_score_codex":0.00022454957,"about_ca_system_score_gemma":0.000441954,"threshold_uncertainty_score":0.84113574},"labels":[],"label_agreement":null},{"id":"W4200081680","doi":"10.21203/rs.3.rs-1100332/v1","title":"Impact of IRS-1 rs956115 and CYP2C19 rs4244285 Genotypes on Clinical Outcome of Patients Undergoing PCI","year":2021,"lang":"en","type":"preprint","venue":"Research Square","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Government of Jiangsu Province","keywords":"Conventional PCI; Outcome (game theory); CYP2C19; Internal medicine; Genotype; Medicine; Political science; Economics; Biology; Genetics; Gene; Mathematical economics","score_opus":0.13549657016255964,"score_gpt":0.48874176057316193,"score_spread":0.3532451904106023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200081680","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912175,0.00680731,0.000044197754,0.0000613883,0.00012775569,0.0009127487,0.0001880719,0.000021751997,0.0006192766],"genre_scores_gemma":[0.9921144,0.0070800493,0.00011146937,0.000021753633,0.00017112143,0.000019011428,0.00032078428,0.000050101185,0.00011129318],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99567145,0.00090290734,0.00081251684,0.0006296021,0.0015479302,0.0004355757],"domain_scores_gemma":[0.9963245,0.0009883804,0.00021442672,0.001058791,0.001074915,0.00033902194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018244395,0.0002762053,0.0012891894,0.00034054628,0.00007479002,0.00003477568,0.00021287058,0.0004513874,0.00023606613],"category_scores_gemma":[0.002025716,0.00021555762,0.0015155675,0.00025914342,0.00036830205,0.000044557088,0.00061608496,0.0012841685,0.000009533169],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015683714,0.0008950945,0.9748796,0.003121192,0.0022390608,0.00010009759,0.00016477297,0.00009294203,0.000043657576,0.00003688753,0.00020381782,0.016654477],"study_design_scores_gemma":[0.0031454777,0.002756237,0.9909799,0.0020323584,0.00021581397,0.0000051639186,0.000265941,0.00003943729,0.00015980047,0.00012111812,0.00010493749,0.00017379872],"about_ca_topic_score_codex":0.00017138198,"about_ca_topic_score_gemma":0.00001748139,"teacher_disagreement_score":0.016480677,"about_ca_system_score_codex":0.00016020297,"about_ca_system_score_gemma":0.0010549863,"threshold_uncertainty_score":0.8790185},"labels":[],"label_agreement":null},{"id":"W4200095816","doi":"10.1056/evidoa2100047","title":"Bentracimab for Ticagrelor Reversal in Patients Undergoing Urgent Surgery","year":2021,"lang":"en","type":"article","venue":"NEJM Evidence","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; McMaster University; University of Toronto","funders":"","keywords":"Medicine; Ticagrelor; Hemostasis; P2Y12; Myocardial infarction; Stroke (engine); Internal medicine; Anesthesia; Acute coronary syndrome; Cangrelor; Cardiology; Clopidogrel","score_opus":0.03947521764220225,"score_gpt":0.28326571597370964,"score_spread":0.2437904983315074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200095816","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881942,0.009337674,0.00076019525,0.0009462324,0.0002943175,0.00034497672,0.00000594336,0.000030996787,0.0000854166],"genre_scores_gemma":[0.9961602,0.0021736082,0.00036149792,0.0009272824,0.000104014805,0.000026174997,0.00003417401,0.00001646026,0.00019655144],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99888605,0.000061653955,0.00023288307,0.0002783973,0.00029301792,0.0002479752],"domain_scores_gemma":[0.99882776,0.0005815928,0.000042043128,0.0002682762,0.0001427199,0.00013762024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026485173,0.000103954895,0.00030374608,0.000053084594,0.00004628872,0.00001755639,0.000044903456,0.000058208127,0.0001685969],"category_scores_gemma":[0.0018694177,0.000099715166,0.0003487036,0.00019148557,0.00002672278,0.00015377079,0.000025078241,0.00008128684,0.000024841167],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014406258,0.00057924754,0.9108292,0.0008475276,0.00038302032,0.00046741407,0.0001746323,0.000037210153,0.0005231162,0.00018695292,0.00719795,0.07733311],"study_design_scores_gemma":[0.0047436133,0.0002629063,0.9653999,0.0040654205,0.00047116278,0.000060596696,0.00023301551,0.00016231913,0.0070802127,0.0002559772,0.016862549,0.00040227952],"about_ca_topic_score_codex":0.0000045620764,"about_ca_topic_score_gemma":0.000007884281,"teacher_disagreement_score":0.07693083,"about_ca_system_score_codex":0.000078106226,"about_ca_system_score_gemma":0.00043621234,"threshold_uncertainty_score":0.40662667},"labels":[],"label_agreement":null},{"id":"W4200140201","doi":"10.3390/ijms222313079","title":"Current and Novel Antiplatelet Therapies for the Treatment of Cardiovascular Diseases","year":2021,"lang":"en","type":"review","venue":"International Journal of Molecular Sciences","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Medicine; Antithrombotic; Aspirin; Hemostasis; Intensive care medicine; Ticagrelor; Thrombosis; P2Y12; Clinical trial; Clopidogrel; Adverse effect; Prasugrel; Pharmacodynamics; Platelet aggregation inhibitor; Pharmacology; Internal medicine; Pharmacokinetics","score_opus":0.05299630568917238,"score_gpt":0.3633785457666596,"score_spread":0.31038224007748727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200140201","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012489886,0.99046713,0.006925427,0.000092821334,0.00075620855,0.00040472086,0.00009452745,0.000003477066,0.000006706293],"genre_scores_gemma":[0.002254523,0.99690056,0.00038096067,0.00002185418,0.00038241604,0.000020685307,0.000017615943,0.000015854512,0.0000055495966],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980501,0.0000894421,0.00052651623,0.0002298306,0.00097166374,0.00013242892],"domain_scores_gemma":[0.99850565,0.0002692092,0.00042711632,0.00021554304,0.0004995817,0.00008289428],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040511257,0.0002304314,0.0014072272,0.00020783611,0.000075692,0.00007742311,0.0003746439,0.000059531983,0.0000099007775],"category_scores_gemma":[0.00007750651,0.00011950146,0.0035683112,0.00017131324,0.0003656561,0.00007131119,0.00003165878,0.000085378466,2.8558617e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038263148,0.00031307017,0.00002278605,0.0004795932,0.0154001685,0.0001374704,0.000054365628,0.000066588895,0.0000052736837,0.00022043538,0.000017162209,0.98324484],"study_design_scores_gemma":[0.0012194533,0.0004815056,0.000034481964,0.0040363306,0.007892172,0.001223021,0.00009432238,0.000016074682,0.00008312558,0.000044071454,0.98475605,0.000119368575],"about_ca_topic_score_codex":0.0000036224671,"about_ca_topic_score_gemma":1.3813711e-7,"teacher_disagreement_score":0.9847389,"about_ca_system_score_codex":0.00005112612,"about_ca_system_score_gemma":0.000583782,"threshold_uncertainty_score":0.48731282},"labels":[],"label_agreement":null},{"id":"W4200210946","doi":"10.1111/jocs.16189","title":"Ticagrelor versus aspirin and vein graft patency after coronary bypass: A randomized trial","year":2021,"lang":"en","type":"article","venue":"Journal of Cardiac Surgery","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Ticagrelor; Aspirin; Randomized controlled trial; Cardiology; Internal medicine; Surgery; Coronary artery disease; Occlusion; Anesthesia; Clopidogrel","score_opus":0.016891850540292346,"score_gpt":0.2555628479302105,"score_spread":0.23867099738991815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200210946","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92062914,0.075424924,0.000041680247,0.00043581222,0.002705912,0.00026694033,0.000011331996,0.000013440037,0.0004707899],"genre_scores_gemma":[0.9813814,0.016683314,0.000100480494,0.00025995495,0.0013383446,0.000021566082,0.000014801909,0.00002784249,0.0001722995],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99760246,0.00070327584,0.0006900795,0.00017659347,0.0005981975,0.00022938261],"domain_scores_gemma":[0.99751973,0.0014080418,0.00022984814,0.0002349331,0.0003294083,0.00027802907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019350862,0.00018269598,0.0018288434,0.00014498501,0.000041282197,0.00003784592,0.000035371268,0.000116539355,0.0002417146],"category_scores_gemma":[0.000909683,0.00013696335,0.0031577789,0.0001612754,0.00013199497,0.00015152525,0.000029903837,0.00025014175,0.000011323368],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.93523675,0.00017423263,0.0040136855,0.00006655141,0.0055460776,0.0044312314,0.00006071921,7.897572e-7,0.00017284884,0.000009486187,0.0029557357,0.047331885],"study_design_scores_gemma":[0.9229091,0.0004951965,0.029434243,0.0005181701,0.006228907,0.0022150031,0.0002869385,0.000004992758,0.0011773836,0.00014052047,0.03621916,0.00037037596],"about_ca_topic_score_codex":0.000002019603,"about_ca_topic_score_gemma":1.7274922e-7,"teacher_disagreement_score":0.060752224,"about_ca_system_score_codex":0.00003707808,"about_ca_system_score_gemma":0.0005173517,"threshold_uncertainty_score":0.5585203},"labels":[],"label_agreement":null},{"id":"W4200267770","doi":"10.1016/j.jcjd.2021.11.008","title":"Trends and Determinants of Self-reported Aspirin Use Among Patients With Diabetes Stratified by Presence and Risk of Cardiovascular Diseases: A Repeated Pan-Canadian Cross-sectional Study","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Diabetes","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of Waterloo","funders":"","keywords":"Medicine; Diabetes mellitus; Logistic regression; Aspirin; Body mass index; Cross-sectional study; Disease; Environmental health; Gerontology; Demography; Family medicine; Internal medicine","score_opus":0.008821131352229162,"score_gpt":0.2197027249581509,"score_spread":0.21088159360592174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200267770","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901667,0.008883835,0.0000010258793,0.0000042473553,0.00006716962,0.00026009363,0.0006002666,0.0000057523494,0.000010861606],"genre_scores_gemma":[0.99969006,0.00011582843,0.000033832923,0.000013297455,0.00003070958,0.0000068223094,0.000058336045,0.00002703701,0.000024080744],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979422,0.00024008985,0.000648395,0.00031210654,0.00048983854,0.00036733356],"domain_scores_gemma":[0.99713635,0.000105952095,0.00040548277,0.0003933133,0.00082685624,0.0011320544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040123236,0.00022192697,0.0008409295,0.0003830738,0.0001482874,0.0000934796,0.00009399893,0.00010057894,0.000034659057],"category_scores_gemma":[0.00038235672,0.00018594998,0.00036237197,0.00037738378,0.00032854936,0.00032681646,0.00001359572,0.00019061514,1.10767054e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032335665,0.00017232313,0.9849626,0.00010682146,0.008965698,0.00022065215,0.00016044805,0.00003429277,0.000028915412,2.5569977e-7,0.00002861903,0.00528703],"study_design_scores_gemma":[0.0034133052,0.00078454666,0.9912493,0.00022976506,0.0032752964,0.000010302186,0.00013976141,0.00004276811,0.00058449025,0.000004578043,0.00008708067,0.00017875536],"about_ca_topic_score_codex":0.012416195,"about_ca_topic_score_gemma":0.04120162,"teacher_disagreement_score":0.028785426,"about_ca_system_score_codex":0.00006551721,"about_ca_system_score_gemma":0.0011483529,"threshold_uncertainty_score":0.99416023},"labels":[],"label_agreement":null},{"id":"W4200348914","doi":"10.1001/jamaneurol.2021.4514","title":"Comparison of Ticagrelor vs Clopidogrel in Addition to Aspirin in Patients With Minor Ischemic Stroke and Transient Ischemic Attack","year":2021,"lang":"en","type":"review","venue":"JAMA Neurology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Ticagrelor; Aspirin; Clopidogrel; Minor stroke; Medicine; Cardiology; Stroke (engine); Internal medicine; Ischemic stroke; Transient (computer programming); Anesthesia; Ischemia; Computer science","score_opus":0.0282642547082918,"score_gpt":0.3184819417652734,"score_spread":0.2902176870569816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200348914","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.48038954,0.51833165,0.000005734065,0.00008492244,0.00005001915,0.0007562202,0.000091217575,0.000008459753,0.0002822127],"genre_scores_gemma":[0.11077296,0.8865017,0.00010490564,0.0008116024,0.00014110567,0.0001813196,0.0012987765,0.00008849755,0.00009911616],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99798805,0.00025103227,0.0006500514,0.0005572528,0.00025864417,0.0002949452],"domain_scores_gemma":[0.9991371,0.00012780007,0.0001768313,0.00036021823,0.00006771853,0.0001303513],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00012075343,0.00032891583,0.0023498514,0.00030312134,0.000012677783,0.000007175657,0.00010323553,0.00046444128,0.00008805955],"category_scores_gemma":[0.000053761698,0.00027064656,0.00032105923,0.0003356611,0.000093198505,0.000040244944,0.000046820525,0.00072348,0.000011814434],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019921265,0.00084048935,0.039200846,0.007859265,0.0004554827,0.00025205043,0.00015109718,0.00000853605,0.000009011684,0.0000019154286,0.007116112,0.94211304],"study_design_scores_gemma":[0.0038636117,0.0014748129,0.03974075,0.003997878,0.00075813255,0.000065310734,0.000010251398,0.0000057030534,0.000017646922,4.6856673e-8,0.94984955,0.00021629206],"about_ca_topic_score_codex":0.000009809451,"about_ca_topic_score_gemma":0.000020968047,"teacher_disagreement_score":0.94273347,"about_ca_system_score_codex":0.000030200003,"about_ca_system_score_gemma":0.00013756173,"threshold_uncertainty_score":0.99997455},"labels":[],"label_agreement":null},{"id":"W4200503058","doi":"10.14740/jmc3815","title":"Heart Block Caused by Ticagrelor Use in a Patient Who Underwent Adenosine Diastolic Fractional Reserve Assessment: A Case Report","year":2021,"lang":"en","type":"article","venue":"Journal of Medical Cases","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Ticagrelor; Medicine; P2Y12; Adenosine; Clopidogrel; Cardiology; Fractional flow reserve; Acute coronary syndrome; Internal medicine; Anesthesia; Pharmacology; Cardioprotection; Myocardial infarction","score_opus":0.03291247648721743,"score_gpt":0.32910865841055553,"score_spread":0.2961961819233381,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200503058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98181224,0.0079071615,0.0002846544,0.009524168,0.00025889062,0.00014186028,0.000024274314,0.000011359469,0.000035368],"genre_scores_gemma":[0.99614525,0.001023911,0.00018196492,0.0020610238,0.00038351415,0.000006968576,0.00003315998,0.000023169297,0.00014106753],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.995962,0.00033365606,0.0009238679,0.00024343614,0.0022605504,0.00027646543],"domain_scores_gemma":[0.99769324,0.0005902657,0.00028316997,0.00029474698,0.00041789535,0.0007206657],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008464591,0.00017564264,0.00069655135,0.00015306298,0.00007555583,0.000048536174,0.00007133699,0.00018579369,0.0009432165],"category_scores_gemma":[0.002810357,0.00013731734,0.0005124225,0.0003101608,0.000106437314,0.00019676457,0.00005987549,0.00077087124,0.000003839223],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036409748,0.001663581,0.01689014,0.000055577515,0.00056854,0.9486913,0.00007631631,0.000031915704,0.000120409386,0.000019020292,0.029629547,0.0018895703],"study_design_scores_gemma":[0.0045047402,0.0008656734,0.01622767,0.00087634043,0.0004056044,0.9306676,0.0008724293,0.00023555799,0.0006248431,0.000021032838,0.044535898,0.00016262903],"about_ca_topic_score_codex":0.00019404161,"about_ca_topic_score_gemma":0.00012361757,"teacher_disagreement_score":0.0180237,"about_ca_system_score_codex":0.00019353353,"about_ca_system_score_gemma":0.001434879,"threshold_uncertainty_score":0.9999701},"labels":[],"label_agreement":null},{"id":"W4205330965","doi":"10.1016/j.jcin.2021.11.005","title":"Ticagrelor Monotherapy After PCI in High-Risk Patients With Prior MI","year":2022,"lang":"en","type":"article","venue":"JACC: Cardiovascular Interventions","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; University Health Network","funders":"St. Jude Medical; Eisai; School of Medicine, CHA University; Bayer Fund; Duke Clinical Research Institute; Daiichi-Sankyo; Medicines Company; Boston Scientific Corporation; Eli Lilly and Company; Bristol-Myers Squibb; AstraZeneca; CSL Behring; Chiesi Farmaceutici; Pfizer; Cardiovascular Research Foundation; Scott R. MacKenzie Foundation; Revance; Boehringer Ingelheim; Amgen; Gilead Sciences","keywords":"Ticagrelor; Medicine; Percutaneous coronary intervention; Conventional PCI; Myocardial infarction; Aspirin; Internal medicine; Cardiology; Stroke (engine); Clinical endpoint; Randomized controlled trial","score_opus":0.007687536231153479,"score_gpt":0.22253206920026233,"score_spread":0.21484453296910885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205330965","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.978134,0.016780721,0.0029891548,0.00010037146,0.00026905982,0.0011591944,0.00016430065,0.00010312249,0.00030009434],"genre_scores_gemma":[0.9970539,0.000453815,0.00055272656,0.00020830294,0.00010968716,0.0009644761,0.00019836536,0.00008417532,0.00037452683],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99705166,0.00052149576,0.00046760548,0.0005780166,0.0009797824,0.00040143065],"domain_scores_gemma":[0.99849135,0.000033025142,0.000101416736,0.001084143,0.00012999104,0.00016006677],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00067495,0.00028513704,0.00075193244,0.00033315227,0.00025482223,0.000038660848,0.00020017276,0.000075487085,0.0027428449],"category_scores_gemma":[0.000040934305,0.00025423724,0.0041023265,0.00057264033,0.000088330286,0.00014386665,0.00012999272,0.0004898261,0.00006921789],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004013884,0.003347738,0.6934738,0.0003378852,0.023358978,0.00096510845,0.0004897361,0.003357777,0.0000048886986,0.00011006427,0.00089091883,0.2696492],"study_design_scores_gemma":[0.017756486,0.0010163208,0.9270812,0.00021778797,0.0028405697,0.000118933815,0.00029405256,0.00002730064,0.000056903595,0.000102685015,0.050046377,0.00044134495],"about_ca_topic_score_codex":0.00021441106,"about_ca_topic_score_gemma":0.00003833387,"teacher_disagreement_score":0.26920786,"about_ca_system_score_codex":0.00021032825,"about_ca_system_score_gemma":0.00008097434,"threshold_uncertainty_score":0.999991},"labels":[],"label_agreement":null},{"id":"W4205396233","doi":"10.36740/abal202104107","title":"Influence of meldonium on the Quality of Life of patients with Coronary Artery Disease and Concomitant Arterial hypertension During the Recovery Treatment period After percutaneous Coronary Intervention","year":2021,"lang":"en","type":"article","venue":"Acta Balneologica","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Concomitant; Conventional PCI; Percutaneous coronary intervention; Angina; Coronary artery disease; Internal medicine; Cardiology; Canadian Cardiovascular Society; Quality of life (healthcare); Myocardial infarction","score_opus":0.012488914489639305,"score_gpt":0.22108328740416808,"score_spread":0.20859437291452876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205396233","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99779963,0.0012881047,0.000001779614,0.0003053848,0.000038407852,0.0004281235,0.00011416953,0.000008786205,0.000015610696],"genre_scores_gemma":[0.9990894,0.0005683202,0.000010542694,0.00022187155,0.000020054627,0.000022619006,0.00003648774,0.000008817751,0.000021885793],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987342,0.00031559434,0.00034576806,0.00022193394,0.00026623276,0.00011632245],"domain_scores_gemma":[0.99895877,0.00020001466,0.00018352362,0.00042452785,0.00016016315,0.00007299492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012259063,0.00015058546,0.00043092744,0.000020037796,0.00006382849,0.000005514322,0.00006291934,0.00005373221,0.00013534997],"category_scores_gemma":[0.0001416444,0.00007179454,0.00026065964,0.00005630496,0.00032883917,0.000049538034,0.000055232107,0.00007117211,6.7958575e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08214336,0.0023343025,0.8766815,0.00039638553,0.0020823288,0.0010625831,0.0005274761,0.00008795648,0.031610996,0.000027406295,0.000013040547,0.003032658],"study_design_scores_gemma":[0.0024552494,0.0016998734,0.9934144,0.0002173521,0.0003517824,0.00016512536,0.00040907715,0.000005679154,0.0011559217,0.000023222883,0.00002074406,0.000081559345],"about_ca_topic_score_codex":0.000016235947,"about_ca_topic_score_gemma":0.000006001757,"teacher_disagreement_score":0.1167329,"about_ca_system_score_codex":0.000028004304,"about_ca_system_score_gemma":0.00007530277,"threshold_uncertainty_score":0.2927696},"labels":[],"label_agreement":null},{"id":"W4205406661","doi":"10.1007/s11239-012-0816-5","title":"Erratum to: Relation between clopidogrel active metabolite levels and different platelet aggregation methods in patients receiving clopidogrel and aspirin","year":2012,"lang":"en","type":"erratum","venue":"Journal of Thrombosis and Thrombolysis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; McMaster University Medical Centre; Hamilton Regional Laboratory Medicine Program; Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"Sanofi; Bristol-Myers Squibb","keywords":"Clopidogrel; Aspirin; Medicine; Platelet aggregation; Platelet; Active metabolite; Internal medicine; Hematology; Metabolite; Cardiology; Pharmacology","score_opus":0.04068767929661638,"score_gpt":0.34026184345401567,"score_spread":0.2995741641573993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205406661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97231644,0.02243636,0.0007896993,0.00049898005,0.0027805625,0.0006278626,0.00009361395,0.000018579296,0.00043792825],"genre_scores_gemma":[0.96068,0.032014325,0.0044581783,0.0002214375,0.0017906203,0.000015744603,0.00023665997,0.000120634104,0.00046237416],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99630576,0.0006597143,0.0012308547,0.0005467818,0.0007822409,0.00047465463],"domain_scores_gemma":[0.99739707,0.0002641632,0.0010987272,0.0003570719,0.0003363761,0.00054657983],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012864047,0.00063119264,0.0027830214,0.00087345357,0.00018168462,0.00011777716,0.00013614289,0.0007523904,0.000035806428],"category_scores_gemma":[0.00026301446,0.00049585244,0.000580535,0.00045681876,0.00015327575,0.00056562835,0.00016926712,0.0013326893,0.0000015533337],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037363908,0.00047037055,0.49782324,0.00074971776,0.008609844,0.0000113245715,0.0024337417,0.000003341186,0.0005441043,0.000036636964,0.0059250887,0.48301893],"study_design_scores_gemma":[0.0029031325,0.0005901441,0.97892004,0.001829083,0.0044450224,0.00002802186,0.00019945757,0.000013635631,0.00050120754,0.00033332585,0.009767177,0.00046976533],"about_ca_topic_score_codex":0.000030703894,"about_ca_topic_score_gemma":0.000009663265,"teacher_disagreement_score":0.4825492,"about_ca_system_score_codex":0.00018007308,"about_ca_system_score_gemma":0.000103212056,"threshold_uncertainty_score":0.9997493},"labels":[],"label_agreement":null},{"id":"W4205524862","doi":"10.18433/jpps32140","title":"Genotype-Guided Antiplatelet Therapy Versus Standard Therapy for Patients with Coronary Artery Disease: An Updated Systematic Review and Meta-Analysis","year":2022,"lang":"en","type":"review","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine; Coronary artery disease; Percutaneous coronary intervention; Meta-analysis; Relative risk; Myocardial infarction; Conventional PCI; Randomized controlled trial; Adverse effect; Stroke (engine); Confidence interval","score_opus":0.2026423768821724,"score_gpt":0.44644546030743815,"score_spread":0.24380308342526574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205524862","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017529962,0.99219275,0.000049229846,0.0002207793,0.00016550634,0.0050929873,0.00048228403,0.000030164203,0.000013334304],"genre_scores_gemma":[0.0019154906,0.9955863,0.00017121415,0.0016310662,0.00010852546,0.00023534603,0.00026896506,0.000060979226,0.000022122995],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9937656,0.0013862569,0.0016468961,0.0006955267,0.0019794402,0.00052631524],"domain_scores_gemma":[0.99637437,0.0005027217,0.0013097813,0.0004487398,0.0004507169,0.00091365183],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0030242836,0.0007390138,0.007233303,0.00047353105,0.00043485337,0.00014385971,0.00069062825,0.00006718027,0.0032874993],"category_scores_gemma":[0.00008184414,0.00038257134,0.004620946,0.001448944,0.00043278898,0.00050332834,0.00006440956,0.00056924875,0.0000023699097],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014912632,0.001530531,0.00026550778,0.16357319,0.62691087,0.00062512007,0.000047949266,0.0000137859,0.0000011824648,0.0000147712535,0.0006793945,0.19142506],"study_design_scores_gemma":[0.006037462,0.0015787126,0.000015054057,0.0015764385,0.5636229,0.00019937729,0.0000106613425,0.00002112554,0.000002220104,0.0000030042545,0.4265925,0.00034056493],"about_ca_topic_score_codex":0.0000010988061,"about_ca_topic_score_gemma":1.9322204e-7,"teacher_disagreement_score":0.4259131,"about_ca_system_score_codex":0.00012571077,"about_ca_system_score_gemma":0.00089295575,"threshold_uncertainty_score":0.9998626},"labels":[],"label_agreement":null},{"id":"W4206296688","doi":"10.4244/eij-d-21-00721","title":"Safety and efficacy of ticagrelor monotherapy according to drug-eluting stent type: the TWILIGHT-STENT study","year":2022,"lang":"en","type":"article","venue":"EuroIntervention","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact; Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"Idorsia Pharmaceuticals; Servier; Abiomed; Abbott Vascular; ZOLL Medical Corporation; Regeneron Pharmaceuticals; Amarin Corporation; Boston Scientific Corporation; Sanofi; Janssen Pharmaceuticals; MyoKardia; Bristol-Myers Squibb; AstraZeneca; Amgen; Pfizer","keywords":"Medicine; Ticagrelor; Percutaneous coronary intervention; Conventional PCI; Internal medicine; Aspirin; Stent; Drug-eluting stent; Everolimus; Cardiology; Surgery; Myocardial infarction","score_opus":0.02252192861365392,"score_gpt":0.287696425627943,"score_spread":0.2651744970142891,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206296688","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952739,0.0023783306,0.0004723621,0.0005323065,0.00021392292,0.00092980696,0.0000051631832,0.000034625882,0.00015962026],"genre_scores_gemma":[0.99904406,0.00008159844,0.00003059271,0.00015524436,0.000057535966,0.000007573444,0.0000083525765,0.000021665915,0.000593402],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99866915,0.0003146831,0.0003205348,0.00022998931,0.00032957032,0.00013608258],"domain_scores_gemma":[0.999437,0.00005617158,0.000095812546,0.00030148425,0.00004921564,0.000060363676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008070536,0.00010647363,0.00024530536,0.00007409079,0.00020744723,0.0000151866425,0.000101699916,0.000009371643,0.00015546584],"category_scores_gemma":[0.000047433885,0.000078492914,0.0003287741,0.00022321132,0.000023094392,0.000032353422,0.0001396881,0.00012945331,0.000007979045],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022835586,0.0070894533,0.38770825,0.0004340168,0.005812636,0.0003485438,0.014788542,0.0021218413,0.014466866,0.00055292016,0.0013717568,0.5424696],"study_design_scores_gemma":[0.012663253,0.0053936937,0.92963076,0.0003467234,0.0010265377,0.00022298371,0.024504118,0.00051058107,0.0020632048,0.000031160096,0.02327951,0.00032749824],"about_ca_topic_score_codex":0.000019494788,"about_ca_topic_score_gemma":0.0000022037702,"teacher_disagreement_score":0.5421421,"about_ca_system_score_codex":0.000039855935,"about_ca_system_score_gemma":0.000017133654,"threshold_uncertainty_score":0.32008484},"labels":[],"label_agreement":null},{"id":"W4206427522","doi":"10.1017/cjn.2021.351","title":"P.072 Ticagrelor vs Clopidogrel in Addition to Aspirin in Minor Ischemic Stroke/ TIA – a Systematic Review &amp; Network Meta-Analysis (NMA)","year":2021,"lang":"en","type":"review","venue":"Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Clopidogrel; Ticagrelor; Aspirin; Internal medicine; Stroke (engine); Odds ratio; Randomized controlled trial; Meta-analysis; Platelet aggregation inhibitor; Cardiology","score_opus":0.11579088003389423,"score_gpt":0.3442987432322766,"score_spread":0.22850786319838237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206427522","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018851465,0.97771716,0.000018773244,0.0014565447,0.00030718313,0.001210923,0.000064619824,0.0000117393165,0.000361616],"genre_scores_gemma":[0.0062095975,0.985655,0.00094944745,0.006722624,0.00026194585,0.000069902555,0.000011092758,0.000028084933,0.00009227372],"study_design_codex":"case_report","study_design_gemma":"not_applicable","domain_scores_codex":[0.9881811,0.0046061887,0.0029943802,0.0010708541,0.0014273975,0.0017200651],"domain_scores_gemma":[0.9936827,0.0011342678,0.0017261127,0.0004969047,0.0004791721,0.0024808804],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.010564924,0.0007973055,0.0083714165,0.0027634564,0.00069377205,0.00047197158,0.002037599,0.0004519149,0.0007068669],"category_scores_gemma":[0.004099253,0.00048496394,0.005318853,0.007511002,0.0017986426,0.00046199097,0.00010383994,0.0022693118,0.000015208957],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007385221,0.0010775187,0.09705442,0.29440144,0.11136603,0.3223897,0.00094517134,0.018069193,0.0000017906503,0.00072294154,0.026459724,0.12677355],"study_design_scores_gemma":[0.0007708745,0.030785928,0.002051197,0.10137678,0.29544598,0.09327261,0.00012382313,0.00010622229,7.3790807e-7,0.00033205922,0.47376382,0.001969972],"about_ca_topic_score_codex":0.0006121826,"about_ca_topic_score_gemma":0.074060105,"teacher_disagreement_score":0.4473041,"about_ca_system_score_codex":0.0005152883,"about_ca_system_score_gemma":0.006287517,"threshold_uncertainty_score":0.9997602},"labels":[],"label_agreement":null},{"id":"W4206767417","doi":"10.21065/19257430.134.2","title":"THE EFFECTIVENESS OF ASPIRIN WITH REGARD TO THE AGE OF THE PERSONS SUFFERING FROM CORONARY HEART DISEASE.","year":2012,"lang":"en","type":"article","venue":"Canadian Journal of Applied Sciences","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Aspirin; Coronary heart disease; Medicine; Internal medicine; Coronary disease; Disease; Cardiology","score_opus":0.01363062227253761,"score_gpt":0.22604808697606824,"score_spread":0.21241746470353062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206767417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994613,0.0033390454,0.000058370082,0.00076976867,0.00015290777,0.00025751276,0.000015204179,0.0000013871004,0.0007928362],"genre_scores_gemma":[0.9995287,0.000012394734,0.000047160007,0.0002795692,0.00010838631,0.000004860369,5.512249e-7,0.0000056618023,0.000012693222],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990534,0.00012007476,0.00014198132,0.000079469355,0.00038360848,0.00022145527],"domain_scores_gemma":[0.9990488,0.00023319622,0.00008619032,0.00022504423,0.000054818825,0.00035190478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00136801,0.00007680334,0.00020504385,0.000046686975,0.00034462527,0.000022108557,0.0003367328,0.00001745838,0.000013048444],"category_scores_gemma":[0.00005008091,0.000031179767,0.00016421209,0.0002666026,0.000729624,0.000052794396,0.000015108584,0.000114147806,0.0000010682213],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027870722,0.00007159205,0.96864545,0.000101509446,0.000754459,0.000078763725,0.0032559207,0.0016169329,0.011949255,0.0031796868,0.0008556524,0.006703683],"study_design_scores_gemma":[0.00036499018,0.00014460078,0.98672915,0.00025221566,0.0001656229,0.000045177592,0.0018697329,0.0000025977054,0.0025169621,0.00014424192,0.0077110324,0.000053657885],"about_ca_topic_score_codex":0.0005258117,"about_ca_topic_score_gemma":0.0011132067,"teacher_disagreement_score":0.018083695,"about_ca_system_score_codex":0.000036953632,"about_ca_system_score_gemma":0.0008495247,"threshold_uncertainty_score":0.268833},"labels":[],"label_agreement":null},{"id":"W4206813830","doi":"10.7775/rac.es.v89.i2.19703","title":"Estrategias de antiagregación plaquetaria en síndromes coronarios agudos","year":2022,"lang":"es","type":"article","venue":"Revista Argentina de Cardiología","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Excellence in Mining Innovation","funders":"","keywords":"Medicine","score_opus":0.009581934509119795,"score_gpt":0.25774782732421864,"score_spread":0.24816589281509885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206813830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8707357,0.121594995,0.0012317454,0.0003710371,0.00068352156,0.0011748787,0.0004869721,0.00023313366,0.0034879856],"genre_scores_gemma":[0.9741825,0.021120327,0.00021182727,0.00071417796,0.0011338219,0.00019473089,0.00060854823,0.00014402356,0.001690032],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9930224,0.00280275,0.00078711513,0.0010553203,0.0008411453,0.0014912876],"domain_scores_gemma":[0.9973408,0.00025808456,0.0003323588,0.0013292773,0.00011987712,0.0006196097],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002751618,0.0007312003,0.0018183606,0.00024483254,0.00083266466,0.00022533577,0.0007075528,0.00034337057,0.0024331699],"category_scores_gemma":[0.00027924392,0.0007599306,0.002533972,0.0005607035,0.0002941927,0.0001451559,0.00044623995,0.0012367932,0.00023686688],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019204448,0.00083255884,0.8648311,0.0024478242,0.015255157,0.01894072,0.0011932068,0.0028597296,0.011207797,0.039693236,0.019537939,0.021280317],"study_design_scores_gemma":[0.0031497865,0.00069265504,0.2705623,0.00033663647,0.0040755365,0.0073090647,0.0014354893,0.00038227093,0.0003887674,0.0002666354,0.71041167,0.0009891677],"about_ca_topic_score_codex":0.00009793531,"about_ca_topic_score_gemma":4.5987602e-7,"teacher_disagreement_score":0.69087374,"about_ca_system_score_codex":0.00079351495,"about_ca_system_score_gemma":0.0013700974,"threshold_uncertainty_score":0.9994852},"labels":[],"label_agreement":null},{"id":"W4210471860","doi":"10.1007/s00380-022-02029-8","title":"Use and outcomes of dual antiplatelet therapy for acute coronary syndrome in patients with chronic kidney disease: insights from the Canadian Observational Antiplatelet Study (COAPT)","year":2022,"lang":"en","type":"article","venue":"Heart and Vessels","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Royal Alexandra Hospital; NOSM University; Southlake Regional Health Center; Saint John Regional Hospital; Institut universitaire de cardiologie et de pneumologie de Québec; Université Laval; Population Health Research Institute; Queen Elizabeth II Health Sciences Centre; Western University; University of Toronto; Hamilton Health Sciences; Dalhousie University; London Health Sciences Centre; Health Sciences North; St. Michael's Hospital; McMaster University; Canadian Heart Research Centre","funders":"Daiichi-Sankyo","keywords":"Medicine; Clopidogrel; Prasugrel; Ticagrelor; Acute coronary syndrome; Internal medicine; Kidney disease; Mace; Percutaneous coronary intervention; Cardiology; Aspirin; Myocardial infarction","score_opus":0.028586768100668528,"score_gpt":0.2611086032386582,"score_spread":0.23252183513798969,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210471860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940575,0.0025224644,0.0000015538261,0.00069220975,0.00006910442,0.0017318152,0.0009105267,0.000013469956,0.0000013650578],"genre_scores_gemma":[0.9977742,0.0002577877,0.000024200204,0.0010592382,0.000022127444,0.00011916717,0.0006853581,0.000026892529,0.000031028096],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987425,0.000117479765,0.00022424485,0.0003180816,0.0003746258,0.00022303905],"domain_scores_gemma":[0.9991871,0.00014945064,0.00005530829,0.00027333925,0.00007190385,0.00026287042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001346876,0.00018746816,0.00047265762,0.000092040755,0.00037770113,0.000037272614,0.00006600821,0.000038305865,0.000053534808],"category_scores_gemma":[0.000019739793,0.00012521708,0.000090288406,0.00016793709,0.00010918916,0.00018392026,0.00004304995,0.00014548072,4.4660572e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019984855,0.00040164177,0.99502385,0.000015323118,0.0012412652,0.00020845237,0.00032238814,0.00001300897,0.000037928676,0.0000402866,0.00020992219,0.00048743715],"study_design_scores_gemma":[0.009537599,0.0012187185,0.98402727,0.000040597155,0.00024376698,0.00003318529,0.00010457626,0.000046085104,0.0000116319725,0.000047173125,0.0045323274,0.0001570468],"about_ca_topic_score_codex":0.0040288013,"about_ca_topic_score_gemma":0.002275094,"teacher_disagreement_score":0.010996568,"about_ca_system_score_codex":0.000057659843,"about_ca_system_score_gemma":0.00051902095,"threshold_uncertainty_score":0.6090369},"labels":[],"label_agreement":null},{"id":"W4210849677","doi":"10.1161/jaha.121.024156","title":"ABCD‐GENE Score and Clinical Outcomes Following Percutaneous Coronary Intervention: Insights from the TAILOR‐PCI Trial","year":2022,"lang":"en","type":"article","venue":"Journal of the American Heart Association","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Canadian VIGOUR Centre; University of Toronto; University of Alberta; St. Michael's Hospital","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Medicine; Percutaneous coronary intervention; Conventional PCI; Clopidogrel; Internal medicine; Myocardial infarction; Stroke (engine); P2Y12; Cardiology; Diabetes mellitus","score_opus":0.021329454900083443,"score_gpt":0.30905008957986757,"score_spread":0.28772063467978415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210849677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99275416,0.0020907563,0.000017176395,0.0035605652,0.0012847404,0.0002591077,0.000011514719,0.000009885296,0.000012080743],"genre_scores_gemma":[0.99649274,0.00021678477,0.00007310663,0.0024660327,0.0005722219,0.000003856634,0.0000050551716,0.00001339942,0.00015678712],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973308,0.0011581146,0.0005225181,0.00011782525,0.0007562572,0.00011447478],"domain_scores_gemma":[0.99829274,0.0007447062,0.0006150625,0.00020192261,0.00007470254,0.00007087095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011734792,0.00009686783,0.0006237954,0.00003248807,0.00034373777,0.000029925766,0.00014635119,0.000030109264,0.00004737552],"category_scores_gemma":[0.0005881764,0.000055542703,0.0018382191,0.00016139969,0.00006520672,0.00007193507,0.00009378941,0.0004651509,0.0000022152506],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004932655,0.000216751,0.98334277,0.0000014827039,0.0026617823,0.00010681844,0.00022048809,0.000017117542,0.00018315806,0.000002076098,0.0016805587,0.006634357],"study_design_scores_gemma":[0.0106431395,0.0012923303,0.97916,0.000031385447,0.0012138349,0.00042673366,0.0011987969,0.000019741217,0.000011857053,0.00013742439,0.0057910723,0.00007369551],"about_ca_topic_score_codex":0.00008513052,"about_ca_topic_score_gemma":0.000008904218,"teacher_disagreement_score":0.0065606614,"about_ca_system_score_codex":0.00024039789,"about_ca_system_score_gemma":0.000112930386,"threshold_uncertainty_score":0.2643788},"labels":[],"label_agreement":null},{"id":"W4211003498","doi":"10.1007/978-1-59259-917-2_15","title":"Antiplatelet Agents","year":2007,"lang":"en","type":"book-chapter","venue":"Humana Press eBooks","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"Environmental science","score_opus":0.12861166739846713,"score_gpt":0.3142690606496449,"score_spread":0.18565739325117775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211003498","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004142479,0.03158948,0.00009621921,0.000004971771,0.00028850048,0.00072853395,0.000044880908,0.00023600004,0.96659714],"genre_scores_gemma":[0.0073181605,0.0050634155,0.000077648154,0.00083949923,0.0010897401,0.00001426103,0.00021488153,0.00021307515,0.9851693],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99785334,0.000017272741,0.0004317401,0.00057561946,0.00071130175,0.0004107152],"domain_scores_gemma":[0.99845,0.000024759838,0.00017351561,0.0009495115,0.00011892042,0.00028331234],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019830167,0.0005275712,0.00088132464,0.00019466715,0.00013091655,0.000039827155,0.00020663346,0.0005618076,0.0010508683],"category_scores_gemma":[0.000006263492,0.00049549824,0.0010237999,0.0000048125003,0.00021703703,0.00003001098,0.00009896711,0.0005537206,0.00021122883],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011871189,0.00009588604,0.000008595361,0.0009856917,0.0077327304,0.009930107,0.00026340253,0.0000030511862,0.000032699227,0.20436242,0.035107084,0.74029124],"study_design_scores_gemma":[0.0017228932,0.00012256778,0.00008223886,0.00057513703,0.0012055655,0.00023789707,0.0000037330794,0.0000045813636,0.00037771926,0.0011035558,0.99408066,0.00048343543],"about_ca_topic_score_codex":0.000021004353,"about_ca_topic_score_gemma":0.0000050339227,"teacher_disagreement_score":0.9589736,"about_ca_system_score_codex":0.000056384903,"about_ca_system_score_gemma":0.00006743848,"threshold_uncertainty_score":0.9998623},"labels":[],"label_agreement":null},{"id":"W4211048687","doi":"10.1016/j.tcm.2022.02.004","title":"Editorial commentary: Antiplatelet therapy post PCI: Evaluating a personalized medicine approach","year":2022,"lang":"en","type":"review","venue":"Trends in Cardiovascular Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Heart and Stroke Foundation","funders":"National Heart, Lung, and Blood Institute","keywords":"Ivabradine; Medicine; Mineralocorticoid receptor; Clinical trial; Heart failure; Pharmacology; Internal medicine; Cardiology; Receptor; Heart rate; Blood pressure","score_opus":0.11751773261016307,"score_gpt":0.38743437384858737,"score_spread":0.2699166412384243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211048687","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000034540968,0.9694099,0.00006312186,0.0005314431,0.02253973,0.002450663,0.00012744717,0.00028682512,0.004556352],"genre_scores_gemma":[0.000021836691,0.89041907,0.00017247215,0.0011066463,0.098507166,0.0009373283,0.008093361,0.000393892,0.00034823915],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98422194,0.0035206494,0.002323258,0.002303767,0.006331559,0.0012988138],"domain_scores_gemma":[0.994542,0.0006558905,0.0006486924,0.003220574,0.00029616582,0.00063670066],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.009637168,0.0019607502,0.012901374,0.00248374,0.00042979993,0.000031237716,0.0009962685,0.0010321081,0.006419902],"category_scores_gemma":[0.0005710236,0.0013918717,0.008671703,0.00355207,0.0011518877,0.0001595077,0.0003122655,0.0032284623,0.000025247607],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008602463,0.0003789832,0.000016284592,0.004788692,0.020442078,0.000814797,0.00071804674,0.000014957198,0.0000016963776,0.00001883395,0.09613895,0.87580645],"study_design_scores_gemma":[0.02773976,0.0020777143,0.000024470086,0.008736993,0.0186859,0.0022885571,0.00084778486,0.000024486946,2.161547e-7,0.000011230574,0.9384613,0.0011015653],"about_ca_topic_score_codex":0.0010368386,"about_ca_topic_score_gemma":0.0000043845703,"teacher_disagreement_score":0.8747049,"about_ca_system_score_codex":0.00092956086,"about_ca_system_score_gemma":0.00055475516,"threshold_uncertainty_score":0.9993136},"labels":[],"label_agreement":null},{"id":"W4211065388","doi":"10.22541/au.161038657.70133032/v1","title":"The FDA and PLATO investigators death lists: Call for a match","year":2021,"lang":"en","type":"preprint","venue":"","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"Institut de Cardiologie de Montréal; Johns Hopkins University","keywords":"Ticagrelor; Medicine; Stroke (engine); Sudden death; Clopidogrel; Sepsis; Emergency medicine; Internal medicine; Myocardial infarction","score_opus":0.02412349158708295,"score_gpt":0.27989641760643275,"score_spread":0.2557729260193498,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211065388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95155305,0.03997724,0.0028232054,0.0018279778,0.00035560527,0.0012516343,0.000041007752,0.00012099789,0.0020492969],"genre_scores_gemma":[0.98016775,0.009049797,0.002885355,0.0026245618,0.0005225739,0.0003639041,0.00027946488,0.00007709451,0.0040294947],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988307,0.000051938492,0.00022660175,0.00041928317,0.00023961403,0.00023190556],"domain_scores_gemma":[0.9988284,0.00013910583,0.000057751153,0.00060729595,0.00012370278,0.00024375074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002898542,0.000238975,0.00048398357,0.000029321578,0.00016031609,0.00013689317,0.00011363431,0.00024214487,0.000030673476],"category_scores_gemma":[0.00014147088,0.0001497133,0.0005303584,0.00004557334,0.00012533706,0.00002446966,0.00022005345,0.00029369388,0.0000025466122],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00759669,0.0016191996,0.28557155,0.024423888,0.07080744,0.003598197,0.01026534,0.00023928107,0.0020541607,0.080126345,0.18922704,0.32447085],"study_design_scores_gemma":[0.016319118,0.0007476848,0.09437029,0.0046473756,0.009624695,0.0017300462,0.009363501,0.0026724343,0.010134347,0.034416977,0.81291664,0.0030568927],"about_ca_topic_score_codex":0.00009439628,"about_ca_topic_score_gemma":0.00003529582,"teacher_disagreement_score":0.6236896,"about_ca_system_score_codex":0.000036265894,"about_ca_system_score_gemma":0.00038187887,"threshold_uncertainty_score":0.61051315},"labels":[],"label_agreement":null},{"id":"W4213304474","doi":"10.1503/cmaj.202863","title":"A practical approach to prescribing antiplatelet therapy in patients with acute coronary syndromes","year":2022,"lang":"en","type":"review","venue":"Canadian Medical Association Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McMaster University; Southlake Regional Health Center; University of Toronto; Toronto General Hospital; St. Michael's Hospital","funders":"","keywords":"Acute coronary syndrome; Medicine; Intensive care medicine; Platelet aggregation inhibitor; Psychological intervention; Cardiology; Residual risk; Internal medicine; Aspirin; Myocardial infarction","score_opus":0.03319403417229691,"score_gpt":0.29072942553788156,"score_spread":0.2575353913655847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213304474","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008093122,0.9861856,0.000067704736,0.0012171243,0.0005477439,0.0022384976,0.00018828483,0.00003976142,0.0014221668],"genre_scores_gemma":[0.0005253949,0.9952284,0.0002623627,0.002811624,0.00040505675,0.00010582301,0.0004155036,0.00008751504,0.00015833454],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99461067,0.0007574473,0.00072689337,0.00042688294,0.0027419317,0.00073616236],"domain_scores_gemma":[0.99684995,0.00020611368,0.00034861668,0.00026187018,0.00016948968,0.0021639476],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016424187,0.00039039474,0.001724466,0.0005931424,0.00025884595,0.0000932697,0.0002744468,0.000606515,0.0024521088],"category_scores_gemma":[0.00057149015,0.00029107276,0.0006431355,0.0007309651,0.000036226404,0.0001472267,0.000038507504,0.0026102962,0.000049133934],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019397803,0.00037660918,0.009862688,0.0003363818,0.004513118,0.007446761,0.00009021705,0.0000011673109,2.3529656e-9,0.000014872007,0.014943277,0.9622209],"study_design_scores_gemma":[0.0030683507,0.00047205304,0.0067610173,0.0018465967,0.00079084677,0.0062391055,0.00006671725,0.0000033515385,1.0997262e-8,0.0000018417578,0.9804265,0.0003235997],"about_ca_topic_score_codex":0.00021291406,"about_ca_topic_score_gemma":0.00015472293,"teacher_disagreement_score":0.96548325,"about_ca_system_score_codex":0.0021635361,"about_ca_system_score_gemma":0.009620435,"threshold_uncertainty_score":0.99995416},"labels":[],"label_agreement":null},{"id":"W4213360021","doi":"10.3389/fcvm.2022.805525","title":"Antiplatelet Therapy for Atherothrombotic Disease in 2022—From Population to Patient-Centered Approaches","year":2022,"lang":"en","type":"review","venue":"Frontiers in Cardiovascular Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Medicine; P2Y12; Intensive care medicine; Aspirin; Perioperative; Population; Precision medicine; Platelet aggregation inhibitor; Cangrelor; Clopidogrel; Internal medicine; Surgery; Pathology","score_opus":0.07652124813326719,"score_gpt":0.2956367787349961,"score_spread":0.21911553060172892,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213360021","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015676203,0.9832798,0.0030424187,0.00009414087,0.0021367976,0.009400312,0.00032823457,0.000090870904,0.000059764432],"genre_scores_gemma":[0.0015397733,0.9878445,0.0010593527,0.00028565078,0.00083311746,0.0027454053,0.005357076,0.00029134605,0.00004376355],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9934257,0.0010368109,0.0014644604,0.0017322282,0.0015110677,0.0008297011],"domain_scores_gemma":[0.9969197,0.00017622304,0.00028152007,0.0020254317,0.000048300168,0.0005488045],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015244643,0.0010310237,0.006836104,0.0013742389,0.0001338249,0.000025789896,0.0004855297,0.00040281285,0.0002183345],"category_scores_gemma":[0.0003408629,0.0008612823,0.0048337323,0.0015062427,0.00013397724,0.000118680946,0.0001371422,0.000781245,0.000007426769],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011117733,0.00036747288,0.0036948372,0.0043391823,0.007622632,0.0006974049,0.0003308763,0.0003207325,2.1802481e-7,0.000005489834,0.0016597036,0.9798497],"study_design_scores_gemma":[0.008283626,0.00048102858,0.00374093,0.009695713,0.0051608165,0.000042484506,0.0003827342,0.0001257469,4.7828655e-7,0.00011524562,0.9711578,0.00081338326],"about_ca_topic_score_codex":0.00029410308,"about_ca_topic_score_gemma":0.0000075702455,"teacher_disagreement_score":0.9790363,"about_ca_system_score_codex":0.00088989525,"about_ca_system_score_gemma":0.00031874856,"threshold_uncertainty_score":0.9993838},"labels":[],"label_agreement":null},{"id":"W4214530973","doi":"10.1007/s12325-022-02061-0","title":"Effects of Ticagrelor and Clopidogrel on Coronary Microcirculation in Patients with Acute Myocardial Infarction","year":2022,"lang":"en","type":"article","venue":"Advances in Therapy","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Ticagrelor; Medicine; Clopidogrel; Cardiology; Internal medicine; Myocardial infarction; Acute coronary syndrome; Anesthesia","score_opus":0.002332707193131385,"score_gpt":0.21613047412250017,"score_spread":0.21379776692936878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214530973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909186,0.008276006,0.000038784547,0.000029834708,0.000087863205,0.00056370226,0.000005248303,0.000010653634,0.00006935303],"genre_scores_gemma":[0.99390924,0.005610386,0.00006361481,0.00028511172,0.00001939298,0.000058742466,0.000035346882,0.000012788791,0.000005384149],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992933,0.000087831024,0.00012374444,0.00016450838,0.00022890921,0.000101671474],"domain_scores_gemma":[0.9997511,0.00005268329,0.00004968056,0.000104292325,0.000018535064,0.000023709907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000776597,0.000089843976,0.00021525961,0.00010622324,0.000037370144,0.0000019882177,0.000031104333,0.000024345143,0.000012714688],"category_scores_gemma":[0.000004422784,0.00007461657,0.000055224693,0.00018114963,0.000050170762,0.00009887227,0.000011608542,0.0001139302,5.146926e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009908904,0.0004647181,0.77300584,0.00003983423,0.0002672862,0.000038800703,0.00029822,0.00065025047,0.00076373987,0.000078503275,0.0000043062087,0.21447958],"study_design_scores_gemma":[0.01056963,0.0017154213,0.98477846,0.000047586935,0.00003863038,0.000010253221,0.00004378222,0.000016025995,0.000642295,0.00020341108,0.0018485704,0.00008594086],"about_ca_topic_score_codex":0.00000516286,"about_ca_topic_score_gemma":9.378021e-7,"teacher_disagreement_score":0.21439363,"about_ca_system_score_codex":0.00005101527,"about_ca_system_score_gemma":0.000021015134,"threshold_uncertainty_score":0.3042775},"labels":[],"label_agreement":null},{"id":"W4214564816","doi":"10.1016/j.cjca.2022.02.022","title":"The Evolution of Antiplatelet Therapy After Percutaneous Coronary Interventions: A 40-Year Journey","year":2022,"lang":"en","type":"review","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Population Health Research Institute; University of Alberta; Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Medicine; Clopidogrel; Aspirin; Percutaneous coronary intervention; Conventional PCI; Coronary artery disease; Intensive care medicine; Acute coronary syndrome; Clinical trial; Angina; Internal medicine; P2Y12; Cardiology; Myocardial infarction","score_opus":0.04476577629461695,"score_gpt":0.3016952023936917,"score_spread":0.25692942609907476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214564816","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011875894,0.99618673,0.00013436793,0.000058972575,0.0011410172,0.0004927844,0.00014581623,0.0000055847854,0.000647155],"genre_scores_gemma":[0.031960484,0.9668451,0.000019203851,0.00003876331,0.0008657173,0.000024581333,0.000037159745,0.000057620415,0.00015139024],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968236,0.0011158433,0.0011155488,0.00021213743,0.00032031437,0.00041253908],"domain_scores_gemma":[0.9978375,0.00025764763,0.00069869106,0.0005121838,0.0002443588,0.000449664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011912478,0.00032040983,0.0024320793,0.00053653814,0.0002345404,0.000024616276,0.00042982912,0.0003004696,0.00045061056],"category_scores_gemma":[0.00019680722,0.00021071275,0.0054456214,0.00029141753,0.00040486446,0.000052891195,0.000029876423,0.00096904434,0.00001148928],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077620783,0.000011521641,0.00043190873,0.0017053601,0.0089653265,0.009642337,0.000065234555,0.000031081803,5.2622903e-7,0.000088342495,0.0038359214,0.97444624],"study_design_scores_gemma":[0.0006448642,0.00072797027,0.0004457014,0.0028685096,0.0022750637,0.08465742,0.00031415082,2.3498792e-7,8.758941e-8,0.000066728,0.9078397,0.00015956513],"about_ca_topic_score_codex":0.00013836907,"about_ca_topic_score_gemma":0.00010435947,"teacher_disagreement_score":0.9742867,"about_ca_system_score_codex":0.00071767124,"about_ca_system_score_gemma":0.0048885006,"threshold_uncertainty_score":0.86719894},"labels":[],"label_agreement":null},{"id":"W4214670214","doi":"10.1161/jaha.121.024291","title":"Ticagrelor Monotherapy or Dual Antiplatelet Therapy After Drug‐Eluting Stent Implantation: Per‐Protocol Analysis of the GLOBAL LEADERS Trial","year":2022,"lang":"en","type":"article","venue":"Journal of the American Heart Association","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Ticagrelor; Myocardial infarction; Clinical endpoint; Intention-to-treat analysis; Internal medicine; Randomized controlled trial; Protocol (science); Population; Drug-eluting stent; Stent; Clinical trial; Percutaneous coronary intervention; Cardiology; Surgery","score_opus":0.02045791873116844,"score_gpt":0.31661788789813183,"score_spread":0.2961599691669634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214670214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910956,0.0001601301,0.000026803551,0.0028300642,0.00029555446,0.005514282,0.000047067402,0.000009632847,0.000020855181],"genre_scores_gemma":[0.9966254,0.000084234765,0.00007788486,0.002018398,0.00032678587,0.000704356,0.0000024827978,0.000015320496,0.00014512498],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99662215,0.0010583873,0.0006479093,0.0001462661,0.0013015638,0.00022375201],"domain_scores_gemma":[0.99799746,0.00019872088,0.0012355822,0.0002905047,0.00021256488,0.00006514223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014236361,0.00014698389,0.0008442028,0.000117863376,0.0002688956,0.000026074522,0.00019306508,0.00003217875,0.00023083057],"category_scores_gemma":[0.00012202829,0.00008019532,0.0019174509,0.001359569,0.000108929395,0.00008151006,0.000048887367,0.00030404943,0.0000011818354],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10553043,0.0005609493,0.86457187,0.000014185651,0.013175277,0.000025231373,0.0014466933,0.0018478555,0.0010139804,0.0000042988554,0.0017009006,0.0101083405],"study_design_scores_gemma":[0.033310547,0.001656399,0.9396937,0.00004162162,0.003103502,0.00024380727,0.0037448162,0.00021537177,0.0008844361,0.000025256126,0.016892932,0.00018762462],"about_ca_topic_score_codex":0.00006681967,"about_ca_topic_score_gemma":0.000011486,"teacher_disagreement_score":0.075121835,"about_ca_system_score_codex":0.00053809496,"about_ca_system_score_gemma":0.0003514275,"threshold_uncertainty_score":0.32702702},"labels":[],"label_agreement":null},{"id":"W4214757611","doi":"10.3410/f.733867970.793554958","title":"Faculty Opinions recommendation of Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial.","year":2019,"lang":"en","type":"dataset","venue":"Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Sanofi; AstraZeneca; Servier; Daiichi-Sankyo; Cilag; Kowa Company; Bristol-Myers Squibb","keywords":"Aspirin; Medicine; Placebo; Disease; Double blind; Randomized controlled trial; Internal medicine; Physical therapy; Intensive care medicine; Alternative medicine; Pathology","score_opus":0.044483739229390314,"score_gpt":0.35060113698245604,"score_spread":0.30611739775306573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214757611","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00614429,0.0040567312,0.00009134381,0.0021459332,0.0006672851,0.01666804,0.9702053,0.000014457966,0.0000066191246],"genre_scores_gemma":[0.002559067,0.0038912683,0.00019333888,0.0002524732,0.00015099124,0.0010356808,0.9917555,0.0000509305,0.00011073516],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9895041,0.0026105216,0.003515334,0.00092529575,0.0030466458,0.0003981186],"domain_scores_gemma":[0.98627883,0.00037750145,0.0034828633,0.0029292828,0.006416349,0.00051517045],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003982469,0.0007376948,0.004253479,0.00083217456,0.00011716866,0.000024798372,0.00096466125,0.0007045309,0.0001464521],"category_scores_gemma":[0.010277117,0.0004956765,0.005532782,0.0018474065,0.0003107313,0.00032856668,0.0004494305,0.0008579055,0.000010982037],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.35343724,0.0027367976,0.00024293918,0.011486076,0.011349881,8.2950646e-7,0.00013532043,0.00014449477,0.0000014531278,0.0000074366717,0.61880064,0.0016568652],"study_design_scores_gemma":[0.3609997,0.0005259722,0.0030675214,0.011040716,0.006621267,0.0000027055737,0.000011379393,0.00003221768,0.000049031085,0.000004362177,0.61733615,0.0003089932],"about_ca_topic_score_codex":0.00022813477,"about_ca_topic_score_gemma":0.0000036068743,"teacher_disagreement_score":0.021550216,"about_ca_system_score_codex":0.00016431569,"about_ca_system_score_gemma":0.000899332,"threshold_uncertainty_score":0.9997495},"labels":[],"label_agreement":null},{"id":"W4214905360","doi":"10.7326/j22-0008","title":"In patients with stroke or TIA and CYP2C19 loss-of-function alleles, ticagrelor vs. clopidogrel reduced 90-d stroke","year":2022,"lang":"en","type":"letter","venue":"Annals of Internal Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Clopidogrel; Medicine; Ticagrelor; Aspirin; Stroke (engine); CYP2C19; Internal medicine; P2Y12; Acute coronary syndrome; Cardiology; Myocardial infarction","score_opus":0.023588872884392906,"score_gpt":0.2818538128198007,"score_spread":0.2582649399354078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214905360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88276863,0.0059654852,0.00007713678,0.108313836,0.00074556976,0.0009794105,0.0003808382,0.000031589185,0.0007374981],"genre_scores_gemma":[0.69434077,0.004429074,0.00008141826,0.29008391,0.0028369392,0.00006376323,0.00096226035,0.00016170168,0.007040163],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967745,0.00016245406,0.0008447413,0.0005108381,0.001327116,0.0003803275],"domain_scores_gemma":[0.9982537,0.0001669023,0.0005226315,0.0005271644,0.00038071425,0.00014890249],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00038487147,0.00043614797,0.0015214657,0.00052823056,0.000034039356,0.0000061841265,0.00023380079,0.00032125448,0.0019565094],"category_scores_gemma":[0.0001837242,0.0002849894,0.00030768805,0.00021127898,0.00043332003,0.000102791986,0.00009339945,0.001259809,0.0000047392305],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.059964776,0.0006283291,0.07308846,0.0021807696,0.0072429813,0.0028133546,0.00046274415,0.0000053043163,0.00020183674,0.000020279505,0.8373484,0.01604276],"study_design_scores_gemma":[0.019668818,0.026226602,0.114045456,0.0052834046,0.001952078,0.0002693567,0.00026705168,0.000009869886,0.00066216,0.000059062386,0.83095586,0.0006002671],"about_ca_topic_score_codex":0.00032630784,"about_ca_topic_score_gemma":0.000009559089,"teacher_disagreement_score":0.18842788,"about_ca_system_score_codex":0.000039811246,"about_ca_system_score_gemma":0.00014758926,"threshold_uncertainty_score":0.99996024},"labels":[],"label_agreement":null},{"id":"W4220684633","doi":"10.29315/gm.v1i1.463","title":"Aspirina, Clopidogrel e Hemorragia Gastrointestinal: Qual a Evidência?","year":2022,"lang":"pt","type":"article","venue":"Gazeta Médica","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Clopidogrel; Medicine; Aspirin; Guideline; Gynecology; Internal medicine","score_opus":0.022150714898351836,"score_gpt":0.2667645380747363,"score_spread":0.2446138231763845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220684633","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82454944,0.13460866,0.0045784055,0.005924368,0.003764532,0.0027785262,0.0007329093,0.00097506214,0.02208808],"genre_scores_gemma":[0.9741649,0.00058330374,0.00034238753,0.0032064454,0.0012930968,0.00019291892,0.00025680897,0.0001786431,0.019781481],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99435616,0.00079977216,0.0007928538,0.0010452131,0.0018093932,0.0011966045],"domain_scores_gemma":[0.9972215,0.00015737719,0.00030330784,0.0014158665,0.00015115348,0.00075076177],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0012566368,0.00064446504,0.0011213551,0.00028546999,0.00087813876,0.00007574587,0.00069360813,0.000112160444,0.015992476],"category_scores_gemma":[0.00027510017,0.00068450125,0.0015251513,0.0008218283,0.0003125546,0.00013758751,0.0006208273,0.0013714897,0.0012093253],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011109484,0.009418189,0.18977082,0.0025692151,0.008103319,0.030370142,0.0043555717,0.0013531849,0.0031022253,0.0030339658,0.4870227,0.24979118],"study_design_scores_gemma":[0.0124975005,0.005733553,0.086128935,0.000942633,0.0036232313,0.014163954,0.006797672,0.0019303513,0.00017322466,0.00014670391,0.8661248,0.0017374502],"about_ca_topic_score_codex":0.00011462996,"about_ca_topic_score_gemma":0.0000065289296,"teacher_disagreement_score":0.37910208,"about_ca_system_score_codex":0.00042515015,"about_ca_system_score_gemma":0.0008500569,"threshold_uncertainty_score":0.99956834},"labels":[],"label_agreement":null},{"id":"W4220765412","doi":"10.1007/s11886-022-01645-0","title":"Antiplatelet Therapy in Patients Undergoing Elective Percutaneous Coronary Intervention","year":2022,"lang":"en","type":"review","venue":"Current Cardiology Reports","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute; Toronto General Hospital","funders":"","keywords":"Medicine; Prasugrel; Clopidogrel; Discontinuation; Percutaneous coronary intervention; Ticagrelor; Conventional PCI; Aspirin; P2Y12; Internal medicine; Cardiology; Platelet aggregation inhibitor; Myocardial infarction","score_opus":0.04280515360592995,"score_gpt":0.3303405560571217,"score_spread":0.28753540245119175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220765412","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.037359323,0.95740616,0.00001743597,0.0000017143445,0.002529894,0.0021517987,0.000031967113,0.000103240134,0.00039847937],"genre_scores_gemma":[0.021259949,0.97489166,0.000004693058,0.000020056194,0.00029411862,0.00027929663,0.0030850088,0.00010721597,0.000057980327],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956503,0.001043824,0.0012241949,0.001081488,0.00047219818,0.0005279795],"domain_scores_gemma":[0.99811494,0.00018821655,0.0006439487,0.0008289454,0.00008294478,0.00014101136],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006735578,0.000644344,0.003498529,0.0003572257,0.00013285952,0.000016741194,0.00014850595,0.00039235264,0.0002916583],"category_scores_gemma":[0.00016958248,0.00055842695,0.0033103807,0.0004221655,0.000120443314,0.00007262909,0.00015843312,0.0011752049,0.000017466038],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024312965,0.00034917943,0.027082162,0.0030727067,0.002492034,0.014158886,0.000031321408,0.0000058501723,8.2532175e-8,0.0000022065765,0.00032820713,0.9522342],"study_design_scores_gemma":[0.0015621373,0.0009803367,0.006161899,0.004461418,0.0015563006,0.03912708,0.00002662239,4.856431e-7,1.9347796e-7,0.000046082794,0.9455633,0.0005141207],"about_ca_topic_score_codex":0.0000052491832,"about_ca_topic_score_gemma":0.0000010308446,"teacher_disagreement_score":0.9517201,"about_ca_system_score_codex":0.0006124601,"about_ca_system_score_gemma":0.00054885686,"threshold_uncertainty_score":0.9996867},"labels":[],"label_agreement":null},{"id":"W4220794714","doi":"10.14309/ajg.0000000000001627","title":"American College of Gastroenterology-Canadian Association of Gastroenterology Clinical Practice Guideline: Management of Anticoagulants and Antiplatelets During Acute Gastrointestinal Bleeding and the Periendoscopic Period","year":2022,"lang":"en","type":"article","venue":"The American Journal of Gastroenterology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":154,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Population Health Research Institute; St. Paul's Hospital; McMaster University; St. Joseph’s Healthcare Hamilton; University of British Columbia; McGill University","funders":"Agency for Healthcare Research and Quality","keywords":"Medicine; Dabigatran; Warfarin; Rivaroxaban; Fresh frozen plasma; Gastrointestinal bleeding; Apixaban; Prothrombin complex concentrate; Hemostasis; Guideline; Vitamin K antagonist; Intensive care medicine; Internal medicine; Anesthesia; Atrial fibrillation; Platelet","score_opus":0.00804483264764963,"score_gpt":0.2792878471288506,"score_spread":0.2712430144812009,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220794714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915638,0.00023432558,0.0005678955,0.006964589,0.00015439918,0.00036735093,0.0001229103,0.000006241238,0.000018511033],"genre_scores_gemma":[0.9929735,0.0015244755,0.0040476266,0.0013109042,0.00009006999,0.000009858297,0.000006185283,0.0000274576,0.0000099428025],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99496955,0.0019384006,0.0016181582,0.00029637967,0.00057391665,0.00060361216],"domain_scores_gemma":[0.99531704,0.00029153336,0.0033771,0.0003681533,0.0004044936,0.00024170104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003295285,0.000263172,0.0019506954,0.0003201949,0.00020627805,0.0000080555765,0.00039679822,0.000027110784,0.000030167876],"category_scores_gemma":[0.00019777524,0.00018754153,0.00046813276,0.00025026343,0.0023774323,0.000097499906,0.00029358125,0.0006440476,2.465484e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12132392,0.00029155516,0.87021595,0.00006649626,0.0050994065,0.00080127374,0.00033993841,0.00011507129,0.0008563986,0.000039170485,0.00014614686,0.00070468837],"study_design_scores_gemma":[0.020323666,0.048568673,0.8590068,0.00017894356,0.004417104,0.050585844,0.016168695,0.00028664258,0.000050795494,0.000024966264,0.00027951907,0.00010829863],"about_ca_topic_score_codex":0.00025721008,"about_ca_topic_score_gemma":0.00011725845,"teacher_disagreement_score":0.10100026,"about_ca_system_score_codex":0.00010275748,"about_ca_system_score_gemma":0.000111481306,"threshold_uncertainty_score":0.87597483},"labels":[],"label_agreement":null},{"id":"W4220848810","doi":"10.1093/jcag/gwac010","title":"American College of Gastroenterology-Canadian Association of Gastroenterology Clinical Practice Guideline: Management of Anticoagulants and Antiplatelets During Acute Gastrointestinal Bleeding and the Periendoscopic Period","year":2022,"lang":"en","type":"review","venue":"Journal of the Canadian Association of Gastroenterology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Population Health Research Institute; St. Paul's Hospital; McMaster University; St. Joseph’s Healthcare Hamilton; University of British Columbia; McGill University","funders":"Agency for Healthcare Research and Quality","keywords":"Medicine; Dabigatran; Warfarin; Rivaroxaban; Fresh frozen plasma; Apixaban; Gastrointestinal bleeding; Guideline; Prothrombin complex concentrate; Hemostasis; Internal medicine; Intensive care medicine; Gastroenterology; Atrial fibrillation; Platelet","score_opus":0.01637136209354037,"score_gpt":0.3042988099732552,"score_spread":0.2879274478797148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220848810","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93704134,0.051386893,0.000056183093,0.007356986,0.0009654069,0.0016400815,0.0014537626,0.000007782414,0.00009158558],"genre_scores_gemma":[0.40503982,0.5923041,0.0015354563,0.00072452356,0.00019350565,0.000017400178,0.00004539411,0.00006324848,0.000076550896],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9922999,0.0027644192,0.002988951,0.00036083857,0.000832346,0.000753557],"domain_scores_gemma":[0.98903334,0.00048544546,0.008866831,0.00042523385,0.0007495194,0.00043961377],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0051647276,0.0004149898,0.003917922,0.0007258002,0.00021703781,0.000015013706,0.0005394626,0.00022121127,0.000055596985],"category_scores_gemma":[0.0011594692,0.00031205924,0.001348686,0.0003149352,0.00070418126,0.00011954359,0.00019806085,0.0010557296,3.477773e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009078382,0.00025746526,0.96267694,0.0024740319,0.019363763,0.0006046345,0.0001990395,0.000024018953,0.000012652139,0.000057307494,0.001156044,0.0040957467],"study_design_scores_gemma":[0.05130964,0.022481399,0.6691439,0.010853211,0.06339636,0.03923262,0.0044573047,0.00012804379,0.000007772258,0.000042633976,0.13836756,0.00057951827],"about_ca_topic_score_codex":0.0031370858,"about_ca_topic_score_gemma":0.034492947,"teacher_disagreement_score":0.5409172,"about_ca_system_score_codex":0.0011143257,"about_ca_system_score_gemma":0.00093060883,"threshold_uncertainty_score":0.9999331},"labels":[],"label_agreement":null},{"id":"W4220885541","doi":"10.1055/s-0042-1743469","title":"Aspirin for Primary Cardiovascular Prevention in Patients with Diabetes: Uncertainties and Opportunities","year":2022,"lang":"en","type":"review","venue":"Thrombosis and Haemostasis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute; Montreal Clinical Research Institute; Université de Montréal","funders":"","keywords":"Medicine; Aspirin; Dosing; Diabetes mellitus; Pharmacodynamics; Regimen; Population; Randomized controlled trial; Clinical trial; Pharmacology; Intensive care medicine; Pharmacokinetics; Internal medicine; Endocrinology","score_opus":0.11946825174271258,"score_gpt":0.3167055431298964,"score_spread":0.19723729138718382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220885541","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02167393,0.9755234,0.000018498838,0.000022090446,0.00004810661,0.0023035398,0.00024510373,0.000033830212,0.00013146049],"genre_scores_gemma":[0.00028462845,0.996933,0.00013517271,0.000115065595,0.000049046565,0.0006663103,0.0016663714,0.00007873347,0.000071706796],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981816,0.00020311422,0.0003926842,0.000516423,0.00040792875,0.00029824203],"domain_scores_gemma":[0.99916923,0.00009874332,0.00014205954,0.00041783432,0.00005161465,0.000120499804],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004748668,0.0004149622,0.002524731,0.00023277418,0.00017166628,0.00004546724,0.0000767234,0.00015225146,0.00006804793],"category_scores_gemma":[0.000013234395,0.00031666385,0.00097218435,0.00015293028,0.00016221256,0.00011302027,0.00009132807,0.00019657702,4.6028384e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008363936,0.00015266275,0.0016087967,0.02077227,0.0053970465,0.0000054036086,0.000061888226,6.314225e-7,7.9882945e-9,0.000029676234,0.00008188668,0.9718061],"study_design_scores_gemma":[0.0030436753,0.0007011716,0.0059523596,0.006244691,0.0104222,0.0000047045282,0.0001737918,7.921241e-7,3.098399e-7,0.000026167363,0.97302824,0.000401906],"about_ca_topic_score_codex":0.000010816446,"about_ca_topic_score_gemma":0.0000018625458,"teacher_disagreement_score":0.97294635,"about_ca_system_score_codex":0.000111325164,"about_ca_system_score_gemma":0.00020660223,"threshold_uncertainty_score":0.99992853},"labels":[],"label_agreement":null},{"id":"W4220908793","doi":"10.1016/s0735-1097(22)02023-x","title":"REAL-WORLD EFFICACY AND SAFETY OF DUAL ANTIPLATELET THERAPY WITH TICAGRELOR AS COMPARED TO CLOPIDOGREL IN ACUTE CORONARY SYNDROME PATIENTS TREATED WITH PERCUTANEOUS CORONARY INTERVENTION","year":2022,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Seven Oaks General Hospital","funders":"","keywords":"Medicine; Ticagrelor; Clopidogrel; Acute coronary syndrome; Percutaneous coronary intervention; Cardiology; Internal medicine; Aspirin; Myocardial infarction","score_opus":0.008233266668332831,"score_gpt":0.2500585319779748,"score_spread":0.24182526530964196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220908793","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983033,0.00038323618,0.000012536882,0.00026158828,0.000071509945,0.0006936873,0.00017527281,0.0000072020484,0.00009167201],"genre_scores_gemma":[0.99870324,0.0008442522,0.00016008818,0.0001437803,0.000021495904,0.000008035049,0.000016827806,0.000028322427,0.00007392796],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978621,0.0006340851,0.0005989232,0.00020454607,0.00048956333,0.00021077746],"domain_scores_gemma":[0.99857634,0.00015583333,0.00064584555,0.0002996243,0.00020558345,0.00011674185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003276575,0.00020004074,0.0014409837,0.00029145964,0.00008449053,0.0000023721805,0.00019028252,0.000028656405,0.000027182077],"category_scores_gemma":[0.00001835862,0.00012439612,0.00036327395,0.0006813685,0.0004826625,0.000043456235,0.00010184494,0.00028941446,3.6971906e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14507274,0.00055749377,0.82844526,0.00003182356,0.0061200843,0.010848001,0.00015702276,0.0031663338,0.0010396084,0.000013976235,0.00020767617,0.0043399595],"study_design_scores_gemma":[0.01063129,0.019508515,0.91488904,0.00018719462,0.0006227977,0.052701864,0.00067546905,0.000011855492,0.00009844734,0.000005450689,0.00053599436,0.00013209172],"about_ca_topic_score_codex":0.000057681584,"about_ca_topic_score_gemma":0.000009419983,"teacher_disagreement_score":0.13444145,"about_ca_system_score_codex":0.00013206256,"about_ca_system_score_gemma":0.00017445532,"threshold_uncertainty_score":0.5072726},"labels":[],"label_agreement":null},{"id":"W4220942019","doi":"10.12688/f1000research.109321.1","title":"CYP2C19 polymorphism and coronary in-stent restenosis: A systematic review and meta-analysis","year":2022,"lang":"en","type":"review","venue":"F1000Research","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Meta-analysis; Medicine; Internal medicine; Genotype; Population; Oncology; Biology; Genetics; Gene","score_opus":0.1896324167140849,"score_gpt":0.4015528227810657,"score_spread":0.2119204060669808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220942019","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000065202744,0.9928326,0.0000021243538,0.00032732674,0.00001309299,0.0063961195,0.00015323093,0.00003696245,0.00023200864],"genre_scores_gemma":[0.000032806118,0.99282295,0.000016887598,0.0004943771,0.000022238182,0.0033031076,0.00025996155,0.00008173398,0.0029659362],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9937649,0.0025107148,0.0011037771,0.00085354823,0.0012921324,0.00047492588],"domain_scores_gemma":[0.9974457,0.0005992683,0.00023965714,0.001282835,0.00007134438,0.00036116285],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0030815366,0.000526083,0.0111330515,0.0010175768,0.00014349274,0.000055768334,0.00032757767,0.00018188162,0.002449733],"category_scores_gemma":[0.00027475704,0.00034344534,0.0043655722,0.0018462351,0.00017314724,0.00006735289,0.0004481631,0.0008260753,0.000034397868],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016437834,0.00008337909,0.000013110549,0.74504143,0.24357063,0.0010410025,0.000020062462,8.9517e-8,1.9270598e-8,0.000028101294,0.00019783372,0.009987931],"study_design_scores_gemma":[0.00027688476,0.00011437387,0.000043089374,0.028249789,0.8017361,0.0009711396,0.00005133173,0.0000018299078,2.1593202e-8,0.0000060649077,0.16829087,0.00025846082],"about_ca_topic_score_codex":0.00006421013,"about_ca_topic_score_gemma":0.000006655062,"teacher_disagreement_score":0.7167916,"about_ca_system_score_codex":0.00014916279,"about_ca_system_score_gemma":0.00032450497,"threshold_uncertainty_score":0.9999018},"labels":[],"label_agreement":null},{"id":"W4221011484","doi":"10.1016/j.ahj.2022.03.008","title":"Balance of benefit and risk of ticagrelor in patients with diabetes and stable coronary artery disease according to bleeding risk assessment with the CRUSADE score: Data from THEMIS and THEMIS PCI","year":2022,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute; University of Toronto; St. Michael's Hospital","funders":"AstraZeneca France; Agence Nationale de la Recherche","keywords":"Ticagrelor; Medicine; Internal medicine; TIMI; Myocardial infarction; Cardiology; Stroke (engine); Coronary artery disease; Population; Diabetes mellitus; Conventional PCI; Aspirin; Percutaneous coronary intervention","score_opus":0.010977815153918751,"score_gpt":0.24035605833965773,"score_spread":0.229378243185739,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221011484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99649525,0.0025258157,0.000066375585,0.00021341215,0.0000113162605,0.0002460834,0.00042981247,0.00000433751,0.0000075892376],"genre_scores_gemma":[0.9975427,0.0015282842,0.00068487605,0.0001578958,0.000031213047,0.000010156846,0.000025356345,0.000016951997,0.0000026014],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988637,0.00012240517,0.00018647229,0.000242465,0.00040009816,0.00018485422],"domain_scores_gemma":[0.9990076,0.00022640711,0.00020283225,0.00031733947,0.000050210925,0.00019562461],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039501142,0.00012627985,0.0004136952,0.000056369292,0.00020333339,0.000025666028,0.00010746365,0.000008802731,0.000027621973],"category_scores_gemma":[0.000036685113,0.00007713458,0.00003684038,0.00017915097,0.00024296946,0.00013446777,0.00018148459,0.0002712629,5.276877e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013230381,0.00011596868,0.98273534,0.000019560812,0.0006216909,0.000015039459,0.00021587145,0.000107478576,0.0002643836,6.462545e-7,0.00005487463,0.014526083],"study_design_scores_gemma":[0.0019417164,0.0008321508,0.9926415,0.00018765694,0.00059833296,0.00002793363,0.0030162567,0.00048315641,0.000053738524,0.000022018612,0.00009503163,0.00010049231],"about_ca_topic_score_codex":0.0001167277,"about_ca_topic_score_gemma":0.000004907955,"teacher_disagreement_score":0.014425591,"about_ca_system_score_codex":0.000024570014,"about_ca_system_score_gemma":0.00007935944,"threshold_uncertainty_score":0.3145457},"labels":[],"label_agreement":null},{"id":"W4221056151","doi":"10.1161/circinterventions.120.009495","title":"Ticagrelor With or Without Aspirin in Chinese Patients Undergoing Percutaneous Coronary Intervention: A TWILIGHT China Substudy.","year":2022,"lang":"en","type":"article","venue":"PubMed","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences","funders":"","keywords":"Ticagrelor; Medicine; Aspirin; Percutaneous coronary intervention; Hazard ratio; Myocardial infarction; Clinical endpoint; Placebo; Internal medicine; Randomized controlled trial; Cardiology; Stroke (engine); Confidence interval","score_opus":0.009131076314596386,"score_gpt":0.2199823150364894,"score_spread":0.21085123872189301,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221056151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99619126,0.00095704,0.000025374766,0.00015610707,0.00014907154,0.0015870257,0.000011999508,0.00008330677,0.00083884073],"genre_scores_gemma":[0.9968946,0.000055933204,0.0000359321,0.0002546914,0.00005388788,0.0011426719,0.00008204487,0.000042840587,0.0014374035],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998327,0.00016076307,0.00026305005,0.00035491702,0.0005325074,0.00036172284],"domain_scores_gemma":[0.99938744,0.000040324816,0.000070076196,0.0003125676,0.000032838438,0.00015674901],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026510775,0.00020175516,0.00040776673,0.00013696309,0.00014602435,0.000018833904,0.0001307264,0.00003361137,0.00040823466],"category_scores_gemma":[0.000051474988,0.00013920297,0.0002242222,0.00040269765,0.000055697732,0.00009061844,0.00010743868,0.00025349812,0.0000075190587],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006638863,0.0012249,0.91751945,0.00011290085,0.0004710474,0.002000536,0.00042856636,0.000067320034,0.000001780823,0.0000066518205,0.000047011228,0.07148099],"study_design_scores_gemma":[0.0077672615,0.000800542,0.9876638,0.000052295236,0.0001688714,0.0017717037,0.000414711,0.000059355716,0.000005376237,0.000021387794,0.0010736348,0.00020106537],"about_ca_topic_score_codex":0.000033367876,"about_ca_topic_score_gemma":0.00015169893,"teacher_disagreement_score":0.07127992,"about_ca_system_score_codex":0.00019968425,"about_ca_system_score_gemma":0.000067352,"threshold_uncertainty_score":0.56765324},"labels":[],"label_agreement":null},{"id":"W4221116726","doi":"10.1093/ehjcvp/pvac016","title":"Ticagrelor monotherapy after PCI in patients with concomitant diabetes mellitus and chronic kidney disease: TWILIGHT DM-CKD","year":2022,"lang":"en","type":"article","venue":"European Heart Journal - Cardiovascular Pharmacotherapy","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Population Health Research Institute; Genome Prairie","funders":"","keywords":"Medicine; Ticagrelor; Internal medicine; Aspirin; Kidney disease; Hazard ratio; Percutaneous coronary intervention; Conventional PCI; Myocardial infarction; Stroke (engine); Clinical endpoint; Coronary artery disease; Cardiology; Diabetes mellitus; Randomized controlled trial; Confidence interval; Endocrinology","score_opus":0.008917903158099448,"score_gpt":0.23306240266298348,"score_spread":0.22414449950488402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221116726","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79986864,0.19780524,0.00015547605,0.000523581,0.00031947633,0.0009792522,0.00007372417,0.00007761794,0.00019701183],"genre_scores_gemma":[0.97786736,0.015771322,0.00013289729,0.0049739303,0.00077859877,0.00008765118,0.00004669076,0.0002310884,0.00011046668],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99456173,0.0019352346,0.0005838377,0.0007082971,0.0014461726,0.000764743],"domain_scores_gemma":[0.99786645,0.000051571995,0.00012159984,0.00074388454,0.00014075404,0.0010757529],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016980853,0.0005325219,0.0010422459,0.00033468317,0.00044325538,0.00012436016,0.00024416656,0.00003899013,0.0013955102],"category_scores_gemma":[0.000019561503,0.00043203804,0.0016174633,0.00043962448,0.00019870019,0.000268886,0.0000877923,0.00092848745,0.00003251481],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014124767,0.0014819251,0.8185518,0.00028030205,0.018674262,0.0054123797,0.0008966052,0.0020826424,0.0011645895,0.0000073103183,0.003910868,0.13341258],"study_design_scores_gemma":[0.030535763,0.0010574824,0.39120898,0.00018816338,0.0010902178,0.0004208073,0.00005225403,0.00011732892,0.00040017706,0.000013116545,0.5742649,0.000650799],"about_ca_topic_score_codex":0.0000031135844,"about_ca_topic_score_gemma":1.3643168e-7,"teacher_disagreement_score":0.57035404,"about_ca_system_score_codex":0.00033544024,"about_ca_system_score_gemma":0.00032491374,"threshold_uncertainty_score":0.99981314},"labels":[],"label_agreement":null},{"id":"W4223424504","doi":"10.1111/jocs.16492","title":"Ticagrelor versus aspirin 2 years after coronary bypass: Observational analysis from the TARGET trial","year":2022,"lang":"en","type":"article","venue":"Journal of Cardiac Surgery","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"AstraZeneca","keywords":"Medicine; Ticagrelor; Aspirin; Surgery; Randomized controlled trial; Internal medicine; Cardiology; Stenosis; Observational study; Adverse effect; Thrombosis; Anesthesia; Clopidogrel","score_opus":0.037836435156343336,"score_gpt":0.2682176701110836,"score_spread":0.23038123495474028,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4223424504","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98171175,0.014400388,0.00004723286,0.000736398,0.0026470493,0.0001541144,0.00019805209,0.000010454366,0.00009454775],"genre_scores_gemma":[0.99638116,0.00054037524,0.00011319646,0.0008028808,0.0018577878,0.00002829626,0.00017596263,0.00001965326,0.000080695456],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99744594,0.0005515513,0.0005080007,0.00014697906,0.0011706499,0.000176898],"domain_scores_gemma":[0.9977931,0.0013695619,0.00026665238,0.00030394332,0.00013730653,0.0001294668],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015509457,0.00012405244,0.00081246666,0.00017243462,0.00010704164,0.000025357984,0.00011810994,0.000046256537,0.0021685],"category_scores_gemma":[0.00019264418,0.00009225088,0.0037636498,0.0005542382,0.000057245354,0.000108242,0.000057119243,0.00034402264,0.000011861302],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22078504,0.000373992,0.62983674,0.000008856032,0.05194892,0.0017717285,0.00020896521,0.0009471313,0.00006487146,0.000012661332,0.07235343,0.02168766],"study_design_scores_gemma":[0.0066952673,0.00020015525,0.81007075,0.000012885792,0.005938986,0.000041956297,0.0003647717,0.000015641413,0.000019807625,0.00003820298,0.17648089,0.0001206958],"about_ca_topic_score_codex":0.000015495507,"about_ca_topic_score_gemma":4.1582527e-7,"teacher_disagreement_score":0.21408977,"about_ca_system_score_codex":0.00010560654,"about_ca_system_score_gemma":0.00044552775,"threshold_uncertainty_score":0.99874365},"labels":[],"label_agreement":null},{"id":"W4223945435","doi":"10.46747/cfp.6804e127","title":"Variation in bleeding risk estimates among online calculators","year":2022,"lang":"en","type":"article","venue":"Canadian Family Physician","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Medicine; Atrial fibrillation; Population; Stroke (engine); Aspirin; Internal medicine; Risk factor","score_opus":0.010399681954974016,"score_gpt":0.22262698787931584,"score_spread":0.21222730592434183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4223945435","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934115,0.0013927973,0.00005120368,0.00008944239,0.00017446287,0.00027411664,0.00018168055,0.000044280925,0.0043805107],"genre_scores_gemma":[0.9910455,0.000042188913,0.00007235267,0.008354704,0.00017009326,0.000033190747,0.0002055432,0.000032301275,0.00004414165],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989319,0.00006444872,0.0001651487,0.0002543365,0.0002418271,0.00034237807],"domain_scores_gemma":[0.99935997,0.0000221107,0.0000543851,0.0002386262,0.000029269871,0.00029566002],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016508676,0.00013720852,0.00026358376,0.0002754924,0.00026136055,0.000016825423,0.000094549476,0.000040697938,0.000020563151],"category_scores_gemma":[0.00001522687,0.00015446063,0.0001868149,0.00050658395,0.000041754058,0.000085226966,0.00002162531,0.00029060722,0.00001129795],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004075533,0.0011143785,0.66199666,0.00018636644,0.0028263696,0.0029689923,0.0028188757,0.0419704,0.009771599,0.0027260436,0.005436546,0.26777622],"study_design_scores_gemma":[0.0010619892,0.00007599521,0.9823752,0.00004040473,0.00020748907,0.0000031942968,0.0015158581,0.0049707666,0.000041356958,0.00038236598,0.009119295,0.0002060984],"about_ca_topic_score_codex":0.048220534,"about_ca_topic_score_gemma":0.006522761,"teacher_disagreement_score":0.32037854,"about_ca_system_score_codex":0.00046968024,"about_ca_system_score_gemma":0.00036033394,"threshold_uncertainty_score":0.9581174},"labels":[],"label_agreement":null},{"id":"W4224002954","doi":"10.31083/j.rcm2304132","title":"Primary Causes of Death Reported to the FDA Suggest Less Ticagrelor Mortality Benefit than the List Issued to the PLATO Trial Investigators","year":2022,"lang":"en","type":"article","venue":"Reviews in Cardiovascular Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Medicine; Ticagrelor; Emergency medicine; Internal medicine; Myocardial infarction; Clopidogrel","score_opus":0.08394186482002965,"score_gpt":0.32283733639760764,"score_spread":0.238895471577578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224002954","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.65660584,0.32675686,0.00017370643,0.007906793,0.0008777917,0.007084617,0.000040577706,0.000045928315,0.00050787115],"genre_scores_gemma":[0.9520145,0.03233931,0.00007006604,0.010773256,0.0020740398,0.002166047,0.00014345312,0.00010240824,0.00031692712],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9928808,0.001848946,0.0015361452,0.0007797091,0.0024318923,0.0005224884],"domain_scores_gemma":[0.99478346,0.00033885965,0.00033211662,0.004003857,0.0001787107,0.00036299927],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013365928,0.0004815874,0.0025717444,0.00017621585,0.000476487,0.000020502312,0.0009382534,0.00009415523,0.00016388406],"category_scores_gemma":[0.002029954,0.00022453058,0.002355726,0.0018726569,0.0003548522,0.000052750678,0.00042649562,0.0007396289,0.00001905696],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026304139,0.0022078303,0.12518108,0.005034016,0.07117199,0.0050180177,0.027242173,0.015348536,0.0010512072,0.0027710341,0.11788667,0.60078335],"study_design_scores_gemma":[0.010110392,0.0006128223,0.084204234,0.0007974544,0.0054969,0.00051487674,0.0011775233,0.000012109095,0.00011372764,0.000040349863,0.8966138,0.00030584534],"about_ca_topic_score_codex":0.0017531345,"about_ca_topic_score_gemma":0.0002451384,"teacher_disagreement_score":0.7787271,"about_ca_system_score_codex":0.00023592,"about_ca_system_score_gemma":0.00031936364,"threshold_uncertainty_score":0.9156091},"labels":[],"label_agreement":null},{"id":"W4224239730","doi":"10.1038/s41397-022-00278-4","title":"Point of care CYP2C19 genotyping after percutaneous coronary intervention","year":2022,"lang":"en","type":"review","venue":"The Pharmacogenomics Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Heart and Stroke Foundation; University of Ottawa; University of Alberta; Canadian VIGOUR Centre; University of Toronto; St. Michael's Hospital","funders":"National Heart, Lung, and Blood Institute; Foundation for the National Institutes of Health","keywords":"Genotyping; Conventional PCI; Medicine; Concordance; CYP2C19; Percutaneous coronary intervention; Randomized controlled trial; Internal medicine; Genotype; Biology; Myocardial infarction; Genetics","score_opus":0.034387172817612166,"score_gpt":0.3339072116909233,"score_spread":0.29952003887331113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224239730","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0034915954,0.9946332,0.00008194909,0.000022637325,0.0006734446,0.0007363997,0.00014572711,0.000018582634,0.00019647712],"genre_scores_gemma":[0.0070074997,0.99173707,0.00003841247,0.00014240744,0.0006970407,0.00003640894,0.00011811771,0.000103160135,0.00011988447],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99771273,0.00056039623,0.00080771785,0.00023453744,0.0004031478,0.00028144533],"domain_scores_gemma":[0.99873495,0.00008832673,0.00054257,0.0003816069,0.00008922534,0.00016333094],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00065743725,0.0003567923,0.0013640624,0.00018266849,0.00024206445,0.000031207644,0.00039220118,0.00009737975,0.0038071945],"category_scores_gemma":[0.000015244413,0.00024175922,0.0037274628,0.00014251334,0.00009329816,0.000049868453,0.0001903209,0.0011772237,0.00003090327],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056735444,0.000090219684,0.0000047777326,0.0066071567,0.0040552057,0.0026721375,0.00045515492,0.000017943852,0.000021243924,0.00000334129,0.00008830641,0.9854172],"study_design_scores_gemma":[0.0007710616,0.00019766374,0.0000060433326,0.0029334265,0.010888871,0.094444394,0.0004721003,0.000006730781,0.0000055068836,0.000014556461,0.8900427,0.00021692122],"about_ca_topic_score_codex":0.000003206972,"about_ca_topic_score_gemma":4.0984784e-7,"teacher_disagreement_score":0.9852002,"about_ca_system_score_codex":0.00052364124,"about_ca_system_score_gemma":0.00039279152,"threshold_uncertainty_score":0.99710345},"labels":[],"label_agreement":null},{"id":"W4224253158","doi":"10.1016/j.ejim.2022.04.014","title":"Dual antiplatelet treatment for minor acute ischemic stroke and high-risk transient ischemic attack: have we reached the limit of antithrombotic management?","year":2022,"lang":"en","type":"article","venue":"European Journal of Internal Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Aspirin; Clopidogrel; Stroke (engine); Antithrombotic; Minor stroke; Ticagrelor; Internal medicine; Cardiology; Platelet aggregation inhibitor; Acute coronary syndrome; Myocardial infarction; Stenosis","score_opus":0.021688201307344168,"score_gpt":0.2626616079443621,"score_spread":0.24097340663701794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224253158","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98389137,0.0086219665,0.0018768018,0.0019327983,0.00039592758,0.00047207763,0.000087923705,0.000012230536,0.0027088916],"genre_scores_gemma":[0.98756087,0.008824046,0.0005353876,0.00031689194,0.00053548266,0.0000065235768,0.000016150037,0.000051964067,0.0021526725],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99778354,0.00032619076,0.0007947508,0.00024269702,0.0006021212,0.0002507281],"domain_scores_gemma":[0.99862975,0.00013055235,0.00060884515,0.0003163906,0.00013157661,0.0001829046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001113636,0.0002671974,0.0007753823,0.00019743202,0.0001403403,0.000011259653,0.00024863947,0.00002019812,0.00019914651],"category_scores_gemma":[0.000041282387,0.00015786685,0.00050947955,0.00010467508,0.00025714457,0.000064675136,0.00007641638,0.00036605165,0.0000026513144],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037250075,0.0020025212,0.011813142,0.0008682983,0.051901788,0.019471424,0.010719942,0.0003815918,0.17458661,0.000054418826,0.18262531,0.50832486],"study_design_scores_gemma":[0.08854676,0.041249402,0.06075477,0.0031465802,0.02527902,0.024367172,0.015270463,0.0005592282,0.03283874,0.000012883293,0.7072632,0.0007118103],"about_ca_topic_score_codex":0.000012012159,"about_ca_topic_score_gemma":7.34745e-7,"teacher_disagreement_score":0.5246379,"about_ca_system_score_codex":0.0000730112,"about_ca_system_score_gemma":0.000035156314,"threshold_uncertainty_score":0.6437623},"labels":[],"label_agreement":null},{"id":"W4225097346","doi":"10.1007/s11239-022-02654-0","title":"Pharmacosimulation of delays and interruptions during administration of tirofiban: a systematic comparison between EU and US dosage regimens","year":2022,"lang":"en","type":"article","venue":"Journal of Thrombosis and Thrombolysis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Heinrich-Heine-Universität Düsseldorf; Deutsche Forschungsgemeinschaft; Medicure","keywords":"Tirofiban; Medicine; Antithrombotic; Dosing; Bolus (digestion); Conventional PCI; Clinical trial; Pharmacology; Intensive care medicine; Anesthesia; Internal medicine; Myocardial infarction","score_opus":0.035219973455589526,"score_gpt":0.3287514512178843,"score_spread":0.29353147776229477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225097346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99396247,0.0052708094,0.00028553183,0.0001654669,0.00003956591,0.00022162795,0.000025832347,0.000004891219,0.00002379352],"genre_scores_gemma":[0.9981417,0.0015922349,0.00017191216,0.000017764654,0.0000478336,0.0000042997995,0.000008015065,0.000011098056,0.0000051511092],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99852145,0.00017963181,0.00072529237,0.000121190875,0.0003627289,0.00008968118],"domain_scores_gemma":[0.9988806,0.0000959982,0.0006944511,0.00012717552,0.000105344916,0.000096411946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049245794,0.00011690656,0.0009883037,0.00019454584,0.00014161065,0.000015459464,0.000049135382,0.000038173795,0.00004415597],"category_scores_gemma":[0.000023539753,0.00009796168,0.00024812203,0.00016866963,0.00009304746,0.00013462192,0.000054248452,0.00014785901,8.945823e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011678254,0.0011821991,0.75004554,0.018443337,0.015195406,0.00004030762,0.005656552,0.0007068316,0.20562546,0.00019840342,0.00009097429,0.0016471834],"study_design_scores_gemma":[0.004070421,0.0015988055,0.95915914,0.002111173,0.009698879,0.00031931355,0.0044030435,0.001350905,0.017008351,0.00006228977,0.000034111177,0.00018358386],"about_ca_topic_score_codex":0.000009747469,"about_ca_topic_score_gemma":0.0000012880173,"teacher_disagreement_score":0.20911361,"about_ca_system_score_codex":0.000029991848,"about_ca_system_score_gemma":0.000032796368,"threshold_uncertainty_score":0.39947614},"labels":[],"label_agreement":null},{"id":"W4225127890","doi":"10.1093/ehjcvp/pvac032","title":"Cost–effectiveness of ticagrelor in patients with type 2 diabetes and coronary artery disease: a European economic evaluation of the THEMIS trial","year":2022,"lang":"en","type":"article","venue":"European Heart Journal - Cardiovascular Pharmacotherapy","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute; University of Toronto; St. Michael's Hospital","funders":"AstraZeneca","keywords":"Ticagrelor; Medicine; Percutaneous coronary intervention; Conventional PCI; Population; Coronary artery disease; Cost effectiveness; Aspirin; Myocardial infarction; Quality-adjusted life year; Stroke (engine); Internal medicine; Environmental health","score_opus":0.03805421151302679,"score_gpt":0.2911033223325112,"score_spread":0.2530491108194844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225127890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98026216,0.017451752,0.000013847615,0.000024979758,0.00033485843,0.0016640314,0.000030066612,0.0000110392075,0.0002072781],"genre_scores_gemma":[0.99880654,0.0007702711,0.000012484443,0.00011927691,0.00017704746,0.00002058856,0.000017246795,0.00006945372,0.0000070841484],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9909992,0.0071278336,0.00038630495,0.00027172096,0.001008762,0.00020615035],"domain_scores_gemma":[0.9989663,0.000084829546,0.000156027,0.0004599689,0.00018465192,0.00014826034],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006591395,0.00019500166,0.0005623922,0.00012103366,0.00016241896,0.000017250577,0.00017263308,0.000012796073,0.00019149062],"category_scores_gemma":[0.000036986123,0.00013830807,0.00088165357,0.00020009231,0.00013671406,0.00009755873,0.0000737102,0.0003231861,0.000003090815],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11940766,0.001785573,0.68313205,0.0003343127,0.018640326,0.00025039804,0.000766723,0.031681966,0.0050557517,0.0000053340063,0.00034677357,0.13859314],"study_design_scores_gemma":[0.08666616,0.0008094839,0.90462506,0.00018933798,0.0017233108,0.00011418823,0.000045081113,0.00015782125,0.00070579536,0.000010051326,0.004778704,0.00017501891],"about_ca_topic_score_codex":0.0000014396737,"about_ca_topic_score_gemma":6.2249725e-8,"teacher_disagreement_score":0.221493,"about_ca_system_score_codex":0.00013755138,"about_ca_system_score_gemma":0.00022201543,"threshold_uncertainty_score":0.5640039},"labels":[],"label_agreement":null},{"id":"W4225270777","doi":"10.1503/cmaj.202863-f","title":"Approche pratique à la prescription des antiplaquettaires chez les patients atteints de syndromes coronariens","year":2022,"lang":"fr","type":"article","venue":"Canadian Medical Association Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto; Toronto General Hospital; St. Michael's Hospital","funders":"","keywords":"Medicine; Gynecology; Medical prescription","score_opus":0.008358654162733892,"score_gpt":0.22392418580306775,"score_spread":0.21556553164033385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225270777","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9637748,0.019146737,0.00071157515,0.011680546,0.0020741585,0.00035838105,0.00024913816,0.00003681819,0.001967826],"genre_scores_gemma":[0.98119915,0.003693833,0.00014210334,0.0052231927,0.0020313438,0.00004850078,0.00014301098,0.00005794121,0.007460937],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9934887,0.0024064987,0.0005681883,0.00028521495,0.0022251094,0.0010262826],"domain_scores_gemma":[0.99647486,0.00026241562,0.000321556,0.00015981642,0.00042198654,0.0023593854],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00424894,0.0002585391,0.00044791066,0.00022029826,0.0014676931,0.00015211318,0.00030639992,0.0006001999,0.013001932],"category_scores_gemma":[0.0024847174,0.00027933743,0.00043528082,0.0003371213,0.00030003817,0.00025110203,0.000056900437,0.0021970626,0.00007096656],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00008299109,0.00038196496,0.59677607,0.000121614044,0.0014457474,0.002923718,0.003198469,0.0001077637,0.000017895687,0.00043319282,0.08491655,0.30959404],"study_design_scores_gemma":[0.0025394477,0.00028983215,0.32358056,0.00033408232,0.00035172355,0.0032865056,0.0034663342,0.00035194028,0.000019950376,0.00027369795,0.6652446,0.0002613701],"about_ca_topic_score_codex":0.004432673,"about_ca_topic_score_gemma":0.0034696506,"teacher_disagreement_score":0.580328,"about_ca_system_score_codex":0.004932125,"about_ca_system_score_gemma":0.008271264,"threshold_uncertainty_score":0.9999659},"labels":[],"label_agreement":null},{"id":"W4225286425","doi":"10.1002/ccd.30217","title":"Impact of proton pump inhibitors on efficacy of antiplatelet strategies with ticagrelor or aspirin after percutaneous coronary intervention: Insights from the GLOBAL LEADERS trial","year":2022,"lang":"en","type":"article","venue":"Catheterization and Cardiovascular Interventions","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Ticagrelor; Medicine; Aspirin; Percutaneous coronary intervention; Clopidogrel; Cardiology; Internal medicine; Platelet aggregation inhibitor; Myocardial infarction","score_opus":0.02617654216185241,"score_gpt":0.2982935096384817,"score_spread":0.27211696747662933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225286425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99161094,0.004071049,0.0019012716,0.00003230276,0.00014525504,0.001845813,0.00025775458,0.000039347196,0.000096283766],"genre_scores_gemma":[0.9990489,0.0001977364,0.000026513762,0.00003051992,0.00008672636,0.00023927465,0.00031071395,0.000028202852,0.000031396212],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99790096,0.00045539837,0.0005185285,0.00036780888,0.00059695437,0.00016037526],"domain_scores_gemma":[0.99896765,0.000053363987,0.00016949941,0.0005998386,0.00012238535,0.00008725552],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022026653,0.0002415008,0.0006167492,0.00009108855,0.00016830277,0.00003804295,0.00014525029,0.000069229725,0.0004348119],"category_scores_gemma":[0.00003409021,0.0001495296,0.0032688975,0.00035781367,0.00033348007,0.00011579933,0.00008911911,0.00018275606,0.000002379854],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6372164,0.016134895,0.06699773,0.0030241047,0.11574375,0.003944531,0.008659954,0.025162943,0.0021484117,0.0010252843,0.00017581436,0.119766176],"study_design_scores_gemma":[0.22021547,0.07272154,0.6384429,0.006533493,0.018953208,0.0075826766,0.025187323,0.0004938442,0.002616444,0.00044713946,0.0049244915,0.0018815194],"about_ca_topic_score_codex":0.00007945892,"about_ca_topic_score_gemma":0.000008501805,"teacher_disagreement_score":0.5714451,"about_ca_system_score_codex":0.00008545741,"about_ca_system_score_gemma":0.00014169242,"threshold_uncertainty_score":0.609764},"labels":[],"label_agreement":null},{"id":"W4225749775","doi":"10.1161/circinterventions.120.009495","title":"Ticagrelor With or Without Aspirin in Chinese Patients Undergoing Percutaneous Coronary Intervention: A TWILIGHT China Substudy","year":2022,"lang":"en","type":"article","venue":"Circulation Cardiovascular Interventions","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences","funders":"","keywords":"Medicine; Percutaneous coronary intervention; Aspirin; Ticagrelor; Conventional PCI; Internal medicine; Cardiology; Myocardial infarction","score_opus":0.01703757719179161,"score_gpt":0.2697097169436141,"score_spread":0.2526721397518225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225749775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9858214,0.0055850926,0.005716136,0.000069128735,0.00031301545,0.0017639055,0.00004047738,0.0001692848,0.0005215492],"genre_scores_gemma":[0.9980817,0.00008999295,0.00019203035,0.000075764096,0.00008482021,0.0003808024,0.00057107024,0.00008690572,0.00043691453],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99636316,0.0006215723,0.00073431083,0.00071954826,0.0011699667,0.00039143497],"domain_scores_gemma":[0.998517,0.000051408097,0.00015853188,0.0009249156,0.00017129567,0.00017686206],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00074928196,0.00037128132,0.00091292255,0.00045382118,0.00045030215,0.000056557852,0.00021712187,0.000080844744,0.0014140387],"category_scores_gemma":[0.00009292409,0.00030956775,0.0034384981,0.0009846843,0.00010105319,0.00024693456,0.0001731209,0.00045589518,0.000034225926],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017241604,0.002545137,0.95234555,0.0006268471,0.0071305293,0.001533241,0.00065757526,0.017115097,0.00001709179,0.000057700563,0.00003645969,0.016210625],"study_design_scores_gemma":[0.011757655,0.001270203,0.97591984,0.0007014944,0.0017598742,0.0043798713,0.0009848906,0.0011798984,0.0000052269447,0.00006776129,0.0015122897,0.00046101463],"about_ca_topic_score_codex":0.00007846121,"about_ca_topic_score_gemma":0.00016801423,"teacher_disagreement_score":0.023574285,"about_ca_system_score_codex":0.0004971533,"about_ca_system_score_gemma":0.00014867626,"threshold_uncertainty_score":0.9999356},"labels":[],"label_agreement":null},{"id":"W4226173040","doi":"10.1093/ehjcvp/pvac024","title":"Perioperative management of P2Y12 inhibitors in patients undergoing cardiac surgery within 1 year of PCI","year":2022,"lang":"en","type":"article","venue":"European Heart Journal - Cardiovascular Pharmacotherapy","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Data Storage Institute; Boston Scientific Corporation; CSL Behring; Chiesi Farmaceutici; Abbott Laboratories; Beth Israel Deaconess Medical Center; Novartis Pharmaceuticals Corporation; Bayer; AstraZeneca; Bristol-Myers Squibb Canada; Medtronic","keywords":"Medicine; Conventional PCI; Clopidogrel; Percutaneous coronary intervention; Perioperative; Myocardial infarction; Prasugrel; Cardiology; Ticagrelor; Internal medicine; Cardiac surgery; Odds ratio; Stent; Ejection fraction; Coronary artery disease; Surgery; Heart failure","score_opus":0.022972286795536728,"score_gpt":0.2649770647735248,"score_spread":0.24200477797798806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4226173040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9726794,0.02420267,0.00008483519,0.000044106597,0.0007973211,0.0006578157,0.00003240802,0.000026789769,0.0014746885],"genre_scores_gemma":[0.9917049,0.0072607216,0.00030010255,0.00021973165,0.0002696624,0.000015417721,0.000022870676,0.00010646695,0.000100140365],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9945455,0.002437997,0.0008770445,0.0003538747,0.0014417804,0.0003437748],"domain_scores_gemma":[0.9988447,0.0000687364,0.00023682318,0.00048628935,0.0001734959,0.00018996237],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003924799,0.0002784348,0.0011756439,0.0004038682,0.0002068206,0.000021848798,0.00017900397,0.000028292723,0.00033886076],"category_scores_gemma":[0.000017954708,0.00026592286,0.003371609,0.00059778075,0.000101891754,0.00015034531,0.00010359065,0.0005361007,0.00000965697],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006621387,0.002721419,0.7732803,0.0012275226,0.05786363,0.0029874365,0.005142272,0.026547443,0.008792753,0.00008559703,0.008120552,0.106609665],"study_design_scores_gemma":[0.041122682,0.0022123123,0.6000179,0.0017510392,0.0046162535,0.0010694726,0.009466675,0.00006469747,0.02763704,0.000026911548,0.31037307,0.0016419482],"about_ca_topic_score_codex":0.000009433361,"about_ca_topic_score_gemma":9.5244715e-8,"teacher_disagreement_score":0.3022525,"about_ca_system_score_codex":0.00016424076,"about_ca_system_score_gemma":0.0001660782,"threshold_uncertainty_score":0.9999793},"labels":[],"label_agreement":null},{"id":"W4229052821","doi":"10.1016/j.ahj.2022.05.005","title":"Morphine and clinical outcomes in patients with ST segment elevation myocardial infarction treated with fibrinolytic and antiplatelet therapy: Insights from the TREAT trial","year":2022,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Saskatchewan Health Authority; St. Michael's Hospital; Western University; London Health Sciences Centre; Canadian Heart Research Centre; Southlake Regional Health Center; Dalhousie University; Saskatchewan Health; University of Toronto","funders":"","keywords":"Medicine; Ticagrelor; Morphine; Myocardial infarction; Clopidogrel; Internal medicine; Anesthesia; Thrombolysis; Randomized controlled trial; Acute coronary syndrome; Hazard ratio; Cardiology; Aspirin; Confidence interval","score_opus":0.01422581331439064,"score_gpt":0.26239957293563876,"score_spread":0.24817375962124813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229052821","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99813867,0.00048098247,0.000018519046,0.0005928287,0.000057571073,0.00066423824,0.000023274702,0.000016589975,0.0000073322544],"genre_scores_gemma":[0.99770725,0.0009221391,0.00006614922,0.0010081576,0.00018783423,0.000020592723,0.00005597633,0.00002200486,0.000009924417],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99833745,0.00043168082,0.00031907004,0.00024681553,0.000492137,0.00017285523],"domain_scores_gemma":[0.99929625,0.00018343638,0.00015549353,0.0001830018,0.00005305338,0.00012876409],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023339411,0.00017502322,0.00056523684,0.00008840051,0.000288314,0.00004663232,0.000043346685,0.000025631412,0.000039691236],"category_scores_gemma":[0.000018902692,0.000093915965,0.00014106152,0.00023364098,0.00023243952,0.000108896646,0.000028520195,0.00038449134,5.6456327e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04756737,0.00033353025,0.9249587,0.0000011126718,0.000968345,0.00004582432,0.00013873306,0.000030572322,0.000018339673,8.355493e-7,0.00007416431,0.025862467],"study_design_scores_gemma":[0.05701652,0.007374437,0.9335092,0.000020397325,0.00024638054,0.00014040481,0.0003562098,0.000033171153,0.0000075274456,0.0000068012387,0.0011679588,0.00012100577],"about_ca_topic_score_codex":0.0003784034,"about_ca_topic_score_gemma":0.000013042016,"teacher_disagreement_score":0.025741462,"about_ca_system_score_codex":0.00006172265,"about_ca_system_score_gemma":0.000087253975,"threshold_uncertainty_score":0.3829782},"labels":[],"label_agreement":null},{"id":"W4229073188","doi":"10.1093/ndt/gfac066.103","title":"MO201: Effects of Aspirin in Primary Prevention of Cardiovascular (CV) Disease in People with Chronic Kidney Disease (CKD): Results of the TIPS3 Trial","year":2022,"lang":"en","type":"article","venue":"Nephrology Dialysis Transplantation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Aspirin; Placebo; Kidney disease; Internal medicine; Polypill; Stroke (engine); Mace; Myocardial infarction; Randomized controlled trial; Percutaneous coronary intervention","score_opus":0.005198742704243115,"score_gpt":0.21320717902042177,"score_spread":0.20800843631617866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229073188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936064,0.0038405582,0.00039290966,0.00012702118,0.000088354005,0.0017217698,0.00018208743,0.000011738703,0.00002915872],"genre_scores_gemma":[0.9972831,0.0014452434,0.00001899744,0.0001022956,0.00004715593,0.0003043463,0.00075963855,0.000018527644,0.00002071554],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99725556,0.0009951071,0.000590101,0.0003357136,0.0006368141,0.00018668675],"domain_scores_gemma":[0.99889827,0.00013549301,0.0002466369,0.0005595471,0.0000521261,0.00010793669],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006263553,0.00016236887,0.00076903985,0.0002866951,0.000046218913,0.0000018717909,0.00014769398,0.00006449889,0.000026258735],"category_scores_gemma":[0.00005889828,0.00012972715,0.00087481964,0.00073310506,0.00014219333,0.00007740842,0.000023155557,0.00018431105,3.697246e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6046775,0.0036336419,0.23182723,0.007030444,0.0055695865,0.00038551283,0.0020445066,0.122145146,0.009120906,0.000054593518,0.00003094662,0.013479972],"study_design_scores_gemma":[0.10260477,0.0011042749,0.88651466,0.00034645558,0.0065424694,0.0000059372737,0.000022891774,0.00029141468,0.0021735951,0.0000654414,0.00019501186,0.00013305382],"about_ca_topic_score_codex":0.00031710227,"about_ca_topic_score_gemma":0.00014407403,"teacher_disagreement_score":0.65468746,"about_ca_system_score_codex":0.000111047,"about_ca_system_score_gemma":0.00069807976,"threshold_uncertainty_score":0.52901196},"labels":[],"label_agreement":null},{"id":"W4229672874","doi":"10.1016/s0828-282x(10)71116-8","title":"Canadian Cardiovascular Society (CCS) CCS585 Oral: Risk Indicators and Prognosis in CVD Monday, October 25, 2010","year":2010,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine","score_opus":0.007674487139715266,"score_gpt":0.21400177539592571,"score_spread":0.20632728825621044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229672874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9831537,0.013360281,0.000108234686,0.0008041389,0.001001989,0.00032380957,0.00008600789,0.000010106483,0.0011517308],"genre_scores_gemma":[0.9957227,0.00260344,0.00030227765,0.00037915361,0.00085408305,0.000011769864,0.000015955588,0.00004667046,0.00006393348],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978764,0.00028162895,0.00047658532,0.00033305128,0.0002806287,0.0007517293],"domain_scores_gemma":[0.99689656,0.000054144217,0.00015356224,0.00043695106,0.00021670117,0.002242048],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015428938,0.00027627675,0.0011863757,0.0007934322,0.0001999853,0.00004075605,0.00023057395,0.0005299941,0.000081783655],"category_scores_gemma":[0.00024379588,0.00024704303,0.0015507231,0.00043347126,0.0004449353,0.00013369738,0.000016612998,0.0013670017,0.000011942212],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042562693,0.0000056374784,0.929669,0.000030944422,0.0040944726,0.0019093401,0.00042138342,0.00017097197,0.000078323465,0.000043435135,0.010419901,0.05311399],"study_design_scores_gemma":[0.0018866191,0.00013079045,0.53495246,0.000037250127,0.00092824665,0.0029153498,0.00023202747,0.000010766787,0.00007652126,0.00007586822,0.4585361,0.0002179664],"about_ca_topic_score_codex":0.13544838,"about_ca_topic_score_gemma":0.22044204,"teacher_disagreement_score":0.4481162,"about_ca_system_score_codex":0.00026021557,"about_ca_system_score_gemma":0.0035867244,"threshold_uncertainty_score":0.99999815},"labels":[],"label_agreement":null},{"id":"W4229839020","doi":"10.3410/f.717948027.793453088","title":"Faculty Opinions recommendation of Antiplatelet drug response status does not predict recurrent ischemic events in stable cardiovascular patients: results of the Antiplatelet Drug Resistances and Ischemic Events study.","year":2012,"lang":"en","type":"dataset","venue":"Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Antiplatelet drug; Medicine; Drug; Drug response; Internal medicine; Cardiology; Ischemic stroke; Aspirin; Clopidogrel; Ischemia; Pharmacology","score_opus":0.016093702249808186,"score_gpt":0.3028738284083156,"score_spread":0.28678012615850745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229839020","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015237128,0.011565649,0.0000018045507,0.013440152,0.00094329333,0.004269457,0.95449865,0.000028129287,0.000015746215],"genre_scores_gemma":[0.01301596,0.0054769744,0.0000773844,0.0004288087,0.00016128461,0.0002255597,0.9801046,0.00004685503,0.00046257343],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99047464,0.0022503375,0.0026343323,0.0010251973,0.002983034,0.0006324476],"domain_scores_gemma":[0.99130994,0.0003182887,0.0020525216,0.0025741237,0.003359599,0.00038552203],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0052988227,0.0007705475,0.0021376421,0.0004579825,0.00024541534,0.000038285492,0.0011812061,0.0005166431,0.000066133274],"category_scores_gemma":[0.0067600887,0.00043059918,0.0015350155,0.0020384344,0.00042428737,0.00046843858,0.00066873897,0.0012863564,0.0000055612763],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021525244,0.0019827941,0.0023819709,0.00794987,0.0017535886,0.0000013092257,0.00061019143,4.3189962e-7,0.000011516742,0.0000017738444,0.9810955,0.0020585563],"study_design_scores_gemma":[0.006735257,0.00019375177,0.06323765,0.017804943,0.0011813372,0.00002224436,0.00023898279,0.0000018706756,0.00025223015,0.0000026841735,0.90994895,0.00038010904],"about_ca_topic_score_codex":0.0001892801,"about_ca_topic_score_gemma":0.000019820085,"teacher_disagreement_score":0.07114653,"about_ca_system_score_codex":0.00020291944,"about_ca_system_score_gemma":0.000657719,"threshold_uncertainty_score":0.99981457},"labels":[],"label_agreement":null},{"id":"W4230613068","doi":"10.1007/s40278-020-80758-2","title":"Health Canada: potential link between ticagrelor and bradyarrhythmia and AV block","year":2020,"lang":"en","type":"article","venue":"Reactions Weekly","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ticagrelor; Link (geometry); Block (permutation group theory); Medicine; Pharmacology; Cardiology; Computer science; Computer network; Mathematics; Myocardial infarction; Percutaneous coronary intervention","score_opus":0.013873335995754408,"score_gpt":0.23592574451855722,"score_spread":0.2220524085228028,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230613068","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79485375,0.007950835,0.0008638834,0.19501117,0.00012500427,0.0004112895,0.00008420744,0.00011406768,0.00058579026],"genre_scores_gemma":[0.99589884,0.0011149418,0.000151264,0.0015702634,0.001003923,0.000003364908,0.00003418431,0.000016354654,0.00020683983],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99922675,0.000036302696,0.00016717394,0.00021867614,0.00018120639,0.00016987602],"domain_scores_gemma":[0.9993168,0.000031567037,0.000042527015,0.00013092763,0.000030815903,0.00044736592],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006289545,0.000105210136,0.00029857393,0.000027875569,0.0001606417,0.000016542741,0.000022718325,0.000050057522,0.000025809677],"category_scores_gemma":[0.000037341946,0.00009709673,0.00007056293,0.00010361321,0.000052010408,0.00004602208,0.00002049042,0.0001726267,0.0000068180466],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059551117,0.00008103025,0.03177652,0.0010675589,0.0032721614,0.001020769,0.00054527324,0.00005099229,0.0018078807,0.00066706346,0.041674484,0.9174408],"study_design_scores_gemma":[0.0021678573,0.00034471758,0.33677956,0.00009547474,0.0005186164,0.0010554626,0.000300561,0.00031099402,0.0001748306,0.000035933463,0.657985,0.00023103875],"about_ca_topic_score_codex":0.024427708,"about_ca_topic_score_gemma":0.0024947736,"teacher_disagreement_score":0.91720974,"about_ca_system_score_codex":0.000043540404,"about_ca_system_score_gemma":0.00046333665,"threshold_uncertainty_score":0.9820687},"labels":[],"label_agreement":null},{"id":"W4232205679","doi":"10.4161/cbt.5.6.2961","title":"Clues to Blockade of Neovascularization through Targeting of SDF-1","year":2006,"lang":"en","type":"article","venue":"Cancer Biology & Therapy","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Blockade; Neovascularization; Cancer research; Angiogenesis; Medicine; Receptor; Internal medicine","score_opus":0.015190931234163938,"score_gpt":0.3004126389811512,"score_spread":0.2852217077469873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4232205679","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94390273,0.050327994,0.0046165814,0.00033409693,0.00013332414,0.00031434433,0.000021911424,0.000031461466,0.00031755434],"genre_scores_gemma":[0.9897257,0.008238039,0.00094687846,0.00054179266,0.00035876455,0.000031769494,0.00007650287,0.000018916591,0.00006162678],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99916637,0.00007417373,0.00027466632,0.00020768479,0.000107406755,0.00016970753],"domain_scores_gemma":[0.99946207,0.000023336439,0.00010189732,0.00023593102,0.00014346023,0.00003332629],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000136696,0.00012217896,0.00042506275,0.000053958436,0.000034898687,0.0000019208549,0.00008258162,0.00011540417,0.00016974335],"category_scores_gemma":[0.000011919209,0.00009612317,0.00030543556,0.00021893345,0.00013225747,0.000029661303,0.000012934598,0.00005888582,0.0000026184316],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010323963,0.00021811492,0.12892702,0.00006279611,0.0012592672,0.000004975703,0.000496815,0.0005345512,0.8211402,0.0011248419,0.00076591276,0.044433054],"study_design_scores_gemma":[0.004082423,0.0006481809,0.06321438,0.00013340834,0.0001797047,0.000009416126,0.00015996698,0.000023629345,0.8200142,0.0017063337,0.10959074,0.00023761592],"about_ca_topic_score_codex":0.00037742284,"about_ca_topic_score_gemma":0.0000054724474,"teacher_disagreement_score":0.10882483,"about_ca_system_score_codex":0.00001999111,"about_ca_system_score_gemma":0.0000736596,"threshold_uncertainty_score":0.39197892},"labels":[],"label_agreement":null},{"id":"W4232225446","doi":"10.3410/f.717955110.793461047","title":"Faculty Opinions recommendation of Effects of clopidogrel added to aspirin in patients with recent lacunar stroke.","year":2012,"lang":"en","type":"dataset","venue":"Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Clopidogrel; Aspirin; Lacunar stroke; Stroke (engine); Internal medicine; Medicine; Cardiology; Ischemic stroke; Engineering; Mechanical engineering","score_opus":0.015808598413499013,"score_gpt":0.3144843633958322,"score_spread":0.29867576498233317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4232225446","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000074088224,0.002989907,0.000022686128,0.032994054,0.00049429626,0.0031760698,0.9602082,0.000019861029,0.000020872732],"genre_scores_gemma":[0.00012964156,0.0008435344,0.0004579522,0.0026310012,0.00016728202,0.00023265119,0.9953225,0.000032269898,0.00018313025],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99551255,0.0004929987,0.001359966,0.00052735367,0.0017373079,0.0003698015],"domain_scores_gemma":[0.99261093,0.00012307393,0.0010499962,0.0014029413,0.0044027683,0.0004103096],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00093216053,0.0004915804,0.0014570036,0.00046659005,0.00007221329,0.000024640894,0.0006938059,0.00052691664,0.00027264853],"category_scores_gemma":[0.0029894775,0.00029765393,0.0007050548,0.001986129,0.00021497761,0.00019328512,0.000244156,0.00072502164,0.000025486903],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002367454,0.0015399358,0.0005720055,0.016929382,0.00057516154,4.842414e-7,0.00008348999,1.3543456e-7,0.0000013760146,0.000025805697,0.9672924,0.012743049],"study_design_scores_gemma":[0.0031107366,0.00062738766,0.05561244,0.025416523,0.00058339775,0.000007753749,0.000013239687,3.666821e-7,0.000054802564,0.0000016804917,0.9143181,0.00025361075],"about_ca_topic_score_codex":0.000027557002,"about_ca_topic_score_gemma":0.0000035275452,"teacher_disagreement_score":0.055040438,"about_ca_system_score_codex":0.00012376749,"about_ca_system_score_gemma":0.00042036324,"threshold_uncertainty_score":0.99994755},"labels":[],"label_agreement":null},{"id":"W4232829172","doi":"10.1001/jama.289.15.1925-b","title":"Clopidogrel and Percutaneous Coronary Interventions","year":2003,"lang":"en","type":"letter","venue":"JAMA","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Clopidogrel; Percutaneous; Percutaneous coronary intervention; Cardiology; Internal medicine; Psychological intervention; Myocardial infarction","score_opus":0.02095009623338655,"score_gpt":0.26563408072569294,"score_spread":0.24468398449230638,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4232829172","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06404695,0.095572494,0.00025993396,0.8230937,0.0010933863,0.001136486,0.00022152124,0.00026264967,0.014312843],"genre_scores_gemma":[0.011453204,0.005555153,0.0003402062,0.9559461,0.0030201,0.00002750097,0.0007836443,0.00009703956,0.022777079],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99887204,0.0001000212,0.00021036585,0.0003242798,0.0002630572,0.00023023029],"domain_scores_gemma":[0.9993636,0.0000440372,0.000057957157,0.0003847748,0.000064867556,0.00008474322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008739805,0.0002283578,0.00047176454,0.00009256024,0.000069992915,0.000041245414,0.000067881556,0.00058375753,0.00082370016],"category_scores_gemma":[0.000041613803,0.0002000097,0.00083607336,0.000061531304,0.00011616208,0.00004163597,0.000029415214,0.00095421786,0.000109068504],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006576506,0.00004131268,0.00044221838,0.000703007,0.0009368361,0.014746956,0.000026467875,1.305077e-7,0.000010049354,0.000011216259,0.9301826,0.052833464],"study_design_scores_gemma":[0.0010537829,0.00018810634,0.0021885673,0.0005070538,0.0009542841,0.022117082,0.000038287715,0.000002216806,0.000005667218,0.00008496596,0.97265047,0.00020950168],"about_ca_topic_score_codex":0.000008521382,"about_ca_topic_score_gemma":8.1688574e-7,"teacher_disagreement_score":0.13285233,"about_ca_system_score_codex":0.0000367909,"about_ca_system_score_gemma":0.00005947928,"threshold_uncertainty_score":0.9018939},"labels":[],"label_agreement":null},{"id":"W4234885179","doi":"10.1007/978-1-60761-219-3_20","title":"Aspirin for Heart Disease","year":2011,"lang":"en","type":"book-chapter","venue":"Humana Press eBooks","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Aspirin; Medicine; Cardiology; Internal medicine; Intensive care medicine","score_opus":0.09258068272782116,"score_gpt":0.28059215253965947,"score_spread":0.1880114698118383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4234885179","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000066040324,0.055170383,0.00032636643,0.0000226101,0.0002351168,0.0018273421,0.00018941076,0.00020944825,0.9419533],"genre_scores_gemma":[0.0055936533,0.00090232637,0.00010444715,0.0011943699,0.0010672413,0.0002161044,0.0002667715,0.00020701841,0.99044806],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99857855,0.0000145977065,0.00028784949,0.0005090983,0.00031876328,0.00029113793],"domain_scores_gemma":[0.9984995,0.000025173069,0.00010093106,0.0008827737,0.00011853265,0.00037308547],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00010481379,0.0004033374,0.0006889583,0.00009073676,0.000116500465,0.000024836454,0.0001492156,0.00024245102,0.00039570173],"category_scores_gemma":[0.00000887757,0.0003720814,0.0012151225,0.0000018047718,0.00017230336,0.000024949279,0.00006178896,0.00022978055,0.00006355438],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003824887,0.00012352674,0.000008040908,0.0026653938,0.0038798412,0.0006376992,0.00019179603,0.0000012469654,0.000019755498,0.7535491,0.04560495,0.18949378],"study_design_scores_gemma":[0.0014738643,0.00017780234,0.000086411346,0.0005720807,0.0020440891,0.000020451978,0.0000013368104,0.0000021613137,0.00010357372,0.0182189,0.9769091,0.00039023542],"about_ca_topic_score_codex":0.000014170665,"about_ca_topic_score_gemma":0.0000022577744,"teacher_disagreement_score":0.93130416,"about_ca_system_score_codex":0.000029640933,"about_ca_system_score_gemma":0.00011579185,"threshold_uncertainty_score":0.9998731},"labels":[],"label_agreement":null},{"id":"W4235168142","doi":"10.1503/cmaj.1090017","title":"Interaction between clopidogrel and proton pump inhibitors","year":2009,"lang":"en","type":"article","venue":"Canadian Medical Association Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Capital District Health Authority; Dalhousie University","funders":"University of Toronto","keywords":"Clopidogrel; Odds ratio; Confidence interval; Myocardial infarction; Medicine; Internal medicine; Cardiology","score_opus":0.007390743958998067,"score_gpt":0.2491943042062701,"score_spread":0.241803560247272,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4235168142","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96081847,0.00064748974,0.00008349756,0.03579988,0.00031112696,0.00023904581,0.000005345234,0.000024205627,0.0020709294],"genre_scores_gemma":[0.99036825,0.00050908484,0.000027104179,0.006271067,0.002654591,0.0000031692573,0.000012388522,0.000007812961,0.00014651481],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99849683,0.00009491201,0.00025505724,0.000113020884,0.00077975687,0.00026041083],"domain_scores_gemma":[0.9982476,0.00003942246,0.00009838916,0.00006272421,0.00015274393,0.001399092],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080526713,0.00008871531,0.00021864279,0.00013975955,0.00016785797,0.00005760848,0.000046546917,0.00025039216,0.0005462058],"category_scores_gemma":[0.00047585473,0.00007691113,0.00014827303,0.0001227675,0.000021435979,0.00012707808,0.0000035156313,0.0006236192,0.000036053792],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037615795,0.00003194491,0.36255327,0.000014232398,0.00035768904,0.0005030682,0.00016428008,4.814505e-7,0.000022373617,0.000044940716,0.01706168,0.61920846],"study_design_scores_gemma":[0.0018140449,0.00022678109,0.37709314,0.00018275931,0.00013498848,0.0010394077,0.00021679746,0.000028050721,0.00017355612,0.00021789668,0.6187439,0.0001287005],"about_ca_topic_score_codex":0.00018591665,"about_ca_topic_score_gemma":0.00020216928,"teacher_disagreement_score":0.6190797,"about_ca_system_score_codex":0.00039136584,"about_ca_system_score_gemma":0.00081200904,"threshold_uncertainty_score":0.59805703},"labels":[],"label_agreement":null},{"id":"W4235872176","doi":"10.1093/eurheartj/ehm506","title":"Comparison of different methods of measurement of aspirin resistance: using the appropriate statistic: reply","year":2007,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital du Sacré-Cœur de Montréal","funders":"","keywords":"Medicine; Statistic; Aspirin; Statistics; Internal medicine","score_opus":0.1471002478095754,"score_gpt":0.4233653662858795,"score_spread":0.2762651184763041,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4235872176","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7884429,0.007298982,0.20262797,0.00006844271,0.00015182597,0.00017783046,0.0000042972515,0.0000067186984,0.0012210241],"genre_scores_gemma":[0.9747776,0.00011062384,0.024853159,0.000058575275,0.00014255248,1.7093753e-7,9.99462e-7,0.00002224079,0.000034107175],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9971645,0.0010277721,0.00074816844,0.00011204748,0.00077391893,0.00017363459],"domain_scores_gemma":[0.99865603,0.00010460382,0.00044092358,0.0003243994,0.00036563663,0.00010839037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0060618203,0.00011163466,0.0005366581,0.00008005603,0.000081484795,0.000007328953,0.00010743992,0.00001709921,0.00004446247],"category_scores_gemma":[0.00020695175,0.00006862619,0.00035731684,0.00012233475,0.00014600357,0.000024529003,0.00002992503,0.00024541054,7.3786924e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004535869,0.0012253615,0.14233607,0.0010523077,0.0027702022,0.00017488033,0.0026847417,0.0003087177,0.73754483,0.0003681063,0.0015657834,0.10543315],"study_design_scores_gemma":[0.0028031243,0.00066702266,0.6778634,0.0014195098,0.00090722984,0.00030625807,0.0014323274,0.00013329666,0.30104935,0.00014123404,0.013110985,0.0001662623],"about_ca_topic_score_codex":0.0000036071954,"about_ca_topic_score_gemma":0.000001366275,"teacher_disagreement_score":0.53552735,"about_ca_system_score_codex":0.000039872135,"about_ca_system_score_gemma":0.000069829824,"threshold_uncertainty_score":0.27984947},"labels":[],"label_agreement":null},{"id":"W4236585531","doi":"10.1016/s0140-6736(02)07352-x","title":"Clopidogrel and percutaneous coronary intervention","year":2002,"lang":"en","type":"article","venue":"The Lancet","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Clopidogrel; Conventional PCI; Thienopyridine; Medicine; Percutaneous coronary intervention; Angioplasty; Cardiology; Loading dose; Stent; Internal medicine; Anesthesia; Surgery; Aspirin; Myocardial infarction","score_opus":0.027919795408616135,"score_gpt":0.25685077874899426,"score_spread":0.22893098334037812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4236585531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.975608,0.017709142,0.000054107157,0.0021461174,0.0000576349,0.00011045762,0.0000045788465,0.0000527908,0.0042571626],"genre_scores_gemma":[0.9937556,0.003596071,0.00005650995,0.0010012632,0.00037930903,0.0000030134668,0.0000051143666,0.0000070627657,0.0011960794],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99964494,0.000035817906,0.000058809772,0.00007948244,0.00008470304,0.00009623022],"domain_scores_gemma":[0.99971443,0.000016032462,0.000013375738,0.00021317835,0.0000104356395,0.000032529537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000085405576,0.000051107687,0.00016262688,0.000009994758,0.000049261645,0.000010053683,0.00004567274,0.000022986023,0.00044077012],"category_scores_gemma":[0.000011237017,0.00003141233,0.00009792346,0.000030838375,0.00005934619,0.000020279409,0.000015962709,0.000072524046,0.00006896596],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011226379,0.00026655677,0.05669581,0.00024568674,0.0010256425,0.0012158334,0.0010783921,0.000006467113,0.0013045411,0.0010881703,0.049141284,0.886809],"study_design_scores_gemma":[0.009559552,0.00090946746,0.49714813,0.00039644892,0.0008839088,0.026520051,0.00072280195,0.0019809157,0.00029978945,0.0013262779,0.45987323,0.00037943604],"about_ca_topic_score_codex":0.0000040229443,"about_ca_topic_score_gemma":8.643801e-7,"teacher_disagreement_score":0.88642955,"about_ca_system_score_codex":0.0000062723757,"about_ca_system_score_gemma":0.0000015498406,"threshold_uncertainty_score":0.48261237},"labels":[],"label_agreement":null},{"id":"W4236787326","doi":"10.1111/j.1538-7933.2004.0615b.x","title":"Aspirin","year":2004,"lang":"en","type":"letter","venue":"Journal of Thrombosis and Haemostasis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Stroke Network","funders":"","keywords":"Sulfinpyrazone; Platelet; Aspirin; Medicine; Phenylbutazone; Ex vivo; Coagulation; Platelet aggregation; Pharmacology; Drug; In vivo; Internal medicine; Chemistry; Biochemistry; In vitro","score_opus":0.0544995484525529,"score_gpt":0.3110491903918781,"score_spread":0.2565496419393252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4236787326","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07486951,0.034428596,0.00019367717,0.88822114,0.0007029887,0.00032409484,0.00006422231,0.000027948194,0.0011678222],"genre_scores_gemma":[0.029162496,0.046775654,0.0014578603,0.9141339,0.007821926,0.000004143534,0.00008099339,0.00012688653,0.00043613525],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983343,0.00006221171,0.000516908,0.00019589964,0.00064461475,0.0002460563],"domain_scores_gemma":[0.99887604,0.00004254064,0.0004171556,0.00028198137,0.00023030829,0.00015198937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002611012,0.00027879726,0.0011737946,0.000225896,0.0000772401,0.00005634467,0.00012576304,0.00049077097,0.00030187034],"category_scores_gemma":[0.000027700866,0.00020407118,0.0011483036,0.00011276731,0.000129324,0.00010243948,0.000034489633,0.0012306201,0.0000149487605],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014668686,0.00010020186,0.0006698761,0.00061954634,0.004934913,0.0021833056,0.000084857274,0.000002430566,0.000052903953,0.000011324851,0.96164095,0.02955299],"study_design_scores_gemma":[0.0029301664,0.00058046234,0.0041094692,0.001373461,0.0035162338,0.0023720365,0.000054988806,4.5768655e-7,0.0004754689,0.00031837204,0.98402834,0.00024051909],"about_ca_topic_score_codex":0.0000108524255,"about_ca_topic_score_gemma":3.8112958e-7,"teacher_disagreement_score":0.045707017,"about_ca_system_score_codex":0.00009315154,"about_ca_system_score_gemma":0.00028227278,"threshold_uncertainty_score":0.8321781},"labels":[],"label_agreement":null},{"id":"W4239583063","doi":"10.1185/030079907x253762","title":"Clopidogrel versus aspirin in patients with atherothrombosis: CAPRIE-based calculation of cost-effectiveness for Germany","year":2008,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Clopidogrel; Aspirin; Myocardial infarction; Internal medicine; Stroke (engine); Cardiology; Framingham Risk Score; Emergency medicine; Disease","score_opus":0.14654931667180354,"score_gpt":0.4303641704455804,"score_spread":0.28381485377377685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239583063","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99261963,0.0029552502,0.0026376704,0.0000633468,0.00013601144,0.0015195503,0.000013008027,0.000016520593,0.00003900839],"genre_scores_gemma":[0.9982209,0.0012777701,0.00003528414,0.000008344624,0.000083008745,0.000176461,0.0001766088,0.000018292303,0.0000033270437],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99823266,0.00016683408,0.0001540685,0.0002148078,0.0009845174,0.00024711914],"domain_scores_gemma":[0.99906975,0.00029588107,0.000030403817,0.00014900656,0.00020343621,0.00025149825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006850873,0.00008883079,0.00026051042,0.00015890844,0.000064273554,0.0000033882468,0.000056059704,0.00008540284,0.00001862117],"category_scores_gemma":[0.00031667587,0.00006522619,0.000074290394,0.00022678047,0.00035406472,0.00003867087,0.00001986572,0.00019275492,0.0000013777529],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018150253,0.0018634252,0.77562207,0.0014040348,0.00017927548,0.000010625655,0.00010560126,0.000008868191,0.000021336704,0.00026966826,0.0005027533,0.20186208],"study_design_scores_gemma":[0.028265376,0.0023639959,0.9562991,0.0016442867,0.00001453602,0.0000013653618,0.000014438152,0.00055859063,0.00027006964,0.000017386172,0.010453936,0.00009688206],"about_ca_topic_score_codex":0.000030047413,"about_ca_topic_score_gemma":0.0000048241895,"teacher_disagreement_score":0.2017652,"about_ca_system_score_codex":0.000048535123,"about_ca_system_score_gemma":0.0002841539,"threshold_uncertainty_score":0.26598468},"labels":[],"label_agreement":null},{"id":"W4239868164","doi":"10.14740/jmc2853w","title":"Acute Ischemic Stroke Associated With OrthoVisc (Hyaluronic Acid) Injection","year":2017,"lang":"en","type":"article","venue":"Journal of Medical Cases","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Viscosupplementation; Hyaluronic acid; Osteoarthritis; Synovial fluid; Stroke (engine); Analgesic; Anesthesia; Anabolism; Surgery; Internal medicine; Intra articular; Pathology","score_opus":0.01767421618883814,"score_gpt":0.2931270120067915,"score_spread":0.27545279581795334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239868164","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99367887,0.003190898,0.00033766736,0.0016371665,0.00024251008,0.00008022907,0.000009781753,0.000019866024,0.00080301776],"genre_scores_gemma":[0.9969716,0.0015215916,0.00005124254,0.00039079515,0.00061789714,0.0000017742855,0.000007036634,0.000019598096,0.0004184327],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99770564,0.000070207825,0.00032330668,0.00012337444,0.001565969,0.0002115124],"domain_scores_gemma":[0.99849516,0.00008318474,0.00046932173,0.00030202404,0.00022826764,0.00042204096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075030373,0.00013758415,0.0004879057,0.000078459954,0.0002095201,0.00005561818,0.00023444818,0.00017804587,0.0004805312],"category_scores_gemma":[0.0017113107,0.00008665355,0.00042026685,0.000051871455,0.00021018022,0.00021385026,0.00003886677,0.00055213104,0.000008173972],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014792195,0.0025749987,0.25532907,0.00026451715,0.027631603,0.15504274,0.00038403287,0.000017668604,0.007316147,0.00009104657,0.05381038,0.48274562],"study_design_scores_gemma":[0.07512017,0.025361495,0.43434215,0.008445842,0.019255713,0.26926348,0.0018972725,0.00039539812,0.044063717,0.00008368413,0.1203388,0.0014322872],"about_ca_topic_score_codex":0.0000110303445,"about_ca_topic_score_gemma":0.000016834376,"teacher_disagreement_score":0.48131332,"about_ca_system_score_codex":0.00006754373,"about_ca_system_score_gemma":0.00058910047,"threshold_uncertainty_score":0.52614796},"labels":[],"label_agreement":null},{"id":"W4239959430","doi":"10.1016/s0828-282x(10)71139-9","title":"Canadian Cardiovascular Society (CCS) CCS825 Oral: Treatment and Outcomes in Acute Coronary Syndromes (ACS) Tuesday, October 26, 2010","year":2010,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Acute coronary syndrome; Canadian Cardiovascular Society; Intensive care medicine; Internal medicine; Cardiology; Emergency medicine; Myocardial infarction","score_opus":0.013558404814349464,"score_gpt":0.24293395106260704,"score_spread":0.22937554624825757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239959430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98424655,0.011606744,0.0000577366,0.0016015894,0.0014137354,0.0003449933,0.0001019287,0.000015536263,0.0006111642],"genre_scores_gemma":[0.99516004,0.0030877686,0.00023760619,0.00058828027,0.00038263015,0.000012432232,0.00002140508,0.000058122743,0.00045173414],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99804765,0.00019351687,0.000464167,0.00033516457,0.00021332393,0.00074615196],"domain_scores_gemma":[0.99725586,0.00006441133,0.00009550846,0.0005487122,0.00019864457,0.0018368894],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00068330666,0.0003480833,0.0016676192,0.0004574477,0.00016341385,0.00003670171,0.00019641838,0.0004225707,0.000079450845],"category_scores_gemma":[0.00006801548,0.00028063497,0.0018242071,0.00018527833,0.00036331746,0.00014668044,0.000014908982,0.0006430436,0.00001756335],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009365747,0.0000133375615,0.93921155,0.00002391929,0.016327962,0.01022351,0.00031278256,0.0001880954,0.000262838,0.000065613734,0.005353485,0.027923232],"study_design_scores_gemma":[0.0038703037,0.00041334113,0.6764286,0.000037244376,0.0019625456,0.017272076,0.0002541064,0.0000072161197,0.000057836605,0.00008872193,0.29931775,0.00029021912],"about_ca_topic_score_codex":0.10452822,"about_ca_topic_score_gemma":0.2667412,"teacher_disagreement_score":0.29396427,"about_ca_system_score_codex":0.0005289921,"about_ca_system_score_gemma":0.0034444947,"threshold_uncertainty_score":0.9999646},"labels":[],"label_agreement":null},{"id":"W4240019765","doi":"10.1016/s0140-6736(06)68040-9","title":"Aspirin resistance","year":2006,"lang":"en","type":"review","venue":"The Lancet","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":497,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Canadian Institutes of Health Research; Canada Research Chairs","keywords":"Aspirin; Platelet; Thromboxane; Thromboxane A2; Thromboxane B2; Medicine; Platelet activation; Antiplatelet drug; Pharmacology; Thromboxane-A synthase; Thromboxane receptor; Internal medicine; Clopidogrel","score_opus":0.0671959277897354,"score_gpt":0.3429544237355043,"score_spread":0.27575849594576884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4240019765","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000031043858,0.9724293,0.000021436128,0.00019287161,0.00010103699,0.00046379524,0.000057077734,0.00009001767,0.02664141],"genre_scores_gemma":[0.000003902258,0.98531187,0.000060063667,0.00035394623,0.0028958723,0.000053566353,0.00019190929,0.000043275108,0.011085579],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989363,0.00014228985,0.00023118466,0.00021496261,0.0002332814,0.00024196577],"domain_scores_gemma":[0.9987016,0.000058500253,0.000102650534,0.0010720744,0.000021232492,0.000043982753],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028249968,0.00022668121,0.0019974012,0.00003159604,0.00006603853,0.000021686243,0.0002739355,0.00012905023,0.00007214019],"category_scores_gemma":[0.000017429054,0.00011861241,0.0010170552,0.00017269718,0.00007964118,0.000014353593,0.000029945983,0.00031275363,0.00027914302],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041384115,0.000021683501,0.0000051049383,0.013037523,0.00063330657,0.00011680556,0.0000038810654,1.1911143e-7,3.4979934e-8,0.00043347987,0.14176272,0.84394395],"study_design_scores_gemma":[0.00044593075,0.000010959765,0.000046180954,0.008513322,0.0019633877,0.000090568814,0.0000014283894,6.866054e-8,2.8861086e-7,0.0000909702,0.9887019,0.00013501452],"about_ca_topic_score_codex":0.000003840908,"about_ca_topic_score_gemma":0.000004263323,"teacher_disagreement_score":0.84693915,"about_ca_system_score_codex":0.00003580198,"about_ca_system_score_gemma":0.000118354896,"threshold_uncertainty_score":0.48368734},"labels":[],"label_agreement":null},{"id":"W4240663677","doi":"10.3410/f.717973247.793469958","title":"Faculty Opinions recommendation of ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets.","year":2013,"lang":"en","type":"dataset","venue":"Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Platelet; Pharmacology; Chemistry; Medicine; Internal medicine","score_opus":0.028958838626156273,"score_gpt":0.319682224322836,"score_spread":0.2907233856966797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4240663677","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007708376,0.004659212,0.000047903348,0.055391017,0.00049779756,0.0023105405,0.9369121,0.000051779083,0.00005256672],"genre_scores_gemma":[0.0003939657,0.0031431688,0.00036184766,0.0016936582,0.00039998238,0.00025295548,0.99328834,0.000037882,0.00042819465],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957975,0.00047581352,0.0011258285,0.0008109009,0.0013911189,0.0003988416],"domain_scores_gemma":[0.9936892,0.000113319045,0.0011465666,0.00122,0.0034090977,0.00042181052],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010064408,0.0006181868,0.0015189934,0.0003666206,0.0002873947,0.00012731114,0.0005907327,0.0006889123,0.00024006108],"category_scores_gemma":[0.0020527982,0.00040153848,0.0009859897,0.0012285379,0.00043130145,0.00046291846,0.00040544829,0.0012185826,0.0000420864],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009074194,0.0006219487,0.0000291685,0.008791676,0.00079960463,0.0000016755548,0.00007197585,1.5073601e-7,0.000014223343,0.00004798188,0.97885597,0.010674908],"study_design_scores_gemma":[0.0015757903,0.00026528013,0.008765705,0.011755833,0.0006567481,0.00021352201,0.000030347437,0.000012713559,0.000121298785,0.000011216903,0.97622895,0.00036257008],"about_ca_topic_score_codex":0.0001033933,"about_ca_topic_score_gemma":0.0000031005684,"teacher_disagreement_score":0.056376245,"about_ca_system_score_codex":0.0001225667,"about_ca_system_score_gemma":0.0005338461,"threshold_uncertainty_score":0.99984366},"labels":[],"label_agreement":null},{"id":"W4241108392","doi":"10.1093/eurheartj/ehz748.0099","title":"2180Estimating individual lifetime benefit and bleeding risk of adding rivaroxaban to aspirin for patients with stable cardiovascular disease: results from the COMPASS trial","year":2019,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Aspirin; Rivaroxaban; Hazard ratio; Myocardial infarction; Atrial fibrillation; Internal medicine; Population; Stroke (engine); Warfarin; Diabetes mellitus; Cohort; Cardiology; Confidence interval","score_opus":0.024243626113250157,"score_gpt":0.24765019204742741,"score_spread":0.22340656593417726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241108392","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952109,0.0018298553,0.00054647034,0.00014579365,0.00019181665,0.0011461391,0.00071244215,0.000023191096,0.00019339498],"genre_scores_gemma":[0.9954557,0.000084414314,0.0033049195,0.0001589595,0.00080807466,0.000005110205,0.000093653485,0.000055952627,0.000033240416],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99785316,0.00032750284,0.0004300828,0.0003217491,0.0007683322,0.00029915594],"domain_scores_gemma":[0.9983686,0.00037736984,0.00026065705,0.000443782,0.00018859195,0.00036095237],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002049755,0.00019725997,0.0005402034,0.00007261633,0.00031883447,0.000115967836,0.0001556918,0.000025632235,0.000029941019],"category_scores_gemma":[0.00048293613,0.0001278231,0.0005028386,0.00012960451,0.000048911774,0.00013562707,0.00008920193,0.00029093042,0.000013576506],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08924556,0.00040271148,0.84172064,0.00012684881,0.011432828,0.000078199475,0.0015437764,0.010203986,0.00010189284,0.000025369858,0.002274197,0.04284402],"study_design_scores_gemma":[0.06065712,0.0013424807,0.913506,0.0009764352,0.0021236837,0.0000290556,0.00020150359,0.00027758296,0.00004032625,0.000013544307,0.020609265,0.00022303872],"about_ca_topic_score_codex":0.000020426236,"about_ca_topic_score_gemma":4.9567444e-7,"teacher_disagreement_score":0.071785346,"about_ca_system_score_codex":0.00002396358,"about_ca_system_score_gemma":0.000064335196,"threshold_uncertainty_score":0.5212475},"labels":[],"label_agreement":null},{"id":"W4241708065","doi":"10.1503/cmaj.1090015","title":"Interaction between clopidogrel and proton pump inhibitors","year":2009,"lang":"en","type":"article","venue":"Canadian Medical Association Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"University of Toronto","keywords":"Temporality; Causation; Causality (physics); Computer science; Clopidogrel; Association (psychology); Medicine; Epistemology; Bioinformatics; Data science; Philosophy; Internal medicine; Biology; Aspirin","score_opus":0.007390743958998067,"score_gpt":0.2491943042062701,"score_spread":0.241803560247272,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241708065","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96081847,0.00064748974,0.00008349756,0.03579988,0.00031112696,0.00023904581,0.000005345234,0.000024205627,0.0020709294],"genre_scores_gemma":[0.99036825,0.00050908484,0.000027104179,0.006271067,0.002654591,0.0000031692573,0.000012388522,0.000007812961,0.00014651481],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99849683,0.00009491201,0.00025505724,0.000113020884,0.00077975687,0.00026041083],"domain_scores_gemma":[0.9982476,0.00003942246,0.00009838916,0.00006272421,0.00015274393,0.001399092],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080526713,0.00008871531,0.00021864279,0.00013975955,0.00016785797,0.00005760848,0.000046546917,0.00025039216,0.0005462058],"category_scores_gemma":[0.00047585473,0.00007691113,0.00014827303,0.0001227675,0.000021435979,0.00012707808,0.0000035156313,0.0006236192,0.000036053792],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037615795,0.00003194491,0.36255327,0.000014232398,0.00035768904,0.0005030682,0.00016428008,4.814505e-7,0.000022373617,0.000044940716,0.01706168,0.61920846],"study_design_scores_gemma":[0.0018140449,0.00022678109,0.37709314,0.00018275931,0.00013498848,0.0010394077,0.00021679746,0.000028050721,0.00017355612,0.00021789668,0.6187439,0.0001287005],"about_ca_topic_score_codex":0.00018591665,"about_ca_topic_score_gemma":0.00020216928,"teacher_disagreement_score":0.6190797,"about_ca_system_score_codex":0.00039136584,"about_ca_system_score_gemma":0.00081200904,"threshold_uncertainty_score":0.59805703},"labels":[],"label_agreement":null},{"id":"W4241887010","doi":"10.1161/circulationaha.111.032953","title":"Response to Letters Regarding Article, “Aspirin Plus Clopidogrel Versus Aspirin Alone After Coronary Artery Bypass Grafting: The Clopidogrel After Surgery for Coronary Artery Disease (CASCADE) Trial”","year":2011,"lang":"en","type":"article","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute; University of Ottawa","funders":"","keywords":"Clopidogrel; Medicine; Aspirin; Coronary artery disease; Artery; Cardiology; Internal medicine; Bypass grafting; Coronary artery bypass surgery; Surgery","score_opus":0.04418464231739544,"score_gpt":0.2646151923521826,"score_spread":0.22043055003478718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241887010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98683566,0.0018673362,0.0048097963,0.0018415158,0.0013784963,0.0029703768,0.00005489573,0.00020368559,0.000038263628],"genre_scores_gemma":[0.9933406,0.000054217075,0.00023607806,0.0038000168,0.00085529767,0.0013647017,0.00015663,0.000118675496,0.00007377532],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99647295,0.0005438862,0.0007813519,0.0008072362,0.00067212613,0.00072246045],"domain_scores_gemma":[0.9973071,0.000705507,0.00019194487,0.0010890237,0.0001635175,0.0005428581],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014048002,0.0004665488,0.00069187954,0.00029753044,0.00026695908,0.00007560898,0.00017605803,0.00018957973,0.00013801533],"category_scores_gemma":[0.00034550767,0.0003953473,0.0011925289,0.00038636196,0.00020012975,0.00039525708,0.00008211635,0.0002546193,0.00012826057],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8062774,0.00040655132,0.16741587,0.00018580003,0.0016482965,0.0020417138,0.0012015591,0.0002259515,0.0021749185,0.000025608402,0.0011704477,0.017225863],"study_design_scores_gemma":[0.032639515,0.00035281994,0.96037084,0.00034318306,0.0011944307,0.00018116347,0.00017769313,0.0004656069,0.00024494005,0.00008219316,0.0033818916,0.00056572753],"about_ca_topic_score_codex":0.000008805152,"about_ca_topic_score_gemma":0.0000068942745,"teacher_disagreement_score":0.792955,"about_ca_system_score_codex":0.00027115914,"about_ca_system_score_gemma":0.00024143588,"threshold_uncertainty_score":0.99984986},"labels":[],"label_agreement":null},{"id":"W4242896580","doi":"10.1016/j.thromres.2006.08.014","title":"Aspirin resistance","year":2007,"lang":"en","type":"review","venue":"Thrombosis Research","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Aspirin; Medicine; Thromboxane A2; Thromboxane B2; Platelet; Antiplatelet drug; Thromboxane; Pharmacology; Intensive care medicine; Internal medicine; Clopidogrel","score_opus":0.49410129444805756,"score_gpt":0.5686650384766839,"score_spread":0.07456374402862637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242896580","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000015653686,0.95411724,0.000026686737,0.000043360433,0.00009698533,0.0013741682,0.000028979239,0.00010532551,0.044191573],"genre_scores_gemma":[0.000015363461,0.98902136,0.00016018919,0.000051533072,0.00068789255,0.0001388474,0.00018376396,0.00013377766,0.009607253],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99513924,0.00069985655,0.00056846935,0.0007237117,0.0019254293,0.0009433073],"domain_scores_gemma":[0.9972736,0.000468613,0.00008549453,0.0014115431,0.00035654605,0.00040417953],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003429781,0.0004004993,0.0024684672,0.0007396434,0.00024738978,0.000061739855,0.00044254714,0.00055519835,0.0008741853],"category_scores_gemma":[0.00019399304,0.00030539924,0.0018002521,0.0015857851,0.0004551141,0.00005575545,0.00017379144,0.0015734409,0.002163717],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047480466,0.0001587175,0.000005746395,0.02937839,0.0014503219,0.00026542408,0.000018467254,1.1709645e-8,0.0000011314718,0.00040289207,0.011342482,0.9569289],"study_design_scores_gemma":[0.00036740184,0.00009465011,0.000057933223,0.023460956,0.0008749512,0.000053197535,0.000024919633,9.548158e-8,0.0000064026012,0.00005959027,0.97473574,0.0002641951],"about_ca_topic_score_codex":0.000013999989,"about_ca_topic_score_gemma":0.000008257389,"teacher_disagreement_score":0.9633932,"about_ca_system_score_codex":0.00034083758,"about_ca_system_score_gemma":0.0008910463,"threshold_uncertainty_score":0.9999398},"labels":[],"label_agreement":null},{"id":"W4244333892","doi":"10.21203/rs.3.rs-97757/v1","title":"P2Y12 Inhibitor Utilization for Acute Coronary Syndrome in the Elderly: A Provincial Analysis From 2008 to 2018","year":2020,"lang":"en","type":"preprint","venue":"Research Square","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Ontario Ministry of Health and Long-Term Care; McMaster University; CorHealth Ontario; Hamilton Health Sciences","keywords":"Acute coronary syndrome; P2Y12; Ticagrelor; Business; Medicine; Internal medicine; Cardiology; Percutaneous coronary intervention; Myocardial infarction","score_opus":0.08321024567121722,"score_gpt":0.3965417881990454,"score_spread":0.3133315425278282,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244333892","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9747946,0.004865127,0.006316477,0.004917918,0.00014635824,0.0065765963,0.002194845,0.000076150165,0.00011188442],"genre_scores_gemma":[0.9917567,0.0010635408,0.00031895834,0.00031393606,0.00057440385,0.0013182634,0.004434994,0.000052772775,0.00016647979],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99591786,0.00064829824,0.00039422276,0.00087339315,0.001625476,0.0005407318],"domain_scores_gemma":[0.9979645,0.00029407037,0.00006786967,0.00097151124,0.000404938,0.0002971049],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011239103,0.0002843687,0.00086305686,0.0006451359,0.00018604573,0.00012052857,0.0004789466,0.00035731413,0.00019232735],"category_scores_gemma":[0.00037510486,0.00021503877,0.0010290359,0.0015678919,0.00010688932,0.00006395272,0.00040416108,0.00093488605,0.000066809254],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.052756157,0.006432902,0.22734012,0.010106219,0.111648545,0.027464464,0.021109747,0.003069234,0.003109605,0.00074035674,0.22320764,0.313015],"study_design_scores_gemma":[0.006241519,0.005888599,0.93020386,0.0019379087,0.009517592,0.00010256756,0.003480258,0.004297577,0.0005538577,0.0027829674,0.0339974,0.0009958798],"about_ca_topic_score_codex":0.00058045896,"about_ca_topic_score_gemma":0.00029585385,"teacher_disagreement_score":0.70286375,"about_ca_system_score_codex":0.00023159523,"about_ca_system_score_gemma":0.0008228427,"threshold_uncertainty_score":0.8769027},"labels":[],"label_agreement":null},{"id":"W4245467674","doi":"10.2196/34080","title":"Patient Onboarding and Engagement to Build a Digital Study After Enrollment in a Clinical Trial (TAILOR-PCI Digital Study): Intervention Study","year":2022,"lang":"en","type":"article","venue":"JMIR Formative Research","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of Toronto; University of Alberta; St. Michael's Hospital; University of Ottawa","funders":"National Institute of Biomedical Imaging and Bioengineering; National Heart, Lung, and Blood Institute","keywords":"Conventional PCI; Medicine; Randomized controlled trial; Randomization; Percutaneous coronary intervention; Onboarding; Intervention (counseling); Informed consent; Digital health; Clinical trial; Family medicine; Physical therapy; Internal medicine; Nursing; Alternative medicine; Psychology; Health care","score_opus":0.07752142721341154,"score_gpt":0.44926027271075264,"score_spread":0.3717388454973411,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245467674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98431456,0.00016644517,0.000025002117,0.00007823592,0.00018051344,0.014908832,0.000049826525,0.00003555202,0.0002410593],"genre_scores_gemma":[0.9928656,0.00000707975,0.0000031736693,0.00003756122,0.00009975347,0.0068408893,0.000022997381,0.000028470924,0.00009444811],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99344885,0.0021922085,0.0010065446,0.0006027303,0.002232648,0.00051702623],"domain_scores_gemma":[0.99869585,0.00028133029,0.00009307361,0.0004882184,0.0001565061,0.000284997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0056531853,0.0002330558,0.0006354203,0.00061234954,0.0003575573,0.0003119525,0.00018776393,0.000033826993,0.00014561815],"category_scores_gemma":[0.0002541036,0.00019465054,0.00037652053,0.00071155204,0.000077934674,0.00049963273,0.0015563355,0.0010109469,0.000036951813],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12389003,0.072204664,0.5000151,0.00005483142,0.0016874401,0.0010555602,0.08311442,0.00001587122,0.0000017005328,0.000003589767,0.00025545093,0.21770136],"study_design_scores_gemma":[0.09384042,0.098894216,0.45450822,0.000067315545,0.000069950824,0.00001280899,0.35003844,0.000038760278,0.0000023042921,0.000018576187,0.002295365,0.00021365176],"about_ca_topic_score_codex":0.000027134778,"about_ca_topic_score_gemma":0.00001362154,"teacher_disagreement_score":0.266924,"about_ca_system_score_codex":0.00039392235,"about_ca_system_score_gemma":0.000087533845,"threshold_uncertainty_score":0.79376185},"labels":[],"label_agreement":null},{"id":"W4246522583","doi":"10.1345/aph.1m051a","title":"Comment: Drug-Drug Interaction Between Clopidogrel and the Proton Pump Inhibitors","year":2009,"lang":"en","type":"letter","venue":"Annals of Pharmacotherapy","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; Providence Health Care","funders":"","keywords":"Medicine; Clopidogrel; Drug; Drug-drug interaction; Drug interaction; Pharmacology; Internal medicine; Aspirin","score_opus":0.04029614861362674,"score_gpt":0.3480031374814592,"score_spread":0.3077069888678325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4246522583","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04579524,0.018293638,0.000021665937,0.9321797,0.0003016833,0.0027099804,0.00006899298,0.00008224238,0.0005468577],"genre_scores_gemma":[0.06325097,0.045048304,0.000017897017,0.8837686,0.006557222,0.00016604997,0.00028813758,0.00009735302,0.00080546114],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973664,0.0005602063,0.0006006104,0.00042879465,0.0006541086,0.00038987366],"domain_scores_gemma":[0.9985411,0.0002588403,0.0004291221,0.0004749304,0.00018219127,0.000113795606],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008213839,0.00046620713,0.0010991058,0.0002084405,0.00012827867,0.000047912275,0.00023214913,0.00025721866,0.00018836596],"category_scores_gemma":[0.000012855474,0.00031233687,0.0010034146,0.00018204813,0.00035580882,0.00014778346,0.000029622213,0.0013349141,0.000014144482],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015212513,0.00010070521,0.0005751363,0.00047045122,0.0026892913,0.000073825904,0.0005059314,8.595221e-7,0.00034446106,0.000009680053,0.92701495,0.066693455],"study_design_scores_gemma":[0.0061501698,0.00012743259,0.0001575466,0.0005076683,0.00059850694,0.000031356674,0.00004637816,0.0000098005985,0.074709006,0.00028335853,0.917106,0.00027279803],"about_ca_topic_score_codex":0.00007321819,"about_ca_topic_score_gemma":3.7542281e-7,"teacher_disagreement_score":0.07436454,"about_ca_system_score_codex":0.000019379564,"about_ca_system_score_gemma":0.00006446577,"threshold_uncertainty_score":0.9999329},"labels":[],"label_agreement":null},{"id":"W4248548309","doi":"10.1111/j.1538-7836.2006.01972.x","title":"More on: enhanced antiplatelet effect of clopidogrel in patients whose platelets are least inhibited by aspirin: a randomized crossover trial","year":2006,"lang":"en","type":"article","venue":"Journal of Thrombosis and Haemostasis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Clopidogrel; Aspirin; Crossover study; Platelet; Medicine; Randomized controlled trial; Internal medicine; Pharmacology; Ticlopidine; P2Y12; Alternative medicine; Pathology","score_opus":0.009108155446729514,"score_gpt":0.2770011602004824,"score_spread":0.2678930047537529,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4248548309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99593264,0.0023658532,0.000033118427,0.0002526221,0.00020700457,0.0010372495,0.00006839018,0.000010700437,0.00009244101],"genre_scores_gemma":[0.99793273,0.0015282413,0.000047993184,0.00020882736,0.00017454666,0.000011446826,0.000042681317,0.000033269916,0.000020264866],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9973105,0.00031336927,0.0010961551,0.00026101182,0.0007299469,0.0002889682],"domain_scores_gemma":[0.9984828,0.0002470604,0.00066798145,0.00023097602,0.00022325346,0.00014793393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084004586,0.00032951927,0.0023563087,0.00028027687,0.00007362014,0.00004154873,0.00010210943,0.00020374452,0.000056754172],"category_scores_gemma":[0.00018514176,0.00022575489,0.00090189767,0.00028436296,0.0002540062,0.00017623157,0.000031870357,0.0003279253,0.0000025407137],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9575987,0.0016004242,0.019713148,0.00028302835,0.0018605037,0.00009874136,0.00016362201,0.00009825499,0.0018731947,0.000007975496,0.0027310061,0.013971406],"study_design_scores_gemma":[0.8968231,0.0043147886,0.040773146,0.0013313913,0.0009932993,0.000030498357,0.00005360957,0.00002341469,0.05498655,0.000020242504,0.00038964552,0.0002603128],"about_ca_topic_score_codex":0.000047533707,"about_ca_topic_score_gemma":0.0000031927111,"teacher_disagreement_score":0.060775593,"about_ca_system_score_codex":0.000058772246,"about_ca_system_score_gemma":0.00004636006,"threshold_uncertainty_score":0.9206017},"labels":[],"label_agreement":null},{"id":"W4248792744","doi":"10.1016/j.jval.2014.08.253","title":"Antithrombotic Therapy and Direct Medical Costs in Patients with Acute Coronary Syndrome in Shanghai, China","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Medicine; Antithrombotic; Acute coronary syndrome; Medical record; Emergency medicine; Comorbidity; Emergency department; Retrospective cohort study; Internal medicine; Cohort; Hyperlipidemia; Diabetes mellitus; Myocardial infarction","score_opus":0.011740001394551919,"score_gpt":0.25301597810182797,"score_spread":0.24127597670727605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4248792744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944789,0.003939279,0.00001718959,0.00064778695,0.00006755722,0.0007035543,0.000005810857,0.000025978805,0.00011396637],"genre_scores_gemma":[0.99406314,0.004832148,0.000087037915,0.0009156827,0.0000186372,0.000017351795,0.00003199563,0.000025109266,0.0000088985635],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99817693,0.000377622,0.00031094256,0.00031537277,0.00047593456,0.00034320937],"domain_scores_gemma":[0.9993932,0.00007837552,0.000055177843,0.0002317464,0.000014071121,0.00022743239],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008559173,0.00015733314,0.00059394934,0.00019302592,0.000032744752,0.000007144353,0.000074114585,0.000095888834,0.00003931598],"category_scores_gemma":[0.000046373854,0.00011877391,0.000050354258,0.00030934263,0.00008889013,0.000070835194,0.000020618032,0.00025582203,0.0000041654894],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007163834,0.00047605683,0.9672953,0.00011441453,0.00008207206,0.00040136944,0.00022157736,0.000059494112,8.827618e-7,0.000060884584,0.0000132456435,0.03055832],"study_design_scores_gemma":[0.008998421,0.0014439882,0.98707193,0.0010793766,0.0000110931005,0.00013630975,0.000017742539,0.0009815185,0.0000022282893,0.00004537047,0.00009229437,0.00011974873],"about_ca_topic_score_codex":0.0014595692,"about_ca_topic_score_gemma":0.0001048677,"teacher_disagreement_score":0.03043857,"about_ca_system_score_codex":0.00013218871,"about_ca_system_score_gemma":0.00021761937,"threshold_uncertainty_score":0.48434594},"labels":[],"label_agreement":null},{"id":"W4249237268","doi":"10.1191/1358863x02vm437xx","title":"Vascular viewpoint","year":2002,"lang":"en","type":"article","venue":"Vascular Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Aspirin; Stroke (engine); Internal medicine; Randomization; Population; Risk factor; Quartile; Odds ratio; Randomized controlled trial; Myocardial infarction; Vascular disease; Surgery; Confidence interval","score_opus":0.023755011397944906,"score_gpt":0.24038586509212015,"score_spread":0.21663085369417523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249237268","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3508822,0.5339581,0.014013063,0.015040172,0.0013263562,0.0024123557,0.0000087659955,0.0011606021,0.08119843],"genre_scores_gemma":[0.93024415,0.050015207,0.000994168,0.012103969,0.002511012,0.0000964319,0.00007540186,0.00015594953,0.0038037088],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99747616,0.00013228766,0.0004130766,0.00049809885,0.0010277242,0.0004526772],"domain_scores_gemma":[0.9981967,0.000042934975,0.00006598396,0.0010980943,0.00014248604,0.00045379438],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00061455177,0.00032257565,0.00089515315,0.00020395973,0.00013339281,0.000010512648,0.00016389479,0.00014936192,0.008835313],"category_scores_gemma":[0.00021391342,0.00023338251,0.0010238318,0.0004928802,0.00026396345,0.00009052383,0.000039742114,0.0002827842,0.000931797],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033917057,0.0022850314,0.009454674,0.001631014,0.017651718,0.0039018586,0.0029767603,0.00010177712,0.014671818,0.0065290774,0.1288095,0.8116476],"study_design_scores_gemma":[0.009174043,0.0005495514,0.016734757,0.000488024,0.0019262732,0.00044906267,0.00021613398,0.0006882661,0.00044964135,0.00018547573,0.9687584,0.00038039527],"about_ca_topic_score_codex":0.000028632927,"about_ca_topic_score_gemma":0.000001014418,"teacher_disagreement_score":0.8399489,"about_ca_system_score_codex":0.000055412755,"about_ca_system_score_gemma":0.000022316875,"threshold_uncertainty_score":0.9998461},"labels":[],"label_agreement":null},{"id":"W4249549775","doi":"10.1161/01.cir.0000047041.66447.29","title":"ACC/AHA 2002 Guideline Update for the Management of Patients With Chronic Stable Angina—Summary Article","year":2003,"lang":"en","type":"article","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":568,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Douglas College","funders":"","keywords":"Medicine; Guideline; Intensive care medicine; Angina; Internal medicine; Myocardial infarction; Pathology","score_opus":0.009685152932786597,"score_gpt":0.23331731669305852,"score_spread":0.22363216376027192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249549775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91141146,0.005241049,0.08113977,0.00009159191,0.00007246033,0.0012328179,0.000017055954,0.00002938014,0.00076438085],"genre_scores_gemma":[0.9985501,0.00016303992,0.00088593864,0.000106261556,0.00003599308,0.000036315923,0.00009960214,0.00001508409,0.0001076463],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993537,0.000019663645,0.00016492061,0.00012576497,0.0002007195,0.0001352191],"domain_scores_gemma":[0.9994932,0.000012337303,0.000059411697,0.0002707397,0.00013177218,0.000032553013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017846815,0.00007419458,0.00012327898,0.000024673387,0.00007071213,0.000007387718,0.000036308047,0.000024822752,0.0001803703],"category_scores_gemma":[0.000006176215,0.00004959798,0.000104022285,0.00013584807,0.000027176797,0.00007710963,0.0000062668587,0.000027316373,0.000008827811],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028280234,0.0019294188,0.6134892,0.002113841,0.009140321,0.000031933,0.0003199117,0.050985865,0.0016664306,0.016592715,0.013169604,0.28773275],"study_design_scores_gemma":[0.008968464,0.000180711,0.89556706,0.00015388968,0.0017274886,0.000004212474,0.00013859241,0.0055403044,0.0021044912,0.00024924614,0.08517745,0.00018806735],"about_ca_topic_score_codex":0.0000020855477,"about_ca_topic_score_gemma":8.324105e-7,"teacher_disagreement_score":0.28754467,"about_ca_system_score_codex":0.000043949,"about_ca_system_score_gemma":0.000029975232,"threshold_uncertainty_score":0.2022547},"labels":[],"label_agreement":null},{"id":"W4250776235","doi":"10.1007/978-1-60761-219-3_11","title":"Angina","year":2011,"lang":"en","type":"book-chapter","venue":"Humana Press eBooks","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Cardiology","score_opus":0.07691531342477177,"score_gpt":0.2536968358694793,"score_spread":0.17678152244470752,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4250776235","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000043650336,0.05348309,0.00006294559,0.000003323066,0.00015996702,0.00045718052,0.000024065814,0.00018092016,0.94558483],"genre_scores_gemma":[0.0049553304,0.0036015727,0.00003699916,0.00030660507,0.0006548651,0.000024038796,0.000069587346,0.00013686315,0.9902141],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988049,0.000012833642,0.00022722213,0.0003878076,0.0003292919,0.00023794625],"domain_scores_gemma":[0.9988334,0.000009570695,0.00010101719,0.0008061978,0.00007944614,0.00017034913],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00007683455,0.00035830465,0.00061008404,0.00009834134,0.000078315104,0.000018440065,0.0001502771,0.00033623594,0.0012043959],"category_scores_gemma":[0.0000029276273,0.0003238556,0.000830917,0.0000018676659,0.0001697691,0.000020771105,0.0000687624,0.0003310943,0.00017445761],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036058738,0.00003430424,0.0000016949733,0.00044464399,0.0033063025,0.0014197881,0.00027307824,1.9553127e-7,0.000011184442,0.61433876,0.013755443,0.36605406],"study_design_scores_gemma":[0.0008055817,0.000118970114,0.000037424117,0.0003806778,0.0013248264,0.000108502354,0.0000020360555,5.974915e-7,0.00021265943,0.0062487307,0.99042505,0.0003349234],"about_ca_topic_score_codex":0.000025497991,"about_ca_topic_score_gemma":0.0000025817835,"teacher_disagreement_score":0.9766696,"about_ca_system_score_codex":0.000027286324,"about_ca_system_score_gemma":0.000057548055,"threshold_uncertainty_score":0.9999213},"labels":[],"label_agreement":null},{"id":"W4251100661","doi":"10.1161/circ.116.suppl_16.ii_483","title":"Abstract 2220: The Relative Safety and Efficacy of Clopidogrel in Women and Men: Meta-Analysis of 79,613 Patients Enrolled in CREDO, CURE, CLARITY-TIMI 28, COMMIT, and CHARISMA","year":2007,"lang":"en","type":"article","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Clopidogrel; Stroke (engine); Internal medicine; TIMI; Placebo; Aspirin; Randomized controlled trial; Cardiology; Myocardial infarction; Surgery; Thrombolysis; Pathology","score_opus":0.024049728683819334,"score_gpt":0.27366386861727404,"score_spread":0.24961413993345472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4251100661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99360067,0.005176051,0.00025498832,0.00009747856,0.000008449981,0.0004860574,0.000015911146,0.000005080278,0.000355312],"genre_scores_gemma":[0.999217,0.0006087335,0.00004120876,0.00005654908,0.000008254801,0.00000667051,0.00004837186,0.000007713856,0.000005515011],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99878323,0.00013433532,0.0004898943,0.00020778924,0.00024973435,0.00013501022],"domain_scores_gemma":[0.9991472,0.00030713677,0.0001989465,0.00020843967,0.000077012766,0.000061262785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011921497,0.00012130672,0.0007933861,0.00028152321,0.000044214725,0.000006556842,0.000034742032,0.00011410685,0.000039229384],"category_scores_gemma":[0.00009804177,0.00008791184,0.00024546895,0.00048235265,0.00013154188,0.000104733415,0.00002196868,0.00015579673,2.0043014e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001255506,0.00026688466,0.96672404,0.00008553553,0.017654605,0.0000064491987,0.0045188153,0.00031978468,0.00016567922,0.00023826379,0.0000027928834,0.008761629],"study_design_scores_gemma":[0.003840093,0.000043925607,0.9872765,0.000017952761,0.007542085,0.0000011526945,0.00033419198,0.0005715049,0.000032409313,0.00022661782,0.000038222475,0.00007534189],"about_ca_topic_score_codex":0.00009464467,"about_ca_topic_score_gemma":0.000025335126,"teacher_disagreement_score":0.020552449,"about_ca_system_score_codex":0.000037549697,"about_ca_system_score_gemma":0.000017146513,"threshold_uncertainty_score":0.35849407},"labels":[],"label_agreement":null},{"id":"W4252030224","doi":"10.3410/f.13440.470927","title":"Faculty Opinions recommendation of Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events.","year":2006,"lang":"en","type":"dataset","venue":"Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Aspirin; Clopidogrel; Medicine; Internal medicine; Cardiology","score_opus":0.044375785410249155,"score_gpt":0.36980787848864105,"score_spread":0.3254320930783919,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4252030224","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000012999817,0.008291713,0.00027600836,0.046471376,0.0006414396,0.0030700308,0.9411988,0.000020480878,0.000017104596],"genre_scores_gemma":[0.00007657672,0.0016945124,0.0005073329,0.00080591656,0.00029406135,0.00032786262,0.9957698,0.000030129811,0.0004938167],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99638635,0.00035147477,0.001360811,0.0005029402,0.0011340278,0.00026439482],"domain_scores_gemma":[0.9941198,0.00026242243,0.0013320483,0.0012355566,0.0028878457,0.00016231216],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014238828,0.00042249437,0.0011871158,0.0002049641,0.00018565779,0.000032737946,0.0006435985,0.000507995,0.000120562174],"category_scores_gemma":[0.0019615104,0.00024599076,0.0013183706,0.00095463666,0.00041183995,0.00016420681,0.00020012859,0.00051520305,0.0000057749344],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018090745,0.00056187087,0.000016332113,0.012197777,0.0010075239,1.474755e-7,0.000034527402,3.8719446e-7,0.0000027857316,0.00013729496,0.974897,0.0109634455],"study_design_scores_gemma":[0.0034613765,0.00052322063,0.004868995,0.011819744,0.0016580867,0.000028466953,0.000029611338,0.000010630729,0.000032887918,0.000039091858,0.9773175,0.00021038715],"about_ca_topic_score_codex":0.00006115667,"about_ca_topic_score_gemma":0.000008315339,"teacher_disagreement_score":0.054570943,"about_ca_system_score_codex":0.00006651052,"about_ca_system_score_gemma":0.0003890687,"threshold_uncertainty_score":0.9999992},"labels":[],"label_agreement":null},{"id":"W4253917067","doi":"10.1007/s40274-014-1042-5","title":"Ticagrelor good value for money in ACS in Canada","year":2014,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ticagrelor; Value (mathematics); Value for money; Quality of Life Research; Business; Economics; Medicine; Mathematics; Internal medicine; Acute coronary syndrome; Public health; Public economics; Statistics","score_opus":0.011728007418592597,"score_gpt":0.290141817118358,"score_spread":0.2784138096997654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253917067","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920817,0.00055189943,0.00015761316,0.0045188395,0.000410262,0.00068607565,0.000032888955,0.000020778625,0.0015399586],"genre_scores_gemma":[0.9795956,0.00038284925,0.00026426528,0.019240353,0.0001419447,0.000081956154,0.000033482193,0.00003817573,0.0002213855],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99873704,0.000056751374,0.00042687292,0.00030811515,0.00009560065,0.00037564556],"domain_scores_gemma":[0.99924374,0.00020730909,0.00007006279,0.00027719242,0.000017533192,0.00018414174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028767157,0.00019871508,0.0006345141,0.000104818406,0.000027661323,0.000013557609,0.00014258534,0.000049078524,0.00006346469],"category_scores_gemma":[0.000053339812,0.00018922889,0.0002445685,0.000071371316,0.000015992966,0.000086423184,0.000028979208,0.00015597785,0.000023769673],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006023374,0.00017128095,0.92669415,0.0001445651,0.000508683,0.000048949227,0.00013073275,0.0024168852,0.00040518926,0.0014066016,0.0041019176,0.06336869],"study_design_scores_gemma":[0.029464101,0.00011797294,0.4141339,0.0000708218,0.00043484312,0.000035782734,0.0003320659,0.01648569,0.0045776386,0.0007056763,0.5328401,0.00080141664],"about_ca_topic_score_codex":0.2808717,"about_ca_topic_score_gemma":0.390591,"teacher_disagreement_score":0.52873814,"about_ca_system_score_codex":0.0005074575,"about_ca_system_score_gemma":0.0005201279,"threshold_uncertainty_score":0.771653},"labels":[],"label_agreement":null},{"id":"W4256269058","doi":"10.1159/000406129","title":"In vitro Methods and the Study of Platelet Mechanisms","year":2015,"lang":"en","type":"book-chapter","venue":"","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto","funders":"","keywords":"In vitro; Chemistry; Biochemistry","score_opus":0.03437326250073647,"score_gpt":0.3252257284487908,"score_spread":0.2908524659480543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4256269058","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014579201,0.046566725,0.006596844,0.00051752204,0.00042410105,0.0060123866,0.00003492855,0.000094461655,0.9251738],"genre_scores_gemma":[0.290188,0.0040090885,0.009593293,0.0014112857,0.00034659554,0.00009778565,0.000054202184,0.00020916901,0.69409055],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9988382,0.0001364398,0.00031213035,0.00025072755,0.00035269372,0.00010982339],"domain_scores_gemma":[0.99918085,0.00011730073,0.000095317744,0.00044991638,0.0000783195,0.000078283985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001313395,0.00022028017,0.0010012317,0.00011347771,0.000019881738,0.000006156981,0.00008635313,0.00017356724,0.00034672496],"category_scores_gemma":[0.000029085135,0.00012390113,0.00025184584,0.000026485168,0.00013110157,0.00002542043,0.000069680085,0.00025151754,0.000006576872],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030742204,0.001011847,0.000013264634,0.0005130692,0.014814365,0.0018305819,0.0041236775,0.000010153067,0.0024317845,0.47305223,0.0029583052,0.46849853],"study_design_scores_gemma":[0.12423255,0.0037115254,0.00013305283,0.0005878804,0.008414845,0.001178474,0.0068195174,0.00022282462,0.01591095,0.46150136,0.3757365,0.0015505336],"about_ca_topic_score_codex":0.00005289902,"about_ca_topic_score_gemma":0.0000066435223,"teacher_disagreement_score":0.466948,"about_ca_system_score_codex":0.000018788827,"about_ca_system_score_gemma":0.00005897114,"threshold_uncertainty_score":0.50525415},"labels":[],"label_agreement":null},{"id":"W4280599262","doi":"10.1097/md.0000000000029202","title":"Association between selective serotonin reuptake inhibitor and risk of peripheral artery disease in diabetes mellitus","year":2022,"lang":"en","type":"article","venue":"Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Brain and Cognition Discovery Foundation; University Health Network","funders":"","keywords":"Medicine; Serotonin reuptake inhibitor; Hazard ratio; Internal medicine; Diabetes mellitus; Propensity score matching; Proportional hazards model; Retrospective cohort study; Antithrombotic; Population; Cohort study; Antidepressant; Endocrinology; Confidence interval","score_opus":0.007310693947121513,"score_gpt":0.22718555777152594,"score_spread":0.2198748638244044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280599262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868546,0.011332325,0.000017208682,0.0010409608,0.00009033402,0.00046314366,0.000068133006,0.000027139538,0.000106139974],"genre_scores_gemma":[0.99793196,0.0011952551,0.000019580919,0.00016961216,0.00031288955,0.00007802717,0.00007758867,0.000017628201,0.00019747797],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99843925,0.000306108,0.00028816264,0.0002384853,0.00051590224,0.00021208097],"domain_scores_gemma":[0.99931693,0.00013936455,0.00014499133,0.00018296059,0.000059310067,0.00015642752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008155745,0.00012875674,0.00050660316,0.00013755067,0.00009204998,0.000003052393,0.000048096375,0.00004159255,0.00020006139],"category_scores_gemma":[0.00027128725,0.000109955916,0.00011460489,0.00031889742,0.00008016365,0.00004781785,0.000038498943,0.00028489667,8.9630083e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003283059,0.000092031274,0.98804945,0.000080628764,0.0007159953,0.00003725761,0.00079689256,0.000029856477,0.00042905417,0.0000056332733,0.0005408901,0.008893995],"study_design_scores_gemma":[0.004122583,0.00059176283,0.98836946,0.000113484915,0.00095373794,0.0000024528024,0.00042923354,0.00015492771,0.00040896618,0.00016731863,0.004583984,0.00010208107],"about_ca_topic_score_codex":0.00008107886,"about_ca_topic_score_gemma":0.0000071236514,"teacher_disagreement_score":0.011077325,"about_ca_system_score_codex":0.0001874133,"about_ca_system_score_gemma":0.00007064602,"threshold_uncertainty_score":0.4483872},"labels":[],"label_agreement":null},{"id":"W4281251548","doi":"10.1093/ehjcvp/pvac028","title":"Patients selected for dual pathway inhibition in clinical practice have similar characteristics and outcomes to those included in the COMPASS randomized trial: The XATOA Registry","year":2022,"lang":"en","type":"article","venue":"European Heart Journal - Cardiovascular Pharmacotherapy","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute; University of Alberta","funders":"","keywords":"Medicine; Mace; Rivaroxaban; Aspirin; Internal medicine; Randomized controlled trial; Coronary artery disease; Adverse effect; Clinical trial; Incidence (geometry); Population; Surgery; Warfarin; Conventional PCI; Myocardial infarction","score_opus":0.04912476325015902,"score_gpt":0.36706721977151824,"score_spread":0.3179424565213592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281251548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98135084,0.006736983,0.00075370265,0.004778383,0.00066697685,0.00547959,0.00006661663,0.00003696713,0.00012995714],"genre_scores_gemma":[0.97686684,0.003890075,0.00031324613,0.01733213,0.0010437946,0.00033043028,0.00007632648,0.00010507211,0.000042113523],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.98129034,0.015169424,0.0013641367,0.00046435438,0.0012724601,0.0004393107],"domain_scores_gemma":[0.9967691,0.0017133605,0.00035632832,0.0006114175,0.00033095744,0.00021884995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.025049746,0.0003509472,0.0015570401,0.00020563927,0.00060162577,0.00015845448,0.00022292126,0.000056149518,0.00004166893],"category_scores_gemma":[0.0018905774,0.0002199704,0.0023464966,0.00045701026,0.0001498312,0.00017201598,0.00010475925,0.0013455775,0.000004407445],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.88385713,0.003363163,0.016402645,0.00008621941,0.0106264325,0.0033667856,0.0058604074,0.0006933794,0.0004767015,0.000023433433,0.008290289,0.066953406],"study_design_scores_gemma":[0.5581213,0.0007611516,0.05472023,0.000067377,0.00096234906,0.0013581102,0.00081698655,0.00013251569,0.000070909955,0.000016060596,0.38268715,0.0002858743],"about_ca_topic_score_codex":0.00001274445,"about_ca_topic_score_gemma":0.0000010196665,"teacher_disagreement_score":0.37439686,"about_ca_system_score_codex":0.00011613472,"about_ca_system_score_gemma":0.00018361793,"threshold_uncertainty_score":0.89701325},"labels":[],"label_agreement":null},{"id":"W4281689178","doi":"10.1161/jaha.121.024992","title":"Cost‐Effectiveness of Cilostazol Added to Aspirin or Clopidogrel for Secondary Prevention After Noncardioembolic Stroke","year":2022,"lang":"en","type":"article","venue":"Journal of the American Heart Association","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Center for Advancing Translational Sciences; National Institute of Neurological Disorders and Stroke; Canadian Institutes of Health Research","keywords":"Cilostazol; Medicine; Clopidogrel; Aspirin; Stroke (engine); Quality-adjusted life year; Cost effectiveness; Internal medicine","score_opus":0.020934460434560345,"score_gpt":0.3177984580542408,"score_spread":0.29686399761968046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281689178","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99693936,0.00032756623,0.0008441023,0.00050719845,0.00031083814,0.0009069624,0.00012277866,0.000006799778,0.00003437967],"genre_scores_gemma":[0.99816823,0.000036788857,0.00037331946,0.00070980255,0.00024992216,0.000110761124,0.000005898014,0.00001907439,0.0003261843],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979982,0.00076642976,0.0003453714,0.00010568598,0.0006242192,0.00016014278],"domain_scores_gemma":[0.9986441,0.0003025306,0.0005125384,0.00017750531,0.00028593937,0.00007735374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019719112,0.00009244594,0.0006834322,0.000116181516,0.00010283055,0.000009298598,0.0001001404,0.000024657174,0.00006193237],"category_scores_gemma":[0.00030769187,0.000067275105,0.0011007261,0.00032511065,0.000025986066,0.0000714217,0.000049208677,0.00021343929,0.000001480702],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04624971,0.0010853254,0.78639334,0.00041055048,0.0075394805,0.000032955384,0.00085583923,0.0019536533,0.036972716,0.000014102831,0.009212934,0.1092794],"study_design_scores_gemma":[0.0037987959,0.003336534,0.9496407,0.00015885042,0.00085187104,0.00012357086,0.00054074376,0.000021159336,0.006578492,0.00007095318,0.03476371,0.00011461435],"about_ca_topic_score_codex":0.0000109282955,"about_ca_topic_score_gemma":0.0000023198104,"teacher_disagreement_score":0.16324738,"about_ca_system_score_codex":0.00052423234,"about_ca_system_score_gemma":0.00037170353,"threshold_uncertainty_score":0.2743399},"labels":[],"label_agreement":null},{"id":"W4281903017","doi":"10.1111/apt.17050","title":"Strongly increased risk of gastric and duodenal ulcers among new users of low‐dose aspirin: results from two large cohorts with new‐user design","year":2022,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; Bundesministerium für Familie, Senioren, Frauen und Jugend; Medical Research Council Canada; Ministerium für Soziales, Gesundheit, Frauen und Familie, Saarland; Northwest Regional Development Agency; Ministerium für Wissenschaft, Forschung und Kunst Baden-Württemberg; Scottish Government Health and Social Care Directorate; Bundesministerium für Bildung und Forschung; Llywodraeth Cymru; British Heart Foundation; Wellcome Trust","keywords":"Aspirin; Medicine; Hazard ratio; Internal medicine; Low dose aspirin; Gastroenterology; Incidence (geometry); Cohort study; Risk factor; Confidence interval; Proportional hazards model; Population; Cohort; Environmental health","score_opus":0.017257092086966994,"score_gpt":0.2679034749777676,"score_spread":0.2506463828908006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281903017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926453,0.0044819037,0.0010100139,0.00022144616,0.00016467436,0.0008895845,0.00052311417,0.00003983572,0.000024078585],"genre_scores_gemma":[0.9944012,0.0017378773,0.0010807989,0.0021187884,0.00016260968,0.000018346853,0.00033859097,0.000051452622,0.000090343834],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99761224,0.00059803016,0.00047044337,0.00043932136,0.00049828656,0.00038165433],"domain_scores_gemma":[0.9986459,0.0002730934,0.00036981452,0.000350049,0.00005853656,0.0003026173],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00047660497,0.00029528287,0.0006347055,0.00015603384,0.00015826098,0.000006720654,0.00018929633,0.000065219516,0.000719632],"category_scores_gemma":[7.8730113e-7,0.0002665088,0.00022087025,0.0002922864,0.00025529007,0.000107044536,0.000109887595,0.0003791293,0.0000016403499],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.055874497,0.0012493427,0.8013417,0.000042628024,0.07262263,0.00040739262,0.0014172682,0.012017132,0.049016327,0.000005348857,0.0018526664,0.004153053],"study_design_scores_gemma":[0.14501017,0.0076067094,0.5817524,0.00014829244,0.09608212,0.00023651739,0.0030204735,0.0033148318,0.15720269,0.00011918698,0.0045574075,0.00094920193],"about_ca_topic_score_codex":0.0025990482,"about_ca_topic_score_gemma":0.000046997942,"teacher_disagreement_score":0.21958932,"about_ca_system_score_codex":0.000089245535,"about_ca_system_score_gemma":0.00048334347,"threshold_uncertainty_score":0.9999787},"labels":[],"label_agreement":null},{"id":"W4282835150","doi":"10.1161/jaha.121.024709","title":"Sex‐Specific Differences in Clinical Outcomes After Percutaneous Coronary Intervention: Insights from the TAILOR‐PCI Trial","year":2022,"lang":"en","type":"article","venue":"Journal of the American Heart Association","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Alberta; Sunnybrook Health Science Centre; St. Michael's Hospital; St. Peter's Hospital; University of British Columbia; Thunder Bay Regional Health Sciences Centre; Vancouver General Hospital; Health Sciences Centre; University of Ottawa; University of Toronto; Heart and Stroke Foundation","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Mace; Percutaneous coronary intervention; Conventional PCI; Hazard ratio; Clopidogrel; Internal medicine; Myocardial infarction; Cardiology; Randomized controlled trial; Confidence interval","score_opus":0.024156834473418515,"score_gpt":0.29763005186773883,"score_spread":0.2734732173943203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282835150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99331725,0.0017610008,0.0000087398985,0.0035393105,0.0010759573,0.00025978565,0.000014194491,0.0000073603383,0.000016376147],"genre_scores_gemma":[0.99671805,0.00036583186,0.000027290767,0.001962207,0.0006583281,0.000011964361,0.0000030664664,0.000010775067,0.000242472],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963967,0.0018739712,0.0006710652,0.00012573715,0.0008057712,0.00012671226],"domain_scores_gemma":[0.9981735,0.00088142627,0.00059624616,0.00022600844,0.00007007956,0.000052759715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011269677,0.00010178536,0.0007122586,0.000047974056,0.00015385149,0.000027520617,0.00019507951,0.000033006498,0.00020772495],"category_scores_gemma":[0.00027953117,0.00005581666,0.00142149,0.00021377944,0.00008603192,0.00006372358,0.000079066995,0.00060801976,0.0000055526552],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0112657165,0.00038006163,0.9789862,0.0000012164656,0.0007067625,0.00010552512,0.0004159136,0.000009037209,0.000025922134,0.0000019196543,0.0018931028,0.0062086023],"study_design_scores_gemma":[0.007822505,0.0008488871,0.97962326,0.00002732507,0.00021347679,0.00018765479,0.0018375198,0.000011985474,0.000002939119,0.00014881892,0.009209947,0.00006567615],"about_ca_topic_score_codex":0.000074211566,"about_ca_topic_score_gemma":0.000019816178,"teacher_disagreement_score":0.007316844,"about_ca_system_score_codex":0.00033665358,"about_ca_system_score_gemma":0.000095626216,"threshold_uncertainty_score":0.2641577},"labels":[],"label_agreement":null},{"id":"W4283275189","doi":"10.1021/acs.jmedchem.2c00359","title":"Discovery of Two Novel Antiplatelet Clinical Candidates (BMS-986120 and BMS-986141) That Antagonize Protease-Activated Receptor 4","year":2022,"lang":"en","type":"article","venue":"Journal of Medicinal Chemistry","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"Ministère de l'Économie, de la Science et de l'Innovation - Québec","keywords":"Chemistry; Pharmacology; Antithrombotic; Clopidogrel; Platelet; Thrombin; Coagulation; Discovery and development of direct thrombin inhibitors; Receptor; Thrombosis; Platelet activation; Aspirin; Medicine; Internal medicine; Biochemistry","score_opus":0.02639156044833222,"score_gpt":0.30633163682969566,"score_spread":0.2799400763813634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283275189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922894,0.006024545,0.00015979106,0.00062478683,0.00031483552,0.00024267161,0.00009992716,0.000016420583,0.00022760632],"genre_scores_gemma":[0.9962976,0.0018333814,0.00032401475,0.00029488397,0.0008376325,0.000005876836,0.000055246885,0.000036838457,0.00031451686],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99714625,0.00012681208,0.0009712491,0.00030052697,0.0011603989,0.00029476947],"domain_scores_gemma":[0.99805117,0.00020321514,0.0008827857,0.00032898295,0.00019328795,0.00034054957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014829781,0.00026745963,0.0011227409,0.00008618116,0.0001364483,0.000020815973,0.00023744263,0.00011817576,0.00047230945],"category_scores_gemma":[0.00031525403,0.00020802279,0.0005902648,0.00023007244,0.00036881506,0.00020513928,0.00012329833,0.001050696,9.667664e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010999246,0.0011592405,0.09945473,0.00066844455,0.002297881,0.0012698328,0.00023669534,0.000017322338,0.87408507,0.000004665251,0.0028364712,0.0069703828],"study_design_scores_gemma":[0.02464956,0.0020024858,0.01682753,0.0010649659,0.0015491537,0.014922536,0.00314214,0.00006610672,0.92226774,0.00005299761,0.013001098,0.0004537104],"about_ca_topic_score_codex":0.000024144729,"about_ca_topic_score_gemma":2.4531045e-7,"teacher_disagreement_score":0.0826272,"about_ca_system_score_codex":0.000095729185,"about_ca_system_score_gemma":0.00055723323,"threshold_uncertainty_score":0.8482923},"labels":[],"label_agreement":null},{"id":"W4283360084","doi":"10.1177/17474930221111898","title":"Cost-effectiveness of testing for CYP2C19 loss-of-function carriers following transient ischemic attack/minor stroke: A Canadian perspective","year":2022,"lang":"en","type":"article","venue":"International Journal of Stroke","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Ticagrelor; Stroke (engine); Quality-adjusted life year; Aspirin; Clopidogrel; Context (archaeology); Population; Cohort; Cost effectiveness; Regimen; Internal medicine","score_opus":0.03639474211421921,"score_gpt":0.31838217300842714,"score_spread":0.2819874308942079,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283360084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99281996,0.0011512603,0.00336536,0.0001562105,0.0008961885,0.00040148498,0.00044262488,0.000004641354,0.000762262],"genre_scores_gemma":[0.9993164,0.000016109076,0.0003020251,0.000056643024,0.00018667056,0.000027391945,0.000022381253,0.000017290133,0.000055108314],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985796,0.00008342374,0.0003578854,0.00013208135,0.0006924799,0.00015452172],"domain_scores_gemma":[0.998302,0.00020845125,0.0002717774,0.000088242254,0.0009835536,0.00014597793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006326454,0.000109117296,0.00035659308,0.00033733883,0.00007873546,0.000009151339,0.0001759177,0.00003675325,0.00008898492],"category_scores_gemma":[0.00024210353,0.00010699969,0.0007952429,0.00011408075,0.000050435312,0.00011189492,0.000017204497,0.00021179003,2.8743145e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028399749,0.0010216632,0.34434986,0.0003801206,0.036985353,0.0015930376,0.004018302,0.024002708,0.52147055,0.0008030128,0.0011476337,0.035827994],"study_design_scores_gemma":[0.095697224,0.02149232,0.42487192,0.004034952,0.0137924,0.007882355,0.07796209,0.003701527,0.2761502,0.00062584796,0.07205512,0.0017340605],"about_ca_topic_score_codex":0.0016790401,"about_ca_topic_score_gemma":0.00010645336,"teacher_disagreement_score":0.24532038,"about_ca_system_score_codex":0.0006813014,"about_ca_system_score_gemma":0.000811269,"threshold_uncertainty_score":0.43633208},"labels":[],"label_agreement":null},{"id":"W4283714826","doi":"10.1161/jaha.121.024835","title":"Hospital‐Level Variation in Ticagrelor Use in Patients With Acute Coronary Syndrome","year":2022,"lang":"en","type":"article","venue":"Journal of the American Heart Association","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; Western University","funders":"Canadian Institutes of Health Research","keywords":"Ticagrelor; Medicine; Acute coronary syndrome; Clopidogrel; Odds ratio; Emergency medicine; Medical prescription; Internal medicine; Acute care; Odds; Cohort; Intensive care medicine; Health care; Myocardial infarction; Logistic regression; Pharmacology","score_opus":0.007516343422432276,"score_gpt":0.22174210072482065,"score_spread":0.21422575730238838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283714826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99852735,0.000036192472,0.000018978151,0.0010188292,0.00013908869,0.00023404304,0.00001756142,0.000004059525,0.0000038969215],"genre_scores_gemma":[0.99900556,0.000024469651,0.00020444689,0.0006410696,0.000021562451,0.000006115905,0.0000048617485,0.000011903693,0.00008004368],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998493,0.00032236936,0.00026682866,0.000082974744,0.0006996503,0.00013514505],"domain_scores_gemma":[0.9992303,0.00009060369,0.00040989462,0.00012215841,0.00010766996,0.00003932935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005449028,0.00007100786,0.00037780462,0.0001241069,0.00006294346,0.000011590866,0.00007388116,0.000017558075,0.00002122843],"category_scores_gemma":[0.00013473655,0.000050832336,0.00019698458,0.0004832121,0.000020047592,0.00017194105,0.000031188378,0.00028934018,0.0000015668901],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007775135,0.0004356918,0.997109,0.0000021564265,0.00040801262,0.00007225974,0.00019617262,0.00025739966,0.000044890603,0.00000223937,0.00026886503,0.00042581576],"study_design_scores_gemma":[0.0026175391,0.001203897,0.99540794,0.000031128395,0.00018327218,0.00010004543,0.0001055975,0.000030097615,0.00000520068,0.000019316913,0.00023332343,0.00006265789],"about_ca_topic_score_codex":0.00006879905,"about_ca_topic_score_gemma":0.0000054375355,"teacher_disagreement_score":0.0018400257,"about_ca_system_score_codex":0.00084460387,"about_ca_system_score_gemma":0.00013648771,"threshold_uncertainty_score":0.22086097},"labels":[],"label_agreement":null},{"id":"W4285744623","doi":"10.3389/fphar.2022.878416","title":"Antiplatelet Therapy in Atherothrombotic Diseases: Similarities and Differences Across Guidelines","year":2022,"lang":"en","type":"review","venue":"Frontiers in Pharmacology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Research Canada; Montreal Heart Institute","funders":"","keywords":"Medicine; Intensive care medicine; Aspirin; Clinical trial; P2Y12; Clinical Practice; Alternative medicine; Clopidogrel; Internal medicine; Physical therapy; Pathology","score_opus":0.1010233195618187,"score_gpt":0.40530199449671234,"score_spread":0.30427867493489363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285744623","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010979264,0.9849007,0.000031897984,0.00010270438,0.001930398,0.001715878,0.0002263403,0.00006505831,0.000047760088],"genre_scores_gemma":[0.00045442334,0.99714065,0.00019205917,0.0007958349,0.00034656125,0.000611882,0.00021244738,0.00009256143,0.00015357902],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965672,0.0007526184,0.00090762984,0.0007844254,0.00032221802,0.00066593586],"domain_scores_gemma":[0.9990571,0.00019356322,0.00021643077,0.0003217476,0.000034565142,0.00017658825],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004890399,0.00062008353,0.0035209586,0.00044941227,0.00013465005,0.00003284056,0.00033540025,0.0003533357,0.00073380274],"category_scores_gemma":[0.000055175275,0.00051260105,0.0007279912,0.000538511,0.00042865702,0.000098181845,0.00017983635,0.0008113264,0.0000034372265],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037986616,0.00034187856,0.01390978,0.0057597673,0.0016416847,0.0012935546,0.0002595008,0.0000036446368,6.7632664e-7,0.000003718427,0.00897257,0.96743333],"study_design_scores_gemma":[0.004568125,0.00027218863,0.002095842,0.0018464077,0.0010878064,0.00021364455,0.00055609934,0.000057087553,0.0000010488484,0.0001096688,0.98867,0.00052209466],"about_ca_topic_score_codex":0.000035363577,"about_ca_topic_score_gemma":0.0000044359253,"teacher_disagreement_score":0.9796974,"about_ca_system_score_codex":0.00019819832,"about_ca_system_score_gemma":0.00033998405,"threshold_uncertainty_score":0.99973255},"labels":[],"label_agreement":null},{"id":"W4285807754","doi":"10.1016/j.hlc.2022.05.043","title":"Balancing the Risks of Recurrent Ischaemic and Bleeding Events in a Stable Post ACS Population","year":2022,"lang":"en","type":"article","venue":"Heart Lung and Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"National Health and Medical Research Council","keywords":"Medicine; Myocardial infarction; Internal medicine; Acute coronary syndrome; Cardiology; Population; Cohort; Stroke (engine); Ischaemic heart disease; Surgery","score_opus":0.023786975479031202,"score_gpt":0.2936713581923005,"score_spread":0.2698843827132693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285807754","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99436796,0.0050394195,0.000046843223,0.00019648098,0.00005438218,0.00025819236,0.000004710611,0.000009779837,0.00002220544],"genre_scores_gemma":[0.99965477,0.00015817853,0.000009654792,0.00007425946,0.000029019227,0.000014826367,0.000046449775,0.0000063569887,0.0000064830747],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993962,0.000084539635,0.00013624158,0.00011584202,0.00018214589,0.000085002626],"domain_scores_gemma":[0.99980485,0.000024220426,0.00004066155,0.000083189996,0.000021270213,0.000025824394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038075968,0.000052050375,0.0001338902,0.000059345875,0.00014733302,0.000004237752,0.000013475119,0.000020812875,0.000016596816],"category_scores_gemma":[0.00001769536,0.00004376327,0.000042673568,0.00012220528,0.000011499372,0.00006110598,0.000022024571,0.00009765726,1.8275146e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010867844,0.00002998865,0.9891714,0.000083517385,0.000038262086,0.0000014057799,0.00051849073,0.00079642877,0.0045317872,0.00007285664,0.0000100297775,0.0046371883],"study_design_scores_gemma":[0.0007093346,0.00004822363,0.9928218,0.000077478704,0.00007159584,0.00007162088,0.0005755821,0.005271731,0.00005796708,0.0001065733,0.00014216648,0.00004589824],"about_ca_topic_score_codex":0.0002676744,"about_ca_topic_score_gemma":0.000007925823,"teacher_disagreement_score":0.005286786,"about_ca_system_score_codex":0.00003967804,"about_ca_system_score_gemma":0.000017417227,"threshold_uncertainty_score":0.17846143},"labels":[],"label_agreement":null},{"id":"W4288428459","doi":"10.1001/jamanetworkopen.2022.24157","title":"Analysis of Prescriptions for Dual Antiplatelet Therapy After Acute Ischemic Stroke","year":2022,"lang":"en","type":"article","venue":"JAMA Network Open","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotchkiss Brain Institute; University of Calgary","funders":"National Institutes of Health; American Stroke Association; Alexion Pharmaceuticals; Novo Nordisk; American Heart Association; Sanofi; AstraZeneca; National Institute on Aging; Eli Lilly and Company","keywords":"Medicine; Clopidogrel; Stroke (engine); Aspirin; Minor stroke; Medical prescription; Internal medicine; Ischemic stroke; Platelet aggregation inhibitor; Cardiology; Acute coronary syndrome; Emergency medicine; Physical therapy; Myocardial infarction; Ischemia","score_opus":0.018945800361714126,"score_gpt":0.28183164562504903,"score_spread":0.2628858452633349,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4288428459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887431,0.0062510073,0.00074560806,0.00046137415,0.00014541966,0.0013341974,0.0007353301,0.000030646042,0.0015533052],"genre_scores_gemma":[0.9925277,0.0011599248,0.0006573649,0.0012722609,0.00027656852,0.00074248546,0.00072733953,0.000032476604,0.002603838],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99860847,0.00014045868,0.000309297,0.00032131205,0.00032669783,0.00029376167],"domain_scores_gemma":[0.9990785,0.00007193982,0.00012543816,0.000538017,0.000090146015,0.00009594338],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006408437,0.0001540174,0.00067398,0.00012796077,0.00020952614,0.000055489418,0.00028363586,0.000063795174,0.0018546156],"category_scores_gemma":[0.000010022133,0.00013821058,0.0009198879,0.0007457286,0.00005021807,0.00015274729,0.00024774545,0.0001759,0.0000030021884],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06880557,0.0017577496,0.39548212,0.00009756672,0.1840132,0.000524149,0.0014020448,0.02622595,0.0081466995,0.00043165314,0.21554841,0.09756486],"study_design_scores_gemma":[0.012620933,0.0010403183,0.27220848,0.00005463239,0.013315954,0.00008797711,0.00043141597,0.004803135,0.0012360262,0.00006606394,0.6936945,0.00044056997],"about_ca_topic_score_codex":0.000027907892,"about_ca_topic_score_gemma":0.0000050724143,"teacher_disagreement_score":0.47814608,"about_ca_system_score_codex":0.000032091197,"about_ca_system_score_gemma":0.000089012734,"threshold_uncertainty_score":0.9990578},"labels":[],"label_agreement":null},{"id":"W4289868667","doi":"10.1161/jaha.121.025058","title":"Impact of Insulin Receptor Substrate‐1 rs956115 and CYP2C19 rs4244285 Genotypes on Clinical Outcome of Patients Undergoing Percutaneous Coronary Intervention","year":2022,"lang":"en","type":"article","venue":"Journal of the American Heart Association","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton General Hospital","funders":"","keywords":"Medicine; Percutaneous coronary intervention; Internal medicine; Coronary artery disease; Myocardial infarction; Diabetes mellitus; Genotype; Cardiology; Clopidogrel; Stroke (engine); Gastroenterology; Endocrinology","score_opus":0.020628597756829105,"score_gpt":0.32884405299309477,"score_spread":0.30821545523626565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4289868667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989932,0.0003818732,0.000007155667,0.00019661097,0.00022475258,0.00014354647,0.000037187412,0.0000039335837,0.000011746235],"genre_scores_gemma":[0.9993271,0.00032940353,0.000068307956,0.00014205054,0.0000746073,8.4236166e-7,0.0000065299982,0.00001189005,0.000039219238],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99786913,0.0006765365,0.0006930547,0.00008750604,0.0005699877,0.00010375731],"domain_scores_gemma":[0.99802667,0.00032838417,0.0012494569,0.00012689555,0.00020794915,0.00006065269],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001129951,0.000084492436,0.0006130677,0.00007944305,0.00007375653,0.0000054791985,0.000078337136,0.000031050182,0.000062571606],"category_scores_gemma":[0.0005305192,0.000059849914,0.0010524947,0.00017582226,0.00006320769,0.000052196807,0.00004001551,0.00029210965,0.0000010764072],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022761612,0.00050662656,0.9876154,0.00001891938,0.0010185556,0.0000049788227,0.00011071127,0.00024782753,0.00061645807,0.0000016651471,0.0003390014,0.0072437087],"study_design_scores_gemma":[0.0015641223,0.0059119966,0.9915637,0.000053320746,0.00027689553,0.00007383864,0.00029004415,0.000021996266,0.000064654625,0.00002280243,0.0001057542,0.000050919003],"about_ca_topic_score_codex":0.000049039212,"about_ca_topic_score_gemma":0.0000028225752,"teacher_disagreement_score":0.00719279,"about_ca_system_score_codex":0.000384956,"about_ca_system_score_gemma":0.00012228158,"threshold_uncertainty_score":0.24406087},"labels":[],"label_agreement":null},{"id":"W4290052559","doi":"10.1016/j.cjco.2022.07.013","title":"Sex Differences in Clopidogrel Effects Among Young Patients With Acute Coronary Syndrome: A Role for Genetics?","year":2022,"lang":"en","type":"article","venue":"CJC Open","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of Alberta; McGill University Health Centre","funders":"National Center for Advancing Translational Sciences; Canadian Institutes of Health Research; McGill University Health Centre; Broad Institute; McGill University; Yale University","keywords":"Clopidogrel; Medicine; Odds ratio; Acute coronary syndrome; Internal medicine; Confidence interval; Logistic regression; Cohort; Antiplatelet drug; Myocardial infarction; Cardiology","score_opus":0.007219111450429995,"score_gpt":0.2337135591804198,"score_spread":0.2264944477299898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4290052559","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957431,0.0011731774,0.00006864013,0.00002653528,0.0000940428,0.0025405001,0.000054855358,0.000021316759,0.00027785308],"genre_scores_gemma":[0.9977734,0.00006728037,0.00016093563,0.00021354224,0.00001564062,0.00089358195,0.0002001759,0.00002838458,0.0006470311],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989667,0.00009749875,0.0001341778,0.0002954122,0.00028217564,0.00022405393],"domain_scores_gemma":[0.9994948,0.00004657474,0.000050427774,0.00027151805,0.000026465008,0.00011025212],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001445727,0.00013805316,0.00045520018,0.000058430574,0.00016461473,0.000035214078,0.00026655765,0.000034077097,0.00010136064],"category_scores_gemma":[0.000009534212,0.000110500674,0.0001109296,0.00014595134,0.00005323767,0.00008561259,0.00022639963,0.00011747601,0.0000032467271],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011126683,0.0003075151,0.98966414,0.0000542015,0.0007151999,0.0005015458,0.00029868213,0.000014360791,0.000016479344,0.000010408392,0.00017883633,0.007125944],"study_design_scores_gemma":[0.007908122,0.0016078772,0.98874277,0.00006261268,0.00030206077,0.00013309812,0.00028197642,0.00011734085,0.00005887781,0.00008359699,0.0005474731,0.00015419415],"about_ca_topic_score_codex":0.0000647766,"about_ca_topic_score_gemma":0.00001412465,"teacher_disagreement_score":0.00697175,"about_ca_system_score_codex":0.000059178044,"about_ca_system_score_gemma":0.00009183612,"threshold_uncertainty_score":0.45060867},"labels":[],"label_agreement":null},{"id":"W4291018528","doi":"10.3389/fcvm.2022.912114","title":"Low-dose aspirin and rivaroxaban combination therapy to overcome aspirin non-sensitivity in patients with vascular disease","year":2022,"lang":"en","type":"article","venue":"Frontiers in Cardiovascular Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; McMaster University; Population Health Research Institute; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Aspirin; Medicine; Rivaroxaban; Ex vivo; Pharmacology; Adverse effect; Platelet; Internal medicine; Anesthesia; Cardiology; In vivo; Warfarin; Atrial fibrillation","score_opus":0.005452548887094084,"score_gpt":0.20403480676151306,"score_spread":0.19858225787441897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4291018528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9654401,0.026376659,0.004417542,0.0004216888,0.00053966744,0.0026101961,0.000028302431,0.00006226306,0.0001036098],"genre_scores_gemma":[0.9970326,0.0005883985,0.00035588414,0.0011927136,0.00014562746,0.0002821909,0.0002716095,0.000088417364,0.000042564818],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954354,0.0006065708,0.0004814689,0.0009527202,0.0019449857,0.00057884405],"domain_scores_gemma":[0.99801356,0.0000392539,0.00008135495,0.0011860462,0.00015015692,0.00052961934],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002150961,0.00046641406,0.0015463928,0.00085054414,0.00018541727,0.000017839066,0.00017238206,0.0000914369,0.000042125317],"category_scores_gemma":[0.00009423095,0.00040446306,0.00064842694,0.0012167516,0.00023300276,0.00017657057,0.00016089536,0.0005547532,0.0000032777984],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037009409,0.000980426,0.9137158,0.00019626318,0.0022959406,0.0012537147,0.0006538805,0.0031440835,0.000031017047,0.000017754255,0.00041297032,0.07359721],"study_design_scores_gemma":[0.032522846,0.0011946412,0.9558348,0.0004030682,0.0005166891,0.000024908337,0.0003302813,0.00035765438,0.000030687395,0.00007431578,0.008258143,0.00045193222],"about_ca_topic_score_codex":0.00022427742,"about_ca_topic_score_gemma":0.000009365464,"teacher_disagreement_score":0.07314528,"about_ca_system_score_codex":0.00048899377,"about_ca_system_score_gemma":0.0001613526,"threshold_uncertainty_score":0.99984074},"labels":[],"label_agreement":null},{"id":"W4291377664","doi":"10.1016/j.amjmed.2022.07.022","title":"Impact of Bleeding on Myocardial Infarction, Stroke, and Death During 12 Months Dual Antiplatelet Therapy After Acute Coronary Syndrome","year":2022,"lang":"en","type":"article","venue":"The American Journal of Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"Bristol-Myers Squibb Canada; Medtronic; Sanofi; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company; Roche","keywords":"Medicine; Myocardial infarction; Acute coronary syndrome; Cardiology; Internal medicine; Stroke (engine)","score_opus":0.01034792316795297,"score_gpt":0.26493709158259465,"score_spread":0.2545891684146417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4291377664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99397427,0.0045413333,0.0000170232,0.0009777691,0.00017039984,0.00021108084,0.000029200302,0.000012247472,0.00006670692],"genre_scores_gemma":[0.99382997,0.0051517594,0.000021828972,0.00053722254,0.0003584074,0.000008013311,0.000003795279,0.000031532072,0.000057464873],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980012,0.00026015606,0.00046393558,0.00015657264,0.00087013975,0.00024798146],"domain_scores_gemma":[0.9987986,0.0001187237,0.00051791006,0.00026832332,0.00009994885,0.00019649834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077820406,0.00021207695,0.0009394518,0.00026975744,0.00016983131,0.000006114815,0.00013595464,0.000020910116,0.00034683716],"category_scores_gemma":[0.000029341742,0.000120888035,0.000480977,0.00025434853,0.00044450362,0.00008452175,0.000057710782,0.0004961553,8.528127e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.091959015,0.0005096793,0.7759282,0.00003811847,0.023680072,0.008269948,0.0034057393,0.0010469828,0.03818476,0.000011887619,0.0008443103,0.056121312],"study_design_scores_gemma":[0.0075800396,0.016715527,0.94195396,0.00013859863,0.0008063309,0.030895574,0.00141166,0.00001333421,0.00014439914,0.000018970959,0.00021033232,0.00011128385],"about_ca_topic_score_codex":0.000056756173,"about_ca_topic_score_gemma":1.445302e-7,"teacher_disagreement_score":0.16602577,"about_ca_system_score_codex":0.00009976666,"about_ca_system_score_gemma":0.00011520111,"threshold_uncertainty_score":0.4929671},"labels":[],"label_agreement":null},{"id":"W4293005092","doi":"10.1038/s41598-022-18654-2","title":"Selective serotonin reuptake inhibitors increase risk of upper gastrointestinal bleeding when used with NSAIDs: a systemic review and meta-analysis","year":2022,"lang":"en","type":"review","venue":"Scientific Reports","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Concomitant; Upper gastrointestinal bleeding; Internal medicine; Odds ratio; Cohort study; Meta-analysis; Lower risk; Randomized controlled trial; Cohort; Confidence interval; Endoscopy","score_opus":0.043500735581277365,"score_gpt":0.29222259314055765,"score_spread":0.24872185755928028,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293005092","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009635732,0.99488914,0.000067334484,0.000012165312,0.00014182809,0.0036094023,0.0001058104,0.00006617998,0.00014455867],"genre_scores_gemma":[0.00072525424,0.9957873,0.000686759,0.000023487066,0.00004329055,0.0007234752,0.0004932462,0.00007883744,0.001438318],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99347574,0.001028944,0.0018132874,0.0017142367,0.0015472674,0.00042055725],"domain_scores_gemma":[0.99450076,0.00019279179,0.00269372,0.0018479148,0.00041068182,0.00035415555],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.006498477,0.0006794612,0.007872575,0.0007413122,0.0003455553,0.00010644643,0.00018214658,0.00010515179,0.0011521501],"category_scores_gemma":[0.00060114893,0.00042915577,0.0058378894,0.0029446387,0.00036706033,0.00013949745,0.00014986547,0.0006220449,0.0000036330634],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012600579,0.00040836324,0.008353888,0.18438262,0.7664874,0.005719357,0.000333167,0.000021960128,0.000012855197,0.000006678502,0.0034688783,0.030678825],"study_design_scores_gemma":[0.00016300123,0.00013432959,0.000018265962,0.0073912367,0.7424459,0.015417634,0.0000759492,0.0000016599366,0.0000070129713,0.000011964648,0.23402306,0.00030997233],"about_ca_topic_score_codex":0.00012862631,"about_ca_topic_score_gemma":0.000007797245,"teacher_disagreement_score":0.2305542,"about_ca_system_score_codex":0.00017443515,"about_ca_system_score_gemma":0.0010673247,"threshold_uncertainty_score":0.999816},"labels":[],"label_agreement":null},{"id":"W4293064226","doi":"10.1016/j.ekir.2022.08.005","title":"CKD Effects on Platelets: Implications for Cardiovascular Risk","year":2022,"lang":"en","type":"editorial","venue":"Kidney International Reports","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Seven Oaks General Hospital; University of Manitoba","funders":"RWTH Aachen University; Else Kröner-Fresenius-Stiftung; Hartstichting; Deutsche Forschungsgemeinschaft","keywords":"Medicine; Cardiology; Internal medicine; Thrombus; Myocardial infarction; Coronary artery disease; Platelet; Hemostasis; Fibrin; Artery; Platelet activation; Disease","score_opus":0.0077348377448693125,"score_gpt":0.2754615122173547,"score_spread":0.2677266744724854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293064226","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009756541,0.005208819,0.0016386345,0.001104413,0.9783715,0.0024829817,0.0039609,0.00027870853,0.0059783584],"genre_scores_gemma":[0.007971463,0.0052941325,0.00048822406,0.0011482007,0.9442431,0.0030929812,0.031946395,0.0002768578,0.0055386582],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958327,0.00012491818,0.0006688558,0.0010920995,0.0019272154,0.00035420904],"domain_scores_gemma":[0.9961206,0.0008035018,0.00053957035,0.0014681985,0.00062366127,0.00044452044],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000997987,0.000466722,0.000988119,0.00023540213,0.00030749722,0.000069686605,0.00029525688,0.0005089671,0.00042189454],"category_scores_gemma":[0.009143893,0.00045113638,0.004180086,0.00014932835,0.00005215563,0.000077201505,0.00011347134,0.00089946506,0.000025845276],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044941847,0.00020072829,0.0005398699,0.00024919002,0.016651021,0.0011894426,0.000019327168,0.000082480634,0.000017122415,0.00009881844,0.9640473,0.016455285],"study_design_scores_gemma":[0.0021365595,0.00031782474,0.0006605794,0.00027078297,0.0032845803,0.00042107256,0.0000073944207,0.000006442989,0.0001633528,0.001051545,0.99127984,0.0004000243],"about_ca_topic_score_codex":0.000059094997,"about_ca_topic_score_gemma":6.699341e-7,"teacher_disagreement_score":0.034128442,"about_ca_system_score_codex":0.0005707211,"about_ca_system_score_gemma":0.0012411841,"threshold_uncertainty_score":0.99979407},"labels":[],"label_agreement":null},{"id":"W4293084342","doi":"10.1186/s43042-022-00313-w","title":"The efficacy of clopidogrel in preventing recurrent cardiovascular events among Arab population carrying different CYP2C19 mutations: systematic review and meta-analysis","year":2022,"lang":"en","type":"article","venue":"Egyptian Journal of Medical Human Genetics","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"CYP2C19; Clopidogrel; Odds ratio; Medicine; Confidence interval; Allele; Internal medicine; Meta-analysis; Genotype; Population; Oncology; Genetics; Gene; Aspirin; Biology","score_opus":0.03465583973085584,"score_gpt":0.3137935146243761,"score_spread":0.27913767489352026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293084342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.54251426,0.45634964,0.00026811284,0.00021267871,0.000053087864,0.000592416,0.000003839256,0.000003152965,0.00000281692],"genre_scores_gemma":[0.983153,0.016575692,0.000048282396,0.00007108756,0.000053354408,0.000042267533,0.000019803516,0.000016210864,0.000020333528],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9945167,0.0014277226,0.0014882004,0.00018440056,0.0021975494,0.00018545617],"domain_scores_gemma":[0.99829894,0.00020946219,0.0007450456,0.00041840816,0.00012775193,0.00020038917],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042658066,0.00017484074,0.0021221826,0.00023067677,0.00023107148,0.00001530511,0.00028301665,0.00005370998,0.00014131359],"category_scores_gemma":[0.00046534656,0.00010907868,0.0029224607,0.00042575994,0.00008660401,0.0000329311,0.00009651476,0.00046275448,2.149376e-7],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019234073,0.0012956464,0.09736705,0.08520128,0.79385275,0.0005259541,0.0020210424,0.0073431293,0.00001209369,0.00012833012,0.0000701592,0.011990218],"study_design_scores_gemma":[0.0025635639,0.00038201467,0.18848526,0.004459621,0.8022289,0.00031188937,0.0006281859,0.0004815155,0.000013980622,0.00017734316,0.000058121263,0.00020956797],"about_ca_topic_score_codex":0.000009693775,"about_ca_topic_score_gemma":0.0000102651975,"teacher_disagreement_score":0.4406387,"about_ca_system_score_codex":0.00007484855,"about_ca_system_score_gemma":0.00006185422,"threshold_uncertainty_score":0.44480994},"labels":[],"label_agreement":null},{"id":"W4295018327","doi":"10.1016/j.iccl.2022.02.003","title":"Recent Advances in Antiplatelet Therapy in Complex Percutaneous Coronary Intervention","year":2022,"lang":"en","type":"review","venue":"Interventional Cardiology Clinics","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Data Science Institute, Columbia University; Canada Excellence Research Chairs, Government of Canada; Medtronic; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Insel Gruppe; Boston Scientific Corporation; Chiesi Farmaceutici; AstraZeneca; CSL Behring; Novartis Pharmaceuticals Corporation; California Institute for Regenerative Medicine; OrbusNeich; Bayer; Abbott Laboratories","keywords":"Medicine; Antithrombotic; Conventional PCI; Percutaneous coronary intervention; Intensive care medicine; Stent; Cardiology; Antiplatelet drug; Internal medicine; Clopidogrel; Myocardial infarction","score_opus":0.11041580254152121,"score_gpt":0.4137941061081286,"score_spread":0.3033783035666074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295018327","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0033680338,0.9929197,0.000036413727,0.000033721462,0.0010844663,0.0014578049,0.00026018897,0.00006428028,0.0007754146],"genre_scores_gemma":[0.002307999,0.99149865,0.000043433694,0.00016147173,0.00030331255,0.00033466844,0.0051068254,0.00009356737,0.00015009924],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99384403,0.002102,0.0021277592,0.00095011905,0.00047874084,0.0004973262],"domain_scores_gemma":[0.9981053,0.0005599779,0.000527835,0.0006061275,0.000084505446,0.00011625042],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018031778,0.000603711,0.003866845,0.0006703263,0.00007693926,0.000016922217,0.00040891062,0.00057521125,0.0036930623],"category_scores_gemma":[0.00021846365,0.00055459817,0.005351286,0.0005421171,0.00022515329,0.000120723875,0.00022312367,0.0015248056,0.000077951096],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010011881,0.0007168515,0.0031176598,0.0027513488,0.0014824823,0.006860694,0.000014219226,0.00005866328,1.020056e-7,0.00005136852,0.0002268862,0.9837185],"study_design_scores_gemma":[0.003101034,0.0014674331,0.0032047925,0.004498241,0.0005115644,0.011974747,0.00007323711,0.0000123580085,3.731944e-8,0.00024230966,0.9744773,0.00043696357],"about_ca_topic_score_codex":0.0000060386155,"about_ca_topic_score_gemma":0.000023495784,"teacher_disagreement_score":0.98328155,"about_ca_system_score_codex":0.00053571636,"about_ca_system_score_gemma":0.00029089444,"threshold_uncertainty_score":0.99969053},"labels":[],"label_agreement":null},{"id":"W4295559984","doi":"10.1016/j.jacc.2022.08.022","title":"TCT-13 Ticagrelor Monotherapy in Patients With Peripheral Artery Disease Undergoing PCI","year":2022,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Ticagrelor; Conventional PCI; Cardiology; Peripheral; Internal medicine; Arterial disease; Coronary artery disease; Disease; Myocardial infarction; Vascular disease; Percutaneous coronary intervention","score_opus":0.005828443879754029,"score_gpt":0.2161534472109762,"score_spread":0.21032500333122217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295559984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972844,0.00089320086,0.0002109353,0.0009467644,0.00019231714,0.00026298995,0.0000542216,0.000005002476,0.00015013925],"genre_scores_gemma":[0.99868536,0.00018846206,0.0001007421,0.00076826557,0.00015024688,0.000008988817,0.0000024583446,0.000023709148,0.000071769064],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982828,0.0005041847,0.00037801615,0.00014062517,0.0004903591,0.00020401827],"domain_scores_gemma":[0.99890023,0.00010091205,0.00042786397,0.0003308733,0.00012072767,0.00011936629],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002917959,0.00013751967,0.0008388831,0.00014850908,0.000092556846,0.000002863537,0.00022532421,0.000017428223,0.000039051785],"category_scores_gemma":[0.00004577679,0.00008792941,0.00064050994,0.0003985259,0.0003164991,0.00005073576,0.00006156112,0.00029056869,3.970265e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018342504,0.00019895338,0.9657253,0.00002164286,0.0016354981,0.0009238186,0.000060542614,0.009666969,0.00008903791,0.000039789928,0.0010031306,0.0022928312],"study_design_scores_gemma":[0.009118895,0.0028461707,0.9783076,0.000064279746,0.00042517492,0.0011033874,0.00091566436,0.0000333371,0.000019046744,0.00010013147,0.0069237035,0.00014257805],"about_ca_topic_score_codex":0.0000026098553,"about_ca_topic_score_gemma":0.0000017286897,"teacher_disagreement_score":0.01258235,"about_ca_system_score_codex":0.00015705205,"about_ca_system_score_gemma":0.00045754606,"threshold_uncertainty_score":0.35856575},"labels":[],"label_agreement":null},{"id":"W4295743143","doi":"10.1016/j.jacc.2022.08.222","title":"TCT-189 The Efficacy and Safety of an Adjunctive Transcoronary Pacing Strategy During Rotational Atherectomy: The Results of the Strategy to Rotablate and PACE (ROTA-PACE) Study","year":2022,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Jubilee Hospital","funders":"","keywords":"Medicine; Pace; Geodesy","score_opus":0.011993756043096429,"score_gpt":0.2607268107550693,"score_spread":0.24873305471197288,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295743143","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955224,0.0016440576,0.00002798047,0.0011599477,0.000104342216,0.0010903416,0.00025656464,0.0000035603475,0.0001908337],"genre_scores_gemma":[0.99943334,0.00023949768,0.000022741622,0.00008806098,0.0001296166,0.000014648835,0.0000011481061,0.00001885733,0.00005211078],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9962282,0.0021589072,0.0006364632,0.0002057791,0.000575275,0.00019538414],"domain_scores_gemma":[0.9978469,0.0005433959,0.00080199266,0.0005048896,0.0002194097,0.00008341511],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015577053,0.00018416233,0.0009511517,0.0000768458,0.0003539044,0.0000055618793,0.00036779934,0.000029120969,0.000009013445],"category_scores_gemma":[0.00012685862,0.00008616671,0.00047730617,0.00048898265,0.0007450102,0.000057813173,0.00014616273,0.00043845997,5.0657434e-8],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20352173,0.0017260024,0.14928347,0.00025204578,0.030308263,0.0010079093,0.017630255,0.4649353,0.08034442,0.00068118115,0.0007336685,0.04957577],"study_design_scores_gemma":[0.0071124714,0.0060187434,0.9412078,0.0000750642,0.0010874505,0.00307608,0.039699376,0.000060276452,0.0010200415,0.00011687661,0.00040470276,0.00012110744],"about_ca_topic_score_codex":0.000055883862,"about_ca_topic_score_gemma":0.000021248909,"teacher_disagreement_score":0.79192436,"about_ca_system_score_codex":0.00005545422,"about_ca_system_score_gemma":0.0003418245,"threshold_uncertainty_score":0.35137764},"labels":[],"label_agreement":null},{"id":"W4297237808","doi":"10.3390/ijms231911317","title":"Aspirin Resistance in Vascular Disease: A Review Highlighting the Critical Need for Improved Point-of-Care Testing and Personalized Therapy","year":2022,"lang":"en","type":"review","venue":"International Journal of Molecular Sciences","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Aspirin; Medicine; Ticagrelor; Thromboelastography; Intensive care medicine; Adverse effect; Rivaroxaban; Disease; Antiplatelet drug; Internal medicine; Platelet; Clopidogrel; Warfarin; Atrial fibrillation","score_opus":0.05339234741281409,"score_gpt":0.3702908889174991,"score_spread":0.31689854150468505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297237808","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00026100935,0.99682796,0.00036948503,0.0014644891,0.00022333351,0.00074221817,0.000029585373,0.0000050796402,0.00007682146],"genre_scores_gemma":[0.00057793193,0.9961544,0.0023497494,0.0006874936,0.00012939217,0.00006242264,0.000011561829,0.000020764424,0.000006239122],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99737203,0.00036811244,0.0007972809,0.0002854368,0.0009954494,0.00018171663],"domain_scores_gemma":[0.99771595,0.0009210769,0.0005751941,0.00018055846,0.0005015718,0.00010563254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019565094,0.00022043473,0.0010811957,0.00024127768,0.00011724246,0.0000600281,0.00064033037,0.000047558362,0.000037854832],"category_scores_gemma":[0.0021994973,0.0001345283,0.0013045403,0.0004089163,0.0003789696,0.00010918438,0.00008051182,0.000285511,1.6076274e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031518142,0.00011958879,0.000043573058,0.013576762,0.0012438557,0.00045444828,0.00014954027,0.0000036002302,0.000045326342,0.0014435351,0.000051474733,0.9825531],"study_design_scores_gemma":[0.0013888224,0.0003076049,0.000054318207,0.055194683,0.0011359103,0.0002809761,0.00020475016,0.000022482456,0.000007884884,0.0005185827,0.9406786,0.00020538433],"about_ca_topic_score_codex":0.0000032957037,"about_ca_topic_score_gemma":6.0451157e-7,"teacher_disagreement_score":0.9823477,"about_ca_system_score_codex":0.00008667248,"about_ca_system_score_gemma":0.0008620933,"threshold_uncertainty_score":0.5485904},"labels":[],"label_agreement":null},{"id":"W4297704090","doi":"10.1378/chest.11-2293","title":"Antiplatelet Drugs","year":2012,"lang":"en","type":"article","venue":"CHEST Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":377,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; Population Health Research Institute; McMaster University","funders":"National Heart, Lung, and Blood Institute; Sanofi; Bristol-Myers Squibb","keywords":"Medicine; Intensive care medicine; Pharmacology","score_opus":0.015198884891806099,"score_gpt":0.2638194747305694,"score_spread":0.24862058983876328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297704090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9772526,0.012609697,0.0007233337,0.00035198612,0.0004471337,0.00006714086,0.0000012044305,0.000039508,0.008507374],"genre_scores_gemma":[0.9949268,0.0013310343,0.00059992593,0.0005830679,0.0019947423,0.000001353788,0.0000047148214,0.000019824438,0.00053854444],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991416,0.00003586242,0.00015391606,0.000071186885,0.0002699215,0.00032751248],"domain_scores_gemma":[0.99930996,0.000015747515,0.00005017199,0.00015750994,0.000053136962,0.00041345824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040062502,0.00010208645,0.00021431113,0.000059155373,0.0001242658,0.000027232738,0.000058878777,0.000061675586,0.00067837135],"category_scores_gemma":[0.000029774961,0.0000768721,0.0003440822,0.00009149482,0.00004763017,0.0001939753,0.000013228193,0.00026633177,0.00025500407],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011462988,0.0013379536,0.51371783,0.00033289823,0.0030154185,0.0012459608,0.0032684768,0.0000076444185,0.012503047,0.00080679567,0.035342496,0.42727515],"study_design_scores_gemma":[0.003507582,0.00011720715,0.25330713,0.000116384064,0.00040177425,0.014218999,0.0006288733,0.000007746011,0.01098524,0.0001245403,0.71634907,0.00023547675],"about_ca_topic_score_codex":5.761592e-7,"about_ca_topic_score_gemma":1.8466048e-8,"teacher_disagreement_score":0.68100655,"about_ca_system_score_codex":0.000032280288,"about_ca_system_score_gemma":0.000055592256,"threshold_uncertainty_score":0.74276906},"labels":[],"label_agreement":null},{"id":"W4298415528","doi":"","title":"5th National Conference on Anticoagulant Therapy. May 14-15, 1999. Vancouver, British Columbia, Canada. Proceedings and abstracts.","year":2000,"lang":"en","type":"other","venue":"PubMed","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Anticoagulant therapy; Family medicine; General surgery; Library science; Internal medicine","score_opus":0.016919507597281735,"score_gpt":0.2107693778520634,"score_spread":0.19384987025478168,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4298415528","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.047107723,0.012527532,7.875589e-7,0.00018082223,0.0006233135,0.0025370633,0.00075284974,0.00022454605,0.93604535],"genre_scores_gemma":[0.4614599,0.015382542,0.000015401696,0.0016243827,0.00068113796,0.00051207474,0.00015289155,0.00026308317,0.5199086],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979044,0.000017706134,0.00024427846,0.0005137254,0.0008856227,0.00043426832],"domain_scores_gemma":[0.99928576,0.000018662015,0.0001436306,0.00015773493,0.00008868999,0.00030550125],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015238192,0.00025570142,0.00059843296,0.000074833384,0.00008288945,0.0001728738,0.000120724675,0.00025661738,0.0017925185],"category_scores_gemma":[0.000029172192,0.00032092704,0.0001512212,0.00010392259,0.00012630832,0.00004212357,0.000014879604,0.0002715262,0.000007250914],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009540302,0.000121163335,0.002516353,0.00013089573,0.00069385965,0.00021290685,0.0000064138235,3.0203225e-7,0.0000010700951,0.0000069481143,0.8662537,0.12996101],"study_design_scores_gemma":[0.001892599,0.00003145406,0.20888454,0.00025408264,0.00010757828,0.00014659594,0.000017199904,0.000001789725,0.0000075632543,0.000024616771,0.78833133,0.00030063966],"about_ca_topic_score_codex":0.3651598,"about_ca_topic_score_gemma":0.74030346,"teacher_disagreement_score":0.41613677,"about_ca_system_score_codex":0.00008751174,"about_ca_system_score_gemma":0.00056478026,"threshold_uncertainty_score":0.9999243},"labels":[],"label_agreement":null},{"id":"W4298616656","doi":"10.1186/s40001-022-00819-4","title":"Point-of-care platelet function testing for guided transfusion in neurosurgical management of intracranial hemorrhage: a systematic review","year":2022,"lang":"en","type":"review","venue":"European journal of medical research","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Neurosurgery; Checklist; MEDLINE; Intensive care medicine; Randomized controlled trial; Perioperative; Cochrane Library; Adverse effect; Platelet transfusion; Systematic review; Emergency medicine; Internal medicine; Surgery; Platelet","score_opus":0.14323748533721864,"score_gpt":0.41547654382652943,"score_spread":0.2722390584893108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4298616656","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00039249295,0.99476105,0.0005582347,0.0001215238,0.00021368623,0.0033012198,0.000014814402,0.000008221684,0.00062876294],"genre_scores_gemma":[0.0004171836,0.9987083,0.00035498853,0.000057572892,0.0002487404,0.00005615317,0.000036387435,0.00008036383,0.000040331328],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9855436,0.0061923917,0.0030803164,0.00032529095,0.0044786544,0.00037972795],"domain_scores_gemma":[0.9960361,0.0017098868,0.00086112774,0.00046141792,0.0005530466,0.0003783927],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.027605943,0.00028396712,0.003681033,0.0005910735,0.000080535254,0.000014881717,0.0007577087,0.000110390225,0.000628524],"category_scores_gemma":[0.0057530897,0.00019244812,0.001846295,0.0011575517,0.00015423252,0.000050933446,0.00019048798,0.0018728727,0.000006372599],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002912311,0.00013684876,5.981604e-7,0.5077784,0.0003534587,0.010016532,0.000018978079,5.200207e-7,5.1824185e-7,0.000010319595,0.00009013069,0.48130244],"study_design_scores_gemma":[0.0037368457,0.0028803358,0.000011074865,0.841898,0.0044448087,0.0065126484,0.00030085133,0.000029534573,7.979618e-7,0.0000057862567,0.14002407,0.00015519874],"about_ca_topic_score_codex":0.0000019936745,"about_ca_topic_score_gemma":1.5964426e-7,"teacher_disagreement_score":0.48114726,"about_ca_system_score_codex":0.0001477207,"about_ca_system_score_gemma":0.00067253434,"threshold_uncertainty_score":0.9567724},"labels":[],"label_agreement":null},{"id":"W4299361804","doi":"10.4244/eij-d-22-00319","title":"Ticagrelor with and without aspirin in patients with a prior coronary artery bypass graft undergoing percutaneous coronary intervention: the TWILIGHT-CABG study","year":2022,"lang":"en","type":"article","venue":"EuroIntervention","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences","funders":"Janssen Pharmaceuticals; Faculty of Medical Sciences, Newcastle University; Abbott Vascular; St. Jude Medical; National Institutes of Health; CytoSorbents Europe; Humanitas Research Hospital; MicroPort; Idorsia Pharmaceuticals; Institut National de la Santé et de la Recherche Médicale; Newcastle University; Fakultet Medicinskih Nauka, Univerziteta U Kragujevcu; Universidad Complutense de Madrid; Sanofi; Abiomed; London School of Hygiene and Tropical Medicine; Osprey Medical; Newcastle upon Tyne Hospitals NHS Foundation Trust; Canada Excellence Research Chairs, Government of Canada; Medicines Company; Duke Clinical Research Institute; Eisai; Cytokinetics; AstraZeneca; Amarin Corporation; Revance; Boston Scientific Corporation; Hamilton Health Sciences; Bristol-Myers Squibb; Eli Lilly and Company; Abbott Laboratories; CSL Behring; MyoKardia; Daiichi Sankyo Europe; Servier; Gilead Sciences; University of Oklahoma Health Sciences Center; Covis Pharma; Deutsches Zentrum für Herz-Kreislaufforschung; University of Oklahoma; Pfizer; BioClinica; Amgen","keywords":"Medicine; Ticagrelor; Percutaneous coronary intervention; Aspirin; Internal medicine; Hazard ratio; Conventional PCI; Cardiology; Stroke (engine); Myocardial infarction; Clinical endpoint; Randomized controlled trial; Confidence interval","score_opus":0.0089241986921768,"score_gpt":0.2297260739462475,"score_spread":0.2208018752540707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4299361804","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99681777,0.0008053552,0.0002465947,0.00019595255,0.00009727186,0.0016636007,0.000011524616,0.000067278954,0.00009465563],"genre_scores_gemma":[0.99901646,0.000012401897,0.000049169845,0.00014813256,0.000026980753,0.000048829792,0.000080282356,0.000049769907,0.0005679532],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978477,0.0004993608,0.00036253926,0.00045525495,0.0005927807,0.00024236497],"domain_scores_gemma":[0.9992819,0.00004174005,0.00013855413,0.00039228838,0.00006174005,0.000083801104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041311915,0.00023518829,0.00034029188,0.00012903144,0.000278657,0.000045370103,0.0001272238,0.00002390857,0.00025270152],"category_scores_gemma":[0.000013100661,0.00015822022,0.000231406,0.00022216846,0.00010582048,0.00014440679,0.00015001117,0.00033436183,0.00000838863],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007439086,0.0027050632,0.9769221,0.00012465267,0.0009362724,0.001378879,0.000646358,0.000052121723,0.000015915739,0.000012048234,0.00003887785,0.009728628],"study_design_scores_gemma":[0.012352167,0.011745936,0.96782565,0.00042581905,0.00054005114,0.0035320984,0.0030176693,0.00008832836,0.0000053107124,0.000019252662,0.00024385637,0.00020384052],"about_ca_topic_score_codex":0.000017180579,"about_ca_topic_score_gemma":0.00015275386,"teacher_disagreement_score":0.009524788,"about_ca_system_score_codex":0.00011322645,"about_ca_system_score_gemma":0.000047787293,"threshold_uncertainty_score":0.64520335},"labels":[],"label_agreement":null},{"id":"W4300817574","doi":"10.1016/j.jcin.2022.07.039","title":"Bleeding and Ischemic Outcomes With Ticagrelor Monotherapy According to Body Mass Index","year":2022,"lang":"en","type":"article","venue":"JACC: Cardiovascular Interventions","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact; University Health Network; Hamilton Health Sciences; Genome Prairie","funders":"Agence Nationale de la Recherche","keywords":"Medicine; Ticagrelor; Overweight; Internal medicine; Body mass index; Aspirin; Percutaneous coronary intervention; Myocardial infarction; Clinical endpoint; Randomized controlled trial; Placebo; Type 2 diabetes; Cardiology; Diabetes mellitus; Endocrinology","score_opus":0.018544386879389346,"score_gpt":0.27245357761567324,"score_spread":0.2539091907362839,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4300817574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92319936,0.015865913,0.056746274,0.0007000637,0.0002849344,0.0012524729,0.000045201807,0.00024013604,0.0016656603],"genre_scores_gemma":[0.99688226,0.00027715677,0.00089864776,0.0004681048,0.00013156956,0.0004568697,0.00003807184,0.00008298717,0.000764362],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99765646,0.00016514823,0.00037228575,0.0005905282,0.0008153793,0.00040017802],"domain_scores_gemma":[0.99870765,0.000045713878,0.000069887756,0.0007999918,0.00010480501,0.00027196147],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00073987216,0.0003035625,0.0008494899,0.0003375072,0.0004567762,0.00008087728,0.00019892103,0.00006317584,0.00038221327],"category_scores_gemma":[0.000048336202,0.00026519987,0.0031011368,0.0005047506,0.000067746194,0.0001580302,0.00018875695,0.0003749639,0.000024841707],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025339455,0.0011693294,0.7281842,0.001025413,0.09944355,0.0016924287,0.00086165615,0.009185823,0.0055830567,0.0008292984,0.0035451653,0.14594613],"study_design_scores_gemma":[0.034491546,0.0036824795,0.39854673,0.0014625742,0.02071112,0.0056399843,0.020371564,0.0012866566,0.0042539495,0.00031469393,0.5060703,0.0031683769],"about_ca_topic_score_codex":0.000050362145,"about_ca_topic_score_gemma":0.0000022715735,"teacher_disagreement_score":0.50252515,"about_ca_system_score_codex":0.00014788788,"about_ca_system_score_gemma":0.00006160474,"threshold_uncertainty_score":0.99998003},"labels":[],"label_agreement":null},{"id":"W4306254685","doi":"10.1093/eurheartj/ehac544.2063","title":"Effect of aspirin discontinuation according to individualised patient bleeding and ischemic risks after PCI: a TWILIGHT trial sub-analysis","year":2022,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Conventional PCI; Discontinuation; Aspirin; Internal medicine; Cardiology; Myocardial infarction; Randomized controlled trial; Clinical endpoint; Coronary artery disease","score_opus":0.025823783237396786,"score_gpt":0.30505010641843067,"score_spread":0.2792263231810339,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306254685","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970791,0.0016119401,0.00021851048,0.00013234232,0.00016968012,0.0004352646,0.000014573628,0.000016538323,0.00032206054],"genre_scores_gemma":[0.9992761,0.00004424321,0.000057359346,0.00021998287,0.000313249,0.000018690245,0.0000149053485,0.000027666776,0.000027777509],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99752885,0.0010997357,0.0003802295,0.00021855842,0.0005723535,0.00020029914],"domain_scores_gemma":[0.99931383,0.00009313306,0.00015544772,0.00018377353,0.000045432123,0.00020836842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022845145,0.00014615862,0.0004930322,0.000359656,0.0002068975,0.000056336765,0.00007091742,0.000016714226,0.00017745094],"category_scores_gemma":[0.000116345465,0.000117651376,0.00063942926,0.00043679893,0.000025615309,0.000096927295,0.0001288384,0.0003157441,0.000007819292],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10759174,0.0005647614,0.63848406,0.00014353861,0.011034304,0.0012896807,0.0046078255,0.0015809707,0.049352724,0.0000029943917,0.0027209166,0.18262649],"study_design_scores_gemma":[0.1902099,0.041502807,0.535117,0.0007920989,0.039639063,0.00463228,0.0036487414,0.00066615257,0.089104,0.0000092895025,0.09287635,0.0018023292],"about_ca_topic_score_codex":0.0000027760525,"about_ca_topic_score_gemma":2.554327e-7,"teacher_disagreement_score":0.18082416,"about_ca_system_score_codex":0.000045448014,"about_ca_system_score_gemma":0.000029966357,"threshold_uncertainty_score":0.47976837},"labels":[],"label_agreement":null},{"id":"W4306320583","doi":"10.1093/eurheartj/ehac544.2716","title":"Comparing dual antiplatelet therapy strategies post-acute coronary syndrome: network meta-analysis","year":2022,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Mace; Acute coronary syndrome; Clopidogrel; Internal medicine; Ticagrelor; Odds ratio; Meta-analysis; Percutaneous coronary intervention; Myocardial infarction; Cardiology","score_opus":0.09752246969342618,"score_gpt":0.30567501016902426,"score_spread":0.20815254047559809,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306320583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9667963,0.029862368,0.00033038188,0.0006109277,0.00034301006,0.00024249847,0.00003418755,0.00011053101,0.0016698355],"genre_scores_gemma":[0.99508286,0.0010528639,0.00038835584,0.0022393884,0.00039901203,0.000007325237,0.00010636824,0.000074502095,0.0006493013],"study_design_codex":"meta_analysis","study_design_gemma":"observational","domain_scores_codex":[0.9960689,0.0016542176,0.0005050797,0.0003648547,0.000882326,0.0005246399],"domain_scores_gemma":[0.9987968,0.00005831183,0.00019056199,0.0004835796,0.00014522717,0.00032550664],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019037072,0.0003107339,0.0014384782,0.0002464196,0.0010773577,0.00020747178,0.00022361902,0.00002663752,0.0058258153],"category_scores_gemma":[0.000008517245,0.0002482575,0.0036037664,0.00071769353,0.0000899526,0.00023911463,0.00015978077,0.00089509616,0.000097369775],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002587375,0.0005282448,0.080642596,0.000017017775,0.78650355,0.053440385,0.00048315822,0.052778874,0.0008107244,0.000100522775,0.020964349,0.0011431936],"study_design_scores_gemma":[0.0030154458,0.001597498,0.7149137,0.000008096245,0.1186746,0.07944472,0.0008674133,0.00022274541,0.000024120074,0.00003971623,0.08072058,0.00047133103],"about_ca_topic_score_codex":0.0000052573096,"about_ca_topic_score_gemma":8.50149e-7,"teacher_disagreement_score":0.667829,"about_ca_system_score_codex":0.00004855735,"about_ca_system_score_gemma":0.00015493037,"threshold_uncertainty_score":0.99999696},"labels":[],"label_agreement":null},{"id":"W4306734779","doi":"10.1161/circinterventions.122.012204","title":"Ticagrelor or Prasugrel in Patients With Acute Coronary Syndrome and High Bleeding Risk","year":2022,"lang":"en","type":"article","venue":"Circulation Cardiovascular Interventions","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Services and Policy Research","funders":"","keywords":"Prasugrel; Ticagrelor; Medicine; Acute coronary syndrome; Percutaneous coronary intervention; Internal medicine; Myocardial infarction; Cardiology; Clinical endpoint; Randomized controlled trial","score_opus":0.014835104165297458,"score_gpt":0.2401758506538088,"score_spread":0.22534074648851135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306734779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989275,0.0038497515,0.005368657,0.00004552885,0.00016302183,0.0010390615,0.00011682437,0.00008214094,0.000060053368],"genre_scores_gemma":[0.9987141,0.00020759349,0.00029376397,0.000047178313,0.000025908037,0.00020693871,0.00034825876,0.000046538735,0.000109748165],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978511,0.00030087712,0.00037873525,0.00046941132,0.00074710924,0.0002527824],"domain_scores_gemma":[0.9990933,0.000035768735,0.000108805245,0.0005211715,0.00011177494,0.0001292105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058181665,0.0002033745,0.00057148415,0.0002985848,0.00035586345,0.000031302476,0.00009169428,0.000060146995,0.0004884508],"category_scores_gemma":[0.00004409713,0.00017761832,0.0012261298,0.00052255625,0.00008449319,0.00019135574,0.000114143055,0.0003272075,0.000010861899],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011041659,0.0007112579,0.9493588,0.00021787912,0.016837344,0.0012032135,0.00015776188,0.00787971,0.0000056338868,0.00017235416,0.00004942828,0.022302434],"study_design_scores_gemma":[0.0074207964,0.0005780809,0.9853199,0.00019656257,0.0037513494,0.0012661973,0.00020577713,0.00026154896,0.0000027490507,0.00006887094,0.0006968072,0.00023137104],"about_ca_topic_score_codex":0.000052045314,"about_ca_topic_score_gemma":0.0000049129226,"teacher_disagreement_score":0.03596107,"about_ca_system_score_codex":0.00019019053,"about_ca_system_score_gemma":0.00007153742,"threshold_uncertainty_score":0.7243065},"labels":[],"label_agreement":null},{"id":"W4306850817","doi":"10.1016/j.ijcard.2022.10.132","title":"External applicability of the Effect of ticagrelor on Health Outcomes in diabEtes Mellitus patients Intervention Study (THEMIS) trial: An analysis of patients with diabetes and coronary artery disease in the REduction of Atherothrombosis for Continued Health (REACH) registry","year":2022,"lang":"en","type":"article","venue":"International Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute; St. Michael's Hospital","funders":"Esperion Therapeutics; Institut Servier; Japan Society for the Promotion of Science; HLS Therapeutics; Idorsia Pharmaceuticals; Assistance publique-Hôpitaux de Paris; Nakatani Foundation for Advancement of Measuring Technologies in Biomedical Engineering; Duke Clinical Research Institute; Eisai; Ministry of Education, Culture, Sports, Science and Technology; Pfizer; Moderna; Regado Biosciences; Medicines Company; AstraZeneca; Amarin Corporation; Ironwood Pharmaceuticals, Incorporated; National Institutes of Health; Regeneron Pharmaceuticals; Fédération Française de Cardiologie; Japan Agency for Medical Research and Development; Brigham and Women's Hospital; Boston VA Research Institute; Boston Scientific Corporation; Eli Lilly and Company; Cleveland Clinic; Bristol-Myers Squibb; CSL Behring; Belvoir Media Group; Novo Nordisk; MyoKardia; Daiichi Sankyo Europe; Servier; Gilead Sciences; Amgen; St. Jude Medical; Kowa Company; Sanofi; American Heart Association","keywords":"Medicine; Coronary artery disease; Diabetes mellitus; Internal medicine; Population; Myocardial infarction; Conventional PCI; Percutaneous coronary intervention; Cardiology; Aspirin; Stroke (engine); Ticagrelor; Endocrinology","score_opus":0.010089433712178244,"score_gpt":0.29889523974398846,"score_spread":0.2888058060318102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306850817","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977078,0.00044810408,0.000047164773,0.00014262476,0.00013297818,0.0013244697,0.00019435746,0.0000012347406,0.0000012581775],"genre_scores_gemma":[0.9997697,0.000038139515,0.000009046585,0.000030086041,0.000026911184,0.0000650412,0.00005313297,0.0000072626517,6.855718e-7],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99687046,0.001452095,0.0008485697,0.00015445126,0.0005724163,0.00010203357],"domain_scores_gemma":[0.9980279,0.00035462578,0.001117871,0.00024490067,0.00021110565,0.000043593725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019795443,0.00010608743,0.0010217641,0.00023200511,0.000025107563,0.0000025196782,0.00021752054,0.000023752216,0.0000049265445],"category_scores_gemma":[0.00016400257,0.000061278595,0.000598012,0.00016172655,0.00014549895,0.00004618095,0.000036773323,0.00013901327,6.9518125e-9],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023955008,0.0017666498,0.9582512,0.00009924982,0.0032552748,0.000001154441,0.00043197582,0.000949603,0.000039502545,0.0000054285956,0.0000027218093,0.011242229],"study_design_scores_gemma":[0.02212416,0.010270786,0.9660579,0.00012160499,0.0007301924,0.0000010773398,0.00046959342,0.00004734849,0.00008331577,0.000051673796,0.0000046395867,0.00003770375],"about_ca_topic_score_codex":0.000026838872,"about_ca_topic_score_gemma":0.000005305017,"teacher_disagreement_score":0.011204525,"about_ca_system_score_codex":0.00010622603,"about_ca_system_score_gemma":0.00005861068,"threshold_uncertainty_score":0.24988687},"labels":[],"label_agreement":null},{"id":"W4307059241","doi":"10.1016/j.mayocpiqo.2022.09.006","title":"Perioperative Management of Antiplatelet Therapy: A Systematic Review and Meta-analysis","year":2022,"lang":"en","type":"review","venue":"Mayo Clinic Proceedings Innovations Quality & Outcomes","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"American College of Chest Physicians; American College of Clinical Pharmacy","keywords":"Medicine; Perioperative; Guideline; Relative risk; Meta-analysis; MEDLINE; Placebo; Aspirin; Platelet aggregation inhibitor; Systematic review; Intensive care medicine; Surgery; Internal medicine; Confidence interval; Alternative medicine","score_opus":0.2735002543576758,"score_gpt":0.46551387833469554,"score_spread":0.19201362397701977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307059241","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009618881,0.99126554,0.000020796431,0.00045849892,0.00003674961,0.0065317187,0.00031036523,0.00009576113,0.0011844158],"genre_scores_gemma":[0.0001072501,0.99112684,0.00040156615,0.0018349767,0.000014310179,0.0025142315,0.00040414726,0.000071646515,0.0035250648],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99330235,0.00040654806,0.004044974,0.00091166625,0.0010162061,0.0003182628],"domain_scores_gemma":[0.99552864,0.00047461982,0.0024453795,0.0009200327,0.0005245864,0.00010676791],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005479155,0.0008155234,0.017434439,0.0007948425,0.0002500994,0.00006694798,0.00043756876,0.00022275852,0.002430675],"category_scores_gemma":[0.0004626846,0.0005256134,0.007943759,0.004528512,0.00020796027,0.00015403348,0.00026260904,0.00059842295,0.000017671638],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010669651,0.00017674647,0.000039269697,0.561558,0.43207312,0.000011568841,0.0001226301,1.829734e-8,2.0451122e-8,0.0016006515,0.000047601003,0.004359695],"study_design_scores_gemma":[0.0005855812,0.00009136292,0.00007688213,0.012883002,0.8263377,0.00005569749,0.00046259913,2.3098006e-7,2.1638299e-7,0.000020388725,0.15904234,0.00044397026],"about_ca_topic_score_codex":0.000010671719,"about_ca_topic_score_gemma":3.6798028e-7,"teacher_disagreement_score":0.548675,"about_ca_system_score_codex":0.00010250566,"about_ca_system_score_gemma":0.00018011754,"threshold_uncertainty_score":0.99971956},"labels":[],"label_agreement":null},{"id":"W4307395322","doi":"10.1016/j.jacc.2022.08.767","title":"Biomarker-Based Prediction of Recurrent Ischemic Events in Patients With Acute Coronary Syndromes","year":2022,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Medicine; Biomarker; Internal medicine; Cardiology; Acute coronary syndrome; Myocardial infarction","score_opus":0.009622493631410819,"score_gpt":0.23483711579999703,"score_spread":0.2252146221685862,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307395322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99827605,0.00059029285,0.00007143493,0.00018409568,0.00023161659,0.0002675805,0.0003235244,0.0000029463263,0.000052425527],"genre_scores_gemma":[0.99965745,0.00011474286,0.0000878098,0.000068812,0.000025385569,0.000007977974,0.000011730621,0.000012210198,0.000013869494],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984194,0.0004274555,0.00042434584,0.00010480026,0.0004968599,0.00012713818],"domain_scores_gemma":[0.998771,0.000060439008,0.0007142913,0.00024661317,0.00015838348,0.000049288756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035478713,0.00010287621,0.00081023737,0.00018562406,0.00004037174,3.2573118e-7,0.0001870958,0.000021920852,0.000014496067],"category_scores_gemma":[0.000031117674,0.000067168876,0.000530231,0.00044899143,0.00023903053,0.000030661213,0.000058705118,0.00020728735,1.1411257e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014789134,0.0002609185,0.9765155,0.000026031777,0.0027619964,0.0001949248,0.000012907126,0.0011471935,0.0009199078,0.0000018550872,0.0012127674,0.0021568781],"study_design_scores_gemma":[0.0052477354,0.004476985,0.9864095,0.000095121984,0.0006932689,0.0011700332,0.00020135914,0.000028565175,0.00026559533,0.000008461978,0.0013476444,0.00005575931],"about_ca_topic_score_codex":0.0000028402258,"about_ca_topic_score_gemma":1.9784805e-7,"teacher_disagreement_score":0.0098939845,"about_ca_system_score_codex":0.00011749827,"about_ca_system_score_gemma":0.00031443764,"threshold_uncertainty_score":0.2739067},"labels":[],"label_agreement":null},{"id":"W4307420012","doi":"10.1016/j.kint.2022.09.023","title":"Effects of aspirin on cardiovascular outcomes in patients with chronic kidney disease","year":2022,"lang":"en","type":"article","venue":"Kidney International","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"Wellcome Trust","keywords":"Medicine; Aspirin; Kidney disease; Placebo; Hazard ratio; Renal function; Internal medicine; Stroke (engine); Myocardial infarction; Confidence interval; Randomized controlled trial; Gastroenterology; Pathology","score_opus":0.003944476966422102,"score_gpt":0.21245106306580738,"score_spread":0.20850658609938527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307420012","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965321,0.0004970726,0.000077595956,0.0007903484,0.00045580164,0.00064898795,0.00026954967,0.00003184791,0.0006966916],"genre_scores_gemma":[0.99707496,0.000027200887,0.000030382838,0.0017930334,0.00007736511,0.00013642924,0.0005440502,0.000024881205,0.00029172483],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981243,0.00009231725,0.0001881728,0.00026928599,0.0011664269,0.00015949828],"domain_scores_gemma":[0.9991935,0.000033449327,0.000057013967,0.00032451097,0.00007077004,0.00032074595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013541365,0.00014810773,0.00035743217,0.00019820067,0.000047371715,0.0000067579745,0.00016614722,0.000022285805,0.00044346147],"category_scores_gemma":[0.00019964766,0.00012238005,0.00051758834,0.00013809583,0.00004620503,0.000056923753,0.00007091875,0.00016918204,0.000012446123],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024541602,0.0017491145,0.9822276,0.00024272635,0.0046618064,0.00028435458,0.000052582793,0.0011685092,0.000042202464,0.0003733085,0.0019231061,0.0048205093],"study_design_scores_gemma":[0.013919989,0.0005630638,0.93344617,0.0002007858,0.0003610613,0.0000035072308,0.0000066535636,0.00007347446,0.0003755531,0.000032062555,0.050865173,0.00015253463],"about_ca_topic_score_codex":0.000023358194,"about_ca_topic_score_gemma":3.4565983e-7,"teacher_disagreement_score":0.048942067,"about_ca_system_score_codex":0.0002657327,"about_ca_system_score_gemma":0.00037799837,"threshold_uncertainty_score":0.49905136},"labels":[],"label_agreement":null},{"id":"W4308052587","doi":"10.1161/strokeaha.122.037717","title":"Pharmacogenomics in Stroke and Cardiovascular Disease: State of the Art","year":2022,"lang":"en","type":"review","venue":"Stroke","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; Population Health Research Institute; McMaster University","funders":"","keywords":"Medicine; Pharmacogenetics; Pharmacogenomics; Clopidogrel; Genetic testing; Stroke (engine); Intensive care medicine; Personalized medicine; Warfarin; Disease; Clinical trial; Randomized controlled trial; Aspirin; Bioinformatics; Pharmacology; Internal medicine; Genotype; Atrial fibrillation; Genetics","score_opus":0.031148149749368862,"score_gpt":0.28558709573790914,"score_spread":0.2544389459885403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308052587","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013676126,0.9949786,0.000010248962,0.000010365418,0.00022643043,0.0012391433,0.001213925,0.000018652428,0.00093499204],"genre_scores_gemma":[0.00031380076,0.9964789,0.000012056375,0.00004059518,0.00010335294,0.00012641803,0.000111672074,0.00006396301,0.0027492146],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99782836,0.00037224666,0.00046265763,0.00043997908,0.0006251589,0.0002715677],"domain_scores_gemma":[0.9986667,0.000064786094,0.00014151487,0.0009376238,0.00002117931,0.00016820559],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047971105,0.000339153,0.0018553875,0.00015363898,0.000070384296,0.000011914955,0.00023376124,0.00006649741,0.0003049618],"category_scores_gemma":[0.000036547743,0.00023846603,0.0032614914,0.00023210302,0.0001435006,0.00003221777,0.0002079704,0.00050781795,0.0000101677915],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008002552,0.00006903085,0.00026244414,0.0067424607,0.006817041,0.00019659182,0.000021214451,0.00003958216,0.0000014587968,0.0000061536184,0.00025403508,0.98550993],"study_design_scores_gemma":[0.0009916978,0.000029109366,0.00022763833,0.0013871221,0.009212184,0.000077840145,0.000020192667,0.0000049091113,0.00000408265,0.0000050606805,0.9878427,0.00019746856],"about_ca_topic_score_codex":0.000009853724,"about_ca_topic_score_gemma":0.0000011598294,"teacher_disagreement_score":0.98758864,"about_ca_system_score_codex":0.00008759124,"about_ca_system_score_gemma":0.0004848855,"threshold_uncertainty_score":0.9724363},"labels":[],"label_agreement":null},{"id":"W4308687103","doi":"10.1002/rth2.12834","title":"Case‐fatality rate of major bleeding events in patients on dual antiplatelet therapy after percutaneous coronary intervention: A systematic review and meta‐analysis","year":2022,"lang":"en","type":"review","venue":"Research and Practice in Thrombosis and Haemostasis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Boston Scientific Corporation; Edwards Lifesciences; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Pfizer","keywords":"Medicine; Conventional PCI; Percutaneous coronary intervention; Internal medicine; Confidence interval; Population; Randomized controlled trial; Meta-analysis; Case fatality rate; Surgery; Myocardial infarction; Epidemiology","score_opus":0.24602298238735745,"score_gpt":0.45977067635733326,"score_spread":0.2137476939699758,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308687103","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.028254624,0.9673058,4.674939e-7,0.00019422367,0.00001547171,0.0038179574,0.00036173442,0.000007451228,0.000042273383],"genre_scores_gemma":[0.049050957,0.9499574,0.000021456097,0.00017683904,0.000010179205,0.00054519594,0.0001783884,0.000037961792,0.000021667838],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9914374,0.0055394876,0.0011563752,0.00073745864,0.000735586,0.0003937415],"domain_scores_gemma":[0.9952931,0.0033101733,0.0004452526,0.00057115156,0.00018419894,0.00019615833],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0074336813,0.00043953428,0.005329194,0.0007808766,0.0001707728,0.0000567933,0.00011458976,0.00018503075,0.0005565],"category_scores_gemma":[0.00092160533,0.00031257595,0.0011318317,0.0013170871,0.00018641318,0.0002674399,0.00023194503,0.0008611254,0.000002170958],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018470271,0.0018323171,0.00063798873,0.7498992,0.18064772,0.0059560235,0.00038743045,2.0294408e-7,1.0712132e-7,0.000015870537,0.000027145854,0.058748953],"study_design_scores_gemma":[0.0047531864,0.0038554308,0.0017844673,0.115801655,0.84263587,0.013725869,0.0019776036,0.0000042808274,0.0000013479198,0.00005526634,0.0144512765,0.0009537362],"about_ca_topic_score_codex":0.00038772688,"about_ca_topic_score_gemma":0.00003636655,"teacher_disagreement_score":0.66198814,"about_ca_system_score_codex":0.00010334279,"about_ca_system_score_gemma":0.00009413371,"threshold_uncertainty_score":0.99993265},"labels":[],"label_agreement":null},{"id":"W4309347087","doi":"10.1016/s1636-5410(22)47171-6","title":"Tratamientos antiplaquetarios","year":2022,"lang":"es","type":"article","venue":"EMC - Tratado de Medicina","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute; Université de Montréal","funders":"","keywords":"Medicine; Prasugrel; Humanities; Ticagrelor; Clopidogrel; Aspirin; Internal medicine; Philosophy","score_opus":0.01048796513746814,"score_gpt":0.25235954280684014,"score_spread":0.241871577669372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309347087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8969924,0.08234946,0.0015676514,0.0027564534,0.0021322132,0.001408491,0.0004975257,0.00031462853,0.011981167],"genre_scores_gemma":[0.9847983,0.0050829095,0.000119499215,0.004137661,0.0016692876,0.00016686402,0.000504133,0.00012926468,0.0033920773],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9945461,0.0008087943,0.0007124442,0.0009029819,0.001858393,0.0011712784],"domain_scores_gemma":[0.99755234,0.0001700588,0.00020845071,0.0012181036,0.00008247347,0.0007685589],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017533811,0.0005973857,0.0011339891,0.00034384074,0.00090883806,0.00008896085,0.00064543076,0.00020080237,0.010188931],"category_scores_gemma":[0.00015082273,0.0005825819,0.0009389409,0.00084583205,0.00039847798,0.00018031381,0.0001999572,0.0014134397,0.00026234632],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011407169,0.009040021,0.20359021,0.0043625557,0.016400399,0.050211117,0.029200403,0.0014755251,0.017638234,0.017834647,0.32671267,0.31212705],"study_design_scores_gemma":[0.011487997,0.0027457634,0.06182022,0.00051670946,0.003523008,0.0030904065,0.0105626555,0.0010497523,0.0014585598,0.0002605691,0.90251017,0.0009742195],"about_ca_topic_score_codex":0.00019095719,"about_ca_topic_score_gemma":0.0000071206196,"teacher_disagreement_score":0.5757975,"about_ca_system_score_codex":0.00041271385,"about_ca_system_score_gemma":0.0011411316,"threshold_uncertainty_score":0.9996626},"labels":[],"label_agreement":null},{"id":"W4310290800","doi":"10.1007/s10557-022-07392-2","title":"Safety and Efficacy of CYP2C19 Genotype-Guided Escalation of P2Y12 Inhibitor Therapy After Percutaneous Coronary Intervention in Chronic Kidney Disease: a Post Hoc Analysis of the TAILOR-PCI Study","year":2022,"lang":"en","type":"article","venue":"Cardiovascular Drugs and Therapy","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; University Health Network; Toronto General Hospital; St. Michael's Hospital","funders":"Duke Clinical Research Institute; National Heart, Lung, and Blood Institute; National Institutes of Health; Regeneron Pharmaceuticals; Bayer Canada; Esperion Therapeutics; Servier; Novo Nordisk; Daiichi-Sankyo; Boston Scientific Corporation; Pfizer; York University; Eli Lilly and Company; Cleveland Clinic; Bristol-Myers Squibb; AstraZeneca; CSL Behring; Eli Lilly Canada; AstraZeneca Canada; University of Toronto; Heart and Stroke Foundation of Canada; American Regent; Sanofi; Amgen; HLS Therapeutics; U.S. Department of Health and Human Services","keywords":"Medicine; Percutaneous coronary intervention; Conventional PCI; Kidney disease; Internal medicine; Clinical endpoint; Renal function; Myocardial infarction; Post-hoc analysis; Cardiology; Randomized controlled trial; Population; P2Y12","score_opus":0.008144742595637439,"score_gpt":0.23868037082058552,"score_spread":0.23053562822494808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310290800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8419311,0.15646172,0.00003741973,0.000051556075,0.000068980524,0.0012872102,0.00013522146,0.000012282209,0.000014531484],"genre_scores_gemma":[0.98516923,0.014466075,0.000007784857,0.00008851377,0.000047785343,0.00006181627,0.0001041073,0.00003283431,0.000021840253],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99723566,0.0007639233,0.0006084654,0.00043133847,0.00077215635,0.00018848435],"domain_scores_gemma":[0.9986337,0.000071953335,0.00019095132,0.0008220121,0.00015487862,0.00012652908],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009848021,0.00024401024,0.0010864689,0.00031103808,0.00011213549,0.00000984513,0.00014069949,0.00006114321,0.00015667484],"category_scores_gemma":[0.000033217104,0.00018304412,0.0022092066,0.0008193243,0.0002077772,0.00006701688,0.00011329076,0.00017997982,1.7847614e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.044011112,0.00320124,0.3496982,0.000473726,0.07352881,0.0002938205,0.009187349,0.0074117896,0.009105714,0.000043599368,0.000014470669,0.5030302],"study_design_scores_gemma":[0.01625574,0.0015119334,0.97270894,0.0001230878,0.0044353735,0.00009830245,0.0017092769,0.00044232112,0.0003331276,0.000016062333,0.0021332956,0.000232545],"about_ca_topic_score_codex":0.00018726705,"about_ca_topic_score_gemma":0.0000049587597,"teacher_disagreement_score":0.62301075,"about_ca_system_score_codex":0.000105654246,"about_ca_system_score_gemma":0.00017771785,"threshold_uncertainty_score":0.7464323},"labels":[],"label_agreement":null},{"id":"W4310938181","doi":"10.1093/eurheartj/ehac515","title":"Acute, periprocedural and longterm antithrombotic therapy in older adults","year":2022,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Antithrombotic; Atrial fibrillation; Aspirin; Clopidogrel; Intensive care medicine; Stroke (engine); Acute coronary syndrome; Guideline; Myocardial infarction; Internal medicine; Warfarin; Cardiology","score_opus":0.015543380804221992,"score_gpt":0.2652438061321605,"score_spread":0.24970042532793849,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310938181","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99046475,0.0078356,0.000014458767,0.00061689096,0.00016896312,0.00018477027,0.0000034128677,0.000025974246,0.00068517827],"genre_scores_gemma":[0.99563694,0.00199624,0.00009548603,0.0017629839,0.0002518695,0.0000028824136,0.0000055389933,0.000036580557,0.00021148605],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987809,0.00032179497,0.00018429574,0.00018563919,0.00029866633,0.00022870746],"domain_scores_gemma":[0.99960494,0.000011716289,0.000042703105,0.00014404717,0.000028746528,0.00016783693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047599364,0.00012021565,0.00024364746,0.00011436297,0.0002673868,0.00004581363,0.00007540263,0.000012925778,0.00077663077],"category_scores_gemma":[0.000011063314,0.00010047583,0.00018732023,0.00014112903,0.000051367108,0.000099606215,0.000055519344,0.00046944697,0.000016652128],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040086913,0.0010804494,0.85912627,0.00009145092,0.001003654,0.01759372,0.0063746725,0.00006976669,0.0047702617,0.000023244555,0.009887652,0.095970154],"study_design_scores_gemma":[0.0057880008,0.0006441637,0.9623984,0.00009701035,0.00004037451,0.020348243,0.00083967746,0.000040507373,0.00008068712,0.0000045278634,0.009587797,0.00013062873],"about_ca_topic_score_codex":0.0000016833773,"about_ca_topic_score_gemma":2.8828023e-7,"teacher_disagreement_score":0.103272095,"about_ca_system_score_codex":0.00003169818,"about_ca_system_score_gemma":0.000055342894,"threshold_uncertainty_score":0.8503562},"labels":[],"label_agreement":null},{"id":"W4311493160","doi":"10.1161/jaha.122.026553","title":"Eligibility and Implementation of Rivaroxaban for Secondary Prevention of Atherothrombosis in Clinical Practice—Insights From the CANHEART Study","year":2022,"lang":"en","type":"article","venue":"Journal of the American Heart Association","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital; Health Sciences Centre; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; Public Health Ontario; Women's College Hospital; University Health Network; University of Toronto","funders":"Canadian Institutes of Health Research; GlaxoSmithKline; HLS Therapeutics; Servier; CorHealth Ontario; University of Toronto; Duke Clinical Research Institute; Novo Nordisk; Daiichi-Sankyo; Heart and Stroke Foundation of Canada; Ontario Ministry of Health and Long-Term Care; Regeneron Pharmaceuticals; Pfizer; York University; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; Institute of Circulatory and Respiratory Health; CSL Behring; Cancer Care Ontario; American Regent; Sanofi; Esperion Therapeutics; Amgen","keywords":"Medicine; Rivaroxaban; Adverse effect; Cohort; Coronary artery disease; Hazard ratio; Population; Internal medicine; Warfarin; Aspirin; Absolute risk reduction; Framingham Risk Score; Emergency medicine; Atrial fibrillation; Disease; Confidence interval","score_opus":0.024383930769783835,"score_gpt":0.4011526823564391,"score_spread":0.37676875158665524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311493160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972187,0.0005001548,0.000029837307,0.0014016022,0.000114696464,0.00069766265,0.000030622323,0.0000015758826,0.0000051452816],"genre_scores_gemma":[0.9991691,0.00013118765,0.00023833576,0.00034026435,0.00009255517,0.000013650708,0.0000030350109,0.000006315722,0.0000055682344],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99728674,0.0014102928,0.00066902745,0.00009070855,0.0004756131,0.000067598296],"domain_scores_gemma":[0.9975376,0.00092155085,0.0011631509,0.0001582424,0.00019482848,0.000024623821],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030915304,0.00005408555,0.00048393317,0.000036348887,0.00008629246,0.0000054363313,0.000068284324,0.000015553987,0.000018319535],"category_scores_gemma":[0.0005584647,0.00003527251,0.00041458936,0.00018743235,0.000046424946,0.00009225064,0.000036061156,0.00020218211,6.6849985e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006534543,0.00058571744,0.9852315,0.000007551097,0.00084598217,5.90209e-7,0.0016054603,0.0000142962,0.0009836964,0.0000037138145,0.0005360042,0.00953201],"study_design_scores_gemma":[0.0024255877,0.0018043861,0.9781592,0.000017826458,0.0005977094,0.000006930758,0.01501641,0.000012772612,0.0003285376,0.00022559728,0.0013747753,0.000030281377],"about_ca_topic_score_codex":0.00083483534,"about_ca_topic_score_gemma":0.00015713881,"teacher_disagreement_score":0.013410949,"about_ca_system_score_codex":0.00016266352,"about_ca_system_score_gemma":0.00024524992,"threshold_uncertainty_score":0.14383712},"labels":[],"label_agreement":null},{"id":"W4312683487","doi":"10.1093/eurheartj/ehab724.2998","title":"Efficacy and safety of early aspirin withdrawal and continuation of ticagrelor monotherapy post PCI for STEMI. A post hoc analysis of the randomized global leaders trial","year":2021,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Medicine; Ticagrelor; Aspirin; Myocardial infarction; Conventional PCI; Internal medicine; Post-hoc analysis; Context (archaeology); Percutaneous coronary intervention; Randomized controlled trial; P2Y12; Cardiology","score_opus":0.023134725255204172,"score_gpt":0.29431200733181107,"score_spread":0.2711772820766069,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312683487","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99317604,0.004298124,0.0009291047,0.0007058555,0.00007899641,0.0006474303,0.00005433104,0.000004360778,0.000105770356],"genre_scores_gemma":[0.9987363,0.0006064246,0.00031517958,0.00016418126,0.000109655986,0.0000013419593,0.000011463088,0.000013572734,0.00004185901],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99804306,0.0008489143,0.0005513188,0.00014440296,0.00029576366,0.0001165687],"domain_scores_gemma":[0.9987631,0.0002656482,0.00029484543,0.00018855184,0.00039653145,0.000091357404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013716017,0.000112214795,0.0008938878,0.00007563058,0.00007407758,0.000019380572,0.000055062257,0.00003333613,0.000027584289],"category_scores_gemma":[0.00033994977,0.00007307182,0.0008591071,0.00026593654,0.00037777267,0.000051705716,0.00002061274,0.000102627266,2.5754252e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9458591,0.000244402,0.014559172,0.00008540848,0.0101621905,0.000022007966,0.0012188774,0.000055126144,0.008419238,0.00012022631,0.000042905496,0.019211372],"study_design_scores_gemma":[0.67157125,0.0018092664,0.31684715,0.00032141447,0.006230701,0.00027721789,0.00093747646,0.00010242324,0.0012842142,0.000010165029,0.0004920291,0.00011670844],"about_ca_topic_score_codex":0.000009818988,"about_ca_topic_score_gemma":0.0000041483977,"teacher_disagreement_score":0.30228797,"about_ca_system_score_codex":0.000011972128,"about_ca_system_score_gemma":0.00013120953,"threshold_uncertainty_score":0.29797822},"labels":[],"label_agreement":null},{"id":"W4313201977","doi":"10.1016/j.ejim.2022.12.008","title":"De-escalation of antiplatelet therapy in patients with coronary artery disease: Time to change our strategy?","year":2022,"lang":"en","type":"review","venue":"European Journal of Internal Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Valeant Pharmaceuticals International; Sanofi; Esperion Therapeutics; MicroPort; Teva Pharmaceutical Industries; Daiichi Sankyo Europe; Eli Lilly and Company; Servier; Amgen","keywords":"Prasugrel; Medicine; Ticagrelor; Clopidogrel; Antithrombotic; Percutaneous coronary intervention; Acute coronary syndrome; P2Y12; Aspirin; Conventional PCI; Cardiology; Cangrelor; Internal medicine; Coronary artery disease; Intensive care medicine; Myocardial infarction","score_opus":0.04083980696039211,"score_gpt":0.29020264970316856,"score_spread":0.24936284274277645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313201977","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.041209664,0.9569731,0.000061016253,0.00013182452,0.00021633046,0.0008673946,0.000041196563,0.000011617743,0.00048789335],"genre_scores_gemma":[0.037207697,0.9609136,0.00003611628,0.00051142916,0.000924595,0.000008302233,0.00009112036,0.0001173953,0.00018976182],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964249,0.00095539005,0.0012000765,0.00025013302,0.0009150044,0.00025448197],"domain_scores_gemma":[0.99806565,0.00006840235,0.0009285184,0.00032534392,0.00018213324,0.00042995755],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012964259,0.0003935496,0.0019266632,0.00054734264,0.00002812842,0.000010730115,0.0003546749,0.000041384912,0.0010375943],"category_scores_gemma":[0.00009832517,0.00024370661,0.0005946342,0.0003566268,0.00005752699,0.0001157673,0.00005558818,0.0006710889,0.000031031297],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050159595,0.00039842652,0.004343083,0.001239293,0.0014417911,0.008171442,0.00015843681,0.000007575651,0.0000015616002,6.282691e-7,0.0010784051,0.9781434],"study_design_scores_gemma":[0.009755578,0.013734271,0.17554241,0.055246428,0.0017188778,0.002119851,0.00009656336,0.0000035687267,6.067354e-7,0.0000019851645,0.74143606,0.0003437683],"about_ca_topic_score_codex":0.0000022137046,"about_ca_topic_score_gemma":1.005384e-7,"teacher_disagreement_score":0.97779965,"about_ca_system_score_codex":0.00015012138,"about_ca_system_score_gemma":0.0002136786,"threshold_uncertainty_score":0.9998756},"labels":[],"label_agreement":null},{"id":"W4313316876","doi":"10.1161/jaha.122.025666","title":"Femoral Vascular Closure Devices and Bleeding, Hemostasis, and Ambulation Following Percutaneous Coronary Intervention","year":2022,"lang":"en","type":"article","venue":"Journal of the American Heart Association","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Medicine; Vascular closure device; Percutaneous coronary intervention; Hemostasis; Bivalirudin; Conventional PCI; Internal medicine; Angina; Femoral artery; Surgery; Cardiology; Myocardial infarction","score_opus":0.008223945635312884,"score_gpt":0.25842255982661827,"score_spread":0.2501986141913054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313316876","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99379885,0.004530915,0.000027160306,0.0012985502,0.00019591679,0.00012623187,0.000003512022,0.000009197318,0.000009670321],"genre_scores_gemma":[0.99870604,0.0003050164,0.00018822035,0.00061172846,0.000117269345,0.0000017607697,0.0000032868156,0.00001141513,0.000055246288],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986873,0.00032968284,0.00023747886,0.00009315223,0.00054504647,0.000107311724],"domain_scores_gemma":[0.9993602,0.00005729532,0.00037229157,0.00008105267,0.00007308995,0.000056071633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009865136,0.00007710565,0.00035582442,0.00006366186,0.0002660077,0.000029101282,0.00004517652,0.000020414343,0.000016237773],"category_scores_gemma":[0.0001015364,0.000060835428,0.0005372613,0.00016671028,0.000028328208,0.000116005416,0.000051522224,0.00021425943,3.530242e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002043878,0.00005935453,0.983574,0.000016584154,0.0008945458,0.00003679524,0.0002546116,0.00008962271,0.0014916703,0.0000024220235,0.00034132507,0.013034731],"study_design_scores_gemma":[0.0009668037,0.00053720357,0.98956436,0.000054398355,0.000820075,0.0017084372,0.0016634063,0.00021432534,0.00005761116,0.00004538999,0.004296858,0.0000711502],"about_ca_topic_score_codex":0.000046875677,"about_ca_topic_score_gemma":0.0000031574689,"teacher_disagreement_score":0.012963581,"about_ca_system_score_codex":0.00023797838,"about_ca_system_score_gemma":0.000039198017,"threshold_uncertainty_score":0.24807967},"labels":[],"label_agreement":null},{"id":"W4313544958","doi":"10.33963/kp.a2022.0283","title":"Dual pathway inhibition for atherosclerotic cardiovascular disease: Recent advances","year":2022,"lang":"en","type":"article","venue":"Kardiologia Polska","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute; Hamilton Health Sciences; Hamilton General Hospital","funders":"","keywords":"Medicine; Cardiology; Internal medicine; Clopidogrel; Aspirin; Rivaroxaban; Myocardial infarction; Kidney disease; Antithrombotic; Heart failure; Acute coronary syndrome; Coronary artery disease; Stroke (engine); Warfarin; Atrial fibrillation","score_opus":0.025391652538164944,"score_gpt":0.24865305069738844,"score_spread":0.2232613981592235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313544958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7316475,0.24854548,0.009722162,0.001306765,0.0013608846,0.003947668,0.001011687,0.00063516916,0.0018226983],"genre_scores_gemma":[0.9903253,0.0058330703,0.00023786366,0.00076169084,0.0006251638,0.001207976,0.00064699247,0.000057774312,0.0003041979],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99776393,0.00029462553,0.00028581082,0.000580524,0.0006194,0.00045572722],"domain_scores_gemma":[0.9987809,0.00006665686,0.0000718759,0.0007312989,0.000106067426,0.00024318937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074378535,0.00025425947,0.00064587686,0.00008822258,0.00047431828,0.000018492845,0.000100749174,0.00006705695,0.0003090653],"category_scores_gemma":[0.00014730683,0.00022740789,0.0016602033,0.00024258098,0.00012031252,0.00010111336,0.00011005859,0.00022559888,0.000025425385],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010972061,0.0017430583,0.021479353,0.0011683886,0.017732793,0.0024674544,0.00050251023,0.04414437,0.008506113,0.005354875,0.016278252,0.8696508],"study_design_scores_gemma":[0.004173348,0.00069093413,0.01545542,0.00004359888,0.0010907516,0.0002658059,0.0004010554,0.00008390974,0.0010644686,0.0010050066,0.9753219,0.00040380924],"about_ca_topic_score_codex":0.000002883604,"about_ca_topic_score_gemma":2.2176508e-7,"teacher_disagreement_score":0.9590436,"about_ca_system_score_codex":0.00017021505,"about_ca_system_score_gemma":0.00018849174,"threshold_uncertainty_score":0.9273424},"labels":[],"label_agreement":null},{"id":"W4315929061","doi":"10.1016/j.ahj.2023.01.008","title":"Total events and net clinical benefit of rivaroxaban and aspirin in patients with chronic coronary or peripheral artery disease: The COMPASS trial","year":2023,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Rivaroxaban; Aspirin; Compass; Coronary artery disease; Peripheral; Internal medicine; Cardiology; Arterial disease; Clinical trial; Vascular disease; Warfarin; Atrial fibrillation","score_opus":0.021723995896437226,"score_gpt":0.3065573558505122,"score_spread":0.284833359954075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4315929061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981637,0.0007340518,0.0000069553535,0.00053925515,0.00011277139,0.00040819228,0.000017652537,0.000012728334,0.0000046905866],"genre_scores_gemma":[0.99867,0.0006672266,0.000033547276,0.00024899343,0.00029147006,0.000009205377,0.00001523542,0.00001813562,0.000046224133],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986462,0.0001980224,0.0003666896,0.00018565256,0.00036545773,0.00023794954],"domain_scores_gemma":[0.999257,0.00012453353,0.00011904073,0.000180451,0.00004619982,0.00027272556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037221715,0.00013206316,0.0005102511,0.00006651119,0.00009943125,0.000016873113,0.00005393701,0.000025847481,0.000052311236],"category_scores_gemma":[0.000034076245,0.00007593792,0.00017367044,0.00021717904,0.00042931072,0.00007762619,0.000041629723,0.00027320877,0.0000021117035],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.038212325,0.00022405796,0.9202151,0.000019193181,0.0003134744,0.00011991943,0.00005642448,0.00003381145,0.0000031066725,0.00000202787,0.00020744214,0.040593132],"study_design_scores_gemma":[0.027629355,0.004362195,0.9664396,0.00014687965,0.00014344684,0.00023783057,0.0001418299,0.00014414715,6.6756655e-7,0.000014663556,0.00064456376,0.00009480616],"about_ca_topic_score_codex":0.00002679722,"about_ca_topic_score_gemma":0.000013406144,"teacher_disagreement_score":0.046224527,"about_ca_system_score_codex":0.000032269265,"about_ca_system_score_gemma":0.000195376,"threshold_uncertainty_score":0.30966583},"labels":[],"label_agreement":null},{"id":"W4316011951","doi":"10.1007/s12630-022-02386-y","title":"Anticoagulation strategies and outcomes during extracorporeal membrane oxygenation support: a single-centre pre-COVID-19 experience","year":2023,"lang":"en","type":"letter","venue":"Canadian Journal of Anesthesia/Journal canadien d anesthésie","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Extracorporeal membrane oxygenation; Coronavirus disease 2019 (COVID-19); 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Medicine; Oxygenation; Intensive care medicine; Anesthesia; Virology; Internal medicine; Disease; Infectious disease (medical specialty)","score_opus":0.023144263700556444,"score_gpt":0.25242664875679727,"score_spread":0.22928238505624082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4316011951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8607903,0.0014662454,0.000023207083,0.13661854,0.00042363763,0.0005204187,0.000025509147,0.0000469072,0.00008520519],"genre_scores_gemma":[0.97120583,0.0005939887,0.00020674522,0.019601388,0.0042848117,0.000013924524,0.00019572816,0.00025920634,0.0036383544],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9954686,0.00028984342,0.0013424574,0.00051316957,0.0011992374,0.001186692],"domain_scores_gemma":[0.9945757,0.00015627041,0.0012174807,0.00041762338,0.0006353818,0.002997545],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00084559823,0.0007157086,0.0014724546,0.0016911757,0.00070026575,0.0009993474,0.00046350583,0.0008443504,0.00033785193],"category_scores_gemma":[0.00036040205,0.00063984795,0.0008848735,0.0005040662,0.0004330976,0.0012402378,0.000012807683,0.0020077513,0.000010850294],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002471873,0.000041115272,0.008406686,0.00062756444,0.0007962339,0.95328003,0.0032942607,0.00022343936,0.000092533126,0.000023367502,0.031433616,0.0015339823],"study_design_scores_gemma":[0.0021619592,0.0006852261,0.046448324,0.00050014805,0.0008739172,0.8831094,0.002073405,0.00001672811,0.000046823632,0.00013902105,0.06331655,0.00062851346],"about_ca_topic_score_codex":0.0035657962,"about_ca_topic_score_gemma":0.005704735,"teacher_disagreement_score":0.11701716,"about_ca_system_score_codex":0.0013295448,"about_ca_system_score_gemma":0.009795457,"threshold_uncertainty_score":0.9996053},"labels":[],"label_agreement":null},{"id":"W4317105117","doi":"10.1093/ehjcvp/pvad006","title":"Ticagrelor with or without aspirin in high-risk patients with anaemia undergoing percutaneous coronary intervention: a subgroup analysis of the TWILIGHT trial","year":2023,"lang":"en","type":"article","venue":"European Heart Journal - Cardiovascular Pharmacotherapy","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences","funders":"Janssen Pharmaceuticals; Abbott Vascular; CytoSorbents Europe; MicroPort; Idorsia Pharmaceuticals; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; PharmaMar; Eisai; Sanofi; Abiomed; Amarin Pharma; Novo Nordisk; AtriCure; Daiichi-Sankyo; Medicines Company; AstraZeneca; Amarin Corporation; Bristol-Myers Squibb; Eli Lilly and Company; CSL Behring; Daiichi Sankyo Europe; Gilead Sciences; Amgen; Pfizer; Boston Scientific Corporation; National Science Foundation","keywords":"Ticagrelor; Medicine; Aspirin; Percutaneous coronary intervention; Internal medicine; Hazard ratio; Conventional PCI; Myocardial infarction; Clinical endpoint; Placebo; Stroke (engine); Cardiology; Randomized controlled trial; Confidence interval","score_opus":0.019628977588347165,"score_gpt":0.2786518573281694,"score_spread":0.25902287973982224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317105117","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946839,0.0030290566,0.00056256197,0.00008490394,0.0002742076,0.0011545289,0.00002803369,0.00008277449,0.00009999028],"genre_scores_gemma":[0.99556625,0.0032562087,0.00020057063,0.0002636846,0.00034009878,0.000013003899,0.00003745198,0.00012979367,0.00019296372],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9945723,0.00222118,0.00072481256,0.00051418203,0.0014889752,0.00047855164],"domain_scores_gemma":[0.9982459,0.000132814,0.0002828971,0.0008314224,0.0002486491,0.0002583218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021032202,0.00039903633,0.0013673165,0.00062071224,0.000263273,0.00006908434,0.00030884298,0.00006138871,0.00026989327],"category_scores_gemma":[0.000046095978,0.0002205575,0.003127645,0.0025624048,0.00019648175,0.00017869621,0.000057960555,0.0006781038,0.00002348932],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.093740724,0.0008246464,0.77144605,0.0001417272,0.07967034,0.0044281404,0.0006657717,0.014199653,0.000252677,0.000002143115,0.00023876398,0.03438936],"study_design_scores_gemma":[0.12999012,0.0033021215,0.83685046,0.0007631472,0.016810317,0.0022255788,0.0003299033,0.00043689276,0.0003232219,0.0000037781901,0.008457263,0.00050721044],"about_ca_topic_score_codex":0.00004391168,"about_ca_topic_score_gemma":0.000040975934,"teacher_disagreement_score":0.0654044,"about_ca_system_score_codex":0.00013673265,"about_ca_system_score_gemma":0.00019563719,"threshold_uncertainty_score":0.8994074},"labels":[],"label_agreement":null},{"id":"W4317424994","doi":"10.1016/j.kint.2022.10.018","title":"TIPS to decide whether to prescribe aspirin for the primary prevention of cardiovascular events in chronic kidney disease","year":2023,"lang":"en","type":"letter","venue":"Kidney International","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Aspirin; Medicine; Kidney disease; Placebo; Renal function; Internal medicine; Randomized controlled trial; Post-hoc analysis; Disease; Subgroup analysis; Kidney; Clinical trial; Intensive care medicine; Cardiology; Pathology; Alternative medicine; Meta-analysis","score_opus":0.026286260345234565,"score_gpt":0.29123275611462457,"score_spread":0.26494649576939,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317424994","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008987,0.0062906747,0.033957966,0.9291883,0.005119526,0.010562972,0.0045770407,0.00021500798,0.0011014866],"genre_scores_gemma":[0.013159043,0.0015794247,0.0012153301,0.9087663,0.016263906,0.005112417,0.015339325,0.000504869,0.03805937],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968226,0.00015304536,0.0005677673,0.0006533757,0.0013999835,0.0004032253],"domain_scores_gemma":[0.99805766,0.00014822502,0.00012602644,0.00092398626,0.00027100198,0.0004730873],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006825244,0.00035641747,0.0007027175,0.0004252867,0.000053797845,0.000022180793,0.00061121234,0.00026694415,0.00026962627],"category_scores_gemma":[0.0008077364,0.0002903768,0.0019882286,0.0002846699,0.00004625854,0.00008645965,0.00018626223,0.00048822208,0.00014780217],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007951029,0.00010571799,0.00080764503,0.00086088816,0.007806921,0.00017376071,0.00006669021,0.00092163833,0.00010959789,0.000020391968,0.9774672,0.010864476],"study_design_scores_gemma":[0.0026790728,0.00015478152,0.012133911,0.0021976086,0.0013365588,0.000019283178,0.0000092500495,0.000114536786,0.00013512385,0.00024075658,0.9806934,0.00028570066],"about_ca_topic_score_codex":0.00009048599,"about_ca_topic_score_gemma":0.0000066670136,"teacher_disagreement_score":0.036957882,"about_ca_system_score_codex":0.0006431253,"about_ca_system_score_gemma":0.0014772305,"threshold_uncertainty_score":0.9999548},"labels":[],"label_agreement":null},{"id":"W4317927131","doi":"10.33590/emjcardiol/10312244","title":"The Changing Landscape in Oral Anticoagulation – The Last Pieces of the Puzzle","year":2013,"lang":"en","type":"article","venue":"EMJ Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"Daiichi Sankyo Europe","keywords":"Geography; History; Aesthetics; Art","score_opus":0.009966062832287527,"score_gpt":0.23944290982992927,"score_spread":0.22947684699764176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317927131","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99119306,0.0043386994,0.00012030159,0.002097906,0.00030281377,0.0003872168,0.000002061115,0.000013205621,0.0015447481],"genre_scores_gemma":[0.9990556,0.0002722131,0.000005516126,0.0002084369,0.0002537792,0.000035033976,0.0000054648863,0.000008212463,0.00015574455],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99915665,0.0002496396,0.00014551803,0.00010925518,0.00013524563,0.00020370263],"domain_scores_gemma":[0.9994047,0.000113258546,0.000048333015,0.00036579068,0.00004755911,0.00002031898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045188717,0.00007674488,0.00024678846,0.000035840127,0.00015930258,0.000010609636,0.00013810053,0.000059407987,0.000028246213],"category_scores_gemma":[0.00007168434,0.00003193562,0.0002629165,0.00020479965,0.00015280141,0.000033195778,0.00005412496,0.00011659083,0.000022676802],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001581418,0.000044207216,0.93063223,0.000045640772,0.001073913,0.00003876813,0.0012328716,0.0018335761,0.0010537868,0.0013127297,0.005622126,0.056952026],"study_design_scores_gemma":[0.00071419217,0.000043704968,0.97435457,0.000027249316,0.00010174445,0.00018098768,0.001238367,0.0004230334,0.00034387494,0.00020600072,0.02230919,0.000057062316],"about_ca_topic_score_codex":0.000029507324,"about_ca_topic_score_gemma":0.00003466102,"teacher_disagreement_score":0.05689496,"about_ca_system_score_codex":0.000008490896,"about_ca_system_score_gemma":0.000024336354,"threshold_uncertainty_score":0.13022967},"labels":[],"label_agreement":null},{"id":"W4318451399","doi":"10.3171/2022.12.jns222316","title":"Natural history of antiplatelet nonresponders undergoing carotid artery stenting","year":2023,"lang":"en","type":"article","venue":"Journal of neurosurgery","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"","keywords":"Medicine; Clopidogrel; Carotid stenting; Internal medicine; Prospective cohort study; Cardiology; Aspirin; Thrombosis; Carotid arteries; Anesthesia; Carotid endarterectomy","score_opus":0.028349262587748166,"score_gpt":0.25075925893081114,"score_spread":0.22240999634306297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318451399","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99324375,0.003555006,0.00004459795,0.00019944702,0.0025948074,0.00008177011,0.0000021127828,0.000039347775,0.00023915459],"genre_scores_gemma":[0.9967853,0.0014472605,0.000033112734,0.00037953496,0.00032288194,6.4955356e-7,0.0000044852545,0.000034268705,0.0009925214],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9981816,0.00015593307,0.00065106753,0.00014356349,0.00060462375,0.00026321647],"domain_scores_gemma":[0.9985373,0.0004529088,0.0004680097,0.00021526079,0.00019007192,0.00013645296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081770384,0.00014747088,0.00061971747,0.00069091405,0.00003570675,0.000010415534,0.000095315096,0.000062206505,0.00003886964],"category_scores_gemma":[0.00039397215,0.00012593462,0.0010309439,0.0004086934,0.00009201113,0.00020267848,0.000029145489,0.000320553,0.000010992042],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00469019,0.0004379648,0.21297829,0.0011302946,0.0030749785,0.026690437,0.00093963713,0.0007909509,0.6578531,0.000029357583,0.07807561,0.013309176],"study_design_scores_gemma":[0.009886987,0.0011614533,0.886436,0.0026697197,0.0014360244,0.024357699,0.0018418961,0.00058050355,0.017585926,0.00008347591,0.053176086,0.0007842585],"about_ca_topic_score_codex":0.0000013990713,"about_ca_topic_score_gemma":3.3885453e-7,"teacher_disagreement_score":0.6734577,"about_ca_system_score_codex":0.000098113705,"about_ca_system_score_gemma":0.00047929763,"threshold_uncertainty_score":0.51354647},"labels":[],"label_agreement":null},{"id":"W4318616804","doi":"10.2174/1570161121666230131120544","title":"Acetylsalicylic Acid (Aspirin) for Primary Prevention of CardiovascularEvents in Patients with Diabetes: A Systematic Review and Meta-Analysisof Randomized Controlled Trials","year":2023,"lang":"en","type":"review","venue":"Current Vascular Pharmacology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Southlake Regional Health Center; University of Alberta; Royal University Hospital; St. Boniface Hospital","funders":"","keywords":"Medicine; Aspirin; Internal medicine; Relative risk; Stroke (engine); Placebo; Diabetes mellitus; Myocardial infarction; Randomized controlled trial; Confidence interval; Meta-analysis; Surgery; Endocrinology; Pathology","score_opus":0.08649370975079997,"score_gpt":0.39789264404604907,"score_spread":0.3113989342952491,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318616804","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018185693,0.9313382,0.00037696623,0.000014440366,0.0002286389,0.06758994,0.00021434293,0.000052382115,0.0000032358835],"genre_scores_gemma":[0.00004534644,0.96331584,0.000048362315,0.00011244477,0.00009613474,0.034541976,0.0016474201,0.00014084578,0.00005161696],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9779,0.0142106535,0.0053717764,0.000991807,0.0009798248,0.0005458953],"domain_scores_gemma":[0.99257934,0.0022247122,0.0035234825,0.00093304215,0.0005160947,0.00022333853],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.021225188,0.0011167721,0.07448108,0.00088613544,0.00006087744,0.000021111693,0.00032488894,0.00034326344,0.000083820545],"category_scores_gemma":[0.0023250626,0.00060198695,0.037778836,0.0008752761,0.00020969188,0.00010272808,0.00011579539,0.00043946743,0.000009509302],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036578213,0.00040470355,0.000005224306,0.61468625,0.3706623,0.0000039395263,0.0000070862293,0.0000016186666,1.9903408e-7,0.0000026375321,0.000045227865,0.010522995],"study_design_scores_gemma":[0.20348011,0.00014874307,0.0000071232807,0.116681,0.67476493,0.0000033633116,0.0000018420262,0.000003715965,0.0000012234266,0.000007961752,0.004557969,0.00034201483],"about_ca_topic_score_codex":0.0000013833419,"about_ca_topic_score_gemma":4.504133e-7,"teacher_disagreement_score":0.49800524,"about_ca_system_score_codex":0.00016362613,"about_ca_system_score_gemma":0.00047487367,"threshold_uncertainty_score":0.99964315},"labels":[],"label_agreement":null},{"id":"W4319302851","doi":"10.1016/j.jacc.2022.11.041","title":"P2Y12 Inhibitor Monotherapy or Dual Antiplatelet Therapy After Complex Percutaneous Coronary Interventions","year":2023,"lang":"en","type":"review","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":119,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences","funders":"Eisai; Abiomed; Osprey Medical; Daiichi-Sankyo; Medicines Company; Boston Scientific Corporation; Eli Lilly and Company; AstraZeneca; CSL Behring; Janssen Pharmaceuticals; Gilead Sciences; Edwards Lifesciences; Amgen; Pfizer; Bayer; Daiichi Sankyo Europe; University of Bern; Sanofi; Abbott Vascular; Abbott Laboratories","keywords":"Conventional PCI; Medicine; Percutaneous coronary intervention; Internal medicine; Clinical endpoint; Cardiology; P2Y12; Clopidogrel; Stent; Myocardial infarction; Randomized controlled trial","score_opus":0.0823996957005993,"score_gpt":0.36080331591676135,"score_spread":0.27840362021616205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319302851","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03121808,0.96553713,0.00006508004,0.0002319445,0.0009301358,0.0011054768,0.000813027,0.000032894273,0.000066213215],"genre_scores_gemma":[0.017420555,0.97986406,0.00019941037,0.00027370403,0.0014304911,0.000034317385,0.000022270604,0.000147213,0.0006079834],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99540824,0.0014254983,0.0017795392,0.00034974763,0.000620208,0.00041676965],"domain_scores_gemma":[0.9959695,0.00052383624,0.0021309527,0.00083353475,0.00034899224,0.00019320012],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007392608,0.0005773268,0.006413029,0.00048601723,0.00010579649,0.000011392203,0.00056226965,0.00025332163,0.00014291957],"category_scores_gemma":[0.00012568156,0.0003136853,0.009526036,0.00092903717,0.0010274717,0.00005714011,0.00015021663,0.0008047492,0.00002031861],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01849477,0.00041921847,0.0006895289,0.0076113543,0.0517086,0.043236934,0.00007551608,0.000058254416,0.00010417759,0.000022458464,0.025170755,0.8524084],"study_design_scores_gemma":[0.0018562393,0.0029637488,0.0014407799,0.008102925,0.004212565,0.12342922,0.0002275902,0.0000014972952,0.0000040860687,0.000025850592,0.85740596,0.00032951764],"about_ca_topic_score_codex":0.000004265905,"about_ca_topic_score_gemma":0.0000023722341,"teacher_disagreement_score":0.8520789,"about_ca_system_score_codex":0.00016772002,"about_ca_system_score_gemma":0.0009827641,"threshold_uncertainty_score":0.9999315},"labels":[],"label_agreement":null},{"id":"W4319348651","doi":"10.9778/cmajo.20210119","title":"Extended dual antiplatelet therapy following percutaneous coronary intervention in clinically important patient subgroups: a systematic review and meta-analysis","year":2023,"lang":"en","type":"review","venue":"CMAJ Open","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa; Canadian Agency for Drugs and Technologies in Health","funders":"Eli Lilly Canada; AstraZeneca Canada; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Percutaneous coronary intervention; Conventional PCI; Internal medicine; Myocardial infarction; Meta-analysis; Cochrane Library; Relative risk; Randomized controlled trial; Acute coronary syndrome; Cardiology; Stroke (engine); Confidence interval","score_opus":0.11050559962782733,"score_gpt":0.3989020942214647,"score_spread":0.28839649459363736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319348651","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00037248182,0.9868755,0.000011046047,0.000043630946,0.00007521973,0.012379475,0.00012787078,0.00007058016,0.00004421925],"genre_scores_gemma":[0.0008495991,0.9956491,0.000073342955,0.0005700816,0.000022202043,0.0014751527,0.00081881526,0.00012536685,0.00041634677],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99217266,0.0017659671,0.0039426605,0.0010758962,0.0006337007,0.00040910908],"domain_scores_gemma":[0.9966243,0.00040963962,0.0013009554,0.0013437127,0.00008657602,0.00023483312],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.0040553818,0.00077630364,0.016319355,0.0004088363,0.00009165296,0.00015848594,0.00047723282,0.00034050056,0.0004209598],"category_scores_gemma":[0.00035451943,0.0004922752,0.012827558,0.0012181129,0.0000621612,0.00016000995,0.0003785922,0.0005028383,0.000062005805],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000107623375,0.00032119633,0.000033601602,0.47196352,0.47265705,0.010015724,0.00007622955,1.9139044e-7,1.0879436e-7,0.0000061019277,0.000054028977,0.044764623],"study_design_scores_gemma":[0.0008607559,0.00047343527,0.00003549181,0.10414545,0.8835893,0.0024810194,0.0001134128,0.0000035554801,8.27803e-8,0.000018583649,0.0077474047,0.0005314974],"about_ca_topic_score_codex":0.00013985304,"about_ca_topic_score_gemma":0.000045699082,"teacher_disagreement_score":0.41093224,"about_ca_system_score_codex":0.000100957885,"about_ca_system_score_gemma":0.00020107016,"threshold_uncertainty_score":0.9997529},"labels":[],"label_agreement":null},{"id":"W4320486999","doi":"10.24095/hpcdp.43.2.04f","title":"Évolution et déterminants de la vaccination contre la grippe saisonnière après une maladie cardiovasculaire au Canada : étude transversale pancanadienne répétée","year":2023,"lang":"fr","type":"article","venue":"Promotion de la santé et prévention des maladies chroniques au Canada","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of Waterloo","funders":"","keywords":"Gynecology; Medicine; Humanities; Philosophy","score_opus":0.010134854802309119,"score_gpt":0.2751243633544251,"score_spread":0.26498950855211595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4320486999","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9424374,0.024049848,0.0038283307,0.0019100982,0.0017455515,0.0014154161,0.0006828333,0.00036583378,0.02356468],"genre_scores_gemma":[0.9576317,0.031930815,0.00019929364,0.00025202244,0.0009117363,0.00026806263,0.00081744726,0.0001579565,0.0078309765],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.990836,0.0045982753,0.0008439318,0.00088498945,0.0010751073,0.0017616481],"domain_scores_gemma":[0.9970592,0.00079776207,0.000355532,0.00063727907,0.00035739643,0.0007928238],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00415159,0.0007753755,0.0010606652,0.00029641524,0.00072093226,0.0001698432,0.00033381992,0.00061124354,0.0016946874],"category_scores_gemma":[0.00051820616,0.000881145,0.0008376594,0.0010116621,0.00060126244,0.0006495648,0.00008301455,0.00082365866,0.000009379983],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0010759995,0.0014018185,0.35941824,0.023800673,0.010994249,0.016642481,0.010817754,0.017960472,0.000990268,0.012333181,0.06868967,0.4758752],"study_design_scores_gemma":[0.0040669832,0.00030102857,0.84625787,0.004647138,0.0016379058,0.0015674473,0.0021093069,0.0036030472,0.0012182471,0.0006394865,0.13307226,0.0008792628],"about_ca_topic_score_codex":0.9588654,"about_ca_topic_score_gemma":0.99910486,"teacher_disagreement_score":0.48683965,"about_ca_system_score_codex":0.013701345,"about_ca_system_score_gemma":0.018292557,"threshold_uncertainty_score":0.9993639},"labels":[],"label_agreement":null},{"id":"W4321487279","doi":"10.1016/j.amjmed.2023.01.029","title":"Time Course of Death After Acute Coronary Syndrome Treated With Dual Antiplatelet Therapy for 1 Year","year":2023,"lang":"en","type":"article","venue":"The American Journal of Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Medicine; Ticagrelor; Acute coronary syndrome; Aspirin; Clopidogrel; Myocardial infarction; Ticlopidine; Internal medicine; Emergency medicine","score_opus":0.011167075156404136,"score_gpt":0.2705614378973869,"score_spread":0.25939436274098276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321487279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949221,0.0020153245,0.00008808499,0.0024917251,0.00004668992,0.00034080236,0.000036793237,0.000028287826,0.000030189045],"genre_scores_gemma":[0.9952356,0.0034342643,0.000106908,0.00065996835,0.000213262,0.0000101146115,0.000021505022,0.000042716794,0.00027565853],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99864787,0.00011105834,0.00037465643,0.00012892397,0.0004953638,0.00024210631],"domain_scores_gemma":[0.99868995,0.00018778235,0.00041377565,0.00030317684,0.0002483262,0.00015699893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069602276,0.00018715979,0.0009896582,0.0001525776,0.000046375117,0.000003254729,0.00014202902,0.0000284951,0.00015391364],"category_scores_gemma":[0.000021191834,0.00008728243,0.0003056765,0.00048539168,0.00090236135,0.00005158144,0.000013421634,0.00016475134,0.000011782866],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.31506354,0.0016513497,0.22882882,0.00025650873,0.06305473,0.03491786,0.004949377,0.00025087167,0.0509814,0.00005701173,0.026841152,0.2731474],"study_design_scores_gemma":[0.021659404,0.033249844,0.9128576,0.00089248864,0.0031221558,0.021531185,0.00239734,0.00008701756,0.0013463928,0.000070814654,0.0025553862,0.00023038623],"about_ca_topic_score_codex":0.0000069356174,"about_ca_topic_score_gemma":1.3674513e-7,"teacher_disagreement_score":0.68402874,"about_ca_system_score_codex":0.000017790424,"about_ca_system_score_gemma":0.00013078077,"threshold_uncertainty_score":0.3559274},"labels":[],"label_agreement":null},{"id":"W4321498868","doi":"10.1101/2023.02.20.23286209","title":"How appropriate is use of antiplatelet medications in patients with transient ischemic attacks and stroke: an analysis of 9132 patients over eight years","year":2023,"lang":"en","type":"preprint","venue":"medRxiv","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Weill Cornell Medicine - Qatar; Weill Cornell Medical College; Medical Research Council; Hamad Medical Corporation","keywords":"Medicine; Stroke (engine); Modified Rankin Scale; Minor stroke; Guideline; Demographics; Emergency medicine; Internal medicine; Prospective cohort study; Ischemic stroke; Intensive care medicine; Pathology","score_opus":0.018009716474728182,"score_gpt":0.2468113823885204,"score_spread":0.22880166591379222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321498868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973549,0.00028216996,0.00022510304,0.00005874418,0.000072749084,0.00073090044,0.0012398303,0.000026326465,0.000009225251],"genre_scores_gemma":[0.9969339,0.0007940261,0.00021674631,0.00004294426,0.000018280598,0.000030215415,0.0018210155,0.000050031387,0.000092839204],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997625,0.00011544278,0.0005002801,0.0006216938,0.00090011145,0.00023747538],"domain_scores_gemma":[0.99826425,0.000048342976,0.00035343424,0.0008940971,0.0002599108,0.00017996437],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022987532,0.00029284516,0.0011482113,0.0007248658,0.000022744302,0.000023605853,0.00016980665,0.00026556547,0.000045571705],"category_scores_gemma":[0.00004764211,0.00024208837,0.00043339646,0.0006787941,0.0002066668,0.00013026455,0.000098437224,0.00032716786,8.3176195e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052546157,0.00064705894,0.9890554,0.00029784007,0.0061748596,0.000018441617,0.000799956,0.00018221706,0.0001197124,0.000001586053,0.00007506773,0.0021023792],"study_design_scores_gemma":[0.003389411,0.00020410943,0.9898377,0.00031013362,0.0046478733,3.822853e-7,0.00006094647,0.0005440394,0.0004254411,0.0000029278433,0.00036076122,0.00021624334],"about_ca_topic_score_codex":0.00012107616,"about_ca_topic_score_gemma":0.00004664812,"teacher_disagreement_score":0.0028639494,"about_ca_system_score_codex":0.000034419732,"about_ca_system_score_gemma":0.00009327646,"threshold_uncertainty_score":0.9872077},"labels":[],"label_agreement":null},{"id":"W4322719434","doi":"10.1111/jvim.16670","title":"Validation of Plateletworks ADP for the ProCyte Dx analyzer","year":2023,"lang":"en","type":"article","venue":"Journal of Veterinary Internal Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"OVC Pet Trust; University of Guelph","keywords":"CATS; Medicine; Platelet; Spectrum analyzer; Clopidogrel; Hematology analyzer; Platelet aggregation; Receiver operating characteristic; Population; Internal medicine; Aspirin","score_opus":0.05124002380646299,"score_gpt":0.34705320154853464,"score_spread":0.29581317774207166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322719434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98444146,0.0039149527,0.008287598,0.0021052102,0.0007889151,0.00028005455,0.00000509968,0.000016797703,0.00015992214],"genre_scores_gemma":[0.99542457,0.0022922354,0.00013458457,0.0002528143,0.0014834077,0.000008467368,0.000007869124,0.00002033884,0.00037572623],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99856824,0.000057073637,0.0006184597,0.00010077953,0.00049088954,0.00016453529],"domain_scores_gemma":[0.9985966,0.0003280802,0.00041534402,0.00019676104,0.00035693395,0.00010626239],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010247991,0.0001269115,0.0005175068,0.00021935777,0.000049536284,0.0000061297924,0.00018981966,0.000058091842,0.00013656389],"category_scores_gemma":[0.00026050973,0.00006828901,0.00048244777,0.00026973596,0.000135924,0.00009173262,0.000029099223,0.00021334158,0.000004585493],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07023403,0.0007068304,0.018970737,0.0023547972,0.01875536,0.007114137,0.004214043,0.0030756213,0.30893058,0.0002116919,0.08486617,0.48056602],"study_design_scores_gemma":[0.059501864,0.08684583,0.22238939,0.018956158,0.011421266,0.055507388,0.008296978,0.012502286,0.06883973,0.0014748477,0.4532867,0.0009775672],"about_ca_topic_score_codex":0.00000635447,"about_ca_topic_score_gemma":1.2999207e-7,"teacher_disagreement_score":0.47958845,"about_ca_system_score_codex":0.00003074144,"about_ca_system_score_gemma":0.00005632375,"threshold_uncertainty_score":0.2784745},"labels":[],"label_agreement":null},{"id":"W4323067192","doi":"10.1093/ehjcvp/pvad016","title":"Within and beyond 12-month efficacy and safety of antithrombotic strategies in patients with established coronary artery disease: two companion network meta-analyses of the 2022 joint clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), European Association for Acute CardioVascular Care (ACVC), and European Association of Preventive Cardiology (EAPC)","year":2023,"lang":"en","type":"article","venue":"European Heart Journal - Cardiovascular Pharmacotherapy","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Ticagrelor; Aspirin; Clopidogrel; Internal medicine; Hazard ratio; Acute coronary syndrome; Myocardial infarction; Coronary artery disease; Stroke (engine); Antithrombotic; Rivaroxaban; Cardiology; Confidence interval; Warfarin; Atrial fibrillation","score_opus":0.06261888568394085,"score_gpt":0.3450688773441085,"score_spread":0.28244999166016765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323067192","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9541658,0.04186493,0.0005943275,0.0000750744,0.00040608965,0.0021292414,0.00046590934,0.000027013288,0.00027157034],"genre_scores_gemma":[0.98876494,0.010489175,0.00021972627,0.00003779203,0.00021689486,0.000007325686,0.00009651051,0.00012402407,0.00004361588],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9749535,0.020035347,0.0022198302,0.0006190522,0.0017304107,0.00044188966],"domain_scores_gemma":[0.99521905,0.00052778784,0.0019855273,0.000920055,0.0011520212,0.00019556549],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.01859616,0.00047752974,0.0030503187,0.00024304393,0.00027018314,0.000053268326,0.00028657907,0.00007687844,0.0000071715967],"category_scores_gemma":[0.0004632911,0.0003297841,0.0067420155,0.00058693433,0.00035330383,0.00018634475,0.00022883328,0.00058621605,6.573308e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022306102,0.0004949899,0.5294132,0.0010517695,0.3471928,0.0002600538,0.001983403,0.10776631,0.0023092157,0.0000142508325,0.00033272427,0.0069506406],"study_design_scores_gemma":[0.013526691,0.00067572953,0.9270122,0.00062737,0.055491045,0.00012617785,0.0007487841,0.00007059558,0.00027497206,0.000016567117,0.001139941,0.00028992546],"about_ca_topic_score_codex":0.00002741942,"about_ca_topic_score_gemma":0.0000071749305,"teacher_disagreement_score":0.39759895,"about_ca_system_score_codex":0.00019746395,"about_ca_system_score_gemma":0.00017821325,"threshold_uncertainty_score":0.9999154},"labels":[],"label_agreement":null},{"id":"W4362458210","doi":"10.4244/eij-d-22-01006","title":"A prospective study comparing short versus standard dual antiplatelet therapy in patients with acute myocardial infarction: design and rationale of the TARGET-FIRST trial.","year":2023,"lang":"en","type":"article","venue":"PubMed","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Abbott Vascular; MicroPort; Servier; Novo Nordisk; Mylan; Boston Scientific Corporation; Canada Excellence Research Chairs, Government of Canada; Alnylam Pharmaceuticals; Daiichi Sankyo Europe; Sanofi; Edwards Lifesciences; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Clinical endpoint; Myocardial infarction; Discontinuation; Internal medicine; Aspirin; P2Y12; Adverse effect; Platelet aggregation inhibitor; Population; Stent; Acute coronary syndrome; Surgery; Clopidogrel; Clinical trial","score_opus":0.030248048633191967,"score_gpt":0.24111669439305003,"score_spread":0.21086864575985806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362458210","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99194825,0.00012335766,0.000046860747,0.0000747811,0.00022928226,0.0074352142,0.000014076215,0.000041680043,0.00008650892],"genre_scores_gemma":[0.99837387,0.00012209768,0.000033551976,0.00001905802,0.00008215251,0.0013163089,0.000019300305,0.000018498315,0.000015158816],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99862325,0.00014371319,0.00021403011,0.00024657857,0.00055805786,0.00021439811],"domain_scores_gemma":[0.9994768,0.000076650256,0.00005249098,0.00022091123,0.000110256165,0.00006291696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000545127,0.00013838691,0.00040356477,0.00009886827,0.00011520827,0.000021737736,0.00005799504,0.000040891147,0.0000045248653],"category_scores_gemma":[0.000041305826,0.00008968083,0.00011059448,0.00048939727,0.000096659365,0.00010093018,0.000037837828,0.00011848389,6.193623e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20779261,0.00035248033,0.7826557,0.0000070732535,0.0023028078,0.000022487937,0.00048092802,0.00034734717,0.0000012879519,0.0000069450357,0.00006613216,0.0059641604],"study_design_scores_gemma":[0.10422067,0.0014620252,0.8935165,0.0000112135285,0.00018775863,0.0000027361186,0.00020843354,0.00002429259,0.00011991217,0.000018739036,0.00013559981,0.0000921392],"about_ca_topic_score_codex":0.000008170991,"about_ca_topic_score_gemma":0.0000073626416,"teacher_disagreement_score":0.11086073,"about_ca_system_score_codex":0.00006060327,"about_ca_system_score_gemma":0.00007172209,"threshold_uncertainty_score":0.3657078},"labels":[],"label_agreement":null},{"id":"W4362505827","doi":"10.1080/14779072.2023.2199155","title":"Are P2Y12 inhibitors superior to aspirin for long-term secondary prevention of cardiovascular disease?","year":2023,"lang":"en","type":"editorial","venue":"Expert Review of Cardiovascular Therapy","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Population Health Research Institute; McMaster University; Hamilton General Hospital","funders":"","keywords":"Medicine; Aspirin; Secondary prevention; P2Y12; Disease; Internal medicine; Term (time); Cardiology; Pharmacology; Clopidogrel","score_opus":0.02541226504409022,"score_gpt":0.32448142135710994,"score_spread":0.2990691563130197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362505827","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020711543,0.7970167,0.0020777714,0.00008725039,0.19111256,0.006721344,0.0007011566,0.00017407867,0.000038025482],"genre_scores_gemma":[0.00031487746,0.76982766,0.0002549457,0.00024780925,0.22386976,0.0021956407,0.0025443684,0.0004728849,0.00027206753],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.989927,0.00092135934,0.0020387426,0.0017874138,0.004459054,0.00086643605],"domain_scores_gemma":[0.9915188,0.00037331873,0.0007969397,0.004721857,0.001862396,0.00072667387],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0038996334,0.0013034542,0.0076334905,0.0005248854,0.00015201542,0.00004287564,0.00082527805,0.0009122896,0.00016397836],"category_scores_gemma":[0.0014138994,0.0011467612,0.033303153,0.00094500656,0.0002556996,0.00020285412,0.00019197735,0.000692624,0.00004236992],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014416379,0.00040800546,0.00008784127,0.057056308,0.10165074,0.00032555524,0.00009594768,0.00010842446,0.00006773718,0.0000021002597,0.47358635,0.36516938],"study_design_scores_gemma":[0.0056012836,0.00062739477,0.0008520985,0.05442759,0.011041482,0.000017097109,0.000039175444,0.000001190055,0.001279055,0.000010361334,0.9251149,0.0009883269],"about_ca_topic_score_codex":0.00005282027,"about_ca_topic_score_gemma":0.0000020361304,"teacher_disagreement_score":0.4515286,"about_ca_system_score_codex":0.00023873139,"about_ca_system_score_gemma":0.0012519847,"threshold_uncertainty_score":0.9999717},"labels":[],"label_agreement":null},{"id":"W4363675194","doi":"10.1016/j.jcin.2023.01.356","title":"Genetic-Guided Oral P2Y12 Inhibitor Selection and Cumulative Ischemic Events After Percutaneous Coronary Intervention","year":2023,"lang":"en","type":"article","venue":"JACC: Cardiovascular Interventions","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute; Université de Montréal; Canadian VIGOUR Centre; University of Alberta; St. Michael's Hospital; University of Ottawa; Heart and Stroke Foundation; University of Toronto","funders":"National Heart, Lung, and Blood Institute","keywords":"Percutaneous coronary intervention; Selection (genetic algorithm); P2Y12; Medicine; Internal medicine; Cardiology; Computer science; Artificial intelligence; Myocardial infarction","score_opus":0.026516570240841805,"score_gpt":0.2980940671466564,"score_spread":0.2715774969058146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4363675194","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9796705,0.0151154185,0.003061814,0.00008754389,0.0004365294,0.00094799214,0.000048258866,0.00039094652,0.00024097491],"genre_scores_gemma":[0.9955677,0.0013703065,0.00048185783,0.00007017654,0.0003299477,0.00024787892,0.0002054797,0.00008511926,0.0016415265],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971857,0.00036414101,0.0006383907,0.00068679586,0.00067559106,0.00044936384],"domain_scores_gemma":[0.9987871,0.000034986755,0.00009999175,0.000579429,0.0002565466,0.00024191703],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006750156,0.00036208736,0.000751156,0.00038164234,0.00021097818,0.000048023925,0.00011196153,0.00021606233,0.0004970119],"category_scores_gemma":[0.00011529492,0.0003581442,0.0051651737,0.00062579144,0.00010188807,0.00024089342,0.00017220061,0.00032034714,0.00035725546],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041082078,0.0028795376,0.43658116,0.0057663433,0.09081805,0.009245262,0.0018877845,0.0046991827,0.009726924,0.00011024277,0.017348932,0.41682836],"study_design_scores_gemma":[0.006639585,0.0007304825,0.94129133,0.0018534433,0.0067010173,0.010390964,0.00066658994,0.0018010141,0.0011998287,0.00018122552,0.02774746,0.00079707184],"about_ca_topic_score_codex":0.0000832569,"about_ca_topic_score_gemma":0.000024683088,"teacher_disagreement_score":0.50471014,"about_ca_system_score_codex":0.00015669277,"about_ca_system_score_gemma":0.000047893715,"threshold_uncertainty_score":0.99988705},"labels":[],"label_agreement":null},{"id":"W4365148741","doi":"10.3389/jpps.2023.11263","title":"Occurrence of intraocular hemorrhages under monotherapy or combination therapy of antiplatelets and anticoagulants using the Japanese Adverse Drug Event Report database","year":2023,"lang":"en","type":"article","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Otsuka Pharmaceutical","keywords":"Medicine; Adverse effect; Drug; Pharmacotherapy; Adverse drug event; Database; Intensive care medicine; Pharmacology; Internal medicine; Computer science","score_opus":0.11783399516274821,"score_gpt":0.4293034849491207,"score_spread":0.31146948978637246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365148741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900725,0.008124199,0.00027058992,0.00087153533,0.00028378007,0.0003259385,0.000025697414,0.000013975685,0.000011774394],"genre_scores_gemma":[0.9744649,0.024999421,0.00014287724,0.0002874545,0.0000785738,0.0000016482629,0.0000058870655,0.0000077869845,0.0000114783215],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974745,0.00024839002,0.00073012995,0.00022611208,0.0010498642,0.00027102433],"domain_scores_gemma":[0.99856925,0.00027121854,0.0005165197,0.0001816924,0.0002651599,0.00019615192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026587641,0.00017651028,0.00051278,0.00022280664,0.00016565279,0.000021183265,0.0002732182,0.000028435368,0.00014808353],"category_scores_gemma":[0.000111374546,0.0000979666,0.00028269328,0.00086613826,0.00083510013,0.00037981648,0.000056100424,0.00023748979,0.000001094172],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0062583233,0.001595159,0.1067748,0.0005171889,0.0019087702,0.003588618,0.001874686,0.0028624872,0.7697396,0.00008238028,0.00060135307,0.10419661],"study_design_scores_gemma":[0.020067431,0.0007644937,0.022619465,0.0007248554,0.0012037252,0.0098381555,0.0037282826,0.04694228,0.88527524,0.00015316554,0.00820155,0.00048133687],"about_ca_topic_score_codex":0.00002792304,"about_ca_topic_score_gemma":3.7392078e-7,"teacher_disagreement_score":0.11553563,"about_ca_system_score_codex":0.00002091745,"about_ca_system_score_gemma":0.00029119133,"threshold_uncertainty_score":0.3994962},"labels":[],"label_agreement":null},{"id":"W4366247600","doi":"10.1055/s-0043-57030","title":"Comparison of De-escalation of DAPT Intensity or Duration in East Asian and Western Patients with ACS Undergoing PCI: A Systematic Review and Meta-analysis","year":2023,"lang":"en","type":"review","venue":"Thrombosis and Haemostasis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Conventional PCI; Medicine; Meta-analysis; Internal medicine; Cardiology; Percutaneous coronary intervention; Myocardial infarction","score_opus":0.22436301993592062,"score_gpt":0.4087463582833017,"score_spread":0.18438333834738108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366247600","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010741908,0.9870558,0.00011360302,0.00007797767,0.000004382482,0.0018886435,0.00009994644,0.000012447465,0.0000053209865],"genre_scores_gemma":[0.070131004,0.9294664,0.000087980035,0.000037213616,0.0000037223879,0.00005799491,0.0001792369,0.000025776595,0.000010616054],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9978942,0.00032630074,0.0010317486,0.0003196204,0.00029877666,0.00012930488],"domain_scores_gemma":[0.9985328,0.00013303335,0.00077573356,0.00032787427,0.00014739961,0.00008316816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005555006,0.0002973946,0.007678682,0.00027146866,0.000045396497,0.00002065172,0.000049618488,0.00012891517,0.000013387604],"category_scores_gemma":[0.00010651275,0.00017392129,0.0006312605,0.00069493864,0.00009898621,0.00008379942,0.000047836118,0.00011890476,5.0661015e-7],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005954511,0.00015405999,0.0136664165,0.85111403,0.12385726,0.0000032525793,0.0004707612,7.9729557e-7,9.2658745e-8,0.0000063842317,0.000007184387,0.0106602395],"study_design_scores_gemma":[0.00063825125,0.0002234454,0.015248984,0.08235315,0.9008403,0.000014773206,0.00040912486,0.000011963072,0.0000013305333,0.0000026844389,0.000058983398,0.00019700539],"about_ca_topic_score_codex":0.000037847793,"about_ca_topic_score_gemma":0.00023092954,"teacher_disagreement_score":0.776983,"about_ca_system_score_codex":0.00003309338,"about_ca_system_score_gemma":0.00007468401,"threshold_uncertainty_score":0.7092304},"labels":[],"label_agreement":null},{"id":"W4366833427","doi":"10.36106/ijsr/6345745","title":"TICAGRELOR VS. CLOPIDOGREL: CLINICAL OUTCOMES IN ST-ELEVATION MYOCARDIAL INFARCTION PATIENTS","year":2023,"lang":"en","type":"article","venue":"INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Ticagrelor; Clopidogrel; Medicine; Myocardial infarction; Internal medicine; Cardiology; Gold standard (test)","score_opus":0.10769722681379446,"score_gpt":0.4599834954670249,"score_spread":0.3522862686532304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366833427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928127,0.000056289868,0.000041674066,0.0026496334,0.0038874273,0.0002225356,0.000017474815,0.000017230408,0.00029505877],"genre_scores_gemma":[0.9977898,0.00041089163,0.000062233004,0.00010218997,0.0005877025,0.000005827286,0.000081445316,0.000012969219,0.0009469134],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995319,0.00033990073,0.00074521016,0.00023872181,0.0030830174,0.00027412863],"domain_scores_gemma":[0.9965506,0.00035583897,0.00015223982,0.00019864828,0.0025734736,0.00016919103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007062198,0.000084230014,0.00029767375,0.0015239392,0.00010106665,0.00017043938,0.00035069275,0.00009032785,0.00013008744],"category_scores_gemma":[0.0021396712,0.00006585271,0.00046490802,0.0009782454,0.00031638643,0.00031447835,0.000105421605,0.0005423788,0.00022036018],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000873801,0.00039125266,0.9334505,0.000008107888,0.00049873494,0.0001677245,0.00011126917,0.000036359885,0.000119150915,0.000113214395,0.010203457,0.054026403],"study_design_scores_gemma":[0.0031966388,0.0002627438,0.95668864,0.00009266398,0.000022882648,0.000025059582,0.00012556912,0.00019174212,0.000055777346,0.00052362646,0.038757592,0.000057086476],"about_ca_topic_score_codex":0.000010759629,"about_ca_topic_score_gemma":0.0000046650207,"teacher_disagreement_score":0.053969316,"about_ca_system_score_codex":0.00017569707,"about_ca_system_score_gemma":0.00034640037,"threshold_uncertainty_score":0.28323576},"labels":[],"label_agreement":null},{"id":"W4367552266","doi":"10.1093/ehjcvp/pvad032","title":"Antithrombotic treatment strategies in patients with established coronary atherosclerotic disease","year":2023,"lang":"en","type":"review","venue":"European Heart Journal - Cardiovascular Pharmacotherapy","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Abbott Vascular; St. Jude Medical; CytoSorbents Europe; Intas Pharmaceuticals; Idorsia Pharmaceuticals; Terumo; Sanofi; Abiomed; Eisai; Biosensors International Group; Medicure; InfraRedx; Medicines Company; Canada Excellence Research Chairs, Government of Canada; Osprey Medical; Novo Nordisk; Daiichi-Sankyo; Regeneron Pharmaceuticals; Boston Scientific Corporation; Bristol-Myers Squibb; Eli Lilly and Company; Biotronik; AstraZeneca; CSL Behring; Daiichi Sankyo Europe; Servier; Gilead Sciences; Bayer HealthCare; Cilag; Cardinal Health; Edwards Lifesciences; Amgen; Pfizer; Universität Basel","keywords":"Antithrombotic; Medicine; Intensive care medicine; Coronary artery disease; Terminology; Regimen; Fibrinolytic agent; Cardiology; Internal medicine","score_opus":0.07401050145086814,"score_gpt":0.3403840332688821,"score_spread":0.266373531818014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367552266","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012425193,0.9833776,0.00009875074,0.000018588407,0.00051686476,0.0030395864,0.000084548185,0.00023343289,0.0002054461],"genre_scores_gemma":[0.0020090635,0.99540323,0.00010094751,0.00014951797,0.0010797426,0.00005880682,0.00025274325,0.00070689135,0.00023907582],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99247086,0.0028660737,0.0011596751,0.0010310803,0.0015340532,0.0009382613],"domain_scores_gemma":[0.9971072,0.00010697806,0.0003134938,0.0013158337,0.00020594873,0.00095055945],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014026962,0.0012546126,0.0044030687,0.00073455845,0.0002647445,0.00036488415,0.00039244723,0.00014290497,0.0002419938],"category_scores_gemma":[0.000024121167,0.00085518934,0.007516617,0.0009792045,0.00020076589,0.00045056772,0.00005527059,0.0010346181,0.00051877525],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014011933,0.0017472561,0.007352949,0.007123766,0.050898325,0.014926766,0.00016257037,0.0010064818,0.0000018259179,0.0000042017127,0.0005459684,0.9148287],"study_design_scores_gemma":[0.013786641,0.00096868735,0.050585806,0.014278513,0.013078999,0.0009637796,0.000046033907,0.000004940281,7.6223427e-7,0.0000047547846,0.9053029,0.0009782205],"about_ca_topic_score_codex":0.000010477348,"about_ca_topic_score_gemma":7.2655547e-7,"teacher_disagreement_score":0.9138505,"about_ca_system_score_codex":0.000557875,"about_ca_system_score_gemma":0.0011726685,"threshold_uncertainty_score":0.9993899},"labels":[],"label_agreement":null},{"id":"W4375866806","doi":"10.1016/j.carrev.2023.05.001","title":"Outcomes with P2Y12 inhibitor monotherapy after PCI according to bleeding risk: A Bayesian meta-analysis","year":2023,"lang":"en","type":"review","venue":"Cardiovascular revascularization medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Abbott Vascular; MicroPort; Abiomed; Boston Scientific Corporation; Canada Excellence Research Chairs, Government of Canada; Medtronic; AstraZeneca; InfraRedx; Philips; St. Jude Medical; Amgen","keywords":"Medicine; Conventional PCI; Percutaneous coronary intervention; P2Y12; Internal medicine; Hazard ratio; Clopidogrel; Population; Adverse effect; Randomized controlled trial; Cardiology; Myocardial infarction; Confidence interval","score_opus":0.08937709783898613,"score_gpt":0.3436899220943788,"score_spread":0.2543128242553927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4375866806","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000059356138,0.86311173,0.13013254,0.00017298997,0.0003084193,0.005331881,0.0001272033,0.0006087231,0.00014716882],"genre_scores_gemma":[0.0004915188,0.9908015,0.0012547275,0.0005866767,0.0014185787,0.002835705,0.0010340288,0.0007256416,0.0008516244],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.988344,0.0016685886,0.0022858586,0.0027129801,0.0038269027,0.001161627],"domain_scores_gemma":[0.99231124,0.00039823243,0.00078619004,0.0046190256,0.00073484913,0.0011504622],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_narrow","metaepi_broad"],"category_scores_codex":[0.0045175673,0.0021786457,0.021006215,0.0034535872,0.0004085492,0.00015805548,0.0006504797,0.0009253847,0.00072307605],"category_scores_gemma":[0.00073188957,0.0013471383,0.04239998,0.009300292,0.00029255592,0.00026955022,0.00020953554,0.0011776158,0.00023907043],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013026851,0.000071188675,0.00062067,0.007175468,0.772539,0.0008443626,0.00016278877,0.00081611285,2.1558351e-7,0.000015702619,0.000101577214,0.2175226],"study_design_scores_gemma":[0.002130052,0.00018887573,0.00022004625,0.002194704,0.60931945,0.0002221951,0.00013435415,0.00003062557,0.000001094522,0.0000073642996,0.38463223,0.00091900723],"about_ca_topic_score_codex":0.00015125684,"about_ca_topic_score_gemma":0.000015852906,"teacher_disagreement_score":0.38453063,"about_ca_system_score_codex":0.0003879187,"about_ca_system_score_gemma":0.000447892,"threshold_uncertainty_score":0.9990954},"labels":[],"label_agreement":null},{"id":"W4375956159","doi":"10.1186/s43044-023-00364-3","title":"Boosting protection for patients with non-acute cardiovascular disease: a focus on antithrombotic regimen (a consensus expert opinion from the Egyptian Society of Cardiology working group of thrombosis and prevention)","year":2023,"lang":"en","type":"article","venue":"The Egyptian Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Egyptian Society of Cardiology","keywords":"Medicine; Antithrombotic; Aspirin; Regimen; Intensive care medicine; Expert opinion; Clopidogrel; Thrombosis; Canadian Cardiovascular Society; Rivaroxaban; Disease; Internal medicine; Warfarin; Atrial fibrillation","score_opus":0.05442505158440887,"score_gpt":0.29491449373894385,"score_spread":0.240489442154535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4375956159","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862575,0.0037718085,0.0057141506,0.0022396792,0.000265485,0.0016559601,0.000041543517,0.000035977904,0.000017878152],"genre_scores_gemma":[0.9955626,0.0027766763,0.00081623375,0.000118843454,0.00058242265,0.00006165589,0.00003315736,0.000040636005,0.000007736995],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99824584,0.00032126953,0.0003516779,0.00027705383,0.0005191625,0.00028498078],"domain_scores_gemma":[0.9988276,0.00020824563,0.00020772066,0.000477948,0.00015824489,0.00012023691],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008749017,0.0002005283,0.0006510134,0.000054114942,0.0004533354,0.000027292439,0.00011184527,0.000081769125,0.0000059374015],"category_scores_gemma":[0.0000499318,0.00011516701,0.0010497591,0.0002490772,0.00028364966,0.000054237866,0.000044706645,0.00026162335,0.0000015671177],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017896546,0.000954571,0.6759282,0.0011490062,0.1267543,0.000092000584,0.008958589,0.008170603,0.011298892,0.00014586173,0.017669532,0.13098195],"study_design_scores_gemma":[0.006775625,0.0017703524,0.9792525,0.0020787094,0.00228108,0.00012846134,0.0011425319,0.0008762696,0.00037872873,0.00048150285,0.004577339,0.00025688348],"about_ca_topic_score_codex":0.000038510447,"about_ca_topic_score_gemma":8.5272086e-7,"teacher_disagreement_score":0.30332437,"about_ca_system_score_codex":0.00003919463,"about_ca_system_score_gemma":0.00009436543,"threshold_uncertainty_score":0.46963742},"labels":[],"label_agreement":null},{"id":"W4376224474","doi":"10.1097/mjt.0000000000001622","title":"Strokes and Transient Ischemic Attacks Occurrence During Annual Dual Antiplatelet Therapy","year":2023,"lang":"en","type":"article","venue":"American Journal of Therapeutics","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Medicine; Ticagrelor; Aspirin; Clopidogrel; Acute coronary syndrome; Stroke (engine); Incidence (geometry); Internal medicine; Minor stroke; Platelet aggregation inhibitor; Cardiology; Post-hoc analysis; Myocardial infarction; Emergency medicine","score_opus":0.018429197309968635,"score_gpt":0.2841823769063218,"score_spread":0.2657531795963532,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376224474","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930577,0.0057520815,0.000117362106,0.00065267546,0.0001443804,0.000115063885,0.00005390721,0.000048087542,0.000058737303],"genre_scores_gemma":[0.97430503,0.024772644,0.00015567403,0.0004746669,0.00020721962,0.0000017039604,0.000007778355,0.000025299545,0.000049980907],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9985849,0.000092717055,0.0003738143,0.00018023048,0.00045064854,0.00031765352],"domain_scores_gemma":[0.999115,0.00007288743,0.00024346302,0.00020689052,0.00016892348,0.0001928693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031259513,0.00020309287,0.0005653036,0.00019769308,0.000095344985,0.000025471903,0.00011359824,0.000046853926,0.000023135808],"category_scores_gemma":[0.000009902791,0.00015676259,0.0003615546,0.00043675784,0.00036520584,0.0001318868,0.000019552253,0.00030198344,0.0000074532095],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007110299,0.0004277414,0.0738621,0.00010909218,0.0059125107,0.0017757581,0.0058846143,0.00018840462,0.10861539,0.000008304625,0.0018944627,0.7942113],"study_design_scores_gemma":[0.023568638,0.0085910475,0.6200976,0.0007087397,0.0018093857,0.014703219,0.022403365,0.00025664747,0.06726652,0.000038029782,0.23921883,0.0013380208],"about_ca_topic_score_codex":0.0000026167122,"about_ca_topic_score_gemma":1.6787506e-7,"teacher_disagreement_score":0.7928733,"about_ca_system_score_codex":0.000022250779,"about_ca_system_score_gemma":0.00009870308,"threshold_uncertainty_score":0.6392593},"labels":[],"label_agreement":null},{"id":"W4376628948","doi":"10.1016/j.amjcard.2023.03.012","title":"Ticagrelor as Compared to Clopidogrel Following Percutaneous Coronary Intervention for Acute Coronary Syndrome","year":2023,"lang":"en","type":"article","venue":"The American Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Manitoba; Seven Oaks General Hospital; Children's Hospital Research Institute of Manitoba; University of Manitoba","funders":"","keywords":"Ticagrelor; Acute coronary syndrome; Clopidogrel; Percutaneous coronary intervention; Medicine; Cardiology; Internal medicine; Myocardial infarction","score_opus":0.017127538926032304,"score_gpt":0.3129040872909838,"score_spread":0.2957765483649515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376628948","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929594,0.00097350247,0.0033112003,0.0015988068,0.0005944005,0.000412429,0.000018774903,0.00004909394,0.00008240115],"genre_scores_gemma":[0.99762744,0.00050164765,0.0003505299,0.0009640356,0.00028275617,0.000017188791,0.000024984762,0.000035657948,0.00019574806],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9984807,0.00029198,0.00042530807,0.00017932548,0.00028978652,0.00033294136],"domain_scores_gemma":[0.9988381,0.00029208587,0.0002264629,0.0003026599,0.00014281478,0.00019783541],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070905854,0.00016820405,0.0011136248,0.00017684173,0.000116338226,0.000010918571,0.00025371398,0.00004175256,0.000016490889],"category_scores_gemma":[0.00010123341,0.00011499498,0.001747847,0.00033198023,0.00022389714,0.00004671184,0.00006395084,0.00020337725,0.000084945576],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06743211,0.0002727759,0.0729064,0.00015887916,0.0930578,0.123002395,0.0021901734,0.007926862,0.023032423,0.0002499547,0.02216237,0.58760786],"study_design_scores_gemma":[0.0054162014,0.017556513,0.5337417,0.00034081572,0.0071590166,0.40861815,0.0055283615,0.00014818873,0.00010946936,0.0007995765,0.020157719,0.00042428696],"about_ca_topic_score_codex":0.0000053489534,"about_ca_topic_score_gemma":2.3591474e-7,"teacher_disagreement_score":0.5871836,"about_ca_system_score_codex":0.00006614044,"about_ca_system_score_gemma":0.000095910975,"threshold_uncertainty_score":0.46893594},"labels":[],"label_agreement":null},{"id":"W4377010778","doi":"10.1161/atvbaha.123.319156","title":"Presence of Peripheral Artery Disease Is Associated With Increased Risk of Heart Failure Events: Insights From EMPEROR-Pooled","year":2023,"lang":"en","type":"letter","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Heart failure; Emperor; Medicine; Internal medicine; Cardiology; History; Ancient history","score_opus":0.017632213078377087,"score_gpt":0.24161432254935403,"score_spread":0.22398210947097694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377010778","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9825343,0.0010428232,0.00007116489,0.013652866,0.00018463154,0.0007567039,0.0016658453,0.00008805965,0.0000036317226],"genre_scores_gemma":[0.95626986,0.005777476,0.00012915918,0.03432955,0.000648319,0.00011122262,0.0025999376,0.00012562121,0.000008875174],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99642426,0.0009137276,0.00069395517,0.00095930794,0.00054089224,0.00046788575],"domain_scores_gemma":[0.997593,0.0002972876,0.0005036583,0.0011066212,0.00026241603,0.00023701975],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022585927,0.00062644837,0.002180709,0.0002085711,0.00014488834,0.000022302143,0.00024330619,0.0008471787,0.00018284816],"category_scores_gemma":[0.00014168846,0.00047145042,0.0012607627,0.00032807534,0.0006052884,0.00010556986,0.0001228759,0.0006734409,0.000009931681],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002066094,0.000676343,0.81786567,0.00069788063,0.035359927,0.000011579244,0.0007940509,0.0000042818474,0.028233996,0.000005778003,0.116027474,0.00011639704],"study_design_scores_gemma":[0.0037009458,0.0007490181,0.9729958,0.0019022353,0.0056015546,8.4999226e-7,0.000122117,0.000048443115,0.00021567947,0.00010497384,0.014055039,0.0005033513],"about_ca_topic_score_codex":0.00054673746,"about_ca_topic_score_gemma":0.000054744676,"teacher_disagreement_score":0.1551301,"about_ca_system_score_codex":0.000043530654,"about_ca_system_score_gemma":0.00017247054,"threshold_uncertainty_score":0.99977374},"labels":[],"label_agreement":null},{"id":"W4377092737","doi":"10.1007/978-1-0716-3175-1_41","title":"Assessment of Platelet Function by High-Throughput Screening Light Transmission Aggregometry: Optimul Assay","year":2023,"lang":"en","type":"article","venue":"Methods in molecular biology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Platelet; Whole blood; Platelet aggregation; Adenosine diphosphate; Chemistry; Biomedical engineering; Medicine; Surgery; Internal medicine","score_opus":0.01896618853162275,"score_gpt":0.38550219216976833,"score_spread":0.3665360036381456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377092737","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0852384,0.0044581783,0.90891916,0.00035470634,0.00018328615,0.00032560254,0.000013731467,0.00009601044,0.00041090738],"genre_scores_gemma":[0.21464397,0.0015476785,0.782538,0.0004210429,0.00006342207,0.00005423757,0.0004593783,0.000058740294,0.00021353937],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99700165,0.001498999,0.00043608353,0.00047764383,0.00022608788,0.00035951613],"domain_scores_gemma":[0.99908733,0.00021486095,0.000121017256,0.00040686634,0.00006182943,0.0001080948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025106338,0.00022044416,0.00071219186,0.00038979316,0.000048822312,0.0000065859713,0.00012701047,0.00033078468,0.0001354532],"category_scores_gemma":[0.00014537948,0.0001879706,0.00037093976,0.000993176,0.00009643912,0.000034658,0.000054125667,0.00029452518,0.000004909984],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019027707,0.000100984136,0.00270335,0.00007305115,0.00049356,0.000120096374,0.000026024854,0.0003681651,0.698055,0.0005083051,0.00019432444,0.29716685],"study_design_scores_gemma":[0.008242233,0.0018772419,0.02316104,0.0003994485,0.00060159265,0.00009534345,0.00019616885,0.006489063,0.8436011,0.0037391796,0.1109408,0.00065678096],"about_ca_topic_score_codex":0.00003203771,"about_ca_topic_score_gemma":2.770466e-7,"teacher_disagreement_score":0.29651007,"about_ca_system_score_codex":0.000037403377,"about_ca_system_score_gemma":0.000059734448,"threshold_uncertainty_score":0.7665218},"labels":[],"label_agreement":null},{"id":"W4377093184","doi":"10.1007/s40256-023-00587-4","title":"Cost-Effectiveness and Budget Impact of a Novel Antithrombotic Drug Removal System to Reduce Bleeding Risk in Patients on Preoperative Ticagrelor Undergoing Cardiac Surgery","year":2023,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; St. Boniface Hospital","funders":"","keywords":"Medicine; Ticagrelor; Perioperative; Cohort; Cost effectiveness; Antithrombotic; Surgery; Anesthesia; Clopidogrel; Internal medicine; Aspirin","score_opus":0.015448452788350098,"score_gpt":0.28272705070754967,"score_spread":0.26727859791919956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377093184","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99559253,0.0024160878,0.00059913995,0.000023442417,0.00028504978,0.0009321702,0.000050156013,0.000032406013,0.00006901643],"genre_scores_gemma":[0.99754363,0.0019542903,0.000226592,0.000016777369,0.0001664761,0.000017659464,0.000009224376,0.0000618357,0.0000035290616],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99637073,0.0010136057,0.0006771313,0.00039554323,0.0011149285,0.0004280314],"domain_scores_gemma":[0.9974656,0.0008520984,0.0003930263,0.00047410975,0.00046215125,0.0003530301],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0037431347,0.00032919776,0.0024414142,0.00078174414,0.0000908056,0.00003229669,0.00012616182,0.000056720248,0.000001730937],"category_scores_gemma":[0.00047291518,0.00026343705,0.002990515,0.0014620253,0.00019736584,0.00017795298,0.00006115682,0.00033991388,0.0000059821796],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007675145,0.0006882803,0.57406604,0.0010525121,0.054005463,0.00086222315,0.0045477618,0.100013256,0.00070906134,0.000025076895,0.00030418977,0.25605097],"study_design_scores_gemma":[0.0051734066,0.0014628472,0.9788453,0.003568655,0.0028303463,0.00028359657,0.005770022,0.00026867673,0.0013122525,0.0000020209045,0.000104366765,0.00037854008],"about_ca_topic_score_codex":0.00027669338,"about_ca_topic_score_gemma":5.9072227e-7,"teacher_disagreement_score":0.40477923,"about_ca_system_score_codex":0.0004329872,"about_ca_system_score_gemma":0.0004231641,"threshold_uncertainty_score":0.99998176},"labels":[],"label_agreement":null},{"id":"W4378172688","doi":"10.1001/jamanetworkopen.2023.14428","title":"Effect of P2Y12 Inhibitors on Organ Support–Free Survival in Critically Ill Patients Hospitalized for COVID-19","year":2023,"lang":"en","type":"article","venue":"JAMA Network Open","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"National Heart, Lung, and Blood Institute; Abbott Vascular; Health Resources and Services Administration; University of Pittsburgh; Medical Center, University of Pittsburgh; National Institutes of Health; Celladon Corporation; Amgen; Alnylam Pharmaceuticals; Centers for Disease Control and Prevention; AstraZeneca; Eisai; American Heart Association","keywords":"Medicine; P2Y12; Ticagrelor; Intensive care unit; Randomized controlled trial; Clopidogrel; Internal medicine; Odds ratio; Clinical trial; Emergency medicine; Intensive care medicine; Myocardial infarction","score_opus":0.015175289552079252,"score_gpt":0.3125239180236928,"score_spread":0.29734862847161353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378172688","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925321,0.00009468263,0.000076634744,0.0019967803,0.0004759421,0.002954892,0.00010112751,0.0000759435,0.0016919202],"genre_scores_gemma":[0.99354184,0.000114627204,0.00008158829,0.004738881,0.0004105421,0.00022338935,0.00055754115,0.000058792666,0.00027280484],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979468,0.000403658,0.00040636514,0.0003662531,0.00043470185,0.00044225264],"domain_scores_gemma":[0.9980218,0.00080162194,0.00008248118,0.00054408563,0.00025673976,0.0002933022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022620994,0.00020728562,0.00075641467,0.00009606146,0.00008149176,0.000044579912,0.00037502442,0.00015769522,0.0002224041],"category_scores_gemma":[0.004228522,0.00016880852,0.00036051936,0.00054930174,0.00008059153,0.00011250513,0.0002250765,0.0001425334,0.00003738327],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019048331,0.00045459848,0.76792395,0.0008315652,0.0006774065,0.00026658247,0.00025906478,0.00043365735,0.00002701674,0.00054018997,0.17525056,0.034287076],"study_design_scores_gemma":[0.08605907,0.012891578,0.80723834,0.0011126791,0.00071253633,0.000008238828,0.00025377388,0.0002943281,0.0013199406,0.0015099811,0.08784987,0.0007496803],"about_ca_topic_score_codex":0.00007326944,"about_ca_topic_score_gemma":0.000012418083,"teacher_disagreement_score":0.08740069,"about_ca_system_score_codex":0.000074886906,"about_ca_system_score_gemma":0.00016021298,"threshold_uncertainty_score":0.6883812},"labels":[],"label_agreement":null},{"id":"W4380986772","doi":"10.1016/j.jtha.2023.05.027","title":"Multicenter evaluation of light transmission platelet aggregation reagents: communication from the ISTH SSC Subcommittee on Platelet Physiology","year":2023,"lang":"en","type":"article","venue":"Journal of Thrombosis and Haemostasis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"Institut National de la Santé et de la Recherche Médicale; International Society on Thrombosis and Haemostasis","keywords":"Platelet; Platelet aggregation; Medicine; Transmission (telecommunications); Internal medicine; Computer science; Telecommunications","score_opus":0.07152608859043708,"score_gpt":0.33808990125095384,"score_spread":0.26656381266051676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380986772","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98854154,0.004217888,0.00005749063,0.0066414354,0.00010235398,0.0003125363,0.000024477997,0.0000129565215,0.00008931357],"genre_scores_gemma":[0.9775637,0.021698564,0.00016183707,0.00034281248,0.00010494,0.000005576601,0.00009850256,0.000016824775,0.000007276946],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9981394,0.00046238172,0.00048439912,0.00014210926,0.000643575,0.00012813792],"domain_scores_gemma":[0.998575,0.00024396571,0.00040149476,0.00036233081,0.0003398328,0.00007738349],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011114704,0.00013832896,0.0004588814,0.000107237756,0.00015950191,0.000019517374,0.00014885515,0.00010545981,0.0001847068],"category_scores_gemma":[0.00009715915,0.000085631415,0.00033462088,0.00020750189,0.00008479797,0.00013311642,0.00002668171,0.0002147623,0.000009314828],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003648517,0.00073520414,0.005570094,0.00012391091,0.004016949,0.00001943345,0.0043985355,0.0003778053,0.04162307,0.00006843238,0.018463442,0.9209546],"study_design_scores_gemma":[0.016742043,0.0010040412,0.75926626,0.0021317431,0.0032254911,0.00006254381,0.002834999,0.003145599,0.1781718,0.0012460538,0.031873185,0.00029625642],"about_ca_topic_score_codex":0.000045001307,"about_ca_topic_score_gemma":0.000004595253,"teacher_disagreement_score":0.92065835,"about_ca_system_score_codex":0.00004533309,"about_ca_system_score_gemma":0.000054632656,"threshold_uncertainty_score":0.3491948},"labels":[],"label_agreement":null},{"id":"W4381192819","doi":"10.1161/circulationaha.123.064473","title":"Defining Strategies of Modulation of Antiplatelet Therapy in Patients With Coronary Artery Disease: A Consensus Document from the Academic Research Consortium","year":2023,"lang":"en","type":"review","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":165,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Duke Clinical Research Institute; National Institutes of Health; CytoSorbents Europe; Daiichi Sankyo Europe; Servier; National Evidence-based Healthcare Collaborating Agency; GlaxoSmithKline; Conselho Nacional de Desenvolvimento Científico e Tecnológico; Medicines Company; Canada Excellence Research Chairs, Government of Canada; Belvoir Media Group; Daiichi-Sankyo; AstraZeneca; Amarin Corporation; Boston Scientific Corporation; Intas Pharmaceuticals; Bristol-Myers Squibb; Eli Lilly and Company; CSL Behring; Alnylam Pharmaceuticals; MicroPort; Idorsia Pharmaceuticals; Abbott Vascular; Brigham and Women's Hospital; Kowa Company; Sanofi; Amgen; Pfizer","keywords":"Medicine; Percutaneous coronary intervention; Coronary artery disease; Acute coronary syndrome; Internal medicine; Cardiology; Myocardial infarction; Clopidogrel; Intensive care medicine; Disease","score_opus":0.08040670466419762,"score_gpt":0.36184171459077785,"score_spread":0.2814350099265802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381192819","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.45255807,0.5458474,0.000014404912,0.000010629028,0.000039788913,0.0013872447,0.000109766566,0.000018657525,0.000014015717],"genre_scores_gemma":[0.52206767,0.4767259,0.000007697465,0.0000043967507,0.000032377695,0.000048888603,0.0010783493,0.000032686916,0.0000020418258],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.996928,0.0006879241,0.0008298062,0.00039149346,0.0009202834,0.00024251603],"domain_scores_gemma":[0.9979167,0.00074138487,0.0004494917,0.0005478504,0.00027139072,0.00007321239],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079276285,0.0002628125,0.0011433329,0.00027885483,0.000068341506,0.000017134213,0.0001417099,0.00024182898,0.00002501654],"category_scores_gemma":[0.00009713984,0.00017305417,0.00036189237,0.00067031285,0.0002874719,0.0000918539,0.00003399342,0.00049290824,0.000009685746],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018519344,0.00022373522,0.34493256,0.005577289,0.002500168,0.00010256821,0.00033800135,0.0009999695,0.0000083604755,0.0007284561,0.00004277334,0.6426942],"study_design_scores_gemma":[0.0026818474,0.00013249181,0.97775793,0.015605472,0.0006719661,0.000007888291,0.0002232741,0.00008279041,0.0000013461416,0.0006287041,0.0020238995,0.00018237914],"about_ca_topic_score_codex":0.000050274193,"about_ca_topic_score_gemma":0.0000032953533,"teacher_disagreement_score":0.6425118,"about_ca_system_score_codex":0.00009408955,"about_ca_system_score_gemma":0.0007163411,"threshold_uncertainty_score":0.70569444},"labels":[],"label_agreement":null},{"id":"W4382192778","doi":"10.1016/j.jscai.2023.100719","title":"A-56 | Genotype vs Conventional Guided P2Y12 Inhibitor in Post-PCI Patients: A Meta-Analysis and Systematic Review","year":2023,"lang":"en","type":"article","venue":"Journal of the Society for Cardiovascular Angiography & Interventions","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Windsor","funders":"","keywords":"Conventional PCI; Meta-analysis; P2Y12; Internal medicine; Medicine; Oncology; Clopidogrel; Aspirin","score_opus":0.03650952584391327,"score_gpt":0.29591829635994155,"score_spread":0.2594087705160283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382192778","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013103342,0.97936195,0.0038072804,0.0010572129,0.0002511051,0.002165332,0.00020920191,0.000031389252,0.000013156143],"genre_scores_gemma":[0.9547963,0.040501386,0.0013924367,0.0018058773,0.0002730671,0.0005228069,0.00029216087,0.00008652399,0.00032942434],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99699134,0.00039942173,0.0012123064,0.00025205076,0.00088922144,0.00025565625],"domain_scores_gemma":[0.99764866,0.0001028044,0.00050409767,0.0006238565,0.0009922894,0.00012828852],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0033626822,0.00023919117,0.0024152505,0.00050654745,0.0001766512,0.000041522184,0.00024086048,0.00010191012,0.00004883979],"category_scores_gemma":[0.00031045347,0.00015146722,0.59061015,0.0026383915,0.00012306964,0.00015272699,0.00007681261,0.0002139642,0.0000031783713],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042136293,0.00019304457,0.00083858526,0.03275469,0.9618071,0.00000954386,0.00006791167,0.00005199751,0.0000033815315,0.000038959468,0.004149072,0.00004359414],"study_design_scores_gemma":[0.0022221894,0.00018730949,0.0059382683,0.007047288,0.98318887,0.00010027853,0.000282609,0.000007797623,0.000004594901,0.00013562836,0.000729501,0.00015568182],"about_ca_topic_score_codex":0.000022260989,"about_ca_topic_score_gemma":0.000007503101,"teacher_disagreement_score":0.94169295,"about_ca_system_score_codex":0.00006858163,"about_ca_system_score_gemma":0.000068801004,"threshold_uncertainty_score":0.6176654},"labels":[],"label_agreement":null},{"id":"W4382515202","doi":"10.1111/vcp.13226","title":"Extended sample storage for platelet function testing in healthy dogs","year":2023,"lang":"en","type":"article","venue":"Veterinary Clinical Pathology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"OVC Pet Trust","keywords":"Platelet; Preservative; Hematology analyzer; Medicine; Chemistry; Biomedical engineering; Internal medicine; Food science","score_opus":0.16970081369089096,"score_gpt":0.41336253078842466,"score_spread":0.2436617170975337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382515202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99429035,0.00042832852,0.003077146,0.00046998105,0.00076485844,0.0005891978,0.000043716518,0.00023987477,0.00009656703],"genre_scores_gemma":[0.99485147,0.00034412713,0.002002956,0.0019554596,0.00044078505,0.00012616764,0.00019261596,0.00003477539,0.00005161997],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9981093,0.00032303968,0.0005757225,0.00047572574,0.00011925062,0.00039700168],"domain_scores_gemma":[0.99780506,0.0015624699,0.000090359834,0.000339994,0.000055833832,0.00014627472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014332607,0.00014542257,0.00057760597,0.00015119344,0.000083240324,0.0000062279937,0.00007444025,0.00023746233,0.000042413856],"category_scores_gemma":[0.0014726137,0.00013495392,0.00034694746,0.0003579215,0.000118383505,0.000050621467,0.00005849544,0.0002724853,0.00007386136],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032954197,0.0014374754,0.09894941,0.0006442049,0.0003843685,0.012744891,0.00016663669,0.00014517417,0.008524529,0.00029401536,0.0019362518,0.84181887],"study_design_scores_gemma":[0.009703213,0.021678222,0.92183363,0.00008417097,0.00010172303,0.00096858747,0.00011665983,0.001305668,0.000014251279,0.0022290524,0.04171343,0.0002513838],"about_ca_topic_score_codex":0.000012389512,"about_ca_topic_score_gemma":0.0000026372581,"teacher_disagreement_score":0.84156746,"about_ca_system_score_codex":0.000028379733,"about_ca_system_score_gemma":0.00007295078,"threshold_uncertainty_score":0.5503261},"labels":[],"label_agreement":null},{"id":"W4383819892","doi":"10.1503/cmaj.230262","title":"Impact of body mass index on efficacy and safety of ticagrelor versus clopidogrel in patients with minor stroke or transient ischemic attack","year":2023,"lang":"en","type":"article","venue":"Canadian Medical Association Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"CAE (Canada)","funders":"National Key Research and Development Program of China; Chinese Academy of Medical Sciences; Capital Medical University","keywords":"Medicine; Ticagrelor; Clopidogrel; Aspirin; Stroke (engine); Internal medicine; Hazard ratio; Body mass index; Cardiology; Confidence interval","score_opus":0.009177431376101696,"score_gpt":0.2590643442136873,"score_spread":0.2498869128375856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4383819892","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987274,0.00006906441,0.000009643523,0.00052550493,0.00010193127,0.00018619128,0.0000852793,0.0000056792624,0.00028931865],"genre_scores_gemma":[0.9994283,0.00021750665,0.000010510291,0.00011646556,0.00010611009,0.0000015915372,0.000030894782,0.000012347283,0.00007630181],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981809,0.00008274489,0.00034012937,0.00011702041,0.0009968072,0.00028239714],"domain_scores_gemma":[0.99868596,0.00017773153,0.00014031302,0.00008972988,0.00017573882,0.0007305431],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048700444,0.00010638943,0.00035691593,0.00023810557,0.000041481584,0.0000067680335,0.000064648855,0.00018012982,0.0004456593],"category_scores_gemma":[0.0005119298,0.00007268203,0.00015864323,0.00031417861,0.000054714536,0.000040211886,0.0000039324436,0.00036543087,0.000006021885],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006567791,0.00013193344,0.96765465,0.000030284107,0.0011416827,0.00019233047,0.00017159079,0.000059857954,0.000016562979,0.0000022331453,0.0042072805,0.019823788],"study_design_scores_gemma":[0.018567443,0.0011643425,0.97671145,0.00022590773,0.00010917267,0.000011293695,0.000098179014,0.000094503084,0.0000114474005,3.4536757e-7,0.0029311648,0.00007477417],"about_ca_topic_score_codex":0.00026603145,"about_ca_topic_score_gemma":0.0006402949,"teacher_disagreement_score":0.019749014,"about_ca_system_score_codex":0.00039792783,"about_ca_system_score_gemma":0.0014411518,"threshold_uncertainty_score":0.48796567},"labels":[],"label_agreement":null},{"id":"W4384925211","doi":"10.1038/s41569-023-00901-2","title":"De-escalation or abbreviation of dual antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention: a Consensus Statement from an international expert panel on coronary thrombosis","year":2023,"lang":"en","type":"review","venue":"Nature Reviews Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Percutaneous coronary intervention; Statement (logic); Cardiology; Coronary thrombosis; Internal medicine; Acute coronary syndrome; Thrombosis; Intensive care medicine; Myocardial infarction","score_opus":0.10874409062139605,"score_gpt":0.4106483105576855,"score_spread":0.30190421993628946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384925211","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.063675694,0.9318422,0.00002286165,0.00010734741,0.0007122755,0.0027998881,0.0007244419,0.00007652433,0.000038780283],"genre_scores_gemma":[0.01901153,0.97444046,0.00026674216,0.00034495967,0.00033754794,0.00027336713,0.005154373,0.000105804356,0.00006524128],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99443376,0.0020434272,0.0016875849,0.0009792504,0.0004714443,0.0003845475],"domain_scores_gemma":[0.99763864,0.0005745386,0.0007608009,0.00072229456,0.00013670108,0.00016702896],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011658487,0.0007380707,0.0046717064,0.0004115599,0.00006707678,0.000024857694,0.00026686297,0.0012352508,0.00023879796],"category_scores_gemma":[0.00016317406,0.0005257532,0.0015887722,0.0003347682,0.00020693408,0.00011205493,0.00011169333,0.0010538099,0.000028100916],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015997658,0.00024141991,0.0022704836,0.0032117884,0.007723488,0.0059144567,0.00014704137,0.0000059782305,0.000022663306,0.000033182027,0.0006358923,0.9781938],"study_design_scores_gemma":[0.0042885807,0.0032660607,0.074034676,0.031759534,0.004254293,0.033639576,0.00018834653,0.000042937052,0.000003518313,0.00009083117,0.8474953,0.0009363495],"about_ca_topic_score_codex":0.000031373882,"about_ca_topic_score_gemma":0.000009182623,"teacher_disagreement_score":0.9772575,"about_ca_system_score_codex":0.00035432162,"about_ca_system_score_gemma":0.00031705518,"threshold_uncertainty_score":0.9997194},"labels":[],"label_agreement":null},{"id":"W4385196239","doi":"10.1111/vcp.13265","title":"Validation of storage and shipping of feline blood samples for analysis on the Platelet Function Analyzer‐200 for determining the effect of clopidogrel","year":2023,"lang":"en","type":"article","venue":"Veterinary Clinical Pathology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"OVC Pet Trust","keywords":"CATS; Clopidogrel; Medicine; Platelet; Whole blood; Anesthesia; Internal medicine; Aspirin","score_opus":0.10092332384531501,"score_gpt":0.38325000606612336,"score_spread":0.28232668222080837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385196239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99444854,0.00025655248,0.004305916,0.00012583479,0.000102818856,0.00064639165,0.00009300178,0.000016559785,0.000004410033],"genre_scores_gemma":[0.99916786,0.00023157016,0.00017472456,0.00007032068,0.00011879753,0.00005999847,0.00015613722,0.000012942261,0.000007641613],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99844,0.00051115383,0.00056894956,0.00023145563,0.000119267745,0.00012915458],"domain_scores_gemma":[0.9946365,0.004636753,0.00029138074,0.00031748947,0.00008755401,0.000030336894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025414408,0.00011069591,0.0007102515,0.00013954367,0.000068294925,0.00000288195,0.00007953622,0.00012023547,0.0000096555395],"category_scores_gemma":[0.00093434367,0.00006309721,0.00075627386,0.0003114014,0.00022660002,0.000020974938,0.0000361708,0.00009104431,3.9599084e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.038644034,0.0007110534,0.6438653,0.0022306112,0.015944498,0.000100858226,0.00044978462,0.0020699634,0.054334637,0.0002482235,0.00019772064,0.24120334],"study_design_scores_gemma":[0.009669474,0.045286488,0.91697156,0.00018178196,0.010611474,0.000052011157,0.0002155696,0.0041244766,0.011720781,0.00023298299,0.0007488361,0.0001845346],"about_ca_topic_score_codex":0.0000018222506,"about_ca_topic_score_gemma":4.7113218e-7,"teacher_disagreement_score":0.2731063,"about_ca_system_score_codex":0.0000034205157,"about_ca_system_score_gemma":0.00001353118,"threshold_uncertainty_score":0.25730297},"labels":[],"label_agreement":null},{"id":"W4385442413","doi":"10.34067/kid.0000000000000223","title":"Early Discontinuation of Aspirin Among Patients with Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention with a Drug-Eluting Stent: A Meta-Analysis","year":2023,"lang":"en","type":"review","venue":"Kidney360","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Daiichi Sankyo Europe; Bristol-Myers Squibb Canada; Servier; Pfizer","keywords":"Medicine; Aspirin; Percutaneous coronary intervention; Discontinuation; Drug-eluting stent; Kidney disease; Internal medicine; Drug; Stent; Cardiology; Coronary artery disease; Surgery; Myocardial infarction; Pharmacology","score_opus":0.03321916915819497,"score_gpt":0.28400577954766537,"score_spread":0.2507866103894704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385442413","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02156348,0.9743855,0.00039449174,0.000029086967,0.00006121134,0.0026358585,0.00071906275,0.00015673703,0.000054543623],"genre_scores_gemma":[0.15528701,0.8331095,0.00008961065,0.000060864222,0.00014742864,0.00043510055,0.008078157,0.00030400298,0.0024882958],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9960593,0.0003921953,0.0010455872,0.00089371233,0.0011553781,0.0004538039],"domain_scores_gemma":[0.99683195,0.00015430563,0.0010543773,0.0009760722,0.00026499986,0.00071828713],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004370191,0.0007330246,0.0042171516,0.0006508778,0.000119382115,0.0000668767,0.00024364829,0.00016244898,0.00023673769],"category_scores_gemma":[0.00016475139,0.00046629753,0.006464198,0.0013898587,0.00020075777,0.00022166745,0.00010090901,0.00038523905,0.000031730822],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008724204,0.0009252353,0.014227951,0.046367306,0.7837262,0.0011438781,0.0002053469,0.00012515552,2.1955888e-7,0.000019110097,0.00012638682,0.15226075],"study_design_scores_gemma":[0.0024669764,0.00079084904,0.011003064,0.020276882,0.95240086,0.00004869378,0.000056165965,0.000050531748,5.4495655e-7,0.0000056457957,0.012222011,0.0006777671],"about_ca_topic_score_codex":0.00015300701,"about_ca_topic_score_gemma":0.00011212746,"teacher_disagreement_score":0.16867463,"about_ca_system_score_codex":0.000262906,"about_ca_system_score_gemma":0.001065625,"threshold_uncertainty_score":0.99977887},"labels":[],"label_agreement":null},{"id":"W4385803814","doi":"10.1016/j.jacc.2023.05.062","title":"Bleeding and Ischemic Risks of Ticagrelor Monotherapy After Coronary Interventions","year":2023,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact; Hamilton Health Sciences","funders":"Abbott Vascular; Idorsia Pharmaceuticals; Centro Nacional de Investigaciones Cardiovasculares; Eisai; InfraRedx; Osprey Medical; Sociedad Española de Cardiología; Boston Scientific Corporation; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; CSL Behring; Janssen Pharmaceuticals; Gilead Sciences; Sanofi; Daiichi-Sankyo; AstraZeneca Mölndal; Amgen; Pfizer","keywords":"Medicine; Ticagrelor; Cardiology; Psychological intervention; Internal medicine; Intensive care medicine; Acute coronary syndrome; Myocardial infarction","score_opus":0.03744651996633993,"score_gpt":0.3252631174177055,"score_spread":0.2878165974513656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385803814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936835,0.0047454066,0.0003084648,0.00068670267,0.00015517704,0.00012025863,0.000045102806,0.000006272277,0.0002491251],"genre_scores_gemma":[0.995223,0.0042222934,0.00016684509,0.00010660932,0.00015389893,0.0000036612553,6.788876e-7,0.000013372982,0.00010964017],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990432,0.00015141348,0.0004083676,0.0000852949,0.0001876173,0.00012408286],"domain_scores_gemma":[0.99903256,0.0001262921,0.0004342711,0.00019863257,0.00014666379,0.000061593935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041021683,0.00008964528,0.0007782622,0.00015285167,0.000028064098,0.0000013157916,0.00012148128,0.000036993733,0.000018918896],"category_scores_gemma":[0.00007748736,0.000058433016,0.00106313,0.0003320235,0.00052528176,0.00003435574,0.000056102588,0.00015035774,0.0000011067127],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013332018,0.0001711241,0.845792,0.0005033517,0.016409403,0.0014654581,0.00028559737,0.00078034826,0.05308867,0.00016010196,0.016324868,0.051687073],"study_design_scores_gemma":[0.0026904778,0.0015214122,0.97694325,0.0003210864,0.0015262653,0.0039632134,0.0015249252,0.000045548742,0.0032360016,0.00020434851,0.007911273,0.00011217558],"about_ca_topic_score_codex":0.0000029763858,"about_ca_topic_score_gemma":2.906818e-7,"teacher_disagreement_score":0.13115129,"about_ca_system_score_codex":0.000018459636,"about_ca_system_score_gemma":0.00007634862,"threshold_uncertainty_score":0.23828292},"labels":[],"label_agreement":null},{"id":"W4385872167","doi":"10.1101/2023.08.12.23294021","title":"The efficacy and safety of the prasugrel, ticagrelor, and clopidogrel dual antiplatelet therapies following an acute coronary syndrome: A systematic review and Bayesian network meta-analysis","year":2023,"lang":"en","type":"review","venue":"medRxiv","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Ticagrelor; Prasugrel; Medicine; Clopidogrel; Acute coronary syndrome; Randomized controlled trial; Internal medicine; Myocardial infarction; Clinical endpoint; Alogliptin; Intensive care medicine","score_opus":0.051489156880898224,"score_gpt":0.3236046628805077,"score_spread":0.2721155059996095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385872167","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0030329104,0.99191517,0.000027063576,0.00026911887,0.00009989768,0.004517494,0.00006883354,0.0000610936,0.000008447331],"genre_scores_gemma":[0.0047741844,0.9943128,0.000045893466,0.00018933376,0.000041783704,0.00023274047,0.00005826858,0.00009876067,0.0002461945],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9946349,0.0020932248,0.0014468076,0.0007212559,0.0006704111,0.000433387],"domain_scores_gemma":[0.995993,0.0014433395,0.0007551407,0.001510795,0.0000721168,0.00022556268],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0033449875,0.0007188024,0.008877452,0.00013362714,0.0005044913,0.000084114276,0.00034068688,0.0002563716,0.000018600249],"category_scores_gemma":[0.0002533385,0.00031910324,0.0039569153,0.0013527697,0.00042250997,0.00009179007,0.00023446608,0.0004522249,0.000003737275],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051867435,0.000044235105,0.00045120917,0.3154747,0.6729342,0.00049727526,0.00010241154,8.1445046e-7,1.5845292e-7,0.000090274065,0.000042106967,0.010310788],"study_design_scores_gemma":[0.0005472985,0.00017397995,0.0021672442,0.058954887,0.9270142,0.0019955814,0.000044087872,0.000010042177,6.024103e-8,0.00002638294,0.008717988,0.00034828266],"about_ca_topic_score_codex":0.00000509366,"about_ca_topic_score_gemma":0.000007232007,"teacher_disagreement_score":0.2565198,"about_ca_system_score_codex":0.000019442781,"about_ca_system_score_gemma":0.00012088362,"threshold_uncertainty_score":0.9999261},"labels":[],"label_agreement":null},{"id":"W4385952725","doi":"10.7759/cureus.43611","title":"An Analysis of the Effect of Stroke on Health-Related Quality of Life of Older Adults With Coronary Heart Disease Who Take Aspirin","year":2023,"lang":"en","type":"article","venue":"Cureus","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Medical Association","funders":"","keywords":"Medicine; Aspirin; Quality of life (healthcare); Stroke (engine); Coronary heart disease; Logistic regression; Mental health; Disease; Gerontology; Internal medicine; Physical therapy; Psychiatry","score_opus":0.014577287663218717,"score_gpt":0.2944272754112048,"score_spread":0.2798499877479861,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385952725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99568176,0.0031086297,0.000014113163,0.00020230497,0.000032287317,0.000572699,0.0003367476,0.000024922367,0.000026530957],"genre_scores_gemma":[0.99952483,0.00014887103,0.0000043278574,0.000104248145,0.000013362915,0.000011585536,0.00013398717,0.000016382026,0.0000423759],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99795485,0.000547603,0.0005446162,0.00022044405,0.00057950616,0.00015299229],"domain_scores_gemma":[0.99834484,0.00016792025,0.0003392001,0.00084014545,0.00011340011,0.00019451194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006718683,0.00013986164,0.0010935777,0.00012431895,0.000030864514,0.0000013078871,0.00012636131,0.000059204904,0.000060540202],"category_scores_gemma":[0.00012449805,0.00008498504,0.0007064585,0.0007700786,0.00019276925,0.000033568314,0.00002252499,0.0000952803,0.0000011395098],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009593053,0.00044860019,0.97847754,0.0012642953,0.0048499843,0.000007984628,0.0004577489,0.0021238036,0.000600867,0.000030401208,0.0001289927,0.0020167392],"study_design_scores_gemma":[0.0033153153,0.0019341537,0.98969984,0.0005582776,0.001740886,7.860865e-7,0.00024496188,0.00029352694,0.002124928,0.0000028142297,0.000014222018,0.00007028436],"about_ca_topic_score_codex":0.00041487475,"about_ca_topic_score_gemma":0.000054804274,"teacher_disagreement_score":0.011222314,"about_ca_system_score_codex":0.000018480945,"about_ca_system_score_gemma":0.00015583482,"threshold_uncertainty_score":0.34655893},"labels":[],"label_agreement":null},{"id":"W4386231015","doi":"10.1161/strokeaha.123.043626","title":"Is There Still a Role for Dual Antiplatelet Therapy in the Secondary Prevention of Lacunar Stroke?","year":2023,"lang":"en","type":"letter","venue":"Stroke","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Population Health Research Institute","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Lacunar stroke; Stroke (engine); Population; Internal medicine; Neurology; Thrombosis; Physical therapy; Cardiology; Intensive care medicine; Surgery; Ischemic stroke; Ischemia; Psychiatry","score_opus":0.02507968985484752,"score_gpt":0.28124248700879523,"score_spread":0.2561627971539477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386231015","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8566884,0.021982644,0.00014388525,0.10729312,0.00064920395,0.0047759614,0.005769204,0.00016733192,0.0025302456],"genre_scores_gemma":[0.57196903,0.017540457,0.0003562801,0.34359276,0.01028605,0.0012654257,0.0063635847,0.00062836875,0.04799805],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976278,0.00024388223,0.0004824019,0.00048366384,0.00069586997,0.0004664026],"domain_scores_gemma":[0.99862534,0.00023597138,0.00022991,0.00075276295,0.000114601506,0.000041398696],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005903301,0.00039052343,0.0008885184,0.00023198745,0.00006213349,0.000031326323,0.00028601443,0.0006355545,0.0003448499],"category_scores_gemma":[0.000028958157,0.00027048052,0.0014336423,0.00019633111,0.00011922966,0.00007319607,0.000033755274,0.0010830883,0.000030274456],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020578688,0.0003436594,0.0034900173,0.0012292139,0.005921696,0.001124633,0.0018936087,0.000005347324,0.0013662492,0.000025283749,0.8785874,0.103955016],"study_design_scores_gemma":[0.0065188976,0.0013334714,0.009703547,0.0004262809,0.00060515024,0.00009275643,0.0009514451,0.000026168644,0.0020057308,0.0004932352,0.9775032,0.00034012186],"about_ca_topic_score_codex":0.000047928006,"about_ca_topic_score_gemma":0.000011234871,"teacher_disagreement_score":0.28471938,"about_ca_system_score_codex":0.0000326148,"about_ca_system_score_gemma":0.00024533508,"threshold_uncertainty_score":0.9999747},"labels":[],"label_agreement":null},{"id":"W4386270680","doi":"10.1016/j.cjco.2023.08.011","title":"Aspirin for the Primary Prevention of Vascular Ischemic Events: An Updated Systematic Review and Meta-analysis to Support Shared Decision-Making","year":2023,"lang":"en","type":"review","venue":"CJC Open","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Institut universitaire de cardiologie et de pneumologie de Québec; Institut Universitaire de Gériatrie de Montréal; Montreal Heart Institute; Université de Montréal; University of Alberta; Population Health Research Institute; Canadian VIGOUR Centre; McMaster University","funders":"Fonds de Recherche du Québec - Santé; Canadian Cancer Society; Canadian Cardiovascular Society; Heart and Stroke Foundation of Canada","keywords":"Aspirin; Primary prevention; Medicine; Primary (astronomy); Computer science; Psychology; Internal medicine","score_opus":0.1140757090134647,"score_gpt":0.4198410865985542,"score_spread":0.3057653775850895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386270680","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000045013157,0.9784918,0.0026926142,0.000031569114,0.000023874194,0.018346565,0.00033333298,0.000027887645,0.000047882757],"genre_scores_gemma":[0.000012030214,0.992082,0.0007843292,0.00047759537,0.000025140685,0.0034252894,0.0022321697,0.000082921644,0.00087854435],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9966802,0.00049592345,0.0014380561,0.0006444765,0.0005249483,0.00021637404],"domain_scores_gemma":[0.99680114,0.0003589824,0.000716019,0.0017564964,0.0002273965,0.00013999264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036823712,0.00041993792,0.010385614,0.00023293424,0.0000975012,0.00007143734,0.00086596847,0.00015521576,0.0006438581],"category_scores_gemma":[0.0003395582,0.00022942097,0.0066877697,0.0011655082,0.00002475821,0.00017564636,0.0003770303,0.00013868738,0.00003959986],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026419362,0.00006039774,3.3957866e-7,0.5404024,0.41545218,0.000010930437,0.0000141801065,0.0000015493027,1.4233817e-7,0.0000049583873,0.0011676382,0.042858884],"study_design_scores_gemma":[0.0002727254,0.00010701237,0.0000050784765,0.07592197,0.8183153,0.000034844754,0.00001676685,0.000002749397,2.6237393e-7,0.00001964027,0.10510284,0.0002007704],"about_ca_topic_score_codex":0.000006564528,"about_ca_topic_score_gemma":0.000005100354,"teacher_disagreement_score":0.46448043,"about_ca_system_score_codex":0.00005882919,"about_ca_system_score_gemma":0.0002766304,"threshold_uncertainty_score":0.9355516},"labels":[],"label_agreement":null},{"id":"W4386271450","doi":"10.1177/10406387231197440","title":"Investigation of Platelet Function Analyzer 200 platelet function measurements in healthy cats and cats receiving clopidogrel","year":2023,"lang":"en","type":"article","venue":"Journal of Veterinary Diagnostic Investigation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"OVC Pet Trust","keywords":"CATS; Clopidogrel; Platelet; Medicine; Hemostasis; Whole blood; Internal medicine; Nuclear medicine; Cardiology; Aspirin","score_opus":0.06988580737723729,"score_gpt":0.2906344879353781,"score_spread":0.22074868055814081,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386271450","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958217,0.0022240332,0.000288917,0.00064070115,0.0005378415,0.0004181577,0.0000070067467,0.000037574817,0.000024024412],"genre_scores_gemma":[0.9967407,0.0021109877,0.00026212388,0.0004288578,0.00028609246,0.00001774845,0.00010837234,0.000031839125,0.000013299234],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99747473,0.00034384936,0.0009556036,0.0002613904,0.0006937973,0.0002706427],"domain_scores_gemma":[0.9981691,0.0003825248,0.00063854083,0.00019506911,0.0003390469,0.00027568443],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015924759,0.00022199731,0.00055425643,0.00076495326,0.000104363775,0.000025535686,0.00007162793,0.00017981823,0.000028438011],"category_scores_gemma":[0.0007558585,0.00021140519,0.00017936694,0.00086443103,0.00015312147,0.00050501805,0.000029466264,0.00031784372,0.000011354428],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005963709,0.00015601306,0.87516934,0.0011878592,0.0008907204,0.00049017,0.0016843134,0.0019188345,0.061915684,0.000038157177,0.0021300432,0.04845517],"study_design_scores_gemma":[0.0042059924,0.004411806,0.9826867,0.0014873608,0.0003465639,0.00065369706,0.00030869752,0.0004692803,0.0037145326,0.0010166047,0.00049389875,0.00020484057],"about_ca_topic_score_codex":0.00006476882,"about_ca_topic_score_gemma":0.000010201932,"teacher_disagreement_score":0.1075174,"about_ca_system_score_codex":0.00015790632,"about_ca_system_score_gemma":0.00028419207,"threshold_uncertainty_score":0.86208534},"labels":[],"label_agreement":null},{"id":"W4386362030","doi":"10.1371/journal.pone.0291061","title":"Short dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk patients: Systematic review and meta-analysis","year":2023,"lang":"en","type":"review","venue":"PLoS ONE","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Horizon Health Network; University of British Columbia; Canadian Heart Research Centre; Montreal Heart Institute; Université de Montréal; University of Alberta","funders":"Canadian Cardiovascular Society","keywords":"Medicine; Percutaneous coronary intervention; Mace; Conventional PCI; Internal medicine; Relative risk; Randomized controlled trial; Meta-analysis; Stent; Confidence interval; Cardiology; Surgery; Myocardial infarction","score_opus":0.10114432370517976,"score_gpt":0.3020283045713167,"score_spread":0.20088398086613693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386362030","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015897507,0.9779703,0.000007677023,0.000019742345,0.000020783315,0.005684069,0.00030587256,0.000088917244,0.0000051331463],"genre_scores_gemma":[0.011434474,0.9854629,0.000043070162,0.00010378215,0.000045183413,0.0012157134,0.0013952199,0.00009750056,0.00020218123],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9955468,0.0010076676,0.0017093827,0.00067616976,0.0007823649,0.00027758238],"domain_scores_gemma":[0.99831253,0.00018694758,0.0005356245,0.00066205446,0.0001800049,0.0001228143],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011316708,0.0005866007,0.009591346,0.000557218,0.000064370164,0.000053213178,0.000113924725,0.000272548,0.00031701723],"category_scores_gemma":[0.0001938109,0.0004013292,0.004171531,0.00097005814,0.00004745657,0.00013991912,0.000063434025,0.00042748006,0.00006330922],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055966404,0.00070388324,0.0002782149,0.56211203,0.4304798,0.00043968853,0.000024998208,2.2201863e-7,1.3996558e-7,8.5266424e-7,0.0000049612695,0.005899242],"study_design_scores_gemma":[0.0003917227,0.00018366684,0.0003885693,0.11521458,0.88321424,0.00012821292,0.000014183975,0.000006631927,5.2940294e-7,0.000004023709,0.00011618431,0.0003374702],"about_ca_topic_score_codex":0.00002367078,"about_ca_topic_score_gemma":0.000011971923,"teacher_disagreement_score":0.45273444,"about_ca_system_score_codex":0.00011839154,"about_ca_system_score_gemma":0.000031867123,"threshold_uncertainty_score":0.99984384},"labels":[],"label_agreement":null},{"id":"W4386401790","doi":"10.1016/j.cjca.2023.08.028","title":"P2Y12 Inhibitor Loading Time Before Elective PCI and the Prevention of Myocardial Necrosis","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"AstraZeneca France; Assistance Publique - Hôpitaux de Paris; AstraZeneca","keywords":"Medicine; Conventional PCI; P2Y12; Cardiology; Necrosis; Internal medicine; Myocardial infarction; Percutaneous coronary intervention","score_opus":0.008599058663477996,"score_gpt":0.22940291316199943,"score_spread":0.22080385449852144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386401790","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936851,0.003247845,0.000241973,0.0007875069,0.0003161474,0.00020609362,0.000016664188,0.000007305437,0.0014913637],"genre_scores_gemma":[0.9984057,0.00033395126,0.000015288384,0.00008596275,0.0009436058,0.0000036321146,0.000008054122,0.000013181923,0.00019064492],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99904805,0.00024173482,0.00026201282,0.000096925614,0.00013116213,0.00022012195],"domain_scores_gemma":[0.999232,0.000080830956,0.0001264469,0.00012943114,0.00018238174,0.00024893554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080330303,0.000092190225,0.000610813,0.00022772422,0.00009174496,0.000009854301,0.00007149076,0.0001011126,0.0000148911195],"category_scores_gemma":[0.00020870789,0.00006346038,0.0006249924,0.00023224864,0.0003589087,0.00005425709,0.000010247213,0.00018057221,0.000008970438],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012543016,0.00003195705,0.35617736,0.00053508073,0.04763194,0.0038901703,0.010605971,0.004331715,0.023005322,0.004992964,0.1259481,0.4103064],"study_design_scores_gemma":[0.036589596,0.0045420667,0.71718776,0.000989634,0.0076395315,0.013878678,0.0027685906,0.00028804838,0.0048703086,0.01586577,0.19467953,0.0007005077],"about_ca_topic_score_codex":0.00011897431,"about_ca_topic_score_gemma":0.00006124342,"teacher_disagreement_score":0.4096059,"about_ca_system_score_codex":0.000055870947,"about_ca_system_score_gemma":0.0006170554,"threshold_uncertainty_score":0.2587839},"labels":[],"label_agreement":null},{"id":"W4386591759","doi":"10.1017/cjn.2023.287","title":"Dual Antiplatelet Therapy in Minor Stroke/Transient Ischemic Attack – An Updated Network Meta-Analysis","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Ottawa Public Health; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Ticagrelor; Aspirin; Clopidogrel; CYP2C19; Minor stroke; Medicine; Stroke (engine); Population; Internal medicine; Randomized controlled trial; Cardiology; Hazard ratio; Confidence interval","score_opus":0.09220958034397309,"score_gpt":0.31112850113821333,"score_spread":0.21891892079424025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386591759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906236,0.0047514136,0.000016126154,0.0030508898,0.00035515777,0.0002445368,0.0000310756,0.00003906954,0.0008881487],"genre_scores_gemma":[0.9941061,0.0015059685,0.00047254132,0.0035360146,0.0002883181,0.000004600791,0.0000062278446,0.000016912274,0.000063288346],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9938479,0.0014375817,0.001080219,0.00073451566,0.0011547625,0.00174502],"domain_scores_gemma":[0.99633837,0.0002773716,0.0005268667,0.00027827467,0.0003809551,0.0021981439],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":["sts"],"category_scores_codex":[0.0065900576,0.00043157418,0.0015579049,0.001977264,0.0014415839,0.00046444815,0.0012108915,0.0002493906,0.0007354886],"category_scores_gemma":[0.0003113521,0.00027200498,0.0017499542,0.0056217983,0.003492057,0.00089026784,0.0000402248,0.0011804535,0.00000742985],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006569453,0.00011374394,0.85462683,0.0000064358123,0.00725763,0.040312503,0.00044671432,0.088217326,0.00015969307,0.0000670843,0.005247333,0.0028877372],"study_design_scores_gemma":[0.0026184365,0.09686532,0.8033909,0.000023206243,0.017359588,0.038489383,0.0007687075,0.007990468,0.00028861224,0.0011326697,0.029973753,0.0010989225],"about_ca_topic_score_codex":0.0008519776,"about_ca_topic_score_gemma":0.034397863,"teacher_disagreement_score":0.09675158,"about_ca_system_score_codex":0.000111659996,"about_ca_system_score_gemma":0.0021737332,"threshold_uncertainty_score":0.99997324},"labels":[],"label_agreement":null},{"id":"W4386596079","doi":"10.2196/47475","title":"Digital Tool-Assisted Hospitalization Detection in the Tailored Antiplatelet Initiation to Lessen Outcomes due to Decreased Clopidogrel Response After Percutaneous Coronary Intervention Study Compared to Traditional Site-Coordinator Ascertainment: Intervention Study","year":2023,"lang":"en","type":"article","venue":"Journal of Medical Internet Research","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; St. Michael's Hospital; Université de Montréal; University of Ottawa; Montreal Heart Institute","funders":"National Heart, Lung, and Blood Institute; National Institute of Biomedical Imaging and Bioengineering; Aurora Research Institute; Greenville Health System; Sunnybrook Research Institute; NYU Langone Medical Center; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Conventional PCI; Percutaneous coronary intervention; Clopidogrel; Medicine; Intervention (counseling); Clinical trial; Emergency medicine; Medical emergency; Telehealth; Telemedicine; Internal medicine; Aspirin; Myocardial infarction; Nursing; Health care","score_opus":0.05133750389744511,"score_gpt":0.37639803804133587,"score_spread":0.32506053414389074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386596079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914107,0.00007586428,0.0020753355,0.0034827318,0.0003219405,0.0025541615,0.000025480342,0.000039980707,0.000013859963],"genre_scores_gemma":[0.99889976,0.000012395579,0.000016615364,0.00037340002,0.0002003163,0.00022476653,0.000091279144,0.000036825917,0.00014464553],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9914208,0.0024197148,0.0012008405,0.00042775663,0.0040977197,0.00043314975],"domain_scores_gemma":[0.99750435,0.00081390224,0.00016042944,0.00035233927,0.0006503261,0.0005186777],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009329353,0.00024800713,0.000637405,0.0015298236,0.00010892718,0.00028769873,0.00050349167,0.00015165964,0.00035558396],"category_scores_gemma":[0.004038641,0.0001807312,0.0004963793,0.0015929864,0.0000713049,0.00032652894,0.00020486151,0.00073648867,0.00013143693],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11551323,0.02091275,0.5743452,0.00020733279,0.002396116,0.044391617,0.022214212,0.0002432186,0.0010362897,0.000012901824,0.0042978157,0.21442933],"study_design_scores_gemma":[0.0064502275,0.011539719,0.96190757,0.00082260417,0.0001251304,0.0012951839,0.01651944,0.0005893022,0.00007549011,0.000028602984,0.00046759887,0.00017915301],"about_ca_topic_score_codex":0.00014821625,"about_ca_topic_score_gemma":0.00041302183,"teacher_disagreement_score":0.38756236,"about_ca_system_score_codex":0.00052707596,"about_ca_system_score_gemma":0.00015151755,"threshold_uncertainty_score":0.7370004},"labels":[],"label_agreement":null},{"id":"W4386660583","doi":"10.1093/eurheartj/ehab724.1217","title":"Assessing the applicability and outcomes of the COMPASS trial a large cohort of atherosclerotic disease patients","year":2021,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Canadian VIGOUR Centre","funders":"","keywords":"Medicine; Mace; Rivaroxaban; Myocardial infarction; Stroke (engine); Internal medicine; Hazard ratio; Cohort; Population; Coronary artery disease; Warfarin; Physical therapy; Surgery; Percutaneous coronary intervention; Confidence interval; Atrial fibrillation","score_opus":0.031184233480645057,"score_gpt":0.3108297454627683,"score_spread":0.2796455119821233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386660583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978242,0.0007488721,0.00013195697,0.0005238332,0.00015536776,0.00035766646,0.000011940422,0.0000056797353,0.00024048981],"genre_scores_gemma":[0.9993644,0.00006649572,0.000038971295,0.0003590841,0.00011697669,0.0000016063884,0.0000025236318,0.000014736614,0.000035237736],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99813384,0.00090048957,0.00030416867,0.0001233634,0.0004090421,0.00012907396],"domain_scores_gemma":[0.9991183,0.00010015419,0.00013663417,0.0003710006,0.00014589677,0.0001280049],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001060626,0.00008978337,0.00031932647,0.000013895617,0.00018808406,0.000038070673,0.00008836103,0.000013311742,0.00005518506],"category_scores_gemma":[0.00027773122,0.000045592227,0.0004627279,0.000093725364,0.00014683539,0.000057181416,0.000082512204,0.00020760894,0.000001772268],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060877117,0.00040901767,0.9972579,0.000033854445,0.00026150854,0.000013770585,0.00006890178,0.0000034007803,0.00013571694,0.000016080323,0.00013464327,0.0010564422],"study_design_scores_gemma":[0.011392066,0.000059795013,0.9856397,0.0000922238,0.0003137802,0.000035541005,0.000109300374,0.0000130524695,0.00009058767,0.000022678047,0.0021872574,0.000044003544],"about_ca_topic_score_codex":7.441486e-7,"about_ca_topic_score_gemma":2.0699785e-7,"teacher_disagreement_score":0.011618178,"about_ca_system_score_codex":0.000011982539,"about_ca_system_score_gemma":0.000104497056,"threshold_uncertainty_score":0.1859197},"labels":[],"label_agreement":null},{"id":"W4386660761","doi":"10.1093/eurheartj/ehab724.1428","title":"Outcomes of patients with high bleeding risks characteristics presenting with acute coronary syndrome undergoing percutaneous coronary intervention","year":2021,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Mace; Percutaneous coronary intervention; Myocardial infarction; Internal medicine; Acute coronary syndrome; Conventional PCI; Cardiology; Stroke (engine); Clopidogrel","score_opus":0.02262025451500148,"score_gpt":0.26608659521448663,"score_spread":0.24346634069948514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386660761","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99850297,0.00039210691,0.00045688872,0.00008611017,0.00017868029,0.00015647554,0.00002483678,0.000035491274,0.00016641793],"genre_scores_gemma":[0.99785155,0.00032697147,0.0011629988,0.00012300383,0.000085712694,6.9104107e-7,0.00008623091,0.000066800814,0.0002960331],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99829775,0.00029447954,0.00037920612,0.0002245449,0.0005415965,0.00026242502],"domain_scores_gemma":[0.9989961,0.0000674179,0.00023789688,0.00023132177,0.00028471227,0.00018256252],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002772412,0.00019607051,0.00049235247,0.00008270955,0.00020081252,0.000059787486,0.000081799335,0.000030364192,0.00024273731],"category_scores_gemma":[0.00004543902,0.00014270961,0.00030079883,0.000118678996,0.00007704689,0.00018571521,0.000070540154,0.00036338737,0.000014267881],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008266944,0.00033325498,0.9634735,0.00010603108,0.002571833,0.030334784,0.00011377641,0.000028018378,0.00025323412,0.00000399739,0.00004647748,0.0019084234],"study_design_scores_gemma":[0.0028007743,0.00116636,0.92967355,0.00068423524,0.00087152445,0.0642055,0.00020799907,0.000010609307,0.000082436505,0.0000031657319,0.00013886408,0.00015494818],"about_ca_topic_score_codex":0.0000021506262,"about_ca_topic_score_gemma":8.3006427e-7,"teacher_disagreement_score":0.03387072,"about_ca_system_score_codex":0.00004799793,"about_ca_system_score_gemma":0.00010525102,"threshold_uncertainty_score":0.5819529},"labels":[],"label_agreement":null},{"id":"W4386843804","doi":"","title":"Prevalence rate of aspirin resistance in cardiovascular disease patients: A systematic review and meta-analysis","year":2020,"lang":"en","type":"review","venue":"DOAJ (DOAJ: Directory of Open Access Journals)","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Meta-analysis; Aspirin; Medicine; Disease; Systematic review; Internal medicine; Intensive care medicine; MEDLINE; Biology","score_opus":0.2610572476778838,"score_gpt":0.5175613637796309,"score_spread":0.2565041161017471,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386843804","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008603882,0.9928659,0.00006114277,0.00003710363,0.00004101818,0.0062296856,0.00054800947,0.000018410756,0.00011267175],"genre_scores_gemma":[0.0008619637,0.9976896,0.00003930306,0.00028919193,0.000031189902,0.0007143829,0.00009916521,0.00009271771,0.0001824773],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99046665,0.0034844452,0.0032032274,0.0010772068,0.0014052353,0.0003632583],"domain_scores_gemma":[0.99367356,0.00043941187,0.0026347027,0.0020827937,0.0005640072,0.0006055242],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.0040675886,0.0008825127,0.02195662,0.0011434981,0.00008063571,0.00024380573,0.0018935922,0.00017468001,0.0016933852],"category_scores_gemma":[0.0014075772,0.000614858,0.013014812,0.003453044,0.00018589443,0.0007356253,0.00061481626,0.00055920123,0.0000073472256],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008264444,0.00018044603,0.0013700518,0.6794972,0.31486425,0.00023636618,0.000013328743,0.000005964092,2.2001072e-7,0.0000057291036,0.0002794751,0.0034643398],"study_design_scores_gemma":[0.00041256595,0.000008164982,0.0033440012,0.16943593,0.7895271,0.0000075273592,0.000003850117,9.3439934e-7,0.000001356797,0.000053077325,0.036754787,0.00045071286],"about_ca_topic_score_codex":0.000066806606,"about_ca_topic_score_gemma":0.000005513596,"teacher_disagreement_score":0.51006126,"about_ca_system_score_codex":0.00012618794,"about_ca_system_score_gemma":0.00043111923,"threshold_uncertainty_score":0.9996303},"labels":[],"label_agreement":null},{"id":"W4386858144","doi":"10.1161/circinterventions.122.012447","title":"Sex-Specific Differences in Potent P2Y <sub>12</sub> Inhibitor Use in British Cardiovascular Intervention Society Registry STEMI Patients","year":2023,"lang":"en","type":"article","venue":"Circulation Cardiovascular Interventions","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Victoria Heart Institute Foundation; Royal Jubilee Hospital","funders":"","keywords":"Prasugrel; Medicine; Clopidogrel; Percutaneous coronary intervention; Ticagrelor; P2Y12; Odds ratio; Internal medicine; Myocardial infarction; Odds; Cardiology; Logistic regression","score_opus":0.042270556526123736,"score_gpt":0.24560267672768857,"score_spread":0.20333212020156483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386858144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9685194,0.020319166,0.008190286,0.000031185307,0.0007247615,0.0016958981,0.00010919518,0.00032941267,0.000080713515],"genre_scores_gemma":[0.9924562,0.0052609867,0.00006535067,0.000036393914,0.00028922976,0.00039069855,0.0012723538,0.00010553058,0.00012323882],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9942696,0.0007962642,0.001403968,0.0012365301,0.001568089,0.0007255631],"domain_scores_gemma":[0.9976527,0.00007981557,0.00019905392,0.0014900527,0.00033142228,0.00024692525],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0020791034,0.00046470127,0.0015372353,0.000623175,0.00023035833,0.00027956683,0.00026242345,0.00041913267,0.000041874602],"category_scores_gemma":[0.00020390513,0.00058072363,0.014201423,0.0015452446,0.0001909489,0.0006788681,0.0001787151,0.0005994061,0.00009860398],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009424722,0.0013678228,0.7536692,0.0013229038,0.010786775,0.000738658,0.0004094574,0.0088863345,0.0003305276,0.00003325381,0.00089406525,0.22146674],"study_design_scores_gemma":[0.0077339276,0.00009356116,0.9821561,0.003040175,0.0009789701,0.00014171645,0.00095524127,0.00092009245,0.0003839788,0.00008962203,0.002922931,0.0005836948],"about_ca_topic_score_codex":0.00045089106,"about_ca_topic_score_gemma":0.00027840858,"teacher_disagreement_score":0.22848687,"about_ca_system_score_codex":0.0005627558,"about_ca_system_score_gemma":0.00007389315,"threshold_uncertainty_score":0.9996644},"labels":[],"label_agreement":null},{"id":"W4386969846","doi":"10.1016/j.cjca.2023.09.021","title":"Impact of Age on Antiplatelet Monotherapy in the Chronic Maintenance Period After Percutaneous Coronary Intervention: A Post Hoc Analysis From the HOST-EXAM Extended Study","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Percutaneous coronary intervention; Conventional PCI; Clopidogrel; Hazard ratio; Myocardial infarction; Internal medicine; Aspirin; Clinical endpoint; Acute coronary syndrome; Confidence interval; Population; Subgroup analysis; Post-hoc analysis; Stroke (engine); Cardiology; Randomized controlled trial","score_opus":0.012607119621425359,"score_gpt":0.2752081173226877,"score_spread":0.26260099770126233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386969846","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99132305,0.007244446,0.000047723574,0.0005825137,0.00015700175,0.00040952628,0.00015458578,0.000005995356,0.00007515824],"genre_scores_gemma":[0.9982768,0.00094024214,0.0000035809499,0.0002701332,0.00040569826,0.000013099524,0.00003860803,0.000020885853,0.000030917894],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978856,0.00079543033,0.0004767385,0.00021304685,0.00026287182,0.0003663226],"domain_scores_gemma":[0.99875766,0.00017865271,0.00017250859,0.0005402272,0.00016101559,0.00018990961],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008789489,0.0002006089,0.0009199686,0.0004418188,0.00008354951,0.000027815957,0.0003519975,0.00010326377,0.00018001425],"category_scores_gemma":[0.000078238445,0.00011002532,0.001960877,0.0007146791,0.00024050947,0.00004645137,0.000012529328,0.00040754338,0.000010013923],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010839546,0.00011970175,0.79821795,0.00002112974,0.031697124,0.106114134,0.007648933,0.0064500305,0.00053759327,0.000010357835,0.0015270524,0.036816467],"study_design_scores_gemma":[0.0027779017,0.0047918814,0.9825553,0.000084312975,0.0012558607,0.0031157879,0.0038604613,0.000028604245,0.000002111168,0.000023687266,0.0013975174,0.000106522646],"about_ca_topic_score_codex":0.0021432326,"about_ca_topic_score_gemma":0.006684868,"teacher_disagreement_score":0.18433742,"about_ca_system_score_codex":0.00025606086,"about_ca_system_score_gemma":0.00061382557,"threshold_uncertainty_score":0.44867024},"labels":[],"label_agreement":null},{"id":"W4387157922","doi":"10.1002/pds.5704","title":"Trajectories of <scp>P2Y12</scp> inhibitor adherence in patients with acute coronary syndromes","year":2023,"lang":"en","type":"article","venue":"Pharmacoepidemiology and Drug Safety","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences","funders":"Canadian Institutes of Health Research","keywords":"Ticagrelor; Medicine; Clopidogrel; P2Y12; Acute coronary syndrome; Internal medicine; Atrial fibrillation; Cohort; Retrospective cohort study; Population; Logistic regression; Cardiology; Cohort study; Emergency medicine; Myocardial infarction","score_opus":0.016628390069446424,"score_gpt":0.28719005773534106,"score_spread":0.2705616676658946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387157922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99628234,0.0025186401,0.000052672098,0.0001978859,0.00017701666,0.00039728286,0.00008734975,0.0000810311,0.00020579489],"genre_scores_gemma":[0.99497736,0.0040604486,0.00009308401,0.00038405962,0.000052035295,0.000029427007,0.0001732955,0.000018561821,0.00021174642],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983687,0.0004055302,0.0003982652,0.00033062373,0.0001606633,0.00033623067],"domain_scores_gemma":[0.9984956,0.0010036783,0.000113623,0.0001794432,0.00006529609,0.00014235538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008599829,0.00019815199,0.00072618655,0.00012818092,0.00007182991,0.0000018956603,0.00007826492,0.000096452124,0.000036188736],"category_scores_gemma":[0.00024035237,0.00014754976,0.00014319617,0.00033880895,0.00030253935,0.00010862812,0.00005101888,0.00023542126,0.000015770029],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012959903,0.00014554698,0.98814994,0.00013443356,0.0007791239,0.00016934997,0.0003703153,0.000037851976,0.00016030009,0.00009115197,0.0021695397,0.0064964406],"study_design_scores_gemma":[0.005446644,0.00030510523,0.9907005,0.00011889698,0.0003175223,0.00005111624,0.00021282259,0.000059763704,0.00059993094,0.00014226467,0.0019702497,0.00007517309],"about_ca_topic_score_codex":0.000028877319,"about_ca_topic_score_gemma":0.0000043303,"teacher_disagreement_score":0.0064212675,"about_ca_system_score_codex":0.000018944456,"about_ca_system_score_gemma":0.00007475658,"threshold_uncertainty_score":0.6016904},"labels":[],"label_agreement":null},{"id":"W4387293999","doi":"10.7326/j23-0075","title":"In healthy older adults, low-dose aspirin increased incident anemia at a median 4.7 y","year":2023,"lang":"en","type":"letter","venue":"Annals of Internal Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Population Health Research Institute; McMaster University","funders":"","keywords":"Medicine; Aspirin; Incidence (geometry); Placebo; Low dose aspirin; Anemia; Internal medicine; Gastroenterology; Pathology","score_opus":0.026980984451368432,"score_gpt":0.3226982277883994,"score_spread":0.295717243337031,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387293999","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.46542746,0.011956417,0.000010717565,0.5195702,0.0011711055,0.0009905368,0.00009982274,0.00009508512,0.00067867915],"genre_scores_gemma":[0.14437275,0.008265904,0.00001622344,0.83525103,0.008359828,0.00010908264,0.00087322143,0.00018853549,0.0025634414],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9947618,0.0003093727,0.0014879736,0.00083227875,0.0017581056,0.0008504197],"domain_scores_gemma":[0.99708694,0.00041915092,0.00061247335,0.0009750511,0.00042382273,0.0004825308],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010206035,0.0006755302,0.0021730235,0.0010597428,0.000045267665,0.0000081918215,0.00049455307,0.00083778874,0.0018197657],"category_scores_gemma":[0.00066262676,0.00052971154,0.00083054596,0.00053918205,0.00044145124,0.0000961783,0.00019041497,0.0019522859,0.00032270513],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00651276,0.00018118258,0.0049448,0.0039578034,0.0008431235,0.023550954,0.00062431145,7.9167245e-7,0.000105664105,0.0000023474577,0.95334923,0.005927012],"study_design_scores_gemma":[0.029967431,0.0063341935,0.08628367,0.06944448,0.0009612704,0.002152224,0.0006084309,0.00006239075,0.002251278,0.00018222374,0.80046153,0.0012908858],"about_ca_topic_score_codex":0.0056326455,"about_ca_topic_score_gemma":0.00027551976,"teacher_disagreement_score":0.3210547,"about_ca_system_score_codex":0.00018240047,"about_ca_system_score_gemma":0.00030160972,"threshold_uncertainty_score":0.99971545},"labels":[],"label_agreement":null},{"id":"W4387326934","doi":"10.1001/jamacardio.2023.3364","title":"Effectiveness and Safety of Enteric-Coated vs Uncoated Aspirin in Patients With Cardiovascular Disease","year":2023,"lang":"en","type":"article","venue":"JAMA Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Aspirin; Myocardial infarction; Internal medicine; Stroke (engine); Dosing; Clinical endpoint; Coronary artery disease; Gastrointestinal bleeding; Incidence (geometry); Cumulative incidence; Adverse effect; Surgery; Randomized controlled trial; Cohort","score_opus":0.006625268045577367,"score_gpt":0.21730568264637928,"score_spread":0.21068041460080192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387326934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970656,0.0014970626,0.00021016574,0.00004617146,0.00009464831,0.0008078777,0.00006998909,0.00008713551,0.00012135813],"genre_scores_gemma":[0.99884397,0.00062842376,0.000009424542,0.000046486708,0.000049920778,0.000058458907,0.0003182269,0.00003228251,0.00001278903],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99811476,0.00056247064,0.00024944165,0.00043107403,0.0003353947,0.0003068435],"domain_scores_gemma":[0.9989919,0.00010766986,0.000048052334,0.00053237606,0.00015251254,0.00016745366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006522991,0.00020577853,0.0010549148,0.00021669672,0.000038972797,0.0000063720704,0.00007222573,0.00013488418,0.0000073510055],"category_scores_gemma":[0.00010997727,0.00014514937,0.00047535464,0.0005793159,0.00019466336,0.000070679314,0.00007089434,0.00015592219,0.000010592118],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013131993,0.00006998429,0.96203935,0.0004513573,0.0039162915,0.0006893117,0.0000359168,0.0019619635,0.00011353396,0.000016930751,0.000030432711,0.01754293],"study_design_scores_gemma":[0.012944667,0.00046077385,0.9824285,0.00026757657,0.00068109843,0.000024316865,0.00003084619,0.000041895844,0.00017220742,0.00001692487,0.002766662,0.0001645273],"about_ca_topic_score_codex":0.00004594343,"about_ca_topic_score_gemma":8.389469e-7,"teacher_disagreement_score":0.02038915,"about_ca_system_score_codex":0.000049913444,"about_ca_system_score_gemma":0.00007717826,"threshold_uncertainty_score":0.591902},"labels":[],"label_agreement":null},{"id":"W4387337799","doi":"10.1016/j.cjca.2023.06.410","title":"ASPIRIN AND ENDOMETRIAL CANCER: RE-VISITING THE ANTITHROMBOTIC/ANTI-CANCER PROPERTIES","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Aspirin; Antithrombotic; Cancer; Endometrial cancer; Internal medicine; Drug; Disease; Oncology; Pharmacology","score_opus":0.048672916736637054,"score_gpt":0.2823259337325801,"score_spread":0.23365301699594304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387337799","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9648915,0.030503912,0.000073755866,0.0029200697,0.0008197391,0.00016213433,0.000022973134,0.00001201905,0.0005939243],"genre_scores_gemma":[0.98800445,0.008931541,0.000007655231,0.00036264135,0.002541973,0.0000074455147,0.0000026077328,0.000017856168,0.0001238423],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989675,0.00016195426,0.00025800095,0.00012580695,0.00016043229,0.00032626733],"domain_scores_gemma":[0.99918103,0.00007310285,0.00010233595,0.00014945315,0.00017045469,0.0003235976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006641495,0.00011348192,0.0005859573,0.00028019227,0.00019187483,0.000031581585,0.000113217095,0.000083664396,0.000041522995],"category_scores_gemma":[0.00020992695,0.00007040852,0.00032858693,0.00031874602,0.000300198,0.00006238341,0.000014365567,0.00024481054,0.000006657142],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072682276,0.000005047299,0.7661912,0.00027540018,0.008925352,0.0027199425,0.0010877646,0.0076766633,0.011058635,0.0003056835,0.027662162,0.17336534],"study_design_scores_gemma":[0.007097472,0.0005820178,0.44955632,0.00058302324,0.0018202711,0.002391766,0.002424577,0.000095335796,0.0035266008,0.00013693985,0.53139156,0.0003941186],"about_ca_topic_score_codex":0.00091617194,"about_ca_topic_score_gemma":0.0004048135,"teacher_disagreement_score":0.5037294,"about_ca_system_score_codex":0.000062081475,"about_ca_system_score_gemma":0.0009794242,"threshold_uncertainty_score":0.2871176},"labels":[],"label_agreement":null},{"id":"W4387337813","doi":"10.1016/j.cjca.2023.06.270","title":"BENEFITS OF ICOSAPENT ETHYL IN PATIENTS WITH RECENT ACUTE CORONARY SYNDROME (ACS): REDUCE-IT ACS","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Antithrombotic; Acute coronary syndrome; Clinical endpoint; Internal medicine; Cardiology; Clinical trial; Myocardial infarction","score_opus":0.01680200705244012,"score_gpt":0.23858636193230134,"score_spread":0.22178435487986123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387337813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960127,0.0020997636,0.0000113501965,0.00083794614,0.00037815832,0.00022677777,0.00006811337,0.000006138497,0.00035907942],"genre_scores_gemma":[0.9974287,0.0020521504,0.000019890942,0.00023853999,0.000114313814,0.0000040591685,0.000065175685,0.00002457961,0.00005255346],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99861985,0.00014367953,0.00042324798,0.00016237909,0.00027094167,0.0003799237],"domain_scores_gemma":[0.99873203,0.00003959885,0.00016256834,0.00025363674,0.00032185504,0.00049029634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038487237,0.00015039145,0.0008221555,0.00046319864,0.00004128968,0.000005321087,0.0001572496,0.0001400459,0.000042107557],"category_scores_gemma":[0.000062336396,0.00012108311,0.00026224583,0.00041722847,0.00015382851,0.000068294845,0.000014251176,0.00028482004,0.000013893398],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001579779,0.000022890548,0.93925864,0.000051704894,0.0036138666,0.0049489555,0.00023259976,0.0047327117,0.000055181743,0.000033453398,0.0064044143,0.03906583],"study_design_scores_gemma":[0.0037148646,0.0013208602,0.9794918,0.00023788262,0.00042236393,0.0019411503,0.00015236154,5.657941e-7,0.000098435434,0.000024906985,0.01247728,0.00011758363],"about_ca_topic_score_codex":0.00009049286,"about_ca_topic_score_gemma":0.00017453913,"teacher_disagreement_score":0.040233135,"about_ca_system_score_codex":0.00016232539,"about_ca_system_score_gemma":0.0011212614,"threshold_uncertainty_score":0.4937626},"labels":[],"label_agreement":null},{"id":"W4387337988","doi":"10.1016/j.cjca.2023.06.317","title":"IMPACT OF TRANSCATHETER AORTIC VALVE IMPLANTATION ON CIRCULATING VON WILLEBRAND FACTOR IN PATIENTS WITH SEVERE AORTIC STENOSIS","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Brampton Civic Hospital","funders":"","keywords":"Medicine; Von Willebrand factor; Cardiology; Internal medicine; Stenosis; Hemostasis; Von Willebrand disease; Population; Aortic valve stenosis; Aortic valve replacement; Surgery; Platelet","score_opus":0.012841142893463674,"score_gpt":0.24626265402128858,"score_spread":0.23342151112782492,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387337988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99929035,0.00010920071,0.00007825983,0.000027008447,0.00009720637,0.00018999499,0.000064827254,0.0000047061208,0.00013847346],"genre_scores_gemma":[0.9997667,0.00004022887,0.000006096495,0.000033412594,0.00009701874,0.0000020604273,0.00003157755,0.000019295865,0.0000035920464],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989784,0.00012151184,0.000325213,0.00011562912,0.00018452792,0.00027475474],"domain_scores_gemma":[0.99923843,0.000059006816,0.00013810338,0.00013554364,0.00014540023,0.00028350408],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015505828,0.00012558853,0.00057436735,0.0004430059,0.000034591707,0.0000061647897,0.000060023172,0.00008901177,0.000026708542],"category_scores_gemma":[0.000047259076,0.00008990066,0.00081216125,0.00024541194,0.00005751387,0.0000671495,0.0000017731062,0.00016640821,0.0000039043207],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048142776,0.000006856202,0.97906256,0.000032515967,0.0016871734,0.00007514715,0.00038571007,0.00497621,0.00008399301,0.0000011928933,0.00004341855,0.013163804],"study_design_scores_gemma":[0.0032898644,0.0012863923,0.9945805,0.00016779809,0.00031831814,0.00010191598,0.00008805979,0.000013080736,0.00002159962,0.000018174967,0.000022404349,0.00009190182],"about_ca_topic_score_codex":0.000221433,"about_ca_topic_score_gemma":0.00005032003,"teacher_disagreement_score":0.015517939,"about_ca_system_score_codex":0.00014846107,"about_ca_system_score_gemma":0.00049716607,"threshold_uncertainty_score":0.36660427},"labels":[],"label_agreement":null},{"id":"W4387338270","doi":"10.1016/j.cjca.2023.06.152","title":"EICOSAPENTAENOIC ACID (EPA) MODULATED EXPRESSION OF PROTEINS LINKED TO PLATELET ACTIVATION IN VASCULAR ENDOTHELIAL CELLS DURING INFLAMMATION","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Inflammation; Eicosapentaenoic acid; Endothelial activation; Endothelial dysfunction; Platelet activation; Platelet; Thrombus; Angiotensin II; Tissue factor; Endothelial stem cell; Internal medicine; Stimulation; Endocrinology; Pharmacology; Immunology; Coagulation; Fatty acid; Biochemistry; Polyunsaturated fatty acid; In vitro; Blood pressure; Chemistry","score_opus":0.011387457514624067,"score_gpt":0.22519461401890167,"score_spread":0.21380715650427762,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387338270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99780494,0.00016057523,0.0010560002,0.00015736929,0.00021889532,0.00047564466,0.000014529142,0.000010568155,0.00010150673],"genre_scores_gemma":[0.99913657,0.00013075162,0.000089224784,0.000025805517,0.0005378066,0.000012648821,0.000027134845,0.00002255753,0.000017480184],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998647,0.00019298441,0.00047251783,0.00015336009,0.00023309562,0.0003010643],"domain_scores_gemma":[0.9990505,0.000032023643,0.00016598993,0.00021571181,0.00018031192,0.00035545332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045163586,0.00013250236,0.00059290463,0.0008603887,0.000055671968,0.000008686769,0.00011673556,0.00017242924,0.000034890225],"category_scores_gemma":[0.00016320994,0.00012239817,0.0003689579,0.00043558798,0.00004797875,0.00011568267,0.000013491187,0.00022798068,0.000017402],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004492712,0.0000035376154,0.005587255,0.00006579844,0.00027957768,0.00037625976,0.00035393407,0.024433559,0.96200776,0.000005271774,0.000077787896,0.006359965],"study_design_scores_gemma":[0.003599965,0.00027482657,0.28660938,0.00041056212,0.00008395823,0.000120852805,0.00019161456,0.00004964913,0.7034229,0.00006015601,0.005032646,0.00014352052],"about_ca_topic_score_codex":0.00014645256,"about_ca_topic_score_gemma":0.00006721577,"teacher_disagreement_score":0.28102213,"about_ca_system_score_codex":0.00016470597,"about_ca_system_score_gemma":0.00044380358,"threshold_uncertainty_score":0.49912524},"labels":[],"label_agreement":null},{"id":"W4387338340","doi":"10.1016/j.cjca.2023.06.348","title":"ROLE OF LOW-DOSE ASPIRIN FOR THE PRIMARY PREVENTION OF ISCHEMIC VASCULAR EVENTS: AN UPDATED SYSTEMATIC REVIEW AND META-ANALYSIS","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Aspirin; Primary prevention; Low dose aspirin; Randomized controlled trial; Meta-analysis; Systematic review; Internal medicine; Secondary prevention; Intensive care medicine; MEDLINE; Cardiology; Disease","score_opus":0.02462328623616602,"score_gpt":0.2742126806231833,"score_spread":0.2495893943870173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387338340","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.251752,0.7417768,0.0031636024,0.00062690314,0.000074190495,0.002247884,0.00017692239,0.000009552465,0.00017211327],"genre_scores_gemma":[0.99315715,0.006255337,0.00005383294,0.00023902413,0.000060693135,0.000036492132,0.000103525694,0.000015164761,0.0000788013],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9985339,0.00038933184,0.0006357243,0.00011667476,0.00016685709,0.00015751045],"domain_scores_gemma":[0.9985892,0.00007833872,0.0003912478,0.00038652515,0.00035167966,0.00020296528],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018219136,0.00011216247,0.0023763124,0.00026629335,0.000040216506,0.0000032319365,0.00014929923,0.00007252186,0.000032673197],"category_scores_gemma":[0.00013302283,0.00006881962,0.0028096666,0.00040537099,0.00008892787,0.000059438964,0.000008594272,0.00009189231,8.5391656e-7],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015417025,0.000018482217,0.0017903933,0.058420684,0.9329597,0.000057491845,0.00015297151,0.0017015503,0.0018429409,0.00006992645,0.0020306872,0.0008009982],"study_design_scores_gemma":[0.0010127504,0.00031886218,0.01007363,0.0009481117,0.983928,0.00026525723,0.0002973345,0.000038817547,0.00023342248,0.00012425863,0.002650725,0.00010880764],"about_ca_topic_score_codex":0.000057456207,"about_ca_topic_score_gemma":0.00005940119,"teacher_disagreement_score":0.7414051,"about_ca_system_score_codex":0.00002832781,"about_ca_system_score_gemma":0.0003793919,"threshold_uncertainty_score":0.2833624},"labels":[],"label_agreement":null},{"id":"W4387338441","doi":"10.1016/j.cjca.2023.06.021","title":"EXPLORING THE GENETIC BASIS OF DYSPNEA IN INDIVIDUALS TREATED WITH TICAGRELOR: RESULTS FROM THREE CLINICAL TRIALS","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Ticagrelor; Medicine; Clopidogrel; Acute coronary syndrome; Clinical trial; Adverse effect; Intensive care medicine; Internal medicine; Cardiology; Aspirin; Myocardial infarction","score_opus":0.2120972290406727,"score_gpt":0.33744262510366385,"score_spread":0.12534539606299114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387338441","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961369,0.0017107356,0.00016646936,0.00093246804,0.00028421966,0.00023262862,0.00015295083,0.0000068157615,0.00037680467],"genre_scores_gemma":[0.99726325,0.0016004785,0.00007769223,0.00009381345,0.0009020805,0.000007804548,0.000024741366,0.000018540924,0.000011580379],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969342,0.0012050204,0.0011726607,0.0001757786,0.00021963143,0.0002927131],"domain_scores_gemma":[0.9973021,0.001449424,0.0003379827,0.00036289528,0.00015670176,0.00039088912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045825443,0.00013117661,0.0013756165,0.00035481813,0.000046457586,0.000009826991,0.00019298351,0.00011764895,0.000015974241],"category_scores_gemma":[0.0021252343,0.00007726557,0.0006681731,0.0004309359,0.00028171288,0.000050009872,0.000010958974,0.00033560442,0.000010028756],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011729675,0.000005143038,0.90294105,0.000009115458,0.0037475505,0.0017911441,0.00026066054,0.00196047,0.000048904105,0.00001485257,0.0016777377,0.0863704],"study_design_scores_gemma":[0.00523281,0.00048377537,0.9818669,0.0001527885,0.00090565026,0.00023968269,0.00038739757,0.000014530427,0.0001319174,0.00010952205,0.010392819,0.00008222416],"about_ca_topic_score_codex":0.0010833539,"about_ca_topic_score_gemma":0.0018488844,"teacher_disagreement_score":0.08628818,"about_ca_system_score_codex":0.00004602592,"about_ca_system_score_gemma":0.00091535714,"threshold_uncertainty_score":0.31507987},"labels":[],"label_agreement":null},{"id":"W4387363074","doi":"10.1093/eurheartj/ehad651","title":"The European Society of Cardiology working group on cardiovascular pharmacotherapy","year":2023,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Medicine; Pharmacotherapy; Internal medicine; Cardiology","score_opus":0.06028185366078456,"score_gpt":0.3003039416843696,"score_spread":0.24002208802358502,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387363074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8670329,0.04285998,0.003139895,0.0027577104,0.002286192,0.00071113155,0.000010759793,0.00048201237,0.08071946],"genre_scores_gemma":[0.97083193,0.023978854,0.00011688208,0.0008707449,0.003684568,0.0000017988327,0.000007661888,0.000104378494,0.00040317344],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962506,0.0021572688,0.00034176043,0.00024543525,0.000586099,0.00041878718],"domain_scores_gemma":[0.9989836,0.00013319154,0.00009222964,0.0005172296,0.00007684676,0.00019690297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0056005483,0.00019337771,0.0004702625,0.00007603781,0.0005512059,0.00005324508,0.00022726835,0.000029640812,0.000022323113],"category_scores_gemma":[0.000034992972,0.00012684392,0.002667649,0.0003333539,0.00017926871,0.000041250136,0.000059393562,0.0005544379,0.00026533043],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009681235,0.00010948334,0.035619922,0.00009112209,0.017896574,0.0036477768,0.0007791785,0.0042548547,0.020646656,0.00011097004,0.23069826,0.6851771],"study_design_scores_gemma":[0.0021405905,0.00022400611,0.13664131,0.0001375317,0.00024852663,0.0013995763,0.00023273668,0.000039054765,0.00032891068,0.000015053729,0.8584603,0.00013236201],"about_ca_topic_score_codex":7.0866884e-7,"about_ca_topic_score_gemma":3.91772e-8,"teacher_disagreement_score":0.6850447,"about_ca_system_score_codex":0.000030587922,"about_ca_system_score_gemma":0.00003629173,"threshold_uncertainty_score":0.5172545},"labels":[],"label_agreement":null},{"id":"W4387418729","doi":"10.1016/j.amjcard.2023.09.008","title":"Clinically Driven Revascularization in High-Risk Patients Treated With Ticagrelor Monotherapy After PCI: Insights from the Randomized TWILIGHT Trial","year":2023,"lang":"en","type":"article","venue":"The American Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences","funders":"Abbott Vascular; Icahn School of Medicine at Mount Sinai; AstraZeneca; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; National Science Foundation","keywords":"Conventional PCI; Ticagrelor; Medicine; Randomized controlled trial; Twilight; Internal medicine; Revascularization; Cardiology; Percutaneous coronary intervention; Myocardial infarction","score_opus":0.007159206926959256,"score_gpt":0.24297575677421704,"score_spread":0.23581654984725778,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387418729","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959982,0.0008347862,0.0013191489,0.00071061996,0.00017564143,0.0008885482,0.000010825035,0.000021999762,0.000040210005],"genre_scores_gemma":[0.9919425,0.0063944696,0.000090116526,0.0006921123,0.00075458805,0.000051937055,0.000030798776,0.000030689094,0.000012759119],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9950219,0.0033824614,0.00076518516,0.00020715673,0.000411275,0.00021201701],"domain_scores_gemma":[0.997023,0.0015182204,0.00068291463,0.0004660602,0.00022054565,0.000089270325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012271093,0.0001953405,0.0017237439,0.00012580393,0.000071135924,0.000015300178,0.00022869675,0.00007088297,0.000016433798],"category_scores_gemma":[0.00041302238,0.00008198161,0.0009776673,0.0005453812,0.00075074274,0.000054307264,0.0000257279,0.00039587345,0.000015566293],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.78680974,0.000059828864,0.18501264,0.0000018756933,0.005119347,0.00020615575,0.00045256436,0.0008411422,0.000018443223,0.000010249673,0.00010960683,0.021358438],"study_design_scores_gemma":[0.4842144,0.0031253444,0.5084363,0.00007213063,0.0022418236,0.00005504381,0.00023078937,0.00008916432,0.000018884028,0.00037633246,0.0009990811,0.0001406712],"about_ca_topic_score_codex":0.000079853795,"about_ca_topic_score_gemma":0.0000042531506,"teacher_disagreement_score":0.3234237,"about_ca_system_score_codex":0.000036563655,"about_ca_system_score_gemma":0.00011536979,"threshold_uncertainty_score":0.3343113},"labels":[],"label_agreement":null},{"id":"W4387598444","doi":"10.1161/jaha.123.030385","title":"Aspirin Dosing for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Patients Treated With P2Y12 Inhibitors","year":2023,"lang":"en","type":"article","venue":"Journal of the American Heart Association","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"American Regent; Amgen Canada; Bristol-Myers Squibb Canada; Duke Clinical Research Institute; Novo Nordisk; Verily Life Sciences; Medicines Company; Boston Scientific Corporation; Eli Lilly and Company; Bristol-Myers Squibb; CSL Behring; AstraZeneca; National Heart, Lung, and Blood Institute; Pfizer; Amgen; Cytokinetics; Intercept Pharmaceuticals; American Heart Association; Regeneron Pharmaceuticals; U.S. Department of Veterans Affairs","keywords":"Prasugrel; Medicine; Aspirin; Clopidogrel; P2Y12; Discontinuation; Internal medicine; Hazard ratio; Clinical endpoint; Dosing; Stroke (engine); Myocardial infarction; Randomized controlled trial; Confidence interval","score_opus":0.011096737353412097,"score_gpt":0.24632427237568788,"score_spread":0.23522753502227578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387598444","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989657,0.00027269765,0.00005837573,0.00015091321,0.00007820988,0.00044563334,0.000011249709,0.000010472979,0.000006795853],"genre_scores_gemma":[0.9995984,0.000076353455,0.00006431088,0.00006468718,0.00010278139,0.0000085151,0.000009790107,0.000018900326,0.00005625014],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986068,0.00024061947,0.00033369326,0.00009731089,0.0005719775,0.00014959862],"domain_scores_gemma":[0.99901605,0.00007651973,0.00043084158,0.00017223932,0.00023696072,0.000067384884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008655227,0.00008754579,0.0005476308,0.00013820258,0.000048472626,0.000008757875,0.000053045173,0.000027022572,0.000002713771],"category_scores_gemma":[0.00020359867,0.000059374004,0.0010053747,0.0005553477,0.000038465536,0.00010190649,0.000012191465,0.00011756841,0.000001117133],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009215268,0.00015839303,0.9864291,0.000049500428,0.0012818525,0.0000029127987,0.00007519201,0.0011741578,0.0004436343,5.680655e-7,0.0002334044,0.009229747],"study_design_scores_gemma":[0.0033670198,0.0006430627,0.9933033,0.00035885797,0.00074548385,0.0000022252689,0.000082388775,0.000083594925,0.0008325843,0.00002300923,0.00049677026,0.00006171763],"about_ca_topic_score_codex":0.000029416356,"about_ca_topic_score_gemma":0.0000020523394,"teacher_disagreement_score":0.009168029,"about_ca_system_score_codex":0.00024366836,"about_ca_system_score_gemma":0.0001494879,"threshold_uncertainty_score":0.24212016},"labels":[],"label_agreement":null},{"id":"W4387710092","doi":"10.1016/j.jacc.2023.09.517","title":"TCT-507 Association of CYP2C19*17 Carrier Status to Ischemic and Bleeding Outcomes Among Patients With Coronary Artery Disease Treated With Clopidogrel: A Meta-Analysis","year":2023,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital; University of Toronto","funders":"","keywords":"Medicine; Clopidogrel; Meta-analysis; Internal medicine; Coronary artery disease; Cardiology; CYP2C19; Myocardial infarction","score_opus":0.011919052105303111,"score_gpt":0.245934131027367,"score_spread":0.23401507892206388,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387710092","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99825615,0.00040376963,0.000067030116,0.0004598094,0.000030354317,0.00030351203,0.0004134236,0.000010304054,0.000055637727],"genre_scores_gemma":[0.99927646,0.00016782797,0.0000815657,0.00015280109,0.00003797452,0.000010333317,0.000013929097,0.000020634181,0.00023846969],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99823964,0.00027857668,0.00045250912,0.00017945713,0.00060523686,0.00024458393],"domain_scores_gemma":[0.99784446,0.00022225335,0.00089522894,0.00031164513,0.0004954068,0.00023099523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041150636,0.00018469276,0.0021831272,0.00035211304,0.000053691383,0.0000042337806,0.000115956034,0.000040938638,0.000009080008],"category_scores_gemma":[0.00014191693,0.000097189346,0.0014561459,0.0012017273,0.00027702283,0.00007140119,0.000046989597,0.00014288374,2.7273288e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026118367,0.000030885112,0.84300244,0.000016790953,0.15151289,0.00020428764,0.00004036531,0.001539486,0.000068844034,0.0000012283283,0.0008823048,0.00008864618],"study_design_scores_gemma":[0.0017704329,0.0008177175,0.8841175,0.000018743927,0.112295575,0.00005113436,0.00040520518,0.000013294552,0.000054933742,0.0000028145957,0.0003593358,0.000093359726],"about_ca_topic_score_codex":0.000017102995,"about_ca_topic_score_gemma":0.000008496319,"teacher_disagreement_score":0.041115016,"about_ca_system_score_codex":0.00008346889,"about_ca_system_score_gemma":0.00015264768,"threshold_uncertainty_score":0.39632666},"labels":[],"label_agreement":null},{"id":"W4387865606","doi":"10.1089/ther.2023.0055","title":"Comparison of Clopidogrel Versus Ticagrelor for Percutaneous Coronary Intervention (PCI) Patients Managed with Therapeutic Hypothermia: A Systematic Review and Meta-Analysis","year":2023,"lang":"en","type":"review","venue":"Therapeutic Hypothermia and Temperature Management","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ticagrelor; Medicine; Clopidogrel; Conventional PCI; Percutaneous coronary intervention; Prasugrel; Randomized controlled trial; Internal medicine; Meta-analysis; Cochrane Library; Intensive care medicine; Cardiology; Myocardial infarction","score_opus":0.09147822711986565,"score_gpt":0.3622082117390142,"score_spread":0.27072998461914854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387865606","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017003709,0.9876837,0.00010588539,0.00008968956,0.000069617556,0.011480767,0.00016816646,0.00011883361,0.000113272115],"genre_scores_gemma":[0.0052243136,0.98990285,0.00019174337,0.00046032292,0.00002997819,0.0014673644,0.00035790054,0.00021619847,0.002149326],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9958076,0.00067081576,0.0014321469,0.0009704894,0.00067009474,0.00044889434],"domain_scores_gemma":[0.9972334,0.0004631415,0.000840957,0.0011160854,0.00017432144,0.00017209628],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00071573135,0.0010316421,0.0092667565,0.00051558175,0.0001805424,0.00008328964,0.0003098851,0.00035281057,0.00011357489],"category_scores_gemma":[0.00001900967,0.0006221872,0.0037243438,0.0009090119,0.00020904404,0.00006764198,0.00009983993,0.00038807341,0.000012438148],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004074947,0.0003025858,0.000008009932,0.5310914,0.41798642,0.00006106673,0.000075249416,0.0000011941108,3.5965616e-7,0.00018072805,0.000023789848,0.049861677],"study_design_scores_gemma":[0.0025435425,0.0010987172,0.000064759246,0.029196767,0.9540812,0.00012388431,0.00023193091,0.000013429144,4.8411283e-7,0.0000358005,0.011988179,0.000621301],"about_ca_topic_score_codex":0.000004372091,"about_ca_topic_score_gemma":0.000008008625,"teacher_disagreement_score":0.5360948,"about_ca_system_score_codex":0.000088391134,"about_ca_system_score_gemma":0.000042377076,"threshold_uncertainty_score":0.99962294},"labels":[],"label_agreement":null},{"id":"W4387871533","doi":"10.1016/j.jcin.2023.08.019","title":"Dyspnea-Related Ticagrelor Discontinuation After Percutaneous Coronary Intervention","year":2023,"lang":"en","type":"article","venue":"JACC: Cardiovascular Interventions","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences","funders":"Idorsia Pharmaceuticals; Servier; Eisai; Abiomed; Amarin Corporation; Abbott Vascular; Regeneron Pharmaceuticals; Boston Scientific Corporation; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; CSL Behring; Janssen Pharmaceuticals; Gilead Sciences; Sanofi; Novo Nordisk; Daiichi-Sankyo; AstraZeneca Mölndal; Amgen; Pfizer","keywords":"Ticagrelor; Medicine; Discontinuation; Percutaneous coronary intervention; Aspirin; Internal medicine; Myocardial infarction; Conventional PCI; Stroke (engine); Cardiology; Coronary artery disease","score_opus":0.018875312567700666,"score_gpt":0.27920988514716816,"score_spread":0.2603345725794675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387871533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9661728,0.022689402,0.0055603916,0.00038125296,0.0009788311,0.0012720034,0.00008305347,0.00091584306,0.0019464184],"genre_scores_gemma":[0.9913219,0.0011538793,0.00017157194,0.00007886116,0.00022329962,0.00029680546,0.00083255017,0.00009818978,0.0058229337],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9967756,0.0003782234,0.00079893024,0.00068473775,0.0008445152,0.00051793887],"domain_scores_gemma":[0.9982215,0.00005211253,0.0001103364,0.0011297393,0.00023879056,0.00024747607],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0010570924,0.00036323577,0.0008355031,0.00046406614,0.0002073714,0.0000914782,0.0001900156,0.00023694562,0.0019635095],"category_scores_gemma":[0.00017646312,0.00034203168,0.010460207,0.00087079627,0.00016121803,0.00029158953,0.00015518063,0.00035808547,0.0026259003],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018771476,0.0027878429,0.01923706,0.0021217898,0.06986495,0.016336335,0.0012255311,0.0018114883,0.001183295,0.0009843135,0.0081285965,0.8744416],"study_design_scores_gemma":[0.014590309,0.0017761221,0.83411807,0.005246411,0.02117487,0.015229095,0.0027728998,0.0026790684,0.00079043675,0.0013968293,0.09829903,0.001926881],"about_ca_topic_score_codex":0.000037066813,"about_ca_topic_score_gemma":0.0000136921,"teacher_disagreement_score":0.8725148,"about_ca_system_score_codex":0.00015285575,"about_ca_system_score_gemma":0.000048984995,"threshold_uncertainty_score":0.99990314},"labels":[],"label_agreement":null},{"id":"W4387933975","doi":"10.1016/j.jcjd.2023.10.394","title":"ASPIRIN AND ENDOMETRIAL CANCER: RE-VISITING THE ANTITHROMBOTIC/ANTI-CANCER PROPERTIES","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Diabetes","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Aspirin; Antithrombotic; Cancer; Endometrial cancer; Drug; Disease; Internal medicine; Oncology; Pharmacology","score_opus":0.03521334753376674,"score_gpt":0.26210299627360306,"score_spread":0.22688964873983633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387933975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9509788,0.04585215,0.0000014502059,0.0025017182,0.0003951769,0.00013964302,0.000022853095,0.00001187455,0.000096309086],"genre_scores_gemma":[0.9963159,0.0021777505,0.000008589754,0.00049901655,0.0008435162,0.0000067372853,0.0000021434537,0.000020061301,0.0001262916],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990535,0.00006587451,0.00023393179,0.00010502378,0.00021362961,0.0003280857],"domain_scores_gemma":[0.99919116,0.000071373855,0.00010651825,0.00012229155,0.00014379252,0.00036488165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004984726,0.000110445326,0.0003720524,0.0002682572,0.00021454376,0.00007606611,0.00010707105,0.00004674347,0.00013964219],"category_scores_gemma":[0.00021073942,0.00006808905,0.00021250157,0.0003979561,0.00018964094,0.000107385305,0.000011194715,0.0001855236,0.0000062923764],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028024304,0.000010843289,0.9241146,0.00019153707,0.0017040988,0.00011744397,0.00056888594,0.0001836841,0.0070351227,0.000041001025,0.0033025953,0.0627022],"study_design_scores_gemma":[0.0063847555,0.000506324,0.9077931,0.0020710784,0.001522696,0.000052060634,0.002520945,0.00029903758,0.028354174,0.00013546633,0.04991465,0.0004456943],"about_ca_topic_score_codex":0.000541164,"about_ca_topic_score_gemma":0.0008013233,"teacher_disagreement_score":0.06225651,"about_ca_system_score_codex":0.000049959337,"about_ca_system_score_gemma":0.0007352321,"threshold_uncertainty_score":0.2776591},"labels":[],"label_agreement":null},{"id":"W4388011692","doi":"10.1016/j.cjca.2023.10.013","title":"Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology 2023 Focused Update of the Guidelines for the Use of Antiplatelet Therapy","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Toronto General Hospital; Montreal Heart Institute; University of Manitoba; London Health Sciences Centre; Dalhousie University; University of Ottawa; Centre Hospitalier de l’Université de Montréal; Health Sciences Centre; Université de Montréal; St. Boniface Hospital; St. Michael's Hospital; Sunnybrook Health Science Centre; Population Health Research Institute; St. Paul's Hospital; Western University; Genome Prairie; University of Toronto; Southlake Regional Health Center; Alberta Health Services; Saint John Regional Hospital; University of British Columbia; McMaster University; University of Alberta; University of Saskatchewan; Hamilton Health Sciences","funders":"University of British Columbia","keywords":"Medicine; Canadian Cardiovascular Society; Internal medicine; Association (psychology); Cardiology; Intensive care medicine; Myocardial infarction","score_opus":0.08175719462570363,"score_gpt":0.28727804844722027,"score_spread":0.20552085382151664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388011692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9321803,0.035147935,0.0035927773,0.019173233,0.004220206,0.001982077,0.003307641,0.000016906686,0.00037895187],"genre_scores_gemma":[0.99393046,0.0040641483,0.00016563466,0.0006119008,0.00090221537,0.000017156906,0.000076567325,0.000040262592,0.00019163436],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99729013,0.0004933164,0.0009760804,0.000211841,0.00040864662,0.0006200072],"domain_scores_gemma":[0.99562407,0.00038672428,0.00053509645,0.00061500416,0.002308516,0.0005305696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027734109,0.00022145291,0.0014016606,0.000501133,0.00021644792,0.000014807899,0.0004625575,0.00036468092,0.000035955458],"category_scores_gemma":[0.0012030974,0.00014937724,0.004985917,0.0006483076,0.00033575954,0.000087529654,0.000019644767,0.00031095062,0.0000031574634],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004952157,0.000010071934,0.3182351,0.00022696317,0.06485023,0.00030407778,0.00040200457,0.07342248,0.0006528869,0.000489584,0.49078712,0.050124273],"study_design_scores_gemma":[0.0030264303,0.00030218376,0.15071528,0.00015835318,0.0015841151,0.0004093731,0.00030136105,0.00022450631,0.0003858063,0.00021504826,0.8424987,0.00017880532],"about_ca_topic_score_codex":0.20519267,"about_ca_topic_score_gemma":0.29052442,"teacher_disagreement_score":0.35171163,"about_ca_system_score_codex":0.00044673905,"about_ca_system_score_gemma":0.005750741,"threshold_uncertainty_score":0.99988574},"labels":[],"label_agreement":null},{"id":"W4388182377","doi":"10.1016/j.jacadv.2023.100675","title":"Lipoprotein(a) and Benefit of Antiplatelet Therapy","year":2023,"lang":"en","type":"article","venue":"JACC Advances","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute; St. Jude Medical; CytoSorbents Europe; Silence Therapeutics; Intas Pharmaceuticals; Idorsia Pharmaceuticals; Assistance publique-Hôpitaux de Paris; Daiichi-Sankyo; Zora Biosciences; Belvoir Media Group; Novo Nordisk; MyoKardia; ARCA Biopharma; Regado Biosciences; Medicines Company; AstraZeneca; Amarin Corporation; Ionis Pharmaceuticals; Ironwood Pharmaceuticals, Incorporated; Brigham and Women's Hospital; Boston VA Research Institute; Boston Scientific Corporation; Alnylam Pharmaceuticals; Duke Clinical Research Institute; Eisai; FibroGen; Daiichi Sankyo Europe; Servier; Gilead Sciences; Bristol-Myers Squibb; Cleveland Clinic; HLS Therapeutics; GlaxoSmithKline; Quest Diagnostics; Abbott Laboratories; CSL Behring; Eli Lilly and Company; Moderna; Pfizer; American Heart Association; Intarcia Therapeutics; AstraZeneca Mölndal; Amgen; Abiomed; Sanofi; National Institutes of Health; Regeneron Pharmaceuticals","keywords":"Lipoprotein(a); Medicine; Lipoprotein; Cardiology; Intensive care medicine; Internal medicine; Cholesterol","score_opus":0.014418201225235237,"score_gpt":0.2766879377190152,"score_spread":0.26226973649377994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388182377","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96284777,0.03535022,0.000055760633,0.0001736303,0.000068167465,0.00023466439,0.000010077607,0.00010535084,0.0011543653],"genre_scores_gemma":[0.9485763,0.050296195,0.0002497085,0.00012609847,0.0001097076,0.000016350297,0.000018286857,0.000017073642,0.00059032603],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9993098,0.00001048967,0.00014207567,0.00017925863,0.00020268917,0.00015571869],"domain_scores_gemma":[0.99960274,0.00003738072,0.000048088674,0.00020068878,0.000044509845,0.00006660425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012019372,0.00010240439,0.0002928013,0.000081795544,0.00004860474,0.00000667204,0.00004751271,0.000045792218,0.00006450549],"category_scores_gemma":[0.000017167313,0.00007862337,0.00013938887,0.0002639925,0.00008831513,0.000115183866,0.00002059142,0.000055863,0.00001928591],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006350185,0.000064813015,0.01848889,0.00014836021,0.0003015712,0.0001262637,0.00015137359,0.00003738548,0.0065652686,0.0005355604,0.00014904524,0.97279644],"study_design_scores_gemma":[0.011415293,0.0014444267,0.50521713,0.0004934088,0.00020717813,0.00037011039,0.0011909051,0.00023974467,0.13857569,0.018055717,0.3221555,0.00063490955],"about_ca_topic_score_codex":0.000007706159,"about_ca_topic_score_gemma":0.000001296197,"teacher_disagreement_score":0.97216153,"about_ca_system_score_codex":0.0000037021703,"about_ca_system_score_gemma":0.000012697771,"threshold_uncertainty_score":0.3206168},"labels":[],"label_agreement":null},{"id":"W4388268036","doi":"10.1016/j.jcjd.2023.10.261","title":"A FUNCTIONAL ASSAY TO QUANTIFY THE HEMOSTATIC PROPERTIES OF STIMULATED PLATELETS","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Diabetes","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Platelet; Hemostasis; Internal medicine","score_opus":0.03698291471863795,"score_gpt":0.23825903119120106,"score_spread":0.2012761164725631,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388268036","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99306065,0.0034193425,0.000025665007,0.0030139934,0.00024642568,0.00015904335,0.000019746776,0.0000102296935,0.000044931014],"genre_scores_gemma":[0.99889946,0.000016392254,0.000022956528,0.00075567,0.00010268326,0.000003169915,0.000008301985,0.000017219503,0.00017414684],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99901175,0.00007775878,0.00028857004,0.00008043312,0.0002795262,0.0002619849],"domain_scores_gemma":[0.9989649,0.00008426403,0.000089770554,0.00015578154,0.000283044,0.00042224923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005530618,0.00009756824,0.00030962474,0.00028192956,0.000099575314,0.000021941116,0.00010946452,0.0000447522,0.00013479579],"category_scores_gemma":[0.0003847918,0.00006035724,0.00025938224,0.00045846612,0.0001041873,0.00005759618,0.0000070941965,0.00014301605,0.000044936798],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007102205,0.0002311006,0.61105883,0.001240863,0.012633272,0.0018565357,0.008716702,0.021612944,0.08615439,0.00046893934,0.13834837,0.11696786],"study_design_scores_gemma":[0.0037607525,0.0010953859,0.91311073,0.001911654,0.0008971679,0.00020132812,0.0029236244,0.0012485867,0.047318224,0.00033013028,0.026816392,0.00038601065],"about_ca_topic_score_codex":0.000100947276,"about_ca_topic_score_gemma":0.00017352025,"teacher_disagreement_score":0.30205193,"about_ca_system_score_codex":0.000039699236,"about_ca_system_score_gemma":0.0008323809,"threshold_uncertainty_score":0.24612969},"labels":[],"label_agreement":null},{"id":"W4388289962","doi":"10.1016/j.cjca.2023.10.026","title":"Clopidogrel Monotherapy in Older Stable Ischemic Heart Disease Patients Receiving Percutaneous Coronary Intervention: A Paradigm Shift?","year":2023,"lang":"en","type":"editorial","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Clopidogrel; Percutaneous coronary intervention; Aspirin; Conventional PCI; Cardiology; Internal medicine; Pharmacotherapy; Coronary artery disease; Disease; Ischemia; Antiplatelet drug; Percutaneous; P2Y12; Myocardial infarction","score_opus":0.008587105366955733,"score_gpt":0.24660851920660376,"score_spread":0.23802141383964803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388289962","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17738098,0.033057906,0.00022412118,0.0009178311,0.78658706,0.0008227827,0.0006138932,0.000042236687,0.00035317903],"genre_scores_gemma":[0.63898236,0.0035743297,0.000022780378,0.0002232958,0.35595647,0.000024858917,0.0006947386,0.00016940586,0.00035173274],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.997092,0.00042304109,0.0008532057,0.00041932738,0.0005226811,0.00068972947],"domain_scores_gemma":[0.99743885,0.0003560763,0.00030496492,0.00045867282,0.00025206653,0.0011893533],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006555617,0.0004030679,0.0016117673,0.000677098,0.00009457251,0.000042674717,0.0003052424,0.00071465154,0.000094819174],"category_scores_gemma":[0.0006412191,0.00039052207,0.0014693502,0.0002596695,0.00019075525,0.00011629122,0.000022580973,0.0012993629,0.00003526402],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014703067,0.00001916129,0.055571172,0.00022613419,0.0013820481,0.008574664,0.00015372389,0.000385079,0.0000019576844,0.000002888283,0.92890096,0.0033119004],"study_design_scores_gemma":[0.0041815606,0.0004828995,0.09259788,0.0013375384,0.00056933647,0.00046737233,0.000060251634,0.000003383471,5.7643325e-7,0.00015046257,0.8998119,0.00033683973],"about_ca_topic_score_codex":0.0008237854,"about_ca_topic_score_gemma":0.0008636429,"teacher_disagreement_score":0.4616014,"about_ca_system_score_codex":0.00088796066,"about_ca_system_score_gemma":0.0043962616,"threshold_uncertainty_score":0.9998547},"labels":[],"label_agreement":null},{"id":"W4388598617","doi":"10.1016/j.rpth.2023.100567","title":"OC 18.4 Actin Bundling Protein L-Plastin Regulates Platelet Spreading and Thrombosis","year":2023,"lang":"en","type":"article","venue":"Research and Practice in Thrombosis and Haemostasis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Actin; Cell biology; Chemistry; Platelet; Biology; Immunology","score_opus":0.21789050018582995,"score_gpt":0.4460083211608287,"score_spread":0.22811782097499878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388598617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98410666,0.00635114,0.000010951791,0.00650554,0.000035084435,0.0008808841,0.000025836363,0.00009402864,0.001989871],"genre_scores_gemma":[0.93971634,0.059030216,0.0006505584,0.00013634129,0.00011989987,0.00008494623,0.000034016353,0.000046572633,0.0001810834],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9969489,0.00057346054,0.00034120862,0.00067337014,0.0007144409,0.00074860075],"domain_scores_gemma":[0.9962505,0.0027507178,0.00008465265,0.000332861,0.00019499111,0.00038623865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036834625,0.00025961583,0.0006082686,0.0004958057,0.00056299346,0.00030121315,0.00009103069,0.00020450947,0.00013087603],"category_scores_gemma":[0.0022557736,0.00022801111,0.00008939709,0.0010196294,0.00047079168,0.00064192776,0.00022843078,0.0006788403,0.000028293938],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009439401,0.001715904,0.06212555,0.003705263,0.004959985,0.001598094,0.0114136,0.000027615564,0.1064892,0.0032764792,0.011029859,0.784219],"study_design_scores_gemma":[0.025093058,0.006132652,0.5351717,0.00783713,0.001467274,0.0022986936,0.07987824,0.0024413816,0.11921587,0.0090317,0.20863196,0.002800352],"about_ca_topic_score_codex":0.00045242635,"about_ca_topic_score_gemma":0.00004048197,"teacher_disagreement_score":0.7814187,"about_ca_system_score_codex":0.000048945192,"about_ca_system_score_gemma":0.000113299066,"threshold_uncertainty_score":0.9298023},"labels":[],"label_agreement":null},{"id":"W4388598656","doi":"10.1016/j.rpth.2023.100568","title":"OC 18.5 Alpha-Dystroglycan Supports Platelet Aggregation and Hemostasis/ Thrombosis Via Binding to GPIbα","year":2023,"lang":"en","type":"article","venue":"Research and Practice in Thrombosis and Haemostasis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Hemostasis; Platelet; Alpha (finance); Thrombosis; Platelet aggregation; Chemistry; Medicine; Internal medicine; Surgery","score_opus":0.16209561942635103,"score_gpt":0.44375415697498277,"score_spread":0.28165853754863174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388598656","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9808924,0.003766644,0.00003769534,0.01290036,0.00006573694,0.0009941807,0.0000731304,0.00008697472,0.0011828694],"genre_scores_gemma":[0.93189216,0.06646674,0.0006254157,0.0005355813,0.00011215378,0.00009042575,0.000113332186,0.00005110086,0.00011309949],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9965834,0.00050376955,0.00039670017,0.0007622798,0.0009138656,0.00083998765],"domain_scores_gemma":[0.99695843,0.0016442814,0.00008629073,0.0003994645,0.00025012414,0.0006614204],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003533484,0.00028548558,0.00064361596,0.0007408311,0.00055288925,0.00028464923,0.00010057181,0.00019162911,0.00018789129],"category_scores_gemma":[0.0012132459,0.0002613504,0.000104062856,0.0015046524,0.00033378488,0.0006666341,0.0002442837,0.00052024657,0.000060725317],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023342008,0.0005178842,0.047198843,0.0006319546,0.0014583509,0.000807442,0.0038894997,0.0000056262797,0.006467179,0.00034280383,0.014699568,0.92164665],"study_design_scores_gemma":[0.019439152,0.007686167,0.5079043,0.0031441124,0.0015936841,0.00332958,0.05340893,0.0007762586,0.05433126,0.0033321958,0.34249476,0.0025596148],"about_ca_topic_score_codex":0.00054456544,"about_ca_topic_score_gemma":0.000064299806,"teacher_disagreement_score":0.91908705,"about_ca_system_score_codex":0.00007999171,"about_ca_system_score_gemma":0.00013284925,"threshold_uncertainty_score":0.99998385},"labels":[],"label_agreement":null},{"id":"W4388601108","doi":"10.1093/eurheartj/ehad655.1167","title":"Effectiveness and tolerability of trimetazidine 80mg once daily in patients with chronic coronary syndrome: the V-GOOD observational study","year":2023,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Servier","keywords":"Medicine; Tolerability; Angina; Trimetazidine; Internal medicine; Observational study; Dyslipidemia; Canadian Cardiovascular Society; Acute coronary syndrome; Diabetes mellitus; Physical therapy; Adverse effect; Disease; Myocardial infarction","score_opus":0.04271962054459124,"score_gpt":0.29025353602876836,"score_spread":0.2475339154841771,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388601108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99830973,0.0008795459,0.000014258523,0.000098811695,0.000060651102,0.00057640235,0.0000054214706,0.000016587606,0.00003859324],"genre_scores_gemma":[0.9997839,0.00005815307,0.000015934109,0.000038671118,0.000047598598,0.0000039861943,0.000008510053,0.000019791612,0.000023459965],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980334,0.000989599,0.00024595167,0.00016858353,0.00040889473,0.0001535803],"domain_scores_gemma":[0.99938285,0.00016493932,0.00006994288,0.00020699053,0.000097448465,0.00007782811],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019431555,0.000108423716,0.00032360104,0.00007115921,0.00012288125,0.000016782911,0.00007550444,0.0000133423455,0.000029880226],"category_scores_gemma":[0.00006576656,0.00006562732,0.00010238888,0.0003259642,0.000087919216,0.00010090315,0.000045091987,0.00025030682,0.000008909503],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092478597,0.0004093675,0.9944658,0.00005805641,0.00028692835,0.00035618225,0.00012081102,0.00018372867,0.00007884984,0.0000025533955,0.000032066822,0.0030808486],"study_design_scores_gemma":[0.00652891,0.0022158988,0.9901283,0.00021199098,0.00010221249,0.00039826872,0.00010210575,0.000017852666,0.000021685637,0.0000063770376,0.00019758262,0.00006885709],"about_ca_topic_score_codex":0.0000036980537,"about_ca_topic_score_gemma":0.0000010882117,"teacher_disagreement_score":0.0056041237,"about_ca_system_score_codex":0.000046772784,"about_ca_system_score_gemma":0.000115194154,"threshold_uncertainty_score":0.26762044},"labels":[],"label_agreement":null},{"id":"W4388869530","doi":"10.1002/jgm.3634","title":"Pharmacogenomic evaluation of CYP2C19 alleles linking low clopidogrel response and the risk of acute coronary syndrome in Indians","year":2023,"lang":"en","type":"article","venue":"The Journal of Gene Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"York University","keywords":"Clopidogrel; CYP2C19; Medicine; Acute coronary syndrome; Internal medicine; Pharmacogenomics; Unstable angina; Myocardial infarction; Population; Cardiology; Cohort; Pharmacology","score_opus":0.02153917072670721,"score_gpt":0.3034247194355266,"score_spread":0.28188554870881943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388869530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9692464,0.028154233,0.00007778209,0.0019880189,0.0001279744,0.00037713675,0.000010782687,0.0000048182033,0.000012878776],"genre_scores_gemma":[0.95614535,0.043524183,0.000024276209,0.0001394196,0.00012136442,0.00000287258,0.000005525325,0.000014551175,0.000022482736],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9969304,0.0014296451,0.00060750527,0.00007780104,0.00082162535,0.0001329898],"domain_scores_gemma":[0.99828494,0.00067992194,0.00051609037,0.00022468595,0.00022968778,0.000064651635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0142878955,0.00011268968,0.0005915798,0.00026988727,0.000054510834,0.0000016989429,0.00016321914,0.000047205132,0.00004454042],"category_scores_gemma":[0.00029190994,0.000054571727,0.00019117672,0.000356382,0.0004378453,0.000039959927,0.00002965252,0.0002698439,0.0000016205056],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18363228,0.0004939906,0.1646769,0.0006442232,0.025982685,0.0025297648,0.045295596,0.009275605,0.38700607,0.000029381068,0.0011241655,0.17930932],"study_design_scores_gemma":[0.029999774,0.0013186017,0.94370234,0.0011414242,0.009209103,0.0045017553,0.0025880437,0.0020943247,0.0048534824,0.00043388107,0.00007180058,0.000085448686],"about_ca_topic_score_codex":0.000025250907,"about_ca_topic_score_gemma":0.0000023202886,"teacher_disagreement_score":0.77902544,"about_ca_system_score_codex":0.000037514597,"about_ca_system_score_gemma":0.0002137072,"threshold_uncertainty_score":0.4951928},"labels":[],"label_agreement":null},{"id":"W4389220514","doi":"10.5770/cgj.26.693","title":"Prevalence of Acetylsalicylic Acid Use for Primary Prevention of Cardiovascular Disease Amongst Older Adults From 2017—2021: a Retrospective Cross-Sectional Study","year":2023,"lang":"en","type":"article","venue":"Canadian Geriatrics Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Island Health; Fraser Health; University of British Columbia; Interior Health","funders":"","keywords":"Medicine; Cross-sectional study; Primary prevention; Retrospective cohort study; Disease; Internal medicine; Pathology","score_opus":0.019619990419418334,"score_gpt":0.26655973304723546,"score_spread":0.24693974262781712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389220514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98676276,0.009159501,0.00071536016,0.000022444552,0.000508959,0.0013863432,0.0014045434,0.000020672862,0.000019406634],"genre_scores_gemma":[0.99574953,0.0028524583,0.00015185923,0.000023488163,0.00070731825,0.00006391998,0.00017332772,0.000043379157,0.00023471675],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99752486,0.00017154633,0.00061193743,0.00043470348,0.0008649964,0.00039195997],"domain_scores_gemma":[0.9974387,0.00006775743,0.00029022276,0.0005900563,0.00083983806,0.00077341305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009918687,0.00021307371,0.00059947046,0.0005061493,0.00022288988,0.000069591355,0.0002056351,0.00013200023,0.00013848794],"category_scores_gemma":[0.000472731,0.00021081505,0.0015338062,0.0006224435,0.00010489748,0.00030573824,0.00003373944,0.00024847913,0.000007227936],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010763786,0.00023686934,0.9888134,0.00037894625,0.004255207,0.00031875368,0.00036085965,0.00033526696,0.00009079362,0.00000662081,0.0005164467,0.0036104445],"study_design_scores_gemma":[0.0051177796,0.00033883486,0.9914256,0.0001772802,0.001857967,0.00005009841,0.00018715857,0.00005659937,0.00008513737,0.000108217915,0.00041163748,0.00018370459],"about_ca_topic_score_codex":0.0034281325,"about_ca_topic_score_gemma":0.00033002553,"teacher_disagreement_score":0.008986763,"about_ca_system_score_codex":0.00039592598,"about_ca_system_score_gemma":0.0015116937,"threshold_uncertainty_score":0.8596788},"labels":[],"label_agreement":null},{"id":"W4389328213","doi":"10.1016/j.cjco.2023.11.024","title":"Potent P2Y12 Inhibitor Selection and De-escalation Strategies in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention: Systematic Review and Meta-analysis","year":2023,"lang":"en","type":"article","venue":"CJC Open","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Montreal Heart Institute; University of Ottawa","funders":"University of Ottawa Heart Institute Foundation","keywords":"Percutaneous coronary intervention; Acute coronary syndrome; De-escalation; Medicine; P2Y12; Internal medicine; Cardiology; Selection (genetic algorithm); Myocardial infarction; Computer science","score_opus":0.025156038683973102,"score_gpt":0.2974624214080817,"score_spread":0.2723063827241086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389328213","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96478343,0.03276887,0.00012449628,0.00021856917,0.000019552355,0.0019740236,0.000017648252,0.000045140023,0.00004828635],"genre_scores_gemma":[0.99284977,0.006196718,0.00006442187,0.00019922604,0.0000043645305,0.00012354764,0.00016693155,0.000015630805,0.00037937358],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9986891,0.00028468433,0.00038763293,0.00028255658,0.0002056697,0.00015034575],"domain_scores_gemma":[0.9995094,0.000057430374,0.000108979046,0.00017922657,0.000062214196,0.000082784434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005204845,0.00015266589,0.0013067643,0.00015560511,0.00008705957,0.00009552019,0.00007449449,0.000059627866,0.00010658415],"category_scores_gemma":[0.000035410958,0.0001202362,0.00041678434,0.00050483044,0.000026843421,0.00031362133,0.00010189474,0.00008943872,0.000011822712],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010410518,0.0009843323,0.102871366,0.26148257,0.6215998,0.00689426,0.0012033659,0.0010388667,0.00013846788,0.0002356031,0.00043490372,0.002075417],"study_design_scores_gemma":[0.0017455415,0.0007090219,0.4294958,0.004532989,0.55626327,0.0047734384,0.0010148238,0.0009623223,0.0000063792368,0.00019409496,0.000005728519,0.00029660563],"about_ca_topic_score_codex":0.00003178196,"about_ca_topic_score_gemma":0.00005722848,"teacher_disagreement_score":0.32662442,"about_ca_system_score_codex":0.00007372977,"about_ca_system_score_gemma":0.000047130914,"threshold_uncertainty_score":0.49030897},"labels":[],"label_agreement":null},{"id":"W4389490617","doi":"10.1007/s11239-023-02914-7","title":"Early assessment of the pharmacokinetic and pharmacodynamic effects following acetylsalicylic acid loading: toward a definition for acute therapeutic response","year":2023,"lang":"en","type":"article","venue":"Journal of Thrombosis and Thrombolysis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Artificial Intelligence in Medicine (Canada)","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Pharmacodynamics; Aspirin; Pharmacokinetics; Pharmacology; Area under the curve; Thromboxane B2; Arachidonic acid; Receiver operating characteristic; Platelet; Internal medicine; Gastroenterology; Chemistry; Biochemistry","score_opus":0.037089373289858105,"score_gpt":0.36144846456431146,"score_spread":0.32435909127445334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389490617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99378383,0.0031480342,0.0009170639,0.0013407746,0.00029384912,0.00045280895,0.000018113979,0.000021210806,0.000024318015],"genre_scores_gemma":[0.99282503,0.0063447733,0.00038415068,0.00028684517,0.000086092376,0.000021912669,0.0000037540292,0.000033171535,0.000014265024],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99841064,0.00026986672,0.00043417807,0.00019328481,0.00045614305,0.0002358582],"domain_scores_gemma":[0.9989078,0.0003276416,0.00032442142,0.00018842454,0.00011940121,0.0001323002],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010257713,0.00020268837,0.0008233727,0.0002319721,0.00016369764,0.000038750113,0.00012636535,0.00007756797,0.000011006344],"category_scores_gemma":[0.000054040956,0.00013305039,0.0010293956,0.00046677754,0.00011340535,0.00015848648,0.000058076967,0.00019066995,6.711628e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008057758,0.0001654562,0.019631274,0.0003080923,0.012406614,0.000026490756,0.0006975415,0.0000126818595,0.9557509,0.00008963086,0.000071832656,0.0100337],"study_design_scores_gemma":[0.0072380505,0.0010824535,0.9235078,0.0005062377,0.015094835,0.00011551375,0.00030410755,0.0008950065,0.05027434,0.0005854665,0.00020409781,0.00019210656],"about_ca_topic_score_codex":0.0000031837822,"about_ca_topic_score_gemma":1.7785533e-7,"teacher_disagreement_score":0.90547657,"about_ca_system_score_codex":0.00004615703,"about_ca_system_score_gemma":0.000098096316,"threshold_uncertainty_score":0.54256374},"labels":[],"label_agreement":null},{"id":"W4389907787","doi":"","title":"Cost-effectiveness of ticagrelor versus clopidogrel in patients with acute coronary syndromes in Canada","year":2014,"lang":"en","type":"article","venue":"DOAJ (DOAJ: Directory of Open Access Journals)","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ticagrelor; Clopidogrel; Medicine; Acute coronary syndrome; Internal medicine; Cardiology; Aspirin; Intensive care medicine; Myocardial infarction","score_opus":0.12733988354349277,"score_gpt":0.46701344733225825,"score_spread":0.33967356378876545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389907787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938225,0.004194869,0.000057450892,0.000018659675,0.00028662715,0.0010662467,0.00004616549,0.000007800263,0.0004996421],"genre_scores_gemma":[0.9975932,0.0021304465,0.000037387203,0.00007357928,0.000022368446,0.00004855143,0.000043347125,0.000038595117,0.000012489666],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975007,0.00046884036,0.00056167896,0.0003336418,0.00080490386,0.00033023377],"domain_scores_gemma":[0.99833775,0.00046704544,0.00032569657,0.00042041528,0.00022954802,0.00021952268],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008031166,0.00026258582,0.0011665645,0.00042858865,0.00004748339,0.000053518892,0.0006816838,0.00007491797,0.0007535551],"category_scores_gemma":[0.00013580675,0.00021175067,0.00016876182,0.0007204942,0.00011407013,0.0005648719,0.00019156754,0.00028938183,0.0000020520774],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011433643,0.00039152635,0.96365976,0.00022137148,0.0010968341,0.00028062088,0.000027706716,0.00025090668,0.00032735517,0.000013047524,0.00025139673,0.022045832],"study_design_scores_gemma":[0.010036911,0.0001104245,0.9858136,0.0012720445,0.0002881793,0.00001973215,0.00004492462,0.000027398472,0.0016409595,0.000073437026,0.00043122133,0.00024116666],"about_ca_topic_score_codex":0.09737063,"about_ca_topic_score_gemma":0.027327625,"teacher_disagreement_score":0.070043005,"about_ca_system_score_codex":0.00037405494,"about_ca_system_score_gemma":0.00081567134,"threshold_uncertainty_score":0.9904211},"labels":[],"label_agreement":null},{"id":"W4389957163","doi":"10.1161/circ.148.suppl_1.18621","title":"Abstract 18621: Platelet Aggregation is Heightened in Those With Metabolic Syndrome and Less Effectively Mediated by Aspirin Therapy","year":2023,"lang":"en","type":"article","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Berger (Canada)","funders":"","keywords":"Medicine; Aspirin; Platelet; Internal medicine; Metabolic syndrome; Ex vivo; Cohort; Adenosine diphosphate; Arachidonic acid; Endocrinology; Cardiology; In vivo; Platelet aggregation; Obesity; Biochemistry","score_opus":0.020197476437344604,"score_gpt":0.25405205667548036,"score_spread":0.23385458023813577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389957163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918609,0.0068833274,0.00013283775,0.00015686471,0.000035929443,0.00068616716,0.000020201313,0.00013784622,0.000085888],"genre_scores_gemma":[0.99658513,0.0026301527,0.000014290834,0.00018195422,0.00003116949,0.00006111509,0.00044684735,0.00003463308,0.000014701062],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99887204,0.00007574359,0.00019577853,0.00032467468,0.00032529107,0.0002064942],"domain_scores_gemma":[0.9995026,0.00007731267,0.00007770762,0.00019430224,0.000056000423,0.00009208591],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003074458,0.0001762383,0.00036594615,0.00020728305,0.00006971003,0.000026798207,0.000038817652,0.00012332939,0.0000342054],"category_scores_gemma":[0.000020627074,0.0001426516,0.00009302411,0.00058691937,0.00005639336,0.00019927292,0.000007889648,0.00012256029,0.00003379598],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012846275,0.00026513648,0.5764203,0.00021920844,0.0012203628,0.0006218568,0.0012683991,0.00036935043,0.035793334,0.000082128,0.00015921051,0.3822961],"study_design_scores_gemma":[0.0045520486,0.000078418416,0.9867741,0.0001719258,0.000059283095,0.00010170629,0.00009200847,0.0006952615,0.0065085315,0.00012628705,0.00066565035,0.00017480782],"about_ca_topic_score_codex":0.0000663808,"about_ca_topic_score_gemma":0.000005961758,"teacher_disagreement_score":0.41035375,"about_ca_system_score_codex":0.000031518004,"about_ca_system_score_gemma":0.00004526863,"threshold_uncertainty_score":0.5817163},"labels":[],"label_agreement":null},{"id":"W4390262423","doi":"10.1056/nejmoa2309137","title":"Dual Antiplatelet Treatment up to 72 Hours after Ischemic Stroke","year":2023,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":143,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"Beijing Young Talent; National Key Research and Development Program of China; National Natural Science Foundation of China; Chinese Government Scholarship; Recruitment Program of Global Experts; China National Funds for Distinguished Young Scientists; Sanofi","keywords":"Medicine; Dual (grammatical number); Ischemic stroke; Stroke (engine); Cardiology; Internal medicine; Ischemia; Engineering; Art","score_opus":0.01882687827061207,"score_gpt":0.2801616700593497,"score_spread":0.26133479178873764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390262423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868756,0.005118633,0.00021242627,0.0059222337,0.0009136082,0.00020000343,0.000012039127,0.000046061028,0.0006994168],"genre_scores_gemma":[0.9842552,0.0036826867,0.000105490406,0.00090182293,0.0063596326,0.000004257342,0.000016426671,0.00003309558,0.0046414007],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99827904,0.0000650319,0.00044674904,0.000179392,0.0006753503,0.0003544277],"domain_scores_gemma":[0.99869704,0.0000998761,0.00012213267,0.00025199054,0.00013790137,0.0006910798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006096628,0.00022262019,0.00074275193,0.0003614603,0.000044901248,0.000010136414,0.00008259007,0.000077757104,0.00051384314],"category_scores_gemma":[0.00014133213,0.000135596,0.00034290075,0.00033997252,0.00006477671,0.00007216968,0.000021096394,0.0002104341,0.00009683228],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014496262,0.0001461884,0.033025358,0.00006589021,0.0029053856,0.014720679,0.0039559,0.000105162,0.023592848,0.000010202687,0.15112604,0.7558501],"study_design_scores_gemma":[0.13643952,0.0074302787,0.072946765,0.0010674563,0.0017730279,0.008957124,0.0012297186,0.000015888207,0.007955107,0.000042707936,0.7618403,0.00030210064],"about_ca_topic_score_codex":0.000028310817,"about_ca_topic_score_gemma":0.0000060257694,"teacher_disagreement_score":0.755548,"about_ca_system_score_codex":0.00006431912,"about_ca_system_score_gemma":0.0001948714,"threshold_uncertainty_score":0.5626222},"labels":[],"label_agreement":null},{"id":"W4390765019","doi":"10.1016/j.ahj.2024.01.001","title":"Identifying the highest risk vascular patients: Insights from the XATOA registry","year":2024,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; McMaster University; Population Health Research Institute","funders":"Bayer","keywords":"Medicine; Mace; Coronary artery disease; Internal medicine; Interquartile range; Aspirin; Incidence (geometry); Risk factor; Diabetes mellitus; Hazard ratio; Chest pain; Adverse effect; Cardiology; Surgery; Percutaneous coronary intervention; Myocardial infarction; Confidence interval","score_opus":0.012320432346415562,"score_gpt":0.2662910376939365,"score_spread":0.253970605347521,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390765019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95016897,0.045766007,0.00092562503,0.0020635764,0.0006557431,0.00017669285,0.000017624267,0.00006578555,0.00015997175],"genre_scores_gemma":[0.9879045,0.007969473,0.00016022613,0.0022565424,0.0015693974,0.000008301601,0.00001424478,0.00003557674,0.00008177356],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982033,0.0003970829,0.00027405724,0.00023828952,0.00064670166,0.000240579],"domain_scores_gemma":[0.99879134,0.000297685,0.000103151826,0.00054235046,0.000093739895,0.00017172821],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033529953,0.00016856927,0.00032167585,0.000046585814,0.0005709054,0.00027010898,0.00020787447,0.000036503225,0.00020028885],"category_scores_gemma":[0.00012232005,0.00008140514,0.00084253313,0.0003604603,0.00037985676,0.0001428128,0.00004350864,0.00080360303,0.00014637313],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040949267,0.00038234747,0.49371648,0.00006836216,0.011253064,0.0012250909,0.0048290547,0.000075540054,0.0009554274,0.00020384321,0.13229443,0.35458687],"study_design_scores_gemma":[0.00051427825,0.00013826825,0.4457442,0.00026571602,0.00090479775,0.0003310466,0.0016574982,0.000065126995,0.00011506802,0.00036603905,0.5497623,0.00013564578],"about_ca_topic_score_codex":0.00040102983,"about_ca_topic_score_gemma":0.0000074566774,"teacher_disagreement_score":0.4174679,"about_ca_system_score_codex":0.000057297188,"about_ca_system_score_gemma":0.00014041815,"threshold_uncertainty_score":0.43910006},"labels":[],"label_agreement":null},{"id":"W4391274883","doi":"10.1016/j.pathol.2023.12.095","title":"Update on diagnostic testing for platelet function disorders","year":2024,"lang":"en","type":"article","venue":"Pathology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Platelet; Function (biology); Diagnostic test; Medicine; Internal medicine; Biology; Pediatrics; Genetics","score_opus":0.01593818674521489,"score_gpt":0.26510127898881686,"score_spread":0.24916309224360197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391274883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96310234,0.010927684,0.020897193,0.0011171672,0.0010272891,0.00060484995,0.000034752982,0.00035309212,0.0019356308],"genre_scores_gemma":[0.997725,0.00039030172,0.00029176043,0.0008907618,0.0003201796,0.00011449843,0.000091274895,0.000029025907,0.00014719539],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993471,0.000033823537,0.00010605827,0.0002517754,0.000077285935,0.00018398384],"domain_scores_gemma":[0.9992519,0.00051023153,0.000013523265,0.00015051986,0.000023085195,0.000050737737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001585948,0.000100400655,0.00017364991,0.00007509104,0.000059881266,0.000012661149,0.000028552662,0.00007454309,0.00006485135],"category_scores_gemma":[0.0004092087,0.00008246378,0.00018154076,0.000114763716,0.000044344128,0.000030155757,0.000008988471,0.00010328301,0.00018912241],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050393457,0.00011658424,0.0047017983,0.00028042117,0.00033553774,0.00080015115,0.000072416,0.000111526264,0.0013134337,0.0035423758,0.0029836465,0.9852382],"study_design_scores_gemma":[0.0063242884,0.0063518006,0.11781514,0.0007205877,0.0017469984,0.001900176,0.00019699734,0.0033028082,0.002279311,0.02479663,0.8338444,0.0007208577],"about_ca_topic_score_codex":0.0000013255121,"about_ca_topic_score_gemma":0.0000011734085,"teacher_disagreement_score":0.98451734,"about_ca_system_score_codex":0.0000149034,"about_ca_system_score_gemma":0.000031750136,"threshold_uncertainty_score":0.33627754},"labels":[],"label_agreement":null},{"id":"W4391482579","doi":"10.1016/j.cjca.2024.01.032","title":"Geographical Variations in the Effectiveness and Safety of Abbreviated or Standard Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients at High Bleeding Risk","year":2024,"lang":"en","type":"letter","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Steno Diabetes Center Aarhus","keywords":"Medicine; Percutaneous coronary intervention; Major bleeding; Internal medicine; Myocardial infarction","score_opus":0.006809808377892908,"score_gpt":0.22623010972588567,"score_spread":0.21942030134799276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391482579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9814195,0.01199021,0.00009675626,0.0047026784,0.0005654412,0.0006442712,0.0005356823,0.000003927747,0.000041501495],"genre_scores_gemma":[0.9894931,0.0055287606,0.000011371888,0.0041825925,0.0005828427,0.000013824484,0.00014520998,0.000035473244,0.000006858114],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966955,0.0017570102,0.00067497196,0.00025698254,0.0002899129,0.00032561406],"domain_scores_gemma":[0.99873817,0.00046856925,0.00023228077,0.00022420827,0.00021041337,0.00012636193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015974999,0.0002616296,0.0012305914,0.00076588785,0.000059901024,0.00002147833,0.00015453549,0.0005737545,0.00006285809],"category_scores_gemma":[0.00014647056,0.00016886811,0.0006931042,0.00032414106,0.00025145672,0.00005447213,0.000019610605,0.0014522694,0.0000012863343],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017856948,0.000019167275,0.92044944,0.0005525919,0.0043017208,0.027465817,0.000391145,0.0001693997,0.0000075387957,0.000010460695,0.009667426,0.019108355],"study_design_scores_gemma":[0.004953279,0.0015393182,0.9193234,0.0012718515,0.0007707977,0.005344664,0.00004903799,0.0000030011256,0.0000026319183,0.00019582367,0.066372536,0.00017370093],"about_ca_topic_score_codex":0.0007256145,"about_ca_topic_score_gemma":0.0007388086,"teacher_disagreement_score":0.05670511,"about_ca_system_score_codex":0.00031125275,"about_ca_system_score_gemma":0.0004136491,"threshold_uncertainty_score":0.68862414},"labels":[],"label_agreement":null},{"id":"W4391751102","doi":"10.1503/cmaj.231262","title":"Differential effect of ticagrelor versus clopidogrel by homocysteine levels on risk of recurrent stroke: a post hoc analysis of the CHANCE-2 trial","year":2024,"lang":"en","type":"article","venue":"Canadian Medical Association Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Key Research and Development Program of China; Capital Medical University; National Institute for Health and Care Research","keywords":"Ticagrelor; Medicine; Clopidogrel; Post-hoc analysis; Homocysteine; Hazard ratio; Stroke (engine); Internal medicine; Confidence interval; Cardiology; Anesthesia; Aspirin","score_opus":0.006619875828620931,"score_gpt":0.2535932390661576,"score_spread":0.24697336323753669,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391751102","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99291295,0.002875827,0.000060083763,0.0011599925,0.001676171,0.000258116,0.00095518306,0.0000060897232,0.000095597185],"genre_scores_gemma":[0.99834406,0.0007798583,0.0000028943687,0.000083360836,0.00062132726,0.000004868953,0.00003584448,0.000011493193,0.00011629339],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9968906,0.00054489815,0.0005427216,0.00014644665,0.0016420124,0.00023329689],"domain_scores_gemma":[0.9982165,0.00054459204,0.00033721174,0.0001780994,0.00023828966,0.00048531356],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00095150236,0.00013387525,0.00070020725,0.0003122672,0.00007376621,0.00001558221,0.00015853734,0.00023094179,0.0011296986],"category_scores_gemma":[0.0016576146,0.00008320045,0.0013111,0.0006146499,0.00008468676,0.000030061143,0.000011924943,0.0005974349,0.0000041490935],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07389974,0.00063257595,0.031512883,0.0005507258,0.10983155,0.000324507,0.0008380202,0.000046651418,0.0014828175,0.00022425615,0.028437687,0.7522186],"study_design_scores_gemma":[0.37421802,0.047223255,0.3272465,0.006029927,0.12533474,0.00022167336,0.0010195738,0.0066495077,0.015583011,0.000055967124,0.09506344,0.0013543926],"about_ca_topic_score_codex":0.0003865028,"about_ca_topic_score_gemma":0.0009711492,"teacher_disagreement_score":0.7508642,"about_ca_system_score_codex":0.0003192663,"about_ca_system_score_gemma":0.0010568148,"threshold_uncertainty_score":0.9997834},"labels":[],"label_agreement":null},{"id":"W4391785853","doi":"10.1161/jaha.122.026921","title":"Age and Aspirin Dosing in Secondary Prevention of Atherosclerotic Cardiovascular Disease","year":2024,"lang":"en","type":"article","venue":"Journal of the American Heart Association","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Medicine; Interquartile range; Aspirin; Hazard ratio; Clinical endpoint; Randomized controlled trial; Internal medicine; Myocardial infarction; Stroke (engine); Dosing; Surgery; Confidence interval","score_opus":0.01265269988961115,"score_gpt":0.26446750856932455,"score_spread":0.2518148086797134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391785853","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98706776,0.012012177,0.00014363155,0.00045267201,0.00013734371,0.00014035923,0.0000031845411,0.000006607247,0.000036284622],"genre_scores_gemma":[0.9986764,0.0008827969,0.0000972172,0.00011362349,0.00013732605,0.0000015684761,8.7243626e-7,0.000011420543,0.00007876042],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99884576,0.00028006692,0.00027215798,0.00008561055,0.0004209317,0.00009547526],"domain_scores_gemma":[0.99952155,0.00007140724,0.0001533371,0.00013591253,0.000057351423,0.00006045316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010662216,0.00006645134,0.00044816468,0.00009838937,0.000026443613,0.000020401645,0.000039215392,0.00002254286,0.000006224768],"category_scores_gemma":[0.00013943289,0.000047429767,0.0008872622,0.00026882542,0.000050143946,0.000107219224,0.00001624966,0.00018913783,9.595736e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055253983,0.00024713046,0.7753414,0.0005203382,0.005556779,0.00025728735,0.00068280916,0.0007991376,0.011465275,0.00003208365,0.0005010928,0.20404413],"study_design_scores_gemma":[0.0006663614,0.00014796271,0.99384385,0.00070673536,0.0007844201,0.000052830674,0.000110391185,0.00011411435,0.00034316434,0.00022495993,0.0029542774,0.00005090735],"about_ca_topic_score_codex":0.00002634553,"about_ca_topic_score_gemma":0.0000017351688,"teacher_disagreement_score":0.21850248,"about_ca_system_score_codex":0.0001705709,"about_ca_system_score_gemma":0.00015383885,"threshold_uncertainty_score":0.19341297},"labels":[],"label_agreement":null},{"id":"W4392267184","doi":"10.1001/jama.289.15.1925-d","title":"Clopidogrel and Percutaneous Coronary Interventions—Reply","year":2003,"lang":"en","type":"article","venue":"JAMA","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Clopidogrel; Psychological intervention; Percutaneous; Percutaneous coronary intervention; Cardiology; Internal medicine; Myocardial infarction","score_opus":0.01678164667126934,"score_gpt":0.26566997620974686,"score_spread":0.24888832953847753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392267184","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9752089,0.016368832,0.00028648807,0.00047528854,0.00010075173,0.0001595747,0.0000046176488,0.00005430984,0.007341281],"genre_scores_gemma":[0.9952349,0.0010337972,0.00046366872,0.0014101048,0.000072127084,0.000005347666,0.000010411052,0.000012803418,0.0017568584],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994609,0.00005200222,0.00011298373,0.00014811383,0.000113918955,0.000112097194],"domain_scores_gemma":[0.99964327,0.000022429736,0.000019079638,0.0001814763,0.000037107908,0.00009661053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001191488,0.000076462995,0.00015885894,0.000033641503,0.000053781085,0.0000179306,0.000024129922,0.00004523701,0.00045864368],"category_scores_gemma":[0.0000796308,0.00006540308,0.00025793345,0.0000535336,0.000055015593,0.00004800091,0.000010529684,0.00008735551,0.000053333893],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010486171,0.0006971022,0.11256321,0.0007095016,0.0018416994,0.006293299,0.00052086875,0.0000060602874,0.0019712492,0.0067159333,0.012719919,0.8549125],"study_design_scores_gemma":[0.0075155203,0.0010069825,0.3250922,0.0006091825,0.0009401555,0.04821852,0.001099842,0.000047971902,0.0011101456,0.0013107789,0.6126103,0.00043841032],"about_ca_topic_score_codex":0.00000449753,"about_ca_topic_score_gemma":7.363725e-7,"teacher_disagreement_score":0.8544741,"about_ca_system_score_codex":0.0000134675165,"about_ca_system_score_gemma":0.00002571097,"threshold_uncertainty_score":0.50218266},"labels":[],"label_agreement":null},{"id":"W4392366229","doi":"10.4244/eij-d-23-00699","title":"One-month DAPT with ticagrelor and aspirin for patients undergoing coronary artery bypass grafting: rationale and design of the randomised, multicentre, double-blind, placebo-controlled ODIN trial","year":2024,"lang":"en","type":"article","venue":"EuroIntervention","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Health Sciences Centre; Population Health Research Institute; University of Toronto; Sunnybrook Health Science Centre","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health; Idorsia Pharmaceuticals; Medizinische Universität Wien; Sahlgrenska Universitetssjukhuset; Università Cattolica del Sacro Cuore; University of California, San Diego; University of Toronto; Assistance publique-Hôpitaux de Paris; Saint Luke's Health System; Regado Biosciences; Canadian Institutes of Health Research; London School of Hygiene and Tropical Medicine; University of Missouri-Kansas City; Boston VA Research Institute; University of Ottawa; Universität Wien; Boston Scientific Corporation; Duke Clinical Research Institute; Eisai; Cytokinetics; Bristol-Myers Squibb; Cleveland Clinic; York University; Pfizer; University of Missouri; Alnylam Pharmaceuticals; Novo Nordisk; MyoKardia; McMaster University; Daiichi Sankyo Europe; Gilead Sciences; Weill Cornell Medical College; CSL Behring; Eli Lilly and Company; AstraZeneca; Edwards Lifesciences; Amgen; Sanofi; American Heart Association","keywords":"Medicine; Ticagrelor; Aspirin; Bypass grafting; Artery; Placebo; Internal medicine; Coronary artery bypass surgery; Cardiology; Platelet aggregation inhibitor; Randomized controlled trial; Surgery; Clopidogrel","score_opus":0.041068248356835806,"score_gpt":0.27359244772319913,"score_spread":0.23252419936636332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392366229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96568096,0.0023140376,0.024434531,0.00019502347,0.0002067205,0.0070592044,0.000014248919,0.00003464371,0.000060619437],"genre_scores_gemma":[0.99884933,0.000105053354,0.00033923876,0.000029385692,0.00008350083,0.00011237575,0.0000551002,0.000024537641,0.0004014925],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99884254,0.00019071331,0.00035091062,0.00025076908,0.00023826247,0.00012680102],"domain_scores_gemma":[0.99919844,0.00041196682,0.00011680349,0.00013852172,0.000076766046,0.000057500736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048751105,0.00013491295,0.00034823178,0.00006739174,0.00008799947,0.000052437157,0.00004046163,0.00004166393,0.000016185017],"category_scores_gemma":[0.00010466872,0.00009043264,0.00036797347,0.00006847813,0.000068734706,0.000120722216,0.000022815439,0.00008134077,0.0000013988628],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.99107647,0.0004367347,0.0010424876,0.0004667787,0.0018385103,0.000011832745,0.0001680822,0.00006986736,0.00029481566,0.00013490857,0.00008149246,0.004378006],"study_design_scores_gemma":[0.9837264,0.002391528,0.004343495,0.001185023,0.0018129792,0.00003440903,0.00010436967,0.0056656995,0.0003940193,0.00009820138,0.000120878525,0.00012303144],"about_ca_topic_score_codex":0.0000017171355,"about_ca_topic_score_gemma":0.0000067044643,"teacher_disagreement_score":0.033168346,"about_ca_system_score_codex":0.000021540016,"about_ca_system_score_gemma":0.000060236776,"threshold_uncertainty_score":0.36877358},"labels":[],"label_agreement":null},{"id":"W4392499402","doi":"10.1093/eurheartj/ehae003","title":"Urinary thromboxane and risk of cardiovascular events: role of aspirin","year":2024,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Thrombosis and Atherosclerosis Research Institute; McMaster University; Population Health Research Institute","funders":"Medical Research Council","keywords":"Medicine; Aspirin; Thromboxane; Urinary system; Thromboxane A2; Internal medicine; Cardiology; Platelet","score_opus":0.015591301602653977,"score_gpt":0.2585152752917323,"score_spread":0.2429239736890783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392499402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8049315,0.19242646,0.00026551838,0.000037178987,0.000110607085,0.00008337727,0.000010167641,0.00001855998,0.0021166368],"genre_scores_gemma":[0.9767621,0.02247765,0.000261707,0.000021899325,0.00035678226,4.0185648e-7,0.0000026040016,0.000034131503,0.000082725455],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986453,0.00042597772,0.00026490013,0.00015505539,0.00036891093,0.00013985949],"domain_scores_gemma":[0.9994499,0.000032105334,0.000050138187,0.0002592363,0.00006472956,0.00014385223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011944834,0.00011137468,0.00042571945,0.00011093442,0.00005673726,0.000013288358,0.00005807747,0.000025382737,0.00010225272],"category_scores_gemma":[0.00003543241,0.0000864649,0.00090017833,0.00012060395,0.00008055967,0.00008615221,0.000042388947,0.00028675303,0.000024394445],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001189253,0.0010975556,0.4384949,0.0023427948,0.05420541,0.0071624573,0.0023180812,0.000634753,0.032911364,0.00032768253,0.0034738022,0.45584196],"study_design_scores_gemma":[0.0019099157,0.0011652892,0.7766419,0.0014610231,0.003156534,0.013530216,0.00048209028,0.00009058664,0.004743586,0.00023119272,0.19639698,0.00019070054],"about_ca_topic_score_codex":0.0000063925063,"about_ca_topic_score_gemma":4.6878007e-8,"teacher_disagreement_score":0.45565125,"about_ca_system_score_codex":0.000011108713,"about_ca_system_score_gemma":0.000055189343,"threshold_uncertainty_score":0.3525936},"labels":[],"label_agreement":null},{"id":"W4392504607","doi":"10.1016/j.ahj.2024.03.002","title":"Ticagrelor with or without aspirin following percutaneous coronary intervention in high-risk patients with concomitant peripheral artery disease: A subgroup analysis of the TWILIGHT randomized clinical trial","year":2024,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences","funders":"AstraZeneca","keywords":"Medicine; Aspirin; Randomized controlled trial; Concomitant; Ticagrelor; Cardiology; Internal medicine; Peripheral; Percutaneous coronary intervention; Coronary artery disease; Myocardial infarction; Clopidogrel","score_opus":0.012822368864888124,"score_gpt":0.3053479242606666,"score_spread":0.29252555539577846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392504607","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99613154,0.001284647,0.0008136674,0.00022312322,0.0004301625,0.0010570385,0.000023986446,0.000028212442,0.000007633626],"genre_scores_gemma":[0.99885726,0.00026834293,0.00030620108,0.00020951896,0.00018089582,0.00002848408,0.000022458851,0.000037341502,0.000089496745],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99602515,0.0016567869,0.0009296134,0.00035217614,0.00075767346,0.0002786269],"domain_scores_gemma":[0.99840415,0.00057210424,0.00029416935,0.00035577136,0.000101807855,0.00027202562],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015122041,0.0002441458,0.0018274471,0.00024333652,0.000105238934,0.00006635331,0.00012107104,0.000046386605,0.00015398339],"category_scores_gemma":[0.00022940645,0.00011459676,0.002432725,0.00091517763,0.00061334,0.00012681696,0.00002836141,0.00056054327,0.0000021886492],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.43313777,0.0004352545,0.54692304,0.00002246084,0.009702989,0.00095955434,0.00016036163,0.00007591423,0.0000035900437,0.0000022018694,0.000018079523,0.0085587865],"study_design_scores_gemma":[0.29248258,0.004470285,0.67758113,0.0009948,0.019875217,0.00061259686,0.00050636235,0.0030103035,0.0000025611007,0.000010705262,0.00021859027,0.00023486358],"about_ca_topic_score_codex":0.000106533844,"about_ca_topic_score_gemma":0.00011279632,"teacher_disagreement_score":0.14065519,"about_ca_system_score_codex":0.00010641164,"about_ca_system_score_gemma":0.0003618423,"threshold_uncertainty_score":0.467312},"labels":[],"label_agreement":null},{"id":"W4392596641","doi":"10.1093/ehjcvp/pvae017","title":"Net clinical benefit of extended dual pathway inhibition according to baseline risk in patients with chronic coronary syndrome: a COMPASS substudy","year":2024,"lang":"en","type":"article","venue":"European Heart Journal - Cardiovascular Pharmacotherapy","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"Bayer","keywords":"Compass; Baseline (sea); Medicine; Internal medicine; Acute coronary syndrome; Dual (grammatical number); Cardiology; Biology; Geography; Cartography; Philosophy","score_opus":0.02427486823496835,"score_gpt":0.30313378165067767,"score_spread":0.27885891341570934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392596641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9553449,0.03972409,0.002807614,0.00010062534,0.00061591587,0.001150948,0.00007785939,0.0001135534,0.000064466694],"genre_scores_gemma":[0.9913923,0.006639152,0.00036560636,0.00044760393,0.0008645206,0.000015718873,0.000058131107,0.00018803851,0.000028933156],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9940794,0.002193939,0.0011410939,0.0007066104,0.001324231,0.0005547092],"domain_scores_gemma":[0.9982268,0.0001475721,0.00015115453,0.0006385569,0.0002951997,0.00054067554],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0055593355,0.0004569968,0.0013777205,0.00049053633,0.00016844405,0.00009806495,0.00015828382,0.00007865088,0.00020258482],"category_scores_gemma":[0.00004564636,0.00036375134,0.0024995054,0.00078543206,0.00011746579,0.00030662972,0.00006138613,0.0011066695,0.00007718125],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0073222867,0.0021186,0.58854365,0.00036457065,0.022874821,0.01718503,0.00045406516,0.0104073435,0.0016115459,0.000008437486,0.0012062663,0.3479034],"study_design_scores_gemma":[0.019538516,0.003119603,0.9413845,0.0014846824,0.0014808439,0.0038888024,0.000106466185,0.00034172618,0.00074047555,0.000008183509,0.02739753,0.0005086926],"about_ca_topic_score_codex":0.000015410002,"about_ca_topic_score_gemma":0.000001980507,"teacher_disagreement_score":0.35284084,"about_ca_system_score_codex":0.00021227168,"about_ca_system_score_gemma":0.00025285129,"threshold_uncertainty_score":0.99988145},"labels":[],"label_agreement":null},{"id":"W4392844932","doi":"10.1016/j.thromres.2024.03.015","title":"Does morphine attenuate the Inhibition of Platelet Aggregation for both oral and parenteral P2Y12 inhibitors?","year":2024,"lang":"en","type":"letter","venue":"Thrombosis Research","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medicure","keywords":"P2Y12; Platelet aggregation; Morphine; Pharmacology; Platelet; Medicine; Chemistry; Internal medicine","score_opus":0.07428877698096405,"score_gpt":0.366967307870379,"score_spread":0.292678530889415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392844932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.58648485,0.005437828,0.00006879027,0.40380856,0.00053580524,0.0027955982,0.0006157358,0.000090178415,0.00016267812],"genre_scores_gemma":[0.9239826,0.00856347,0.00015038525,0.05241243,0.007322501,0.00081118825,0.0033899376,0.0002779508,0.0030894983],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99680805,0.00035568967,0.000448689,0.00057804905,0.0012590487,0.0005504459],"domain_scores_gemma":[0.9985101,0.00034406694,0.00010728862,0.0005703491,0.00038106804,0.000087120476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014579971,0.00031392352,0.0007417974,0.00036076523,0.00022464903,0.00012025928,0.00015348698,0.00047365137,0.00014994046],"category_scores_gemma":[0.00012265753,0.00016100888,0.0005437044,0.00037788748,0.00064855756,0.00011966236,0.0001553921,0.0015017138,0.000028155093],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037076313,0.00008599544,0.0005136883,0.0030867525,0.0017489474,0.00015903791,0.00044826782,0.0000013598362,0.0028919915,0.000052573592,0.97538614,0.015254499],"study_design_scores_gemma":[0.0037801864,0.0012148822,0.003940578,0.004492385,0.0012797951,0.00010090106,0.0004259884,0.00031227752,0.029071458,0.004941437,0.94988054,0.0005595822],"about_ca_topic_score_codex":0.00015932744,"about_ca_topic_score_gemma":0.000016995753,"teacher_disagreement_score":0.3513961,"about_ca_system_score_codex":0.00009463949,"about_ca_system_score_gemma":0.00015246696,"threshold_uncertainty_score":0.65657514},"labels":[],"label_agreement":null},{"id":"W4392882696","doi":"10.1016/j.atherosclerosis.2024.117486","title":"Applicability and impact of the COMPASS trial in a Canadian population of patients with atherosclerotic disease","year":2024,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian VIGOUR Centre; University of Alberta","funders":"Bayer Canada; Government of Alberta; Alberta Health Services","keywords":"Compass; Disease; Medicine; Atherosclerotic cardiovascular disease; Population; Internal medicine; Geography; Environmental health; Cartography","score_opus":0.008992655037590568,"score_gpt":0.2421982074552735,"score_spread":0.23320555241768295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392882696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99834627,0.0003381075,0.000008603995,0.00006058864,0.000036869948,0.0010537929,0.00012574672,0.0000117801965,0.000018243643],"genre_scores_gemma":[0.9998406,0.000030890962,0.000009995763,0.000020695637,0.000018163113,0.000032822463,0.000022353704,0.000018771696,0.000005662901],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99912524,0.00007170024,0.00021207145,0.00019589828,0.00022774516,0.00016733806],"domain_scores_gemma":[0.99938214,0.00003725797,0.00004497734,0.00031464396,0.00004037911,0.00018060592],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016886287,0.00011722609,0.00028880217,0.000070779264,0.000032246706,0.000011341817,0.00005999043,0.00004588657,0.000034908495],"category_scores_gemma":[0.000029863933,0.000067918845,0.00026882256,0.00030183993,0.00011815534,0.000054365588,0.000014980434,0.00008090706,7.451499e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003249248,0.00017700245,0.99368256,0.000119004944,0.00015372262,4.612631e-7,0.000111119574,0.000041254803,0.00007906733,0.000049482827,0.000006313509,0.0023307356],"study_design_scores_gemma":[0.008969311,0.00025732885,0.9899215,0.00029895807,0.00017679068,2.3498903e-7,0.000010409075,0.00018692856,0.000027082027,0.00006061677,0.000023243307,0.00006756192],"about_ca_topic_score_codex":0.048193898,"about_ca_topic_score_gemma":0.0059345867,"teacher_disagreement_score":0.042259313,"about_ca_system_score_codex":0.00012838875,"about_ca_system_score_gemma":0.00021209056,"threshold_uncertainty_score":0.95814425},"labels":[],"label_agreement":null},{"id":"W4392986179","doi":"10.1001/jamacardio.2024.0133","title":"Ticagrelor or Clopidogrel Monotherapy vs Dual Antiplatelet Therapy After Percutaneous Coronary Intervention","year":2024,"lang":"en","type":"review","venue":"JAMA Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences","funders":"","keywords":"Ticagrelor; Medicine; Clopidogrel; Prasugrel; Percutaneous coronary intervention; Conventional PCI; Internal medicine; Myocardial infarction; P2Y12; Randomized controlled trial; Cardiology","score_opus":0.03826667492362654,"score_gpt":0.3376362987079834,"score_spread":0.29936962378435683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392986179","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0040207575,0.9906798,0.00011479156,0.00014344632,0.0018166959,0.00202152,0.00032818553,0.0003664201,0.000508372],"genre_scores_gemma":[0.0033721658,0.98842907,0.000099653524,0.0007250114,0.003137424,0.0004656681,0.0008954045,0.00032020328,0.0025553834],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954275,0.00095875195,0.0011163744,0.0012782244,0.00046341433,0.0007557565],"domain_scores_gemma":[0.99796146,0.00023587576,0.00022961394,0.0011570619,0.00013286284,0.00028310763],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0005822038,0.0011064858,0.005111252,0.0004563297,0.00009255091,0.00010613648,0.00029368923,0.0016078599,0.0010158732],"category_scores_gemma":[0.000058846836,0.0006978372,0.0064714784,0.00043824184,0.00034643358,0.00010798185,0.00014458383,0.0013247641,0.0012608746],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056984965,0.0001131859,0.000042682237,0.0073677227,0.014358002,0.047197115,0.00006743038,8.33385e-7,0.0000019734573,0.000026163762,0.0053646355,0.9197618],"study_design_scores_gemma":[0.00233866,0.0015233707,0.00013463048,0.0071531655,0.006313517,0.096328944,0.000036415837,0.000004803541,9.674017e-7,0.000036739515,0.8854607,0.0006680922],"about_ca_topic_score_codex":0.000010031332,"about_ca_topic_score_gemma":0.000001826014,"teacher_disagreement_score":0.91909367,"about_ca_system_score_codex":0.00022701234,"about_ca_system_score_gemma":0.00046100793,"threshold_uncertainty_score":0.99989736},"labels":[],"label_agreement":null},{"id":"W4393255540","doi":"10.3390/jcm13071956","title":"The Net Clinical Outcome of Dual-Pathway Inhibition in Clinical Practice: The “Xarelto plus Acetylsalicylic Acid: Treatment Patterns and Outcomes in Patients with Atherosclerosis” Registry","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Alberta; McMaster University","keywords":"Medicine; Mace; Rivaroxaban; Myocardial infarction; Internal medicine; Clinical trial; Stroke (engine); Randomized controlled trial; Warfarin; Percutaneous coronary intervention; Atrial fibrillation","score_opus":0.06030541134281899,"score_gpt":0.41973080341297314,"score_spread":0.35942539207015417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393255540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9773596,0.004192567,0.00007841317,0.016597748,0.0010437146,0.00060180126,0.000015154627,0.000012383887,0.00009860234],"genre_scores_gemma":[0.98322517,0.013759817,0.000086921755,0.0017658664,0.0010226421,0.000010554721,0.000007974526,0.000032417338,0.00008865195],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99251974,0.0013174202,0.0045420104,0.00035944252,0.0009829989,0.00027839403],"domain_scores_gemma":[0.9904247,0.007179382,0.0012353717,0.0005780119,0.0002741861,0.00030835342],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010344794,0.0002799222,0.0019624329,0.00011686216,0.00006062285,0.00003003058,0.00013908707,0.00029525708,0.000024165174],"category_scores_gemma":[0.007079164,0.000112507514,0.0008012382,0.00027243764,0.0008776915,0.00018221363,0.000057367153,0.0013758778,0.0000027459223],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043808217,0.0011545651,0.91136867,0.00006708411,0.0010764993,0.00041823628,0.00022095833,0.000004005315,0.0000018868795,0.00005432488,0.00026829375,0.080984645],"study_design_scores_gemma":[0.022067018,0.008356402,0.95641637,0.0016836241,0.0009013751,0.00013578426,0.0008079667,0.000034711942,0.0000064607284,0.000054222586,0.009426607,0.00010946813],"about_ca_topic_score_codex":0.00005916818,"about_ca_topic_score_gemma":0.00008091138,"teacher_disagreement_score":0.08087517,"about_ca_system_score_codex":0.000087436274,"about_ca_system_score_gemma":0.00037356417,"threshold_uncertainty_score":0.8474932},"labels":[],"label_agreement":null},{"id":"W4393278002","doi":"10.25259/jassm_4_2023","title":"The efficacy of aspirin as a prophylactic agent for patients recovering from total knee arthroplasties","year":2024,"lang":"en","type":"article","venue":"Journal of Arthroscopic Surgery and Sports Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Aspirin; Medicine; Total knee replacement; Surgery; Internal medicine","score_opus":0.011818429485911929,"score_gpt":0.2560876279949534,"score_spread":0.24426919850904144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393278002","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95851445,0.038080845,0.00014580291,0.00042825742,0.0025062957,0.00026048554,0.0000049382083,0.00001115911,0.000047779962],"genre_scores_gemma":[0.99254805,0.006384598,0.000042391683,0.00009209593,0.00074260647,0.000004427025,0.000008993193,0.000017008068,0.00015983042],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99854845,0.00004136249,0.0006428582,0.00014224727,0.0004663446,0.00015872752],"domain_scores_gemma":[0.99817234,0.001173957,0.000239563,0.00014836797,0.00014641829,0.00011933805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006597692,0.00014117017,0.0005977925,0.00011843159,0.000106845175,0.000018119712,0.000027754731,0.0000516113,0.00009667702],"category_scores_gemma":[0.00056401116,0.00007824292,0.00034775824,0.000106085216,0.00020455416,0.00011037654,0.000012428868,0.00017172741,9.570165e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054086135,0.00036830115,0.120680936,0.0010038645,0.0019528314,0.00078744604,0.0013795552,0.00002041321,0.00068280665,0.00006501927,0.0022338163,0.8654164],"study_design_scores_gemma":[0.008181107,0.005218534,0.87425625,0.0137883695,0.0022595061,0.0007771023,0.001834287,0.00007160543,0.0017590681,0.0008304369,0.09070537,0.00031835947],"about_ca_topic_score_codex":0.000009469515,"about_ca_topic_score_gemma":7.1375166e-7,"teacher_disagreement_score":0.86509806,"about_ca_system_score_codex":0.000020436008,"about_ca_system_score_gemma":0.00019600721,"threshold_uncertainty_score":0.3190654},"labels":[],"label_agreement":null},{"id":"W4393975939","doi":"10.1016/s0735-1097(24)04312-2","title":"DIRECT ORAL ANTICOAGULANT DOSING IN EAST ASIAN IMMIGRANTS TO ONTARIO CANADA: A POPULATION-BASED COHORT STUDY","year":2024,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute for Clinical Evaluative Sciences; University Health Network","funders":"","keywords":"Medicine; Dosing; Immigration; Cohort; Demography; Oral anticoagulant; Cohort study; Internal medicine; Warfarin; Atrial fibrillation; Geography","score_opus":0.01020815287549925,"score_gpt":0.25415002169615764,"score_spread":0.24394186882065838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393975939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970886,0.00048862095,0.00008954122,0.001104649,0.0004801356,0.0004932034,0.000036970407,0.000006240069,0.00021200026],"genre_scores_gemma":[0.99938214,0.0000105573745,0.00008155345,0.000289937,0.00014862501,0.0000054026755,0.0000019260162,0.00001748566,0.000062385276],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982471,0.0003859362,0.0005019469,0.00017351957,0.00048298313,0.00020854866],"domain_scores_gemma":[0.9992242,0.00007087487,0.00019257549,0.00028159385,0.000112072375,0.000118718286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065313,0.00014538314,0.0012843686,0.00023085736,0.00004417117,0.000006714131,0.00016863446,0.000027951477,0.000010126852],"category_scores_gemma":[0.000088071894,0.00009532383,0.00052645983,0.0005825706,0.000074425065,0.000031191015,0.00002812818,0.00023651728,4.851007e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009485218,0.000059196565,0.9893576,0.000019561809,0.0016111775,0.0025878858,0.000100059646,0.0028797607,0.0001988481,0.0000033200356,0.0010128897,0.0012212158],"study_design_scores_gemma":[0.00096058735,0.0005975186,0.9934452,0.00021390995,0.00067516824,0.00084354077,0.0008975889,0.00004376678,0.000058246722,0.0000039842384,0.0021662093,0.000094257346],"about_ca_topic_score_codex":0.38192123,"about_ca_topic_score_gemma":0.58396924,"teacher_disagreement_score":0.202048,"about_ca_system_score_codex":0.0005610592,"about_ca_system_score_gemma":0.002010613,"threshold_uncertainty_score":0.6221946},"labels":[],"label_agreement":null},{"id":"W4394513206","doi":"10.6084/m9.figshare.19745858","title":"The use of FEIBA for refractory bleeding in cardiac surgery - a systematic review","year":2022,"lang":"en","type":"review","venue":"Figshare","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Refractory (planetary science); Medicine; Cardiac surgery; Surgery; General surgery; Intensive care medicine; Biology","score_opus":0.25471905358853775,"score_gpt":0.35679651080407576,"score_spread":0.10207745721553801,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394513206","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[6.120314e-8,0.9123717,9.6662156e-8,0.0000055226137,0.00009112473,0.005219688,0.08226312,0.000022577957,0.000026113887],"genre_scores_gemma":[2.8435116e-7,0.8670954,0.0000022960417,0.00008443656,0.00009221495,0.0057559176,0.12675042,0.00006189107,0.00015714338],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99747074,0.00061458116,0.0009797098,0.00027990778,0.00040928935,0.0002457481],"domain_scores_gemma":[0.9945337,0.0038791166,0.00064404466,0.00078623643,0.00008569775,0.00007118326],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00079222285,0.0002974329,0.0046285167,0.00012694688,0.00009200269,0.000024302817,0.00019598949,0.00013356732,0.006723028],"category_scores_gemma":[0.005816767,0.00018340761,0.0044331322,0.00039702415,0.000008530991,0.00006385762,0.00007772355,0.0002984562,0.000041994237],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000006860637,0.000017127639,2.2183417e-7,0.7727408,0.0009999216,0.000026428572,0.0000041205058,5.0083145e-8,4.4478954e-9,6.9802553e-7,0.119845845,0.10635794],"study_design_scores_gemma":[0.00003200485,0.000010863814,2.857727e-7,0.48645756,0.0025522094,0.000019974535,0.000005809439,3.2041515e-7,4.298608e-8,1.6564667e-7,0.5108342,0.000086527856],"about_ca_topic_score_codex":0.0000019692181,"about_ca_topic_score_gemma":3.684084e-7,"teacher_disagreement_score":0.39098838,"about_ca_system_score_codex":0.00014167433,"about_ca_system_score_gemma":0.000527593,"threshold_uncertainty_score":0.994185},"labels":[],"label_agreement":null},{"id":"W4394572547","doi":"10.1016/s0828-282x(24)00214-9","title":"CCS Announcement: New 2023 Focused Update of the Guidelines for the Use of Antiplatelet Therapy","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Intensive care medicine","score_opus":0.13251579065925237,"score_gpt":0.3132949406850884,"score_spread":0.18077915002583603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394572547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.59400016,0.30033487,0.05531631,0.040770378,0.0065712812,0.0018329918,0.00071528164,0.000020746813,0.00043796288],"genre_scores_gemma":[0.9849345,0.010756792,0.00044342416,0.0014657029,0.0019374083,0.000005004002,0.000012415648,0.000032791766,0.00041193597],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987998,0.00011771049,0.00053427665,0.00011711394,0.00019797737,0.00023310981],"domain_scores_gemma":[0.99843204,0.00020631147,0.00016993852,0.00035815898,0.0006308093,0.00020271755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006239758,0.00013239407,0.00058373035,0.00014557241,0.0000747745,0.000021193327,0.00025119956,0.00010234704,0.000039726627],"category_scores_gemma":[0.00030520436,0.00006796391,0.0011124198,0.00024182211,0.00024355442,0.00007559055,0.000010523839,0.00017479082,0.0000016860563],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011373165,0.000007249329,0.0076948283,0.00013838433,0.01070125,0.00031241798,0.00028706112,0.0063079437,0.0026279665,0.0013271257,0.65168333,0.31777513],"study_design_scores_gemma":[0.0015583268,0.00026475536,0.004216874,0.00019474504,0.0005576277,0.00065023586,0.00006966225,0.00012172006,0.0011094616,0.00032683904,0.99085796,0.000071819646],"about_ca_topic_score_codex":0.00050425983,"about_ca_topic_score_gemma":0.00021133278,"teacher_disagreement_score":0.39093435,"about_ca_system_score_codex":0.000036360725,"about_ca_system_score_gemma":0.0020434477,"threshold_uncertainty_score":0.36249885},"labels":[],"label_agreement":null},{"id":"W4394740845","doi":"10.15190/d.2023.13","title":"Impact of the reporting source on Platelet Inhibition and Treatment Outcomes (PLATO) trial deaths","year":2023,"lang":"en","type":"article","venue":"Discoveries","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Medicine; Platelet; Randomized controlled trial; Intensive care medicine; Internal medicine; Emergency medicine; Pharmacology","score_opus":0.034359587555148646,"score_gpt":0.3232747369961804,"score_spread":0.2889151494410318,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394740845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998806,0.00012988047,0.000009041611,0.00013872898,0.000079561076,0.00041416133,0.000032308693,0.00004948012,0.00034083202],"genre_scores_gemma":[0.9990378,0.00017948908,0.0000034409177,0.00003977883,0.0000691155,0.000021673892,0.000040245828,0.0000143939815,0.00059405545],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991499,0.000035984896,0.00032027348,0.00015185616,0.00020847266,0.0001335216],"domain_scores_gemma":[0.99939924,0.000058835507,0.00022877433,0.000253875,0.00001646877,0.00004281414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014589715,0.00012714251,0.00035257242,0.00004470286,0.00009870305,0.000018503346,0.000020645812,0.00004315575,0.00002217421],"category_scores_gemma":[0.00020445694,0.00006474062,0.0005720522,0.00013165027,0.00009121184,0.000061395345,0.000022843687,0.000047157988,0.0000043473565],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026805604,0.00045653366,0.91236126,0.000076223965,0.0026762977,0.00024284727,0.002357063,0.0004310995,0.0020035363,0.00033249604,0.0005509624,0.051706083],"study_design_scores_gemma":[0.022250455,0.0015448009,0.9649813,0.00011986852,0.0002363571,0.00006643188,0.0006139884,0.000022732085,0.0088021485,0.00011602134,0.0011246055,0.00012127304],"about_ca_topic_score_codex":0.000088394496,"about_ca_topic_score_gemma":0.000005299542,"teacher_disagreement_score":0.052620064,"about_ca_system_score_codex":0.000040231,"about_ca_system_score_gemma":0.00007342405,"threshold_uncertainty_score":0.2640046},"labels":[],"label_agreement":null},{"id":"W4395014846","doi":"10.1016/j.jacc.2024.03.377","title":"Limb Outcomes With Ticagrelor Plus Aspirin in Patients With Diabetes Mellitus and Atherosclerosis","year":2024,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Hamilton Health Sciences; University of Toronto; McMaster University; Population Health Research Institute","funders":"AstraZeneca Mölndal","keywords":"Medicine; Mace; Ticagrelor; Internal medicine; Myocardial infarction; Aspirin; Cardiology; Coronary artery disease; Placebo; Diabetes mellitus; Stroke (engine); Revascularization; Amputation; Randomized controlled trial; Acute coronary syndrome; Surgery; Percutaneous coronary intervention; Endocrinology","score_opus":0.006436319979968554,"score_gpt":0.22015006909930482,"score_spread":0.21371374911933627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395014846","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99602896,0.0028059385,0.00006505787,0.0006784635,0.00009409256,0.000199467,0.000030249083,0.0000065871805,0.000091157846],"genre_scores_gemma":[0.9990421,0.00041771,0.00020961331,0.00020082662,0.00006700802,0.0000034869033,7.3992106e-7,0.000020543564,0.000037968213],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99896,0.00015915022,0.00027776134,0.00013254092,0.0002969664,0.00017354112],"domain_scores_gemma":[0.9992544,0.000155773,0.00018652488,0.00021077372,0.00011500399,0.000077505996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002389698,0.00013854541,0.0009884859,0.00013790213,0.000025764875,0.0000060265115,0.000109177185,0.000033115823,0.0000031132288],"category_scores_gemma":[0.00003683774,0.000065965454,0.00033273175,0.00032971194,0.0005193207,0.00005229785,0.000032863067,0.00019721124,6.116599e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016119936,0.00003886582,0.9915971,0.00006480884,0.0023377768,0.00010471695,0.000034028377,0.0001925558,0.00008793807,0.000038406954,0.000120372984,0.003771415],"study_design_scores_gemma":[0.0026912796,0.0028829384,0.9910122,0.00033967462,0.00069166947,0.00012650478,0.00018988924,0.000015595502,0.00013345048,0.00002596376,0.0018012781,0.000089534755],"about_ca_topic_score_codex":0.0000030165845,"about_ca_topic_score_gemma":0.0000018136985,"teacher_disagreement_score":0.0036818802,"about_ca_system_score_codex":0.000055078544,"about_ca_system_score_gemma":0.00016309514,"threshold_uncertainty_score":0.2689993},"labels":[],"label_agreement":null},{"id":"W4395043094","doi":"10.1161/svin.124.001324","title":"Managing Clopidogrel Resistance in Neurointervention: Surveying Current Approaches","year":2024,"lang":"en","type":"article","venue":"Stroke Vascular and Interventional Neurology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Clopidogrel; Current (fluid); Medicine; Computer science; Internal medicine; Engineering; Aspirin; Electrical engineering","score_opus":0.038366767878932465,"score_gpt":0.2813545864455681,"score_spread":0.24298781856663565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395043094","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.73307145,0.25308925,0.0082928445,0.0023544577,0.00090676564,0.00038110904,0.000031925236,0.00013711878,0.0017350934],"genre_scores_gemma":[0.9958671,0.003314626,0.0000710769,0.00011501301,0.00016823827,0.00003348307,0.00006747552,0.000027985428,0.0003350091],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99836206,0.0002761977,0.00034924402,0.00052241236,0.000238086,0.00025200183],"domain_scores_gemma":[0.99959606,0.000052651492,0.000031941297,0.000209929,0.000023240143,0.0000861682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005341846,0.00017660912,0.00031649368,0.00029206934,0.00005529156,0.000056323905,0.0000780909,0.000067884714,0.00012000753],"category_scores_gemma":[0.000029407767,0.00016517229,0.00092881604,0.0001881634,0.00011655091,0.00013088509,0.000075962365,0.00039903258,0.000017460015],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004091386,0.0026692848,0.29287556,0.016405553,0.0048874696,0.0055163256,0.0005003351,0.00027658782,0.00053511094,0.13648176,0.0039117746,0.53184885],"study_design_scores_gemma":[0.0044538574,0.0010320098,0.7937925,0.0026028599,0.00054811756,0.00079735875,0.000056912326,0.0045525245,0.00009859844,0.008182866,0.1833644,0.00051799085],"about_ca_topic_score_codex":0.0000095100195,"about_ca_topic_score_gemma":0.00003951843,"teacher_disagreement_score":0.5313309,"about_ca_system_score_codex":0.000016330703,"about_ca_system_score_gemma":0.000029024517,"threshold_uncertainty_score":0.673553},"labels":[],"label_agreement":null},{"id":"W4395061111","doi":"10.1161/circ.126.suppl_21.a18777","title":"Abstract 18777: Glucagon-like Peptide-1 Inhibits Thrombin-induced Human Platelet Aggregation","year":2012,"lang":"en","type":"article","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Heart and Stroke Foundation; Toronto General Hospital; St. Michael's Hospital; Canadian Blood Services; University of Toronto","funders":"","keywords":"Medicine; Thrombin; Platelet; Platelet aggregation; Thrombin generation; Platelet activation; Peptide; Glucagon-like peptide-1; Glucagon; Pharmacology; Internal medicine; Endocrinology; Biochemistry; Diabetes mellitus; Hormone; Type 2 diabetes","score_opus":0.03298761953462005,"score_gpt":0.28353678326295506,"score_spread":0.250549163728335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395061111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941103,0.0012366351,0.00026673434,0.00006315169,0.000353028,0.0004786517,0.0000034538748,0.00017618801,0.0033118483],"genre_scores_gemma":[0.9985789,0.000048269132,0.000042483374,0.00021792516,0.00065336365,0.000020548103,0.00033778642,0.000042438438,0.000058301346],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986286,0.000046900288,0.00030593362,0.0002519728,0.0004237201,0.00034283174],"domain_scores_gemma":[0.9991652,0.000023091126,0.00013127043,0.00037503624,0.00010109904,0.00020433732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033188198,0.00019602674,0.00029303043,0.000119796954,0.00020741265,0.0000323976,0.00005472158,0.000183617,0.00030746948],"category_scores_gemma":[0.000035086967,0.00019264742,0.0002998616,0.00020460141,0.000040317904,0.00047341106,0.000015940477,0.00017428871,0.00028586845],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017771864,0.0007351137,0.2880158,0.0002770596,0.00081753015,0.000042622,0.0013410336,0.00014335323,0.61419445,0.0016487679,0.0010212645,0.09158529],"study_design_scores_gemma":[0.001892219,0.000038116286,0.92849296,0.0001407419,0.00017599495,0.00012831858,0.00011981527,0.00006295507,0.06685119,0.00020819204,0.0016443413,0.0002451753],"about_ca_topic_score_codex":0.000028557863,"about_ca_topic_score_gemma":0.0000023907728,"teacher_disagreement_score":0.6404771,"about_ca_system_score_codex":0.00011031459,"about_ca_system_score_gemma":0.00004855319,"threshold_uncertainty_score":0.7855934},"labels":[],"label_agreement":null},{"id":"W4395061568","doi":"10.1161/circ.126.suppl_21.a18502","title":"Abstract 18502: Bleeding Post PCI: Predictors of “ANY” Bleeds: Six Month Results from the PARIS (Patterns of Non-Adherence to Antiplatelet Regimens in Stented Patients) Registry","year":2012,"lang":"en","type":"article","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Berger (Canada)","funders":"","keywords":"Medicine; Prasugrel; Major bleeding; Conventional PCI; Internal medicine; Warfarin; Angina; Acute coronary syndrome; Surgery; Atrial fibrillation; Myocardial infarction","score_opus":0.01613023144573793,"score_gpt":0.24660893028145717,"score_spread":0.23047869883571923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395061568","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977588,0.000434418,0.00021569217,0.000074399075,0.00023451446,0.000671885,0.00034161084,0.000023277586,0.00024540312],"genre_scores_gemma":[0.9989253,0.000104044964,0.000041733452,0.00006237679,0.00019077679,0.000011302383,0.0006286565,0.000023562796,0.0000122136025],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99825215,0.00007377824,0.0006356835,0.000268933,0.0004959776,0.00027347644],"domain_scores_gemma":[0.9985681,0.0001539158,0.00036381942,0.00056076655,0.00021865404,0.00013470008],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049239304,0.0001741294,0.00040458635,0.00010280205,0.000049368897,0.000011164001,0.00013454471,0.00014022306,0.000040495986],"category_scores_gemma":[0.00018609173,0.00013988094,0.00021701428,0.00027189543,0.00005283888,0.00021210115,0.00003617481,0.00016236774,0.00000990001],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071843824,0.00028757285,0.9810924,0.00007861506,0.00035100704,0.000005386593,0.0018631524,0.00048827787,0.012762454,0.0000047857125,0.00012917687,0.0022187503],"study_design_scores_gemma":[0.0034317696,0.000117123,0.98959273,0.00076014234,0.00023123044,0.0000030697745,0.0008513176,0.0001299142,0.004653056,0.0000030956492,0.00009735534,0.0001291707],"about_ca_topic_score_codex":0.0014736969,"about_ca_topic_score_gemma":0.000030837284,"teacher_disagreement_score":0.008500372,"about_ca_system_score_codex":0.00006270852,"about_ca_system_score_gemma":0.000051536223,"threshold_uncertainty_score":0.5704179},"labels":[],"label_agreement":null},{"id":"W4396219519","doi":"10.1177/1098612x241241404","title":"Determination of clopidogrel effect in cats using point-of-care Plateletworks ADP and shipped samples for PFA-200 analysis in a clinical practice setting","year":2024,"lang":"en","type":"article","venue":"Journal of Feline Medicine and Surgery","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Guelph","funders":"OVC Pet Trust; EveryCat Health Foundation","keywords":"Clopidogrel; Medicine; CATS; Platelet; Antithrombotic; Clinical Practice; Internal medicine; Aspirin; Physical therapy","score_opus":0.04276161861638267,"score_gpt":0.39298651915686034,"score_spread":0.35022490054047767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396219519","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92549247,0.06871782,0.0046282457,0.0007638994,0.00018196073,0.00020061237,0.000004076582,0.000003719402,0.0000072095736],"genre_scores_gemma":[0.98879534,0.008436663,0.002002549,0.00016082088,0.0005679826,0.0000020157177,0.000019558898,0.0000133203675,0.000001776839],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99768925,0.00033565037,0.0013611527,0.00016780444,0.00030242593,0.00014373683],"domain_scores_gemma":[0.9937111,0.005377707,0.00044286984,0.00010084921,0.00027058236,0.00009687045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0063330685,0.00013023353,0.0013400876,0.00090937346,0.000019714951,0.000008127207,0.0000297231,0.000119238146,0.000005943413],"category_scores_gemma":[0.0038492118,0.00009106198,0.0005016187,0.00061329984,0.00009876196,0.00016016305,0.000012636981,0.0002807741,2.7298752e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028484839,0.00008047624,0.71138483,0.001687445,0.0013268826,0.00083573785,0.00086338446,0.00008795704,0.0001854126,0.0000037972734,0.0001289236,0.28056666],"study_design_scores_gemma":[0.018170288,0.0048997654,0.81040365,0.032936227,0.030882664,0.0036965888,0.011943628,0.081953354,0.00065183535,0.00027695822,0.0035283996,0.00065663265],"about_ca_topic_score_codex":0.000044510438,"about_ca_topic_score_gemma":0.000016904973,"teacher_disagreement_score":0.27991003,"about_ca_system_score_codex":0.000028134364,"about_ca_system_score_gemma":0.00016810872,"threshold_uncertainty_score":0.46081442},"labels":[],"label_agreement":null},{"id":"W4396673803","doi":"10.26685/urncst.574","title":"Investigating Therapeutic Potential of Targeting Platelets in Cancer Treatment: A Literature Review","year":2024,"lang":"en","type":"review","venue":"Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Metropolitan University","funders":"","keywords":"Platelet; Cancer; Medicine; Internal medicine","score_opus":0.0952007366382498,"score_gpt":0.47436146120957473,"score_spread":0.37916072457132494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396673803","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0072118067,0.98414505,5.090738e-7,0.0076173255,0.00020606122,0.0007568708,0.000007824561,0.000021182244,0.000033396558],"genre_scores_gemma":[0.026331402,0.9731863,0.00006658948,0.00009464067,0.00018143115,0.000036877904,0.000007748969,0.000021055452,0.00007392093],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9957114,0.00057201134,0.0012659202,0.0007446142,0.0009470063,0.0007590521],"domain_scores_gemma":[0.99839413,0.00032148682,0.00028578308,0.00025138957,0.00043577704,0.00031141462],"candidate_categories":["sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00626474,0.0003589982,0.0020192412,0.0016597817,0.00028210992,0.00014027407,0.00038219843,0.0005515251,0.000007647052],"category_scores_gemma":[0.000926445,0.00019788617,0.0004805916,0.005390837,0.002721959,0.00020577127,0.000252177,0.0044625695,0.00000406273],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020908741,0.00011707417,0.00052049,0.010354266,0.00034533362,0.0013287878,0.000013234628,9.231674e-8,0.000018896048,0.0003176112,0.00009623004,0.9868671],"study_design_scores_gemma":[0.003873512,0.0022392052,0.00034371208,0.63402176,0.002871681,0.013086824,0.0002556418,0.0003627068,0.000019836472,0.036329184,0.3057616,0.00083436054],"about_ca_topic_score_codex":0.000022782348,"about_ca_topic_score_gemma":0.000014316029,"teacher_disagreement_score":0.9860327,"about_ca_system_score_codex":0.00029944762,"about_ca_system_score_gemma":0.0018592896,"threshold_uncertainty_score":0.9999921},"labels":[],"label_agreement":null},{"id":"W4396831080","doi":"10.1016/j.cjca.2024.05.001","title":"Erratum to “Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology 2023 Focused Update of the Guidelines for the Use of Antiplatelet Therapy” [Can J Cardiol 40 (2024):160-181].","year":2024,"lang":"en","type":"erratum","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"","funders":"University of British Columbia","keywords":"Medicine; Cardiology; Internal medicine; Canadian Cardiovascular Society; Association (psychology); Intensive care medicine; Myocardial infarction; Psychotherapist","score_opus":0.05888323811523355,"score_gpt":0.2817296375407266,"score_spread":0.22284639942549306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396831080","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.024840897,0.5971611,0.008940818,0.076492384,0.21393505,0.0133927185,0.0530876,0.00007375068,0.012075691],"genre_scores_gemma":[0.86015046,0.050548192,0.0011521084,0.008381518,0.032971006,0.0003466224,0.0021421611,0.00085946015,0.04344848],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9938973,0.0010142192,0.0021669506,0.00065882906,0.0010037764,0.0012589154],"domain_scores_gemma":[0.9903436,0.0003913307,0.0011200536,0.0015641404,0.0051914467,0.0013894531],"candidate_categories":["metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0038068148,0.0007423039,0.0041755037,0.0013270985,0.00032394126,0.00006731676,0.0011991315,0.0015933405,0.000084652456],"category_scores_gemma":[0.0020915326,0.0005221026,0.013617233,0.001047644,0.00062400504,0.000109501845,0.00007498647,0.0017052329,0.000007235722],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021359429,0.0000047860076,0.0029794062,0.00034869838,0.049889013,0.00023656816,0.00015129753,0.008596453,0.0000359225,0.00006614045,0.93106264,0.006415507],"study_design_scores_gemma":[0.0017575623,0.0005170331,0.008605378,0.0009827818,0.0064616464,0.0007990604,0.000252018,0.000055381166,0.000061260616,0.0001978852,0.9798867,0.0004232819],"about_ca_topic_score_codex":0.16376732,"about_ca_topic_score_gemma":0.35155377,"teacher_disagreement_score":0.83530957,"about_ca_system_score_codex":0.0015418187,"about_ca_system_score_gemma":0.021364873,"threshold_uncertainty_score":0.9997231},"labels":[],"label_agreement":null},{"id":"W4396989450","doi":"10.1681/asn.20223311s1222c","title":"Early Discontinuation of Aspirin Among Patients With CKD Undergoing Percutaneous Coronary Intervention With a Drug Eluting Stent: A Meta-Analysis","year":2022,"lang":"en","type":"article","venue":"Journal of the American Society of Nephrology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Aspirin; Percutaneous coronary intervention; Discontinuation; Drug-eluting stent; Internal medicine; Meta-analysis; Drug; Cardiology; Stent; Myocardial infarction; Pharmacology","score_opus":0.012569112740304115,"score_gpt":0.23754272035765972,"score_spread":0.2249736076173556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396989450","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99738795,0.0009429192,0.00095091603,0.000487316,0.000014359746,0.00019079659,0.000013290622,0.0000044744615,0.000007979662],"genre_scores_gemma":[0.99851096,0.00004930646,0.00077489443,0.0005563299,0.000021340786,0.0000044184294,0.0000069510816,0.0000152293205,0.00006056387],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99825156,0.0003562378,0.0004706644,0.00013422965,0.00064484135,0.00014245229],"domain_scores_gemma":[0.9974831,0.000109697314,0.0018882302,0.00023646773,0.0002349307,0.000047618836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004999052,0.0001241292,0.0010587706,0.00008555555,0.00011634305,0.0000052255664,0.00017602698,0.000017267292,0.000064800544],"category_scores_gemma":[0.0000110942565,0.00007186547,0.002964027,0.0005452491,0.00046263653,0.000083540195,0.00007804472,0.00026514757,8.519815e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058122133,0.0010555118,0.5826666,0.00007360945,0.38865256,0.00005733717,0.0034016664,0.011655095,0.0017438198,0.000005173031,0.00022336308,0.004653058],"study_design_scores_gemma":[0.0021274516,0.0041538468,0.866532,0.000027829139,0.12066288,0.00033930692,0.0056921355,0.00022255477,0.00005095284,0.000013749134,0.000086285574,0.00009096012],"about_ca_topic_score_codex":0.00018272389,"about_ca_topic_score_gemma":0.00002555665,"teacher_disagreement_score":0.28386545,"about_ca_system_score_codex":0.000065304936,"about_ca_system_score_gemma":0.000084993466,"threshold_uncertainty_score":0.29893005},"labels":[],"label_agreement":null},{"id":"W4397023830","doi":"10.4244/eij-d-23-00658","title":"One- versus three-month dual antiplatelet therapy in high bleeding risk patients undergoing percutaneous coronary intervention for non-ST-segment elevation acute coronary syndromes","year":2024,"lang":"en","type":"article","venue":"EuroIntervention","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Abbott Vascular; School of Medicine, University of Kansas; National Institutes of Health; Daiichi Sankyo Europe; Instituto de Investigación Marqués de Valdecilla; Humanitas University; Newcastle upon Tyne Hospitals NHS Foundation Trust; Fudan University; Newcastle University; AstraZeneca; CSL Behring; York University; Duke Clinical Research Institute; Daiichi-Sankyo; Cedars-Sinai Medical Center; Inselspital, Universitätsspital Bern; Bayer; Belvoir Media Group; American Heart Association","keywords":"Medicine; Percutaneous coronary intervention; Acute coronary syndrome; Cardiology; Internal medicine; Coronary stenting; ST elevation; Drug-eluting stent; Coronary stent; ST segment; Platelet aggregation inhibitor; Stent; Aspirin; Myocardial infarction; Restenosis","score_opus":0.024285673642080424,"score_gpt":0.2786316903031098,"score_spread":0.2543460166610294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4397023830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98169917,0.0027158312,0.011820881,0.00011405103,0.0016126578,0.0016020748,0.00018360392,0.00020555772,0.000046151923],"genre_scores_gemma":[0.9948573,0.002495366,0.0004228071,0.00003414125,0.00016586224,0.000045815144,0.001682999,0.00009477688,0.00020089706],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9976184,0.00014936374,0.00068627816,0.0006518329,0.0004929445,0.00040118385],"domain_scores_gemma":[0.99911946,0.00016703445,0.00019224883,0.0002942999,0.00012383878,0.00010309955],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005704606,0.00033050345,0.00048000907,0.00034862183,0.0001530693,0.00011510203,0.00010992934,0.00014070125,0.00021391062],"category_scores_gemma":[0.000057298683,0.00033710306,0.0010584879,0.00027320118,0.000052711424,0.00045585172,0.00006302065,0.0003006159,0.000044528693],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030557163,0.0036212313,0.24992591,0.0021866474,0.009913499,0.0028736854,0.00062071515,0.00034566643,0.0042117126,0.00040093693,0.0009240426,0.6944188],"study_design_scores_gemma":[0.02758789,0.014391541,0.94105387,0.0049549374,0.0014695573,0.00072852103,0.00029747913,0.0068153655,0.0008429617,0.000783969,0.00046349672,0.0006103988],"about_ca_topic_score_codex":0.000056802593,"about_ca_topic_score_gemma":0.00008220985,"teacher_disagreement_score":0.6938084,"about_ca_system_score_codex":0.00034195863,"about_ca_system_score_gemma":0.000058591813,"threshold_uncertainty_score":0.9999081},"labels":[],"label_agreement":null},{"id":"W4400010426","doi":"10.14740/cr1528","title":"Disparity in the Under-Utilization of Novel P2Y12 Inhibitors in ST-Elevation Myocardial Infarction Following Percutaneous Coronary Intervention","year":2024,"lang":"en","type":"article","venue":"Cardiology Research","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Percutaneous coronary intervention; Cardiology; Internal medicine; Myocardial infarction; P2Y12","score_opus":0.09548332044056343,"score_gpt":0.39576184078643056,"score_spread":0.3002785203458671,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400010426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98789483,0.007869508,0.0022777913,0.00037112087,0.00037088635,0.00067919603,0.0000118208145,0.000028321725,0.0004965089],"genre_scores_gemma":[0.9987709,0.00065964734,0.000012645135,0.000041071828,0.00022660641,0.00006259224,0.00017958257,0.000016237776,0.00003071953],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976377,0.00092013204,0.0003292181,0.00030983167,0.0005230039,0.00028010784],"domain_scores_gemma":[0.9992233,0.00034552536,0.000022074648,0.00026528057,0.00010618498,0.000037617512],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003320476,0.00010749176,0.00038172127,0.00047215642,0.000068193636,0.000023222628,0.00010617821,0.00019999727,0.000014579954],"category_scores_gemma":[0.00028232406,0.000084269515,0.00045830655,0.0008727149,0.00018957966,0.00012859062,0.000051997635,0.0005861821,0.0000059256727],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018358837,0.00062142254,0.8517138,0.00081778876,0.0018231368,0.0021350777,0.0022391733,0.0046960707,0.024860164,0.0035728111,0.0010904935,0.1045942],"study_design_scores_gemma":[0.0018499522,0.0004579708,0.98636556,0.0005724555,0.00015862002,0.0011194835,0.0036430394,0.002881607,0.00014604347,0.0008187837,0.0018565201,0.00012998283],"about_ca_topic_score_codex":0.0001270182,"about_ca_topic_score_gemma":0.000052390646,"teacher_disagreement_score":0.13465177,"about_ca_system_score_codex":0.00019766738,"about_ca_system_score_gemma":0.0001384872,"threshold_uncertainty_score":0.3436411},"labels":[],"label_agreement":null},{"id":"W4400621451","doi":"10.5220/0012718300003758","title":"Detecting the Impact of Changes in Platelet Demand following the Implementation of PRT Platelets in Canada","year":2024,"lang":"en","type":"article","venue":"","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Blood Services; Dalhousie University","funders":"","keywords":"Platelet; Computer science; Environmental science; Internal medicine; Medicine","score_opus":0.010595096380733342,"score_gpt":0.29670096610907243,"score_spread":0.28610586972833907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400621451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954422,0.0036846732,0.000025003708,0.0002475655,0.000060353534,0.00037937093,0.0000077144605,0.0000076279434,0.00014549405],"genre_scores_gemma":[0.9996742,0.00020625345,0.000006401151,0.000044958437,0.000027163791,0.000015141073,0.0000055898877,0.000010394421,0.000009889142],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99920243,0.00007006851,0.00023003625,0.00011124769,0.00022070199,0.00016549851],"domain_scores_gemma":[0.9996149,0.00016131724,0.00003733845,0.00014817154,0.000014444563,0.000023862414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004813941,0.00008967738,0.00023565488,0.0000783929,0.000024505161,0.000007691723,0.000066596505,0.000024344867,0.00010571072],"category_scores_gemma":[0.000018422192,0.000044096618,0.00019323204,0.00032514447,0.000017914897,0.000041934723,0.000017409233,0.000113335496,3.5287513e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039904454,0.0000670737,0.65455866,0.00045233255,0.0028609987,0.00090573414,0.005969954,0.001733417,0.020989299,0.00008647839,0.00038613714,0.31159085],"study_design_scores_gemma":[0.0032484313,0.00035266715,0.8032331,0.00067288964,0.0002363985,0.00016265259,0.024303649,0.002645072,0.16457678,0.00011436423,0.00025194345,0.00020204237],"about_ca_topic_score_codex":0.67576784,"about_ca_topic_score_gemma":0.81975085,"teacher_disagreement_score":0.31138882,"about_ca_system_score_codex":0.00015661668,"about_ca_system_score_gemma":0.00058381935,"threshold_uncertainty_score":0.32639122},"labels":[],"label_agreement":null},{"id":"W4400737517","doi":"10.1186/s12872-024-04029-0","title":"Adverse cardiovascular outcomes associated with proton pump inhibitor use after percutaneous coronary intervention: a systematic review and meta-analysis","year":2024,"lang":"en","type":"review","venue":"BMC Cardiovascular Disorders","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Percutaneous coronary intervention; Mace; Observational study; Meta-analysis; Internal medicine; Conventional PCI; Randomized controlled trial; Myocardial infarction; Angiology; Adverse effect; Coronary artery disease","score_opus":0.03970310520594901,"score_gpt":0.28879052623953255,"score_spread":0.24908742103358356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400737517","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008187519,0.977551,0.00046997584,0.000021604093,0.00010877294,0.02082757,0.0005286009,0.00037472998,0.00003586108],"genre_scores_gemma":[0.0009737604,0.9854506,0.00008564295,0.00017940233,0.000056998422,0.010711551,0.0009533104,0.0004103003,0.0011784288],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9887911,0.0032085117,0.002111569,0.0023518703,0.0027079294,0.00082902453],"domain_scores_gemma":[0.99398434,0.00027826827,0.0005257976,0.0043680076,0.0003492845,0.00049430964],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_narrow","metaepi_broad"],"category_scores_codex":[0.0029327027,0.0021766748,0.029411849,0.00090952055,0.00018022793,0.00022444714,0.00040278523,0.0007370092,0.00023590836],"category_scores_gemma":[0.0005186348,0.0013287482,0.1213293,0.0022814386,0.00035051617,0.00033692844,0.00029621983,0.0009718245,0.00011599474],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033401833,0.0001282139,0.00006814682,0.45419136,0.54224646,0.0014731148,0.000021663127,0.000028875167,8.8957797e-10,0.0000011861381,0.0000160978,0.0017915012],"study_design_scores_gemma":[0.0009680307,0.00014490641,0.000074207754,0.07642617,0.83857626,0.0029161652,0.00007333584,0.000004823711,2.4521949e-8,0.0000025798836,0.07960747,0.0012060239],"about_ca_topic_score_codex":0.00009404805,"about_ca_topic_score_gemma":0.00009070926,"teacher_disagreement_score":0.37776518,"about_ca_system_score_codex":0.0003677177,"about_ca_system_score_gemma":0.00038315766,"threshold_uncertainty_score":0.99909735},"labels":[],"label_agreement":null},{"id":"W4400847550","doi":"10.1016/j.revmed.2024.07.002","title":"Chez les patients présentant un syndrome coronarien aigu et ayant subi une intervention coronarienne percutanée avec des endoprothèses contemporaines et qui n’ont pas eu d’événement ischémique ou hémorragique pendant 1 mois sous traitement antiplaquettaire double, est-ce qu’un traitement par ticagrélor seul entre le 1er et le 12e mois diminue le risque de saignement cliniquement important tout en étant efficace pour prévenir les complications vasculaires comparativement au ticagrélor combiné à l’aspirine ?","year":2024,"lang":"fr","type":"letter","venue":"La Revue de Médecine Interne","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Medicine; Gynecology","score_opus":0.018880599125691226,"score_gpt":0.27529973669796254,"score_spread":0.2564191375722713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400847550","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8071072,0.007461907,0.030629432,0.14142953,0.00079122896,0.009669023,0.0021020097,0.00039793446,0.00041172598],"genre_scores_gemma":[0.9699282,0.004778709,0.002577734,0.007907378,0.00060197635,0.005067774,0.007546415,0.00057767075,0.0010141348],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9832475,0.0038638948,0.005306498,0.0031544778,0.0018648439,0.002562752],"domain_scores_gemma":[0.992616,0.0012082019,0.002154963,0.0020184114,0.0008276739,0.0011747236],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0047074007,0.0029097272,0.003919291,0.00066555216,0.0009972955,0.00051924004,0.0014329222,0.0010477647,0.00088957965],"category_scores_gemma":[0.00026826115,0.0026875783,0.003091903,0.00058077794,0.0013836394,0.00047754368,0.0012650782,0.0026496204,0.00007994759],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018187087,0.11231257,0.38414976,0.030577805,0.075081415,0.03496166,0.14909256,0.009173876,0.030728692,0.08275467,0.030475441,0.042504475],"study_design_scores_gemma":[0.06754144,0.010994291,0.60161084,0.032909743,0.010302677,0.007882144,0.02730873,0.00830986,0.043541774,0.001658749,0.18159218,0.0063475757],"about_ca_topic_score_codex":0.02142154,"about_ca_topic_score_gemma":0.015197742,"teacher_disagreement_score":0.21746108,"about_ca_system_score_codex":0.005138765,"about_ca_system_score_gemma":0.0027125974,"threshold_uncertainty_score":0.9996513},"labels":[],"label_agreement":null},{"id":"W4400877894","doi":"10.1161/circulationaha.124.069012","title":"Demystifying the Contemporary Role of 12-Month Dual Antiplatelet Therapy After Acute Coronary Syndrome","year":2024,"lang":"en","type":"review","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences","funders":"CytoSorbents Europe; Idorsia Pharmaceuticals; Novo Nordisk; Abiomed; InfraRedx; Boston Scientific Corporation; Daiichi Sankyo Europe; Sanofi; Abbott Vascular; ZOLL Medical Corporation; Bristol-Myers Squibb; AstraZeneca; Edwards Lifesciences; Amgen; Pfizer; GlaxoSmithKline","keywords":"Medicine; Prasugrel; Ticagrelor; Clopidogrel; Acute coronary syndrome; Percutaneous coronary intervention; Internal medicine; Cardiology; Aspirin; Conventional PCI; Myocardial infarction","score_opus":0.045105059972810974,"score_gpt":0.30371808500550057,"score_spread":0.25861302503268957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400877894","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.025826141,0.97156966,0.00003369397,0.000028966033,0.0002770767,0.0017265218,0.00014341656,0.00008975481,0.0003047543],"genre_scores_gemma":[0.395096,0.6039562,0.000006933363,0.00004443094,0.00012228871,0.00011234421,0.00053624203,0.00007335637,0.00005220225],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978368,0.00024977492,0.0006993013,0.00047819983,0.00050024764,0.0002356703],"domain_scores_gemma":[0.9988013,0.000088234956,0.00027449342,0.00067498,0.00006700858,0.00009397853],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003782272,0.00046471125,0.0017064394,0.00019309457,0.00008325123,0.000040920128,0.00014281612,0.00037744673,0.00010968435],"category_scores_gemma":[0.000011643037,0.00028499324,0.0018108763,0.0003180004,0.00013679695,0.00012658867,0.00005407913,0.00042947158,0.00009427802],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036582854,0.00012257382,0.0021633713,0.008590452,0.011119572,0.0023937123,0.00022284687,0.000004499506,0.000025287369,0.00006290573,0.00022666251,0.9747023],"study_design_scores_gemma":[0.0016331594,0.00022521029,0.029308619,0.022025637,0.01294006,0.009212032,0.00009840294,0.000081474805,0.000009525486,0.00029249323,0.9234749,0.00069845055],"about_ca_topic_score_codex":0.000007674588,"about_ca_topic_score_gemma":3.754154e-7,"teacher_disagreement_score":0.97400385,"about_ca_system_score_codex":0.00007378105,"about_ca_system_score_gemma":0.00038835072,"threshold_uncertainty_score":0.99996024},"labels":[],"label_agreement":null},{"id":"W4401001624","doi":"10.14740/jmc4239","title":"Navigating Aspirin Hypersensitivity in Patients Undergoing Percutaneous Coronary Intervention","year":2024,"lang":"en","type":"article","venue":"Journal of Medical Cases","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Aspirin; Percutaneous coronary intervention; Internal medicine; Cardiology; Myocardial infarction","score_opus":0.015729464028283773,"score_gpt":0.3073706912132541,"score_spread":0.2916412271849703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401001624","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99062085,0.007922991,0.00013659571,0.0007383902,0.0004266048,0.000072623494,0.000002887145,0.000018442113,0.000060585906],"genre_scores_gemma":[0.9985918,0.0007291561,0.00006425381,0.00027369976,0.00030684608,4.645707e-7,0.000008420123,0.000014158967,0.000011240844],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9982063,0.00013854788,0.00040465398,0.00011117798,0.0010009063,0.00013841355],"domain_scores_gemma":[0.9992541,0.00032843096,0.00006873845,0.00007313479,0.00007562411,0.00019995762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079874217,0.00009336493,0.0002998861,0.00006463942,0.000027084003,0.000023790475,0.000054821874,0.000098527926,0.00019368027],"category_scores_gemma":[0.0007845074,0.00007036726,0.0004269034,0.00012688483,0.000060947044,0.000120048695,0.000027601589,0.00062611693,0.0000103603825],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000722668,0.00055055175,0.04961467,0.0005199106,0.0004028589,0.13199347,0.0002327458,0.000013557952,0.00008351369,0.000023044346,0.00021422336,0.81562877],"study_design_scores_gemma":[0.018232385,0.010830145,0.4387777,0.069355085,0.0016880344,0.44382653,0.006402048,0.0028570264,0.0007753832,0.00033839527,0.006207078,0.0007102053],"about_ca_topic_score_codex":0.000019166046,"about_ca_topic_score_gemma":0.00001420151,"teacher_disagreement_score":0.8149186,"about_ca_system_score_codex":0.000109871115,"about_ca_system_score_gemma":0.00019201143,"threshold_uncertainty_score":0.28694937},"labels":[],"label_agreement":null},{"id":"W4401074043","doi":"10.1016/j.cjca.2024.06.030","title":"Associations Between Dual Antiplatelet Therapy Score and Long-Term Mortality After Percutaneous Coronary Intervention: Analysis of More Than 27,000 Patients","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Mace; Conventional PCI; Percutaneous coronary intervention; Internal medicine; Myocardial infarction; Cardiology","score_opus":0.020977556102755715,"score_gpt":0.2796935886533859,"score_spread":0.2587160325506302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401074043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98281205,0.015344623,0.0002032546,0.0001196262,0.00034004988,0.00014619996,0.0009513509,0.000007844151,0.00007499357],"genre_scores_gemma":[0.9981412,0.0010101654,0.000007590313,0.00007403172,0.00039500103,0.0000016433312,0.00032175574,0.000018500472,0.000030108355],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99862915,0.00019989548,0.0005076164,0.00019476395,0.00023209363,0.0002365002],"domain_scores_gemma":[0.9989304,0.00007342543,0.00014463051,0.00020299667,0.00026547196,0.0003830729],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037363928,0.00015903522,0.00097647856,0.0005650132,0.00005560623,0.000028577402,0.00008203596,0.00016651842,0.000113741575],"category_scores_gemma":[0.00004122456,0.00013307946,0.0012044857,0.00035016067,0.00023474658,0.00009824089,0.000012390813,0.00024367133,0.0000015592176],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013151244,0.000008872198,0.96021914,0.000037034864,0.02257582,0.0034471408,0.0002445078,0.00006000473,0.000011758774,0.000005297716,0.00017544438,0.013083453],"study_design_scores_gemma":[0.00078120467,0.00038379486,0.9915096,0.00012745196,0.005462967,0.0009122981,0.000050567232,0.000006401477,0.00001208933,0.000022996746,0.00061922835,0.00011135628],"about_ca_topic_score_codex":0.00026002334,"about_ca_topic_score_gemma":0.0005504883,"teacher_disagreement_score":0.031290494,"about_ca_system_score_codex":0.00010817568,"about_ca_system_score_gemma":0.0003102505,"threshold_uncertainty_score":0.5426823},"labels":[],"label_agreement":null},{"id":"W4401155965","doi":"10.1055/s-0044-1788303","title":"Corrigendum: Bleeding Risk Prediction in Patients Treated with Antithrombotic Drugs According to the Anatomic Site of Bleeding, Indication for Treatment, and Time Since Treatment Initiation","year":2024,"lang":"en","type":"erratum","venue":"TH Open","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"","keywords":"Antithrombotic; Medicine; Bleeding time; Surgery; Internal medicine; Platelet; Platelet aggregation","score_opus":0.017672366784271504,"score_gpt":0.2726920243487401,"score_spread":0.25501965756446865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401155965","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98815536,0.001833699,0.000044128417,0.00009262403,0.00081775093,0.0057071173,0.0009967282,0.000053852233,0.002298719],"genre_scores_gemma":[0.98270524,0.0031781204,0.0000555196,0.00004264736,0.00032743745,0.00044095804,0.0041846046,0.00008726708,0.008978208],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985246,0.00008776615,0.00037871287,0.00052357814,0.00024696882,0.00023835669],"domain_scores_gemma":[0.9990859,0.000049808797,0.00031608317,0.00033770525,0.00011360356,0.00009691492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028548262,0.00034987228,0.00079162733,0.0003313932,0.000155999,0.000107823456,0.0001285218,0.00019453124,0.000021551567],"category_scores_gemma":[0.00002639986,0.00021932466,0.000159821,0.0004234607,0.000051460094,0.00021051001,0.000059950933,0.00013543847,0.000022945467],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008092148,0.0015993142,0.85382456,0.0009962628,0.009573544,0.000031158874,0.008763102,0.00015653776,0.00032639073,0.0000725727,0.04333351,0.073230885],"study_design_scores_gemma":[0.039816998,0.02550948,0.8287716,0.010996885,0.027724538,0.00004975369,0.0028496264,0.009999763,0.0025705628,0.0001380017,0.050068345,0.0015044734],"about_ca_topic_score_codex":0.00068364054,"about_ca_topic_score_gemma":0.00006832683,"teacher_disagreement_score":0.07172641,"about_ca_system_score_codex":0.0005490449,"about_ca_system_score_gemma":0.0002639482,"threshold_uncertainty_score":0.89438},"labels":[],"label_agreement":null},{"id":"W4401185250","doi":"10.69944/pjc.d5a0e28ae9","title":"The Effect of Rabeprazole on the Antiplatelet Efficacy of Clopidogrel: A Systematic Review","year":2016,"lang":"en","type":"review","venue":"Philippine journal of cardiology.","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Clopidogrel; Rabeprazole; Medicine; Aspirin; Cardiology; Internal medicine; Proton-pump inhibitor","score_opus":0.021211371459288562,"score_gpt":0.32557935593899856,"score_spread":0.30436798447971,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401185250","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022491289,0.995377,0.000041293755,0.00035188897,0.00045508318,0.0031125215,0.00003341123,0.000010587517,0.00039332264],"genre_scores_gemma":[0.0017226551,0.9971094,0.0000026463067,0.00008444253,0.00088204,0.000059564296,0.0000083378445,0.000059053724,0.000071850256],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9923141,0.0036987972,0.002590146,0.00024350308,0.000828984,0.00032448868],"domain_scores_gemma":[0.98909426,0.0056563644,0.003322134,0.0013995029,0.00039770908,0.00013004859],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007397353,0.00056165975,0.010036103,0.00019138066,0.00009798411,0.000008624247,0.0007938561,0.00027467773,0.0000365696],"category_scores_gemma":[0.0040275226,0.00018752558,0.008238779,0.00036805987,0.00046437152,0.000037735823,0.00007874985,0.00075831654,0.000027873026],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005251952,0.00003013013,0.000012624845,0.7009577,0.020328559,0.0001857418,0.0000071421555,0.0000018439183,0.000004805413,0.00007960451,0.002148918,0.2757177],"study_design_scores_gemma":[0.0013993325,0.0013949261,0.000012619767,0.57841563,0.022585485,0.004116541,0.0000036375457,1.16827955e-7,0.000022225406,0.000007790441,0.39190778,0.00013393462],"about_ca_topic_score_codex":2.3830955e-7,"about_ca_topic_score_gemma":2.1688475e-8,"teacher_disagreement_score":0.38975886,"about_ca_system_score_codex":0.000063845466,"about_ca_system_score_gemma":0.0002975089,"threshold_uncertainty_score":0.830903},"labels":[],"label_agreement":null},{"id":"W4401322343","doi":"10.7326/annals-24-00968-jc","title":"After PCI and 1 mo of DAPT for ACS, ticagrelor alone vs. continued DAPT for 11 mo reduced bleeding without increasing MACCE","year":2024,"lang":"en","type":"letter","venue":"Annals of Internal Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Ticagrelor; Medicine; Conventional PCI; Internal medicine; Cardiology; Clopidogrel; Major bleeding; Percutaneous coronary intervention; Aspirin; Myocardial infarction","score_opus":0.04202811475629713,"score_gpt":0.3298123239004819,"score_spread":0.28778420914418473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401322343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.70127434,0.045221504,0.0019247752,0.24699526,0.0009832743,0.002565669,0.0006167039,0.000088556975,0.00032991663],"genre_scores_gemma":[0.8486091,0.0022014307,0.000731213,0.13867871,0.0069239787,0.00020803264,0.00025411567,0.00019567186,0.002197757],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99687266,0.00009134772,0.001114933,0.0006826613,0.0007070916,0.0005312837],"domain_scores_gemma":[0.9974741,0.00060676545,0.00050821766,0.0004047363,0.00079538074,0.00021082106],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010949877,0.00056600344,0.0022854425,0.00044504195,0.00004231707,0.000024295394,0.00026841916,0.00050549366,0.000072643656],"category_scores_gemma":[0.0009714247,0.00042081258,0.0008214341,0.00014566656,0.00050352735,0.000103190054,0.00009846397,0.00065771095,0.0000026835517],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025454551,0.00015835733,0.003538782,0.014505245,0.0115971025,0.000732256,0.0010850227,7.447471e-7,0.026423983,0.00008978968,0.89312816,0.023286005],"study_design_scores_gemma":[0.018737374,0.0063535664,0.004362848,0.059492245,0.012627879,0.0019035789,0.000629637,0.00047613893,0.05793692,0.0015075039,0.8347493,0.0012230383],"about_ca_topic_score_codex":0.0003061517,"about_ca_topic_score_gemma":0.0000049093355,"teacher_disagreement_score":0.14733472,"about_ca_system_score_codex":0.000026761376,"about_ca_system_score_gemma":0.000086423795,"threshold_uncertainty_score":0.99982435},"labels":[],"label_agreement":null},{"id":"W4401323144","doi":"10.7326/annals-24-00961-jc","title":"After PCI in older adults, DAPT for 3 vs. 6 or 12 mo reduces bleeding without increasing NACE or MACE","year":2024,"lang":"en","type":"article","venue":"Annals of Internal Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Mace; Medicine; Conventional PCI; Percutaneous coronary intervention; Internal medicine; Cardiology; Myocardial infarction","score_opus":0.03818233431060016,"score_gpt":0.3505437198360488,"score_spread":0.3123613855254487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401323144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95755684,0.036529772,0.00059497013,0.0036411225,0.000428816,0.00062974915,0.000021711283,0.000068639805,0.0005283686],"genre_scores_gemma":[0.9896394,0.0036482087,0.00034921351,0.0023272135,0.0011218998,0.00007996816,0.000011981056,0.000055729633,0.0027663847],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99812394,0.00006959406,0.00057873334,0.00040749897,0.00046265044,0.000357553],"domain_scores_gemma":[0.99897236,0.00032336477,0.00009512428,0.00021290101,0.00019454281,0.00020168825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008491801,0.00026369403,0.00076892663,0.00032743462,0.000027506956,0.000019970626,0.00015593096,0.0001102225,0.0005314064],"category_scores_gemma":[0.0006709054,0.0001557648,0.0003011035,0.0002545865,0.00017752202,0.00017220007,0.000043942902,0.00024499738,0.00000839076],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.30799213,0.00092847313,0.042791232,0.010762506,0.0062114717,0.005855312,0.013681813,0.00001533764,0.018082894,0.00018430184,0.046437975,0.54705656],"study_design_scores_gemma":[0.052590147,0.018716265,0.14834607,0.37035137,0.0039300174,0.009731135,0.020850066,0.008299683,0.13980287,0.00064333883,0.22446544,0.0022735763],"about_ca_topic_score_codex":0.0003475654,"about_ca_topic_score_gemma":0.00003804028,"teacher_disagreement_score":0.544783,"about_ca_system_score_codex":0.000030085454,"about_ca_system_score_gemma":0.00011159567,"threshold_uncertainty_score":0.6351904},"labels":[],"label_agreement":null},{"id":"W4401328120","doi":"10.1016/j.rpth.2024.102539","title":"How to undertake procedures while on antiplatelet agents: a hematologist's view","year":2024,"lang":"en","type":"review","venue":"Research and Practice in Thrombosis and Haemostasis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton","funders":"","keywords":"Platelet; Business; Medicine; Internal medicine","score_opus":0.37767565895600386,"score_gpt":0.5109341402781854,"score_spread":0.13325848132218154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401328120","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00042808152,0.98486197,0.0000046144432,0.009745318,0.000072209776,0.0023659614,0.00010950655,0.00005301693,0.0023593481],"genre_scores_gemma":[0.0017218615,0.9964195,0.00016623533,0.00061015587,0.00016034103,0.00035181482,0.000094624666,0.000094249284,0.00038119886],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99579203,0.0009366184,0.00047566084,0.0011016366,0.0009506238,0.0007434341],"domain_scores_gemma":[0.99637556,0.0021539566,0.00011498869,0.00061111286,0.00021166903,0.00053273723],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0023557,0.00054959604,0.0022746809,0.0007804393,0.00025620605,0.0007310719,0.00019408547,0.00042981416,0.000064389766],"category_scores_gemma":[0.002790311,0.0003773393,0.00041728548,0.0013166296,0.0002926529,0.00029161837,0.0002463074,0.0013310037,0.00010937394],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037653538,0.0004216696,0.000009561329,0.04154998,0.0020423247,0.0009865599,0.00025364527,6.8812035e-8,6.212477e-7,0.0008439187,0.019381147,0.93413395],"study_design_scores_gemma":[0.00059173565,0.0008742502,0.000032117525,0.03369144,0.0018227566,0.0011746186,0.001186442,0.0000011221052,0.0000045802994,0.00017499285,0.9600888,0.00035716558],"about_ca_topic_score_codex":0.00006399374,"about_ca_topic_score_gemma":0.00003918742,"teacher_disagreement_score":0.9407076,"about_ca_system_score_codex":0.00011914225,"about_ca_system_score_gemma":0.0005601364,"threshold_uncertainty_score":0.99986786},"labels":[],"label_agreement":null},{"id":"W4401432082","doi":"10.1136/bmjopen-2023-078197","title":"Impact of aspirin dose according to race in secondary prevention of atherosclerotic cardiovascular disease: a secondary analysis of the ADAPTABLE randomised controlled trial","year":2024,"lang":"en","type":"article","venue":"BMJ Open","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Janssen Pharmaceuticals; Duke Clinical Research Institute; Université de Montréal; National Heart, Lung, and Blood Institute; American Heart Association; Canadian Institutes of Health Research; Bayer; Institut de Cardiologie de Montréal; Moderna; Boston Scientific Corporation; Patient-Centered Outcomes Research Institute; Bristol-Myers Squibb; Eli Lilly and Company","keywords":"Medicine; Aspirin; Clinical endpoint; Myocardial infarction; Stroke (engine); Internal medicine; Randomized controlled trial; Incidence (geometry); Atherosclerosis Risk in Communities; Clinical trial; Physical therapy; Cumulative incidence; Disease; Cohort","score_opus":0.04507188391551499,"score_gpt":0.37017959722502025,"score_spread":0.3251077133095053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401432082","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9698139,0.0067139138,0.0004029127,0.00004114476,0.00012572696,0.022009704,0.000071842296,0.000011962214,0.000808896],"genre_scores_gemma":[0.9981329,0.00010294379,0.00004548212,0.000020458172,0.000057516114,0.0012290467,0.000033842934,0.000026872545,0.00035096184],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9972771,0.0007060922,0.0008737945,0.00034890257,0.00059295073,0.00020119803],"domain_scores_gemma":[0.998316,0.00020244249,0.00021631108,0.0010223385,0.000111955334,0.00013097646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030617327,0.00019896934,0.0022385782,0.0003704302,0.000033060303,0.00003595993,0.0003423169,0.00007325231,0.00045649425],"category_scores_gemma":[0.0003426807,0.00012798449,0.005759436,0.0014074966,0.00006196219,0.0001905154,0.00018546,0.00015740067,0.0000022922636],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8420508,0.0006705633,0.008648182,0.00090360537,0.08529224,0.000059160742,0.00048307312,0.020013168,0.0030571257,0.000030622712,0.00009558374,0.038695857],"study_design_scores_gemma":[0.7223655,0.0008155349,0.24464753,0.001994044,0.02534548,0.000006292467,0.00035281305,0.0033329818,0.00066210114,0.00006760214,0.00016441844,0.0002457131],"about_ca_topic_score_codex":0.00038425933,"about_ca_topic_score_gemma":0.000022838121,"teacher_disagreement_score":0.23599935,"about_ca_system_score_codex":0.000080645295,"about_ca_system_score_gemma":0.0013374467,"threshold_uncertainty_score":0.5808546},"labels":[],"label_agreement":null},{"id":"W4401941396","doi":"10.1097/hco.0000000000001172","title":"Coronary artery bypass grafting in acute coronary syndromes: modern indications and approaches","year":2024,"lang":"en","type":"review","venue":"Current Opinion in Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Conventional PCI; Percutaneous coronary intervention; Cardiology; Myocardial infarction; Internal medicine; Coronary artery disease; Revascularization; Acute coronary syndrome; Antithrombotic; Randomized controlled trial; Artery; Intensive care medicine","score_opus":0.16206899300325067,"score_gpt":0.38115703490472097,"score_spread":0.2190880419014703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401941396","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00087266037,0.994789,0.00020306133,0.00004605771,0.0023582904,0.0013600445,0.00018528393,0.0000756082,0.000109982466],"genre_scores_gemma":[0.00873282,0.98779935,0.000028177405,0.000010754245,0.00045471443,0.0007110226,0.0021693814,0.000073579504,0.00002021529],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971302,0.00052358425,0.0007973721,0.00090169423,0.00021911775,0.00042804235],"domain_scores_gemma":[0.9990059,0.00015555847,0.00014783202,0.0005248433,0.000020334695,0.00014549909],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004604269,0.0005295074,0.0027033612,0.0007081375,0.000051485225,0.000021605103,0.00018580555,0.0005217024,0.00000814577],"category_scores_gemma":[0.000028762242,0.0004373716,0.00094738096,0.00044171553,0.0002454895,0.00007482183,0.00020127403,0.0011129617,0.000045343513],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035992227,0.000084596446,0.0035228333,0.017508283,0.0026649,0.00042430215,0.00012653727,0.0000065639338,6.4582025e-8,0.00015185552,0.000495223,0.97497886],"study_design_scores_gemma":[0.0019014903,0.00020419703,0.01245022,0.03638444,0.005133907,0.022415396,0.00015005474,0.00018880623,2.47813e-8,0.0006033028,0.9197377,0.000830461],"about_ca_topic_score_codex":0.0000013946085,"about_ca_topic_score_gemma":3.750775e-7,"teacher_disagreement_score":0.9741484,"about_ca_system_score_codex":0.00018916988,"about_ca_system_score_gemma":0.00040360025,"threshold_uncertainty_score":0.99980783},"labels":[],"label_agreement":null},{"id":"W4402089707","doi":"10.1016/s0140-6736(24)01616-7","title":"De-escalation to ticagrelor monotherapy versus 12 months of dual antiplatelet therapy in patients with and without acute coronary syndromes: a systematic review and individual patient-level meta-analysis of randomised trials","year":2024,"lang":"en","type":"review","venue":"The Lancet","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences","funders":"Ente Ospedaliero Cantonale; Esperion Therapeutics; Boston Scientific Corporation; Bristol-Myers Squibb; CSL Behring; Bayer Corporation; Istituto Cardiocentro Ticino; Beth Israel Deaconess Medical Center; Janssen Pharmaceuticals; Gilead Sciences; BioClinica; Amgen; Duke Clinical Research Institute","keywords":"Medicine; Ticagrelor; Acute coronary syndrome; Internal medicine; Meta-analysis; Antiplatelet drug; Randomized controlled trial; Cardiology; Coronary stent; Stent; Clopidogrel; Aspirin; Myocardial infarction","score_opus":0.16887992259495113,"score_gpt":0.36568161995668,"score_spread":0.1968016973617289,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402089707","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.030765396,0.95953053,0.00002230013,0.00006369381,0.000026623955,0.008423105,0.0011434695,0.000016886263,0.000008005793],"genre_scores_gemma":[0.016921105,0.9817691,0.00013100987,0.00021006315,0.000021682066,0.0005730111,0.000305075,0.000052472555,0.000016518856],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9956018,0.0016197514,0.0015358091,0.00040952014,0.00059406157,0.00023907906],"domain_scores_gemma":[0.9974628,0.00069019635,0.0008901058,0.000757452,0.00009843885,0.00010100177],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.002756145,0.00049681147,0.014990826,0.00038623723,0.00003067403,0.000030971994,0.00018148667,0.0001577347,0.000041901723],"category_scores_gemma":[0.00020742354,0.00022537739,0.0019472677,0.000754606,0.00010735385,0.000055932287,0.000048221937,0.00021986598,0.000001439395],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013550909,0.00015874705,0.0004469545,0.18225437,0.7647628,0.00002466093,0.00057717203,0.00000393286,2.915311e-7,0.000009073565,0.00008646637,0.03812457],"study_design_scores_gemma":[0.021733558,0.0010172287,0.0014677239,0.041246478,0.93352664,0.00003746849,0.000030546264,0.000006344358,0.0000011679974,0.0000045711454,0.0006645857,0.00026371828],"about_ca_topic_score_codex":0.000011696944,"about_ca_topic_score_gemma":0.0000033312392,"teacher_disagreement_score":0.16876377,"about_ca_system_score_codex":0.000033027758,"about_ca_system_score_gemma":0.00011798534,"threshold_uncertainty_score":0.99963266},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"meta_analysis","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"meta_analysis","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W4402469491","doi":"10.1016/j.cjco.2024.09.003","title":"Impact of Vanessa's Law on the Reporting of Serious Adverse Events: A Retrospective Study Among Antiplatelet Users in a Tertiary-Care Cardiology Centre","year":2024,"lang":"en","type":"article","venue":"CJC Open","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Université du Québec à Trois-Rivières; Université Laval; Centre Hospitalier Universitaire Sainte-Justine; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"Fondation de l’UQTR; Fondation Institut Universitaire de Cardiologie et de Pneumologie de Québec; Institut universitaire de cardiologie et de pneumologie de Québec, Université Laval; Université du Québec à Trois-Rivières","keywords":"Retrospective cohort study; Medicine; Internal medicine; Family medicine; Cardiology; Emergency medicine; Medical emergency","score_opus":0.013054525105223497,"score_gpt":0.3123287400748793,"score_spread":0.29927421496965584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402469491","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951743,0.0006442657,0.0000036638442,0.00004846687,0.00009874594,0.0019200424,0.000037656846,0.000025722997,0.0020471667],"genre_scores_gemma":[0.9997225,0.000053700096,0.000006554073,0.000035970934,0.00004448028,0.000032690994,0.00002355811,0.000030008869,0.00005053878],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981682,0.00025842516,0.0007073152,0.00037349205,0.00026866025,0.00022391033],"domain_scores_gemma":[0.9988646,0.00005943171,0.00031647072,0.00058213813,0.00011600266,0.00006139538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007854176,0.00018557148,0.0009196934,0.000090887006,0.000049924576,0.000012312785,0.00022862596,0.00008211913,0.0000788277],"category_scores_gemma":[0.00019854646,0.00011539326,0.00057477143,0.00031095374,0.00011628689,0.00013554841,0.00013689065,0.00024020034,0.0000050943436],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006871244,0.00018954245,0.9891254,0.000103042024,0.0024492247,0.0026768493,0.003120422,0.00028118826,0.00024728576,0.00007955791,0.00006882953,0.0009715427],"study_design_scores_gemma":[0.0019851292,0.00058154017,0.987799,0.00069740124,0.00033691945,0.00009891495,0.007901006,0.00003457079,0.0003440188,0.000048159985,0.000058484748,0.00011486426],"about_ca_topic_score_codex":0.0015172436,"about_ca_topic_score_gemma":0.00016268497,"teacher_disagreement_score":0.004780584,"about_ca_system_score_codex":0.00014503804,"about_ca_system_score_gemma":0.000147868,"threshold_uncertainty_score":0.47056004},"labels":[],"label_agreement":null},{"id":"W4402582166","doi":"10.1161/circulationaha.124.070541","title":"Arterial Thrombosis: Present and Future","year":2024,"lang":"en","type":"review","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Medicine; Thrombosis; Cardiology; Intensive care medicine; Internal medicine","score_opus":0.04246188458434295,"score_gpt":0.3335870099609565,"score_spread":0.29112512537661356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402582166","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012444975,0.9979666,0.000028009752,0.00007546942,0.00066204986,0.00064041436,0.00001689131,0.00007993656,0.0004061773],"genre_scores_gemma":[0.00038777018,0.9927854,0.0000104726405,0.000020799787,0.006330684,0.00004800853,0.00034193878,0.00004102182,0.00003393225],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991658,0.000056494533,0.00020793245,0.00028775947,0.00017981445,0.00010224985],"domain_scores_gemma":[0.99959993,0.000009072905,0.000051516192,0.00024565388,0.00002101683,0.00007281182],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007739916,0.00020333042,0.00080987485,0.00008407888,0.000036360896,0.000044549826,0.000028994324,0.00023528123,0.00007808322],"category_scores_gemma":[0.0000026183145,0.00014500417,0.00062781636,0.00012256493,0.000028240325,0.00004111463,0.000018090708,0.00015177013,0.0000920626],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000051900993,0.000015861397,0.000007977587,0.01600257,0.0010152593,0.00002571938,0.00002962182,1.0905269e-7,7.834699e-7,0.00013738543,0.00085034483,0.98190916],"study_design_scores_gemma":[0.0002120751,0.0000103576385,0.00068568095,0.004923071,0.008062134,0.00019577342,0.000011874302,0.000008944986,1.0849719e-7,0.00006133925,0.9856935,0.00013510953],"about_ca_topic_score_codex":9.2981816e-7,"about_ca_topic_score_gemma":5.952654e-8,"teacher_disagreement_score":0.9848432,"about_ca_system_score_codex":0.000038456863,"about_ca_system_score_gemma":0.00009491707,"threshold_uncertainty_score":0.59130985},"labels":[],"label_agreement":null},{"id":"W4402903648","doi":"10.1093/ehjopen/oeae083","title":"Health-related quality of life with rivaroxaban plus aspirin vs. aspirin alone in chronic stable cardiovascular disease: Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) trial","year":2024,"lang":"en","type":"article","venue":"European Heart Journal Open","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Population Health Research Institute; McMaster University; SickKids Foundation; Hamilton Health Sciences; Institute for Clinical Evaluative Sciences; Impact; Hospital for Sick Children; McMaster University Medical Centre","funders":"EuroQol Research Foundation; Bayer","keywords":"Rivaroxaban; Aspirin; Medicine; Quality of life (healthcare); Disease; Compass; Warfarin; Intensive care medicine; Physical therapy; Internal medicine; Atrial fibrillation","score_opus":0.11184494977257366,"score_gpt":0.36449527568459644,"score_spread":0.2526503259120228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402903648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9308242,0.05773043,0.0067392583,0.00070489565,0.00038329733,0.0033286826,0.000056677833,0.000074863674,0.00015770512],"genre_scores_gemma":[0.99771106,0.00069969485,0.00069788145,0.0001277247,0.00042257068,0.00002607931,0.00010999643,0.00014165061,0.00006333377],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.994039,0.0019581546,0.0014999484,0.00065861206,0.0012325753,0.0006117088],"domain_scores_gemma":[0.99777573,0.00014429782,0.00026711635,0.0009856296,0.00026999332,0.000557234],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0070638536,0.00041998544,0.002824456,0.0003223715,0.00028813744,0.00047559667,0.00035767828,0.00007388461,0.000052777898],"category_scores_gemma":[0.00016328774,0.00033241394,0.0026104252,0.00061333657,0.0001104223,0.00086139166,0.00014602969,0.0005264509,0.000015246203],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10008514,0.0015537592,0.14890528,0.008248298,0.06670067,0.0017821258,0.0016815966,0.64936286,0.00030669812,0.00077996356,0.001202787,0.019390842],"study_design_scores_gemma":[0.10872815,0.0018272841,0.85533845,0.0027980113,0.0026290498,0.00027038713,0.0003778823,0.0044718883,0.000036123492,0.000094019066,0.022683658,0.00074510643],"about_ca_topic_score_codex":0.0014881318,"about_ca_topic_score_gemma":0.00008036548,"teacher_disagreement_score":0.7064332,"about_ca_system_score_codex":0.00057008205,"about_ca_system_score_gemma":0.0031777974,"threshold_uncertainty_score":0.9999128},"labels":[],"label_agreement":null},{"id":"W4402945148","doi":"10.1016/j.oftale.2024.09.001","title":"Cyclodestruction and cyclophotocoagulation: Where are we?","year":2024,"lang":"es","type":"review","venue":"Archivos de la Sociedad Española de Oftalmología (English Edition)","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Optometry; Medicine","score_opus":0.013595112694887588,"score_gpt":0.29524766820645626,"score_spread":0.28165255551156865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402945148","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012373627,0.97005767,0.0007193674,0.0008080686,0.0027529607,0.0027344967,0.0007564153,0.0006546294,0.00914274],"genre_scores_gemma":[0.021919606,0.96243584,0.0010021691,0.00025881018,0.010926055,0.0010558928,0.00090990594,0.000299734,0.0011919577],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99348575,0.001862879,0.0010970504,0.0014909876,0.00086953584,0.0011938163],"domain_scores_gemma":[0.99623704,0.0011382647,0.00059333735,0.0009720345,0.00026114754,0.0007982003],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.00147623,0.0013147166,0.0024766128,0.00044249598,0.00062685966,0.0005805336,0.00044421456,0.0016252013,0.0007046805],"category_scores_gemma":[0.0004514146,0.001232113,0.0023333658,0.00070569053,0.0014541164,0.00043376267,0.00028239322,0.0025750084,0.00025407973],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070566236,0.0012517323,0.014683534,0.1214134,0.017021915,0.009112707,0.0075441916,0.00011728697,0.00008774086,0.015097548,0.15066326,0.662301],"study_design_scores_gemma":[0.0018377238,0.00024802756,0.011331413,0.024895,0.009880058,0.0061130472,0.0016521194,0.00015681621,0.000010608951,0.0100302445,0.932565,0.0012799706],"about_ca_topic_score_codex":0.00002678607,"about_ca_topic_score_gemma":0.0000037169089,"teacher_disagreement_score":0.7819017,"about_ca_system_score_codex":0.00057147554,"about_ca_system_score_gemma":0.00087954063,"threshold_uncertainty_score":0.9999604},"labels":[],"label_agreement":null},{"id":"W4402959184","doi":"10.1345/aph.lk591a","title":"Comment: Aspirin, Clopidogrel, and Warfarin: Is the Combination Appropriate and Effective or Inappropriate and Too Dangerous?","year":2008,"lang":"en","type":"article","venue":"Annals of Pharmacotherapy","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre","funders":"","keywords":"Medicine; Clopidogrel; Aspirin; Warfarin; Intensive care medicine; Cardiology; Atrial fibrillation; Internal medicine","score_opus":0.05397793213068128,"score_gpt":0.3356656101835863,"score_spread":0.28168767805290507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402959184","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97083235,0.019391173,0.00016780202,0.008448184,0.000049181337,0.0009237148,0.000014533161,0.000025356418,0.0001477008],"genre_scores_gemma":[0.90766346,0.07957006,0.00008601943,0.012386246,0.00007677203,0.000048565547,0.000007786407,0.000025123783,0.00013596764],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99894464,0.00016470636,0.00020429728,0.00026219198,0.00023455161,0.00018961138],"domain_scores_gemma":[0.9993538,0.00011282807,0.00010694009,0.00019179893,0.000118051765,0.000116566276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038907482,0.00019245791,0.0003806227,0.00006616467,0.00019338146,0.00001874621,0.00006337855,0.000067329565,0.00004832106],"category_scores_gemma":[0.000013067875,0.000119924065,0.00011066489,0.00013436783,0.00037228115,0.00012595233,0.000037169593,0.00014573804,0.0000019714346],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052932072,0.00059341296,0.0264678,0.00043390205,0.0027853562,0.000089149245,0.0062914155,0.0000012852748,0.022108044,0.000519625,0.003862098,0.9315547],"study_design_scores_gemma":[0.03764262,0.005069447,0.19127335,0.00041506617,0.00081064325,0.0012441212,0.0007622817,0.00078270526,0.43634388,0.0031876285,0.3214885,0.0009797576],"about_ca_topic_score_codex":0.000032578773,"about_ca_topic_score_gemma":5.231845e-7,"teacher_disagreement_score":0.93057495,"about_ca_system_score_codex":0.000005285974,"about_ca_system_score_gemma":0.000024284314,"threshold_uncertainty_score":0.48903614},"labels":[],"label_agreement":null},{"id":"W4403104246","doi":"10.1111/bjh.19816","title":"Warfarin reversal in patients with antiphospholipid syndrome: Caution required, but clear guidance not available","year":2024,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Warfarin; Medicine; Antiphospholipid syndrome; Intensive care medicine; Internal medicine; Thrombosis; Atrial fibrillation","score_opus":0.009687052408266093,"score_gpt":0.215298940964952,"score_spread":0.2056118885566859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403104246","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9370308,0.025451133,0.00004582539,0.0352857,0.0011736432,0.00050109223,0.0001173974,0.000045235796,0.0003491854],"genre_scores_gemma":[0.71382266,0.013412348,0.0012552333,0.2609206,0.0023702122,0.000033909615,0.0004953388,0.00045992428,0.007229796],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.9970046,0.00026779078,0.00094723125,0.0004662836,0.0007939729,0.0005200846],"domain_scores_gemma":[0.99870586,0.000062033316,0.0004898959,0.00033536204,0.00028542773,0.000121437624],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00041247875,0.00033160957,0.001748561,0.0003343132,0.000063451575,0.00006832651,0.00025035738,0.0007745465,0.000360119],"category_scores_gemma":[0.00013872529,0.00032395983,0.00056168874,0.0002646476,0.00024391923,0.00020343173,0.00006105189,0.0023384246,0.00020075549],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001037391,0.000119543176,0.0023704516,0.00081374176,0.0007387493,0.45297053,0.00001638946,0.000003003595,0.0000061256997,0.000006779329,0.5407,0.0012172728],"study_design_scores_gemma":[0.006514852,0.0011345763,0.00809026,0.008930759,0.0010423278,0.61100316,0.000021971635,0.000004734583,0.00023284639,0.000066534056,0.36250678,0.00045118667],"about_ca_topic_score_codex":0.00010684669,"about_ca_topic_score_gemma":0.00001054909,"teacher_disagreement_score":0.2256349,"about_ca_system_score_codex":0.00017403327,"about_ca_system_score_gemma":0.00048118684,"threshold_uncertainty_score":0.9999632},"labels":[],"label_agreement":null},{"id":"W4403218367","doi":"10.1038/s41397-024-00353-y","title":"Cost analysis of CYP2C19 genetic testing in percutaneous coronary intervention patients","year":2024,"lang":"en","type":"article","venue":"The Pharmacogenomics Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Heart and Stroke Foundation; University of Toronto","funders":"National Institutes of Health","keywords":"Percutaneous coronary intervention; CYP2C19; Genetic testing; Medicine; Internal medicine; Cardiology; Myocardial infarction","score_opus":0.03617624345590881,"score_gpt":0.3176171968966884,"score_spread":0.2814409534407796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403218367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98713267,0.011439063,0.00082117197,0.00006250728,0.0002080511,0.00019370574,0.000027221906,0.000013370677,0.000102238664],"genre_scores_gemma":[0.9977167,0.0018555807,0.00013461545,0.000102060316,0.000119495606,0.0000027162198,0.000017989863,0.000017948443,0.00003285987],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99903053,0.000119708086,0.00036797614,0.00011953559,0.00020820939,0.00015404362],"domain_scores_gemma":[0.999549,0.00008797564,0.000079273574,0.000116651114,0.00008750835,0.00007961108],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004171578,0.00009883928,0.00026067966,0.0002972092,0.000059347552,0.000031266187,0.00011452039,0.000026200234,0.00022616514],"category_scores_gemma":[0.000027197088,0.00007009321,0.00055386074,0.00054682686,0.00004881279,0.000045428114,0.000029922832,0.00026869547,0.000009879218],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009192345,0.00045655604,0.22154877,0.0001351466,0.0124325855,0.002578678,0.0009970241,0.017045164,0.021347074,0.000007940161,0.00011477321,0.72241706],"study_design_scores_gemma":[0.005027011,0.0005635725,0.7706018,0.00066761277,0.027100973,0.013696866,0.00060688355,0.17630973,0.0016446285,0.00025717943,0.0031303333,0.00039338574],"about_ca_topic_score_codex":0.00001290817,"about_ca_topic_score_gemma":0.000002634503,"teacher_disagreement_score":0.72202367,"about_ca_system_score_codex":0.00012722217,"about_ca_system_score_gemma":0.000063545434,"threshold_uncertainty_score":0.28583178},"labels":[],"label_agreement":null},{"id":"W4403227197","doi":"10.1016/j.cjca.2024.08.019","title":"COMPARING OUTCOMES OF TICAGRELOR AND CLOPIDOGREL IN ST-ELEVATION MYOCARDIAL INFARCTION PATIENTS REQUIRING CORONARY ARTERY BYPASS GRAFTING DURING INDEX HOSPITALIZATION","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Ticagrelor; Clopidogrel; Bypass grafting; Cardiology; Internal medicine; Myocardial infarction; Artery","score_opus":0.010998514003434691,"score_gpt":0.22938726849568106,"score_spread":0.21838875449224637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403227197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957626,0.0020340595,0.0011557596,0.00012794537,0.0005942549,0.00014696972,0.000007569672,0.0000079544225,0.00016291294],"genre_scores_gemma":[0.99938107,0.00023464739,0.000024067984,0.000033963806,0.0002816119,0.0000024336316,0.000020750755,0.000016139122,0.0000053141225],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99898523,0.00009817988,0.00043358206,0.00013322034,0.00015390207,0.00019589976],"domain_scores_gemma":[0.9994446,0.000044468972,0.00010416006,0.000091301736,0.00014138763,0.00017410348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030091786,0.00010959356,0.00050832366,0.0005023069,0.000049696257,0.000018936547,0.00004412177,0.00010503734,0.0000035382197],"category_scores_gemma":[0.00011362697,0.000102255275,0.0002135014,0.00017231317,0.00009548642,0.00019312791,0.000011031693,0.00020348074,6.494576e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000096923104,0.00000296922,0.99034107,0.000082179526,0.00087110634,0.00018923962,0.0002248672,0.0015615091,0.00010112659,0.000072038536,0.000031154326,0.0064258096],"study_design_scores_gemma":[0.0016629422,0.00013734358,0.99622023,0.00023554571,0.00020492764,0.0003794739,0.00015638104,0.0002477903,0.000019196126,0.00009515569,0.00055447087,0.00008651884],"about_ca_topic_score_codex":0.00010633636,"about_ca_topic_score_gemma":0.00012288404,"teacher_disagreement_score":0.006339291,"about_ca_system_score_codex":0.00016132253,"about_ca_system_score_gemma":0.0002927689,"threshold_uncertainty_score":0.41698492},"labels":[],"label_agreement":null},{"id":"W4403227586","doi":"10.1016/j.cjca.2024.08.002","title":"ADVERSE MEDICATION REACTIONS IN WOMEN WITH NON-OBSTRUCTIVE CORONARY SYNDROMES: IMPACT ON SYMPTOM MANAGEMENT AND QUALITY OF LIFE","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Burnaby Hospital","funders":"","keywords":"Medicine; Quality of life (healthcare); Adverse effect; Intensive care medicine; Internal medicine; Nursing","score_opus":0.013525705526869467,"score_gpt":0.26809127247186737,"score_spread":0.2545655669449979,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403227586","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951568,0.0026179028,0.00034640075,0.00016986139,0.00014025222,0.00013430082,0.00002284565,0.000003373685,0.0014082596],"genre_scores_gemma":[0.9988985,0.00083711784,0.000030774638,0.000075756696,0.00010638856,0.0000061409646,0.0000048540123,0.000009533091,0.00003091885],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99919367,0.00011599716,0.00027487642,0.00011491752,0.00013609511,0.00016446429],"domain_scores_gemma":[0.9992409,0.00006712026,0.0000810246,0.00013430504,0.00006138709,0.0004152764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045346795,0.00009101218,0.00046267905,0.0003832014,0.000023597353,0.000004309701,0.000046327918,0.00006458904,0.000022660519],"category_scores_gemma":[0.00003364216,0.00006476731,0.00014595698,0.00014936946,0.00016547999,0.00005720079,0.0000037991151,0.00018070608,0.0000015664449],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008760197,0.00003944181,0.8143018,0.0013805581,0.026521046,0.009601731,0.0033938638,0.008860748,0.00031767823,0.0017533582,0.0018104028,0.12325917],"study_design_scores_gemma":[0.0013292,0.00061575545,0.9903963,0.00036803872,0.00017892399,0.0012333709,0.0016501669,0.0000060748844,0.000004933144,0.00010673867,0.0040480453,0.00006240547],"about_ca_topic_score_codex":0.00037067942,"about_ca_topic_score_gemma":0.00010128172,"teacher_disagreement_score":0.17609455,"about_ca_system_score_codex":0.00029831377,"about_ca_system_score_gemma":0.0007842991,"threshold_uncertainty_score":0.26411343},"labels":[],"label_agreement":null},{"id":"W4403227612","doi":"10.1016/j.cjca.2024.08.042","title":"TICAGRELOR VS RIVAROXABAN: EFFECTS ON HEMOSTASIS, THROMBOTIC AND INFLAMMATORY BIOMARKERS","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Rivaroxaban; Ticagrelor; Hemostasis; Internal medicine; Cardiology; Warfarin; Aspirin; Clopidogrel; Atrial fibrillation","score_opus":0.007910527891643801,"score_gpt":0.22993838484713763,"score_spread":0.22202785695549382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403227612","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9504714,0.041419614,0.00046224307,0.0019497225,0.0013572173,0.00020859727,0.000012600675,0.000021285497,0.004097321],"genre_scores_gemma":[0.99746335,0.00086425664,0.000046255394,0.0005414018,0.0010199357,0.0000019453826,0.0000040337727,0.000023399256,0.000035444948],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990904,0.0001435749,0.00021228532,0.00015557006,0.00013100219,0.00026721705],"domain_scores_gemma":[0.99891245,0.00016218482,0.000036043646,0.00016795576,0.00006571035,0.000655652],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003423446,0.00014085717,0.00052290276,0.00032491138,0.000063608335,0.000029715311,0.0000690597,0.00013025469,0.000022702197],"category_scores_gemma":[0.00013198487,0.000110329325,0.0004076656,0.00011891335,0.00020354966,0.00005664397,0.0000061419864,0.00026005748,0.000027953829],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018332351,0.000012400593,0.105876125,0.0021229987,0.029466813,0.07828373,0.0007942169,0.0003650327,0.0033358224,0.0064425236,0.10676767,0.66469944],"study_design_scores_gemma":[0.002996923,0.0019640843,0.31107703,0.0014158464,0.0022052277,0.018060721,0.0002170269,0.000040355666,0.0017489268,0.0008632765,0.659033,0.00037756085],"about_ca_topic_score_codex":0.000029204662,"about_ca_topic_score_gemma":0.00002046886,"teacher_disagreement_score":0.6643219,"about_ca_system_score_codex":0.0001016594,"about_ca_system_score_gemma":0.0008476815,"threshold_uncertainty_score":0.44990993},"labels":[],"label_agreement":null},{"id":"W4403227624","doi":"10.1016/j.cjca.2024.08.046","title":"A SIMPLE DOSING RULE TO IMPROVE EFFICACY AND SAFETY OF TICAGRELOR","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Dosing; Ticagrelor; Simple (philosophy); Intensive care medicine; Pharmacology; Internal medicine; Aspirin","score_opus":0.009158930804268389,"score_gpt":0.2487655298824061,"score_spread":0.23960659907813772,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403227624","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97189987,0.019371867,0.0044351853,0.0009132231,0.0005250728,0.00018291418,0.000047179998,0.000007727171,0.002616966],"genre_scores_gemma":[0.9987162,0.00026297642,0.00010571378,0.0001980653,0.00065786665,8.1885076e-7,0.000003039306,0.0000138585265,0.000041495714],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992916,0.000059241745,0.0002522758,0.000111815665,0.000086798915,0.00019827028],"domain_scores_gemma":[0.9990878,0.00007673807,0.00003403624,0.00012845299,0.000104449544,0.00056853826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031805655,0.00008369247,0.00047509163,0.00022413488,0.000037605587,0.000013279815,0.00005592639,0.00007404075,0.000028104656],"category_scores_gemma":[0.00010875387,0.000067289606,0.0002855753,0.00012362648,0.00010971933,0.000036670128,0.000008060448,0.00015273092,0.0000058673827],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024055534,0.00001155053,0.026256623,0.0006353868,0.008975403,0.0072736284,0.0013658672,0.0014319166,0.026737146,0.0028113825,0.016987126,0.9051084],"study_design_scores_gemma":[0.0030614634,0.0012307456,0.12570244,0.0004811736,0.0013068058,0.0054122545,0.00030826038,0.00003222499,0.002067309,0.00043495346,0.859747,0.00021540387],"about_ca_topic_score_codex":0.000113005575,"about_ca_topic_score_gemma":0.000035287932,"teacher_disagreement_score":0.90489304,"about_ca_system_score_codex":0.000057477388,"about_ca_system_score_gemma":0.00076786825,"threshold_uncertainty_score":0.27439904},"labels":[],"label_agreement":null},{"id":"W4403502574","doi":"10.1093/ehjcvp/pvae080","title":"Impact of ticagrelor with or without aspirin on total and recurrent bleeding and ischaemic events after percutaneous coronary intervention: a sub-study of the TWILIGHT trial","year":2024,"lang":"en","type":"article","venue":"European Heart Journal - Cardiovascular Pharmacotherapy","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences","funders":"Icahn School of Medicine at Mount Sinai; AstraZeneca","keywords":"Ticagrelor; Medicine; Aspirin; Percutaneous coronary intervention; Cardiology; Twilight; Conventional PCI; Internal medicine; Clopidogrel; Myocardial infarction","score_opus":0.027032535262793134,"score_gpt":0.3263635839791255,"score_spread":0.29933104871633237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403502574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95177627,0.046514943,0.000057912985,0.000041262312,0.00036809067,0.0011579868,0.000012485353,0.000026660447,0.000044362798],"genre_scores_gemma":[0.9947522,0.0044996613,0.000022484468,0.000050741048,0.0005187857,0.000010682577,0.0000013428167,0.00008169161,0.000062380794],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9971629,0.0009813146,0.00047831974,0.00036805178,0.00077512587,0.0002343136],"domain_scores_gemma":[0.99918115,0.00005469875,0.00009533686,0.00035703098,0.00010399486,0.00020777338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011696998,0.0003070005,0.00076776586,0.00016285782,0.000111256406,0.000050985942,0.00009979961,0.00003598121,0.00011617513],"category_scores_gemma":[0.00001398751,0.0001614751,0.0018252273,0.00022799511,0.00012855906,0.00012494584,0.000051367133,0.00048558516,0.000003708019],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.428096,0.004084148,0.087214865,0.0011477813,0.097207084,0.01297177,0.007470526,0.000632081,0.021511097,0.0000019486301,0.0004131253,0.33924958],"study_design_scores_gemma":[0.22260417,0.067510046,0.4381381,0.008686836,0.017254671,0.22878645,0.0015272858,0.000727205,0.003839352,0.000010868877,0.009618449,0.0012965513],"about_ca_topic_score_codex":0.00000716452,"about_ca_topic_score_gemma":6.72336e-7,"teacher_disagreement_score":0.35092324,"about_ca_system_score_codex":0.00006130643,"about_ca_system_score_gemma":0.00009593934,"threshold_uncertainty_score":0.65847635},"labels":[],"label_agreement":null},{"id":"W4403665676","doi":"10.1016/j.jacc.2024.09.266","title":"TCT-230 Ticagrelor Monotherapy vs Ticagrelor Plus Aspirin in Patients With Chronic Coronary Syndrome and High Ischemic Risk: A Post Hoc Analysis of the TWILIGHT Trial","year":2024,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Ticagrelor; Aspirin; Post-hoc analysis; Internal medicine; Cardiology; Acute coronary syndrome; Myocardial infarction; Clopidogrel","score_opus":0.004122960669795592,"score_gpt":0.2205817063131876,"score_spread":0.21645874564339201,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403665676","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930838,0.0051938416,0.00007248688,0.00062924373,0.0002491772,0.0005448326,0.0001904936,0.000005970212,0.000030157482],"genre_scores_gemma":[0.9984087,0.001188367,0.00006489186,0.00012543163,0.00012288177,0.0000070146966,0.000004368805,0.00002519827,0.000053192853],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99791867,0.00050956156,0.00063567096,0.00022582647,0.00048792458,0.00022232978],"domain_scores_gemma":[0.9983646,0.00026756222,0.00060284504,0.00048481105,0.00019352685,0.00008659789],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048995315,0.00020652544,0.0017455211,0.00034908007,0.0000493202,0.000005580737,0.00029211736,0.00007786623,0.000020275971],"category_scores_gemma":[0.00007234961,0.000104341685,0.001203573,0.0012414417,0.0008020803,0.000059601953,0.00007409456,0.0003874516,7.0949073e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.26866242,0.0003565691,0.63798445,0.00023579251,0.06939267,0.0014874677,0.00026552659,0.004475628,0.000997198,0.00008487522,0.0009078338,0.015149528],"study_design_scores_gemma":[0.026693678,0.00896181,0.951421,0.00031363484,0.008891247,0.0014017527,0.00015662595,0.00018925212,0.00019181255,0.000023263332,0.0015964555,0.00015942845],"about_ca_topic_score_codex":0.000022752149,"about_ca_topic_score_gemma":0.000010581435,"teacher_disagreement_score":0.31343657,"about_ca_system_score_codex":0.00017943817,"about_ca_system_score_gemma":0.0005759431,"threshold_uncertainty_score":0.42549306},"labels":[],"label_agreement":null},{"id":"W4403697408","doi":"10.1111/jvim.17198","title":"The effect of concurrent clopidogrel and omeprazole administration on clopidogrel metabolism and platelet function in healthy cats","year":2024,"lang":"en","type":"article","venue":"Journal of Veterinary Internal Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Cegep de Saint Hyacinthe","funders":"Washington State University","keywords":"Clopidogrel; Omeprazole; Medicine; Crossover study; Platelet; Pharmacology; CATS; Pharmacodynamics; Pharmacokinetics; Active metabolite; Internal medicine; Anesthesia; Aspirin; Pathology","score_opus":0.017275842295189844,"score_gpt":0.3297901974461305,"score_spread":0.3125143551509406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403697408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9236782,0.07264548,0.00014772835,0.0018665612,0.0013754509,0.00018858846,0.0000031647257,0.0000074067884,0.000087421686],"genre_scores_gemma":[0.9856589,0.01345517,0.000008044115,0.00016459248,0.00066494604,0.000004711586,0.0000026208131,0.000012954215,0.00002807265],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99861515,0.00017762756,0.0005586261,0.00014378903,0.00036972237,0.00013508636],"domain_scores_gemma":[0.9991261,0.00038183996,0.00018377526,0.000106860105,0.00005717935,0.00014425181],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009945668,0.00015544471,0.00051837694,0.00021400405,0.000040166295,0.00001710189,0.00005931566,0.00006073332,0.000016103277],"category_scores_gemma":[0.0001129683,0.000083224906,0.0001409714,0.00011636621,0.00019039302,0.00009775356,0.00001993017,0.00039179242,0.0000011217297],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05221562,0.00012774696,0.0069017997,0.0013807089,0.0013204373,0.00299341,0.00068274554,0.0000056900108,0.0068864054,0.00041040056,0.0009251743,0.92614985],"study_design_scores_gemma":[0.03209665,0.2966524,0.3865222,0.016763985,0.0020056488,0.048414346,0.0009780582,0.0008951679,0.0054732775,0.00031661353,0.20945676,0.00042490102],"about_ca_topic_score_codex":0.000012930871,"about_ca_topic_score_gemma":0.0000017771031,"teacher_disagreement_score":0.925725,"about_ca_system_score_codex":0.000036257887,"about_ca_system_score_gemma":0.000056225468,"threshold_uncertainty_score":0.3393813},"labels":[],"label_agreement":null},{"id":"W4404100186","doi":"10.1183/13993003.congress-2024.pa2563","title":"Bleeding risk with antiplatelet use during thoracentesis: systematic review with confounder matrix","year":2024,"lang":"en","type":"article","venue":"","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Thoracentesis; Confounding; Internal medicine","score_opus":0.009455731624142398,"score_gpt":0.2585650649679268,"score_spread":0.2491093333437844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404100186","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6396223,0.35056928,0.0040698345,0.0002982472,0.00008756837,0.0030004426,0.000017744356,0.00084834814,0.0014862487],"genre_scores_gemma":[0.93468636,0.060119417,0.00062335184,0.00037635196,0.000090382724,0.00008739981,0.000019605397,0.00008526774,0.003911858],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9982763,0.00010776356,0.00035410776,0.0004034254,0.00054725533,0.00031116587],"domain_scores_gemma":[0.99901855,0.00010305404,0.00008418668,0.0005008606,0.000119967546,0.00017340633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004072258,0.00029298587,0.000930734,0.00011174086,0.00012334986,0.000183026,0.00007880453,0.000058488524,0.00022213101],"category_scores_gemma":[0.00005135467,0.0001557722,0.00031460985,0.00043927444,0.00006738358,0.0003465473,0.000020634408,0.00023600835,0.00013254961],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000841507,0.00011954747,0.012049586,0.96846604,0.011398632,0.005173562,0.00013465287,0.00003099328,0.00026669455,0.0008272289,0.0004908145,0.00020075629],"study_design_scores_gemma":[0.0037879527,0.00057185855,0.005463653,0.94125617,0.030745007,0.012704634,0.0009483579,0.0005126151,0.0016595116,0.000014335029,0.0014176926,0.0009182364],"about_ca_topic_score_codex":0.000019404357,"about_ca_topic_score_gemma":0.0000026396597,"teacher_disagreement_score":0.2950641,"about_ca_system_score_codex":0.000053999735,"about_ca_system_score_gemma":0.00009518889,"threshold_uncertainty_score":0.6352206},"labels":[],"label_agreement":null},{"id":"W4404172850","doi":"10.1101/2024.11.06.24316875","title":"Ticagrelor Compared to Clopidogrel in aCute Coronary syndromes (TC4) – A Bayesian pragmatic cluster randomized controlled trial","year":2024,"lang":"en","type":"preprint","venue":"medRxiv","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Ticagrelor; Clopidogrel; Randomized controlled trial; Medicine; Acute coronary syndrome; Internal medicine; Cardiology; Bayesian network; Myocardial infarction; Computer science; Artificial intelligence","score_opus":0.012960951797303106,"score_gpt":0.2863166088165885,"score_spread":0.2733556570192854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404172850","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.955608,0.009657942,0.0013152492,0.0037506674,0.0028512354,0.024898656,0.00005984423,0.0002924264,0.0015659455],"genre_scores_gemma":[0.98846924,0.0009798625,0.00076318794,0.0010956647,0.0005140505,0.005176226,0.0002198292,0.0001379293,0.0026440225],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99422765,0.0015010857,0.0017056331,0.0010345235,0.00094098545,0.0005900959],"domain_scores_gemma":[0.9970643,0.0009445346,0.0002780859,0.0011381431,0.00012416809,0.00045075055],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0029414634,0.00078007975,0.0067348233,0.0006800987,0.000057883168,0.00011744205,0.00038502665,0.000507738,0.0004795074],"category_scores_gemma":[0.0007809615,0.0005518818,0.0035938846,0.00035294905,0.00020044856,0.000038445047,0.00058788806,0.0011499015,0.00036906032],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9775808,0.000468602,0.00040334073,0.0010054826,0.013964712,0.0035542254,0.00057531806,0.00018065804,0.000027381051,0.00013686837,0.001047566,0.0010550516],"study_design_scores_gemma":[0.9777967,0.00028043575,0.00089788926,0.0025398233,0.009199289,0.00034119535,0.0000748575,0.0058368077,0.0000141322025,0.0016234207,0.00081499445,0.00058047223],"about_ca_topic_score_codex":0.000027483007,"about_ca_topic_score_gemma":0.000013249459,"teacher_disagreement_score":0.032861196,"about_ca_system_score_codex":0.00016431125,"about_ca_system_score_gemma":0.0005649748,"threshold_uncertainty_score":0.9996933},"labels":[],"label_agreement":null},{"id":"W4404687179","doi":"10.1016/j.jcin.2024.08.027","title":"International Consensus Statement on Platelet Function and Genetic Testing in Percutaneous Coronary Intervention","year":2024,"lang":"en","type":"review","venue":"JACC: Cardiovascular Interventions","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Statement (logic); Percutaneous coronary intervention; Cardiology; Internal medicine; Medicine; Genetic testing; Function (biology); Biology; Political science; Myocardial infarction; Genetics","score_opus":0.07012135143226035,"score_gpt":0.34266267242325316,"score_spread":0.2725413209909928,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404687179","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025755882,0.99225473,0.00048123734,0.000047743364,0.0014903615,0.0019077442,0.00020733621,0.00019084802,0.0008443981],"genre_scores_gemma":[0.009652756,0.98769057,0.00044511576,0.000035254907,0.00041853488,0.00036416936,0.0006760236,0.0001584548,0.00055910874],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956696,0.00055247976,0.0015029736,0.0010948514,0.0007709864,0.00040911936],"domain_scores_gemma":[0.99844813,0.00014021044,0.00024376549,0.00082169415,0.00015536514,0.000190852],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008251599,0.0007002197,0.002233872,0.0009653559,0.000105820116,0.00015914031,0.00020319522,0.00037733812,0.0002674173],"category_scores_gemma":[0.0001889351,0.00061217794,0.008862084,0.00050677994,0.00012643474,0.00006929304,0.00021211896,0.0008957435,0.00030031407],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012181589,0.0003840899,0.000048374157,0.01995446,0.020132469,0.006311938,0.000022367305,0.00009623363,9.771411e-7,0.000043726322,0.00071440043,0.9521691],"study_design_scores_gemma":[0.0019361593,0.0007072229,0.0008382069,0.06864863,0.02015456,0.02012831,0.0001277976,0.0001212286,5.7309046e-7,0.00011961797,0.8866146,0.00060307136],"about_ca_topic_score_codex":0.000055047574,"about_ca_topic_score_gemma":0.00001242587,"teacher_disagreement_score":0.9515661,"about_ca_system_score_codex":0.0005789535,"about_ca_system_score_gemma":0.00015294403,"threshold_uncertainty_score":0.99963295},"labels":[],"label_agreement":null},{"id":"W4404687811","doi":"10.1016/j.jcin.2024.09.027","title":"DAPT After PCI in High Bleeding Risk","year":2024,"lang":"en","type":"editorial","venue":"JACC: Cardiovascular Interventions","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"","keywords":"Conventional PCI; Medicine; Cardiology; Internal medicine; Myocardial infarction","score_opus":0.011546993166671763,"score_gpt":0.27800146798207637,"score_spread":0.26645447481540463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404687811","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010320652,0.3270862,0.001753514,0.00007619259,0.6561552,0.0013833296,0.0012605271,0.00042167437,0.0015426688],"genre_scores_gemma":[0.14946073,0.032980237,0.00041026188,0.000048837795,0.80626965,0.0013902353,0.0024809092,0.0005260528,0.006433086],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9938469,0.0005542986,0.0011997393,0.001484174,0.0021425562,0.0007723603],"domain_scores_gemma":[0.99680436,0.00021482691,0.00018799109,0.0020846487,0.00039007154,0.00031807882],"candidate_categories":["metaepi_narrow","metaepi_broad","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0022447535,0.0008468327,0.0024776696,0.0010282804,0.00013365924,0.00024989626,0.00041199793,0.001397502,0.0009011502],"category_scores_gemma":[0.00078420056,0.00080109976,0.021370076,0.00083590177,0.00016503525,0.00022383983,0.00033900313,0.002844494,0.0011256869],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049117603,0.00048757423,0.0005996915,0.0051890914,0.050735116,0.006813337,0.00015399154,0.00023302616,0.0000030803703,0.00005263483,0.9055717,0.029669583],"study_design_scores_gemma":[0.0037696245,0.00020335466,0.0018003933,0.00861398,0.021012986,0.00019894191,0.0001314907,0.000024745414,0.00001689395,0.00033848494,0.9631045,0.00078463915],"about_ca_topic_score_codex":0.00069537736,"about_ca_topic_score_gemma":0.0001330133,"teacher_disagreement_score":0.29410598,"about_ca_system_score_codex":0.00053235213,"about_ca_system_score_gemma":0.00038990178,"threshold_uncertainty_score":0.9998989},"labels":[],"label_agreement":null},{"id":"W4404851859","doi":"10.1016/j.jtha.2024.11.016","title":"Molecular basis of platelet granule defects","year":2024,"lang":"en","type":"review","venue":"Journal of Thrombosis and Haemostasis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Platelet; Granule (geology); Computational biology; Chemistry; Medicine; Biology; Immunology","score_opus":0.0691010027022736,"score_gpt":0.3673574493789368,"score_spread":0.2982564466766632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404851859","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00752623,0.9914113,0.00004117136,0.0000900352,0.00025657626,0.00034270476,0.000092720125,0.000012954919,0.00022625395],"genre_scores_gemma":[0.0026343234,0.9967219,0.00024775974,0.000083769366,0.00018705499,0.000005756369,0.000020615453,0.000079214835,0.000019575782],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99774724,0.00015287343,0.0010378481,0.00026278102,0.0005737587,0.00022546874],"domain_scores_gemma":[0.99845886,0.000084293795,0.0006666045,0.00034777977,0.00019187221,0.00025057924],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00051559263,0.00042528333,0.0036976116,0.00045939372,0.000046342568,0.000043834625,0.00016612544,0.00031124303,0.0001042003],"category_scores_gemma":[0.00005786973,0.00027582518,0.0037446204,0.00040486336,0.00013332228,0.000080002734,0.000070821545,0.0005176988,0.000012998422],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006811215,0.00015575718,0.000017656159,0.030651797,0.01193941,0.0006284192,0.000057824884,6.777031e-7,0.00001637862,0.000089201974,0.0037113014,0.9526635],"study_design_scores_gemma":[0.0010996908,0.0005202823,0.00003763914,0.03576671,0.0417408,0.0021081115,0.000066249544,0.0000011244653,0.0005537467,0.00010198933,0.9177031,0.00030057167],"about_ca_topic_score_codex":0.000004730817,"about_ca_topic_score_gemma":3.5768272e-7,"teacher_disagreement_score":0.9523629,"about_ca_system_score_codex":0.00005784276,"about_ca_system_score_gemma":0.00033294383,"threshold_uncertainty_score":0.99996936},"labels":[],"label_agreement":null},{"id":"W4404904682","doi":"10.1186/s40246-024-00699-1","title":"The associations of candidate gene polymorphisms with aspirin resistance in patients with ischemic disease: a meta-analysis","year":2024,"lang":"en","type":"review","venue":"Human Genomics","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Key Research and Development Program of China; National Natural Science Foundation of China","keywords":"Human genetics; Aspirin; Disease; Meta-analysis; Candidate gene; Gene; Bioinformatics; Genetics; Medicine; Biology; Internal medicine","score_opus":0.04724155169843578,"score_gpt":0.3017303533205292,"score_spread":0.2544888016220934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404904682","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004420444,0.99325657,0.0000133229705,0.00001879208,0.000014653587,0.0009148117,0.0011626083,0.000019663143,0.00017915737],"genre_scores_gemma":[0.0051784613,0.98997146,0.00009237085,0.000034213757,0.00005439038,0.00019697339,0.0026323944,0.000097015574,0.001742734],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99808574,0.00013805786,0.00059872476,0.00044979175,0.00047112256,0.00025658362],"domain_scores_gemma":[0.99834937,0.000051286417,0.00043627006,0.00092458323,0.000111566565,0.00012695238],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002873584,0.0003923708,0.0026655125,0.00026007553,0.00013047742,0.00004423397,0.00022621152,0.000101535494,0.0000432919],"category_scores_gemma":[0.000009090282,0.0002015319,0.002315531,0.00076528254,0.00013457137,0.000029710927,0.000045402085,0.00028191335,0.000009995264],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004998575,0.00037288538,0.0034841944,0.005772186,0.9783131,0.0001930831,0.00016271048,0.000033985627,7.0093444e-7,0.00039980796,0.00063757977,0.010129898],"study_design_scores_gemma":[0.00057364977,0.000050278726,0.0038584084,0.0004971116,0.6746041,0.0000011200714,0.0000053211247,4.969807e-7,7.9891214e-7,0.000016506876,0.32013723,0.0002549399],"about_ca_topic_score_codex":0.000029331743,"about_ca_topic_score_gemma":0.00044630418,"teacher_disagreement_score":0.31949967,"about_ca_system_score_codex":0.00024462663,"about_ca_system_score_gemma":0.0005060037,"threshold_uncertainty_score":0.8218233},"labels":[],"label_agreement":null},{"id":"W4405035337","doi":"10.1182/blood-2024-198905","title":"“I Didn't Know I Had a Choice” - Patient Values and Preferences Regarding Resumption of Oral Anticoagulants after Gastrointestinal Bleeding","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; Ottawa Hospital; McMaster University","funders":"","keywords":"Medicine; Gastrointestinal bleeding; Dabigatran; Rivaroxaban; Apixaban; Warfarin; Intensive care medicine; Gastroenterology; Internal medicine; Atrial fibrillation","score_opus":0.016625647636525222,"score_gpt":0.26303119634408106,"score_spread":0.24640554870755585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405035337","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98274577,0.016444175,0.00012703221,0.000039226183,0.00007045702,0.00017392357,0.00001571,0.00007316553,0.00031057172],"genre_scores_gemma":[0.998259,0.0007142581,0.0007794934,0.000020705413,0.00011578911,0.000013559365,0.000011608786,0.000015386946,0.00007019649],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990961,0.000042600597,0.00019139903,0.00024442785,0.0002538286,0.00017162912],"domain_scores_gemma":[0.9996457,0.00004573143,0.00003476971,0.00013630393,0.000051091916,0.00008640188],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015408269,0.00012470451,0.00028007603,0.000096249045,0.000038576727,0.00004085319,0.000032893342,0.000035584373,0.000040076942],"category_scores_gemma":[0.00006115417,0.000095538504,0.00015699358,0.00010130339,0.00007765146,0.000112423964,0.000033933946,0.00010206922,0.0000051654656],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072807586,0.0005906322,0.87962735,0.0016370115,0.0015842265,0.000691946,0.0008210003,0.000005010143,0.025341509,0.00006729902,0.00021793542,0.08868799],"study_design_scores_gemma":[0.0057230885,0.002497327,0.92830324,0.015017677,0.0045764796,0.0028570006,0.0008318527,0.0007934845,0.036230452,0.0006602144,0.0019968082,0.0005123482],"about_ca_topic_score_codex":0.00002081318,"about_ca_topic_score_gemma":0.000002072263,"teacher_disagreement_score":0.08817565,"about_ca_system_score_codex":0.000007842281,"about_ca_system_score_gemma":0.00003554446,"threshold_uncertainty_score":0.3895947},"labels":[],"label_agreement":null},{"id":"W4405537858","doi":"10.1016/j.jacadv.2024.101453","title":"Patient Management Following Percutaneous Coronary Intervention","year":2024,"lang":"en","type":"review","venue":"JACC Advances","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Public Health Ontario; Jewish General Hospital; University of Toronto","funders":"","keywords":"Percutaneous coronary intervention; Medicine; Cardiology; Percutaneous; Internal medicine; Intensive care medicine; Myocardial infarction","score_opus":0.01676560729124781,"score_gpt":0.33405035162995544,"score_spread":0.3172847443387076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405537858","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007727056,0.99448353,0.00009342748,0.0000073972374,0.0011876402,0.0010396685,0.000022629523,0.00016503723,0.002923414],"genre_scores_gemma":[0.00025106312,0.9965276,0.00030329684,0.00005072221,0.00019152867,0.0001425797,0.00025471178,0.00007592612,0.0022025555],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983737,0.00008033997,0.00045719443,0.0004857204,0.00037549037,0.00022755306],"domain_scores_gemma":[0.9993828,0.000025323736,0.000107965716,0.00037420692,0.000016365462,0.00009337281],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00009901986,0.00037844863,0.0012561466,0.00016219611,0.000059803577,0.00003600805,0.000101880425,0.00012393476,0.00012636726],"category_scores_gemma":[0.0000074696704,0.00026636184,0.0033452075,0.00020118986,0.000028656254,0.00009495161,0.00009745808,0.00025047452,0.00037538627],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028916671,0.00008502265,0.0000019641013,0.03586407,0.0031403075,0.009674739,0.000022342196,6.658181e-7,3.6863412e-8,0.000034378456,0.00036840638,0.95077914],"study_design_scores_gemma":[0.00020259955,0.00017968404,0.0000017106655,0.03974434,0.011219437,0.002417483,0.00018437611,0.0000013442443,1.687061e-7,0.000114297785,0.9456846,0.00024996177],"about_ca_topic_score_codex":9.513261e-7,"about_ca_topic_score_gemma":4.031571e-7,"teacher_disagreement_score":0.95052916,"about_ca_system_score_codex":0.00013205194,"about_ca_system_score_gemma":0.000035184927,"threshold_uncertainty_score":0.99997884},"labels":[],"label_agreement":null},{"id":"W4405632588","doi":"10.1161/strokeaha.124.049246","title":"Dual Antiplatelet Treatment up to 72 Hours After Ischemic Stroke Stratified by Risk Profile: A Post Hoc Analysis","year":2024,"lang":"en","type":"article","venue":"Stroke","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Population Health Research Institute","funders":"Capital Medical University; National Natural Science Foundation of China","keywords":"Medicine; Aspirin; Clopidogrel; Internal medicine; Interquartile range; Hazard ratio; Stroke (engine); Post-hoc analysis; Cardiology; Confidence interval","score_opus":0.00680940345926817,"score_gpt":0.2522974967907138,"score_spread":0.2454880933314456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405632588","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9769301,0.014375296,0.0005490665,0.00028634878,0.00026413592,0.00072336715,0.005249855,0.00023963896,0.0013822004],"genre_scores_gemma":[0.98230964,0.0014378214,0.00023151575,0.00020237803,0.00032950574,0.00017975441,0.000764214,0.000059528975,0.01448562],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977396,0.00009059961,0.00033858957,0.0007254408,0.00054014986,0.0005655806],"domain_scores_gemma":[0.99877536,0.000049770722,0.00005081681,0.0006306757,0.000089214016,0.00040416452],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018667613,0.000407681,0.0007175635,0.00035087572,0.00010259276,0.00013582145,0.00009527931,0.00016474091,0.0011700676],"category_scores_gemma":[0.000019977126,0.0003165207,0.0012891389,0.0006112462,0.000072830706,0.00012406736,0.000037600523,0.00024379253,0.0003344103],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022251613,0.0014526687,0.09667115,0.000466043,0.15528099,0.009733283,0.0048315274,0.00016814882,0.18749471,0.00006609721,0.08081381,0.44076997],"study_design_scores_gemma":[0.02225925,0.013970093,0.12546088,0.0008170115,0.09803564,0.0008973249,0.007310529,0.0014724403,0.32840103,0.000019300278,0.39756888,0.0037876058],"about_ca_topic_score_codex":0.00014190824,"about_ca_topic_score_gemma":0.000050222352,"teacher_disagreement_score":0.43698236,"about_ca_system_score_codex":0.00012877626,"about_ca_system_score_gemma":0.0002060254,"threshold_uncertainty_score":0.9999287},"labels":[],"label_agreement":null},{"id":"W4405927454","doi":"10.53576/bashir.005.01.0146","title":"Efficacy of Trimetazidine 80mg in Treatment of Stable Angina: A Systematic Analysis","year":2024,"lang":"en","type":"article","venue":"Journal of Bashir Institute of Health Sciences","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Trimetazidine; Stable angina; Medicine; Internal medicine; Cardiology; Coronary heart disease","score_opus":0.044339545957059835,"score_gpt":0.35492417257022063,"score_spread":0.3105846266131608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405927454","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89451146,0.103652775,0.0006933864,0.0004164036,0.00024926732,0.00033340734,0.0000079467,0.0000043878263,0.00013095929],"genre_scores_gemma":[0.99440426,0.004545109,0.0009489827,0.000019567196,0.000039332892,0.0000022456197,0.0000015475522,0.000003843613,0.000035117457],"study_design_codex":"systematic_review","study_design_gemma":"observational","domain_scores_codex":[0.99755514,0.00014493767,0.0013004156,0.00013609204,0.00068631826,0.00017711273],"domain_scores_gemma":[0.9987883,0.00014468622,0.0006481091,0.00017175564,0.0001438964,0.00010328446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026831045,0.000108434404,0.0015483679,0.0011716528,0.000042388496,0.000010587003,0.00013515033,0.000033496504,0.000019613153],"category_scores_gemma":[0.00012219952,0.00006509201,0.00079627516,0.002314507,0.0002579436,0.00023816459,0.000008482123,0.000062767336,6.1290774e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0077224975,0.020336846,0.2700636,0.33742094,0.06782352,0.0028312327,0.022085184,0.093307495,0.011940484,0.012274345,0.0009279075,0.15326592],"study_design_scores_gemma":[0.042808402,0.05781435,0.5772572,0.18250063,0.044625677,0.0023376534,0.014342635,0.018355431,0.04719855,0.0006862455,0.0107693225,0.0013039031],"about_ca_topic_score_codex":0.0001963255,"about_ca_topic_score_gemma":0.000022445633,"teacher_disagreement_score":0.30719358,"about_ca_system_score_codex":0.00010847754,"about_ca_system_score_gemma":0.001524099,"threshold_uncertainty_score":0.27036864},"labels":[],"label_agreement":null},{"id":"W4406172853","doi":"10.5603/cj.98323","title":"Maintenance therapy with a P2Y12 receptor inhibitor after cangrelor in patients with acute coronary syndrome. The ELECTRA-SIRIO 2 investigators’ viewpoint","year":2025,"lang":"en","type":"review","venue":"Cardiology Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Agencja Badań Medycznych","keywords":"Cangrelor; Prasugrel; P2Y12; Medicine; Ticagrelor; Clopidogrel; Percutaneous coronary intervention; Acute coronary syndrome; Thienopyridine; Cardiology; Anesthesia; Internal medicine; Pharmacology; Myocardial infarction","score_opus":0.009306273148210703,"score_gpt":0.24173296368802855,"score_spread":0.23242669053981785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406172853","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06270499,0.9343652,0.00006895678,0.00022366189,0.00046663437,0.0019908072,0.00008185439,0.00003224229,0.000065631335],"genre_scores_gemma":[0.0041848174,0.9931245,0.000104216815,0.0013137633,0.00036796211,0.00045864613,0.00013667578,0.000104030936,0.00020543137],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962255,0.001075502,0.00078962435,0.00063203,0.00051959435,0.00075777946],"domain_scores_gemma":[0.9980678,0.00015258463,0.00042737147,0.0007437324,0.00027881347,0.0003297103],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0006786113,0.0007983536,0.0035155618,0.0002615137,0.00018635494,0.000045397504,0.00038521067,0.0005062287,0.000072903],"category_scores_gemma":[0.000058963084,0.00037567568,0.0014268152,0.00064851384,0.0005738415,0.00010812995,0.00005873295,0.0023369174,0.000024730743],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060593267,0.0002162034,0.03745644,0.0025584223,0.02639949,0.020129897,0.00015267046,0.000005063457,3.7743308e-7,0.000011990703,0.0056890263,0.9013211],"study_design_scores_gemma":[0.0075339708,0.0027061277,0.049949408,0.03270668,0.0053882524,0.042463996,0.00004024798,1.4932215e-7,0.0000010901812,0.000023327088,0.85845715,0.0007295991],"about_ca_topic_score_codex":0.00000294189,"about_ca_topic_score_gemma":0.000003236641,"teacher_disagreement_score":0.9005915,"about_ca_system_score_codex":0.00042900702,"about_ca_system_score_gemma":0.0023785944,"threshold_uncertainty_score":0.9999647},"labels":[],"label_agreement":null},{"id":"W4406383084","doi":"10.1016/s0029-7437(06)72220-0","title":"10.1016/s0029-7437(06)72220-0","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Misoprostol; Medicine; Obstetrics; Pregnancy; Abortion; Biology","score_opus":0.005854642091765026,"score_gpt":0.1885752822640476,"score_spread":0.18272064017228257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406383084","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0071011423,0.0014937086,0.0000032024848,0.00027385246,1.596194e-7,0.0002854624,0.000014556174,0.000212267,0.99061567],"genre_scores_gemma":[0.0011931394,0.000008104624,0.00006709191,0.00020060729,0.00029620714,0.0000185193,0.000055761375,0.000035043966,0.99812555],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990137,0.000039792027,0.00015378193,0.00024697103,0.00027773005,0.00026803202],"domain_scores_gemma":[0.99922705,0.000020040172,0.000015643194,0.00042567236,0.000044184006,0.00026742625],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0001255113,0.00015556015,0.00030095616,0.000060308415,0.000068421374,0.000019441537,0.00010379909,0.00007335989,0.9981696],"category_scores_gemma":[0.00002049098,0.00013739013,0.00030443672,0.00018333158,0.00004107934,0.000057442714,0.000017295273,0.00010293848,0.9946802],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036129216,0.00008638791,9.560584e-7,0.0000130186445,0.00019997304,0.000050868228,0.000009254147,0.000017401335,0.000050722996,3.839078e-7,0.6943029,0.30490682],"study_design_scores_gemma":[0.0010717656,0.00021299015,0.00027435494,0.000048030775,0.00018572464,0.0001038363,0.0000019875515,0.000034526634,0.00022307265,0.000004637103,0.99767053,0.00016852393],"about_ca_topic_score_codex":0.0000067064184,"about_ca_topic_score_gemma":2.5348616e-8,"teacher_disagreement_score":0.30473828,"about_ca_system_score_codex":0.000025783058,"about_ca_system_score_gemma":0.00004428344,"threshold_uncertainty_score":0.5602607},"labels":[],"label_agreement":null},{"id":"W4406386993","doi":"10.1016/j.ymed.2014.06.005","title":"10.1016/j.ymed.2014.06.005","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Observational study; Percutaneous coronary intervention; Internal medicine; Cardiology; Prospective cohort study; Myocardial infarction","score_opus":0.004383786489896514,"score_gpt":0.18107400301762483,"score_spread":0.17669021652772832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406386993","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006453222,0.0019835834,0.0000026885577,0.0003677125,0.0000013341048,0.00026949623,0.000013021656,0.00018060507,0.9907283],"genre_scores_gemma":[0.0011295413,0.000011862784,0.000055335313,0.00024406498,0.0003108927,0.000017311402,0.00005424568,0.00003332175,0.99814343],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990589,0.000039693845,0.00014353135,0.00023293644,0.0002682429,0.00025668147],"domain_scores_gemma":[0.99924695,0.000019940933,0.000015054206,0.00041653134,0.000034066008,0.00026747945],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00012861498,0.00014440132,0.00028379625,0.000056606106,0.00006038827,0.000018097431,0.00009924299,0.000069815964,0.9978532],"category_scores_gemma":[0.000017637258,0.00012576013,0.00028246592,0.00013301197,0.000040380597,0.00005654471,0.000016112284,0.00009514311,0.9946172],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002988235,0.00007454285,0.0000011146864,0.00001096093,0.00017478151,0.000051594376,0.000007908501,0.00001322017,0.000055820172,3.3061633e-7,0.41275105,0.58655983],"study_design_scores_gemma":[0.0009817439,0.00018781085,0.00029751778,0.00003943099,0.00016254155,0.00009142926,0.0000016779568,0.000025118825,0.00024767686,0.000003631067,0.99780655,0.00015487106],"about_ca_topic_score_codex":0.00000619247,"about_ca_topic_score_gemma":2.554635e-8,"teacher_disagreement_score":0.586405,"about_ca_system_score_codex":0.000023278937,"about_ca_system_score_gemma":0.000044728713,"threshold_uncertainty_score":0.5128349},"labels":[],"label_agreement":null},{"id":"W4406401959","doi":"10.12688/f1000research.109321.3","title":"CYP2C19 polymorphism and coronary in-stent restenosis: A systematic review and meta-analysis","year":2025,"lang":"en","type":"review","venue":"F1000Research","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Meta-analysis; Open peer review; Medicine; Restenosis; Internal medicine; Cardiology; Bioinformatics; Stent; Biology; Plant biology; Botany","score_opus":0.10837790915428731,"score_gpt":0.4022407513159678,"score_spread":0.2938628421616805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406401959","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000030722672,0.9922196,0.000006461602,0.00045656165,0.000012310995,0.0067946026,0.00013377392,0.00003632013,0.00033725402],"genre_scores_gemma":[0.00003062657,0.99028325,0.000025064099,0.00053232146,0.000019856941,0.001989925,0.00016242177,0.00004831168,0.006908197],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99487627,0.0018210631,0.0011198556,0.00082817295,0.0009021222,0.00045254768],"domain_scores_gemma":[0.9974043,0.00066970894,0.00019474252,0.0012701058,0.00014397342,0.00031721423],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0023054203,0.00053996296,0.012115182,0.0012051471,0.000090103604,0.000061745355,0.0002928128,0.00027330933,0.00034402456],"category_scores_gemma":[0.00038269415,0.0003385514,0.0042423448,0.0019863644,0.00018076431,0.00006289252,0.00031700477,0.0006185721,0.00003267231],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012896041,0.000060550945,0.000013950178,0.76415056,0.2261758,0.00050834345,0.000009677935,4.299698e-8,1.779699e-8,0.00004072336,0.00024367712,0.008783741],"study_design_scores_gemma":[0.00028344686,0.000064965665,0.00005861678,0.13932441,0.83078295,0.00035250935,0.000022451675,0.0000014217005,4.9371653e-8,0.000008945932,0.02886763,0.00023259856],"about_ca_topic_score_codex":0.00005096872,"about_ca_topic_score_gemma":0.000009174775,"teacher_disagreement_score":0.6248262,"about_ca_system_score_codex":0.00009809808,"about_ca_system_score_gemma":0.00045422255,"threshold_uncertainty_score":0.99990666},"labels":[],"label_agreement":null},{"id":"W4406417805","doi":"10.1016/s0029-7437(05)70123-3","title":"10.1016/s0029-7437(05)70123-3","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Aspirin; Medicine; Intensive care medicine; Internal medicine; Cardiology","score_opus":0.005941635723897486,"score_gpt":0.1893143617873103,"score_spread":0.1833727260634128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406417805","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0063432404,0.0014155371,0.000003359942,0.0003205488,3.7067093e-7,0.0002856793,0.0000134086395,0.00021084493,0.99140704],"genre_scores_gemma":[0.001111784,0.000007997516,0.00006795339,0.0002362565,0.0002905007,0.000019340103,0.00004086217,0.000035157325,0.99819016],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99901634,0.00004100433,0.00015400388,0.00024465407,0.00027186298,0.0002721181],"domain_scores_gemma":[0.99922407,0.000020406387,0.000015738084,0.00042581596,0.00004087585,0.00027311704],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00012870622,0.00015537495,0.0003019833,0.000059606766,0.000067895184,0.000018502607,0.00010199677,0.00007303137,0.99818456],"category_scores_gemma":[0.00002067233,0.00013690833,0.00030738735,0.00017884118,0.00004138803,0.000058795766,0.000016575801,0.00010182512,0.99275917],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043517648,0.000084768384,6.289384e-7,0.000012178743,0.00018743575,0.000064903725,0.000008506273,0.000017194146,0.000053589458,3.6133883e-7,0.5981778,0.40095747],"study_design_scores_gemma":[0.0010791618,0.00025914225,0.0002479854,0.00003938213,0.00018352317,0.00013668406,0.000001928877,0.000032320702,0.00025809975,0.000004684744,0.9975898,0.00016727574],"about_ca_topic_score_codex":0.00000773688,"about_ca_topic_score_gemma":3.0464676e-8,"teacher_disagreement_score":0.40079018,"about_ca_system_score_codex":0.000026161802,"about_ca_system_score_gemma":0.000042227268,"threshold_uncertainty_score":0.55829597},"labels":[],"label_agreement":null},{"id":"W4406430259","doi":"10.1016/s0029-7437(09)70443-4","title":"10.1016/s0029-7437(09)70443-4","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Oncology; Internal medicine","score_opus":0.005865554737683831,"score_gpt":0.18854060040909126,"score_spread":0.18267504567140744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406430259","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006127925,0.0014899756,0.0000033417236,0.00027748678,3.3047144e-7,0.00028684363,0.000013035242,0.00021320139,0.9915879],"genre_scores_gemma":[0.0008691876,0.000008168867,0.0000662403,0.00015960599,0.00030005697,0.000019596571,0.000039008104,0.000035329882,0.9985028],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99900997,0.000040083054,0.00015431795,0.00024813248,0.0002778847,0.00026958607],"domain_scores_gemma":[0.9992221,0.000019752322,0.000015716785,0.00042894017,0.000044381486,0.00026913898],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00012577146,0.00015605075,0.00030181254,0.000060459555,0.000068735884,0.000019372135,0.00010394906,0.0000735803,0.998213],"category_scores_gemma":[0.000020254729,0.00013781754,0.00030648735,0.00018472754,0.000041389805,0.00005760121,0.000017286096,0.00010338488,0.9937298],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043694643,0.00008243798,8.290657e-7,0.0000123744385,0.00018950844,0.00005479694,0.0000090608255,0.00001650192,0.00005379837,3.6988212e-7,0.49788484,0.50125855],"study_design_scores_gemma":[0.001073877,0.00024395429,0.0002571495,0.000047275375,0.00018293483,0.000106288826,0.000002026774,0.000034180775,0.0002619441,0.0000047116678,0.9976166,0.00016909113],"about_ca_topic_score_codex":0.000007722934,"about_ca_topic_score_gemma":2.472414e-8,"teacher_disagreement_score":0.50108945,"about_ca_system_score_codex":0.000026152164,"about_ca_system_score_gemma":0.000045019315,"threshold_uncertainty_score":0.5620036},"labels":[],"label_agreement":null},{"id":"W4406456870","doi":"10.1016/s1544-8800(10)70191-3","title":"10.1016/s1544-8800(10)70191-3","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Clopidogrel; Medicine; Internal medicine; Polymorphism (computer science); Cardiology; Biology; Genotype; Genetics; Aspirin; Gene","score_opus":0.004963469650885708,"score_gpt":0.17988777378888776,"score_spread":0.17492430413800206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406456870","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0069220196,0.0014935418,0.0000023944854,0.00028082388,0.0000016388562,0.00028625794,0.000014555357,0.00018481094,0.990814],"genre_scores_gemma":[0.0010496629,0.000007282079,0.000054021857,0.00017017173,0.0003063457,0.000019814308,0.000050672515,0.00003731606,0.9983047],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989617,0.00004389075,0.00016211651,0.00025996077,0.0002917492,0.0002806223],"domain_scores_gemma":[0.9991847,0.000022109693,0.000017229595,0.0004507579,0.000051735446,0.0002734266],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00012754489,0.00016519416,0.00031849433,0.00006266981,0.00007092873,0.000020560079,0.00011029101,0.00007859815,0.99881846],"category_scores_gemma":[0.000023178698,0.00014600113,0.00032372767,0.00018791217,0.000043744574,0.000060078928,0.0000187008,0.00009837198,0.99534005],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006890534,0.000095640404,4.3954302e-7,0.0000148790095,0.00022068007,0.00007802828,0.000009456383,0.000021048672,0.000058763817,3.265686e-7,0.34669214,0.6521195],"study_design_scores_gemma":[0.0011691027,0.0002793501,0.00029535804,0.00004783813,0.0001967571,0.00009202324,0.0000020301281,0.000035766614,0.0002491244,0.0000037858163,0.9974504,0.0001784583],"about_ca_topic_score_codex":0.000009855466,"about_ca_topic_score_gemma":3.9457987e-8,"teacher_disagreement_score":0.65194106,"about_ca_system_score_codex":0.000028074157,"about_ca_system_score_gemma":0.000051561907,"threshold_uncertainty_score":0.5953753},"labels":[],"label_agreement":null},{"id":"W4406457295","doi":"10.1016/s1544-8800(07)70441-4","title":"10.1016/s1544-8800(07)70441-4","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Prasugrel; Medicine; Cardiology; Internal medicine; Clopidogrel","score_opus":0.004901272668738713,"score_gpt":0.1804113913585002,"score_spread":0.1755101186897615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406457295","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008575243,0.001445603,0.000002795309,0.00029560467,0.0000016253359,0.00028515697,0.000015328482,0.00018145257,0.9891972],"genre_scores_gemma":[0.0013665978,0.000008031996,0.00006114952,0.00020286428,0.00028675215,0.000018645807,0.000043777716,0.000034319335,0.99797785],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990165,0.000040539315,0.00015315063,0.00024534616,0.00027670586,0.000267727],"domain_scores_gemma":[0.99922776,0.0000199307,0.00001538868,0.0004252051,0.000044289278,0.00026739898],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00011991758,0.00015497624,0.00030212454,0.00005673599,0.00006788732,0.000019144003,0.00010018122,0.00007321446,0.9983241],"category_scores_gemma":[0.000019679394,0.00013688751,0.00030249794,0.00016603214,0.000041273743,0.000057422276,0.000016928372,0.00010221132,0.99555814],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055915106,0.00009388179,8.1654974e-7,0.0000145605545,0.0002178978,0.000090663925,0.000009418244,0.000020669546,0.00006288294,3.734434e-7,0.23679166,0.762138],"study_design_scores_gemma":[0.0010738133,0.00024042408,0.00043969395,0.000046952046,0.00018210468,0.000115783245,0.0000018040702,0.000030552354,0.000238243,0.0000042686074,0.9974584,0.00016796445],"about_ca_topic_score_codex":0.0000108465365,"about_ca_topic_score_gemma":3.5431828e-8,"teacher_disagreement_score":0.76197004,"about_ca_system_score_codex":0.000025115238,"about_ca_system_score_gemma":0.000047930193,"threshold_uncertainty_score":0.5582111},"labels":[],"label_agreement":null},{"id":"W4406472890","doi":"10.1016/s1541-9800(06)70857-2","title":"10.1016/s1541-9800(06)70857-2","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine","score_opus":0.004889489392310698,"score_gpt":0.1802654746895247,"score_spread":0.175375985297214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406472890","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007934856,0.0015218904,0.0000029624207,0.00031679482,0.0000011357685,0.00028780455,0.000013893121,0.00018496,0.9897357],"genre_scores_gemma":[0.0015695498,0.000008373203,0.000056992638,0.00023046618,0.00028925124,0.000019453157,0.000055682387,0.00003536422,0.99773484],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990027,0.000041179297,0.00015459894,0.00024770515,0.00028158448,0.00027225073],"domain_scores_gemma":[0.99921924,0.000019828245,0.000015385576,0.00042747826,0.00004469992,0.00027336588],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00010419711,0.0001561465,0.0003026078,0.00006085334,0.00006855786,0.000019312354,0.00010361231,0.000073942014,0.99761385],"category_scores_gemma":[0.000020849706,0.00013783411,0.00030714116,0.00018434766,0.00004165662,0.00005756889,0.00001730925,0.000103194485,0.9942909],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043373267,0.00010002406,9.4801834e-7,0.000015484231,0.00022943463,0.00008372945,0.00001154576,0.000022856688,0.00009106155,4.339956e-7,0.35113305,0.6478777],"study_design_scores_gemma":[0.0011057034,0.00021105027,0.00032145504,0.00004728538,0.00018335665,0.00010392828,0.0000020860464,0.000035538247,0.00024507407,0.00000474664,0.9975706,0.00016917543],"about_ca_topic_score_codex":0.0000066943057,"about_ca_topic_score_gemma":2.713012e-8,"teacher_disagreement_score":0.64770854,"about_ca_system_score_codex":0.000026446398,"about_ca_system_score_gemma":0.000047534788,"threshold_uncertainty_score":0.5620712},"labels":[],"label_agreement":null},{"id":"W4406479382","doi":"10.1016/s0029-7437(06)71394-5","title":"10.1016/s0029-7437(06)71394-5","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Aspirin; Stroke (engine); Medicine; Internal medicine; Cardiology; Engineering; Mechanical engineering","score_opus":0.005820810697223111,"score_gpt":0.18833648930483218,"score_spread":0.18251567860760906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406479382","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0070969546,0.0014488254,0.000003385139,0.0002633841,1.7340909e-7,0.00028586312,0.00001332073,0.00021379469,0.9906743],"genre_scores_gemma":[0.0012389477,0.000007655059,0.00006637909,0.00020183138,0.00030166793,0.000019064044,0.000054158463,0.000035236404,0.99807507],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990156,0.000040058887,0.00015366047,0.00024655875,0.00027613557,0.00026795384],"domain_scores_gemma":[0.9992258,0.000019968578,0.000015649675,0.0004276787,0.0000432997,0.0002675888],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00012462519,0.00015548643,0.00030011815,0.000060339415,0.00007024663,0.000020434956,0.00010317509,0.00007306683,0.9977364],"category_scores_gemma":[0.000019771032,0.00013740294,0.0003057182,0.00018146876,0.000041905423,0.000058468173,0.000016933212,0.000103057624,0.9947946],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036649435,0.0000879989,9.261763e-7,0.000013240537,0.00020034534,0.00005120574,0.000009811115,0.000017023964,0.00006160635,4.0903188e-7,0.70037013,0.2988208],"study_design_scores_gemma":[0.0010613725,0.00021503672,0.00030149863,0.000046139972,0.00018266462,0.00010764074,0.0000020710202,0.000034242516,0.00019741374,0.0000049509354,0.99767846,0.000168516],"about_ca_topic_score_codex":0.0000065379495,"about_ca_topic_score_gemma":2.658621e-8,"teacher_disagreement_score":0.29865226,"about_ca_system_score_codex":0.000026933365,"about_ca_system_score_gemma":0.00004536823,"threshold_uncertainty_score":0.5603129},"labels":[],"label_agreement":null},{"id":"W4406490157","doi":"10.1016/0024-7804(96)83110-1","title":"10.1016/0024-7804(96)83110-1","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.004755375780898264,"score_gpt":0.17850252025367858,"score_spread":0.1737471444727803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406490157","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0071957307,0.0015911988,0.000003357398,0.00036039884,0.0000022060462,0.00026199117,0.000013771969,0.00018723767,0.9903841],"genre_scores_gemma":[0.0015530108,0.0000080339,0.000059089114,0.00019053338,0.00031090892,0.00001874342,0.000037616453,0.00003491321,0.9977872],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99902654,0.000039928156,0.00015121154,0.00024429194,0.00027448998,0.000263547],"domain_scores_gemma":[0.9992311,0.00002579849,0.000015028173,0.00042078982,0.000042873555,0.0002643937],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00011932694,0.00015340924,0.00029639853,0.00005980998,0.000065394735,0.000019249701,0.00010100838,0.00007251307,0.9977392],"category_scores_gemma":[0.000025434423,0.00013492997,0.00030288525,0.00018192436,0.000040531388,0.00005584489,0.00001697541,0.00009819557,0.9906266],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005206321,0.00009412996,0.0000014336028,0.00001473679,0.00022791981,0.00009260602,0.000010500101,0.000015787415,0.00006594924,5.59732e-7,0.2689037,0.73005205],"study_design_scores_gemma":[0.0010556125,0.0002387027,0.00019555146,0.000047758702,0.0001809629,0.00011268866,0.0000018807901,0.000040849067,0.00029814002,0.0000046225405,0.9976574,0.00016579175],"about_ca_topic_score_codex":0.0000073341043,"about_ca_topic_score_gemma":2.5964235e-8,"teacher_disagreement_score":0.72988623,"about_ca_system_score_codex":0.000025640282,"about_ca_system_score_gemma":0.000043054657,"threshold_uncertainty_score":0.5502284},"labels":[],"label_agreement":null},{"id":"W4406500796","doi":"10.1016/j.ymed.2015.06.145","title":"10.1016/j.ymed.2015.06.145","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Ticagrelor; Medicine; Term (time); Myocardial infarction; Cardiology; Internal medicine; Clopidogrel","score_opus":0.004827440922074716,"score_gpt":0.19092894403242094,"score_spread":0.18610150311034623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406500796","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006593074,0.0022059712,0.0000030245208,0.0004368805,0.0000014157699,0.00028545148,0.000013212603,0.00017821646,0.9902828],"genre_scores_gemma":[0.0015947681,0.000009183521,0.000052509826,0.00019975247,0.00029641142,0.00001778515,0.000052354455,0.000032739877,0.9977445],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990569,0.000039259707,0.0001438032,0.0002289333,0.00027487677,0.0002562649],"domain_scores_gemma":[0.99924016,0.000019074798,0.000014840144,0.00041018278,0.00004286829,0.00027288613],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00012428731,0.00014523132,0.0002863871,0.00005713077,0.000060365437,0.000017143526,0.00009809401,0.00007019175,0.99709475],"category_scores_gemma":[0.000019710931,0.00012682176,0.00027552826,0.0001642411,0.00004055809,0.00005548133,0.000016134638,0.00009528722,0.993007],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036620072,0.00008690239,9.866292e-7,0.000012586239,0.00021129423,0.00006998735,0.00001099273,0.000024316198,0.000059964164,3.4239085e-7,0.38016772,0.6189887],"study_design_scores_gemma":[0.0010188968,0.00019779545,0.00023044909,0.00004548576,0.00017788414,0.00009595817,0.0000019809938,0.000034826513,0.0002382542,0.0000037152777,0.9977981,0.00015664956],"about_ca_topic_score_codex":0.000008196096,"about_ca_topic_score_gemma":1.8984137e-8,"teacher_disagreement_score":0.61883205,"about_ca_system_score_codex":0.000023658526,"about_ca_system_score_gemma":0.00004590896,"threshold_uncertainty_score":0.5171641},"labels":[],"label_agreement":null},{"id":"W4406501240","doi":"10.1016/j.ysur.2014.02.076","title":"10.1016/j.ysur.2014.02.076","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Discontinuation; Clopidogrel; Peripheral; Surgery; Internal medicine; Aspirin","score_opus":0.004286517438821753,"score_gpt":0.17798699130079115,"score_spread":0.1737004738619694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406501240","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008659353,0.0016967143,0.0000025383792,0.00029597757,0.000001595021,0.0002629186,0.000012199781,0.00017530877,0.9888934],"genre_scores_gemma":[0.0019104541,0.0000098939245,0.000049923565,0.00021093214,0.00027309702,0.000015323138,0.000038656544,0.00003316867,0.9974586],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99907357,0.00004213337,0.00014230312,0.00023183506,0.00026106648,0.0002491095],"domain_scores_gemma":[0.99926084,0.000021360953,0.000014894998,0.00041108037,0.00004232943,0.0002495121],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00013308559,0.00014371441,0.00028577386,0.00005208278,0.00006185598,0.000017501558,0.00009453407,0.00006782022,0.9978757],"category_scores_gemma":[0.000017803603,0.00012575525,0.00028779323,0.0001345654,0.00003850135,0.000052290023,0.000015273652,0.0000919608,0.9936106],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004374181,0.00008059851,0.0000011051785,0.000012145837,0.00019256897,0.0000633048,0.000008084549,0.00001878895,0.0000645089,3.33013e-7,0.32024246,0.67887866],"study_design_scores_gemma":[0.00096476014,0.0002364065,0.00029749214,0.0000371471,0.0001634694,0.000086063985,0.0000015569266,0.000027695212,0.00027878754,0.00000407923,0.9977469,0.00015565469],"about_ca_topic_score_codex":0.000008596125,"about_ca_topic_score_gemma":3.1230858e-8,"teacher_disagreement_score":0.67872304,"about_ca_system_score_codex":0.000021931857,"about_ca_system_score_gemma":0.00004242172,"threshold_uncertainty_score":0.512815},"labels":[],"label_agreement":null},{"id":"W4406506030","doi":"10.1016/j.yvas.2013.05.005","title":"10.1016/j.yvas.2013.05.005","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Ezetimibe; External jugular vein; Jugular vein; Intimal hyperplasia; Hyperplasia; Anatomy; Surgery; Internal medicine; Cholesterol; Smooth muscle","score_opus":0.005228334088565844,"score_gpt":0.1827795719968394,"score_spread":0.17755123790827354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406506030","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0061826212,0.0019980003,0.0000027277345,0.00048311453,0.0000017785306,0.00028274642,0.0000111195395,0.00017093451,0.99086696],"genre_scores_gemma":[0.0009410676,0.000014875593,0.00005590692,0.00022310881,0.0002858863,0.000017014903,0.000035762827,0.000032317537,0.9983941],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990942,0.000034780405,0.00013978135,0.00022369131,0.00025760598,0.0002499481],"domain_scores_gemma":[0.99927944,0.000017164064,0.0000142036415,0.00040023852,0.000033451623,0.00025552063],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0001113823,0.0001435516,0.00028162816,0.000054955264,0.000059090522,0.000017202576,0.000094539086,0.00006912399,0.99722314],"category_scores_gemma":[0.000013811403,0.00012403926,0.00029311673,0.00015448313,0.00003755387,0.00005405768,0.000015458034,0.000092733484,0.99032575],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035833556,0.0000744398,4.8912665e-7,0.0000115236635,0.0001913595,0.00007056479,0.0000069979715,0.000022688739,0.00004862275,3.0423934e-7,0.33140412,0.66781056],"study_design_scores_gemma":[0.0009962395,0.00023507734,0.00018305496,0.00004172134,0.0001648822,0.00013105558,0.0000014992677,0.00003892209,0.00020297467,0.0000032709722,0.9978483,0.0001530198],"about_ca_topic_score_codex":0.000012443496,"about_ca_topic_score_gemma":4.6771355e-8,"teacher_disagreement_score":0.66765755,"about_ca_system_score_codex":0.000022572862,"about_ca_system_score_gemma":0.000038246675,"threshold_uncertainty_score":0.5058174},"labels":[],"label_agreement":null},{"id":"W4406520568","doi":"10.1016/s0765-2046(98)80206-2","title":"10.1016/s0765-2046(98)80206-2","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Aspirin; Medicine; Cardiology; Internal medicine","score_opus":0.006175134104283012,"score_gpt":0.19043269002497967,"score_spread":0.18425755592069665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406520568","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0062786024,0.0013490915,0.0000022891447,0.0003159539,0.0000014943605,0.00028348275,0.000011640266,0.00014774578,0.9916097],"genre_scores_gemma":[0.001264423,0.0000070363994,0.000061727675,0.00022470736,0.00030762906,0.000019439174,0.000037362955,0.000033458426,0.9980442],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99904823,0.00003898438,0.00014722666,0.0002391086,0.00026827582,0.00025814798],"domain_scores_gemma":[0.99925685,0.0000187708,0.000014982791,0.0004086021,0.000041250263,0.0002595239],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000115940675,0.00014997063,0.00030137188,0.000057244524,0.00006358335,0.000018435527,0.00010008167,0.00007122284,0.99861777],"category_scores_gemma":[0.000017371716,0.00013256402,0.00028989924,0.00017742449,0.00003881275,0.000054871987,0.000016353726,0.00009916893,0.9950512],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052513793,0.00009518797,7.770111e-7,0.000015242863,0.00023362068,0.00008340714,0.000010847795,0.000017899174,0.00006498762,4.1033408e-7,0.30411938,0.6948331],"study_design_scores_gemma":[0.001043688,0.00022777883,0.00030090823,0.00004472901,0.00018247475,0.000085467764,0.0000018782082,0.000031236446,0.00026366586,0.0000051567376,0.9976504,0.0001626235],"about_ca_topic_score_codex":0.000008533484,"about_ca_topic_score_gemma":3.6560845e-8,"teacher_disagreement_score":0.6946705,"about_ca_system_score_codex":0.000025403215,"about_ca_system_score_gemma":0.000044743003,"threshold_uncertainty_score":0.54058033},"labels":[],"label_agreement":null},{"id":"W4406522598","doi":"10.1016/j.yvas.2015.06.172","title":"10.1016/j.yvas.2015.06.172","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Clopidogrel; Arterial disease; Restenosis; Peripheral; CYP2C19; Cardiology; Internal medicine; Stent; Endovascular treatment; Surgery; Vascular disease; Aspirin; Aneurysm","score_opus":0.004959503082667979,"score_gpt":0.19061865196255473,"score_spread":0.18565914887988674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406522598","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0064533167,0.002030218,0.0000033912986,0.00037677193,0.0000013016698,0.00027768026,0.000012480222,0.00017834772,0.9906665],"genre_scores_gemma":[0.0018495885,0.000008570927,0.000055829012,0.00020148045,0.00028380242,0.000016738935,0.000050625342,0.00003293792,0.9975004],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990717,0.000037746482,0.0001422834,0.00022842643,0.00026743606,0.0002523634],"domain_scores_gemma":[0.9992492,0.000018000506,0.000014396971,0.00041339593,0.000043483687,0.0002614905],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00012392802,0.0001454073,0.0002847242,0.000056511366,0.000060394716,0.000017580467,0.00009706903,0.000069681395,0.9969985],"category_scores_gemma":[0.000016148002,0.000127622,0.00028543087,0.00016353792,0.000038098508,0.000054556076,0.000015908627,0.00009409139,0.9932109],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036104664,0.0000866357,0.0000012651204,0.000013004173,0.00022989986,0.00007179911,0.000009630345,0.000021630458,0.000065415355,4.0581799e-7,0.35234815,0.6467911],"study_design_scores_gemma":[0.0010259051,0.00019897208,0.0002581026,0.000042525953,0.00018389508,0.000101616606,0.0000017391295,0.000034591158,0.00022454723,0.0000035206147,0.9977667,0.00015791909],"about_ca_topic_score_codex":0.0000069110442,"about_ca_topic_score_gemma":2.2092944e-8,"teacher_disagreement_score":0.6466332,"about_ca_system_score_codex":0.000023871136,"about_ca_system_score_gemma":0.000044365126,"threshold_uncertainty_score":0.5204274},"labels":[],"label_agreement":null},{"id":"W4406545175","doi":"10.1016/s1544-8800(11)70343-8","title":"10.1016/s1544-8800(11)70343-8","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Cardiology; Residual; Internal medicine; Medicine; Residual risk; Computer science; Algorithm","score_opus":0.0046897941233344145,"score_gpt":0.17874763569257845,"score_spread":0.17405784156924403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406545175","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011944668,0.0013366734,0.0000037423692,0.00033000988,0.000001770112,0.0002934922,0.000012966405,0.00018761525,0.9858891],"genre_scores_gemma":[0.0015475053,0.000006947708,0.00006674042,0.00019004909,0.00029654652,0.000019458272,0.00003909258,0.000035290446,0.9977984],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99901146,0.0000412257,0.00015353096,0.0002470825,0.00027853384,0.00026819427],"domain_scores_gemma":[0.9992235,0.000021825226,0.000015605074,0.00043113806,0.000043716915,0.000264248],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00012324465,0.00015506425,0.00029976078,0.00005925591,0.00006841082,0.00001914346,0.000105233165,0.00007364314,0.9977554],"category_scores_gemma":[0.000020267797,0.00013703282,0.00030364702,0.00018009655,0.00004203497,0.00005573137,0.000017523063,0.00008839748,0.9904924],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043502092,0.000110860215,0.000001891686,0.000015564765,0.00014672407,0.000086342465,0.000010467202,0.000024267854,0.00006535852,4.7866126e-7,0.25123018,0.7478728],"study_design_scores_gemma":[0.0010535995,0.00019928426,0.0005701097,0.000046034962,0.00018120807,0.00010419026,0.000001922477,0.00003258333,0.00027401344,0.0000039307965,0.9973651,0.00016799825],"about_ca_topic_score_codex":0.000014479043,"about_ca_topic_score_gemma":7.686265e-8,"teacher_disagreement_score":0.74770486,"about_ca_system_score_codex":0.000025917918,"about_ca_system_score_gemma":0.000046031975,"threshold_uncertainty_score":0.5588037},"labels":[],"label_agreement":null},{"id":"W4406545425","doi":"10.1016/s1544-8800(11)70009-4","title":"10.1016/s1544-8800(11)70009-4","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Cardiology","score_opus":0.004613061885917089,"score_gpt":0.17844686958237788,"score_spread":0.17383380769646078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406545425","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013212299,0.0013017004,0.0000029788048,0.00035225868,0.0000017533717,0.00029612964,0.000013303889,0.00018866756,0.9846309],"genre_scores_gemma":[0.0014536973,0.0000056477797,0.00006526868,0.00019980219,0.00029601177,0.000019241252,0.0000382969,0.000035672274,0.99788636],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990043,0.00004169182,0.00015490323,0.00024872035,0.00028047976,0.00026989658],"domain_scores_gemma":[0.99921936,0.000021455044,0.000015652908,0.00043394094,0.000043403936,0.00026620156],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00012355675,0.00015644399,0.0003018258,0.00005968038,0.00006860709,0.000019392513,0.00010645493,0.00007428326,0.9978473],"category_scores_gemma":[0.000019257865,0.00013829078,0.00030511105,0.00018095369,0.000042552983,0.000056193305,0.000017205419,0.00008895839,0.9910508],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004486338,0.0001007575,0.0000020102507,0.000015318481,0.00018096063,0.00008710113,0.000009945345,0.00002538085,0.00005623031,4.5277142e-7,0.26264927,0.73642397],"study_design_scores_gemma":[0.0010643174,0.00020359781,0.0005243122,0.000047068563,0.00018208694,0.00010491777,0.0000016797657,0.00003353943,0.00024798466,0.0000037395057,0.9974173,0.00016947872],"about_ca_topic_score_codex":0.000016273205,"about_ca_topic_score_gemma":8.994283e-8,"teacher_disagreement_score":0.73625445,"about_ca_system_score_codex":0.000026102163,"about_ca_system_score_gemma":0.000046577094,"threshold_uncertainty_score":0.56393343},"labels":[],"label_agreement":null},{"id":"W4406546311","doi":"10.1016/s1544-8800(05)70108-1","title":"10.1016/s1544-8800(05)70108-1","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Cardiology; Internal medicine; Medicine; Dual (grammatical number)","score_opus":0.0048426243537089695,"score_gpt":0.18013950315961114,"score_spread":0.17529687880590217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406546311","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008769372,0.0012904702,0.0000029006228,0.000357325,0.0000020543957,0.00029040308,0.000013261261,0.00018498329,0.98908925],"genre_scores_gemma":[0.001339537,0.00000752777,0.00006133415,0.00024302586,0.0003023592,0.0000191891,0.000040473697,0.000035185203,0.9979514],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990142,0.00004074487,0.00015328133,0.00024456478,0.00027563496,0.00027159037],"domain_scores_gemma":[0.9992298,0.00001974685,0.000015670148,0.00042244286,0.000044328342,0.0002680258],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000119293996,0.00015452316,0.000301512,0.000059656206,0.000069419024,0.000018425819,0.000102515296,0.00007571372,0.99774593],"category_scores_gemma":[0.000018941495,0.00013659454,0.0003040399,0.00017973964,0.000041576248,0.000056917957,0.000017241837,0.00010690769,0.99211675],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052430975,0.00009146197,6.176693e-7,0.000013748834,0.00019904145,0.0000996726,0.000010428687,0.00001795755,0.00006963059,3.9998883e-7,0.29801103,0.7009617],"study_design_scores_gemma":[0.0011220442,0.00026630177,0.00039851575,0.00004743042,0.00018132069,0.00013462617,0.0000020533002,0.000029307084,0.0002555303,0.0000044528306,0.9973914,0.00016700238],"about_ca_topic_score_codex":0.00001099945,"about_ca_topic_score_gemma":4.370593e-8,"teacher_disagreement_score":0.7007947,"about_ca_system_score_codex":0.000026339369,"about_ca_system_score_gemma":0.000047862217,"threshold_uncertainty_score":0.5570163},"labels":[],"label_agreement":null},{"id":"W4406548738","doi":"10.1016/s1155-1984(20)30037-6","title":"10.1016/s1155-1984(20)30037-6","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Chemistry","score_opus":0.004583133511240074,"score_gpt":0.1784035694547276,"score_spread":0.17382043594348753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406548738","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007237819,0.0015136632,0.0000027508272,0.00033323842,0.000001684095,0.00028949237,0.000016151584,0.00018483214,0.99042034],"genre_scores_gemma":[0.0009924043,0.0000065879963,0.000058851943,0.00023794147,0.000283606,0.000019614972,0.000053030202,0.00003528909,0.99831265],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99901384,0.00004113768,0.00015358375,0.00024798262,0.0002717753,0.00027170617],"domain_scores_gemma":[0.9992217,0.00001931304,0.000015602407,0.00042855283,0.000045221554,0.00026960918],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00012516828,0.00015549053,0.00030184357,0.00006115856,0.00006859307,0.000018970028,0.000102948914,0.00007359976,0.99771696],"category_scores_gemma":[0.00001929137,0.00013766291,0.00029765654,0.0001923062,0.000041532636,0.000057238554,0.000016783879,0.00010270191,0.9915626],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005604721,0.00009927625,9.681688e-7,0.000015339314,0.00022720189,0.00006740541,0.000010888873,0.00002641599,0.00009754412,3.9717494e-7,0.27073953,0.7281546],"study_design_scores_gemma":[0.0011012895,0.0002383937,0.00017637582,0.00004563804,0.00018072045,0.000109521854,0.0000019059448,0.000032677282,0.00027696154,0.0000045425054,0.99766296,0.00016901939],"about_ca_topic_score_codex":0.000006091827,"about_ca_topic_score_gemma":4.021721e-8,"teacher_disagreement_score":0.72798556,"about_ca_system_score_codex":0.000026587446,"about_ca_system_score_gemma":0.00005018606,"threshold_uncertainty_score":0.56137305},"labels":[],"label_agreement":null},{"id":"W4406550266","doi":"10.1016/s1541-9800(05)70410-5","title":"10.1016/s1541-9800(05)70410-5","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Aspirin; Regimen; Medicine; Internal medicine","score_opus":0.00489752381096715,"score_gpt":0.18047166148285343,"score_spread":0.1755741376718863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406550266","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006565668,0.0014081467,0.0000028256295,0.0003465841,0.0000019234444,0.0002868389,0.00001401485,0.0001848452,0.9911892],"genre_scores_gemma":[0.0013765999,0.00000792968,0.00005978802,0.00026350963,0.00029735366,0.000019433352,0.000043277185,0.000035372872,0.99789673],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99900484,0.000040819523,0.0001541683,0.00024760302,0.0002801138,0.00027243208],"domain_scores_gemma":[0.999219,0.00001943116,0.000015683694,0.00043038928,0.00004393991,0.000271585],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00012588674,0.00015628502,0.00030250393,0.000060978837,0.00006860326,0.000019360581,0.00010405963,0.00007347279,0.99794275],"category_scores_gemma":[0.000020054365,0.00013764239,0.0003068788,0.00018214592,0.00004171757,0.000057705267,0.000017355525,0.000101291516,0.991617],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048594232,0.00009023572,5.1416816e-7,0.000013246431,0.0002009234,0.0000959801,0.000010253585,0.000017603112,0.00006619971,3.8107945e-7,0.32539842,0.67362034],"study_design_scores_gemma":[0.0011334098,0.0002703327,0.0002017482,0.00004643275,0.00018337819,0.00013556491,0.0000020980494,0.00003255023,0.0002963994,0.000005103195,0.9975244,0.00016857388],"about_ca_topic_score_codex":0.000008105063,"about_ca_topic_score_gemma":3.4408828e-8,"teacher_disagreement_score":0.6734517,"about_ca_system_score_codex":0.000027187243,"about_ca_system_score_gemma":0.000046899946,"threshold_uncertainty_score":0.56128937},"labels":[],"label_agreement":null},{"id":"W4406551081","doi":"10.1016/s1541-9800(09)70152-8","title":"10.1016/s1541-9800(09)70152-8","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Clopidogrel; Medicine; Medical emergency; Internal medicine; Aspirin","score_opus":0.004952295557030271,"score_gpt":0.18056601896104454,"score_spread":0.17561372340401427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406551081","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0065331412,0.0015780951,0.0000028418424,0.00031078543,0.0000016456929,0.00028699325,0.000013304264,0.00018267504,0.99109054],"genre_scores_gemma":[0.0009856977,0.000008109462,0.000060161958,0.00017085455,0.00029876697,0.000019486806,0.00004194681,0.000035364515,0.9983796],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990016,0.000041276075,0.00015461203,0.0002478978,0.00028403423,0.00027053765],"domain_scores_gemma":[0.99921745,0.000019428368,0.000015695332,0.00042858635,0.00004571115,0.00027314905],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00012908649,0.00015619211,0.0003037002,0.000060719845,0.0000678213,0.000019301762,0.00010391108,0.000073588904,0.99798244],"category_scores_gemma":[0.000020563497,0.00013782385,0.00030411256,0.00018663106,0.00004162503,0.000057834048,0.000017346676,0.00010340525,0.9934216],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005255698,0.00009436966,7.4244406e-7,0.000014219972,0.00021582053,0.00008435016,0.0000111789495,0.000020124382,0.0000663021,4.0846152e-7,0.22660893,0.772358],"study_design_scores_gemma":[0.0011247866,0.00024381457,0.00024705988,0.000046840418,0.00018344546,0.00010560121,0.000002130949,0.000032800595,0.00027531854,0.0000051721718,0.99756384,0.0001691881],"about_ca_topic_score_codex":0.000007959359,"about_ca_topic_score_gemma":3.2646902e-8,"teacher_disagreement_score":0.7721888,"about_ca_system_score_codex":0.000026836125,"about_ca_system_score_gemma":0.00004815142,"threshold_uncertainty_score":0.56202936},"labels":[],"label_agreement":null},{"id":"W4406552070","doi":"10.1016/s1553-3212(09)70090-1","title":"10.1016/s1553-3212(09)70090-1","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Antithrombotic; Stroke (engine); Medicine; Anesthesia; Cardiology","score_opus":0.004781227124489722,"score_gpt":0.17945835704252633,"score_spread":0.1746771299180366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406552070","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0081143165,0.0015933798,0.0000027553297,0.00030049743,0.0000016571926,0.00029112096,0.000013172418,0.00018382627,0.9894993],"genre_scores_gemma":[0.0010455047,0.000008585282,0.00005473153,0.0001832875,0.00030002923,0.000019165296,0.000041264273,0.00003458304,0.99831283],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999019,0.00003944742,0.00015356689,0.000246184,0.00027532678,0.0002664239],"domain_scores_gemma":[0.999227,0.000019633275,0.00001576437,0.00042618273,0.000044481243,0.00026694834],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0001231191,0.00015487362,0.00030235256,0.00006161229,0.0000673715,0.000019777113,0.00010145824,0.0000723677,0.99763983],"category_scores_gemma":[0.000018594492,0.00013716219,0.00030951758,0.00018517283,0.00004161128,0.000057703775,0.000017351022,0.00010095811,0.993178],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005868676,0.000098758166,7.7264906e-7,0.000014474796,0.00021985295,0.00008778321,0.000011900383,0.000021478842,0.00006456914,3.9641785e-7,0.24554262,0.7533505],"study_design_scores_gemma":[0.0011234982,0.00023616348,0.0002956637,0.000046929126,0.00018397863,0.00010614183,0.0000021003543,0.0000325871,0.00028307762,0.000004568744,0.99751693,0.00016834274],"about_ca_topic_score_codex":0.000008795328,"about_ca_topic_score_gemma":3.6179124e-8,"teacher_disagreement_score":0.7531822,"about_ca_system_score_codex":0.000026930686,"about_ca_system_score_gemma":0.00004570574,"threshold_uncertainty_score":0.5593312},"labels":[],"label_agreement":null},{"id":"W4406560282","doi":"10.1016/s2211-0364(20)30116-3","title":"10.1016/s2211-0364(20)30116-3","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.004651979244333728,"score_gpt":0.17768848773783677,"score_spread":0.17303650849350305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406560282","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0057254736,0.001602995,0.0000027135081,0.00033291313,0.00000162557,0.00028501678,0.000015738313,0.00018356102,0.99184996],"genre_scores_gemma":[0.0009664547,0.000007238231,0.000059172657,0.0002271309,0.00030113535,0.000019452069,0.000053839573,0.00003521221,0.99833035],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990087,0.000040478055,0.0001541099,0.00024786094,0.0002769113,0.00027193333],"domain_scores_gemma":[0.9992211,0.000019118163,0.000015639784,0.00042845675,0.000044793538,0.00027089924],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00012242403,0.00015591088,0.00030192317,0.00006107386,0.00006811859,0.000018796856,0.00010380721,0.00007363131,0.99788713],"category_scores_gemma":[0.000017462111,0.00013751331,0.00030360525,0.00017883297,0.00004174341,0.000057635007,0.000017105114,0.000102072176,0.9919561],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005294333,0.00009652566,7.7978575e-7,0.000014352051,0.0002235543,0.00008686748,0.000010099564,0.000024144585,0.000090259535,3.8505544e-7,0.29058263,0.70834094],"study_design_scores_gemma":[0.0010891628,0.00024249704,0.00018095541,0.00004571953,0.00018383058,0.000106974694,0.000002000097,0.00003440422,0.00025797402,0.0000046962573,0.99768287,0.00016892259],"about_ca_topic_score_codex":0.0000067856345,"about_ca_topic_score_gemma":4.0018055e-8,"teacher_disagreement_score":0.708172,"about_ca_system_score_codex":0.00002688048,"about_ca_system_score_gemma":0.00004603763,"threshold_uncertainty_score":0.560763},"labels":[],"label_agreement":null},{"id":"W4406561126","doi":"10.1016/s2211-9698(24)47770-4","title":"10.1016/s2211-9698(24)47770-4","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Environmental science","score_opus":0.005208794775721496,"score_gpt":0.1775673133665318,"score_spread":0.1723585185908103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406561126","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008218421,0.0016807652,0.0000028544737,0.00032550137,0.000002341552,0.000287961,0.00001319343,0.00018556204,0.9892834],"genre_scores_gemma":[0.0011610233,0.000008809341,0.00006716293,0.00023000507,0.00030880392,0.000018972407,0.000039587503,0.000035425946,0.9981302],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99900657,0.0000412811,0.00015462028,0.00024794514,0.00027963554,0.00026994688],"domain_scores_gemma":[0.9992218,0.000018961377,0.000015676707,0.0004299324,0.00004328139,0.00027033023],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00012375861,0.00015618392,0.00030245277,0.000060975322,0.000069157584,0.000019385501,0.00010375085,0.00007282897,0.997706],"category_scores_gemma":[0.00002066495,0.00013782726,0.00030687335,0.00018486548,0.00004159608,0.000057032124,0.000017231572,0.00010823188,0.9915966],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005024166,0.00009155421,7.423063e-7,0.000013990075,0.00021904851,0.000084471,0.0000104480605,0.000019003177,0.00006760387,4.2720686e-7,0.30386224,0.6951281],"study_design_scores_gemma":[0.0010936073,0.00023671736,0.00026423007,0.000046124424,0.00018846127,0.00010639819,0.0000021233943,0.000033644756,0.00023655503,0.0000044927615,0.9976186,0.00016905039],"about_ca_topic_score_codex":0.0000074750324,"about_ca_topic_score_gemma":2.7694526e-8,"teacher_disagreement_score":0.694959,"about_ca_system_score_codex":0.000026056267,"about_ca_system_score_gemma":0.00004733868,"threshold_uncertainty_score":0.56204325},"labels":[],"label_agreement":null},{"id":"W4406561168","doi":"10.1016/s2211-9698(20)30004-2","title":"10.1016/s2211-9698(20)30004-2","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Psychology; Computer science","score_opus":0.00450881570111609,"score_gpt":0.17767081679200117,"score_spread":0.1731620010908851,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406561168","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005692666,0.0016533864,0.0000026780338,0.00035179057,0.0000016982822,0.0002898488,0.000016319365,0.0001904222,0.9918012],"genre_scores_gemma":[0.0009866523,0.000007255872,0.00006120529,0.00022579041,0.00030345496,0.000019741175,0.000048860496,0.000035851615,0.99831116],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989985,0.00004055623,0.00015541962,0.00024999457,0.00028124364,0.0002742648],"domain_scores_gemma":[0.9992175,0.000018338116,0.000015583282,0.00043217663,0.000044566943,0.000271825],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00012464412,0.0001573983,0.0003037696,0.000061550665,0.00006893576,0.00001932538,0.000104866725,0.00007429508,0.9980395],"category_scores_gemma":[0.000017747574,0.00013906811,0.0003137555,0.00018648563,0.00004164636,0.000058331374,0.000016916747,0.00010328446,0.9918193],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005229899,0.0000969743,8.0480504e-7,0.000014421204,0.00023356847,0.00008844054,0.000009986965,0.000025986097,0.0000865157,4.0311298e-7,0.23934424,0.75957566],"study_design_scores_gemma":[0.0011099475,0.00023912967,0.00016998546,0.00004669488,0.00019154864,0.00010770853,0.0000018784821,0.00003904524,0.00025470692,0.0000046386062,0.9976642,0.00017050626],"about_ca_topic_score_codex":0.00000648852,"about_ca_topic_score_gemma":4.174878e-8,"teacher_disagreement_score":0.75940514,"about_ca_system_score_codex":0.000027325392,"about_ca_system_score_gemma":0.000050766026,"threshold_uncertainty_score":0.5671033},"labels":[],"label_agreement":null},{"id":"W4406565130","doi":"10.1016/j.ypdi.2015.01.035","title":"10.1016/j.ypdi.2015.01.035","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Myocardial infarction; Pneumonia; Cardiology; Internal medicine; Platelet; Platelet activation","score_opus":0.004975258487913863,"score_gpt":0.19137186020949562,"score_spread":0.18639660172158176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406565130","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005791586,0.0019879737,0.0000031573254,0.00036771825,0.0000016794157,0.00027496787,0.000012347325,0.00017813106,0.9913824],"genre_scores_gemma":[0.0012558198,0.000008206745,0.00006948088,0.0002072011,0.00028451718,0.000016376107,0.000040324638,0.000033126922,0.99808496],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990788,0.000038382535,0.00014306926,0.00022677475,0.00026220488,0.0002507537],"domain_scores_gemma":[0.99926835,0.0000150458845,0.000014724792,0.0004073039,0.000037068457,0.00025751116],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00012009189,0.00014390069,0.0002831273,0.000055210214,0.00006079046,0.000017648666,0.00009619363,0.0000682567,0.99744534],"category_scores_gemma":[0.00001840281,0.00012596874,0.00027541808,0.00016464278,0.00003901003,0.000056923865,0.000016040367,0.00009350025,0.9907967],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053198123,0.000091555456,7.8887507e-7,0.000012499044,0.00021412734,0.00007158798,0.000010173727,0.000016117861,0.000051710875,4.3309362e-7,0.30584842,0.6931506],"study_design_scores_gemma":[0.0010589776,0.00023536556,0.0002449995,0.000041208918,0.00017440873,0.00009263847,0.0000021083902,0.000035681358,0.00021329807,0.0000040029413,0.99774116,0.0001561241],"about_ca_topic_score_codex":0.0000073796136,"about_ca_topic_score_gemma":3.3562532e-8,"teacher_disagreement_score":0.6929945,"about_ca_system_score_codex":0.000022976166,"about_ca_system_score_gemma":0.000043230648,"threshold_uncertainty_score":0.5136856},"labels":[],"label_agreement":null},{"id":"W4406575787","doi":"10.1016/s1558-0164(08)70404-8","title":"10.1016/s1558-0164(08)70404-8","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Prasugrel; Medicine; Diabetes mellitus; Internal medicine; Endocrinology; Clopidogrel; Myocardial infarction","score_opus":0.004723008424212875,"score_gpt":0.17888644737821396,"score_spread":0.17416343895400108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406575787","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00674069,0.0017013543,0.0000031488569,0.00029533048,0.0000016194523,0.0002836994,0.000013609371,0.00018402116,0.99077654],"genre_scores_gemma":[0.0013519615,0.000008422021,0.0000615184,0.00021657447,0.00028682192,0.00001915354,0.000039758004,0.00003566443,0.9979801],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989991,0.000040713345,0.0001549042,0.00024895748,0.0002861405,0.00027016824],"domain_scores_gemma":[0.99922293,0.000019938805,0.000016308399,0.00042723358,0.00004390152,0.0002696592],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00012602509,0.0001566593,0.0003032224,0.000059393828,0.00006827573,0.000019247505,0.000104470295,0.000072637835,0.9981564],"category_scores_gemma":[0.000020957146,0.00013761794,0.00030825756,0.00018264948,0.00004201557,0.000057159516,0.000017357383,0.00010299125,0.9978311],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007407473,0.00013019891,2.8619186e-7,0.000019563446,0.00029964602,0.000117354495,0.000015748767,0.00002556015,0.00009382275,6.38382e-7,0.49826092,0.5002955],"study_design_scores_gemma":[0.0011149467,0.00024208608,0.00025935457,0.000046960857,0.00018099957,0.00010619155,0.0000022184563,0.000030696196,0.00027843975,0.0000045671277,0.9975633,0.0001702589],"about_ca_topic_score_codex":0.000007847516,"about_ca_topic_score_gemma":3.2084895e-8,"teacher_disagreement_score":0.5001252,"about_ca_system_score_codex":0.00002776264,"about_ca_system_score_gemma":0.000048288653,"threshold_uncertainty_score":0.56118965},"labels":[],"label_agreement":null},{"id":"W4406577055","doi":"10.1016/s1544-8800(12)70106-9","title":"10.1016/s1544-8800(12)70106-9","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Prasugrel; Clopidogrel; Medicine; Cardiology; Internal medicine; Aspirin","score_opus":0.00508814914647266,"score_gpt":0.17680030679400183,"score_spread":0.17171215764752917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406577055","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006897889,0.0011722479,0.0000029667622,0.0002899575,0.0000016875307,0.00028641112,0.0000125511215,0.0001813764,0.9911549],"genre_scores_gemma":[0.0013032816,0.000007650142,0.000063821186,0.00020865523,0.00029322796,0.000019099869,0.000040902505,0.000035259727,0.9980281],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990148,0.00003978889,0.00015330572,0.0002459802,0.0002773591,0.00026877824],"domain_scores_gemma":[0.9992317,0.000019735919,0.000015576807,0.00042632438,0.00003802694,0.0002686256],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00011997693,0.00015549347,0.00030057444,0.000059554743,0.00006824343,0.000019196143,0.00010282943,0.00007378786,0.9977381],"category_scores_gemma":[0.000018957893,0.00013724464,0.00030337388,0.00014436222,0.00004173541,0.00005711747,0.000017107588,0.00010460435,0.99168605],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059977383,0.000095763084,9.839558e-7,0.0000145873655,0.00021885963,0.000085266896,0.0000107674905,0.000020554364,0.00007267378,3.8194344e-7,0.24065557,0.7582248],"study_design_scores_gemma":[0.0010959498,0.00025311194,0.00049221405,0.000045345598,0.00018305777,0.000106158346,0.0000018310535,0.000030665593,0.0002457473,0.0000043905375,0.9973732,0.00016830291],"about_ca_topic_score_codex":0.000011575487,"about_ca_topic_score_gemma":6.524759e-8,"teacher_disagreement_score":0.7580565,"about_ca_system_score_codex":0.00002581909,"about_ca_system_score_gemma":0.000047694175,"threshold_uncertainty_score":0.5596674},"labels":[],"label_agreement":null},{"id":"W4406577154","doi":"10.1016/s1544-8800(10)70244-x","title":"10.1016/s1544-8800(10)70244-x","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Ticagrelor; Medicine; Internal medicine; Clopidogrel; Aspirin","score_opus":0.004991715707692418,"score_gpt":0.1803636757932923,"score_spread":0.17537196008559988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406577154","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0060069254,0.0017542437,0.0000027731203,0.00028501262,0.0000016333253,0.0002833823,0.000014451133,0.00018904002,0.9914625],"genre_scores_gemma":[0.0010252,0.000006034483,0.000055162887,0.00016697908,0.0003065437,0.000020567491,0.000048226946,0.000037962374,0.99833333],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989564,0.00004351238,0.00016324245,0.0002619063,0.0002925758,0.00028236737],"domain_scores_gemma":[0.99918234,0.000021834168,0.000017089604,0.0004493229,0.00005190174,0.0002774946],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0001273594,0.00016689654,0.00031744796,0.00006370864,0.000071380884,0.000021231783,0.0001106689,0.0000792288,0.99891675],"category_scores_gemma":[0.000023020253,0.00014727077,0.00032501365,0.00019036219,0.000044444532,0.000060206257,0.000018932136,0.000100158126,0.9953899],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006886697,0.000097228076,6.278451e-7,0.000015727137,0.0002308029,0.00008623391,0.00000934481,0.000020270958,0.000060344297,3.411472e-7,0.35201484,0.64677554],"study_design_scores_gemma":[0.0011510679,0.00027397258,0.00038905718,0.000049180006,0.00020202964,0.000096237345,0.000001925877,0.000033425924,0.00025226473,0.0000039128586,0.99736714,0.00017976192],"about_ca_topic_score_codex":0.0000090351405,"about_ca_topic_score_gemma":3.8962924e-8,"teacher_disagreement_score":0.64659584,"about_ca_system_score_codex":0.000028561864,"about_ca_system_score_gemma":0.000052719693,"threshold_uncertainty_score":0.6005528},"labels":[],"label_agreement":null},{"id":"W4406577235","doi":"10.1016/s1544-8800(12)70340-8","title":"10.1016/s1544-8800(12)70340-8","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Clopidogrel; Conventional PCI; Cardiology; Medicine; Internal medicine; Myocardial infarction","score_opus":0.005145963358355137,"score_gpt":0.1770341845702047,"score_spread":0.17188822121184957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406577235","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007399963,0.0012565549,0.0000025710485,0.00028059632,0.0000016177679,0.00028764326,0.000012235625,0.00018138094,0.99057746],"genre_scores_gemma":[0.0013726713,0.0000064343153,0.00006013932,0.0001998217,0.00029223325,0.000019150779,0.000039095394,0.000035303445,0.9979752],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990118,0.000040476527,0.00015370874,0.00024644745,0.00027801417,0.00026955784],"domain_scores_gemma":[0.99923146,0.0000200988,0.0000156192,0.00042611192,0.0000380246,0.00026871142],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00011985292,0.00015577495,0.00030181656,0.000059516617,0.000068151836,0.000019118972,0.00010275241,0.00007266475,0.99778366],"category_scores_gemma":[0.000019280387,0.00013748083,0.0003032588,0.000144618,0.000040861483,0.000057162157,0.00001716464,0.00010199176,0.99154234],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005976129,0.00009495636,0.0000010710735,0.000014514981,0.00022040939,0.0000847849,0.0000107866335,0.000020894744,0.00008212228,3.1108482e-7,0.23003149,0.768841],"study_design_scores_gemma":[0.0010771484,0.0002554592,0.0004731464,0.000046461635,0.0001841412,0.00010537741,0.0000018558936,0.000026107758,0.00030454696,0.0000042837937,0.9973529,0.00016858774],"about_ca_topic_score_codex":0.000010889543,"about_ca_topic_score_gemma":5.9389762e-8,"teacher_disagreement_score":0.76867247,"about_ca_system_score_codex":0.00002638577,"about_ca_system_score_gemma":0.000047280828,"threshold_uncertainty_score":0.56063056},"labels":[],"label_agreement":null},{"id":"W4406577440","doi":"10.1016/s1544-8800(09)70285-4","title":"10.1016/s1544-8800(09)70285-4","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Clopidogrel; Medicine; Internal medicine; Aspirin","score_opus":0.004868492430074597,"score_gpt":0.17994192908584386,"score_spread":0.17507343665576927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406577440","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007394333,0.001726483,0.0000030706833,0.00029871892,0.0000016131551,0.0002881641,0.000012766197,0.00018360093,0.99009126],"genre_scores_gemma":[0.0011388435,0.0000074476175,0.000060087823,0.00015043427,0.00029041254,0.000019353793,0.000038624632,0.000035325553,0.9982595],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99901086,0.00004065184,0.00015382328,0.0002468105,0.00027874333,0.00026910793],"domain_scores_gemma":[0.99922633,0.000019777259,0.000015677533,0.00042551174,0.000043913114,0.00026876765],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000121150886,0.00015570046,0.00030164846,0.000059766295,0.000068411086,0.000019241272,0.0001032958,0.00007345943,0.99766743],"category_scores_gemma":[0.000019211884,0.00013740556,0.000306005,0.00018232536,0.00004158121,0.000057396384,0.000017191021,0.00010291884,0.99317807],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005547887,0.000094714975,8.2564134e-7,0.000014450654,0.00025444743,0.000084127416,0.000010600377,0.000021284995,0.00006803062,4.233759e-7,0.18702781,0.8118685],"study_design_scores_gemma":[0.0010785409,0.00024282036,0.0003891236,0.000046559333,0.00021855488,0.00010450402,0.0000017686092,0.000032828382,0.00026307497,0.0000044933445,0.9974491,0.00016865949],"about_ca_topic_score_codex":0.000010701894,"about_ca_topic_score_gemma":4.0326515e-8,"teacher_disagreement_score":0.8116998,"about_ca_system_score_codex":0.000026248634,"about_ca_system_score_gemma":0.00004780415,"threshold_uncertainty_score":0.5603236},"labels":[],"label_agreement":null},{"id":"W4406577685","doi":"10.1016/s1544-8800(09)70145-9","title":"10.1016/s1544-8800(09)70145-9","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Clopidogrel; Medicine; Internal medicine; Cardiology; Aspirin","score_opus":0.004823507872297753,"score_gpt":0.1798368538012152,"score_spread":0.17501334592891743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406577685","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0073142517,0.0014768176,0.0000031764612,0.00030915803,0.0000016581621,0.00028611431,0.000012421359,0.00018336413,0.990413],"genre_scores_gemma":[0.0010938095,0.0000084617395,0.000061630504,0.00015526223,0.00029830026,0.00001928426,0.000038804304,0.000035312052,0.9982891],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990112,0.000040491992,0.0001532248,0.00024723654,0.00027953027,0.00026829133],"domain_scores_gemma":[0.9992273,0.00001943796,0.000015603628,0.0004260993,0.000044345685,0.0002672324],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00012268452,0.00015563762,0.0003016999,0.00005734632,0.00006920398,0.000019195746,0.000102785125,0.00007419909,0.99756944],"category_scores_gemma":[0.000018786212,0.00013739357,0.0003146394,0.00018124002,0.000041275467,0.000056546134,0.000017151573,0.00010507012,0.9933986],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005419717,0.00009115499,7.507291e-7,0.000014513241,0.00021334946,0.000076236414,0.000010556294,0.000022148124,0.000066642366,3.8777284e-7,0.214733,0.7842293],"study_design_scores_gemma":[0.0010744274,0.0002496062,0.00039017608,0.000046024452,0.00018337849,0.000101590376,0.0000020915052,0.00003447296,0.00026038376,0.0000043923565,0.997485,0.00016846192],"about_ca_topic_score_codex":0.000010837444,"about_ca_topic_score_gemma":4.036357e-8,"teacher_disagreement_score":0.78406084,"about_ca_system_score_codex":0.00002630418,"about_ca_system_score_gemma":0.000047503036,"threshold_uncertainty_score":0.56027466},"labels":[],"label_agreement":null},{"id":"W4406577725","doi":"10.1016/s1544-8800(09)70062-4","title":"10.1016/s1544-8800(09)70062-4","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Prasugrel; Medicine; Internal medicine; Aspirin; Clopidogrel","score_opus":0.004796273072149508,"score_gpt":0.1795360378182903,"score_spread":0.1747397647461408,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406577725","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007926597,0.0014389172,0.0000030650294,0.00030727065,0.0000016530331,0.00029012805,0.000013036009,0.00018321275,0.9898361],"genre_scores_gemma":[0.0010758992,0.0000075361795,0.000060271646,0.00014965875,0.0002969452,0.00001941381,0.00004019379,0.000035302564,0.9983148],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99901056,0.00004055435,0.00015403995,0.0002468787,0.0002787605,0.0002692231],"domain_scores_gemma":[0.99923104,0.000019482424,0.000015704216,0.00042509503,0.000043084037,0.00026558136],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00012037512,0.00015578524,0.0003019049,0.000059778686,0.000068267014,0.000019259378,0.00010295181,0.00007341124,0.99767464],"category_scores_gemma":[0.000018405233,0.0001375259,0.00030682446,0.00017657375,0.000041498137,0.000057106685,0.000017118084,0.00010255894,0.9934738],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005308947,0.00009403164,8.382025e-7,0.000014188137,0.0002095708,0.00007946956,0.000010400209,0.000021197542,0.00006451212,4.0655462e-7,0.19845238,0.8005221],"study_design_scores_gemma":[0.0010832765,0.00024547058,0.00040663712,0.00004541291,0.00018293814,0.000100640966,0.000001971476,0.000031694573,0.00026600555,0.0000045652755,0.9974623,0.00016912805],"about_ca_topic_score_codex":0.000011380907,"about_ca_topic_score_gemma":4.0502055e-8,"teacher_disagreement_score":0.800353,"about_ca_system_score_codex":0.000026700334,"about_ca_system_score_gemma":0.000048568512,"threshold_uncertainty_score":0.5608143},"labels":[],"label_agreement":null},{"id":"W4406578029","doi":"10.1016/s1544-8800(07)70457-8","title":"10.1016/s1544-8800(07)70457-8","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Aspirin; Medicine; Cardiology; Internal medicine","score_opus":0.004909245684458436,"score_gpt":0.18051229728051432,"score_spread":0.17560305159605588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406578029","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00731822,0.0015068084,0.000003666478,0.00029498653,0.0000016527174,0.0002851962,0.000013177208,0.00018355239,0.99039274],"genre_scores_gemma":[0.001536753,0.000008129462,0.000060419126,0.0001939818,0.00029515242,0.000019167508,0.000039211605,0.000035211076,0.997812],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99901307,0.000040602965,0.0001533858,0.0002466361,0.000277214,0.00026906788],"domain_scores_gemma":[0.99922585,0.000020006004,0.000015624822,0.00042537315,0.000044518183,0.00026861965],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000120378216,0.00015556609,0.00030165366,0.000056700064,0.00006837232,0.000019260093,0.00010301832,0.00007240742,0.9983545],"category_scores_gemma":[0.000019624495,0.0001373841,0.00030091804,0.00016613251,0.000041548243,0.000057467947,0.000017159218,0.00010262453,0.99552673],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005526225,0.00009791174,8.193519e-7,0.00001473602,0.00022778942,0.000095205694,0.000009994968,0.000019373705,0.00007493397,4.0523832e-7,0.22318068,0.77572554],"study_design_scores_gemma":[0.0010537299,0.00025305874,0.0003555727,0.000046573852,0.00018891494,0.00011568333,0.0000019513077,0.00003879551,0.0002111304,0.000004294032,0.9975617,0.00016858045],"about_ca_topic_score_codex":0.000010644336,"about_ca_topic_score_gemma":3.308853e-8,"teacher_disagreement_score":0.7755569,"about_ca_system_score_codex":0.00002618527,"about_ca_system_score_gemma":0.00004871407,"threshold_uncertainty_score":0.56023604},"labels":[],"label_agreement":null},{"id":"W4406578174","doi":"10.1016/s1544-8800(06)70777-1","title":"10.1016/s1544-8800(06)70777-1","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Conventional PCI; Medicine; Cardiology","score_opus":0.005017097180700356,"score_gpt":0.18069348721771353,"score_spread":0.17567639003701319,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406578174","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009476929,0.0014746421,0.0000029940493,0.0003182587,0.0000011588668,0.0002895528,0.0000134889,0.00018544434,0.98823756],"genre_scores_gemma":[0.0015519408,0.00000814804,0.000060357186,0.00020126918,0.00028920846,0.000019202173,0.000050973773,0.000035299563,0.9977836],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99900687,0.00004091153,0.00015408047,0.00024688113,0.00027974823,0.0002715079],"domain_scores_gemma":[0.99922,0.000019929737,0.000015358717,0.000425366,0.000044664554,0.00027466522],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00012243933,0.00015583652,0.00030225806,0.00006033842,0.00006831561,0.000019295567,0.000103128375,0.000073905605,0.99741876],"category_scores_gemma":[0.00002017143,0.00013763433,0.00030705341,0.00018220424,0.000041529172,0.00005734127,0.000017216778,0.00010338569,0.994259],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044886692,0.000097545286,0.0000011069952,0.000015139451,0.00022192282,0.0000814048,0.000010963556,0.000021998527,0.00007142898,4.1229683e-7,0.33536935,0.6636599],"study_design_scores_gemma":[0.0010792451,0.00021050121,0.0004499699,0.000046715177,0.00018326641,0.00010420022,0.0000020043224,0.000032501775,0.00023525569,0.0000041648295,0.9974834,0.00016877841],"about_ca_topic_score_codex":0.000008966258,"about_ca_topic_score_gemma":3.1683697e-8,"teacher_disagreement_score":0.6634911,"about_ca_system_score_codex":0.000026488324,"about_ca_system_score_gemma":0.000048830596,"threshold_uncertainty_score":0.5612565},"labels":[],"label_agreement":null},{"id":"W4406578288","doi":"10.1016/s1544-8800(07)70330-5","title":"10.1016/s1544-8800(07)70330-5","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Clopidogrel; Medicine; Term (time); Cardiology; Internal medicine; Aspirin; Physics","score_opus":0.004931533927569584,"score_gpt":0.1807504079761827,"score_spread":0.1758188740486131,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406578288","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008308747,0.0015354361,0.0000030013102,0.00030323796,0.0000016242998,0.00028568791,0.00001309682,0.00018348517,0.9893657],"genre_scores_gemma":[0.0014810277,0.0000084553585,0.00005912318,0.00019957332,0.0002932581,0.000019176834,0.0000386988,0.000035283265,0.9978654],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99900997,0.000040592688,0.00015378032,0.00024723724,0.00027872913,0.0002697113],"domain_scores_gemma":[0.99922276,0.000020017535,0.000015641168,0.00042845652,0.000044077202,0.0002690412],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00012090502,0.00015584701,0.0003024886,0.000056869078,0.00006839917,0.000019249954,0.00010340014,0.00007346904,0.9983269],"category_scores_gemma":[0.000019411049,0.00013756826,0.00030712556,0.00016217124,0.000041565112,0.000057543122,0.00001721147,0.00010277795,0.9956129],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056135777,0.00009714663,8.299831e-7,0.000014762031,0.0002205683,0.000088200366,0.000010528882,0.000021146121,0.00006031375,4.0829093e-7,0.23103808,0.76788664],"study_design_scores_gemma":[0.001077647,0.0002429798,0.0003970358,0.000046031357,0.0001836248,0.000107261745,0.0000019475672,0.000031869324,0.00024177168,0.0000045630377,0.9974964,0.00016881226],"about_ca_topic_score_codex":0.000010345877,"about_ca_topic_score_gemma":3.4361992e-8,"teacher_disagreement_score":0.76771784,"about_ca_system_score_codex":0.00002673972,"about_ca_system_score_gemma":0.000048192276,"threshold_uncertainty_score":0.5609871},"labels":[],"label_agreement":null},{"id":"W4406578298","doi":"10.1016/s1544-8800(06)70670-4","title":"10.1016/s1544-8800(06)70670-4","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Spur; Charisma; Anxiety; Psychology; Medicine; Psychiatry; Theology; Philosophy; Anatomy","score_opus":0.004852885697996764,"score_gpt":0.17994014429647853,"score_spread":0.17508725859848176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406578298","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009447347,0.0014913073,0.0000030741671,0.0003079084,0.0000011604437,0.00029116563,0.000016770995,0.00017488001,0.9882664],"genre_scores_gemma":[0.0014590716,0.000008249978,0.000060646402,0.00019572407,0.00028708956,0.000019172496,0.000065925495,0.000035164627,0.99786896],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990075,0.0000415778,0.00015385794,0.00024652245,0.0002793015,0.00027119904],"domain_scores_gemma":[0.9992198,0.00002035556,0.000015326006,0.0004250611,0.00004440967,0.00027508358],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00012345903,0.00015575903,0.00030177637,0.00006114888,0.000068581874,0.000019442716,0.00010294467,0.00007397512,0.9977652],"category_scores_gemma":[0.00002049022,0.00013757014,0.00030612436,0.00018457398,0.000042107924,0.00005655805,0.000017173788,0.000104458006,0.9940055],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004461683,0.000096067066,0.0000012113265,0.000015177572,0.00022150506,0.00007993581,0.000010840484,0.000022364655,0.000067565015,4.357345e-7,0.33161604,0.6674227],"study_design_scores_gemma":[0.0010741486,0.00021433728,0.00042540944,0.00004669498,0.00018572647,0.00010401184,0.0000020047091,0.000032423537,0.00022674538,0.0000043027476,0.99751556,0.00016864705],"about_ca_topic_score_codex":0.000011114628,"about_ca_topic_score_gemma":3.8953626e-8,"teacher_disagreement_score":0.66725403,"about_ca_system_score_codex":0.0000264866,"about_ca_system_score_gemma":0.000049389277,"threshold_uncertainty_score":0.56099474},"labels":[],"label_agreement":null},{"id":"W4406578763","doi":"10.1016/s1544-8800(07)70251-8","title":"10.1016/s1544-8800(07)70251-8","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Aspirin; Medicine; Cardiology; Internal medicine; Medical emergency","score_opus":0.004834470852624051,"score_gpt":0.18050627238535383,"score_spread":0.17567180153272977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406578763","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0088985665,0.0014781243,0.0000030566923,0.00030621275,0.0000016481272,0.0002855401,0.00001294052,0.00018171092,0.9888322],"genre_scores_gemma":[0.0014477274,0.000008119909,0.00005949579,0.00019411721,0.000291275,0.000019165387,0.000037571343,0.000034391105,0.9979081],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990167,0.00004058377,0.0001533764,0.0002458992,0.000275646,0.00026777582],"domain_scores_gemma":[0.9992319,0.000020058927,0.000015443376,0.00042234096,0.000044499426,0.00026579213],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00012017805,0.00015506931,0.00030142977,0.00005731927,0.000069149966,0.00001954052,0.0001029251,0.000073795876,0.9984402],"category_scores_gemma":[0.000019141919,0.00013700905,0.0003056547,0.000162662,0.000041891224,0.00005689749,0.00001715054,0.000102588274,0.99558836],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005763462,0.00009860076,8.75122e-7,0.000014942787,0.00022290937,0.00008933577,0.000010708933,0.000020106649,0.00006217408,4.1700966e-7,0.22892825,0.7699753],"study_design_scores_gemma":[0.0010802902,0.00023922184,0.00041295306,0.00004718735,0.0001808057,0.00010576009,0.000002057807,0.000031174208,0.0002325992,0.0000044914655,0.9974963,0.00016712963],"about_ca_topic_score_codex":0.000010414181,"about_ca_topic_score_gemma":3.478395e-8,"teacher_disagreement_score":0.7698082,"about_ca_system_score_codex":0.000026482425,"about_ca_system_score_gemma":0.00004925631,"threshold_uncertainty_score":0.5587067},"labels":[],"label_agreement":null},{"id":"W4406579092","doi":"10.1016/s1544-8800(06)70783-7","title":"10.1016/s1544-8800(06)70783-7","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Clopidogrel; Cardiology; Medicine; Internal medicine","score_opus":0.004829325053830511,"score_gpt":0.17971141453605524,"score_spread":0.17488208948222472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406579092","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009457406,0.0014763344,0.0000029086216,0.00032363672,0.0000011559554,0.0002895795,0.0000132913765,0.00018557518,0.98825014],"genre_scores_gemma":[0.0015414885,0.000007857115,0.00006159165,0.00019958595,0.00028849815,0.000019159754,0.00005140422,0.000035290097,0.9977951],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990069,0.00004094825,0.00015426152,0.00024687147,0.0002795327,0.000271451],"domain_scores_gemma":[0.9992205,0.000019953697,0.00001537324,0.0004250326,0.000044603938,0.000274553],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00012271825,0.0001557765,0.00030207227,0.00006022461,0.00006834626,0.000019157875,0.000103013466,0.000073846895,0.997307],"category_scores_gemma":[0.000020101212,0.00013755012,0.00030689995,0.00018289757,0.00004147001,0.00005622584,0.000017207234,0.00010360522,0.9940216],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004412405,0.00009694178,0.0000011196599,0.000015061396,0.00022064589,0.00008092584,0.000010481438,0.000022358146,0.00007060379,4.2726612e-7,0.32307342,0.6759668],"study_design_scores_gemma":[0.0010731366,0.00021222128,0.00045271183,0.000046866706,0.00018346385,0.000104508115,0.0000020195791,0.000033370776,0.00023658232,0.0000043076316,0.9974821,0.00016867263],"about_ca_topic_score_codex":0.000009226502,"about_ca_topic_score_gemma":3.1130593e-8,"teacher_disagreement_score":0.6757981,"about_ca_system_score_codex":0.00002650955,"about_ca_system_score_gemma":0.00004845195,"threshold_uncertainty_score":0.5609131},"labels":[],"label_agreement":null},{"id":"W4406639930","doi":"10.1016/b978-1-4557-0984-7.00193-9","title":"10.1016/b978-1-4557-0984-7.00193-9","year":2000,"lang":"en","type":"book-chapter","venue":"Time to knit","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Antithrombotic; Medicine; Business; Intensive care medicine; Cardiology","score_opus":0.007761938722560913,"score_gpt":0.18135501038493917,"score_spread":0.17359307166237825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406639930","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000043480386,0.0061735557,0.0000021338642,0.00013710702,0.0000055521914,0.0006634162,0.00012381937,0.00027128088,0.9926188],"genre_scores_gemma":[0.0000041140133,0.000039703555,0.00004714666,0.00022727794,0.00093018264,0.00002272806,0.00039739182,0.00019411417,0.99813735],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998016,0.000025444186,0.0003648249,0.0005907711,0.00061294006,0.00039002878],"domain_scores_gemma":[0.99838877,0.000038729224,0.00008408333,0.00093002844,0.00010613049,0.0004522789],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00014367962,0.0005416281,0.0009803468,0.00022825695,0.00008759843,0.000033473505,0.00021833678,0.0004526192,0.99814516],"category_scores_gemma":[0.000016143478,0.000512905,0.0010555633,0.000054953223,0.00010367729,0.000049882987,0.000061717765,0.0004187877,0.9948157],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000754421,0.00004856156,2.3404539e-8,0.00006243781,0.0011859068,0.0003924835,0.000006043255,0.000004157932,0.000005388946,0.000024023599,0.122885846,0.8746307],"study_design_scores_gemma":[0.0010658599,0.00038848803,0.000005882104,0.00044906785,0.0010903551,0.00023267583,4.7440867e-7,0.00000434796,0.000022511907,0.000109956614,0.9960843,0.00054613256],"about_ca_topic_score_codex":0.00000519299,"about_ca_topic_score_gemma":5.6809263e-8,"teacher_disagreement_score":0.8740846,"about_ca_system_score_codex":0.00008256006,"about_ca_system_score_gemma":0.00015841221,"threshold_uncertainty_score":0.99973226},"labels":[],"label_agreement":null},{"id":"W4406642957","doi":"10.1016/b978-2-294-76306-9.50511-1","title":"10.1016/b978-2-294-76306-9.50511-1","year":2000,"lang":"en","type":"book-chapter","venue":"Time to knit","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Traditional medicine; Medicine","score_opus":0.007790985766821592,"score_gpt":0.1813480561954012,"score_spread":0.17355707042857962,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406642957","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000005790277,0.0066783954,0.0000017746438,0.00014901918,0.0000048327606,0.0006877668,0.00013301817,0.00026601227,0.9920734],"genre_scores_gemma":[0.000005207272,0.000039040686,0.000035621604,0.00023092041,0.0010547513,0.000023783543,0.00042093624,0.00019466215,0.9979951],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99800634,0.000025609015,0.00036813645,0.00059264177,0.00061715744,0.0003901083],"domain_scores_gemma":[0.9983692,0.00003739413,0.00008445392,0.00094238506,0.00010676595,0.00045978918],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00014612022,0.00054788333,0.0009953436,0.00023322165,0.00008940608,0.000033637214,0.00022271615,0.0004563356,0.99812245],"category_scores_gemma":[0.000016454249,0.0005157215,0.0010551137,0.000056050387,0.00010573742,0.00005125004,0.000062649364,0.0004190545,0.9943138],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075215794,0.000047063295,2.4608541e-8,0.000060308048,0.0011578135,0.00041855316,0.0000058442206,0.000005310535,0.000007236451,0.000023543162,0.26786545,0.7296567],"study_design_scores_gemma":[0.0010939509,0.00037919352,0.0000045206166,0.00044554553,0.0010909876,0.00024048038,4.6558134e-7,0.0000036576687,0.000027196635,0.0001238768,0.9960416,0.00054853596],"about_ca_topic_score_codex":0.0000051223133,"about_ca_topic_score_gemma":6.579352e-8,"teacher_disagreement_score":0.72910815,"about_ca_system_score_codex":0.000082916806,"about_ca_system_score_gemma":0.00016628446,"threshold_uncertainty_score":0.99972945},"labels":[],"label_agreement":null},{"id":"W4406648005","doi":"10.1016/b978-81-312-5651-0.00032-9","title":"10.1016/b978-81-312-5651-0.00032-9","year":2000,"lang":"en","type":"book-chapter","venue":"Time to knit","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Obstetrics; Medicine","score_opus":0.007771080117500504,"score_gpt":0.1806385187880284,"score_spread":0.1728674386705279,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406648005","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000005970213,0.009510587,0.0000019544027,0.00015284281,0.0000064210694,0.00072246173,0.0001329646,0.00026991565,0.9891969],"genre_scores_gemma":[0.0000061732558,0.00005594992,0.000036471472,0.00025351305,0.0009859527,0.00002554629,0.00041094582,0.00020503544,0.9980204],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978621,0.000028920063,0.00039505577,0.0006308052,0.00065502233,0.00042812384],"domain_scores_gemma":[0.9982506,0.000040145613,0.0000920407,0.0010053698,0.00011424778,0.0004975948],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00016449025,0.00057995867,0.0010376234,0.0002465348,0.00009756193,0.000037290858,0.00024126738,0.00048447563,0.99800795],"category_scores_gemma":[0.000018390532,0.0005458989,0.0011247272,0.00006149727,0.00011809629,0.000055327164,0.000066017856,0.00044057838,0.9930852],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007487812,0.000049636423,2.4701082e-8,0.00006320718,0.0011955685,0.00040890148,0.0000067939113,0.0000056982212,0.000006070904,0.00002921184,0.29618782,0.7012983],"study_design_scores_gemma":[0.0011327582,0.00039319828,0.000004963471,0.00045821146,0.0011659499,0.00023398512,5.512047e-7,0.0000040995515,0.000025302978,0.00012649353,0.9958734,0.0005810718],"about_ca_topic_score_codex":0.000006480178,"about_ca_topic_score_gemma":7.807253e-8,"teacher_disagreement_score":0.7007172,"about_ca_system_score_codex":0.00009088224,"about_ca_system_score_gemma":0.00018339761,"threshold_uncertainty_score":0.99969923},"labels":[],"label_agreement":null},{"id":"W4406663000","doi":"10.1016/b978-0-323-63600-1.00005-3","title":"10.1016/b978-0-323-63600-1.00005-3","year":2000,"lang":"en","type":"book-chapter","venue":"Time to knit","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Pharmacology; Medicine; Psychology","score_opus":0.007709350831464639,"score_gpt":0.18165393138045158,"score_spread":0.17394458054898693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406663000","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000005028264,0.007936044,0.0000015463481,0.00016545714,0.000005577732,0.00069941673,0.00012768176,0.00027788137,0.99078137],"genre_scores_gemma":[0.000004948165,0.000038538114,0.00003431759,0.00023644899,0.0009815192,0.000024548532,0.00040852703,0.00020160523,0.9980695],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979467,0.000026012933,0.00038010493,0.00060937594,0.0006338074,0.0004040251],"domain_scores_gemma":[0.9983245,0.000038147184,0.00008595139,0.0009688971,0.00010547502,0.0004770136],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00014850179,0.0005629748,0.001010095,0.00024041168,0.00009168771,0.000035003002,0.0002306467,0.00046928343,0.99837977],"category_scores_gemma":[0.000015824506,0.0005305714,0.0010848865,0.000056941604,0.00010884194,0.000053052874,0.000062902276,0.00042503097,0.9945779],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007734919,0.000047912246,2.0193484e-8,0.000059842907,0.0011575032,0.00039138662,0.0000061048795,0.0000063016582,0.0000058947176,0.00002397139,0.21754454,0.77998304],"study_design_scores_gemma":[0.0010813155,0.00037209282,0.0000042465235,0.00045030285,0.0011148498,0.00022844336,4.5694964e-7,0.000004034508,0.000025986696,0.00011752844,0.9960352,0.00056552095],"about_ca_topic_score_codex":0.000005425063,"about_ca_topic_score_gemma":6.933318e-8,"teacher_disagreement_score":0.7794175,"about_ca_system_score_codex":0.00008721999,"about_ca_system_score_gemma":0.00016780001,"threshold_uncertainty_score":0.9997146},"labels":[],"label_agreement":null},{"id":"W4406731176","doi":"10.1016/j.cjco.2025.01.013","title":"Dual Pathway Inhibition in Patients with Atherosclerosis with or without Heart Failure: Insights from the XATOA Registry","year":2025,"lang":"en","type":"article","venue":"CJC Open","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Alberta","funders":"Bayer","keywords":"Heart failure; Dual (grammatical number); Internal medicine; Medicine; Cardiology; Philosophy","score_opus":0.010404269496888607,"score_gpt":0.23379991125920574,"score_spread":0.22339564176231713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406731176","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968479,0.0002275333,0.000100727746,0.0007010814,0.000035941233,0.0012557079,0.000030144174,0.000031266023,0.00076969963],"genre_scores_gemma":[0.9969015,0.000020338903,0.0003128983,0.001883605,0.000051595867,0.00010282846,0.00014507583,0.00002425652,0.0005578811],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99892163,0.00010924214,0.00017215393,0.00033838488,0.00029243447,0.00016616685],"domain_scores_gemma":[0.9991776,0.0000467196,0.000058480953,0.00056900113,0.000079786376,0.00006844754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000986656,0.00017610533,0.0004369405,0.000037413884,0.00013045328,0.00010300381,0.00012620249,0.00008120104,0.00010380281],"category_scores_gemma":[0.000022651779,0.00008682295,0.000070617454,0.0003456353,0.00012295437,0.0001976016,0.00009023742,0.00018147727,0.000016070519],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0077267396,0.00054811273,0.9838975,0.000039192757,0.0006546323,0.00006084392,0.0006551605,0.000011472307,0.00047780204,0.00014400903,0.0033735551,0.0024109574],"study_design_scores_gemma":[0.01666051,0.00059796026,0.9465081,0.0017167571,0.00023188899,0.000009830044,0.0009624675,0.000008005271,0.0038234731,0.0000713243,0.029171756,0.00023789986],"about_ca_topic_score_codex":0.00032225132,"about_ca_topic_score_gemma":0.0005936011,"teacher_disagreement_score":0.03738939,"about_ca_system_score_codex":0.00004889134,"about_ca_system_score_gemma":0.00025143323,"threshold_uncertainty_score":0.3540537},"labels":[],"label_agreement":null},{"id":"W4406859063","doi":"10.1002/micr.70029","title":"Current Practices and Evidence of Aspirin Usage in Microvascular Surgery: A Systematic Review and Meta‐Analysis","year":2025,"lang":"en","type":"review","venue":"Microsurgery","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Aspirin; Surgery; Postoperative hematoma; Complication; Hematoma; Placebo; Cochrane Library; Meta-analysis; Randomized controlled trial; Anesthesia; Internal medicine","score_opus":0.11106773014013123,"score_gpt":0.39502870017300495,"score_spread":0.28396097003287374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406859063","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008873896,0.99714804,0.00002040373,0.00006583372,0.000044662487,0.0025683441,0.000041280036,0.000019311174,0.0000033593137],"genre_scores_gemma":[0.000059555572,0.9991233,0.000028161088,0.0001652599,0.000014903371,0.00040781117,0.00007040973,0.000029693963,0.000100929676],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99514866,0.00166953,0.0017772076,0.000754497,0.0003591563,0.00029096997],"domain_scores_gemma":[0.99359256,0.0034054844,0.0017428779,0.000998613,0.000127931,0.0001325397],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0049334806,0.0005765946,0.016232405,0.0010575346,0.000041668645,0.000046858342,0.0001390833,0.00019914506,0.00004899478],"category_scores_gemma":[0.001833875,0.0004016693,0.007224585,0.0018838301,0.00014382113,0.0001512561,0.00012636726,0.0003478556,0.000003926648],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009226411,0.00007599458,0.00018175492,0.83201915,0.15168618,0.00008629989,0.0000075808734,3.27888e-8,8.9018135e-7,7.391429e-7,0.00010193956,0.015830185],"study_design_scores_gemma":[0.00005035535,0.000006013143,0.000022082639,0.41113597,0.55998856,0.00012150799,0.0000035686903,1.2827975e-7,0.0000024967542,6.0663905e-7,0.02848299,0.00018571249],"about_ca_topic_score_codex":0.00005208766,"about_ca_topic_score_gemma":0.000011979366,"teacher_disagreement_score":0.4208832,"about_ca_system_score_codex":0.00004312036,"about_ca_system_score_gemma":0.0005786535,"threshold_uncertainty_score":0.99984354},"labels":[],"label_agreement":null},{"id":"W4407000887","doi":"10.1016/j.ahj.2025.01.016","title":"Characterizing high-risk enrollment criteria and impact on clinical outcomes in a large randomized clinical trial: Insights from the TWILIGHT trial","year":2025,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences","funders":"Icahn School of Medicine at Mount Sinai; AstraZeneca","keywords":"Medicine; Randomized controlled trial; Twilight; Clinical trial; MEDLINE; Intensive care medicine; Internal medicine","score_opus":0.03568504691928886,"score_gpt":0.4126011168114288,"score_spread":0.37691606989213994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407000887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99124026,0.0015394392,0.00011949827,0.0036731176,0.0017382691,0.0015862248,0.000027031534,0.000027725066,0.00004840484],"genre_scores_gemma":[0.983226,0.0068144538,0.00014218448,0.007974412,0.0017206453,0.000046698147,0.000013615839,0.000022767315,0.000039207483],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9911822,0.00587081,0.0017297871,0.0004175529,0.0004351549,0.00036449108],"domain_scores_gemma":[0.9925311,0.0061398884,0.00046853398,0.00048271348,0.00006556113,0.00031219373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0062019043,0.00030233362,0.0028503754,0.0001588575,0.0002305165,0.00012675577,0.00015162492,0.00012787805,0.00013906973],"category_scores_gemma":[0.0027964425,0.0001537357,0.0022575401,0.00023887464,0.000475975,0.00009596575,0.00006399608,0.0011690988,0.000014589624],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.77818865,0.0009499797,0.2012835,0.0000022154484,0.0026193592,0.00009805808,0.0001344596,3.8256368e-7,0.0000147395585,0.000018216671,0.0006668843,0.016023558],"study_design_scores_gemma":[0.5733884,0.0022607204,0.41981938,0.00011157997,0.000627891,0.000016675476,0.000170835,0.000030138111,0.000008028891,0.00016774898,0.0032913706,0.000107194566],"about_ca_topic_score_codex":0.0002741284,"about_ca_topic_score_gemma":0.000012229977,"teacher_disagreement_score":0.2185359,"about_ca_system_score_codex":0.000060686183,"about_ca_system_score_gemma":0.00034775963,"threshold_uncertainty_score":0.626916},"labels":[],"label_agreement":null},{"id":"W4407301911","doi":"10.1007/s00392-025-02603-w","title":"Dual pathway inhibition in patients with coronary artery disease (CAD) in clinical practice in Germany: results from the German CAD subgroup of the XATOA Registry","year":2025,"lang":"en","type":"article","venue":"Clinical Research in Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"Bayer","keywords":"CAD; Medicine; Coronary artery disease; Internal medicine; Cardiology; German; Subgroup analysis","score_opus":0.06373530533196045,"score_gpt":0.4212951516823432,"score_spread":0.35755984635038274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407301911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99172574,0.0015082868,0.0000063322473,0.004113095,0.00029003562,0.0013354863,0.00017863525,0.000010328238,0.000832051],"genre_scores_gemma":[0.9964583,0.0017818859,0.00001551875,0.0011606719,0.00026738812,0.00008906179,0.00015918084,0.00001837677,0.00004965214],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9874345,0.008628347,0.0017992676,0.0007952392,0.00078107207,0.00056155946],"domain_scores_gemma":[0.9850441,0.012894774,0.00022456529,0.0013771787,0.00026660305,0.00019276878],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.012341378,0.00019421044,0.0009939653,0.00021446771,0.0000619036,0.000013520373,0.0003016668,0.00045542666,0.000007377336],"category_scores_gemma":[0.016419487,0.000119927965,0.0004507006,0.00093622936,0.0015935774,0.00012568153,0.00035322027,0.0027439743,0.000009225853],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028475357,0.0011625075,0.95194006,0.000041493317,0.00022836193,0.0032110517,0.0001360444,0.000048446487,0.00000692406,0.00011958912,0.0005909664,0.014039205],"study_design_scores_gemma":[0.014475026,0.00046294858,0.97860175,0.00086398504,0.00006389635,0.000014561212,0.00030029603,0.000043037486,0.0000059470235,0.0009061335,0.0041519487,0.00011045307],"about_ca_topic_score_codex":0.0003061715,"about_ca_topic_score_gemma":0.00038051166,"teacher_disagreement_score":0.026661715,"about_ca_system_score_codex":0.00015519379,"about_ca_system_score_gemma":0.0011818411,"threshold_uncertainty_score":0.9995567},"labels":[],"label_agreement":null},{"id":"W4407375034","doi":"10.1002/ana.27207","title":"Efficacy and Safety of Dual Antiplatelet Treatment up to 72 Hours in Acute Ischemic Stroke Stratified by Glycemic Status","year":2025,"lang":"en","type":"article","venue":"Annals of Neurology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"National Key Research and Development Program of China; National Natural Science Foundation of China","keywords":"Medicine; Aspirin; Clopidogrel; Internal medicine; Interquartile range; Diabetes mellitus; Hazard ratio; Stroke (engine); Glycemic; Type 2 Diabetes Mellitus; Randomized controlled trial; Confidence interval; Surgery; Insulin; Endocrinology","score_opus":0.02018847455066396,"score_gpt":0.3097011687749951,"score_spread":0.2895126942243311,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407375034","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99378407,0.0032970507,0.000025807403,0.0016677709,0.000073192714,0.00042963473,0.00018762838,0.000015656731,0.0005192043],"genre_scores_gemma":[0.99095285,0.007360658,0.000014401024,0.0013950078,0.000013834129,0.000009780295,0.000057531528,0.000011650161,0.00018430011],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99882114,0.00008869626,0.00034358783,0.00029956084,0.0001221308,0.0003249014],"domain_scores_gemma":[0.9993629,0.00011546436,0.0000731383,0.00027981453,0.00005535756,0.00011332945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009575829,0.00016528385,0.0006210625,0.00017113815,0.000021517399,0.0000033079853,0.000057270732,0.00012248156,0.000020613776],"category_scores_gemma":[0.000036415506,0.00014610679,0.0001537469,0.00017991487,0.00012189961,0.000032667704,0.00003721381,0.00011832026,0.0000017486425],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18828702,0.001700335,0.08351467,0.00024295913,0.006172574,0.00093858916,0.0010138075,0.00020519659,0.5566355,0.00029165545,0.01607652,0.14492115],"study_design_scores_gemma":[0.040715735,0.015757682,0.45632523,0.00019945616,0.0009765467,0.00023582925,0.00021335087,0.000048941227,0.43974623,0.00007223398,0.04529022,0.00041856148],"about_ca_topic_score_codex":0.00006964843,"about_ca_topic_score_gemma":0.000009516819,"teacher_disagreement_score":0.37281054,"about_ca_system_score_codex":0.000005791018,"about_ca_system_score_gemma":0.00010013955,"threshold_uncertainty_score":0.5958062},"labels":[],"label_agreement":null},{"id":"W4407722315","doi":"10.1001/jamasurg.2024.7066","title":"Early vs Delayed Bypass Surgery in Patients With Acute Coronary Syndrome Receiving Ticagrelor","year":2025,"lang":"en","type":"letter","venue":"JAMA Surgery","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Montreal Heart Institute; University of Ottawa","funders":"","keywords":"Medicine; Perioperative; Ticagrelor; Acute coronary syndrome; Randomized controlled trial; Surgery; Coronary artery bypass surgery; Artery; Myocardial infarction; Anesthesia; Internal medicine","score_opus":0.008380789558570578,"score_gpt":0.20623228051441347,"score_spread":0.1978514909558429,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407722315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94394845,0.0012420582,0.000025562404,0.052434754,0.0010221057,0.00062068854,0.0002677832,0.00018470526,0.0002539123],"genre_scores_gemma":[0.64429253,0.0013408874,0.00007084338,0.340456,0.0011186639,0.00021961561,0.006821582,0.00029649335,0.005383349],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9955819,0.00042975025,0.0008890146,0.00092867826,0.0012202653,0.00095034303],"domain_scores_gemma":[0.99622285,0.001959327,0.0003143286,0.0010590864,0.00025599374,0.00018838527],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006518459,0.0007204466,0.0024432626,0.0010192271,0.00010437427,0.00009673256,0.00019868212,0.0012164044,0.0002830105],"category_scores_gemma":[0.00022792876,0.00061273243,0.0014021525,0.00081169314,0.0001482704,0.00030031565,0.00009202003,0.002004583,0.000090071706],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024370148,0.00014273578,0.46168768,0.0003882333,0.0037148406,0.030655967,0.00001574259,7.518698e-7,4.2452623e-7,2.7015076e-7,0.49299544,0.007960896],"study_design_scores_gemma":[0.0016199267,0.00013964366,0.8687386,0.002953003,0.0013115511,0.00045048277,0.0000049419423,0.000001712304,0.0000046639043,0.0000061502656,0.1241196,0.0006497417],"about_ca_topic_score_codex":0.00011908315,"about_ca_topic_score_gemma":0.000002897713,"teacher_disagreement_score":0.4070509,"about_ca_system_score_codex":0.00024245866,"about_ca_system_score_gemma":0.000936444,"threshold_uncertainty_score":0.9996324},"labels":[],"label_agreement":null},{"id":"W4407975341","doi":"10.1177/23969873251323180","title":"Dual versus single antiplatelet therapy in patients with non-cardioembolic acute ischemic stroke and baseline MRI","year":2025,"lang":"en","type":"article","venue":"European Stroke Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Interquartile range; Stroke (engine); Thrombolysis; Clinical endpoint; Internal medicine; Placebo; Cardiology; Post-hoc analysis; Clinical trial; Surgery; Myocardial infarction","score_opus":0.007708662510000296,"score_gpt":0.22543824470694268,"score_spread":0.21772958219694238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407975341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9794628,0.0020091052,0.00074613164,0.00015886367,0.00029158875,0.00027923984,0.00004550729,0.000034819725,0.016971918],"genre_scores_gemma":[0.995704,0.0019260296,0.00041530817,0.0003640844,0.00035723878,0.0000018070803,0.000035709745,0.0000500473,0.0011458074],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99823755,0.00025870305,0.00036928462,0.00031664173,0.0004362089,0.00038161123],"domain_scores_gemma":[0.999166,0.000047389516,0.00011566759,0.00030932968,0.00015023207,0.00021134815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005776383,0.00027984226,0.0005321368,0.00028108212,0.00014553055,0.000093217044,0.00011780307,0.00005643984,0.00007472581],"category_scores_gemma":[0.000030200516,0.0002110654,0.0002643684,0.00021997695,0.00010697899,0.00017747722,0.00005710863,0.00054245326,0.000021491564],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.042893514,0.0016120402,0.6143669,0.000075215976,0.010553975,0.004761374,0.000431417,0.0001370024,0.017103992,0.000008053904,0.020096608,0.28795993],"study_design_scores_gemma":[0.08157103,0.0032809174,0.8282902,0.0004867795,0.0008833472,0.0004792084,0.00027397246,0.000058173504,0.004680453,0.0000012472442,0.0795167,0.00047792925],"about_ca_topic_score_codex":0.000002065214,"about_ca_topic_score_gemma":8.470125e-7,"teacher_disagreement_score":0.28748202,"about_ca_system_score_codex":0.00005916786,"about_ca_system_score_gemma":0.00009821949,"threshold_uncertainty_score":0.8606998},"labels":[],"label_agreement":null},{"id":"W4408020029","doi":"10.1016/j.rpth.2025.102715","title":"Illustrated capsules from the Advanced Course in Platelet Research","year":2025,"lang":"en","type":"article","venue":"Research and Practice in Thrombosis and Haemostasis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Sociedad Española de Trombosis y Hemostasia; Instituto de Salud Carlos III; National Institute for Health and Care Research; Birmingham Biomedical Research Centre; International Society on Thrombosis and Haemostasis; Fundación Séneca","keywords":"Course (navigation); Engineering; Aerospace engineering","score_opus":0.1836073311528513,"score_gpt":0.4949458309263085,"score_spread":0.3113384997734572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408020029","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9182218,0.047336347,0.000004897464,0.028871201,0.000033444114,0.0007647048,0.000037707734,0.000013919444,0.00471601],"genre_scores_gemma":[0.8806269,0.11849281,0.00015675547,0.00044752806,0.000046856752,0.000070235445,0.000030000148,0.000012914945,0.00011596],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99632984,0.0016310923,0.00027383913,0.00046952922,0.0007180272,0.0005776875],"domain_scores_gemma":[0.99229944,0.006707596,0.00003165161,0.00042649792,0.00038227843,0.00015251739],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005866714,0.00014315812,0.0003861878,0.00026676097,0.00039640974,0.00016886744,0.00015039723,0.00015697563,0.000088986984],"category_scores_gemma":[0.0026575401,0.00010195528,0.000056649198,0.0013444991,0.0007700776,0.00031442582,0.00015795532,0.0012024964,0.000009796109],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01107168,0.002155376,0.063897386,0.00029712066,0.0017514935,0.000942237,0.0050029038,0.000019192303,0.0036776322,0.0056020273,0.014165287,0.8914177],"study_design_scores_gemma":[0.012047426,0.00089028955,0.6941133,0.0018333306,0.00021143019,0.00008415995,0.078862295,0.00020663373,0.003945897,0.008327265,0.19911659,0.00036140106],"about_ca_topic_score_codex":0.0035084288,"about_ca_topic_score_gemma":0.00083279336,"teacher_disagreement_score":0.89105624,"about_ca_system_score_codex":0.000069728085,"about_ca_system_score_gemma":0.00038571667,"threshold_uncertainty_score":0.53037184},"labels":[],"label_agreement":null},{"id":"W4408250719","doi":"10.1016/j.cjca.2025.02.035","title":"Potent P2Y12 Inhibitors vs Clopidogrel in Cancer Patients Undergoing Percutaneous Coronary Intervention","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Deutsche Herzstiftung","keywords":"Medicine; Clopidogrel; Percutaneous coronary intervention; P2Y12; Internal medicine; Cardiology; Myocardial infarction","score_opus":0.00798215806416922,"score_gpt":0.24675449674465735,"score_spread":0.23877233868048814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408250719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853791,0.010535726,0.00031792285,0.00057942595,0.0014677362,0.0001600584,0.000012154628,0.000004704007,0.0015431995],"genre_scores_gemma":[0.9980908,0.0009350422,0.000019345593,0.00046405368,0.0003347478,0.0000032598657,0.000012033818,0.000011497526,0.00012918825],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99892735,0.00016289327,0.00039683268,0.00013229426,0.00011608122,0.00026454093],"domain_scores_gemma":[0.9992902,0.00004073273,0.00009719118,0.000120264514,0.0001856871,0.0002659201],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022295967,0.00011650413,0.00049704924,0.0004476381,0.000055906803,0.000010126771,0.00009143813,0.00013313066,0.000036136662],"category_scores_gemma":[0.00010995724,0.00010653818,0.0005313529,0.0001705687,0.000095894655,0.00005652751,0.000010949485,0.00026929213,0.000003267793],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004943751,0.000016208816,0.9118892,0.00008374497,0.0009488336,0.0021728883,0.00009215855,0.0016575592,0.000037433543,0.000060009974,0.004724815,0.077822745],"study_design_scores_gemma":[0.004307618,0.00081466074,0.93776965,0.0010336363,0.0004414784,0.0018916529,0.0003882952,0.000013327933,0.000056042434,0.000240909,0.052890487,0.00015222981],"about_ca_topic_score_codex":0.00081739406,"about_ca_topic_score_gemma":0.0038344802,"teacher_disagreement_score":0.077670515,"about_ca_system_score_codex":0.0005104868,"about_ca_system_score_gemma":0.0012760569,"threshold_uncertainty_score":0.4344501},"labels":[],"label_agreement":null},{"id":"W4408773376","doi":"10.58931/cct.2025.115","title":"Use of Antiplatelet Agents in Canadian Patients: A Reflection of the 2023 Antiplatelet Guidelines","year":2025,"lang":"en","type":"article","venue":"Canadian Cardiology Today","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Medicine; Reflection (computer programming); Clopidogrel; Aspirin; Internal medicine; Intensive care medicine; Computer science","score_opus":0.04725302066431902,"score_gpt":0.30671100616232005,"score_spread":0.25945798549800103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408773376","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991777,0.0015741338,0.000009534379,0.001031678,0.00077876064,0.00057276076,0.00030177418,0.000009827197,0.003944506],"genre_scores_gemma":[0.99668425,0.00053118105,0.000034064567,0.0018779133,0.000061072846,0.000014500888,0.000104422266,0.000017384102,0.0006751909],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998248,0.00022584181,0.0005346181,0.00030426055,0.00016355982,0.00052372116],"domain_scores_gemma":[0.9985148,0.00005348419,0.00009185097,0.00060853607,0.00041039055,0.0003209714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037511287,0.00018816003,0.00069881754,0.00072776724,0.00009929222,0.0000075135354,0.00018781079,0.00030392248,0.00006225801],"category_scores_gemma":[0.0005988441,0.00015351307,0.00043529752,0.0008983842,0.00021226489,0.00007244008,0.00002810401,0.0002175981,0.000006318212],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000117645424,0.000017048083,0.96105826,0.000058252717,0.0005768928,0.00018281754,0.00003902812,0.00042019782,0.00020555187,0.00017239375,0.02958811,0.0075638182],"study_design_scores_gemma":[0.0012733199,0.00006584272,0.7747926,0.0002521933,0.00017166746,0.00004707943,0.000040562434,0.00004810611,0.00059503195,0.00003976432,0.22255109,0.00012273173],"about_ca_topic_score_codex":0.6928416,"about_ca_topic_score_gemma":0.7914166,"teacher_disagreement_score":0.19296299,"about_ca_system_score_codex":0.0003840807,"about_ca_system_score_gemma":0.0021815822,"threshold_uncertainty_score":0.62600815},"labels":[],"label_agreement":null},{"id":"W4408994978","doi":"10.1016/j.cjca.2025.03.026","title":"Editorial Commentary to Potent P2Y12 Inhibitors in Patients with Cancer Who Undergo Percutaneous Coronary Intervention","year":2025,"lang":"en","type":"editorial","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Percutaneous coronary intervention; P2Y12; Internal medicine; Cardiology; Percutaneous; Myocardial infarction","score_opus":0.00373928341159148,"score_gpt":0.22839862828636454,"score_spread":0.22465934487477304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408994978","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022513848,0.003657069,0.000084875144,0.0006417979,0.9717725,0.00053551624,0.0005630921,0.0000066515713,0.00022468812],"genre_scores_gemma":[0.08009823,0.0005418073,0.000015963886,0.00044210016,0.9182531,0.000014061113,0.00045612507,0.00004645325,0.00013216495],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975312,0.0003321022,0.00065961503,0.0003257445,0.0006738219,0.0004775441],"domain_scores_gemma":[0.9976979,0.00014612738,0.00025251647,0.0002974604,0.00085740775,0.00074861],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00039785012,0.0003544847,0.0014348384,0.00076085783,0.00008311932,0.000028092092,0.00026144867,0.0007724657,0.00004054837],"category_scores_gemma":[0.00024448754,0.0003047768,0.0007605876,0.00021970856,0.00013171983,0.00007577126,0.000032413216,0.0012471239,0.00000298358],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003212139,0.000018773986,0.028967269,0.00011781859,0.0022538134,0.001344353,0.00006407837,0.00086057617,7.5682476e-7,7.596822e-7,0.9526197,0.010539971],"study_design_scores_gemma":[0.0051581548,0.0018674408,0.011350106,0.002011287,0.0010155127,0.0001050721,0.00011197569,3.1209362e-7,0.0000015143673,0.000012310417,0.9781006,0.00026570607],"about_ca_topic_score_codex":0.004594283,"about_ca_topic_score_gemma":0.008541952,"teacher_disagreement_score":0.057584375,"about_ca_system_score_codex":0.001713044,"about_ca_system_score_gemma":0.0040025567,"threshold_uncertainty_score":0.99994045},"labels":[],"label_agreement":null},{"id":"W4409033045","doi":"10.1503/cmaj.241862","title":"Ticagrelor Compared to Clopidogrel in Acute Coronary Syndromes trial (TC4): a Bayesian pragmatic cluster randomized controlled trial","year":2025,"lang":"en","type":"article","venue":"Canadian Medical Association Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Clopidogrel; Ticagrelor; Randomized controlled trial; Medicine; Cluster (spacecraft); Acute coronary syndrome; Internal medicine; Cluster randomised controlled trial; Bayesian network; Cardiology; Myocardial infarction; Computer science; Artificial intelligence; Computer network","score_opus":0.00540213345883094,"score_gpt":0.2609198754456456,"score_spread":0.25551774198681465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409033045","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9073374,0.0013675252,0.0020567086,0.07098242,0.0039932556,0.0107326545,0.000024960214,0.000049686074,0.0034553441],"genre_scores_gemma":[0.9727878,0.00039741723,0.00020863612,0.022386506,0.0012521073,0.00051103544,0.00004077765,0.000026938422,0.0023888052],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99454767,0.0016689817,0.0014100352,0.0002582831,0.0015116191,0.0006033894],"domain_scores_gemma":[0.9962639,0.001330332,0.00029008527,0.00019774992,0.0002812657,0.001636661],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.006253165,0.00024460896,0.002409813,0.0006601262,0.00019338222,0.000103770435,0.00021911794,0.00045647402,0.0019368158],"category_scores_gemma":[0.007657746,0.00018680451,0.0012066612,0.0004912419,0.00007562608,0.00009006989,0.000021157193,0.0008714719,0.00007303006],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9637681,0.00019675048,0.00080604333,0.000018617306,0.004669439,0.0015983937,0.00016656915,0.000009818204,8.093309e-7,0.00013415002,0.022724442,0.005906817],"study_design_scores_gemma":[0.9814934,0.00027980705,0.0012099702,0.0003883345,0.0012965952,0.00033158003,0.00016720404,0.001131742,6.4075465e-7,0.00023742105,0.013293129,0.00017013946],"about_ca_topic_score_codex":0.00032672557,"about_ca_topic_score_gemma":0.0021431297,"teacher_disagreement_score":0.065450326,"about_ca_system_score_codex":0.0010572366,"about_ca_system_score_gemma":0.0054329685,"threshold_uncertainty_score":0.9989756},"labels":[],"label_agreement":null},{"id":"W4409136830","doi":"10.1177/25166085251327817","title":"Aspirin Resistance Among Patients with Recurrent Ischaemic Stroke, and Outcome of Patients at 120 Days with Alternative Antiplatelet: A Cohort Study in a Tertiary Care Hospital in Bangladesh","year":2025,"lang":"en","type":"article","venue":"Journal of Stroke Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Aspirin; Medicine; Ischaemic stroke; Cohort; Tertiary care; Stroke (engine); Cohort study; Internal medicine; Atrial fibrillation","score_opus":0.004443876315585168,"score_gpt":0.23870282861473716,"score_spread":0.234258952299152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409136830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99483526,0.0032371886,0.000028280203,0.00010099297,0.00016106825,0.0013760888,0.000048378573,0.000005552047,0.00020717821],"genre_scores_gemma":[0.9993952,0.00025600308,0.000052653475,0.000060738043,0.000052309755,0.000012405537,0.00002711789,0.000021967971,0.00012163932],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99737066,0.00013380493,0.0009239592,0.0003123929,0.001001768,0.000257395],"domain_scores_gemma":[0.9984829,0.00007175835,0.00055839133,0.0002604281,0.00047915574,0.00014735691],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039815236,0.00028264895,0.0011359791,0.00058761094,0.00003950968,0.0000064505844,0.00014431568,0.00006913227,0.000018928382],"category_scores_gemma":[0.00008774,0.00017623353,0.00011435439,0.0003150801,0.00026516127,0.00017449795,0.000058720412,0.0004509531,2.375977e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054399488,0.0010226443,0.98748654,0.00028595174,0.0009888511,0.0005834527,0.002320284,0.000017710303,0.000017422171,0.000001235932,0.000066835266,0.0017691195],"study_design_scores_gemma":[0.032439776,0.004335646,0.95610523,0.0034190768,0.0005909879,0.000007026644,0.0027911535,0.000005305878,0.000087289045,0.0000017970679,0.0000720727,0.00014460993],"about_ca_topic_score_codex":0.00007988111,"about_ca_topic_score_gemma":0.000333086,"teacher_disagreement_score":0.031381283,"about_ca_system_score_codex":0.00026170668,"about_ca_system_score_gemma":0.00008122058,"threshold_uncertainty_score":0.7186595},"labels":[],"label_agreement":null},{"id":"W4409284034","doi":"10.1016/j.cjca.2025.04.005","title":"Dual Antiplatelet Therapy in Cancer Patients Who Undergo Revascularization—Which Second Agent to Use?","year":2025,"lang":"en","type":"letter","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; Dual (grammatical number); Revascularization; Internal medicine; Intensive care medicine; Oncology; Myocardial infarction","score_opus":0.0203217286784209,"score_gpt":0.2522354161760651,"score_spread":0.23191368749764418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409284034","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6599361,0.019623589,0.0012205443,0.3028916,0.00781056,0.002795292,0.0014192581,0.000030256917,0.004272834],"genre_scores_gemma":[0.42640176,0.008389714,0.00006590613,0.5523013,0.00849855,0.00005180297,0.0007632763,0.00014578058,0.003381937],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971223,0.0005428945,0.0007908755,0.00042894215,0.00041934248,0.0006956797],"domain_scores_gemma":[0.9976104,0.00012200479,0.0002624306,0.00048921275,0.0009668757,0.00054909784],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00040886583,0.00041888098,0.0017968272,0.0012876268,0.00009691977,0.00006291213,0.0002733452,0.0009960115,0.00025577965],"category_scores_gemma":[0.00026709432,0.00037913388,0.0009576839,0.0006160413,0.000099396835,0.00011747994,0.000022665445,0.0016313102,0.000011157721],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021137447,0.0000068323566,0.107804745,0.00012974076,0.00370729,0.00421163,0.00010601277,0.0008902964,0.0000069563384,0.000007281292,0.8774789,0.005438931],"study_design_scores_gemma":[0.002925736,0.00036399227,0.14246653,0.00055344444,0.0003491046,0.00030746352,0.000014023218,0.000001327044,0.000023194652,0.000027798706,0.8526819,0.00028549082],"about_ca_topic_score_codex":0.0011828797,"about_ca_topic_score_gemma":0.0036402931,"teacher_disagreement_score":0.24940968,"about_ca_system_score_codex":0.0006427555,"about_ca_system_score_gemma":0.004757427,"threshold_uncertainty_score":0.99986607},"labels":[],"label_agreement":null},{"id":"W4409340539","doi":"10.1161/atvbaha.124.318260","title":"Regulation of Platelet Function by HDL","year":2025,"lang":"en","type":"review","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Reverse cholesterol transport; Cholesterol; Apolipoprotein B; Platelet activation; Platelet; Lipoprotein; ABCA1; High-density lipoprotein; Population; Medicine; Apolipoprotein E; Endocrinology; Internal medicine; Biology; Bioinformatics; Disease; Biochemistry; Transporter; Environmental health","score_opus":0.03484105330174347,"score_gpt":0.31473628900218903,"score_spread":0.27989523570044555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409340539","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0027734898,0.9952479,0.00063482753,0.000024793693,0.00020413709,0.00077459874,0.00013364022,0.000050824932,0.00015575901],"genre_scores_gemma":[0.0050449637,0.99337506,0.000058837177,0.00011408911,0.00008672232,0.00008885589,0.0011684283,0.00003600058,0.00002703011],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99812853,0.00028941478,0.0006181997,0.00056875596,0.0001431934,0.0002518944],"domain_scores_gemma":[0.99891174,0.000088711895,0.00026063962,0.00056571263,0.00007355204,0.000099656216],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00027572905,0.00041237075,0.0025022246,0.00020077225,0.00009643466,0.000016474922,0.00010049092,0.0006085793,0.00014221107],"category_scores_gemma":[0.000026184902,0.0003204591,0.0014620225,0.0002832425,0.0002020559,0.000050849405,0.000070905015,0.00018348309,0.000011620898],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010882669,0.00021217311,0.00051152636,0.014853761,0.006447085,6.3059e-8,0.000021402255,1.02363025e-7,0.0012710526,0.00031114332,0.0016787167,0.9746821],"study_design_scores_gemma":[0.0009686072,0.00039560223,0.026198974,0.008113334,0.0060196253,0.0000020420541,0.00001327992,0.0000022026336,0.000016098405,0.000035558456,0.9579345,0.00030015595],"about_ca_topic_score_codex":0.000019730514,"about_ca_topic_score_gemma":0.0000013696117,"teacher_disagreement_score":0.9743819,"about_ca_system_score_codex":0.000032113378,"about_ca_system_score_gemma":0.00010627063,"threshold_uncertainty_score":0.9999247},"labels":[],"label_agreement":null},{"id":"W4409605650","doi":"10.1177/17474930251338618","title":"Effect of history of hypertension on efficacy of clopidogrel-aspirin in ischemic stroke","year":2025,"lang":"en","type":"article","venue":"International Journal of Stroke","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"National Natural Science Foundation of China","keywords":"Medicine; Aspirin; Clopidogrel; Stroke (engine); Internal medicine; Randomized controlled trial; Clinical trial; Cardiology","score_opus":0.011271318781565356,"score_gpt":0.27115964266852594,"score_spread":0.2598883238869606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409605650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99204266,0.004059214,0.000093214185,0.00012474724,0.0006399257,0.000097907505,0.00001453928,0.0000026933192,0.0029251245],"genre_scores_gemma":[0.99881655,0.00054118596,0.00006446631,0.00007965197,0.000092412105,8.4556285e-7,0.0000043793734,0.0000069476123,0.00039353568],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986285,0.0000772982,0.00056685135,0.000086737644,0.00056671415,0.00007392454],"domain_scores_gemma":[0.9988778,0.00024390887,0.00036457917,0.00013246367,0.0003433781,0.000037866044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040648648,0.00009617828,0.0005141075,0.0004638634,0.000003593647,0.0000013240159,0.00017756096,0.00006400056,0.0000447015],"category_scores_gemma":[0.0001749358,0.000075042284,0.0005574548,0.00006180357,0.00008908735,0.000046914294,0.000025128176,0.00018983462,9.929905e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019883763,0.0010883001,0.1063673,0.0003533363,0.003484452,0.00031206224,0.00012557868,0.00044768894,0.72561944,0.00015501818,0.0017909784,0.14037208],"study_design_scores_gemma":[0.021664368,0.0029557792,0.1344255,0.0039870795,0.0006922653,0.00018408555,0.00007166109,0.00008583231,0.82105327,0.000013243772,0.014753161,0.00011377678],"about_ca_topic_score_codex":0.000018661964,"about_ca_topic_score_gemma":7.0241697e-7,"teacher_disagreement_score":0.14025831,"about_ca_system_score_codex":0.00017193203,"about_ca_system_score_gemma":0.00020530623,"threshold_uncertainty_score":0.30601355},"labels":[],"label_agreement":null},{"id":"W4410221641","doi":"10.1016/j.cjca.2025.04.028","title":"Dual Antiplatelet Therapy in Cancer Patients Undergoing Revascularization: Which Second Agent to Use? Reply","year":2025,"lang":"en","type":"letter","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Dual (grammatical number); Revascularization; Internal medicine; Cancer; Oncology; Cardiology; Intensive care medicine; Myocardial infarction","score_opus":0.02074132455989569,"score_gpt":0.2510136980412955,"score_spread":0.23027237348139978,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410221641","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5843265,0.019701947,0.0009672378,0.3796413,0.008362577,0.00246856,0.00075036817,0.000034621877,0.003746893],"genre_scores_gemma":[0.3688636,0.006535979,0.00008857684,0.6141313,0.007913266,0.00003746119,0.00052312796,0.00011463851,0.001792082],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971373,0.00052396255,0.0008279061,0.0004503526,0.00040066076,0.00065978203],"domain_scores_gemma":[0.9975983,0.00016366191,0.00028900628,0.00052568986,0.0009317554,0.00049160735],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004798021,0.00039409107,0.0016219019,0.0011753622,0.00010358157,0.0000666917,0.00024577722,0.0007670315,0.00019983527],"category_scores_gemma":[0.00041059483,0.00036279298,0.0008916241,0.00061296014,0.0000807056,0.00012662545,0.000022880333,0.0015449761,0.000008993668],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022967855,0.0000059392223,0.123192154,0.00017296497,0.003481607,0.005748024,0.00011578943,0.0009511957,0.000007865787,0.000004289247,0.8607925,0.0052979495],"study_design_scores_gemma":[0.0032597985,0.00047712078,0.09142275,0.00080237637,0.00035548597,0.00048632835,0.000018845198,0.0000010561755,0.000025100118,0.000021976946,0.9028391,0.0002900355],"about_ca_topic_score_codex":0.00092022447,"about_ca_topic_score_gemma":0.003862192,"teacher_disagreement_score":0.23448998,"about_ca_system_score_codex":0.00065599394,"about_ca_system_score_gemma":0.0057546496,"threshold_uncertainty_score":0.9998824},"labels":[],"label_agreement":null},{"id":"W4410235757","doi":"10.4244/eij-d-24-00973","title":"Ticagrelor monotherapy versus ticagrelor plus aspirin in patients with chronic coronary syndrome and high ischaemic risk: a post hoc analysis of the TWILIGHT trial","year":2025,"lang":"en","type":"article","venue":"EuroIntervention","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences","funders":"","keywords":"Medicine; Ticagrelor; Aspirin; Post-hoc analysis; Internal medicine; Cardiology; Acute coronary syndrome; Myocardial infarction; Clopidogrel","score_opus":0.006157446760067419,"score_gpt":0.23698638753341889,"score_spread":0.23082894077335148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410235757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965162,0.0019352162,0.0002690796,0.00013453198,0.0002186272,0.00082917407,0.00003914758,0.000019824189,0.000038152677],"genre_scores_gemma":[0.9994151,0.00017989079,0.00002203458,0.000039637067,0.000015017271,0.000008703376,0.00007937039,0.0000147352675,0.0002255201],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99874413,0.00021112993,0.00034830358,0.00028262637,0.00026093118,0.0001528627],"domain_scores_gemma":[0.9992931,0.000054081927,0.00015568019,0.0003832472,0.0000717438,0.000042172607],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021013833,0.00015163941,0.00047036714,0.00028448424,0.00005215209,0.000011759091,0.00009941805,0.00005816908,0.0001112557],"category_scores_gemma":[0.000035735506,0.00010218939,0.00056988775,0.00066441455,0.00011084629,0.00006984766,0.000046470115,0.00015309323,0.0000037261195],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3426624,0.0013363459,0.6016506,0.00035084842,0.016599817,0.00009308687,0.00020827458,0.0002945538,0.000105136256,0.00022592863,0.00006011167,0.036412906],"study_design_scores_gemma":[0.083577625,0.004011858,0.90810174,0.00041955,0.0032791004,0.0000044946696,0.000026316759,0.00029104797,0.000077774086,0.000013601387,0.000106230036,0.00009067211],"about_ca_topic_score_codex":0.000075164025,"about_ca_topic_score_gemma":0.00012525858,"teacher_disagreement_score":0.30645114,"about_ca_system_score_codex":0.00012529285,"about_ca_system_score_gemma":0.00008451556,"threshold_uncertainty_score":0.41671625},"labels":[],"label_agreement":null},{"id":"W4410957053","doi":"10.1016/j.jacc.2025.04.045","title":"Perspective on the Choice and Duration of Dual Antiplatelet Therapy Recommendations in the 2025 Acute Coronary Syndrome Management Guideline","year":2025,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Guideline; Acute coronary syndrome; Perspective (graphical); Intensive care medicine; Dual (grammatical number); Duration (music); Cardiology; Internal medicine; Myocardial infarction","score_opus":0.016600705156661674,"score_gpt":0.31310713630821346,"score_spread":0.2965064311515518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410957053","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9593007,0.0016648299,0.00021455163,0.036898956,0.00015831347,0.00046162456,0.000046139892,0.0000023733014,0.001252538],"genre_scores_gemma":[0.990352,0.0069501353,0.00013513336,0.0023521406,0.000055390632,0.000008187871,0.0000023889106,0.0000060247226,0.00013864381],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99837255,0.00067031634,0.0005015682,0.00011137145,0.00023506118,0.00010914263],"domain_scores_gemma":[0.9985688,0.00042005585,0.00045112715,0.0003274754,0.00021520843,0.000017374085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009812836,0.000110518136,0.00060565077,0.00016117987,0.000084346124,0.0000036594815,0.00022125052,0.00003176141,0.000009156523],"category_scores_gemma":[0.00009670678,0.000052913947,0.0003893754,0.0005024382,0.00038874304,0.000036551675,0.000048540638,0.00022479883,2.6841565e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03552504,0.002066775,0.30176762,0.0002553556,0.09528007,0.005993907,0.0025486932,0.004707386,0.012003267,0.06370017,0.39516878,0.08098295],"study_design_scores_gemma":[0.004546211,0.0020445844,0.94113475,0.0002634099,0.0011961585,0.004331307,0.012083593,0.00005065409,0.00044881846,0.0013889606,0.032398723,0.00011282786],"about_ca_topic_score_codex":0.00001404393,"about_ca_topic_score_gemma":0.000002498836,"teacher_disagreement_score":0.63936716,"about_ca_system_score_codex":0.000062553874,"about_ca_system_score_gemma":0.000103626844,"threshold_uncertainty_score":0.21577682},"labels":[],"label_agreement":null},{"id":"W4410957815","doi":"10.1016/j.jacc.2025.04.040","title":"The 2025 Guideline Update Endorses Ticagrelor Monotherapy After ≥1 Month of DAPT Post-PCI in Patients With ACS","year":2025,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; Ticagrelor; Conventional PCI; Guideline; Internal medicine; Cardiology; Percutaneous coronary intervention; Intensive care medicine; Myocardial infarction; Pathology","score_opus":0.00425280157410764,"score_gpt":0.24308480250088227,"score_spread":0.23883200092677462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410957815","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913015,0.003990191,0.0002997946,0.0034960147,0.00019449827,0.00033709116,0.000080728016,0.000003147789,0.0002970698],"genre_scores_gemma":[0.9966288,0.0017339062,0.0003045163,0.0010898947,0.00008965899,0.000006695426,0.0000022529232,0.00001414794,0.00013011743],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982285,0.0003681814,0.0007314216,0.00012641937,0.000344898,0.00020058491],"domain_scores_gemma":[0.9979773,0.00019315316,0.0006213407,0.00048467817,0.0006729842,0.000050504616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050165295,0.00015622829,0.0010689978,0.00016307848,0.000046703397,0.0000032229505,0.00031869946,0.00004615237,0.000010159076],"category_scores_gemma":[0.0001757842,0.00007571709,0.000599729,0.00047289167,0.00064338546,0.000043440665,0.000059989543,0.00021547632,5.269428e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05439525,0.00028687503,0.88622904,0.000053016578,0.0076939254,0.00024298161,0.00006684048,0.0015022119,0.0006528417,0.0001980099,0.011422962,0.037256032],"study_design_scores_gemma":[0.008753047,0.002388074,0.9299298,0.00022581474,0.0009864205,0.00016557358,0.00074116973,0.000016675016,0.0014043738,0.00018164857,0.055067737,0.00013967085],"about_ca_topic_score_codex":0.000015566779,"about_ca_topic_score_gemma":0.000007993694,"teacher_disagreement_score":0.045642205,"about_ca_system_score_codex":0.000050231232,"about_ca_system_score_gemma":0.00036449885,"threshold_uncertainty_score":0.30876535},"labels":[],"label_agreement":null},{"id":"W4411015828","doi":"10.1136/bmj.r1089","title":"Antiplatelet monotherapy after percutaneous coronary intervention","year":2025,"lang":"en","type":"editorial","venue":"BMJ","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; Canadian Institutes of Health Research; University of Oxford","keywords":"Percutaneous coronary intervention; Medicine; Percutaneous; Cardiology; Computer science; Internal medicine; Myocardial infarction","score_opus":0.006123893442885092,"score_gpt":0.28746718567699026,"score_spread":0.28134329223410515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411015828","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017500672,0.03469683,0.00035737004,0.00043615556,0.9395546,0.0017635883,0.00050629873,0.0003199274,0.0048645837],"genre_scores_gemma":[0.025244994,0.010125352,0.00025847458,0.0005699647,0.9258455,0.00023260035,0.0024987962,0.0001399346,0.035084397],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99758,0.00015290704,0.00052504934,0.0005906087,0.000818681,0.00033274235],"domain_scores_gemma":[0.9985344,0.00016151136,0.00014863182,0.00079551764,0.00022908843,0.00013087847],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00034280517,0.00043759012,0.000915501,0.00019572618,0.0000674195,0.000051211024,0.00018164548,0.0009833992,0.0015404567],"category_scores_gemma":[0.00016860983,0.00039648687,0.0014847086,0.00014314092,0.000086760614,0.00006362199,0.000063850806,0.00069821114,0.00017187219],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060826107,0.00021613995,0.00016361086,0.0006021143,0.0022535848,0.006271824,0.000040880663,0.0000021313288,0.000025317175,0.000002710524,0.90861213,0.07572692],"study_design_scores_gemma":[0.003083095,0.00038131245,0.0008628556,0.0012325391,0.000927892,0.0006409802,0.000034460652,0.000013547791,0.000043112475,0.00004471807,0.9923477,0.00038775202],"about_ca_topic_score_codex":0.000036407728,"about_ca_topic_score_gemma":0.000006830877,"teacher_disagreement_score":0.08373558,"about_ca_system_score_codex":0.00013294097,"about_ca_system_score_gemma":0.0003885698,"threshold_uncertainty_score":0.9998487},"labels":[],"label_agreement":null},{"id":"W4411053822","doi":"10.2196/75363","title":"Safety and Efficacy of Aspirin and Indobufen in the Treatment of Atherosclerotic Diseases: Systematic Review and Meta-Analysis","year":2025,"lang":"en","type":"review","venue":"Interactive Journal of Medical Research","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Preprint; Meta-analysis; Aspirin; Medicine; Intensive care medicine; Systematic review; MEDLINE; Internal medicine; Computer science; Political science; World Wide Web","score_opus":0.12814305001880355,"score_gpt":0.48305393791331647,"score_spread":0.3549108878945129,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411053822","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004089642,0.9967971,0.000028198134,0.0005586394,0.000010845104,0.0021132757,0.0000506304,9.787537e-7,0.000031390307],"genre_scores_gemma":[0.003793078,0.9959679,0.0000074672093,0.000068665824,0.00002681924,0.00006280401,0.00000762659,0.000010973467,0.000054621356],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9917598,0.0042326935,0.0016014043,0.00024251828,0.0019800651,0.00018355608],"domain_scores_gemma":[0.98920035,0.009019744,0.00071264664,0.0003930187,0.00039816496,0.00027608153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005847454,0.00025976592,0.008142294,0.0007768137,0.000035536228,0.000021431817,0.00030083393,0.00015533381,0.00015324594],"category_scores_gemma":[0.004569624,0.00011232312,0.0025862248,0.00089949364,0.00042380943,0.000055501965,0.0000841436,0.00070941664,4.9334204e-7],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003418191,0.0009276599,0.00003264954,0.6406502,0.23816577,0.00031560325,0.0003584525,1.2685514e-7,8.948237e-8,0.0000261968,0.000017768152,0.11916368],"study_design_scores_gemma":[0.0015910305,0.0011280735,0.00031611824,0.21383253,0.77495223,0.00033380202,0.00034061377,0.0000030569656,6.1847686e-7,0.000016144935,0.0074014324,0.000084322666],"about_ca_topic_score_codex":0.000030808653,"about_ca_topic_score_gemma":0.0000052482724,"teacher_disagreement_score":0.5367865,"about_ca_system_score_codex":0.000100074736,"about_ca_system_score_gemma":0.00061612454,"threshold_uncertainty_score":0.556591},"labels":[],"label_agreement":null},{"id":"W4411505763","doi":"10.1136/bmj.r1273","title":"Rethinking approaches to analysis of global randomised controlled trials","year":2025,"lang":"en","type":"editorial","venue":"BMJ","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Data science; Computer science; Medicine; Information retrieval","score_opus":0.07144499524407771,"score_gpt":0.3419372126816836,"score_spread":0.2704922174376059,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411505763","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0031546198,0.02824613,0.008393804,0.0017185529,0.91673726,0.015326886,0.0018876401,0.00020984262,0.024325257],"genre_scores_gemma":[0.021745322,0.0009758704,0.00096320343,0.0003062365,0.9691751,0.0009298715,0.002283062,0.00004446347,0.0035768817],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9948749,0.0013209623,0.0016920711,0.00050548476,0.0013637658,0.00024280959],"domain_scores_gemma":[0.9940125,0.0038637547,0.0007866823,0.0008443759,0.00032646686,0.00016625115],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.008997932,0.00036960575,0.008690171,0.00036743566,0.000051736744,0.000034236942,0.00022670891,0.0008143864,0.00013408205],"category_scores_gemma":[0.024631461,0.0002608105,0.008237518,0.0011605889,0.000053120923,0.000021764507,0.0000584406,0.00029310267,0.0000052700593],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.098125584,0.000110306726,0.000098144184,0.0002686671,0.12379605,0.000045624744,0.00007827233,0.0001918419,0.0000061643755,0.000089701374,0.7720831,0.0051065115],"study_design_scores_gemma":[0.28904063,0.00022960875,0.00034996239,0.0010854661,0.28008187,0.0000019928655,0.00009443436,0.00023063854,0.000070186776,0.00032809388,0.42797363,0.0005134871],"about_ca_topic_score_codex":0.000051174015,"about_ca_topic_score_gemma":0.00001511,"teacher_disagreement_score":0.3441095,"about_ca_system_score_codex":0.00012821777,"about_ca_system_score_gemma":0.0011368322,"threshold_uncertainty_score":0.9999844},"labels":[],"label_agreement":null},{"id":"W4411764223","doi":"10.56808/3027-7922.3004","title":"Pharmacogenetic-guided antiplatelet therapy for personalized medicine in patients with stroke and transient ischemic attack without cardioembolic stroke: A systematic review of economic evaluations","year":2025,"lang":"en","type":"review","venue":"The Thai Journal of Pharmaceutical Sciences","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Faculty of Pharmaceutical Sciences, Burapha University; Burapha University","keywords":"Medicine; Stroke (engine); Pharmacogenetics; Ischemic stroke; Transient (computer programming); Personalized medicine; Cardiology; Intensive care medicine; Internal medicine; Bioinformatics; Ischemia; Computer science; Genotype; Gene","score_opus":0.08059028402544524,"score_gpt":0.44357387197263215,"score_spread":0.3629835879471869,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411764223","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0128047755,0.9815463,0.000079109865,0.000368191,0.00013443052,0.0047541917,0.00010832624,0.000005758637,0.00019891768],"genre_scores_gemma":[0.005811963,0.9932674,0.00007404572,0.0005394736,0.000107941545,0.00009570401,0.000012506339,0.000020993955,0.000069928166],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9960405,0.000821276,0.0015143964,0.0003182791,0.0009842408,0.00032127925],"domain_scores_gemma":[0.9976048,0.0007063438,0.0009164463,0.0002530476,0.0003195485,0.00019980894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004486334,0.00040269824,0.0039240443,0.0003014539,0.00011411146,0.000020122076,0.00047745922,0.00008842777,0.000105462575],"category_scores_gemma":[0.00019985606,0.00018676146,0.000925662,0.00043946883,0.00079850404,0.00009782854,0.000029102092,0.00035938353,0.0000012077617],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012553022,0.00031790356,0.00041824003,0.87745935,0.0077886907,0.000012725484,0.0003877255,0.000035555793,0.000048133497,0.000021059139,0.0013727942,0.11088253],"study_design_scores_gemma":[0.017721133,0.0013599866,0.00008839421,0.8578344,0.039219294,0.0004546552,0.00019675633,0.00012979464,0.00007472009,0.0000036719564,0.082519576,0.00039764433],"about_ca_topic_score_codex":0.0000026045875,"about_ca_topic_score_gemma":4.4503125e-7,"teacher_disagreement_score":0.11048488,"about_ca_system_score_codex":0.00009642089,"about_ca_system_score_gemma":0.0011366634,"threshold_uncertainty_score":0.76159114},"labels":[],"label_agreement":null},{"id":"W4412008315","doi":"10.1080/09537104.2025.2524624","title":"Differential effects of dual antiplatelet and dual antithrombotic therapy on hemostasis in chronic coronary syndrome patients: the DEFINE CCS study","year":2025,"lang":"en","type":"article","venue":"Platelets","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; McMaster University Medical Centre; Population Health Research Institute; Queen Elizabeth II Health Sciences Centre; Hamilton Health Sciences; Dalhousie University","funders":"","keywords":"Antithrombotic; Medicine; Hemostasis; Acute coronary syndrome; Platelet; Cardiology; Clopidogrel; Dual (grammatical number); Internal medicine; Aspirin; Myocardial infarction","score_opus":0.008041126497795339,"score_gpt":0.247271358791624,"score_spread":0.23923023229382867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412008315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931546,0.0044579986,0.000010580004,0.000104999366,0.00028581423,0.0018591338,0.000018552499,0.000044843382,0.00006349445],"genre_scores_gemma":[0.99729604,0.0022514232,0.000004954373,0.00024851615,0.000033841567,0.00004585495,0.000051363582,0.00003144837,0.000036538127],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99807763,0.00022439577,0.0004199364,0.00045267597,0.00046068087,0.00036465545],"domain_scores_gemma":[0.9989405,0.00032792494,0.0000988121,0.0004913238,0.00006202328,0.00007939287],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001565686,0.0003333528,0.00082699535,0.0002262204,0.00012858098,0.00002487409,0.000113783906,0.00012703921,0.00005942152],"category_scores_gemma":[0.00006229706,0.00022648703,0.00021005863,0.00040352458,0.00019126115,0.00007822653,0.00008526665,0.00030923853,0.000009090523],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00791191,0.011647719,0.82493246,0.0014710067,0.007405695,0.007640961,0.0015837417,0.00017945307,0.006649923,0.00026772215,0.00043650728,0.12987289],"study_design_scores_gemma":[0.017982466,0.0036606246,0.9708611,0.00049979374,0.0003184921,0.00016344734,0.00010258985,0.00007551894,0.0059567983,0.000035459194,0.00013516926,0.00020857435],"about_ca_topic_score_codex":0.000048908925,"about_ca_topic_score_gemma":0.000015206473,"teacher_disagreement_score":0.14592859,"about_ca_system_score_codex":0.00008838612,"about_ca_system_score_gemma":0.00011510605,"threshold_uncertainty_score":0.92358726},"labels":[],"label_agreement":null},{"id":"W4412389082","doi":"10.1161/jaha.124.040492","title":"Relationship Between Neutrophil Count and 90‐Day Outcomes and Effect of Dual Antiplatelet Therapy in Patients With Acute Ischemic Stroke or Transient Ischemic Attack: A Post Hoc Analysis of the INSPIRES Trial","year":2025,"lang":"en","type":"article","venue":"Journal of the American Heart Association","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Post-hoc analysis; Stroke (engine); Ischemic stroke; Internal medicine; Clinical trial; Post hoc; Cardiology; Brain ischemia; Acute stroke; Ischemia; Tissue plasminogen activator","score_opus":0.008797480650110838,"score_gpt":0.27624179491629924,"score_spread":0.2674443142661884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412389082","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99825245,0.00029939675,0.000004778248,0.00086732494,0.000051043175,0.00044975747,0.00006459119,0.000002952523,0.000007678529],"genre_scores_gemma":[0.99954605,0.0001900132,0.000017400733,0.0001680904,0.000028122426,0.0000030756028,0.000005803462,0.000008024117,0.00003342534],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99829054,0.00048582593,0.00047588837,0.00011007931,0.0005196103,0.000118085896],"domain_scores_gemma":[0.99809235,0.000803257,0.00070976105,0.00017558131,0.00018205847,0.000037001133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008820079,0.00012836263,0.0010378622,0.0002212466,0.00006512454,0.000011714275,0.00007479201,0.00005660149,0.0000017757529],"category_scores_gemma":[0.000299098,0.000061669314,0.0005062561,0.00079325546,0.0001250053,0.00008425726,0.000019243811,0.00023293801,4.1583668e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023864847,0.00009561718,0.9681475,0.00001901475,0.005556073,0.0000013333115,0.0002186863,0.000035594232,0.0008994053,3.6019918e-7,0.00013562797,0.0010259072],"study_design_scores_gemma":[0.0219582,0.0020651158,0.97066087,0.00009336437,0.004088707,0.0000025628267,0.00006127023,0.000010059175,0.0008877541,5.360199e-7,0.000116064184,0.000055512864],"about_ca_topic_score_codex":0.000041051422,"about_ca_topic_score_gemma":0.000011599305,"teacher_disagreement_score":0.0025133186,"about_ca_system_score_codex":0.00010609149,"about_ca_system_score_gemma":0.00013742578,"threshold_uncertainty_score":0.25148016},"labels":[],"label_agreement":null},{"id":"W4412488811","doi":"10.1161/jaha.125.041449","title":"Dual Antiplatelet Therapy in Patients With Metabolic Syndrome After Mild Ischemic Stroke or Transient Ischemic Attack","year":2025,"lang":"en","type":"article","venue":"Journal of the American Heart Association","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Clopidogrel; Aspirin; Internal medicine; Stroke (engine); Hazard ratio; Metabolic syndrome; Confounding; Proportional hazards model; Acute coronary syndrome; Cardiology; Confidence interval; Myocardial infarction","score_opus":0.00747074660536014,"score_gpt":0.25064095140790416,"score_spread":0.243170204802544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412488811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99699557,0.0012861288,0.000015094921,0.0011332484,0.00014488392,0.0003155845,0.000016082395,0.000009416857,0.000083981264],"genre_scores_gemma":[0.9969517,0.0006496487,0.00012135059,0.0016913121,0.00006955349,0.000007901531,0.0000030127014,0.000017962777,0.00048756553],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99834645,0.0002057517,0.00041132688,0.00014305228,0.0006487791,0.0002446251],"domain_scores_gemma":[0.99906164,0.00008630097,0.00035486653,0.00021356557,0.0002153824,0.00006821572],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004768481,0.00016093401,0.000813138,0.00016838277,0.00005099404,0.000020543777,0.00009763393,0.00005868307,0.000032702013],"category_scores_gemma":[0.00007776871,0.00009186128,0.0005140292,0.0005995361,0.00006285617,0.00013934213,0.000015000988,0.0003490976,0.0000034308932],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055673337,0.00034161014,0.9825221,0.000013509093,0.0015465666,0.000026726126,0.00013101098,0.000036454756,0.0012668269,2.0058549e-7,0.0059446003,0.0026030699],"study_design_scores_gemma":[0.0056984606,0.00056533277,0.966136,0.00019516738,0.00034010233,0.000050983315,0.000098166034,0.0000062172785,0.0017900879,5.4271055e-7,0.025018051,0.00010093017],"about_ca_topic_score_codex":0.000016470914,"about_ca_topic_score_gemma":0.0000051659904,"teacher_disagreement_score":0.019073451,"about_ca_system_score_codex":0.00020997229,"about_ca_system_score_gemma":0.00022305324,"threshold_uncertainty_score":0.37459943},"labels":[],"label_agreement":null},{"id":"W4412659546","doi":"10.7759/cureus.88817","title":"Comparative Efficacy and Safety of P2Y12 Inhibitor Monotherapy Versus Dual Antiplatelet Therapy in Patients Following Percutaneous Coronary Intervention (PCI): A Systematic Review","year":2025,"lang":"en","type":"review","venue":"Cureus","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Conventional PCI; Percutaneous coronary intervention; P2Y12; Clopidogrel; Internal medicine; Ticagrelor; Cardiology; Aspirin; Myocardial infarction","score_opus":0.03236607912858219,"score_gpt":0.339538234138091,"score_spread":0.3071721550095088,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412659546","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011970544,0.9801735,0.000008487406,0.000006883224,0.00040248325,0.007240552,0.00008022241,0.000041463292,0.000075850556],"genre_scores_gemma":[0.008031208,0.9910675,0.00002455258,0.00006768121,0.0000505094,0.00016090523,0.0004838091,0.000050501647,0.00006330737],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9963183,0.00085180264,0.0015374315,0.0005523112,0.00046082152,0.00027935865],"domain_scores_gemma":[0.99807465,0.0004996867,0.0005695244,0.0006361747,0.0001108289,0.00010910773],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005376674,0.00061986,0.005968244,0.0002031948,0.000063371685,0.000018846886,0.00017837813,0.00030331133,0.000039487124],"category_scores_gemma":[0.00015730786,0.00046739206,0.001913873,0.00041559065,0.000084215964,0.00010013741,0.0000676511,0.00035816798,0.000007995709],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026739647,0.0009455835,0.00010606143,0.770176,0.00823263,0.00032784443,0.00025514304,4.2192525e-7,7.551205e-7,0.000007447377,0.00010398503,0.21717016],"study_design_scores_gemma":[0.012707426,0.0017354263,0.00018498041,0.95932114,0.008009711,0.00022264442,0.000089857866,0.0000014157699,0.0000017939695,0.0000020178106,0.017250808,0.0004727809],"about_ca_topic_score_codex":0.000012224316,"about_ca_topic_score_gemma":0.0000030366784,"teacher_disagreement_score":0.21669738,"about_ca_system_score_codex":0.0001992816,"about_ca_system_score_gemma":0.00019688548,"threshold_uncertainty_score":0.9997778},"labels":[],"label_agreement":null},{"id":"W4412695333","doi":"10.1002/phar.70047","title":"Effect of P2Y12 Inhibitors on Major Adverse Cardiovascular Events After Coronary Artery Bypass Graft Surgery: A Population‐Based Cohort Study","year":2025,"lang":"en","type":"article","venue":"Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre for Advancing Health Outcomes; Surrey Memorial Hospital; BC Innovation Council; University of British Columbia","funders":"Faculty of Pharmaceutical Sciences, University of British Columbia","keywords":"Mace; Medicine; Percutaneous coronary intervention; Hazard ratio; Myocardial infarction; Clopidogrel; Internal medicine; Population; Cardiology; Cohort; Coronary artery bypass surgery; Surgery; Confidence interval; Artery","score_opus":0.007666452314632981,"score_gpt":0.2998272709743558,"score_spread":0.2921608186597228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412695333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96952945,0.027040474,0.000031950363,0.00034836773,0.0008956775,0.0020816075,0.000010930116,0.000032203367,0.000029323097],"genre_scores_gemma":[0.9916676,0.005027532,0.0000043844466,0.0026556575,0.000376776,0.000107862914,0.000009293715,0.000050677892,0.000100167344],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9947498,0.003037293,0.0008711694,0.00031311653,0.0006950246,0.0003336302],"domain_scores_gemma":[0.99800044,0.00082610943,0.000426057,0.00039291283,0.0001868074,0.00016765275],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004479851,0.00044449698,0.001415077,0.0005522851,0.0002896313,0.0000099194485,0.00024646884,0.0001016168,0.00048765505],"category_scores_gemma":[0.000013042458,0.00028378027,0.0015016886,0.00034939882,0.00019682663,0.00015193879,0.000025853713,0.0005454238,0.000002622236],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.047101177,0.0019173227,0.8906098,0.00015265883,0.024859523,0.00040122092,0.0004277726,0.00028400373,0.0149805695,0.0000017005055,0.0030383407,0.016225934],"study_design_scores_gemma":[0.049606767,0.003919833,0.853011,0.0003243528,0.01012472,0.00026041665,0.00018789538,0.000041433523,0.07799578,0.000070825794,0.0040162825,0.00044068508],"about_ca_topic_score_codex":0.000029544548,"about_ca_topic_score_gemma":0.0000014693852,"teacher_disagreement_score":0.06301521,"about_ca_system_score_codex":0.000085014144,"about_ca_system_score_gemma":0.00013409022,"threshold_uncertainty_score":0.99996144},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"agree"},{"id":"W4412791011","doi":"10.1016/j.carrev.2025.07.014","title":"Editorial: Predicting the peril: A novel high-risk PCI score","year":2025,"lang":"en","type":"editorial","venue":"Cardiovascular revascularization medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Impella; Percutaneous coronary intervention; Internal medicine; Cardiology; Framingham Risk Score; Percutaneous; Ventricular assist device; Myocardial infarction; Heart failure","score_opus":0.008592216002456216,"score_gpt":0.2419159143952653,"score_spread":0.2333236983928091,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412791011","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002341241,0.10378706,0.03640946,0.00042599242,0.8538117,0.0033241303,0.00036395557,0.00058653974,0.0010570852],"genre_scores_gemma":[0.00086578785,0.05482328,0.00025602145,0.00027166455,0.93568516,0.00047490746,0.005447844,0.00033330903,0.0018420006],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98594385,0.0012307843,0.0017106328,0.0022103474,0.0078376075,0.001066764],"domain_scores_gemma":[0.98908967,0.0011689801,0.00075403583,0.005360524,0.0030702816,0.00055649405],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0068318713,0.001535266,0.0043191225,0.00066412793,0.0011094124,0.00017711983,0.0011236961,0.0027495828,0.00023544961],"category_scores_gemma":[0.014572642,0.0010496652,0.00685198,0.002020361,0.0009584138,0.00023619531,0.00039158773,0.003850508,0.00005533762],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036030577,0.0001470952,0.00022160445,0.0018554541,0.033227928,0.00011664767,0.00024201354,0.0010198483,0.000039054594,0.00012384946,0.94724,0.015406224],"study_design_scores_gemma":[0.012836055,0.00032564325,0.00027207925,0.0038706,0.040281944,0.00012787973,0.00022889308,0.00018917584,0.000032559125,0.000095178606,0.9408913,0.0008486401],"about_ca_topic_score_codex":0.0010049265,"about_ca_topic_score_gemma":0.000011224502,"teacher_disagreement_score":0.08187353,"about_ca_system_score_codex":0.0005167939,"about_ca_system_score_gemma":0.002132647,"threshold_uncertainty_score":0.9997396},"labels":[],"label_agreement":null},{"id":"W4412956407","doi":"10.1038/s12276-025-01517-x","title":"Endothelial PRMT7 prevents dysfunction, promotes revascularization and enhances cardiac recovery post-myocardial infarction","year":2025,"lang":"en","type":"article","venue":"Experimental & Molecular Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Aging","funders":"National Research Foundation of Korea; Korea Health Industry Development Institute; National Research Foundation","keywords":"Downregulation and upregulation; Endothelial dysfunction; Unfolded protein response; Angiogenesis; Cardiac fibrosis; Apoptosis; Endoplasmic reticulum; Medicine; Fibrosis; Cell biology; Cancer research; Biology; Internal medicine","score_opus":0.0044454623925798305,"score_gpt":0.25701962783730375,"score_spread":0.25257416544472394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412956407","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9462908,0.043215267,0.0044523627,0.0008121546,0.0011351588,0.0012874419,0.000012626477,0.00012226672,0.0026719586],"genre_scores_gemma":[0.9952584,0.001593605,0.00023645558,0.0013769885,0.00043685242,0.00014878529,0.00023080275,0.000035254343,0.0006828899],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99816734,0.00020245588,0.00035173682,0.0005057563,0.0005200754,0.00025263318],"domain_scores_gemma":[0.9992296,0.000028047243,0.00008272164,0.0003797453,0.00012873179,0.00015114709],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030093023,0.00028461005,0.0005618521,0.00021247385,0.00016126488,0.000024248597,0.00006960118,0.00014161176,0.00013584764],"category_scores_gemma":[0.0001410245,0.00024437398,0.0003527063,0.00029390832,0.00021992034,0.00015923593,0.000058616064,0.00015978902,0.000009961255],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073868054,0.00018395348,0.001348071,0.00011396402,0.0016407836,0.000041373194,0.00031335268,0.000003598163,0.9748447,0.00033064204,0.00038980125,0.020051068],"study_design_scores_gemma":[0.007940044,0.0023967468,0.024360018,0.00091539987,0.0014230885,0.000118077136,0.0012970634,0.00002919121,0.94156456,0.00030814743,0.019251864,0.0003957853],"about_ca_topic_score_codex":0.00007262757,"about_ca_topic_score_gemma":4.761087e-7,"teacher_disagreement_score":0.048967604,"about_ca_system_score_codex":0.000105099265,"about_ca_system_score_gemma":0.000112567854,"threshold_uncertainty_score":0.9965282},"labels":[],"label_agreement":null},{"id":"W4413436594","doi":"10.1177/17562864251360913","title":"Platelet inhibition strategies in rescue stenting after failed thrombectomy: a large retrospective multicenter registry","year":2025,"lang":"en","type":"article","venue":"Therapeutic Advances in Neurological Disorders","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"Freiwillige Akademische Gesellschaft","keywords":"Medicine; Retrospective cohort study; Intensive care medicine; Internal medicine","score_opus":0.006398649536665043,"score_gpt":0.27690314426865786,"score_spread":0.27050449473199284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413436594","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9797536,0.014111948,0.0021099155,0.00063243625,0.00013520686,0.0007583567,0.000009602033,0.0001060503,0.002382843],"genre_scores_gemma":[0.9920252,0.0054446715,0.000077189485,0.002185493,0.000028050817,0.0001549346,0.000018139523,0.000020114701,0.000046214333],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980072,0.00025943844,0.00039171093,0.0005917033,0.0002434176,0.00050655566],"domain_scores_gemma":[0.9994116,0.000102757826,0.000063423395,0.00033815118,0.000034175566,0.000049920756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002548336,0.00027299413,0.00053682807,0.00018413781,0.000066128094,0.000035360477,0.000111360074,0.00018509422,0.00013293],"category_scores_gemma":[0.00007407714,0.00021994105,0.0002435698,0.0005258228,0.00023069012,0.00034627935,0.00006479612,0.0005758331,0.0000071703485],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008059051,0.0012145631,0.95202005,0.0002273866,0.00017668078,0.0005946088,0.00039630098,0.00074443064,0.00031318865,0.0031745057,0.000006274387,0.033072937],"study_design_scores_gemma":[0.008316879,0.00033868165,0.9674031,0.00024216462,0.00006608322,0.000005965617,0.0012082522,0.0009931517,0.00009497023,0.016917033,0.0041617053,0.00025201056],"about_ca_topic_score_codex":0.000012344605,"about_ca_topic_score_gemma":0.00035444746,"teacher_disagreement_score":0.032820925,"about_ca_system_score_codex":0.000048706264,"about_ca_system_score_gemma":0.000052415326,"threshold_uncertainty_score":0.8968936},"labels":[],"label_agreement":null},{"id":"W4413842055","doi":"10.1093/ejcts/ezaf243","title":"Antithrombotic therapy after coronary artery bypass graft surgery: a Clinical Consensus Statement of the ESC Working Group on Cardiovascular Surgery, the ESC Working Group on Cardiovascular Pharmacotherapy, and the European Association for Cardio-Thoracic Surgery (EACTS)","year":2025,"lang":"en","type":"review","venue":"European Journal of Cardio-Thoracic Surgery","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Medicine; Antithrombotic; Aspirin; Pharmacotherapy; Artery; Clopidogrel; Platelet aggregation inhibitor; Cardiology; Coronary artery bypass surgery; Bypass grafting; Surgery; Internal medicine; Intensive care medicine","score_opus":0.08309087085260664,"score_gpt":0.33577252018005105,"score_spread":0.2526816493274444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413842055","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.024240721,0.962116,0.0006035328,0.0005061749,0.0077381446,0.003976136,0.00015932329,0.00012303371,0.0005369148],"genre_scores_gemma":[0.25633234,0.73801017,0.000031254298,0.0008537048,0.0039384603,0.00013903879,0.00010775823,0.00049766805,0.000089609995],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.91440207,0.07210821,0.0061040395,0.0016524257,0.004071934,0.001661307],"domain_scores_gemma":[0.95411354,0.035844415,0.0050309133,0.0035063557,0.00089845544,0.000606292],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.14654383,0.0021113986,0.014023824,0.001356229,0.0009848818,0.00046440784,0.0010649945,0.00048844016,0.00002080466],"category_scores_gemma":[0.0034526568,0.0012193088,0.052090306,0.0019245422,0.001157432,0.00022011864,0.0003229871,0.0030518775,0.000021111708],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056270533,0.0003760791,0.008117896,0.0037936063,0.096709065,0.0048696734,0.00013337446,0.00017951612,0.0000016113645,0.0000046941873,0.008564332,0.8716231],"study_design_scores_gemma":[0.0023246177,0.00018312833,0.012741188,0.039326,0.03410215,0.0027946017,0.00018752555,0.0000058247597,0.000018016244,0.00001477061,0.90695065,0.0013515061],"about_ca_topic_score_codex":0.000016542403,"about_ca_topic_score_gemma":0.0000020362068,"teacher_disagreement_score":0.89838636,"about_ca_system_score_codex":0.0006969849,"about_ca_system_score_gemma":0.0015702264,"threshold_uncertainty_score":0.99924815},"labels":[],"label_agreement":null},{"id":"W4413842056","doi":"10.1093/eurheartj/ehaf423","title":"Antithrombotic therapy after coronary artery bypass graft surgery: a Clinical Consensus Statement of the ESC Working Group on Cardiovascular Surgery, the ESC Working Group on Cardiovascular Pharmacotherapy, and the European Association for Cardio-Thoracic Surgery (EACTS)","year":2025,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Medicine; Antithrombotic; Pharmacotherapy; Artery; Coronary artery bypass surgery; Surgery; Cardiology; Internal medicine","score_opus":0.06621011395851696,"score_gpt":0.3161269875180597,"score_spread":0.24991687355954273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413842056","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90958625,0.079795666,0.0007307303,0.0034435233,0.0034553586,0.0021070405,0.00002548599,0.000094994495,0.0007609265],"genre_scores_gemma":[0.96317554,0.030250538,0.000038380706,0.004180462,0.0020061147,0.000047872993,0.000018973922,0.00017633391,0.00010576434],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9755279,0.019403523,0.0016730797,0.0007907169,0.0017180427,0.0008867789],"domain_scores_gemma":[0.990699,0.0065937624,0.0007060111,0.0014720906,0.00026898418,0.00026016397],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.04787831,0.0006431629,0.0023309623,0.00031469858,0.0010793656,0.00030954622,0.00036352256,0.00012874728,0.000020844644],"category_scores_gemma":[0.0007160649,0.00036504777,0.009553286,0.00062884786,0.00058477494,0.00010242333,0.00012787846,0.0013188418,0.0000142243225],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012247175,0.000760625,0.5064757,0.00023714405,0.066312745,0.001960632,0.0005053098,0.00079132186,0.00017365211,0.000045195142,0.02666557,0.3838249],"study_design_scores_gemma":[0.005960869,0.00018745536,0.6532487,0.002341683,0.00415054,0.0010276493,0.0002813031,0.00006445828,0.00016074114,0.000053907337,0.33199137,0.00053128233],"about_ca_topic_score_codex":0.00001955875,"about_ca_topic_score_gemma":0.0000035895557,"teacher_disagreement_score":0.38329363,"about_ca_system_score_codex":0.00021634552,"about_ca_system_score_gemma":0.00027215455,"threshold_uncertainty_score":0.99988014},"labels":[],"label_agreement":null},{"id":"W4413849634","doi":"10.1093/eurheartj/ehaf680","title":"Aspirin dosing after acute coronary syndrome with suspected aspirin resistance: the ANDAMAN trial","year":2025,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Saint-François d'Assise","funders":"Assistance Publique - Hôpitaux de Paris","keywords":"Medicine; Acute coronary syndrome; Aspirin; Internal medicine; Interquartile range; Mace; Myocardial infarction; Hazard ratio; Population; Cardiology; Surgery; Percutaneous coronary intervention; Confidence interval","score_opus":0.01449726118388638,"score_gpt":0.2712797373716283,"score_spread":0.2567824761877419,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413849634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9849599,0.005287142,0.00035530477,0.0019930052,0.0003610502,0.00044780129,0.0000058549826,0.00007120673,0.006518764],"genre_scores_gemma":[0.99204373,0.00028111716,0.00023049185,0.0019373434,0.00044635942,0.000006459114,0.000008015218,0.000044847595,0.005001657],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99806273,0.00060725614,0.0003090059,0.00024778885,0.00044512254,0.00032808978],"domain_scores_gemma":[0.99916327,0.000050681097,0.00007868732,0.00042716466,0.000105821244,0.00017435882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008532554,0.000204695,0.00036902502,0.00011808194,0.00040737627,0.00015092285,0.00015369148,0.00003622877,0.0002636211],"category_scores_gemma":[0.0000234736,0.00012171825,0.00038520084,0.0003025376,0.0001646042,0.000118174554,0.000051792293,0.00060859136,0.000061396335],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5372539,0.0012887822,0.1805487,0.00036934158,0.015132287,0.17715287,0.0010591245,0.00006993084,0.0023496607,0.00033516836,0.064419895,0.02002031],"study_design_scores_gemma":[0.03703233,0.0010681171,0.80845237,0.0010820803,0.00084311067,0.014494585,0.00013132655,0.000003201586,0.00012776197,0.000040494353,0.13651381,0.0002107948],"about_ca_topic_score_codex":8.6650056e-7,"about_ca_topic_score_gemma":0.0000031437394,"teacher_disagreement_score":0.6279037,"about_ca_system_score_codex":0.000063453335,"about_ca_system_score_gemma":0.00020147003,"threshold_uncertainty_score":0.49635264},"labels":[],"label_agreement":null},{"id":"W4414714349","doi":"10.1016/j.cjca.2025.08.292","title":"P302 FEMALE REPRESENTATION IN THE ANTIPLATELET MEDICATION LITERATURE INFORMING THE 2023 CANADIAN ANTIPLATELET GUIDELINES","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacodynamics; Pharmacotherapy; Disease; Drug; Representation (politics); Platelet aggregation inhibitor; Clinical Practice; Antiplatelet drug","score_opus":0.025981194616000198,"score_gpt":0.30962964864177267,"score_spread":0.2836484540257725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414714349","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87453246,0.049738258,0.00065570127,0.04565332,0.0019171587,0.0004670739,0.000068454436,0.000010892778,0.026956664],"genre_scores_gemma":[0.9910389,0.003034436,0.00004733126,0.0045783003,0.0009217063,0.000008867041,0.000058222915,0.000010174326,0.00030202576],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99831593,0.0003121283,0.0005909595,0.00015736607,0.00022908064,0.00039451107],"domain_scores_gemma":[0.9984992,0.00015333961,0.00014329646,0.00042393128,0.00047345064,0.00030677693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016227654,0.00015515322,0.00048037688,0.000693673,0.00024556828,0.00007149038,0.00037195132,0.00021802196,0.000025470916],"category_scores_gemma":[0.00079569255,0.00009318769,0.0003795362,0.0008361548,0.0001942885,0.00015148861,0.0000089901905,0.0005428218,0.000007921673],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047860306,0.000009459453,0.35475639,0.00016661356,0.0023336392,0.009433886,0.004103018,0.004844226,0.00022851082,0.0024164948,0.26650444,0.35472474],"study_design_scores_gemma":[0.0016854536,0.00008936762,0.16975732,0.0004972389,0.00029395422,0.004603489,0.002869629,0.000060668342,0.000068762856,0.00030707946,0.8196288,0.00013825257],"about_ca_topic_score_codex":0.021291146,"about_ca_topic_score_gemma":0.07031619,"teacher_disagreement_score":0.5531243,"about_ca_system_score_codex":0.00016368616,"about_ca_system_score_gemma":0.0027571877,"threshold_uncertainty_score":0.98522615},"labels":[],"label_agreement":null},{"id":"W4415072818","doi":"10.7759/cureus.94333","title":"Low-Molecular-Weight Heparin in Orthopedic Patients Taking Clopidogrel: A Focused Review","year":2025,"lang":"en","type":"review","venue":"Cureus","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Clopidogrel; Orthopedic surgery; Randomized controlled trial; Low molecular weight heparin; Venous thromboembolism; Heparin; Venous thrombosis; Narrative review; Ticlopidine","score_opus":0.02054232827832085,"score_gpt":0.33006408556486394,"score_spread":0.3095217572865431,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415072818","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000041257506,0.99347156,0.000061948136,0.0000321884,0.0004077491,0.0029486192,0.000041269766,0.0000996472,0.0028957326],"genre_scores_gemma":[0.000030592615,0.99702454,0.00005913707,0.0010392566,0.00018548507,0.00040059566,0.0007719876,0.000096501535,0.00039193247],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967467,0.000430078,0.0010219053,0.0007499278,0.0005685407,0.00048280504],"domain_scores_gemma":[0.9980342,0.00009516345,0.00042965205,0.0011060971,0.00012581005,0.00020907297],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00039308338,0.0006560732,0.0036802595,0.00024043884,0.000051447943,0.000021578917,0.00033593693,0.00043023913,0.00024973],"category_scores_gemma":[0.00045801298,0.00051879266,0.0023827418,0.00095381634,0.00005926587,0.00006720221,0.00015222876,0.0006116723,0.000108072105],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017680955,0.00027386998,0.00050790404,0.14466988,0.0008427132,0.00049518864,0.000006106631,5.0342116e-8,1.9383718e-8,0.00003122,0.0014593072,0.8516961],"study_design_scores_gemma":[0.0010049691,0.000060152128,0.0001229725,0.26515117,0.004115519,0.000027188758,6.6711743e-7,1.7779408e-7,4.411578e-7,0.0000061536025,0.72917515,0.0003354463],"about_ca_topic_score_codex":0.000013822865,"about_ca_topic_score_gemma":0.000010186846,"teacher_disagreement_score":0.8513606,"about_ca_system_score_codex":0.00023880758,"about_ca_system_score_gemma":0.00081454875,"threshold_uncertainty_score":0.99972636},"labels":[],"label_agreement":null},{"id":"W4415148836","doi":"10.1007/978-3-031-96344-5_19","title":"Platelet Function Tests","year":2025,"lang":"en","type":"book-chapter","venue":"","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Platelet; Function (biology); Blood Platelet Disorders; Hematology; Platelet aggregation; Clinical Practice","score_opus":0.01183477266176615,"score_gpt":0.23330436539646196,"score_spread":0.2214695927346958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415148836","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009202631,0.007933046,0.00063802046,0.00014361949,0.00030134676,0.0003513332,0.000017906443,0.0002149519,0.99030775],"genre_scores_gemma":[0.0035595377,0.0019300585,0.0000706437,0.0016858529,0.0003952589,0.000007020735,0.0002650637,0.000039418606,0.99204713],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99907416,0.000005840166,0.00019043482,0.00031206332,0.00027905853,0.00013846849],"domain_scores_gemma":[0.9992953,0.00002741846,0.000045745972,0.00044270474,0.000088036206,0.00010079983],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00006629395,0.00025680623,0.0004909339,0.00013900478,0.000047575813,0.000012574621,0.000051096275,0.0003566723,0.005724653],"category_scores_gemma":[0.0000108357235,0.00021120669,0.00069017697,0.000023234219,0.000047258487,0.000026969052,0.000027482838,0.00025969578,0.0006142784],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009890732,0.00006253008,0.00008684234,0.00046900279,0.005310173,0.0006598468,0.00000781683,0.0000017374659,0.000050012466,0.18525495,0.20892772,0.5981803],"study_design_scores_gemma":[0.0010671832,0.0001487311,0.00030436605,0.0003786421,0.0009776443,0.000088535584,0.0000034781556,0.0000036631695,0.00007253225,0.0038706923,0.99287856,0.00020597354],"about_ca_topic_score_codex":0.0000032319401,"about_ca_topic_score_gemma":0.0000021950527,"teacher_disagreement_score":0.78395087,"about_ca_system_score_codex":0.00004087806,"about_ca_system_score_gemma":0.00015686343,"threshold_uncertainty_score":0.99518424},"labels":[],"label_agreement":null},{"id":"W4415172542","doi":"10.1503/cmaj.250486","title":"Allergy to acetylsalicylic acid among patients with acute coronary syndrome","year":2025,"lang":"en","type":"article","venue":"Canadian Medical Association Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre; Western University","funders":"","keywords":"Acute coronary syndrome; Adverse effect; Allergy; Aspirin; Coronary disease; Medical history","score_opus":0.0027641226690743453,"score_gpt":0.20568411281707766,"score_spread":0.20291999014800333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415172542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868634,0.0002962876,0.00025354527,0.010252378,0.00036190133,0.00023087718,0.000027203849,0.000025002955,0.0016894353],"genre_scores_gemma":[0.9756155,0.00013825463,0.000070265196,0.022431651,0.00016117956,0.000012339487,0.000043032527,0.000017457129,0.0015103201],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99781823,0.00010106222,0.00026551393,0.00017684359,0.001202406,0.00043596193],"domain_scores_gemma":[0.9974506,0.000031028874,0.0000791933,0.00014979728,0.00036478377,0.0019245839],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00043447426,0.00013828474,0.00032631835,0.00024478583,0.00022618369,0.000048843805,0.00015433379,0.00025247457,0.0016733878],"category_scores_gemma":[0.00028069576,0.000111802015,0.00018790929,0.00038069242,0.000039632356,0.00010020075,0.000016108095,0.0005133437,0.00008592778],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017451188,0.00008860931,0.89756703,0.0000106032285,0.004467245,0.00416774,0.00009371899,0.000005317919,0.000004962556,0.0000783764,0.06470134,0.028640546],"study_design_scores_gemma":[0.002644724,0.00017626122,0.8831412,0.00018098128,0.00018081706,0.0004822727,0.00007007285,0.000007659003,0.000008430932,0.000016967662,0.11297824,0.00011233266],"about_ca_topic_score_codex":0.00037365084,"about_ca_topic_score_gemma":0.00318666,"teacher_disagreement_score":0.0482769,"about_ca_system_score_codex":0.0007773485,"about_ca_system_score_gemma":0.002551103,"threshold_uncertainty_score":0.9992392},"labels":[],"label_agreement":null},{"id":"W4415681421","doi":"10.1016/j.cjca.2025.10.027","title":"Impact of P2Y12 Inhibitors Pretreatment on Stent Thrombosis in Patients Undergoing Percutaneous Coronary Intervention: Insight France PCI Registry","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Conseil Régional Provence-Alpes-Côte d'Azur; Conseil Régional du Centre-Val de Loire; Société Française de Cardiologie; Ministère des Affaires Sociales et de la Santé","keywords":"Conventional PCI; P2Y12; Percutaneous coronary intervention; Stent; Thrombosis; Percutaneous; Reduction (mathematics)","score_opus":0.009310887078558603,"score_gpt":0.25544860377129824,"score_spread":0.24613771669273965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415681421","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99218285,0.0050227502,0.00008788891,0.000109397966,0.0004661871,0.00019642619,0.00002454921,0.0000029842574,0.0019069928],"genre_scores_gemma":[0.9992689,0.00040582588,0.000015846086,0.00009277721,0.00012051208,0.0000021422438,0.000014144654,0.000010953497,0.00006889409],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99886256,0.00017692175,0.0004443301,0.00014629493,0.00014942612,0.00022048285],"domain_scores_gemma":[0.99912304,0.00006315885,0.00016863833,0.00023509757,0.00017505736,0.00023502063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014897311,0.00014717663,0.0006744332,0.00036909166,0.000041367908,0.0000064830024,0.00009974064,0.00013259093,0.000031429412],"category_scores_gemma":[0.00010255103,0.00011843533,0.0009367427,0.00017545732,0.00011805008,0.000047317204,0.000009362214,0.00022617143,0.000001755416],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054466515,0.00004858185,0.9797175,0.00006829531,0.002393326,0.00084203493,0.00012634028,0.0023354779,0.00003134976,0.000025921796,0.0013099579,0.012556542],"study_design_scores_gemma":[0.0036914765,0.002755723,0.9890126,0.0009991545,0.00030166775,0.0005729089,0.0001652707,0.0000027563044,0.00005182649,0.000046813057,0.0023127159,0.000087059576],"about_ca_topic_score_codex":0.00045354542,"about_ca_topic_score_gemma":0.00026589373,"teacher_disagreement_score":0.012469483,"about_ca_system_score_codex":0.0006169125,"about_ca_system_score_gemma":0.0011041601,"threshold_uncertainty_score":0.48296526},"labels":[],"label_agreement":null},{"id":"W4415793986","doi":"10.1161/circ.152.suppl_3.4359647","title":"Abstract 4359647: Results of Pilot Trials in the United States and Phase I Bridging Trials in China of a Novel Antiplatelet P2Y12 Inhibitor Evategrel (CG-0255)","year":2025,"lang":"en","type":"article","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Altasciences (Canada)","funders":"","keywords":"P2Y12; Clopidogrel; Prasugrel; Prodrug; Pharmacokinetics; Bolus (digestion); Thienopyridine; Active metabolite; Pharmacodynamics","score_opus":0.07281049428635071,"score_gpt":0.35973821851741733,"score_spread":0.2869277242310666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415793986","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99565536,0.0014635901,0.0009393488,0.0003431771,0.0000870567,0.0012343755,0.00012416761,0.000016188022,0.00013675631],"genre_scores_gemma":[0.9985774,0.0007382618,0.00003830083,0.00008871017,0.00007711929,0.00001726364,0.00044698265,0.000011627806,0.0000043124337],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99682,0.00075926824,0.0016890737,0.00025253496,0.00031211184,0.00016705638],"domain_scores_gemma":[0.99759233,0.0013817361,0.0005889237,0.00030096268,0.000099758,0.000036308928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010564599,0.00016549465,0.0012522881,0.00063901796,0.00003780099,0.00002161172,0.00007504563,0.00009967793,0.000008798673],"category_scores_gemma":[0.0037418737,0.000120123084,0.00028340562,0.0008528092,0.00008848683,0.00011279804,0.000015037349,0.00017008369,4.012558e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05860525,0.007890943,0.1182958,0.002876281,0.002394904,0.00018110531,0.0071576294,0.022724632,0.63291776,0.0010821889,0.00058565894,0.14528786],"study_design_scores_gemma":[0.054849032,0.00023612543,0.9148006,0.0016061042,0.00043819923,0.000015507856,0.00062294264,0.007085998,0.019644117,0.0003598994,0.00018244321,0.00015905022],"about_ca_topic_score_codex":0.0006152103,"about_ca_topic_score_gemma":0.000017126726,"teacher_disagreement_score":0.7965048,"about_ca_system_score_codex":0.000036703448,"about_ca_system_score_gemma":0.000112703514,"threshold_uncertainty_score":0.48984772},"labels":[],"label_agreement":null},{"id":"W4416072980","doi":"10.1053/j.jvca.2025.09.114","title":"INTRAOPERATIVE REMOVAL OF TICAGRELOR DURING URGENT CORONARY ARTERY BYPASS GRAFTING REDUCES PERIOPERATIVE BLEEDING IN A POOLED ANALYSIS OF A RANDOMIZED TRIAL AND AN INTERNATIONAL REGISTRY","year":2025,"lang":"en","type":"article","venue":"Journal of Cardiothoracic and Vascular Anesthesia","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; St. Joseph’s Healthcare Hamilton; Western University; London Health Sciences Centre; Population Health Research Institute","funders":"","keywords":"Perioperative; Ticagrelor; Randomized controlled trial; Cardiopulmonary bypass; Clinical endpoint; Coronary artery bypass surgery; Bypass grafting; Artery","score_opus":0.008995142536433333,"score_gpt":0.29459432859588036,"score_spread":0.285599186059447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416072980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98585933,0.012782126,0.00058893464,0.00015457852,0.000058666305,0.00042829537,0.0000024144947,0.000005042851,0.00012062723],"genre_scores_gemma":[0.9937753,0.0053140805,0.0006885826,0.000038902333,0.00012549941,0.000009055997,0.0000067091564,0.000010409651,0.000031431377],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99767554,0.00056252675,0.0009466834,0.00022658831,0.0004524796,0.0001361959],"domain_scores_gemma":[0.998799,0.00013831843,0.00039220636,0.00018778935,0.00035592765,0.00012672898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020676258,0.000184943,0.0020304315,0.0007000283,0.000058465037,0.00003749788,0.000100816025,0.000109031644,0.000016612363],"category_scores_gemma":[0.000338037,0.000140661,0.0012524492,0.0004393203,0.00022659177,0.00025119423,0.000023302286,0.00021527433,3.160945e-8],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7888322,0.0006770623,0.029014716,0.00037401405,0.122463636,0.004538336,0.006117701,0.0014802375,0.026037341,0.000494645,0.0000044619387,0.01996566],"study_design_scores_gemma":[0.7159701,0.001069089,0.18702905,0.002278427,0.055257473,0.008902345,0.010367384,0.005947916,0.012385396,0.00005409321,0.000214557,0.0005241817],"about_ca_topic_score_codex":0.0000108490985,"about_ca_topic_score_gemma":9.2326326e-7,"teacher_disagreement_score":0.15801433,"about_ca_system_score_codex":0.000048743925,"about_ca_system_score_gemma":0.0002061601,"threshold_uncertainty_score":0.57359886},"labels":[],"label_agreement":null},{"id":"W4416208187","doi":"10.1302/1358-992x.2025.13.125","title":"PROLONGED PLATELET-MEDIATED HYPERCOAGULABILITY EXISTS FOLLOWING PRIMARY TOTAL HIP AND KNEE ARTHROPLASTY","year":2025,"lang":"en","type":"article","venue":"Orthopaedic Proceedings","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Platelet; Hemostasis; Prospective cohort study; Thrombelastography; Thromboelastography; Coagulation; Anticoagulant; Thrombosis; Arthroplasty; Clot formation","score_opus":0.006804039709678027,"score_gpt":0.22868497690504588,"score_spread":0.22188093719536786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416208187","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853353,0.006331678,0.000051156712,0.00055796286,0.0003137972,0.00097267,0.0000089803,0.00035905692,0.0060694246],"genre_scores_gemma":[0.9971602,0.0003126951,0.0003300064,0.0009327435,0.00017288451,0.00011000727,0.000055272376,0.000037337835,0.0008888397],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99787486,0.000024876987,0.0004091349,0.00068825355,0.00051014504,0.0004927102],"domain_scores_gemma":[0.99916226,0.00007691878,0.00008208197,0.00023029934,0.00016020572,0.0002882242],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00062015594,0.00034559565,0.000702804,0.00019876592,0.0002635584,0.000064143045,0.00006851148,0.0002476293,0.000054710068],"category_scores_gemma":[0.00041147938,0.00030529272,0.00050710054,0.000535649,0.00026938785,0.0002886267,0.00011850967,0.0003916975,0.000023175822],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022084971,0.0005165923,0.7394561,0.0017953216,0.0020257956,0.00043059618,0.0006445287,5.4115895e-7,0.014773847,0.00036179496,0.001800008,0.23598634],"study_design_scores_gemma":[0.011132395,0.0005489753,0.9589249,0.00079313293,0.00095997343,0.0006622721,0.0006168068,0.0001141282,0.0016632314,0.00037174832,0.023572931,0.0006395064],"about_ca_topic_score_codex":0.0000078752555,"about_ca_topic_score_gemma":0.0000010501275,"teacher_disagreement_score":0.23534682,"about_ca_system_score_codex":0.00010152574,"about_ca_system_score_gemma":0.00026930048,"threshold_uncertainty_score":0.9999399},"labels":[],"label_agreement":null},{"id":"W4416839791","doi":"10.1080/01616412.2025.2597833","title":"Outcomes of mechanical thrombectomy after recent cardiovascular procedures: a multicenter descriptive cohort","year":2025,"lang":"en","type":"article","venue":"Neurological Research","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Prospective cohort study; Cohort; Cohort study; Multicenter study; MEDLINE; Quality of life (healthcare)","score_opus":0.0518217489902487,"score_gpt":0.3582726795163644,"score_spread":0.30645093052611566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416839791","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98915166,0.005729979,0.0004419326,0.0011712067,0.00010731501,0.0014580563,0.000008554611,0.0000662078,0.0018650793],"genre_scores_gemma":[0.99461186,0.0037107382,0.00020653672,0.00081455236,0.00004393473,0.00030770942,0.000006313872,0.00001794724,0.00028039512],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99636555,0.0007451444,0.00034254906,0.0006317713,0.001356853,0.00055814243],"domain_scores_gemma":[0.9980388,0.00036362317,0.000024995503,0.00074325234,0.0006280528,0.00020127173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014579974,0.00019662426,0.0008301576,0.00021080348,0.0000938651,0.0000213155,0.00023811801,0.00022895545,0.00040803629],"category_scores_gemma":[0.0024879747,0.00013005342,0.00097262306,0.00061268266,0.00040882686,0.000050485076,0.00024761588,0.0007290944,0.00003995844],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00833422,0.0016372142,0.96462035,0.0003885595,0.005581352,0.0009166583,0.000075047,0.000008810208,0.001675921,0.0006807256,0.0006672042,0.015413921],"study_design_scores_gemma":[0.002828393,0.00077681325,0.9743092,0.00008986887,0.00046885374,0.000023334747,0.0000744001,0.00007977909,0.0025576956,0.0004243797,0.018252896,0.00011437659],"about_ca_topic_score_codex":0.000024878074,"about_ca_topic_score_gemma":0.0000046606287,"teacher_disagreement_score":0.017585691,"about_ca_system_score_codex":0.00005109916,"about_ca_system_score_gemma":0.000262082,"threshold_uncertainty_score":0.53034246},"labels":[],"label_agreement":null},{"id":"W4416858572","doi":"10.1513/annalsats.202510-1095ed","title":"When LOFTy Ideals Meet Clinical Trial Reality","year":2025,"lang":"en","type":"article","venue":"Annals of the American Thoracic Society","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; McGill University; McGill University Health Centre","funders":"","keywords":"","score_opus":0.1821578129339199,"score_gpt":0.49198883703614976,"score_spread":0.30983102410222985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416858572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9783956,0.0018054703,0.000744625,0.015719762,0.00032222987,0.0006360219,0.000039871207,0.00007046085,0.0022659875],"genre_scores_gemma":[0.97704023,0.0032097197,0.0005793093,0.017880807,0.00033397507,0.00002104741,0.000009715795,0.000017052233,0.00090816995],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9977099,0.0006423847,0.00061143254,0.00033413034,0.00042435562,0.00027780156],"domain_scores_gemma":[0.99787754,0.0002924695,0.0004283356,0.0010675413,0.00021392434,0.00012019385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022729358,0.00017193067,0.00091252726,0.000021801057,0.00012873563,0.000013592411,0.00033500284,0.000093481125,0.000036883495],"category_scores_gemma":[0.0004904995,0.000114557464,0.0031619915,0.0004832876,0.0010687769,0.000046637084,0.00014380585,0.00024636457,0.0000055170854],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.045869026,0.0011026859,0.048223108,0.00023228808,0.0068771997,0.000008575429,0.0004784474,0.000008347507,0.00026427294,0.00054872327,0.45585814,0.44052917],"study_design_scores_gemma":[0.036518384,0.0023843602,0.56834126,0.0008322287,0.0036412075,0.000025469652,0.002694798,0.00020329401,0.013026267,0.01915846,0.35240042,0.000773828],"about_ca_topic_score_codex":0.00015359733,"about_ca_topic_score_gemma":0.0000023853784,"teacher_disagreement_score":0.5201182,"about_ca_system_score_codex":0.000016731503,"about_ca_system_score_gemma":0.00030157864,"threshold_uncertainty_score":0.46715176},"labels":[],"label_agreement":null},{"id":"W4417031775","doi":"10.1161/strokeaha.125.053030","title":"Switching From Aspirin Monotherapy After Noncardioembolic Stroke: A Systematic Review and Network Meta-Analysis","year":2025,"lang":"en","type":"review","venue":"Stroke","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Population Health Research Institute","funders":"","keywords":"Antithrombotic; Aspirin; Stroke (engine); Ischemic stroke; Clinical trial; Fibrinolytic agent; Randomized controlled trial","score_opus":0.037614837010112756,"score_gpt":0.3236575533452468,"score_spread":0.28604271633513406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417031775","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000034065588,0.9929644,0.0012618063,0.000038983555,0.000086406675,0.0041314643,0.00085207477,0.00009294467,0.0005685244],"genre_scores_gemma":[0.000031171185,0.9930528,0.00028302707,0.0014385759,0.00031211914,0.0018585665,0.0003263529,0.00008296703,0.0026144688],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99546844,0.0011032297,0.0013966865,0.00094957964,0.0006134468,0.00046860607],"domain_scores_gemma":[0.9968838,0.00038019835,0.0005504605,0.001841969,0.00009221567,0.00025132688],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.0009142855,0.000933971,0.020464404,0.00034937612,0.00010137479,0.00009377108,0.00029187356,0.00036481387,0.0005619695],"category_scores_gemma":[0.000068914684,0.0006096408,0.018551035,0.0008380999,0.000046441968,0.00007168023,0.00010457085,0.0005702458,0.000046250243],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014873661,0.000018825669,0.000007668834,0.43609416,0.53519386,0.00011314089,0.0000082959805,0.0000012545091,1.8632917e-8,0.000006044992,0.00007427258,0.028467571],"study_design_scores_gemma":[0.00027519587,0.000026266485,0.000008385488,0.096685246,0.7775945,0.000036811314,0.000005547532,0.0000019925938,6.9347244e-8,0.000008163418,0.12500778,0.00035004475],"about_ca_topic_score_codex":0.000047295613,"about_ca_topic_score_gemma":0.000013159216,"teacher_disagreement_score":0.3394089,"about_ca_system_score_codex":0.00007168638,"about_ca_system_score_gemma":0.00026744843,"threshold_uncertainty_score":0.9996355},"labels":[],"label_agreement":null},{"id":"W4417035758","doi":"10.4244/eij-e-25-00049","title":"Do we still need more data to adopt a short duration of DAPT routinely following PCI in high bleeding risk patients?","year":2025,"lang":"en","type":"article","venue":"EuroIntervention","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Conventional PCI; Duration (music); MEDLINE; Percutaneous coronary intervention; Risk assessment; Major bleeding","score_opus":0.03268619390403776,"score_gpt":0.31096357784329776,"score_spread":0.27827738393926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417035758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896863,0.0012669642,0.007681596,0.0003190008,0.00032041458,0.00049758935,0.000055935016,0.00004140497,0.0001307567],"genre_scores_gemma":[0.99887764,0.00016100751,0.00033290227,0.0000556265,0.000037612477,0.0000045039715,0.0003550738,0.000016608294,0.00015899085],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985795,0.000112261834,0.00051894854,0.00034505862,0.00028887595,0.0001553797],"domain_scores_gemma":[0.99921393,0.000026508484,0.00009542958,0.00052873977,0.00007904815,0.00005635008],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054689223,0.00013177014,0.000323212,0.0002651704,0.00003527704,0.000023620581,0.00016199474,0.000048899383,0.000030916737],"category_scores_gemma":[0.00030311316,0.00012738511,0.00036717232,0.00042363483,0.000015102251,0.0002222572,0.00014187706,0.00012739545,0.0000064127375],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000950815,0.0006076158,0.91873854,0.0003559041,0.0007175528,0.000054430093,0.00040738215,0.0001890654,0.0021852558,0.00016598208,0.0010335273,0.07459393],"study_design_scores_gemma":[0.0037084331,0.000321213,0.98750687,0.0030307018,0.0006545767,0.000003945537,0.00056205655,0.0013936568,0.0012002342,0.00008268894,0.0013883567,0.00014724542],"about_ca_topic_score_codex":0.00009294644,"about_ca_topic_score_gemma":0.000019456842,"teacher_disagreement_score":0.074446686,"about_ca_system_score_codex":0.000051148036,"about_ca_system_score_gemma":0.000027145377,"threshold_uncertainty_score":0.5194614},"labels":[],"label_agreement":null},{"id":"W4417304124","doi":"10.1002/cpt.70154","title":"Prognostic Implication of <i>CYP2C19</i> Genotype According to Clinical Risk Stratification After Drug‐Eluting Stent Implantation","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Daiichi Sankyo Europe; Idorsia Pharmaceuticals; Chung-Ang University; Yuhan; Daewoong Pharmaceutical Company; Bayer HealthCare; Medicure; Sanofi; Amgen","keywords":"CYP2C19; Confidence interval; Risk stratification; Clinical endpoint; Genotype; Genotyping; Clopidogrel; Coronary stent","score_opus":0.04887897696284085,"score_gpt":0.4250951989225361,"score_spread":0.3762162219596953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417304124","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854734,0.0025765027,0.0066018575,0.002338921,0.0013481203,0.0013913795,0.000029134348,0.00009140105,0.00014928207],"genre_scores_gemma":[0.9783574,0.0044308593,0.0009413767,0.015467197,0.0005329945,0.00011896721,0.00005203323,0.00002660333,0.00007258018],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967805,0.0007697502,0.0013899761,0.00053849234,0.00021636987,0.0003048967],"domain_scores_gemma":[0.99746156,0.0011577246,0.00039088438,0.0004330194,0.00037449627,0.00018234074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017072625,0.0002127504,0.0006650376,0.00012480184,0.000117481206,0.000016481714,0.00019470601,0.00025116358,0.000044935718],"category_scores_gemma":[0.00012203338,0.00019094236,0.00057713425,0.00038643804,0.00023344,0.00006625565,0.00006981995,0.00052530074,0.00004883076],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035185805,0.00095942745,0.78622735,0.00010191374,0.0025002554,0.000011427058,0.00010344559,0.000052233107,0.0076728687,0.000032338983,0.00065559853,0.19816454],"study_design_scores_gemma":[0.0040992033,0.00061254465,0.9706635,0.00011575253,0.0068815663,0.000012313253,0.0002553616,0.00054226076,0.006597268,0.0002741409,0.009721454,0.00022463073],"about_ca_topic_score_codex":0.000006705293,"about_ca_topic_score_gemma":0.0000026852167,"teacher_disagreement_score":0.19793992,"about_ca_system_score_codex":0.000043960077,"about_ca_system_score_gemma":0.00029880155,"threshold_uncertainty_score":0.77864033},"labels":[],"label_agreement":null},{"id":"W45326695","doi":"10.1016/j.jcin.2008.08.017","title":"The Effects of Aspirin and Clopidogrel Response on Myonecrosis After Percutaneous Coronary Intervention","year":2008,"lang":"en","type":"article","venue":"JACC: Cardiovascular Interventions","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Clopidogrel; Aspirin; Percutaneous coronary intervention; Eptifibatide; Conventional PCI; Medicine; Internal medicine; Cardiology; Loading dose; Anesthesia; Myocardial infarction","score_opus":0.011518535430175133,"score_gpt":0.25019960725335794,"score_spread":0.2386810718231828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W45326695","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90186757,0.095745906,0.0009114013,0.000103168335,0.0003637626,0.00076585985,0.000019696961,0.000070360955,0.00015225566],"genre_scores_gemma":[0.99021804,0.008232966,0.000107887885,0.000094400406,0.00008878326,0.00017578466,0.00002094647,0.000046468973,0.0010147124],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9974361,0.00073687447,0.0005121417,0.00041481262,0.0006069641,0.0002931306],"domain_scores_gemma":[0.9982113,0.00036435467,0.00010112998,0.0009977429,0.00016808133,0.00015736735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008986045,0.00026572632,0.00065977586,0.00016871165,0.00033344023,0.000028625638,0.0001444609,0.00013658853,0.00006339468],"category_scores_gemma":[0.00039176727,0.00019999381,0.006123343,0.00021383158,0.0004209996,0.00009103709,0.00010568669,0.00026365434,0.000046397592],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.048006505,0.0047837864,0.044532042,0.00819687,0.0778275,0.018658739,0.0020385317,0.00019504955,0.0061975447,0.00052584655,0.003304264,0.78573334],"study_design_scores_gemma":[0.007372058,0.0041721724,0.9202904,0.0050609866,0.005043161,0.01250099,0.00039532525,0.00003290201,0.004247798,0.000105979125,0.040251475,0.00052671734],"about_ca_topic_score_codex":0.000031899046,"about_ca_topic_score_gemma":0.000006450575,"teacher_disagreement_score":0.8757584,"about_ca_system_score_codex":0.00007570047,"about_ca_system_score_gemma":0.00004459932,"threshold_uncertainty_score":0.81555104},"labels":[],"label_agreement":null},{"id":"W66266787","doi":"10.1177/229255031001800109","title":"Phosphodiesterase Inhibitors in Vascular Ischemia: A Case Report and Review of Their Use in Ischemic Conditions","year":2010,"lang":"en","type":"article","venue":"Canadian Journal of Plastic Surgery","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Western University; Hand and Upper Limb Clinic","funders":"","keywords":"Medicine; Phosphodiesterase; Ischemia; Pharmacology; Cardiology; Enzyme; Biochemistry","score_opus":0.014481798729865268,"score_gpt":0.23106489234752403,"score_spread":0.21658309361765876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W66266787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9664119,0.03291869,0.000006922171,0.0000661603,0.00041869373,0.0001077741,0.000031563573,0.0000020183156,0.000036263496],"genre_scores_gemma":[0.99595726,0.003712772,0.000028650247,0.00018048468,0.00008058198,0.0000041219764,0.000016576818,0.000013916593,0.0000056125505],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9987803,0.00005458318,0.0006985684,0.00012534663,0.00014123104,0.00019996027],"domain_scores_gemma":[0.9980846,0.0008312301,0.00023493009,0.00020446254,0.00015850468,0.00048628545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009287843,0.00012721874,0.0006463058,0.0004266346,0.00002769657,0.000011361938,0.000034203396,0.00009369807,0.00013432682],"category_scores_gemma":[0.002530644,0.000107972606,0.0003928922,0.00027053122,0.00015036236,0.00015563588,0.000005652713,0.0004091484,6.8812784e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006202957,0.000066132874,0.65039086,0.0014056333,0.00034976142,0.33788636,0.00015579611,0.0000049382456,0.001907097,0.0000047017793,0.0060283653,0.0017383333],"study_design_scores_gemma":[0.0040702666,0.00011891668,0.30093354,0.046547633,0.0012418323,0.5970334,0.0012106551,0.00002625548,0.007741898,0.000031657102,0.040359467,0.00068446726],"about_ca_topic_score_codex":0.0020008609,"about_ca_topic_score_gemma":0.0067402413,"teacher_disagreement_score":0.3494573,"about_ca_system_score_codex":0.000049348193,"about_ca_system_score_gemma":0.0016319666,"threshold_uncertainty_score":0.4402995},"labels":[],"label_agreement":null},{"id":"W66884010","doi":"10.1016/j.jacc.2014.08.053","title":"Effect of Prasugrel Pre-Treatment Strategy in Patients Undergoing Percutaneous Coronary Intervention for NSTEMI","year":2014,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"Daiichi Sankyo Company; Eli Lilly and Company","keywords":"Prasugrel; Medicine; Percutaneous coronary intervention; Conventional PCI; Myocardial infarction; Clopidogrel; Cardiology; Internal medicine; Clinical endpoint; Ticagrelor; Randomized controlled trial","score_opus":0.006154953500885274,"score_gpt":0.2641487534789248,"score_spread":0.2579937999780395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W66884010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979194,0.0006334379,0.0005632121,0.00005075676,0.00015833725,0.000511131,0.00003031023,0.0000026004386,0.00013081572],"genre_scores_gemma":[0.99950254,0.00024440512,0.000069641326,0.00002160312,0.000098007244,0.0000058453925,0.0000029583784,0.00001304556,0.000041952655],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983721,0.00070845574,0.0004829649,0.00010061979,0.00019090797,0.00014494779],"domain_scores_gemma":[0.9984332,0.00048399405,0.00067371177,0.00020839671,0.00015420822,0.000046531844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006181925,0.000121452314,0.0010706526,0.000100480174,0.000024806632,0.0000012383678,0.00011678037,0.000044641103,0.0000022610625],"category_scores_gemma":[0.00021088675,0.00007251731,0.0010787924,0.00011705579,0.00019140122,0.000029237792,0.000023756038,0.00008429657,1.9388304e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033894755,0.0003919262,0.8418186,0.0005694749,0.004481444,0.00016263672,0.000057023244,0.008385846,0.0028421497,0.00006087923,0.00030284017,0.10703243],"study_design_scores_gemma":[0.024935672,0.12018988,0.83808714,0.0010466313,0.0027884278,0.0051544793,0.0005984866,0.0003105347,0.0053949803,0.000174023,0.0011064247,0.00021333864],"about_ca_topic_score_codex":0.000007950378,"about_ca_topic_score_gemma":0.0000034239952,"teacher_disagreement_score":0.11979796,"about_ca_system_score_codex":0.000116841125,"about_ca_system_score_gemma":0.00010625411,"threshold_uncertainty_score":0.295717},"labels":[],"label_agreement":null},{"id":"W6889080863","doi":"10.25384/sage.24061931","title":"sj-pdf-1-vdi-10.1177_10406387231197440 – Supplemental material for Investigation of Platelet Function Analyzer 200 platelet function measurements in healthy cats and cats receiving clopidogrel","year":2023,"lang":"en","type":"article","venue":"Sage Journals Data","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"CATS; Clopidogrel; Platelet; Function (biology); Platelet aggregation; Carnivora","score_opus":0.0834164872494579,"score_gpt":0.3250341649665866,"score_spread":0.24161767771712872,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6889080863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98882693,0.0054701203,0.0007774625,0.000656392,0.0006427783,0.0010256859,0.002503806,0.000062913634,0.0000339203],"genre_scores_gemma":[0.9788025,0.0069524366,0.00026633352,0.0003878777,0.00066365977,0.000052884225,0.012670085,0.000056639998,0.00014759498],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9972147,0.0002387124,0.0008440688,0.0005468267,0.00068635907,0.00046936586],"domain_scores_gemma":[0.9985543,0.0000794196,0.00036065205,0.0005983813,0.00015310632,0.00025417507],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0025333702,0.00026823176,0.000611009,0.00048570297,0.00020435367,0.000074557756,0.00019342905,0.00018061548,0.004081429],"category_scores_gemma":[0.0001251314,0.00025376506,0.00015436223,0.0005920063,0.00007986596,0.00067010015,0.00013040648,0.000226646,0.000038341666],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025325773,0.00047707002,0.34423676,0.0017945858,0.004168798,0.0001807439,0.0008844209,0.00019559619,0.09223204,0.0000052867917,0.11407115,0.41642776],"study_design_scores_gemma":[0.030589424,0.0029880088,0.8915212,0.0034035684,0.001729504,0.00042693625,0.0016482908,0.0019941598,0.020366836,0.0007444814,0.04362082,0.0009667405],"about_ca_topic_score_codex":0.00017055504,"about_ca_topic_score_gemma":0.00016358723,"teacher_disagreement_score":0.5472845,"about_ca_system_score_codex":0.00011376571,"about_ca_system_score_gemma":0.00019655575,"threshold_uncertainty_score":0.9999915},"labels":[],"label_agreement":null},{"id":"W6902012264","doi":"10.6084/m9.figshare.24142521","title":"<b>Comparison of Clopidogrel versus Ticagrelor for Percutaneous Coronary Intervention (PCI) Patients Managed with Therapeutic Hypothermia: A Systematic Review and Meta-Analysis</b>","year":2023,"lang":"en","type":"preprint","venue":"Figshare","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Clopidogrel; Ticagrelor; Conventional PCI; Percutaneous coronary intervention; Acute coronary syndrome; Prasugrel; Randomized controlled trial; Platelet aggregation inhibitor","score_opus":0.15499993917854624,"score_gpt":0.36245345119059996,"score_spread":0.20745351201205373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6902012264","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0053401124,0.77399415,0.00022037032,0.00028505907,0.0001278817,0.020755095,0.19882444,0.0003311747,0.000121749414],"genre_scores_gemma":[0.860647,0.0018076242,0.0002285533,0.00033607922,0.00004248267,0.0041725547,0.13138868,0.00017110823,0.0012058842],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9977415,0.00024235825,0.0007617065,0.00056135067,0.0004835622,0.00020951928],"domain_scores_gemma":[0.9976899,0.0003414677,0.000660637,0.0008377118,0.00036770303,0.00010257422],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018856033,0.00041238972,0.0038799567,0.00018438864,0.00005661328,0.00002875375,0.00021164924,0.00021162668,0.006483475],"category_scores_gemma":[0.00035205824,0.00027898783,0.0032861964,0.0002523266,0.000022828088,0.00003524398,0.00015859473,0.00027593473,0.000058669862],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069608254,0.00024752505,0.00009616461,0.6239296,0.3726899,0.000053201216,0.00008539912,0.00005753417,4.1402348e-7,0.0000021586684,0.0018271874,0.00031483674],"study_design_scores_gemma":[0.0017054302,0.00076925,0.0013676492,0.041837946,0.9533081,0.00003824963,0.00012021975,0.00029590295,0.0000072586645,0.000017055574,0.00019029439,0.0003426645],"about_ca_topic_score_codex":0.0000047501576,"about_ca_topic_score_gemma":0.000011766169,"teacher_disagreement_score":0.8553069,"about_ca_system_score_codex":0.000051162064,"about_ca_system_score_gemma":0.000051190076,"threshold_uncertainty_score":0.9999662},"labels":[],"label_agreement":null},{"id":"W6902378746","doi":"10.6084/m9.figshare.14478827","title":"Additional file 1 of Effect of low salicylate diet on clinical and inflammatory markers in patients with aspirin exacerbated respiratory disease – a randomized crossover trial","year":2021,"lang":"en","type":"article","venue":"Open MIND","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Western University","funders":"","keywords":"Crossover study; Aspirin; Randomized controlled trial; Respiratory disease; Respiratory system; Clinical trial","score_opus":0.014018958471611597,"score_gpt":0.2923177420452532,"score_spread":0.2782987835736416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6902378746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97040606,0.00009352238,3.0090243e-7,0.000005257099,0.000031016632,0.0015382111,0.02709027,0.0000012305624,0.00083412766],"genre_scores_gemma":[0.98182905,0.00002130997,0.00014089952,0.00013316126,0.00008982429,0.00038459705,0.016908174,0.000033568205,0.00045941139],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9980049,0.0007622095,0.0004905717,0.00029434607,0.0003289887,0.00011895569],"domain_scores_gemma":[0.997575,0.0016950569,0.00019327032,0.00028307512,0.000101919926,0.00015169893],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00063392735,0.00014208129,0.0008863893,0.000055359425,0.000022775303,0.00001671456,0.00006774951,0.00008065549,0.13783666],"category_scores_gemma":[0.0017256195,0.000101888036,0.00030979599,0.00012053986,0.00033552528,0.00008031256,0.000061326544,0.0001235981,0.000016929765],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9658707,0.00051541114,0.010358234,0.00008693714,0.000692252,0.00014654075,0.000013875537,0.000005550131,0.000003477699,6.716084e-7,0.011771987,0.010534375],"study_design_scores_gemma":[0.7520631,0.00249299,0.23000838,0.0014245793,0.00028660323,7.005426e-7,0.000008014154,0.000013397572,0.00017289071,0.0000030325753,0.01340184,0.00012448983],"about_ca_topic_score_codex":0.0000019231884,"about_ca_topic_score_gemma":0.0000028466193,"teacher_disagreement_score":0.21965013,"about_ca_system_score_codex":0.000013130641,"about_ca_system_score_gemma":0.00036373327,"threshold_uncertainty_score":0.86295146},"labels":[],"label_agreement":null},{"id":"W6908221567","doi":"10.25446/oxford.20241126","title":"Introduction to Narrative Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick","year":2022,"lang":"en","type":"other","venue":"University of Oxford","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Storytelling; Narrative; Syllabus; Reading (process); Space (punctuation)","score_opus":0.006479555099101563,"score_gpt":0.2186409495319122,"score_spread":0.21216139443281065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6908221567","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018961824,0.0089195175,0.0035336346,0.035355154,0.0012970096,0.0013049523,0.000035629055,0.0004074409,0.9472505],"genre_scores_gemma":[0.0006354657,0.007718873,0.00083494745,0.0012751172,0.003481509,4.5245378e-7,0.00040213633,0.00019612123,0.9854554],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981265,0.00009974318,0.00015847765,0.0004624968,0.00092853233,0.00022425367],"domain_scores_gemma":[0.99846774,0.000019976336,0.00014739318,0.00050304213,0.000058410238,0.0008034115],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002018177,0.00024956503,0.0007333667,0.0004863078,0.000108282526,0.000003173613,0.0002850996,0.00028156835,0.24874987],"category_scores_gemma":[0.00020933706,0.00025575908,0.00035948536,0.00039928372,0.0001903373,0.000048599315,0.00010922375,0.00041703854,0.00007283931],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006270967,0.00007909246,0.00024892623,0.00009490416,0.0011587876,0.00021484913,0.0008985,0.000004766044,0.000018729055,0.00009736373,0.9844945,0.012062453],"study_design_scores_gemma":[0.0026885825,0.00049870095,0.00030600702,0.0002798563,0.00054634066,0.00006252964,0.0028638993,0.0000027976666,0.000013802139,0.000009792924,0.9925152,0.00021246912],"about_ca_topic_score_codex":0.003405717,"about_ca_topic_score_gemma":0.00041843747,"teacher_disagreement_score":0.24867703,"about_ca_system_score_codex":0.00018558092,"about_ca_system_score_gemma":0.0014704964,"threshold_uncertainty_score":0.99998945},"labels":[],"label_agreement":null},{"id":"W6921077185","doi":"10.6084/m9.figshare.24142521.v1","title":"<b>Comparison of Clopidogrel versus Ticagrelor for Percutaneous Coronary Intervention (PCI) Patients Managed with Therapeutic Hypothermia: A Systematic Review and Meta-Analysis</b>","year":2023,"lang":"en","type":"article","venue":"Figshare","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Clopidogrel; Ticagrelor; Conventional PCI; Percutaneous coronary intervention; Acute coronary syndrome; Prasugrel; Randomized controlled trial; Platelet aggregation inhibitor","score_opus":0.10534466667276751,"score_gpt":0.34716681911122005,"score_spread":0.24182215243845254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6921077185","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.057596706,0.80500156,0.00016299756,0.0006028447,0.000096268595,0.022576781,0.11287741,0.0006191484,0.0004663122],"genre_scores_gemma":[0.97620547,0.00038484932,0.000049745948,0.00022666332,0.00001111225,0.0008052844,0.02174179,0.000039976523,0.0005350931],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9987759,0.00012328595,0.0003926683,0.00025435202,0.0002960716,0.00015774558],"domain_scores_gemma":[0.99893135,0.00023194324,0.00021954747,0.00036825697,0.00017944186,0.0000694423],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00012390535,0.00018322731,0.0016870457,0.00011925066,0.00005272495,0.000012310465,0.000091914066,0.00005972558,0.0064352336],"category_scores_gemma":[0.0002104744,0.00011840359,0.0013503368,0.00041659884,0.000014365725,0.00004618634,0.000028840992,0.00007327795,0.00007758069],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013804397,0.00041716415,0.00044733463,0.57442284,0.41560766,0.00009769871,0.00021165548,0.000036142737,0.000005994354,0.0000104202945,0.0058530355,0.0015095993],"study_design_scores_gemma":[0.0029939548,0.0014126907,0.004302682,0.013391727,0.9761224,0.00006223362,0.00028019413,0.0004714956,0.000028441184,0.000008335594,0.0006491206,0.00027673342],"about_ca_topic_score_codex":0.0000011692061,"about_ca_topic_score_gemma":0.0000038562716,"teacher_disagreement_score":0.9186088,"about_ca_system_score_codex":0.00001897555,"about_ca_system_score_gemma":0.000016053851,"threshold_uncertainty_score":0.99447304},"labels":[],"label_agreement":null},{"id":"W6930355490","doi":"10.5064/f6buax58/e8o8bx","title":"Burke_EDI_NENA.NY001.ResearcherSurvey.2017.09.23.docx","year":2018,"lang":"en","type":"dataset","venue":"Syracuse University Qualitative Data Repository","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Identifier; Survey data collection; Plan (archaeology); Survey methodology; Identification (biology); Scale (ratio); Data collection","score_opus":0.10749429612982325,"score_gpt":0.3809779155716488,"score_spread":0.27348361944182553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6930355490","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001958529,0.0016161202,0.000105401006,0.0002195947,0.0010919037,0.00079062127,0.9930017,0.00015355472,0.001062568],"genre_scores_gemma":[0.00016608699,0.0021716275,0.0003194666,0.00016619932,0.0014739141,0.000002915591,0.9885819,0.000058318587,0.0070595783],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9917702,0.0035590758,0.0005276541,0.0017510903,0.0016351894,0.0007568035],"domain_scores_gemma":[0.99188995,0.00096395746,0.00047133229,0.0051157693,0.0008253086,0.0007336988],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0027784505,0.00072295894,0.0013050878,0.0005722464,0.00071891677,0.00011097917,0.0022080098,0.0007750694,0.0005108461],"category_scores_gemma":[0.0008448446,0.0007214447,0.0006669604,0.0005899199,0.0015183884,0.000736942,0.0015227159,0.0013264832,0.0009254702],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018091287,0.0005017669,0.000030869956,0.0005676961,0.004256844,0.0053664013,0.0011439346,3.0685047e-7,0.00006517309,0.00002504861,0.9860594,0.00017338418],"study_design_scores_gemma":[0.0025585464,0.00046450656,0.00028321918,0.0004066519,0.002021836,0.00026397643,0.00803108,0.000007941809,0.00006933447,0.00001371288,0.98512983,0.00074935413],"about_ca_topic_score_codex":0.0017354893,"about_ca_topic_score_gemma":0.00012566663,"teacher_disagreement_score":0.006887145,"about_ca_system_score_codex":0.0004766986,"about_ca_system_score_gemma":0.0013151492,"threshold_uncertainty_score":0.9998524},"labels":[],"label_agreement":null},{"id":"W6957874599","doi":"10.6084/m9.figshare.19382398.v1","title":"Additional file 2 of Effect of CYP2C19 genetic polymorphism on the pharmacodynamics and clinical outcomes for patients treated with ticagrelor: a systematic review with qualitative and quantitative meta-analysis","year":2022,"lang":"en","type":"article","venue":"Figshare","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacodynamics; CYP2C19; Genotype; Pharmacogenetics; Meta-analysis; Clinical trial; MEDLINE","score_opus":0.06086201688653848,"score_gpt":0.35632718427835014,"score_spread":0.29546516739181167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6957874599","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007429177,0.0051794853,0.0000020875084,0.000040835494,0.0000012277352,0.0020781867,0.9852422,0.000006692004,0.000020138135],"genre_scores_gemma":[0.18229674,0.00013917031,0.00032124697,0.0006510932,0.000006492409,0.009326886,0.8069998,0.000037416172,0.00022114832],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99814993,0.00083812635,0.00035290752,0.000201908,0.0003751837,0.00008193486],"domain_scores_gemma":[0.9891653,0.010019711,0.00038157037,0.00020261978,0.00017883685,0.00005197848],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002102177,0.00015502781,0.0014863275,0.00006301149,0.00007158831,0.0000038685926,0.000059363665,0.000019189883,0.36450768],"category_scores_gemma":[0.0017828625,0.00007102158,0.000817679,0.00025609048,0.0000497967,0.00002004615,0.000025125464,0.00008230223,0.0000039218953],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029706473,0.0006385016,0.00088054134,0.10157102,0.57578,0.000032272266,0.00050227955,0.000023325834,3.1565136e-7,0.000026277945,0.31743893,0.00013590015],"study_design_scores_gemma":[0.0073474483,0.019818429,0.026571795,0.036837395,0.9044673,0.000042844906,0.0010348911,0.0013066992,0.000013993281,0.00001165194,0.0020130414,0.0005345323],"about_ca_topic_score_codex":0.0000021862948,"about_ca_topic_score_gemma":0.0000012929272,"teacher_disagreement_score":0.36450374,"about_ca_system_score_codex":0.000011149133,"about_ca_system_score_gemma":0.000036787165,"threshold_uncertainty_score":0.63607323},"labels":[],"label_agreement":null},{"id":"W6958218801","doi":"10.6084/m9.figshare.19382398","title":"Additional file 2 of Effect of CYP2C19 genetic polymorphism on the pharmacodynamics and clinical outcomes for patients treated with ticagrelor: a systematic review with qualitative and quantitative meta-analysis","year":2022,"lang":"en","type":"article","venue":"Figshare","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacodynamics; CYP2C19; Genotype; Pharmacogenetics; Meta-analysis; Clinical trial; MEDLINE","score_opus":0.06086201688653848,"score_gpt":0.35632718427835014,"score_spread":0.29546516739181167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6958218801","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007429177,0.0051794853,0.0000020875084,0.000040835494,0.0000012277352,0.0020781867,0.9852422,0.000006692004,0.000020138135],"genre_scores_gemma":[0.18229674,0.00013917031,0.00032124697,0.0006510932,0.000006492409,0.009326886,0.8069998,0.000037416172,0.00022114832],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99814993,0.00083812635,0.00035290752,0.000201908,0.0003751837,0.00008193486],"domain_scores_gemma":[0.9891653,0.010019711,0.00038157037,0.00020261978,0.00017883685,0.00005197848],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002102177,0.00015502781,0.0014863275,0.00006301149,0.00007158831,0.0000038685926,0.000059363665,0.000019189883,0.36450768],"category_scores_gemma":[0.0017828625,0.00007102158,0.000817679,0.00025609048,0.0000497967,0.00002004615,0.000025125464,0.00008230223,0.0000039218953],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029706473,0.0006385016,0.00088054134,0.10157102,0.57578,0.000032272266,0.00050227955,0.000023325834,3.1565136e-7,0.000026277945,0.31743893,0.00013590015],"study_design_scores_gemma":[0.0073474483,0.019818429,0.026571795,0.036837395,0.9044673,0.000042844906,0.0010348911,0.0013066992,0.000013993281,0.00001165194,0.0020130414,0.0005345323],"about_ca_topic_score_codex":0.0000021862948,"about_ca_topic_score_gemma":0.0000012929272,"teacher_disagreement_score":0.36450374,"about_ca_system_score_codex":0.000011149133,"about_ca_system_score_gemma":0.000036787165,"threshold_uncertainty_score":0.63607323},"labels":[],"label_agreement":null},{"id":"W6958669211","doi":"10.6084/m9.figshare.14478827.v1","title":"Additional file 1 of Effect of low salicylate diet on clinical and inflammatory markers in patients with aspirin exacerbated respiratory disease – a randomized crossover trial","year":2021,"lang":"en","type":"article","venue":"Figshare","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Western University","funders":"","keywords":"Crossover study; Aspirin; Randomized controlled trial; Respiratory disease; Respiratory system; Clinical trial","score_opus":0.012707379816844094,"score_gpt":0.26322483246139683,"score_spread":0.2505174526445527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6958669211","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.41940975,0.00014756045,1.7869183e-8,0.0000018994332,0.000012248582,0.0007475514,0.5795024,0.00000955851,0.00016901265],"genre_scores_gemma":[0.29755232,0.000006149692,0.000008468262,0.00018354558,0.00009749876,0.00082480966,0.7012066,0.000030029878,0.0000905246],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.998261,0.0005585083,0.00042583758,0.00025740423,0.00037028984,0.00012695925],"domain_scores_gemma":[0.99688846,0.0023503394,0.00018923842,0.00026090775,0.00015678747,0.00015424372],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00016952009,0.00015252204,0.0007656582,0.00006315654,0.000020361536,0.000007680019,0.000041737567,0.000097437674,0.66851306],"category_scores_gemma":[0.0069362363,0.000111987465,0.00042929966,0.0001305735,0.00008834317,0.000054079712,0.0000361355,0.00014551291,0.00003822261],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.71504986,0.00024868784,0.0018372475,0.00049339567,0.00041278166,0.00012349336,0.00000458019,0.000005041038,5.0078563e-7,3.396561e-7,0.28088102,0.0009430346],"study_design_scores_gemma":[0.65418804,0.00183763,0.31593072,0.008275955,0.00013641921,6.2891576e-7,0.0000025204727,0.000017891425,0.00005468296,0.0000021530075,0.019422196,0.0001311441],"about_ca_topic_score_codex":4.2643433e-7,"about_ca_topic_score_gemma":7.93639e-7,"teacher_disagreement_score":0.6684748,"about_ca_system_score_codex":0.000013856854,"about_ca_system_score_gemma":0.0002883674,"threshold_uncertainty_score":0.83038235},"labels":[],"label_agreement":null},{"id":"W7010634690","doi":"","title":"Intravenous alteplase has different effects on the efficacy of aspiration and stent retriever thrombectomy: analysis of the COMPASS trial","year":2022,"lang":"en","type":"article","venue":"Scholarly Commons - Baptist Health South Florida (Baptist Health South Florida)","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Labrador Retriever; Compass; Clinical trial; Stent; Randomized controlled trial; Context (archaeology)","score_opus":0.04171302918083093,"score_gpt":0.2792463177314985,"score_spread":0.23753328855066758,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7010634690","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9768607,0.0051276633,0.00074921193,0.0072394847,0.0024356493,0.005965988,0.0014453497,0.00012629035,0.00004965979],"genre_scores_gemma":[0.99435127,0.00014033896,0.000076039745,0.0039458885,0.0006576221,0.0003287859,0.00034111948,0.00010982217,0.000049112627],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98895323,0.003630972,0.002258853,0.0011381926,0.002846104,0.0011726443],"domain_scores_gemma":[0.9929681,0.0013292986,0.001911354,0.0025508078,0.00032586287,0.0009145656],"candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0043118396,0.00079305825,0.0029834115,0.00068704446,0.0033391316,0.00023046439,0.0008393495,0.00022574862,0.00016744401],"category_scores_gemma":[0.0006709283,0.00055322953,0.0015141615,0.0027519637,0.0006777412,0.00022161618,0.0004618705,0.0025144166,0.0000096735785],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22983597,0.009239324,0.5112523,0.00945219,0.037411112,0.00026554783,0.096854396,0.006160546,0.00038892115,0.018118883,0.0071432707,0.07387756],"study_design_scores_gemma":[0.054030683,0.014659395,0.9161254,0.00074439467,0.0038996385,0.00005018733,0.004208218,0.0012122011,0.00022454034,0.00009563413,0.003958245,0.0007914255],"about_ca_topic_score_codex":0.0008359963,"about_ca_topic_score_gemma":0.00021001477,"teacher_disagreement_score":0.40487316,"about_ca_system_score_codex":0.00090167887,"about_ca_system_score_gemma":0.0019498704,"threshold_uncertainty_score":0.9997868},"labels":[],"label_agreement":null},{"id":"W7016022570","doi":"","title":"Variabilidad Farmacodinámica en la Respuesta a Clopidogrel: Mecanismos Implicados y Uso de Inhibidores Más Potentes del Receptor Plaquetario P2Y12 en Pacientes con Enfermedad Coronaria","year":2016,"lang":"es","type":"dissertation","venue":"Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medicines Company; Medicure; Eisai; Sanofi; Abbott Vascular; GlaxoSmithKline; AstraZeneca; Daiichi Sankyo Europe; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Clopidogrel; Exploratory analysis; Prasugrel; Coronary heart disease","score_opus":0.0038517471798449753,"score_gpt":0.2359714421472464,"score_spread":0.23211969496740142,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7016022570","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9460256,0.003267576,0.004535053,0.0012908261,0.0004377309,0.002079692,0.004421453,0.00072224677,0.03721982],"genre_scores_gemma":[0.972013,0.0069421697,0.001611885,0.00068351853,0.0004640783,0.000056491936,0.005338061,0.00049017055,0.012400618],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98810107,0.003565141,0.0009750966,0.0024298504,0.0019062972,0.0030225664],"domain_scores_gemma":[0.9896433,0.0051422194,0.00078993564,0.001448438,0.0006871992,0.002288956],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0022098983,0.002104708,0.0022527932,0.0016950212,0.0016413688,0.000763576,0.002327443,0.0022225212,0.0025226602],"category_scores_gemma":[0.00088224164,0.0023549742,0.0025474809,0.0011665672,0.0015215372,0.0020335875,0.00095352856,0.002559273,0.0003089181],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.051423863,0.0053326446,0.37973723,0.004475415,0.030578105,0.04272507,0.08386239,0.0010317133,0.16687268,0.09989099,0.02641969,0.10765021],"study_design_scores_gemma":[0.04151204,0.004297681,0.36522567,0.0061048786,0.015823154,0.00506292,0.17569031,0.0019034948,0.007375228,0.012827867,0.35417545,0.010001302],"about_ca_topic_score_codex":0.0009550427,"about_ca_topic_score_gemma":0.000052894844,"teacher_disagreement_score":0.32775578,"about_ca_system_score_codex":0.0062989667,"about_ca_system_score_gemma":0.0049363896,"threshold_uncertainty_score":0.99974185},"labels":[],"label_agreement":null},{"id":"W7029392664","doi":"","title":"International multicentre study assessing the effects of anti-thrombotic use in patients with upper GI bleeding","year":2016,"lang":"en","type":"article","venue":"University of Southern Denmark Research Portal (University of Southern Denmark)","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Joseph's Health Care","funders":"","keywords":"GI bleeding; MEDLINE; Upper gastrointestinal bleeding; Incidence (geometry); Population; Clinical trial; Gastrointestinal bleeding","score_opus":0.015890386565140323,"score_gpt":0.24734670243117401,"score_spread":0.23145631586603369,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7029392664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977654,0.000072312105,0.00015487072,0.00008029757,0.000042542975,0.0009312274,0.00017712895,0.000014972134,0.000761226],"genre_scores_gemma":[0.9980809,0.00009578522,0.00018122175,0.000004673486,0.000018805176,1.3064692e-7,0.000015051363,0.000026007381,0.0015774153],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99708617,0.00044370518,0.00021041502,0.00042274376,0.0014401342,0.000396859],"domain_scores_gemma":[0.9978672,0.00044266524,0.00027723526,0.0005099564,0.0007341246,0.00016881153],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008010182,0.00020766881,0.0005558044,0.0005064611,0.0002501104,0.000018833887,0.00059464946,0.00012925132,0.0014810306],"category_scores_gemma":[0.00018975127,0.00015968079,0.00031890848,0.00051970716,0.00098734,0.00034881418,0.0003094926,0.00031016572,0.00007621956],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016908568,0.0013047339,0.9818095,0.00015952179,0.0011827451,0.00044046677,0.008542281,0.000009675169,0.0012087646,0.000008245517,0.000060518683,0.0035827102],"study_design_scores_gemma":[0.011114651,0.0004532806,0.7864783,0.000996717,0.00041108782,0.000004617355,0.20007658,0.000040367755,0.00008453223,0.000007970674,0.00015029435,0.00018164393],"about_ca_topic_score_codex":0.0013215762,"about_ca_topic_score_gemma":0.0003558416,"teacher_disagreement_score":0.19533123,"about_ca_system_score_codex":0.000091082504,"about_ca_system_score_gemma":0.00017679163,"threshold_uncertainty_score":0.9994317},"labels":[],"label_agreement":null},{"id":"W7100872853","doi":"","title":"EDITORIAL Aspirin — Effective in Males Threatened with Stroke","year":2016,"lang":"en","type":"article","venue":"","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Stroke (engine); Aspirin; Threatened species; Cause of death; Platelet aggregation inhibitor","score_opus":0.00486051690034277,"score_gpt":0.22467555247549784,"score_spread":0.21981503557515505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7100872853","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902314,0.0003008902,0.0010433876,0.00018255302,0.0026990487,0.0004062543,0.000005977874,0.0000668721,0.0050635957],"genre_scores_gemma":[0.9873531,0.00010463631,0.00007787224,0.000066873414,0.011151232,0.000042852465,0.0000029809758,0.000014088253,0.001186385],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992996,0.00004002831,0.00007968917,0.0001784591,0.00024244605,0.00015980574],"domain_scores_gemma":[0.9996282,0.000055887624,0.000014863393,0.00017999097,0.000046393954,0.000074671174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011735385,0.00010066426,0.00022077684,0.000050514776,0.000017408112,0.0000055109226,0.00003497885,0.000066001805,0.00016223484],"category_scores_gemma":[0.000017732027,0.0000471363,0.00011490703,0.000066675675,0.00006088364,0.00006845068,0.000010474136,0.00005282643,0.00006236972],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006600444,0.0003379626,0.71642125,0.00005571106,0.001330083,0.00032622158,0.00006801501,0.0000040820078,0.019142125,0.00055122044,0.0051327082,0.2500302],"study_design_scores_gemma":[0.034621846,0.0025904696,0.8160481,0.0006777585,0.00043819187,0.00010866195,0.00017979009,0.0000040958776,0.066533364,0.000245547,0.07809643,0.00045576078],"about_ca_topic_score_codex":0.00002718507,"about_ca_topic_score_gemma":0.000029512998,"teacher_disagreement_score":0.24957444,"about_ca_system_score_codex":0.00003574276,"about_ca_system_score_gemma":0.00004497216,"threshold_uncertainty_score":0.19221625},"labels":[],"label_agreement":null},{"id":"W7117234095","doi":"10.1016/j.injury.2025.113011","title":"Polypharmacy, Outpatient Prescriptions and TBI Risk: a systematic review","year":2025,"lang":"en","type":"article","venue":"Injury","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Montreal Heart Institute; Centre Hospitalier de l’Université de Montréal; Université de Montréal; Hôpital du Sacré-Cœur de Montréal","funders":"","keywords":"Medical prescription; Risk assessment; MEDLINE; Risk factor; Population; Systematic review","score_opus":0.008069269976854662,"score_gpt":0.287354153213846,"score_spread":0.27928488323699135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117234095","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.25480363,0.73846143,0.00045673715,0.0007698193,0.00023476515,0.002397383,0.00005245266,0.00012316763,0.0027006287],"genre_scores_gemma":[0.912174,0.08178191,0.00006079522,0.0038892026,0.00004177456,0.00017420684,0.00001321041,0.0000109756975,0.0018539391],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9992469,0.00012801343,0.00023561732,0.00014555918,0.00013878885,0.00010510263],"domain_scores_gemma":[0.9994922,0.000028946812,0.00005515389,0.000302148,0.000049742903,0.000071780305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023806277,0.00009375191,0.00041622683,0.00005687,0.00007372886,0.000011516355,0.000045080156,0.000030939445,0.00005146997],"category_scores_gemma":[0.000172217,0.000070049115,0.00020710341,0.00013367734,0.000037897655,0.000038228944,0.000028415512,0.00010599881,0.000029442448],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054391834,0.0006423816,0.021904306,0.8832546,0.0051048645,0.00009887739,0.00034399633,8.4029966e-7,0.0006863554,0.001315978,0.050574332,0.035529565],"study_design_scores_gemma":[0.007145423,0.0008849243,0.040941596,0.8226091,0.043703083,0.00032566115,0.00061835157,0.00028428796,0.0032695055,0.00083615584,0.078410454,0.00097146275],"about_ca_topic_score_codex":0.000016477188,"about_ca_topic_score_gemma":5.087094e-7,"teacher_disagreement_score":0.6573703,"about_ca_system_score_codex":0.000020157058,"about_ca_system_score_gemma":0.0000481885,"threshold_uncertainty_score":0.285652},"labels":[],"label_agreement":null},{"id":"W7117257433","doi":"10.1016/j.cjca.2025.11.051","title":"Long-term Clopidogrel vs Aspirin Monotherapy in Coronary Artery Disease Patients With High Ischemic Risk: HOST-EXAM Extended Study Post hoc Analysis","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"People-Centered Research Foundation","keywords":"Post-hoc analysis; Clopidogrel; Aspirin; Coronary artery disease; Post hoc; Disease","score_opus":0.005083380571439039,"score_gpt":0.22568856230036993,"score_spread":0.2206051817289309,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117257433","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99295396,0.0052559692,0.00053485413,0.00021716117,0.00025355187,0.00056897994,0.00010013339,0.000009381198,0.000106011394],"genre_scores_gemma":[0.99859416,0.00044003155,0.000025583702,0.00052580587,0.00021151506,0.000016708796,0.00009775416,0.000025708367,0.00006270441],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980236,0.0004312663,0.0005269114,0.00033612316,0.00025655128,0.00042554762],"domain_scores_gemma":[0.99809456,0.00006765307,0.00021625313,0.00051655294,0.0003755967,0.0007293589],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003677281,0.0002698894,0.0011939403,0.0011593327,0.00010172357,0.000024015759,0.00022591435,0.00012455031,0.000052585314],"category_scores_gemma":[0.00005923569,0.00021700248,0.00073746074,0.00068667595,0.00019178976,0.00010968173,0.000014157141,0.0004238592,0.0000039055953],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069820373,0.00009622561,0.9628398,0.000023044431,0.01212458,0.004166252,0.00010472125,0.0006367289,0.000006922862,0.0000038365815,0.00019867736,0.012817187],"study_design_scores_gemma":[0.010225914,0.0018287271,0.9815759,0.00010309361,0.0049914406,0.000099553195,0.00015897647,0.0000036685844,0.0000046141413,0.000010941458,0.0008005143,0.00019667103],"about_ca_topic_score_codex":0.00044551588,"about_ca_topic_score_gemma":0.0026523063,"teacher_disagreement_score":0.0187361,"about_ca_system_score_codex":0.00024674964,"about_ca_system_score_gemma":0.0014414964,"threshold_uncertainty_score":0.88491046},"labels":[],"label_agreement":null},{"id":"W7117712788","doi":"10.1016/j.cjca.2025.12.049","title":"Clopidogrel Monotherapy Is Enough for Most Stable Patients With Coronary Artery Disease After Percutaneous Coronary Intervention","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University; Université de Montréal; Montreal Heart Institute","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research","keywords":"Percutaneous coronary intervention; Aspirin; Clopidogrel; Coronary artery disease; Myocardial infarction; P2Y12; Antithrombotic; Conventional PCI","score_opus":0.005814043549808199,"score_gpt":0.21827365276276547,"score_spread":0.21245960921295728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117712788","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9796604,0.01153467,0.0064244615,0.0007333998,0.000535563,0.0005532638,0.0002844756,0.000008610052,0.0002651873],"genre_scores_gemma":[0.99672633,0.00033174956,0.00014621037,0.0019888477,0.0002908004,0.00002440675,0.00008582355,0.00002720607,0.0003786244],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998907,0.00009955049,0.00033007402,0.00019834703,0.00013641166,0.00032857887],"domain_scores_gemma":[0.9986951,0.000045765584,0.00010041685,0.00025307978,0.00039913083,0.00050650624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014615961,0.00017884218,0.0005535222,0.00023877258,0.000099728786,0.000019259374,0.00011062243,0.000106676795,0.00009972308],"category_scores_gemma":[0.000031743548,0.0001455793,0.00059947313,0.000111636444,0.0001582427,0.00009985242,0.0000068201953,0.00016585882,0.0000033832046],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01480025,0.000046105393,0.90799916,0.00015125444,0.0043202317,0.0035815723,0.00014564059,0.0003073591,0.000015731575,0.00005082689,0.011627819,0.05695405],"study_design_scores_gemma":[0.0059678727,0.0013255696,0.78428954,0.00031282872,0.001014646,0.0012910932,0.00013968426,0.000014845234,0.00001194035,0.00024738247,0.20520559,0.00017900343],"about_ca_topic_score_codex":0.000058020047,"about_ca_topic_score_gemma":0.00009605921,"teacher_disagreement_score":0.19357777,"about_ca_system_score_codex":0.00018759622,"about_ca_system_score_gemma":0.0011224317,"threshold_uncertainty_score":0.59365517},"labels":[],"label_agreement":null},{"id":"W7120651279","doi":"","title":"The ARAMIS Trial (Allopurinol in Patients with Refractory Angina to Improve Ischemic Symptoms)","year":2025,"lang":"pt","type":"dissertation","venue":"Digital Library of Theses and Dissertations  (Universidade de São Paulo)","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Angina; Refractory (planetary science); Clinical trial; Coronary heart disease; Randomized controlled trial","score_opus":0.00382700409441605,"score_gpt":0.20404503430408344,"score_spread":0.20021803020966739,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7120651279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98760414,0.0018317596,0.000025376932,0.00014722686,0.00018183069,0.0017429369,0.0008681585,0.000052836138,0.007545745],"genre_scores_gemma":[0.9835595,0.00044078197,0.00003158459,0.0000757829,0.00004406543,0.00005646225,0.0034770877,0.00006290084,0.012251825],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.997946,0.00008390558,0.00047521628,0.000571329,0.00044343364,0.00048010258],"domain_scores_gemma":[0.9983371,0.00039511573,0.00029201814,0.0005503388,0.00013320662,0.00029222216],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00007586387,0.00049615494,0.00069940963,0.0005384727,0.00031730704,0.00028034835,0.00040922733,0.00028394858,0.000052109266],"category_scores_gemma":[0.00012756139,0.0003930678,0.00043766949,0.000822762,0.00010728952,0.0012619048,0.0000761595,0.00035056105,0.000010109765],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.39198524,0.0049458737,0.27073964,0.002566739,0.007959553,0.00024546706,0.016720217,0.00016567162,0.00034314615,0.0048574577,0.0010306754,0.2984403],"study_design_scores_gemma":[0.056551628,0.005005489,0.8151295,0.0036357525,0.0018897116,0.000004813345,0.1091254,0.00014252358,0.0012106856,0.00024187582,0.0056553176,0.001407305],"about_ca_topic_score_codex":0.000032375643,"about_ca_topic_score_gemma":0.000038351154,"teacher_disagreement_score":0.54438984,"about_ca_system_score_codex":0.000055235727,"about_ca_system_score_gemma":0.00052649964,"threshold_uncertainty_score":0.9998521},"labels":[],"label_agreement":null},{"id":"W7161985493","doi":"10.82308/10292","title":"Investigating the effectiveness and safety of dual-antiplatelet therapies in acute coronary syndrome patients","year":2024,"lang":"en","type":"dissertation","venue":"","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ticagrelor; Acute coronary syndrome; Clopidogrel; Prasugrel; Coronary heart disease","score_opus":0.0069516870369970875,"score_gpt":0.2502827267018612,"score_spread":0.2433310396648641,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7161985493","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862596,0.0114902,0.0000021452613,0.000031842505,0.00025949333,0.0010588387,0.000041826912,0.0000416146,0.0008144625],"genre_scores_gemma":[0.9956507,0.002799269,0.000026173146,0.00007283322,0.000017010778,0.00005736494,0.0008091286,0.00005474086,0.000512784],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984764,0.0002389585,0.00038315327,0.00034719266,0.00037296317,0.00018136768],"domain_scores_gemma":[0.99923,0.00024659603,0.00010460505,0.0002678439,0.00008883137,0.00006206938],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048371978,0.00029346804,0.00073527655,0.00014907192,0.00006556403,0.000020603116,0.00007386297,0.00022447949,0.000053211865],"category_scores_gemma":[0.000048349044,0.00018269925,0.00028975803,0.00025820822,0.00012550085,0.00006830336,0.00003068426,0.00035888652,0.000007716742],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011234339,0.0007619618,0.8129597,0.015063124,0.026341325,0.0023172388,0.010164072,0.00004069384,0.0044045565,0.0018728767,0.00028147048,0.11455867],"study_design_scores_gemma":[0.0021711483,0.0002776397,0.9910823,0.002509718,0.0009406267,0.00018119098,0.0010962319,0.000018106597,0.00095993356,0.0004457668,0.00011926858,0.00019805178],"about_ca_topic_score_codex":0.000046534497,"about_ca_topic_score_gemma":0.000022878976,"teacher_disagreement_score":0.17812264,"about_ca_system_score_codex":0.000032227137,"about_ca_system_score_gemma":0.00011068981,"threshold_uncertainty_score":0.74502593},"labels":[],"label_agreement":null},{"id":"W7163908666","doi":"10.1163/23523085-bja10132","title":"Ten Years of ADVA Journal – 10th Anniversary Issue","year":2024,"lang":"","type":"article","venue":"Asian Diasporic Visual Cultures and the Americas","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University","funders":"","keywords":"","score_opus":0.0060873725823373534,"score_gpt":0.2892353100527059,"score_spread":0.28314793747036854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7163908666","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19814007,0.79016215,0.00038692734,0.0025799433,0.0015911573,0.00066329783,0.000051741525,0.00007439603,0.006350345],"genre_scores_gemma":[0.87158614,0.123941146,0.00003925444,0.0005087634,0.0018936094,0.000005385759,0.000014949243,0.000047986763,0.0019627532],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975674,0.00033809172,0.00053436647,0.00043727137,0.00065739214,0.00046546024],"domain_scores_gemma":[0.9988003,0.0001527086,0.0002234701,0.00034397605,0.000115913965,0.00036368298],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062818924,0.0003762607,0.00097061065,0.00016308817,0.00022281827,0.00013968762,0.00026164856,0.00015985819,0.00062404765],"category_scores_gemma":[0.00009659931,0.00023109636,0.0011168903,0.0007629197,0.0012666831,0.00023924562,0.00010913452,0.0006689304,0.00009577727],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022854456,0.00025133285,0.00029720718,0.0003458206,0.0057728942,0.0025854218,0.016036265,0.000018582794,0.00009785075,0.0017007341,0.010942372,0.9596661],"study_design_scores_gemma":[0.012365865,0.0042182556,0.071857855,0.0025129279,0.011542639,0.0066438806,0.13787194,0.00086327957,0.00032816263,0.0017239196,0.74880713,0.001264149],"about_ca_topic_score_codex":0.00010746583,"about_ca_topic_score_gemma":6.6897246e-7,"teacher_disagreement_score":0.9584019,"about_ca_system_score_codex":0.000041160885,"about_ca_system_score_gemma":0.00019893968,"threshold_uncertainty_score":0.9423836},"labels":[],"label_agreement":null},{"id":"W750414040","doi":"10.18705/1607-419x-2011-17-5-474-477","title":"Coagulation system reaction to blood loss volume as a result of coronary artery bypass surgery in aspirin-resistant patients with coronary heart disease and arterial hypertension","year":2011,"lang":"en","type":"article","venue":"Arterial’naya Gipertenziya (Arterial Hypertension)","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Aspirin; Cardiology; Angina; Internal medicine; Coronary artery disease; Extracorporeal circulation; Coagulation; Artery; Surgery; Anesthesia; Myocardial infarction","score_opus":0.018545300949241325,"score_gpt":0.19979430055144737,"score_spread":0.18124899960220603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W750414040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99517834,0.00021820782,0.000032022344,0.000294747,0.0018781531,0.0018913471,0.0002144685,0.00022439886,0.00006830099],"genre_scores_gemma":[0.9966886,0.00007242437,0.0003898052,0.0010961838,0.0006322499,0.00017038919,0.0007368861,0.0001605829,0.00005289977],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99465823,0.00051443244,0.0014985071,0.0013721335,0.0010869303,0.0008697494],"domain_scores_gemma":[0.9965806,0.00014869162,0.0004040785,0.0012462873,0.0006938629,0.00092648703],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00053637486,0.0008319322,0.0020379163,0.00056148175,0.0002810988,0.00007358414,0.00018923673,0.00036562615,0.0001304276],"category_scores_gemma":[0.00015958353,0.0007023929,0.0004632664,0.00048552232,0.00036801197,0.0007017298,0.00013259398,0.0002440096,0.00009796503],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19113718,0.005233243,0.15676944,0.000682896,0.0015802294,0.009989069,0.00065133115,0.000007237863,0.6276625,0.00009300563,0.00120088,0.0049929773],"study_design_scores_gemma":[0.015494064,0.0023504072,0.9724111,0.0015640364,0.0016548813,0.0029188879,0.00031720725,0.00010446642,0.0014093919,0.000033533808,0.000862811,0.000879225],"about_ca_topic_score_codex":0.0004282472,"about_ca_topic_score_gemma":0.000045469158,"teacher_disagreement_score":0.81564164,"about_ca_system_score_codex":0.00013153364,"about_ca_system_score_gemma":0.00035657873,"threshold_uncertainty_score":0.9995427},"labels":[],"label_agreement":null},{"id":"W91109828","doi":"10.1161/circ.126.suppl_21.a9964","title":"Abstract 9964: Vorapaxar, a Platelet Thrombin-Receptor Antagonist, in Medically Managed Patients with Non-ST-Segment Elevation Acute Coronary Syndrome: Results from the TRACER Trial","year":2012,"lang":"en","type":"article","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Acute coronary syndrome; Internal medicine; Cardiology; Platelet; Platelet activation; Antagonist; Thrombin; Platelet aggregation inhibitor; Receptor; Anesthesia; Myocardial infarction","score_opus":0.012618251725683354,"score_gpt":0.2373532334513201,"score_spread":0.22473498172563675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W91109828","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99553543,0.00031129536,0.0013301179,0.0003060749,0.00038088526,0.0017874003,0.00017147855,0.000053405525,0.00012390775],"genre_scores_gemma":[0.9949494,0.00012497444,0.00019493874,0.0002745056,0.00025991956,0.00006902625,0.004077196,0.000037838156,0.000012214728],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978239,0.000144983,0.00051632774,0.0003565964,0.00082253834,0.00033566012],"domain_scores_gemma":[0.9989122,0.00015805865,0.00023816185,0.00045431202,0.00008125231,0.00015597363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007053991,0.00023824663,0.00039508712,0.000075458905,0.00014348276,0.0000336531,0.000112720125,0.00017682136,0.00023743595],"category_scores_gemma":[0.00008045401,0.00016473226,0.00018889632,0.0002472169,0.00009017844,0.000359307,0.00001976293,0.00027020823,0.000045462293],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.111250356,0.0040515237,0.79655486,0.000108903885,0.0037504132,0.00016504453,0.0028312767,0.0017187252,0.0019100273,0.00005106317,0.0016899565,0.07591786],"study_design_scores_gemma":[0.061104387,0.0002183494,0.9368976,0.00017811217,0.0003467078,0.000017228458,0.0001050207,0.00031662965,0.00007480425,0.000019220573,0.0005224331,0.00019950177],"about_ca_topic_score_codex":0.0000768232,"about_ca_topic_score_gemma":0.0000071773147,"teacher_disagreement_score":0.14034276,"about_ca_system_score_codex":0.00015185059,"about_ca_system_score_gemma":0.00008243773,"threshold_uncertainty_score":0.67175865},"labels":[],"label_agreement":null},{"id":"W941392450","doi":"10.1017/cbo9780511545283.069","title":"Design of trials to evaluate antiplatelet agents","year":2002,"lang":"en","type":"book-chapter","venue":"Cambridge University Press eBooks","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"","keywords":"Computer science; Content (measure theory); Information retrieval; Mathematics","score_opus":0.10277699464304899,"score_gpt":0.27210134375101525,"score_spread":0.16932434910796626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W941392450","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001504351,0.0012745418,0.005691648,0.00001839223,0.00022085402,0.0023064143,0.00034233672,0.000117325486,0.98852414],"genre_scores_gemma":[0.0050382605,0.0016239801,0.00032381373,0.00015884555,0.00016777946,0.000001693598,0.0000682027,0.0000801435,0.99253726],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977482,0.0002631867,0.00047702173,0.00054922584,0.00066343765,0.00029893144],"domain_scores_gemma":[0.99799645,0.00014920393,0.00037284105,0.00081763923,0.00030677638,0.000357117],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00075805694,0.000453392,0.001737713,0.00032755165,0.00009258566,0.000015332922,0.00030196292,0.00041409212,0.00011176195],"category_scores_gemma":[0.00006754299,0.00046255888,0.0011285504,0.000017917213,0.0001588522,0.00004377945,0.00015285694,0.00029369607,0.000063726744],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02729564,0.0004781569,0.000038482765,0.0025358177,0.03715602,0.01754489,0.0005431448,0.00084033585,0.004846661,0.22645685,0.58812594,0.094138056],"study_design_scores_gemma":[0.0056536603,0.00048324474,0.00005362158,0.00094018306,0.00513443,0.000108261724,0.000015275471,0.00013811258,0.0032909033,0.0000047575763,0.9835968,0.00058076147],"about_ca_topic_score_codex":0.000022229222,"about_ca_topic_score_gemma":4.6708454e-8,"teacher_disagreement_score":0.39547083,"about_ca_system_score_codex":0.00012000188,"about_ca_system_score_gemma":0.00014090532,"threshold_uncertainty_score":0.9997826},"labels":[],"label_agreement":null},{"id":"W979863887","doi":"10.1161/circ.116.suppl_16.ii_517-d","title":"Abstract 2363: Effect Of Aspirin And Clopidogrel Resistance On Myonecrosis Following Percutaneous Coronary Intervention","year":2007,"lang":"en","type":"article","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"Medicine; Clopidogrel; Aspirin; Conventional PCI; Percutaneous coronary intervention; Internal medicine; Cardiology; Eptifibatide; Myocardial infarction","score_opus":0.008613130598908263,"score_gpt":0.26840771867131885,"score_spread":0.25979458807241057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W979863887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99453014,0.0032001259,0.00073836074,0.000017578814,0.00011207218,0.00029904072,0.000002562325,0.000038424885,0.0010616971],"genre_scores_gemma":[0.9996953,0.00005795622,0.000056046527,0.000034324024,0.000051472365,0.0000029633227,0.000047759077,0.000015714504,0.000038485716],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991925,0.000039671442,0.0002234669,0.00018444296,0.00024006606,0.0001198517],"domain_scores_gemma":[0.999555,0.000107436514,0.00007561889,0.00017258087,0.000029020732,0.000060323684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005150285,0.00010546145,0.00023871176,0.00008094582,0.000056190678,0.000008152634,0.000024937573,0.00008225654,0.000029938774],"category_scores_gemma":[0.000052658183,0.00009635093,0.00034697747,0.000088892055,0.000036028905,0.00006359684,0.0000068844106,0.00007905658,0.000009103666],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042223535,0.00020251134,0.6270155,0.0010674199,0.00074302225,0.0006356569,0.0002025755,0.000109660585,0.08697063,0.00012694052,0.000037634276,0.2786661],"study_design_scores_gemma":[0.0015482439,0.00022175266,0.99107164,0.00059435423,0.00023630465,0.00009627468,0.00003744372,0.000030155483,0.005783866,0.000043738004,0.00024561808,0.00009061219],"about_ca_topic_score_codex":0.000009045345,"about_ca_topic_score_gemma":0.0000055500846,"teacher_disagreement_score":0.36405614,"about_ca_system_score_codex":0.000048689268,"about_ca_system_score_gemma":0.000008483183,"threshold_uncertainty_score":0.39290768},"labels":[],"label_agreement":null},{"id":"W999976674","doi":"10.1182/blood.v124.21.1529.1529","title":"Epidural Analgesia Use in Women with Von Willebrand Disease","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Von Willebrand disease; Population; Pregnancy; Confidence interval; Von Willebrand factor; Pediatrics; Obstetrics; Disease; Internal medicine; Platelet","score_opus":0.006646339297653731,"score_gpt":0.20238396479751272,"score_spread":0.19573762549985899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W999976674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983503,0.000881495,0.00009805659,0.00014161428,0.000015469004,0.00018376729,0.000004554285,0.000045190383,0.00027950155],"genre_scores_gemma":[0.99888307,0.00012219606,0.00008516234,0.00059072225,0.000103912935,0.000028908464,0.000013340976,0.000019857329,0.00015281697],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991797,0.00006700617,0.000110384026,0.00020243687,0.0002016076,0.00023881809],"domain_scores_gemma":[0.9993538,0.000028108043,0.000023534016,0.00030381285,0.000023452196,0.00026726697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014000593,0.00011675538,0.00025545966,0.0000669117,0.000031783402,0.000018820425,0.000045844547,0.00003286708,0.00007143021],"category_scores_gemma":[0.00004782019,0.00008470702,0.000087245615,0.0001406428,0.000052355994,0.00009904235,0.000010547907,0.00007858243,0.00001577448],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031302369,0.00066733203,0.98598266,0.00009158036,0.00048060762,0.00057268864,0.000155208,0.000025982616,0.00024411033,0.00011170665,0.00009119777,0.008446692],"study_design_scores_gemma":[0.009334198,0.00026298832,0.9852807,0.000124562,0.00029713838,0.000046317033,0.000052204312,0.000032835876,0.00024793672,0.00006818271,0.0041094595,0.00014349753],"about_ca_topic_score_codex":0.000010519672,"about_ca_topic_score_gemma":0.000005652806,"teacher_disagreement_score":0.008303194,"about_ca_system_score_codex":0.000014303659,"about_ca_system_score_gemma":0.000044747874,"threshold_uncertainty_score":0.3454252},"labels":[],"label_agreement":null}]}